MHTPøO EP°A™IøN
E§§HNøN EPEYNHTøN & ™Y°°PAºEøN
ME °Nø™TIKO ANTIKEIMENO TON ™AKXAPø¢H ¢IABHTH
DIABETES LITERATURE
INDEX
FOR GREEK INVESTIGATORS AND AUTHORS
Third Edition
DIABETES LITERATURE
INDEX
FOR GREEK INVESTIGATORS AND AUTHORS
∂diting by: N.Ch. PAPAZOGLOU
NORTHERN GREECE DIABETES ASSOCIATION
MHTPøO EP°A™IøN
E§§HNøN EPEYNHTøN & ™Y°°PAºEøN
ME °Nø™TIKO ANTIKEIMENO
TON ™AKXAPø¢H ¢IABHTH
EÈ̤ÏÂÈ·: N.Ã. ¶∞¶∞∑O°§OÀ
¢IABHTO§O°IKH ETAIPEIA BOPEI∞™ E§§A¢A™
HELLENIC DIABETOLOGICAL CHRONICLE
Quarterly Official Journal of Northern Greece Diabetes Association
Ownership
Northern Greece Diabetes Association
http://www.ngda.gr
Printing by
UNIVERSITY STUDIO PRESS
32 Armenopoulou str. Tel. 2310 209 637 & 2310 209 837, 546 35 Thessaloniki – Greece
Editor - in - Chief
Dimitrios T. Karamitsos
Editorial Board
Tr. Didagelos, K. Kazakos, Ch. Manes,
E. Pagkalos, Ch. Sabanis, D. Skoutas
Special Editing Advisers
Athyros V, Alevizos M, Anastasiadis K, Argiropoulos A, Arsos G, Bakatselos S, Balogiannis S,
Charsoulis F, Chatzimiltiadis S, Chatzitolios A, Chatseras D, Christakis I, Daniilidis M, Deligiannis A,
Dimitriadis A, Dimitriadis A.Ch., Dimitriadis G, Dombros N, Efthimiou H, Fassas A, Gerasimidis Th,
Georgiadis N, Giouleme O, Giovos I, Kanakoudi F, Karamanos B, Karamitsos Th, Karamouzis M,
Karvounis Ch, Katzos G, Katsilambros N, Kefalogianis N, Kiskinis D, Klonizakis I, Krassas G, Kotsis A,
Lazaridis A, Mamopoulos A, Mitrakou A, Mouslech T, Mygdalis H, Pazaitou-Panagiotou K, Papagianni A,
Papadopoulos K, Papadopoulou-Kechagiopoulou M, Papazoglou N, Papameletiou B, Papanikolaou V,
Patakas D, Psirogiannis N, Raptopoulou-Gigi M, Raidis Ch, Rousso I, Savopoulos Ch, Settas L,
Tzafettas I, Triantafillou G, Tsatalas K, Tsatoulis A, Vazeou A, Vasilikos V, Veves A, Vlaikidis N,
Vlachogiannis E, Voliotis K, Zampoulis Ch.
Executive Board of
Northern Greece Diabetes Association
President
Vice President
Gen. Secretary
Treasurer
Members
:
:
:
:
:
Tr. Didagelos
E. Pagkalos
K. Kazakos
D. Skoutas
D. Karamitsos, Ch. Manes, Ch. Sabanis
Every inquiry should be forwarded to Editing Manager
Dimitrios Δ. Karamitsos
D.A.N.G. Office, Tsimiski 109, 546 22 – Thessaloniki, Tel. & Fax. 2310 250 034
E-mail: [email protected]
No responsibility is assumed by the Editorial board for any injury or damages from any use or operation of any methods, products,
instructions or ideas contained in the material herein. The responsibility is assumed by the authors or the companies advertising their
products.
E§§HNIKA ¢IABHTO§O°IKA XPONIKA
TÚÈÌËÓÈ·›· ¤Î‰ÔÛË Ù˘ ¢È·‚ËÙÔÏÔÁÈ΋˜ EÙ·ÈÚ›·˜ BfiÚÂÈ·˜ EÏÏ¿‰·˜
I‰ÈÔÎÙ‹Ù˘
¢È·‚ËÙÔÏÔÁÈ΋ EÙ·ÈÚ›· BfiÚÂÈ·˜ EÏÏ¿‰·˜
¢È·‰ÈÎÙ˘·Îfi˜ ÙfiÔ˜ (Website) http://www.ngda.gr
EÎÙ‡ˆÛË
UNIVERSITY STUDIO PRESS
AÚÌÂÓÔÔ‡ÏÔ˘ 32 – ÙËÏ. 2310 209 637 & 2310 209 837, 546 35 £ÂÛÛ·ÏÔÓ›ÎË
E¶ITPO¶H ™YNTA•H™
¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘: ¢ËÌ‹ÙÚÈÔ˜ £. ∫·Ú·Ì‹ÙÛÔ˜
™˘ÓÙ·ÎÙÈ΋ EÈÙÚÔ‹
ΔÚ. ¢È‰¿ÁÁÂÏÔ˜, K. K·˙¿ÎÔ˜, Ã. ª·Ó¤˜,
∂. ¶¿ÁηÏÔ˜, Ã. ™·Ì¿Ó˘, ¢. ™ÎÔ‡Ù·˜
EȉÈÎÔ› ™‡Ì‚Ô˘ÏÔÈ ™˘Óٿ͈˜
Õı˘ÚÔ˜ μ, ∞Ï‚›˙Ô˜ ª, ∞Ó·ÛÙ·ÛÈ¿‰Ë˜ ∫, ∞ÚÁ˘ÚfiÔ˘ÏÔ˜ ∞, ÕÚÛÔ˜ °, μ·˙·›Ô˘ ∞,
μ·ÛÈÏÈÎfi˜ μ, μ¤‚Â˜ ∞, μÏ·˚Λ‰Ë˜ ¡, μÏ·¯ÔÁÈ¿ÓÓ˘ ∂, μÔÏÈÒÙ˘ ∫, °ÂÚ·ÛÈÌ›‰Ë˜ £, °ÂˆÚÁÈ¿‰Ë˜ ¡,
°ÈÔ˘ÏÂ̤ Ÿ, °ÈÒ‚Ô˜ π, ¢·ÓÈËÏ›‰Ë˜ ª, ¢ÂÏËÁÈ¿ÓÓ˘ ∞, ¢ËÌËÙÚÈ¿‰Ë˜ ∞, ¢ËÌËÙÚÈ¿‰Ë˜ ∞.Ã, ¢ËÌËÙÚÈ¿‰Ë˜ °,
∂˘ı˘Ì›Ô˘ ∏, ∑·ÌÔ‡Ï˘ Ã, ∫·Ó·ÎÔ‡‰Ë º, ∫·Ú·Ì¿ÓÔ˜ μ, ∫·Ú·Ì‹ÙÛÔ˜ £, ∫·Ú·ÌÔ‡˙˘ ª, ∫·Ú‚Ô‡Ó˘ Ã,
∫·Ù˙fi˜ °, ∫·ÙÛÈÏ¿ÌÚÔ˜ ¡, ∫ÂÊ·ÏÔÁÈ¿ÓÓ˘ ¡, ∫ÈÛΛÓ˘ ¢, ∫ψÓÈ˙¿Î˘ π, ∫Ú·ÛÛ¿˜ °, ∫ÒÙÛ˘ ∞,
§·˙·Ú›‰Ë˜ ∞, ª·ÌfiÔ˘ÏÔ˜ ∞, ªËÙÚ¿ÎÔ˘ ∞, ªÔ‡Ûϯ Δ, ª·Î·ÙÛ¤ÏÔ˜ ™, ª·ÏÔÁÈ¿ÓÓ˘ ™,
ª˘Á‰¿Ï˘ ∏Ï. ¡ÙfiÚÔ˜ ¡, ¶·˙·˝ÙÔ˘-¶·Ó·ÁÈÒÙÔ˘ ∫, ¶··ÁÈ¿ÓÓË ∞, ¶··‰fiÔ˘ÏÔ˜ ∫,
¶··‰ÔÔ‡ÏÔ˘-∫¯·ÁÈÔÔ‡ÏÔ˘ ª, ¶·¿˙ÔÁÏÔ˘ ¡, ¶··ÌÂÏÂÙ›Ô˘ μ, ¶··ÓÈÎÔÏ¿Ô˘ μ, ¶·Ù¿Î·˜ ¢,
ƒ·ÙÔÔ‡ÏÔ˘-°ÈÁ‹ ª, ƒ·˝‰Ë˜ Ã, ƒÔ‡ÛÛÔ π, ™·‚‚fiÔ˘ÏÔ˜ Ã, ™¤ÙÙ·˜ §, Δ˙·Ê¤ÙÙ·˜ π, ΔÚÈ·ÓٷʇÏÏÔ˘ °,
ΔÛ·Ù·Ï¿˜ ∫, ΔÛ·ÙÛÔ‡Ï˘ ∞, º¿ÛÛ·˜ ∞, ÷ÚÛÔ‡Ï˘ º, ÷Ù˙ËÌÈÏÙÈ¿‰Ë˜ ™, ÷Ù˙ËÙfiÏÈÔ˜ ∞, ÷ÙÛ¤Ú·˜ ¢,
ÃÚËÛÙ¿Î˘ π, æ˘ÚÔÁÈ¿ÓÓ˘ ¡.
¢ÈÔÈÎËÙÈÎfi ™˘Ì‚Ô‡ÏÈÔ
¢È·‚ËÙÔÏÔÁÈ΋˜ EÙ·ÈÚ›·˜ BfiÚÂÈ·˜ EÏÏ¿‰·˜
¶Úfi‰ÚÔ˜
AÓÙÈÚfi‰ÚÔ˜
°Ú·ÌÌ·Ù¤·˜
T·Ì›·˜
M¤ÏË
:
:
:
:
:
TÚ. ¢È‰¿ÁÁÂÏÔ˜
∂. ¶¿ÁηÏÔ˜
K. K·˙¿ÎÔ˜
¢. ™ÎÔ‡Ù·˜
¢. K·Ú·Ì‹ÙÛÔ˜, Ã. ª·Ó¤˜, Ã. ™·Ì¿Ó˘
Y‡ı˘ÓÔ˜ T˘ÔÁÚ·Ê›Ԣ
§.A. Mȯ¿Ï˘, AÚÌÂÓÔÔ‡ÏÔ˘ 32, 546 35 – £ÂÛÛ·ÏÔÓ›ÎË, TËÏ. 2310 209 637
EÁÁڷʤ˜, EÌ‚¿ÛÌ·Ù·, AÏÏËÏÔÁÚ·Ê›·,
EÚÁ·Û›Â˜ ÁÈ· ‰ËÌÔÛ›Â˘ÛË ÛÙÔÓ ‰È¢ı˘ÓÙ‹ Û‡ÓÙ·Í˘
¢ËÌ‹ÙÚÈÔ˜ £. ∫·Ú·Ì‹ÙÛÔ˜
°Ú·Ê›· ¢.E.B.E, TÛÈÌÈÛ΋ 109, 546 22 – £ÂÛÛ·ÏÔÓ›ÎË, TËÏ. & Fax. 2310 250 034,
E-mail: [email protected]
EÙ‹ÛÈ· Û˘Ó‰ÚÔÌ‹: 10 €
∏ Û˘ÓÙ·ÎÙÈ΋ ÂÈÙÚÔ‹ ‰ÂÓ Ê¤ÚÂÈ Â˘ı‡ÓË ÁÈ· ÔÔÈ·‰‹ÔÙ ‚Ï¿‚Ë ËıÈ΋ ‹ ۈ̷ÙÈ΋ ÚÔÎÏËı› ·fi ÙË ¯Ú‹ÛË ÌÂıfi‰ˆÓ, ÚÔ˚fiÓÙˆÓ ‹
ÂÊ·ÚÌÔÁ‹ ȉÂÒÓ Ô˘ ÂÚȤ¯ÔÓÙ·È ÛÙȘ ‰ËÌÔÛȇÛÂȘ. ∏ ¤ÁÎÚÈÛË ‰ËÌÔÛ›Â˘Û˘ ÔÔÈ·Û‰‹ÔÙ ÌÂϤÙ˘ ‹ ‰È·ÊËÌÈÛÙÈÎÔ‡ ˘ÏÈÎÔ‡ ‰ÂÓ ÛËÌ·›ÓÂÈ ·Ô‰Ô¯‹ ÙˆÓ ·fi„ÂˆÓ ÙÔ˘ Û˘ÁÁڷʤ· ‹ Ù˘ ÂÙ·ÈÚ›·˜ Ô˘ ‰È·ÊËÌ›˙ÂÈ ÙÔ ÚÔ˚fiÓ. ∏ ¢ı‡ÓË ·ÊÔÚ¿ ÙÔ˘˜ Û˘ÁÁÚ·Ê›˜ ‹ ÙȘ ‰È·ÊËÌÈ˙fiÌÂÓ˜ ÂÙ·ÈÚ›˜.
¶ÂÚȯfiÌÂÓ·
∂ÈÛ·ÁˆÁÈÎfi ™ËÌ›ˆÌ· ¢È¢ı˘ÓÙ‹ ™‡ÓÙ·Í˘
¢.£. ∫∞ƒ∞ª∏Δ™O™
9
¶ÚfiÏÔÁÔ˜ ∂ÈÌÂÏËÙ‹ ŒÎ‰ÔÛ˘
¡.X. ¶∞¶∞∑O°§OY
11
∫·Ù¿ÏÔÁÔ˜ ™˘ÁÁڷʤˆÓ
13
£ÂÌ·ÙÈ΋ ∫·Ù·ÁÚ·Ê‹ – ¶ÚfiÛıÂÙÔÈ ŸÚÔÈ
53
¶Ï‹Ú˘ μÈ‚ÏÈÔÁÚ·ÊÈ΋ ∫·Ù·ÁÚ·Ê‹
77
∂ÈÛ·ÁˆÁÈÎfi ™ËÌ›ˆÌ· ¢È¢ı˘ÓÙ‹ ™‡ÓÙ·Í˘
£ÂÛÛ·ÏÔÓ›ÎË 1-7-2009
∞Á·ËÙÔ› Û˘Ó¿‰ÂÏÊÔÈ
∞ÔÙÂÏ› ÎÔÈÓ‹ ‰È·›ÛÙˆÛË fiÙÈ Ë Û˘ÁΤÓÙÚˆÛË ÂÈÛÙËÌÔÓÈÎÒÓ ‰ËÌÔÛȇÛÂˆÓ ∂ÏÏ‹ÓˆÓ ÂÚ¢ÓËÙÒÓ, ·ÔÙÂÏ› ¤Ó· ‰‡ÛÎÔÏÔ ¤ÚÁÔ, ‰ÈfiÙÈ ‰ÂÓ ˘¿Ú¯ÂÈ Ï‹Ú˘ ‚¿ÛË ‰Â‰ÔÌ¤ÓˆÓ ∂ÏÏËÓfiÁψÛÛˆÓ ‰ËÌÔÛȇۈÓ, fiˆ˜
˘¿Ú¯Ô˘Ó ÔÈ ÁÓˆÛÙ¤˜ ∞ÁÁÏfiÁψÛÛ˜ Ô˘ ÙȘ ‚Ú›ÛÎÂÈ Ô Î·ı›˜ Û‹ÌÂÚ· ̤ۈ ÙÔ˘ ‰È·‰ÈÎÙ‡Ô˘. ∞˘Ùfi ÙÔ ÌÂÈÔÓ¤ÎÙËÌ· ‰˘Û¯ÂÚ·›ÓÂÈ ÙËÓ Ï‹ÚË ‚È‚ÏÈÔÁÚ·ÊÈ΋ ηٷÁÚ·Ê‹ ÙˆÓ ‰ËÌÔÛȇÛÂˆÓ Ô˘ ¤¯Ô˘Ó Á›ÓÂÈ Û ∂ÏÏËÓÈο
ÂÚÈÔ‰Èο Î·È ‚È‚Ï›· ÁÂÁÔÓfi˜ Ô˘ Ô‰ËÁ› ·ÎfiÌË Î·È Û ·ÚÂÍËÁ‹ÛÂȘ.
O Î. ¡›ÎÔ˜ ¶·¿˙ÔÁÏÔ˘ ›¯Â ÚÔ ÂÙÒÓ ÙËÓ È‰¤· Ó· Û˘ÓÙ·¯ı› Î·È Ó· Ù˘ˆı› ¤Ó· MËÙÚÒÔ fiÏˆÓ ÙˆÓ ‰ËÌÔÛȇÛÂˆÓ Ô˘ ¤ÁÈÓ·Ó ·fi ŒÏÏËÓ˜ Û˘ÁÁÚ·Ê›˜ Û ∂ÏÏËÓÈο Î·È ‰ÈÂıÓ‹ ÂÚÈÔ‰Èο Î·È ‚È‚Ï›·. ∏ ¤Î‰ÔÛË
ÙÔ˘ ªËÙÚÒÔ˘ Ú·ÁÌ·ÙÔÔÈ‹ıËΠ΢ڛˆ˜ Ì ÛËÌ·ÓÙÈ΋ ÚÔÛˆÈ΋ ÂÚÁ·Û›· ÙÔ˘ ȉ›Ô˘ Î·È ‹Ú ÙË ÌÔÚÊ‹ Û˘ÌÏËڈ̷ÙÈÎÔ‡ Ù‡¯Ô˘˜ ÙˆÓ ∂ÏÏËÓÈÎÒÓ ¢È·‚ËÙÔÏÔÁÈÎÒÓ ÃÚÔÓÈÎÒÓ. ΔÔ ÂÓ ÏfiÁˆ MËÙÚÒÔ ¤Ù˘¯Â Ôχ ÂÓıÔ˘ÛÈÒ‰Ô˘˜ ˘Ô‰Ô¯‹˜, ·‰›¯ıË ¯Ú‹ÛÈÌÔ Î·È ÁÈ’ ·˘Ùfi Â·ÓÂΉfiıËΠ̠ÂÈϤÔÓ Î·Ù·¯ˆÚ›ÛÂȘ ÙÔ 2002.
™‹ÌÂÚ·, ÌÂÙ¿ ·fi ÂÙ¿ ¯ÚfiÓÈ·, ÎÚ›ıËΠ·fi ÙÔ ¢.™. Ù˘ ¢.∂.μ.∂. fiÙÈ ‹Ù·Ó ÛˆÛÙfi Ó· Ú·ÁÌ·ÙÔÔÈËı›
Ë ÙÚ›ÙË ¤Î‰ÔÛË ÙÔ˘ ªËÙÚÒÔ˘ ∂ÚÁ·ÛÈÒÓ. ∏ ¤Î‰ÔÛË ÙÔ˘ 2002 ··ÚÈıÌÔ‡ÛÂ Û˘ÓÔÏÈο 1.979 ‚È‚ÏÈÔÁڷʛ˜. ªÂ
ÙËÓ ·ÚÔ‡Û· ¤Î‰ÔÛË, ÛÂ Û˘Ó¤¯ÂÈ· Ù˘ ÚÔËÁÔ‡ÌÂÓ˘, Û˘ÁÎÂÓÙÚÒıËÎ·Ó Ì¤¯ÚÈ ÙÔÓ ∞Ú›ÏÈÔ ÙÔ˘ 2009, Û˘ÓÔÏÈο 3.723 ‚È‚ÏÈÔÁڷʛ˜.
ΔÔ Û˘ÁÎÂÎÚÈ̤ÓÔ ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ, ·ÔÙÂÏÂ›Ù·È Î˘Ú›ˆ˜ ·fi:
– ¢È·‚ËÙÔÏÔÁÈο ¿ÚıÚ· ‰ËÌÔÛÈÂ˘Ì¤Ó· Û ÂÈÛÙËÌÔÓÈο ÂÚÈÔ‰Èο Ô˘ ·¢ı‡ÓÔÓÙ·È Û ȷÙÚÔ‡˜ Î·È ‰ËÌÔÛȇÔÓÙ·È ÌÂÙ¿ ·fi ÎÚ›ÛË ÎÚÈÙÒÓ Î·È Û˘ÓÙ·ÎÙÈ΋˜ ÂÈÙÚÔ‹˜.
– ¢È·‚ËÙÔÏÔÁÈο ‚È‚Ï›·, Î·È Ú·ÎÙÈο Û˘Ó‰ڛˆÓ Ì ηٷ¯ÒÚÈÛË Ï‹ÚˆÓ ‰ËÌÔÛȇۈÓ.
– ¢È‰·ÎÙÔÚÈΤ˜ ‰È·ÙÚÈ‚¤˜, ÌÂÙ·Ù˘¯È·Î¤˜ ‰È·ÙÚÈ‚¤˜ Î·È Ù˘¯È·Î¤˜ ÂÚÁ·Û›Â˜.
¢ÂÓ ÂÚÈÏ‹ÊıËÎ·Ó ÂÚÈÏ‹„ÂȘ ·fi ∂ÏÏËÓÈο Û˘Ó¤‰ÚÈ·, ·ÊÂÓfi˜ ‰ÈfiÙÈ ÔÈ ÂÚÈÏ‹„ÂȘ ·˘Ù¤˜ ‰ÂÓ ‰ËÌÔÛȇÔÓÙ·È ÌÂÙ¿ ·fi ÎÚ›ÛË, ·ÊÂÙ¤ÚÔ˘ ÁÈ·Ù› ÂӉ¯Ô̤ӈ˜ ¤¯Ô˘Ó ‰ËÌÔÛÈ¢Ù› Û Ï‹ÚË ÌÔÚÊ‹ Û ÂÚÈÔ‰Èο ηÈ
‹‰Ë ¤¯Ô˘Ó ηٷ¯ˆÚËı› ÛÙÔ ªËÙÚÒÔ.
°È· Ó· ˘ÏÔÔÈËı› Ë ΔÚ›ÙË ¤Î‰ÔÛË ÙÔ˘ ªËÙÚÒÔ˘ ¢È·‚ËÙÔÏÔÁÈÎÒÓ ∂ÚÁ·ÛÈÒÓ ÛÙ¿ÏıËÎ·Ó ÂÚ›Ô˘ 2.000
ÂÈÛÙÔϤ˜ Û ŒÏÏËÓ˜ ÂÚ¢ÓËÙ¤˜, Ì ÙËÓ ·Ú¿ÎÏËÛË Ó· Ì·˜ ·ÔÛÙ›ÏÔ˘Ó ÙȘ ‚È‚ÏÈÔÁڷʛ˜ ÙÔ˘˜ Ô˘ ›ӷÈ
Û¯ÂÙÈΤ˜ Ì ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
∂ÈϤÔÓ ¤ÁÈÓ·Ó Ì·˙ÈΤ˜ ·Ó·˙ËÙ‹ÛÂȘ Ì ı¤Ì· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Û ÂÏÏËÓÈΤ˜ Î·È Í¤Ó˜ ‚È‚ÏÈÔÁÚ·ÊÈΤ˜ ‚¿ÛÂȘ ‰Â‰Ô̤ӈÓ. ™ÙË ‚¿ÛË PubMed ·Ó·˙ËÙ‹ıËÎ·Ó ‰ËÌÔÛȇÛÂȘ Ì ÚԤϢÛË ÙËÓ ∂ÏÏ¿‰·
(ÎÏÂȉȿ diabetes & Greece).
9
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
OÈ ‚¿ÛÂȘ ‰Â‰ÔÌ¤ÓˆÓ Ô˘ ¯ÚËÛÈÌÔÔÈ‹ıËÎ·Ó Â›Ó·È:
– NLM PubMed
http://www.ncbi.nlm.nih.gov/pubmed
– π∞ΔƒOΔ∂∫
http://www.iatrotek.org
– ™˘ÏÏÔÁÈÎfi˜ ∫·Ù¿ÏÔÁÔ˜ ∞η‰ËÌ·˚ÎÒÓ μÈ‚ÏÈÔıËÎÒÓ
http://www.unioncatalog.gr/ucportal
– μ¿ÛË ¢Â‰ÔÌ¤ÓˆÓ ∂ıÓÈÎÔ‡ ∞Ú¯Â›Ô˘ ¢È‰·ÎÙÔÚÈÎÒÓ ¢È·ÙÚÈ‚ÒÓ ∂∫Δ
http://www.ekt.gr
– μ¿ÛË ¢Â‰ÔÌ¤ÓˆÓ ∞Ô‰ÂÏÙ›ˆÛ˘ π·ÙÚÈÎÒÓ ∂ÈÛÙËÌÔÓÈÎÒÓ ¶ÂÚÈÔ‰ÈÎÒÓ
μÈ‚ÏÈÔı‹Î˘ ¡ÔÛÔÎÔÌ›Ԣ ∞Ã∂¶∞
¶ÈÛÙ‡ԢÌ fiÙÈ Ì ÙÔÓ ÙÚfiÔ Ô˘ Û˘ÏϤ¯ıËÎ·Ó ÔÈ ‚È‚ÏÈÔÁڷʛ˜ ¤¯ÂÈ Î·Ï˘Êı› ÙÔ Û‡ÓÔÏÔ Û¯Â‰fiÓ ÙˆÓ
‰È·‚ËÙÔÏÔÁÈÎÒÓ ‰ËÌÔÛȇۈÓ, Ì ÂÏ¿¯ÈÛÙ˜ ÂÍ·ÈÚ¤ÛÂȘ ÁÈ· ÙȘ Ôԛ˜ ¢ı‡ÓÂÙ·È Ë ·Ì¤ÏÂÈ· ÌÂÚÈÎÒÓ Û˘Ó·‰¤ÏÊˆÓ Ó· ··ÓÙ‹ÛÔ˘Ó ÛÙȘ ÂÈÛÙÔϤ˜ Ì·˜ ‹ ÔÈ ·ÏÏ·Á¤˜ ÙˆÓ ‰È¢ı‡ÓÛÂÒÓ ÙÔ˘˜.
∂˘¯·Ú›ÛÙˆ˜ ı· ‰Â¯ıÔ‡ÌÂ Û˘ÌÏËڈ̷ÙÈΤ˜ ÏËÚÔÊÔڛ˜, ÒÛÙ ӷ ¯ÚËÛÈÌÔÔÈËıÔ‡Ó Û ÌÂÏÏÔÓÙÈ΋
Â·Ó¤Î‰ÔÛË.
∂Ï›˙Ô˘Ì ÙÔ Û˘ÁÎÂÎÚÈ̤ÓÔ ¤ÚÁÔ Ó· ‚ÔËı‹ÛÂÈ ÙÔ˘˜ Û˘ÁÁÚ·Ê›˜ ‰È·‚ËÙÔÏÔÁÈÎÒÓ ‰ËÌÔÛȇۈÓ, ÒÛÙÂ
·ÊÂÓfi˜ Ó· ‰È¢ÎÔÏ˘Óı› ÙÔ ¤ÚÁÔ ÙÔ˘˜, ·ÊÂÙ¤ÚÔ˘ Ó· ÌËÓ ·Ú·Ï›ÔÓÙ·È ·ÍÈfiÏÔÁ˜ ‰ËÌÔÛȇÛÂȘ ∂ÏÏ‹ÓˆÓ
ÂÚ¢ÓËÙÒÓ.
∏ Ú·ÁÌ·ÙÔÔ›ËÛË ·˘Ù‹˜ Ù˘ ÂΉfiÛˆ˜, ÂÎÙfi˜ ·fi ÙË Û˘Ì‚ÔÏ‹ ÙÔ˘ Î. ¡. ¶·¿˙ÔÁÏÔ˘, Ô ÔÔ›Ô˜, ÂÎÙfi˜
·fi ÙËÓ ·Ú¯È΋ ȉ¤· ›¯Â fiˆ˜ Î·È ÛÙȘ ÚÔËÁÔ‡ÌÂÓ˜ ÂΉfiÛÂȘ ÙÔ ÁÂÓÈÎfi ÚfiÛÙ·ÁÌ·, ¤ÁÈÓ Ì ÛËÌ·ÓÙÈ΋
‚Ô‹ıÂÈ· Ù˘ ‚È‚ÏÈÔıËÎÔÓfiÌÔ˘ Î. ∂ÈÚ‹Ó˘ ΔÛÔ˘Ú¿ÎË, Ë ÔÔ›· Ì ÙȘ ÁÓÒÛÂȘ Ù˘ Î·È ÙÔÓ ÂÓıÔ˘ÛÈ·ÛÌfi Ù˘, ÂÚÁ·˙fiÌÂÓË Î·È ˘ÂÚˆÚȷο, Û˘Ó¤‚·Ï ԢÛȈ‰Ò˜ ÛÙËÓ Â›Ù¢ÍË ÙÔ˘ ÛÎÔÔ‡ ·˘Ù‹˜ Ù˘ ¤Î‰ÔÛ˘.
¢ËÌ. £. ∫·Ú·Ì‹ÙÛÔ˜
¢È¢ı˘ÓÙ‹˜ ™‡ÓÙ·Í˘ ∂¢Ã
10
¶ÚfiÏÔÁÔ˜ ∂ÈÌÂÏËÙ‹ ŒÎ‰ÔÛ˘
∞Á·ËÙÔ› ™˘Ó¿‰ÂÏÊÔÈ,
¶ÚÈÓ ·fi ÌÂÚÈο ¯ÚfiÓÈ· ›¯· ÙËÓ ¤ÌÓ¢ÛË Ó· ·Û¯ÔÏËıÒ Ì ÙËÓ Û‡ÓÙ·ÍË ÙÔ˘ «ªËÙÚÒÔ˘ ∂ÚÁ·ÛÈÒÓ
∂ÏÏ‹ÓˆÓ ∂Ú¢ÓËÙÒÓ & ™˘ÁÁڷʤˆÓ Ì ÁÓˆÛÙÈÎfi ·ÓÙÈΛÌÂÓÔ ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË». ΔÔ 2002 ΢ÎÏÔÊfiÚËÛ· ÙËÓ μ′ ¤Î‰ÔÛË.
ΔfiÙ ۷˜ ›¯· ÁÚ¿„ÂÈ Î·È ÙÔ˘ ÏfiÁÔ˘˜ ‰È· ÙÔ˘˜ ÔÔ›Ô˘˜ ˘Ô‚Ï‹ıËη Î·È ˘¤‚·ÏÏ· Î·È ÙÔ˘˜ ™˘ÓÂÚÁ¿Ù˜
ÌÔ˘ ÛÙË ‰È·‰Èηۛ· ÙˆÓ ÂΉfiÛˆÓ. ΔÒÚ· ‰ÂÓ ı· ÙÔ Í·Ó·Î¿Óˆ. ªÔ˘ ‰fiıËΠÂÍ ¿ÏÏÔ˘ Ë Â˘Î·ÈÚ›·, ·fi ÙÔ˘
‚‹Ì·ÙÔ˜ Û˘Ó‰ڛˆÓ, Ó· ÛÙËÏÈÙ‡ۈ ÙȘ ·Ú·Ï›„ÂȘ ·Ó·ÊÔÚ¿˜ Û ÂÏÏËÓÈΤ˜ ‚È‚ÏÈÔÁڷʛ˜, ÛÎfiÈ̘ ÙȘ ÂÚÈÛÛfiÙÂÚ˜ ÊÔÚ¤˜. °È· ÙËÓ ÈÛÙÔÚ›· Û·˜ ·Ó·Ê¤Úˆ fiÙÈ ¤Ó·˜ ÌfiÓÔ Î·ıËÁËÙ‹˜ ¶·ıÔÏÔÁ›·˜ ÙÔ˘ ∞.¶.£. ÌÂ Û˘Ó¯¿ÚË, ‰È’ ÂÈÛÙÔÏ‹˜, ÁÈ· ÙËÓ ÚˆÙÔ‚Ô˘Ï›· ȉȷ›ÙÂÚ·, ·ÏÏ¿ Î·È ÁÈ· ÙËÓ ÚÔÛ¿ıÂÈ·. ŒÎÙÔÙ ›¯· ÔÏϤ˜ ·ÌÊÈ‚Ôϛ˜ ÁÈ· ÙË ¯ÚËÛÈÌfiÙËÙ· Ù˘ ¤Î‰ÔÛ˘, ·ÊÔ‡ ηٿ ÙËÓ ÁÓÒÌË ÌÔ˘ Ô ÛÙfi¯Ô˜ ÌfiÓÔ ÌÂÚÈÎÒ˜ ÂÂÙ‡¯ıË.
¶ÚÈÓ ·fi ÌÂÚÈÎÔ‡˜ Ì‹Ó˜ ·ÂÙ¤ÏÂÛ ȉȷ›ÙÂÚË ¤ÎÏËÍË ÁÈ· ̤ӷ fiÙ·Ó Ô ¶Úfi‰ÚÔ˜ Ù˘ ¢.∂.μ.∂. Î. ΔÚ.
¢È‰¿ÁÁÂÏÔ˜ ÌÔ˘ › fiÙÈ ÙÔ ¢.™. Ù˘ ∂Ù·ÈÚ›·˜ Ì·˜ ·ÔÊ¿ÛÈÛ ÙËÓ Â·Ó¤Î‰ÔÛË ÙÔ˘ «ªËÙÚÒÔ˘». ™Â ÂÚÒÙËÛ‹ ÌÔ˘ ÔÈÔ˜ ı· ÙÔ ·Ó·Ï¿‚ÂÈ, ·¿ÓÙËÛ «ª· Û ۷˜ ˘ÔÏÔÁ›˙·Ì».
¶·Ú¿ ÙËÓ ·Ú¯È΋ ÌÔ˘ ¿ÚÓËÛË, ‰ÂÓ ¿ÓÙÂÍ·.
∏ ÙÂÏÂ˘Ù·›· ¤ÎÏËÍË ÁÈ· ̤ӷ ‹Úı ·fi ÙËÓ ÏÂ˘Ú¿ ÙÔ˘ ηıËÁËÙÔ‡ Î. ¢. ∫·Ú·Ì‹ÙÛÔ˘ Ì ÙËÓ ÚfiÙ·ÛË
Ó· ÁÚ¿„ˆ ¤Ó·Ó ÚfiÏÔÁÔ ÛÙËÓ ΔÚ›ÙË ¤Î‰ÔÛË. ŒÙÛÈ ·ÔÊ¿ÛÈÛ· Ó· «ı˘ÛÈ·ÛÙÒ» Î·È ¿ÏÈ.
∏ ·Ó¿ ¯Â›Ú·˜ «ΔÚ›ÙË ŒÎ‰ÔÛË» ÔÏÔÎÏËÚÒıËΠ̠ÂÈÙ˘¯›· Û ۇÓÙÔÌÔ Û¯ÂÙÈο ‰È¿ÛÙËÌ·, ¯¿ÚȘ ÛÙËÓ Ù¯ÓÔÏÔÁ›·, ·ÏÏ¿ Î·È ÛÙË ‰˘Ó·ÌÈ΋ Ù˘ ÁÚ·ÌÌ·Ù¤ˆ˜ Ù˘ ¢.∂.μ.∂. Î. ∂ÈÚ‹Ó˘ ΔÛÔ˘Ú¿ÎË ÙËÓ ÔÔ›· Î·È Â˘¯·ÚÈÛÙÒ.
∏ ·Ô‰Ô¯‹ fï˜ Ù˘ Û˘ÁÁÚ·Ê‹˜ «ÂÓfi˜» ÚÔÏfiÁÔ˘ (ÁÈ·Ù› ˘Ôı¤Ùˆ fiÙÈ ı· ÁÚ¿„ÂÈ Î·È Î¿ÔÈÔ˜ ¿ÏÏÔ˜) ¤ÁÈÓ ÁÈ·Ù› ÌÔ˘ ‰›‰ÂÙ·È Ë Â˘Î·ÈÚ›·, ·¢ı˘ÓfiÌÂÓÔ˜ ÚÔ˜ ·ÓÂÈÛÙËÌÈ·ÎÔ‡˜ ‰·ÛοÏÔ˘˜ ȉȷ›ÙÂÚ·, Ó· ˘ÔÁÚ·Ì̛ۈ fiÙÈ ·ÔÙÂÏ› ÚˆÙ·Ú¯ÈÎfi ηı‹ÎÔÓ Î·È ˘Ô¯Ú¤ˆÛ‹ ÙÔ˘˜ Ó· ‰È‰¿ÛÎÔ˘Ó fiÙÈ, ÛÙËÓ ¤Ú¢ӷ, Ë ·Ó·ÊÔÚ¿ ÛÂ
ÚÔËÁËı›Û˜ ÂÚÁ·Û›Â˜ Î·È Û ı¤Ì·Ù· Ì fiÌÔÈ· ÁÓˆÛÙÈο ·ÓÙÈΛÌÂÓ· Â›Ó·È ˘Ô¯ÚˆÙÈ΋, ηıÒ˜ Î·È Ë Û‡ÁÎÚÈÛË Î·È ÎÚÈÙÈ΋. ∏ ÚÔÛ¿ıÂÈ· ··Í›ˆÛ˘ ÂÚ¢ÓËÙÈÎÒÓ ÂÚÁ·ÛÈÒÓ Ì ÙËÓ ·ÔÛÈÒËÛË ÙˆÓ ‰ËÌÔÛȇÛÂÒÓ ÙÔ˘˜, ·ÔÙÂÏ› ÂÓ¤ÚÁÂÈ· ‰ÂÔÓÙÔÏÔÁÈο ··Ú¿‰ÂÎÙË.
ΔËÓ ‰È¢ÎfiÏ˘ÓÛË ÛÙËÓ ·Ó‡ÚÂÛË ÙˆÓ ‚È‚ÏÈÔÁÚ·ÊÈÎÒÓ ‰Â‰ÔÌ¤ÓˆÓ ÛÙËÓ ¤Ú¢ӷ ÙË Û¯ÂÙÈ΋ Ì ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË ·fi ŒÏÏËÓ˜ ÂÚ¢ÓËÙ¤˜, ÊÈÏÔ‰ÔÍ› Ó· ηχ„ÂÈ Ë ·Ó¿ ¯Â›Ú·˜ ¤Î‰ÔÛË. £· Â›Ì·È Â˘Ù˘¯‹˜ ·Ó
ηχ„ÂÈ Î·È ÌÂÙÚÈ¿ÛÂÈ ÙÔ˘Ï¿¯ÈÛÙÔÓ ÙȘ ·Ú·¿Óˆ ·Ó·ÊÂÚı›Û˜ ·Ú·Ï›„ÂȘ, ·ÎÔ‡ÛȘ ‹ ÂÛÎÂÌ̤Ó˜.
ªÂ ÂÎÙ›ÌËÛË
¡ÈÎ. Ã. ¶·¿˙ÔÁÏÔ˘
11
KATA§O°O™
™Y°°ƒAºEø¡
13
14
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∞μ¢∂§π¢∏™ ¢., 707
∞μƒ∞∞ª °., 1479
∞μƒ∞∞M Ã., 1580
∞μƒ∞ªπ¢∏™ ∞., 250, 254, 265, 282, 323, 1842, 2667
∞μƒ∞ªπ¢∏™ ¢., 19
∞μƒ∞ªπ¢∏™ ª., 286, 359, 509, 790
∞μƒ∞ªπ¢∏™ ™., 2735
∞μƒ∞ªπ∫∞ ª., 354
∞°∞£O∫§∂OÀ™ ∫., 791
∞°∞§πøΔ∏™ ¢., 704
∞°∞¶∞∫∏™ ¢., 2169
∞°°∂§π¢OÀ ∫., 3270
∞°°∂§O¶OÀ§O™ ∞., 3482
∞°°∂§O¶OÀ§O™ μ., 2912, 3484
∞°°∂§O¶OÀ§O™ ∂., 2926
∞°°∂§O¶OÀ§O™ £., 2119
∞°°∂§O¶OÀ§OÀ ¡., 3205, 3218, 3250, 3265, 3539
∞°°∂§OÀ ª., 3294
∞°°∂§OÀ ™., 357
∞°°∂§OÀ¢∏ ª., 3031
∞°°OÀƒπ¢∞∫∏ Ã., 3626
A°¡∞¡Δ∏™ ¡., 3321
∞°Oƒ∞™ΔO™ π., 181, 192, 551, 821
∞°Oƒ°π∞¡¡πΔ∏™ ¢., 2427
∞°ƒ∞¶π¢∏™ Ã., 3077
∞°ƒO°π∞¡¡∏™ μ., 3033, 3480
∞¢∞ª ∞., 2950
∞¢∞ª ∂., 1207, 2006
∞¢∞ª ∫., 1922
A¢AMAKH™ I., 1960
∞¢∞ª∏ ∏., 3432
∞¢∞ªπ¢∏™ °., 2936
∞¢∞ªπ¢∏™ π., 383
∞¢∞ªπ¢OÀ ∞., 203, 2013, 2148, 2158
∞¢∞ªO¶OÀ§O™ ¶., 855
∞¢∞ªO¶OÀ§OÀ ∂., 2425, 2430, 2435, 2440, 2766,
3364
∞∑∞™ ∂., 1641
∞∏¢O¡O¶OÀ§O™ ∞., 2704, 2760
∞£∞¡∞™∞∫∏™ π., 1705
∞£∞¡∞™π∞¢∏™ ∞., 212, 3352
∞£∞¡∞™π∞¢∏™ §., 1404
∞£∞¡∞™π∞¢OÀ °., 3438
∞£∞¡∞™πOÀ °., 2946, 3416
∞£∞¡∞™πOÀ ∂., 3031
∞£∞¡∞™πOÀ ¶., 2688
∞£∞¡∞™O¶OÀ§O™ ∞., 3303, 3398, 3412
∞£∞¡∞™O¶OÀ§O™ °., 237
∞£∞¡∞™O¶OÀ§O™ ¡., 1
∞£∞¡∞™O¶OÀ§OÀ ª., 3061
∞£∞¡∞™O¶OÀ§OÀ Ã., 485
∞£ÀƒO™ μ., 313, 336, 359, 497, 509, 777, 790, 935,
1680, 1681, 1682, 1683, 1891, 1947, 2015, 2041,
2042, 2043, 2044, 2056, 2132, 2135, 2196, 2197,
2209, 2543, 2544, 3155, 3212, 3303, 3373, 3616
∞£ÀƒOÀ μ., 2132
∞∫ƒπΔπ¢∏™ ¡., 3386
∞§∞μ∂ƒ∞™ ∞., 2085, 2414, 2589, 2590, 2787, 2827,
2841, 2962, 2999, 3273, 3274
∞§∞ª∞¡O™ °., 772
∞§∞ª∞¡O™ π., 3359
∞§∞ª¢∞ƒ∏ ¢., 3261, 3271
∞§∞ƒ°∫øº ∂., 2664
∞§∂μπ∑∞∫∏ ª., 1542, 1549, 1715, 1800, 2454, 2456,
2495, 2496, 3009, 3189, 3281, 3312, 3329, 3439,
3458, 3528
∞§∂μπ∑∞∫∏ Ã., 3439, 3458, 3471
∞§∂μπ∑O¶OÀ§OÀ O., 2926
∞§∂μπ∑O™ ∞., 2340, 2438
∞§∂μπ∑O™ ª., 177, 189, 203, 223, 280, 386, 574, 575,
578, 1793, 1846, 2013, 2141, 2148, 2234, 2488,
3218, 3250, 3265, 3539, 3541
∞§∂μπ∑OÀ μ., 664, 665, 669, 692
∞§∂•∞¡¢ƒ∞∫∏ ∫., 2611, 2980, 3210, 3274
∞§∂•∞¡¢ƒπ¢∏™ ∞., 803, 950
∞§∂•∞¡¢ƒπ¢∏™ £., 2836, 3676
∞§∂•∞¡¢ƒπ¢∏™ ∫., 2935
∞§∂•∞¡¢ƒπ¢∏™ Δ., 2592, 3260, 3443
∞§∂•∂§§∏ ∞., 3138
∞§∂•π∞¢∏™ A.¢., 3718, 3719
∞§∂•π∞¢∏™ ¢., 379, 758
∞§∂•π∞¢∏™ ™., 1902
∞§∂•π∞¢OÀ ∂., 2214
∞§∂•πOÀ ∑., 240, 244, 666, 2189
∞§∂•πOÀ £., 882
∞§∂•πOÀ ¶., 3158
∞§∂•O¶OÀ§O™ ∂., 294, 927, 1155, 1203
∞§∂•O¶OÀ§O™ π., 655
∞§∂•O¶OÀ§OÀ ∞., 1880, 2662, 2956, 3293
∞§∂•O¶OÀ§OÀ £., 3056
∞§∂Δƒ∞™ O., 798
∞§∏μ∞¡∏™ ∞., 183
∞§∏™πª∏™ ∂., 3041
∞§∏º∂ƒ∏™ ∫., 240, 244
∞§πμπ∑∞ΔO™ π., 45, 51, 65, 70, 72, 93, 94, 95, 96, 127,
131, 132, 133, 160, 188, 247, 257, 258, 480, 1512
∞§π°∫π∑∞∫∏™ ∞., 3405
∞§πºπ∂ƒ∞∫∏ Δ., 3425
A§πÃ∞¡π¢OÀ O., 1941
∞§Δπ¡O°§OÀ ∂., 3488
∞ªμƒO™π∞¢OÀ μ., 3463
∞ª¶∞Δ∑π¢∏™ °., 3218
∞ª¶∂¡Δπ¡π ƒ., 1993, 2192
∞ª¶∂ƒπ∞¢∏ ¶., 1539, 1540
∞¡∞°∂∞™ ™., 910
∞¡∞°¡OÀ ¡., 3306, 3332
∞¡∞°¡ø™ΔO¶OÀ§O™ ¢., 3241
∞¡∞°¡ø™ΔO¶OÀ§OÀ ∂., 3337
∞¡∞°¡ø™ΔO¶OÀ§OÀ Δ., 3415
∞¡∞°¡ø™ΔOÀ ∞., 2058
15
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∞¡∞°¡ø™ΔOÀ E., 119, 1458
∞¡∞°¡ø™ΔOÀ-∫∞∫∞ƒ∞ ∂., 1927
∞¡∞°ø¡∞∫∏ ¡., 3332
∞¡∞¶§πøΔOÀ-μ∞™π§O¶OÀ§OÀ ª., 850, 1866
∞¡∞™Δ∞™∞∫∏™ ∂., 3252
∞¡∞™Δ∞™π∞¢∏™ §., 2952
∞¡∞™Δ∞™π∞¢∏™ ∫., 2648, 3272, 3588, 3608, 3717
∞¡∞™Δ∞™π∞¢∏™ ¡., 387
∞¡∞™Δ∞™π∞¢OÀ μ., 473, 474, 476
∞¡∞™Δ∞™π§∞∫∏™ ∞., 2667
∞¡∞™Δ∞™π§∞∫∏™ ∫., 2017, 2025
∞¡∞™Δ∞™πOÀ ∂., 1542, 1549, 1715, 1800, 1926, 2068,
2166, 2515, 2991, 3011, 3082, 3189, 3228, 3281,
3312, 3329, 3439, 3458, 3512
∞¡∞™Δ∞™πOÀ ∫., 1186, 1198
∞¡∞™Δ∞™πOÀ O., 3626
∞¡∞™Δ∞™πOÀ ƒ., 3395
∞¡∞™Δ∞™O¶OÀ§O™ π., 3342
∞¡∞™Δ∞™O¶OÀ§OÀ ∞., 2432
∞¡∞™Δ∞™O¶OÀ§OÀ π., 2791
∞¡∞™Δ∞™O¶OÀ§OÀ ∫., 657
∞¡¢ƒ∂∞¢∏™ ∂., 2449, 2450, 3388, 3404, 3533
∞¡¢ƒ∂∞¢∏™ ¶., 871
∞¡¢ƒ∂∞¢OÀ ∂ 1606, 3494
∞¡¢ƒπ∫O¶OÀ§O™ °., 3361
∞¡¢ƒπ∫O¶OÀ§O™ ™., 1603, 1845
∞¡¢ƒπ∫O¶OÀ§OÀ ∞., 3083
∞¡¢ƒπ∫O™ ∞., 383
∞¡¢ƒπ∫OÀ§∞ ª., 2954
∞¡¢ƒπO¶OÀ§O™ π., 159
∞¡¢ƒπøΔ∞∫∏™ ∫., 74, 2913, 2865
∞¡¢ƒπøΔ∏™ ∞., 612, 623, 1357
∞¡¢ƒO¡π∫∞∫∏-º∞§¢∞ª∏ ∞., 963
∞¡¢ƒOÀ§∞∫∏™ π., 3516, 3531
∞¡¢ƒOÀ§∞∫∏™ ¶., 2549, 2663
∞¡¢ƒOÀ§∞∫∏™ ∞., 3361
∞¡¢ƒOÀ§∏™ ∞., 2528
∞¡£πªπ¢∏™ °., 284, 295, 299, 390, 505, 1939, 2154,
3605
∞¡£O¶OÀ§O™ §., 855, 1450, 3286
∞¡£O¶OÀ§O™ ¶., 1450
∞¡πº∞¡Δ∏™ °., 3152
∞¡Oπ¡O™ ¢., 936
∞¡OÀ™∏™ ™., 3036
∞¡Δ∞ƒ∞∫∏ ∞., 767
∞¡Δ∑OÀ-∞°°OÀƒπ¢∞∫∏ Ã., 525, 1126
∞¡ΔO™π¢∏™ ∫., 802
∞¡ΔƒOÀ¢∏ ™., 2938
∞¡Δ™∞∫§∏™ ∞., 1926, 3200, 3270
∞¡Δø¡∞∫∏™ ¡., 1914, 1915, 2948
∞¡Δø¡∞∫O™ ¶., 911
∞¡Δø¡π∞¢∏™ ∞., 1790
∞¡Δø¡π∞¢∏™ ∞., 501, 1828, 3583
∞¡Δø¡π∞¢∏™ π., 3475
∞¡Δø¡π∞¢∏™ §., 1309
16
∞¡Δø¡π∞¢∏™ ¡., 1790
∞¡Δø¡π∞¢∏™ Ã., 85, 97, 135, 1719, 1720, 1721, 1722,
1723, 1724, 1725, 1726, 1727, 1728, 1729, 1730,
1731, 1732, 1733, 1734, 1735, 1736, 1737, 1738,
1739, 1740, 1741, 1742, 1743, 1744, 1745, 1746,
1747, 1748, 1749, 1750, 1751, 1752, 1753, 1754,
1755, 1756, 1757, 1758, 1759, 1760, 1761, 1762,
1763, 1764, 1765, 1766, 1767, 1768, 1769, 1770,
1771, 1772, 1773, 1774, 1775, 1776, 1777, 1778,
1779, 1780, 1781, 1782, 1783, 1784, 1785, 1786,
3253, 3358, 3486
∞¡Δø¡π∞¢OÀ ∫., 576
∞¡Δø¡π∞¢OÀ §., 771
∞¡Δø¡πOÀ ∞., 1550, 3042, 3183
∞¡Δø¡πOÀ ™., 403
∞¡Δø¡πOÀ Ã., 691
∞¡Δø¡O°§OÀ Ã., 2447, 3355
∞¡Δø¡O¶OÀ§O™ ∞., 664, 668, 678, 692, 2011, 2126,
2164, 2167, 2189, 2952, 3322
∞¡Δø¡O¶OÀ§O™ ª., 2903
∞¡Δø¡O¶OÀ§O™ ™., 2432, 3282
∞¡Δø¡O¶OÀ§OÀ ∞., 3113
∞¡ΔO¡O¶OÀ§OÀ ™., 3282, 3311
∞¡Àº∞¡Δ∞∫∏ ¢., 1386
∞¡Àº∞¡Δ∞∫∏ º., 3517
∞•∞ƒ§∏ ∫., 856
∞¶O™ΔO§π¢∏ ∂., 3131
∞¶O™ΔO§π¢∏™ ∞., 1831, 1832, 1980, 2185
∞¶O™ΔO§π¢∏™ ¡., 2647
∞¶O™ΔO§π¢OÀ ∫., 383, 1136, 3536
∞¶O™ΔO§O¶OÀ§O™ ¡., 3210
∞¶O™ΔO§O¶OÀ§O™ ¶., 3263
∞¶O™ΔO§O¶OÀ§OÀ ¢., 1942, 2032
∞¶O™ΔO§OÀ £., 2709
∞¶O™ΔO§OÀ O., 1799, 2155, 2479, 2516, 2587, 3151,
3276, 3299
∞ƒ∞μ∞¡Δπ¡O™ ¢., 2950
∞ƒ∞μ∞¡Δπ¡OÀ ¢., 1926
∞ƒ∞¶∞∫∏™ °., 157, 159, 1434
∞ƒ∞¶O™Δ∞£∏ ∫., 3156
∞ƒμ∞¡πΔ∞∫∏™ ∂., 1575, 2193
∞ƒμ∞¡πΔ∞∫∏™ ∫., 347, 348, 349, 350, 788
∞ƒμ∞¡πΔ∏ º., 3264
∞ƒμ∞¡πΔ∏™ ¢., 2035
∞ƒμ∞¡πΔ∏™ ∫., 240, 244
∞ƒμ∞¡πΔ∏™ ª., 666, 3324
∞ƒμ∞¡πΔ∏™ Ã., 3184
∞ƒμ∞¡πΔπ¢∏™ ∫., 2378
∞ƒ°Àƒ∞∫∏™ ™., 2423, 2430, 2435, 3364
∞ƒ°Àƒ∞∫O¶OÀ§O™ °., 3209
∞ƒ°ÀƒπOÀ ∫., 2208, 2231
∞ƒ°ÀƒO¶OÀ§O™ ∞., 3319
∞ƒ°ÀƒO¶OÀ§OÀ ∂., 2547
∞ƒ°ÀƒO™ π., 3077
∞ƒ∂∞§∏™ ∂., 871
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∞ƒ∂Δ∞πO™ O ∫∞¶¶∞¢O∫∏™., 219
∞ƒ∫∞¢O¶OÀ§O™ ¡., 614, 617, 621, 622, 624
∞ƒª∞Δ∞™ ∞., 420, 421
∞ƒª∂¡Δ∑πO´OÀ-Δ∞™πO¶OÀ§OÀ ∫. 2740
∞ƒ¡∏™ ™., 3032
∞ƒO¢πΔ∏™ ∫., 439
∞ƒ™∂¡πOÀ ∞., 3390
∞ƒ™∂¡πOÀ Ã., 2007
∞ƒ™O™ °., 1998, 2008, 2023, 2135, 2144, 2209, 3610
∞ƒΔO¶OÀ§O™ π., 1991, 2222, 2225, 2464
∞ƒº∞¡∞∫∏™ ¢., 3217
∞ƒÃ∞¡πøΔ∞∫∏ ª., 386, 574, 575, 1396, 1457, 1459,
1589
∞ƒÃπª∞¡¢ƒπΔ∏™ ∞., 2511, 2561, 2573, 3293, 3525
∞ƒø¡∏ ∫., 3467
∞™∏ª∞∫O¶OÀ§O™ ∞., 2937
∞™∏ª∞∫O¶OÀ§O™ μ., 2176
∞™∏ª∞∫O¶OÀ§O™ ¢., 2937
∞™∏ª∞∫O¶OÀ§O™ ∂., 3352, 3468
∞™∏ª∞∫O¶OÀ§O™ ¶., 2423, 2424, 2527
∞™∏ª∞∫O¶OÀ§OÀ °., 907, 963, 1886
∞™∫∂¶π¢∏™ ¡., 2499, 2524, 2552, 2553, 2554
∞™∫∏ΔO¶OÀ§OÀ ∏., 3301
∞™§∞¡π¢∏™ ™., 2745
∞™§∞¡O°§OÀ ∂., 3223
∞™¶πøΔ∏™ ª., 895, 928, 942, 3359, 3474
∞™™∞¡∏™ π., 1483, 1716
∞™™∞¡Δ∏™ μ., 2229
∞À°OÀ™Δ∞∫∏™ ¢., 13
∞À°OÀ™Δ∏™ π., 2545
∞À°OÀ™Δπ¢OÀ-™∞μμO¶OÀ§OÀ ¶., 795, 931
∞À§ø¡πΔ∏ ∞., 3689
∞À§ø¡πΔ∏™ ™., 161, 1920º
∞º∂¡ΔOÀ§π¢∏™ ¢., 1148
∞º£∂¡ΔO¶OÀ§O™ π., 3434
∞Ãπ§§∂ø™ ∫., 3176
∞ÃΔ∞ƒO¶OÀ§O™ ∞., 419
∞ÃΔ™π¢∏™ μ., 3220
μ∞μ∞§∂∫∞™ °., 255
μ∞μ∞Δ™∏-Ã∞Δ∑∏§∂ø¡π¢∞ ª., 593
μ∞μπ§∏™ ¢., 2752
μ∞μOÀƒ∞¡∞∫∏™ ∂ª., 2113, 3192, 3318
μ∞°°∂§O¶OÀ§O™ π., 2747
μ∞°∂¡∞∫∏™ ∞., 1813, 2063, 2592, 3002, 3283, 3284,
3317, 3413, 3704
μ∞°∂¡∞™ ¡., 2935, 3160
μ∞°¢∞Δ§∏ ∂., 1584
μ∞°πø¡∞™ °., 757, 1125, 1127, 2497, 2498, 2499,
2524, 2552, 2553
μ∞¢∞ƒ§∏™ ∂., 1136
μ∞¢π∞∫∞ ª., 2164
μ∞∑∞πOÀ ∞., 483, 1685, 1686, 1687, 1688, 1689, 1690,
1691, 1692, 1693, 1694, 1695, 1696, 1697, 1795,
2216, 2218, 2219, 2221, 3362, 3027, 3222, 3223,
3226, 3230, 3368, 3636, 3681, 3682, 3683, 3722
μ∞∑°πOÀƒ∞∫∏™ μ., 2947
μ∞´¡∞™ ™., 3192, 3318
μ∞´O¶OÀ§O™ °., 122
μ∞´ƒ∞∫Δ∞ƒ∏™ ∂., 2909, 3208, 3221, 3236, 3242, 3243,
3249, 3291
μ∞∫∞§∏™ ∞., 2025
μ∞∫∞§∏™ ¢., 577
μ∞∫O§∞™ π., 181
μ∞§∞μ∞¡∏™ ∫., 827
μ∞§∞øƒ∞™ μ., 555
μ∞§∫OÀª∞ ¢., 773, 1127, 1468, 1469
μ∞§§π∞¡∞ΔOÀ ∂., 2919
μ∞§§π∞¡OÀ ¡., 3065
μ∞§§π§∞∫∏™ π., 3440
μ∞§OΔ∞™πOÀ μ., 3537
μ∞§™∞ª∞∫∏™ °., 2167, 2336
μ∞§Δ∏™ ¢., 445, 553, 559
μ∞ªμ∞∫OÀ °., 3235
μ∞ªμ∞§∏™ Ã., 539, 545, 553, 800
μ∞ªμOÀ∫O™ ¢., 493, 943
μ∞¡Δ∑OÀ Ã., 3389
μ∞ƒμ∞ƒπ°O™ ¡., 1890, 1910, 1977, 2604, 2629, 2636,
3048, 3409, 3410
μ∞ƒ°∂ª∂∑∏™ μ., 447, 2378, 2554, 2718, 2719, 3430,
3444, 3582
μ∞ƒ¢∞∫∞™ ∫., 3206, 3234
μ∞ƒ¢∞∫∏ ª., 814
μ∞ƒ¢∞™ ¶∂., 2543, 3255, 3268, 3217, 3292
μ∞ƒ∂§∞ ª., 158
μ∞ƒ∂§§∏ ∫., 1704
μ∞ƒ∂§Δ∑π¢∏™ ∂., 1393
μ∞ƒ∏-Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ ª., 576
μ∞ƒπ∞ª∏ ∂., 332
μ∞ƒ§∞ ª., 473, 476
μ∞ƒ™∞ª∏-£øªO¶OÀ§OÀ ∏., 3037
B∞ƒ™∞ª∏™ ∂., 1501, 3037, 3039
μ∞ƒΔ∑∂§∏-∫O¡¢À§∞∫∏ ™., 3162
μ∞ƒø¡O™ ¢., 650, 697
μ∞™π§∞∫∏™ π., 3442
μ∞™π§∞∫O™ ¶., 3317
μ∞™π§∂π∞¢∏™ ∫., 1927, 1929, 1987
μ∞™π§∂π∞¢∏™ ª., 2378
μ∞™π§∂π∞¢∏™ ¶., 1983, 2008, 2154
μ∞™π§∂π∞¢∏™ ™., 1702, 1703, 1705
μ∞™π§∂π∞¢OÀ ∂., 574
μ∞™π§∂π∞¢OÀ Ã., 3358
μ∞™π§∂πOÀ ∞ª., 2172, 2228
μ∞™π§∂πOÀ ∫., 531
μ∞™π§∂πOÀ ™., 2909, 3242, 3243, 3249, 3221, 3236,
3291, 3581
μ∞™π§Oª∞¡ø§∞∫∏™ ª., 2939
μ∞™π§O¶OÀ§O™ ¢., 951, 3336
μ∞™π§O¶OÀ§O™ ¶., 2939
μ∞™π§O¶OÀ§O™ Ã., 3388, 3404
μ∞™πª¶O™™∏™ ∞., 3248
17
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
μ∞™πOÀ ∫., 3356
μ∞™∫O¡™∂§O™ ¶., 2582
μ∞™§∞ª∞Δ∑∏™ °., 3197
μ∞™™π§O¶OÀ§O™ ∫., 2449
μ∞Δ∞§∞™ π., 3394
μ∞Δ∑π∞™ ∫., 94
μ∞º∂π∞¢∏™ ¶., 1628, 1629, 1630, 1631
μ∞º∂π∞¢OÀ ∂., 401, 1898, 2379, 3626
μ∂μ∂™ ∞., 321, 330, 331, 409, 410, 750, 755, 756,
2089, 2090, 2091, 2092, 2093, 2094, 2095, 2096,
2097, 2098, 2099.2100, 2101, 2102, 2103, 2104,
2105, 2187, 2193, 2238, 2239, 2240, 2241, 2242,
2243, 2244, 2245, 2246, 2247, 2248, 2249, 2250,
2251, 2252, 2253, 2254, 2255, 2256, 2257, 2258,
2259, 2260, 2261, 2262, 2264, 2265, 2266, 2267,
2268, 2269, 2270, 2271, 2272, 2273, 2274, 2275,
2276, 2277, 2278, 2279, 2280, 2281, 2282, 2283,
2284, 2285, 2286, 2287, 2288, 2289, 2290, 2291,
2292, 2293, 2294, 2295, 2296, 2297, 2298, 2299,
2300, 2301, 2302, 2303, 2304, 2305, 2306, 2307,
2308, 2309, 2310, 2311, 2312, 2313, 2314, 2315,
2316, 2317, 2318, 2319, 2320, 2321, 2322, 2323,
2324, 2325, 2326, 2327, 2328, 2329, 2330, 2331,
2332, 2333, 2334, 2335, 2342, 2343, 2344, 2345,
2346, 2347, 2348, 2349, 2350, 2351, 2352, 2353,
2354, 2355, 2356, 2357, 2358, 2359, 2360, 2361,
2362, 2363, 2364, 2365, 2366, 2367, 2368, 2369,
2370, 2371, 2372, 2373, 2374, 2375, 2376, 3178,
3519
μ∂μ∂™ ¡., 1
μ∂§∂°ƒ∞∫∏ ∞., 2537
μ∂§∂°ƒ∞∫∏™ °., 3195
μ∂§∂¡Δ∑∞™ Ã., 150, 3399
μ∂§πμ∞™∞∫∏™ ∂., 3405
μ∂§π™™∞ƒπ¢OÀ ∞., 2162
μ∂§πøΔ∏™ Ã., 2666
μ∂§O¡∞∫∏™ ∂., 12, 13, 2722
μ∂ªªO™ ∫., 2083
μ∂¡∂Δ∏™ Ã., 3535
μ∂ƒμ∂ƒπ¢∏™ ∞., 2525
μ∂ƒ°OÀ§∞™ °., 452, 1125
μ∂ƒ∂ΔΔ∞™ ¢., 2525
μ∂ƒƒOÀ ∂., 2027
μ∂ƒÀ∫O∫π¢OÀ ∂., 605, 655, 674, 702, 738
μ∂ƒÀ∫O∫O™ Ã., 733
μ∂™Ãπ∞ Ã., 3401
μ∏∫∞™ π., 807
μ∏Δ∞™ ∞., 2668
μ∏ΔΔ∞ π., 3539
μπ∫∂¡ΔπOÀ ª., 3228
μπ§§πøΔOÀ º., 13
μπª¶∂ƒΔ∏ °., 3419
μπO§∞∫∏ ª.. 18
μπ™μ∞ƒ¢∏™ °., 261, 757
μπΔ∞§∏ °., 2164
18
μπΔ∞§∏™ ª., 2394
μπΔøƒ∞ΔO™ ¡., 872, 2336, 3136, 3387, 3426, 3429
μ§∞´∫π¢∏™ ¡., 883
μ§∞ªπ¢∏™ ∫., 788
μ§∞™O¶OÀ§O™ ¢., 2793
μ§∞™™∞ƒ∞ ∂., 1486, 1609, 1614, 1615, 1616, 1617,
1618, 1619, 1620, 1621, 1622, 1623, 1624, 1625,
1646, 1647, 1648, 2605, 2608, 2610
μ§∞™™∏™ °., 353, 776
μ§∞Δ∞ ª., 3442
μ§∞Δ™∞™ °., 591
μ§∞ÃO°π∞¡¡∏™ ∞., 2232
μ§∞ÃO°π∞¡¡∏™ ∂., 231, 816, 3618, 3720
μ§∞ÃOª∏ΔƒO™ π., 816
μ§∞ÃO¡π∫O§∏™ π., 927, 1203, 1663, 3388, 3404
μ§∞ÃO¶OÀ§O™ Ã., 1801, 2928
μ§∞ÃO™ °., 3270
μ§∞ÃO™ π., 96
μ§∞ÃO™ §., 346, 3701
μ§∞ÃO™ ¡., 3136
μ§∞ÃOÀ ∂., 2557, 2558, 2559, 2560
μ§∞ÃOÀ £., 363
μ§∞ÃOÀ π., 3237
μ§∞ÃOÀ-™πªO¶OÀ§OÀ £., 8
μ§∞ÃOÀ-πø∞¡¡π¢OÀ Ã., 908, 1882
μ§OΔπ¢∏™ π., 805
μO°π∞Δ∑∏™ ¢., 1413
μO°π∞Δ∑∏™ π.∞., 2053
μO°π∞Δ∑∏™ π.ª., 2053
μO°π∞Δ∑∏™ ¡., 791
μO°π∞Δ∑O°§OÀ ¢., 665, 1591, 2029, 2058, 2754,
2771, 2774, 2775, 2776, 2777, 2801, 2805, 2806,
2808, 2809, 2811, 2813
μO§∞∫§∏™ ∫., 2021, 2117, 2736, 3353
μO§πøΔ∏™ °., 3316
μO§πøΔ∏™ ∫., 202, 231, 283, 420, 421, 1578, 1839,
1840, 1939, 2033, 2154, 2186, 3539
μO§OÀ¢∞∫∏™ ∫., 437
μOƒπ¢∏™ ∂., 44
μO™∫∞∫∏ ∂., 474, 485
μO™¡∞∫π¢∏™ £., 816, 1999, 2154, 2224, 2485
μOΔΔ∂∞™ μ., 351, 3289, 3369
μOÀ°∞™ μ., 2762
μOÀ°πOÀ∫∞™ ∞., 182, 531
μOÀ°πOÀ∫∞™ °., 2378
μOÀ°πOÀ∫§∏™ ¡., 2971
μOÀ¢OÀƒ∏ ∞., 944, 3479
μOÀ¢OÀƒ∏ ¶., 2016
BOY¢OÀƒ∏™ °., 1101, 1102, 1106, 1108, 1110, 1111,
1112, 1117, 3451, 3477
μOÀ¢OÀƒ∏™ ∫., 773, 802, 1466, 1467, 1468, 1469,
1470, 1471, 1472, 1473
μOÀ∫π∞™ ª., 326, 373, 392, 416, 438, 1464, 1568,
1907
μOÀ∫π¢∏™ Ã., 122
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
μOÀ§°∞ƒ∏ ∫., 3213
μOÀ§°∞ƒ∏ Ã., 3289
μOÀ§OÀª¶∞™∏ ∑., 3219
μOÀ¡μOÀƒ∞∫∏™ ∫., 3083
μOÀ¡Δ∞ Ã., 1317
μOÀ¡Δƒ∏™ μ., 2908, 3349
μOÀƒ§πøΔ∞∫∏™ °., 3343
μOÀΔ™∞¢∞∫∏™ ∞., 122
μƒ∞¢∂§∏™ ∫., 2030
μƒ∞∫∞™ •., 2936
μƒ∞¡OÀ O., 1138
μƒ∞Δ™π™Δ∞ ∂., 3277, 3326
μƒ∞Ã∞™™OΔ∞∑∏™ ¡., 3440
μƒ∂¡Δ∑O™ ∫., 2133
μƒ∂ΔΔO™ ∞., 1344
μƒ∂ΔΔO™ ª., 316, 317, 328, 533
μƒ∂ΔΔOÀ ∂., 2488
μƒ∂ΔΔOÀ ∫., 3699
μƒO¡Δ∞∫∏ ª., 8
μÀ∑∞¡Δπ∞¢∏™ ∞., 193, 260, 408, 505, 508, 805, 924
μÀ£OÀ§∫∞™ π., 351
μÀ§§πøΔ∏™ ∞., 2909, 3242, 3243, 3249, 3208, 3221,
3236
μÀ™™OÀ§∏™ °., 469, 481, 888, 896, 1673, 1956, 3086,
3161
°∞μƒ∞ ª., 1899, 3488
°∞∑∂Δ∞™ °., 690
°∞∫∏ μ., 2176
°∞∑∏ ∂., 2087
°∞∫∏™ ¢., 270, 501
°∞∫O™ ∂., 1595
°∞§∞∑πO™ °., 2466
°∞§∞¡∞∫∏™ ¡., 4, 700
°∞§∞¡∞∫∏™ ∂., 2947, 3350, 3367, 3379
°∞§∞¡O¶OÀ§O™ ∞., 676, 706
°∞§∞¡O¶OÀ§OÀ ¶., 3517
°∞§∞Δ™∞ΔO™ °., 618, 623
°∞§§∏-Δ™π¡O¶OÀ§OÀ ∞., 2669, 2743, 3421, 3431,
3435, 3437, 3452, 3637
°∞ªμƒO™ O., 798, 2760
°∞¡øΔ∞∫∏™ ∂., 1155, 2042, 2044, 2056, 2133, 2543,
3212, 3442
°∞ƒ¢π∫∞™ Ã., 158, 159, 861, 3483
°∞ƒ¢π∫∏-∫OÀ´¢OÀ ¶., 541
°∞ƒ∑ø¡∏™ ¶., 701
°∞ƒΔ∞°∞¡∏™ ™., 880, 946, 2082
°∞Δ∞∫∏™ °., 1993
°∞ΔO™ ª., 815
°∞Δ™OÀ ª., 824
°∂§∞™ΔO¶OÀ§OÀ ∫., 2910
°∂¡¡∞¢πOÀ ¢., 374
°∂ƒ∞∫∞ƒ∏ ™., 2438
°∂ƒ∞™πªπ¢∏™ £., 794, 805, 3591
°∂ƒ∞™πªπ¢∏™ Δ., 2750
°∂ƒª∞¡π¢∏™ °., 774, 1701, 2488
°∂ƒª∂¡∏™ ∞., 3340, 3341
°∂ƒO°π∞¡¡∏ °., 2977
°∂ƒO°π∞¡¡∏ ™., 2977
°EPO§YMOY B., 1977, 3451, 3457
°∂øƒ°∞ ™., 1998, 2023, 2144, 2209, 3610
°∂øƒ°∞∫O¶OÀ§O™ ¢., 3226
°∂øƒ°∞∫O¶OÀ§O™ ∫., 407, 658, 662, 1375
°∂øƒ°∞∫O¶OÀ§OÀ ∂., 212, 256, 288, 326, 370, 601,
1835, 2001
°∂øƒ°∞§∞ ∞., 401
°∂øƒ°∏∂º∂¡¢∏™ ∫., 1566, 1579, 1595, 1992, 2154
°∂øƒ°π∞¢∏™ °., 566, 2443, 3225, 3723
°∂øƒ°π∞¢∏™ ∂., 667, 670, 3399
°∂øƒ°π∞¢∏™ ∏., 1580
°∂øƒ°π∞¢∏™ π., 2688
°∂øƒ°π∞¢∏™ ª., 3411
°∂øƒ°π∞¢∏™ ¡., 950, 2938, 3577
°∂øƒ°π∞¢OÀ ∂., 1299
°∂øƒ°π∞¢OÀ ™., 1949
°∂øƒ°π§∞™ ¡., 576, 803
°∂øƒ°πO¶OÀ§O™ ¢., 2449, 2450, 3494, 3533
°∂øƒ°πOÀ ™., 2058
°∂øƒ°O¶∞§∏ ∞., 2341
°∂øƒ°O¶OÀ§O™ °., 944, 3479
°∂øƒ°O¶OÀ§O™ ¡., 1813, 2762, 3036, 3177
°∂øƒ°O¶OÀ§O™ ™., 2035, 2789, 3343
°∂øƒ°O¶OÀ§OÀ μ., 531
°EøP°O¶OY§OY °., 1960
°∂øƒ°O¶OÀ§OÀ ª., 3025
°∂øƒ°OÀ§π∞™ ¶., 2629, 3268, 3537
°∂øƒ°OÀ§π¢OÀ ∞., 2445
°∏Δ∞™ Ã., 871
°π∞μƒO°§OÀ ∫., 804
°π∞μƒO¶OÀ§OÀ ª., 3626
°π∞°∞ ∞., 1468
°π∞°π∞∫OÀ ∂., 813, 879
°π∞°§∏™ °., 2185, 2889
°π∞°OÀƒΔ∞ ∂., 2058
°π∞∫OOÀª¶∫Oμ∞ ª., 2191
°π∞§∏ ™., 2876, 3417
°π∞§OÀƒ∏™ ∞., 164, 1129, 1186, 1200, 1684
°π∞§OÀƒO™ ∫., 663
°π∞ª∞§∏™ ¢., 835, 2944
°IAMAPE§§O™-M¶OYM¶OY§H™ E., 1960, 2080, 2996
°π∞ª∞ƒ∂§§OÀ ∂., 686, 1807, 2080, 2996
°π∞¡¡∞∫∞ ª., 668
°π∞¡¡∞∫∞∫∏™ £., 2883
°π∞¡¡∞∫∏ ª., 1550
°π∞¡¡∞∫∏™ π., 1991, 2051, 2107, 2222, 2225, 2227,
2460, 2464, 2469
°π∞¡¡∞∫O¶OÀ§O™ ¡., 3388, 3404
°π∞¡¡∞∫O¶OÀ§O™ º., 480, 916
°π∞¡¡∞∫O¶OÀ§OÀ ∞., 481, 1673
°π∞¡¡∞∫O¶OÀ§OÀ μ. 6
°π∞¡¡∞∫O¶OÀ§OÀ ∫., 2218
19
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
°π∞¡¡∞∫O¶OÀ§OÀ ª., 3152
°π∞¡¡∞∫O¶OÀ§OÀ ¶., 959
°π∞¡¡∞∫O¶OÀ§OÀ-μƒ∂¡Δ∑OÀ Ã., 1923, 3405
°π∞¡¡∞∫OÀ-¢∞ƒ¢∞ ∞., 2748, 3297
°π∞¡¡∞∫OÀ§∞™ °., 1988
°π∞¡¡∞∫OÀ§π∞ ª., 3258, 2532
°π∞¡¡∞∫OÀƒ∞™ π., 68, 113
°π∞¡¡∞∫OÀƒ∏™ ¡., 2165
°π∞¡¡∞ƒ∏™ ¢., 3426
°π∞¡¡∞ΔO™ π., 54, 96, 133, 144, 262, 1146, 1148
°π∞¡¡πΔ™∞™ ∫., 3398
°π∞¡¡O°§OÀ °., 1988
°π∞¡¡O¶OÀ§O™ ∞., 346, 761, 1332, 1960, 3085, 3243
°π∞¡¡OÀ∫∞∫∏™ ¡., 1598, 1608, 1629, 1632, 1633
°π∞¡¡OÀ§∏ Ã., 270, 271, 572, 573
°π∞¡¡OÀ§∞∫∏ ∂., 3512
°π∞¡¡OÀ§∏™ °., 2427, 2432
°π∞¡¡OÀ§∏™ ∂., 378
°π∞¡Δ™∂§π¢∏™ Ã., 3720
°π∞¶π∑∞∫∏™ Ã., 2909, 3242, 3243, 3249, 3208, 3221,
3226, 3291
°π∞ƒO™ ¶., 1170
°π∞™™∞∫∏™ °., 2474, 2483, 2484
°π∞ΔƒOª∞¡O§∞∫∏ ∞., 2466
°π¢∞ƒ∞∫OÀ π., 2537
°πO∫∞ƒ∞∫∏™ £., 537
°πOÀ§∂ª∂ O., 2196
°πOÀΔπ∫∞™ ™., 207
°πøμO™ π., 401, 508, 590, 1456, 1505, 1559, 1820,
2071, 2232, 2237, 2579, 2626, 2764, 2765, 2988,
3046, 2906, 3201, 3262, 3626, 3630
°πøƒ°πøΔ∏™ ∫., 1308
°πøΔ∏™ Ã., 773, 1469, 1470, 1471, 1472
°∫∞´Δ∞Δ∑∏ ª., 3420
°∫∞§∂∞™ £., 3029
°∫∞§π∞°∫OÀ™∏ ∂., 1983, 1997
°∫∞¡π∞ ¶., 1339
°∫∞¡Δ∑∞ƒOÀ ∞., 1835, 1836
°∫∞ƒ∑ø¡∏™ ¶., 3395
°∫∞Δ∑πOÀ μ., 2800
°∫∞Δ∑O§∞-∫∞ƒ∞μ∂§∏ ª., 589, 791
°∫∞Δ™πOÀ Ã., 3433
°∫∞Δ™OÀ ¶., 3483
°∫∂ªπΔ∑∏™ ∫., 1586, 2040
°∫π∞§∞ºO™ ∂., 3289
°∫π∫∞ ∂., 2162, 2870
°∫π∫∞™ ∞., 3151, 3276, 3345, 3348, 3365, 3378
°∫π¡∂ƒ∏-∫O∫O™™∏ ª., 3197
°∫π¡∏ ™., 906
°∫π¡∏™ ∞., 3282
°∫π¡O™ π., 463, 984, 1001, 1002, 1004, 1009, 1013,
1014, 1070
°∫πOªπ™∏ §., 2667
°∫πOªπ™∏™ £., 815
°∫πƒΔ∑∏™ π., 356, 372, 1458, 1578, 2154
20
°∫Oμ∞ ∞., 2340
°∫O°∫O™ °., 1403
°∫O°∫O™ ∫., 2946
°∫O°∫O™ Ã., 3417
°∫O°∫OÀ °., 2894, 3385, 3436
°∫O§ºπ¡O¶OÀ§O™ §., 1307
°∫Oª∏™ ƒ., 3499, 3512, 3513, 3514, 3704
°∫O¡π∞¢∞∫∏™ Ã., 3440
°∫O¡O™ ∂™., 2529
°∫Oƒ∂∑∏™ ™., 3321
°∫OƒπΔ™∞™ Ã., 3395, 3443
°∫OΔ∑∞ª∞¡∏-æ∞ƒƒ∞∫OÀ ∞., 2579
°∫OΔ™∏™ ¡., 356, 371, 372, 384, 435, 436, 633, 799,
816, 2379, 2380
°∫OÀμ∂ƒ∏ ∂., 3533
°∫OÀª∞™ ∞., 68
°∫OÀª∞™ ª., 1875
°∫OÀ¡∏ π., 797
°∫OÀƒ°πøΔ∏™ ¢., 3304
°∫OÀƒ¡∂∑∞∫∏ °., 3337
°∫OÀƒΔ™OÀ°π∞¡¡∏™ ¡., 3367
°∫OÀΔ∑∞¡∏™ ∞., 3208, 3221
°∫OÀΔ∑∞¡∏™ §., 2909, 3236, 3242, 3243, 3249, 3291
°∫OÀΔ∑∞ƒπ¢OÀ º., 2000
°∫OÀΔ∑OÀƒ∂§∞ ª., 626, 636, 886, 1524, 1573, 1581,
1796, 1853, 1854
°∫OÀΔ∫π¢OÀ ™., 373, 384, 405, 438, 461, 598, 1461,
1562, 1582, 1835, 1837, 1856, 1950, 2001
°∫OÀΔ™∞ƒπ¢∏™ ¡., 789
°∫ƒ∂∫∞™ ¢., 3216, 3232
°∫ƒ∂ª¶O°π∞¡¡∏ ¢., 393, 458
°∫ƒπª¶π∑∞™ °., 794
°§∏¡∂§∏ ∂., 471, 1409
°¡∞ƒ¢∂§§∏™ Ã., 3519
°O§∂ª∞Δ∏™ μ., 43, 610, 611, 612, 613, 614, 616, 617,
618, 619, 620, 621, 622, 623, 624, 3461
°Oª∞ΔO¶OÀ§O™ π., 133
°Oƒ°O§∏™ ™., 895
°OÀ¢∂μ∂¡O™ π., 1843, 2056, 2108, 2671
°OÀ∂§∞ ª., 393, 458
°OÀ§∞ ∞., 3132
°OÀ§∞ ∂., 2735
°OÀ§∏™ °., 181, 192, 571, 820, 822, 823
°OÀ§∏™ ¢., 1842, 2733, 2752, 2753, 3463, 3535, 3536
°OÀ§π∞ O., 2031
°OÀ§π∂§ªO™ °., 2039, 2947
°OÀª∂¡O™ ¢., 3534
°OÀ¡∞ƒπ¢∏™ ∂§., 1595
°OÀƒ°πøΔ∏™ ¢., 3363
°OÀƒ°OÀ§π∞¡∏™ ∫., 3340, 3341, 3356, 3376, 3383,
3390
°OÀƒ¡∞ƒ∏ ¡., 3140
°OÀΔΔ∞™ ∞ƒ∫., 558
°ƒ∞°OÀ¢∞™ ∂., 3171
°ƒ∞ªª∞Δπ∫∞∫∏ ∂., 3219
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
°ƒ∞ªª∞Δπ∫O™ º., 788
°ƒ∞ªª∂¡O™ ∞., 1583
°ƒ∞ªª∂¡OÀ-™∞μμO°§OÀ ™., 3084
°ƒ∞ªªOÀ™Δπ∞¡O™ ∫., 1265
°ƒ∞¡πΔ™∞™ ∞., 86, 197
°ƒ∞æ∞ °., 3349
°ƒ∞æ∞™ ∂., 3441
°ƒ∂∫∞™ ¢., 183, 2214, 3581
°ƒ∏°Oƒ∞∫∏™ ™., 1534, 1542, 1800, 3329, 3439, 3458
°ƒ∏°Oƒπ∞¢∏™ °., 1610, 1611, 1612, 1613
°ƒ∏°Oƒπ∞¢OÀ ∂., 1523, 2140
°ƒ∏°Oƒπ∞¢OÀ ª., 1811, 1928, 2478, 2653, 2654,
2993, 3018, 3449
°ƒ∏°OƒπOÀ O., 853
°ƒ∏°OƒO¶OÀ§O™ μ., 3339
°ƒ∏°OƒO¶OÀ§OÀ ∫., 2921
°ƒ∏°OƒO¶OÀ§OÀ ¶., 3150
°ÀºΔO¶OÀ§O™ ∫., 3303, 3398, 3412
°ø°OÀ μ., 3174
¢∞μ∞ƒ∏™ ¶., 612, 619, 620
¢∞μπ§§∞™ ¡., 3085
¢∞μOÀ§O™ °., 707
¢∞°∫ƒ∂ ∞., 3407
¢∞¢πøΔ∏™ §., 2109, 2142, 2339, 2526
¢∞´∫O™ °., 3, 4, 10, 15, 165, 169, 241, 306, 606, 607,
608, 655, 656, 674, 683, 685, 686, 690, 698, 699,
700, 701, 703, 704, 723, 724, 725, 726, 727, 728,
729, 736, 738, 847, 3065
¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ K., 143, 149, 160, 312, 363, 535,
1201, 2531, 631, 633, 846, 902, 960, 1465, 1550,
1672, 1698, 1718, 1921, 1957, 1958, 3425, 3447,
3448, 3467, 3490
¢∞§∞ª∞°∫∞ ∂°., 2540, 2541
¢∞§∞ª∞°∫∞™ °., 2118
¢∞ª∞¡π¢OÀ ¢., 408
¢∞ªπ∞¡∞∫∏ ¢., 363, 1460, 1465, 2394, 2676
¢∞ªπ∞¡π¢∏™ °., 2022
¢∞ªπ§∞∫∏™ π., 3367
¢∞¡∞§∞ΔO™ ∞., 898
¢∞¡¢OÀ§∞∫∏ ∂., 3057
¢∞¡∂§∞ΔOÀ-∞£∞¡∞™π∞¢OÀ ∫., 1142
¢∞¡π∏§π¢∏™ ∞., 2672
¢∞¡π∏§π¢∏™ ª., 222, 381
¢∞¡π∏§π¢OÀ ¡., 2537
¢∞¡O¶OÀ§O™ ∂., 561, 2912, 3484
¢∞¶∂ƒ°O§∞™ °., 1610, 1612
¢∞ƒμπƒ∏ ∫., 240, 244
¢∞ƒ™π¡O™ π., 862, 3153
¢∞™∂¡∞∫∏ ª., 3198
¢∞™∫∞§∞∫∏ °., 3200
¢∞™∫∞§∞∫∏ £., 1
¢∞™∫∞§Oμ∞ ™., 2425
¢∞™∫∞§O¶OÀ§OÀ ∂., 287, 3618
¢∞™∫∞§O¶OÀ§OÀ ™., 2042, 3333, 3520
¢∞ÀƒO™ π., 20
¢∞º¡∏™ ∂., 3255, 3292
¢∞ºO¶OÀ§O™ ∫., 3390
¢∂¢OÀ™∏™ °., 3251
¢∂§∏μ∂§πøΔOÀ ∞., 3136
¢∂§∏μOƒπ∞ Ã., 1589
¢∂§∏°∂øƒ°∏™ ¢., 1920
¢∂§∏°∂øƒ°πOÀ ∂., 3408
¢∂§∏°π∞¡¡∏™ ∞., 1350, 2639
¢∂§∏∫ø¡™Δ∞¡Δπ¡OÀ ∏., 2813
¢∂§∏™ ¢., 468, 474, 476, 1384, 1520
¢∂§∏™Δ∞£∏ ¢., 3140
¢∂§πOÀ™∏™ ∞., 2689
¢∂ªπƒΔ∑O°§OÀ £., 1833, 1834
¢∂ƒμ∂¡πøΔ∏™ μ., 183
¢∂ƒμπ™∏™ ∫., 2035
¢∂ƒ∂∫§∏™ ¢., 946, 2673, 2674
¢∂ƒ∫∞ ™., 3242, 3249, 3221, 3236, 3291
¢∂™™∂™ ¡., 1715
¢∂™ΔOÀ¡∏ ∞., 3699
¢∂ÀΔ∂ƒ∂μO™ ∂., 84
¢∏§∞μ∂ƒ∏™ ¶., 3289
¢∏ª∞∫O¶OÀ§O™ ¡., 1107, 1115, 1120, 2629, 3268,
3537
¢∏ª∏Δƒ∞∫O¶OÀ§O™ °., 3417
¢∏ª∏Δƒ∞∫O¶OÀ§O™ ∫., 2024, 2497, 2499, 2524
¢∏ª∏Δƒ∞∫O™ ™., 2938
¢∏ª∏Δƒ∞ΔO™ ™., 493, 945
¢∏ª∏Δƒπ∞¢∏™ ∞., 403
¢∏ª∏Δƒπ∞¢∏™ °., 23, 24, 809, 899, 927, 930, 1128,
1155, 1163, 1164, 1182, 1183, 1185, 1203, 1264,
1307, 1311, 1312, 1313, 1345, 1600, 1601, 1640,
1641, 1642, 1643, 1644, 1650, 1651, 1652, 1653,
1654, 1655, 1656, 1657, 1658, 1659, 1660, 1661,
1662, 1663, 1664, 1665, 1666, 1667, 1668, 2062,
2449, 2450, 2451, 2452, 2453, 2454, 2455, 2456,
2457, 2458, 2493, 2494, 2495, 2496, 2500, 2512,
2582, 2660, 2790, 2850, 2984, 3006, 3528, 3634
¢∏ª∏Δƒπ∞¢∏™ ¢., 2132
¢∏ª∏Δƒπ∞¢∏™ Ã., 953, 3510
¢∏ª∏Δƒπ∞¢OÀ-μ∞º∂π∞¢OÀ ∞., 540, 789, 3437
¢∏ª∏ΔƒπOÀ ¢., 434, 2055
¢∏ª∏ΔƒπOÀ ∏., 3349
¢∏ª∏ΔƒπOÀ ∫., 2544, 3511
¢∏ª∏ΔƒπOÀ º., 288, 339
¢∏ª∏ΔƒO¶OÀ§O™ ™., 2936
¢∏ª∏ΔƒO¶OÀ§OÀ ¢., 2946
¢∏ª∏ΔƒOÀ§∞ Ã., 2005, 2016
¢∏ª∏Δ™π∫O°§OÀ ∞π∫., 230, 1992
¢∏ª∏Δ™π∫O°§OÀ ∞¡., 2037
¢∏ª∏Δ™π∫O°§OÀ π., 1833, 1917, 2052
¢∏ª∏Δ™π∫O°§OÀ ¡., 178, 179, 204, 208, 229, 230,
255, 356, 385, 417, 1134, 1566, 1458, 1526, 1527,
1528, 1529, 1530, 1579, 1592, 1595, 1833, 1834,
1852, 1917, 1918, 1939, 1992, 2037, 2052
¢∏ªO¶OÀ§O™ μ., 2114, 3158
21
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¢∏ªO¶OÀ§O™ ¶., 3534
¢∏ªO¶OÀ§O™ ™., 946
¢∏ªO¶OÀ§O™ Ã., 3311
¢∏ªO™ °., 3391
¢∏ªO™£∂¡O¶OÀ§O™ ∫., 2585, 3522
¢∏ªOÀ ∂., 2161, 2340, 2428, 2431, 2436
¢∏ªOÀ¢∏™ ™., 2186
¢π∞∫O°§OÀ ∞., 2670
¢π∞∫O°§OÀ ∂., 2670
¢π∞∫Oª∞¡ø§∏™ ∂ªª., 1328
¢π∞∫O¶OÀ§O™ °., 3094
¢π∞∫OÀªO¶OÀ§OÀ ∂., 1430, 2199, 2873, 2905, 3369
¢π∞ª∞¡Δ∏-∫∞¡Δ∞ƒ∞∫∏ ∂., 1299, 1506, 1821, 2077,
2413, 2611, 2964, 2974, 2980, 3010, 3210
¢π∞ª∞¡Δ∏-∫∏¶πøΔ∏ ∞., 907, 963
¢π∞ª∞¡ΔO¶OÀ§O™ ∂., 20, 37, 38, 854, 856, 859, 874,
1172, 1176, 1190, 1194, 1198, 1205, 1206, 1254,
1255, 1256, 1257, 1260, 1261, 1265, 1295, 1497,
1516, 1811, 1928, 2081, 2449, 2450, 2478, 2521,
2543, 2653, 2654, 2782, 2879, 2993, 3018, 3388,
3404, 3449, 3494, 3533, 3534
¢π∞ª∞¡ΔO¶OÀ§O™ ™Δ., 46, 55
¢π∞ª∞¡ΔO¶OÀ§OÀ ∞π., 2192
¢π∞ƒ∂ª∂ ª., 2895
¢π°∂¡∏™ °., 929, 1359
¢π¢∞°°∂§O™ Δ., 322, 327, 338, 355, 434, 498, 509,
1398, 1457, 1584, 1680, 1681, 1682, 1683, 1827,
1857, 1891, 1947, 1983, 1994, 1997, 1998, 2008,
2009, 2015, 2022, 2023, 2028, 2043, 2055, 2075,
2135, 2140, 2144, 2147, 2154, 2171, 2173, 2042,
2182, 2188, 2196, 2197, 2209, 2233, 2518, 2536,
2539, 2540, 2541, 2544, 2563, 2579, 2580, 2783,
2825, 2847, 3064, 3155, 3554, 3576, 3584, 3598,
3635, 3666
¢π∑∞ ∂., 1459, 2228
¢πO¡À™πOÀ-∞™Δ∂ƒπOÀ ∞., 3394
¢πO¡À™O¶OÀ§OÀ ∂., 3350
¢πO¡À™O¶OÀ§OÀ ™., 2041
¢π¶§∞ μ., 1918
¢Oμ∞™ ¡., 733
¢Oμ∞™ ™., 3152
¢O¢OÀƒ∞™ £., 383
¢O∫∞™ ™., 2488
¢O∫O¶OÀ§OÀ ª., 2218, 3362
¢OªμƒO™ ¡., 3216
¢O¡Δ∞ ∞., 2942
¢O¡Δ∞ π., 3208, 3291
¢O¡Δ∞ Ã., 3478
¢O•π∞¢∏™ ™., 116, 119
¢O§°Àƒ∞™ ™., 2154
¢O™πO™ Δ., 2424
¢OÀμ∞ƒ∞-¶∞¶∞ƒ∏ °., 857, 3084
¢OÀ¢∞ ∂., 2162
¢OÀ∫∞™ §., 2632
¢OÀ∫π¢∏™ ¢., 460, 600
22
¢OÀ§°∂ƒ∞∫∏™ ¢., 2199, 3302
¢OÀ§°∂ƒ∏™ Ã., 2055
¢OÀ§OÀª¶∞∫∞™ π., 2745, 3714
¢OÀª∞ ™., 3715
¢OÀª∞™ ª., 359
¢OÀ¡∞μ∏™ ∞., 2796
¢OÀ¡∏™ μ., 3280
¢OÀ¡∏™ ∂., 2702, 3196
¢OÀƒ∞∫∏™ ™., 3293
¢OÀƒμ∞™ °., 787
¢OÀ™∏ μ., 3121
¢OÀ™OÀ μ., 458, 2194
¢OÀº∂•∏™ ¢., 3233
¢ƒ∞°π¡∏™ ∂., 651, 683, 684
¢ƒ∞°∫πøΔ∏ μ., 2859
¢ƒ∞°∫πøΔ∏™ μ., 1705
¢ƒ∞°∫πøΔ∏™ ∂., 2050
¢ƒ∞°OÀª∏™ ∫., 3352
¢ƒ∞∫∞ΔO™ ∞., 3226
¢ƒ∞∫O¶OÀ§O™ π., 3207
¢ƒ∞∫O¶OÀ§O™ ™., 2762
¢ƒ∞∫O¶OÀ§OÀ ª., 1550, 1672, 1698, 3315, 3318,
3448
¢ƒ∞∫OÀ§∞∫O™ ¢., 418, 3435, 3437, 3452, 3453
¢ƒ∞∫ø¡∞∫∏™., 2763
¢ƒ∞ª¶∞ μ., 3627
¢ƒ∞¡π¢∏™ μ., 686
¢ƒπ∞°∫∞ ∫., 2737
¢ƒπμ∞™ °., 3032
¢ƒπ∑∏ §., 1118
¢ƒπª∏™ ™., 263, 2940
¢ƒO°∫∞ƒ∏ ∂., 766
¢ƒO™π¡O™ ∂., 1128, 1376
¢ƒO™O™ °., 2525
¢ƒO™O™ £., 3036
¢ƒO™O™ Δ., 2437
¢ƒO™OÀ ∞., 3059
¢ƒOÀ∑∞™ ∞., 2973
¢ƒOÀΔ™∞™ ¢., 3464
∂∫∞ΔOª∞Δ∏™ ¶., 8
∂∫ª∂Δ∑O°§OÀ ∫., 2679, 3295
∂§∂À£∂ƒπ∞¢∏™ ∂., 387
∂§∂À£∂ƒπ∞¢∏™ £., 2552, 2553, 3316
∂§∂À£∂ƒπ∞¢OÀ π., 2517, 3150
∂§π™∞º ª., 268, 334, 343, 344, 875, 954, 955, 956,
957, 958, 1843, 1911, 1912, 2042, 2043, 2044, 2056,
2087, 2196, 2431, 2433, 2436, 2530, 2543, 2837,
2953, 3001, 3212, 3373, 3391, 3422, 3423, 3677
∂ªª∞¡OÀ∏§π¢OÀ ª., 2000, 2743
∂•∞ƒÃ∞∫O™ °., 621
∂•∞ƒÃ∂∞™ ¢., 607
∂•∞ƒÃO™ Δ., 3062
∂•π∞ƒ∞ Δ., 2381, 3355
∂¶∞¡øª∂ƒπΔ∞∫∏™ ∂., 2881, 3442, 3455
∂ƒ∂À¡π¢OÀ ∫., 3269
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∂ƒøΔO∫ƒπΔOÀ °., 3049
∂À∞°°∂§∞ΔOÀ ∂., 2897
∂À∞°°∂§O¶OÀ§O™ ∞., 1420
∂À∞°°∂§O¶OÀ§OÀ ∫., 667, 670
∂À∞°°∂§πOÀ ∞., 3332, 3350
∂À∞°°∂§OÀ ∞., 773, 1469, 1470, 1471, 1472
∂À∞°°∂§OÀ ¡., 3186
∂À¢øƒπ¢OÀ π., 2971
∂À£Àªπ∞¢∏™ ∞., 339, 340, 345, 401, 439, 459, 1463,
1561. 2756
∂À£Àªπ∞¢∏™ °., 787
∂À£Àªπ∞¢∏™ π., 439, 1561, 2752
∂À£Àªπ∞¢∏™ ¡., 1910
∂À£Àªπ∞¢∏™ ¶., 832
∂À£ÀªπOÀ ∂., 3120
∂À£ÀªπOÀ ∏., 227, 236, 267, 270, 271, 369, 402, 404,
411, 460, 572, 573, 596, 599, 600, 603, 604, 759,
805, 1455, 1560, 1564, 1592, 1906, 1942, 1984,
2026, 2032, 2137, 2175, 2675, 2680, 2681, 2943
∂À£ÀªπOÀ ¡., 452
∂ÀªOƒºπ∞¢∏™ ∏., 2808
∂À™Δ∞£π∞¢OÀ ª., 1917, 2037
∂À™Δ∞£π∞¢OÀ-™Δ∞ª∞ΔO¶OÀ§OÀ ª., 1527, 1529,
1833, 1918
∂À™Δ∞£πOÀ ™., 3393
∂À™Δƒ∞Δπ∞¢∏™ °., 204, 208, 229, 230, 2445, 2748,
3297
∂À™Δƒ∞Δπ∞¢OÀ ª., 848
∂À™Δƒ∞ΔπOÀ ∂., 3716
∂À™Δƒ∞ΔO¶OÀ§O™ ∞., 915, 3079, 3081
∂ºƒ∞πªπ¢OÀ ∞., 2939,
∑∞μπΔ™∞¡∞∫∏™ ∞., 808
∑∞μO™ ∫., 2488
∑∞°∞¡π¢∏™ ∞., 3537
∑∞°∫∞ ∞., 1415
∑∞°∫§∞μ∞ƒ∞ Δ∞., 2040
∑∞´ƒ∏™ ª., 2109, 2339, 2341, 2423, 2430, 2435, 2526,
2527, 2766, 3364, 3538
∑∞ª∞¡∏™ ¡., 1422, 1450
∑∞ª¶∂§∞™ ∞., 3259
∑∞ª¶∂§∏™ £., 1606
∑∞ª¶OÀ§∏™ Ã., 225, 359, 445, 452, 508, 790, 2201,
2744, 3240, 3714, 3715
∑∞¡Δπ¢∏™ ∞., 2233, 2563, 2580
∑∞ƒ∞ºø¡πΔ∏™ X., 109
∑∞ƒμ∞§∏ ∞., 2669
∑∞ƒ∫O°π∞¡¡∏ ∫., 3222, 3223
∑∞ƒ¶∞Δ∏ ¶., 2670
∑∞ƒƒ∞ ∞., 3073
∑∞ƒƒO™ ∞., 3517
∑∞º∂πƒ∏ ª., 3064
∑∞º∂πƒ∏™ ∞., 2164
∑∞º∂πƒπOÀ ¢., 2971
∑∞º∂πƒπOÀ ∫., 326, 371, 601, 1563
∑∞º∂πƒO¶OÀ§O™ ∞., 3374
∑∞ºƒ∞∫∞ ª., 3352
∑∞ºƒ∞¡∞™ ∞., 552
∑∞Ã∞ƒ∏™ ∞., 1129
∑∞Ã∞ƒ∏™ ∂., 2133, 3217
∑∞Ã∞ƒπ∞¢∏™ μ., 529
∑∞Ã∞ƒπ∞¢∏™ ¢., 779, 1110, 1111, 1112, 1113, 1116,
1121, 1122, 1410
∑∞Ã∞ƒπ∞¢∏™ O., 2678
∑∞Ã∞ƒπOÀ ª., 1546
∑∞Ã∞ƒπOÀ ¡., 154, 211
∑∞Ã∞ƒπOÀ¢∞∫∏ ∫., 311, 461, 1562, 1582
∑∞Ã∞ƒO™ π., 3393
∑∞Ã∞ƒOÀ§∏™ ¢., 2288
∑∞Ã∞ƒøº ∞., 831, 2689
∑∞ÃO™ ∞., 144
∑∞ÃO™ ∫., 3065
∑∞ÃO™ §., 574, 575
∑∂μ§∞ ª., 3092
∑∂´ª¶∂∫∏™ ∞., 2910, 3237
∑∂ª¶∂∫∞∫∏™ ¶., 1894, 1895, 2626, 2695, 2764, 2765
∑∂ƒμ∞ ∞., 2413
∑∂ƒμ∞ §., 1699
∑∂ƒμ∞∫∏™ π., 1918
∑∂ƒμ∞™ μ., 3723
∑∂ƒμ∞™ π., 846
∑∂ƒμO¶OÀ§O™ °., 13
∑∂ƒμO™ ∫., 105
∑∂ƒμOÀ ª., 2039
∑∂ƒ∂ºO™ ¡., 738
∑∂ƒª¶∞§∞ ™., 2973
∑∏∫∞ π., 1460
∑∏∫∞ Ã., 2893
∑∏∫π¢OÀ Ã., 288
∑∏ƒπ¡∏™ º., 1553
∑∏ƒO°π∞¡¡∏™ ¶., 168, 661, 854, 864, 1249, 1252,
1500
∑∏™ μ., 1606
∑∏™∞∫∏ ∞., 3273
∑∏Δ∏™ ∏., 2714
∑π∞∫∞™ ∞., 1589
∑π∞∫∞™ °., 189, 574, 575, 1589
∑π∞∫∞™ ¶., 3210
∑π∞¡¡∞™ π., 878
∑π∫∞ π., 1460
∑π¡Δ∑∞ƒ∞™ ∂., 3239, 3314, 3327, 3338
∑πOÀΔ∞™ °., 518, 887, 2148
∑πOÀΔ∞™ ¢., 1585
∑πø°∞™ ∫., 2017
∑O§øΔ∞™ ¡., 1408
∑Oƒª¶∞™ ™., 2973
∑OÀ§πøΔ∏™ Ã., 1146
∑OÀª∞∫∏™ ∂., 3235
∑OÀª¶∞ƒπ¢∏™ ¡., 757
∑OÀª¶O™ ¡., 3416
∑OÀª¶OÀ§∏™ Ã., 3044
23
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∑OÀ¶∞™ ∫., 3512, 3704
∑OÀ¶∞™ Ã., 37, 38, 172, 186, 775, 854, 856, 864,
1163, 1164, 1249, 1250, 1252, 1253, 1254, 1502
∑OÀƒπ¢∞∫∏™ ∞., 1500
∑OÀƒ§∞™ ¶., 3050
∑OÀΔ™O™ ¢., 383
∑À°∫∞§∞∫∏ ∂., 3227
∑ø°πOÀ ¶., 2670
∑ø°ƒ∞ºO™ °., 2679, 3295
∑ø°ƒ∞ºOÀ μ., 3117
∑ø°ƒ∞ºOÀ π., 1983, 1997, 3240, 3714
∑ø∏™ Ã., 2021, 2117, 3353
∑ø´¢OÀ ∞., 298
∑ø™∏ ¶., 1903
∏°OÀª∂¡π¢∏™ ¡., 3374
∏§π∞¢∏™ μ., 437, 1137, 1568
∏§π∞¢∏™ º., 2013, 2141, 2148, 2171, 2182, 2234,
2579, 2580, 2862, 3192, 3218, 3250, 3265, 3539,
3564, 3572, 3586, 3619, 3641
∏§π∞™ π., 3366, 3415
∏§πO¶OÀ§O™ °., 2130, 3306
∏§πO¶OÀ§O™ ¢., 733, 3192
∏§πO¶OÀ§O™ π., 2476
∏§πO¶OÀ§O™ ™., 240
∏§πO¶OÀ§OÀ μ., 1098, 1099, 1102, 1103, 1105, 1108,
1113, 1872, 3477, 3409, 3413
∏§πO¶OÀ§OÀ ¢., 3230, 3266
∏§πO¶OÀ§OÀ ∂., 1534, 1711
∏¶πøΔOÀ ª., 684
∏ƒ∞∫§∂π∞¡OÀ ™., 1138, 1565, 1594, 1911, 2108, 2338,
2382, 2384, 2389, 2394, 2397, 2405, 2406, 2407,
2408, 2425, 2433, 2440, 2507, 2822, 2826, 2940,
3188, 3300, 3662, 3664
∏ƒ∞∫§∂πøΔ∏ ™., 1565, 2397
£∞§∞™™π¡O™ ¡., 26, 147, 153, 164, 174, 279, 448,
865, 876, 893, 902, 960, 961, 962, 963, 1186, 1256,
1434, 1480, 1521, 1662, 1817, 1927, 1930, 1959,
2451, 3022, 3277, 3286, 3326, 3471, 3512
£∞§∞™™π¡OÀ §., 1800, 3281
£∞¡∞™∞ °., 3434
£∞¡O¶OÀ§OÀ ∞., 1399, 1858, 2481, 2511, 2544,
2561, 2562, 2564, 2565, 2566, 2567, 2568, 2569,
2570, 2571, 2572, 2573, 2574, 2575, 2576, 2577,
2583, 2584, 2586
£∞¡O™ ∞., 3085
£∞¡O™ §., 3293
£∂π∞™¶ƒ∞™ §., 2814
£∂O¢O™π∞¢∏™ °., 737, 3339, 3479, 3464, 3470
£∂O¢O™π∞¢∏™ ¶., 944, 3339
£∂O¢O™πOÀ ∂., 2190
£∂O¢O™O¶OÀ§OÀ ∂., 2559
£∂O¢øƒ∞ ª., 3270
£∂O¢øƒ∞∫O¶OÀ§O™ ¶., 910
£∂O¢øƒπ¢∏™ ª., 3582
£∂O¢øƒπ¢∏™ •., 3460
24
£∂O¢øƒπ¢∏™ ™., 395, 954, 1580, 2499, 2524
£∂O¢øƒπ¢∏™ Δ., 3326
£∂O¢øƒπ¢∏™ Ã., 363, 633, 1465, 1916, 3305
£∂O¢øƒπ¢OÀ ∞., 3510
£∂O¢øƒO¶OÀ§O™ μ., 1101
£∂O¢øƒO¶OÀ§OÀ °., 580
£∂O¢øƒO¶OÀ§OÀ ∂., 3278
£∂O¢øƒOÀ ∞., 3105
£∂O¢øƒOÀ π., 2875, 3488
£∂O¢øƒOÀ Ã., 3309
£∂OΔO∫∞ π., 3366
£∂Oº∞¡π¢∏™ ¢., 2755
£∂Oº∞¡π¢∏™ ∫., 651, 653, 654, 3088
£∂OÃ∞ƒ∏ ª., 467, 469, 481, 1593, 1673
£∂OÃ∞ƒ∏™ ∞., 911
£Àª∂§§∏ π., 1863, 2219, 3362
£ø¢∏™ ∏., 2717, 3430, 3444
£ø´¢OÀ ∂., 2050
£øª∞´¢∏™ μ., 802
£øª∞´¢∏™ £., 143, 149
£øª∞´¢∏™ Δ., 2625
£øª∞∫O™ ¶., 3687, 3688, 3691, 3700
£øªO¶OÀ§O™ ¶., 542
£øªO¶OÀ§OÀ ™., 2908
π∞∫øμπ¢∏™ ∞., 2232
π∞∫øμπ¢∏™ °., 58, 106
π∞Δƒπ¢∏™ ¶., 1785
π∞ΔƒOÀ Ã., 2973
π∂ƒ∂ªπ∞™ ¢., 351
π∂ƒO¢π∞∫O¡OÀ Ã., 2232
π∫∫O™ ¢., 50, 87, 88, 89, 90, 91, 92, 125, 126, 127,
142, 737, 833, 913, 1145, 1146, 3483
πªμƒπO™ °., 501
𪶃π∞§O™ ¶., 632, 820, 832
πOƒ¢∞¡π¢OÀ ª., 2005, 2030, 2378
πOÀ§π∞¡OÀ ™., 1838
π™∞∞∫π¢∏™ ¶., 2747
πø∞∫∂πª ∂., 3321, 3359
πø∞∫∂πªO°§OÀ °., 1721
πø∞¡¡π¢∏™ ∞., 437, 640, 1569, 1570, 1596
πø∞¡¡π¢∏™ °., 1480, 1817, 1927, 1930, 3277, 3286,
3326
πø∞¡¡π¢∏™ ¢., 180
πø∞¡¡π¢∏™ ∏., 1835, 1856, 2553, 2554
πø∞¡¡π¢∏™ π., 586, 751, 1479, 1912, 2546, 2585, 2593,
2677, 2786, 2851, 2873, 2966, 3320, 3347, 3500,
3512
πø∞¡¡π¢∏™ ∫., 2936
πø∞¡¡π¢∏™ ¶., 663
πø∞¡¡π¢OÀ ¢., 1593
πø∞¡¡π¢OÀ ∂., 439
πø∞¡¡π¢OÀ ª., 2730
πø∞¡¡π¢OÀ-¶∞¶∞°π∞¡¡∞∫∏ ∂., 464, 792, 3045
πø∞¡¡π¢OÀ-¶O£OÀ§∞∫∏ ™., 182
πø∞¡¡OÀ μ., 461
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
πø∞¡¡OÀ π., 1080, 2060
πø∞¡¡OÀ ∫., 3346
πø™∏ºπ¢∏™ ¡., 1944
∫∞μ∞¢π∞™ °., 3467
∫∞μ∞∑∞ƒ∞∫∏™ ∂., 3363
∫∞μ∞¡O∑∏-∞§∂μπ∑OÀ ∞., 386, 534, 1793
∫∞μ∞¡Δ∑∞™ ¡., 3291
∫∞μOÀƒ∞ º., 3320, 3347
∫∞μOÀƒ∞™ ¢., 3372
∫∞μOÀƒ∞™ ™., 2721
∫∞°π∞™ ™., 3033
∫∞°ª∞∫∏™ ¶., 1
∫∞¢O°§OÀ ¡., 2143, 2163, 2234, 2690, 3265, 3205,
3218, 3250, 3333
∫∞∑∞∫O™ ∫., 400, 432, 456, 1401, 1456, 1559, 2057,
2059, 2154, 2183, 2232, 2237, 2525, 2626, 2764,
2833, 2906, 3262, 3201, 3225, 3539, 3542, 3543,
3544, 3626, 3631, 3672
∫∞∑∞∫O™ ¡., 3530
∫∞∑∞¡Δ∑∏™ ª., 493
∫∞∑∞ƒ∞™ π., 1855
∫∞∑∏™ ∞., 2970
∫∞∑π∞¡∏™ °., 2618, 3190
∫∞∑π¡∞∫∏™ °., 439
∫∞∑§∞ƒ∏™ ∂., 49
∫∞´ª∞ƒ∞-¶∞¶∞£∞¡∞™πOÀ ∞., 1916
∫∞´™∏™ Ã., 182
∫∞∫∞μ∞™ ¡., 3240
∫∞∫∞μ∂§∞™ ∂., 3487
∫∞∫∞°π∞ ¢., 3225
∫∞∫∞ƒπ¡OÀ ∂., 2000
∫∞∫∞Δ™O™ π., 2142, 2383
∫∞∫∞º∏∫∞ ∞.π., 2042, 2043, 2056, 2196, 2602, 3212
∫∞∫§∞ª∞¡∏™ §., 3227
∫∞∫§∞ª∞¡∏™ º., 74
∫∞∫§∞ª∞¡∏™ ¶., 262
∫∞∫§∞™ ¡., 1299
∫∞∫§∂∞™ ∫., 1201, 2531, 2618, 2911
∫∞∫OÀ °., 3137
∫∞∫OÀ ª., 3388, 3404
∫∞∫OÀ§∞∫∏ ™., 2763
∫∞∫OÀ§π¢∏™ π., 1585
∫∞∫OÀ§Àƒ∏™ ™., 2940
∫∞∫OÀƒOÀ Δ., 3467
∫∞§∞μƒOÀ∑πøΔ∏™ °., 1879
∫∞§∞πΔ∑∏™ ∂., 1548
∫∞§∞´Δ∑π¢∏™ ƒ., 2989
∫∞§∞´Δ∑π¢OÀ-∫O§§π∞ Ã., 3074
∫∞§∞ª∞À∫π∞¡∞∫∏ ∫., 1606
∫∞§∞ª¶∞∫∞™ ∞., 181
∫∞§∞ª¶∞§π∫∞ ¢., 203, 386, 519
∫∞§∞¡Δ∑∏™ °., 3294
∫∞§∞¡Δ∑∏™ §., 1117, 1119, 1122
∫∞§∞¡Δ∑∏™ ¡., 3263
∫∞§∞¡Δ∑∏™ Ã., 3263
∫∞§∞¡Δπ¢OÀ ∞., 12, 19
∫∞§∞¶O¢∏ ª., 2678
∫∞§∞¶O£∞∫∏ μ., 3469
∫∞§∞™ π., 109
∫∞§∞Δ∑∏™ π., 3372
∫∞§∞Ã∞¡∏™ π., 1135
∫∞§¢ƒÀªπ¢∏™ ¶., 3704
∫∞§¢ƒÀªπ¢∏™ º., 27, 1546, 3705
∫∞§∂ªπ∫∂ƒ∞∫∏™ π., 2807
∫∞§∂ƒπ¢∏™ μ., 3438
∫∞§∏ª∂ƒ∞™ ∂., 3242
∫∞§π°∫∞Δ™∏™ Ã.., 182, 270, 385, 387, 531
∫∞§π¢ø¡∏ ∂., 1382
∫∞§πøƒ∞ ∞., 3251
∫∞§§πμƒ∂Δ∞∫∏™ ¡., 3, 169, 1340
∫∞§§π°π∞¡¡∏ ∫., 2799
∫∞§§π∫∞Δ∑∞ƒO™ π., 3361
∫∞§§πª∞¡∏™ °., 779
∫∞§§π¶O§πΔ∏™ °., 2950
∫∞§§πºƒO¡∞™ ª., 3286
KALO I., 2002
∫∞§O°∂ƒ∞∫∏ §., 2723
∫∞§O°∂ƒO¶OÀ§O™ ∞°., 799
∫∞§O°∂ƒO¶OÀ§O™ ∞Ã., 776, 786, 796
∫∞§O°∂ƒO¶OÀ§O™ Ã., 3359, 3465
∫∞§O°∂ƒO¶OÀ§OÀ ∫., 1099, 1102, 1105, 1107, 1109,
3185, 3409, 3410, 3413, 1116, 1119, 1121, 2625,
3399, 3477
∫∞§O°∂ƒOÀ¢∏™ °., 382, 601
∫∞§O°∏ƒOÀ ¢., 872
∫∞§O°∏ƒOÀ ¶., 569, 2874
∫∞§O°π∞¡¡∏ ª., 3193, 3261, 3518, 3529
∫∞§O°π∞¡¡π¢OÀ., 2740
∫∞§O∫∞πƒπ¡O™ °., 3236, 3243, 3249
∫∞§O™ ∞., 1351, 3032
∫∞§OΔ∞πƒ∞∫∏™ ∞., 2662, 2956
∫∞§OÀª∂¡OÀ π., 3305
∫∞§OºOÀΔ∏™ ∞., 2523, 3273, 3274, 3210, 3414
∫∞§OºOÀΔ∏™ Ã., 2523, 3273, 3274, 3414
∫∞§OÃ∞πƒ∂Δ∏™ ¶., 2973
∫∞§¶∞∫O°§OÀ ™., 184
∫∞§¶π¡∏-ª∞ÀƒOÀ ∞., 143
∫∞§Δ™∞™ °., 3210
∫∞§Δ™∞™ £., 227, 270, 271, 596, 603, 604, 1984
∫∞§Δ™OÀ¢∞ ∞., 3319
∫∞§Àμ∞ Δ., 3099
∫∞§Àμπ¡O™ ∞., 2168
∫∞§º∞ £., 2871
∫∞§º∞ Δ., 1090
∫∞§º∞∫∏™ ¡., 3336
∫∞§º∞ƒ∂¡Δ∑O™ º., 2592, 3260
∫∞ª∞ƒ∞¢OÀ ∂., 1910
∫∞ª∞ƒ∞ΔO™ ∞., 2142, 2383, 2389, 2402, 2426, 2427,
2438
∫∞ª∞ƒπ∞ º., 574, 575
25
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∫∞ª¶∞ƒOÀ¢∏™ ∞., 2750
∫∞ª¶∞™ ¡., 2693, 3625
∫∞ª¶∞Δ™∞™ Ã., 3314, 3327
∫∞ª¶πΔ™∏ ∂., 2053
∫∞ª¶OÀƒ∞∫∏™ °., 572, 573, 599
∫∞ª¶OÀƒ∏ ∞., 2925
∫∞ª¶OÀƒOªÀΔ∏ °., 3355
∫∞¡∞μ∞∫∏™ ∂., 3363, 3699
∫∞¡∞°∫π¡∏™ £., 1392, 3483
∫∞¡∞∫∞-GANTEBEIN X., 2685
∫∞¡∞∫∏ ∞., 2548, 2765, 3152, 3262
∫∞¡∞∫∏™ £., 607
∫∞¡∞∫∏™ ∫., 2689
∫∞¡∞∫OÀ¢∏-Δ™∞∫∞§π¢OÀ º., 259, 260, 795, 924
∫∞¡∞ƒπOÀ ª., 2734, 2911, 3342, 3447
∫∞¡¢∏§øƒO™ Ã., 414, 423, 424, 754, 2555, 2556
∫∞¡∂§§∞∫O¶OÀ§OÀ ∫., 724
∫∞¡∂§§∞™ ¢., 885
∫∞¡∂§§O¶OÀ§OÀ O., 3122
∫∞¡π∞ƒ∏™ ¶., 653, 654, 826
∫∞¡πO°§OÀ Ã., 3530
∫∞¡πOÀƒ∞™ ¢., 2025
∫∞¡Δ∞ƒΔ∑∏™ ∫., 3492, 3503, 3504, 3505, 3629
∫∞¡Δ∏™ ¶., 691
∫∞¡Δƒ∂ ∞., 363, 474, 1957, 1958
∫∞OÀΔ™OÀ ™., 2788
∫∞¶∞¡Δ∞∏™ ∂., 669, 3522
∫∞¶∞ƒπ∞¡O™ ∞., 2547
∫∞¶∂§§∞™ °., 3036
∫∞¶∂Δ∞¡∞∫∏™ ∂., 3241
∫∞¶O¶OÀ§OÀ μ., 3028
∫∞¶OÀ™OÀ∑∏ ª., 2041
∫∞¶OÀ§∞™ ™., 517, 789
∫∞¶ƒ∞§O™ ¶., 346
∫∞¶ƒ∞¡OÀ ∞., 2437, 3360
∫∞¶ƒπ¡∏™ °., 2232
∫∞ƒ∞μ∞°°∂§∏-μ§∞Δ™∞ ∂., 333, 1999, 2224, 2226,
2485, 2486
∫∞ƒ∞μ∞¡∞∫∏ ∫., 380, 535, 1201, 1921, 2531, 2618,
2624, 2911, 3190, 3384, 3402
∫∞ƒ∞μ∞™π§∏ ∫., 1838
∫∞ƒ∞μ∞™π§∏™ π., 793
∫∞ƒ∞μ∞ΔO™ ∞., 2743
∫∞ƒ∞μOÀ§∞ ∫., 190
∫∞ƒ∞°∂øƒ°∏™ μ., 2853
∫∞ƒ∞°π∞¡¡∞∫O™ ¶., 1262, 1912
∫∞ƒ∞°π∞¡¡∏ ¢∂™., 361, 373, 394, 417, 598, 1137,
1431, 1457, 1562, 1578, 1582, 1596, 1837, 1847,
1853, 1996, 2007, 2018, 2748, 3297
∫∞ƒ∞°π∞¡¡∏ ∂., 476
KAPA°IANNH K., 1201, 1957, 1958, 2531, 2618, 2911,
3190
∫∞ƒ∞°π∞¡¡∏ ª., 2232
∫∞ƒ∞°π∞¡¡∏ ¶., 835, 3714
∫∞ƒ∞°π∞¡¡∏ Δ., 1583, 2735
26
∫∞ƒ∞°π∞¡¡∏ Ã., 298, 363, 473, 1465, 1718, 3363
∫∞ƒ∞°π∞¡¡∏™ ∞., 790, 2043, 2196, 2602, 3212, 3240
∫∞ƒ∞°π∞¡¡∏™ μ., 776, 1135
∫∞ƒ∞°π∞¡¡∏™ π., 3627
∫∞ƒ∞°π∞¡¡∏™ ¡., 773, 1469, 1470, 1471, 1472
∫∞ƒ∞°π∞¡¡∏™ ™., 3173, 3483
∫∞ƒ∞°π∞¡¡π¢∏™ Ã., 890
∫∞ƒ∞°π∞¡¡O¶OÀ§O™ ™., 882, 3078
∫∞ƒ∞°π∞¡¡O¶OÀ§OÀ °., 797
∫∞ƒ∞°πøƒ°O™ ª., 787
∫∞ƒ∞°∫πO∑∞∫∏ μ., 2696
∫∞ƒ∞°∫πO∑O°§OÀ-§∞ª¶OÀ¢∏ £., 795, 931, 1922
∫∞ƒ∞°∫OÀ¡∏ ∞., 2915
∫∞ƒ∞¢∏ª∞ °, 3447
∫∞ƒ∞£∞¡∞™∏™ ∂., 2381
∫∞ƒ∞´™∫O™ ∫., 23, 24, 37, 38, 854, 856, 859, 864,
1183, 1194, 1249, 1252, 1253, 1254, 1255
∫∞ƒ∞´Δπ∞¡OÀ ∞., 12
∫∞ƒ∞∫∞Δ™∞¡∏ ∞., 3469
∫∞ƒ∞∫∞Δ™∞¡∏™ ∫.°., 1998 , 2008 , 2023, 2144, 2193
∫∞ƒ∞∫∞Δ™∞¡∏™ ¡., 3231
∫∞ƒ∞∫π¢OÀ ∞., 2694
∫∞ƒ∞∫πOÀ§∞∫∏™ °., 2938
∫∞ƒ∞∫πΔ™O™ ¢., 3255, 3292
∫∞ƒ∞∫O§πO™ ∞., 184, 191, 1566
∫∞ƒ∞∫OÀ§∞∫∏™ ™., 2018
∫∞ƒ∞∫ÀƒπOÀ ª., 2379
∫∞ƒ∞∫ø™Δ∞ ª., 2915
∫∞ƒ∞∫ø™Δ∞™ ∂., 684
∫∞ƒ∞§∏ ª., 2432
∫∞ƒ∞ª∞¡∞∫OÀ-Oƒº∞¡∞∫OÀ °., 3189
∫∞ƒ∞ª∞¡πø§∞™ ∫., 3409, 3410
∫∞ƒ∞ª∞¡O™ μ., 16, 18, 147, 154, 167, 210, 211, 397,
472, 480, 626, 627, 628, 630, 634, 635, 636, 637,
638, 639, 640, 641, 642, 659, 762, 778, 835, 886,
1349, 1350, 1351, 1352, 1353, 1354, 1355, 1356,
1357, 1358, 1359, 1360, 1361, 1362, 1363, 1364,
1365, 1366, 1367, 1368, 1369, 1370, 1371, 1372,
1373, 1464, 1493, 1524, 1569, 1570, 1573, 1649,
1791, 1796, 1798, 1803, 1858, 1859, 1860, 1861,
1862, 1907, 1913, 1975, 1976, 2084, 2481, 2511,
2544, 2561, 2562, 2564, 2565, 2570, 2575, 2577,
2583, 2584, 2586, 2588, 2986, 3023, 3079, 3513,
3514, 3525
∫∞ƒ∞ª∞¡O™ ¢., 2750, 3591
∫∞ƒ∞ª∞¡ø§∏™ ™., 544
∫∞ƒ∞ª∂ƒΔ∑∞¡∏ ª., 2
∫∞ƒ∞ª∂™π¡∏™ ¶., 2899
∫∞ƒ∞ª∏Δ™O™ ¢.£., 28, 176, 184, 185, 187, 191, 193,
194, 96, 205, 206, 215, 225, 232, 236, 253, 254,
266, 284, 286, 295, 299, 301, 309, 313, 315, 317,
322, 325, 327, 338, 355, 358, 360, 364, 368, 375,
377, 399, 408, 434, 445, 446, 447, 448, 449, 450,
451, 452, 453, 457, 489, 490, 491, 492, 493, 494,
495, 496, 497, 498, 499, 500, 501, 502, 503, 504,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
505, 506, 507, 508, 509, 510, 511, 512, 513, 1133,
1139, 1458, 1554, 1557, 1584, 1680, 1681, 1682,
1683, 1792, 1816, 1825, 1826, 1827, 1857, 1891,
1940, 1947, 1983, 1994, 1997, 1998, 2008, 2009,
2015, 2019, 2022, 2023, 2028, 2047, 2055, 2065,
2135, 2136, 2140, 2141, 2144, 2146, 2148, 2154,
2171, 2180, 2195, 2209, 2212, 2213, 2228, 2229,
2233, 2234, 2505, 2537, 2538, 2539, 2540, 2541,
2543, 2544, 2579, 2580, 2619, 2648, 2651, 2657,
2684, 2844, 2987, 3064, 3450, 3512, 3540, 3541,
3542, 3543, 3545, 3546, 3547, 3548, 3549, 3550,
3553, 3554, 3555, 3556, 3557, 3558, 3559, 3560,
3563, 3564, 3565, 3566, 3567, 3568, 3569, 3570,
3571, 3572, 3574, 3575, 3576, 3577, 3578, 3579,
3580, 3583, 3584, 3585, 3586, 3587, 3589, 3592,
3593, 3594, 3595, 3596, 3597, 3600, 3601, 3602,
3603, 3604, 3606, 3607, 3608, 3609, 3611, 3612,
3613, 3614, 3615, 3616, 3617, 3619, 3622, 3628,
3646, 3679, 3680, 3717
∫∞ƒ∞ª∏Δ™O™ £.¢., 2053, 2054, 2393, 2536, 2539,
2540, 2541, 2619, 2891, 3587
KAPAMO™XO™ K., 2193
∫∞ƒ∞ªOÀ∑∏™ ª., 789, 2117, 2234, 3421, 3435, 3437
∫∞ƒ∞ª¶∞∫∞§∏™ ¡., 2791
∫∞ƒ∞ª¶∞§∏™ £., 3142
∫∞ƒ∞ª¶∂∫πO™ ™., 3378
∫∞ƒ∞ª¶∂§∞ º., 3091
∫∞ƒ∞ª¶∂§∏™ ∞., 332
∫∞ƒ∞ª¶∂ƒ∏ ∞., 3137
∫∞ƒ∞ª¶∂ƒ∏ ∂., 194
∫∞ƒ∞ª¶∂ƒ∏™ ™., 548
∫∞ƒ∞ª¶∂ƒO¶OÀ§O™ ¢., 1717, 2699
KAƒ∞ª¶π¡∞ ™., 1912, 3375
∫∞ƒ∞ª¶π¡∏™ ∞., 3255, 3292
∫∞ƒ∞ª¶π¡O™ π., 3326
∫∞ƒ∞ª¶OÀ§∞ ∞., 3075
∫∞ƒ∞¡¢ƒ∂∞™ ¡., 3309
∫∞ƒ∞¡π∫∞™ ∏., 2734
∫∞ƒ∞¡π∫∞™ ª., 3225
∫∞ƒ∞¡Δ∞°∏ ™., 3319
∫∞ƒ∞¡Δ∞¡∞™ ∞., 2803
∫∞ƒ∞¡Δ∏ ∞., 2905
∫∞ƒ∞¡Δø¡∏™ ∏., 3282, 3311
∫∞ƒ∞¶π¶∂ƒ∏™ ∞., 265
∫∞ƒ∞¶OÀ§πO™ ∂., 3231
∫∞ƒ∞Δ∞∏™-∑OÀª¶O™ ∫., 3416
∫∞ƒ∞Δ∞¶∞¡∏™ ™., 1186
∫∞ƒ∞Δ∑∞¡∏™ ∞., 3195
∫∞ƒ∞Δ∑∞™ °., 1262
∫∞ƒ∞Δ∑∞™ ¡., 185, 2135, 2209
∫∞ƒ∞Δ∑π¢OÀ ∫., 2000, 2632, 3627, 3640
∫∞ƒ∞Δ™∏™ ¶., 3301
∫∞ƒ∞ºOÀ§π¢OÀ ∞., 2791
∫∞ƒ∞ºø§∞™ π., 2027
∫∞ƒ∞ºøΔπ∞™ ∞., 2857
∫∞ƒ∞Ã∞§πO™ ∞., 2413
∫∞ƒ∞Ã∞§πO™ °., 2689
∫∞ƒ∞Ã∞§πOÀ º., 468
∫∞ƒμOÀ¡∏ ∂., 621
∫∞ƒμOÀ¡∏™ ∏π., 2040, 2536, 2539, 2540, 2541
∫∞ƒμOÀ¡∏™ Ã., 1586
∫∞ƒ¢∞ªÀ§∞™ ∞., 523
∫∞ƒ¢∞ƒ∏ ∞., 749, 3036
∫∞ƒ¢∞ΔO™ Ã., 210, 1350
∫∞ƒ¢O°π∞¡¡∏™ £., 1364
∫∞ƒ∑∏ ∂., 2432
∫∞ƒ∏™ Ã., 363
∫∞ƒπ¡∞ ª., 3155
∫∞ƒπOºÀ§§∏™ ¶., 2908
∫∞ƒ∫∞μπΔ™∞™ ¡., 3217
∫∞ƒ∫O™ Ã., 2750
∫∞ƒ∫OÀ§∏™ ¢., 2714
∫∞ƒ∫OÀ§π∞™ ∫., 2547
∫∞ƒ§∏ π., 813, 879, 1309, 3153
∫∞ƒ§Oμ∞™πΔOÀ-∫O¡π∞ƒ∏ ∞., 883
KAPMANIO§A™ K., 1977, 2604, 3457
∫∞ƒOÀ§∞™ Δ., 787
∫∞ƒOÀ§π∞™ ™Δ., 1561
∫∞ƒOÀª¶∞§∏ π., 1538
∫∞ƒOÀ™™∏™ π., 3287
∫∞ƒOÀΔ∞™ ™., 948
∫∞ƒOÀΔ™O™ ∫., 888, 896
∫∞ƒOÀΔ™OÀ ª., 576
∫∞ƒ¶∞£πO™ £., 1593, 3075
∫∞ƒ¶∞£πO™ ™., 853
KAP¶ANOY E., 1956
∫∞ƒ¶OÀ∑∞™ π., 1142, 1922
∫∞ƒΔ∞§∏ ¡., 3715
∫∞ƒΔ∞§∏™ °., 3361
∫∞ƒΔ™∞¡∏™ °., 3303
∫∞ƒÀ¢∞-∫∞μ∞§πøΔ∏ ™., 520
∫∞ƒÀ¢∏ ¡., 363
∫∞™πªO™ Ã., 924
∫∞™∫∞ƒ∂§∏™ °., 819
∫∞™∫∞ƒ∂§∏™ ¢., 697
∫∞™∫∏ π., 3307
∫∞™™∞¡O™ ¢., 3050, 3387, 3426, 3429
∫∞™™∞ƒ∞™ ∞., 880
∫∞™™∏ °., 1994, 2154, 2538
∫∞™™πª∞Δ∏™ Δ., 3203
∫∞™™πOÀ ∫., 160, 298, 363, 473, 474, 479, 485, 486,
633, 1465, 1481, 1519, 1718, 1957, 1958, 3446
∫∞™Δ∞¡∞ O., 2797
∫∞™Δ∞¡∞™ ∏., 653, 654
∫∞™Δ∞¡∞™ Δ., 826
∫∞™Δƒπ¡O™ ¶., 839, 840, 841, 842
∫∞Δπ¢∂¡πOÀ ∞., 3425
∫∞ΔƒπΔ™∏™ O., 3277
∫∞Δ™∞ƒO™ ∞., 2794, 3361
∫∞Δ™∞ƒO™ Δ., 3381
27
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∫∞™ΔƒOÀ¡∏-∞ƒ¡∞OÀΔO°§OÀ ∂., 584
KATA§AM¶PO™ N., 1960
∫∞Δ∞ª∏™ Ã., 3305
∫∞Δ∞™O™ £., 3050
∫∞Δ∂ƒ°∞ƒ∏ ™., 2176
∫∞Δ∂Ã∏™ ∞., 277
∫∞Δ∑O™ °., 249, 924, 931, 932, 2687, 3154
∫∞ΔπƒΔ∑O°§OÀ ∞., 1359
∫∞ΔO¶O¢∏™ ∫., 956
∫∞ΔO™Δ∞ƒ∞™ Δ., 3326
∫∞ΔOÀ§∏™ ∂., 1128, 1605, 3501, 3502
∫∞Δ™∞μ∂§∏ ∞., 327
∫∞Δ™∞¢øƒO™ ¢., 341
∫∞Δ™∞ª¶∞™ ∞., 691
∫∞Δ™∞¡OÀ ¶., 2449, 2450, 3494, 3533
∫∞Δ™∞ƒ∏™ °., 236, 954
∫∞Δ™∞ƒO™ £., 2193
∫∞Δ™∞ƒO™ ¡., 1606
∫∞Δ™∞ƒO™ Δ., 2416
∫∞Δ™∏™ ∫., 1142
∫∞Δ™π∫∞ƒ∏ ª., 1593
∫∞Δ™π∫∏ ¡., 2020, 2170, 2563, 2579, 3562, 3563
∫∞Δ™π∫∏™ π., 2773
∫∞Δ™π∫O°π∞¡¡∏™ ™., 1100
∫∞Δ™π§∞ª¶ƒO™ ¡., 3, 4, 10, 15, 29, 30, 165, 169, 173,
201, 217, 218, 239, 240, 241, 242, 243, 244, 296,
306, 396, 407, 448, 472, 480, 605, 606, 607, 608,
609, 626, 627, 628, 630, 634, 635, 636, 637, 638,
639, 640, 641, 642, 643, 644, 645, 646, 647, 648,
649, 650, 651, 652, 653, 654, 655, 656, 657, 658,
659, 662, 663, 664, 665, 666, 667, 668, 669, 670,
671, 672, 673, 674, 675, 676, 677, 678, 679, 680,
681, 682, 683, 684, 685, 686, 687, 688, 689, 690,
691, 692, 693, 694, 695, 696, 697, 698, 699, 700,
701, 702, 703, 704, 705, 706, 707, 708, 709, 710,
711, 712, 713, 714, 715, 716, 717, 718, 719, 720,
721, 722, 723, 724, 725, 726, 727, 728, 729, 730,
731, 732, 733, 734, 735, 736, 737, 738, 739, 740,
741, 742, 743, 744, 745, 746, 747, 749, 750, 751,
753, 762, 811, 886, 1262, 1476, 1479, 1495, 1524,
1558, 1569, 1570, 1573, 1588, 1639,1791, 1796,
1798, 1810, 1841, 1859, 1862, 1912, 1913, 2076,
2174, 2198, 2199, 2318, 2481, 2504, 2546, 2561,
2583, 2584, 2585, 2586, 2594, 2612, 2614, 2622,
2623, 2665, 2702, 2715, 2749, 2791, 2838, 2842,
2873, 2905, 2966, 2985, 3012, 3065, 3150, 3156,
3196, 3209, 3211, 3213, 3214, 3220, 3275, 3278,
3279, 3285, 3289, 3231, 3233, 3235, 3246, 3302,
3324, 3339, 3369, 3375, 3427, 3441, 3454, 3461,
3500, 3512, 3513, 3514, 3522, 3532, 3704
∫∞Δ™πª∞¡Δ∏™ ¢., 1
∫∞Δ™πºøΔ∏™ Ã., 3309
∫∞Δ™πÃΔ∏™ ¶., 1145
∫∞Δ™O°π∞¡¡∏™ ¶., 463, 968, 969, 970, 971, 972, 973,
974, 975, 976, 977, 978, 979, 980, 981, 982, 983,
28
984, 985, 986, 987, 988, 989, 990, 991, 992, 993,
994, 995, 996, 997, 998, 999, 1000, 1001, 1002,
1003, 1004, 1005, 1006, 1007, 1008, 1009, 1010,
1011, 1012, 1013, 1014, 1015, 1016, 1017, 1018,
1019, 1020, 1021, 1022, 1023, 1024, 1025, 1026,
1027, 1028, 1029, 1030, 1031, 1032, 1033, 1034,
1035, 1036, 1037, 1038, 1039, 1040, 1041, 1042,
1043, 1044, 1045, 1046, 1047, 1048, 1049, 1050,
1051, 1052, 1053, 1054, 1055, 1056, 1057, 1058,
1059, 1060, 1061, 1062, 1063, 1064, 1065, 1066,
1067, 1068, 1069, 1070, 1071, 1072, 1073, 1074,
1075, 1076, 1077, 1078
∫∞Δ™OÀ°π∞¡¡∏ ∫., 468
∫∞Δ™OÀ§∞∫OÀ ™., 2432
∫∞Δ™OÀ§∏™ Ã., 3714
∫∞Δ™OÀƒ∞™ Ã., 3530
∫∞Δ™øƒÃ∏™ £., 610, 611, 616, 622
∫∞ΔΔ∞ª∏™ Ã., 64, 190
∫∞À∫∞§∞™ ª., 144
∫∞À∫π∞™ μ., 820
∫∞º∞ΔO™ ∞., 1204, 2133, 3219
∫∞ºOÀƒOÀ ∞., 357, 471, 1718, 1957, 1958
∫∞Ãπª∞¡π¢OÀ ª., 2053, 2536
∫∞æ∞§∏ ∞., 1920
∫∞æ∞§∏™ ∞., 819
∫∞æ∞§π∞ƒ∏™ ∞., 2024
∫∞æπª∞§∞∫OÀ °., 296
∫∞æπª∞¡∏ ∞., 2804
∫∞Δø¶O¢∏ Ã., 3058
∫∞ºπƒ∏ °., 3298
∫∂∫§π∫π∞¡-§∞°OÀ¢∞∫∏ ¶., 333
∫∂∫∂™ ∞., 2462, 2502
∫∂∫∫∂ ∂., 3098
∫∂§∂∫∏™ §., 805
∫∂§§∞ƒΔ∑∏™ ¢., 375
∫∂¶∞¶Δ™O°§OÀ O., 1502
∫∂ƒ∞ª∂À™ ¡., 308
∫∂ƒ∞ªπ¢∞-∫∞ƒ∞ª∏Δ™OÀ ¶., 318
∫∂ƒ∫OÀ§∞™ ∂., 2636
∫∂™π¢∏™ ¢., 827
∫∂™π¢∏™ Ã., 462, 1461
∫∂™OÀ§π¢OÀ π., 3098
∫∂™™∂ ª., 3286
∫∂Δπ∫O°§OÀ ¢., 1586
∫∂Δ™∂∞™ £., 74
∫∂º∞§∞™ ¡., 2911
∫∂º∞§π¢∏™ ¡., 1571, 1572
∫∂º∞§O°π∞¡¡∏™ π., 3169
∫∂º∞§O°π∞¡¡∏™ ¡., 241, 1489, 2620, 2682, 2990
∫∂Ã∞°πO°§OÀ ∫., 168
∫∏§∞∏¢O¡∏™ ¶., 74
∫∏¶OÀƒOÀ μ., 3071
∫∏Δ∞ ª., 282, 323
∫π∞°π∞™ π., 1412, 2557, 2558, 2559, 2560
∫π∞°O™ π., 1877
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∫π§π¡Δ∑∏™ μ., 490
∫𧪶∞™∞¡∏™ ¡., 241
∫πª¶O¡∂ƒπOÀ ∞., 3189
∫πª¶OÀƒ∏™ π., 662
∫πO™∂O°§OÀ °., 3064
∫πO™∂™ μ., 531
∫πOÀ§∞¡∏™ π., 3455
∫πOÀª∏™ π., 3487
∫πƒπª§π¢∏™ π., 231
∫πƒ§∞∫∏ ∂., 2199
∫πƒªπ∑∏™ ¢., 2445
∫π™∫π¡∏™ ¢., 3590
∫πΔ™πO™ ∞., 3623
∫πΔ™πO™ ∫., 2163, 2186
∫πΔ™πO™ Ã., 372
∫πΔ™πOÀ-Δ∑∂§∏ ™., 3074
∫πΔ™O™ ∫., 2033, 2143
∫πΔ™OÀ ∂., 665, 692, 2199, 3368, 3375
∫πΔΔ∞™ ∫., 2478
∫πΔΔ∞™ Ã., 813, 879, 3042
∫§∞°∫∞™ π., 2938
∫§∂∞¡£OÀ™ π., 1884
∫§∂π™π∞ƒ∏™ μ., 225, 835, 2154, 3376, 3383, 3390
∫§∂π™πOÀ¡∏™ ¡., 844
∫§∂πΔ™∞™ ∞., 3488
∫§∂Δ∞-¶∞¡∞°πøΔπ¢OÀ ¢., 406, 2043
∫§∏ª∂¡ΔπøΔ∏ ∞., 465
∫§∏ªO¶OÀ§O™ ™., 793
∫§OÀμ∞-ªO§Àμ¢∞ ¶., 959
∫§OÀμ∞ΔOÀ ∂., 2918
∫§ø¡∞ƒ∏™ Ã., 3343
∫§ø¡π∑∞∫∏™ π., 464, 792, 3045
∫O¢OÀ¡∏™ ∞., 3083
∫O∑∞¡π¢OÀ °., 3451, 3457
∫O´O™ °., 878
∫O∫∫∞§OÀ ∂., 3158
∫O∫∫∞ƒ∞∫∏ °., 3626
∫O∫∫π¡π¢∏™ ª., 1636, 1709
∫O∫∫π¡O™ ∞., 2749, 3275, 3302, 3532
∫O∫∫π¡O™ ¢., 158, 237, 1809, 2425, 2749, 2908, 3275,
3289, 3302, 3349, 3481
∫O∫∫π¡OÀ μ., 3326
∫O∫∫πOÀ ∂., 3125
∫O∫∫Oƒ∏™ ™., 2142, 2416, 2427, 2428, 2429, 2431,
2432, 2436, 2438
∫O∫∫ø¡π¢∏™ ¶., 428, 2194
∫O∫§∞ª∏™ ∂., 448
∫O∫§∞¡∏™ ∂., 60, 107
∫O∫§πøΔ∏ ∞., 3053
∫O∫O§∞∫∏ ∞., 3151
∫O∫O§∞∫∏ ∂., 2763
∫O∫O§∞∫∏™ ¡., 3464
∫O∫OΔ∏™ ¶., 2905
∫O§μ∞Δ∑∏™ £., 954
∫O§π∞ ª., 3375
∫O§π∞∫∏ Ã., 3233
∫O§π∞∫O™ °., 592, 1564, 1984, 2230, 2538, 2872,
2906, 3190, 3261, 3271, 3224, 3420, 3518, 3529
∫O§π∞∫O™ ∫., 291
∫O§πO¶OÀ§O™ μ., 1342
∫O§πO¶OÀ§O™ °., 2890
∫O§πO¶OÀ§O™ π., 781, 946, 1487, 1511, 1804, 2958,
3256, 3389
∫O§πOÀ™∫∞™ ¢., 189, 2180, 3595
∫O§§∞ƒ∞™ ¶., 3031
∫O§§π∞ Ã., 3117
∫O§§π∞™ ∞., 2452, 2454, 2456, 3528
∫O§OμOÀ °., 2425
∫O§O∫OΔƒø¡∏ ¢., 532
∫O§O∫OÀ§π∞™ ª., 2935
∫O§O∫OÀ™∏™ Ã., 2856
∫O§Àª¶π∞¡∞∫∏™ ∂., 3535
∫Oª∞¡Δ∑π∞ ∞., 2383
∫Oª∂™π¢OÀ-ª∞°∫§∞ƒ∞ μ., 877, 912, 916, 1155
∫OªπΔO¶OÀ§O™ ¡., 3037, 3039
∫Oª¡∏¡O™ ¢., 2854
∫Oª¡∏¡O™ ∑., 1357
∫Oª¡∏¡OÀ ∂., 750
∫Oª¶O§∏-∫O¡ΔOμ∞∑∞π¡πΔ∏ ª., 277
∫Oª¶OΔ∏ ª., 959, 2340, 3300
∫O¡π∞μπΔOÀ ∫., 3323, 3344, 3351
∫O¡π∞ƒ∏ ∫., 3207
∫O¡π¢∞ƒ∏™ ∫., 1700, 1705, 2869
∫O¡π¢∞ƒ∏™ ™., 801
∫O¡π¢∞ƒ∏™ Ã., 3380
∫O¡∫OÀƒ∏™ §., 41, 127, 464, 632, 792, 821, 822, 832,
3045
∫O¡Δ∂™∏™ ¶., 810, 1359, 1534
∫O¡Δ∑O°§OÀ °., 329
∫O¡Δπ∑∞™ °., 797
∫O¡ΔO∞°°∂§O™ ∫., 3231
∫O¡ΔO°π∞¡¡∞∫∏™ ™., 1309
∫O¡ΔO°π∞¡¡∏ ª., 2165, 2686, 2532
∫O¡ΔO°π∞¡¡∏™ ¢., 263, 771, 813, 879, 3042, 3475
∫O¡ΔO°π∞¡¡∏™ π., 180, 181, 207, 228, 256, 288, 326,
361, 379, 382, 392, 405, 417, 437, 438, 602, 629,
630, 634, 635, 637, 638, 639, 641, 642, 762, 773,
1570, 1798
∫O¡ΔO°π∞¡¡∏™ ¶., 651, 683, 684
∫O¡ΔO°π∞¡¡∏™ ™., 263, 771, 3042, 3475
∫O¡ΔO¢∏ªOÀ ∞., 906
∫O¡ΔO¢∏ªO¶OÀ§O™ ¡., 2377, 3247
∫O¡ΔO¶OÀ§O™ ∞., 205, 254, 286, 359, 509, 777, 790,
935, 1680, 1680, 1683, 2015, 2132, 3155
∫O¡ΔO¶OÀ§O™ ª., 1596
∫O¡ΔOÀ§π¢∏™ ∫., 779
∫O¡Δø¡∏™ ¢., 3036
∫Oƒ∞´¢∏™ ∫., 1949, 2031, 2050
∫Oƒ∞∫∞∫∏ ∂., 3405
∫Oƒ∞¡Δ∑O¶OÀ§O™ ¶., 2416, 2428, 2429, 2431, 2436
29
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∫Oƒμ∂™∏ ª., 312, 1698
∫Oƒ¢∞ΔO™ ¶., 789
∫Oƒ¢O¡OÀƒ∏ O., 114, 275, 278, 307, 528, 927, 1155,
1203, 1283, 1324, 1397, 1453, 1908, 1932, 1933,
1934, 1935, 1936, 1951, 1952, 1953, 1955, 1978,
1985, 2038, 2111, 2121, 2122, 2123, 2124, 2127,
2128, 2129, 2200, 2202, 2203, 2390, 2395, 2398,
2400, 2417, 2422, 2533, 2542, 2633, 2634, 2741,
2767.2768, 2772, 2863, 2864, 2884, 3063, 3127,
3515, 3638, 3647, 3648, 3649, 3650, 3651, 3652,
3653, 3654, 3655, 3656, 3657, 3658, 3659
∫Oƒ¢O¶∞Δ∏™ ¶., 3399, 3409, 3410, 3413
∫Oƒ∂§∏ ∞., 2923
∫Oƒ∫∞∫∞ ∂., 2191
∫Oƒ∫O§∏™ ™., 154, 167
∫Oƒ∫O™ ™., 137
∫OƒΔ™∞ƒ∏™ ∞., 2487
∫Oƒø¡∏ ª., 3092
∫O™∫π¡∞™ π., 3525
∫O™ª∞ΔO™ ∞., 1009, 1010, 1013, 1014, 1016, 1019,
1021, 1024, 1026, 1027, 1028, 1071
∫O™ªπ¢∏™ ¶., 332
∫O™ªπ¢∏™ Ã., 547, 571
∫O™ªπ¢OÀ ª., 2013, 2235
∫O™ªO¶OÀ§OÀ ª., 3061
∫O™™Àμ∞ μ., 3058
∫OΔ∑∞ª¶∞™∏™ ∞., 1321
∫OΔOÀ§∞ ª., 3314
∫OΔƒ∞ƒ∂§∏™ ¢., 1262
∫OΔ™∞ ∫., 2117, 3353
∫OΔ™∞¡O™ π., 1452
∫OΔ™π¡∏ μ., 1799, 1823, 2957
∫OΔ™πƒ∏ ∞., 3060
∫OÀμ∞ƒ∞™ °., 237, 2337, 3481
∫OÀμ∞Δ™∏ ∞., 2014
∫OÀμ∞Δ™OÀ ∑., 2140
∫OÀμ∂§∏™ ™., 2940
∫OÀμ∂§OÀ ª., 815
∫OÀμ∂ΔO¶OÀ§OÀ ∫., 1434
∫OÀμƒOÀ∫∏ ™., 3114
∫OÀ°∂μ∂ΔO¶OÀ§OÀ ∫., 3180
∫OÀ°π∞§∏™ ™., 1097
∫OÀ°π∞™ ¶., 2186
∫OÀ°πOÀªΔ∑O°§OÀ ¢., 461, 598, 1563, 1837
∫OÀ∑∏-∫O§π∞∫OÀ ∫., 2020, 2131
∫OÀ∑OÀƒ∏™ ∞., 3231
∫OÀ´¢∏ ∂., 2048, 2639
∫OÀ∫∞ƒ∞™ ¢., 1416
∫OÀ∫∫OÀ ∂., 2451, 2455, 3337
∫OÀ∫OÀμπΔ∏™ ∞., 323, 1633, 3626
∫OÀ∫OÀ§∏ ª., 2440
∫OÀ∫OÀ§∏™ °., 913, 2691, 3239, 3314, 3316, 3340,
3341, 3356
∫OÀ∫OÀƒ∞∫∏ ™., 3217
∫OÀ∫OÀƒπ∫O™ ™., 1941, 1946
30
∫OÀ∫OÀƒπ∫OÀ ª., 2022, 2154, 3163
∫OÀ§∞∫∏ ∂., 2192
∫OÀ§∞™ °., 3240
∫OÀ§OÀƒ∏™ ¡., 2760
∫OÀ§OÀƒ∏™ ™., 3245, 3326
∫OÀ§OÃ∂ƒ∏ ™., 738, 1341
∫OÀ§OÀƒ∏™ ™., 3277
∫OÀ§OÀƒπ¢∏™ ∂., 3403
∫OÀª∞¡Δ∞∫∏™ ∂., 3269, 3306, 3332
∫OÀª∂§∞™ ¢., 1920
∫OÀª¶OÀ§∏™ ∏., 2427
∫OÀ¡∞¡∏™ ∞., 1589
∫OÀ¡∂¡OÀ ∫., 2738, 3739, 3165, 3331
∫OÀ¡Δ∞¡∞ ∂., 3240
∫OÀ¡ΔOÀƒ∞ ª., 1993, 2017
∫OÀ¡ΔOÀƒ∞™ π., 285, 783, 2488
∫OÀ¡ΔOÀƒ∏™ ¢., 806, 922
∫OÀ¡ΔOÀƒ∏™ ∂., 2429
∫OÀ¶π¢OÀ ™., 287
∫OÀƒ∞∫∏™-™Àª∂¡π¢∏™ ∞., 3317
∫OÀƒ∂§∏ Ã., 669
∫OÀƒ∂Δ∞™ ¢., 3694, 3699
∫OÀƒ∏ ∂., 1870
∫OÀƒ∏-∫∞§∂ƒ°∏ O., 1867, 1926
∫OÀƒ∏™ Ã., 911, 3149, 3483
∫OÀƒ∫OÀª¶∞™ μ., 2691
∫OÀƒ∫OÀª¶∂Δ∏ ∫., 3025
∫OÀƒ§∞μ∞ °., 3219
∫OÀƒ§∞ª¶∞ °., 3257
∫OÀƒO°§OÀ ª., 835
∫OÀƒO°§OÀ ™.∞., 1987
∫OÀƒΔ∏ ∞., 779, 1098, 1103, 1104, 1106, 1110, 1111,
1113, 11115, 1122, 1910
∫OÀƒΔ∏ ¶., 3316
∫OÀƒΔ∏™ ∞., 2698, 2773
∫OÀƒΔ∏™ ¶™., 3704
∫OÀƒΔO°§OÀ °., 185, 254, 281, 286, 322, 325, 327,
338, 360, 434, 477, 498, 508, 1584, 1681, 1682,
1857, 1891, 1939, 1947, 2055, 2154, 3546, 3639
∫OÀ™∫OÀ¡∏ ∂., 2336, 3387, 3429
∫OÀ™Δ∞¡O™ ∫., 808
∫OÀΔ∞§∞™ ¶., 761, 770, 2945
∫OÀΔ∏™ ∞., 772, 1914, 2948
∫OÀΔ∏º∞ƒ∏™ μ., 853, 872
∫OÀΔ§∞™ ∂., 360
∫OÀΔ§π∞¡O™ ¡., 2639
∫OÀΔª∂ƒπ¢∏™ ª., 1566
∫OÀΔOÀ§π¢∏™ ∫., 1099, 1102, 1105, 1107, 1109,
1112, 1115, 1116, 1120, 3477
∫OÀΔƒ∞ ¶., 1926
∫OÀΔƒ∞™ ¢., 63, 121, 123, 137, 146, 274, 850, 1309,
1715
∫OÀΔƒOÀª¶∞¡OÀ ∞., 2858
∫OÀΔ™∞¡¢ƒ∂∞ Ã., 3479
∫OÀΔ™∂§π¡∏ ∂., 848
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∫OÀΔ™∂§π¡∏™ ∞., 703
∫OÀΔ™∏™ °., 3083
∫OÀΔ™π∫O™ ¢., 3033, 3480
∫OÀΔ™π∫OÀ ∞., 959
∫OÀΔ™πOÀ ∫., 1944, 1950, 2190
∫OÀΔ™Oμ∞™π§∏™ ∞., 2161.2167, 2389, 2431, 2436,
2440
∫OÀΔ™OμOÀ§OÀ μ., 69
∫OÀΔ™O°π∞¡¡∏™ O., 416
∫OÀΔ™OÀ∫OÀ £., 3112
∫OÀΔ™OÀ§π∂ƒ∏™ ∏., 36
∫OÀΔ™OÀª∞¡∏ π., 835, 1364
∫OÀΔ™OÀª¶∏ ¶., 3442
∫OÀΔ™OÀƒ∏ ∞., 3433
∫OÀΔ™OÀƒ∏™ ¢., 3265
∫OÀΔ™OÀº§∞∫∏™ ¢., 2408
∫OÀºO™ Ã., 3032
∫Oºπ¡∏™ ∞., 595, 626, 627, 628, 630, 634, 635, 636,
637, 638, 639, 640, 641, 642, 659, 762, 886, 1464,
1524, 1569, 1570, 1573, 1649, 1791, 1796, 1798,
1859, 1860, 1861, 1862, 1907, 1913, 1975, 1976,
3015
∫OºΔ∂ƒπ¢∏™ ¢., 2947, 3195, 3378
∫OÃπ∞¢∞∫∏™ °., 3217, 3374
∫Oæ∞Ã∂π§∏™ ∂., 2673
∫ƒ∞μμ∞ƒπΔ∏ ª., 2896
∫ƒ∞ª¶OμπΔ∏™ ∂., 3374
∫ƒ∞¡π¢∏™ ∞., 1450
∫ƒ∞¡π¢πøΔ∏™ ∞., 1385
∫ƒ∞¡πΔ™∞™ ¢., 3155
∫ƒ∞™™∞™ °., 151, 404, 599, 878, 1564, 1942, 1989,
2026, 2032, 2236, 2720, 2773
∫ƒ∂∞Δ™∞™ °., 2336, 3136, 3387, 3408, 3426, 3429
∫ƒ∂ª∞™Δπ¡O™ ¢., 2732, 3227, 3308, 3411
∫ƒ∂ª∂¡O¶OÀ§O™ °., 2971
∫ƒ∂™¶∏ ¶., 351
∫ƒπ∂§∂™∏ μ., 3200
∫ƒπ∫∂§∏™ ¡., 1896
∫ƒπ∫ø¡∏™ Δ., 3252
∫ƒπΔ™π∫∏™ ™.. 13
∫ƒO∫π¢∞ ∞., 2932
∫ƒOªªÀ¢∞™ °., 3390
∫Δ∂¡π¢OÀ-∫∞ƒΔ∞§∏ ™., 2381
∫À¢ø¡π∞Δ∏ ∞., 3092
∫ÀªπO¡∏™ °., 3229
∫À¶ƒπ∞¡OÀ ª., 1542
∫À¶ƒπ¡OÀ Ã., 891
∫Àƒ∑O¶OÀ§O™ ™., 3227, 3308
∫Àƒπ∞∑∏™ °., 195
∫Àƒπ∞∑∏™ ∑., 2151
∫Àƒπ∞∑∏™ π., 2340, 2341, 2830, 3068, 3255, 3292,
3538, 3625, 3670
∫Àƒπ∞∑O¶OÀ§OÀ μ., 1459, 2522, 3283, 3284, 3317,
3371, 3416
∫Àƒπ∞∫∞∫∏ ¢., 2379
∫Àƒπ∞∫∂∞ ∞., 3058
∫Àƒπ∞∫∏ ¢., 2791, 3156, 3279, 3375
∫Àƒπ∞∫π¢∏™ ∞., 3337
∫Àƒπ∞∫π¢∏™ °., 2027, 2107, 2139, 2222, 2696
∫Àƒπ∞∫π¢∏™ ∑., 3227, 3308, 3411
∫Àƒπ∞∫O¶OÀ§OÀ ∫., 3687, 3688, 3691
∫Àƒπ∞∫O¶OÀ§O™ °., 821
∫Àƒπ∞∫O¶OÀ§O™ ∫., 3522
∫Àƒπ∞∫O¶OÀ§O™ ª., 1910, 2627
∫Àƒπ∫§π¢OÀ ¶., 532
∫ÀƒπO¶OÀ§O™ π., 14, 1118
∫ÀƒπΔ™∏™ ∞., 947
∫Àƒ∫∞¡π¢∏™ ¢., 554
∫Àƒ∫OÀ¢∏™ ∞., 356, 416, 1458, 1855
∫Àƒ§∞∫∏ ∞., 2167
∫Àƒªπ∑∞∫∏™ ¢., 3378
∫ÀƒO¶OÀ§O™ ∞., 2177
∫ÀƒOÀ ∞., 408, 449, 450
∫ÀƒOÀ π., 1638, 1639, 2729, 3082, 3406
∫Àƒ¶π∑π¢∏™ Ã., 226
∫ø§∂ΔΔ∏™ Δ., 3530
∫ø¡™Δ∞¡Δ∞™ ∂., 2154
∫ø¡™Δ∞¡Δ∂§OÀ ∂., 1911, 2394, 2433
∫ø¡™Δ∞¡Δ∂§OÀ π., 2338
∫ø¡™Δ∞¡Δπ§∞∫∏ O., 2692
∫ø¡™Δ∞¡Δπ¡π¢∏™ μ., 104
∫ø¡™Δ∞¡Δπ¡π¢∏™ ™., 2973
∫ø¡™Δ∞¡Δπ¡π¢OÀ ∞., 1548
∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §., 178, 179,
204, 208, 229, 230, 255, 1526, 1527, 1528, 1529,
1530, 1566, 1579, 1595, 1833, 1917, 1918, 1992,
2037, 2052
∫ø¡™Δ∞¡Δπ¡O¶OÀ§O™ ¶., 2426
∫ø¡™Δ∞¡ΔO¶OÀ§OÀ ™., 2950
∫ø¡™Δ∞¡Δπ¡OÀ ∞., 3130
∫ø¡™Δ∞¡Δπ¡OÀ μ., 2235
∫ø¡™Δ∞¡Δπ¡OÀ ∂., 406, 2185
∫ø¡™Δ∞¡Δπ¡OÀ π., 1943
∫ø¡™Δ∞¡Δπ¡OÀ §., 911
∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∞., 3303
∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∏., 69
∫ø¡™Δ∞¡ΔO¶OÀ§O™ π., 1201, 2618, 2911, 3190
∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∫., 103, 846
∫ø¡™Δ∞¡ΔO¶OÀ§O™ Ã., 1320
∫ø¡™Δ∞¡ΔOÀ§∞∫∏™ ª., 3481
∫ø¡™Δ∞™ ¶., 803, 948, 950
∫ø™Δ∞∫∏ ª., 2707
∫ø™Δ∞∫∏™ ∞., 1262, 1488, 1522, 3196, 3278
∫ø™Δ∞∫∏™ ª., 3214
∫ø™Δ∞§∞™ °., 669
∫ø™Δ∞§O™ Ã., 161, 1924, 2683, 3087
∫ø™Δ∂§∂ΔO™ °., 296, 678
∫ø™Δ∏™ ¢., 3104
∫ø™Δπ¢OÀ ∂., 2872, 3193, 3261, 3518, 3529
∫ø™ΔO°§OÀ ∞πª., 196
31
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∫ø™ΔO°§OÀ-∞£∞¡∞™πOÀ π., 2688, 3035
∫ø™ΔO¶OÀ§O™ ∞., 428
∫ø™ΔO¶OÀ§O™ π., 3031
∫ø™ΔO¶OÀ§O™ Ã., 862
∫øΔOÀ§∞™ O., 123, 849, 851, 852, 866, 867, 868, 869
∫øΔ™∞ ∫., 3626
∫øΔ™πOÀ ™., 2467, 2468, 2617
∫øΔ™Oμπ§∏™ ™., 3287
∫øΔ™O¶OÀ§OÀ ª., 3486
∫øºOΔ∑OÀ§∏ §., 296, 407, 658, 663, 676, 706
§∞μƒ∞¡O™ °., 3233
§∞°πOÀ ¶., 3401, 3432
§∞°∫ø¡∞ ∂., 2666
§∞¢∞™ π., 949, 3382, 3470
§∞¢∞™ ™., 819, 899, 1124, 1185, 1308, 1314, 3263
§∞¢∏™ μ., 3305
§∞¢øª∂¡OÀ º., 2763
§∞∑∞¡∞™ ª., 1492, 2788
§∞∑∞ƒ∞∫∏ °., 2488, 2600, 2886
§∞∑∞ƒ∏™ ∞., 3236, 3242, 3243, 3249
§∞∑∞ƒ∏™ ∫., 2909, 3208, 3221
§∞∑∞ƒπ¢∏™ ∞., 224, 858, 2003, 2237, 2548, 2626,
2695, 2727, 2764, 2765, 2906, 3046, 3216, 3232,
3262, 3377
§∞∑∞ƒπ¢∏™ ∂., 830, 1140
§∞∑∞ƒπ¢∏™ ª., 2443, 3723
§∞∑∞ƒπ¢OÀ ¶., 1125
§∞∑∞ƒO¶OÀ§OÀ Ã., 3689
§∞£OÀƒ∏™ ∏., 2652
§∞∫∞™∞™ °., 1991, 1999, 2051, 2107, 2222, 2224,
2225, 2227, 2460, 2464, 2485
§∞∫∂ ™., 2673, 3577
§∞∫∫∞-¶∞¶∞¢O¢∏ª∞ ∂., 160, 2558, 2559, 2560
§∞∫OÀª∂¡Δ∞ O., 2920
§∞∫OÀª∂¡Δ∞ ™., 2762
§∞§§∞™ ∞., 3536
§∞§O™ π., 158
§∞ª¶∞¢∞ƒπ¢∏™ π., 3087
§∞ª¶∞¢π∞ƒ∏ μ., 2451, 2452, 2453, 2455, 2456, 2494,
2512, 3528
§∞ª¶ƒ∞∫∏™ ∫., 1351
§∞ª¶ƒO¶OÀ§O™ ¢., 576
§∞ª¶ƒO¶OÀ§O™ ∂., 3212
§∞ª¶ƒO¶OÀ§O™ §., 764, 2159, 2697
§∞ª¶ƒO¶OÀ§O™ ™., 3212
§∞ª¶ƒO¶OÀ§O™ T., 2341
§∞ª¶ƒO¶OÀ§OÀ-∫∞ƒ∞Δ∑∞ Ã., 3443
§∞ª¶ƒOÀ π., 3363
§∞¡∞ƒ∞ O., 479
§∞¡∞ƒ∞™ §., 296, 3345
§∞¶∞Δ™∞¡∏™ ¶., 82
§∞¶¶∞™ Ã., 3029
§∞ƒªOÀ Ã., 2060
§∞™∫∞ƒ∞ΔO™ π., 938, 3041, 3076, 3081
§∞™∫∞ƒ∏™ π., 1, 12
32
§∞ΔOÀº∏™ Ã., 819
§∞Δ™πO™ °., 3253
§∂μ∞¡Δ∞∫∏™ ¶., 576
§∂μ∂π¢πøΔOÀ-™Δ∂º∞¡OÀ ™., 3069
§∂μ∂¡Δ∏ ∂., 3051
§∂μπ™π∞¡OÀ ¢., 2142, 2161, 2167, 2340, 2440
§∂μπ™π∞¡OÀ π., 2340
§∂°∞∫∏™ π., 3325
§∂∫∞∫∏™ ¢., 826
§∂∫∞∫∏™ π., 1335, 1549, 1715, 3235, 3352, 3407
§∂∫π¢OÀ-¶∞ª¶OÀ∫∞ O., 1922, 1994
§∂§∂∫∏™ ª., 2058
§∂ªO¡π¢OÀ Ã., 3146
§∂ª¶π¢∞∫∏™ ∂., 1594
§∂ª¶π¢∞∫∏™ ∫., 2114
§∂¡Δ∑∞™ π., 2340, 2389, 2427, 2438, 3157, 3300
§∂O¡Δπ∞¢∏™ ∂., 1890, 1977, 2604
§∂O¡Δ™π¡∏ ¢., 3700
§∂O¡Δ™π¡∏ ª., 501
§∂OΔ™π¡π¢∏™ ª., 3283, 3317
§∂ΔΔ∞ μ., 1853
§∂À∫O™ ¡., 340, 345, 459, 821, 1463, 1561, 1893,
1986, 2024, 2756
§∂À∫O¶OÀ§O™ ∞., 2600
§∏¡O™ ∞., 3454
§π∞∫O¶OÀ§O™ μ., 2477, 3152, 3316
§π∞∫O¶OÀ§OÀ ª., 312, 362, 933, 2531, 2924, 3425
§π∞∫O¶OÀ§OÀ º., 3096
§π∞ª∏™ °., 3423
§π∞ªOÀ ∂., 511
§π∞¡π¢OÀ ∂., 3227
§π∞¡OÀ ¶., 726
§π∞¶∏-∞¢∞ªπ¢OÀ °., 898
§π∞¶∏ Ã., 3517
§π∞¶∏™ Ã., 733, 3196, 3205, 3218, 3250, 3265, 3333,
3539
§π∞Δ∏™ ™., 2076, 2504, 2614, 2623, 2838, 2873, 3214,
3235, 3369, 3522
§π∞Δ™∏™ π., 340, 345, 1463
§π∞Δ™π∫O™ ∂., 3303
§πμ∂ƒ∏™ ∫., 3530
§π§∏ ∫., 1800, 3189
§π§§∏™ £., 2975
§πª∂¡O¶OÀ§O™ μ., 455, 1559, 1586
§π¡∞ƒ¢∞∫∏™ ª., 1204
§π¡O™ ¢., 1462
§π¡O™ π., 899
§π¡OÀ ∞., 1588, 2622
§πO§πO¶OÀ§O™ £., 579
§πO¡∏™ Ã., 772, 1914, 1915, 2434, 2910, 2948, 3237
§πOƒ¢OÀ ∞., 793
§πO™∏™ °., 2757
§πO™∏™ ∫., 3037
§πOÀ¶∏™ Ã., 3330, 3335
§πOÀƒ∏ ∂., 2161
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
§πOÀƒΔ∞™ ∫., 3133
§πOÀΔ∞™ ∞., 256, 314, 361, 392, 602
§πΔOÀ ∏., 3281
§O°∞ƒ∞ ¶., 3122
§O°O£∂Δ∏™ π., 948, 2965
§O°O£∂ΔO¶OÀ§O™ π., 129, 130
§O°Ã∏™ ™., 3426, 3429
§O´∑O™ ∂., 882
§O´∑OÀ Δ., 2562
§OÀ∫O¶OÀ§O™ ¢., 775
§OÀ∫∞ °., 914, 2693
§OÀ∫π¢∏™ ™., 2759, 3462
§OÀ¶∞ Ã., 665, 1591, 2029, 2058, 2777, 2785
§OÀ¶∞™∞∫∏ Ã., 532
§OÀƒπ¢∞ ∂., 2791, 3279
§OÀƒπ¢∞™ °., 787, 1586, 2040, 2461, 2462, 2465,
2469, 2501, 2502, 2540, 2541
§OÀƒO™ ¡., 108
§OÀ™Δ∏™ ∫., 2026, 2032
§OÀΔƒ∞¢∏™ ¢., 3077
§OÀΔ™π¢∏™ °., 2916
§À°¡O™ ª., 3167, 3306
§À¢∞∫∏™ Ã., 915
§À∫O™ ¢., 2747
§À∫OÀ¢∏ ∞., 1100, 1106, 1107, 1120
§À∫OÀƒπ¡OÀ ∑., 2932
§Àª¶∂ƒO¶OÀ§O™ ∂., 2196, 2530, 3422, 3677
§Àª¶∂ƒO¶OÀ§OÀ ¢., 119
§Àƒ∞∫∏ ¶., 240
§Àƒ∞™ ∞., 2341, 2407, 2408, 3364
§ø§∏™ ¢., 697, 848
ª∞°∫π¡∞™ ∞., 3344, 3349
ª∞°∫§∞μ∂ƒ∞™ ¡., 3385, 3436
ª∞°∫§∞ƒ∞ ∂., 296, 472, 480, 663, 665, 669, 706, 749,
753
ª∞°∫OÀ Ã., 2437, 3360
ª∞°∫OÀƒπΔ™∞™ π., 429
ª∞°¡∏™∞§∏™ ∞., 1472
ª∞°OÀ§∞ π., 228, 261, 285, 297, 310, 1547, 1986,
2024, 2758, 3476
ª∞¢π∞™ ¡., 2951
ª∞∑O∫O¶∞∫∏™ ∂., 2133
ª∞£πOÀ¢∞∫∏™ ™., 2762
ª∞´§§∏™ ∞., 737
ª∞∫∞ƒø¡∏™ °., 161
ª∞∫∂¢OÀ ∫., 2698
ª∞∫ƒ∞Δ∑∞∫∏™ ª., 170
ª∞∫ƒ∏ ∞., 3520
ª∞∫ƒ∏ ∂., 3340
ª∞∫ƒ∏ ∫., 3237
ª∞∫ƒ∏™ °., 1425
ª∞∫ƒ∏™ £., 351
ª∞∫ƒ∏™ ∫., 3207
ª∞∫ƒO¶OÀ§O™ Ã., 3445
ª∞∫ƒÀ°π∞¡¡∞∫∏ ∂., 315, 449
ª∞∫ƒÀ°π∞¡¡∏™ ¢., 3530
ª∞∫ƒÀ°π∞¡¡∏™ ∏., 3, 9, 685, 703, 730, 738
ª∞∫ƒÀ°π∞¡¡∏™ ™., 2430, 2435, 3364, 3704
ª∞∫ƒÀ§∞∫∏™ ∫., 2585, 2593, 2741, 2838, 2985, 3210,
3285, 3231, 3233
ª∞§∞∫∞ ∞π∫., 403, 553
ª∞§∞∫O™ π., 3349
ª∞§∞∫OÀ £., 3055, 3128
ª∞§∞ªπΔ™∏-PUCHNER A., 468, 1531, 1597, 2219,
3362
ª∞§∞ªO™ μ., 562
ª∞§∞ªO™ ∫., 2017, 2031, 2050
ª∞§∞ªO™ ¶., 2693
ª∞§∂∑∞ ∞., 2154
ª∞§∂Àƒ∏ μ., 3052
ª∞§§π∞ƒ∞∫∏ ¡., 2133, 3255
ª∞§§π∞™ π., 1551, 1998
ª∞§§πOÀ ¡., 3573
ª∞§OÀΔ∞™ ™., 785, 2673
ª∞§Δ∂∑O™ ∂., 2051, 2223, 2224, 2225, 2226, 2227,
2379, 2380, 2381, 2443, 2444, 2447, 2448, 2459,
2460, 2461, 2462, 2464, 2465, 2466, 2467, 2468,
2469, 2470, 2471, 2472, 2473, 2474, 2475, 2476,
2477, 2482, 2483, 2485, 2486, 2487, 2489, 2490,
2491, 2492, 2501, 2502, 2617, 2907, 3355, 3485,
3521, 3524, 3723
ª∞ªO¶OÀ§O™ ∞., 3601
ª∞ªO¶OÀ§O™ ª., 375, 376, 492, 507, 1135, 1826,
3468, 3601
ª∞ªOÀ§∞∫∏™ ¢., 2039, 2218, 2725, 2947, 3350,
3367, 3379
ª∞¡∞º∏ £., 807
ª∞¡°∫π¡∞™ ∞., 2908
ª∞¡¢ƒOÀ∫∞™ ∫., 2639
ª∞¡∂™ Ã., 175, 180, 181, 199, 207, 228, 251, 256,
285, 297, 311, 314, 321, 339, 356, 361, 369, 372,
373, 378, 379, 381, 385, 391, 392, 394, 405, 416,
417, 430, 437, 438, 462, 526, 598, 602, 626, 627,
628, 629, 630, 633, 634, 635, 636, 637, 638, 639,
640, 641, 642, 659, 750, 752, 755, 756, 762, 886,
1134, 1137, 1458, 1464, 1482, 1524, 1568, 1569,
1570, 1573, 1581, 1582, 1592, 1596, 1649, 1791,
1796, 1798, 1806, 1836, 1837, 1854, 1856, 1859,
1860, 1861, 1862, 1907, 1913, 1941, 1945, 1946,
1949, 1950, 1954, 1975, 1976, 1979, 1996, 2007,
2020, 2116, 2154, 2193, 2748, 2778, 3005, 3297,
3723
ª∞¡∂™∏™ ∂., 3298, 3525
ª∞¡∂Δ∞™ ™., 3288
ª∞¡π∞Δ∏ ª., 902, 960, 2666, 3425
ª∞¡π∞Δ∏-Ãπ™Δπ¢∏ ª., 1319, 3447
ª∞¡π∞Δ∏™ ∞., 1909, 3376
ª∞¡πO™ °., 3219
ª∞¡OÀ¢∏™ º., 205
ª∞¡OÀƒ∞ ∞., 3405
33
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ª∞¡OÀ™∞∫∏ °., 3678
ª∞¡OÀ™∞∫∏ ª., 3700
ª∞¡OÀ™∞∫∏™ ™., 2109, 2339, 2430, 2435, 2526
ª∞¡OÀ™O™ O., 119
ª∞¡OÀ™™∞∫∏™ ª., 1201
ª∞¡Δ∞ ª., 707, 753
ª∞¡Δ∞™ Ã., 3319
ª∞¡Δ∞¢∞∫∏™ ∂., 3195
ª∞¡Δ∞§∂¡∞∫∏™ ™., 375, 3040, 3468
ª∞¡Δ∞™ ¶., 1479
ª∞¡Δ∑∞ƒ∞ º., 1890, 1977, 2625
ª∞¡Δ∑∞ƒ∏™ μ., 698, 699, 729
ª∞¡Δ∑∞ƒ∏™ §., 1348
ª∞¡Δ∑øƒO™ ∫., 2165, 2321
ª∞¡Δ∑øƒO™ Ã., 667, 670, 917, 1475, 1477, 1871
ª∞¡Δπ¢∏™ ∞., 3455
ª∞¡ø§∞∫∏ Ã., 1580, 2154
ª∞¡ø§∞∫∏™ ¡., 766
ª∞¡ø§∞™ ∫., 3225
ª∞¡ø§∏™ ∞., 2430, 2435, 2543
ª∞¡ø§O¶OÀ§O™ μ., 2378
ª∞¡ø§O¶OÀ§O™ ∫., 3408
ª∞¶OÀƒ∞™ ¢., 3466
ª∞ƒ∞μ∂°π∞™ ¡., 341
ª∞ƒ∞°°O™ ª., 4, 306, 407, 605, 607, 608, 656, 657,
658, 669, 698, 699, 701, 702, 706, 729, 738
ª∞ƒ∞∫∏ ¶., 2565
ª∞ƒ∞£ø¡πΔ∏™ °., 2058
ª∞ƒ∞∫OªπÃ∂§∞∫∏™ °., 1497
ª∞ƒ∞™ ¶., 382, 1458, 1578, 2154
ª∞ƒ∞ΔOÀ-FLIER ∂., 1475, 2451, 2452, 2453, 2454,
2455, 2456, 2495, 2496, 3528
ª∞ƒ°∞ƒ∏ ∫ª., 2711
ª∞ƒ°∞ƒπΔ∏ °., 2654, 3449
ª∞ƒ°∞ƒπΔ∏™ ™., 3097
ª∞ƒ°∞ƒπΔπ¢∏™ Ã., 2148
ª∞ƒ°∂§§O™ μ., 2709, 3203
ª∞ƒ°πøƒ∏™ ∞., 2133
ª∞ƒ°ø¡∏™ ∫., 3694, 3699
ª∞ƒ¢∞™ Ã., 119
ª∞ƒπ§∏™ ª., 167
ª∞ƒπ¡∞ ∂., 2140
MAPINAKH™ A., 1956
ª∞ƒπ¡∞∫∏™ £., 775, 1378
ª∞ƒπ¡O¶OÀ§O™ ™., 3200
ª∞ƒπ¡O™ ∂., 416, 1458, 1578
ª∞ƒπ¡O™ Ã., 1387
ª∞ƒπ¡OÀ ∫., 2614, 2905, 3220, 3253, 3517
ª∞ƒπO§∏™ ∞., 2340, 2438, 3300
ª∞ƒ∫∞∫∏ £., 1537
ª∞ƒ∫∞∫∏ ¡., 1322
ª∞ƒ∫∞¡Δø¡∞ΔO™ ∞., 808
ª∞ƒ∫∞¡Δø¡∏-∫ÀƒOÀ¢∏ ™., 1794
ª∞ƒ∫∂Δ∞∫∏™ ∞., 2693
ª∞ƒ∫∂ΔO™ ™., 67, 75, 123, 137, 850
34
ª∞ƒ∫∂ΔOÀ ª., 3217
ª∞ƒ∫π¢OÀ-Ãπ™ΔO¶OÀ§OÀ º., 3182
ª∞ƒ∫O°π∞¡¡∞∫∏™ ∞., 3241
ª∞ƒ∫OªπÃ∂§∞∫∏™ ¡., 3339
ª∞ƒ∫O¶OÀ§O™ ∞., 418, 457, 1474, 3450, 3453
ª∞ƒ∫OÀ °., 3065, 3315, 3318
ª∞ƒ∫OÀ ∫., 1381, 2437
ª∞ƒ∫OÀ ™., 3398
ª∞ƒ∫OÀ º., 2052
ª∞ƒO¶OÀ§O™ °., 3332
ª∞ƒOÀ™∏™ °., 168
ª∞ƒOÀΔ∞ π., 3126
ª∞ƒΔ∞™π¢OÀ ∫., 1836
ª∞ƒΔ∏-∑ø°ƒ∞ºOÀ ∫., 2965
ª∞ƒΔπ¡∏™ ∞., 272, 3024, 3028, 3043
ª∞™¢ƒ∞∫∏™ μ., 3231
ª∞™OÀ§∞™ °., 2935, 3169
ª∞™OÀƒ∞™ Ã., 141
ª∞™ΔOƒ∞∫O™ °., 2336, 3136, 3235, 3689, 3694, 3697,
3699
ª∞™ΔOƒO∞¡Δø¡∞∫∏™ ™., 3393
ª∞™ΔƒOª∏¡∞™ ª., 3038
ª∞Δ∞§πøΔ∞∫∏™ π., 1523
ª∞Δπ∞∫∏™ ∞., 3620, 3621
ª∞Δπ¢∏™ ¡., 385, 428
ª∞Δ™∞°∫OÀƒ∞ ª., 3324
ª∞Δ™∞´¢ø¡∏™ ¢., 2341
ª∞Δ™∞¡πøΔ∏™ ¡., 190, 766
ª∞Δ™∞™ ™., 262
ª∞Δ™OÀ∫∞ ¶., 3438, 3443
ª∞Àƒ∂∞™ μ., 3319
ª∞Àƒ∏™ ª., 3472
ª∞Àƒπ¢∏™ ∞., 2809
ª∞Àƒπ¢∏™ °., 1991, 1999, 2051, 2107, 2154, 2222,
2223, 2224, 2225, 2226, 2227, 2228, 2443, 2460,
2464, 2469, 2485, 2486
ª∞Àƒπ∫∞∫∏™ ª., 168, 263, 771, 812, 813, 879, 918,
1309, 1395, 2940, 2949, 3475
ª∞Àƒπ∫∞∫∏™ ¡., 3042
ª∞Àƒπ∫πOÀ ª., 1201, 2531
ª∞ÀƒO°π∞¡¡∞∫∏ ∞., 2010, 2070, 2167, 2513, 2597,
2598, 3525
ª∞ÀƒO∫∂º∞§O™ ¶., 1080, 1128
ª∞ÀƒOª∞Δ∏™ ∞., 3385, 3436
ª∞ÀƒOª∞Δπ¢∏™ °., 1135, 1402
ª∞ÀƒOª∞Δπ¢∏™ ∫., 261, 757, 1127, 2497, 3476
ª∞ÀƒOªπÃ∞§∏™ π., 791
ª∞ÀƒO¶OÀ§OÀ ∂., 2499, 2524
ª∞ÀƒOÀ¢∏ ª., 509
ª∞ÀƒOÀ¢∏™ ∫., 656, 675
ª∞Ã∞πƒ∞ ∫., 3715
ª∂°∞§OÀ¢∏ ∞., 2880
ª∂°∞™ π., 940, 1549, 2941
ª∂°°ƒ∂§∏ Ã., 160
ª∂´¢∞¡∏ ª., 227
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ª∂§∞ ∞., 242, 1336
ª∂§∞ π., 880
ª∂§∞™ ¡., 3590
ª∂§∂OÀ¡∏ ∞., 1135
ª∂§∂Δ∏ Ã., 771
ª∂§∂Δ§π¢OÀ ∂., 531
ª∂§π¢∏™ ¢., 2000
ª∂§π¢ø¡∏™ ∞., 1138, 1460, 1490, 1517, 1533, 1565,
1594, 1911, 1995, 2073, 2108, 2109, 2110, 2112,
2114, 2115, 2138, 2142, 2161, 2167, , 2337, 2338,
2339, 2340, 2341, 2383, 2385, 2386, 2387, 2388,
2389, 2391, 2392, 2394, 2396, 2397, 2399, 2401,
2402, 2403, 2404, 2406, 2407, 2408, 2409, 2415,
2416, 2418, 2419, 2420, 2421, 2423, 2424, 2426,
2427, 2428, 2429, 2430, 2431, 2432, 2433, 2435,
2436, 2437, 2438, 2439, 2440, 2441, 2442, 2520,
2526, 2527, 2529, 2534, 2535, 2642, 2700, 2781,
2816, 2820, 2824, 2828, 2829, 2840, 3019, 3300,
3512, 3513, 3514, 3660, 3661, 3663, 3665, 3667,
3668, 3674, 3675, 3704
ª∂§π™™∞ƒπΔ∞∫∏™ π., 3075
ª∂§§πO™ ∑., 3517
ª∂ªªO™ ¢., 447, 2445
ª∂¡¢ƒ∏™ π., 654
ª∂¡¢ƒπ¡O™ ¢., 3625
ª∂ƒπ∫∞™ °..16, 18, 69, 167, 1352
ª∂ƒ∫OÀƒ∏™ ¶., 3248, 3345
ª∂™∏ª∂ƒ∏™ £., 2812
ª∂™O°πΔ∏ ™., 1926, 3200
ª∂™™∞ƒπΔ∞∫∏™ π., 190
ª∂Δ∞§§π¢∏™ ™., 2192, 2488, 3031
ª∂Δ∞§§∏¡O™ °., 3237, 3293
ª∂Δ∞•∞™ ¶., 196, 205, 408, 445
ª∂Δ∞•∞ΔO™ °., 2709
ª∂Δ∞•∞ΔO™ π., 306
ª∂Δ∂μ∂§∏™ ∂., 2927
ª∏§∞ƒ∞∫∏™ ¢., 356, 373, 597, 1458, 1979, 1945,
2116
ª∏§π¢∏™ £., 417, 1566
ª∏§πΔ™∏™ ª., 2154
ª∏§πø¡∏™ ∞., 287, 954, 1580, 2499, 2524
ª∏§πø¡∏™ ∏., 3391, 3422, 3423
ª∏§πø¡∏™ π., 2431, 2436
ª∏§OÀ™∏™ ∞., 2176, 2379, 2469
ª∏¡∞¢∞∫∏ ª., 341
ª∏¡∞∫∞∫∏™ ¶., 885
ª∏¡∞™ ∞., 180
ª∏Δ§π∞°∫∞ ¶., 774, 1705, 1873, 3380
ª∏Δƒ∞∫OÀ ∞., 440, 441, 829, 1185, 1198, 1206, 1296,
1297, 1299, 1300, 1301, 1302, 1303, 1304, 1305,
1306, 1338, 1434, 1435, 1436, 1437, 1438, 1439,
1440, 1441, 1442, 1443, 1444, 1445, 1446, 1447,
1448, 1449, 1450, 1525, 1604, 1669, 1670, 1671,
1819, 1824, 2119, 2835, 2843, 3397, 3642, 3684,
3685, 3686, 3687, 3688, 3689, 3690, 3691, 3692,
3693, 3694, 3695, 3696, 3697, 3698, 3699, 3700,
3701, 3702, 3703
ª∏ΔƒOμ°∂¡∏ ™., 3099
ª∏ΔƒOª∞ƒ∞™ ª., 3393
ª∏ΔƒO¶OÀ§O™ π., 3315, 3318
ª∏ΔƒO¶OÀ§O™ ∫., 444
ª∏ΔƒO¶OÀ§OÀ ∂., 3070
ª∏ΔƒOÀ ¶., 2062, 2451, 2452, 2453, 2455, 2456,
2494, 2850, 3528, 3634
ª∏Δ™π∞¢∏™ ∫.™., 1638
ª∏Δ™OÀ ∂., 3282
ª∏Δ™ø¡∏™ π., 1868
ª∏ΔΔ∞™ ∂., 3166, 3269
ªπ∫∂¢∏™ ™., 771
ªπ∫∏∫∏™ μ., 1834
ªπ∫OÀ¢∏ ∫., 2007, 2178
ªπ§∏ ∂., 2805
ªπ¡∂ΔOÀ ∂., 1865
ªπ¡Δ∑πO™ ¢., 1377
ªπƒ∞ÃΔ™∏™ £., 2735
ªπ™∂ƒ§∏™ °., 3714
ªπ™πƒ§∏™ μ., 3438
ªπ™™πƒ§∏™ π., 3416
ªπΔ§π∞¡°∫∞ ¶., 1701, 1704, 1706
ªπÃ∞∏§ π., 3300
ªπÃ∞∏§ ª., 819
ªπÃ∞∏§π¢∏™ ∞., 505
ªπÃ∞∏§π¢∏™ °., 568
ªπÃ∞∏§π¢∏™ ¢.¶., 2041, 2042, 2043, 2044, 2056,
2196, 2197, 2530, 2602, 3212, 3373, 3399
ªπÃ∞∏§π¢∏™ ∫., 3288
ªπÃ∞∏§π¢∏™ ¡., 3039
ªπÃ∞∏§π¢OÀ °., 609, 1418
ªπÃ∞§∞∫∏ ª., 2522
ªπÃ∞§∞∫∏™ ∂., 669
ªπÃ∞§∞™ ™., 848, 2950, 3408
ªπÃ∞§∏ ¶., 2424
ªπÃ∞§∏™ ∞., 3097
ªπÃ∞§∏™ §., 3530
ªπÃ∞§π∞ ª., 959
ªπÃ∞§πOÀ ¢., 2694
ªπÃ∞§O¶OÀ§O™ ∞., 2
ªπÃ∞§O¶OÀ§O™ ∂., 880
ªπÃ∞§O¶OÀ§O™ ¡., 865
ªπÃ∞§O¶OÀ§O™ ¶., 2933
ªπÃ∞™ °., 2710
ªπÃ∞™ ¢., 137
ªπÃ∞™ ¶., 1145
ªπÃ∞ ª., 3226
ªπÃ∂§∏ ª., 3237
ªπÃ∂§∏™ ∫., 3460
ªOπƒ∞™ °., 674
ªOπƒ∞™ ∫., 1129
ªOπƒ∞™ ¡., 4, 10, 15, 165, 607, 608, 655, 685, 698,
699, 700, 701, 729
35
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ªOπƒ∞™°∂¡Δ∏ ∞., 1943º
ªO§∂ ∂., 419, 2194
ªO§Àμ¢∞™ ¶., 3376, 3383, 3390
ªO¡∞™Δ∏ƒπøΔ∏™ Ã., 2448, 2472, 2474, 2483, 2484,
2490, 2907, 3485
ªO¡∂¢∞™ π., 2056
ªOƒ∞§∏ ∞., 822, 823
ªOƒπÃOμπΔOÀ ∞., 2000
ªOƒΔ∑O™ °., 3399, 3409, 3410, 3413
ªO™ÃOμ∏ ª., 2734, 3342
ªO™ÃO¡∏™ °., 3219
ªO™ÃO™ ∞., 1142
ªO™ÃO™ °., 3272
ªO™ÃO™ ª., 1323, 3482
ªO™ÃOÀ ∫., 1579
ªO™ÃOÀ ª., 3175
ªO™Ãø¡∞™ π., 2866
ªOÀ°π∞∫∞∫OÀ ™., 3222, 3223, 3230, 3266, 3267, 3418
ªOÀ°πO™ μ., 3689, 3697
ªOÀ§O¶OÀ§O™ °., 3077
ªOÀ§O¶OÀ§O™ ¢., 3475
ªOÀ§O¶OÀ§O™ ™., 37, 38, 855, 856, 859, 862, 1163,
3153, 1190, 1205, 1250, 1253, 1254, 1255, 1261,
1265, 1295, 1309
ªOÀ§O¶OÀ§OÀ ¢., 771
ªOÀ§O¶OÀ§OÀ ∂., 263, 813, 879, 3042
ªOÀ§OÀ¢∏™ ∫., 841
ªOÀ¡Δ∑OÀƒ∏™ ∞., 3288
ªOÀ¡ΔO∫∞§∞∫∏™ £., 814, 1808, 2998, 3017, 3026,
3393
ªOÀƒ∞Δπ¢∏™ Ã., 393, 419
ªOÀƒ∂§∞ΔO™ ∞., 3282
ªOÀƒΔ∑πO™ °., 226
ªOÀ™™∞∫∏™ π., 3369, 3532
ªOÀ™§∂à Δ., 433, 456, 1456, 1459, 1559, 1586, 2184,
2232, 2237, 2578, 3624, 3716
ªOÀ™OÀ§∏™ °., 1337
ªOÀ™™∞∫∏™ π., 2198, 3214, 3289
ªOÀ™Δ∞∫∞™ ∞., 3396
ªOÀ™Δ∞∫∞™ ™., 255
ªOÀΔ∑π£ƒO¶OÀ§O™ ∫., 2914
ªOÀΔ∑OÀƒ∏ ∞., 2946
ªOÀΔ∑OÀƒ∏™ ¢., 3203
ªOÀΔOÀ™∏™ ¡., 68, 113
ªOÀΔ™O¶OÀ§O™ Ã., 774, 1699, 1701
ª¶∞¢∂∫∞™ ∞., 2798
ª¶∞£π∞¡∞∫∏ ª., 1915, 2056
ª¶∞∫∞ ¢., 2537
ª¶∞∫∞§O™ ¢., 220, 2854
ª¶∞∫∞Δ™∂§O™ ™¶., 184, 187, 191, 206, 225, 253,
254, 264, 284, 286, 294, 295, 299, 313, 315, 322,
325, 327, 338, 355, 358, 360, 434, 442, 489, 490,
497, 498, 501, 508, 1457, 1849, 1850, 1851, 1982,
2005, 2012, 2016, 2030, 2055, 2168, 3575, 3643
ª¶∞∫∞Δ™∂§O™ ™Δ∂ƒ., 799, 839, 840, 841, 842
36
ª¶∞∫π¢∏™ ™., 1117, 2557
ª¶∞∫O°π∞¡¡∏ ª., 3414
ª¶∞∫O°π∞¡¡∏™ Ã., 2789, 3343
ª¶∞∫OÀ§∞ Ã., 3467
ª¶∞∫ƒ∏™ °., 1518, 2204, 2205, 2206, 2207, 2210,
2211, 2989, 3216, 3262, 3254
ª¶∞§∞™ ¶., 239, 242, 320, 3473
ª¶∞§∞ª¶∞¡π¢OÀ ∂., 2229, 2760
ª¶∞§∞¡π∫∞™ °., 2673
ª¶∞§∞™∫∞ ∞., 3240
ª¶∞§O°π∞¡¡∏™ ™., 238
ª¶∞§O¢∏ªO™ ª., 47, 53, 66, 71, 73, 76, 101, 110,
111, 112, 136, 1757
ª¶∞§Δ∞ ¢., 3090
ª¶∞§Δ∞°π∞¡¡∏™ ¡., 3241
ª¶∞§Δ∞ƒ∂Δ™OÀ ∂., 2337
ª¶∞§Δ∞Δ∑∏ ª., 2141, 2148, 2179
ª¶∞ª¶∞™∏™ μ., 227, 270
ª¶∞ª¶π¡πOΔ∞∫∏™ ∞., 3032
ª¶∞¡∞μ∞™ ∫., 802, 1468
ª¶∞¡ΔπO™ ™., 2033
ª¶∞ƒ∞ª¶∞Δ∏™ ¡., 3102
ª¶∞ƒ∫OÀ∫∏™ °., 1757
ª¶∞ƒª¶∞∫∏ ¶., 3407
ª¶∞ƒª¶∞§π∞™ °., 2703, 3398, 3412, 3534
M¶APM¶ET™EA™ I., 1956
ª¶∞ƒª¶OÀΔ∏™ ∫., 1834
ª¶∞ƒΔ™O∫∞™ Ã., 20, 22, 298, 357, 363, 468, 469,
470, 471, 472, 473, 474, 475, 476, 478, 479, 480,
481, 482, 484, 485, 486, 487, 488, 629, 631, 633,
898, 934, 1465, 1481, 1503, 1520, 1531, 1544,
1593, 1597, 1645, 1673, 1718, 1802, 1896, 1954,
1957, 1958, 1959, 2060, 2074, 2215, 2216, 2217,
2218, 2219, 2220, 2221, 2701, 3008, 3074, 3222,
3223, 3230, 3362, 3368, 3400, 3512
ª¶∞™πOÀ∫∞™ ¶., 896
ª¶∞™™∞ƒ∏™ ∏., 3417
ª¶∞™ΔOÀ¡∏™ ∂., 2789, 3196, 3343, 3394
ª¶∞™ΔOÀ¡∏™ ∏., 793
ª¶∞Δƒπ¡O™ ª., 100
ª¶∞Ω§OÀ μ., 3096
ª¶∂∑πƒ°π∞¡¡π¢∏™ Ã., 2000
ª¶∂∑∞∑∏-¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂., 1125, 1127,
2497
ª¶∂∑∞∑∏ ª., 3453
ª¶∂∑O™ ∏., 10, 15, 165, 607, 725
ª¶∂∏ ™., 3124
ª¶∂∏™ Ã., 1417, 3329, 3439
ª¶∂∫π∞ƒ∏ ∂., 1986, 2024
ª¶∂§∞∑∏ ª., 418, 457, 1474, 2537, 3450, 3452
ª¶∂§∂μ∂™§∏™ £.∂., 1987
ª¶∂§O°π∞¡¡∏™ ∞., 229
ª¶∂§∂Ã∏ ∞ª., 2445
ª¶∂§¡Δ∂∫O™ ¢., 1138, 2423, 2430, 2435, 2766
ª¶∂¡∞∫∏™ μ., 346
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ª¶∂¡∂ΔO™ ∞., 3246
ª¶∂¡∂ΔO™ ™., 363
ª¶∂¡∏™ ∞., 1589
ª¶∂¡∏™ ¡., 374
ª¶∂¡O™ ∞., 1914
ª¶∂¡ƒOÀª¶∏ ª., 188, 494, 782, 1491, 1805, 2166,
2802, 3004, 3159, 3309, 3512, 3526, 3632
ª¶∂ƒ∑OμπΔ∏™ ∞., 2706
ª¶∂º∞¡∏ Ã., 2906, 3271
ª¶π∑∞∫∏™ π., 3378
ª¶π∫∞™ ¡., 1927, 1929, 1930
ª¶π∫OÀμ∞ƒ∞∫∏™ ™., 3332
ª¶π§∏ ∏., 3468
ª¶π§π∞¡OÀ ∂., 2167, 2406
ª¶π§π¡∏™ Ã., 341
ª¶π§§∏ ∂., 325
ª¶π§§∏™ ∞., 2709
ª¶πª¶∞∫∏™ ∂., 2763
ª¶π™¢ƒ∂ª∏™ ∂., 2005
ª¶π™Ãπ¡πøΔ∏™ π., 2229, 2704, 2760
ª¶πΔ™πO™ ∞., 2154
ª¶§∞Δ™πO™ μ., 897
ª¶O∑∞™ ∂., 2218, 2219, 2221, 3362
ª¶O§∞¡O™ ¡., 3241
ª¶O§∂Δ∏™ π., 656, 675, 3278, 3292
ª¶O§∏ ¶., 3109
ª¶Oª¶Oƒπ¢∏™ ¢., 2236
ª¶Oª¶OΔ∏™ °.Ã., 1987
ª¶O¡∞Δ™O™ °., 43, 610, 611, 616, 619
ª¶O¡∏ ∞., 420
ª¶O¡Oμ∞™ ™., 3354, 3357, 3360, 3381
ª¶O¡Δ∏™ π., 3352
ª¶O¡øƒ∏™ ¶., 888
ª¶O™∂ΔΔ∏ Ã., 3401
ª¶O™π¡∞∫OÀ ∂., 3253, 3486
ª¶O™π¡∞∫OÀ π., 1534
ª¶O™™πO™ ∞., 3304
ª¶O™Δ∞¡Δ™O¶OÀ§OÀ ª., 189
ª¶OΔπΔ™∏ ∂., 3472
ª¶OΔ™∏™ ¢., 853, 3050, 3136
ª¶OÀ°∞™ π., 97, 135, 1742, 1743, 1744, 1745, 1748
ª¶OÀ°OÀ§π∞ ª., 404, 460, 599, 600, 603, 604, 1455,
1560, 1564, 1942, 2026, 2032, 2049, 2137, 2175,
2675, 2680
ª¶OÀ∑∞ ∂., 939, 2712
ª¶OÀ∑∞™ ∞., 59
ª¶OÀ∫∏ Δ., 1450
ª¶OÀ∫Oμπ¡∞™ π., 420, 421
ª¶OÀ∫OÀμ∞§∞™ μ., 687
ª¶OÀ§ª¶OÀ ª., 3340, 3341, 3356, 3376, 3383, 3390
ª¶OÀ§OÀ∫O™ ∞., 351, 898, 934, 1119, 1121, 1593
ª¶OÀ§OÀ∫O™ μ., 2041, 2197
ª¶OÀª¶∞™ ¢., 2039, 2947
ª¶OÀ¡ΔOÀ§∞™ Ã., 377, 1683, 3328
ª¶OÀ¡Δø¡∞™ °., 340, 345, 1463, 2705
ª¶OÀƒ∞ ¶., 228, 311, 828
ª¶OÀƒ∞¡Δ∞™ ∫., 726
ª¶OÀƒ∞™ ∞., 910
ª¶OÀƒ∞™ π., 2325
ª¶OÀƒπ∫∞™ °., 359
ª¶OÀƒO§π∞™ ∫., 3195
ª¶OÀƒO¶OÀ§O™ ∫., 2978
ª¶OÀƒO™ ¢., 897, 3521
ª¶OÀ™π∞ Ã., 2917
ª¶OÀ™πOÀ £., 461, 1461
ª¶OÀ™ª¶OÀ§∞™ ™., 2544, 2587, 2848, 3511
ª¶OÀΔ∞Δ∏ ∂., 383, 2067, 2451, 2452, 2453, 2454,
2455, 2456, 2457, 2493, 2494, 2495, 2496, 2503,
2599, 2645, 2784, 2791, 3021, 3082, 3527, 3528
ª¶OÀΔ∑πOÀ∫∞ μ., 3237
ª¶OÀΔ™π∞¢∏™ ∞., 2336
ª¶OÀΔ™π∫OÀ £., 3010
ª¶OÀºπ¢OÀ ∞., 226
ª¶ƒ∞ª∏™ π., 793, 2789
ª¶ƒ∂™Δ∞™ ¶., 2416, 2428, 2431, 2436
ª¶ƒπª∏™ ¢., 2763
ª¶ƒπ™πªπΔ∑∏ ª., 1201, 2531
ª¶ƒOÀª∞ ∂., 3119
ª¶ƒOÀ¡Δ∑O™ ∏., 3527
ªÀ°¢∞§∏™ ∏., 25, 391, 398, 779, 835, 900, 941, 1093,
1094, 1095, 1096, 1097, 1098, 1099, 1100, 1101,
1102, 103, 1104, 1105, 1106, 1107, 1108, 1109,
1110, 1111, 1112, 1113, 1114, 1115, 1116, 1117,
1118, 1119, 1120, 1121, 1122, 1123, 1484, 1494,
1514, 1890, 1910, 1961, 1972, 1977, 2010, 2061,
2078, 2088, 2166, 2193, 2481, 2506, 2543, 2557,
2561, 2583, 2584, 2591, 2604, 2613, 2615, 2625,
2628, 2629, 2636, 2637, 2638, 2643, 2644, 2646,
2650, 2655, 2586, 2967, 2979, 2995, 3013, 3048,
3370, 3399, 3409, 3410, 3413, 3451, 3457, 3477,
3512, 3513, 3514, 3645, 3704, 3708, 3709, 3710,
3711, 3712, 3713
ªÀ§ø¡∞∫∏™ ∞., 2549, 2550, 2551, 2708, 3531
ªÀ§ø¡∞∫∏™ ∂., 511
ªÀ§ø¡∞™ ¢., 3029
ªÀ§O¶OÀ§O™ ª., 393
ªÀ§O¶OÀ§O™ ¡., 426, 427, 919
ªÀ§ø¡∞∫∏™ ∞., 3516
ªÀ§ø¡∞∫∏™ §., 2663
ªÀ§ø¡∞ ∞., 2532
ªÀ§ø¡∞-∫∞ƒ∞°π∞¡¡∏ Ã., 3304
ªÀ§ø¡∞™ °., 2194
ªÀ§ø¡∞™ π., 948
ªÀ§ø¡∞™ ¡., 1389
ªÀΔ∞ºΔ™∏™ ∞., 1918
ªÀΔ∞™ ¢., 2766, 3068, 3538, 3670
ªÀΔ∏™ °., 1411
ªøƒ∞´Δ∏™ °., 178, 179, 208, 229, 255, 1527, 1528,
1529, 1530
¡∞μƒO∑π¢OÀ ∂., 1833
37
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¡∞∫∫∞ ∫., 3530
¡∞∫O¶OÀ§OÀ §., 766
¡∞§ª¶∞¡Δ∏™ π., 1526
¡∞¡∞™ π., 3326
¡∞•∞∫∏ ∞., 2406
¡∂°ƒ∏ ∂., 3401
¡∂¡∞ ∂., 3521
¡∂OÀ ¶., 298
¡∂™ΔOƒ∞ ∫., 3494
¡∂™ΔOƒπ¢∏ ∂., 1462
¡π∞∫∞™ ¢., 1118, 2377, 3216, 3247
¡π∫∑∞™ ¢., 2456, 3528
¡π∫∏Δ∞ ∫., 3222, 3223, 3230, 3266, 3267, 3418
¡π∫∏Δπ∞¢∏™ ∂., 2408
¡π∫O§∞´¢∏™ ∞¡¢., 1552
¡π∫O§∞´¢∏™ ∞., 226, 825, 3388, 3404
¡π∫O§∞´¢∏™ ∂., 2153
¡π∫O§∞´¢∏™ £., 391
¡π∫O§∞´¢∏™ π., 372
¡π∫O§∞´¢∏™ ª°., 3694
¡π∫O§∞´¢∏™ ¡., 2733
¡π∫O§∞´¢∏™ ¶., 183, 378, 789, 2488, 3031
¡π∫O§∞´¢∏™ º., 1316
¡π∫O§∞π¢OÀ ∞., 3487
¡π∫O§∞´¢OÀ ¶., 920, 3075, 3447
¡π∫O§∞∫O¶OÀ§O™ ∞., 1856
¡π∫O§∞OÀ ∞., 610, 611, 612, 616, 618, 619, 620, 623,
2714, 3233
¡π∫O§∞OÀ ∫., 43, 611, 612, 613, 618, 619, 620, 623
¡π∫O§∞OÀ ¡., 3227
¡π∫O§∞OÀ O., 2935
¡π∫O§∞OÀ Δ., 3345
¡π∫O§O¶OÀ§O™ ∞., 2612, 2707, 2715
¡π∫O§O¶OÀ§O™ °., 2415, 2416, 2428, 2431, 2436
¡π∫O§O¶OÀ§O™ °., 2161
¡π∫O§O¶OÀ§O™ ¢., 56, 102, 115, 117
¡π∫O§O¶OÀ§OÀ μ., 3107
¡π∫O§O¶OÀ§OÀ ¡., 2709
¡π∫OÀ ∞., 913
¡π∫OÀ °., 692, 693
¡π∫OÀ ¢., 1325
¡∫∂¡∫∂ ∂., 2909, 3221, 3236, 3242, 3243, 3249, 3291
¡O´Δ™∏-ªπÃ∞§∏ º., 522
¡Oªπ∫O™ π., 763
¡Oªπ∫O™ ¡., 425
¡Oªπ∫O™ Δ., 3238
¡OÀ¡O¶OÀ§O™ Ã., 351, 934, 1119, 1121, 1593
¡OÀ™π∞-∞ƒμ∞¡πΔ∞∫∏ ™., 795, 2669, 2743, 3421,
3431, 3435, 3437
¡OÀ™πO™ °., 329, 374
¡OÀ™∫∞™ π., 2040
¡OÀΔ™OÀ ª., 2167, 2818, 3513, 3514
¡Δ∞μOÀ§O™ °., 663
¡Δ∞°π∞¡Δ∞ ª., 2763
¡Δ∞°∫OÀ¡∞ O., 406
38
¡Δ∞§∏ °., 2860
¡Δ∞ª™∞ ∞π∫., 345
¡Δ∞¡OÀ ¶., 3139
¡Δ∞ºO°π∞¡¡∏ Ã., 466, 486, 660, 1481, 1531, 1532,
1597, 1697
¡Δ∂°π∞¡¡∏™ ¢., 3323, 3344, 3351
¡Δ∂§∞∫∏ ª., 2922
¡Δπ¡O¶OÀ§OÀ ∂., 1548
¡ΔOμ∞™ ∞., 3029
¡ΔO°πƒ¡Δ∞™ π., 342
¡ΔOÀ¡Δ∞ Ã., 2117
¡ΔOÀ¶∏™ π., 2334, 2373, 2376, 3164, 3519
¡ΔOÀƒ∞∫∏™ ™., 2728, 2968
¡ΔOÀƒOÀ¡ΔO™ π., 3689, 3694, 3700
¡À∫Δ∞ƒ∏ μ., 3301
•∞´¢∞ƒ∞ ∞., 3447
•∞¡£∏™ ∞., 2016, 2173, 2230, 3224, 3561
•∞¡£O¶OÀ§O™ π., 329
•∞ƒ§∞¡Δ∂ƒ∏™ ¶., 3268
•∞ƒÃ∞™ ∫., 2525
•∂¡∞∫∏™ ∫., 1844, 2113
•∂¡O™ ∫., 2604
•∂¶∞¶∞¢∞∫∏™ °., 815
•∂ºΔ∂ƒ∏ ∂., 657, 726
•∂ºΔ∂ƒ∏ ª., 3435
•∏ƒ∞∫∏ μ., 2723
•∏ƒOÀÃ∞∫∏ ∂.. 19
•À¢∞∫∏™ ∞., 2304
•À¢∏ ∫., 3108
•À¢∏™ ∫., 3268
•À¡O™ ∂., 3442, 3455
•À¶O§ÀΔ∞-Δ™∞¡Δπ§∏ ¢., 161
•Àƒ∞º∏™ •., 2077
Oπ∫O¡Oª∞∫∏™ ∂., 2377, 3247
Oπ∫O¡Oª∞∫O™ ¡., 3392
Oπ∫O¡Oªπ¢∏™ §., 2379
Oπ∫O¡Oªπ¢∏™ ¶., 803, 950, 2091, 2304, 2315, 2318,
2320, 2321, 2322, 2323, 2331, 2354, 2356
Oπ∫O¡Oªπ¢OÀ ¢., 2445
Oπ∫O¡Oªπ¢OÀ π., 893, 902, 960
Oπ∫O¡OªO¶OÀ§O™ ¡., 3527
Oπ∫O¡OªO¶OÀ§O™ Δ., 2453, 2455, 2456, 2549,
3516, 3527, 3528, 3531
Oπ∫O¡OªO¶OÀ§OÀ ¶., 1535
Oπ∫O¡OªOÀ ∂., 468
Oπ∫O¡OªOÀ ª., 3237
Oπ∫O¡OªOÀ ¡., 133
Oπ∫O¡OªOÀ ¶., 262
Oπ∫O¡OªOÀ ™., 2714
Oπ∫O¡OªOÀ º., 262
Oπ∫O¡OªOÀ-∞¡Δø¡π∞¢OÀ ª., 193, 315, 406
Oπ∫O¡OªOÀ-ª∞ÀƒOÀ ∫., 143
O§Àª¶πO™ ∫., 2527
O§Àª¶πO™ â., 2716
Oƒº∞¡∞∫∏™ ∞., 3268, 3538
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Oƒº∞¡π¢∏™ ∑., 896, 3086
Oƒº∞¡O™ ¶., 3296
Oƒº∞¡OÀ-∫OÀª∂ƒ∫∂ƒπ¢OÀ ∂., 828
OÀμ∂¡∏™ π., 231, 2154
OÀ∑OÀ¡∏ ∞., 2497
OÀ∑OÀ¡∏™ ∫., 1709, 1711, 1636
OÀ§∏™ ¶., 3231
•∞ƒÃ∞™ ∫., 3225
•À¶¡∏ΔO™ Ã., 3248
¶∞°π¢∏™ ¶., 2498
¶∞°∫∞§∏™ °., 332
¶∞°∫∞§O™ ∂., 253, 287, 352, 355, 365, 395, 431, 597,
905, 906, 953, 954, 1567, 1580, 1998, 1400, 2048,
2154, 2193, 2410, 2499, 2524, 2554, 2626, 2632,
2635, 2639, 2761, 2764, 2831, 3046, 3047, 3488,
3506, 3507, 3508, 3509, 3510, 3511, 3512, 3513,
3514, 3549, 3550, 3627, 3644, 3669, 3704
¶∞°∫∞§O™ ª∂., 2639, 2888, 3047
¶∞°∫ƒ∞Δ∏ ∞., 480
¶∞°ø¡∏™ ¢., 3115
¶∞°ø¡∏ ™., 2614, 3427
¶∞¢π∞Δ∂§§∏™ ∫., 103
¶∞∑∞´ΔOÀ-¶∞¡∞°πøΔOÀ ∫., 227, 596, 1592, 2236
¶∞∑∞ƒ§O°§OÀ ª., 287, 2154, 2498, 2499, 2524,
2552, 2553, 2554
¶∞πO¡π¢∏™ ∞., 2669
¶∞§∞πO§O°O™ ∞., 481, 1673
¶∞§∂Δ∞™ ∫., 261, 310, 2024, 2154, 3193, 3261, 3271,
3476, 3518
¶∞§∏ª∂ƒ∏™ °., 949
¶∞§∏O™ πª., 2732
¶∞§π∞∫∞™∏™ ∫., 1636, 1709
¶∞§πO°π∞¡¡∏ º., 3417
¶∞§§∏∫∞ƒ∏™ °., 1186
¶∞§§∏∫∞ƒπ¢∏™ ¢., 815
¶∞ª¶OÀ∫∞™ π., 2160
¶∞ª¶OÀ∫π¢∏™ π., 1527, 1529
¶∞¡∞°πøΔ∞∫O™ ¢., 2045, 2134, 2451, 2453, 2455,
2585, 2910, 3157, 3237, 3238, 3251, 3257, 3259,
3264, 3310, 3313, 3365
¶∞¡∞°πøΔπ¢∏™ π., 3378
¶∞¡∞°πøΔπ¢∏™ ¡., 3085
¶∞¡∞°πøΔO°§OÀ Δ., 3229, 3252
¶∞¡∞°πøΔO¶OÀ§O™ ¢., 3204
¶∞¡∞°πøΔO¶OÀ§O™ ∂., 553, 632, 823, 839, 840, 841,
842
¶∞¡∞°πøΔO¶OÀ§O™ π., 793
¶∞¡∞°πøΔO¶OÀ§O™ ¡., 3429
¶∞¡∞°πøΔO¶OÀ§O™ ™., 2150, 2151, 2152
¶∞¡∞°πøΔO¶OÀ§OÀ °., 901
¶∞¡∞°πøΔO¶OÀ§OÀ ∫., 3110
¶∞¡∞°πøΔOÀ ∞., 2918
¶∞¡∞°πøΔOÀ £., 2167, 2412, 2821, 2849, 2969, 3017
¶∞¡∞°πøΔOÀ ª., 3192
¶∞¡∞°πøΔOÀ ¶., 563
¶∞¡∞°πøΔOÀ Δ., 3393
¶∞¡∞°∫OÀ§π∞™ °., 1124
¶∞¡∞°O¶OÀ§O™ ∫., 68
¶∞¡∞°O¶OÀ§O™ °., 79
¶∞¡∞°O¶OÀ§O™ Ã., 113
¶∞¡∞°O¶OÀ§OÀ ∂., 2917
¶∞¡∞°O¶OÀ§OÀ ¶., 2235
¶∞¡∞°O™ Ã., 1940
¶∞¡∞ƒπΔ∏™ μ., 3337
¶∞¡∞Δ∞∫∏™ ∂., 3482
¶∞¡π∞ƒ∞ ∫., 2654
¶∞¡π∞ƒ∞ O., 3433, 3449
¶∞¡π∂ƒ∞∫∏™ ∫., 2039
¶∞¡π¢∏™ ¢., 776, 786, 796, 1135, 2773
¶∞¡O™ °., 2868
¶∞¡OÀ™O¶OÀ§O™ ¢., 623, 3374
¶∞¡OÀΔ™OÀ ∞., 2934
¶∞¡Δ∞∑∞ΔOÀ ¡., 2922
¶∞¡Δ∞§∏ ª., 253
¶∞¡Δ∂§∞∫∏ ¶., 668
¶∞¡Δ∂§∞∫∏™ ™., 57, 363, 631, 633
¶∞¡Δ∂§π¢OÀ ∞., 1699
¶∞¡Δ∑∞∫∏ ∞., 2445
¶∞¡Δ∑πO™ ∞., 3097
¶∞¶∞ ∞., 572, 573, 599, 603, 604, 1560
¶∞¶∞μ∞™π§∂πOÀ ∞., 3284
¶∞¶∞μ∞™π§∂πOÀ ∂., 3279
¶∞¶∞μ∞™π§∂πOÀ ™., 1914, 1915, 3269
¶∞¶∞μ∞™π§O¶OÀ§O™ °., 2855
¶∞¶∞μƒ∞ªπ¢OÀ ª., 3202, 3244
¶∞¶∞°°∂§O¶OÀ§O™ ™., 2940
¶∞¶∞°∂øƒ°π∞¢∏™ °., 118
¶∞¶∞°∂øƒ°πOÀ ∞., 313, 359, 490, 497, 509, 790,
1682, 1683, 1891, 1947, 2015, 2041, 2042, 2043,
2056, 2132, 2197, 3155, 3212, 3373
¶∞¶∞°∂øƒ°πOÀ °., 587, 855, 3040
¶∞¶∞°∂øƒ°πOÀ ¢., 1548
¶∞¶∞°∂øƒ°πOÀ ∂., 157
¶∞¶∞°∂øƒ°πOÀ π., 1926
¶∞¶∞°∂øƒ°πOÀ ∫., 1588, 1606, 2030, 2622, 3042,
3441, 3454
¶∞¶∞°∂øƒ°πOÀ ¡., 3253
¶∞¶∞°∂øƒ°πOÀ Ã., 3231
¶∞¶∞°π∞¡¡∏ ∞., 183
¶∞¶∞°π∞¡¡∏ ∫., 182
¶∞¶∞°π∞¡¡∏™ ∞., 157, 159, 2125
¶∞¶∞¢∞∫∏ ∞., 1204
¶∞¶∞¢∞∫∏ ∏., 3306
¶∞¶∞¢∞∫∏ ª., 775
¶∞¶∞¢∞∫∏-ª¶∂£ÀªOÀΔ∏ ∞., 857
¶∞¶∞¢∞∫∏™ °., 846
¶∞¶∞¢∞∫∏™ π., 1249, 1252, 2133
¶∞¶∞¢∞∫∏™ Ã., 2723
¶∞¶∞¢∞∫OÀ-™∞ƒ∞ ∞., 162
¶∞¶∞¢∞ª ∞., 1504, 3513, 3514
39
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¶∞¶∞¢∞ΔO™ π., 1919
¶∞¶∞¢∞ΔO™ ∫., 20, 22, 56, 1896
¶∞¶∞¢∂§∏ ∂., 180, 285, 339, 378, 379, 382, 394, 405,
416, 462, 598, 633, 1137, 1433, 1562, 1581, 1853,
1854, 1855
¶∞¶∞¢∏ª∞™ π., 1145, 2752, 3535
¶∞¶∞¢∏ª∏ΔƒπOÀ ∞., 363, 3038, 3368
¶∞¶∞¢∏ª∏ΔƒπOÀ μ., 187
¶∞¶∞¢∏ª∏ΔƒπOÀ °., 825
¶∞¶∞¢∏ª∏ΔƒπOÀ ¢., 1548
¶∞¶∞¢∏ª∏ΔƒπOÀ π., 614, 617, 621, 622, 624
¶∞¶∞¢∏ª∏ΔƒπOÀ §., 2134
¶∞¶∞¢∏ª∏ΔƒπOÀ ª., 294, 300, 447, 1983, 1994,
1997, 2445
¶∞¶∞¢∏ª∏ΔƒπOÀ ¶., 210
¶∞¶∞¢∏ª∏ΔƒπOÀ Ã., 797, 3286
¶∞¶∞¢∏ª∏ΔƒπOÀ-ªπ™∫∞ ∑., 1526
¶∞¶∞¢∏ª∏ΔƒπOÀ-¶∞¶∞∫ø™Δ∞ §., 881
¶∞¶∞¢∏ª∏ΔƒO¶OÀ§O™ º., 3095
¶∞¶∞¢π∞™ ∫., 3136
¶∞¶∞¢O°∂øƒ°∞∫∏™ ¡., 1543, 2965
¶∞¶∞¢O°π∞¡¡∞∫∏™ ∫., 1249
¶∞¶∞¢O°π∞¡¡∞∫∏™ ¡., 77, 1252
¶∞¶∞¢O°π∞¡¡∏™ ¢., 239, 2749, 3275, 3289, 3302,
3454
¶∞¶∞¢O°π∞¡¡∏™ ª., 1593
¶∞¶∞¢O¶OÀ§O™ ∞., 3247, 3263
¶∞¶∞¢O¶OÀ§O™ ∞°°., 1380
¶∞¶∞¢O¶OÀ§O™ ∞£., 521, 1314
¶∞¶∞¢O¶OÀ§O™ ∞ƒ., 212
¶∞¶∞¢O¶OÀ§O™ °., 322, 327, 2005, 2016, 3396
¶∞¶∞¢O¶OÀ§O™ °K., 381, 774, 1634, 1635, 1636,
1699, 1700, 1701, 1702, 1703, 1704, 1705, 1706,
1707, 1708, 1709, 1710, 1711, 1712, 1713, 1714
¶∞¶∞¢O¶OÀ§O™ °., 650, 726, 736, 2763, 3380
¶∞¶∞¢O¶OÀ§O™ π., 459, 1561, 2756
¶∞¶∞¢O¶OÀ§O™ ∫., 818, 821, 832, 2040, 2536,
2540, 2541
¶∞¶∞¢O¶OÀ§O™ ƒ., 2018
¶∞¶∞¢O¶OÀ§O™ ™Δ., 43, 623, 954, 1595
¶∞¶∞¢O¶OÀ§OÀ ∞., 228, 3100, 3226, 3368
¶∞¶∞¢O¶OÀ§OÀ-∞§∞Δ∞∫∏ ∂., 2632
¶∞¶∞¢O¶OÀ§OÀ ∂., 2487, 2725
¶∞¶∞¢O¶OÀ§OÀ-§∂°ª¶∂§OÀ ∫., 2632
¶∞¶∞¢O¶OÀ§OÀ-ª∞ƒ∫O¶OÀ§OÀ ∫., 963
¶∞¶∞¢O¶OÀ§OÀ ª., 259, 931, 1922, 2143, 2163,
3420
¶∞¶∞¢O¶OÀ§OÀ º., 185, 227, 271, 596, 604, 1406,
1984, 1989, 3599
¶∞¶∞¢ƒO™O™ ∏., 1883
¶∞¶∞∂ªª∞¡OÀ∏§ μ., 882, 3078
¶∞¶∞∂À∞°°∂§OÀ °., 17, 19
¶∞¶∞∂À™Δ∞£πOÀ ∞°., 2549, 3516, 3531
¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞., 2086, 2157, 2174, 2198,
2174, 2181, 2510, 3151, 3196, 3214, 3246, 3532
40
¶∞¶∞∑∞Ã∞ƒπOÀ °., 226
¶∞¶∞∑∞ÃO™ °., 169, 239, 700, 701, 723, 3454
¶∞¶∞∑∏™∏™ ∫., 2236
¶∞¶∞∑O°§OÀ ∞., 760
¶∞¶∞∑O°§OÀ ¢∂™¶., 246
¶∞¶∞∑O°§OÀ ¢., 2051, 2227, 2381, 2448, 2460,
2467, 2468, 2472, 2474, 2483, 2484, 2490, 2617,
3195, 3355, 3485
¶∞¶∞∑O°§OÀ ∫., 1919, 2193
¶∞¶∞∑O°§OÀ §., 2381
¶∞¶∞∑O°§OÀ ¡., 175, 180, 181, 199, 207, 212, 228,
251, 256, 285, 288, 297, 311, 314, 326, 337, 339,
356, 361, 369, 370, 371, 372, 373, 378, 379, 381,
382, 384, 385, 391, 392, 394, 405, 416, 417, 435,
436, 437, 438, 461, 462, 502, 514, 515, 516, 598,
601, 602, 626, 627, 628, 629, 630, 631, 632, 633,
634, 635, 636, 637, 638, 639, 640, 641, 642, 659,
752, 762, 886, 1137, 1433, 1458, 1461, 1464, 1524,
1544, 1555, 1562, 1563, 1568, 1569, 1570, 1573,
1576, 1577, 1581, 1582, 1596, 1649, 1718, 1791,
1796, 1798, 1829, 1835, 1836, 1837, 1848, 1853,
1854, 1855, 1856, 1859, 1860, 1861, 1862, 1907,
1913, 1941, 1944, 1945, 1946, 1949, 1950, 1954,
1957, 1958, 1959, 1975, 1976, 1979, 2001, 2006,
2116, 2156, 2190, 3552, 3718
¶∞¶∞∏§πOÀ ∞., 843
¶∞¶∞∏ƒ∞∫§∂OÀ™ ¡., 2910
¶∞¶∞£∞¡∞™πOÀ ∞., 2056, 2434, 3239, 3424, 3460
¶∞¶∞£∞¡∞™πOÀ ∂., 3029
¶∞¶∞£∞¡∞™πOÀ ª., 2437, 2438
¶∞¶∞£∂O¢øƒπ¢∏™ °., 3298, 3525
¶∞¶∞£∂O¢øƒOÀ ∫., 340, 341, 2051, 2227, 2448,
2460, 2467, 2468, 2472, 2474, 2483, 2484, 2490,
2617, 3485, 3530
¶∞¶∞´ø∞∫∂πª ª., 2380
¶∞¶∞´ø∞¡¡π¢∏™ ¢., 773, 1468, 1469, 1470, 1471,
1472, 3386
¶∞¶∞´ø∞¡¡OÀ ∞., 81, 287, 3301
¶∞¶∞´ø∞¡¡OÀ °., 2971
¶∞¶∞´ø∞¡¡OÀ π., 2134
¶∞¶∞´ø∞¡¡OÀ ¶., 1470
¶∞¶∞´ø∞¡¡OÀ ™., 1926
¶∞¶∞´ø∞¡¡OÀ Δ., 3312, 3407
¶∞¶∞´ø∞¡¡OÀ-Δ™∂§∂¶O°§OÀ ∞., 905
¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∞., 2721, 2762
¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂., 1468, 2938, 3259, 3313
¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ª., 3086, 3161
¶∞¶∞§∞ª¶ƒO™ ∂., 2789, 3343
¶∞¶∞§∂•πOÀ °., 200, 214, 225, 253, 2154
¶∞¶∞§O∏™ ∞., 43, 610, 611, 612, 613, 614, 615, 616,
617, 618, 619, 620, 621, 622, 623, 624, 625, 1925
¶∞¶∞§O∏™ μ., 612, 613, 616, 617, 618, 619, 620, 623
¶∞¶∞ª∞ƒ°∞ƒπΔ∏™ ∫., 250
¶∞¶∞ª∂§∂Δ∏ ª., 2694
¶∞¶∞ªπÃ∞∏§ Ã., 1549, 1715, 3312, 3395, 3407
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
¶∞¶∞ªO™ÃOÀ ª., 1527, 1529
¶∞¶∞¡∞°πøΔOÀ ¡., 2629, 3450, 3452
¶∞¶∞¡∞OÀª §., 2537
¶∞¶∞¡∞™ ¡., 1991, 1999, 2010, 2051, 2107, 2222,
2223, 2224, 2225, 2226, 2227, 2443, 2444, 2445,
2446, 2447, 2448, 2459, 2460, 2461, 2462, 2463,
2464, 2465, 2466, 2467, 2468, 2469, 2470, 2471,
2472, 2473, 2474, 2475, 2476, 2477, 2482, 2483,
2484, 2485, 2486, 2487, 2489, 2490, 2491, 2492,
2501, 2502, 2519, 2617, 2810, 2815, 2907, 3485,
3521, 3524, 3723
¶∞¶∞¡∞™Δ∞™πOÀ ™., 3051
¶∞¶∞¡∞°πøΔOÀ ¶., 418, 457
¶∞¶∞¡∞°πøΔOÀ ™., 862
¶∞¶∞¡π∫O§∞OÀ ∞., 3720
¶∞¶∞¡π∫O§∞OÀ μ., 294, 501
¶∞¶∞¡π∫O§∞OÀ °., 216
¶∞¶∞¡π∫O§∞OÀ ¢., 1638
¶∞¶∞¡π∫O§∞OÀ ª., 473, 476
¶∞¶∞¡π∫O§∞OÀ ¡., 827
¶∞¶∞¡π∫O§∞OÀ-∫ƒÀø¡∞ ∫., 1526
¶∞¶∞¡Δø¡∞∫∏ ™., 3301
¶∞¶∞¡Δø¡∞∫O™ ∞., 3364
¶∞¶∞¡Δø¡πOÀ ∞., 1534
¶∞¶∞¡Δø¡πOÀ ª., 3200
¶∞¶∞¡Δø¡πOÀ ¡., 1926
¶∞¶∞Oπ∫O¡OªOÀ ¶., 1579, 2154
¶∞¶∞¶∞¡∞°πøΔOÀ ∞., 3200
¶∞¶∞¶∂ΔƒOÀ ∞., 3343
¶A¶A¶O§YXPONIOY £., 1973
¶∞¶∞¶O™ΔO§OÀ ∞., 890
¶∞¶∞ƒ°ÀƒπOÀ π., 693
¶∞¶∞™ Δ., 2443
¶∞¶∞™π¢∂ƒ∏ π., 3042
¶∞¶∞™¶ÀƒO™ ¡., 48, 52, 83, 84
¶∞¶∞™Δ∞ª∞Δ∏™ ™., 61
¶∞¶∞™Δ∞ª∞ΔπOÀ ª., 3394
¶∞¶∞™Δ∞ÀƒOÀ-ª∞ÀƒOÀ¢∏ £., 1912
¶∞¶∞™Δ∂ƒ°πOÀ ™Ù., 802
¶∞¶∞™Δ∂ƒπ∞¢∏ Ã., 1927, 1930, 3388
¶A¶A™TEPIA¢H™ K., 1959
¶∞¶∞™Δ∂ƒπ∞¢∏™ Ã., 2495, 2496, 3228, 3404
¶∞¶∞™øΔ∏ƒπOÀ π., 3235, 3689, 3694, 3697, 3699
¶∞¶∞ºøΔπOÀ Δ., 314, 339
¶∞¶∞Ã∞ƒ∞§∞ª¶OÀ™ ª., 3130
¶∞¶∞Ã∞ƒ∞§∞ª¶OÀ™ ¡., 726
¶∞¶∞Ã∏™ΔOÀ ∞π∫., 340
¶∞¶∞Ã∏™ΔOÀ ∞§., 182, 531, 532
¶∞¶∞Ã∏™ΔOÀ ¢., 2176
¶∞¶∞Ã∏™ΔOÀ ∂., 934
¶∞¶∞Ã∏™ΔOÀ ∫., 22
¶∞¶∞Ã∏™ΔOÀ º., 3420, 3460
¶∞¶∞Ãπ™ΔO¢OÀ§OÀ º., 460, 600
¶∞¶OÀ§∏™ Ã., 2389
¶∞¶OÀ§π∞™ ¢., 1943
¶∞¶¶∞ ∞., 2498
¶∞¶¶∞ ∂., 1930
¶∞¶¶∞ ∫., 3168, 3270, 3332
¶∞¶¶∞ ¶., 3103
¶∞¶¶∞ Δ., 3028
¶∞¶¶∞-Oπ∫O¡Oªπ¢OÀ ¶., 883
¶∞¶¶∞™ ∞., 3513, 3514
¶∞¶¶∞™ ¢., 3372
¶∞¶¶∞™ ∫., 788, 2795, 3306, 3530
¶∞¶¶∞™ ª., 343
¶∞¶¶∞™ ™., 341, 835, 884, 911, 1496, 1799, 1815,
2086, 2155, 2157, 2181, 2510, 2544, 2587, 2852,
2959, 3000, 3020, 3151, 3276, 3299, 3345, 3365,
3436, 3511, 3512, 3513, 3514, 3704
¶∞¶¶∞™ Δ., 676
¶∞¶¶∞™ Ã., 776, 3385, 3463
¶∞ƒ∞ƒ∞ ª., 1100
¶∞ƒ∞ƒ∞™ ª., 845
¶∞ƒ∞™∫∂À∞´¢∏™ ™., 787
¶∞ƒ£∂¡∞∫∏™ º., 3255, 3292
¶∞ƒ£∂¡πOÀ Ã., 2693
¶∞ƒπ∞Δ∂§∏™ ∫., 1388
¶∞ƒπ¢OÀ ∞., 959
¶∞ƒπ™∏ ƒ., 2934
¶∞ƒ§∞¶∞¡∏ ∞., 883
¶∞ƒ§∞¶∞¡∏™ ∞., 883
¶∞ƒOÀ™∏™ ¶., 885
¶∞ƒOÀΔO°§OÀ º., 13
¶∞ƒÃ∞ƒπ¢∏™ °., 787, 1586, 2040, 2461, 2462, 2465,
2502, 2536, 2539, 2540, 2541
¶∞ƒÃ∞ƒπ¢OÀ μ., 1580
¶∞™∞¢∞∫∏™ ¶., 2717, 2718, 2719, 3428, 3430, 3444
¶∞™Ã∞§∏ ∂., 2911
¶∞™Ã∞§π¢OÀ ∂., 1857, 1905, 1940, 1997
¶∞™∞§π¢OÀ ∫., 392, 393
¶∞™O°§OÀ μ., 3627
¶∞™ΔOƒ∂ º., 2051, 2227, 2228, 2460
¶∞™ΔO™ ∫., 3135
¶∞™Δƒøª∞™ ™., 2713, 3245
¶∞™Ã∞§π¢∏™ £., 885
¶∞™Ã∞§π¢OÀ ∂., 2154, 2756, 3627
¶∞™Ãπ¢∏™ ∫., 889, 1587
¶∞™ÃOÀ ¶., 1864, 1892, 2218, 2219, 2221, 2955, 3362
¶∞Δ∞∫∞™ ∂., 269, 273
¶∞Δ∞¶∏™ ¶., 3527
¶∞Δ∞ƒ°π∞™ £., 610, 611, 614, 616, 617, 621, 622, 624
¶∞Δ∂¢∞∫∏™ °., 346
¶∞Δ∂ƒ∞∫∏™ £., 2964, 2974
¶∞Δƒπ∞¡∞∫O™ ∞., 3255, 3292
¶∞Δ™∞ ∫., 3192
¶∞Δ™π∞OÀƒ∞ ∫., 501, 794
¶∞Δ™π§π¡∞∫O™ ∞., 2164
¶∞Δ™π§π¡∞∫O™ ™., 1450, 2908
¶∞Δ™OÀƒ∏™ ∂., 2909, 3208, 3221, 3236, 3242, 3243,
3249, 3291
41
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¶∞Δ™OÀƒ∞∫O™ ¡., 2430, 2435
¶∞ΔΔ∞∫O™ ∂., 3192
¶∞À§∞ΔO™ º., 2, 62, 98, 127, 780, 833, 846, 964, 965,
966, 967, 2034, 2145
¶∞À§∞ΔOÀ ª., 3235
¶∞À§π¢∏™ °., 2191, 2908, 3349
¶∞À§πΔOÀ-Δ™πO¡Δ™∏ ∞., 2632, 3297
¶∞À§O¶OÀ§O™ ™., 3223
¶∞À§OÀ ∫., 880
¶∞ÃOÀ§∞ ∞Ã., 377
¶∞ÃOÀ§∞-¶∞¶∞™Δ∂ƒπ∞¢∏ Ã., 235, 902, 960
¶∂μ∂ƒ∂ΔO™ ¶., 43, 613, 620
¶∂°πOÀ-ΔO¶OÀ∑∏ £., 585, 3271
¶∂§∂Δπ¢OÀ ∞., 315, 2043
¶∂§∂Δπ¢OÀ-∞ƒ∞ª¶∞Δ∑O¶OÀ§OÀ ∞., 406
¶∂¡Δ∂∞ ™., 1379, 1869
¶∂¶O¡∏ ∂., 3360
¶∂¶O¡∏™ μ., 2437, 3357, 3360
¶∂¶¶∞-¶∞Δƒπ∫πOÀ ª., 1550, 1672, 2454, 2456, 2605,
2608, 3187, 3286, 3425, 3448, 3527, 3528
¶∂¶¶∞™ £., 706, 707
¶∂¶¶∞™ Δ., 1799, 3299, 3365
¶∂¶¶∞™ Ã., 3433
¶∂ƒ∞¡Δπ¡OÀ ¶., 99
¶∂ƒ¢π∫∞ƒ∏™ °., 239, 243
¶∂ƒπª∂¡∏ ¶., 3303
¶∂ƒπª∂¡∏™ ¶., 2724, 3303, 3398, 3412
¶∂ƒπ™Δ∂ƒO¶OÀ§O™ ¶., 3389
¶∂ƒ¶∂ƒπ¢OÀ ¶., 2730
¶∂ƒƒ∞ ª., 3189, 3191
¶∂ƒƒ∂∞ ¢., 609, 1912, 2198, 2199, 2679, 2791, 3156,
3205, 3208, 3214, 3218, 3246, 3250, 3265, 3279,
3291, 3333, 3375, 3532
¶∂Δ∂π¡∞∫∏ ∂., 3340, 3341, 3356, 3376
¶∂Δπ¢∏™ ∫., 3715
¶∂Δƒ∞ μ., 1579
¶∂Δƒ∞∫∏ ∂., 2656, 2947
¶∂Δƒ∞∫∏ ∫., 2662, 2956, 3298
¶∂Δƒ∞∫∏™ π., 3440
¶∂Δƒ∞ΔO™ ∫., 1636, 1709
¶∂Δƒπ¢∏™ ∞., 1454
¶∂Δƒπ¢∏™ ¢., 2041
¶∂Δƒπ¢∏™ π., 369, 2378
¶∂Δƒπ¢∏™ ¶§., 833
¶∂Δƒπ¢∏™ ™., 1580
¶∂Δƒπ¢OÀ ∞., 3689, 3697
¶∂Δƒπ¢OÀ ∂., 2557, 3048, 3520
¶∂Δƒπ∫∫O™ °., 686, 1960, 2662, 2956
¶∂ΔƒπΔ∏™ π., 1318
¶∂ΔƒO°∞ªμƒ∞∫∏™ °., 2723
¶∂ΔƒO°π∞¡¡O¶OÀ§O™ ∫., 764, 831, 2689
¶∂ΔƒO¶OÀ§O™ ∞., 808, 3451
¶∂ΔƒO¶OÀ§O™ π., 3256, 3389
¶∂ΔƒO¶OÀ§OÀ ∫., 3309
¶∂ΔƒOÀ ∞., 2722
42
¶∂ΔƒOÀ μ., 1201, 2531, 2911
¶∂ΔƒOÀ °., 2058, 2811
¶∂ΔƒOÀ ∑., 2192
¶∂ΔƒOÀ ∫., 626, 627, 628, 630, 634, 635, 636, 637,
638, 639, 640, 641, 642, 659, 762, 886, 1426, 1464,
1524, 1569, 1570, 1573, 1791, 1796, 1798, 1859,
1860, 1861, 1862, 1907, 1913, 1975, 1976, 3016
¶∂ΔƒOÀ-∞ª∂ƒπ∫∞¡OÀ Ã., 418, 457, 1876, 3450
¶∂ΔƒOÃ∂π§O™ ª., 865
¶∂Δ™∞™ ∞., 2952
¶∂º∞¡∏™ ∞., 239, 243
¶∂çπμ∞¡π¢∏™ ∞., 1940, 2041, 2197
¶∂çπμ∞¡π¢∏™ ∫., 1135
¶∏Δ∞ °., 3573
¶∏Δ∞ ƒ., 2140
¶π∞¢πΔ∏™ °., 661, 3459, 3513, 3514, 3704
¶π°°∞™ °., 2007
¶π∂ƒƒ∞∫∞∫∏™ ™., 815
¶π∂ƒƒ∞∫O™ °., 2963
¶π∂ƒƒ∞∫OÀ ∂., 2942
¶π∂ƒƒOÀΔ™∞∫O™ π., 472
¶π∫OÀ§∏-°π∞¡¡∞∫O¶OÀ§OÀ ¶., 99
¶π∫OÀ¡∏™ μ., 3527
¶π§∞Δ∏™ ¡., 2425
¶π§π∞¡π¢∏™ Δ., 2117
¶π§πOÀƒ∞™ ¡., 3372
¶π¶∂ƒ∏ Ã., 2523, 3210, 3273, 3274
¶π¶∂ƒ∂§∏ ∂., 3071
¶π¶∂ƒπ¢OÀ ∏., 2474, 2476, 2483, 2484
¶π¶π§∏ ∫., 3198
¶π¶¶∏ ∂., 3523
¶π¶¶π¢OÀ ∂., 1201, 2531
¶π™Δ∂ÀΔO™ ∞., 862, 3153
¶πΔ∞ƒO∫Oπ§∏™ π., 3, 21, 605, 702
¶πΔ™∞μ∞ ∂., 2016
¶πΔ™∞μO™ Ã., 1844, 2045, 2113, 2134, 2585, 3157,
3238, 3257, 3258, 3264, 3310, 3313
¶πΔ™π°∞À¢∞∫∏ ∂., 857, 3084
¶πΔ™πOÀ ¶., 2930
¶§∞™∫∞™ ¢., 2696
¶§∞Δ∞¡∏™πøΔ∏™ ¢., 441, 1299, 3701
¶§∞Δ∏ Ã., 486
¶§∞Δ∏™ O., 3319
¶§∞ΔO°π∞¡¡∏™ ¢., 340, 345
¶§∞Δ™∞∫∏™ ∫., 929
¶§∂™™∞™ ™., 903
¶§∂™™∞™ Ã., 903
¶§π∞∫O™ ∫., 3046
¶§π∞∫O™ Ã., 2626, 2764
¶O°°∞™ ¡., 3084
¶Oπ∫π§π¢OÀ ª., 2765, 2906, 3262
¶O§πΔ∞∫∏™ ¶., 3276
¶O§§∞§∏™ ™., 946
¶O§À¢øƒπ¢∏™ °., 891
¶O§À∑ø°O¶OÀ§O™ ¢., 3462
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
¶O§À∑ø°O¶OÀ§O™ ∂., 2592
¶O§À∑O™ ∞., 685
¶O§À∑O™ ™., 3714
¶O§Àª∂¡π¢∏™ ∑., 194, 221, 233, 234, 236, 795, 1585
¶O§À™Δ∏ƒπøΔ∏ ∞., 3204
¶O§ÀÃO¡∞∫O™ ∫., 1628, 1629, 1630, 1631, 1632,
1633, 2149
¶O§ÀÃO¡π∞¢∏™ º., 538
¶O§ÀÃO¡O¶OÀ§O™ ∂., 2910, 3204, 3237
¶O§ÀÃO¡O¶OÀ§O™ ¶., 1878
¶Oªø¡∏™ ∂., 2945
¶O¡Δπ∫π¢∏™ ¡., 227, 271, 596, 1592, 1981, 2720
¶O¡Δπº∏• π., 346
¶OΔ™∏ º., 2898
¶OÀ°°OÀƒ∞™ ¶., 3086, 3161
¶OÀ§∞∫∏ £., 272, 290, 3043
¶OÀ§∞∫O™ ¶., 2033
¶OÀ§∞∫OÀ-ƒ∂ª¶∂∞∫OÀ ∂., 3284
¶OÀ§∞∫OÀ ª., 2529
¶OÀ§π∞ ∫., 2532
¶OÀ§π∞™ ∏., 2978
¶OÀ§O¶OÀ§OÀ ∑., 662
¶OÀ§O¶OÀ§OÀ Ã., 2142
¶OÀ§Δ™π¢∏ ∞., 2762
¶OÀ§OÀ ∞., 1536, 1541, 1852, 1917, 2037
¶OÀ§OÀ∫∞™ ™., 2562
¶OÀƒ¡∞ƒ∞™ π., 858
¶OÀƒOÀ ∂., 1857, 1940, 1997
¶ƒ∞°∫∞Δ™∏™ ¢., 690
¶ƒ∞´¢OÀ ∞., 2938
¶ƒ∞¶∞™ °., 366
¶ƒ∞¶∞™ ¡., 366
¶ƒ∞Δ™π∫∞-OÀ°OÀƒO°§OÀ ∫., 78
¶ƒ∂∫∞Δ∂™ ∞., 3364
¶ƒ∂¡Δ∑∞ ∞., 3266
¶ƒ∂¶O¡∏™ Ã., 329, 374
¶ƒO°π∞ ∂., 184, 450, 1567, 1941
¶ƒO¢ƒOªπ¢∏™ ¶ , 2053
¶ƒO∂™ΔOÀ-μOÀ¢OÀƒ∏ £., 1419
¶ƒO∫Oμ∞™ π., 1343
¶ƒOÀ¡Δ∑OÀ ∞., 3222, 3230
¶ƒOÀ¡Δ∑OÀ ∫., 3267
¶ƒø´ªO™ ∂., 2723
¶ƒøΔO°∂ƒOÀ ∞., 3312
¶ƒøΔO¶∞¶∞¢∞∫∏™ ∂., 1705
¶ƒøΔO¶∞¶∞™ π., 657
¶ƒøΔOæ∞§Δ∏™ π., 2142, 2161, 2340, 2383, 2415,
2416, 2426, 2427, 2428, 2429, 2431, 2432, 2436
¶Àƒ°∞∫∏™ μ., 2766, 3538
¶Àƒ°πøΔ∏ ª., 3337
¶Àƒ¶∞™O¶OÀ§OÀ ∞., 2745
¶Àƒ¶∞™O¶OÀ§O™ ª., 183, 887
ƒ∞¢OÀ-™ºÀƒ∏ ª., 1097, 1890
ƒ∞∑∏™ ¡., 3248
ƒ∞´¢∏™ Ã., 207, 335
ƒ∞§§∏™ ∞., 802
ƒ∞§§π¢∏™ §™., 2732
ƒ∞ª¶∞μπ§∞™ ∞., 3235
ƒ∞ª¶∞OÀ¡∏-∞¡Δø¡∂§∏ ∞., 3207
ƒ∞¡°∫OÀ ¢., 3459
ƒ∞¶Δ∏ ∂., 3458
ƒ∞¶π¢∏ Ã., 3309
ƒ∞¶Δ∏™ ∞., 1129, 1162, 1176, 1185, 1194, 1206, 1256,
1257, 1258, 1260, 1261, 1347, 1525, 1684, 2411,
2479, 2549, 2550, 2551, 2663, 2708, 2762, 2790,
3308, 3419, 3511, 3516, 3531
ƒ∞¶Δ∏™ °., 1306
ƒ∞¶Δ∏™ ™., 11, 20, 23, 24, 32, 33, 34, 35, 36, 37, 38,
39, 40, 127, 138, 168, 171, 172, 332, 441, 472, 480,
643, 662, 809, 819, 854, 856, 859, 864, 870, 874,
899, 916, 927, 930, 1080, 1128, 1129, 1152, 1153,
1154, 1155, 1156, 1157, 1158, 1159, 11601161,
1163, 1164, 1165, 1166, 1167, 1168, 1169, 1170,
1171, 1172, 1173, 1174, 1175, 1176, 1177, 1178,
1179, 1180, 1181, 1182, 1183, 1184, 1185, 1186,
1187, 1188, 1189, 1190, 1191, 1192, 1193, 1194,
1195, 1196, 1197, 1198, 1199, 1200, 1202, 1203,
1205, 1206, 1207, 1208, 1209, 1210, 1211, 1212,
1213, 1214, 1215, 1216, 1217, 1218, 1219, 1220,
1221, 1222, 1223, 1224, 1225, 1226, 1227, 1228,
1229, 1230, 1231, 1232, 1233, 1234, 1235, 1236,
1237, 1238, 1239, 1240, 1241, 1242, 1243, 1244,
1245, 1246, 1247, 1248, 1249, 1250, 1251, 1252,
1253, 1254, 1255, 1256, 1257, 1258, 1259, 1260,
1261, 1262, 1263, 1264, 1265, 1266, 1267, 1268,
1269, 1270, 1271, 1272, 1273, 1274, 1275, 1276,
1277, 1278, 1279, 1280, 1281, 1282, 1284, 1285,
1286, 1287, 1288, 1289, 1290, 1291, 1292, 1293,
1294, 1295, 1298, 1299, 1307, 1308, 1309, 1311,
1314, 1354, 1450, 1485, 1507, 1508, 1509, 1510,
1525, 1639, 1650, 1684, 2067, 2449, 2450, 2451,
2452, 2453, 2454, 2455, 2456, 2457, 2478, 2493,
2494, 2495, 2496, 2503, 2549, 2550, 2551, 2599,
2645, 2653, 2654, 2663, 2762, 2790, 2791, 2965,
2983, 3003, 3074, 3082, 3191, 3228, 3308, 3323,
3344, 3351, 3404, 3406, 3449, 3493, 3494, 3495,
3496, 3497, 3498, 3499, 3500, 3501, 3502, 3511,
3512, 3516, 3527, 3528, 3531, 3634
ƒ∞¶ΔO¶OÀ§OÀ-°π°∏ ª., 550, 820, 828, 2756
ƒ∞™π¢∞∫∏™ ∞., 263
ƒ∞™π¢∞∫∏™ ¡., 1315
ƒ∞ºΔO¶OÀ§OÀ ∞., 2734, 3342
ƒ∞ÃπøΔ∏™ π., 3135
ƒ∂μ∂¡∞™ ∫., 3156, 3278
ƒ∂´∑O°§OÀ ª., 808
ƒ∂§∞∫∏™ Ã., 3306
ƒ∂ª∂¡Δ∑∏™ π., 3282, 3311
ƒ∂¡π∂ƒ∏™ π., 2058
ƒ∂¡ΔO°π∞¡¡∏ ¶., 3286
ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂., 212, 256, 326, 370, 371, 384,
43
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
435, 436, 461, 601, 1131, 1461, 1563, 1835, 1836,
1938, 1944, 2001, 2006, 2018, 2190
ƒ∂¶∞¡Δ∏ ª., 3443
ƒ∂Δ∑∂¶∏ μ., 3111
ƒ∏°∞∫OÀ-∫∞ƒ¢∞∫OÀ ¢., 1146
ƒ∏°∞ μ., 3093
ƒ∏°∞ ª., 1838
ƒ∏°∞™ ∞., 127, 128, 140, 141, 142, 144, 145, 262, 817,
921, 1141, 1142.1143, 1144, 1145, 1146, 1147,
1148, 1149, 1150, 1151, 1451
ƒ∏°∞™ ∫., 666
ƒπ°O¶OÀ§O™ ∞., 3048
ƒπ∑∞-™Δ∞ª∞Δ∏ ¶., 888
ƒπ∑O¶OÀ§OÀ ¢., 2009, 2144
ƒπ∑O™ ¢., 532, 3207
PIZO™ I., 1956
ƒπΔ∞ ƒ., 3064
ƒO¢∏™ π., 2164
ƒO∑∏-¶∞¡OÀ ¶., 178, 179, 204, 208, 229, 255, 1526,
1528, 1529, 1530, 1834, 2052
ƒO∏§π¢∏™ π., 1922
ƒOπ∫OÀ ∫., 3064
ƒO∫∫∞™ £., 819, 3263
ƒOª¶OΔ∏ ∫., 1307
ƒO¡ΔO°π∞¡¡∏ ¢., 2965
ƒO¡ΔO°π∞¡¡∏™ °., 213, 3030
ƒOÀª∂§πøΔOÀ ∫., 3363
ƒOÀª¶∂§∞∫∏ ª., 3270
ƒOÀ¡ΔOÀ μ., 2747
ƒOÀ™™∏ ª., 298
ƒOÀ™™∏-¶∂¡∂™™∏ ¢., 626, 636, 886, 1524, 1534,
1573, 1796, 1858, 2481, 2561, 2564, 2565, 2586
ƒOÀ™™O π., 791, 904, 2773
ƒOÀ™™O™ ¢., 776, 786, 796, 1135, 2698
ƒOÀ™™O™ Ã., 123, 722
ƒOÀ™™OÀ μ., 3300
ƒOÀΔ™π∞™ π., 1635, 1636, 1708, 1709
ƒøª∞ ∂., 143
ƒøª∞¡π¢OÀ ∞., 2055
™∞μμ∞™ ™., 3298
™∞μμπ¢∏™ ¡., 1900
™∞μμO¶OÀ§O™ °., 1586
™∞μμO¶OÀ§O™ ∑., 1589
™∞μμO¶OÀ§O™ Ã., 2013, 2141, 2179, 2208, 2231,
2235, 2600, 3085, 3592, 3613
™∞μπO§∞∫∏™ ∞., 749
™∞´§∂ƒ ¡., 329, 374, 420, 421, 597, 1592, 1839, 1840,
2033, 2143, 2154, 2163, 2186, 3539
™∞∫∞§§∂ƒOÀ ∞π∫., 598, 1137, 1945, 1979, 2005, 2016
™∞∫∞¡Δ∞ª∏™ °., 818
™∞∫∂§§∞ƒπ¢∏™ ¡., 2528, 3290
™∞∫∂§§∞ƒπOÀ ∞., 2116
™∞∫∂§§∞ƒπOÀ °., 294
™∞∫∂§§∞ƒπOÀ Δ., 855, 2694
™∞∫∂§§∞ƒπOÀ Ã., 669
44
™∞∫∂§§∞ƒπOÀ-¶∞ƒ∞ƒ∞ ∑., 1874
™∞∫∂ΔOÀ μ., 3094
™∞∫∫π∞™ °., 426
™∞∫§∞ƒπ¢∏™ π., 168
™∞§∞ Ã., 3375
™∞§∞∫O™ ¡., 2336
™∞§∞ª∞§∂∫∏™ ∂., 872, 3332, 3387, 3426, 3429
™∞§∞¶¶∞ ¶., 1423
™∞§μ∞¡O™ §., 2416, 2438
™∞§∂ª ¡., 795
™∞§∂¶Δ™∏ ¶., 3134
™∞§¶π°∫Δ∏™ π., 2159
™∞§Δπ∫∏ ∫., 3189
™∞ª∞¡π¢∏™ ¢., 2053
™∞ª∞ƒ∞-∫O∫∫∂μ∏ μ., 760, 905
™∞ª∞ƒ∞™ ¡., 387
™∞ª∞ƒΔ∑∏™ ª., 1097, 1098, 1099, 1100, 1101, 1102,
1103, 1105, 1106, 1107, 1108, 1109, 1110, 1111,
1112, 1113, 1115, 1116, 1117, 1119, 1121, 3477
™∞ª∞ƒΔ∑π¢∏™ ∏., 788
™∞ª∞ƒΔ∑π¢∏™ ∫., 1834, 1852, 1992, 2154
™∞ª¢∞¡∏™ μ., 2769
™∞ª∂§§∞™ μ., 124
™∞ªπO™ μ., 148
™∞ªOÀ∏§π¢∏™ π., 3720
™∞ª¶∞¡∏™ Ã., 2009, 2019, 2022, 2201, 2544, 2726,
2743, 2745, 2746, 3240, 3714, 3715
™∞ª¶∞Δ∞∫∞∫∏™ £., 329
™∞ªæOÀ¡∏ ™., 2154
™∞ªæø¡∞™ º., 2547
™∞¡Δπ∫ °., 323
™∞¶π∫∞™ π., 798
™∞ƒ∞μ∏™ ∫., 1750
™∞ƒ∞´Δπ∫∞ ∂., 3123
™∞ƒ∞¡Δ∞∫OÀ ∞., 1531, 1597
™∞ƒ∞¡Δ∏ ∂., 2752, 2753
™∞ƒ∞¡ΔO¶OÀ§OÀ μ., 1132
™∞ƒ∞¡ΔO¶OÀ§OÀ ¡., 3093
™∞ƒ∞Δ∑∏™ ¡., 3590
™∞ƒ∞ºπ¢∏™ ∞., 3201
™∞ƒ∞ºπ¢∏™ ¶∞., 2003, 2237, 2548, 2626, 2727, 2764,
2765, 2906, 2960, 2989, 3046, 3194, 3215, 3216,
3262, 3232, 3254, 3377
™∞ƒ∞ºπ¢OÀ ∂., 485
™∞ƒ°πøΔ∏™ ∞., 2787
™∞ƒ∏°π∞¡¡∏ ª., 3271
™∞ƒπ¢∞∫∏ ∑., 3378
™∞ƒπ¢∞∫∏™ ¡., 813, 879
™∞ƒπ∫∞ ∏., 3281
™∞ƒπ∫∞ §., 1262, 1534
™∞ƒƒ∏ Ã., 3447
™∞ƒƒ∏™ ∂., 3033
™∞™∞ƒO§∏™ ™., 1914, 2948
™∞Δ™O°§OÀ ∞πª., 325, 338, 373, 1134, 1458, 1945,
1979, 2014, 2041, 2116, 2154
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
™∞º§π∞¡∏™ π., 1407, 2823, 3662
™∞ç∞ ∑., 2191
™°OÀƒO™ °., 891
™∂μ∞™Δπ∞¡O™ μ., 2662, 2728, 2956, 3298
™∂∫∂ƒ∏ ∑., 752
™∂§∞§ª∞Δ∑π¢OÀ ¢., 2005, 2016
™∂ª∂ƒΔ∑π¢∏™ ¶., 2009
™∞ªO¡∏™ °., 3195
™∂¡ΔOÀ∫∞™ ∞., 824
™∂ƒπº∞ª¶OÀ Ã., 2940
™∂ƒπøΔ∏™ π., 1327
™∂ƒΔ∂¢∞∫∏ ∫., 3447
™∂Ã∞™ ª., 733
™∏ª∞πO¶OÀ§OÀ-¢∏ªO¶OÀ§OÀ ¶., 164
™∏º∞∫∏™ ™., 2725
™∏ºπ∞¡OÀ ¶., 784
™π∞ªO¶OÀ§O™ ∫., 268, 334, 343, 344, 875, 955, 956,
957, 958, 2953, 3488
™π∞ª¶∞¡∏™ Ã., 254, 286
™π∞™O™ °., 3253
™π∞º∞∫∞-∫∞ƒ∞¡Δ∞∏ ∞., 3472
™π∞º∞™ ∫., 1520
™πμƒπ¢∏™ ¢., 2740
™πμƒπ¢∏™ ∂., 2466
™π°∞§∞ º., 2789
™π°∞§∞™ π., 2737
™π°∞§∞™ ∫., 2789
™π¢∂ƒ∏ °., 1919
™π¢∂ƒ∏ °∫., 2861
™π¢∂ƒ∏™ ¢., 1911, 2108, 2433
™π¢∂ƒ∏™ π., 3038
™π¢∏ƒO¶OÀ§O™ π., 2600
™π¢∏ƒO¶OÀ§O™ ∫., 231
™π¢∏ƒO¶OÀ§O™ §., 532
™π∂ª¶O™ π., 3234
™πª∂§π¢∏™ ¢., 369, 383, 576, 1134, 1136, 1346, 1578,
1585, 1939
™πªO¶OÀ§O™ ∞., 292, 1602, 2731
™πªO¶OÀ§OÀ Δ., 3152
™πªO™ °., 3064
™π¡∞∫O™ ∑., 193
™πO°∫∞™ ∫., 2429
™πO§∞μO™ ∞.∂., 1987
™πOÀ§∞ §., 1434
™πOÀ§∏™ ∞., 789
™πOÀ¡∞-μ∞™π§O¶OÀ§OÀ Ã., 3087
™π™∫OÀ¢∏™ ¶., 407, 657, 658, 663, 664, 665, 676,
706, 725, 749, 753
™πΔ∞ƒ∞ ª., 3282
™πΔ∞ƒ∞™ ¡., 2437, 3360
™πΔ™O°§OÀ ∫., 3720
™πç∂Δπ¢∏™ ∞., 287
™πøª¶O§O™ ∫., 502
™πø¡ ª., 583, 887
™πøÃOÀ ∞., 2730
™∫∞§∫∂∞™ °., 567, 733
™∫∞¡¢∞∫∏™ ¶., 3291
™∫∞¡¢∞§∏ ¡., 3517
™∫∞ƒ∞°∫∞™ °., 207, 212, 228, 256, 288, 297, 310, 326,
337, 361, 370, 371, 379, 382, 384, 392, 401, 405,
415, 417, 435, 436, 437, 438, 443, 461, 597, 601,
602, 629, 630, 633, 634, 635, 637, 638, 639, 641,
642, 762, 1131, 1433, 1461, 1562, 1563, 1568,
1569, 1570, 1582, 1590, 1596, 1798, 1835, 1836,
1837, 1856, 1938, 1944, 1950, 1954, 1990, 2001,
2006, 2007, 2018, 2190, 3512
™∫∂ª¶∂ƒ∏™ μ., 1527, 1528, 1530, 1918
™∫∂ª¶∂ƒ∏™ °., 490
™∫∂¡Δ∂ƒ∏ ∞., 420
™∫∂¡Δ∂ƒ§∏ ∫., 3414
™∫∂OºÀ§∞∫∞™ ª., 3223
™∫π∞¢O¶OÀ§O™ ™., 530, 786, 796, 1135
™∫π∞∫∫∞ μ., 2656
™∫§∞μOÀ¡OÀ-Δ™OÀƒOÀ∫Δ™O°§OÀ ™., 536
™∫§∂π¢∏™ ¢., 865
™∫§∏ƒO™ ∂., 1799, 3248, 3299, 3345, 3365
™∫§∏ƒO™ º., 2913
™∫O¡¢ƒ∞ ∂., 3101
™∫O¡¢ƒ∞ ª., 806, 922
™∫O¡¢ƒ∞™ ™., 806, 922
™∫Oƒ¢∞™ ∞., 2192
™∫Oƒ¢∏™ ¡., 3034, 3456
™∫Oƒ¢π§∏ ª., 1550
™∫OÀ§∞ƒπ°∫∏ ™., 3349
™∫OÀª∞™ π., 2045, 3157, 3238, 3313
™∫OÀƒ∞∫∏ ∂., 2921
™∫OÀƒΔ∏™ ™., 3345
™∫OÀΔ∞™ ¢., 1581, 1854, 1949, 2007, 2581, 3707,
3723
™∫OÀΔ∂§∏™ ∞., 2946
™∫OÀº∞ƒ∞™ ∞., 1583
™∫ƒ∞¶∞ƒ∏ π., 1912, 3211
™∫ƒOÀª¶∏™ °., 3260
™ª∞ƒ∞°¢∏™ ™., 799
™ªOÀ™ΔO¶OÀ§O™ ¢., 324
™ª¶∞ƒOÀ¡∏ ∂., 316, 328, 533, 2904, 3308, 3411
™ª¶∞ƒOÀ¡∏™ Ã., 316, 317, 328, 533, 794, 797, 805
™ª¶Àƒ∞∫∏™ ™., 3350, 3367
™O§¢∞ΔO™ Ã., 3196, 3231
™OÀμ∞Δ∑O°§OÀ ∞., 20, 38, 1194, 1534, 1542, 1549,
1715, 1800, 1926, 3415, 3439, 3458
™OÀμ∞Δ∑O°§OÀ ∂., 3082, 3312
™OÀ°πOÀ§Δ∑O°§OÀ º., 439, 1857, 1897, 1940, 1983,
1994, 1997, 2538, 3547
™OÀ§∏™ ∫., 314, 356, 361, 369, 372, 373, 381, 391,
405, 416, 417, 437, 462, 602, 1134, 1432, 1464,
1568, 1581, 1592, 1853, 1854, 1855, 1907, 1941,
1945, 1946, 1979, 2014, 2116, 2154, 2191, 3488,
3633
™OÀ§πOÀ ∂., 1459, 2228, 2487, 3704
45
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
™OÀ§πøΔ∏™ ∞., 2857
™OÀª¶∞™∏ §., 2972
™OÀƒ§∞™ °., 472
™OÀ™∞¡∏™ ∏., 3161
™OÀΔO™ ¢., 896, 3086
™OÀº§∂ƒO™ ∫., 3523
™¶∞´∞ ™., 757, 2497, 2498, 2499, 2524, 2552, 2553,
2554
™¶∞¡¢π¢O™ ¢., 3374
™¶∞¡O™ ∞., 3192
™¶∞¡O™ ∏., 819
™¶∞¡O™ ¶., 543, 860
™¶∞¡OÀ ∂∞., 2544, 2973, 3276
™¶∞¡OÀ §., 3207
™¶∞ƒ°∫π∞™ ∫., 2908
™¶∞ƒƒO™ §.. 19
™¶∞™OÀ ∂., 3043
™¶∂¡Δ∑O™ ¢., 1477
™¶∏§πO¶OÀ§O™ ∞., 193, 378, 462, 602, 1556, 1839,
1840
™¶∏§πO¶OÀ§OÀ μ., 3123
™¶∏§πOΔO¶OÀ§OÀ ¶., 2929
™¶π¡∞ π., 3459
™¶Àƒπ¢∞∫∏ ∞., 3219
™¶Àƒπ¢∏™ Ã., 316, 317, 328, 533
™¶Àƒπ¢ø¡π¢OÀ ™., 2909, 3208, 3221, 3236, 3242,
3243, 3249
™¶ÀƒO°§OÀ ∫., 1922
™¶ÀƒO¶OÀ§O™ ∫., 2547
™¶ÀƒO¶OÀ§OÀ ∂., 371
™¶ÀƒO¶OÀ§OÀ π., 2480
™¶ÀƒO¶OÀ§OÀ ª., 473, 475, 476, 3481
™¶ÀƒO¶OÀ§OÀ ¡., 2432
™¶ÀƒO¶OÀ§OÀ ¶., 2416
™¶ÀƒO¶OÀ§OÀ-μ§∞ÃOÀ ª., 1427
™¶ÀƒOÀ ¡., 1896
™Δ∞°∫π¢∏™ °., 598, 1562
™Δ∞£∞∫∏ ª., 3217
™Δ∞£∞∫∏™ ¡., 861, 3383
™Δ∞£∞∫O™ ¢., 1786
™Δ∞£∞ΔO™ ∞., 94
™Δ∞£∞ΔO™ ª., 2529, 3368
™Δ∞£∏™ μ., 372
™Δ∞∫O™ ¢., 2461, 2465, 2469, 3328
™Δ∞´∫O™ ∫., 2525
™Δ∞ª∞Δ∞∫∏ ∞., 1881
™Δ∞ª∞Δ∞∫∏ ∫., 3459
™Δ∞ª∞Δ∂§O¶OÀ§O™ ∫., 3407
™Δ∞ª∞Δ∂§O¶OÀ§O™ ™., 1549, 1715, 3326, 3407
™Δ∞ª∞Δ∏™ ¢., 888, 896, 3086, 3161
™Δ∞ª∞Δπ∞¢∏™ ¢., 664, 678, 692
™Δ∞ª∞Δπ¡∏™ Ã., 3041
™Δ∞ª∞ΔπOÀ ¡., 2931
™Δ∞ªO°π∞¡¡OÀ §., 357, 471
™Δ∞ª¶OÀ§∏ ™., 3363
46
™Δ∞ª¶OÀ§∏™ ∂., 1513, 1515, 1588, 2616, 2622,
2630, 3083, 3336, 3441, 3454
™Δ∞¡O¶OÀ§O™ π., 3487
™Δ∞ƒ∞∫∏™ π., 2878
™Δ∞Àƒ∂∞™ ¡., 1265
™Δ∞Àƒπ∞¡∂∞™ ¡., 3291
™Δ∞Àƒπ∞¡O¶OÀ§O™ £., 3143
™Δ∞Àƒπ¢∏™ ∏., 1839, 1840
™Δ∞Àƒπ¢∏™ π., 1639
™Δ∞ÀƒO¶OÀ§O™ ∫., 800
™Δ∞ÀƒO¶OÀ§OÀ ∞., 473, 475, 476, 3060, 0
™Δ∞ÀƒOÀ ¶.. 4, 685, 698, 700, 726, 729
™Δ∞ºÀ§∞™ ¶., 2237, 2548, 2765, 3216, 3262, 3232
™Δ∂πƒO¶OÀ§O™ ¶., 3521
™Δ∂§πOÀ π∫., 2506
™Δ∂§§∞ΔO™ ª., 3106
™Δ∂ƒ°πO¶OÀ§O™ ∫., 1135
™Δ∂ƒ°πO¶OÀ§O™ ¶., 3714
™Δ∂ƒ°πOÀ °., 803
™Δ∂ƒ°πOÀ π., 2158
™Δ∂ƒ°πOÀ ¶., 421, 426, 890, 950
™Δ∂ƒπøΔ∏™ π., 10, 15, 165, 606, 728, 736
™Δ∂º∞¡∞¢∏ ∂., 3192, 3253
™Δ∂º∞¡∞¢∏™ Ã., 1801, 2585, 3253, 3257, 3259, 3310,
3486
™Δ∂º∞¡∞ΔO™ ∞., 3102
™Δ∂º∞¡π¢∏™ ∞., 2108, 2109, 2339, 2406, 2407, 2423,
2424, 2526, 2527, 2832, 3671
™Δ∂º∞¡π¢∏™ °., 3455
™Δ∂º∞¡π¢∏™ π., 2477, 3152, 3239, 3323, 3338
™Δ∂º∞¡π¢∏™ ∫., 3157, 3192
™Δ∂º∞¡π¢∏™ Δ., 3478
™Δ∂º∞¡π¢∏™ Ã., 2134, 3264, 3289, 3238, 3313, 3315,
3318, 3358, 3361, 3460
™Δ∂º∞¡πøΔOÀ ª., 889, 895, 928, 1587, 2045, 3028,
3043, 3321, 3359, 3465, 3474
™Δπæ∞¡∂§§∏ ∫., 1534
™ΔO´Δ™∏™ π., 3265
™ΔO∫π¢∏™ ¢., 2693
™ΔOÀ°π∞¡¡O™ ¶., 2766, 3361, 3538
™Δƒ∞μ∂§™∞ μ.°., 1987
™Δƒ∞μO§∞πªO™ ™., 730
™Δƒ∞¡Δ∑π∞™ ¶., 2909, 3242
™Δƒ∞Δ∏ μ., 3052
™Δƒ∞Δ∏°∏ ∫., 2947
™Δƒ∞Δ∏°O™ π., 691, 768, 769
™Δƒ∞Δ∏§∞Δ∏ ™., 2000
™ΔÀ§π∞¢∏™ π., 787, 1463, 1586
™ΔÀ§π∞¡∂∞-ºOÀ¡ΔOÀ§∞∫∏ ∞., 882, 3078
™ΔÀ§π∞¡π¢∏™ Ã., 524
™Δ§π∞¡OÀ ∞., 3279
™À°∫∂§∞∫∏™ ¶., 913
™À∫πøΔ∏™ ∫., 1330
™ÀªμOÀ§π¢∏™ ∞., 155, 1359, 2041
™Àª∂ø¡π¢∏™ ∞., 557, 2042, 2197, 3283, 3317, 3416
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
™Àª∂ø¡π¢∏™ °., 1456, 1459, 1991, 1999, 2051, 2107,
2222, 2223, 2224, 2225, 2226, 2227, 2228, 2443,
2460, 2464, 2469, 2485, 2486, 2487, 2970
™Àª∂ø¡π¢∏™ π., 1467
™Àª∂ø¡π¢∏™ ¶., 3277, 3326
™Àª¶∞ƒ¢∏ ™., 2164
™À¡O¢π¡OÀ-TRAEGER I., 3363
™Àƒ∂°°∂§∞™ ¢., 355, 358, 403, 597
™Àƒπ°O™ ∫., 3461
™ÀƒπOÀ μ., 3210
™ÀƒO°π∞¡¡π¢∏™ ¢., 3361
™º∞∫π∞¡∞∫∏™ °., 549
™º∞∫π∞¡∞∫∏™ ª., 2549, 2550, 2551, 2708, 3516,
3531
™º∂Δ™πOÀ ¶., 1901
™º∏∫∞∫∏™ ¶.. 4, 240, 296, 407, 658, 662, 663, 753,
676, 687, 691, 692, 693, 698, 700, 706, 707, 725,
728, 729, 753, 847, 1309, 3339, 3475
™º∏¡π∞¢∞∫∏™ π., 2950
™ºÀƒπ¢∏™ ¶., 3241
™Ãπ∑∞™ ¡., 1164
™Ãπ¡∞ ª., 3700
™ø™™π¢OÀ ∂., 438, 1137, 1945, 1979, 2116
™øΔ∏ƒ∞∫O¶OÀ§O™ ¡., 2740
™øΔ∏ƒπ∞¢OÀ ∫., 1703
™øΔ∏ƒπOÀ π., 3420, 3460
™øΔ∏ƒO¶OÀ§O™ ∞., 341, 1599, 1799, 1823, 2155,
2479, 2516, 2957, 3151, 3276, 3248, 3299, 3345,
3348, 3365
™øΔ∏ƒO¶OÀ§OÀ °., 3039
™øºƒO¡π∞¢OÀ ™., 2973
Δ∞μ∞¡∏ ∞., 3401
Δ∞°∞ƒ∏™ ¡., 608, 699
Δ∞°∫∞Δπ¢OÀ ª., 3054
Δ∞∫OÀ¢∞™ ¢., 501
Δ∞∫OÀ§∏ §., 2754, 2793
Δ∞§¶π¢∏™ ∞., 2747
Δ∞ª¶∞∫∏ ∞., 3375
Δ∞ª¶∞∫∏™ £., 2737
Δ∞ª¶∞∫OÀ¢∏™ ¶., 325, 3040
Δ∞ª¶OÀ∫∞ ∞., 2552, 2553
Δ∞ª¶OÀƒ∏™ ∂., 3445
Δ∞ª¶OÀƒ§OÀ ª., 3238
TANI§A™™H K., 1959
Δ∞¡Δ∞¡∞™∏™ £., 2672
Δ∞•π§¢∞ƒ∏™ ∫., 3694, 3699, 3700
Δ∞¶∞ª¶∏ƒ∞ ∞., 2636
Δ∞ƒ∞∑∏ ∞., 2000
Δ∞ƒ∞§∏ ª., 3472
Δ∞ƒ∞¡§∏™ ∂., 3361
Δ∞ƒ∞™∏ ∞., 1927, 1930
Δ∞ƒ∞™™∏ ∫., 3388, 3404
Δ∞ƒ§∞∑∏™ μ., 3535
Δ∞™O¶OÀ§O™ Ã., 127, 737
Δ∞™™O¶OÀ§O™ §., 765
Δ∞Δ∞ƒπ¢∏™ °., 2192
Δ∞ΔO§∞ μ., 3224
Δ∞Àƒπ¢OÀ ∞., 2378
Δ∞º§∞¡π¢OÀ-¶∞¡ΔøΔ∏ ∞., 2733
Δ∞ê∞Δ∑π¢∏™ ¢., 3536
Δ∂°O™ ∫., 1307, 1641, 1662, 1688
Δ∂¡ΔO§OÀƒ∏™ ∫., 1844, 2113
Δ∂¡ΔO§OÀƒ∏™ ¡., 696, 748, 1124, 1558, 1588, 1797,
1810, 1841, 2174, 2198, 2199, 2517, 2546, 2612,
2614, 2622, 2623, 2702, 2707, 2715, 2749, 2779,
2791, 2842, 2905, 3012, 3065, 3083, 3150, 3156,
3196, 3209, 3210, 3211, 3213, 3214, 3246, 3253,
3275, 3279, 3289, 3302, 3324, 3358, 3369, 3375,
3427, 3441, 3454, 3532
Δ∂ƒ∂∑∞∫∏ ¡., 3122
Δ∂ƒ∑∏ ∞., 3067, 3245
Δ∂ƒ∑O°§OÀ ∫., 893
Δ∂ƒª∂¡Δ∑∏ ∞., 3158
Δ∂ƒΔπ¶∏ ∞., 1546
Δ∂™™∂ƒOª∞Δ∏ Ã., 2885, 3243
Δ∑∞ª∞§OÀ∫∞™ ∞., 342
Δ∑∞¡∞ΔOÀ-∂•∞ƒÃOÀ ∏., 3480
Δ∑∞¡∂§∞ ª., 2451, 3471
Δ∑∞ƒ¢∏™ ¶., 610, 611, 612, 616, 619, 620, 623
Δ∑∞Δ∑∞°OÀ °., 1563, 1836, 1837, 1950, 2018, 2190
Δ∑∞º∂Δ∞™ π., 2667
Δ∑∂°∞™ °., 2936
Δ∑∂§§O™ Δ., 3536
Δ∑∂ªOÀ ∞., 3130
Δ∑∂Δ∑∏™ μ., 261, 270, 369, 385, 597, 878, 1126
Δ∑∏∫∞™ ¢., 3425
Δ∑∏ª∞ ¡., 3259
Δ∑∏ªOÀ °., 3573
Δ∑π∞∫∞™ ¢., 2461, 2462, 2465, 2469, 2487, 2501, 2502,
3307
Δ∑π∞ªOÀƒΔ∞™ ∞., 3689, 3694, 3699, 3700
Δ∑π°°OÀ¡∏™ μ., 1329, 3077
Δ∑πOμ∞-∫OΔ∑∞ §., 333
Δ∑πO§∞™ π., 2626, 2764, 2765, 2906
Δ∑πOª∞§O™ ∫., 2043, 2196, 2233, 3212, 3240
Δ∑πOÀ¶∏™ Ã., 2688
Δ∑πOÀƒ∏™ ¢., 2937
Δ∑πOÀº∞ μ., 2488
Δ∑πøΔ∏™ π., 1531, 1597
Δ∑Oμ∞ƒ∞™ °., 3455
Δ∑Oμ∞ƒ∞™ ¶., 2929
Δ∑O§∞ μ., 3141
Δ∑OÀμ∂§∂∫∏™ ∞., 3521
Δ∑OÀ¡∞™ ∫., 297, 339, 361, 379, 405, 1580
Δ∑ø¡OÀ ∞., 3401, 3427, 3432, 3469
Δ∑øƒΔ∑∞ΔOÀ-™Δ∞£O¶OÀ§OÀ º., 2734, 3342
Δ∑øƒΔ∑∏™ ∂., 3036
Δ∑øΔ∑∞™ £., 460, 572, 573, 599, 600, 603, 604, 1560,
1564, 1942, 2236
ΔπªO™π¢∏™ ª., 284, 295, 299, 2154
47
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ΔO∫ª∞∫π¢∏™ ™, . 2021, 2117, 2119, 2120, 2162, 2736,
3353
ΔO§∏™ ∞., 1097, 1101, 1107, 1108, 1109, 1115, 1120,
2834, 3673
ΔO§O™ ∞., 2806
ΔOª∞ƒ∞ ™., 3053
ΔO¶OÀƒπ¢OÀ ∫., 3518
ΔO¶∏ ∞., 3129
ΔO™∫∞™ ∞., 657
ΔOΔO§O™ ¡., 3048
ΔOÀμƒ∞ ∞., 2736, 3353
ΔOÀ§∏™ ∫., 3535
ΔOÀ§π∞ΔOÀ ∞., 407, 658
ΔOÀ§OÀª∏ °., 243
ΔOÀ¡Δ∞™ ∫., 560
ΔOÀ¡Δ∞™ ¡., 865, 893, 1129, 1450, 1525, 1684, 2455,
2456, 3528
ΔOÀ¡Δ∞™ Ã., 16, 31, 211, 507, 626, 627, 628, 630,
634, 635, 636, 637, 638, 639, 640, 641, 642, 659,
762, 835, 836, 886, 1334, 1352, 1357, 1364, 1374,
1498, 1524, 1569, 1570, 1573, 1649, 1650, 1791,
1798, 1812, 1859, 1862, 1913, 2046, 2066, 2514,
2562, 2567, 2647, 2652, 2728, 2997, 3007, 3079,
3080, 3086, 3299, 3358, 3486, 3706
ΔOÀ¶∞¢∞∫∏ ¡., 3469
ΔOÀƒ∫∞¡Δø¡∏™ ∞., 378, 789, 858, 1154, 1188, 2237,
2626, 2727, 2764, 2765, 3031, 3046
ΔOÀƒªOÀ∑∏™ ∞., 891
ΔOÀƒ¡∏™ ™., 1565, 1594, 1911, 2108, 2109, 2112,
2337, 2338, 2339, 2394, 2397, 2406, 2407, 2420,
2423, 2424, 2433, 2526, 2527, 3300, 3687, 3688,
3689, 3691, 3695, 3700
ΔOÀƒΔOÀƒ∏™ ™., 403, 2005
ΔOÀ™OÀ§∏™ ¢., 1801, 2045, 2134, 3245, 3253, 3358,
3486
ΔOÀ∑∞ ª., 3358
ΔOÀΔOÀ∑∞ ª., 2045
ΔOÀΔOÀ∑∞™ ∫., 1801, 3315, 3318
ΔOÀΔOÀ∑∞™ ¶., 888, 1545, 1673, 1801, 1931, 1956,
2045, 2113, 2134, 3086, 3161, 3192, 3326, 3358,
3486
ΔOÀΔ™π¡O™ ∞ , 1460
ΔOº∞§π¢∏™ ª., 329, 374
Δƒ∞´∞¡π¢∏™ ∫., 1478
Δƒ∞´∞¡π¢∏™ ¶., 270, 271, 385, 394, 421, 426, 458,
1583, 1838, 1943, 1993, 2017, 2031, 2192, 2194,
2735
Δƒ∞∫∞Δ∂§§∏™ ∞., 163, 412, 463, 995, 996, 1003, 1004
Δƒ∞ª¶∞™ ∞., 3623
Δƒ∞¡O™ ¶., 2892
Δƒ∞¶∞§∏ ª., 3172
Δƒ∞Ã∞¡∞ μ., 3420
Δƒ∂μπ∑∞¡ ƒ., 1534
Δƒπ∞¡Δ∞ºÀ§§π¢∏™ ∞., 2177
Δƒπ∞¡Δ∞ºÀ§§π¢∏™ π., 3319
48
Δƒπ∞¡Δ∞ºÀ§§π¢∏™ ∫., 2014
Δƒπ∞¡Δ∞ºÀ§§π¢OÀ ∂., 323
Δƒπ∞¡Δ∞ºÀ§§OÀ ∞., 162, 793, 948, 2177, 2745
Δƒπ∞¡Δ∞ºÀ§§OÀ °., 270, 271, 370, 385, 392, 393,
394, 404, 419, 426, 427, 428, 458, 493, 627, 628,
630, 634, 635, 890, 937, 1568, 1583, 1838, 1943,
1948, 1949, 1993, 2017, 2031, 2050, 2154, 2177,
2192, 2194, 2735
Δƒπ∞¡Δ∞ºÀ§§OÀ °., 683, 684
Δƒπ∞¡Δ∞ºÀ§§OÀ ∫., 3263, 3277, 3326
Δƒπ∞¡Δ∞ºÀ§§OÀ ¶., 1887, 3048, 3413
Δƒπ∞¡ΔO¶OÀ§O™ π., 185, 196, 445, 559
Δƒπ∞¡ΔO™ ∞., 289, 293, 581, 1560, 1564
Δƒπ°π¢OÀ ƒ., 3395
Δƒπ°∫OÀ¢∏™ ¢., 1993
Δƒπ∫∫∞-°∫ƒ∞º∞∫OÀ ∂., 959
Δƒπ∫∫∏ Ã., 2934
Δƒπª∏™ °., 2734, 3342
Δƒπ¶O§πΔ∏™ ∞., 863
ΔƒπΔO™ ¡., 240, 244, 666
ΔƒπÃO¶OÀ§O™ ¢.. 19, 166, 3296, 3401, 3432, 3469
ΔƒπÃO¶OÀ§OÀ ∞.. 12, 3296
ΔƒπÃO¶OÀ§OÀ-¶O§ÀÃO¡O¶OÀ§OÀ ∞., 144
ΔƒO¡Δ∑O™ ∫., 788
ΔƒO¡Δ∑O™ Ã., 2690
ΔƒOÀ°∫∞∫O™ π¶., 2529
ΔƒOÃO¶OÀ§O™ ª., 2050
ΔƒÀºø¡ ™., 2446, 3487
ΔƒÀºø¡π¢∏™ º., 1
ΔƒÀºø¡O¶OÀ§O™ ¢., 3312
ΔƒÀæπ∞¡∏™ °., 2487, 3225
Δ™∞μ∞ƒ∏™ ¡., 332
Δ™∞μ¢∞ƒπ¢∏™ π., 2160
Δ™∞°∫∞ƒ∞∫∏ μ., 1794
Δ™∞°∫∞ƒ∞∫∏™ ∂., 2036
Δ™∞°∫∞ƒ∞∫∏™ ™., 1521
Δ™∞∫∞§∞∫O™ ¡., 3170
Δ™∞∫∞Δ∞ƒ∞™ ¢., 3512
Δ™∞∫πƒ∏ ∫., 3627
Δ™∞∫πƒ∏™ ¢., 294, 303, 3346
Δ™∞∫πƒ∏™ π., 749
Δ™∞∫πƒ∏™ ™., 3517
Δ™∞∫πƒπ¢OÀ ∂., 2208, 2231
Δ™∞∫¡∏ ∂., 3216
Δ™∞∫OÀ¡Δ∞∫∏™ ¡., 3237
Δ™∞∫ƒ∏ ª., 290
Δ™∞§∏ §., 3511
Δ™∞ª∞¡¢OÀƒ∞∫∏ ∫., 772
Δ™∞ª∞™πƒO™ π., 3400, 3446
Δ™∞ª∏ ¢., 3143
Δ™∞ª∏™ ¡.∂., 1987
Δ™∞ªπΔ∞ ª., 2547
Δ™∞ª¶∞ƒ§∏ ∞., 2738, 2739, 3331
Δ™∞¡π∫π¢∏™ ∏., 2033
Δ™∞¡OÀ ∂., 3321
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Δ™∞¡Δ∞§∏ Ã., 3468
Δ™∞¡Δ∂™ ∞., 3354
Δ™∞OÀ™∏™ °., 3433
Δ™∞OÀ™∏™ π., 3442
Δ™∞¶∞ƒ∞ ∂., 3145
Δ™∞¶∞™ ∞., 1405, 1986, 2024, 2154, 2393, 3199, 3261,
3518, 3551
Δ™∞¶∞™ μ., 1982, 1986, 2005, 2012, 2016
Δ™∞¶∞™ °., 228, 252, 261, 285, 297, 310, 311, 439,
459, 783, 1463, 1561, 3476
Δ™∞¶O°∞™ ¶., 240, 244, 666, 1476, 1639, 1810, 2546,
2702, 2780, 3065, 3369, 3522
Δ™∞ƒ∞ μ., 3521
Δ™∞ƒ¢∞∫∏ ª., 1567
Δ™∞Δ™∞¡∏™ ∞., 3440
Δ™∞Δ™∞ƒø¡∏™ ∞., 847
Δ™∞Δ™OÀ§∏™ ∞., 956, 1594, 1911, 2064, 2108, 2337,
2338, 2433, 2509, 2954, 2982, 3512, 3530
Δ™∂°∫∞ ∫., 2454, 2456, 3528
Δ™∂∫OÀƒ∞ ∞., 2025, 2031
Δ™∂§∂ª¶∏™ ∞., 1912, 2791, 3279, 3366, 3415
Δ™∂§∂ƒ∏™ ∞., 3375
Δ™∂ƒ°∏™ ∞., 2940
Δ™∂Δ™∏™ ¢., 2803
Δ™π∞μOÀ ∞., 3323, 3344, 3351
Δ™π∞∫OÀ ∞., 3393
Δ™π∞ª∏™ ∂., 1801, 3192, 3315, 3318
Δ™π∞ª∏™ ¡., 1585
Δ™π∞ª¶∞§∏™ π., 271, 428
Δ™π∞¡∞∫∞ ∞., 1855
Δ™π∞¡O™ ∂., 861, 1333
Δ™π∞OÀ™∏™ °., 2748, 3297
Δ™πμ°OÀ§∏™ °., 3083
Δ™πμπΔ∞¡π¢∏™ ∞., 2154
Δ™πμπΔ∞¡π¢OÀ Δ., 1920
Δ™π°∫O™ ∫., 1638, 1639, 1674, 1675, 1676, 1677,
1678, 1679, 2729, 3082, 3228, 3406, 3500
Δ™π°∫OÀ¡∏™ μ., 697
Δ™π°∫OÀƒ∞∫O™ ¢., 137
Δ™π∫ƒπ∫∞™ Δ., 3383
Δ™π§πª¶∞ƒ∏ ∂., 291, 1079, 1081, 1082, 1083, 1084,
1085, 1088, 1089, 1090, 1091, 1092, 1626, 1627
Δ™π§πª¶∞ƒ∏™ ª., 3229, 3252
Δ™πª¶O™ ∫§., 17
Δ™πOΔƒ∞ ¶., 3082
Δ™πOΔƒ∞™ ™., 134, 139
Δ™πOΔ™π∞ °., 1942
Δ™πOÀ¶ƒOÀ O., 1904
Δ™πOÀº∏™ Ã., 1801, 3253, 3358
Δ™π¶OÀƒ∞™ ª., 3062
Δ™π¶Δ™πO™ π., 435, 3720
Δ™π¶Δ™πO™ ¢., 3720
Δ™πƒ§∏™ ∞., 2975
Δ™πƒO°π∞¡¡∏ ∞., 3523
Δ™πƒO°π∞¡¡∏ ∂., 2235
Δ™πƒOÀ ª., 891, 938, 2882, 3076, 3089
Δ™πΔ∞ªπ¢OÀ ∑., 395, 760, 905, 906, 953, 1567, 3510
Δ™πΔ§∞∫π¢OÀ ª., 459
Δ™πΔOÀƒ∞-§À∫O¶OÀ§OÀ ™., 161
Δ™πΔOÀƒπ¢∏™ π., 2000, 2193, 2971
Δ™πΔ™π∞ ∂., 1984
Δ™πOΔ™πO™ Δ., 2740
Δ™πΔ™πOÀ ¡., 2009, 2022
Δ™πºO¢∏ªO™ ¢., 787
Δ™πøΔ™∏ ∫., 3072
Δ™O∫∞ ∂., 363, 535, 1201, 1465, 1921, 2531
Δ™O∫∞¡∏ ¶., 288
Δ™O§∞∫∏ ª., 2970
Δ™O§∫∞™ ¶., 1548
Δ™O¶∞¡O°§OÀ ¡., 1087
Δ™O¶∂§∞™ ¡., 3464
Δ™Oƒμ∞ ª., 1100
Δ™OÀμ∞§∞™ ∂., 3190
Δ™OÀ°∫O™ π., 3537
Δ™OÀ°∫ƒ∞¡∏™ ∞., 760
Δ™OÀ∫∞¡∞™ μ., 3181
Δ™OÀ∫∞§∞ Ã., 2791
Δ™OÀ§∫∞™ £., 2498
Δ™OÀ§º∞ ™., 395, 906
Δ™OÀƒ¢∏™ ∞., 3044
Δ™OÀƒOÀ™ °., 2449, 2450, 3494, 3533
Δ™OÀƒOÀΔ™O°§OÀ °., 189, 203, 553, 839, 840, 841,
842, 887, 3489
Δ™OÀ™∏ π., 206, 254
Δ™OÀ™™∏™ ¢., 3305
Δ™OÀΔ™π¡O™ ∞., 1460, 2676
Δ™OÀº∞∫∏™ °., 661
Δ™OÃ∞™ ∫., 1467
Δ™OÃ∞Δ∑∏™ π., 2014
Δ™ø∫OÀ ª., 947
Δ™ø¡∞ ∞., 3031
ΔÀ§π°∞¢∞ ∞., 2437
ΔÀÃ∞§∞™ ∞., 2014
Àº∞¡Δ∏ °., 1497, 2081, 2449, 2478, 2521, 2543,
2653, 2654, 2782, 3449, 3533
Àº∞¡Δ∏ ∂., 3082, 3228
Àº∞¡Δ∏™ Δ., 3319
YºANTO¶OY§O™ I., 1974, 2631
Àæ∏§∞¡Δ∏™ ∫., 800
º∞π¡∂∫O™ ∫., 3282, 3311, 3472, 3512, 3513, 3514
º∞∫∞Δ™∂§∏ ∫., 2389
º∞§∞°∫∞™ ª., 3206, 3234
º∞§Oƒ¡∏ A., 1994, 2538
º∞§Δ™∏™ ™., 195, 198, 570, 825, 878, 1125, 1126, 1127
º∞ƒ¢∂§§∞™ π., 527
º∞ƒª∞∫∞∫∏™ ¡., 3389
º∞ƒª∞∫π¢∏™ °., 3468
º∞ƒª∞∫πøΔ∏™ ∞., 858
º∞ƒª∞∫πøΔ∏™ ¢., 2773
º∞ΔOÀƒO™ π., 2119, 3689, 3694, 3697, 3699, 3700
49
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
º∂μƒ∞¡O°§OÀ ∂., 885
º∂∑OÀ§π¢∏™ π., 3268, 3356, 3537
º∂§∂∫π¢∏™ ∞., 2177
º∂ƒ∞∫∏™ ¡., 2978
º∂ƒ∂Δ∏™ ∏., 272, 290, 324, 939, 946, 1885, 3024,
3028, 3043
º∂ƒ∂Δ∏™ ∞., 324
º∂ƒ¡Δ∂ƒπ∫O™ ¡., 1022, 1026, 1027, 1028, 1032, 1060
º∂ƒ¡Δ∂ƒπ∫OÀ ∞., 1026
º∂ƒΔ∏ ∞., 3395
º∂™™∞™ º., 846
ºπ§∞§∏£∏™ ∞., 1915
ºπ§∞¡¢ƒ∞ º., 2868
ºπ§∏™ ∫., 3343
ºπ§∏™ Δ™πªπ∫∞™ ∞., 2770
ºπ§πOÀ™™∏ ∫., 3354, 3357, 3360, 3381
ºπ§πO¶OÀ§O™ μ., 2754, 2793
ºπ§π¶¶∞∫∏™ ª., 815
ºπ§π¶¶π¢∏™ º., 3, 169, 296, 306, 363, 407, 655, 656,
657, 658, 663, 665, 674, 675, 676, 685, 686, 691,
692, 693, 701, 706, 707, 725, 727, 728, 730, 733,
749, 750, 753, 1326, 2069, 2508, 2596, 2607, 2845,
2981, 3673
ºπ§π¶¶OÀ °., 1542, 1800, 3281, 3329
ºπ§πøΔ∏ ∫., 2432
ºπ§O£∂OÀ ∞., 834
ºπ§O∫À¶ƒOÀ ¢., 3471
ºπ§O¶OÀ§O™ ∂., 2939
ºπOƒ∂¡Δπ¡ ª., 2530
ºπOƒ∂ΔO™ ª., 772, 1914, 2948
ºπΔ™πøƒ∏™ º., 2755
ºπº∏ ¶., 2858
º§∂μ∞ ∞., 3452
º§∂μ∞ƒ∏™ Ã., 2689
º§∂ø∞ ∞., 2537
º§øƒ∞∫∏ ∫., 272, 1429, 3024, 3043
º§øƒO™ ¢., 2487
º§øƒO™ π., 3037
ºO¡ΔOƒ∂∞¡ ª., 3116
ºOÀ¡Δ∞™ ∞., 1198, 2965
ºOÀ¡ΔOÀ§∞∫∏ ¢., 2792
ºOÀ¡ΔOÀ§∞∫∏™ ∫., 2232
ºOÀ¡ΔOÀ§∞∫∏™ ™., 2982
ºOÀƒ§∞™ Ã., 2728
ºOÀƒªOÀ™∏™ π., 3287
ºOÀƒΔOÀ¡∞™ Ã., 3255
ºOÀ™™∞™ ™., 1138, 1594, 2108, 2109, 2114, 2337,
2338, 2339, 2341, 2406, 2407, 2423, 2424, 2430,
2435, 2440, 2526, 2527, 2766, 2832, 2846, 3364,
3538, 3671
ºOÀ™Δ∞§π∂ƒ∞∫∏™ ™., 2857
ºƒ∞°∫∞∫∏ ¢., 306, 407, 605, 656, 657, 658, 675, 676,
701, 702, 706, 730, 738
ºƒ∞°∫∞∫∏ ª., 662
ºƒ∞°∫∞∫∏ ª∞ƒπO°∫∞ ∫., 1331
50
ºƒ∞°∫∞∫∏™ Ã., 1390
ºƒ∞°∫π∞ ¢., 953, 3510
ºƒ∞°∫π∞¢∞∫∏™ °., 3219
ºƒ∞°∫π™∫O™ º., 276, 2935, 3160
ºƒ∞°∫O¶∞¡∞°OÀ ∏., 3443
ºƒ∞°∫O¶OÀ§OÀ ∂., 3282, 3311
ºƒ∞°∫O™ Ã., 3520
ºƒ∞°∫OÀ§∞∫∏™ °., 472, 480
ºƒ∞°∫OÀ§∏ ∂., 2947
ºƒ∞°∫OÀ§π∞ ∞., 3704
ºƒ∞°∫OÀ§π¢OÀ ∂., 1853, 1944
ºƒ∞°∫OÀ§O¶OÀ§O™ ∂., 3375
ºƒ∞π¢∞∫∏™ O., 3301
ºƒ∞¡Δ∑∂™∫∞∫∏™ °., 2948
ºƒ∂ƒ∏™ ¡., 2855
ºƒÀ¢∞™ ∞., 1314, 2377, 3247
ºÀ§∞∫ΔOÀ ∫., 479
ºÀ™™∞™ π., 3461
ºÀΔπ§∏ Ã., 395, 760, 905, 906, 1567, 1941, 3521
ºø∫∞ ∑., 3510
ºø∫∞™ ∂., 74, 2900, 2901, 2902
ºø™Δ∏ƒO¶OÀ§O™ °., 3483
ºøΔ∞∫O¶OÀ§OÀ O., 3064
ºøΔπ∞ ª., 3324
ºøΔπ∞¢∏™ °., 3539
ºøΔπ∞¢∏™ ¢., 3062
ºøΔπ∞¢∏™ ∫., 1925
ºøΔπ∞¢∏™ ¡., 786
ºøΔπ∞¢∏™ ™., 2887
ºøΔπ∞¢OÀ ∞., 324, 2803
ºøΔπ∞¢OÀ-¶∞¶¶∞ ∂., 2961
ºøΔπOÀ ¢., 3720
ºøΔπOÀ º., 3720
ºøΔO¶OÀ§O™ ¢., 286
ºøΔO¶OÀ§OÀ ∞., 779, 1112
Ã∞μ∞§∂ π., 271, 757
Ã∞μ∞ƒ∞¡∏ μ., 3362
Ã∞´¢∞ƒO°§OÀ ∞., 3323, 3344
Ã∞´¢O™ ∫., 2154
Ã∞πƒO¶OÀ§O™ ∫., 2604, 2625, 2629
Ã∞´Δπ¢OÀ ∫., 953
Ã∞´ΔO°§OÀ ∫., 1082
Ã∞§∞ ∂., 1421, 1639, 3522
Ã∞§∞Δ™∏™ ∫., 911
Ã∞§μ∞Δ™πøΔ∏™ ¶., 1080, 1185, 1684
Ã∞§∞μ∂§∞∫∏™ °., 152, 923, 1130, 1186, 2965, 3433
Ã∞§π∞™™O™ ∞., 3207
Ã∞§π∫π∞ ¡., 2402, 2529
Ã∞§π∫π∞™ °., 2487, 2501, 3307
Ã∞§∫π∞¢∞∫∏™ °., 3440
Ã∞§∫π¢∏™ Ã., 205, 452, 594
Ã∞§∫π¢OÀ ∂., 450
Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OÀ ∞¡., 382, 758, 2751, 3491,
3718, 3719, 3720, 3721
Ã∞ª∞§π¢OÀ Ã., 1922
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Ã∞ªOÀƒ∞Δπ¢∏™ ¡., 858
Ã∞ª¶∂O™ π., 3284, 3371, 3424
Ã∞¡¢ƒπ¡OÀ Ã., 3697
Ã∞¡πøΔ∏™ ¢., 16, 18, 605, 675, 702, 855, 2972
Ã∞¡Δ∞¡∏™ ™., 2108, 2109, 2337, 2339, 2423, 2430,
2435, 2526, 2527, 3364
Ã∞ƒ∞§∞ª¶∞∫∏™ ∞., 3148
Ã∞ƒ∞§∞ª¶π¢∏™ π., 1890, 1977, 2625, 3413
Ã∞ƒ∞§∞ª¶π¢∏™ Ã., 2194
Ã∞ƒ∞§∞ª¶π¢OÀ-μƒ∞¡πΔ™∞ ™., 464, 792, 3045
Ã∞ƒ∞§∞ª¶O°π∞¡¡∏™ ¡., 2978
Ã∞ƒ∞§∞ª¶O¶OÀ§O™ ∞., 736
Ã∞ƒ∞§∞ª¶O¶OÀ§O™ ¢., 704
Ã∞ƒ∞§∞ª¶OÀ™ ∞., 2976
Ã∞ƒ∞§∞ª¶OÀ™ ™., 3466
Ã∞ƒ∞ª∏™ ∞., 2142
Ã∞ƒ∞Δ™∏-°πøΔ∞∫∏ ∂., 2867, 2907
Ã∞ƒμ∞§∞∫OÀ ª., 3070
Ã∞ƒπ∑O¶OÀ§OÀ μ., 2752, 2753
Ã∞ƒπ™∏™ ™., 3252
Ã∞ƒπΔ∞¡Δ∏ ¶., 2600
Ã∞ƒπΔπ¢∏™ ∂., 1836, 1855
Ã∞ƒπΔO™ ¢., 874, 2478, 2654, 3449
Ã∞ƒª∞¡∏™ °., 2408
Ã∞ƒO∫O¶O™ ™., 564, 565, 966
Ã∞ƒO∫O¶OÀ ∞., 3118
Ã∞ƒ™OÀ§∏™ º., 193, 194, 248, 259, 260, 360, 367,
377, 389, 413, 422, 408, 454, 505, 794, 797, 805,
924, 931, 1557, 1574, 1830, 1937
Ã∞ƒø¡∏™ ∞., 291, 1079, 1081, 1082, 1083, 1084,
1085, 1086, 1087, 2131
Ã∞™∞∫∏™ μ., 3144
Ã∞™∞¶O°π∞¡¡∏™ ∫., 157
Ã∞™πøΔ∏™ ¢., 209, 2119
Ã∞™ª¶∞¡Δ Δ., 2164
Ã∞Δ∑∞∫∏™ ∞., 239, 243
Ã∞Δ∑∂§∏ º., 3043
Ã∞Δ∑∏ ∞., 158, 839, 840, 842
Ã∞Δ∑∏ °., 3054
Ã∞Δ∑∏∞°°∂§∞∫∏ ∂., 245, 899, 927, 930, 1155, 1185,
1203, 1637, 2790, 2819, 3323, 3344, 3351
Ã∞Δ∑∏∞°Oƒ∞∫∏™ ∞., 925
Ã∞Δ∑∏∞£∞¡∞™πOÀ Ã., 1916
Ã∞Δ∑∏∞ê∂Δ ∞., 207, 285, 297, 311, 314, 394, 1848
Ã∞Δ∑∏°∞∫∏™ ™., 3457
Ã∞Δ∑∏°∂øƒ°πOÀ °., 2425
Ã∞Δ∑∏°π∞¡¡∞∫∏™ ∂π., 2762
Ã∞Δ∑∏°π∞¡¡∏ ¶., 3471
Ã∞Δ∑∏°π∞¡¡∏™ ™., 2662, 2728, 2956
Ã∞Δ∑∏¢∞∫∏ ∂., 3405
Ã∞Δ∑∏¢∞∫∏™ ¢., 37, 38, 926, 1080, 1128, 1129, 1162,
1176, 1194, 1198, 1206, 1252, 1253, 1254, 1256,
2663, 1257, 1258, 1259, 1260, 1264, 1267, 1310,
2454, 2456, 2549, 2550, 2551, 2708, 3516, 3527,
3528, 3531
Ã∞Δ∑∏¢∞∫∏™ ™., 1120, 1122, 3451
Ã∞Δ∑∏¢∏ª∏ΔƒπOÀ ∞., 582
Ã∞Δ∑∏¢∏ªO™ ∞., 133
Ã∞Δ∑∏∑∞Ã∞ƒπ∞™ ∞., 351, 3324
Ã∞Δ∑∏πø∞¡¡π¢∏™ ∞., 2030
Ã∞Δ∑∏πø∞¡¡π¢∏™ ∏., 2971
Ã∞Δ∑∏πø∞¡¡OÀ π., 164, 819, 1256
Ã∞Δ∑∏∫Àƒπ∞∫OÀ ª., 606, 608, 699
Ã∞Δ∑∏∫Àƒ∫OÀ Ã., 2005, 2016
Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ μ., 3203
Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ Ã., 338, 501, 3155
Ã∞Δ∑∏§O´∑OÀ ™., 3456
Ã∞Δ∑∏§OÀ∫∞-ª∞¡Δ∞∫∞ ∞., 2, 448
Ã∞Δ∑∏ª∏¡∞™ π., 120
Ã∞Δ∑∏ª∏ΔƒOº∞¡OÀ™ ƒ., 379
Ã∞Δ∑∏ªπÃ∞§∏™ ∞., 3241
Ã∞Δ∑∏ªπÃ∂§∞∫∏ ∂., 3366, 3415
Ã∞Δ∑∏ª¶∞§∏™ ∂., 546
Ã∞Δ∑∏¡π∫O§∞OÀ ∞., 3689, 3694, 3697
Ã∞Δ∑∏¡π∫O§∞OÀ ∂., 1987, 2461, 2462, 2465, 2501,
2502
Ã∞Δ∑∏¡π∫O§∞OÀ §., 3147
Ã∞Δ∑∏¶∞¶∞™ ∫., 2525
Ã∞Δ∑∏¶∂ΔƒOÀ ∞., 356, 382, 406, 1458
Ã∞Δ∑∏¶∂ΔƒOÀ ª., 1607
Ã∞Δ∑∏™ ¢., 898, 2060
Ã∞Δ∑∏™ ∫., 3219
Ã∞Δ∑∏™∞μμ∞™ π., 1594, 2114, 2337, 2430, 2435
Ã∞Δ∑∏™¶∞™OÀ ∂., 272, 290, 324
Ã∞Δ∑∏ΔO§πO™ ∞., 2013, 2141, 2147, 2179, 2208,
2229, 2230, 2231, 2233, 2234, 2235, 2600, 3224,
3561, 3592, 3613
Ã∞Δ∑∏Ã∏™ΔOÀ ¢., 1831, 1832, 1980, 2106, 3066
Ã∞Δ∑πOÀ μ., 601
Ã∞Δ∑OÀ§∏™ ¢., 3314, 3327
Ã∞Δ™∂ƒ∞™ ¢., 371, 384, 435, 436, 816, 2461, 2462,
2465, 2469, 2487, 2501, 2502, 2543
Ã∂§π¢ø¡∏™ ∂., 3269
Ã∂§πøΔ∏ ∂., 3278
Ãπ¡∏ ª., 2788
Ãπ™™∞¡ ™., 3627
ÃπΔO°§OÀ- ª∞∫∂¢OÀ ∞., 2237, 2626, 2764, 3046
ÃπøΔ∏™ ¢., 160
çøƒO¶OÀ§OÀ ¶., 2525
çOÀμ∂ƒ∞∫∏™ °., 3217
çOÀμ∂ƒ∞∫∏™ ∫., 767, 873, 1391
çOÀμ∂ƒ∞∫∏™ Ã., 3459
çøƒO°π∞¡¡∏™ π., 733, 3192
ÃO§∂μ∞™ ª., 632, 820, 832, 841, 1941
ÃO§O¡°∫πΔ∞™ ∂., 3198
ÃOÀƒ∏ ª., 3227
ÃOÀ™∂´¡ ª., 819
ÃO¡¢ƒOª∞Δπ¢OÀ ™., 2000
Ã∏™Δ∞∫∏ ∂., 890
Ã∏™Δ∞∫∏ ¶., 3521
51
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
Ã∏™Δπ¢OÀ °., 2498
Ã∏™ΔOª∞¡O™ ∞., 42, 556, 837, 838
Ã∏™ΔOÀ ∫., 3319
Ã∏™ΔOÀ ª., 2413
Ãπ™Δ∞∫π¢∏™ ¢., 356, 372, 1458, 1889, 2154, 2378,
2379, 2380, 2381, 2467, 2468, 2472, 2474, 2483,
2484, 2490, 2617, 2907, 3485
Ãπ™Δ∞∫O¶OÀ§O™ ¶., 16, 18, 147, 154, 167, 210,
211, 397, 494, 892, 1350, 1351, 1352, 1356, 1357,
1394, 1499, 1818, 1822, 2072, 2817, 2992
Ãπ™Δ∞∫O™ ™., 319
Ãπ™Δπ¢OÀ º., 757
Ãπ™ΔO¢OÀ§∞∫∏™ ∂., 3252
Ãπ™ΔO¢OÀ§∞∫O™ °., 3387
Ãπ™ΔO¢OÀ§π¢OÀ Ã., 2709
Ãπ™ΔO¢OÀ§O¶OÀ§O™ Ã., 729
Ãπ™ΔO¢OÀ§O™ ∞., 2004, 2162
Ãπ™ΔO¢OÀ§OÀ ∞., 889, 3359
Ãπ™ΔO¢OÀ§OÀ ¢., 588
Ãπ™ΔO¢OÀ§OÀ ª., 1205
Ãπ™ΔO¶OÀ§O™ ∞., 3534
Ãπ™ΔO¶OÀ§OÀ-∞§∂Δƒ∞ ∏., 3202, 3244
Ãπ™ΔOº∂§∏ ∞., 2694
Ãπ™ΔOºOƒ∞∫∏™ ∑., 2711
ÃO¡O¶OÀ§O™ ∞., 2035
ÃO¡O¶OÀ§O™ π., 3248
ÃOÀ™O™ °., 1638, 2666, 3235
ÃÀ™∞°∏™ ¢., 387
ÃÀ™∞¡£∏™ ∞., 835
ÃÀ™∞¡O™ ¡., 3298
ÃÀ™∞¡£O¶OÀ§OÀ °., 3286
ÃÀ™π∫O¶OÀ§O™ ∞., 872
52
ÃÀ™π∫OÀ ª., 1191, 1290
ÃÀ™Oª∞§§∏™ ¡., 3411
ÃÀ™O¶OÀ§O™ Ã., 226
ÃÀ™OÃOOÀ Ã., 1545, 3259, 3238, 3310, 3313
ÃÀ™OÃOOÀ ∫., 2045, 2134, 2585
ÃÀΔ∏ƒπ¢OÀ ¢., 1839, 1840
Ãøƒ∂ª∏ ∂., 893
Ãøƒ∂ª∏™ ∫., 117
Ãøƒπ∞¡O¶OÀ§OÀ ª., 3206
æ∞§§∞™ ª., 2199, 2749, 3275, 3302, 3324, 3369
æ∞§ΔO¶OÀ§OÀ Δ., 3296
æ∞ƒƒ∞ ∫., 2495, 2496, 3228
æ∞ƒƒ∞ ¶., 1838, 2747
æ∞ƒƒ∞™ ∞., 80
æ∞ƒO°π∞¡¡∏ ¶., 3364
æ∏§O¶∞¡∞°πøΔOÀ ∞., 3284
æÀ§§∞ ª., 3359
æÀ§§∞™ ∫., 889, 894, 895, 928, 946, 1587, 3321,
3359, 3465, 3474
æÀƒO°π∞¡¡∏™ ∞., 1888, 2079, 2839, 2877, 2994,
3014, 3283, 3284, 3416
æÀƒƒO¶OÀ§O™ ¢., 2756
æÀÃ∞ƒ∏ ™., 3411
æÀÃO°π∞¡¡∏™ ∞., 3371
æÀÃO°πO¶OÀ§OÀ °., 272
æÀÃO°πO™ ∞., 494
æÀÃO°ÀπOÀ ¶., 3144
æÀÃOÀ º., 3075
æøª∞-Δ™πΔƒOÀ ∂., 1852, 1917, 1992, 2037
æøªO¶OÀ§O™ ∏., 3301
øƒ∞πO¶OÀ§O™ ¢., 156, 302, 304, 305, 2717, 3428,
3430, 3444
£EMATIKH KATA°PAºH
¶PO™£ETOI OPOI
53
54
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∞ÁÁÂȷο ÂÁÎÂÊ·ÏÈο ÂÂÈÛfi‰È· 2147, 2233, 2083,
2431, 2432, 2436, 2992, 3592
∞ÁÁÂȷ΋ ‰È·ÂÚ·ÙfiÙËÙ· 1085
∞ÁÁÂȷ΋ ıˆڛ· 3584
∞ÁÁÂÈÔÁÚ·Ê›· 3591
- Laser ˘„ËÏ‹˜ Ù·¯‡ÙËÙ·˜ 3577
∞ÁÁÂÈÔÁÚ·ÊÈΤ˜ ÌÂϤÙ˜ 2114
- ÂÂÌ‚¿ÛÂȘ Â·Ó·ÁÁ›ˆÛ˘ 2716
∞ÁÁÂÈÔ¿ıÂÈ· ‰È·‚ËÙÈ΋ 60, 107, 242, 320, 798, 936,
1318, 1336, 1516, 1791, 1810, 1978, 3183
- ·ÓÔÛÔÏÔÁÈÎÔ› Ì˯·ÓÈÛÌÔ› 2819
- ‰È·ÙÚÔÊ‹ 2230
- Î·È buflomedil 1265
- Î·È ÂÚ˘ıÚ¿ ·ÈÌÔÛÊ·›ÚÈ· 1205
- Î·È ÛÈ·ÏÈÎfi Ô͇ 1862
- Î·È Û˘Ì·ıËÙÈÎfi ¡™ 1883
- ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· 2611, 2624
- ·ıÔÁ¤ÓÂÈ· 2781, 2782, 2789, 2799, 2816, 2817,
2818, 2824, 2879, 3163
- ÂÚÈÊÂÚÈ΋ ·ÔÊÚ·ÎÙÈ΋ 239, 242, 603, 604,
666, 856, 859, 863, 1104, 1106, 1108, 1110, 1111,
1115, 1480, 1497, 1498, 1548, 1811, 2084, 2462,
2501, 2502, 2900, 3018,
- ÛÙ· ·È‰È¿ 1453, 1503
- ÙÚȯÔÂȉÒÓ 3473
AÁÁÂÈÔ¿ıÂÈ· Î·È ÏÈ›‰È· 1975
- ÛÂÏÂÎÙ›ÓË 3356
- Ê¿Ú̷η 2993
∞ÁÁÂÈÔÏ·ÛÙÈ΋ 3588, 3590, 3591
∞ÁÁÂÈÔÙ·Û›ÓË 1105, 2152, 2758, 3217, 3509, 3612
- ·Ó·ÛÙÔÏ›˜ 3232
- ˘Ô‰Ô¯¤·˜ 3235
∞ÁÁÂÈÔ¯ÂÈÚÔ˘ÚÁÈ΋ οو ¿ÎÚˆÓ 3343
∞‰ÂÓÔÛ›ÓË Î˘ÎÏÈ΋ ÌÔÓÔÛʈÚÈ΋ (C-AMP) ÌÂÙ¿
ÁÏ˘Î·ÁfiÓË 8
∞‰ÈÔÓÂÎÙ›ÓË 2321, 2325, 2336, 2579, 3292, 3136,
3562, 3563, 3599, 3687, 3700
∞‰ÚÂÓ·Ï›ÓË Î·È ÈÓÛÔ˘Ï›ÓË 838
∞‰ÚÂÓÔÎÔÚÙÈÎÔÙÚÔ›ÓˆÌ· 1538
A‰ÚÂÓÔÌÔ‰Ô˘Ï›ÓË 1984
∞ıËÚÔÁ¤ÓÂÛË ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 3515
∞ıËÚÔÛÎÏ‹ÚˆÛË 3669
∞ıËڈ̷ÙÔÁ¤ÓÂÛË 288, 502, 689, 1495, 1928, 1977,
2831, 2840, 2848, 2849, 2959, 3315, 3318, 3509
- ·ÁÁÂÈ·Îfi ÂÓ‰Ôı‹ÏÈÔ 3358
- ‰È·ÙÚÔÊ‹ 739, 3224
- Ù‡Ô˜ π 1550
∞ıËڈ̿وÛË 3569, 3663, 3586, 3617
ÕıÏËÛË 3606
AıÏËÙÈÛÌfi˜ 499, 1793, 1816
∞ıÏÔ·È‰È˜ 3604
∞Èı·ÓfiÏË 3560
∞ÈÌ·ÙÔÎÚÈÙ˘ 2013
∞ÈÌ·ÙÔÏÔÁÈΤ˜ ·Ú¿ÌÂÙÚÔÈ Î·È ÂÈÏÔΤ˜ 153, 2013
∞›Ì·ÙÔ˜ ÔÌ¿‰Â˜ 607
∞ÈÌ¿ÙˆÛË Î¿Ùˆ ¿ÎÚˆÓ 533
∞›ÌË 1377
∞ÈÌԉȸÏÈÛË
- ÏÈ›‰È· 957
∞ÈÌÔ‰˘Ó·ÌÈ΋ ÌÈÎÚÔ΢ÎÏÔÊÔÚ›· 1394
∞ÈÌÔÏ˘ÙÈÎfi Ô˘Ú·ÈÌÈÎfi Û‡Ó‰ÚÔÌÔ 1985
∞ÈÌÔοı·ÚÛË 3534, 3580, 3581
∞ÈÌÔοı·ÚÛË-ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË Hb 757
- ·fiÚÚÈ„Ë ÌÔۯ‡̷ÙÔ˜ 3203
- οÏÈÔ 2973
- ÂÚÈÔ‰È΋ 183
∞ÈÌfiÏ˘ÛË Î·È ÎÂÙÔͤˆÛË 498
- ÌÔÓÔ˙˘ÁÒÙ˜ ‰›‰˘ÌÔÈ 3431
AÈÌÔÂÙ¿ÏÈ· 159, 337, 464, 792, 936, 1295, 1563,
1999, 2001, 2224, 2226, 2485, 2486, 3045, 3172
∞ÈÌÔÚÚ·Á›· ÂÓ‰Ô¸·ÏÔÂȉԇ˜ 889, 2177
∞ÈÌÔÚÚÂÔÏÔÁÈΤ˜ ‰È·Ù·Ú·¯¤˜ 836
∞ÈÌÔÛÊ·›ÚÈ· ÂÚ˘ıÚ¿-Ù·¯‡ÙËÙ· ηı›˙ËÛ˘ 2013
- ÏÂÈÙÔ˘ÚÁ›· 2478, 2556, 3489
- ˘ÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›· 2555
∞ÈÌÔÛÊ·›ÚÈ· ÏÂ˘Î¿ 899
- Ì‹ÎÔ˜ ÙÂÏÔÌÂÚÒÓ 3246
∞ÈÌÔÛÊ·ÈÚ›ÓË 2013, 3416
∞ÈÌÔÛÊ·ÈÚ›ÓË ∞1c 152, 154, 757, 760, 1334, 1884,
1889, 2005, 3182, 3207, 3416
- ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 1343
- ·Ó·ÈÌ›· ÚÂ˘Ì·ÙÔÂȉԇ˜ ·ÚıÚ›ÙȉԘ 1468
- ·ÛÈÚ›ÓË 1470
- ηٷ‚ÔÏ‹ 1469
- ÏÈ›‰È· 1338, 1434
- ÌÂÙ·ÛÙÚÔÊ‹ ·Ï‡ÛÂˆÓ 775
- ÓÂÊÚÔ¿ıÂÈ· 854, 2497
- Ù·¯Â›Â˜ ÌÂÙ·‚ÔϤ˜ 1346
- Ù¯ÓÈΤ˜ ÚÔÛ‰ÈÔÚÈÛÌÔ‡ 1459
∞ÈÌÔÛÊ·ÈÚ›ÓË ÂÌ‚Ú˘È΋ 1378
∞ÈÌÔÛÊ·ÈÚ›ˆÓ ÂÚ˘ıÚÒÓ ·Ú·ÌfiÚʈÛË 856, 3489
∞ÈÌԯڈ̿وÛË 3284, 3596
∞ÈÙÈÔÏÔÁ›· ™¢ Ù‡Ô˘ 1 232, 3604
∞ÈÙÈÔ·ıÔÁ¤ÓÂÈ· 380
∞οÓıˆÛË ÌÂÏ·Ó›˙Ô˘Û· 776
∞ηڂfi˙Ë 20, 22, 23, 24, 899, 1183, 1185, 1197, 1201,
1264, 1284, 1285, 1311, 1314, 1345, 1580, 2126,
3493, 3564
∞ÎÂÙ·˙ÔÏ·Ì›‰Ë 1196
∞ÎÂÙ˘ÏÔÛ·ÏÈ΢ÏÈÎfi Ô͇ 340
AÎÔ˘ÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù· 329, 2723
∞ÎÚÔÌÂÁ·Ï›· 964
∞ÎÚˆÙËÚÈ·ÛÌÔ› 1431, 1996, 2193, 3196, 3723
∞ÎÙÈÓÔÌ˘ÎËÙ›·ÛË 857
∞Ï·Ó›ÓË 1325
∞ÏÁfiÚÈıÌÔ˜ ıÂÚ·›·˜ ™¢ Ù‡Ô˘ 2 3569
∞ÏÁÔ˜ ÚÔοډÈÔ 911
∞ωÔÛÙÂÚÔÓÈÛÌfi˜ ‰Â˘ÙÂÚÔ·ı‹˜ 652
∞ÏÈÛÎÈÚ¤ÓË 3488
∞ÏηÏÈ΋ ʈÛÊ·Ù¿ÛË Î·È ÈÓÛÔ˘Ï›ÓË 113
∞ÏÎÔfiÏË Î·È ¯ÏˆÚÔÚÔ·Ì›‰Ë 45
- ·ÓÔ¯‹ ÁÏ˘Îfi˙˘ 215
- ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë 408, 3564
- ‰È·‚‹Ù˘ 200, 1199, 2189, 2195
55
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
- ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ 215, 408, 1199
- ‹·Ú 214, 2065
- ÏÂÙfi ¤ÓÙÂÚÔ 214
- ÏÈȉ·ÈÌ›· 215
- ¿ÁÎÚ·˜ 214
- ˘ÔÁÏ˘Î·ÈÌ›· 536
∞ÏÏÂÚÁ›· ÛÙËÓ ÈÓÛÔ˘Ï›ÓË 143, 194, 1201, 3566
∞ÏÔı¿ÓË, ∂§O Î·È ÁÏ˘Îfi˙Ë ·›Ì·ÙÔ˜ 6
∞ψÂΛ· 3536
∞ÌÈÓÔÁÔ˘·Óȉ›ÓË 1609
∞ÌÈÓÔ˘Ú›ÓË 1380, 1383
∞ÌÈÔ‰·ÚfiÓË Î·È ÁÏ˘Îfi˙Ë 1472
∞Ì˘Ï¿Û˜ ÔÚÔ‡ 623
∞Ì˘Ï›ÓË 389, 1603, 1651, 3458, 3548
∞Ì˘ÏÔ˚‰¤˜ 1845
∞ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 74, 324, 384, 385, 392, 394,
404, 419, 458, 627, 630, 673, 737, 781, 865, 888,
895, 1090, 1102, 1105, 1120, 1140, 1323, 1386,
1487, 1511, 1583, 1587, 1804, 1860, 1925, 1949,
1952, 1953, 1976, 1993, 2017, 2025, 2031, 2032,
2122, 2192, 2194, 2236, 2082, 2673, 2696, 2747,
2882, 2890, 2892, 2938, 2958, 3016, 3024, 3028,
3041, 3043, 3074, 3076, 3084, 3089, 3108, 3113,
3256, 3286, 3294, 3314, 3321, 3327, 3339, 3341,
3389, 3479, 3482, 3513, 3577
- ·Ó·ÛÙÔÏ›˜ ∞ª∂ 1568
- Â›‰· ∞1c 1343
- ÂÚ˘ıÚ¿ ·ÈÌÔÛÊ·›ÚÈ· 1190
- ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·ÛË 1861
- ηٷÚÚ¿ÎÙ˘ 2192, 2194
- ̤ıÔ‰ÔÈ ÊˆÙÔÁÚ¿ÊËÛ˘ 634
- ÊÏÔ˘ÔÚÂÛËÙ›ÓË 1426
- Laser 785, 803, 1942, 1943, 1948
∞ÌÊÈ‚ÏËÛÙÚÔÂȉԇ˜ ÂÓ‰ÔıËÏȷο ·ÙÙ·Ú· 1090
- ÂÚÈ·ÙÙ·Ú· 1090
∞Ì̈ӛ·˜ Â›‰· ÌÂÙ¿ ÁÏ˘Îfi˙Ë 527
- ÂÎÎÚÈÌ·Ù›ÓË 527
∞Ì˘Ï¿ÛË 1393
∞Ó·ÈÌ›· 2214
∞Ó·ÈÌ›· ÌÂÁ·ÏÔ‚Ï·ÛÙÈ΋ Î·È ‰ÈÁÔ˘·Ó›‰È· 3381
∞Ó·ÈÌ›· ÌÂÛÔÁÂȷ΋ Î·È ™¢ 1593
∞Ó¿ÏÔÁ· ۈ̷ÙÔÛÙ·Ù›Ó˘ 404, 411
∞Ó·ÈÛıËÛ›· Î·È ·˘ÙÔÓÔÌÈ΋ Ó¢ÚÔ¿ıÂÈ· 593
- Â›‰· ÁÏ˘Îfi˙˘ 808, 826, 1330
∞Ó·Ó¢ÛÙÈ΋ ÏÂÈÙÔ˘ÚÁ›· 287
- ‰ÔÎÈÌ·Û›· ·ÌÈÓÔ˘Ú›Ó˘ 1383
∞Ó·Ó¢ÛÙÈÎfi Û‡Ó‰ÚÔÌÔ ·È‰ÈÒÓ 102
∞Ó¿ÛÙËÌ· ·È‰ÈÒÓ 471, 2163
- Î·È ÂÈÏÔΤ˜ 1093
∞Ó·ÛÙÔÏ›˜
- ·ÁÁÂÈÔÙÂÓÛ›Ó˘ 3217
- ÁÏ˘ÎÔÛȉ·ÛÒÓ 657
- ηڂÔÓÈ΋˜ ·Ó˘‰Ú¿Û˘ 1993
- ÌÂÙ·ÙÚÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘ 477, 1982, 2590, 2695,
3017, 3613
- Aldose reductase 2252, 2266, 3158
- DPP-IV 2138, 3674, 3564
56
- HIV ÚˆÙ¿Û˘ 3572
∞Ó·ÙÔÌÈ΋ ˘Ê‹ ·ÏÏÔÈÒÛÂˆÓ 49, 65
∞Ó‰ÚÔÁfiÓ· 530, 786, 796, 1299, 3572
∞Ó‰ÚÔÁÔÓ·ÈÌ›· 776
∞Ó‰ÚÔÁÔÓÔÂÓ›· 2720
∞ÓÂ›ÁÓˆÛÙË ˘ÔÁÏ˘Î·ÈÌ›· 3575
ÕÓÔÈ· 3592
∞ÓÔÛÔ·ÓÙȉڷÛÙÈÎfiÙËÙ· ·ÁÎÚ¤·ÙÔ˜ 1161
∞ÓÔÛÔÁÂÓÂÙÈ΋ 221
∞ÓÔÛÔ˚ÛÙÔ¯ËÌ›· 620
∞ÓÔÛÔηٷÛÙ·ÏÙÈο 3572
∞ÓÔÛÔηٷÛÙÔÏ‹ Î·È ÏÂÙ›ÓË 1901
∞ÓÔÛÔÛÊ·ÈÚ›ÓË IgE 1358
∞ÓÔ¯‹ ÁÏ˘Îfi˙˘ 1456, 2826
- Ë·Ù›Ùȉ· 684
- Î·È ·ÏÎÔfiÏË 215
∞ÓÙ·ÁˆÓÈÛÙ¤˜
- ·Û‚ÂÛÙ›Ô˘ 3572
- ·Û‚ÂÛÙ›Ô˘ Î·È ÏÂ˘ÎˆÌ·ÙÔ˘Ú›· 835
- ‰È·‡ÏˆÓ ·Û‚ÂÛÙ›Ô˘ 3613
- ÈÓÛÔ˘Ï›Ó˘ 66
- ˘Ô‰Ô¯¤ˆÓ AT1 ·ÁÁÂÈÔÙÂÓÛ›Ó˘ 3613
∞ÓÙÈ-VEGF 3577
∞ÓÙÈ·ÈÌÔÂÙ·Ïȷ΋ ·ÁˆÁ‹ 2833, 3672
∞ÓÙÈ·ÈÌÔÊÈÏÈ΋ ÁÏÔ‚Ô˘Ï›ÓË Î·È ˘ÔÁÏ˘Î·ÈÌ›· 158
∞ÓÙÈÁfiÓ· HLA 846, 960, 1319, 1585, 1702, 1703,
1704,1705, 1707, 1708, 1709, 1712, 1713, 1714,
1927, 1930, 1959, 2200, 2202, 3127, 3547, 3549,
3682
∞ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ·
- ·ÓÙÂӉ›ÍÂȘ 2171, 2761
- ·ÛÙÔ¯›· 1880
- ηډÈÔÏÔÁÈ΋ ‰Ú¿ÛË 2713
- ÓÂfiÙÂÚ· 2572, 2903, 2966, 3005
- Û˘ÁÎÚÈÙÈο ·ÔÙÂϤÛÌ·Ù· 3324
- ˘ÔÁÏ˘Î·ÈÌ›· 189, 562, 2148
∞ÓÙȉȷ‚ËÙÈο Ê¿Ú̷η 3673
∞ÓÙÈıÚÔÌ‚›ÓË πππ 370
∞ÓÙÈıÚ˘„›ÓË ∞1 3032
∞ÓÙÈÌÂÙ·ÊÔÚ¿ Na-Li 3612
∞ÓÙÈÏÈȉ·ÈÌÈο 338, 2022
∞ÓÙÈÔÍÂȉˆÙÈο ¤Ó˙˘Ì· 1567, 2437
∞ÓÙÈÛ‡ÏÏË„Ë Î·È ‰È·‚‹Ù˘ 353, 786, 1813, 2974, 3408
∞ÓÙÈÛÒÌ·Ù· 130, 259, 269, 311, 893, 924, 1425, 1637,
1880, 1909, 2538
- ·ÓÙÈÁÏÔÈ·ÓȉÈο 1922
- ·ÓÙÈı˘ÚÂÔÂȉÈο 3173
- ı˘ÚÂÔÂȉÈο 114, 275, 2741
- ÌÔÓÔÎψÓÈο 1699, 1700, 3577
- GAD 65 245, 528, 1637, 1909, 2121, 3547
- IA-2 528, 3547
- IAA 3547
∞ÓÙÈ˘ÂÚÙ·ÛÈο Î·È ÏÈÔÂȉ‹ 336
- ¢·ÈÛıËÛ›· ÛÙËÓ ÈÓÛÔ˘Ï›ÓË 3254
∞ÓÙÈ˘ÂÚÙ·ÛÈ΋ ·ÁˆÁ‹ 1983, 2003, 2411, 3613
∞ÓÙÈÊÏÂÁÌÔÓÒ‰Ë ÌË ÛÙÂÚÔÂȉ‹ 2123
∞ÓÙÈÊ˘Ì·ÙÈο Ê¿Ú̷η 3572
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∞ÍÔÓÈ΋ ·ÁÁÂÈÔÁÚ·Ê›· 3590
∞ÍÔÓÈ΋ ÙÔÌÔÁÚ·Ê›· 3610
∞ÔÚÙ‹˜
- ÏÂÈÙÔ˘ÚÁ›· 3589
- ›ÂÛ˘ Û¯¤Û˘ 1801, 2198, 2540, 2892, 3369
∞ÔÚÙÈÎÔ‡ ÙfiÍÔ˘ ··Û‚¤ÛÙˆÛË 1991, 2107, 2222,
2225, 2464, 2469
∞ÔÚÙÔÛÙÂÊ·ÓÈ·›· ·Ú¿Î·Ì„Ë 3717
∞¢·ÈÛıËÙÔÔ›ËÛË 194
ÕÔÈÔ˜-Û˘Ó‡·ÚÍË 913
∞ÔÏÈÔÚˆÙ½Ó˘ Â›‰· 3394
∞Ô̇˙ËÛȘ ıÚÂÙÈÎÒÓ Ô˘ÛÈÒÓ 120
∞ÔÓÂ˘ÚˆÛ›Ùȉ· ÓÂÎÚˆÙÈ΋ 1562
∞ÔÊÚ·ÎÙÈ΋ ·ÚÙËÚȷ΋ ÓfiÛÔ˜ 3590
ÕÓÔȘ ‡ÓÔ˘ 3521
∞ÔÎÏÂÈÛÙ¤˜
- ∞1 ·‰ÚÂÓÂÚÁÈÎÒÓ ˘Ô‰Ô¯¤ˆÓ 3613
- μ 1261, 3613
∞ÔÚˆÙ½Ó˜ 3614
∞fiÙˆÛË 1608, 1632, 1705
- ‚-΢ÙÙ¿ÚˆÓ 3548
∞ÔÙˆÙÈ΋ ‰Ú¿ÛË ÌÔÚ›ˆÓ 2142
∞ÔʈÛÊÔÚ˘Ï›ˆÛË ÚˆÙÂ˚ÓÒÓ 592
∞ÙÔÛÊ·ÈÚ›Ó˜ 3032
∞ÚÁÈÓ›ÓË 1176, 1231, 1691
∞ÚÁ˘ÚfiÊÈÏ· ·ÙÙ·Ú· ÂÓÙ¤ÚÔ˘ 582
- ÓËÛȉ›ˆÓ 582
∞ÚıÚÔ¿ıÂÈ· ‰È·‚ËÙÈ΋ 704, 918, 1466, 1473, 1920,
2783, 2798
- ∞¡™ 3584
- ·Û‚ÂÛÙÔÔÈfi˜ ·ÚıÚ›Ùȉ· 2940, 2949
- ÛËÙÈ΋ 2030
- Ù‡Ô˘ Charcot 802, 1589, 3584
∞ÚÙËÚÈÒÓ ¤ÏÂÁ¯Ô˜ Ì ˘ÂÚ‹¯Ô˘˜ 316, 317, 1810
∞ÚÙËÚȷ΋ ·ÚÔ¯‹ 328, 528
∞ÚÙËÚȷ΋ ÛÎÏ‹Ú˘ÓÛË 3532
∞ÚÙËÚȷ΋ ›ÂÛË 607, 3681
ÕÚÙÔ˜ Î·È ‰›·ÈÙ· 386
∞ڈ̷ٿÛË 1402
∞Û‚¤ÛÙÈÔ 3695
∞Û‚¤ÛÙÈÔ Î·È ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘ 517
∞Û‚ÂÛÙ›Ô˘ ÌÂÙ·‚ÔÏÈÛÌfi˜ 323, 517, 912, 916, 2710
- ·ÓÙ·ÁˆÓÈÛÙ¤˜ 2206
- ‰›·˘ÏÔÈ 2205
- ÂÓ‰Ô΢ÙÙ¿ÚÈÔ 2158
∞Û‚ÂÛÙÔÔÈfi˜ ÂÚÈ·ÚıÚ›ÙȘ 1395
AÛ‚¤ÛÙˆÛË ·ÔÚÙÈÎÔ‡ ÙfiÍÔ˘ 2107, 2198
ÕÛËÙË ÊÏÂÁÌÔÓ‹ 3600
∞ÛıÂÓ‹˜ ‰È·‚ËÙÈÎfi˜ ÛÙÔ ¯ÂÈÚÔ˘ÚÁÂ›Ô 70
∞ÛıÂÓÒÓ ˘ÔÛÙ‹ÚÈÍË ÓÔËÙÈ΋ 1403
ÕÛÎËÛË Î·È ÁÏ˘ÎÔÁfiÓÔ 209, 1816
- ·ÓÙÈıÚÔÌ‚ˆÙÈÎfi˜ ÚfiÏÔ˜ 2048
- Á·Ï·ÎÙÈ΋ ÔͤˆÛË 210, 211
- ÁÏ˘ÎÔÁÔÓfiÏ˘ÛË 209
- ÁÏ˘Îfi˙Ë 212, 486, 499, 688, 892, 1653, 1654, 1793
- ‰È·‚‹Ù˘ 199, 213, 499, 1532, 1533, 1793, 2506,
2568, 2650, 2655, 2721, 2736, 2753, 3218
- ‰È·ÙÚÔÊ‹ 3296
- ıÓËÛÈÌfiÙËÙ· 3296
- ηډȷ΋ Û˘¯ÓfiÙËÙ· 3268
- ÌÂ ‚¿ÚË 2021
- Ú‡ıÌÈÛË 3353
- ÙÚÈÁÏ˘ÎÂÚ›‰È· 212
- ¯ÔÏËÛÙÂÚ›ÓË 212
- HDL 212, 892
AÛÎÔÚ‚ÈÎfi Ô͇ Î·È ÌÔÓÔ‡ÚËÓ· 228, 297
- Ï¿ÛÌ·ÙÔ˜ 1108
∞ÛÈÚ›ÓË 3587, 3572
- ÌÈÎÚÔ΢ÎÏÔÊÔÚ›· 2304, 2383, 3348,
- ÛÙËÓ ˘ÔÁÏ˘Î·ÈÌ›· 157
∞ÛÙ·ı‹˜ ‰È·‚‹Ù˘ 72, 187, 364, 3571
∞ÙÂÓÔÏfiÏË 790
ÕÙÔÓË ÌÂÁ·Î‡ÛÙË 3584
∞ÙÔÚ‚·ÛÙ·Ù›ÓË 2132, 2197, 2320, 2600
∞ÙÚÔ›ÓË 700, 1192
∞ÙÚÔÊ›· ÔÙÈ΋ 1606
ÕÙ˘· ·ÓÙÈ„˘¯ˆÙÈο 3572
A˘ÍËÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ 20, 87, 88, 89, 90, 91, 92, 227,
250, 596, 647, 878, 1119, 1132, 1154, 1312, 1313,
1597, 1701, 1907, 1942, 2144, 2483, 2537, 2748,
3162, 3460
- ·ÁÁÂÈ·Îfi˜ ÂÓ‰ÔıËÏÈ·Îfi˜ Î·È ACE ·Ó·ÛÙÔÏ‹
1907
- ÏÂÙ›ÓË 1903
- ÌÂÙ·‚ÔÏÈÛÌfi˜ ÛÎÂÏÂÙÈÎÒÓ Ì˘ÒÓ 1660
- Û‡ÓıÂÛË ÁÏ˘ÎÔÁfiÓÔ˘ 1652
∞˘ÛÙÚ·ÏÈ·Ófi ·ÓÙÈÁfiÓÔ 181
∞˘ÙÔ¿ÓÔÛË ÔÏ˘ÂÓ‰ÔÎÚÈÓÔ¿ıÂÈ· 791, 1598, 3447
∞˘ÙÔ·ÓÔÛ›· 222, 3547
- ‚ – ΢ÙÙ¿ÚˆÓ 2533
∞˘ÙÔ¿ÓÔÛÔ˜ ‰È·‚‹Ù˘ 1598, 1897, 2911
- ÈÓÙÂÚÊÂÚfiÓË 3323
- Ï·Óı¿ÓˆÓ 3351
∞˘ÙÔ·ÓÙÈÛÒÌ·Ù· 1994, 2538, 2869, 3435, 3437, 3461
- ·ÓÙÈ΢ÙÙ·ÚÔÛÎÂÏÂÙÈÎÒÓ ÚˆÙÂ˚ÓÒÓ 3466
- ÁÏÔ˘Ù·ÌÈÓÈ΋˜ ·ÔηڂÔÍ˘Ï¿Û˘ ÛÙÔ Û›ÂÏÔ
3454
- ÓËÛȉȷο 3523
∞˘ÙÔÎÈÓ‹ÙÔ˘ ¿‰ÂÈ· Ô‰‹ÁËÛ˘ 629
∞˘ÙÔÌÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·ÙÔ˜ 543, 544, 623
∞˘ÙfiÓÔÌÔ Ó¢ÚÈÎfi Û‡ÛÙËÌ· 430, 509
∞˘ÙÔÓÔÌÈ΋ Ó¢ÚÔ¿ıÂÈ· 574, 3666
- Î·È ·Ó·ÈÛıËÛ›· 593, 2800
- ˘ÔÁÏ˘Î·ÈÌ›· 639
∞Ê˘‰¿ÙˆÛ˘ ıÂÚ·›· 115, 116, 117
- ÌÔÚʤ˜ ÛÙË ‚ÚÂÊÈ΋ ËÏÈΛ· 589
μ-·‰ÚÂÓÂÚÁÈÎÔ› ‰ÈÂÁ¤ÚÙ˜ 3572
μ-·Ó·ÛÙÔÏ›˜ ÙÔ˘ Û˘Ì·ıËÙÈÎÔ‡ 3572
μ2 ÌÂÙ·‚Ôϛ٘ ÛÙ· Ô‡Ú· 2128
μ·ÎÙËÚÈÔ˘Ú›· 686, 1461, 1910
μ·ÚÔ·ÓÙ·Ó·ÎÏ·ÛÙÈÎfi 3211
μ·ÛÈ΋ ÌÂÌ‚Ú¿ÓË 291, 1079, 1084, 1085, 1086, 1090,
1571, 1572, 2871
μÂÓÏ·Ê·Í›ÓË 2560
57
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
μËÌ·ÙÈÛÌÔ‡ ‰È·Ù·Ú·¯¤˜ 3598
- Î·È Ó¢ÚÔ¿ıÂÈ· 1605
μËÙ·ÁÏÔ˘Î¿ÓË 3522
μÈÏÓÙ·ÁÏÈÙ›ÓË 3564
μÈÔ˚·ÙÚÈ΋ ¤Ú¢ӷ 2145
μÈÔÛ˘ÓıÂÙÈ΋ ÈÓÛÔ˘Ï›ÓË 463
μÈÔÙ›ÓË 3480
μÈÔÊ˘ÛÈÎfi ÚÔÊ›Ï 360
μÈÔ„›· ÔÛÙÔ‡ 3611
μ›ˆÌ· 1535, 1537, 1541
μÈÛÊ·Ù›ÓË 2176
μÈÙ·Ì›ÓË 310, 485
- ·ÓÙÈÔÍÂȉˆÙÈ΋ 3271
- C 285, 3360, 3486
- D 485, 2710, 3547, 3695
- ∂ 898, 2322, 3360
μÈÙÚÂÎÙÔÌ‹ 2673, 2674
μfiÙ·Ó· Î·È ‰È·‚‹Ù˘ 1136
μÚ·‰˘Î›ÓË 3612
μ˘ıÔÛÎfiËÛË 3577
°¿ÁÁÚ·ÈÓ· ¤Ô˘˜ 2978
°·Ï·ÎÙÈ΋ ÔͤˆÛË 196, 516, 518, 632, 1372, 1436,
1555, 2567, 3574
- ¿ÛÎËÛË 210, 211
- ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë 211
- ÊÂÓÊÔÚÌ›ÓË 210, 211, 1399, 2740, 2907
°·Ï·ÎÙÈÎfi Ô͇ 577, 3030
°·Ï·ÎÙfi˙˘ ‰˘Û·ÔÚÚfiÊËÛË 122, 1175
- ‰ÔÎÈÌ·Û›· 520
°·Ï·ÎÙfiÓÔ (HPL) Û ÂÁ΢ÌÔÛ‡ÓË 3077
°¿Ï·ÎÙÔ˜ ‰˘Û·ÓÂÍ›· 119
°·Ï·ÎÙÔÊÂÚ›ÓË 2330
°·Ï·Ó›ÓË 3325
°·ÛÙÚÂÓÙÂÚÈο Û˘ÌÙÒÌ·Ù· 3683
°·ÛÙÚÂÓÙÂÚÈΤ˜ ÔÚÌfiÓ˜ 1228, 1229, 1233, 1237,
1240, 1257, 1263, 1275, 1293
°·ÛÙÚÈ΋ ¤ÎÎÚÈÛË Î·È ÛˆÌ·ÙÔÛÙ·Ù›ÓË 33
- ΤӈÛË 779, 3198
°·ÛÙÚÂÓÙÂÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÂÓ‰ÔÛÎfiËÛË 3263
°·ÛÙÚÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ÂÎÙ›ÌËÛË 3455, 3368
°·ÛÙÚ›ÓË 32, 33, 692, 1112, 1199, 1217, 1227, 1245,
1536, 3544
°·ÛÙÚÔ¿ıÂÈ· ·˘ÙÔ¿ÓÔÛË 3483
°·ÛÙÚÔ¿ÚÂÛË 3571, 3584
- Î·È ÛÈÍ·Ú›‰Ë 2008
°ÂÌÊÈÌÚÔ˙›ÏË 3451
°ÂÓÂÙÈο Û‡Ó‰ÚÔÌ· 3545, 3549
°ÂÓÂÙÈ΋ ÚԉȿıÂÛË 473, 475, 476, 488
°ÂÓÂÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 381, 1628, 1629,
1630, 1631, 1632, 1633, 1634, 1635, 2149, 2216,
2217, 2219, 2221
°ÂÓÈ΋ Ó¿ÚΈÛË, ·Ó·ÈÛıËÛ›· 3607
°Â˘ÛÙÈ΋ ÂÊ›‰ÚˆÛË 3584
°‹Ú·˜ Î·È ™¢ 745, 1817
- ·ÓÙÈÚÚfiËÛË ÔÚÌÔÓÈ΋ 1444
°ÈÁ·ÓÙÈÛÌfi˜-ÌÂÁ·Ï·ÎÚ›· 3029
°ÎÏ·ÚÁΛÓË 2456
58
°ÎÏÈÎÏ·˙›‰Ë 2968, 3472
°ÎÚÂÏ›ÓË 3562
°Ï·‡ÎˆÌ· 290, 3357
- ÁÏ˘Îfi˙Ë ˘‰·ÙÔÂȉԇ˜ ˘ÁÚÔ‡ 7
°ÏÈ‚ÂÓÎÏ·Ì›‰Ë 35, 36, 135, 137, 138, 136, 211, 408,
690, 700, 831, 850, 1129, 1144, 1146, 1160, 1171,
1218, 1223, 1234, 1235, 1684, 1866, 2790
°ÏÈÌÂÈÚ›‰Ë 1376, 2141, 2559, 2790, 3499, 3530, 3564
°ÏÈÈ˙›‰Ë 2, 1364, 3564
°ÏÈÙ·˙fiÓ˜ 2086, 2509
°ÏԢηÁfiӈ̷ 1535, 1538, 1541
°ÏÔ˘Ù·Ì›Ó˘ ÌÂÙ·‚ÔÏÈÛÌfi˜ 1656, 1657, 1659, 1664,
1665, 1706
°ÏÔ˘Ù·ÌÈÓÈÎfi Ô͇ 3380
°ÏÔ˘Ù¤ÓË 795, 3547
°Ï˘Î·ÁfiÓË 430, 1157, 1176, 1256, 1257, 1258, 1291,
1292, 1417, 1536, 3439, 3542
- ÂÁ΢ÌÔÛ‡ÓË 1417
- ¤ÎÎÚÈÛË 713, 727
- ıÂÔÊ˘ÏÏ›ÓË 783
- ηډȷΤ˜ ·ı‹ÛÂȘ 821
- ÓËÛÙ›· 783
°Ï˘Î·ÈÌÈÎfi˜ ¤ÏÂÁ¯Ô˜ 3521
- ÛËÌ·Û›· 2834, 2843
°Ï˘Î·ÈÌ›·˜ Â›‰· 3, 2143
- ·ÏÔı¿ÓË 6
- ÎÔÚÙÈÎÔÂȉ‹ 847
- Û˘Ó¯‹˜ ηٷÁÚ·Ê‹ 3
°Ï˘Î·ÈÌÈÎfi˜ ‰Â›ÎÙ˘ 173, 358, 2143, 2076, 2985,
2989, 3557
°Ï˘Î·ÓÙÈΤ˜ Ô˘Û›Â˜ 46
°Ï˘ÎÔ·ÈÌÔÛÊ·ÈÚ›Ó˜ 412
°Ï˘ÎÔÁÔÓ›·ÛË Ù‡Ô˘ 1· 766
°Ï˘ÎÔÁfiÓÔ 163, 164, 209, 267, 274, 866, 867, 1157,
1176, 1301, 3329, 3606
- ÎÈÓËÙÔÔ›ËÛË 849, 851, 852, 866, 867
- ΢ÎÏÈ΋ ÌÔÓÔʈÛÊÔÚÈ΋ ·‰ÂÓÔÛ›ÓË 8
- ÛÙ· ÓÂÔÁÓ¿ 537, 548
- ʈÛÊÔÚ˘Ï¿ÛË 3392
°Ï˘ÎÔÁÔÓfiÏ˘ÛË 3606
°Ï˘ÎÔ˙·ÌÈÓÔÁÏ˘Î¿Ó˜ 813, 879, 1423, 3175
°Ï˘Îfi˙Ë
- ·ÈÛıËÙ‹Ú˜ 2075
- ·ÏÎÔfiÏË 215, 1199
- ·ÏÏËÏÂ›‰Ú·ÛË ÌÂÙ·‚ÔÏÈÛÌÔ‡ Ì ¿ÏϘ ÙÚÔʤ˜
1478, 2458
- ·ÌÈÔ‰·ÚfiÓË 1472
- ·ÓÔ¯‹-Ë·Ù›Ùȉ· 684, 1669
- ·ÓÙ·ÏÏ·Á‹ Â› ÔÏÈÔÌ˘ÂÏ›ÙȉԘ 1388
- ¿ÛÎËÛË 212, 688, 1438, 1439, 1653, 1654, 1655,
1816
- ·˘ÙÔ¤ÏÂÁ¯Ô˜ 465, 466, 2178, 2182
- ‰È·Ù·Ú·¯‹ ·ÓÔ¯‹˜ 3664
- ‰˘Û·ÔÚÚfiÊËÛË 122, 350, 550, 1437, 2452
- ÂÁÎÂÊ·ÏÔÓˆÙÈ·›Ô ˘ÁÚfi 99, 1677, 1679
- ÂÓ‰ÔÏ·ÛÌ·ÙÈÎfi ‰›ÎÙ˘Ô Ë·ÙÔ΢ÙÙ¿ÚˆÓ 591,
1669
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
- ÂÈÓÂÊÚ›‰È· 265
- Â›‰· ÓËÛÙ›·˜ 1097
- ÂÚ˘ıÚÔ·ÙÙ·Ú· 195, 1641
- ›ÎÙÂÚÔ˜ 579, 684, 1669
- ÏÂ˘Î¿ ·ÈÌÔÛÊ·›ÚÈ· 197
- ÏÈ›‰È· 554, 965, 1478, 1529
- ÌÂÁ·Ï·ÎÚ›· 227, 250, 1216
- ÌÂÙ·‚ÔÏÈÛÌfi˜ 3618
- ÌÂÙ·ÁÂ˘Ì·ÙÈ΋ 1302, 1851, 1890
- ÌÂÙ·ÊÔÚ¿ 3543
- ̤ÙÚËÛË Û˘Ó¯‹˜ 3636, 2129, 2203, 3546
- ÓÂÊÚÈ΋ ·Ú·ÁˆÁ‹ 829, 1669
- ÓÈʉÈ›ÓË 1471
- Ô˘Ú·ÈÌ›· 1125, 1127, 1188, 1669
- ·ıÔÏÔÁÈ΋ ηÌ‡ÏË ·ÓÔ¯‹˜ 1304
- ÚÔÛ‰ÈÔÚÈÛÌfi˜ 99, 1352, 1528, 2182
- Û ‰˘ÛÙÚÔÊÈο ‚Ú¤ÊË 1316, 1317
- ÛÔ˘ÏÊÔÓ˘ÏÔ˘Ú›Â˜ 1141, 1152, 1172, 1226, 1260,
1282, 1451
- ˘ԉԯ›˜ 1239, 1641, 1642, 1644, 2454
- ÊfiÚÙÈÛË Î·È ·Ó‰ÚÔÁfiÓ· 786, 1299
- ʈÛÊfiÚÔ˜ 839, 840, 841, 842
- ¯ÚÒÌÈÔ Ï¿ÛÌ·ÙÔ˜ ÌÂÙ¿ ¯ÔÚ‹ÁËÛË ÁÏ˘Îfi˙˘ 9,
703
- „ˆÚ›·ÛË 691
°Ï˘ÎÔ˙Ô·ÌÈÓȉ¿Û˜ 395, 1113
°Ï˘ÎÔ˙ÔÌÂÙ·ÊÔÚ›˜ 367
°Ï˘ÎÔ˙ÔÍÂȉ¿Û˘ ̤ıÔ‰Ô˜ 449, 450
°Ï˘ÎÔ˙Ô˘Ú›· 702
- ÂÁ΢ÌÔÛ‡ÓË 728
- Â›ÙˆÛË ÛÙËÓ ∂ÏÏ¿‰· 16, 605, 1327
- ÛÙÂÚÈÓÔÂȉ‹˜ 546
°Ï˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌÔÛÊ·ÈÚ›ÓË 298, 315, 332, 333,
406, 412, 757, 760, 1884, 1889, 2480, 3546, 3702
- ·Ó·ÈÌ›· ÚÂ˘Ì·ÙÔÂȉԇ˜ ·ÚıÚ›ÙȉԘ 1468
- ·ÛÈÚ›ÓË 1470
- ηٷ‚ÔÏ‹ 1469
- ÔÍ›˜ ·ÈÌÔÚÚ·Á›Â˜ 773
- Ú‡ıÌÈÛË Û·Î¯¿ÚÔ˘ 1931
- Ê˘ÙÈΤ˜ ›Ó˜ 1524
°Ï˘ÎÔ˙˘Ï›ˆÛË
- ÂÌ‚Ú˘È΋ 1186
- οÓÈÛÌ· 326
- ÌË ÂÓ˙˘Ì·ÙÈ΋ 291, 1079, 1082, 1083, 1084,
1085, 1086, 1087, 1088, 1090, 1091, 1486
- ÚˆÙÂ˚ÓÒÓ 280, 298, 326, 754, 1626, 1627, 2131,
3561, 3584, 3586
- ÙÂÏÈο ÚÔ˚fiÓÙ· 1087, 1486, 1609, 1614, 1615,
1616, 1617, 1618, 1619, 1620, 1621, 1622, 1623,
1624, 1625, 1646, 1647, 1648, 2020
°Ï˘ÎÔÎÈÓ¿ÛË 1845
°Ï˘ÎÔÎÔÚÙÈÎÔÂȉ‹ 3572
°Ï˘ÎfiÏ˘ÛË 3541
°Ï˘ÎÔÓÂÔÁ¤ÓÂÛË 3541, 3606
°Ï˘ÎÔÛȉ¿ÛË fiÍÈÓÔ˜ 849, 2948
°Ï˘ÎÔÛȉ·ÛÒÓ ·Ó·ÛÙÔÏ›˜ 657, 1525
°ÔÓ›‰È· 3547
°ÔÓȉȷÎfi˜ ÔÏ˘ÌÔÚÊÈÛÌfi˜ 3320, 3347, 3320, 3347,
3492, 3503, 3504, 3505
°ÔÓȉȷΤ˜ ÌÔÚʤ˜ 3549
°ÚÂÏ›ÓË 3562, 3563
°˘Ó·›Î˜ Î·È ™¢ 1847
ÁGT 3037
¢ÂÍ·ÌÂı·˙fiÓË ÔÊı·ÏÌÈΤ˜ ÛÙ·ÁfiÓ˜ 3229
¢ÂÚÌ·ÙÈΤ˜ ÂΉËÏÒÛÂȘ 180, 768, 769, 3386
¢ÂÛÔÍ˘ÊˆÛÊÔÚÔÁÏ˘ÎÂÚÈÓÈÎfi Ô͇ (2,3 DPG) 1335
¢ÂÛÊÂÚÚÈÔÍ·Ì›ÓË 425
¢Â¸‰ÚÔÁÔÓ¿ÛË 540, 541
- ·‰Ú·ÓÔÔ›ËÛË 580
- ·ÓÂ¿ÚÎÂÈ· 3431
- ‚ÈÔÛ‡ÓıÂÛË 588
- ‰È·Î›ÓËÛË 588
- ‰È·¯ˆÚÈÛÌfi˜ 586, 587
- Â·ÁˆÁ‹ 584
- ÌÔÚʤ˜ 585
¢Â¸‰ÚÔÂÈ·Ó‰ÚÔÛÙÂÚfiÓË 670
¢È·‚‹Ù˘ 2093, 2418, 3070, 3073, 3079, 3097, 3098,
3104, 3105, 3106, 3110, 3112, 3116, 3540, 3705,
3706, 3708, 3709, 3710, 3711, 3712
- ·ÁÚÔÙÈÎfi Â¿ÁÁÂÏÌ· 1526
- ·ÏÎÔfiÏË 200, 2172
- ·ÏÏÂÚÁ›· 2405, 3149
- ·Ó·ÛÙÔϤ·˜ ·-ÁÏ˘ÎÔÛȉ¿Û˘ 20, 738
- ¿ÛÎËÛË 199, 213, 486, 499, 720, 901, 1134, 1357,
1532, 1533, 1816, 2048, 2244, 2506, 2772, 2888,
2895, 3623
- ·ÛÙ·ı‹˜ 72, 187
- ·˘ÙÔ¿ÓÔÛÔ˜ 1598, 1897, 3149
- ·˘ÙÔ¤ÏÂÁ¯Ô˜ 876, 3546
- ‚fiÙ·Ó· 1136, 1483, 1818, 1822
- ÁÂÓÂÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ 1710, 1802, 1863, 1864,
2149, 2961, 3035
- ÁÂÓÈÎfi˜ È·ÙÚfi˜ 2438, 2873
- Á‹Ú·˜ 745, 1133, 1444, 1603, 1817, 2099, 2571,
2652, 3204
- Á˘Ó·›Î˜ 1847, 2407
- ‰ÂÚÌ·ÙÈΤ˜ ÂΉËÏÒÛÂȘ 180, 768, 769, 776, 1543
- ‰Â˘ÙÂÚÔ·ı›˜ ÌÔÚʤ˜ 454
- ‰È¿ÁÓˆÛË 318, 448, 553, 558, 744, 909, 1476,
1939, 2488, 3545
- ‰˘ÛÏÈȉ·ÈÌ›· 2384, 2396, 2410, 2543, 2558,
2564, 2756, 2969, 3662
- ∂ıÓÈÎfi ∫ÂÓÙÚÔ ¢È·‚‹ÙË (∂.∫∂.¢π.) 870
- ÂÎ·›‰Â˘ÛË 25, 26, 27, 28, 29, 30, 31, 41, 42, 47,
86, 127, 128, 188, 202, 220, 258, 446, 466, 491, 494,
478, 660, 661, 782, 833, 843, 962, 967, 1151, 1349,
1355, 1362, 1367, 1507, 1554, 1825, 1839, 1840,
1865, 2125, 2154, 2155, 2489, 2507, 2546, 2665,
2914, 2915, 2916, 2920, 2925, 2926, 2928, 2931,
2933, 2934, 2976, 3004, 3051, 3146, 3400, 2542
- ÂÌ‚ÔÏÈ·ÛÌÔ› 3345
- ÂÌ‚Ú˘ÔÓÈο ‚Ï·ÛÙÔ·ÙÙ·Ú· 2706
- ÂÌÌËÓfi·˘ÛË 1148, 1813, 1842, 1882, 1898,
2549, 2551, 2830, 3516, 3625, 3670, 3687
59
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
- ÂӉ›ÍÂȘ 3247
- ÂÓ‰ÔÁÂÓ‹˜ ·Ú¿ÁˆÓ ÙÔ˘ Castle 1392
- ÂÓ‰Ôı‹ÏÈÔ Î·È ÔÈÛÙÚÔÁfiÓ· 2289, 2296
- ÂÓ‰ÔıËÏ›Ô˘ ÏÂÈÙÔ˘ÚÁ›· 2286, 2288, 2293, 2301,
2315, 2318, 2323
- ÂÓÙ·ÙÈ΋ 470, 2512
- Â͈ÙÂÚÈο È·ÙÚ›· 884, 1556, 1839, 1840, 1865,
2125, 2944, 3174, 3718
- Â·ÁÁÂÏÌ·ÙÈ΋ ·Ó¿Ù˘ÍË 2861
- ÂȉËÌÈÔÏÔÁ›· ·Ú·ÁfiÓÙˆÓ ÎÈÓ‰‡ÓÔ˘ 2839, 2843
- ÂÈÏÔΤ˜ 2246, 2570, 2605, 2608, 2610, 2612,
2715, 2841, 2921, 2927, 3091, 3120, 3129, 3131,
3145, 3053, 3080, 3093, 3605
- ÂÈÙÒÛÂȘ 3552
- Â›ÙÔÎÔ˜ ÛÙÔ ¯ÂÈÚÔ˘ÚÁÂ›Ô 925
- ÂԇψÛË ÙÚ·˘Ì¿ÙˆÓ 3295
- ÂÚ˘Û›ÂÏ·˜ 532, 1543
- ËÏÂÎÙÚÔχÙ˜ 2604
- ıÂÚ·›· 11, 20, 52, 53, 54, 134, 147, 172, 176,
177, 178, 179, 186, 204, 206, 208, 240, 254, 309,
390, 452, 510, 513, 561, 562, 625, 715, 734, 759,
903, 904, 932, 1269, 1270, 1271, 1272, 1274, 1276,
1278, 1281,1362, 1363, 1483, 1485, 1508, 1509,
1510, 1554, 1600, 1601, 1698, 1792, 1846, 2010,
2160, 2067, 2070, 2072, 2073, 2166, 2247, 2375,
2376, 2503, 2514, 2479, 2575, 2577, 2596, 2692,
2698, 2746, 2751, 2835, 2862, 3049, 3199, 3230,
3512
- ıÂÚ·›· ‰È· ÌÂÙ·ÏÏÈÎÒÓ ˘‰¿ÙˆÓ 2865
- ıÂÚ·›· Ù‡Ô˘ 1 2398
- ıÂÚ·›· ¯Ú‹ÛË Ù¯ÓËÙ‹˜ ÓÔËÌÔÛ‡Ó˘ 2894
- ÈÛÙÔÏÔÁÈΤ˜ ·ÏÏÔÈÒÛÂȘ 49, 129, 557
- ÈÛÙÔÚ›· 84, 219, 1716, 1717, 2046, 2699, 2962,
3628, 3679, 3565
- ÈÛÙÔÚ›·, μ˘˙·ÓÙÈÓÔ› ¯ÚfiÓÔÈ 3202
- Î·È ¿ÏϘ ÔÚÌfiÓ˜ 85, 878, 964, 1504, 1521,
1557, 1813, 1842, 1881, 1898, 1906, 3177
- Î·È ¿ÔÈÔ˜-Û˘Ó‡·ÚÍË 913
- Î·È ÈÔ› 145
- ηډȿ 207, 509, 568, 594, 640, 719, 855, 862,
911, 954, 1103, 1138, 1357, 1361, 1432, 1499,
1570, 1586, 1595, 1596, 1673, 1809, 1844, 2095,
2096, 2115, 2153, 2241, 2256, 2409, 2424, 2534,
2536, 2539, 2541, 2587, 2615, 2618, 2732, 2847,
291, 2952, 3093, 3161
- ηډÈÔÌ˘Ô¿ıÂÈ· 2393, 2691, 2619, 2829, 2842,
3538
- ηÚΛÓÔ˜ 557
- ηÚΛӈ̷ 2466
- ηْ Ô›ÎÔÓ 742, 743, 1556, 3415
- ηٿıÏÈ„Ë 3064, 3151, 3573
- ÎÂÓÙÚÈÎfi Ó¢ÚÈÎfi Û‡ÛÙËÌ· 1559
- ΛӉ˘ÓÔÈ 177, 2722, 2725, 2039
- ÎÈÓËÙÈÎfiÙËÙ· ·ÚıÚÒÛÂˆÓ 2173, 2783, 2798
- ÎÏËÚÔÓÔÌÈÎfiÙËÙ· 248, 1384, 1385, 2215, 3035
- ÎÔÈÓˆÓÈÎfi Úfi‚ÏËÌ· 747, 2738, 2739, 2743
- ÎÔÚÙÈÎÔÂȉ‹ 2446, 3010
60
- ·ËÛË 61, 108, 141, 492, 507, 563, 595, 642, 752,
801, 2068, 827, 853, 1321, 1502, 1542 , 1549, 1826,
2097, 2515, 2667, 2670, 2672, 2683, 2711, 2730,
2733, 2991, 3011, 3038, 3055, 3109, 3128, 3142,
3050, 3535, 3601
- ·ËÛË ‰È·‚ËÙÈ΋-ÓÂÔÁÓfi 2752, 2757, 3306
- Ï·Óı¿ÓˆÓ ·˘ÙÔ¿ÓÔÛÔ˜ 3351
- ÏÈÔ·ÙÚÔÊÈÎfi˜ 144
- ÏÔÈÌÒ‰Ë 531, 845, 874, 1492, 1807, 1823, 2784,
2785
- ÏÔÈÌÒÍÂȘ 2689, 2784, 2785, 2957, 2996, 3021,
3069, 3234
- ÏÔÈÌÒÍÂȘ ÙÚ·¯ËÏÔÚÔÛˆÈ΋˜ ¯ÒÚ·˜ 1543,
1876, 1886, 1887
- Ì·ÁÓ‹ÛÈÔ 761, 1396, 1455, 2604
- Ì ÌÂÙ·ÌfiÛ¯Â˘ÛË 625, 1488, 2706
- ̤ÏÏÔÓ 2962
- ÌÂÛÔÁÂȷ΋ ·Ó·ÈÌ›· 2878
- ÌÂÙ·ÏÏ·Á‹ ¯ÚfiÓÔ˘ 2912
- ÌÂÙ·ÌfiÛ¯Â˘ÛË ÓÂÊÚÒÓ 447
- ÌÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ·ÙÔ‰ˆ‰Âη‰·ÎÙ˘ÏÈ΋
501, 612, 613, 614, 615, 619, 620, 623, 624, 1262,
1266, 1488, 3027
- ªËÙÚÒÔ ÂÏÏËÓÈÎÒÓ ‚È‚ÏÈÔÁÚ·ÊÈÒÓ 1433, 1954,
2156
- ÌÈÎÚԂȷ΋ ¯ÏˆÚ›‰· 1869, 1874, 2331
- ÌÔÓÔˆÔÁÂÓ›˜ ‰›‰˘ÌÔÈ 2669
- ÌÔ˘ÎÔÚ̇ΈÛË 2662, 2956, 2965, 3031, 3487
- Ó·ÓÈÎfi˜ 57, 104
- ÓÂÔÁÓÈÎfi˜ 1142
- ÓÂÔÁÓÈÎfi˜ ·ÚÔ‰ÈÎfi˜ 2737, 2398
- ÓÂfiÙÂÚ˜ ÂÍÂÏ›ÍÂȘ 62, 1841, 2414, 2599
- Ó¢ÚÔÏÔÁÈ΋ Î·È „˘¯È·ÙÚÈ΋ ¿Ô„Ë 58, 489
- ÓÂÊÚÔ‡ ÏÂÈÙÔ˘ÚÁ›· 1409, 1599, 2305, 2318
- ÓÔÛËÏ›· 2434, 3051, 3052, 3054, 3056, 3058,
3059, 3060, 3067, 3071, 3072, 3090, 3095, 3096,
3101, 3103, 3107, 3111, 3114, 3115, 3117, 3119,
3121, 3124, 3125, 3126, 3132, 3133,3134, 3136,
3139, 3140, 3141, 3143, 3144, 3497
- ÓÔÛËÏ›· ̤ۈ ‰È·‰ÈÎÙ‡Ô˘ 3094, 3266, 3445
- ÔÈÎÔÁÂÓÂȷ΋ ·ÓÙ·fiÎÚÈÛË 3331, 3415, 3425,
3446, 3415, 3506
- ÔÚÌÔÓÈ΋ ˘ÔηٿÛÙ·Û˘ 1842, 2446, 2964,
3022, 3177
- ÔÛÙÂÔÌ˘ÂÏ›Ùȉ· 2734, 2788
- Ô‡ÏˆÓ 885
- Ô˘ÚÈÎfi Ô͇ 168, 252, 261, 2384
- ÔʤÏË 177
- ÔÊı·ÏÌfi˜ 59, 74, 493, 566, 1868, 1885, 2712,
2714, 2735, 3043
- ·ÁÎÚ·ÙÈÎfi˜ 96
- ·ÁÎÚ·ٛÙȉ· 2756, 3044
- ·ıÔÁ¤ÓÂÈ· 50, 1384, 1385, 1446, 1479, 1602,
1604, 1802, 1892, 2954, 2983
- ·ıÔÏÔÁÈ΋ ·Ó·ÙÔÌÈ΋ 49, 129, 557, 1873
- ·È‰ÈÎfi˜ 57, 482, 484, 487, 564, 966, 966, 1897,
1989, 2074, 2930, 2932
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
- ·È‰ÈÎfi˜ Ù‡Ô˘ 1 1936
- ·È‰ÈÎfi˜ Ù‡Ô˘ 2 2687, 3008, 3604
- ·ÚˆÙ›Ùȉ· 190, 1474, 1543, 3490, 3547
- ÂÈı·Ú¯›· 299, 1865
- ÂÈÚ·Ì·ÙÈÎfi˜ 350, 543, 544, 726, 1309, 2150,
2152, 3042
- ÂÙÈÎfi 2573, 2629, 2881
- Ï·ÎÔ‡ÓÙÔ˜ ÏÂÈÙÔ˘ÚÁ›· 1406, 1867
- Ó¢ÌÔÓÔ¿ıÂÈ· 2759, 3241
- ÔÈfiÙËÙ· ˙ˆ‹˜ 2140, 2377, 2441, 2743, 2792,
2929, 3064, 3165, 3573
- ÔÛÔÙÈΤ˜ ÌÂÙÚ‹ÛÂȘ 3367
- ÚÈÓ Î·È ÌÂÙ¿ ÙÔÓ fiÏÂÌÔ 3484
- ÚfiÁÓˆÛË 76
- Úԉȷ‚‹Ù˘ 73, 1897, 2677
- ÚfiÏË„Ë 126, 904, 1410, 1506, 2028, 2110, 2069,
2419, 2508, 2576, 2721, 2955, 2987, 3009, 3099,
3114, 3285
- ÚÒÈ̘ ÂÈÙÒÛÂȘ 1410
- ÚˆÙÔ‚¿ıÌÈÔ˜ ÊÚÔÓÙ›‰· ˘Á›·˜ 2418, 2873
- ƒ·Ì·˙¿ÓÈ 1848
- ÛÂÍÔ˘·ÏÈ΋ ·ÓÈηÓfiÙËÙ· 2275, 2578, 2729,
2995, 3015, 3066, 3584
- Û‹ÌÂÚÔÓ 48, 1841
- ÛÈ·ÏÈÎfi Ô͇ Ï¿ÛÌ·ÙÔ˜ 1950
- ÛÔÚ‚›Ù˘ 146
- Û˘ÌÙÒÌ·Ù· 203, 553, 832, 3555
- Û˘ÓıÂÙ¿ÛË 2886
- Ù·ÍÈÓfiÌËÛË 175, 832, 909
- ˘¤ÚÙ·ÛË 224, 225, 351, 504, 576, 630, 667,
1139, 1287, 1457, 1482, 1523, 1569, 1798, 1812,
2589, 2678, 2694, 2697, 2726, 2744, 2821, 2945,
2998, 2999, 3081
- ˘¤ÚÙ·ÛË Î·È Â›Î˘„Ë 2622
- ˘ÂÚÙÔÓ›· 1267, 1294
- Ê¿Ú̷η 2569
- Ê·ÚÌ·ÎÔÎÈÓËÙÈ΋ 1794
- ÊÏÂÁÌÔÓ‹ 3238, 3274
- ÊÚÔ˘ÎÙfi˙Ë 146
- Ê˘Ì·Ù›ˆÛË 800, 910, 1875
- Ê˘ÛÈΤ˜ ‰˘Ó¿ÌÂȘ 3244
- Ê˘ÛÈ΋ ηٿÛÙ·ÛË Î·È Ú‡ıÌÈÛË 1134, 2441,
3244
- ʈÛÊ·ÙÔ˘ÚÈÎfi˜ 858
- ¯ÂÈÚÔ˘ÚÁÈ΋ ·Ó·ÈÛıËÛ›· 925, 2800
- ¯ËÌÈÎfi˜ 149
- ¯ÔÏÔÏÈı›·ÛË 231, 2913, 3491
- „˘¯ÔÎÔÈÓˆÓÈΤ˜ Û˘Óı‹Î˜ 2857, 2858, 2866,
2870
- „˘¯ÔÏÔÁÈ΋ ˘ÔÛÙ‹ÚÈÍË 354, 362, 489, 1360,
1403, 2438, 2857, 2858, 2866, 2870, 2917, 2918,
2919, 2923, 2924, 3057, 3058, 3118, 3130, 3165,
3197
- LADA 1852, 3344, 3351, 3547
- MODY 3346, 3550, 3604
¢È·‚ËÙÈ΋ ‰›·ÈÙ· 217, 253, 313, 407, 495, 497, 561,
569, 636, 663, 665, 669, 675, 731, 843, 877, 1368,
1373, 1534, 1796, 1853, 1854, 1855, 1856, 1890,
2565, 2583, 2838, 2860, 2867, 3047, 3100, 3122
- ÚˆÙ½Ó˘ Î·È ÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›· 886, 1853
- ·fi computer 497
¢È·‚ËÙÈ΋ ¤ÁÎ˘Ô˜ 492, 507, 642, 1826, 3167, 3168,
3170
¢È·‚ËÙÈ΋ Ì·ÛÙÔ¿ıÂÈ· 3600
¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· 155, 156, 641, 714, 727,
1480, 1500, 1808, 1934, 2231, 2263, 2298, 2305,
2498, 2499, 2787, 2789, 2793, 2875, 2951, 2972,
2998, 2999, 3026, 3032, 3092, 3720
- ·ÚıÚÔ¿ıÂÈ· 704, 918, 1351, 1519, 2783, 2798,
3176
¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· 3584
¢È·‚ËÙÈÎfi ÁÏ·‡ÎˆÌ· 3577
¢È·‚ËÙÈÎfi ÎÒÌ· 55, 82, 139, 514, 717, 1370, 1555,
2868
- ÛÙ· ·È‰È¿ 82
¢È·‚ËÙÈÎfi fi‰È 400, 409, 410, 733, 755, 874, 1491,
1554, 1961, 1962, 1963, 1964, 1965, 1966, 1967,
1968, 1969, 1970, 1971, 1972, 1973, 1974, 2035,
2347, 2348, 2421, 2444, 2448, 2459, 2463, 2470,
2471, 2475, 2477, 2492, 2519, 2638, 2656, 2702,
2704, 2707, 2750, 2771, 2774, 2777, 2793, 2796,
2797, 2798, 2803, 2804, 2815, 2904, 3013, 3014,
3123, 3135, 3330, 3591, 3707, 3713, 3723
- ÂÎ·›‰Â˘ÛË 2802, 2977
- ÂȉËÌÈÔÏÔÁ›· 2775
- ÂÊ˂›· 2701
- ÈÛÙÔÚ›· 2774
- ÎfiÛÙÔ˜ ıÂÚ·›·˜ 2963
- ÏÔÈÌÒÍÂȘ 874, 1797, 2080, 2352, 2643, 2654,
2707, 3065
- ÔÈÎÔÓÔÌÈΤ˜ ‰È·ÛÙ¿ÛÂȘ 1974, 2631
- ÔÚıÔ‰È΋ ÂÎÙ›ÌËÛË 1973, 2229
- ·ıÔÊ˘ÛÈÔÏÔÁ›· 2776
- ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 750, 2263, 2298, 2333,
2353
- Ô‰ÔÏfiÁÔ˜ 2801
- ÚfiÏË„Ë 3067
- ÛËÙÈÎfi 2936, 3206, 3449
- Ù·ÍÈÓfiÌËÛË 2794, 2795
- ˘ÂÚ‚·ÚÈ΋ ıÂÚ·›· 2656
- ˘¤Ú‚·ÛË 2812
- Ê·ÈÓ˘ÙÔ˝ÓË 2552, 2553
¢È·‚ËÙÈÎfi ¯¤ÚÈ 3524
¢È·‚ËÙÈÎÔ› ˘ÂÚ‹ÏÈΘ 184, 2571
¢È·‚ËÙÈÎÔ› ‰›‰˘ÌÔÈ 3549
¢È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜
- ¿ÛÎËÛË 2004, 2119, 2120
- È·ÙÚÈ΋ ÊÚÔÓÙ›‰· 2002, 2117, 2125, 2382
¢È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜ ÛÙÔ ¯ÂÈÚÔ˘ÚÁÂ›Ô 70, 147, 170,
325, 567, 718, 735, 1366, 2382, 2420, 2620,
2647,2651, 2676, 2682, 2853, 290, 3138
- ÌÂÙÂÁ¯ÂÈÚËÙÈ΋ ÔÚ›· 2597, 2598, 2679
¢È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜ ÛÙËÓ ÂÚÁ·Û›· ÙÔ˘ 456, 843, 2861
¢È·‚ËÙÔÁfiÓ˜ Ô˘Û›Â˜ 44
61
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¢È·‚ËÙÔÏÔÁÈΤ˜ ªÔÓ¿‰Â˜-∫¤ÓÙÚ· 758
¢È¿ÁÓˆÛË 51, 1939
¢È·ÁÓˆÛÙÈΤ˜ ÎÏÈÓÈΤ˜ ‰ÔÎÈ̷ۛ˜ Ó¢ÚÔ¿ıÂÈ·˜
205, 1489, 1490, 1515, 1891
¢È·‰ÂÚÌ·ÙÈÎfi˜ ηıÂÙËÚÈ·ÛÌfi˜ ·ÁÎÚ·ÙÈÎÒÓ ÊÏ‚ÒÓ 804
¢È·‰ÂÚÌÈ΋ Ô͢ÌÂÙÚ›· 3590
¢È·‰›ÎÙ˘Ô ÁÈ· ™¢ 3622
¢È·˙ÔÍ›‰Ë-˘ÔÁÏ˘Î·ÈÌ›· 121, 1173, 1179, 1215, 123
¢›·ÈÙ· 2213
- ·‰˘Ó·Ù›ÛÌ·ÙÔ˜ 2146
- ‰È·Ù‹ÚËÛ˘ ÚˆÙÂ˚ÓÒÓ 3558
- ÚˆÙÂ˚ÓÈ΋ 3558
- ˘ÔıÂÚÌȉÈ΋ 3558
- Zone 3558
¢›·ÈÙ· Î·È ‰fiÛÂȘ ÈÓÛÔ˘Ï›Ó˘ 110, 2489, 2504, 2505,
3366
- ·ıËڈ̿وÛË 739, 1649
- ¿ÚÙÔ˜ 386
- ‚Ô‡Ù˘ÚÔ 306
- ‰È·‚ËÙÈÎÒÓ 217
- ÂÏ·ÈfiÏ·‰Ô 386, 669, 675
- ˙¿¯·ÚË 174, 705
- ËÏȤϷÈÔ 669
- ηÚfiÙ· 676
- Ï·¯·ÓÈο 675
- Ï›Ô˜ 2584
- ÏÔ˘ÎÔ‡ÌÈ· 665
- ̷ηÚfiÓÈ· 706
- ̤ÏÈ 407
- ÌÂÛÔÁÂȷ΋ 218, 2134, 2481, 2565, 3282, 3716
- ÓÙÔÌ¿Ù˜ 753
- ÔÏÈÁÔıÂÚÌȉÈ΋ 434
- ·ÛÙ¤ÏÈ 296
- ÂÈı·Ú¯›· 295, 306, 636
- ÚˆÙ½Ó˜ 811, 1534
- Û·Ï¿ÌÈ 306
- ÛÔ˘Û¿ÌÈ 663, 671
- ˘¤ÚÙ·ÛË ÛÙ· ·È‰È¿ 481
- computer 497
¢È¿ÚÚÔÈ· 3584
¢È·Ì·ÚÙ›· ‰È¿Ï·Û˘ 3352
¢È·Ù·Ú·¯¤˜ ÏÈÔÚˆÙÂ˚ÓÒÓ ÛÙÔÓ ™¢ 3615
¢È·ÙÚÔÊ‹ 201, 216, 399, 626, 636, 1204, 1373, 1581,
2532, 2593, 2594, 2686, 2838, 2860, 2867,2874,
2922, 3224, 3251, 3258, 3259, 3311, 3313,
- ÂÁ·Ԣ 2897
- Â·Ó¿ÏË„Ë 626
- ÂÈÏÔΤ˜ 1649, 2230
- ÌÂÛÔÁÂȷ΋ 3264, 3311, 3716
- Ô‰ËÁfi˜ 3722
- ÛËÌ·Û›· ÙÔ˘ ÙÚfiÔ˘ Ì·ÁÂÈڤ̷ÙÔ˜ 749, 2191
- ˘ÂÚËÏ›ÎˆÓ 1133
¢ÈÁÔ˘·Ó›‰Â˜ 3564
¢ÈÁÔ˘·Ó›‰È· Î·È Á·Ï·ÎÙÈ΋ ÔͤˆÛË 98, 196, 210,
211, 256, 423, 1399, 2234
- ·ÔÚÚfiÊËÛË 347, 349, 350, 1684
62
- ¿ÛÎËÛË 210, 211
- ÁÏ˘Îfi˙Ë 210, 211, 648, 709
- ÌÂÁ·ÏÔ‚Ï·ÛÙÈ΋ ·Ó·ÈÌ›· 3381
¢È¤ÁÂÚÛË ¿ÍÔÓ· ÀÔı·Ï¿ÌÔ˘-ÀfiÊ˘ÛË-∂ÈÓÂÊÚ›‰È· 3618
¢ÈË·ÙÈÎfi˜ ηıÂÙËÚÈ·ÛÌfi˜ ÊÏ‚ÒÓ 804
¢ÈÔ˘ÚËÙÈο 3613
- Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi˙˘ 570, 1650
¢›ψ̷ Ô‰ËÁÔ‡ Ô¯ËÌ¿ÙˆÓ 361, 629
¢È۷ί·Úȉ¿Û˜ 348, 1180
¢È۷ί·ÚÈÙÒÓ ‰˘Û·ÔÚÚfiÊËÛË 118, 350
¢ÈÛÏÈȉ·ÈÌ›·-ıÂÚ·›· 2019, 2087, 2822, 2823
¢ÈʈÛÊÔÚÔÁÏ˘ÎÂÚÈÓÈÎfi Ô͇ 519, 583
¢ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘ 4, 375, 744, 1456, 1824,
2826, 3545, 3546, 3551
- ÎfiˆÛ˘ 911, 3537
¢ÔÎÈÌ·Û›· Ô͢ÙÔΛÓ˘ 3601
¢ÔÎÈÌ·Û›· Ratschow 3590
¢˘Û·ÓÂÍ›· Á¿Ï·ÎÙÔ˜ 119
¢˘Û·ÔÚÚfiÊËÛË ÁÏ˘Îfi˙˘-Á·Ï·ÎÙfi˙˘ 122
¢˘ÛÎÔÈÏÈfiÙËÙ· 3584
¢˘ÛÏÈȉ·ÈÌ›· 1139, 1494, 1495, 1496
∂ÁÎÂÊ·ÏÈ΋ ÌÔ˘ÎÔÚ̇ΈÛË 3609
∂ÁÎÂÊ¿ÏÔ˘ ‰È·Ù·Ú·¯¤˜ 3372
∂ÁÎÂÊ·ÏÈο ÂÂÈÛfi‰È· 632, 1878, 2233
∂ÁÎÂÊ·ÏÈÎfi Ô›‰ËÌ· 3574
∂ÁÎÂÊ·ÏÔÓˆÙÈ·›Ô ˘ÁÚfi Î·È ÁÏ˘Îfi˙Ë 99
∂Á΢ÌÔÛ‡ÓË Î·È ÂÈÏÔΤ˜ 438, 492, 507, 1502
- ÁÏ˘ÎÔ˙Ô˘Ú›· 728
∂Á¯ÂÈÚ‹ÛÂȘ Î·È ‰È·‚‹Ù˘ 170, 1366, 3607
∂ıÓÈÎfi ¢›ÎÙ˘Ô ÀÁ›·˜ 3519
EıÓÈÎfi ∫¤ÓÙÚÔ ¢È·‚‹ÙË 870
∂ÎÎÚÈÌ·Ù›ÓË 527
∂Î·›‰Â˘ÛË ·˘ÙÔÚ‡ıÌÈÛ˘ 466, 2109, 3622
∂Î·›‰Â˘ÛË ‰È·‚ËÙÈÎÒÓ 2117, 2546, 2665
∂Î·›‰Â˘ÛË ÓÔÛÔÎfiÌˆÓ 480
∂ÎÛÂÚÌ¿ÙÈÛ˘ ·Ó·ÛÙÚÔÊ‹ 1135, 1584
∂Ï·ÈfiÏ·‰Ô Î·È ‰›·ÈÙ· 386, 669, 675
∂ÏÈÎÔ‚·ÎÙËÚ›‰ÈÔ pylori Î·È ™¢ 1836, 2488, 3395
ŒÏÎË Ô‰ÒÓ 755, 1416, 1591, 2102, 2103, 2116, 2144,
2193, 2248, 2250, 2253,2288, 2356, 2483, 2805,
2806, 2807, 2808, 2809, 2810, 2811, 2813, 2814
- ·ÂÚÔ‚È΋ ıÂÚ·›· 2286
- ·ÓÙÈÔÍÂȉˆÙÈο 2368
- Â›ÁÔ˘Û· ıÂÚ·›· 2359, 2367
- ÂԇψÛË 2314, 3225, 3335
- ıÂÚ·›· 2091, 2094, 2100, 2101, 2104, 2105,
2239, 2242, 2257, 2264, 2265, 2267, 2269, 2273,
2274, 2285, 2287, 2295, 2296, 2302, 2306, 2308,
2314, 2355, 2365, 2367, 2369, 2373
- ÌÈÎÚÔ΢ÎÏÔÊÔÚ›· 2251, 2254, 2272, 2277, 2280,
2281, 2284, 2290, 2291, 2293, 2294, 2297, 2303,
2310, 2327, 2328, 2332, 2354, 2443, 3501
- ÌÔۯ‡̷ٷ ‰ÂÚÌ·ÙÈο 2295
- ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 2333
- ÚfiÏË„Ë 2090, 2238, 2240, 2267, 2274, 2288,
2292, 2302
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
- ÚÔÔÙÈ΋ 2343, 2346, 2347, 2348, 2349, 2350,
2351, 2357, 2358, 2370, 2374
- ˘·ÈÛıËÛ›· 2905
- ÊÏÂÁÌÔÓ¤˜ 2352
- ¯ÂÈÚÔ˘ÚÁÈ΋ ıÂÚ·›· 2364
ŒÏÏÂÈ„Ë ·ÓÙ›Ï˄˘ ˘ÔÁÏ˘Î·ÈÌ›·˜ 3571, 3575
∂Ì‚ÔÏÈÛÌfi˜ 3527
ŒÌ‚Ú˘Ô Î·È ÔÚÌfiÓ˜ 100
∂ÌÌËÓfi·˘ÛË Î·È ÔÛÙÈ΋ Ì¿˙· 1882, 3516, 3531
ŒÌÊÈÛË ÈÓÛÔ˘Ï›Ó˘ 3605
ŒÌÊÚ·ÁÌ· Ì˘Ôηډ›Ô˘ 226, 237, 286, 954, 1481,
2053, 2526, 2527, 2528, 2529, 2530, 2531
- ıÓËÛÈÌfiÙËÙ· 3257, 3481
- ıÚÔÌ‚fiÏ˘ÛË 3364
ŒÌÊÚ·ÁÌ· Ì˘fi˜ 3593
∂ÌʇÛËÌ· ˘Ô‰fiÚÈÔ 871
∂Ó‰ÔÁ·ÛÙÚ›ÓË 1199
∂Ó‰ÔıËÏ›ÓË 468, 1597, 1672, 1715, 3185, 3187, 3308,
3316, 3410, 3413, 3584
- Ô‡ÚˆÓ 3448
∂Ó‰ÔıËÏ›ˆÓ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· 2137, 2187, 2289, 2296,
2315, 2320, 2323, 3156, 3358
∂Ó‰Ôηӷ‚ȉÔÂȉ‹ 3562
∂Ó‰ÔÎÚÈÓÔÏÔÁÈΤ˜ ‰È·Ù·Ú·¯¤˜ Â› ·¯˘Û·ÚΛ·˜ 151,
1504
- ÂÊ˂›· 1906
- ·È‰È¿ 160, 1916
- ÙÚ›ÙË ËÏÈΛ· 732
∂Ó‰ÔÌËÙÚ›Ô˘ ˘ÂÚÏ·Û›· ·‰Âӈ̷Ù҉˘ ·‰ÂÓÔ΢ÛÙÈ΋ 872,
- ηÚΛÓÔ˜ 3040
∂Ó‰ÔÌÈÙÔ¯ÔÓ‰Úȷο ÎÔÎΛ· 851
∂Ó‰ÔÏ·ÛÌ·ÙÈÎfi ‰›ÎÙ˘Ô Ë·ÙÔ΢ÙÙ¿ÚˆÓ Î·È ÁÏ˘Îfi˙Ë 591, 851
- ÈÓÛÔ˘Ï›ÓË 591
∂Ó‰ÔÚÔı¤ÛÂȘ (stents) 3588
∂Ó‰ÔÛÙÔÌ·ÙÈΤ˜ ÏÔÈÌÒÍÂȘ 3620
ŒÓ˙˘Ì· ·ÓÙÈÔÍÂȉˆÙÈο 1567
∂ÓÙÂÚÈΤ˜ ÔÚÌfiÓ˜ 643, 1165, 1181, 1184
ŒÓÙÂÚÔ ÏÂÙfi Î·È ·ÏÎÔfiÏË 214
- ‰ÈÁÔ˘·Ó›‰È· 347, 349, 350
∂ÓÙÂÚÔ˚Ô› 3547
EÓÙÂÚÔ·ÁÎÚ·ÙÈÎfi˜ ¿ÍˆÓ 1353
∂ÓÙÂÚÔ¿ıÂÈ· ÁÏÔ˘Ù¤Ó˘ Î·È Úԉȷ‚ËÙÈÎÔ› ‰Â›ÎÙ˜
795
∂Í¿ÓıËÌ· ‰ÂÚÌ·ÙÈÎfi 3386
∂ÍÂÓ·Ù›‰Ë 3564
∂ÍȉÚÒÌ·Ù· 3577
∂ÍÔ˙·Ì›ÓË 3586
∂͈ÎÚÈÓ‹˜ ÌÔ›Ú· ·ÁÎÚ¤·ÙÔ˜ Î·È ‰È·‚‹Ù˘ 551,
643, 1872
- ÌÂÙ·ÌfiÛ¯Â˘ÛË 611, 623, 1522
∂ÍˆÎ˘ÙÙ¿ÚÈ· Ô˘Û›· 1081, 1082, 1088, 1089
- ˘ԉԯ›˜ 1089
∂͈ۈ̷ÙÈ΋ ΢ÎÏÔÊÔÚ›· 3608
∂¿ÁÁÂÏÌ· Î·È ‰È·‚‹Ù˘ 1526, 2861
∂·Ó·ÈÌ¿ÙˆÛË Ì˘Ôηډ›Ô˘ 3588
∂ȉËÌÈÔÏÔÁ›· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 3552
- ‰Â›ÎÙ˘ Ì¿˙·˜ ÛÒÌ·ÙÔ˜ 13, 607, 772, 1941, 3500
- ÂȉÈ΋ ıÓËÛÈÌfiÙËÙ· 12, 14, 17, 19
- ÂȉÈ΋ ÓÔÛËÚfiÙËÙ· 12, 1431, 1432, 1994
- ÂÈ‚›ˆÛË 3424
- ÂÈÔÏ·ÛÌfi˜ (prevalence) 15, 16, 18, 142, 164,
165, 166, 167, 184, 191, 240, 241, 244, 372, 373,
379, 380, 382, 396, 397, 416, 417, 555, 605, 606,
1387, 1829, 1914, 1915, 1940, 1957, 1958, 1959,
1994, 2223, 2570, 3102, 3169, 3204, 3310
- Âԯȷ΋ ηٷÓÔÌ‹ 633, 1458
- ËÏÈΛ· 633
- ηٷӿψÛË ÙÂ˚Ô˘ Î·È ÂÈÔÏ·ÛÌfi˜ 2910
- ηʤ 3237
- ÌÂ ¢∞° (OGTT)4
- ·Ú·ÁfiÓÙˆÓ ÎÈÓ‰‡ÓÔ˘ 3365
- ·¯˘Û·ÚΛ· 3233, 3500
- ÚÈÓ Î·È ÌÂÙ¿ ÙÔÓ fiÏÂÌÔ 3484
- ÛÂ ·ÁÚÔÙÈÎfi ÏËı˘ÛÌfi 3300
- Û ·¯˘Û¿ÚÎÔ˘˜ Ì ¢∞° (OGTT) 4, 2820
- Û ٤ÎÓ· ‰È·‚ËÙÈÎÒÓ ÁÔÓ¤ˆÓ 4, 1544
- Û˘¯ÓfiÙËÙ· (incidence) 356, 363, 396, 535, 631,
1458, 1465, 1544, 1718, 1829, 1921
- Ù‡Ô˘ 1 278, 3604
- Ù‡Ô˘ 1 ÛÙËÓ ∫Ú‹ÙË 3379
- Ù‡Ô˘ 1 ÛÙËÓ ∫‡ÚÔ 3456
- ÊÔÈÙËÙ¤˜ È·ÙÚÈ΋˜ 3233
Eȉȉ˘Ì›Ùȉ· 1960
∂ÈÎÔÈÓˆÓ›· È·ÙÚÔ‡-·ÚÚÒÛÙÔ˘ 257, 258, 782, 2125
∂ÈÓÂÊÚ›‰È· 265
∂ÈÂÊ˘ÎÒ˜ - ‰¿ÎÚ˘· 3360
∂ÈÏÔΤ˜ 558, 560, 575, 598, 628, 737, 1143, 1803,
1946
- ·ÎÚˆÙËÚÈ·ÛÌÔ› 1431
- ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 74, 270, 271, 272, 279,
324, 392, 394, 737, 830, 873, 942, 943, 944, 946,
947, 949, 950, 1386, 1464, 3513, 3514, 1397
- ·˘ÙfiÓÔÌÔ˜ Ó¢ÚÔ¿ıÂÈ· 509, 639, 756, 1112,
1122, 1398, 1401, 1419, 1595, 1596, 1670, 1671,
1680, 1681, 1682, 1683, 1827, 1891, 1947
- ‰È·ÙÚÔÊ‹ 1649
- ‰˘ÛÏÈȉ·È̛˜ 500, 506, 1098, 1099, 1117, 1126,
1495, 1815
- ÂÁ΢ÌÔÛ‡ÓË 438, 507, 642, 1502
- ÂȉËÌÈÔÏÔÁ›· 717, 1555, 1576, 1577, 1578
- Â›Â‰Ô Ú‡ıÌÈÛ˘ 254
- Î·È Î¿ÓÈÛÌ· 462, 635
- ηډȷÁÁÂȷο ÂÂÈÛfi‰È· 125, 169, 437, 640,
659, 818, 1107, 1432
- Ó¢ÚÔÏÔÁÈΤ˜ 106, 169, 321, 330, 331, 360, 391,
398, 496, 503, 522, 638, 756, 1095, 1101, 1114,
1137, 1513, 1514, 1527, 1605, 1827, 1945
- ÓÂÊÚÈΤ˜ 67, 71, 75, 77, 78, 123, 124, 155, 156,
294, 300, 301, 302, 303, 304, 305, 422, 461, 598,
641, 788, 789, 810, 1081, 1092, 1386, 1409, 1599,
1833, 1834, 944
- ÔÈÎÔÓÔÌÈ΋ Î·È ÎÔÈÓˆÓÈ΋ ηٿÛÙ·ÛË 637
63
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
- ÔÊı·ÏÌfi˜ 59, 384, 385, 393, 493, 806, 939, 1487
- ÂÙÈÎÔ‡ 1805
- ÚÔˆÚfiÙËÙ·˜ 880
- Ú‡ıÌÈÛË 575, 1121, 2109
- Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜ 1503, 1520
- ÛÙ˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· 1806
∂ÈÔÏ·ÛÌfi˜ ™¢ 3552, 3553
∂›ÙÔÎÔ˜ ÛÙÔ ¯ÂÈÚÔ˘ÚÁÂ›Ô 925
∂Ò‰˘Ó· Û‡Ó‰ÚÔÌ· 2079
∂ÚÁÔÙ·Ì›ÓË 851, 869, 1317
∂ÚÂÈÛÙÈÎfi Û‡ÛÙËÌ· 812, 1605, 2883, 3516
∂Ú˘ıÚÔÔÈËÙ›ÓË 1411, 2524, 3317, 3468
EÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Û˘ÁÎfiÏÏËÛË 754
- ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 1190
- ·Ú·ÌfiÚʈÛË Î·È ·ÁÁÂÈÔ¿ıÂÈ· 1205, 1255
∂Ú˘Û›ÂÏ·˜ 532
∂˘ÁÏ˘Î·ÈÌÈÎfi˜ ˘ÂÚÈÓÛÔ˘ÏÈÓÈÎfi˜ ·ÔÎÏÂÈÛÌfi˜ 2024
∏ÏÂÎÙÚÔηډÈÔÁÚ·ÊÈΤ˜ ·ÏÏÔÈÒÛÂȘ 799, 1595,
1596, 3161
∏ÏÂÎÙÚÔÏ˘ÙÒÓ ‰È·Ù·Ú·¯¤˜ 334, 550, 1900
- ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ 1899
∏ÏÂÎÙÚÔÊfiÚËÛË ÏÈÔÚˆÙÂ˚ÓÒÓ 608
∏ÏÈΛ· ¤Ó·Ú͢ ™¢ Ù‡Ô˘ 1 2038
∏ÏÈΛ· ÙÚ›ÙË -ÂÓ‰ÔÎÚÈÓ›˜ 732
∏ÌÈÏËÁ›· Î·È ˘ÔÁÏ˘Î·ÈÌ›· 707
◊·Ú Î·È ·ÏÎÔfiÏË 214, 2180, 2181, 2065
- ÏÈ҉˜ 1850, 2180, 2181, 2065
- C-peptide 2227
∏·ÙÈ΋ ÁÏ˘ÎÔÁÔÓ›·ÛË 3594
∏·ÙÈ΋ ÏÂÈÙÔ˘ÚÁ›· 378, 526, 547, 571, 783
∏·ÙÈ΋ ÓfiÛÔ˜ Î·È ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë 831
∏·ÙÈÎÒÓ Î˘ÙÙ¿ÚˆÓ ÌÂÙ·ÌfiÛ¯Â˘ÛË 617, 621, 622,
624
- ·Ó¿Ù˘ÍË 852
- ‚ÈÔÛ‡ÓıÂÛË 852, 867, 869
- ‰È·ÊÔÚÔÔ›ËÛË 852
∏·Ù›Ùȉ· 3596, 3609
- ·ÓÔ¯‹ ÁÏ˘Îfi˙˘ 181, 182, 684, 1100
∏·Ù›Ùȉ· C 1799
∏·Ù›Ùȉ· μ 3298, 3443
∏·Ù›Ùȉ· - ÁÎÏÈÎÏ·˙›‰Ë 2968
∏·Ù›Ùȉ· ¯ÚfiÓÈ· 3525
◊·ÙÔ˜ ηÚΛÓÔ˜ 3432, 3596
- Î·È ˘ÔÁÏ˘Î·ÈÌ›· 794
◊·ÙÔ˜ ÓfiÛÔÈ 547, 571, 748, 1100, 1799, 1849, 2227,
2334
∏·ÙÔÛÙ¿وÛË 3595
£·Ï·Û·ÈÌ›· 3443, 3305
£ÂÈ·˙›‰Â˜ Î·È ™¢ 44, 1322, 3039
£ÂÈ·˙Ô‰ÈÏÈÓ‰ÈfiÓ˜ 2316, 2429, 2588, 2986, 2989,
3194, 3215, 3564, 3599
£ÂÈÔÌÂÓÙ¿ÏË 653, 654
£ÂÔÊ˘ÏÏ›ÓË-ÁÏԢηÁfiÓÔ 783
£ÂÚÌȉÈΤ˜ ·Ó¿ÁΘ 3559
£ËÏ·ÛÌfi˜ 1951, 2884
£ÓËÛÈÌfiÙËÙ· 125, 243
- ÎÔÈÓˆÓÈΤ˜ Î·È ÔÈÎÔÓÔÌÈΤ˜ ·Ú¿ÌÂÙÚÔÈ 14
64
- ÂÚÈÁÂÓÓËÙÈ΋ 1328
£ÚÔÌ‚ÔÌÔ‰Ô˘ÏÈÓË 2006
£ÚÔÌ‚ÔÍ¿ÓË 2124, 2128
£ÚÔÌ‚Ô¿ıÂÈ· 1396
£ÚÔÌ‚ÔÛÊ·ÈÚ›ÓË-‚ 859
£ÚÔÌ‚ÔÊÈÏÈ΋ ‰È¿ıÂÛË 3586
£ÚfiÌ‚ˆÛË 444
£˘ÚÂÔÂȉÂÎÙÔÌ‹ 649
£˘ÚÂÔÂȉ‹˜ 2236
£˘ÚÂÔÂȉÈΤ˜ ÔÚÌfiÓ˜
- ˘ԉԯ›˜ ÈÓÛÔ˘Ï›Ó˘ 1413, 916
£˘ÚÂÔÂȉ›Ùȉ· ·˘ÙÔ¿ÓÔÛË 3312, 3447, 3483, 2395
£˘ÚÂÔÙÚÔÊ›ÓË 1109
£˘ÚÔÍ›ÓË 20, 1661, 1662, 1663, 1664, 1666, 1668,
2495
π·ÙÚÈΤ˜ ∂Ù·ÈÚ›˜ ÁÈ· ™¢ 3622
π·ÙÚÈ΋ ÊÚÔÓÙȉ· 2002, 2125
π‰ÈÔ·ı‹˜ ÔÌÊÔχÁˆÛË 3585
ÿÎÙÂÚÔ˜ Î·È ÁÏ˘Îfi˙Ë 579
ÿÓ˜ Ê˘ÙÈΤ˜ 740, 3557
πÓÎÚÂÙ›Ó˜ 2439, 2510, 2511, 3624, 3564
πÓÎÚÂÙ›Ó˘ Ê·ÈÓfiÌÂÓÔ 1401, 2061, 2071, 2391, 3201,
3631
πÓÎÚÂÙÈÓÔÌÈÌËÙÈο 2138, 3674
IÓÔ‚Ï·ÛÙÒÓ ·˘ÍËÙÈÎfi˜ ·Ú¿ÁˆÓ 1597
πÓÛÔ˘Ï›ÓË 1400, 3542, 3543, 3562, 3684
- Aspart 3566
- Detemir 2390, 3566
- Glargine 2390, 2768, 3566
- Glulysine 3566
- IGTT 1448
- Lispro 1452, 1151, 1153, 3566
- ·ÏηÏÈ΋ ʈÛÊ·Ù¿ÛË 113
- ·ÏÎÔfiÏË 215, 681, 683, 700, 1199
- ·ÏÏÂÚÁ›· 143, 194, 2060, 2660
- ·ÌÓÈ·ÎÔ‡ ˘ÁÚÔ‡ 697, 784
- ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 1861
- ·Ó·Î¿Ï˘„Ë 453, 780
- ·Ó·ÏÁËÙÈ΋ ‰Ú¿ÛË 815
- ·Ó¿ÏÔÁ· 352, 3645
- ·ÓıÚÒÈÓË 266, 463, 723, 2057, 2423, 2877
- ·ÓÙ·ÁˆÓÈÛÙ¤˜ 66, 282, 414, 424, 1440, 1650
- ·ÓÙÈ·ıËڈ̷ÙÈΤ˜ ‰Ú¿ÛÂȘ 3646
- ·ÓÙ›ÛÙ·ÛË 282, 414, 424, 764, 897, 1139, 1391,
1440, 1460, 1477, 1493, 1547, 2011, 2108, 2112,
2062, 2456, 2524, 2554, 2557, 2557, 2836, 2837,
2844, 2850, 2979, 3219, 3521, 3522, 3528, 3676,
3677, 3548, 3551, 3586, 3602, 3605, 3612, 3686
- ·ÓÙÈÛÒÌ·Ù· 1425, 1909, 3149, 3571
- ·ÓÙϛ˜ 1286, 2073, 2212, 2389, 2864, 3502,
3567, 3635, 3638
- ·ÓÙϛ˜ Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜ 3604
- ·ÔÚÚfiÊËÛË 111, 674, 1128, 1600, 1601, 3571
- ·ÚˆÌ·Ù¿ÛË 1402
- ¿ÛÎËÛË 964, 3639
- ‚-blockers 790
- ‚ÈÔÛ˘ÓıÂÙÈ΋ 38, 39, 40, 289, 647, 648, 998
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
- ‚ÈÔ¯ËÌÈΤ˜ ÌÂÙ·‚ÔϤ˜ ηٿ ÙËÓ ıÂÚ·›· ‰È·‚ËÙÈÎÒÓ ÎˆÌ¿ÙˆÓ 68
- ÁÂÓÂÙÈΤ˜ ‚Ï¿‚˜ 423, 433
- ‰›·ÈÙ· Î·È ‰fiÛÂȘ 110, 1640, 1642, 1643, 2770,
3418, 3421
- ‰È·Î˘Ì¿ÓÛÂȘ Î·È C ÂÙ›‰ÈÔ 5, 21, 1127, 1149,
1156, 1178, 1182, 1193, 1199, 1872
- ‰ÈÛΛ· 2007
- ‰Ú¿ÛË 97, 413, 549, 655, 1118, 1207, 1213, 1253,
1445, 1449, 1640, 1642, 1643, 1719, 1720, 1721,
1722,1723, 1724, 1725, 1726, 1727, 1728, 1729,
1730, 1731, 1732, 1733, 1734, 1735, 1736, 1737,
1738, 1739,1740, 1741, 1742, 1743, 1744, 1745,
1746, 1747, 1748, 1749, 1750, 1751, 1752, 1753,
1754, 1755, 1756, 1757, 1758, 1759, 1760, 1761,
1762, 1763, 1764, 1765, 1766, 1767, 1768, 1769,
1770, 1771, 1772, 1773, 1774, 1775, 1776, 1777,
1778, 1779, 1780, 1781, 1782, 1783, 1784, 1785,
1786, 1787, 1788, 1789, 1790, 3006, 3007, 3267,
3634
- ÂÈÛÓÂÔ̤ÓË 2157, 2387, 2388, 2403, 2685, 3675
- ¤ÎÎÚÈÛË 1221, 1225, 1236, 1238, 1242, 1251,
1256, 1268, 1273, 1279, 1289, 1291, 1292, 1306,
1536, 1824, 3629
- ¤ÎÎÚÈÛË ·ÏÌÈ΋ 3548
- ¤ÎÎÚÈÛË Û ÎÈÚÚˆÙÈÎÔ‡˜ ·ÛıÂÓ›˜: 1, 696, 748
- ¤ÎÎÚÈÛË Ê¿ÛÂȘ 3548
- ¤Ì‚Ú˘Ô 697, 784
- ÂÓ‰ÂÁÎÂÊ·ÏÔÎÔÈÏȷ΋ ¯ÔÚ‹ÁËÛË 590
- ÂӉ›ÍÂȘ 3253
- ÂÓ‰ÔÏ·ÛÌ·ÙÈÎfi ‰›ÎÙ˘Ô Ë·ÙÔ΢ÙÙ¿ÚˆÓ 591,
1341
- ÂÓ˙˘ÌÈ΋ ‰Ú¿ÛË 556
- ÂÓÙ·ÙÈ΋ ıÂÚ·›· 741, 767, 2832, 2854, 2855,
2856, 3159, 3495, 3496, 3507, 3508, 3567, 3568
- Â͈·ÁÎÚ·ÙÈΤ˜ ÔÚÌfiÓ˜ 1220
- Â›ÁÔ˘Û· ¯Ú‹ÛË 148, 2070
- Â›‰· ÂÌ‚Ú‡Ô˘ 1329
- Â›‰· Î·È Î›ÚÚˆÛË ‹·ÙÔ˜ 1, 696, 748
- Â›‰· ÌÂÙ¿ ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë Î·È ·ÙÚÔ›ÓË 700
- Â›‰· ÌÂÙ¿ ÁÏÈÈ˙›‰Ë 2, 1141, 1451
- Â›‰· ÌÂÙ¿ ÁÏ˘Îfi˙Ë 1, 643, 649, 724, 1454
- Â›‰· ÛÙÔ ∂¡À 651
- ¢·ÈÛıËÙÔÔÈÔ› 2851, 2852, 2906, 3371
- Âʉڛ· 2494
- ËÏÂÎÙÚÔηډÈÔÁÚ·ÊÈΤ˜ ÌÂÙ·‚ÔϤ˜ 722, 799
- ËÏÂÎÙÚÔχÙ˜ 1894, 1895, 1899, 1900, 2906
- ËÏÈΛ· 1445, 1824
- ËÏÈΛ· ¤Ó·Ú͢ 1857
- ıÂÚ·›· 3, 68, 283, 355, 358, 513, 767, 1118,
1354, 1857, 2500, 2513, 2657, 2684, 3418, 3421,
3604, 3605, 3607
- ıÂÚ·›· „˘¯Ô·ıÒÓ Î·Ù¿ Sakel 68, 1315
- ı˘ÚÂÔÂȉÈΤ˜ ÔÚÌfiÓ˜ 1413, 2451
- ηډȿ 3641
- ·ËÛË 697, 784, 1924, 2009
- ΢ÙÙ·ÚÔΛÓ˜ 1420, 2158
- ÏÂ˘Î¿ ·ÈÌÔÛÊ·›ÚÈ· 197, 1662, 1909, 2496
- Ï¢ΛÓË 730
- Ï¢¯·È̛˜ 542
- ÏÈ·Ú¿ Ôͤ· 1449
- Ì·ÁÓ‹ÛÈÔ 761
- ÌÂÙ·‚ÔÏÈÛÌfi˜ ÏÈȉ›ˆÓ 3614
- ̤ÙÚËÛË 645
- ÌÈÎÚ¤˜ ‰fiÛÂȘ 150, 358
- ÌÔÚȷ΋ Û‡ÓıÂÛË 968, 969, 970, 971, 972, 973,
974, 975, 976, 977, 978, 979, 980, 981, 982, 983,
984, 985, 986, 987, 988, 989, 990, 991, 992, 993,
994, 995, 996, 997, 999, 1000, 1001, 1002, 1003,
1004, 1005, 1006, 1007, 1008, 1009, 1010, 1011,
1012, 1013, 1014, 1015, 1016, 1017, 1018, 1019,
1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027,
1028, 1029, 1030, 1031, 1032, 1033, 1034, 1035,
1036, 1037, 1038, 1039, 1040, 1041, 1042, 1043,
1044, 1045, 1046, 1047, 1048, 1049, 1050, 1051,
1052, 1053, 1054, 1055, 1056, 1057, 1058, 1059,
1060, 1061, 1062, 1063, 1064, 1065, 1066, 1067,
1068, 1069, 1070, 1071, 1072, 1073, 1074, 1075,
1076, 1077, 1078, 1206, 1222, 1258, 1298, 1719
- ÓÂÊÚ¿ 3642
- ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ· Î·È C ÂÙ›‰ÈÔ 21, 1125,
1127
- ÔÚÌfiÓ˜ 85, 680, 681, 682, 838, 964, 1413, 1871
- ÂÚÈÙfiÓ·ÈÔ 1249
- Ï¿ÛÌ·ÙÔ˜ 3546
- ÚÔÛÙ·ÁÏ·‰›Ó˜ 345
- ÛÔ˘ÏÊÔÓ˘ÏÔ˘Ú›Â˜ 713, 727, 1141, 1451, 2007,
- ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ 770, 1499, 1844, 2415
- Û‡ÁÎÚÈÛË Ì ¯Ô›ÚÈÔ 1206, 1339, 1347, 1888
- Û‡ÛÙËÌ· ¤Á¯˘Û˘ 3222
- Û‡ÛÙËÌ· Ú‡ıÌÈÛ˘ 3223
- ÙÔÈ΋ ÂÊ·ÚÌÔÁ‹ 538
- ÙÚfiÔÈ «È‰Â·ÙÔ›» 1510
- ˘ԉԯ›˜ 351, 1413, 3154
- Ê·ÚÌ·ÎÔÎÈÓËÙÈ΋ 413, 3566
πÓÛÔ˘ÏÈÓÈÎfi Ô›‰ËÌ· 3569
πÓÛÔ˘ÏÈÓÈÎfi˜ ·ÔÎÏÂÈÛÌfi˜ 2024
πÓÛÔ˘ÏÈÓÔ·ÓÙÔ¯‹ 1477, 1898, 2979
- Î·È ÌÔÓfiÓÂÊÚÔÈ 1902
πÓÛÔ˘ÏÈÓÔ¢·ÈÛıËÛ›· 3633, 3687, 3691
πÓÛÔ˘ÏÈÓÔıÂÚ·›· 3526, 3632, 3637, 3639, 3640,
3671, 3566, 3607, 3716
- ·ËÛË 3603
- Û˘Ó‰˘·Ṳ̂ÓË 3644
πÓÛÔ˘ÏÈÓÔÁ¤ÓÂÛ˘ ‰Â›ÎÙ˘ 340, 1463
πÓÛÔ˘Ï›ÓˆÌ· 441, 765, 804, 805, 1145, 1163, 1212,
1247, 1535, 1537, 1557, 3527
- ‰È¿ÁÓˆÛË 804, 805, 1332, 1462
- ıÂÚ·›· 805, 1462, 1541
πÓÙÂÁÎÚ›Ó˜ 1089, 1092, 3529
πÓÙÂÚÏ¢ΛÓË 1‚ 774, 1608, 1638, 1701, 2859, 2336,
3417
πÓÙÂÚÊÂÚfiÓË 3323
πÓÙÂÚÊÂÚfiÓË · 3572
65
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
πÓˆ‰ÔÁfiÓÔ Ï¿ÛÌ·ÙÔ˜ 256, 371, 600, 762, 1563, 1835,
1837, 1938, 2379, 2380, 2406
πÓˆ‰fiÏ˘ÛË 2109, 3188, 3510
- Î·È ÈÓÛÔ˘Ï›ÓË 1904, 1905
ÿÓˆÛË Î˘ÛÙÈ΋ 3421, 3437
πÔ› Î·È ‰È·‚‹Ù˘ 145, 1896
πÔ› Rota 3547
πÔÓÙÔÊfiÚËÛË ÓÈÙÚÔÚˆÛÛÈÎÔ‡ ¡a 2317
πfi˜ Epstein-Barr 3547
πÔÎÚ¿ÙË ı¿Ó·ÙÔ˜ 2034
πÛÔ‰‡Ó·Ì· ÙÚÔÊÒÓ 3556
πÛÙÔÏÔÁÈΤ˜ ·ÏÏÔÈÒÛÂȘ 65, 78
πÛÙÔÛ˘Ì‚·ÙfiÙËÙ·˜ Û‡ÛÙËÌ· 221, 233, 234, 235, 236,
846, 902, 960, 1427, 1634, 1635, 1636, 1702, 1703,
1704, 1705, 1707, 1708, 1709, 1712, 1713, 1714,
2218, 3034, 3362, 3388, 3396, 3438
πÛ¯·ÈÌ›· ÛȈËÏ‹ 459, 3584
πÛ¯·ÈÌÈ΋ ÌÔÓÔÌÂÏ‹˜ Ó¢ÚÔ¿ıÂÈ· 3581
πÛ¯·ÈÌÈÎfi Ì˘ÔοډÈÔ 3608
πÛ¯·ÈÌÈÎfi˜ fiÓÔ˜ 3591
π¯ÓÔÛÙÔȯ›· 310
πÒÛÂȘ 3547
∫·Ï›Ô˘ ÌÂÙ·‚ÔÏÈÛÌfi˜ 3471
∫¿ÏÔ˜ (Ù‡ÏÔ˜) 1575
∫·ÏÙÛÈÙÔÓ›ÓË 687, 1408
- Â›‰Ú·ÛË ÛÙËÓ ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë 1348
∫·ÏÛÈÙÔӛӈ̷ 1538
∫¿ÓÈÛÌ· 3619
- ÂÈÏÔΤ˜ 462, 2066, 2581
- Î·È HbA1c 326
∫·ÙÔÚ›ÏË 887
∫·Ú‰È¿ Î·È ‰È·‚‹Ù˘ 207, 335, 568, 659, 1138, 1361,
1152, 1809, 1844, 2174, 2183, 2523, 3157, 3190,
3704, 3191, 3226, 3273, 3275, 3280, 3226, 3286,
3289, 3302, 3307, 3328
- ¿ÛÎËÛË 1357, 2772
- ÁÏԢηÁfiÓÔ 821
- ΛӉ˘ÓÔ˜ 2772
∫·Ú‰È·Î‹ ·ÓÂ¿ÚÎÂÈ· 1995, 2040, 2135, 2153, 3668,
3564
- Î·È ÏÈ›‰È· 2153
- Î·È Hb1c 2153
∫·Ú‰ÈÔ·Ó·Ó¢ÛÙÈ΋ ÈηÓfiÙËÙ· ™¢ Ù‡Ô˘ 2 3539
∫·Ú‰ÈÔÁÚ·ÊÈο Â˘Ú‹Ì·Ù· 241, 659, 799, 816, 1570,
2183, 3302
∫·Ú‰ÈÔÏÔÁÈ΋ ÌÔÓ¿‰· 2167
∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜ 3684
∫·Ú‰ÈÔÌ˘Ô¿ıÂÈ· 3068, 3087, 3147
∫·Ú‰ÈÔÏËÁ›· 3147
∫·Ú‰ÈÔÓ¢ÌÔÓÈ΋ ·Ú¿Î·Ì„Ë 2124
∫·Ú‰ÈÔ¯ÂÈÚÔ˘ÚÁÈ΋ 3192, 3411
∫·ÚΛÓÔ˜
- ‹·ÙÔ˜ 3432
- ·ÁÎÚ¤·ÙÔ˜ 3469
- ÚÔÛÙ¿ÙÔ˘ 3354, 3401
∫·ÚÓÈÙ›ÓË 3168, 3332, 3350
∫·ÚˆÙ›‰· 3592, 3687, 3688
66
∫·ÚˆÙ›‰ˆÓ ¿¯˘ÓÛË 2016, 3399, 3404, 3409, 3410,
3451, 3457
∫·Ù¿ÁÌ·Ù· 2769, 3599
∫·Ù·ÁÚ·Ê‹˜ Û˘ÛÙ‹Ì·Ù·-DIABcard 3385, 3436, 3463
∫·Ù¿ıÏÈ„Ë 511, 2893, 3573, 3605
∫·Ù·ÚÚ¿ÎÙ˘ ÔÊı·ÏÌÈÎfi˜ 3578
- ÁÏ˘Îfi˙Ë ˘‰·ÙÔÂȉԇ˜ ˘ÁÚÔ‡ 7
∫·Ù¯ÔϷ̛Ә 23, 1676, 2901, 3608
∫·Ù¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ 2767
∫·Ê½ÓË 1199, 3572
∫ÂÙÔÓÈο ÛÒÌ·Ù· 1303, 3541
∫ÂÙÔͤˆÛË 2169, 2666, 2681, 2728, 2876, 2903, 3680,
3566, 3574, 3715
- ·ÈÌfiÏ˘ÛË 498
∫‹ÏË ÌÂÛÔÛÔÓ‰˘Ï›Ô˘ ‰›ÛÎÔ˘ 3290
∫ÈÓ¿Û˜ ÁÏ˘ÎÔÏ˘ÙÈΤ˜ 1307
∫ÈÓ¿ÛË C 2151, 2980, 3586
∫ÈÓ‰‡ÓÔ˘ ·Ú¿ÁÔÓÙ˜ 602
∫›ÚÚˆÛË ‹·ÙÔ˜ 3595
- Î·È ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ 1, 69, 696
∫ÈÙÔΛÓ˜ 3270
∫ÏÈÌ·ÎÙ‹ÚÈÔ 667, 670, 1813
∫ÏÔÓȉ›ÓË (·/2 ·ÁˆÓÈÛÙ‹˜) 3572, 3613
∫ÏÔÊÈÌÚ¿ÙË 672
∫ÓËÛÌfi˜ 3585
∫ÔÈÏÈÔοÎË 920, 1922, 2395, 3127
- ™¢ Ù‡Ô˘ 1 1324
∫ÔÈÓˆÓÈÎÔ-ÔÈÎÔÓÔÌÈ΋ ηٿÛÙ·ÛË Î·È ¢∞ 602, 637,
747, 3721
∫Ôη˝ÓË 3572
∫ÔÏÏ·ÁfiÓÔ
- Ù‡Ô˘ πππ 1116
- Ù‡Ô˘ πV 1079, 1083, 1091, 3193
∫ÔÏÈο ÂȯڛÛÌ·Ù· 848
∫ÔÏÈ΋ Ì·ÚÌ·Ú˘Á‹ 3592
∫ÔÏÈÎfi Ó·ÙÚÈÔ˘ÚËÙÈÎfi ÂÙ›‰ÈÔ 789
∫fiÏÔ˜ ·ÙÚÔÊÈÎfi˜ 848
∫fiˆÛ˘ ‰ÔÎÈÌ·Û›· 911
∫ÔÚÙÈ˙fiÏË 20, 24, 647, 847, 1657, 1658
- ÔÚÔ‡ 3618
∫ÔÛÙÔÏfiÁËÛË ÂÍÂÙ¿ÛÂˆÓ 246, 314
∫Ú›ÛÈÌË ÈÛ¯·ÈÌ›· 3590, 3591
∫Ú˘ÔËÍ›· 889, 938
∫‡ËÛË Î·È ‰È·‚‹Ù˘ 61, 108, 103, 141, 366, 375, 492,
507, 563, 595, 642, 752, 801, 827, 853, 1321, 1800,
1923, 1924, 1926, 2009, 2027, 3167, 3168, 3170,
3200, 3269, 3270, 3281, 3306, 3332, 3352, 3426,
3429, 3439, 3458, 3601
- ‰È·Ì·Úٛ˜ 3352
- Û˘¯ÓfiÙËÙ· 2762
∫‡ËÛË Î·È ÈÓÛÔ˘Ï›ÓË 2009
∫‡ËÛË Û ÚÔ¸¿Ú¯ÔÓÙ· ‰È·‚‹ÙË 3601
∫‡ËÛË ˘„ËÏÔ‡ ÎÈÓ‰‡ÓÔ˘ 376
∫˘ÎÏÔÎÚ˘ÔËÍ›· 938
∫˘ÎÏÔÛÔÚ›ÓË 620, 3572
∫˘ÛÙ·Ù›ÓË C 2896
∫˘ÛÙÈ΋ ›ÓˆÛË 3421, 3437
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∫˘ÙÔΛÓ˜ 3270, 3519
∫‡ÙÙ·Ú·
- APUD 1536
- ∞ 3542, 3630
- B 3542, 3692, 3703
- D 3542, 3630,
- pp 3542, 3630
∫˘ÙÙ·ÚÈ΋
- ÏÂÈÙÔ˘ÚÁ›· 2899
- ÚÔÛÎfiÏÏËÛË 1082, 1086, 1088, 1379
- Ú‡ıÌÈÛË p16 3221
∫˘ÙÙ·ÚÈÎfi˜ ÔÏÏ·Ï·ÛÈ·ÛÌfi˜ 3236
∫˘ÙÙ·ÚÔΛÓ˜ 415, 774, 1420, 2158, 2228, 3210, 3265
∫˘ÙÙ·ÚÔÌÂÁ·ÏÔ˚Ô› 3547
∫˘ÙÙfi¯ÚˆÌ· Ë·ÙÈÎfi 1380
∫ÒÌ· ‰È·‚ËÙÈÎfi 55, 105, 139, 559, 930, 1370, 1555,
2516, 2868, 3023
- Àª∫À∫ 342, 445, 451, 1371, 1555, 2570, 2213,
2516, 3023
∫ÒÌ· ˘ÔÁÏ˘Î·ÈÌÈÎfi 2939
- Û Ë·ÙÈ΋ Ì·Ù¿ÛÙ·ÛË 2033
∫ÒÌ·-ıÂÚ·›· „˘¯Ô·ıÒÓ 68
∫ÒʈÛË 1606
- ÛÙ· ·È‰È¿ 82
§·ÎÙfi˙˘ ‰ÔÎÈÌ·Û›· ·ÔÚÚfiÊËÛ˘ 119
§·ÌÈÓ›ÓË 291, 1083, 2131, 2872, 3261, 3518
§·Ú˘ÁÁfiÛ·ÛÌÔ˜ 3301
§·Û·ÚÙ¿ÓË 1984
§Âȯ‹Ó ÛÙÔÌ·ÙÈÎfi˜ 457, 3450
§ÈÔÚˆÙ½Ó˜ 3179, 3180
- ‰È·Ù·Ú·¯¤˜ ÛÙÔÓ ™¢ 3615
§ÂÙ›ÓË 751, 1564, 1901, 1903, 2433, 2579, 2898,
3387, 3429, 3562, 3563, 3599, 3700
- ·ÓÔÛÔηٷÛÙÔÏ‹ 1901
- ·ÓÙ›ÛÙ·ÛË 1475
- ·˘ÍËÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ 1903
- ÌÂÙ·ÁÂ˘Ì·ÙÈ΋ 1911
§ÂÙfi ¤ÓÙÂÚÔ
- ÌÂÙ·ÌfiÛ¯Â˘ÛË 614, 615, 624
- ¤„Ë Î·È ·Ô̇˙ËÛË 120
- ˘Ê‹ ‚ÏÂÓÓÔÁfiÓÔ˘ 822
§›Ô˜ ÛÒÌ·ÙÔ˜ 2863
§Â˘Î¿ ·ÈÌÔÛÊ·›ÚÈ· 197, 828, 1662
§Â‡ÎË 3585
§Â˘Î›ÓË 578, 685, 730, 1691
§Â‡ÎˆÌ· ·ÁÂÏ¿‰Ô˜ 3547
§Â˘ÎˆÌ·Ù›ÓË Ô‡ÚˆÓ 630, 835, 887, 915, 953, 1480,
1599, 1715, 1859, 1929, 1956
§Â˘ÎˆÌ·ÙÔ˘Ú›· 2127
§Â˘ÎˆÌ·ÙÔ˘Ú›·˜ ÚfiÏË„Ë Ì ∞-ª∂∞ 2151, 2207,
2209, 2210
§Â˘¯·ÈÌ›· Î·È ˘ԉԯ›˜ ÈÓÛÔ˘Ï›Ó˘ 542
§›ıÈÔ 3572
§È·Ú¿ Ôͤ· Î·È ·ÏÔı¿ÓË 6
- ÈÓÛÔ˘Ï›ÓË 837
- ™¢ 63, 109, 837, 1447, 1449
- ø̤Á· 281, 292
§È·ÚÒÓ ÙÚÔÊÒÓ Â›ÙˆÛË 658, 714
§È¿ÛË 1412, 3541, 3614, 3615
§È›‰È· 3614
- ·ÏÎÔfiÏË 215
- ·ÓÙÈ˘ÂÚÙ·ÛÈο 336
- ·¤ÎÎÚÈÛË ÏÂ˘ÎˆÌ·Ù›Ó˘ 1859
- ¿ÛÎËÛË 212
- ‰ÔÎÈÌ·Û›· ÊfiÚÙÈÛ˘ 1407
- ÂȉËÌÈÔÏÔÁ›· 772
- ηٷÓÔÌ‹ ηٿ ʇÏÔ 1548
- ÌÂÙ·‚ÔÏÈÛÌfi˜ 107, 193, 223, 288, 322, 444, 554,
600, 603, 607, 608, 609, 664, 667, 678, 698, 699,
701, 714, 729, 875, 934, 953, 955, 957, 965, 1139,
1157, 1202, 1418, 1529, 1584, 1843, 1877, 1912,
1913, 2132, 2087, 2122, 2425, 282, 2823, 3084, 3150
- ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ 777, 1548, 1573, 1844, 1928
- Ê˘ÙÈΤ˜ ›Ó˜ 1573
§ÈÔ·ÙÚÔÊ›· 3566
§ÈÔ·ÙÚÔÊÈÎfi˜ ‰È·‚‹Ù˘ 144
§ÈÔ‰˘ÛÙÚÔÊ›· 3467
§ÈÔÂȉÈ΋ ÓÂÎÚÔ‚›ˆÛË 3585
§ÈÔ·ÙÙ·Ú· 2982
§ÈÔ΢ÙÙ·ÚÔΛÓ˜ 3618
§ÈfiÏ˘ÛË 1208, 3606, 3689
§ÈÔۈ̿ÙÈ· Î·È ÙÔ˘ÌÔÎÔ˘Ú·Ú›ÓË 1612
- ¤Ó˙˘Ì· 1613
§ÈÔۈ̷ٛˆÓ ÊÔÚ›˜ 1612
- ˘ÔÁÏ˘Î·ÈÌÈ΋ ‰Ú¿ÛË 1610, 1611, 1612
§ÈÔÚˆÙ½Ó˜ 712, 905, 906, 1546, 1912, 2902
- ÌÂÙ·‚ÔÏÈÛÌfi˜ 3614
§ÈÔÙÔÍÈÎfiÙËÙ· 2457, 3548
§›Ô˘˜ ηٷÓÔÌ‹ 668, 708, 1479, 1871
§ÈÔ͢ÁÔÓ¿ÛË ·ÈÌÔÂÙ·Ï›ˆÓ 521
§ÈÔ¸ÂÚÙÚÔÊ›· 3659, 3566
§È҉˘ ‰È‹ıËÛË ·ÁÎÚ¤·ÙÔ˜ 2000
- ‹·ÙÔ˜ 2051, 3595
§È҉˜ ‹·Ú 3595, 3686
§È҉˘ ÈÛÙfi˜ 2493
§ÈÚ·ÁÏÔ˘Ù›‰Ë 3564
§ÈÛÈÓÔÚ›ÏË Î·È ·ÌÊÈ‚ËÛÙÚÔÂȉÔ¿ıÂÈ· 1464
§ÔÁÈÛÌÈÎfi ÁÈ· ™¢ 3622
§ÔÈÌÒ‰Ë ÓÔÛ‹Ì·Ù· 531, 845, 874, 923, 1130, 1131,
1823, 2029
§ÔÈÌÒÍÂȘ 959, 2036, 2080
- ÌÔ˘ÎÔÚ̇ΈÛË 2662, 2956, 2965, 3031, 3378,
3433
§ÔÈÌÒÍÂȘ ÙÚ·¯ËÏÔÚÔÛˆÈ΋˜ ¯ÒÚ·˜ 1543
§ÔÛ·ÚÙ¿ÓË
- ÎfiÛÙÔ˜ ·ÁˆÁ‹˜ 3216, 3488
§˘Ûfiۈ̷ 849, 851
ª·ÁÓ‹ÛÈÔ 761, 931, 1335, 1455, 3355
ª·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· 339, 603, 604, 710, 1982, 039,
2042, 2043, 2055, 2134, 2147, 2520, 2521, 2980,
3179
- ÂȉËÌÈÔÏÔÁ›· 2084
- ÚfiÏË„Ë 746
- ÚÒÈÌË ‰È¿ÁÓˆÛË 746
67
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ª·ÛÙÔ¿ıÂÈ· ÈÓ҉˘ ‰È·‚ËÙÈ΋ 2580
ª·ÛÙÔ·ÙÙ·Ú· Î·È ÂÚÈÔ‰ÔÓÙ›Ùȉ· 1870
ª·ÁÓËÛ›Ô˘ Â›‰· 524, 599, 1560
ª·ÁÓËÙÈ΋ ·ÁÁÂÈÔÁÚ·Ê›· 3590
ª·ÁÓËÙÈ΋ ÙÔÌÔÁÚ·Ê›· 3610
ªÂÁ·Ï·ÎÚ›· 1216, 3029
- Î·È ÁÏ˘Îfi˙Ë 227, 964
ªÂÁ·ÏÔ‚Ï·ÛÙÈ΋ ·Ó·ÈÌ›· 3536
ªÂıÂÈÔÓ›ÓË 3164
ªÂı˘ÏÔÓÈÎÔÙÈÓ·Ì›‰Ë 2313
ªÂÈÔÓÂÎÙÈ΋ ·ÓÔ¯‹ ÁÏ˘Îfi˙˘ 3545, 3605, 3685,
3692
ªÂÈÔÓÂÎÙÈ΋ ÁÏ˘Î·ÈÌ›· ÓËÛÙ›·˜ 3703
ªÂÈÔÓÂÎÙÈ΋ ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ 3602
ªÂÏ·Ó›˙Ô˘Û· ·Î¿ÓıˆÛË 3585
ªÂϤÙ˜ ÚfiÏ˄˘ ™¢ 3554
ªÂϤÙË
- BARI 3588
- CABRI 3588
- CARDS 3616
- CARE 3616
- DCCT 3576, 3577
- DIGAMI 3589
- EAST 3588
- EDIC 3576
- ENDIT 3604
- EURODIAB 3577, 3587
- FIELD 3616
- FREEDOM 3588
- HHS 3616
- HPS 3616
- RESEARCH 3588
- KUMAMOTO 3576
- LIPID 3616
- NIP 3604
- MRFIT 3616
- TRIGR 3604
- UGDP 3564
- UKPDS 3564
- PROACTIVE 3564
- RECORD 3564
- TNT 3616
- VEGF 3577
- 4S 3616
ª¤ÏÈ Î·È ‰›·ÈÙ· 407
ªÂÌ‚Ú¿Ó˜ Â·ÌÊÈ‚ÏËÛÙÚÔÂȉÈΤ˜ 1429
ªÂÌ‚Ú¿ÓË ‚·ÛÈ΋ 291, 1079, 1084, 1085, 1086, 1090,
1571, 1572
ªÂÍÈÏÂÙ›ÓË 360
ªÂÛ·ÁÁ›Ԣ ·ÙÙ·Ú· 1088, 1089, 1091
ªÂÛÔÁÂȷ΋ ·Ó·ÈÌ›· Î·È ™¢ 1593
ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ 368, 455, 1893, 2041, 2043,
2044, 2045, 2056, 2134, 2136, 2196, 2064, 2392,
2394, 2428, 2431, 2440, 2442, 2449, 2450, 2544,
2561, 2562, 2602, 2623, 2677, 2727, 2742, 2816,
2817, 3002, 3003, 3209, 3214, 3260, 3297, 3663,
3676, 3677, 3617, 3696
68
- ·ÏÎÔfiÏË 3212
- ËÏÂÎÙÚÔχÙ˜ 1899
- ·È‰È΋ ËÏÈΛ· 2162
- ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ 2161, 3494
ªÂÙ·‚ÔÏÈÎfi stress 3607
ªÂÙ·‚ÔÏÈÛÌfi˜
- ·ÏÏËÏÂ›‰Ú·ÛË ÙÚÔÊÒÓ 1478
- ‰È·Ù·Ú·¯¤˜ 95
- Â› ·¯˘Û·ÚΛ·˜ 151
ªÂÙ·‚ÔÏÈÛÌfi˜ Ê·ÚÌ¿ÎˆÓ 378
- ÚˆÙÂ˚ÓÒÓ 1590
ªÂÙ·ÁÂ˘Ì·ÙÈ΋ ˘ÂÚÁÏ˘Î·ÈÌ›· 656, 1495, 2012,
2827, 2984, 3665
- ΢ÎÏÔÊÔÚ›· 2453
- ˘ÂÚÏÈȉ·ÈÌ›· 1858, 3150, 3245, 3279, 3375
ªÂÙ·ÁˆÁ‹ Û‹Ì·ÙÔ˜ 1086
ªÂÙ·ÏÏ¿ÍÂȘ ÁÔÓȉ›Ô˘ ÈÓÛÔ˘Ï›Ó˘ 2422
ªÂÙ·ÏÏÔÚˆÙ¿Û˜ 1091
- ·Ó·ÛÙÔÏ›˜ 1091
ªÂÙ·ÏÏÔÚˆÙ½Ó˜ 3333
ªÂÙ·ÌfiÛ¯Â˘ÛË ÓËÛȉ›ˆÓ 43, 402, 483, 610, 611, 613,
614, 615, 616, 617, 618, 621, 622, 625, 763, 1685,
1686, 1687, 1688, 1689, 1690, 1691, 1692, 1693,
1694, 1695, 1696, 1706, 1925
- ÓÂÊÚÒÓ 860
- ·ÁÎÚ·ÙÔ‰ˆ‰Âη‰·ÎÙ˘ÏÈ΋ 501, 614, 615, 624
- ·ÁÎÚ¤ÙÔ˜ 612, 613, 614, 615, 619, 620, 623,
1488, 1795, 1828
ªÂÙÂÁ¯ÂÈÚËÙÈΤ˜ ÏÔÈÌÒÍÂȘ 3607
ªÂÙÔÚÔÏfiÏË 2204
MÂÙÚËÙ¤˜ ۷ί¿ÚÔ˘ 327, 1528
ªÂÙÊÔÚÌ›ÓË 1684, 2234, 2558, 2559, 2558, 2559,
2740, 2907, 3533, 3564
ªË ·ÏÎÔÔÏÈ΋ ÏÈ҉˘ ÓfiÛÔ˜ ‹·ÙÔ˜ 2180, 3595
ªËÙÚÒÔ ∂ÏÏ‹ÓˆÓ ™˘ÁÁڷʤˆÓ 1433, 1954, 2156
ªÈÁÏÈÙfiÏË 1155, 3498
ªÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· 370, 371, 401, 405, 443, 628,
721, 1081, 1382, 1791, 2611, 2624, 3171, 3576
ªÈÎÚÔ·Ï‚Ô˘ÌÈÓÔ˘Ú›· 1955, 3579
ªÈÎÚÔ·Ó¢ڇÛÌ·Ù· 3577
ªÈÎÚԂȷ΋ ¯ÏˆÚ›‰· 733
- ‰È·‚ËÙÈÎfi fi‰È 733
ªÈÎÚÔ‚ÈÔ˘Ú›· 1430, 1492
ªÈÎÚÔ΢ÎÏÔÊÔÚ›·˜ ·ÈÌÔ‰˘Ó·ÌÈ΋ 1394
ªÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›· 1715, 1984, 2026, 2142, 3579
ªÈÎÚÔÚˆÙÂ˚ÓÔ˘Ú›· 2123
ªÔÓÔ·ÎfiÚÂÛÙ· Ï›Ë 609
ªÔÓÔ·ÙÙ·Ú· 3518
ªÔÓÔ΢ÙÙ¿ÚˆÓ ˘ԉԯ›˜ 1662
- ‚ÈÛÊ·Ù›ÓË Δ¡º 3228
- ÌÂÙ·Ó¿ÛÙ¢ÛË 3193
ªÔÓfiÓÂÊÚÔ˜ Î·È Ó¿ÙÚÈÔ 1405
- ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·ÛË 1902
ªÔÓÔÍ›‰ÈÔ ÙÔ˘ ·˙ÒÙÔ˘ 3584
ªÔÓÔÍȉ›ÓË 1561, 3613
ªÔÓÔ‡ÚËÓ· Î·È ·ÛÎÔÚ‚ÈÎfi Ô͇ 228
ªÔÓÈÏ›·ÛË ÛÙÔÌ·ÙÈ΋ 420
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ªfiÚÈ· ÚÔÛÎfiÏÏËÛ˘ 3697
ªÔÛ¯Â˘Ì¿ÙÔ˜ ÂÈ‚›ˆÛË 1607
ªÂ˙·ÊÈÌÚ¿ÙË 3036
ªÂηÏÂÚÌ›ÓË 2491
ªÔÌÂÛ›ÓË 590, 3562
ªÔÈÓÙÔÏfiÏË 790
ª˘·ÙÚÔÊ›· 951
ª˘›·ÛȘ 2425
ª˘È΋ ¿ÛÎËÛË 2402, 3694
- ÌÂ ·ÓÙ›ÛÙ·ÛË 3697
ª˘ÈÎfi Û‡Ó‰ÚÔÌÔ
- ÎÏÔÊÈÌÚ¿ÙË 672
ª‡ÎËÙ˜ 3609
ª˘ÔηډÈÔ¿ıÂÈ· 935, 1988, 2054, 3068, 3087, 3147,
3277, 3668, 3589
ª˘Ôηډ›Ô˘ ¤ÌÊÚ·ÁÌ· 2526, 2527, 2528, 2529,
2530, 2531
ª˘Ôηډ›Ô˘ ›ÓˆÛË 3589
ª˘ÙÔ¯ÔÓ‰ÚȷΤ˜ ‚Ï¿‚˜ 3550
¡·ÙÈÁÏÈÓ›‰Ë 2791, 3213, 3564
¡¿ÙÚÈÔ Î·È ÌÔÓfiÓÂÊÚÔ˜ 1405
N·ÙÚÈÔ˘ÚËÙÈÎfi ÎÔÏÈÎfi 789
- ÂÙ›‰ÈÔ Î·È ª∂∞ 2887
¡¤ÎÚˆÛ˘ fiÁÎˆÓ ·Ú¿ÁˆÓ (Δ¡F) 1639, 2381
¡ÂÎÚˆÙÈ΋ ıËÏ›ÙȘ 123, 124
- ·ÔÓÂ˘ÚˆÛ›Ùȉ· 1562
- ΢ÙÙ·Ú›Ùȉ· 3609
- ÂÚÈÙÔÓ·˝Ùȉ· 1562, 3609
¡ÂÎÚˆÙÈ΋ ÂÚÈÙÔÓÈ›Ùȉ· 3609
¡ÂÔÁÓ¿ ‰È·‚ËÙÈÎÒÓ ÌËÙ¤ÚˆÓ 56, 103, 308, 565, 2757
- ·Ï‡ÛÂȘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ 775
- Î·È ÁÏ˘Î·ÁfiÓË 537, 548
¡ÂÔÁÓÈ΋ Ì·ÎÚÔۈ̛· 3601
¡ÂÔÁÓÔ‡ ˘ÔÁÏ˘Î·ÈÌ›· 64, 79
¡ÂÔÁÓÔ‡ ·Ó·Ó¢ÛÙÈÎfi Û‡Ó‰ÚÔÌÔ (RDS) 102
¡Â˘ÚÔ·Ó·ÏÁËÛ›·, ∂§O Î·È ÁÏ˘Îfi˙Ë 6
¡Â˘ÚÔÁÂÓ‹˜ ·ÓÔÚÂÍ›· 3604
¡Â˘ÚÔÁÂÓ‹˜ ‚Ô˘ÏÈÌ›· 3604
¡Â˘ÚÔÂÓ‰ÔÎÚÈÓÈÎÔ› fiÁÎÔÈ 1535, 1538
¡Â˘ÚÔÂÓ‰ÔÎÚÈÓÈÎÔ› fiÁÎÔÈ ·ÁÎÚ¤·ÙÔ˜ 797
- ‰È·ÁÓˆÛÙÈ΋ 1540
- ıÂÚ·›· 1541
¡Â˘ÚÔÏËÙ·Ó·ÏÁËÛ›· 1330
¡Â˘ÚÔ¿ıÂÈ· ∞¡™ 58, 3584, 3589, 3621
¡Â˘ÚÔ¿ıÂÈ· º¡™ 58, 205, 509, 574, 756, 779, 1340,
1558, 1588, 1918, 2059, 2079, 2088, 2114, 2116,
2188, 2518, 2539, 2625, 2644, 2646, 2690, 2749,
2755, 2825, 2888, 2889, 3209, 3275, 3368, 3402,
3454, 3484, 3720
- Á·ÛÙÚÈ΋ ΤӈÛË 779
- ‰È¿ÁÓˆÛË 2309, 2312, 2313, 2326, 2329, 2344,
2345, 2346, 2347, 2349, 2350, 2351, 2353, 2483,
2484, 2490, 2780
- ‰ÔÎÈ̷ۛ˜ 1566, 3220
- ÂÒ‰˘ÓÔ˜ 755, 756, 1674, 1675, 1676, 2079,
2371, 2560, 2779
- ¢·ÈÛıËÛ›· 2299, 2329
- ËÏÂÎÙÚÔχÙ˜ 2604
- ıÂÚ·›· 2517, 2994
- Ì¿˙· ÛÒÌ·ÙÔ˜ 3441
- ÌÈÎÚÔ΢ÎÔÊÔÚ›· 2270, 2281, 2284, 2290, 2291,
2297, 2303, 2309, 2322, 2327, 2328, 2332, 2360,
2361, 2362, 2363, 2366, 2372
- ÌÔÓÔ- Î·È ÔÏ˘Ó¢ÚÔ¿ıÂÈ· 58, 3083, 3336,
3427
- Ì˘˚΋ ·ÙÚÔÊ›· 2324, 2327
- ÔÙÈ΋ 1838
- Ô˘‰fi˜ ·ÓÙ›Ï˄˘ 230, 1527, 3485
- ·ıÔÁ¤ÓÂÈ· 2778, 3419
- ÂÚÈÊÂÚÈ΋ 238, 522, 756, 900, 929, 940, 941,
1579, 2116, 588, 1676, 1677, 1678, 2057, 2078,
2081, 2088, 2089, 2092, 2098, 2114, 2057, 2187,
2226, 2243, 2249, 2250, 2251, 2255, 2258, 2265,
2269, 2270, 2279, 2283, 2284, 2285, 2286, 2292,
2298, 2299, 2301, 2472, 2473, 2474, 2486, 2560,
2591, 2607, 2613, 2614, 2616, 2617, 2630, 2637,
2941, 2981, 2994, 3012, 3033, 3046, 3147, 3178,
2548, 3480
- ›ÂÛË 2259, 2260, 2261, 2262, 2263, 2268, 2271,
2276, 2278, 2282, 2292, 2300, 2307, 2335, 2342
- ˘·ÈÛıËÛ›· 2317, 2319
- ˘ÔÁÏ˘Î·ÈÌ›· 1670
- neuropad 3485
¡Â˘ÚÔ·ıËÙÈÎfi Ô›‰ËÌ· 3584
¡Â˘ÚÔ·ıËÙÈÎfi fi‰È 3584
¡Â˘ÚÔ·ıËÙÈÎfi˜ fiÓÔ˜ 3584, 3591
¡Â˘ÚÔÂÙ›‰ÈÔ X 3563
¡Â˘ÚÔÙÂÓÛ›ÓË 590
¡Â˘ÚÔÙÂÓۛӈ̷ 1538
¡Â‡ÚˆÓ ·ÁˆÁÈÌfiÙËÙ· 883, 2258
¡ÂÊÚÈΤ˜ ·ÏÏÔÈÒÛÂȘ 67, 261
- ·ÚÙËڛ˜ 3337
NÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ· 21, 77, 3621
¡ÂÊÚÈ΋ ÏÂÈÙÔ˘ÚÁ›· Î·È ª∂∞ 477, 2318
¡ÂÊÚÈÎfi˜ ‰È·‚‹Ù˘ 824
¡ÂÊÚÈÎfi˜ ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi˙˘ 3701
¡ÂÊÚ›ÓË 2150
¡ÂÊÚfiÁÚ·ÌÌ· 788
¡ÂÊÚÔ¿ıÂÈ· 2001, 2006, 2047, 2231, 2412, 2412,
2416, 2477, 2498, 2499, 2709, 2717, 2718, 2719,
2746, 2754, 2758, 3232, 3239, 3255, 3334, 3403,
3434
- ·ÁˆÁ‹ ˘¤ÚÙ·Û˘ 2003, 2208, 2211, 3377
¡ÂÊÚÔ¿ıÂÈ· Î·È ÛÈ·ÏÈÎfi Ô͇ 1565.2397
- ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›· 2416, 2680, 3286
- ÔÌÔ΢ÛÙ½ÓË 2190
- ÂÈÚ·Ì·ÙÈÎfi˜ ‰È·‚‹Ù˘ 2150, 2152
- ÛÎÈ·ÛÙÈο ‰È·Ï‡Ì·Ù· 2445
- Glut 3338
¡ÂÊÚˆÛÈÎfi Û‡Ó‰ÚÔÌÔ 78
¡ËÛ›‰È· ·ÁÎÚ·ÙÈο 129
¡ËÛȉȷÎÔ› ˘ԉԯ›˜ ‚ÈÙ·Ì›Ó˘ D 319
¡ËÛȉțÙȉ· 3542
¡ËÛȉ›ˆÓ ·ÚÁ˘ÚfiÊÈÏ· ·ÙÙ·Ú· 582
69
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
- ÌÂÙ·ÌfiÛ¯Â˘ÛË 610, 611, 613, 614, 615, 616, 617,
618, 621, 622, 625, 763, 1685, 1686, 1687, 1688,
1689, 1690, 1691, 1692, 1693, 1694, 1695, 1696,
1925
¡ËÛÙ›·˜ Ì˯·ÓÈÛÌÔ› 264
- ÔÚÌfiÓ˜ 695
¡ÈÎÔÙÈÓ·Ì›‰Ë 425, 2313
¡ÈÎÔÙÈÓÈÎfi Ô͇ 3572
¡ÈÙÚÈÎÒÓ ÔÍÂȉ›ˆÓ Û˘ÓıÂÙ¿ÛË 2947
¡ÈÙÚÔ˙·Ì›Ó˜ 3547
¡ÈʉÈ›ÓË Î·È ˘ÂÚÁÏ˘Î·ÈÌ›· 1471
¡ÔËÌÔÛ‡ÓË Ù¯ÓËÙ‹ 1403
¡ÔÌÔıÂÛ›· ÁÈ· ÊÚÔÓÙ›‰· ‰È·‚ËÙÈÎÒÓ 472
¡fiÛÔ˜ ÛÙÂÊ·ÓÈ·›ˆÓ ·ÚÙËÚÈÒÓ 3587
NfiÛÔ˜
- Dextrostix 1356
- Raynaud 3390
•·Óı›ÓË 1187
•ËÚÔÛÙÔÌ›· 3620
OÁÎÔÁ¤ÓÓËÛË ÛÙÔÌ·ÙÈ΋ 3208, 3242, 3243, 3249
ŸÁÎÔÈ Î·È ÁÏ˘ÎÔÁfiÓÔ 163
O‰‹ÁËÛË Ô¯ËÌ¿ÙˆÓ 361
O‰ÔÓÙÈ·ÙÚÈο ÚÔ‚Ï‹Ì·Ù· 1374, 2935, 2942, 2975,
3025, 3160, 3164, 3195, 3287
O‰fiÓÙˆÓ ÂÍ·ÁˆÁ¤˜ 276
O‰fi˜ ÂÍÔ˙·Ì›Ó˘ 3580
O›‰ËÌ· ıËÏ‹˜ 3359, 3382
O›‰ËÌ· ÈÓÛÔ˘ÏÈÓÈÎfi 3566
OÈÎÔÁÂÓ‹˜ Û˘Ó‰˘·Ṳ̂ÓË ˘ÂÚÏÈȉ·ÈÌ›· 3614
OÈÎÔÁÂÓ‹˜ ˘¯ÔÏËÛÙÂÚÔÏ·ÈÌ›· 3614
- ÚˆÙÔ·ı‹˜ ÌË ÔÈÎÔÁÂÓ‹˜ 3614
OÈÎÔÓÔÌÈ΋ ηٿÛÙ·ÛË ¢∞ 602
OÈÓfiÓÂ˘Ì· 3560, 3572
OÈÛÙÚÔÁfiÓ· 725, 1326, 3572
OÎÙÚÂÔÙ›‰ÈÔ 404, 612, 620, 623
OÏ·Ó˙·›ÓË 2728, 2970
OÌ¿‰Â˜ ·›Ì·ÙÔ˜ 607
OÌ·Ïfi˜ ÏÂȯ‹Ó·˜ 3620
OÌÔÈÔÛÙ·Û›· ÂÓ¤ÚÁÂÈ·˜ 3562
OÌÔ΢ÛÙ½ÓË 1990, 2001, 2006, 2133, 2190, 2199,
2430, 2435, 3164
OÍ›· ÈÛ¯·ÈÌ›· 3590
OÍÂȉˆÙÈÎfi stress 2049, 3304, 3579, 3694
OÍ›˜ ÂÈÏÔΤ˜-ÂȉËÌÈÔÏÔÁ›· 717, 1555, 1576,
1577, 1578
OÍÂÔ‚·ÛÈ΋ ÈÛÔÚÚÔ›· 268, 344, 559, 1555
OͤˆÛË ‰È·‚ËÙÈ΋ 930, 956, 958, 961, 1555, 1576,
1919, 2186
- ıÓËÛÈÌfiÙËÙ· 3393
- Î·È ¿ÏϘ ÔÚÌfiÓ˜ 1442
- Î·È Ê˘ÙÈΤ˜ ›Ó˜ 1524
- ÔÏ·Ó˙·›ÓË 2970
OͤˆÛË Î·È ÚÂÓ›ÓË 652
OÍηڂ·ÛÂ›ÓË 3231
O͢ÁfiÓÔ ˘ÂÚ‚·ÚÈÎfi 529
O͢ÁfiÓˆÛË ÈÛÙÈ΋ 528
O͢ÌÔÓÙÔ˘Ï›ÓË 3562
70
O͢ÛÙÂÚÈÓÔÂȉ‹ 1389
OÈÔÂȉ‹ 3562, 3572
OÙÈ΋ ·ÙÚÔÊ›· 1606
OÙÈ΋ ÙÔÌÔÁÚ·Ê›· Û˘ÓÔ¯‹˜ 3577
ŸÚ·Û˘ ÂͤÏÈÍË 419, 458, 627
OÚÂ͛Ә 3562
OÚıÔÚˆÎÙÈ΋ ÏÂÈÙÔ˘ÚÁ›· 3442
OÚıÔÛÙ·ÙÈ΋ ˘fiÙ·ÛË 3584
OÚÌfiÓ˜ Î·È ¤Ì‚Ú˘Ô 100
- ÂÓÙÂÚÈΤ˜ 643, 1165, 1228, 1229, 1233, 1237,
1240, 1257, 1263, 1275, 1293, 1536
- ÓËÛÙ›· 695
OÚÌfiÓ˜ ÙÔ˘ ʇÏÔ˘ 3572
OÚÌÔÓÔ¢·›ÛıËÙË ÏÈ¿ÛË 3614
OÛÙÂÔ·ÚıÚ›Ùȉ· 3597
OÛÙÂÔÌ˘ÂÏ›Ùȉ· 1998, 2023, 2734, 3152, 3293, 3342,
3609, 3610, 3611
OÛÙÂÔ¿ıÂÈ· Charcot 1094, 1096, 1320, 1344, 2636
OÛÙÂÔÂÓ›· 474, 485, 1310
OÛÙÂÔfiÚˆÛË 908, 926, 3597, 3599
OÛÙÈο ηٿÁÌ·Ù· 2760
OÛÙÈΤ˜ ·ÏÏÔÈÒÛÂȘ 825, 2688, 2745
OÛÙÈ΋˜ Ì¿˙·˜ ÚÔÛ‰ÈÔÚÈÛÌfi˜ 1381, 1882, 2550,
2663, 2708, 2883
OÛÙÒÓ ÌÂÙ·‚ÔÏÈÛÌfi˜ 323, 3626
O‡ÚËÛ˘ ‰È·Ù·Ú·¯¤˜ 2185
O˘ÚÈÎfi Ô͇ 168, 1337, 2384, 3476
O˘ÚÔ‰fi¯Ô˘ ·ÛÙˆ˜ ‰È·Ù·Ú·¯¤˜ 3309
O˘ÚÔÏÔÈÌÒÍÂȘ 3609
OÊı·ÏÌÈ΋ ˘ÂÚÙÔÓ›· 393
OÊı·ÏÌfi˜ 59, 74, 393, 566, 677, 914, 919, 922, 937,
3252, 3359, 3382, 3464, 3465
OÊı·ÏÌÔÏËÁ›· 2017
O¯ËÌ¿ÙˆÓ ‰›ψ̷ Ô‰‹ÁËÛ˘ 629
¶¿ÁÎÚ·˜ Î·È ·ÏÎÔfiÏË 214
- ÂÓ‰ÔÎÚÈÓÈ΋ ÏÂÈÙÔ˘ÚÁ›· 1574, 1917
- Ù¯ÓËÙfi 809, 864, 1080, 1248, 1252, 1254, 3546
¶·ÁÎÚ·ÙÈÎÔ‡ ‰È·‚‹ÙË ÌÔÚʤ˜ 94
¶·ÁÎÚ·ٛÙȉ· 348
- ÌÂÙÂÁ¯ÂÈÚËÙÈ΋ 612
¶·ÁÎÚ·ÙÔ˙˘Ì›ÓË 1167, 1170, 1187, 1209, 1210,
1214, 1217
¶·ÁÎÚ¤·ÙÔ˜ ·‰¤ÓˆÌ· 96, 823
- ·Ó·Á¤ÓÓËÛË 793
- ·ÓÂ¿ÚÎÂÈ· 1308
- ‚·ÛÈ΋ ¤ÎÎÚÈÛË 2037
- ÂÎÎÚÈÙÈ΋ Âʉڛ· 1992
- ÂÎÙÔÌ‹ 1288, 1522
- Â͈ÎÚÈÓ‹˜ ÌÔ›Ú· 192, 551, 643, 1211, 1246
- ηÚΛÓÔ˜ 3469
- ̤ÁÂıÔ˜ 3477
- ÌÂÙ·ÌfiÛ¯Â˘ÛË 1262, 1266, 1522, 1795, 3278,
3583
- Ó¢ÚÔÂÓ‰ÔÎÚÈÓÈÎfi˜ fiÁÎÔ˜ 797
- ÙÚ·‡Ì·Ù· 1879
¶·ıÔÁ¤ÓÂÈ· 50
¶·È‰È¿ Î·È ÂÓ‰ÔÎÚÈÓÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù· 160
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
¶·È‰ÈÎfi˜ ™¢ 57, 104, 249, 564, 3604
- Ù‡Ô˘ 1 2633, 2634, 3604, 3547
¶·È‰ÈÎÔ› Û·ÛÌÔ› 161
¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 437
¶·Ú¿ÁÔÓÙ˜ ‹Íˆ˜ 439, 461, 762, 953
¶·Ú¿ÁˆÓ von Willebrand 762, 1563, 1582
- Ó¤ÎÚˆÛ˘ fiÁÎÔ˘ (TNF) 1639
¶·Ú¿Ï˘ÛË ÚÔÛˆÈÎÔ‡ Ó. 2427
¶·Ú·ÔÍfiÓ·ÛË 1283
¶·ÚˆÙ›Ùȉ· Î·È ‰È·‚‹Ù˘ 190
¶·¯˘Û·ÚΛ· 2213, 3690
- ·Î¿ÓıˆÛË ÌÂÏ·Ó›˙Ô˘Û· 776, 3585
- ·Ó‰ÚÔÁÔÓ·ÈÌ›· 776, 1871, 2578
- ™¢ 490, 678, 1123, 1147, 1365, 1391, 1479, 1505,
1592, 1820, 2522, 2592, 2786, 2967, 2988, 3406,
3533, 3661
- Ê¿Ú̷η 3520
¶·¯˘Û·ÚΛ·˜ ‰È·Ù·Ú·¯¤˜ 151, 2061, 2063, 2076,
2077, 2522
- ıÂÚ·›· 716, 1821, 2175, 2184, 2574, 2997,
3019
¶ÂÈÚ·Ì·ÙÈ΋ ¯ÂÈÚÔ˘ÚÁÈ΋ 623
¶ÂÈÚ·Ì·ÙÈÎfi˜ ‰È·‚‹Ù˘ 543
¶ÂÓÙ·Ìȉ›ÓË 3572
¶ÂÓÙÔ‚·Ú‚ÈÙfiÏË ıÂÈÔ‡¯Ô˜ 826
¶ÂÓÙÔ˙Ô˘Ú›· 556
¶ÂÓÙÔÍÈÊ˘ÏÏ›ÓË 1198
¶¤Ô˘˜ Á¿ÁÁÚ·ÈÓ· 2978
¶ÂÙȉÈΤ˜ ÔÚÌfiÓ˜ 1536
¶ÂÙ›‰ÈÔ 1 (GLP-1) 1981, 2059, 3544, 3548, 3562,
3563
¶ÂÙ›‰ÈÔ-C 3546, 3548
¶ÂÙ›‰ÈÔ-C Î·È Â›‰· ÈÓÛÔ˘Ï›Ó˘ 5, 1149, 1153,
2052, 1158, 1159, 1164, 1241, 1243, 1244, 1280,
1852, 1872, 2057, 2460,
- Â͈ÎÚÈÓ‹˜ ÌÔ›Ú· 1872
¶ÂÙ›‰ÈÔ YY 3562
¶ÂÚÈ·ÚıÚ›ÙȘ ÒÌÔ˘ 255, 262, 263, 771, 3597
- ·Û‚ÂÛÙÔÔÈfi˜ 1395, 3475
¶ÂÚÈ‚·ÏÏÔÓÙÔÏÔÁÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ 381
¶ÂÚÈηډ›Ùȉ· Ê˘Ì·ÙÈ҉˘ 2164
¶ÂÚÈÔ‰ÔÓÙÈ΋ ÓfiÛÔ˜ 269, 277, 907, 963, 3621
- ıÂÚ·›· 273
- Ì·ÛÙÔ·ÙÙ·Ú· 1870
¶ÂÚÈÔÚÈṲ̂ÓË ÎÈÓËÙÈÎfiÙËÙ· ·ÚıÚÒÛÂˆÓ 3598
¶ÂÚÈÔ˘ÚËıÚÈÎfi˜ ÊϤÁÌˆÓ 3085
¶ÂÚÈÙÔÓ·˚΋ ‰È‡ÏÈÛË 156, 3428, 3430, 3444
¶ÂÚÈÙÔÓ·˚΋ οı·ÚÛË 3582
¶ÂÚÈÙÔÓÈ˝Ùȉ· ÓÂÎÚˆÙÈ΋ 1562
¶ÂÚÈÊÂÚÈ΋ ·ÔÊÚ·ÎÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ· 239
¶ÂÚȯÔÓ‰Ú›Ùȉ· 2937
¶ÂÚÔÓÈ·›Ô˘ Ó‡ÚÔ˘ ‚Ï¿‚Ë 3405
¶¤„Ș ıÚÂÙÈÎÒÓ Ô˘ÛÈÒÓ 120
¶ËÎÙÈÎfi˜ Ì˯·ÓÈÛÌfi˜ Î·È ·ÁÁÂÈÔ¿ıÂÈ· 604, 726,
953
¶‹Íˆ˜ ‰ÔÎÈÌ·Û›· 1331
¶‹ÍË ÂÓ‰Ô·ÁÁÂȷ΋ 861, 1333
¶ÈÓ‰ÔÏfiÏË 1231
¶ÈÔÁÏÈÙ·˙fiÓË 3240, 3530, 3564
¶Ï·ÎÔ‡ÓÙÔ˜ ‰È·‚·ÙfiÙ˘ 1390, 3200
¶Ó¢ÌÔÌÂÛÔÓ¢ÌfiÓÈÔ 185, 3574, 3627
¶Ó¢ÌÔÓ›· 3609
¶Ó¢ÌÔÓÈΤ˜ ·ı‹ÛÂȘ Î·È ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË Hb 760
2547, 3241, 3376, 3383, 3462
¶ÔÈÔÙÈΤ˜ ‰È·Ù·Ú·¯¤˜ ÛÙÔÓ ™¢ 3615
¶ÔÏÈÔÌ˘ÂÏ›ÙȘ-·ÓÙ·ÏÏ·Á‹ ÁÏ˘Îfi˙˘ 1388
¶ÔÏÏ·Ϥ˜ ÂÓ¤ÛÂȘ ÈÓÛÔ˘Ï›Ó˘ 3714
¶ÔÏ˘ÂÓ‰ÔÎÚÈÓÔ¿ıÂÈ· ·˘ÙÔ¿ÓÔÛË 791
¶ÔÏ˘Î˘ÛÙÈΤ˜ ˆÔı‹Î˜ 3535
¶ÔÏ˘Î˘ÛÙÈÎfi˜ ÓÂÊÚfi˜ 2413
¶ÔÏ˘Î˘ÙÙ·Ú·ÈÌ›· 3601
¶ÔÏ˘ÌÂÚ¿ÛË-ÚÈ‚fi˙Ë 2310
¶ÔÏ˘ÌÔÚÊÈÛÌfi˜ 2378, 2467, 2468
¶ÔÏ˘ÌÔÚÊÈÛÌfi˜ ·ÌÈÓÔͤˆÓ 1800, 2014
¶ÔÏ˘ÌÔÚÊÈÛÌfi˜ ÁÔÓȉ›Ô˘ MEA 3691
¶ÔÏ˘ÌÔÚÊÔ˘Ú‹ÓˆÓ ÏÂÈÙÔ˘ÚÁ›· 828, 3181
¶ÔÏ˘fiϘ 3584, 3586
¶ÔÏ˘ÂÙ›‰ÈÔ ·ÁÎÚ·ÙÈÎfi 1538, 3562, 3563
¶fiÓÔ˜ ÎÔÈÏÈ·Îfi˜ 1124
¶ÔÚÊ˘Ú›ÓË 1200
¶Ô˘ÚÔÌ˘Î›ÓË 851, 869
¶Ô˘ÙÚÂÛΛÓË 1087
¶Ú·‚·ÛÙ·Ù›ÓË 3407
¶Ú·ÌÏÈÓÙ›‰Ë 3564
¶ÚÔÁÂÛÙÂÚÔÓÔÂȉ‹ 3572
¶ÚfiÁÓˆÛË ‰È·‚‹ÙË 76
¶Úԉȷ‚‹Ù˘-·ÁÁÂÈÔ¿ıÂÈ· 3494
¶Úԉȷ‚ËÙÈ΋ ηٿÛÙ·ÛË 73
¶Úԉȷ‚ËÙÈÎÔ› ‰Â›ÎÙ˜ Î·È ÁÏÔ˘Ù¤ÓË 795
¶ÚÔÂÎÏ·Ì„›· 1411, 3601
¶ÚÔı¤ÛÂˆÓ (stents) ıÚfiÌ‚ˆÛË 2908
¶ÚÔıÚÔÌ‚›ÓË 1835
¶ÚÔ˚ÓÛÔ˘Ï›ÓË 293, 581, 645, 694, 1162, 3548, 3693
¶ÚÔοډÈÔ ¿ÏÁÔ˜ 911
¶ÚÔÎÏËÙ‹ ·ÛÙ¿ıÂÈ· 3571
¶ÚÔÏ·ÎÙ›ÓË 20, 878
¶ÚfiÏË„Ë 2028
¶ÚfiÏË„Ë ™¢ Ù‡Ô˘ 2 3664
¶ÚÔÓ¿ÚΈÛË-Â›‰· ÁÏ˘Îfi˙˘ 808
¶ÚÔ·ÓfiÏË 1191
¶ÚÔÈÔÌÂÏ·ÓÔÎÔÚÙ›ÓË 3562
¶ÚÔÛÙ·ÁÏ·‰›Ó˜ 346
¶ÚÔÛÙ·ÙÈ΋ ÓfiÛÔ˜ 2703, 3354
¶ÚÔÛˆÈÎfiÙËÙ· ‰È·‚ËÙÈÎÒÓ 312
¶ÚÔÛˆÈÎÔ‡ Ó. ÂÚÈÊÂÚÈ΋ ·Ú¿Ï˘ÛË 229, 2427
¶ÚˆÙ½Ó˜ Ï¿ÛÌ·ÙÔ˜ 754, 2158, 3086, 3186, 3420
¶ÚˆÙ½ÓË C (PrC) 601, 2611, 3287, 3326, 3417
¶ÚˆÙÂ˚ÓÈ΋ ÎÈÓ¿ÛË C‚ (PKC‚) 3579
¶ÚˆÙÂ˚ÓÔ˘Ú›· 3681
¶ÚˆÙÂ˚ÓÒÓ ÌÂÙ·‚ÔÏÈÛÌfi˜ 1590
- ˘ԉԯ›˜ 1711
¶˘ÂÏÔÓÂÊÚ›Ùȉ· 75, 112, 341, 346, 1944, 2186, 3288
¶˘ÚÔÛÙ·Ê˘ÏÈÎfi Ô͇ 552, 577
¶˘ÚÔ˘‚ÈÎÔ‡ ÔͤԘ ÌÂÙ·‚ÔϤ˜ 518
71
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ƒ·‚‰ÔÌ˘fiÏ˘ÛË 185, 3574
ƒ·ÌÈÚ›ÏË 3277, 3326
ƒÂ˙ÈÛÙ›ÓË 2159, 2165, 2321, 3082, 3265, 3562, 3599
ƒÂÓ›ÓË 3612
- ·ÁÁÂÈÔÙ·Û›ÓË 2548, 3509
- ÔͤˆÛË 652
ƒÂ·ÁÏȉ›ÓË 2141, 3375, 3564
ƒÂÙÚÔ˚Ô› 3547
ƒÂ˘Ì·ÙÔÂȉ‹˜ ·Ú¿ÁˆÓ 1351
ƒÈ‚ÔÛÒÌ·Ù· 852
ƒÈÓÔÂÁÎÂÊ·ÏÈ΋ ÌÔ˘ÎÔÚ̇ΈÛË 3609
ƒÔÛÈÁÏÈÙ·˙fiÓË 2234, 2237, 2559, 2559, 2960, 3046,
3205, 3250, 3511, 3564, 3704
ƒ‡ıÌÈÛË Î·È ÂÈÏÔΤ˜ 575, 597, 2058
™·Î¯·Ú›ÓË 46, 1150
™·Î¯·ÚÔ˘Ú›· Î·È ÂȉÈÎfi ‚¿ÚÔ˜ Ô‡ÚˆÓ 1467
™ÂÎÚÂÙ›ÓË 1166, 1167, 1174, 1196, 1210, 1214, 1217,
3544
™ÂÏÂÎÙ›ÓË 3356
- L ÛÂÏÂÎÙ›ÓË 1933
™·Ù·ÁÏÈÙ›ÓË 3564
™ÂÍÔ˘·ÏÈ΋ ÏÂÈÙÔ˘ÚÁ›· 1404, 1831, 1832, 1980, 2106,
2275
™ÂÚÔÙÔÓ›ÓË 403, 1168
™ÂÊÙÚÈ·ÍfiÓË 3440
™‹Ì·ÙÔ˜ ÌÂÙ·ÁˆÁ‹ 1086
™È·ÏÈÎfi Ô͇ 1565, 1862, 1950, 2397
- ·ÁÁÂÈÔ¿ıÂÈ· 1862
™È·ÏÔÁfiÓÔÈ ·‰¤Ó˜ 418, 1474, 3452
™›·ÏÔ˜ 418
™›‰ËÚÔ˜ ÔÚÔ‡ 3283
™È˙·Ú›‰Ë 2008, 2629
™ÈÏÈÎfiÓË 939
™ÈÚÔÊÈÌÚ¿ÙË 1584
™ÈÙ·ÁÏÈÙ›ÓË 2530, 3564
™ÎÂÏÂÙÔ‡ Ì¿˙· 1101, 1310
™Î˘ÙÔ‚Ú·¯›ÔÓ·˜ ‰Â›ÎÙ˘ 3590, 3591
™ÎÏËÚÔ›‰ËÌ· 3585
™ÔÚ‚›Ù˘ 146
™ÔÚ‚ÈÙfiÏË 3584
™Ô˘ÏÊÔÓ·ÌȉÈο ·Ú¿ÁˆÁ· 844
™Ô˘ÏÊÔÓ˘ÏÔ˘Ú›Â˜ 136, 284, 690, 713, 727, 831, 1129,
1141, 1172, 1226, 1260, 1282, 1545, 1866, 1880,
2007, 3564
- ˘ԉԯ›˜ 1830
™·ÛÌÔ› 161
™ÂÈÚ·Ì·ÙÈ΋ ‰È‹ıËÛË 2909
™ÂÈÚ·Ì·ÙÔÛÎÏ‹Ú˘ÓÛË 3579
™ÈÓıËÚÔÁÚ¿ÊËÌ· ÔÛÙÒÓ 3610
- ÌÂ Á¿ÏÏÈÔ 3610
- Ì ÂÈÛËÌ·Ṳ̂ӷ ÏÂ˘Î¿ ·ÈÌÔÛÊ·›ÚÈ· 3610
- ÌÂ Ì˘ÂÏÔ‡ ÙˆÓ ÔÛÙÒÓ 3610
™Ï·Á¯ÓÈÎfi Ï›Ô˜ 455
™Ù¿‰È· ÈÛ¯·ÈÌ›·˜ Fontaine 3590
™Ù·Ù›Ó˜ 2086, 3000, 3001, 3020, 3036, 3155, 3373,
3587, 3616
™Ù·ÙÈÛÙÈ΋ 166
72
™Ù·ÙÔË·Ù›Ùȉ· 3595
™ÙÂÚÈÓÔÂȉ‹˜ ÁÏ˘ÎÔ˙Ô˘Ú›· 546
™ÙÂÊ·ÓÈ·›· ‰È·‰ÂÚÌÈ΋ Â·Ó·ÈÌ¿ÙˆÛË 1987
™ÙÂÊ·ÓÈ·›· Â·Ó·ÁÁ›ˆÛË 3671
™ÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ 359, 377, 383, 459, 770, 777, 787,
862, 896, 927, 1350, 1422, 1450, 1517, 1594, 1987,
2113, 2118, 2381, 2385, 2399, 2404, 2407, 2415,
2423, 2426, 2428, 2430, 2435, 2461, 2465, 2501,
2535, 2642, 2668, 2671, 2700, 2705, 2828, 2845,
2846, 3086, 3153, 3188, 3308, 3322, 3349, 3361,
3374, 3414, 3667
- ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘ 1342
- ÂÌÌËÓfi·˘ÛË 3189
- ηډÈÔ¯ÂÈÚÔ˘ÚÁfi˜ 3192, 3272, 3349
- Û ·‰ÂÏÊÔ‡˜ ‰È·‚ËÙÈÎÒÓ 1421
- ÛÔ˘ÏÊÔÓ˘ÏÔ˘Ú›Â˜ 1545
™ÙÔÌ·ÙÈ΋ ÎÔÈÏfiÙËÙ· Î·È ÁÏ˘ÎÔÁfiÓÔ 163
- ÂͤٷÛË 3478
- ÌÔÓÈÏ›·ÛË 420
- ÔÁÎÔÁ¤ÓÓËÛË 3208, 3242, 3243, 3249, 3291
™ÙÔÌ·ÙÈÎfi˜ ÏÂȯ‹Ó 457
™ÙÔÌ·ÙÔ‰˘Ó›· 3620
™ÙÔÌ·ÙÔÏÔÁÈΤ˜ ÂΉËÏÒÛÂȘ 3620
™ÙÚÂÙÔ˙ÔÙÔΛÓË 644, 646, 679, 726, 3517
™Ù˘ÙÈ΋ ÏÂÈÙÔ˘ÚÁ›· 2079, 2627, 2628, 2664, 2675,
2724, 2995, 3015, 3066, 3303, 3412
- sildenafil 3398
™˘ÁÁÂÓ›˜ ·ÓˆÌ·Ï›Â˜ 3601
™˘Ì·ıËÙÈ΋ Ó‡ڈÛË 3184
™˘Ì·ıËÙÈÎfi ¡™ Û ·ÁÁÂÈÔ¿ıÂÈ· 1883
™˘Ì·ıËÙÈÎÔ‡ ÙfiÓÔ˜ 3612
™˘ÌÏËÚÒÌ·Ù· ‰È·ÙÚÔÊ‹˜ 3678
™˘ÌÏËÚÒÌ·ÙÔ˜ C3 Î·È C4 Â›‰· 525, 3078
™‡Ó‰ÚÔÌ·
- ·Ó·Ó¢ÛÙÈ΋˜ ‰˘Û¯¤ÚÂÈ·˜ 3574, 3601
- ·ÓÙÈʈÛÊÔÏÈȉÈÎfi Û ÓÂÔÁÓfi 2971
- ¿ÓÔÈ·˜-˘fiÓÔÈ·˜ 3618
- ·ÒÏÂÈ· ‚¿ÚÔ˘˜ 2773
- ·˘ÙÔ¿ÓÔÛ˘ ÔÏ˘ÂÓ‰ÔÎÚÈÓÔ¿ıÂÈ·˜ 791
- ‰˘Û·ÔÚÚfiÊËÛ˘ ‰È۷ί·ÚÈÙÒÓ 118
- Ì˘ÈÎfi-ÎÏÔÊÈÌÚ¿ÙË 672
- ·¯˘Û·ÚΛ· 2773
- ÔÏÏ·Ï‹˜ ÂÓ‰ÔÎÚÈÓÔ¿ıÂÈ·˜ 1539
- ÔÏ˘Î˘ÛÙÈÎÒÓ ÓÂÊÚÒÓ 2773
- ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ 3088
- ˘ÔÁÏ˘Î·ÈÌÈÎfi 83, 132
- Ã ‹ ÌÂÙ·‚ÔÏÈÎfi 368, 1547, 3617
- „¢‰Ô·ÔϤÈÛ˘ 3474
- Hair-∞n 530
- Mauriac 3594
- M∂¡ 1539
- Prader-Willi 2235
- Sipple 1539
- Verner-Morrison 1537
- Wolfram 1606
- Zollinger-Ellison 1538
™˘Ó¯‹˜ ̤ÙÚËÛË ÁÏ˘Îfi˙˘ 3546, 3636, 2129, 2203
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
™˘Ó¯‹˜ ˘Ô‰fiÚÈ· ¤Á¯˘ÛË ÁÏ˘Îfi˙˘ (·ÓÙÏ›· ÈÓÛÔ˘Ï›Ó˘) 2417, 3063
™˘Ó¯‹˜ ˘Ô‰fiÚÈ· ¤Á¯˘ÛË ÈÓÛÔ˘Ï›Ó˘ 3608, 3714
™˘ÓıÂÙ¿ÛË ÔÍÂȉ›Ô˘ ÙÔ˘ ·˙ÒÙÔ˘ 2947
™˘Û΢‹ Colgi 851
™¯¤ÛÂȘ ÏÂÎÈı›Ó˘ – ÛÊÈÁÁÔÌ˘ÂÏ›Ó˘ 3601
™¯‹Ì·Ù· ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ 3567
™ˆÏËÓ·Úȷ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· 1932
™ˆÌ·ÙÈ΋ ·Ó¿Ù˘ÍË 249, 357, 2111
- Î·È ÔÚÌfiÓ˜ 1667, 1668, 1672
™ˆÌ·ÙÈÎfi ‚¿ÚÔ˜ 3569
- Ú‡ıÌÈÛË 1134
- ™¢ Ù‡Ô˘ 1 3647
™ˆÌ·ÙÔÛÙ·Ù›ÓË 33, 171, 693, 727, 1080, 1157, 1189,
1194, 1245, 1248, 1259, 1277, 1536
- ·Ó¿ÏÔÁ· 404, 411, 1250, 2943
™ˆÌ·ÙÔÛٷٛӈ̷ 1538, 1541
Δ·ÎÚfiÏÈÌÔ˘˜ 3572
Δ·ÌÔÍÈʤÓË 3422
Δ·ÛÂÔ¸ԉԯ›˜ 523, 3148
ΔÂÏÌÈÛ·ÚÙ¿ÓË 3277, 3326
ΔÂÛÙÔÛÙÂÚfiÓË 670
Δ¯ÓËÙfi ¿ÓÁÎÚ·˜ 37
ΔÔÏ‚Ô˘Ù·Ì›‰Ë 125, 135, 138, 687, 1169, 1219, 1322
ΔÔÏÚÂÛÙ¿ÙË 1398, 2015
ΔÔÍÈÎfiÙËÙ· ·ÓÙÈÏÈȉ·ÈÌÈÎÒÓ 2022
ΔÔ˘ÌÔÎÔ˘Ú·Ú›ÓË Î·È ÏÈÔۈ̿ÙÈ· 1612
ΔÚ·˘Ì¿ÙˆÓ ÂԇψÛË 3295
ΔÚÈ·ÌÎÈÓÔÏfiÓË 3577
ΔÚÈ·ÌÎÈÓÔÏfiÓË Î·È laser 2050
ΔÚÈÁÏ˘ÎÂÚ›‰È· 24, 609, 711, 3363, 3616
ΔÚ›ÙË ËÏÈΛ· 3559, 3605
ΔÚȯÔÂȉÔÛÎfiËÛË 1382
TÚÔÁÏÈÙ·˙fiÓË 764, 2311, 2325
ΔÚ˘ÙÔÊ¿ÓË 736
Δ‡ÏÔ˜ (οÏÔ˜) 1575
Δ‡ÔÈ ™¢ 369
Δ˘ÚÔÛ›Ó˘ ʈÛÊÔÚ˘Ï›ˆÛË 1086
Δ‡ÊψÛ˘ ·›ÙÈ· 534
À·ÏÔÂȉ¤˜ Î·È ÛÈÏÈÎfiÓË 939
ÀÁ›· ‰È·‚ËÙÈÎÔ‡ 247
ÀÁ›·˜ Û˘ÛÙ‹Ì·Ù· 2002
À‰·Ù¿ÓıڷΘ 3541, 3557
À‰·Ù·ÓıÚ¿ÎˆÓ ÌÂÙ·‚ÔÏÈÛÌfi˜ 140, 399, 714, 1796
- ‰ÈÔ˘ÚËÙÈο 570, 1650
- Ê˘Ì·Ù›ˆÛË 539, 545
À‰Ú·Ï·Í›ÓË 3613
À‰Ú¿ÌÓÈÔ 3601
À‰ÚÔ͢ÚÔÏ›ÓË Ô‡ÚˆÓ 819, 1309
ÀÂÚ·Û‚ÂÛÙÈ·ÈÌ›· 3601
ÀÂÚ‚·ÚÈÎfi Ô͢ÁfiÓÔ 529
ÀÂÚÁÏ˘Î·ÈÌ›· 3680, 3586
ÀÂÚÁÏ˘Î·ÈÌ›· ·Û˘Ìو̷ÙÈ΋ 343
- ÌÂÙ·ÁÂ˘Ì·ÙÙÈ΋ 656, 2012, 2386
- ÔÍ›· ΢ÎÏÔÊÔÚ›· ·›Ì·ÙÔ˜ 2393, 2394
- ·ıÔÁ¤ÓÂÈ· 3397
ÀÂÚËÏ›ÎˆÓ ‰È·ÙÚÔÊ‹ 1133
À¤Ú˯ÔÈ Î·È ¤ÏÂÁ¯Ô˜ ·ÚÙËÚÈÒÓ 316, 317
- ÔÛÔÙÈΤ˜ ÌÂÙÚ‹ÛÂȘ 3367
ÀÂÚı˘ÚÂÔÂȉÈÛÌfi˜ 2062
ÀÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›· Î·È Û‡Ó‰ÚÔÌÔ Ã 368, 1139, 1195,
1232, 1290, 1986, 2555
- ·Ó‰ÚÔÁfiÓ· 796
- Ó¿ÙÚÈÔ 1405
- Û˘Ì·ıËÙÈÎfi Ó¢Ú. Û‡ÛÙËÌ· 1305
ÀÂÚÈÓÛÔ˘ÏÈÓÈÎfi clamp 3551
ÀÂÚηÏÈ·ÈÌ›· 3391
ÀÂÚÏÈȉ·ÈÌ›· 3560
ÀÂÚÔÍ˘ÛˆÌ¿ÙˆÓ ˘ԉԯ›˜ 1937
ÀÂÚfiÛÙˆÛË 1415, 3597
ÀÂÚËÎÙÈÎfiÙËÙ· ·›Ì·ÙÔ˜ 444
À¤ÚÙ·ÛË ·ÚÙËÚȷ΋ 224, 225, 359, 403, 576, 630,
667, 678, 790, 835, 887, 917, 954, 1400, 1457,
1482, 1501, 1518, 1523, 1569, 1798, 1956, 1997,
2085, 3377, 3605, 3612, 3617
- ÂȉËÌÈÔÏÔÁ›· 772
- ıÂÚ·›· 2179, 2201, 3248, 3262, 3276,
- Î·È ‰›·ÈÙ· ÛÙ· ·È‰È¿ 481
- ÌÔÍÔÓȉ›ÓË 1561
- Û ·È‰È¿ 467, 469
- Û‡Ó‰ÚÔÌÔ Ã 1547
ÀÂÚÙ·ÛÈ΋ ÓfiÛÔ˜ ΢‹Ûˆ˜ 3601
ÀÂÚÙÔÓ›· ÔÊı·ÏÌÈ΋ 393
ÀÂÚÙÚÈÁÏ˘Î·Úȉ·ÈÌ›· 3614
ÀÂÚÙÚÔÊ›· ÌÂÛÔÎÔÈÏÈ·ÎÔ‡ ‰È·ÊÚ¿ÁÌ·ÙÔ˜ 3601
ÀÂÚ¯ÔÏÂÚ˘ıÚÈÓ·ÈÌ›· 3601
ÀÂÚˆÛ̈ÙÈÎfi ÌË ÎÂÙÔÓÈÎfi ˘ÂÚÁÏ˘Î·ÈÌÈÎfi ÎÒÌ·
3574
ÀÂÚˆÛ̈ÙÈÎfi ÎÒÌ· 342, 445, 451, 814, 820, 930,
1577, 2566, 3423
- ÂȉËÌÈÔÏÔÁ›· 717
ÀÔÁÏ˘Î·ÈÌ›· 83, 132, 515, 662, 707, 734, 1177,
1179, 1296, 1297, 1300, 1369, 1375, 1441, 1819,
2447, 3680, 2768, 3566, 3567, 3570, 3575, 3584,
3605, 3621
- ·ÈÌÔÂÙ¿ÏÈ· 159
- ·ÓıÚÒÈÓË ÈÓÛÔ˘Ï›ÓË 266
- ·Ó›¯Ó¢ÛË 3, 431, 1435, 1443, 1908
- ·ÓÙÈ·ÈÌÔÊÈÏÈ΋ ÁÏÔ‚Ô˘Ï›ÓË 158
- ·ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ· 189, 690, 1512, 3605
- ·fi ÏÈÔۈ̿ÙÈ· 1610, 1611, 1612
- ·fi fiÁÎÔ˘˜ 81, 441, 794, 1557, 3643
- ·fi ¯ÂÈÚÔ˘ÚÁÈ΋ ¿Ô„Ë 80, 807
- ·ÛÈÚ›ÓË 157, 3588, 3605
- ·˘ÙfiÓÔÌÔ ¡™ 430, 639, 1670, 1671
- ‚ÚÂÊÈ΋˜ Î·È ·È‰È΋˜ ËÏÈΛ·˜ 79, 536, 1908
- ÁÈ· ˘fiÎÚÈÛË ÓfiÛÔ˘ 505
- ‰È·˙ÔÍ›‰Ë - ıÂÚ·›· 121, 662
- ÂȉËÌÈÔÏÔÁ›· 717
- ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÛË 69
- Ë·ÙÔηÚΛӈ̷ 69
- ıÂÚ·›· 2563
- È·ÙÚÔÁÂÓ‹˜ 1512, 2168
- ȉÈfiÌÔÚÊË Û˘ÌÂÚÈÊÔÚ¿ 133
73
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
- ηÏÙÛÈÙÔÓ›ÓË 1408
- ΛÚÚˆÛË ‹·ÙÔ˜ 69
- ÌÂÙ·ÁÂ˘Ì·ÙÈ΋ 2645
- ÓÂÔÁÓÔ‡ 64, 79
- ÚÔ‚Ï‹Ì·Ù· 131, 430, 431, 3293
- Ú˘ıÌÈÛÙÈΤ˜ ÔÚÌfiÓ˜ 440
- Û·ÛÌÔ› 161
- ÙÚ˘ÙÔÊ¿ÓË 736
- ˘ԉԯ›˜ ÈÓÛÔ˘Ï›Ó˘ 351
- Ê˘ÙÈΤ˜ ›Ó˜ 1524
- ¯ÚfiÓÔ˜ ÚÔ‹˜ 157
- ¯ˆÚ›˜ ÚÔÂȉÔÔ›ËÛË 101, 430, 431, 442, 508,
1435, 1443
ÀÔÁÏ˘Î·ÈÌÈο ‰ÈÛΛ·-·ÚÂÓ¤ÚÁÂȘ 365
ÀÔÁÔÓ·‰ÈÛÌfi˜-ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·ÛË 2557, 2756
ÀÔÁÔÓÈÌfiÙËÙ· Î·È ·Ó·ÛÙÚÔÊ‹ ÂÎÛÂÚÌ¿ÙÈÛ˘ 1135
Àԉԯ›˜ ÈÓÛÔ˘Ï›Ó˘ 351, 3543
- ·‰ÚÂÓÂÚÁÈÎÔ› Î·È ‰È·‚‹Ù˘ ·ËÛ˘ 1800
- ÚˆÙÂ˚ÓÒÓ 1711
- ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ 1830
- ˘ÂÚÔÍ˘ÛˆÌ¿ÙˆÓ 1937
ÀÔı¿Ï·ÌÔ˜ 3562
ÀÔı˘ÚÂÔÂȉÈÛÌfi˜ 3528
ÀÔı˘ÚÂÔÂȉÈÛÌfi˜ Î·È Û‡Ó‰ÚÔÌÔ Prader-Willi 2235
- ÈÓÛÔ˘Ï›ÓË 2451
- Ì˘˚΋ ÚfiÛÏË„Ë ÁÏ˘Îfi˙˘ 2455
- ˘ԉԯ›˜ ÁÏ˘Îfi˙˘ 2459
ÀfiÎÚÈÛË ÓfiÛÔ˘ Ì ˘ÔÁÏ˘Î·ÈÌ›· 505
ÀÔÏÈȉ·ÈÌÈ΋ ·ÁˆÁ‹ 3587
ÀÔÌ·ÁÓËÛÈ·ÈÌ›· 3301
ÀÔÓ·ÙÚÈ·ÈÌ›· 2408
ÀfiÊ˘ÛË 93
º·ÈÓfiÌÂÓÔ
- ·˘Á‹˜ 3571, 3604
- ÈÓÎÚÂÙ›Ó˘ 1401, 3544
- Dawn 251, 927, 1203
- Somogyi 251, 3571, 3604
º·ÈÓfiÙ˘ÔÈ ‰˘ÛÏÈȉ·ÈÌÈÒÓ 3614
º·ÈÓÔÊÈÌÚ¿ÙË 600
º·ÈÓÊÏÔ˘Ú·Ì›ÓË 434, 460
º·Èԯڈ̷ÙÔ·Ùو̷ 3715
º·ÚÌ·ÎÔÎÈÓËÙÈ΋ Î·È ™¢ 1794
º·ÚÌ¿ÎˆÓ ÌÂÙ·‚ÔÏÈÛÌfi˜ 378
ºÂÓ·˙›ÓË 650
ºÂÓÊÔÚÌ›ÓË ‚Ï. ‰ÈÁÔ˘·Ó›‰È·
ºÈÌÚÔÓÂÎÙ›ÓË 384, 435, 436, 443, 882
º›ÌˆÛË Ô˘Ï҉˘ 2693
ºÏÂÁÌÔÓÒ‰ÂȘ ‰Â›ÎÙ˜ 3695
ºÏÂÁÌÔÓÒ‰ÂȘ ΢ÙÙ·ÚÔΛÓ˜ 3618
ºÏÔ˘ÔÚÔ·ÁÁÂÈÔÁÚ·Ê›· 945, 948
ºÏÔ˘ÔÚÔÛËÙ›ÓË 1426
ºÔÛÈÓÔÚ›ÏË 3457
ºÔ˘ÚÔÛÂÌ›‰Ë 1644, 1650
ºÚÔ˘ÎÙÔ˙·Ì›ÓË 572, 573
ºÚÔ˘ÎÙfi˙Ë 146
º˘Ì·Ù›ˆÛË 800, 910, 3534, 3609
º˘ÛÈ΋ ηٿÛÙ·ÛË ÛÒÌ·ÙÔ˜ Î·È Ú‡ıÌÈÛË 1134
74
º˘ÙÈΤ˜ ›Ó˜ 512, 740, 778, 817, 921, 1524, 1573,
3557
ºˆÛÊ·Ù¿ÛË 332, 2950
ºˆÛÊ·ÙÔ˘ÚÈÎfi˜ ‰È·‚‹Ù˘ 858
ºˆÛÊÔÂÓÔÏÔ˘ÚÔÛÙ·Ê˘ÏÈÎfi Ô͇ 552
ºˆÛÊÔ˚ÓÔÛÈÙ›‰Ë 3584
ºˆÛÊÔÚÔÁÏ˘ÎÂÚÈÓÈÎfi Ô͇ 552, 583
ºˆÛÊfiÚÔ˜ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚÈˆÓ 839, 840, 841,
842
ºˆÛÊfiÚÔ˜-ıÂÚ·›· 1483
ºˆÛÊÔÚ˘Ï›ˆÛË ÚˆÙÂ˚ÓÒÓ 592
- Ù˘ÚÔÛ›Ó˘ 1086
ºˆÙÔËÍ›· Laser 419, 421, 426, 427, 428, 429, 803,
890, 885, 891, 2025, 3470, 3577
- Î·È ÙÚÈ·ÌÈÓÔÏfiÓË 2050, 3577
ºˆÙÔÏËı˘ÛÌÔÁÚ·Ê›· 533
÷ÏÎfi˜ 1335
ÃÂÈÚÔ·ÚıÚÔ¿ıÂÈ· 3597
ÃÂÈÚÔ˘ÚÁÈΤ˜ ÂÂÌ‚¿ÛÂȘ Î·È ‰È·‚‹Ù˘ 70, 325, 567,
925, 1366
- ·Ó·ÈÛıËÛ›· 881, 925
- Â›ÙÔÎÔ˜ 925
ÃÂÈÚÔ˘ÚÁÈ΋ ÂÈÚ·Ì·ÙÈ΋ 623
ÃËÌÈÎfi˜ ‰È·‚‹Ù˘ 149
ÃψÚÔıÂÈ·˙›‰Ë Î·È ÁÏ˘Îfi˙Ë 198
ÃψÚÔÚÔÌ·˙›ÓË 3572
ÃψÚÔÚÔ·Ì›‰Ë 1224
- Î·È ÔÈÓfiÓÂ˘Ì· 45
ÃÔÏËÛÙÂÚfiÏË
- HDL 2139
- LDL 3522, 3616
ÃÔÏÔ΢ÛÙ›Ùȉ· ÂÌÊ˘ÛËÌ·ÙÈ΋ 2018, 2130
ÃÔÏÔ΢ÛÙÔÎÈÓ›ÓË 1161, 1167, 1187, 3544, 3562, 3563
ÃÔÏÔÏÈı›·ÛË 231, 3596
ÃÔÏÔÛÙ¿و̷ 374
ÃÔÚÈÔÂȉÈ΋ ÓÂÔ·ÁÁ›ˆÛË 2031
ÃÚfiÓÔ˜ ÚÔ‹˜ Î·È ˘ÔÁÏ˘Î·ÈÌ›· 157
ÃÚÒÌÈÔ Ï¿ÛÌ·ÙÔ˜ ÌÂÙ¿ ¯ÔÚ‹ÁËÛË ÁÏ˘ÎÔ˙˘ 9, 703
á∞ 3571, 3580
梉¿ÚÁ˘ÚÔ˜ 1335
梉ԷÔÊÔÏ›‰ˆÛË 928
梉ԸÔÍ›· 3584
æ˘¯È·ÙÚÈ΋ ¿Ô„Ë ÙÔ˘ ™¢ 59
æ˘¯È·ÙÚÈ΋ ıÓËÛÈÌfiÙ˘ 2232
æ˘¯ÔÏÔÁ›· ÁÔÓ¤ˆÓ Î·È ·È‰ÈÒÓ 3604
æ˘¯ÔÏÔÁ›· Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜ 3604
æ˘¯ÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù· 479, 489, 834, 933, 2220,
2531
- ÂÚˆÙËÌ·ÙÔÏfiÁÈÔ 489
æ˘¯ÔÏÔÁÈ΋ ˘ÔÛÙ‹ÚÈÍË 354, 362
æ˘¯Ô·ıÒÓ ıÂÚ·›· Ì ÈÓÛÔ˘Ï›ÓË 68
æ˘¯Ôۈ̷ÙÈ΋ È·ÙÚÈ΋ 1360
æ˘¯ÔÙÚfi· Ê¿Ú̷η 3572
æˆÚ›·ÛË 691, 3075
ø̤Á·-3 Ôͤ· 2600, 2731
flÌÔ˘ ÂÚÈ·ÚıÚ›Ùȉ· 771
øÔıËÎÒÓ ÏÂÈÙÔ˘ÚÁ›· 3459
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
øÔÚËÍ›·˜ ·Ó·ÛÙ·ÏÙ¤˜ Î·È ˘‰·Ù¿ÓıڷΘ 140
øÙ›Ùȉ· ηÎÔ‹ı˘ Â͈ÙÂÚÈ΋ 3609
ø¯Ú¿˜ ËÏȷ΋ ÂÎʇÏÈÛË 2031
ø¯Ú¿˜ Ô›‰ËÌ· 890, 891, 885, 894, 2050
ø¯ÚÔ¿ıÂÈ· 421, 426, 427, 428, 429
ACTH 680
AGEs 3561
AMP ∫ÈÓ¿ÛË 3564
Anecortave acetate 3577
Angiogenin 1531
ATP 3518
ATP¿ÛË 3517
BCG Î·È IDDM 1697
Buflomedil 1977, 2653
CART 3562
Dextrostix 1356
DNA 3699
GIP 3544
GRP 3544
Homa 3551
L ÛÂÏÂÎÙ›ÓË 1933
Lucilia sericata 1591
Minimal Model 3551
Non-stress test 3601
PET 3610
TSH 20
Tumor necrosis factor 1639, 2381
VIP 3544
75
76
¶§∏ƒ∏™ μπμ§πO°ƒAºπ∫∏
KATA°PAºH
77
78
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1. BEB∂™ ¡, ∫∞°ª∞∫∏™ ¶, §∞™∫∞ƒ∏™ π, ∞£∞¡∞™O¶OÀ§O™ ¡, ¢∞™∫∞§∞∫∏ £, ΔƒÀºø¡π¢∏™
º, ∫∞Δ™πª∞¡Δ∏™ ¢. ªÂÙ·‚ÔÏ·› Ù˘ ÈÓÛÔ˘Ï›Ó˘
Â› ÎÈÚÚÒÛˆ˜ ÙÔ˘ ‹·ÙÔ˜. πÔÎÚ¿Ù˘ 1979; 7: 18993.
2. ∫∞ƒ∞ª∂ƒΔ∑∞¡∏ ª, ¶∞À§∞ΔO™ º, ªπÃ∞§O¶OÀ§O™ ∞, Ã∞Δ∑∏§OÀ∫∞-ª∞¡Δ∞∫∞ ∞. ªÂϤÙË ÁÈ· ÙË ‰Ú¿ÛË Ù˘ ÁÏÈÈ˙›‰Ë˜, ÂÓfi˜ Ó¤Ô˘ ·ÓÙȉȷ‚ËÙÈÎÔ‡ ‰ÈÛΛԢ. πÔÎÚ¿Ù˘ 1979; 7: 175-80.
3. ºπ§π¶¶π¢∏™ º, ∫∞§§πμƒ∂Δ∞∫∏™ ¡, ª∞∫ƒÀ°π∞¡¡∏™ ∏, ¶πΔ∞ƒO∫Oπ§∏™ π, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞´∫O™ °. ™˘Ó¯‹˜ ηٷ̤ÙÚËÛË-ηٷÁÚ·Ê‹ ÁÏ˘Î·ÈÌ›·˜ Û ‰È·‚ËÙÈο ¿ÙÔÌ· Ù‡Ô˘ π. πÔÎÚ¿Ù˘ 1982; 10: 447-54.
4. KAΔ™π§∞ª¶ƒO™ ¡, ™Δ∞ÀƒOÀ ¶, °∞§∞¡∞∫∏™
¡, ªOπƒ∞™ ¡, ª∞ƒ∞°°O™ ª, ™º∏∫∞∫∏™ ¶,
¢∞´∫O™ °∫. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Û ٤ÎÓ· Ì ·ÌÊÔÙ¤ÚÔ˘˜ ÙÔ˘˜ ÁÔÓ›˜ ‰È·‚ËÙÈÎÔ‡˜. πÔÎÚ¿Ù˘ 1980;
8: 161-5.
5. μƒO¡Δ∞∫∏ ª. ∞fiÙÔ̘ ‰È·Î˘Ì¿ÓÛÂȘ Ù˘ ÛÙ¿ıÌ˘
Ù˘ ÈÓÛÔ˘Ï›Ó˘ Î·È ÙÔ˘ C-ÂÙȉ›Ô˘ ÛÙÔÓ ÔÚfi. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
6. ª∞∫∞ƒø¡∞-°π∞¡¡∞∫O¶OÀ§OÀ μ. ∏ Â›‰Ú·ÛË
Ù˘ Ó¢ÚÔÏËÙ·Ó·ÏÁËÛ›·˜ Î·È ÙÔ˘ ·ÏÔı·Ó›Ô˘ ¿Óˆ
ÛÙ· ÂχıÂÚ· ÏÈ·Ú¿ Ôͤ· ÙÔ˘ ÔÚÔ‡ Î·È ÙË ÁÏ˘Îfi˙Ë
ÙÔ˘ ·›Ì·ÙÔ˜ ÛÙÔ˘˜ ÂÓ‹ÏÈΘ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1982. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
7. ∂∫∞ΔOª∞Δ∏™ ¶. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Û·Î¯¿ÚÔ˘ ·›Ì·ÙÔ˜ Î·È ˘‰·ÙÔÂȉԇ˜ ˘ÁÚÔ‡ Â› ·ÛıÂÓÒÓ ·Û¯fiÓÙˆÓ ·fi ηٷÚÚ¿ÎÙË Î·È ÁÏ·‡ÎˆÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
8. μ§∞ÃOÀ-™πªO¶OÀ§OÀ £. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÙˆÓ
ÌÂÙ·‚ÔÏÒÓ Ù˘ ΢ÎÏÈ΋˜ ÌÔÓÔʈÛÊÔÚÈ΋˜ ·‰ÂÓÔÛ›Ó˘ (C-AMP) ÂȘ ÙÔ˘˜ ÈÛÙÔ‡˜ Î·È ÙÔ Ï¿ÛÌ· ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÁÏ˘Î·ÁfiÓ˘. ¶ÂÈÚ·Ì·ÙÈ΋ ÂÚÁ·Û›·. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
9. ª∞∫ƒÀ°π∞¡¡∏™ ∏. ªÂÙ·‚ÔϤ˜ ÙÔ˘ ¯ÚˆÌ›Ô˘ ÙÔ˘
Ï¿ÛÌ·ÙÔ˜ ηٿ ÙËÓ ÂÓ‰ÔÊϤ‚ÈÔ ¯ÔÚ‹ÁËÛË ÁÏ˘ÎÔ˙˘
Û ˘ÁÈ‹ Î·È ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
10. KATSILAMPROS N, STERYOTIS J, MOIRAS N,
BEZOS H, DAIKOS GK. Prevalence of diabetes
among glycosuric individuals in an urban area of
Greece. Acta Diabet Lat 1977; 14: 211-21.
11. ƒ∞¶Δ∏™ ™. ¡ÂÒÙÂÚ˜ ÂÍÂÏ›ÍÂȘ ÂȘ ÙËÓ ·ÓÙÈÌÂÙÒÈÛÈÓ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. £ÂÚ·¢ÙÈΤ˜ ÂÍÂÏ›ÍÂȘ. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
1978.
12. μ∂§O¡∞∫∏™ ∂, ∫∞§∞¡Δπ¢OÀ ∞, ∫∞ƒ∞´Δπ∞¡OÀ ∞, §∞™∫∞ƒ∏™ π, ΔƒπÃO¶OÀ§OÀ ∞. ∂ȉËÌÈÔÏÔÁÈο ¯·Ú·ÎÙËÚÈÛÙÈο ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·. πÔÎÚ¿Ù˘ 1983; 11: 257-64.
13. μ∂§O¡∞∫∏™ ∂, ∫ƒπΔ™π∫∏™ ™, ¶∞ƒOÀΔO°§OÀ
º, ∑∂ƒμO¶OÀ§O™ °, μπ§§πøΔOÀ º, ∞À°OÀ™Δ∞∫∏™ ¢. ∏ Û˘¯ÓfiÙËÙ· ‰È·‚‹ÙÔ˘ Û 2556 ÂÓ‹ÏÈΘ
ÙÔ˘ ÏËı˘ÛÌÈ·ÎÔ‡ ‰Â›ÁÌ·ÙÔ˜ Ù˘ Ó‹ÛÔ˘ ™·Ï·Ì›Ó·˜
Î·È Ë Û˘Û¯¤ÙÈÛË ÙÔ˘ Ì ÙÔÓ ¢Â›ÎÙË ª¿˙·˜ ™ÒÌ·ÙÔ˜
(μªπ). ™ÙÔ: 38Ô ¶·ÓÂÏÏ‹ÓÈÔ π·ÙÚÈÎfi ™˘Ó¤‰ÚÈÔ π·ÙÚÔ¯ÂÈÚÔ˘ÚÁÈ΋˜ ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ. 1982: (ÛÂÏ.?).
14. ∫ÀƒπO¶OÀ§O™ π. ∫ÔÈÓˆÓÈΤ˜ Î·È ÔÈÎÔÓÔÌÈΤ˜ ·Ú¿ÌÂÙÚÔÈ Ù˘ ηٿ ·Èٛ˜ ıÓËÛÈÌfiÙËÙ·˜ ÛÙËÓ ∂ÏÏ¿‰·:
∞Ó¿Ï˘ÛË Î·Ù¿ ÂÚÈʤÚÂȘ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1982. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
15. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∂ƒ°πøΔ∏™ π, ªOπƒ∞™ ¡,
ª¶∂∑O™ ∏, ¢∞π∫O™ ¢. ¶ÚÔηٷÚÎÙÈο ·ÔÙÂϤÛÌ·Ù· ÂÎ Ù˘ ·ÓȯÓ‡Ûˆ˜ ÙÔ˘ ‰È·‚‹ÙÔ˘ ÂȘ ÚÔ¿ÛÙÂÈÔÓ ÙˆÓ ∞ıËÓÒÓ. ∞گ›· π·ÙÚ ∂Ù·ÈÚ ∞ıËÓÒÓ
1975; 1: 322-5.
16. ª∂ƒπ∫∞™ °, Ãπ™Δ∞∫O¶OÀ§O™ ¶, ∫∞ƒ∞ª∞¡O™ μ, Ã∞¡πøΔ∏™ ¢, ΔOÀ¡Δ∞™ Ã. ∏ ÂÓ ∂ÏÏ¿‰È
Û˘¯ÓfiÙ˘ Ù˘ ÁÏ˘ÎÔ˙Ô˘Ú›·˜ Î·È Ë Û¯¤ÛȘ Ù·‡Ù˘ ÚÔ˜
ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙËÓ. ∂ÂÙËÚ›˜ π·ÙÚÈ΋˜ ™¯ÔÏ‹˜
∂ıÓÈÎÔ‡ ¶·ÓÂÈÛÙËÌ›Ô˘. ∞ı‹Ó·, 1976: ÙfiÌ. ∞′: 169.
17. ¶∞¶∞∂À∞°°∂§OÀ °, Δ™πª¶O™ ∫§. ™ËÌ·ÓÙÈ΋
·‡ÍËÛË Ù˘ ıÓËÛÈÌfiÙËÙ·˜ ·fi ηډȷÁÁÂȷΤ˜ ·ı‹ÛÂȘ ÛÙËÓ ∂ÏÏ¿‰· ηٿ Ù· ÙÂÏÂ˘Ù·›· ¯ÚfiÓÈ·. ªater
Med Greca 1982; 10: 239.
18. Ãπ™Δ∞∫O¶OÀ§O™ ¶, ∫∞ƒ∞ª∞¡O™ μ, μπO§∞∫∏ ª, Ã∞¡πøΔ∏™ ¢, ª∂ƒπ∫∞™ °. ∏ Û˘¯ÓfiÙ˘
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ÂȘ ÙÔÓ ·ÁÚÔÙÈÎfiÓ ÏËı˘ÛÌfiÓ Ù˘ ∂ÏÏ¿‰Ô˜. ∂ȉËÌÈÔÏÔÁÈ΋ ÌÂϤÙË. π·ÙÚÈ΋
1976; 29: 537.
19. ∫∞§∞¡Δπ¢OÀ ∞, ∞μƒ∞ªπ¢∏™ ¢, •∏ƒOÀÃ∞∫∏
∂, ™¶∞ƒƒO™ §, ¶∞¶∞∂À∞°°∂§OÀ °, ΔƒπÃO¶OÀ§O™ ¢. ªÂϤÙË Ù˘ ıÓËÛÈÌfiÙËÙ·˜ ·fi ‰È¿ÊÔÚ˜ ·Èٛ˜ ÛÙȘ ·ÛÙÈΤ˜ Î·È ÛÙȘ ·ÁÚÔÙÈΤ˜ ÂÚÈÔ¯¤˜
Ù˘ ∂ÏÏ¿‰·˜. π·ÙÚÈ΋ 1977; 31: 57.
20. ª¶∞ƒΔ™O∫∞™ Ã, ƒ∞¶Δ∏™ ™, ¢∞ÀƒO™ π, ™OÀμ∞Δ∑O°§OÀ ∞, ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, ¶∞¶∞¢∞ΔO™ ∫. ∂›‰Ú·ÛË Ù˘ Ì·ÎÚÔ¯ÚfiÓÈ·˜ ıÂÚ·›·˜ Ì ·Ó·ÛÙÔϤ· Ù˘ ·-ÁÏ˘ÎÔÛȉ¿Û˘ Û ·È‰È¿
Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË: ªÂϤÙË ‰È·ÊfiÚˆÓ ÔÚÌÔÓÈÎÒÓ ·Ú·Ì¤ÙÚˆÓ. πÔÎÚ¿Ù˘
1983; 11: 185-90.
21. ¶πΔ∞ƒO∫Oπ§∏™ π. πÓÛÔ˘Ï›ÓË Î·È C-ÂÙ›‰ÈÔÓ ÔÚÔ‡
ηٿ ÙËÓ ¯ÚÔÓ›·Ó ÓÂÊÚÈÎ‹Ó ·ÓÂ¿ÚÎÂÈ·Ó. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
22. BARTSOCAS CH, PAPACHRISTOU C, HILLEBRAND I, PAPADATOS CJ. Acarbose as an adjunct
in the management of juvenileonset diabetes. In:
Creutzfeldt W. Proceedings of the First International
Symposium on Acarbose: Effects on carbohydrate
and fat metabolism, Montreux, October 8-10, 1981.
Amsterdam; Oxford: Excerpta Medica, 1982: 422-6.
23. RAPTIS S, DIMITRIADIS G, KARAISKOS K, ROSENTHAL J, ZOUPAS CH, MOULOPOULOS S.
Long term effects of an a-glucosidase inhibitor on catecholamine levels and insulin requirements as assessed by the artificial beta-cell. Diabetes 1980; 29
(Supplem 2): 41A.
79
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
24. RAPTIS S, DIMITRIADIS G, KARAISKOS K. Langzeitbehandlung mit einem Glykosidhydrolasen-Inhibitor: Effekte beim täglichen Insulinbedarf, Cortisoltriglyzerids piege und biochemische Laborprofil
bei Diabetikern. Aktuel Endokrinol Stoffwechsel
1980; 1: 195-?.
25. MÀ°¢∞§∏™ ∏. ΔÔ ·ÏÊ¿‚ËÙÔ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ∞ı‹Ó·: μÈ‚ÏÈÔˆÏÂ›Ô ∫.& °. ∑ÂÚÌ›ÓË, 1996: 62 ÛÂÏ.
26. £∞§∞™™π¡O™ ¡. ΔÔ ‚È‚Ï›Ô ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ∞ı‹Ó·,
1981: 59 ÛÂÏ.
27. ∫∞§¢ƒÀªπ¢∏™ º. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ ππ:
¶ÚÔ‚ÏËÌ·ÙÈÛÌÔ› ÛÙËÓ Ú¿ÍË. 2Ë ¤Î‰. ∞ı‹Ó·, 1994:
206 ÛÂÏ.
28. ∫∞ƒ∞ª∏Δ™O™ ¢. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: ∞fi ÙË
ıˆڛ· ÛÙË Ú¿ÍË. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 1987: 306 ÛÂÏ.
29. ∫∞Δ™π§∞ª¶ƒO™ ¡. O‰ËÁ›Â˜ ÁÈ· ÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜.
∞ı‹Ó·: °ÂÓÈÎfi ¡ÔÛÔÎÔÌÂ›Ô ∞ıËÓÒÓ «§·˚Îfi», 1977.
30. ∫∞Δ™π§∞ª¶ƒO™ ¡. O‰ËÁ›Â˜ ÁÈ· ÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜.
2Ë ¤Î‰. ∞ı‹Ó·: §·˚Îfi ¡ÔÛÔÎÔÌÂ›Ô ∞ıËÓÒÓ. 1996.
31. ΔOÀ¡Δ∞™ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›· –
Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 670 ÛÂÏ.
32. RAPTIS S, ROTHENBUCHNER G, SCHRODER
KE, STRAUB K, BIRK J, PFEIFFER EF. Radioimmunologische Bestimmung von Gastrin im menschlichen Serum. Acta Endocrinol (Copenh) 1971; 152
(Suppl): 10.
33. RAPTIS S, DOLLINGER HC, BERGER LV,
SCHLEGEL W, SCHRODER KE, PFEIFFER EF.
Effects of somatostatin on gastric secretion and gastrin release in man. Digestion 1975; 13: 15-27.
34. PFEIFFER EF, THUM CH, ZIEGLER R, RAPTIS
S. Hypoglycemia in diabetics. Horm Metab Res 1976;
6 (Suppl): 112-26.
35. PFEIFFER EF, RAPTIS S. Controlled extension of
oral antidiabetic therapy on former insulin dependent
diabetics by means of the combined i.v. glibenclamideglucose-response-test. Diabetologia 1972; 8:
41-7.
36. PFEIFFER EF, RAPTIS S, SCHRODER KE. Die Bedeurung der einmalingen kombinierten i.v. Glibenclamidglucosebelastung für Auswahl, Indikationsstellung und Prognose der Glibenclamidbehandlung des
sogenannten “insulinbedürftigen” tolbutamidresistenten erwachsenen Diabetes. Dtsch Med Wochenschr 1974; 90: 1281-94.
37. RAPTIS S, KARAISKOS K, HATZIDAKIS D,
ZOUPAS CH, DIAMANTOPOULOS E, MOULOPOULOS S. Comparison of glycaemic and metabolic
control in diabetics achieved by an artificial endocrine
pancreas versus an open loop intravenous delivery
system. Horm Metab Res Suppl 1976; (Suppl): (p.?).
38. RAPTIS S, KARAISKOS K, ENZMANN F, HADZIDAKIS D, ZOUPAS CH, SOUVATZOGLOU A,
DIAMANTOPOULOS E, MOULOPOULOS S. Bio-
80
logic activities of biosynthetic human insulin in
healthy volunteers and insulindependent diabetic patients monitored by the artificial endocrine pancreas.
Diabetes Care 1981; 4: 155-62.
39. SKYLER JS, RAPTIS S. Symposium on biosynthetic
human insulin. Diabetes Care 1981; 4: 139-264.
40. SKYLER JS, PFEIFFER EF, RAPTIS S, VIBERTI
GC. Biosynthetic human insulin: Progress and Prospects. Diabetes Care 1981; 4: 140-43.
41. ∫O¡∫OÀƒ∏™ §. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∫oÓÎo˘Ú˘
§. ª·ı‹Ì·Ù· ∂ÛˆÙÂÚÈ΋˜ ¶·ıÔÏÔÁ›·˜. ¢È·Ù·Ú·¯·›
ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ ˘‰·Ù·ÓıڿΈÓ. £ÂÛÛ·ÏÔÓ›ÎË,
1975: ÙfiÌ. °′: 664-711.
42. Ã∏™ΔOª∞¡O™ ∞. ¢ÔÌ‹ Î·È ÁÂÓÈη› ȉÈfiÙËÙ˜ ÙˆÓ
˘‰·Ù·ÓıڿΈÓ. ™ÙÔ: ÃÚËÛÙÔÌ·ÓÔ˜ ∞. ™ÙÔȯ›· ÁÂÓÈ΋˜ Î·È Û˘ÁÎÚÈÙÈ΋˜ ‚ÈÔÏÔÁÈ΋˜ ¯ËÌ›·˜. OÈ ÔÈÎÔ‰ÔÌÈÎÔ› Ï›ıÔÈ Ù˘ ˙ÒÛ˘ ‡Ï˘. ∞ı‹Ó·: ∂ΉfiÛÂȘ ™˘ÚÔÔ‡ÏÔ˘, 1961: 1031-120.
43. ¶∞¶∞§O∏™ ∞, ¡π∫O§∞OÀ ∫, ª¶O¡∞Δ™O™ °,
¶∞¶∞¢O¶OÀ§O™ ™, ¶∂μ∂ƒ∂ΔO™ ¶, °O§∂ª∞Δ∏™ μ. ªÂÙ·ÌÔۯ‡ÛÂȘ ÓËÛȉ›ˆÓ ÙÔ˘ Langerhans. NÔÛÔÎ °Ú·ÌÌ‹ 1995; 36: 6-7.
44. μOƒπ¢∏™ ∂. ∞È ıÂÈ·˙›‰·È ˆ˜ Ô˘Û›·È ‰È·‚ËÙÔÁfiÓÔÈ.
π·ÙÚÈ΋ 1961; 1: 87.
45. ∞§∂μπ∑∞ΔO™ π. ÃψÚÔÚÔ·Ì›‰Ë Î·È ÔÈÓÔÓÂ˘Ì·ÙÒ‰Ë. π·ÙÚÈ΋ 1961; 1: 312.
46. ¢π∞ª∞¡ΔO¶OÀ§O™ ™. ™·Î¯·Ú›ÓË. π·ÙÚÈ΋ 1961;
1: 203.
47. ª¶∞§O¢∏ªO™ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋
1962; 2: 104-15.
48. ¶∞¶∞™¶ÀƒOÀ ¡. O ‰È·‚‹Ù˘ Û‹ÌÂÚÔÓ. π·ÙÚÈ΋
1963; 3: 387-91.
49. ∫∞∑§∞ƒ∏™ ∂. ∏ ·ıÔÏÔÁÈ΋ ·Ó·ÙÔÌ›· ÙÔ˘ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1963; 3: 392-96.
50. π∫∫O™ ¢. ¶·ıÔÁ¤ÓÂÈ· ÙÔ˘ ‰Â˘ÙÂÚÔ·ıÔ‡˜ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1963; 3: 397-9.
51. ∞§πμπ∑∞ΔO™ π. ¢È¿ÁÓˆÛȘ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1963; 3: 410-34.
52. ¶∞¶∞™¶ÀƒOÀ ¡. °ÂÓÈη› ·Ú¯·› ıÂÚ·›·˜ ÙÔ˘
‰È·‚‹ÙÔ˘ Î·È ‰È·ÈÙÔÏÔÁÈ΋ ·ÁˆÁ‹. π·ÙÚÈ΋ 1963; 3:
435-42.
53. ª¶∞§O¢∏ªO™ ª. ∏ ·fi ÙÔ˘ ÛÙfiÌ·ÙÔ˜ Ê·Ú̷΢ÙÈ΋ ıÂÚ·›· ÙÔ˘ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1963; 3: 443-52.
54. °π∞¡¡∞ΔO™ π. £ÂÚ·›· ‰È· ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋
1963; 3: 453-63.
55. ¢π∞ª∞¡ΔO¶OÀ§O™ ™Δ. ¢È·‚ËÙÈÎfiÓ ÎÒÌ· Î·È ıÂÚ·›· ·˘ÙÔ‡. π·ÙÚÈ΋ 1963; 3: 464-70.
56. ¶∞¶∞¢∞ΔO™ ∫, ¡π∫O§O¶OÀ§O™ ¢. Δ· ÓÂÔÁÓ¿
ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÌËÙ¤ÚˆÓ. π·ÙÚÈ΋ 1963; 3: 471-8.
57. ¶∞¡Δ∂§∞∫∏™ ™. O ·È‰ÈÎfi˜ ‰È·‚‹Ù˘. π·ÙÚÈ΋
1963; 3: 479-84.
58. π∞∫øμπ¢∏™ °. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ·fi Ó¢ÚÔÏÔÁÈ΋˜ Î·È „˘¯È·ÙÚÈ΋˜ ÏÂ˘Ú¿˜. π·ÙÚÈ΋ 1963; 3:
485-93.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
59. ª¶OÀ∑∞™ ∞. ¢È·‚‹Ù˘ Î·È ÔÊı·ÏÌfi˜. π·ÙÚÈ΋ 1963;
3: 494-510.
60. ∫O∫§∞¡∏™ ∂. ∏ ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·. π·ÙÚÈ΋
1963; 3: 511-9.
61. ¶∞¶∞™Δ∞ª∞Δ∏™ ™. ¢È·‚‹Ù˘ Î·È Î‡ËÛȘ. π·ÙÚÈ΋
1963; 3: 520-32.
62. ¶∞À§∞ΔO™ º. ¡ÂÒÙÂÚ·È ·ÓÙÈÏ‹„ÂȘ ‰È· ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙËÓ. π·ÙÚÈ΋ 1963; 3: 533-5.
63. ∫OÀΔƒ∞™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂχıÂÚ· ÏÈ·Ú¿ Ôͤ·. π·ÙÚÈ΋ 1963; 3: 535-6.
64. ∫∞ΔΔ∞ª∏™ Ã. ÀÔÁÏ˘Î·ÈÌ›· ÙÔ˘ ÓÂÔÁÓÔ‡. π·ÙÚÈ΋
1963; 3: 536-53.
65. ∞§πμπ∑∞ΔO™ π. ∂ȉÈ΋ ·ıÔÏÔÁÔ·Ó·ÙÔÌÈ΋ ·ÏÏÔ›ˆÛȘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1963; 4: 83.
66. ª¶∞§O¢∏ªO™ ª. ∞ÓÙ·ÁˆÓÈÛÙÈÎÔ› ·Ú¿ÁÔÓÙ˜
ÚÔ˜ ÙËÓ ÈÓÛÔ˘Ï›ÓËÓ Î·È Ë ÛËÌ·Û›· ÙˆÓ ‰È· ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙËÓ. π·ÙÚÈ΋ 1963; 4: 99-106.
67. ª∞ƒ∫∂ΔO™ ™. ∞È ÓÂÊÚÈη› ÂÈÏÔη› ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1964; 5: 325-37.
68. ªOÀΔOÀ™∏™ ¡, ¶∞¡∞°O¶OÀ§O™ ∫, °π∞¡¡∞∫OÀƒ∞™ π, °∫OÀª∞™ ∞. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ¤Ú¢ӷÓ
ÙˆÓ Î˘ÚÈˆÙ¤ÚˆÓ ‚ÈÔ¯ËÌÈÎÒÓ ÌÂÙ·‚ÔÏÒÓ Î·Ù· ÙËÓ ‰È¿
ÈÓÛÔ˘ÏÈÓÈÎÒÓ ÎˆÌ¿ÙˆÓ ıÂÚ·›·Ó ÙÔ˘ Sakel. π·ÙÚÈ΋
1964; 6: 533-41.
69. ª∂ƒπ∫∞™ °, ∫OΔ™OμOÀ§OÀ μ, ∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∏. ¶ÚˆÙÔ·ı¤˜ Ë·ÙÔηÚΛӈ̷ ÌÂÙ¿
ÂÚ˘ıÚÔ΢ÙÙ·ÚÒÛˆ˜ Î·È ˘ÔÁÏ˘Î·ÈÌ›·˜. π·ÙÚÈ΋
1965; 7: 62-5.
70. ∞§πμπ∑∞ΔO™ π. ∞ÓÙÈÌÂÙÒÈÛȘ ‰È·‚‹ÙÔ˘ ηٿ ÙËÓ
ËÌ¤Ú·Ó Ù˘ ÂÁ¯ÂÈÚ‹Ûˆ˜. π·ÙÚÈ΋ 1965; 8: 314-5.
71. ª¶∞§O¢∏ªO™ ª. ∏ ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· ÂÓ
Ùˆ Ï·ÈÛ›ˆ Ù˘ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ ÙÔ˘ ‰È·‚‹ÙÔ˘.
π·ÙÚÈ΋ 1966; 10: 540-52.
72. ALIVISATOS J, MCCULLAGH EP. Stable and brittle diabetes. Amer J Med 1956; 21: 344.
73. BALODIMOS MC, HURJTHAL LM. The remote
prediabetic state. Geriatrics, 1966; 21: 119.
74. ºø∫∞™ ∂, ∞¡¢ƒπøΔ∞∫∏™ ∫, ∫∞∫§∞ª∞¡∏™ º,
∫∏§∞∏¢O¡∏™ ¶, ∫∂Δ™∂∞™ £. ¶·Ú·ÙËÚ‹ÛÂȘ
Î·È Û˘ÌÂÚ¿ÛÌ·Ù· Â› Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ·ı›·˜. ∂ÏÏËÓ. π·ÙÚ. 1961; 30: 113.
75. ª∞ƒ∫∂ΔO™ ™. ¶˘ÂÏÔÓÂÊÚ›ÙȘ. π·ÙÚÈ΋ 1966; 10:
493-506.
76. ª¶∞§O¢∏ªO™ ª. ∏ ÚfiÁÓˆÛȘ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘ Î·È Ù· ̤۷ ‚ÂÏÙÈÒÛˆ˜ Ù·‡Ù˘. ∞Ú¯. π·ÙÚ.
∂ÈÛÙ. 1962; 18: 676.
77. ¶∞¶∞¢O°π∞¡¡∞∫∏™ ¡. ÃÚÔÓ›· ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ·. π·ÙÚÈ΋ 1966; 10: 457-71.
78. ¶ƒ∞Δ™π∫∞-OÀ°OÀƒO°§OÀ ∫. ΔÔ ·ıÔÏÔÁÔ·Ó·ÙÔÌÈÎfiÓ ˘fiÛÙڈ̷ ÙÔ˘ ÓÂÊÚˆÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. π·ÙÚÈ΋ 1964; 6: 281.
79. ¶∞¡∞°O¶OÀ§O™ °. ÀÔÁÏ˘Î·È̛˜ ÛÙË ÓÂÔÁÓÈ΋,
‚ÚÂÊÈ΋ Î·È ·È‰È΋ ËÏÈΛ·. π·ÙÚÈ΋ 1967; 11: 34-49.
80. æ∞ƒƒ∞™ ∞. ∏ ˘ÔÁÏ˘Î·ÈÌ›· ·fi ¯ÂÈÚÔ˘ÚÁÈ΋˜ ·fi„ˆ˜. π·ÙÚÈ΋ 1967; 12: 358-64.
81. PAPAIOANNOU A. TumÔrs other than insulinomas
associated with hypoglycemia. Surg Gynec Obstet
1965; 123: 1093.
82. §∞¶∞Δ™∞¡∏™ ¶. ∫ÒÌ· ÛÙ· ·È‰È¿. π·ÙÚÈ΋ 1967;
12: 401-10.
83. ¶∞¶∞™¶ÀƒO™ ¡. ∏ ÈÓÛÔ˘Ï›ÓË Î·È ÙÔ ˘ÔÁÏ˘Î·ÈÌÈÎfiÓ Û‡Ó‰ÚÔÌÔÓ. §ÔÓ‰›ÓÔ: 1953.
84. PAPASPYROS N. The history of diabetes mellitus.
London, 1952: 100 p.
85. ANTONIADES H. Hormones in human plasma:
Nature and transport. London: J. & A. Churchill,
1960: 667 p.
86. °ƒ∞¡πΔ™∞™ ∞. ∂›ÙÔÌÔ˜ ‚ÈÔÏÔÁÈ΋ ¯ËÌ›· Î·È ¯ËÌÈ΋ Ê˘ÛÈÔÏÔÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1961.
87. IKKOS D, LUFT R. Effects of short term administration of large doses of human growth hormone on carbohydrate metabolism in adult, nondiabetic, hypophysectomized women; Studies with 14C-labelled glucose.
Acta Endocrinol 1962; 39: 567-83.
88. IKKOS D, LUFT R, GEMZELL CA. The effect of human growth hormone in man. Acta Endocrinol 1959;
32: 341.
89. IKKOS D, LUFT R, GEMZELL CA, ALMQUIST S.
Effect of human growth hormone on glucose tolerance and some intermediary metabolites in man. Acta Endocrinol 1962; 39: 547.
90. LUFT R, IKKOS D, GEMZELL CA, OLIVECRONA
H. The Effect of human growth hormone in hypophysectomized diabetic subjects. Lancet 1958; 1: 721-2.
91. LUFT R, IKKOS D, GEMZELL CA, OLIVECRONA
H. Effect of human growth hormone in hypophysectomized human diabetic subjects. Acta Endocrinol
1959; 32: 330-40.
92. LUFT R, OLIVERCRONA H, IKKOS D, KORNRUP T, LJUNGGREN H. Hypophysectomy in man.
Further experience with severe diabetes mellitus. Brit
Med J 1955; 2: 752-6.
93. MCCULLACH EP, ALIVIZATOS JG. Diabetes of
arterior pituitary and adrenal origin. Diabetes 1954; 3:
349.
94. ∞§πμπ∑∞ΔO™ π, ™Δ∞£∞ΔO™ ∞, μ∞Δ∑π∞™ ∫. ªÔÚÊ·› ·ÁÎÚ·ÙÈÎÔ‡ ‰È·‚‹ÙÔ˘. ∏ ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÂȘ
Ù· ˘ÔÁÏ˘Î·ÈÌÈο ÛÔ˘ÏÊ·ÌȉÈο ·Ú¿ÁˆÁ·. ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ 1957; 677.
95. ∞§πμπ∑∞ΔO™ π. ™˘ÌÊ˘Â›˜ ‰È·Ù·Ú·¯·› ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡. ¢È¿ÏÂÍȘ CIBA, 1960.
96. ∞§πμπ∑∞ΔO™ π, μ§∞ÃO™ π, °π∞¡¡∞ΔO™ π. §ÂÈÙÔ˘ÚÁÔ‡Ó ·‰¤ÓˆÌ· ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜. ¶·Ú·ÙËÚ‹ÛÂȘ
Â› ÙˆÓ ÓÂˆÙ¤ÚˆÓ ‰È·ÁÓˆÛÙÈÎÒÓ ÏÂÈÙÔ˘ÚÁÈÎÒÓ ‰ÔÎÈÌ·ÛÈÒÓ. ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο 1961; 4: 558.
97. ANDONIADES HN, GUNDERSEN K, BEIGEL-
81
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
MAN PM, PYLE HM, BOUGAS JA. Studies on the
state, transport and regulation of insulin in human
blood. Diabetes 1962; 11: 261.
98. GRODSKY GM, KARAM JH, PAVLATOS F,
FORSHAM PH. Reduction by phenformin of excessive insulin levels after glucose loading in obese and
diabetic subjects. Metabolism 1963; 12: 278.
99. ¶π∫OÀ§∏-°π∞¡¡∞∫O¶OÀ§OÀ ¶, ¶∂ƒ∞¡Δπ¡OÀ ¶. ∂Ó˙˘Ì·ÙÈÎfi˜ ÚÔÛ‰ÈÔÚÈÛÌfi˜ (Glycose oxydase) ηı·Ú¿˜ ÁÏ˘Îfi˙˘ ÂȘ ÙÔ ·›Ì·, Ô‡Ú· Î·È ÂÁÎÂÊ·ÏÔÓˆÙÈ·›ÔÓ ˘ÁÚfiÓ. ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο 1961;
23: 772.
100. ª¶∞Δƒπ¡O™ ª. ∏ ‚Ï·ÙÈ΋ Â›‰Ú·ÛȘ ÙˆÓ ÔÚÌÔÓÒÓ Â› ÙÔ˘ ÂÌ‚Ú‡Ô˘. π·ÙÚÈ΋ 1963; 3: 184.
101. BALODIMOS M, ROOT H. Hypoglycemic insulin
reactions without warning symptoms. JAMA 1959;
171: 261.
102. NIKOLOPOULOS D, SMITH C. Metabolic aspects
of idiopathic respiratory distress in newborn infants.
Pediatrics 1961; 28: 206.
103. ¶∞¢π∞Δ∂§§∏™ ∫, ∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∫. ∏
Â›‰Ú·ÛË ÙÔ˘ ‰È·‚‹ÙÔ˘ Ù˘ ÌËÙÚfi˜ Â› ÙÔ˘ ÂÌ‚Ú‡Ô˘
Î·È ÓÂÔÁÓÔ‡. ∞Ú¯. ∂ÏÏËÓ. ¶·È‰. ∂Ù·ÈÚ. 1961; 24: 25.
104. ∫ø¡™Δ∞¡Δπ¡π¢∏™ μ°. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘
·È‰È΋˜ ËÏÈΛ·˜. ¢ÂÏÙ›ÔÓ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜
¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ 1956; °′: (ÛÂÏ.?).
105. ∑∂ƒμO™ ∫. £ÂÚ·›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ÎÒÌ·ÙÔ˜.
¢ÂÏÙ›ÔÓ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ 1962; £′: 269.
106. JACOBIDES G. Neurological complications of
diabetes mellitus. National Hospital London, 1955.
107. ∫O∫§∞¡∏™ ∂. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ ÏÈȉ›ˆÓ ‰È· Ù˘ Ú·‰ÈÂÓÂÚÁÔ‡ π-131
ÙÚÈÔÏ½Ó˘ Î·È Ù˘ Û¯¤Ûˆ˜ ÚÔ˜ ÙËÓ ÛÙÂÊ·ÓÈ·›·Ó ·ÚÙËÚÈÔ¿ıÂÈ·Ó. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1961. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
108. §OÀƒO™ ¡. ª·È¢ÙÈ΋ Î·È °˘Ó·ÈÎÔÏÔÁ›·. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1963.
109. ∑∞RAFONETIS CJD, SEIFTER J, BAEDER DH,
KALAS JP. Current Clinical Status of Lipid-Mobilizer Hormone. AMA Arch πnt ªed 1959; 104: 974-81.
110. BALODIMOS M. Influence of diet upon insulin
dosage in diabetes mellitus. Diabetes 1959; 8: 196.
111. BALODIMOS M, WILLIAMS RH. Absorption of
insulin-131 from subcutaneous tissue in diabetic patients. Am J Med Sc 1962; 243: 49.
112. ª∂ƒπ∫∞™ °, ∞¡∞™Δ∞™πOÀ μ, ª∞ƒ∫∂ΔO™ ™. ΔÔ
‰È·ÁÓˆÛÙÈÎfi Úfi‚ÏËÌ· Ù˘ ˘ÂÏÔÓÂÊÚ›ÙȉԘ. π·ÙÚÈ΋
1962; 1: 344.
113. ªOÀΔOÀ™∏™ ¡, °π∞¡¡∞∫OÀƒ∞™ π, ¶∞¡∞°O¶OÀ§O™ Ã. ¢È·Î˘Ì¿ÓÛÂȘ Ù˘ ·ÏηÏÈ΋˜ ʈÛÊÛ·Ù¿Û˘ ÙÔ˘ ÔÚÔ‡ ÙÔ˘ ·›Ì·ÙÔ˜, ‰ËψÙÈη› ·Ô ÙÂÏÂÛÌ·ÙÈÎfiÙËÙÔ˜ Ù˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋
1958; 32: 10.
82
114. KORDONOURI O, KLINGHAMMER A, LANG
EB, GRÜTERS-KIESLICH A, GRABERT M,
HOLL RW. Thyroid autoimmunity in children and
adolescents with type 1 diabetes: A multicenter survey. Diabetes Care 2002; 25: 1346-50.
115. ¡π∫O§O¶OÀ§O™ ¢. ∏ ıÂÚ·¢ÙÈ΋ ÙˆÓ ·Ê˘‰·ÙÒÛˆÓ. π·ÙÚÈ΋ 1966; 9: 104-18.
116. ¢O•π∞¢∏™ ™. ¶·È‰È·ÙÚÈ΋ £ÂÚ·¢ÙÈ΋. ∞ı‹Ó·:
∫Ô‚¿Ó˘, 1955.
117. CHOREMIS C, NICOLOPOULOS D. Serum and
urine amino acids in infantile toxicosis. J of Paediatrics 1958; 53: 515.
118. ¶∞¶∞°∂øƒ°π∞¢∏™ °. ™‡Ó‰ÚÔÌ· ‰˘Û·ÔÚÚÔÊ‹Ûˆ˜ ÙˆÓ ‰È۷ί·ÚÈÙÒÓ. π·ÙÚÈ΋ 1968; 14: 239-48.
119. ¢O•π∞¢∏™ ™, ª∞¡OÀ™O™ O, ª∞ƒ¢∞™ Ã,
∞¡∞°¡ø™ΔOÀ ∂, §Àª¶∂ƒO¶OÀ§OÀ ¢. ¢˘Û·ÓÂÍ›· ÂȘ Ï‹„ÈÓ Á·Ï·ÎÙÔ˜ Î·È ‰ÔÎÈÌ·Û›· ·ÔÚÚÔÊ‹Ûˆ˜ Ï·ÎÙfi˙˘ Â› ·ÌÔÈ‚·‰ÈÎÒÓ Î·È ÌË ·ÛıÂÓÒÓ.
∂ÏÏËÓ. π·ÙÚÈ΋ 1967; 2: 252.
120. Ã∞Δ∑∏ª∏¡∞™ π. ¶¤„Ș Î·È ·Ô̇˙ËÛȘ ÙˆÓ Î˘Ú›ˆ˜ ıÚÂÙÈÎÒÓ Ô˘ÛÈÒÓ ÂȘ ÙÔ ÏÂÙfiÓ ¤ÓÙÂÚÔÓ. π·ÙÚÈ΋ 1968; 13: 81-93.
121. ∫OÀΔƒ∞™ ¢. H ıÂÚ·›· Ù˘ ˘ÔÁÏ˘Î·ÈÌ›·˜ ÌÂ
‰È·˙ÔÍ›‰ËÓ. π·ÙÚÈ΋ 1969; 15: 292-93.
122. μOÀΔ™∞¢∞∫∏™ ∞, μ∞πO¶OÀ§O™ °, μOÀ∫π¢∏™ Ã. ¶ÂÚ›ÙˆÛȘ ‰˘Û·ÔÚÚÔÊ‹Ûˆ˜ ÁÏ˘Îfi˙˘Á·Ï·ÎÙfi˙˘. π·ÙÚÈ΋ 1970; 18: 521-5.
123. ∫øΔOÀ§∞™ O, ƒOÀ™™O™ Ã, ∫OÀΔƒ∞™ ¢, ª∞ƒ∫∂ΔO™ ™. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· ÌÂÙ¿ ÓÂÎÚˆÙÈ΋˜
ıËÏ›ÙȉԘ. π·ÙÚÈ΋ 1971; 19: 528-32.
124. ™∞ª∂§§∞™ μ. ¡ÂÎÚˆÙÈ΋ ıËÏ›ÙȘ ÙÔ˘ ÓÂÊÚÔ‡. π·ÙÚÈ΋ 1968; 14: 368.
125. π∫∫O™ ¢. ∏ Â›‰Ú·ÛȘ Ù˘ ÙÔÏ‚Ô˘Ù·Ì›‰Ë˜ Î·È Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÂȘ ÙËÓ ıÓËÛÈÌfiÙËÙ· ·fi ηډȷÁÁÂȷο
ÂÂÈÛfi‰È· Û ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÙˆÓ ÂÓËϛΈÓ. π·ÙÚÈ΋ 1971; 19: 221-5.
126. π∫∫O™ ¢. ¶ÚfiÏ˄Ș ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1971; 19: 47-59.
127. π∫∫O™ ¢, ƒ∏°∞™ ∞, ƒ∞¶Δ∏™ ™, ∞§πμπ∑∞ΔO™ π,
Δ∞™O¶OÀ§O™ Ã, ¶∞À§∞ΔO™ º, ∫O¡∫OÀƒ∏™ §. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™˘˙‹ÙËÛȘ ™ÙÚÔÁÁ˘Ï‹˜ ΔÚ·¤˙˘. π·ÙÚÈ΋ 1970; 18: 393-424.
128. ƒ∏°∞™ ∞. ™‡Á¯ÚÔÓÔÈ ·ÓÙÈÏ‹„ÂȘ Â› ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1969; 15: 131.
129. LOGOTHETOPOULOS J, BELL EG. Histological
and autoradiographic studies of the islets of mice injected with insulin antibody. Diabetes 1966; 15: 205.
130. LOGOTHETOPOULOS J, DAVIDSON JK, HAIST
RE, BELL CH. Degranulationof beta cells and loss of
pancreatic insulin after infusion of insulin antibody or
glucose. Diabetes 1965; 14: 493.
131. A§πμπ∑∞ΔO™ π. ∂›ÁÔÓÙ· ÚÔ‚Ï‹Ì· Ù˘ ˘ÔÁÏ˘Î·ÈÌ›·˜ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1971;
20: 242-54.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
132. ∞§πμπ∑∞ΔO™ π. ÀÔÁÏ˘Î·ÈÌÈο Û‡Ó‰ÚÔÌ·. ™ÙÔ:
¢¿˚ÎÔ˜ °∫. ¡ÔÛÔÏÔÁ›·. ∞ı‹Ó·: ∫·Ú·‚›·˜, 1971:
684-?.
133. ∞§πμπ∑∞ΔO™ π, Oπ∫O¡OªOÀ ¡, Ã∞Δ∑∏¢∏ªO™ ∞, °Oª∞ΔO¶OÀ§O™ π, °π∞¡¡∞ΔO™ π.
™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ 1958; 611.
134. Δ™πOΔƒ∞™ ™. ™‡Á¯ÚÔÓÔÈ ·fi„ÂȘ ‰È· ÙËÓ ·fi ÙÔ˘
ÛÙfiÌ·ÙÔ˜ ıÂÚ·›·Ó ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1970; 18: 343-61.
135. ANTONIADES HN, BOUGAS JA, CAMERINIDAYALOS R, PYLE HM, MAZURKIE SJ, LOZANO-CASTANEDA O, MARBLE A. Insulin-regulatory mechanisms and diabetes mellitus. Effect of
tolbutamide on the insulin-regulatory mechanisms.
New Engl J Med 1963; 269: 386.
136. BALODIMOS M. Pathological findings after long
term sulfonylurea therapy. Diabetes 1968; 17: 503.
137. MARKETOS S, TSIGOURAKOS D, MICHAS D,
KORKOS S, KOUTRAS D. Clinical and metabolic
studies on the antidiabetic drug: Glibenglamide. Clin
Med 1970; 77: 248.
138. RAPTIS S, RAU RM, SCHRODER KE, FAULHABER JD, PFEIFFER EF. Comparative study of insulin secretion following repeated administration of
glucose, tolbutamide, and glybenclamide (HB 419) in
diabetic and non diabetic subjects. Horm Metab Res
1969; (Suppl 1): 65-72.
139. Δ™πOΔƒ∞™ ™. ∂›ÁÔÓÙ· ıÂÚ·¢ÙÈο ÚÔ‚Ï‹Ì·Ù·
ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÎˆÌ¿ÙˆÓ. π·ÙÚÈ΋ 1971; 20: 232-41.
140. ƒ∏°∞™ ∞. ∂›‰Ú·ÛȘ ÙˆÓ ·Ó·ÛÙ·ÏÙÈÎÒÓ Ù˘ ˆÔÚÚËÍ›·˜ Â› ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ ˘‰·Ù·ÓıڿΈÓ. π·ÙÚÈ΋ 1972; 22: 28-32.
141. ƒ∏°∞™ ∞, ª∞™OÀƒ∞™ Ã. ¢È·‚‹Ù˘ Î·È Î‡ËÛȘ. π·ÙÚÈ΋ 1974; 26: 13-24.
142. ƒ∏°∞™ ∞, π∫∫O™ ¢. ™˘¯ÓfiÙ˘ ÎÏÈÓÈÎÔ‡ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ÂȘ Ù¤ÎÓ· ‰È·‚ËÙÈÎÒÓ ÁÔÓ¤ˆÓ. ¡ÔÛÔÎ.
ÃÚÔÓ. 1971; 33: 453.
143. ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, £øª∞´¢∏™ £, ƒøª∞
∂, ∫∞§¶π¡∏-ª∞ÀƒOÀ ∞, Oπ∫O¡OªOÀ-ª∞ÀƒOÀ ∫. °ÂÓÈÎÂ˘Ì¤ÓË ·ÏÏÂÚÁÈ΋ ·ÓÙ›‰Ú·ÛȘ ÚÔ˜ ÙËÓ
ÈÓÛÔ˘Ï›ÓËÓ Â› Ó·ÓÈÎÔ‡ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘.
∂ÈÙ˘¯‹˜ ·¢·ÈÛıËÙÔÔ›ËÛȘ. π·ÙÚÈ΋ 1975; 27: 85-9.
144. ƒ∏°∞™ ∞, ∑∞ÃO™ ∞, ∫∞À∫∞§∞™ ª, °π∞¡¡∞ΔO™ π, ΔƒπÃO¶OÀ§OÀ-¶O§ÀÃO¡O¶OÀ§OÀ ∞. §ÈÔ·ÙÚÔÊÈÎfi˜ ‰È·‚‹Ù˘. ™‡Ó‰ÚÔÌÔÓ Lawrence. π·ÙÚÈ΋ 1975; 27: 555-62.
145. ƒ∏°∞™ ∞. πÔ› Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋
1975; 28: 497-9.
146. ∫OÀΔƒ∞™ ¢. ΔÚfiÔ˜ ¯ÚËÛÈÌÔÔÈ‹Ûˆ˜ Ù˘ ÊÚÔ˘ÎÙfi˙˘ Î·È ÛÔÚ‚›ÙÔ˘ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. π·ÙÚÈ΋
1975; 28: 313.
147. Ãπ™Δ∞∫O¶OÀ§O™ ¶, ∫∞ƒ∞ª∞¡O™ μ, £∞§∞™™π¡O™ ¡. ∏ ·ÓÙÈÌÂÙÒÈÛȘ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘ Â› ¯ÂÈÚÔ˘ÚÁÔ˘Ì¤ÓÔ˘ ·ÛıÂÓÔ‡˜. π·ÙÚÈ΋
1976; 29: 657-65.
148. ™∞ªπO™ μ. ∏ ÈÓÛÔ˘Ï›ÓË ÛÙËÓ Â›ÁÔ˘Û· ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. π·ÙÚÈ΋ 1976; 30: 567-71.
149. ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, £øª∞´¢∏™ £. ÃËÌÈÎfi˜ ‰È·‚‹Ù˘ ÛÙËÓ ·È‰È΋ ËÏÈΛ·. ¢È·ÁÓˆÛÙÈο ÎÚÈÙ‹ÚÈ·. π·ÙÚÈ΋ 1978; 33: 397-401.
150. μ∂§∂¡Δ∑∞™ Ã. ªÈÎÚ·› ‰fiÛÂȘ ÈÓÛÔ˘Ï›Ó˘ ÂȘ ÙËÓ
ıÂÚ·›·Ó ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ÎÒÌ·ÙÔ˜. π·ÙÚÈ΋ 1978;
33: 134-7.
151. ∫ƒ∞™™∞™ °. ªÂÙ·‚ÔÏÈη› Î·È ÂÓ‰ÔÎÚÈÓÔÏÔÁÈη›
‰È·Ù·Ú·¯·› Â› ·¯˘Û·ÚΛ·˜. π·ÙÚÈ΋ 1977; 31: 3149.
152. Ã∞§∂μ∂§∞∫∏™ °: ∞ÈÌÔÛÊ·ÈÚ›ÓË ∞1c Î·È Û¯¤ÛȘ
·˘Ù‹˜ Ì ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙËÓ. π·ÙÚÈ΋ 1979; 35:
357-8.
153. £∞§∞™™π¡O™ ¡. ∞ÈÌ·ÙÔÏÔÁÈη› ·Ú¿ÌÂÙÚÔÈ Î·È
Èı·Ó‹ Û¯¤ÛȘ ·˘ÙÒÓ ÚÔ˜ Ù·˜ ÂÈÏÔο˜ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1980; 4: 286-90.
154. KARAMANOS B, CHRISTAKOPOULOS P, ZACHARIOU N, KORKOLIS S. Rapid changes of the
haemoglobin A1c (HbA1c) fraction following alterations of diabetic control. Diabetologia 1977; 13:
406.
155. ™ÀªμOÀ§π¢∏™ ∞. ∏ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘˘ ÙÂÏÈÎÔ‡
ÛÙ·‰ÈÔ˘ Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ·ı›·˜. π·ÙÚÈ΋ 1980;
38: 336-40.
156. OREOPOULOS DG. Peritoneal dialysis is here to
stay. Nephron 1979; 24: 7-9.
157. ¶∞¶∞°π∞¡¡∏™ ∞, ¶∞¶∞°∂øƒ°πOÀ ∂, Ã∞™∞¶O°π∞¡¡∏™ ∫, ∞ƒ∞¶∞∫∏™ °: ∂›‰Ú·ÛË Ù˘
˘ÔÁÏ˘Î·ÈÌ›·˜ Ì ÈÓÛÔ˘Ï›ÓË ÛÙÔÓ ·Ú·ÙÂٷ̤ÓÔ ·fi
Ï‹„Ë ·ÛÈÚ›Ó˘ ¯ÚfiÓÔ ÚÔ‹˜ Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfïÓ.
π·ÙÚÈ΋ 1981; 39: 419-25.
158. °∞ƒ¢π∫∞™ ∫, ∫O∫∫π¡O™ ¢, Ã∞Δ∑∏ ∞, §∞§O™
π. ∏ Â›‰Ú·ÛȘ ÚÔÎÏËÙ‹˜ ˘ÔÁÏ˘¯·ÈÌ›·˜ Â› Ù˘ ˘ÎÓfiÙËÙÔ˜ Ù˘ ·ÓÙÈ·ÈÌÔÊÈÏÈ΋˜ ÁÏÔ‚Ô˘Ï›Ó˘. ¡ÔÛÔÎ.
ÃÚÔÓÈο 1967; 29: 653.
159. ARAPAKIS C, ANDRIOPOULOS J, PAPAYANNIS A, GARDIKAS C. The effect of hypoglycaemia on platelet count, platelet adhesiveness and
bleeding time. Vth Congress of the International Society on thrombosi and haemostasis. Paris: 358.
160. ∞§πμπ∑∞ΔO™ π, ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, §∞∫∫∞-¶∞¶∞¢O¢∏ª∞ ∂, ÃπøΔ∏™ ¢, ª∂°°ƒ∂§∏
Ã, ∫∞™™πOÀ ∫. ∂Ó‰ÔÎÚÈÓÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù·
ÛÙ· ·È‰È¿. π·ÙÚÈ΋ 1981; 40: 469-86.
161. ª∞∫∞ƒø¡∏™ °, ∞À§ø¡πΔ∏™ ™, ∫ø™Δ∞§O™
Ã, •À¶O§ÀΔ∞-Δ™∞¡Δπ§∏ ¢, Δ™πΔOÀƒ∞-§À∫O¶OÀ§OÀ ™. ™·ÛÌÔ› ÛÙ· ·È‰È¿. π·ÙÚÈ΋ 1981;
40: 487-503.
162. Δƒπ∞¡Δ∞ºÀ§§OÀ ∞, ¶∞¶∞¢∞∫OÀ-™∞ƒ∞ ∞.
∏ ÈÛÙÔ¯ËÌ›· ÙÔ˘ ÁÏ˘ÎÔÁfiÓÔ˘ Î·È Ë ÛËÌ·Û›· Ù˘ ÛÙËÓ
ÔÁÎÔÏÔÁ›· ÙÔ˘ ÛÙfiÌ·ÙÔ˜. π·ÙÚÈ΋ 1982; 41: 287-93.
163. Δƒ∞∫∞Δ∂§§∏™ ∞. μÈÔ¯ËÌ›·. £ÂÛÛ·ÏÔÓ›ÎË,
1979; ÙfiÌ. ∞′.
83
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
164. £∞§∞™™π¡O™ ¡, ™∏ª∞πO¶OÀ§OÀ-¢∏ªO¶OÀ§OÀ ¶, °π∞§OÀƒ∏™ ∞, Ã∞Δ∑∏πø∞¡¡OÀ
π. ∫ÏËÚÔÓÔÌÈ΋ ÂÈ‚¿Ú˘ÓÛȘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘
Â› ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Î·È Ì·ÚÙ‡ÚˆÓ. π·ÙÚÈ΋
1983; 43: 469-73.
165. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∂ƒπøΔ∏™ π, ªOπƒ∞™ ¡,
ª¶∂∑O™ ∏, ¢∞´∫O™ °. OÈÎÔÁÂÓÂÈ·ÎfiÓ ·Ó·ÌÓËÛÙÈÎfiÓ ‰È·‚‹ÙÔ˘ ÂÈ ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ ·
ÙfïÓ. πÔÎÚ¿Ù˘ 1977; 5: 29-35.
166. ΔƒπÃO¶OÀ§O™ ¢. π·ÙÚÈ΋ ÛÙ·ÙÈÛÙÈ΋. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1975.
167. Ãπ™Δ∞∫O¶OÀ§O™ ¶, ∫∞ƒ∞ª∞¡O™ μ, ª∞ƒπO§∏™ ª, ∫Oƒ∫O§∏™ ™, ª∂ƒπ∫∞™ °. ∏ Û˘¯ÓfiÙ˘Ù˘ ÎÏËÚÔÓÔÌÈ΋˜ ÂÈ‚·Ú‡ÓÛˆ˜ Â› ÂÓËϛΈÓ
‰È·‚ËÙÈÎÒÓ ÂÓ ∂ÏÏ¿‰È. ™ÙÔ: ¶Ú·ÎÙÈο 3Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. 1977: 125-6.
168. ª∞Àƒπ∫∞∫∏™ ª, ™∞∫§∞ƒπ¢∏™ π, ª∞ƒOÀ™∏™
°, ∫∂Ã∞°πO°§OÀ ∫, ƒ∞¶Δ∏™ ™, ∑∏ƒO°π∞¡¡∏™ ¶. ªÂÙ·‚ÔÏ·› Ù˘ ·Ô‚ÔÏ‹˜ ÙÔ˘ Ô˘ÚÈÎÔ‡ ÔͤԘ
Ô‡ÚˆÓ 24ÒÚÔ˘ Â› ÌË Ú˘ıÌÈ˙Ô̤ÓÔ˘ Î·È Î·ÙfiÈÓ Ú˘ı̛ۈ˜ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1983; 44: 6973.
169. ∫∞§πμƒ∂Δ∞∫∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º, ¶∞¶∞∑∞ÃO™ °, ¢∞´∫O™ °. ∫·Ú‰È·ÁÁÂȷΤ˜ ‰È·Ù·Ú·¯¤˜ ·fi ÚÔÛ‚ÔÏ‹ ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ Û ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋ 1984; 45: 91-6.
170. ª∞∫ƒ∞Δ∑∞∫∏™ ª. ∏ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ¯ÂÈÚÔ˘ÚÁÈÎÔ‡ ‰È·‚ËÙÈÎÔ‡ ·ÚÚÒÛÙÔ˘. π·ÙÚÈ΋ 1984; 45: 280-7.
171. PFEIFFER EF, MEISSNER C, BEISCLER W,
KERNER W, LEFE-BYRE PJ, RAPTIS S, GY R,
TAMAS JR. Antidiabetic action of somatostatin assessed by artificial B-Cell. Metabolism 1978; 18: (Suppl): 1415.
172. RAPTIS S, ZOUPAS C∏. Recent progress in the
therapy of diabetes mellitus. In: Papadatos CJ.
Progress in clinical and biological Research. New
York: Alan R Liss, 1979; 34: 299-?.
173. ∫∞Δ™π§∞ª¶ƒO™ ¡. °Ï˘Î·ÈÌÈÎfi˜ ‰Â›ÎÙ˘. ª›· ÓÂÒÙÂÚË ¤ÓÓÔÈ· ÙÔ˘ ‰È·‚‹ÙË. π·ÙÚÈ΋ 1985; 48: 191-2.
174. £∞§∞™™π¡O™ ¡. ªÔÚ› Ô ‰È·‚ËÙÈÎfi˜ Ó· ÙÚÒÂÈ
˙¿¯·ÚË; π·ÙÚÈ΋ 1986; 49: 129-30.
175. ª∞¡∂™ Ã, ¶∞¶∞∑O°§OÀ ¡. Δ·ÍÈÓfiÌËÛË Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 1-8.
176. ∫∞ƒ∞ª∏Δ™O™ ¢. ™‡Á¯ÚÔÓ· Û¯‹Ì·Ù· Î·È Ì¤ıÔ‰ÔÈ
ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1:
9-23.
177. ∞§∂μπ∑O™ ª £ÂÚ·›· ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘
ˆÊ¤ÏË Î·È Î›Ó‰˘ÓÔÈ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1:
24-37.
178. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ªøƒ∞´Δ∏™ °, ƒO∑∏-¶∞¡OÀ ¶. μ·ıÌfi˜ Ú‡ıÌÈÛ˘ Î·È Ù‡Ô˜ ıÂÚ·›·˜ ÛÂ
1000 ‰È·‚ËÙÈÎÔ‡˜ ÙÔ˘ ¡. ™ÂÚÚÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 38-42.
84
179. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ƒO∑∏-¶∞¡OÀ ¶, ªøƒ∞´Δ∏™ °. μ·ıÌfi˜ Ú‡ıÌÈÛ˘ 220 ÈÓÛÔ˘ÏÈÓÔıÂÚ·¢fiÌÂÓˆÓ ‰È·‚ËÙÈÎÒÓ. ™‡ÁÎÚÈÛË ıÂÚ·¢ÙÈÎÒÓ Û¯ËÌ¿ÙˆÓ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 43-9.
180. MHNA™ ∞, ¶∞¶∞∑O°§OÀ ¡, πø∞¡¡π¢∏™ ¢,
¶∞¶∞¢∂§∏ ∂, MANE™ Ã, KONTO°π∞¡¡∏™ π.
¢ÂÚÌ·ÙÈΤ˜ ÂΉËÏÒÛÂȘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 50-3.
181. ∞°Oƒ∞™ΔO™ π, ¶∞¶∞∑O°§OÀ ¡, μ∞∫O§∞™ π,
∫∞§∞ª¶∞∫∞™ ∞, ∫O¡ΔO°π∞¡¡∏™ π, ª∞¡∂™
Ã, °OÀ§∏™ °. ™˘¯ÓfiÙËÙ· ‰ÂÈÎÙÒÓ ÙÔ˘ HBV ÛÂ
·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™˘Û¯¤ÙÈÛË Ì ·Ú¿ÁÔÓÙ˜ Ô˘ Èı·ÓfiÓ Â˘ı‡ÓÔÓÙ·È ÁÈ· ÙËÓ ÌfiÏ˘ÓÛË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 54-8.
182. ¶∞¶∞Ã∏™ΔOÀ ∞, ¶∞¶∞°π∞¡¡∏ ∫, πø∞¡¡π¢OÀ-¶O£OÀ§∞∫∏ ™, ∫∞´™∏™ Ã, ∫∞§§π°∫∞Δ™∏™ Ã, μOÀ°πOÀ∫∞™ ∞. ™˘Ó‡·ÚÍË ÈÔÁÂÓÔ‡˜ Ë·Ù›Ùȉ·˜ Î·È Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1988; 1: 59-65.
183. ∞§∏μ∞¡∏™ ∞, ¢∂ƒμ∂¡πøΔ∏™ μ, °ƒ∂∫∞™ ¢,
¶∞¶∞°π∞¡¡∏ ∞, ¡π∫O§∞´¢∏™ ¶, ¶Àƒ¶∞™O¶OÀ§O™ ª. ™˘ÁÎÚÈÙÈ΋ ·ÍÈÔÏfiÁËÛË Ù˘ ·ÔηٿÛÙ·Û˘ ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ÛÂ
¯ÚfiÓÈ· ÂÚÈÔ‰È΋ ·ÈÌÔοı·ÚÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 66-70.
184. ª¶∞∫∞Δ™∂§O™ ™, ∫∞ƒ∞∫O§πO™ ∞, ∫∞§¶∞∫O°§OÀ ™, ¶ƒO°π∞ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢. ∫ÏÈÓÈο Î·È ‚ÈÔ¯ËÌÈο ¯·Ú·ÎÙËÚÈÛÙÈο ˘ÂÚËÏ›ÎˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 71-4.
185. ∫∞ƒ∞ª∏Δ™O™ ¢, ∫OÀƒΔO°§OÀ °, ¶∞¶∞¢O¶OÀ§OÀ º, ∫∞ƒ∞Δ∑∞™ ¡, Δƒπ∞¡ΔO¶OÀ§O™
π. ¶Ó¢ÌÔÌÂÛÔÓ¢ÌfiÓÈÔ Î·È ÌË ÙÚ·˘Ì·ÙÈ΋ Ú·‚‰ÔÌ˘fiÏ˘ÛË Û ‰È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 75-80.
186. ∑OÀ¶∞™ Ã. ∂ÍÂÏ›ÍÂȘ ÛÙËÓ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·.
∞ı‹Ó·: Nordisc Gentofte, 1983.
187. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ¶∞¶∞¢∏ª∏ΔƒπOÀ μ. ∏ ·ÈÙÈÔÏÔÁ›· Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
‰˘ÛÚ‡ıÌÈÛÙÔ˘ Î·È ·ÛÙ·ı‹ ‰È·‚‹ÙË. ∂ÏÏËÓ. π·ÙÚÈ΋
1986; 52: 30-6.
188. ALIVIZATOS J, BENROUBI M. Education, the
most important form of treat ment. In: Krall LP, Alberti KGMM, Serrano-Rios M. World book of diabetes in practice. Amsterdam: Elsevier, 1986; 2: 92-6.
189. ∞§∂μπ∑O™ ª, ∑π∞∫∞™ °, ª¶O™Δ∞¡Δ™O¶OÀ§OÀ ª, ∫O§πOÀ™∫∞™ ¢, Δ™OÀƒOÀ∫Δ™O°§OÀ °. ÀÔÁÏ˘Î·ÈÌÈο ÂÂÈÛfi‰È· ·fi ·ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ·. ∫ÏÈÓÈ΋ ÂÌÂÈÚ›·. °·ÏËÓfi˜ 1984; 26: 68894.
190. MESSARITAKIS J, KARABULA C, KATTAMIS
C, MATSANIOTIS N. Diabetes following mumps in
Sibs. Arch Dis Child 1971; 46: 561-2.
191. ∫∞ƒ∞ª∏Δ™O™ ¢, ∫∞ƒ∞∫O§πO™ ∞, ª¶∞∫∞Δ™∂§O™ ™. ∏ÏÈΛ· ‰È·ÁÓÒÛˆ˜ Î·È Ù‡Ô˜ ۷ί·-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ¶Ú·ÎÙÈο 1Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡
π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1986; ÙÔÌ. μ′:
652-(?).
192. ∞°Oƒ∞™ΔO™ π, °OÀ§∏™ °. ∏ ÏÂÈÙÔ˘ÚÁ›· Ù˘ Â͈ÎÚÈÓÔ‡˜ ÌÔ›Ú·˜ ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ Â› ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ. ¢ÂÏÙ. ¶Ú·ÎÙ. π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢ 1977; ∞-μ: 105-6.
193. Ã∞ƒ™OÀ§∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢, μÀ∑∞¡Δπ∞¢∏™ ∞, ™¶∏§πO¶OÀ§O™ ∞, Oπ∫O¡OªOÀ∞¡Δø¡π∞¢OÀ ª, ™π¡∞∫O™ ∑. πÓÛÔ˘Ï›ÓË Î·È ÏÈ›‰È· ÙÔ˘ ÔÚÔ‡ Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfïÓ, ·¯˘Û¿ÚÎˆÓ Î·È ‰È·‚ËÙÈÎÒÓ. Materia Medica Greca 1976; 4:
13-7.
194. ∫∞ƒ∞ª∏Δ™O™ ¢, ¶O§Àª∂¡π¢∏™ ∑, ∫∞ƒ∞ª¶∂ƒ∏ ∂, Ã∞ƒ™OÀ§∏™ º. ∂Ê·ÚÌÔÁ‹ ·¢·ÈÛıËÙÔÔÈ‹Ûˆ˜ Û ÂÚ›ÙˆÛË ÁÂÓÈÎÂ˘Ì¤Ó˘ ·ÏÏÂÚÁ›·˜ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. ¢ÂÏÙ. ¶Ú·ÎÙ. π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢ 1979; ∞-μ: 177-84.
195. º∞§Δ™∏™ ™. ¶·Ú·ÙËÚ‹ÛÂȘ ÙÈÓ¤˜ Â› Ù˘ ·ÓÙ·ÏÏ·Á‹˜ ÙÔ˘ ۷ί¿ÚÔ˘ ˘fi ÙˆÓ ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÓ. ¢ÂÏÙ.
¶Ú·ÎÙ. π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢ 1968; ∞:
118-24.
196. ª∂Δ∞•∞™ ¶, Δƒπ∞¡ΔO¶OÀ§O™ π, ∫∞ƒ∞ª∏Δ™O™ ¢, ∫ø™ΔO°§OÀ ∞πª. ∏ Á·Ï·ÎÙÈ΋ ÔͤˆÛȘ
Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ¶ÂÚ›ÙˆÛȘ ·ÛıÂÓÔ‡˜
Ï·Ì‚¿ÓÔÓÙÔ˜ Ê·ÈÓÊÔÚÌ›ÓËÓ. °·ÏËÓfi˜ 1972; 14: 411-9.
197. °ƒ∞¡πΔ™∞™ ∞. ∏ Â›‰Ú·ÛȘ Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÂȘ ÙÔÓ
ÌÂÙ·‚ÔÏÈÛÌfiÓ ÙˆÓ Ï¢ÎÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ ÂÈ̇ˆÓ.
¢ÂÏÙ. ¶Ú·ÎÙ. π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢
1970; ∞: 73-7.
198. º∞§Δ™∏™ ™. ∏ Â›‰Ú·ÛȘ Ù˘ ¯ÏˆÚÔıÂÈ·˙›‰Ë˜ Â›
Ù˘ ·ÓÙ·ÏÏ·Á‹˜ Ù˘ ÁÏ˘Îfi˙˘. ¢ÂÏÙ. ¶Ú·ÎÙ. π·ÙÚÈ΋˜
∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢ 1970; ∞: 77-81.
199. MANE™ Ã, ¶∞¶∞∑O°§OÀ ¡. ¢È·‚‹Ù˘ Î·È ¿ÛÎËÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 81-7.
200. ¶∞¶∞§∂•πOÀ °. OÈÓfiÓÂ˘Ì· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 87-95.
201. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¶ÚÔ‚ÏËÌ·ÙÈÛÌÔ› ÛÙËÓ ‰È·ÙÚÔÊ‹ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ¶Ô‡ Ô‰ËÁ› ÙÔ Ì¤ÏÏÔÓ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1988; 1: 96-9.
202. μO§πøΔ∏™ ∫. O ÚfiÏÔ˜ Ù˘ ÂÎ·›‰Â˘Û˘ ÛÙËÓ ıÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 100-4.
203. ∞§∂μπ∑O™ ª, ∫∞§∞ª¶∞§π∫∞ ¢, ∞¢∞ªπ¢OÀ
∞, Δ™OÀƒOÀ∫Δ™O°§OÀ °. ∞Ú¯Èο Û˘ÌÙÒÌ·Ù·
‰È·‚‹ÙË Û 418 ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1988; 1: 105-9.
204. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ∂À™Δƒ∞Δπ∞¢∏™ °, ƒO∑∏¶∞¡OÀ ¶. ™˘Ó‰˘·Ṳ̂ÓË ıÂÚ·›· (ÈÓÛÔ˘Ï›ÓË Î·È
˘ÔÁÏ˘Î·ÈÌÈο ·fi ÙÔ ÛÙfiÌ·) ÛÙÔ ‰È·‚‹ÙË Ù‡Ô˘ 2.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 110-6.
205. ∫∞ƒ∞ª∏Δ™O™ ¢, Ã∞§∫π¢∏™ Ã, ª∞¡OÀ¢∏™
º, ∫O¡ΔO¶OÀ§O™ ∞, ª∂Δ∞•∞™ ¶. ∏ ¯ÚËÛÈÌÔÔ›ËÛË ÎÏÈÓÈÎÒÓ ‰ÔÎÈÌ·ÛÈÒÓ ÛÙËÓ ‰È¿ÁÓˆÛË Ó¢ÚÔ-
¿ıÂÈ·˜ ÙÔ˘ Ê˘ÙÈÎÔ‡ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÙÔ˘ ΢ÎÏÔÊÔÚÈÎÔ‡ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 117-24.
206. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, Δ™OÀ™∏
π. ¶·Ú·ÙËÚ‹ÛÂȘ ·fi ÙËÓ ÂÊ·ÚÌÔÁ‹ Û¯‹Ì·ÙÔ˜ ÂÓÙ·ÙÈÎÔÔÈË̤Ó˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ 4 ÂÓ¤ÛˆÓ/ 24ˆÚÔ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 125-9.
207. ƒ∞´¢∏™ Ã, ¶∞¶∞∑O°§OÀ ¡, °πOÀΔπ∫∞™ ™,
ª∞¡∂™ Ã, ™∫∞ƒ∞°∫∞™ °, ∫O¡ΔO°π∞¡¡∏™ π,
Ã∞Δ∑∏∞ê∂Δ ∞. §ÂÈÙÔ˘ÚÁÈÎfiÙËÙ· Ù˘ ·ÚÈÛÙÂÚ‹˜
ÎÔÈÏ›·˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ì ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 130-5.
208. ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ¢∏ª∏Δ™π∫O°§OÀ ¡∞, ∂À™Δƒ∞Δπ∞¢∏™ °™, ªøƒ∞´Δ∏™ °™, ƒO∑∏-¶∞¡OÀ ¶. £ÂÚ·¢ÙÈΤ˜ ·Ó¿ÁΘ Î·È ‚·ıÌfi˜ Ú‡ıÌÈÛ˘ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1988; 1: 136-43.
209. CHASIOTIS D, SAHLIN K, HULTMAN E. Regulation of glycogenolysis in human muscle at rest and
during exercise. J App Physiol 1982; 53: 708-15.
210. CHRISTAKOPOULOS P, KARAMANOS B, PAPADIMITRIOU P, KARDATOS CH. The influence
of phenphormin (PH) on blood lactate (BL) and
blood glucose (Bcb) levels after heavy exercise in rats
(abstr). Diabetologia 1974; 10: 361-2.
211. CHRISTAKOPOULOS P, KARAMANOS B, ZACHARIOU N, TOUNTAS C. The pre and post -exercise lactate levels in diabetics treated with phenphormin or glibenclamide. ∂xcerpta Medica ICSN
1976; 400: 76.
212. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ™∫∞ƒ∞°∫∞
∂, °∂øƒ°∞∫O¶OÀ§OÀ ∂, ¶∞¶∞¢O¶OÀ§O™
∞, ∞£∞¡∞™π∞¢∏™ ∞. μÈÔÏÔÁÈο Â˘Ú‹Ì·Ù· (ÁÏ˘Îfi˙Ë, ÙÚÈÁÏ˘ÎÂÚ›‰È·, ¯ÔÏËÛÙÂÚ›ÓË, HDL) Ú›Ó Î·È ÌÂÙ¿ ·fi ¤ÓÙÔÓË ¿ÛÎËÛË Û ·ıÏËÙ¤˜ Î·È ÌË ·ÛÎÔ‡ÌÂÓ·
¿ÙÔÌ·. °·ÏËÓfi˜ 1990; 32: 465-74.
213. ƒO¡ΔO°π∞¡¡∏™ °, DRUCKENMILLER M,
NICHOLAS C, WANGSNESS P, BUSKIRK ER.
∞ÔÙÂÏÂÛÌ·Ù· ·fi ÙËÓ ÂÊ·ÚÌÔÁ‹ Ù˘ Ì˘È΋˜ ·Û΋Ûˆ˜ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙË̤ÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1983; 9: 136-44.
214. ¶∞¶∞§∂•πOÀ °. ∏ Â›‰Ú·ÛË Ù˘ ·Èı˘ÏÈ΋˜ ·ÏÎÔfiÏ˘ ÛÙÔ ‹·Ú, ÙÔ ¿ÁÎÚ·˜ Î·È ÙÔ ÏÂÙfi ¤ÓÙÂÚÔ ÙˆÓ
ÂÈÌ˘ÒÓ: §ÂÈÙÔ˘ÚÁÈΤ˜ Î·È ÌÔÚÊÔÏÔÁÈΤ˜ ‰È·Ù·Ú·¯¤˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1988. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
215. ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ÔÍ›· Â›‰Ú·ÛË Ù˘ ·Èı·ÓfiÏ˘
ÛÙËÓ ·ÓÔ¯‹ ÁÏ˘Îfi˙˘, ÙËÓ ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ Î·È ÙËÓ
ÌÂÙ·ÁÂ˘Ì·ÙÈ΋ ˘ÂÚÏÈȉ·ÈÌ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
216. ¶∞¶∞¡π∫O§∞OÀ °. ™‡Á¯ÚÔÓË ‰È·ÙÚÔÊ‹ Î·È ‰È·ÈÙÔÏÔÁ›·: ¢›·ÈÙ˜ ÁÈ· fiϘ ÙȘ ·ı‹ÛÂȘ. ∞ı‹Ó·, 1982.
217. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚ËÙÈ΋ ‰›·ÈÙ· Î·È ÚˆÙ½Ó˜. π·ÙÚÈ΋ 1988; 54: 325-6.
218. KATSILAMPROS N. Mediterranean-type fiber-rich
85
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
foods for diabetes. In: Krall LP, Alberti KGMM, Turtle JR. World Book of Diabetes in Practice. Amsterdam: Elsevier, 1988; vol.3: 110-3.
219. ∞ƒ∂Δ∞πO™ O ∫∞¶¶∞¢O∫∏™. ¶ÂÚ› ·ÈÙ›ˆÓ ηÈ
ÛËÌ›ˆÓ ÔͤˆÓ Î·È ¯ÚÔÓ›ˆÓ ·ıÒÓ. 2Ô˜ ·ÈÒÓ Ì.¯.
220. ª¶∞∫∞§O™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∫ÏÈÓÈο ÌÂÙÂÎ·È‰Â˘ÙÈο Ì·ı‹Ì·Ù· ÂÛˆÙÂÚÈ΋˜ ·ıÔÏÔÁ›·˜ ηÈ
ıÂÚ·¢ÙÈ΋˜. ∞ı‹Ó·: ™˘ÚfiÔ˘ÏÔ˜, 1985: 808 ÛÂÏ.
221. ¶O§Àª∂¡π¢∏™ ∑. ∞ÓÔÛÔÁÂÓÂÙÈ΋ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ π. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2:
11-4.
222. ¢∞¡π∏§π¢∏™ ª. ∞˘ÙÔ·ÓÔÛ›· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘ Ù‡Ô˘ π. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 1522.
223. ∞§∂μπ∑O™ ª. ¢È·Ù·Ú·¯‹ ÙˆÓ ÏÈÒÓ ÙÔ˘ ·›Ì·ÙÔ˜
ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1989; 2: 23-34.
224. §∞∑∞ƒπ¢∏™ ∞. ∏ ·ıÔÁ¤ÓÂÈ· Ù˘ ˘¤ÚÙ·Û˘ ÛÙÔÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2:
35-9.
225. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ∫§∂π™π∞ƒ∏™ μ, ¶∞¶∞§∂•πOÀ °, ∑∞ª¶OÀ§∏™ Ã.
∏ Û˘¯ÓfiÙËÙ· Ù˘ ·ÚÙËÚȷ΋˜ ˘¤ÚÙ·Û˘ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ·ÛıÂÓ›˜ ‰È·‚ËÙÔÏÔÁÈÎÒÓ È·ÙÚ›ˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 40-4.
226. ∫Àƒ¶π∑π¢∏™ Ã, ª¶OÀºπ¢OÀ ∞, ¡π∫O§∞´¢∏™ ∞, ªOÀƒΔ∑πO™ °, ÃÀ™O¶OÀ§O™ Ã, ¶∞¶∞∑∞Ã∞ƒπOÀ °. ∂ÎÙ›ÌËÛË ÙÔ˘ ÌÂÁ¤ıÔ˘˜ ÙÔ˘ ÂÌÊÚ¿ÁÌ· ÙÔ˜ ÙÔ˘ Ì˘Ôηډ›Ô˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 45-8.
227. ∂À£ÀªπOÀ ∏, ¶O¡Δπ∫π¢∏™ ¡, ª∂´¢∞¡∏ ª,
∫∞§Δ™∞™ £, ¶∞¶∞¢O¶OÀ§OÀ º, ª¶∞ª¶∞™∏™ μ, ¶∞∑∞´ΔOÀ ∫. ™˘Û¯¤ÙÈÛË ÂÈ¤‰ˆÓ Ù˘ GH
Î·È ÙÔ˘ ۷ί¿ÚÔ˘ Û ÌÂÁ·Ï·ÎÚÈÎÔ‡˜ ·ÛıÂÓ›˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 49-54.
228. ª¶OÀƒ∞ ¶, ¶∞¶∞∑O°§OÀ ¡, ¶∞¶∞¢O¶OÀ§OÀ ∞, ª∞¡∂™ Ã, ª∞°OÀ§∞ π, Δ™∞¶∞™ °,
∫O¡ΔO°π∞¡¡∏™ π, ™∫∞ƒ∞°∫∞™ °. ∏ ÎÈÓËÙÈÎfiÙËÙ· ÙˆÓ ÂÚÈÊÂÚÈÎÒÓ ÌÔÓÔ˘Ú‹ÓˆÓ ·ÛıÂÓÒÓ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË Ù‡Ô˘ π Î·È Ë in vivo
Â›‰Ú·ÛË ÙÔ˘ ·ÛÎÔÚ‚ÈÎÔ‡ ÔͤԘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 55-9.
229. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ∂À™Δƒ∞Δπ∞¢∏™ °, ƒO∑∏¶∞¡OÀ ¶, ª¶∂§O°π∞¡¡∏™ ∞, ªøƒ∞´Δ∏™ °.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÚÈÊÂÚÈ΋ ·Ú¿Ï˘ÛË ÙÔ˘
ÚÔÛˆÈÎÔ‡ Ó‡ÚÔ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2:
60-4.
230. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ∂À™Δƒ∞Δπ∞¢∏™ °, ¢∏ª∏Δ™π∫O°§OÀ ∞π∫. O Ô˘‰fi˜ ·ÓÙ›Ï˄˘ ËÏÂÎÙÚÈÎÒÓ
ÂÚÂıÈÛÌ¿ÙˆÓ ÛÙËÓ ÚÒ˚ÌË ‰È¿ÁÓˆÛË Ù˘ ÂÚÈÊÂÚÈ΋˜
‰È·‚ËÙÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1989; 2: 65-73.
231. OÀμ∂¡∏™ π, μ§∞ÃO°π∞¡¡∏™ ∂, μO§πøΔ∏™
86
∫, ™π¢∏ƒO¶OÀ§O™ ∫, ∫ƒπª§π¢∏™ π. ™˘Ó‡·ÚÍË Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Î·È ·Û˘Ìو̷ÙÈ΋˜ ¯ÔÏÔÏÈı›·Û˘. O ÚfiÏÔ˜ ÙˆÓ ÏÈȉ›ˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 74-9.
232. ∫∞ƒ∞ª∏Δ™O™ ¢. ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ ÁÈ· ÙËÓ ·ÈÙÈÔÏÔÁ›· ÙÔ˘ Ó·ÓÈÎÔ‡ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (‰È·‚‹ÙË
Ù‡Ô˘ π). ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 1982; 48: 67-9.
233. ¶O§Àª∂¡π¢∏™ ∑. ΔÔ Û‡ÛÙËÌ· HLA. ¶Ú·ÎÙÈΤ˜
ÂÊ·ÚÌÔÁ¤˜. ™ÙÔ: ™ÂÌÈÓ¿ÚÈÔ ∞ÓÔÛÔÏÔÁ›·˜ 4Ô˜ ·ÎÏÔ˜. ∞ı‹Ó·, 1985; 59-77.
234. ¶O§Àª∂¡π¢∏™ ∑. ∏ ÂͤÏÈÍË ÙÔ˘ M. H. C. ™ÙÔ:
¶ÚÔÛ˘Ó‰Úȷ΋ ËÌÂÚ›‰· ÙÔ˘ 13Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. ∞ı‹Ó·, 1987: 1-13.
235. ¶∞ÃOÀ§∞-¶∞¶∞™Δ∂ƒπ∞¢∏ Ã. ∞ÓÙÈÁfiÓ· ÈÛÙÔÛ˘Ì‚·ÙfiÙËÙ·˜ HLA Î·È ÓÔÛ‹Ì·Ù·. ™ÙÔ: ¶ÚÔÛ˘Ó‰Úȷ΋ ËÌÂÚ›‰· ÙÔ˘ 13Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. ∞ı‹Ó·, 1987: 67-75.
236. KARAMITSOS D, POLYMENIDIS Z, KATSARIS
G, EFTHIMIOU EL. HLA-A, B antigens in Greek
patients with type I diabetes mellitus. Diabetologia
1980; 19: 287.
237. ∫OÀμ∞ƒ∞™ °, ∞£∞¡∞™O¶OÀ§O™ °, ∫O∫∫π¡O™ ¢. ªÂ›ˆÛË Ù˘ ÂÈ‚›ˆÛ˘ ÙˆÓ ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÌÂÙ¿ ·fi Ô͇ ¤ÌÊÚ·ÁÌ· ÙÔ˘ Ì˘Ôηډ›Ô˘. ∂ÏÏËÓ. ∫·Ú‰ÈÔÏ. ∂ÈıÂÒÚËÛË 1987; 28: 1949.
238. ª¶∞§O°π∞¡¡∏™ ™Δ. ∫ÏÈÓÈ΋ ¡Â˘ÚÔ·ıÔÏÔÁ›·.
£ÂÛÛ·ÏÔÓ›ÎË, 1984; ÙÔÌ. ∞′: 345 ÛÂÏ.
239. KATSILAMBROS N, HATZAKIS A, PERDIKARIS G, PEFANIS A, PAPAZACHOS G, PAPADOGIANNHS D, BALAS P. Peripheral occlusive arterial disease in longstanding diabetes mellitus. Internat.
Angiol. 1989; 8: 36-40.
240. KATSILAMBROS N, ALIFERIS K, DARVIRI C,
TSAPOGAS P, ALEXIOU Z, TRITOS N, ARVANITIS K, LYRAKI P, HELIOPOULOS S, SFIKAKIS P. Pat tern of treatment among diabetic patients
in a sample of urban Greek population. Diabete &
Metabolisme 1993; 19: 130-2.
241. KATSILAMBROS N, KEFALOGIANNHS N, KILBASANIS H, KEEN A, DAπKOS G. Glukosetoleranz und electrokardiographische Befunde bei ein
whonernmittleren Alters eines Dorfes auf Kreta. Die
Medizinische Welt 1981; 43: 2-4.
242. BALAS P, MELA A, KATSILAMBROS N. Comparison of clinical angiographic and laboratory findings in diabetic and non diabetic patients with peripheral arterial occlusive disease. Folia Angiologica
1982/83; XXX/XXXI: 333-6.
243. KATSILAMBROS N, HATZAKIS A, PERDICARIS G, PEFANIS A, TOULOUMI G. Total and
cause-specific mortality in a population based cohort
of diabetics in Greece. Diabete & Metabolisme 1991;
17: 410-14.
244. KATSILAMBROS N, ALIFERIS K, DARVIRI CH,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
TSAPOGAS P, ALEXIOU Z, TRITOS N, ARVANITIS M. Evidence for an increase in the prevalence
of known diabetes in a sample of an urban population
in Greece. Diabetic Medicine 1993; 10: 87-90.
245. HAGIANGELAKI E, JAEGER C, MAESER E,
BRETZEL RG, FEDERLIN K. GAD 65 antibody
but not ICA positivity in adultonset diabetic patients
is associated with early progression to clinical insulin
dependency. Acta Diabetol 1996; 33: 291-4.
246. ¶∞¶∞∑O°§OÀ ¢∂™¶. ªÂϤÙË ÙÔ˘ ÎfiÛÙÔ˘˜ Ù˘
ÂͤٷÛ˘ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙ· ∂͈ÙÂÚÈο π·ÙÚ›· ÙÔ˘ ¢È·‚ËÙÔÏÔÁÈÎÔ‡ ∫¤ÓÙÚÔ˘ ÙÔ˘ ∞′ °ÂÓÈÎÔ‡
¡ÔÛÔÎÔÌ›Ԣ «ÕÁÈÔ˜ ¶·‡ÏÔ˜» £ÂÛÛ·ÏÔӛ΢. £ÂÛÛ·ÏÔÓ›ÎË: City Liberal Studies-Business Administration and Economics Department, 1994.
247. A§πμπ∑∞ΔO™ π. ∏ ÊÚÔÓÙ›‰· ˘Á›·˜ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡¡¤Â˜ ·ÓÙÈÏ‹„ÂȘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 81-9.
248. Ã∞ƒ™OÀ§∏™ º. ¢È·‚‹Ù˘ Î·È ÎÏËÚÔÓÔÌÈÎfiÙËÙ·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 90-7.
249. ∫∞Δ∑O™ °. ∏ ۈ̷ÙÈ΋ ·‡ÍËÛË Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1989; 2: 98-104.
250. ¶∞¶∞ª∞ƒ°∞ƒπΔ∏™ ∫. ∞μƒ∞ªπ¢∏™ ∞. ∞˘ÍËÙÈ΋ ÔÚÌfiÓË Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi˙˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1989; 2: 105-12.
251. ª∞¡∂™ Ã, ¶∞¶∞∑O°§OÀ ¡. º·ÈÓfiÌÂÓ· Somogyi Î·È Dawn. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 113-9.
252. Δ™∞¶∞™ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Ô˘ÚÈÎfi Ô͇.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 120-4.
253. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ¶∞°∫∞§O™ ∂, ¶∞¡Δ∞§∏ ª, ¶∞¶∞§∂•πOÀ °. ¢›·ÈÙ·
‰È·‚ËÙÈÎÔ‡. ¶ÔÈ¿ ‰›·ÈÙ· Î·È Ò˜; ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 125-45.
254. K∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ™π∞ª¶∞¡∏™ Ã, ∫OÀƒΔO°§OÀ °, ∞μƒ∞ªπ¢∏™ ∞,
Δ™OÀ™∏ π, ∫O¡ΔO¶OÀ§O™ ∞. ∏ Ùˆ¯‹ Ú‡ıÌÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ·Ú¿ÁÔÓÙ·˜ ÎÈÓ‰‡ÓÔ˘ ÁÈ·
ÂÈÏÔΤ˜ Î·È ıÓËÙfiÙËÙ· ÛÙËÓ ÔÍ›· Ê¿ÛË ÂÌÊÚ¿ÁÌ·ÙÔ˜ Ì˘Ôηډ›Ô˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2:
146-51.
255. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §, ƒO∑∏-¶∞¡OÀ ¶, ªOÀ™Δ∞∫∞™ ™, μ∞μ∞§∂∫∞™ °, ªøƒ∞´Δ∏™ °. ¶ÂÚÈ·ÚıÚ›ÙȘ ÙÔ˘ ÒÌÔ˘ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1989; 2: 152-8.
256. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞™∫∞ƒ∞°∫∞ ∂, ª∞¡∂™ Ã, ∫O¡ΔO°π∞¡¡∏™ π,
§πOÀΔ∞™ ∞, °∂øƒ°∞∫O¶OÀ§OÀ ∂. ∂›‰Ú·ÛË
ÙˆÓ ‰ÈÁÔ˘·‰ÈÓÒÓ Â› ÙÔ˘ ÂÈ¤‰Ô˘ ÙÔ˘ ÈÓˆ‰ÔÁfiÓÔ˘
Ï¿ÛÌ·ÙÔ˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÚÚÒÛÙÔ˘˜. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1989; 2: 159-62.
257. ∞§πμπ∑∞ΔO™ π. ∏ ÂÈÎÔÈÓˆÓ›· È·ÙÚÔ‡-·ÚÚÒÛÙÔ˘.
π·ÙÚÈ΋ 1980; 37: 273-6.
258. ALIVIZATOS J. The diabetic-his own doctor. The
diabetologist’s view. In: Diabetes Mellitus in Europe:
A problem at all ages in all Countries. A model for
prevention and self-care. WHO and IDF Europe. St.
Vincent (Aosta), Italy. 10-12 October 1989: (p.?).
259. ∫∞¡∞∫OÀ¢∏-Δ™∞∫∞§π¢OÀ º, Ã∞ƒ™OÀ§∏™
º, ¶∞¶∞¢O¶OÀ§OÀ ª, ∞ÓÙÈÓËÛȉȷο ·ÓÙÈÛÒÌ·Ù· Û ·È‰È¿ Ì ÚfiÛÊ·ÙË ‰È¿ÁÓˆÛË Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË Î·È Ì ÔÚÈṲ̂Ó˜ ÈÔÁÂÓ›˜ ÏÔÈÌÒÍÂȘ. ªat
Med Greca 1983; 11: 428-33.
260. HARSOULIS F, KANAKOUDI-TSAKALIDOU F,
VYZANTIADIS A, et al. Beta cell residual function
and islet-cell antibodies in newly diagnosed juvenileonset diabetes. Acta Endocrinologica 1983; 161:
(Suppl): 49-50.
261. ¶∞§∂Δ∞™ ∫, ª∞°OÀ§∞ π, Δ™∞¶∞™ °, ª∞ÀƒOª∞Δπ¢∏™ ∫, Δ∑∂Δ∑∏™ μ, μπ™μ∞ƒ¢∏™ °. ™ˆÏËÓ·Úȷ΋ ÌÂÙ·ÊÔÚ¿ ÙÔ˘ Ô˘ÚÈÎÔ‡ ÔͤԘ Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ π ·ÛıÂÓ›˜ Ì ˘ÔÔ˘Úȯ·ÈÌ›·. ™ÙÔ: ¶Ú·ÎÙÈο 5Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ ™˘Ó‰ڛԢ ¡ÂÊÚÔÏÔÁ›·˜.
1989; 359-64.
262. KAKLAMANIS P, RIGAS A, GIANNATOS G,
MATSAS S, ECONOMOU P. Calcification of the
shoulders and diabetes mellitus. New Engl J Med
1975; 293: 1266-7.
263. MAVRIKAKIS M, DRIMIS S, KONTOYANNIS D,
RASIDAKIS A, MOULOPOULOU E, KONTOYANNIS S. Calcific shoulder periarthritis (tendinitis)
in adult onset diabetes mellitus: a controlled study.
Ann Rheum Dis 1989; 48: 211.
264. ª¶∞∫∞Δ™∂§O™ ™. ªÂÙ·‚ÔÏÈÎÔ› ÚÔÛ·ÚÌÔÛÙÈÎÔ›
Ì˯·ÓÈÛÌÔ› ÛÙË ÓËÛÙ›·. ∞fiÏ˘ÙË ÓËÛÙ›· Î·È ÔÏÈÁÔıÂÚÌȉÈΤ˜ ‰›·ÈÙ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 113.
265. ∫∞ƒ∞¶π¶∂ƒ∏™ ∞, ∞μƒ∞ªπ¢∏™ ∞. ¶·ı‹ÛÂȘ ÙÔ˘
ÊÏÔÈÔ‡ ÙˆÓ ÂÈÓÂÊÚȉ›ˆÓ Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ Ù˘ ÁÏ˘Îfi˙˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 14-9.
266. ∫∞ƒ∞ª∏Δ™O™ ¢. ∞ÓıÚÒÈÓË ÈÓÛÔ˘Ï›ÓË Î·È ˘ÔÁÏ˘Î·ÈÌ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 20-3.
267. ∂À£ÀªπOÀ ∏. °Ï˘Î·ÁfiÓË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 24-6.
268. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫. ¢È·Ù·Ú·¯¤˜ ÔÍÂÔ‚·ÛÈ΋˜ ÈÛÔÚÚÔ›·˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 27-31.
269. ¶∞Δ∞∫∞™ ∂. ¢È·‚‹Ù˘ Î·È ÓfiÛÔ˜ ÙÔ˘ ÂÚÈÔ‰ÔÓÙ›Ô˘.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 32-4.
270. ∂À£ÀªπOÀ ∏, Δƒπ∞¡Δ∞ºÀ§§OÀ °, °π∞¡¡OÀ§∏ Ã, ∫∞§Δ™∞™ £, Δ∑∂Δ∑∏™ μ, °∞∫∏™ ¢,
Δƒ∞´∞¡π¢∏™ ¶, ∫∞§π°∫∞Δ™∏™ Ã, ª¶∞ª¶∞™∏™ μ. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ ππ (ÚˆÁÓˆÛÙÈÎÔ› ·Ú¿ÁÔÓÙ˜).
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 35-40.
271. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∂À£ÀªπOÀ ∏, °π∞¡¡OÀ§∏ Ã, ∫∞§Δ™∞™ £, Ã∞μ∞§∂ π, Δ™π∞ª¶∞§∏™ π, ¶O¡Δπ∫π¢∏™ ¡, ¶∞¶∞¢O¶OÀ§OÀ º,
Δƒ∞´∞¡π¢∏™ ¶. ¶·Ú·ÎÔÏÔ‡ıËÛË Ù˘ ‰È·‚ËÙÈ΋˜
·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Â› ÔÎÙ¿ÌËÓÔ Û ÈÓÛÔ˘ÏÈ-
87
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ÓÔıÂÚ·¢fiÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì ÌÈÎÙfi Û¯‹Ì· ‰‡Ô
ÂÓ¤ÛˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 41-7.
272. º∂ƒ∂Δ∏™ ∏, ª∞ƒΔπ¡∏™ ∞, Ã∞Δ∑∏™¶∞™OÀ ∂,
æÀÃO°πO¶OÀ§OÀ °, ¶OÀ§∞∫∏ £, º§øƒ∞∫∏ ∫. ∞ÓÙÈÌÂÙÒÈÛË ÂÈÏÔÎÒÓ ˘ÂÚÏ·ÛÙÈ΋˜ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1990; 3: 48-50.
273. ¶∞Δ∞∫∞™ ∂. ¶Ú·ÎÙÈΤ˜ Ô‰ËÁ›Â˜ ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜ ÛÙÔ Ô‰ÔÓÙÈ·ÙÚ›Ô.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 51-5.
274. ∫OÀΔƒ∞™ ¢. ∂ÈÛ·ÁˆÁ‹ ÛÙËÓ ÂÓ‰ÔÎÚÈÓÔÏÔÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1983: 299
ÛÂÏ.
275. KORDONOURI O, DEISS D, DANNE T, DOROW
A, BASSIR C, GRÜTERS-KIESLICH A. Predictivity of thyroid autoantibodies for the development of
thyroid disorders in children and adolescents with
Type 1 diabetes. Diabet Med 2002; 19: 518-21.
276. ºƒ∞°∫π™∫O™ ºƒ. ∂Í·ÁˆÁ¤˜ ‰ÔÓÙÈÒÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ. O‰ÔÓÙÔÛÙÔÌ·ÙÔÏÔÁÈ΋ ¶ÚfiÔ‰Ô˜ 1989; 43: 67-75.
277. ∫Oª¶O§∏-∫O¡ΔOμ∞∑∞π¡πΔ∏ ª, ∫∞Δ∂Ã∏™
∞. ∫ÏÈÓÈ΋ Û¯¤ÛË ‰È·‚‹ÙË Î·È ÓfiÛˆÓ ÙÔ˘ ÂÚÈÔ‰ÔÓÙ›Ô˘. ™ÙÔÌ·ÙÔÏÔÁ›· 1983; 40: 241-5.
278. KORDONOURI O, SHUGA N, LEWY H, ASHKENAZI I, LARON Z. Seasonality of month of birth of
children and adolescents with type 1 diabetes mellitus
in Berlin differs from the general population. Eur J
Pediatr 2002; 161: 291-2.
279. £∞§∞™™π¡O™ ¡Ã. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∂Í¿ÚÙËÛË ·fi ÙË ÌÂÙ·‚ÔÏÈ΋ Ú‡ıÌÈÛË. ¡ÔÛÔÎ. ÃÚÔÓÈο 1989; 51: 20-5.
280. ∞§∂μπ∑O™ ª. ªË ÂÓ˙˘Ì·ÙÈ΋ ÁÏ˘ÎÔ˙˘Ï›ˆÛË ÚˆÙÂ˚ÓÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 57-63.
281. ∫OÀƒΔO°§OÀ °. ø̤Á·-3 ÏÈ·Ú¿ Ôͤ· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3:
64-72.
282. ∫∏Δ∞ ª, ∞μƒ∞ªπ¢∏™ ∞. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 73-80.
283. μO§πøΔ∏™ ∫. ∂Ӊ›ÍÂȘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 81-6.
284. ∫∞ƒ∞ª∏Δ™O™ ¢, ∞¡£πªπ¢∏™ °, ª¶∞∫∞Δ™∂§O™ ™, ΔπªO™π¢∏™ ª. ∫ÏÈÓÈΤ˜ ·Ú·ÙËÚ‹ÛÂȘ ÁÈ·
ÙË ‰Â˘ÙÂÚÔ·ı‹ ·ÛÙÔ¯›· ÙˆÓ ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 87-91.
285. ª∞°OÀ§∞ π, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã,
∫OÀ¡ΔOÀƒ∞™ π, ¶∞¶∞¢∂§∏ ∂, Ã∞Δ∑∏∞ê∂Δ ∞, Δ™∞¶∞™ °. πÛÙÈο ·Ôı¤Ì·Ù· Ù˘ ‚ÈÙ·Ì›Ó˘ C ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜: ¶·Ú·ÙËÚ‹ÛÂȘ
ÛÙËÓ ·ÔÚÚfiÊËÛ‹ Ù˘ ·fi ÙÔ Á·ÛÙÚÂÓÙÂÚÈÎfi Û‡ÛÙËÌ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 92-8.
286. ª¶∞∫∞Δ™∂§O™ ™, ∫OÀƒΔO°§OÀ °, ∞μƒ∞ªπ¢∏™ ª, ™π∞ª¶∞¡∏™ Ã, ºøΔO¶OÀ§O™ ¢, ∫O¡ΔO¶OÀ§O™ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢. ŒÎ‚·ÛË Ù˘
ÓÔÛÔÎÔÌÂȷ΋˜ Ê¿Û˘ ÔͤԘ ÂÌÊÚ¿ÁÌ·ÙÔ˜ Ì˘ÔηÚ-
88
‰›Ô˘ Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1990; 3: 99-106.
287. ¶∞°∫∞§O™ ∂, ™πç∂Δπ¢∏™ ∞, ¶∞∑∞ƒ§O°§OÀ ª, ¶∞¶∞´ø∞¡¡OÀ ∞, ¢∞™∫∞§O¶OÀ§OÀ ∂, ∫OÀ¶π¢OÀ ™, ª∏§πø¡∏™ ∞. ªÂϤÙË
Ù˘ ·Ó·Ó¢ÛÙÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ Û ·ÛıÂÓ›˜ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1990; 3: 107-10.
288. ™∫∞ƒ∞°∫∞™ °, ∫O¡ΔO°π∞¡¡∏™ π, Δ™O∫∞¡∏
¶, ¢∏ª∏ΔƒπOÀ º, ∑∏∫π¢OÀ Ã, °∂øƒ°∞∫O¶OÀ§OÀ ∂, ¶∞¶∞∑O°§OÀ ¡. ªÂÙ·‚ÔϤ˜ ÙˆÓ
ÂÈ¤‰ˆÓ Ù˘ HDL ¯ÔÏËÛÙÂÚfiÏ˘ Î·È ÙÔ˘ ‰Â›ÎÙË ·ıËڈ̷ÙÔÁ¤ÓÂÛ˘ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÚÚÒÛÙÔ˘˜ ÌÂÙ¿ ·fi
¯ÔÚ‹ÁËÛË ÌÂ˙·ÊÈÌÚ¿Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1990; 3: 111-5.
289. Δƒπ∞¡ΔO™ ∞. μÈÔÛ‡ÓıÂÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘ ·fi ÙÔ
‚fiÂÈÔ ¿ÁÎÚ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1990; 3: 11623
290. º∂ƒ∂Δ∏™ ∏, Ã∞Δ∑∏™¶∞™OÀ ∂, Δ™∞∫ƒ∏ ª,
¶OÀ§∞∫∏ £. ∞ÓÙÈÌÂÙÒÈÛË ÓÂÔ·ÁÁÂÈ·ÎÔ‡ ÁÏ·˘ÎÒÌ·ÙÔ˜ Ì ÂÓ‰ÔʈÙÔËÍ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1990; 3: 124-7.
291. CHARONIS A, REGER L, DEGE J, ∫OLIAKOS
K, FURCHT L, WOHLHUETER R, TSILIBARY E.
Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 1990; 39: 807-14.
292. SIMOPOULOS A. Omega-3 fatty acids from fish and
fish oils. Nutritional and health effects Epitheorese
Klinikes Farmakologias and Farmakokinetikes. International Edition 1987; 1: 23-31.
293. Δƒπ∞¡ΔO™ ∞. ª¤ıÔ‰Ô˜ ·ÔÌÔÓÒÛˆ˜ ÚÔ˚ÓÛÔ˘Ï›Ó˘ ·fi ÙÔ ‚fiÂÈÔ ¿ÁÎÚ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1976. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
294. ¶∞¶∞¢∏ª∏ΔƒπOÀ ª, ª¶∞∫∞Δ™∂§O™ ™,
Δ™∞∫πƒ∏™ ¢, ™∞∫∂§§∞ƒπOÀ °, ∞§∂•O¶OÀ§O™ ∂, ¶∞¶∞¡π∫O§∞OÀ μ. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ¢È¿ÁÓˆÛË-ÚfiÏË„Ë-ıÂÚ·›·. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 1-42.
295. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ΔπªO™π¢∏™ ª, ∞¡£πªπ¢∏™ °. ∏ Û˘ÌÌfiÚʈÛË ÛÙË ‰›·ÈÙ·
·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1991; 4: 43-6.
296. ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º, ∫∞æπª∞§∞∫OÀ °, §∞¡∞ƒ∞™ §, ∫ø™Δ∂§∂ΔO™ °, ∫øºOΔ∑OÀ§∏ §, ª∞°∫§∞ƒ∞ ∂, ™º∏∫∞∫∏™ ¶.
¶·ÛÙ¤ÏÈ, ÁχÎÈÛÌ· ηٿÏÏËÏÔ ÁÈ· ‰È·‚ËÙÈÎÔ‡˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 47-51.
297. ª∞°OÀ§∞ π, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã,
™∫∞ƒ∞°∫∞™ °, Ã∞Δ∑∏∞ê∂Δ ∞, Δ∑OÀ¡∞™
∫, Δ™∞¶∞™ °. ∏ Â›‰Ú·ÛË Ù˘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ ÛÙËÓ
˘ÎÓfiÙËÙ· ÙÔ˘ ·ÛÎÔÚ‚ÈÎÔ‡ ÔͤԘ ÛÙ· Ï¢ÎÔ·ÙÙ·Ú·
‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4:
52-7.
298. ¡∂OÀ ¶, ∫∞™™πOÀ ∫, ∑ø´¢OÀ ∞, ƒOÀ™™∏ ª,
∫∞ƒ∞°π∞¡¡∏ Ã, ª¶∞ƒΔ™O∫∞™ Ã. ™˘Û¯¤ÙÈÛË
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ÙÈÌÒÓ ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ Ì ÙËÓ ËÏÈΛ·
ÂÌÊ¿ÓÈÛ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË, ÙË ‰È¿ÚÎÂÈ· Ù˘ ÓfiÛÔ˘ Î·È ÙË ‚·Ú‡ÙËÙ· ÂÌÊ¿ÓÈÛ˘ ÛÙ· ·È‰È¿. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4:
58-62.
299. ΔπªO™π¢∏™ ª, ª¶∞∫∞Δ™∂§O™ ™, ∞¡£πªπ¢∏™ °, ∫∞ƒ∞ª∏Δ™O™ ¢. ™˘ÌÌfiÚʈÛË ·ÛıÂÓÒÓ
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ ÛÙË Ê·Ú̷΢ÙÈ΋
·ÁˆÁ‹. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 63-6.
300. ¶∞¶∞¢∏ª∏ΔƒπOÀ ª. ¡ÂÊÚÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 1988.
301. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ™ÙÔ:
¶··‰ËÌËÙÚ›Ô˘ ª. NÂÊÚÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 1988; ÙfiÌÔ˜ ππ: 789-800.
302. OREOPOULOS D, ROBSON M, IZATT S, CLAYTON S, DE VEBER G. A simple and safe technique
for CAPD. Trans Am Soc Artif Int Organs 1978; 24:
484-9.
303. TSAKIRIS D, SMITH W, BRIGGS J, JUNOR B.
Three years experience of CAPD. Scot Med 1986; 31:
79-84.
304. KHANNA R, OREOPOULOS D. CAPD in patients
with diabetes mellitus. In: Gokal R. Continuous ambulatory peritoneal dialysis. Edinburgh: Churchill Livingstone, 1986; 295-305.
305. KHANNA R, WU G, CHISHOLM L, OREOPOULOS D. Further experience with CAPD in diabetics
with end stage renal disease. In: Keen H, Legrain M.
Prevention and treatment of diabetic nephropathy.
Boston: MTP Press, 1983: 279-88.
306. KATSILAMBROS N, PHILIPPIDES PH, METAXATOS I, FRANGAKI D, MARANGOS M, DAIKOS G. Effect of butter and salami ingestion on the
post- prandial hyperglycemia in NIDDS. Diabetes
Res Clin Pract 1985; 2: (Suppl 1): 291.
307. DANNE T, DEISS D, HOPFENMÜLLER W, VON
SCHÜTZ W, KORDONOURI O. Experience with
insulin analogues in children. Horm Res 2002; 57
(Suppl 1): 46-53.
308. ∫∂ƒ∞ª∂À™ ¡. ΔÔ ÓÂÔÁÓfi ‰È·‚ËÙÈ΋˜ ÌËÙ¤Ú·˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 67-70.
309. ∫∞ƒ∞ª∏Δ™O™ ¢. ∂ÓÙ·ÙÈÎÔÔÈË̤ÓË ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 71-6.
310. Δ™∞¶∞™ °, ª∞°OÀ§∞ π, ¶∞§∂Δ∞™ ∫, ™∫∞ƒ∞°∫∞™ °. μÈٷ̛Ә Î·È È¯ÓÔÛÙÔȯ›· ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. ™ÙÚÔÁÁ‡ÏË ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1991; 4: 77-101.
311. ª¶OÀƒ∞ ¶, ª∞¡∂™ Ã, ∑∞Ã∞ƒπOÀ¢∞∫∏ ∂,
Ã∞Δ∑∏∞ê∂Δ ∞, ¶∞¶∞∑O°§OÀ ¡, Δ™∞¶∞™
°. ∂›ÙˆÛË ·˘ÙÔ·ÓÙÈÛˆÌ¿ÙˆÓ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 102-7.
312. §π∞∫O¶OÀ§OÀ ª, ∫Oƒμ∂™∏ ª, ¢∞∫OÀμOÀΔ∂Δ∞∫∏ ∫. ÷ڷÎÙËÚÈÛÙÈο Ù˘ ÚÔÛˆÈÎfiÙËÙ·˜ ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÂÊ‹‚ˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1991; 4: 108-14.
313. ¶∞¶∞°∂øƒ°πOÀ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ∞£ÀƒO™ μ. ¶ÚfiÁÚ·ÌÌ· ËÏÂÎÙÚÔÓÈÎÔ‡ ˘ÔÏÔÁÈÛÙ‹ ÁÈ· ηٷÛ΢‹ ‰È·ÈÙÔÏÔÁ›Ô˘ ‰È·‚ËÙÈÎÔ‡. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 115-9.
314. ª∞¡∂™ Ã, ¶∞¶∞∑O°§OÀ ¡, ™OÀ§∏™ ∫, Ã∞Δ∑∏∞ê∂Δ ∞, §πOÀΔ∞™ ∞, ¶∞¶∞ºøΔπOÀ Δ.
∫fiÛÙÔ˜ Â͈ÓÔÛÔÎÔÌÂȷ΋˜ ÊÚÔÓÙ›‰·˜ (Ê·Ú̷΢ÙÈ΋ ·ÁˆÁ‹ Î·È ·Ú·ÎÔÏÔ‡ıËÛË) ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÚÚÒÛÙˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1991; 4: 120-5.
315. ª∞∫ƒÀ°π∞¡¡∞∫∏ ∂, ¶∂§∂Δπ¢OÀ ∞, ª¶∞∫∞Δ™∂§O™ ™, Oπ∫O¡OªOÀ-∞¡Δø¡π∞¢OÀ ª,
∫∞ƒ∞ª∏Δ™O™ ¢. ¶ÔÈÔÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ Ù˘ ÌÂıfi‰Ô˘
ÌÂÙÚ‹Ûˆ˜ Ù˘ ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ Hb (HbA1) Ì ÈÔÓÙÔ·ÓÙ·ÏÏ·ÎÙÈΤ˜ ÚËÙ›Ó˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1991; 4: 126-8.
316. μƒ∂ΔΔO™ ª, ™¶Àƒπ¢∏™ Ã, ™ª¶∞ƒOÀ¡∏ ∂,
™ª¶∞ƒOÀ¡∏™ Ã. ∂ÎÙ›ÌËÛË Ù˘ ‰È·Ì¤ÙÚÔ˘ Ù˘ Ú·¯È·›·˜ Î·È ÔÈÛı›·˜ ÎÓËÌÈ·›·˜ ·ÚÙËÚ›·˜ Ì ˘ÂÚ‹¯Ô˘˜ Û fi‰È· ‰È·‚ËÙÈÎÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1991; 4: 129-32.
317. ™¶Àƒπ¢∏™ Ã, μƒ∂ΔΔO™ ª, ∫∞ƒ∞ª∏Δ™O™ ¢,
™ª¶∞ƒOÀ¡∏™ Ã. ™¯¤ÛË ÌÂٷ͇ ÙÔ˘ ·ÚÙËÚÈ·ÎÔ‡
‰Â›ÎÙË Î·È ÙÔ˘ ΔcPO2 Û ‰È·‚ËÙÈο ¿ÙÔÌ·. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1991; 4: 133-6.
318. ∫∂ƒ∞ªπ¢∞-∫∞ƒ∞ª∏Δ™OÀ ¶. ∂ÚÁ·ÛÙËÚȷ΋
‰È¿ÁÓˆÛË Î·È ·Ú·ÎÔÏÔ‡ıËÛË Û·Î¯·Úԉȷ‚ËÙÈÎÔ‡
·ÛıÂÓÔ‡˜. ªÈÎÚÔ‚ÈÔÏÔÁÈο ÃÚÔÓÈο 1987; 3: 126-36.
319. CHRISTAKOS S, NORMAN AW. Studies on the
mode of calciferol XVII. Evidence for a specific high
affinity binding protein for 1, 25-dihydroxyvitamin D3
in chick kidney and pancreas. Biochem Biophys Res
Commun 1979; 89: 56-63.
320. ª¶∞§∞™ ¶. ¶·ı‹ÛÂȘ ÙˆÓ ·ÁÁ›ˆÓ. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1983: 5-26.
321. μ∂μ∂™ ∞, ª∞¡∂™ Ã, BOULTON A. ¢È·‚ËÙÈ΋
Ó¢ÚÔ¿ıÂÈ·. ∏ ¿Ô„Ë ÙÔ˘ ‰È·‚ËÙÔÏfiÁÔ˘. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1992; 5: 1-8.
322. ∫∞ƒ∞ª∏Δ™O™ ¢, ¢π¢∞°°∂§O™ Δ, ª¶∞∫∞Δ™∂§O™ ™, ¶∞¶∞¢O¶OÀ§O™ °, ∫OÀƒΔO°§OÀ °. ÀÂÚÏÈȉ·È̛˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÚÔÁÁ‡ÏË ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1992; 5: 9-38.
323. ∞μƒ∞ªπ¢∏™ ∞, ∫OÀ∫OÀμπΔ∏™ ∞, ∫∏Δ∞ ª,
Δƒπ∞¡Δ∞ºÀ§§π¢OÀ ∂, ™∞¡Δπ∫ °. ªÂÙ·‚ÔÏÈÛÌfi˜ ·Û‚ÂÛÙ›Ô˘ Î·È ÔÛÙÒÓ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
™ÙÚÔÁÁ‡ÏË ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5:
39-54.
324. º∂ƒ∂Δ∏™ ∏, º∂ƒ∂Δ∏™ ∞, ºøΔπ∞¢OÀ ∞, Ã∞Δ∑∏™¶∞™OÀ ∂, ™ªOÀ™ΔO¶OÀ§O™ ¢. ÃÚfiÓÔ˜
ÁÈ· ÙËÓ ¯ÂÈÚÔ˘ÚÁÈ΋ ·Ú¤Ì‚·ÛË ÛÙËÓ ‚·ÚÂÈ¿ ÌÔÚÊ‹
Ù˘ ˘ÂÚÏ·ÛÙÈ΋˜ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 55-8.
325. ™∞Δ™O°§OÀ ∞, ª¶∞∫∞Δ™∂§O™ ™, ∫OÀƒΔO°§OÀ °, Δ∞ª¶∞∫OÀ¢∏™ ¶, ª¶π§§∏ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚‹Ù˘ Î·È ¯ÂÈÚÔ˘ÚÁÈΤ˜ ÂÂÌ‚¿-
89
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ÛÂȘ. ¢È·‚ËÙÔÏÔÁÈ΋ ·ÓÙÈÌÂÙÒÈÛË. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1992; 5: 59-62.
326. ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, ™∫∞ƒ∞°∫∞™ °, ∑∞º∂πƒπOÀ ∫, ∫O¡ΔO°π∞¡¡∏™ π, μOÀ∫π∞™ ª,
°∂øƒ°∞∫O¶OÀ§OÀ ∂, ¶∞¶∞∑O°§OÀ ¡. °Ï˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌÔÛÊ·ÈÚ›ÓË Î·È Î¿ÓÈÛÌ·. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1992; 5: 63-7.
327. ¶∞¶∞¢O¶OÀ§O™ °, ∫∞Δ™∞μ∂§∏ ∞, ª¶∞∫∞Δ™∂§O™ ™, ¢π¢∞°°∂§O™ Δ, ∫OÀƒΔO°§OÀ
°, ∫∞ƒ∞ª∏Δ™O™ ¢. ¶ÔÈÔÙÈÎfi˜ ¤ÏÂÁ¯Ô˜ ÙÚÈÒÓ ÌÂÙÚËÙÒÓ Û·Î¯¿ÚÔ˘ ·›Ì·ÙÔ˜ Î·È Û‡ÁÎÚÈÛË Ì ÌÂıfi‰Ô˘˜
·Ó·ÊÔÚ¿˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 68-73.
328. μƒ∂ΔΔO™ ª, ™¶Àƒπ¢∏™ Ã, ™ª¶∞ƒOÀ¡∏ ∂,
™ª¶∞ƒOÀ¡∏™ Ã. ™¯¤ÛË ÌÂٷ͇ ÛÊ˘ÚÔ‚Ú·¯ÈÔÓ›Ô˘
‰Â›ÎÙË Î·È ·ÚÙËÚȷ΋˜ ·ÚÔ¯‹˜ Û fi‰È· ‰È·‚ËÙÈÎÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 74-7.
329. ΔOº∞§π¢∏™ ª, ¡OÀ™πO™ °, ™∞´§∂ƒ ¡, ™∞ª¶∞Δ∞∫∞∫∏™ £, •∞¡£O¶OÀ§O™ π, ∫O¡Δ∑O°§OÀ °, ¶ƒ∂¶O¡∏™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ·ÎÔ˘ÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1992; 5: 78-80.
330. MALIK RA, VEVES A, MASSON E, SHARMA
AK, AH-SEE AK, SCHADY W, LYE R H, BOULTON AJ. Endoneureal capillary abnormalities in mild
human diabetic neuropathy. J Neurol Neurosurg
Psychiatry. 1992; 55: 557-61.
331. VEVES A, MALIK RA, LYE RH, MASSON EA,
SHARMA AK, SCHADY W, BOULTON AJM. The
relationship between sural nerve morphometric findings and measures of peripheralnerve functionin mild
diabetic neuropathy. Diabetic Medicine 1991; 8: 91721.
332. TSAVARIS N, PANGALIS G, VARIAMI E, KARABELIS A, KOSMIDIS P, RAPTIS S, Association
of neutrophil alkaline phosphatase activity and
glycosylated haemoglobin in diabetes mellitus. Acta
Haematol (Basel) 1990; 83: 22-5.
333. ∫∞ƒ∞μ∞°°∂§∏-μ§∞Δ™∞ ∂, ∫∂∫§π∫π∞¡-§∞°OÀ¢∞∫∏ ¶, Δ∑πOμ∞∫OΔ∑∞ §. ª¤ÛË ÙÈÌ‹ Ù˘
ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ (∏bA1) ÛÂ Ê˘ÛÈÔÏÔÁÈο ¿ÙÔÌ·. °·ÏËÓfi˜ 1989; 31: 281-5.
334. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫. ∏ÏÂÎÙÚÔÏ˘ÙÈΤ˜
‰È·Ù·Ú·¯¤˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1992; 5: 81-9.
335. ƒ∞´¢∏™ Ã. ¶ÚˆÙÔ·ı‹˜ Î·È ‰Â˘ÙÂÚÔ·ı‹˜ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ Î·Ú‰È¿. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1992; 5: 90-8.
336. ∞£ÀƒO™ μ. OÈ ÂÈÙÒÛÂȘ ÙˆÓ ·ÓÙÈ˘ÂÚÙ·ÛÈÎÒÓ
Ê·ÚÌ¿ÎˆÓ ÛÙÔ ÌÂÙ·‚ÔÏÈÛÌfi ÙˆÓ ÏÈÔÚˆÙÂ˚ÓÒÓ ÙÔ˘
ÔÚÔ‡ ÙˆÓ ·ÛıÂÓÒÓ Ì ȉÈÔ·ı‹ ˘¤ÚÙ·ÛË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1992; 5: 99-108.
337. ™∫∞ƒ∞°∫∞™ °, ¶∞¶∞∑O°§OÀ ¡. ∏ ÏÂÈÙÔ˘ÚÁ›·
ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ Î·È ÔÈ ·ÏÏËÏÂȉڿÛÂȘ Ï¿ÛÌ·ÙÔ˜-·ÈÌÔÂÙ·Ï›ˆÓ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÛÙËÓ
·ıËڈ̿وÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 109-18.
90
338. ∫OÀƒΔO°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™, ™∞Δ™O°§OÀ ∞, Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ Ã, ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ¢. ∞ÔÙÂϤÛÌ·Ù· ÙÔ˘
∞cipimox ÛÙÔ ÌÂÙ·‚ÔÏÈÛÌfi ÙˆÓ ÏÈȉ›ˆÓ Î·È Ù˘ ÁÏ˘Îfi˙˘ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 119-24.
339. ∂À£Àªπ∞¢∏™ ∞, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™
Ã, Δ∑OÀ¡∞™ ∫, ¶∞¶∞¢∂§∏ ∂, ¶∞¶∞ºøΔπOÀ
Δ, ¢∏ª∏ΔƒπOÀ º. ∂ÈÔÏ·ÛÌfi˜ Ù˘ Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ οو ¿ÎÚˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5: 125-31.
340. ∂À£Àªπ∞¢∏™ ∞, §∂À∫O™ ¡, §π∞Δ™∏™ π,
ª¶OÀ¡Δø¡∞™ °, ¶∞¶∞Ã∏™ΔOÀ ∞π∫, ¶§∞ΔO°π∞¡¡∏™ ¢, ¶∞¶∞£∂O§O°OÀ ∫. ¢ÈÂÚ‡ÓËÛË ÙˆÓ ÌÂÙ·‚ÔÏÒÓ ÙÔ˘ «‰Â›ÎÙË ÈÓÛÔ˘ÏÈÓÔÁ¤ÓÂÛ˘» ÛÂ
ÛÙÂÊ·ÓÈ·›Ô˘˜ ·ÚÚÒÛÙÔ˘˜ Ì ‹ ¯ˆÚ›˜ ¯ÔÚ‹ÁËÛË ·ÎÂÙ˘ÏÔÛ·Ï˘ÎÈÏÈÎÔ‡ ÔͤԘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992;
5: 132-9.
341. ¶∞¶¶∞™ ™, ª¶π§π¡∏™ Ã, ª∏¡∞¢∞∫∏ ª,
™øΔ∏ƒO¶OÀ§O™ ∞, ¶∞¶∞£∂O¢øƒOÀ ∫,
ª∞ƒ∞μ∂°π∞™ ¡, ∫∞Δ™∞¢øƒO™ ¢. ∂ÌÊ˘ÛËÌ·ÙÈ΋ ˘ÂÏÔÓÂÊÚ›ÙȘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1992; 5:
140-5.
342. DAUGIRDAS JT, KRONFOL NO, TZAMALOUKAS AH, ING TS. Hyperosmolar coma: Cellular dehydration and the serum concetration. Ann Inter Med
1989; 110: 855-7.
343. SIAMOPOULOS KC, ELISAF M, PAPPAS M. Severe asymptomatic hyperglycemia in a non diabetic
CAPD patient. Per Dial Intern 1992; 12: 72-3.
344. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫Ã. ¢ÈÂÚ‡ÓËÛË ÌÂÙ·‚ÔÏÈ΋˜ ÔͤˆÛ˘. π·ÙÚÈ΋ 1990; 58: 2: 138-43.
345. §∂À∫O™ ¡, ∂À£Àªπ∞¢∏™ ∞, ª¶OÀ¡Δø¡∞™
°, §π∞Δ™∏™ π, ¡Δ∞ª™∞ ∞π∫, ¶§∞ΔO°π∞¡¡∏™
¢. OÚfiÏÔ˜ ÙˆÓ ÚÔÛÙ·ÁÏ·‰ÈÓÒÓ ÛÙËÓ ·ÂÏ¢ı¤ÚˆÛË
Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÂ Ê˘ÛÈÔÏÔÁÈο Î·È ˘ÂÚÙ·ÛÈο ¿ÙÔÌ·. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 1991; 1: 57-64.
346. VLACHOS L, BENAKIS BP, PATEDAKIS G,
GIANNOPOULOS A, KAPRALOS P, PONTIFEX
G. Unilateral emphysematous pyelonephritis. Eur
Urol 1979; 5: 220-2.
347. ARVANITAKIS C, LORENZSONN V, OLSEN
WA. Phenformin induced alterations of small intestinal function and mitochondria structure in man. Journal of Laboratory and Clinical Medicine 1973; 82:
195-200.
348. ARVANITAKIS C, OLSEN WA. Intestinal mucosal
disaccharidases in chronic pancreatitis. American
Journal of Digestive Diseases 1974; 19: 417-21.
349. ARVANITAKIS C. Intestinal effect of phenformin
on glucose absorption in man (Letter to the Editor).
The Journal of Clinical Pharmacology 1975; 15: 550.
350. ARVANITAKIS C, OLSEN WA. Intestinal digestion
and absorption of sucrose in experimental diabetes.
Acta Diabetologica Latina 1976; 13: 154-7.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
351. ª∞∫ƒ∏™ £, ∫ƒ∂™¶∏ ¶, μOΔΔ∂∞™ μ, ¡OÀ¡O¶OÀ§O™ Ã, Ã∞Δ∑∏∑∞Ã∞ƒπ∞™ ∞, μÀ£OÀ§∫∞™ π, π∂ƒ∂ªπ∞™ ¢, ª¶OÀ§OÀ∫O™ ∞. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ ÙˆÓ ˘Ô‰Ô¯¤ˆÓ Ù˘ ÈÓÛÔ˘Ï›Ó˘ Û ·ÛıÂÓ›˜ Ì ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË
1995; 4: 63-9.
352. ¶∞°∫∞§O™ ∂. ∞Ó¿ÏÔÁ· ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1993; 6: 1-4.
353. μ§∞™™∏™ °. ∞ÓÙÈÛ‡ÏÏË„Ë ÛÙË ‰È·‚ËÙÈ΋ Á˘Ó·›Î·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 5-9.
354. ∞μƒ∞ªπ∫∞ ª. æ˘¯ÔÏÔÁÈ΋ ˘ÔÛÙ‹ÚÈÍË ·ÚÚÒÛÙˆÓ
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993;
6: 10-7.
355. ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ¶∞°∫∞§O™ ∂, ¢π¢∞°°∂§O™ Δ, ™Àƒ∂°°∂§∞™ ¢. πÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2.
™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6:
18-30.
356. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ™OÀ§∏™ ∫, Ã∞Δ∑∏¶∂ΔƒOÀ ∞, ª∏§∞ƒ∞∫∏™ ¢, ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫Àƒ∫OÀ¢∏™ ∞, °∫πƒΔ∑∏™ π,
Ãπ™Δ∞∫π¢∏™ ¢, °∫OΔ™∏™ ¡. ™˘¯ÓfiÙËÙ· ÂÌÊ¿ÓÈÛ˘ Ó¤ˆÓ ÂÚÈÙÒÛÂˆÓ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ·È‰È¿ Ù˘ μfiÚÂÈ·˜ ∂ÏÏ¿‰·˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 31-6.
357. ™Δ∞ªO°π∞¡¡OÀ §, ∫∞ºOÀƒOÀ ∞, ∞°°∂§OÀ
™, ª¶∞ƒΔ™O∫∞™ Ã. ™ˆÌ·ÙÈ΋ ·Ó¿Ù˘ÍË Û ·È‰È¿ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1993; 6: 37-41.
358. ∫∞ƒ∞ª∏Δ™O™ ¢, ™Àƒ∂°°∂§∞™ ¢, ª¶∞∫∞Δ™∂§O™ ™. ¢fiÛÂȘ ÈÓÛÔ˘Ï›Ó˘ Î·È ÁÏ˘Î·ÈÌÈÎfi˜
¤ÏÂÁ¯Ô˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 42-5.
359. ∞£ÀƒO™ μ, ¶∞¶∞°∂øƒ°πOÀ ∞, ∞μƒ∞ªπ¢∏™
ª, ¢OÀª∞™ ª, ∑∞ª¶OÀ§∏™ Ã, ∫O¡ΔO¶OÀ§O™ ∞, ª¶OÀƒπ∫∞™ °. ™˘Û¯¤ÙÈÛË ÂÈ¤‰ˆÓ ÈÓÛÔ˘Ï›Ó˘ ÓËÛÙ›·˜ Ì ‚ÈÔÏÔÁÈΤ˜ ·Ú·Ì¤ÙÚÔ˘˜ Ù˘
ÈÛ¯·ÈÌÈ΋˜ ÓfiÛÔ˘ ÙÔ˘ Ì˘Ôηډ›Ô˘ Û ·ÛıÂÓ›˜ ÌÂ
ȉÈÔ·ı‹ ˘¤ÚÙ·ÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6:
46-57.
360. ª¶∞∫∞Δ™∂§O™ ™, ∫OÀƒΔO°§OÀ °, ∫OÀΔ§∞™ ∂, Ã∞ƒ™OÀ§∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢. ∞ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ· Ù˘ ÌÂÍÈÏÂÙ›Ó˘ ÛÙËÓ ÂÒ‰˘ÓË ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6:
58-64.
361. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ™OÀ§∏™ ∫,
∫O¡ΔO°π∞¡¡∏™ π, ª∞¡∂™ Ã, §πOÀΔ∞™ ∞,
∫∞ƒ∞°π∞¡¡∏ ¢, Δ∑OÀ¡∞™ ∫. ¶ÚÔ¸Ôı¤ÛÂȘ
·fiÎÙËÛ˘ Î·È ‰È·Ù‹ÚËÛ˘ ¿‰ÂÈ·˜ Ô‰ËÁÔ‡ ‰È·ÊfiÚˆÓ
Ù‡ˆÓ Ô¯ËÌ¿ÙˆÓ ·fi ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1993; 6: 65-9.
362. §π∞∫O¶OÀ§OÀ ª. æ˘¯ÔÏÔÁÈο ÚÔ‚Ï‹Ì·Ù· ·È‰ÈÔ‡ Î·È ÂÊ‹‚Ô˘ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÙˆÓ ÔÈÎÔÁÂÓÂÈÒÓ ÙÔ˘˜. π·ÙÚÈ΋ 1987; 52: 301-6.
363. ª¶∞ƒΔ™O∫∞™ Ã, ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, ¢∞ªπ∞¡∞∫∏ ¢, £∂O¢øƒπ¢∏™ Ã, ∫∞¡Δƒ∂ ∞, ∫∞-
ƒ∞°π∞¡¡∏ Ã, ∫∞ƒ∏™ Ã, ∫∞ƒÀ¢∏ ¡, ∫∞™™πOÀ
∫, ∫OÀΔ™OÀ§π∂ƒ∏™ ∏, μ§∞ÃOÀ £, ª¶∂¡∂ΔO™ ™, ¶∞¡Δ∂§∞∫∏™ ™, ¶∞¶∞¢∏ª∏ΔƒπOÀ
∞, Δ™O∫∞ ∂, ºπ§π¶¶π¢∏™ º. ™˘¯ÓfiÙËÙ· ÙÔ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙËÓ
∞ı‹Ó· (Ì›˙ÔÓ· ÂÚÈÔ¯‹ ÚˆÙÂ‡Ô˘Û·˜, ¤ÙË 19891990). Mat Med Greca 1991; 19: 249-51.
364. K∞ƒ∞ª∏Δ™O™ ¢. O ·ÛÙ·ı‹˜ ‹ ‰˘ÛÚ‡ıÌÈÛÙÔ˜ ‰È·‚‹Ù˘. ∂ÏÏËÓ. π·ÙÚÈ΋ 1986; 52: 1-11.
365. ¶∞°∫∞§O™ ∂. ∞ÓÂÈı‡ÌËÙ˜ ÂÓ¤ÚÁÂȘ ÙˆÓ ˘ÔÁÏ˘Î·ÈÌÈÎÒÓ ‰ÈÛΛˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6:
81-6.
366. ¶ƒ∞¶∞™ ¡, ¶ƒ∞¶∞™ °. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘
Ù˘ ·ËÛ˘ ·fi Ì·È¢ÙÈ΋ ÏÂ˘Ú¿. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 87-91.
367. Ã∞ƒ™OÀ§∏™ º. ªÂÙ·ÊÔÚ›˜ ÁÏ˘Îfi˙˘. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1993; 6: 92-8.
368. ∫∞ƒ∞ª∏Δ™O™ ¢. ÀÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›· Î·È Û‡Ó‰ÚÔÌÔ Ã. ª‡ıÔ˜ ‹ Ú·ÁÌ·ÙÈÎfiÙËÙ·; ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 99-103.
369. ¶∞¶∞∑O°§OÀ ¡, ¶∂Δƒπ¢∏™ π, ™πª∂§π¢∏™ ¢,
Δ∑∂À∑∏™ μ, ∂À£ÀªπOÀ ∏, ª∞¡∂™ Ã, ™OÀ§∏™ ∫. ∞ÏÏÔÈ Ù‡ÔÈ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÚÔÁÁ˘Ï‹
ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 104-23.
370. ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, ™∫∞ƒ∞°∫∞™ °, Δƒπ∞¡Δ∞ºÀ§§OÀ °, °∂øƒ°∞∫O¶OÀ§OÀ ∂, ¶∞¶∞∑O°§OÀ ¡. ∂›‰· ·ÓÙÈıÚÔÌ‚›Ó˘ πππ (∞Δπππ)
ÛÙË ‰È·‚ËÙÈ΋ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· (¢ªπ∞). ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1993; 6: 124-7.
371. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, ∑∞º∂πƒπOÀ ∫, ™¶ÀƒO¶OÀ§OÀ ∂, ¶∞¶∞∑O°§OÀ ¡, Ã∞Δ™∂ƒ∞™ ¢, °∫OΔ™∏™ ¡. ∏ ·‡ÍËÛË
ÙÔ˘ ÈÓˆ‰ÔÁfiÓÔ˘ ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ ·Ú¿ÁˆÓ ÎÈÓ‰‡ÓÔ˘
ÛÙË ‰È·‚ËÙÈ΋ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· (¢ªπ∞). ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1993; 6: 128-33.
372. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, °∫πƒΔ∑∏™ π,
Ãπ™Δ∞∫π¢∏™ ¢, ¡π∫O§∞´¢∏™ π, ∫πΔ™πO™ Ã,
™Δ∞£∏™ μ, ™OÀ§∏™ ∫, °∫OΔ™∏™ ¡. ∂ȉËÌÈÔÏÔÁ›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (™¢) ÛÙËÓ ∂ÏÏ¿‰·. ππ.
¡ÔÌfi˜ Œ‚ÚÔ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 134-40.
373. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ª∏§∞ƒ∞∫∏™ ¢,
™∞Δ™O°§OÀ ∞πª, ™OÀ§∏™ ∫, ∫∞ƒ∞°π∞¡¡∏
¢, °∫OÀΔ∫π¢OÀ ™, μOÀ∫π∞™ ª. ∂ȉËÌÈÔÏÔÁ›·
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (™¢) ÛÙËÓ ∂ÏÏ¿‰·. πππ. ¡ÔÌfi˜ ∫ÈÏΛ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 141-5.
374. ΔOº∞§π¢∏™ ª, ¡OÀ™πO™ °, ª¶∂¡∏™ ¡, °∂¡¡∞¢πOÀ ¢, ™∞´§∂ƒ ¡, ¶ƒ∂¶O¡∏™ Ã. ÃÔÏÔÛÙ¿و̷ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1993; 6: 146-8.
375. ∫∂§§∞ƒΔ∑∏™ ¢, ∫∞ƒ∞ª∏Δ™O™ ¢, ª∞ªO¶OÀ§O™ ª, ª∞¡Δ∞§∂¡∞∫∏™ ™. ∏ ‰ÔÎÈÌ·Û›·
·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘ ÁÈ· ÙËÓ ¤ÁηÈÚË ‰È¿ÁÓˆÛË ÙÔ˘ ‰È·‚‹ÙË Î˘‹Ûˆ˜. ∞Ú¯. ∂ÏÏËÓ. π·ÙÚ. 1986; 3: 137-41.
376. ª∞ªO¶OÀ§O™ ª. ∫‡ËÛË ˘„ËÏÔ‡ ÎÈÓ‰‡ÓÔ˘. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 1988.
91
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
377. ª¶OÀ¡ΔOÀ§∞™ Ã, Ã∞ƒ™OÀ§∏™ º, ¶∞ÃOÀ§∞ ∞Ã, ∫∞ƒ∞ª∏Δ™O™ ¢. ªÂÙ·‚ÔÏÈη› ‰È·Ù·Ú·¯·› Â› Ó·ÚÒÓ ·ÛıÂÓÒÓ ÌÂÙ¿ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘.
∂ÏÏËÓÈ΋ ∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 1974; 15: 20812.
378. MANES CH, GIANNOYLIS E, PAPAZOGLOU N,
SPILIOPOULOS A, NIKOLAIDIS P, PAPADELI
E, TOURKANTONIS A. Hepatic function and drug
metabolizing capacity in type 2 diabetic patients.
European J Internal Medicine 1996; 7: 77-82.
379. PAPAZOGLOU N, MANES CH, CHATZIMITROFANOUS P, PAPADELI E, TZOUNAS K, SCARAGAS G, KONTOYIANNIS J, ALEJIADES D. The
epidemiology of diabetes mellitus in the elderly in
Northern Greece: ∞ population study. Diabedic
Medicine 1995; 12: 397-400.
380. ∫∞ƒ∞μ∞¡∞∫∏ ∫, μ∞UM JD. ∏ ÂȉËÌÈÔÏÔÁ›·
Î·È Ë Û˘Ì‚ÔÏ‹ Ù˘ ÛÙËÓ ·ÈÙÈÔ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7:
13-23.
381. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ™OÀ§∏™ ∫, ¶∞¶∞¢O¶OÀ§O™ °, ¢∞¡π∏§π¢∏™ ª. °ÂÓÂÙÈÎÔ›
Î·È ÂÚÈ‚·ÏÏÔÓÙÔÏÔÁÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘.
™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7:
24-40.
382. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, Ã∞Δ∑∏¶∂ΔƒOÀ ∞, ª∞ƒ∞™ ¶, ¶∞¶∞¢∂§∏ ∂, ∫O¡ΔO°π∞¡¡∏™ π, ∫∞§O°∂ƒOÀ¢∏™ °, Ã∞ª∞§π¢OÀ
∞. ∂ȉËÌÈÔÏÔÁ›· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·.
VI. NÔÌfi˜ ∏Ì·ı›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7:
41-4.
383. ™πª∂§π¢∏™ ¢, ∑OÀΔ™O™ ¢, ¢O¢OÀƒ∞™ £,
∞¡¢ƒπ∫O™ ∞, ∞¶O™ΔO§π¢OÀ ∫, ∞¢∞ªπ¢∏™ π.
∂ÈÔÏ·ÛÌfi˜ Ù˘ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘ (™¡) Û ‰È·‚ËÙÈο Î·È ÌË ¿ÙÔÌ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 4550.
384. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂,
°∫OÀΔ∫π¢OÀ ™, ¶∞¶∞∑O°§OÀ ¡, Ã∞Δ™∂ƒ∞™ ¢, °∫OΔ™∏™ ¡. Δ· Â›‰· Ù˘ ÊÈÌÚÔÓÂÎÙ›Ó˘ ÛÙÔ ‰È·‚‹ÙË Î·È ÛÙË ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· (¢∞). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 51-4.
385. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ¢∏ª∏Δ™π∫O°§OÀ ¡, Δ∑∂Δ∑∏™ μ, ª∞Δπ¢∏™ ¡, ∫∞§π°∫∞Δ™∏™ Ã, Δƒ∞´∞¡π¢∏™ ¶.
¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· (¢∞ª) Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ (¢∞) Ù‡Ô˘ π. (∂˘Ú‹Ì·Ù· ÂÎ Ù˘
Eurodiab IDDM Complicatios Study). ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1994; 7: 55-62.
386. ∞§∂μπ∑O™ ª, ∞ƒÃ∞¡πøΔ∞∫∏ ª, ∫∞μ∞¡O∑∏
∞, ∫∞§∞ª¶∞§π∫∞ ¢. ∏ Â›‰Ú·ÛË ÙÔ˘ ¿ÚÙÔ˘ ηÈ
ÙÔ˘ ÂÏ·ÈÔÏ¿‰Ô˘ ÛÙË ÁÏ˘Îfi˙Ë ÙÔ˘ ·›Ì·ÙÔ˜ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ù‡Ô˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 637.
387. ™∞ª∞ƒ∞™ ¡, ÃÀ™∞°∏™ ¢, ∂§∂À£∂ƒπ∞¢∏™
∂, ∞¡∞™Δ∞™π∞¢∏™ ¡, ∫∞§π°∫∞Δ™∏™ Ã. πÛÙÔÏÔÁÈΤ˜ ·ÏÏÔÈÒÛÂȘ ÙÔ˘ ‚ÏÂÓÓÔÁfiÓÔ˘ ÙÔ˘ ÛÙÔÌ¿¯Ô˘
92
Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1994; 7: 68-72.
388. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ¢È·‚ËÙÈ΋ Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. ªÂÙÂÎ·È‰Â˘ÙÈο Ì·ı‹Ì·Ù· ÛÙËÓ ÂÓ‰ÔÎÚÈÓÔÏÔÁ›·. (3Ô˜ ¯ÚfiÓÔ˜). ∞ı‹Ó·, 1992.
389. Ã∞ƒ™OÀ§∏™ º. ∞Ì˘Ï›ÓË (ÔÏ˘ÂÙ›‰ÈÔ ·Ì˘ÏÔÂȉԇ˜ ÙˆÓ ÓËÛȉ›ˆÓ): μÈÔÏÔÁÈΤ˜ ȉÈfiÙËÙ˜ Î·È Ô Èı·Ófi˜ ÚfiÏÔ˜ ÛÙËÓ ·ıÔÁ¤ÓÂÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË
Ù‡Ô˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 85-92.
390. ∞¡£πªπ¢∏™ °. ∞ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ÙÚ›ÙË ËÏÈΛ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994;
7: 93-106.
391. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ¡π∫O§∞´¢∏™ £,
™OÀ§∏™ ∫, ªÀ°¢∞§∏™ ∏. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1994; 7: 107-20.
392. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ∫O¡ΔO°π∞¡¡∏™ π, ™∫∞ƒ∞°∫∞™ °,
μOÀ∫π∞™ ª, §πOÀΔ∞™ ∞, ¶∞™∞§π¢OÀ ∫. ∂ÎÙ›ÌËÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ (¢∞)
Ì ‚¿ÛË ÊˆÙÔÁÚ¿ÊËÛË ‚˘ıÔ‡ Ì οÌÂÚ· 450 (ªÂıÔ‰ÔÏÔÁ›· Ù˘ Eurodiab IDDM Complications Study).
EÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 121-6.
393. ªÀ§O¶OÀ§O™ ª, Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¶∞™∞§π¢OÀ ∫, °∫ƒ∂ª¶O°π∞¡¡∏ ¢, ªOÀƒ∞Δπ¢∏™ Ã, °OÀ∂§∞ ª. OÊı·ÏÌÈ΋ ˘ÂÚÙÔÓ›· ηÈ
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994;
7: 127-30.
394. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ¶∞¶∞¢∂§∏ ∂, ∫∞ƒ∞°π∞¡¡∏ ¢, Ã∞Δ∑∏∞ê∂Δ ∞, Δƒ∞´∞¡π¢∏™ ¶. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· (¢∞ª), ÔÙÈ΋ Ô͇ÙËÙ· Î·È Ù˘ÊÏfiÙËÙ· Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ (¢∞) Ù‡Ô˘ π (∂˘Ú‹Ì·Ù· ÂÎ Ù˘ Eurodiab IDDM Complications
Study). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1994; 7: 131-6.
395. Δ™πΔ∞ªπ¢OÀ ∑, ¶∞°∫∞§O™ ∂, ºÀΔπ§∏ Ã,
Δ™OÀ§º∞ ™, £∂O¢øƒπ¢∏™ ™. ∏ ¡-·ÎÂÙ˘ÏÔ-b-DÁÏ˘ÎÔ˙Ô·ÌÈÓȉ¿ÛË ÛÙ· Ô‡Ú· ·ÛıÂÓÒÓ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1994; 7: 137-40.
396. KATSILAMPROS N. World prevalence and incidence
of diabetes mellitus with emphasis on some Greek
Studies. Medigographia 1989; 11 (Suppl 1): 16-9.
397. CHRISTACOPOULOS P, KARAMANOS B. The
prevalence of diabetes mellitus. Epidemiological studies in Greece. Medigographia 1987; 9 (Suppl 1): 44- 6.
398. MIGDALIS IN. Clinical types and characteristics of
neuropathy. Diabetes Metabolism (DIAMET) 1993;
33: 1-4.
399. ∫∞ƒ∞ª∏Δ™O™ ¢. OÈ ˘‰·Ù¿ÓıڷΘ ÛÙË ‰È·ÙÚÔÊ‹
ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 11-21.
400. ∫∞∑∞∫O™ ∫. ΔÔ ‰È·‚ËÙÈÎfi fi‰È. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 22-32.
401. °πøμO™ π, ∂À£Àªπ∞¢∏™ ∞, ™∫∞ƒ∞°∫∞™ °,
°∂øƒ°∞§∞ ∞, μ∞º∂π∞¢OÀ ∂. ¢È·‚ËÙÈ΋ ÌÈÎÚÔ-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
·ÁÁÂÈÔ¿ıÂÈ·. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1995; 8: 33-52.
402. ∂À£ÀªπOÀ ∏. ∏ ÌÂÙ·ÌfiÛ¯Â˘ÛË ÙˆÓ ÓËÛȉ›ˆÓ ÙÔ˘
·ÁÎÚ¤·ÙÔ˜ ˆ˜ ıÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 53-8.
403. ∞¡Δø¡πOÀ ™, ª∞§∞∫∞ ∂, ™Àƒ∂°°∂§∞™ ¢,
ΔOÀƒΔOÀƒ∏™ ™, ¢∏ª∏Δƒπ∞¢∏™ ∞. O ÚfiÏÔ˜
Ù˘ ÛÂÚÔÙÔÓ›Ó˘ ÛÙËÓ ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË ·ÛıÂÓÒÓ
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995;
8: 59-62.
404. ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª, Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∫ƒ∞™™∞™ °. ∏ ‰Ú¿ÛË ÙÔ˘ Û˘ÓıÂÙÈÎÔ‡
·Ó·ÏfiÁÔ˘ ۈ̷ÙÔÛÙ·Ù›Ó˘ (ÔÎÙÚÂÔÙ›‰ÈÔ) ÛÙËÓ ‚·ÚÂÈ¿ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1995; 8: 63-7.
405. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ™∫∞ƒ∞°∫∞™ °,
∫O¡ΔO°π∞¡¡∏™ π, ¶∞¶∞ ¢∂§∏ ∂, ™OÀ§∏™
∫, °∫OÀΔ∫π¢OÀ ™, Δ∑OÀ¡∞™ ∫. OÍ›˜ Î·È ¯ÚfiÓȘ (ÌÈÎÚÔ·ÁÁÂȷΤ˜) ÂÈÏÔΤ˜ Û ·ÛıÂÓ›˜ Ì هÔ˘ π ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ μ. ∂ÏÏ¿‰· (Â˘Ú‹Ì·Ù· ÂÎ Ù˘ ∂urodiab IDDM Complications Study).
EÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 68-72.
406. ∫§∂Δ∞-¶∞¡∞°πøΔπ¢OÀ ¢, ¶∂§∂Δπ¢OÀ-∞ƒ∞ª¶∞Δ∑O¶OÀ§OÀ ∞, ¡Δ∞°∫OÀ¡∞ O, ∫ø¡™Δ∞¡Δπ¡OÀ ∂, Oπ∫O¡OªOÀ-∞¡Δø¡π∞¢OÀ
ª, Ã∞Δ∑∏¶∂ΔƒOÀ ∞. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ Ù˘ ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ (HbA1c). ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÙˆÓ ÙÈÌÒÓ Ù˘ Ì ÙÚ›˜ ÌÂıfi‰Ô˘˜. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1995; 8: 73-7.
407. KATSILAMPROS N, PHILIPPIDES P, TOULIATOU A, GEORGAKOPOULOS K, KOFOTZOULI
L, FRANGAKI D, SISKOUDIS P, MARANGOS M,
SFIKAKIS P. Metabolic effects of honey (alone or
combined with other foods) in type II diabetics. Acta
Diabetol Latina 1988; 25: 197-203.
408. ∫∞ƒ∞ª∏Δ™O™ ¢, ¢∞ªI∞¡π¢OÀ ¢, Ã∞ƒ™OÀ§∏™ º, ∫ÀƒOÀ ∞, μÀ∑∞¡Δπ∞¢∏™ ∞, ª∂Δ∞•∞™ ¶. ∏ ÔÍ›· Â›‰Ú·ÛË Ù˘ ·Èı·ÓÔÏ˘ ÛÙËÓ ·ÓÔ¯‹
ÁÏ˘ Îfi˙˘ Î·È ÙËÓ ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ Û ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜ Ô˘ ·›ÚÓÔ˘Ó ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë. ∞گ›· π·ÙÚ.
∂Ù·ÈÚÂÈÒÓ 1980; 6: 22-7.
409. VEVES A, MURRAY HJ, YOUNG MJ, BOULTON AJM. The risk of foot ulceration in diabetic patients with high foot pressure: A prospective study.
Diabetologia 1992; 35: 660-3.
410. VEVES A, MASSON EA, FERNANDO DJS,
BOULTON AJM. Use of experimental padded
hosiery to reduse abnormal foot pressure in diabetic
neuro pathy. Diabetes Care 1989; 12: 653-5.
411. ∂À£ÀªπOÀ ∏. ™ˆÌ·ÙÔÛÙ·Ù›ÓË Û˘ÓıÂÙÈÎfi ·Ó¿ÏÔÁÔ
SMS 201-995 (Sandostatin). ™·Î·¯·Ú҉˘ ‰È·‚‹Ù˘
(™¢). °·ÏËÓfi˜ 1992; 34: 439-44.
412. Tƒ∞∫∞Δ∂§§∏™ ∞. °Ï˘ÎÔ·ÈÌÔÛÊ·ÈÚ›Ó˜. ™ÙÔ:
Δڷη٤ÏÏ˘ ∞. μÈÔ¯ËÌ›·. £ÂÛÛ·ÏÔÓ›ÎË, 1992; ÙfiÌ.
μ′: 69-70
413. Ã∞ƒ™OÀ§∏™ º. ∏ Ê·ÚÌ·ÎÔÎÈÓËÙÈ΋ Ù˘ ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 93-101.
414. ∫∞¡¢∏§øƒO™ Ã. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. O
ÚfiÏÔ˜ Ù˘ ΢ÙÙ·ÚÈ΋˜ ÌÂÌ‚Ú¿Ó˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 102-14.
415. ™∫∞ƒ∞°∫∞™ °. ∫˘ÙÙ·ÚÔΛÓ˜ Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 115-25.
416. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ∫Àƒ∫OÀ¢∏™ ∞,
ª∞ƒπ¡O™ ∂, ¶∞¶∞¢∂§∏ ∂, ™OÀ§∏™ ∫, μOÀ∫π∞™ ª, ∫OÀΔ™O°π∞¡¡∏™ O. ∂ȉËÌÈÔÏÔÁ›·
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·. V. NÔÌfi˜ ƒÔ‰fi˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 126-31.
417. ¶∞¶∞∑O°§OÀ ¡, ¢∏ª∏Δ™π∫O°§OÀ ¡, ª∞¡∂™ Ã, ™OÀ§∏™ ∫, ∫O¡ΔO°π∞¡¡∏™ π, ™∫∞ƒ∞°∫∞™ °, ∫∞ƒ∞°π∞¡¡∏ ¢, ª∏§π¢∏™ £. ∂ȉËÌÈÔÏÔÁ›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·.
VI. NÔÌfi˜ ™ÂÚÚÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8:
132-7.
418. ¶∂ΔƒOÀ-∞ª∂ƒπ∫∞¡OÀ Ã, ª∞ƒ∫O¶OÀ§O™
∞, ª¶∂§∞∑∏ ª, ¢ƒ∞∫OÀ§∞∫O™ ¢, ¶∞¶∞¡∞°πøΔOÀ ¶. ™‡ÛÙ·ÛË Û¿ÏÈÔ˘ Î·È Â˘Ú‹Ì·Ù· ·fi ÙÔ˘˜
ÂÏ¿ÛÛÔÓ˜ ÛÈ·ÏÔÁfiÓÔ˘˜ ·‰¤Ó˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995;
8: 138-43.
419. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ªO§∂ ∂, ªOÀƒ∞Δπ¢∏™
Ã, ∞ÃΔ∞ƒO¶OÀ§O™ ∞. ∂ͤÏÈÍË Ù˘ fiÚ·Û˘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· ˘ÔÛÙÚÒÌ·ÙÔ˜ Î·È ÎÏÈÓÈο ÛËÌ·ÓÙÈÎfi Ô›‰ËÌ· ˆ¯Ú¿˜
(CSME) ÌÂÙ¿ Laser ʈÙÔËÍ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 144-8.
420. ™∞´§∂ƒ ¡, ª¶OÀ∫Oμπ¡∞™ π, ™∫∂¡Δ∂ƒ∏ ∞,
ª¶O¡∏ ∞, ∞ƒª∞Δ∞™ ∞, μO§πøΔ∏™ ∫. ™ÙÔÌ·ÙÈ΋ ÌÔÓÈÏ›·ÛË Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1995; 8: 14953.
421. ™Δ∂ƒ°πOÀ ¶, ™∞´§∂ƒ ¡, ∞ƒª∞Δ∞™ ∞, ª¶OÀ∫Oμπ¡∞™ π, μO§πøΔ∏™ ∫, Δƒ∞´∞¡π¢∏™ ¶.
Laser ıÂÚ·›· Ù˘ ‰È·‚ËÙÈ΋˜ ˆ¯ÚÔ¿ıÂÈ·˜. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1995; 8: 154-6.
422. Ã∞ƒ™OÀ§∏™ º. ¶·ıÔÁ¤ÓÂÈ· ÙˆÓ ÂÓ‰ÔÎÚÈÓÒÓ ‰È·Ù·Ú·¯ÒÓ Ù˘ ¯ÚfiÓÈ·˜ ÓÂÊÚÈ΋˜ ·ÓÂ¿ÚÎÂÈ·˜. ™ÙÔ:
¶··‰ËÌËÙÚ›Ô˘ ª. ¡ÂÊÚÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 1988: 358-67.
423. CANDILOROS H, DENET S, ZIEGLER O,
MUELLER S, DONNER M, DROUIN P. Effect de
la metformine in vitro sur la fluidite membranaire des
erythrocytes. Diabete Metab 1994; 20: 18A.
424. CANDILOROS H, ZEGHARI N, ZIEGLER O,
DONNER M, DROUIN P. Insulin resistance and
membrane abnormalities. Lancet 1995; 345: 994-5.
425. NOMIKOS N, PROWSE SJ, CAROTENUTO P,
LAFFERTY KJ. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft
destruction in NOD mice. Diabetes 1986; 35: 1302-4.
426. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ™Δ∂ƒ°πOÀ ¶, ™∞∫∫π∞™
93
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
°, ªÀ§O¶OÀ§O™ ¡, Δƒ∞´∞¡π¢∏™ ¶. Laser ʈÙÔËÍ›· ÙÔ˘ ÔÈÛı›Ô˘ fiÏÔ˘ ÛÙË ‰È·‚ËÙÈ΋ Î·È ÛÎÏËÚ˘ÓÙÈ΋ ˆ¯ÚÔ¿ıÂÈ·. OÊı·ÏÌÔÏÔÁ›· 1991; 3: 243-5.
427. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ªÀ§O¶OÀ§O™ ¡,
∫∏∞πR ª, Î.·. ∞ÔÙÂϤÛÌ·Ù· Ù˘ Laser ʈÙÔËÍ›·˜ ÛÙË ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ™ÙÔ:
¶Ú·ÎÙÈο 3Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ.
£ÂÛÛ·ÏÔÓ›ÎË. 1988; ÙfiÌ. μ′: 451-6.
428. Tƒπ∞¡Δ∞ºÀ§§OÀ °, ∫O∫∫ø¡π¢∏™ ¶, Δ™π∞ª¶∞§∏™ π, ª∞Δπ¢∏™ ¡, ∫ø™ΔO¶OÀ§O™ ∞.
∞ÔÙÂϤÛÌ·Ù· Ù˘ ·ÓÙÈÌÂÙÒÈÛ˘ Ù˘ ‰È·‚ËÙÈ΋˜
ˆ¯ÚÔ¿ıÂÈ·˜ Ì ÂÈıÂÙÈΤ˜ Ù¯ÓÈΤ˜ Laser ʈÙÔËÍ›·˜. ™ÙÔ: 22Ô ¶·ÓÂÏÏ‹ÓÈÔ OÊı·ÏÌÔÏÔÁÈÎfi ™˘Ó¤‰ÚÈÔ.
∞ı‹Ó·, 1989: (ÛÂÏ.?).
429. ª∞°∫OÀƒπΔ™∞™ π, Î.·. ∏ ·ÓÙÈÌÂÙÒÈÛË Ì ʈÙÔËÍ›· Argon Laser Ù˘ ‰È·‚ËÙÈ΋˜ ˆ¯ÚÔ¿ıÂÈ·˜. ππ.
∂ÛÙÈ·Îfi Ô›‰ËÌ· ˆ¯Ú¿˜. OÊı·ÏÌÔÏÔÁ›· 1992; 42:
160-7.
430. MANE™ Ã. ∞˘ÙfiÓÔÌÔ Ó¢ÚÈÎfi Û‡ÛÙËÌ·. ∂›‰Ú·ÛË
ÛÙËÓ ¤ÎÎÚÈÛË ÈÓÛÔ˘Ï›Ó˘ Î·È ÁÏԢηÁfiÓÔ˘ ÛÙËÓ ˘ÔÁÏ˘Î·ÈÌ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 11-6.
431. ¶∞°∫∞§O™ ∂. ∂ÏÏÂÈ„Ë ·ÓÙ›Ï˄˘ ÛÙËÓ ˘ÔÁÏ˘Î·ÈÌ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 17-23.
432. ∫∞∑∞∫O™ ∫. ∫ÏÈÓÈ΋ ÂÈÎfiÓ· – ¢È¿ÁÓˆÛË Û˘Ó‰ÚfiÌˆÓ Ô˘ ÔÊ›ÏÔÓÙ·È Û ÁÂÓÂÙÈ΋ ‚Ï¿‚Ë ÙÔ˘ ÌÔÚ›Ô˘
Ù˘ ÈÓÛÔ˘Ï›Ó˘ ‹ ÙÔ˘ ˘Ô‰Ô¯¤· Ù˘. ∂ÏÏËÓ. ¢È·‚ ÃÚÔÓÈο 1996; 9: 24-30.
433. ªOÀ™§∂à Δ. ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‰ÚfiÌˆÓ Ô˘ ÔÊ›ÏÔÓÙ·È Û ÁÂÓÂÙÈ΋ ‚Ï¿‚Ë ÙÔ˘ ÌÔÚ›Ô˘ Ù˘ ÈÓÛÔ˘Ï›Ó˘
‹ ÙÔ˘ ˘Ô‰Ô¯¤· Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9:
31-5.
434. ¢∏ª∏ΔƒπOÀ ¢, ∫OÀƒΔO°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™, ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ¢.
∏ Û˘ÓÙ‹ÚËÛË ÙÔ˘ ·ÔÙÂϤÛÌ·ÙÔ˜ ÔÏÈÁÔıÂÚÌȉÈ΋˜ ‰›·ÈÙ·˜ ˘fi D-Ê·ÈÓÊÏÔ˘Ú·Ì›ÓË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1996; 9: 36-40.
435. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, Δ™π¶Δ™πO™ π, ¶∞¶∞∑O°§OÀ ¡, Ã∞Δ™∂ƒ∞™ ¢,
°∫OΔ™∏™ ¡. ºÈÌÚÔÓÂÎÙ›ÓË Ï¿ÛÌ·ÙÔ˜ Î·È ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 414.
436. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, ¶∞¶∞∑O°§OÀ ¡, Ã∞Δ™∂ƒ∞™ ¢, °∫OΔ™∏™ ¡. Δ·
Â›‰· Ù˘ ÊÈÌÚÔÓÂÎÙ›Ó˘ ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ ÛÙË ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÔÓÈο 1996; 9:
45-8.
437. ¶∞¶∞∑O°§OÀ ¡, ™OÀ§∏™ ∫, ª∞¡∂™ Ã, ™∫∞ƒ∞°∫∞™ °, ∫O¡ΔO°π∞¡¡∏™ π, πø∞¡¡π¢∏™ ∞,
μO§OÀ¢∞∫∏™ ∫, ∏§π∞¢∏™ μ. ∫·Ú‰È·ÁÁÂȷΤ˜
ÂÈÏÔΤ˜ Î·È ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ Û هÔ˘ π ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ (∂˘Ú‹Ì·Ù· ÂÎ Ù˘ Eurodiab
Complications Study). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9:
49-53.
438. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ™ø™™π¢OÀ ∂,
™∫∞ƒ∞°∫∞™ °, ∫O¡ΔO°π∞¡¡∏™ π, °∫OÀΔ-
94
∫π¢OÀ ™, μOÀ∫π∞™ ª. ∂Á΢ÌÔÛ‡ÓË Î·È ¯ÚfiÓȘ
ÂÈÏÔΤ˜ Û هÔ˘ π ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (∂˘Ú‹Ì·Ù· ÂÎ Ù˘ ∂urodiab Complications Study). ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1996; 9: 54-7.
439. ∂À£Àªπ∞¢∏™ ∞, ™OÀ°πOÀ§Δ∑O°§OÀ º,
πø∞¡¡π¢OÀ ∂, ∞ƒO¢πΔ∏™ ∫, ∫∞∑π¡∞∫∏™ °,
∂À£Àªπ∞¢∏™ π, Δ™∞¶∞™ °. ¶ÚÔÁÓˆÛÙÈ΋ ·Í›·
Ù˘ ∞Δ-πππ, ÙÔ˘ PAI-1, ÙÔ˘ t-PA, ÙÔ˘ ÈÓˆ‰ÔÁfiÓÔ˘ ηÈ
Ù˘ ÏÈÔÚˆÙ½Ó˘ (·), Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 58-63.
440. ªπTRAKOU A, RYAN C, VENEMAN T, MOKAN
M, JENSSEN T, KISS I, DURRANT J, CRYER P,
GERICH J. Hierarchy of glycemic thre-shold for
counterregulatory hormone secretion symptoms,
cerebral dysfunction. Am J Physiol 1991; 260: E67E74.
441. MITRAKOU A, FANELLI C, VENEMAN T, PERIELLO G, CALDERONE S, PLATANISIOTIS D,
RAMBOTTI A, RAPTIS S, BRUNETTI P, CRYER
P, BOLLI G. Reversibility of unwareness of hypofglycemia in patients with insulinomas. New Engl J Med
1993; 329: 834-9.
442. ª¶∞∫∞Δ™∂§O™ ™. ¶·ıÔÁ¤ÓÂÈ· Ù˘ ¤ÏÏÂȄ˘ ÚÔÂȉÔÔÈËÙÈÎÒÓ ·‰ÚÂÓÂÚÁÈÎÒÓ Û˘ÌÙˆÌ¿ÙˆÓ ˘ÔÁÏ˘Î·ÈÌ›·˜ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1992. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
443. ™∫∞ƒ∞°∫∞™ °I. ∏ ºÈÌÚÔÓÂÎÙ›ÓË ÙÔ˘ Ï¿ÛÌ·ÙÔ˜
ÛÙË ‰È·‚ËÙÈ΋ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. π·ÙÚÈ΋ ™¯ÔÏ‹
¢¶£, 1994. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
444. MITROPOULOS K. Lipoprotein metabolism and
thrombosis. Current Opinion Lipidology 1994; 5: 22735.
445. ª∂Δ∞•∞™ ¶, Δƒπ∞¡ΔO¶OÀ§O™ π, ∫∞ƒ∞ª∏Δ™O™ ¢, ∑∞ª¶OÀ§∏™ Ã, μ∞§Δ∏™ ¢. ÀÂÚˆÛ̈ÙÈÎfi˜ ‰È·‚‹Ù˘ (∂ ¢ηÈÚ›· ‰‡Ô ÂÚÈÙÒÛˆÓ).
™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢,
1973: 129-36.
446. ∫∞ƒ∞ª∏Δ™O™ ¢. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: ¶·ıÔÁ¤ÓÂÈ· – ¢È¿ÁÓˆÛȘ – £ÂÚ·›· – ∂ÈÏÔη›. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 1976: 256 ÛÂÏ.
447. ∫∞ƒ∞ª∏Δ™O™ ¢, μ∞ƒ°∂ª∂∑∏™ μ, ª∂ªªO™
¢, ¶∞¶∞¢∏ª∏ΔƒπOÀ ª. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Û ·ÛıÂÓ›˜ Ô˘ ˘Ô‚Ï‹ıËÎ·Ó Û ÓÂÊÚÈ΋ ÌÂÙ·ÌfiÛ¯Â˘ÛË. Mat Med Greca 1979; 7: 493-6.
448. £∞§∞™™π¡O™ ¡, ∫∞ƒ∞ª∏Δ™O™ ¢, ∫∞Δ™π§∞ª¶ƒO™ ¡, ∫O∫§∞ª∏™ ∂, Ã∞Δ∑∏§OÀ∫∞ª∞¡Δ∞∫∞ ∞. ∏ ‰È¿ÁÓˆÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο
1980; 42: 386-99.
449. ∫ÀƒOÀ ∞, ª∞∫ƒÀ°π∞¡¡∞∫∏ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢. ∞ÎÚ›‚ÂÈ· Î·È Â·Ó·ÏË„ÈÌfiÙËÙ· ÙÔ˘ ÚÔÛ‰ÈÔÚÈÛÌÔ‡ Ù˘ ÁÏ˘Îfi˙˘ Û ·›Ì· ‹ Ï¿ÛÌ· Ì ÙË Ì¤ıÔ‰Ô Ù˘ ÁÏ˘ÎÔ˙ÔÍÂȉ¿Û˘. °·ÏËÓfi˜ 1982; 24: 1003-6.
450. KAƒ∞ª∏Δ™O™ ¢, ¶ƒO°π∞ ∂, Ã∞§∫π¢OÀ ∂,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
∫ÀƒOÀ ∞. ∏ ÛËÌ·Û›· ÙÔ˘ ¯ÚËÛÈÌÔÔÈÔ‡ÌÂÓÔ˘ ·ÓÙÈËÎÙÈÎÔ‡ ÛÙÔÓ ÚÔÛ‰ÈÔÚÈÛÌfi Ù˘ ÁÏ˘Îfi˙˘ ÙÔ˘ ·›Ì·ÙÔ˜ Ì ÙË Ì¤ıÔ‰Ô Ù˘ ÁÏ˘ÎÔ˙ÔÍÂȉ¿Û˘. °·ÏËÓfi˜
1982; 24: 777-80.
451. ∫∞ƒ∞ª∏Δ™O™ ¢. ÀÂÚˆÛ̈ÙÈÎfi ÌË ÎÂÙÔÓÈÎfi
˘ÂÚÁÏ˘Î·ÈÌÈÎfi ÎÒÌ·. ™ÙÔ ∞‚Ú·Ì›‰Ë˜ ∞, πÎÎÔ˜ ¢.
∂Ó‰ÔÎÚÈÓÔÏÔÁÈο £¤Ì·Ù·. £ÂÛÛ·ÏÔÓ›ÎË: University
Studio Press, 1983: 93-100.
452. ∫∞ƒ∞ª∏Δ™O™ ¢, μ∂ƒ°OÀ§∞™ °, ∂À£ÀªπOÀ
¡, ∑∞ª¶OÀ§∏™ Ã, Ã∞§∫π¢∏™ Ã. ∏ ıÂÚ·›·
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∞˘ÙÔÙÂϤ˜ Ù‡¯Ô˜. £ÂÛÛ·ÏÔÓ›ÎË, 1984: 62 ÛÂÏ.
453. ∫∞ƒ∞ª∏Δ™O™ ¢. ΔÔ ÈÛÙÔÚÈÎfi Ù˘ ·Ó·Î¿Ï˘„˘ Ù˘
ÈÓÛÔ˘Ï›Ó˘. ¶·ÚfiÓ Î·È Ì¤ÏÏÔÓ Ù˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 79-93.
454. Ã∞ƒ™OÀ§∏™ º. ¢Â˘ÙÂÚÔ·ı›˜ ÌÔÚʤ˜ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 94-104.
455. §πª∂¡O¶OÀ§O™ μ. O ÚfiÏÔ˜ ÙÔ˘ ÛÏ·Á¯ÓÈÎÔ‡ Ï›Ô˘˜ ÛÙËÓ ·ÈÙÈÔ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. ™‡Á¯ÚÔÓ˜ ·ÓÙÈÏ‹„ÂȘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1996; 9: 105-12.
456. ∫∞∑∞∫O™ ∫, ªOÀ™§∂à Δ. O ‰È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜ ÛÙËÓ ÂÚÁ·Û›· ÙÔ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9:
113-7.
457. ¶∂ΔƒOÀ-∞ª∂ƒπ∫∞¡OÀ Ã, ª∞ƒ∫O¶OÀ§O™
∞, ª¶∂§∞∑∏ ª, ∫∞ƒ∞ª∏Δ™O™ ¢, ¶∞¶∞¡∞°πøΔOÀ ¶. ∂ÈÔÏ·ÛÌfi˜ ÙÔ˘ ÛÙÔÌ·ÙÈÎÔ‡ ÔÌ·ÏÔ‡
ÏÂȯ‹Ó· Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 118-22.
458. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¢OÀ™OÀ μ, °∫ƒ∂ª¶O°π∞¡¡∏ ¢, °OÀ∂§∞ ª, Δƒ∞´∞¡π¢∏™ ¶. ∂ͤÏÈÍË Ù˘ fiÚ·Û˘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì ÚÔ·Ú·ÁˆÁÈ΋ ‹ ·Ú·ÁˆÁÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· Î·È ÎÏÈÓÈο ÛËÌ·ÓÙÈÎfi Ô›‰ËÌ· ˆ¯Ú¿˜ (CSME) ÌÂÙ¿ Laser
ʈÙÔËÍ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996; 9: 123-9.
459. ∂À£Àªπ∞¢∏™ ∞, §∂À∫O™ ¡, ¶∞¶∞¢O¶OÀ§O™ π, Δ™πΔ§∞∫π¢OÀ ª, Δ™∞¶∞™ °. ∏ Û˘¯ÓfiÙËÙ· Ù˘ ÛȈËÏ‹˜ ÈÛ¯·ÈÌ›·˜ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜, Ì ‰ÔÎÈÌ·Û›· ÎÔÒÛˆ˜ Î·È ÛÈÓıËÚÔÁÚ¿ÊËÌ·
ηډȿ˜ Ì ı¿ÏÏÈÔ 201. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1996;
9: 130-4.
460. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏, Δ∑øΔ∑∞™ £,
¶∞¶∞Ãπ™ΔO¢OÀ§OÀ º, ¢OÀ∫π¢∏™ ¢. ∏ Â›‰Ú·ÛË Ù˘ ‚Ú·¯Â›·˜ ¯ÔÚ‹ÁËÛ˘ Ù˘ D-ÊÂÓÊÏÔ˘Ú·Ì›Ó˘ ÛÙÔ ÁÏ˘Î·ÈÌÈÎfi ÚÔÊ›Ï Û ·ÛıÂÓ›˜ Ì ™¢ Ù‡Ô˘
ππ Î·È ·Ó‰ÚÈÎÔ‡ Ù‡Ô˘ ·¯˘Û·ÚΛ·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1996; 9: 135-7.
461. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂,
°∫OÀΔ∫π¢OÀ ™, ª¶OÀ™πOÀ £, ∫OÀ°πOÀªΔ∑O°§OÀ ¢, πø∞¡¡OÀ μ, ∑∞Ã∞ƒπOÀ¢∞∫∏ ∫,
¶∞¶∞∑O°§OÀ ¡. ∂›‰· ‚-ıÚÔÌ‚ÔÛÊ·ÈÚ›Ó˘
(‚-ΔG) Î·È ·ÈÌÔÂÙ·ÏÈ·ÎÔ‡ ·Ú¿ÁÔÓÙ· 4 (PF-4) ÛÂ
IDDM Ì ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1996; 9: 138-41.
462. ¶∞¶∞∑O°§OÀ ¡, ™OÀ§∏™ ∫, ª∞¡∂™ Ã, ¶∞-
¶∞¢∂§∏ ∂, ™¶∏§πO¶OÀ§O™ ∞, ∫∂™π¢∏™ Ã.
∫¿ÓÈÛÌ· Î·È ÂÈÏÔΤ˜ (ÔÍ›˜ Î·È ¯ÚfiÓȘ) Û هÔ˘ π ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1996; 9: 142-8.
463. KATSOYANNIS PG, TRAKATELIS AC, ZALUT
C, JOHNSON S, TOMETSKO A, SCHWARTZ G,
GINOS J. Studies on the synthesis of insulin from
natural and synthetic A- and B-chains. III. Synthetic
insulins. Biochemistry 1967; 6: 2656-68.
464. πø∞¡¡π¢OÀ-¶∞¶∞°π∞¡¡∞∫∏ μ, Ã∞ƒ∞§∞ª¶π¢OÀ-μƒ∞¡πΔ™∞ ™, ∫§ø¡π∑∞∫∏™ π, ∫O¡∫OÀƒ∏™ §. §ÂÈÙÔ˘ÚÁÈÎfiÙËÙ· ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ
ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì ‹ ¯ˆÚ›˜ ·ÁÁÂȷΤ˜ ·ÏÏÔÈÒÛÂȘ.
°·ÏËÓfi˜ 1988; 30: 367-72.
465. ∫§∏ª∂¡ΔπøΔ∏ ∞. ŒÓ· ·ÚÂÌ‚·ÙÈÎfi ÚfiÁÚ·ÌÌ·
·˘ÙÔÂϤÁ¯Ô˘ Û ÂÊ‹‚Ô˘˜ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ºÈÏÔÛÔÊÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1995. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
466. ¡Δ∞ºO°π∞¡¡∏ Ã. ∏ ÂÎ·›‰Â˘ÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡
·È‰ÈÔ‡ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÂ
Û¯¤ÛË Ì ÙË ÛˆÌ·ÙÈ΋ ¿ÛÎËÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∂∫¶∞, 1995. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
467. £∂OÃ∞ƒ∏ ª. ¶ÚÒ˚ÌË ˘¤ÚÙ·ÛË Î·È ·ıÔÏÔÁÈÎfi
ÊÔÚÙ›Ô ·ÚÙËÚȷ΋˜ ›ÂÛ˘ ÌÂ Û˘Ó¯‹ ÂÁÁÚ·Ê‹ Ù˘ ÌÂ
Ù·Ï·ÓÙÔÛ›ÌÂÙÚÔ Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜ ¿Û¯ÔÓÙ˜
·fi ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¶ÂÚÈÊÂÚÂÈ·Îfi °ÂÓÈÎfi ¡ÔÛÔÎÔÌÂ›Ô ¶·›‰ˆÓ ¶∞¡∞°πøΔ∏ Î·È ∞°§∞´∞™ ∫Àƒπ∞∫OÀ. ∫ÏÈÓÈ΋ ∞′ ¶·È‰È·ÙÚÈ΋. ∫¤ÓÙÚÔ ¢È·‚ËÙÔÏÔÁÈÎfi, 1996. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
468. MALAMITSI-PUCHNER A, ECONOMOU E, KATSOUYANNI K, KARACHALIOU F, DELIS D,
BARTSOCAS CS. Endothelin l-2l plasma concentrations in children and adolescents with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab
1996; 9: 463-8.
469. THEOCHARI M, VYSSOULIS GP, TOUTOUZAS
PK, BARTSOCAS CS. Arterial blood pressure
changes in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 1996; 129: 66770.
470. BARTSOCAS CS. Intensive therapy of diabetes in
children. Yes or no? Medicographia 1991; 13: (Suppl
1): 37-8.
471. ∫∞ºOÀƒOÀ ∞, ™Δ∞ªO°π∞¡¡OÀ §, °§∏¡∂§∏ ∂, ª¶∞ƒΔ™O∫∞™ Ã. ΔÔ ·Ó¿ÛÙËÌ· ÙˆÓ ·È‰ÈÒÓ Ì ÓÂԉȷÁÓˆṲ̂ÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. Mater
Med Greca 1991; 19: 445-50.
472. ƒ∞¶Δ∏™ ™, ª¶∞ƒΔ™O∫∞™ Ã, ºƒ∞°∫OÀ§∞∫∏™ °, ∫∞ƒ∞ª∞¡O™ μ, ∫∞Δ™π§∞ª¶ƒO™ ¡,
ª∞°∫§∞ƒ∞ ∂, ¶π∂ƒƒOÀΔ™∞∫O™ π, ™OÀƒ§∞™
°. ∏ ∂ÏÏ¿˜ ÂÈÛ¿ÁÂÈ ÓÔÌÔıÂÛ›· ÁÈ· ÙËÓ ÊÚÔÓÙ›‰· ÙˆÓ
‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ (Greece introduces legislation
for the management of diabetic patients). Giornale
Italiano di Diabetologia e Metabolisimo 1992; 12:
(Suppl 1): 16.
95
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
473. ∫∞ƒ∞°π∞¡¡∏ Ã, ∞¡∞™Δ∞™π∞¢OÀ μ, ™¶ÀƒO¶OÀ§OÀ ª, ∫∞™™πOÀ ∫, ¶∞¶∞¡π∫O§∞OÀ
ª, μ∞ƒ§∞ ª, ™Δ∞ÀƒO¶OÀ§OÀ ∞, ª¶∞ƒΔ™O∫∞™ Ã. °ÂÓÂÙÈ΋ ÚԉȿıÂÛË Î·È ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˜ ‰È·‚‹Ù˘ ÛÙËÓ ∂ÏÏ¿‰·. Mat Med Greca 1991;
19: 503-8.
474. ∫∞¡Δƒ∂ ∞, μO™∫∞∫∏ ∂, ¢∂§∏™ ¢, ∞¡∞™Δ∞™π∞¢OÀ μ, ∫∞™™πOÀ ∫, ª¶∞ƒΔ™O∫∞™ Ã. ∏
ÔÛÙÂÔÂÓ›· ÛÙ· ·È‰È¿ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË. O™ΔOÀ¡ 1991; 2: 119-23.
475. KHALIL I, SPYROPOULOU M, MALLET C, LOSTE N, DOUAY C, LA PERRIERE J, BARTSOCAS CH, CHARRON D, STAVROPOULOU C.
HLA-Class II polymorphism and IDDM susceptibility in the Greek population. Europe an Journal of Immunogenetics 1993; 20: 193-9.
476. KARAYANNI E, ANASTASIADOU V, SPYROPOULOU M, DELIS D, KHALIL I, LEPAGE V,
PAPANIKOLAOU M, VARIA M, STAVROPOULOU A, BARTSOCAS C. Genetic predisposition and
IDDM in Greece. Genetic Coun Seling 1993; 4: 1815.
477. ∫OÀƒΔO°§OÀ °. ∂›‰Ú·ÛË Ù˘ ·Ó·ÛÙÔÏ‹˜ ÙÔ˘ ÌÂÙ·ÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘ Ù˘ ·ÁÁÂÈÔÙÂÓÛ›Ó˘ ÛÙËÓ ÓÂÊÚÈ΋
ÏÂÈÙÔ˘ÚÁ›· ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1997. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
478. ª¶∞ƒΔ™O∫∞™ Ã. ¶ÚÔ‚Ï‹Ì·Ù· ÛÙË Ú‡ıÌÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∑ËÚÔÁÈ¿ÓÓ˘ ¶ª, ¶È·‰›Ù˘ °, ΔÛÔ˘Ê¿Î˘ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÈÏÔΤ˜. ∞ı‹Ó·: ∂Ù·ÈÚ›· ¡ÔÛËÏ¢ÙÈÎÒÓ ™Ô˘‰ÒÓ, 1997;
121-5.
479. BARTSOCAS CS, KASSIOU K, LANARA O,
PHYLAKTOU C. The medicopsychosocial problems
of families with diabetic children. Diabetes in the
Young 1992; 28: 14-20.
480. GIANNAKOPOULOS F, ALIVISATOS J, BARTSOCAS C, FRANGOULAKIS G, KARAMANOS
B, KATSILAMPROS N, MANGLARA E, PANGRATI A, RAPTIS S. A plan for the diabetes teaching nurses education. St Vincent Declaration Newsletter 1994; 5: 19-20.
481. £∂OÃ∞ƒ∏ ª, μÀ™™OÀ§∏™ °, °π∞¡¡∞∫O¶OÀ§OÀ ∞, ¶∞§∞πO§O°O™ ∞, ª¶∞ƒΔ™O∫∞™ Ã, ΔOÀΔOÀ∑∞™ ¶. ∏ ÙÚÔÊÈ΋ Û˘ÌÌÂÙÔ¯‹ Ù˘
·ÚÙËÚȷ΋˜ ›ÂÛ˘ ÛÙÔ Ì˘ÔοډÈÔ ‰È·‚ËÙÈÎÒÓ ·È‰ÈÒÓ. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 1994; 2: 306-11.
482. μARTSOCAS C, IONESCU-TIRGOVISTE C. Children and adolescents. The St Vincent Declaration
Newsletter 1995; 8: 19.
483. μ∞∑∞πOÀ-°∂ƒ∞™πªπ¢∏ ∞. ªÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·ÙÔ˜ Î·È ÓËÛȉ›ˆÓ ÙÔ˘ Langerhans Û ·ÛıÂÓ›˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: £ÂˆÚ›·-¶Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜,
1995: 567-90.
484. ª¶∞ƒΔ™O∫∞™ Ã. O ‰È·‚‹Ù˘ ÛÙ· ·È‰È¿ Î·È ÙÔ˘˜
96
ÂÊ‹‚Ô˘˜. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘:
£ÂˆÚ›· - ¶Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 158-68.
485. AL-QADREH A, VOSKAKI I, KASSIOU K,
ATHANASOPOULOU H, SARAFIDOU E, BARTSOCAS C. Treatment of osteopenia in children with
insulin dependent diabetes mellitus: The effect of l·hydroxyvitamin D3. European Journal of Pediatrics
1996; 155: 15-7.
486. ¡Δ∞ºO°π∞¡¡∏-∫OÀƒΔ∏ Ã, ¶§∞Δ∏ Ã, ∫∞™™πOÀ ∫, ª¶∞ƒΔ™O∫∞™ Ã. ∏ Â›‰Ú·ÛË Ù˘ ۈ̷ÙÈ΋˜ ¿ÛÎËÛ˘ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ·È‰ÈÔ‡ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ÕıÏËÛË Î·È ∫ÔÈÓˆÓ›· 1995; 11: 85.
487. ª¶∞ƒΔ™O∫∞™ Ã. ¶·È‰ÈÎfi˜ ¢È·‚‹Ù˘: ∫ÔÓÙ¿ ÛÙËÓ
ÔÚÈÛÙÈ΋ ıÂÚ·›·. π·ÙÚÈΤ˜ ∂ÍÂÏ›ÍÂȘ 1994; 16: 20-5.
488. ª¶∞ƒΔ™O∫∞™ Ã. °ÂÓÂÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÂÎÙfi˜
HLA ÛÙËÓ ÚfiÎÏËÛË Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ π.
™ÙÔ: ¶Ú·ÎÙÈο ™ÂÌÈÓ·Ú›Ô˘ ∞ÓÔÛÔÏÔÁ›·˜ (12Ô˜ ·ÎÏÔ˜), ∞ı‹Ó·: 1994; 55-9.
489. KAƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™. ÃÚËÛÈÌÔÔ›ËÛË ÂÚˆÙËÌ·ÙÔÏÔÁ›Ô˘ ÁÈ· ÙÔÓ ¤ÏÂÁ¯Ô ÙˆÓ ÁÓÒÛÂˆÓ Î·È ÂÎÙ›ÌËÛË „˘¯ÔÏÔÁÈ΋˜ ηٿÛÙ·Û˘ ‰È·‚ËÙÈÎÒÓ Ù‡Ô˘ π. ™ÙÔ: ∂ÂÙËÚ›‰· π·ÙÚÈ΋˜ ™¯ÔÏ‹˜ 1988;
17: 107-15.
490. KARAMITSOS D, BACATSELOS S, KILINTZIS
V, SKEMBERIS G, PAPAGEORGIOU A. Heredity
obesity and non-insulin dependent diabetes mellitus.
A study of Greek diabetics. Yearbook of Medical
School AUTH (∂ÂÙËÚ›‰· π·ÙÚÈ΋˜ ™¯ÔÏ‹˜ ∞¶£)
1996; 22: 7-11.
491. ∫∞ƒ∞ª∏Δ™O™ ¢. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: ºÔÈÙËÙÈΤ˜ ·Ú·‰fiÛÂȘ. £ÂÛÛ·ÏÔÓÈÎË: University Studio
Press, 1985: 65 ÛÂÏ.
492. ª∞ªO¶OÀ§O™ ª, ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ‰È·‚ËÙÈ΋ ¤ÁÎ˘Ô˜. ∂ÏÏËÓ. ª·È¢Ù. °˘Ó·ÈÎÔÏ. 1987; 1: 11-26.
493. ∫∞∑∞¡Δ∑∏™ ª, μ∞ªμOÀ∫O™ ¢, ¢∏ª∏Δƒ∞ΔO™ ™, ∫∞ƒ∞ª∏Δ™O™ ¢, Δƒπ∞¡Δ∞ºÀ§§OÀ °.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÔÊı·ÏÌfi˜. ™ÙÔ: ¶Ú·ÎÙÈο
ÙÔ˘ 2Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË.
1987; ÙfiÌ. ∞: 334-7.
494. BENROUBI M, CHRISTACOPOULOS P, KARAMITSOS D, MALDONATO A, PSYCHOGIOS A,
STEIN M, VULEBIC L, WISE P. Evaluating diabetes education. In: Alivisatos JG. The teaching letter, DESG of EASD. Athens, 1987.
495. ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ‰›·ÈÙ· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. π·ÙÚÈÎfi˜ Δ‡Ô˜ 1990; 23: 12-3.
496. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ:
£·Ï·ÛÛÈÓfi˜ ¡. ∂ȉÈÎfi˜ ΔfiÌÔ˜ ª·ıËÌ¿ÙˆÓ. ∞ı‹Ó·:
1990: 123-9.
497. ¶∞¶∞°∂øƒ°πOÀ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, ∞£ÀƒO™ μ. ¶ÚfiÁÚ·ÌÌ· ËÏÂÎÙÚÔÓÈÎÔ‡ ˘ÔÏÔÁÈÛÙ‹ ÁÈ· ¯ÔÚ‹ÁËÛË ‰È·ÈÙÔÏÔÁ›Ô˘ ÓÂÊÚÔ·ıÔ‡˜ ‰È·‚ËÙÈÎÔ‡. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 1991; 4:
333-8.
498. ∫∞ƒ∞ª∏Δ™O™ ¢, ¢π¢∞°°∂§O™ Δ, ª¶∞∫∞-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Δ™∂§O™ ™, ∫OÀƒΔO°§OÀ °. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË Î·È ÔÍ›· ·ÈÌfiÏ˘ÛË Û ·ÛıÂÓ‹ Ì ‰È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ∂ÏÏËÓ. π·ÙÚÈ΋ 1991; 57: 218-21.
499. ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ¿ıÏËÛË ÛÙÔ ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹. ™ÙÔ: ¶Ú·ÎÙÈο 1Ô˘ ™˘Ó‰ڛԢ ∞ıÏËÙÈ·ÙÚÈ΋˜
∂Ù·ÈÚ›·˜ μÔÚ›Ԣ ∂ÏÏ¿‰Ô˜. £ÂÛÛ·ÏÔÓ›ÎË: University Studio Press, 1990; 185-94.
500. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢˘ÛÏÈȉ·È̛˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÈÛ‹ÁËÛË ·fi ÛÙÚÔÁÁ˘Ï‹ ÙÚ¿Â˙· Ì ٛÙÏÔ
«¢˘ÛÏÈÔÚˆÙÂ˚Ó·È̛˜». π·ÙÚÈΤ˜ ∂ÍÂÏ›ÍÂȘ 1993:
13-5.
501. A¡Δø¡π∞¢∏™ ∞, Δ∞∫OÀ¢∞™ ¢, ¶∞¶∞¡π∫O§∞OÀ μ, πªμƒπO™ °, °∞∫∏™ ¢, Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ Ã, ∫∞ƒ∞ª∏Δ™O™ ¢, ª¶∞∫∞Δ™∂§O™ ™, §∂O¡Δ™π¡∏ ª, ¶∞Δ™π∞OÀƒ∞ ∫. ™‡Á¯ÚÔÓË ·ÁÎÚ·ÙÔ‰ˆ‰Âη‰·ÎÙ˘ÏÈ΋ Î·È ÓÂÊÚÈ΋ ÌÂÙ·ÌfiÛ¯Â˘ÛË Ì ·ÚÔ¯¤Ù¢ÛË Ù˘ ¤Íˆ ¤ÎÎÚÈÛ˘ ÙÔ˘
·ÁÎÚ¤·ÙÔ˜ ÛÙËÓ Ô˘ÚÔ‰fi¯Ô ·ÛÙË. ∂ÏÏËÓ. π·ÙÚÈ΋
1992; 58: 62-8.
502. ¶∞¶∞∑O°§OÀ ¡, ∫∞ƒ∞ª∏Δ™O™ ¢, ™πøª¶O§O™ ∫. ¢È·‚‹Ù˘ Î·È ·ıËڈ̿وÛË. ™ÙÚÔÁÁ˘Ï‹
ΔÚ¿Â˙·. ™ÙÔ: ¶Ú·ÎÙÈο 8Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË: 1993; 303-10.
503. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚ËÙÈ΋ ¡Â˘ÚÔ¿ıÂÈ·. ™ÙÔ:
μ·ÛÈΤ˜ ·Ú¯¤˜ ÂÓ‰ÔÎÚÈÓÔÏÔÁ›·˜. ∞ı‹Ó·: ∂Ó‰ÔÎÚÈÓÔÏÔÁÈÎfi ΔÌ‹Ì· ¡ÔÛÔÎÔÌ›Ԣ ∂˘·ÁÁÂÏÈÛÌfi˜. 1994;
186-94.
504. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚‹Ù˘ Î·È ˘¤ÚÙ·ÛË. ªÈ·
ÛÙÂÓ‹ Û¯¤ÛË Ì ÂÈÙÒÛÂȘ. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË
1994; 2: 271-79.
505. ∫∞ƒ∞ª∏Δ™O™ ¢, Ã∞ƒ™OÀ§∏™ º, ªπÃ∞∏§π¢∏™ ∞, ∞¡£πªπ¢∏™ °, μÀ∑∞¡Δπ∞¢∏™ ∞. ¶ÂÚ›ÙˆÛË ÚÔÎÏ‹Ûˆ˜ ˘ÔÁÏ˘Î·ÈÌ›·˜ ÁÈ· ÏfiÁÔ˘˜ ˘fiÎÚÈÛ˘ ÓfiÛÔ˘. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 1996; 62: 455-7.
506. ∫∞ƒ∞ª∏Δ™O™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ‰˘ÛÏÈȉ·È̛˜. ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘:
£ÂˆÚ›· - ¶Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 504-14.
507. ª∞ªO¶OÀ§O™ ª, ∫∞ƒ∞ª∏Δ™O™ ¢, ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÁ΢ÌÔÛ‡ÓË.
ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: £ÂˆÚ›· - ¶Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 543-58.
508. BACATSELOS S, KARAMITSOS D, KOURTOGLOU G, ZAMBOULIS CH, YOVOS J, VYZANTIADES A. Hypoglycemia unwareness in type 1
diabetes mellitus patients under conventional insulin
treatment. Diabetes Nutr Metab 1995; 8: 265-7.
509. KONTOPOULOS A, ATHYROS V, DIDANGELOS T, PAPAGEORGIOU A, AVRAMIDIS M,
MAVROUDI M, KARAMITSOS D. Effect of chronic quinapril administrarion on heart rate variability in
patients with diabetic autonomic neuropathy. Diabetes Care 1997; 20: 355-61.
510. ∫∞ƒ∞ª∏Δ™O™ ¢. ™ÙÚ·ÙËÁÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. £ÂÛÛ·ÏÔÓ›ÎË:
University Studio Press, 1997.
511. LIAMOU E, MYLONAKIS E, KARAMITSOS D.
Frequency of depression in IDDM patients in Greece.
Letter to the editor. Diabetes Care 1994; 17: 1075.
512. ∫∞ƒ∞ª∏Δ™O™ ¢. OÈ Ê˘ÙÈΤ˜ ›Ó˜ ÛÙË ‰È·ÙÚÔÊ‹.
¢È·ÙÚÔÊ‹ - ¢È·ÈÙÔÏÔÁ›· 1997; 1: 25-7.
513. ∫∞ƒ∞ª∏Δ™O™ ¢. πÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘
¢È·‚‹Ù˘: £ÂˆÚ›·-¶Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995:
244-9.
514. ¶∞¶∞∑O°§OÀ ¡. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË-¢È·‚ËÙÈÎfi ÎÒÌ·. ™ÙÔ: ∂›ÁÔ˘Û· π·ÙÚÈ΋ ÛÙËÓ ¶·ıÔÏÔÁ›·.
£ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£ - ΔÔ̤·˜ ¶·ıÔÏÔÁ›·˜. ÀËÚÂÛ›· ¢ËÌÔÛÈÂ˘Ì¿ÙˆÓ, 1991: 175-9.
515. ¶∞¶∞∑O°§OÀ ¡. ÀÔÁÏ˘Î·ÈÌ›·. ™ÙÔ: ∂›ÁÔ˘Û·
π·ÙÚÈ΋ ÛÙËÓ ¶·ıÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£ - ΔÔ̤·˜ ¶·ıÔÏÔÁ›·˜. ÀËÚÂÛ›· ¢ËÌÔÛÈÂ˘Ì¿ÙˆÓ, 1991: 180-4.
516. ¶∞¶∞∑O°§OÀ ¡. °·Ï·ÎÙÈ΋ ÔͤˆÛË. ™ÙÔ: ∂›ÁÔ˘Û· π·ÙÚÈ΋ ÛÙËÓ ¶·ıÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£ - ΔÔ̤·˜ ¶·ıÔÏÔÁ›·˜. ÀËÚÂÛ›· ¢ËÌÔÛÈÂ˘Ì¿ÙˆÓ, 1991: 185-6.
517. ∫∞¶OÀ§∞™ ™. ƒfiÏÔ˜ ÙÔ˘ ·Û‚ÂÛÙ›Ô˘ ÛÙËÓ ·fi ÙÔ˘
ÛÙfiÌ·ÙÔ˜ ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘ Û ·ÚÚÒÛÙÔ˘˜ Ì ¯ÚÔÓ›· ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ· ¶·Ú·ÙËÚ‹ÛÂȘ ÁÈ· ÙËÓ Û¯¤ÛË ·Û‚ÂÛÙ›Ô˘, ÈÓÛÔ˘Ï›Ó˘ Î·È ·Ú·ıÔÚÌfiÓ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1985. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
518. ∑πOÀΔ∞™ °. ªÂÙ·‚ÔϤ˜ ÙÔ˘ ˘ÚÔ˘‚ÈÎÔ‡ Î·È ÙÔ˘ Á·Ï·ÎÙÈÎÔ‡ ÔͤԘ ÛÙÔ Ï¿ÛÌ· Î·È Ù· ÂÚ˘ıÚ¿ ·ÈÌÔÛÊ·›ÚÈ· Û ‰È·‚ËÙÈο ¿ÙÔÌ· ÌÂÙ¿ ·fi ¯ÔÚ‹ÁËÛË ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
519. ∫∞§∞ª¶∞§π∫∞ ¢. ªÂϤÙË ÙÔ˘ 2, 3-‰ÈʈÛÊÔÚÔÁÏ˘ÎÂÚÈÎÔ‡ ÔͤԘ ÙˆÓ ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÓ Û ‰È·‚ËÙÈο
¿ÙÔÌ· ÌÂÙ¿ ·fi ¯ÔÚ‹ÁËÛË ÈÓÛÔ˘Ï›Ó˘. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1985. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
520. ∫∞ƒÀ¢∞-∫∞μ∞§πøΔ∏ ™. ¢ÔÎÈÌ·Û›· Á·Ï·ÎÙfi˙˘
Ì ÚÔÛ‰ÈÔÚÈÛÌfi Ù˘ Á·Ï·ÎÙfi˙˘ ÛÙ· Ô‡Ú·. π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£, 1985. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
521. ¶∞¶∞¢O¶OÀ§O™ ∞. ¢È¤ÁÂÚÛË Ù˘ ‰Ú·ÛÙÈÎfiÙËÙÔ˜ ÙÔ˘ ‰ÚfiÌÔ˘ Ù˘ ÏÈÔ͢ÁÔÓ¿Û˘ ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ
Û ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1985. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
522. ¡O´Δ™∏-ªπÃ∞§∏ º. ¡Â˘ÚÔÊ˘ÛÈÔÏÔÁÈ΋ ÌÂϤÙË
‰È·‚ËÙÈ΋˜ ÔÏ˘Ó¢ÚÔ¿ıÂÈ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1990. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
523. ∫∞ƒ¢∞ªÀ§∞™ ∞. ∂›‰Ú·ÛË Ù˘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜
ÛÙÔ ·ÓÙ·Ó·ÎÏ·ÛÙÈÎfi ÙˆÓ Ù·ÛÂÔ¸Ô‰Ô¯¤ˆÓ ÛÂ Û˘Óı‹Î˜ ·Ó·ÈÛıËÛ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1991. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
524. ™ΔÀ§π∞¡π¢∏™ Ã. ªÂϤÙË ÙÔ˘ Ì·ÁÓËÛ›Ô˘ ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Î·È ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Û ¿Û¯ÔÓÙ˜
·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1991.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
97
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
525. ∞¡Δ∑OÀ-∞°°OÀƒπ¢∞∫∏ Ã. Δ· Â›‰· ÙÔ˘ Û˘ÌÏËÚÒÌ·ÙÔ˜ C3 Î·È C4 ÛÙÔ˘˜ ÈÓÛÔ˘ÏÈÓÔÂÍ·Úو̤ÓÔ˘˜ Î·È ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·Úو̤ÓÔ˘˜ ·ÛıÂÓ›˜ ÛÂ
Û¯¤ÛË ÌÂ Ê˘ÛÈÔÏÔÁÈο ¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1989. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
526. MANE™ X. ∏ οı·ÚÛË Ù˘ ·ÓÙÈ˘Ú›Ó˘ ÛÙË ‰ÈÂÚ‡ÓËÛË Ù˘ Ë·ÙÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1992. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
527. º∞ƒ¢∂§§∞™ π. Δ· Â›‰· Ù˘ ·Ì̈ӛ·˜ ÛÙÔ ÊÏ‚ÈÎfi ·›Ì· ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ Î·È ÙÔ˘ ‰ˆ‰Âη‰·ÎÙ‡ÏÔ˘
ÌÂÙ¿ ·fi ¯ÔÚ‹ÁËÛË ÁÏ˘Îfi˙˘ Î·È ÂÎÎÚÈÌ·Ù›Ó˘: ¶ÂÈÚ·Ì·ÙÈ΋ ÂÚÁ·Û›· Â› ΢ÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1992. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
528. KORDONOURI O, HARTMANN R, GRÜTERSKIESLICH A, KNIP M, DANNE T. Age-specific levels of diabetes-related GAD and IA-2 antibodies in
healthy children and adults. J Pediatr Endocrinol
Metab 2002; 15: 47-52.
529. ∑∞Ã∞ƒπ∞¢∏™ μ. ∏ Â›‰Ú·ÛË ÙÔ˘ ˘ÂÚ‚·ÚÈÎÔ‡
Ô͢ÁfiÓÔ˘ ÛÙȘ ÌÂÙ·‚ÔϤ˜ Ù˘ Û˘ÁΤÓÙÚˆÛ˘ Ù˘ ÁÏ˘Îfi˙˘ ÙÔ˘ ·›Ì·ÙÔ˜ ÙÔ˘ ·ÓıÚÒÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1993. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
530. ™∫π∞¢O¶OÀ§O™ ™. ∞ÓÙ·fiÎÚÈÛË ·Ó‰ÚÔÁfiÓˆÓ
Î·È ÈÓÛÔ˘Ï›Ó˘ ÛÙË ÊfiÚÙÈÛË Ì ÁÏ˘Îfi˙Ë Û Á˘Ó·›Î˜
Ì ۇӉÚÔÌÔ Hair-An. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1992. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
531. ¶∞¶∞Ã∏™ΔOÀ ∞, μ∞™π§∂πOÀ ∫, ª∂§∂Δ§π¢OÀ ∂, °∂øƒ°O¶OÀ§OÀ μ, ∫∞§§π°∫∞Δ™∏™
Ã, ∫πO™∂™ μ, μOÀ°πOÀ∫∞™ ∞. §ÔÈÌÒ‰Ë ÓÔÛ‹Ì·Ù· Û ‰È·‚ËÙÈÎÔ‡˜. ™ÙÔ: ¶Ú·ÎÙÈο 5Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1990; ÙfiÌ. μ′:
904-10.
532. ¶∞¶∞Ã∏™ΔOÀ ∞, ∫Àƒπ∫§π¢OÀ ¶, §OÀ¶∞™∞∫∏ Ã, ∫O§O∫OΔƒø¡∏ ¢, ƒπ∑O™ ¢, ™π¢∏ƒO¶OÀ§O™ §. ΔÔ ÂÚ˘Û›ÂÏ·˜ Û ‰È·‚ËÙÈο Î·È ÌË
¿ÙÔÌ·. ™ÙÔ: ¶Ú·ÎÙÈο 9Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡
™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1994; ÙfiÌ. μ′: 799-805.
533. μƒ∂ΔΔO™ ª, ™¶Àƒπ¢∏™ Ã, ™ª¶∞ƒOÀ¡∏ ∂,
™ª¶∞ƒOÀ¡∏™ Ã. ∂ÎÙ›ÌËÛË Ù˘ ·ÈÌ·ÙÒÛˆ˜ ÙˆÓ
οو ¿ÎÚˆÓ ‰È·‚ËÙÈÎÒÓ ·ÙfiÌˆÓ Ì ʈÙÔÏËı˘ÛÌÔÁÚ·Ê›·. ™ÙÔ: ¶Ú·ÎÙÈο 7Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1992: 141-6.
534. KABA¡O∑∏-∞§∂μπ∑OÀ ∞. ∞ÈÙÈÔÏÔÁÈ΋ ‰ÈÂÚ‡ÓËÛË Ù˘ Ù‡ÊψÛ˘ ÛÙÔ˘˜ Ì·ıËÙ¤˜ Ù˘ ™¯ÔÏ‹˜ Δ˘ÊÏÒÓ μÔÚ›Ԣ ∂ÏÏ¿‰Ô˜ ÁÈ· ÙÔ ¯ÚÔÓÈÎfi ‰È¿ÛÙËÌ·
1950-1983. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1984. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
535. DACOU-VOUTETAKI A, KARAVANAKI K,
TSOKA-GENNATAS H, THE HELLENIC EPIDEMIOLOGY SOCIETY. National data on the epidemiology of IDDM in Greece. Cases diagnosed in
1992. Diabetes Care 1995; 18: 552-4.
536. ™∫§∞μOÀ¡OÀ-Δ™OÀƒOÀ∫Δ™O°§OÀ ™. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ ˘ÔÁÏ˘Î·ÈÌ›·˜ ÂÍ ·Èı˘ÏÈ΋˜
98
·ÏÎÔfiÏ˘ ηٿ ÙËÓ ·È‰ÈÎ‹Ó ËÏÈΛ·Ó. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1967. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
537. °πO∫∞ƒ∞∫∏™ £. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ Âȉ¿Ûˆ˜ Ù˘ ÁÏ˘Î·ÁfiÓ˘ Â› ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ
˘‰·Ù·ÓıÚ¿ÎˆÓ Î·Ù¿ Ù·˜ ÚÒÙ·˜ ÒÚ·˜ Ù˘ ˙ˆ‹˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1969. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
538. ¶O§ÀÃO¡π∞¢∏™ º. ∂›‰Ú·ÛȘ Ù˘ ÙÔÈ΋˜
ÂÊ·ÚÌÔÁ‹˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘ Â› ÂÓ›ˆÓ ‰È·‚ËÙÈÎÒÓ ·ÏÏÔÈÒÛÂˆÓ ÙÔ˘ ÔÊı·ÏÌÔ‡. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1973.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
539. μ∞ªμ∞§∏™ Ã. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ ÙÔ˘ ÂӉȷ̤ÛÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ ˘‰·Ù·ÓıÚ¿ÎˆÓ Â› ·Û¯fiÓÙˆÓ ÂÎ Ó¢ÌÔÓÈ΋˜ Ê˘Ì·ÙÈÒÛˆ˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1970. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
540. ¢∏ª∏Δƒπ∞¢OÀ-μ∞º∂π∞¢OÀ ∞. ªÂÙ·‚ÔϤ˜ Ù˘
‰Â¸‰ÚÔÁÔÓ¿Û˘ Ù˘ ‚-ʈÛÊÔÚÈ΋˜ ÁÏ˘Îfi˙˘ ÙˆÓ
ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÓ ÙÔ˘ ·ÓıÚÒÔ˘ ηٿ ÙÔÓ Î·Ù·‚ÔÏÈÛÌfiÓ Ù˘. ¢È·ÙÚÈ‚‹ Â› ÀÊËÁÂÛ›·. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
541. °∞ƒ¢π∫∏-∫OÀ´¢OÀ ¶. ªÂϤÙË Ù˘ ‰Â¸‰ÚÔÁÔÓ¿Û˘ ÙˆÓ 6-ʈÛÊÔÚÈÎÒÓ ÂÍÔ˙ÒÓ. πππ. ¢ÔÌ‹. ÀÔÌÔÓ¿‰Â˜ ÙˆÓ ‰È·ÊfiÚˆÓ ÌÔÚÊÒÓ ÙÔ˘ ÂÓ˙‡ÌÔ˘ ÙÔ˘ ‹·ÙÔ˜
ÙˆÓ ÂÈ̇ˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
542. £øªO¶OÀ§O™ ¶. OÈ ˘ԉԯ›˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘
ÛÙȘ ÔÍ›˜ ÏÂÌÊÔ‚Ï· ÛÙÈΤ˜ Î·È ÛÙȘ ¯ÚfiÓȘ ÏÂÌÊÈΤ˜ Ï¢¯·È̛˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
543. ™¶∞¡O™ ¶. ™˘Ì‚ÔÏ‹ ÛÙË ÌÂϤÙË ÙÔ˘ ÂÈÚ·Ì·ÙÈÎÔ‡
‰È·‚‹ÙË Ì ·˘ÙÔÌfiÛ¯Â˘ÛË ÙÌËÌ¿ÙˆÓ ·ÁÎÚ¤·ÙÔ˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1982. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
544. ∫∞ƒ∞ª∞¡ø§∏™ ™. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÌÂٷ͇ ·˘ÙÔÌÔۯ‡Ûˆ˜ ÓËÛȉȷÎÔ‡ ÈÛÙÔ‡ Î·È ·ÁÁÂÈÔ̤ÓÔ˘
ÙÌ‹Ì·ÙÔ˜ ·ÁÎÚ¤·ÙÔ˜ Û·ÏÔ˘ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
ÂÈÚ·Ì·ÙÈÎÔ‡ ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1983.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
545. BAMμ∞§∏™ Ã. ¶ÂÈÚ·Ì·ÙÈη› ÌÂÙ·‚ÔÏ·› Ù˘ ÛÙ¿ıÌ˘ ÙÔ˘ ۷ί¿ÚÔ˘ ÙÔ˘ ·›Ì·ÙÔ˜ ·Ú·ÙËÚÔ‡ÌÂÓ·È Â›
ÙˆÓ ·Û¯fiÓÙˆÓ ÂÎ ¯ÚÔÓ›·˜ Ó¢ÌÔÓÈ΋˜ Ê˘Ì·ÙÈÒÛˆ˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1963. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
546. Ã∞Δ∑∏ª¶∞§∏™ ∂. ™ÙÂÚÈÓÔÂȉ‹˜ ÁÏ˘ÎÔ˙Ô˘Ú›·.
∂›‰Ú·ÛȘ Ù˘ Ú‰ÓÈ˙ÔÏfiÓ˘ Â› Ù˘ ÈηÓfiÙËÙÔ˜ ÙˆÓ
Ô˘ÚÔÊfiÚˆÓ ÛˆÏËÓ·Ú›ˆÓ Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ ÚÔ˜
·ÏÈÚÚfiÊËÛÈÓ ÁÏ˘Îfi˙˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1969.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
547. ∫O™ªπ¢∏™ Ã. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ·ıÔÁÔÓ›·Ó ÙÔ˘
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ Â› ÓÔÛËÌ¿ÙˆÓ ÙÔ˘ ‹·ÙÔ˜.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1970. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
548. KAƒ∞ª¶∂ƒ∏™ ™. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ ÂȉڿÛˆ˜ Ù˘ ÁÏ˘Î·ÁfiÓ˘ Â› ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ
˘‰·Ù·ÓıÚ¿ÎˆÓ Î·Ù¿ ÙËÓ ‚ÚÂÊÈÎ‹Ó Î·È ·È‰ÈÎ‹Ó ËÏÈΛ·Ó. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1971. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
549. ™º∞∫π∞¡∞∫∏™ °. ∏ ‰È¿ÊÔÚÔ˜ Â›‰Ú·ÛȘ Ù˘ ÈÓ-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ÛÔ˘Ï›Ó˘ Â› Ù˘ ÁÏ˘Îfi˙˘ ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Î·È ÙˆÓ
ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ ÙÔ˘ ·ÓıÚÒÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1971. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
550. ƒ∞¶ΔO¶OÀ§OÀ-°π°∏ ª. ªÂϤÙË Ù˘ ·ÔÚÚÔÊ‹Ûˆ˜ ÙˆÓ ËÏÂÎÙÚÔÏ˘ÙÒÓ, ÙÔ˘ ‡‰·ÙÔ˜ Î·È ÙÔ˘ ۷ί¿ÚÔ˘ ˘fi ÙÔ˘ ÏÂÙÔ‡ ÂÓÙ¤ÚÔ˘, Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ Î·È ·Û¯fiÓÙˆÓ ÂÎ ·ıÔÏÔÁÈÎÒÓ ÙÈÓˆÓ Î·Ù·ÛÙ¿ÛˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1974. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
551. ∞°Oƒ∞™ΔO™ π. ∏ ÏÂÈÙÔ˘ÚÁ›· Ù˘ Â͈ÎÚÈÓÔ‡˜ ÌÔ›Ú·˜ ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ Â› ·ÛıÂÓÒÓ ·Û¯fiÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1974. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
552. ZAºƒ∞¡∞™ ∞. ªÂÙ·‚ÔÏ·› ÙÔ˘ ˘ÚÔÛÙ·Ê˘ÏÈÎÔ‡,
ÙÔ˘ ʈÛÊÔÂÓÔÏÔ˘ÚÔÛÙ·Ê˘ÏÈÎÔ‡, ÙÔ˘ 2-ʈÛÊÔÁÏ˘ÎÂÚÈÚÈÓÈÎÔ‡ Î·È ÙÔ˘ 3-ʈÛÊÔÁÏ˘ÎÂÚÈÓÈÎÔ‡ ÔͤԘ ÙˆÓ
ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÓ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÈÓÛÔ˘Ï›Ó˘ ÂȘ ˘ÁÈ›˜ ·ÓıÚÒÔ˘˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1975. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
553. ¶∞¡∞°πøΔO¶OÀ§O™ ∂, μ∞§Δ∏™ ¢, Δ™OÀƒOÀ∫Δ™O°§OÀ °, ª∞§∞∫∞ ∞, μ∞ªμ∞§∏™ Ã.
™˘ÌÙÒÌ·Ù·, ‰È¿ÁÓˆÛȘ Î·È ÎÏÈÓÈη› ÌÔÚÊ·› ÙÔ˘
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ™ÙÔ: XV ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ Ù˘ π·ÙÚÔ¯ÂÈÚÔ˘ÚÁÈ΋˜ ∂Ù·ÈÚ›·˜
∞ıËÓÒÓ, 1959: 123-44.
554. KÀƒ∫∞¡π¢∏™ ¢. ∂›‰Ú·ÛȘ Ù˘ ·fi ÙÔ˘ ÛÙfiÌ·ÙÔ˜
¯ÔÚËÁ‹Ûˆ˜ ÁÏ˘Îfi˙˘ Â› ÙˆÓ ÏÈȉ›ˆÓ ÙÔ˘ ·›Ì·ÙÔ˜.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞ - ∂ÚÁ·ÛÙ‹ÚÈÔ ¶ÂÈÚ·Ì·ÙÈ΋˜
º˘ÛÈÔÏÔÁ›·˜, 1969. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
555. μ∞§∞øƒ∞™ μ. ∏ ÂȉËÌÈÔÏÔÁ›· ÙÔ˘ ‰È·‚‹ÙÔ˘. ∂ÈÔÏ·ÛÌfi˜, ÚÔ·› Î·È Ô ÎÏËÚÔÓÔÌÈÎfi˜ ·Ú¿ÁˆÓ. ™ÙÔ:
2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 18-27.
556. Xƒ∏™ΔOª∞¡O™ A. ™¯¤ÛÂȘ ÂÓÙÔ˙Ô˘Ú›·˜ Î·È ‰È·‚‹ÙÔ˘. ¡¤·È ·ÓÙÈÏ‹„ÂȘ ÂÚ› Ù˘ ÂÓ˙˘ÌÈ΋˜ ‰Ú¿Ûˆ˜
Ù˘ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘».
∫·‚¿Ï·, 1967: 28-31.
557. ™Àª∂ø¡π¢∏™ ∞. ¶·ıÔÏÔÁÈ΋ ·Ó·ÙÔÌ›· ÙÔ˘ ‰È·‚‹ÙÔ˘-¢È·‚‹Ù˘ Î·È Î·ÚΛÓÔ˜. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘
¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 32-6.
558. °OÀΔΔ∞™ ∞ƒ∫. ¢È¿ÁÓˆÛȘ-¶·ıÔÏÔÁÈη› ÂÈÏÔη› ‰È·‚‹ÙÔ˘. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜
∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 37-42.
559. μ∞§Δ∏™ ¢, Δƒπ∞¡ΔO¶OÀ§O™ π. ¢È·‚ËÙÈ΋ ÔͤˆÛȘ Î·È ÎÒÌ·. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘».
∫·‚¿Ï·, 1967: 43-56.
560. ΔOÀ¡Δ∞™ ∫. ∞È ·ÁÁÂȷη› ÂÈÏÔη› ÙˆÓ ‰È·‚ËÙÈÎÒÓ. ¶ÚÔʇϷÍȘ-£ÂÚ·›·. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘
¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 57-63.
561. ¢∞¡O¶OÀ§O™ ∂. ∏ ‰È·ÈÙËÙÈ΋ ıÂÚ·›· ÙÔ˘ η-
ÏÔ‹ıÔ˘˜ ‰È·‚‹ÙÔ˘. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘».
∫·‚¿Ï·, 1967: 64-6.
562. ª∞§∞ªO™ μ. ∞ÓÙȉȷ‚ËÙÈο Ê¿Ú̷η. ™ÙÔ: 2ÔÓ
π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜
«™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 67-72.
563. ¶∞¡∞°πøΔOÀ ¶. ¢È·‚‹Ù˘ Î·È Î‡ËÛȘ. ™ÙÔ: 2ÔÓ
π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜
«™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 73-8.
564. Ã∞ƒO∫O¶O™ ™. π‰ÈÔÌÔÚÊ›·È ·È‰ÈÎÔ‡ ‰È·‚‹ÙÔ˘.
™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 7985
565. Ã∞ƒO∫O¶O™ ™. ¡ÂÔÁÓ¿ ‰È·‚ËÙÈÎÒÓ ÌËÙ¤ÚˆÓ. ™ÙÔ:
2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 86.
566. °∂øƒ°π∞¢∏™ °. ¢È·‚‹Ù˘ Î·È ÔÊı·ÏÌfi˜. ™ÙÔ: 2ÔÓ
π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜
«™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 87-96.
567. ™∫∞§∫∂∞™ °. ¶ÚÔÂÁ¯ÂÈÚËÙÈ΋ ÂÎÙ›ÌËÛȘ Î·È ÌÂÙÂÁ¯ÂÈÚËÙÈ΋ ·ÓÙÈÌÂÙÒÈÛȘ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜. ™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·,
1967: 97-105.
568. ªπÃ∞∏§π¢∏™ °. ¢È·‚‹Ù˘ Î·È Î·Ú‰ÈÔ¿ıÂÈ·È.
™ÙÔ: 2ÔÓ π·ÙÚÈÎfiÓ ™˘ÌfiÛÈÔÓ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∫·‚¿Ï·˜ «™·Î¯·Ú҉˘ ¢È·‚‹Ù˘». ∫·‚¿Ï·, 1967: 10612.
569. ∫∞§O°∏ƒOÀ ¶. ¶·Ï·È·› Î·È Ó¤·È ηÙ¢ı‡ÓÛÂȘ
Â› Ù˘ ‰È·ÈÙËÙÈ΋˜ ıÂÚ·›·˜ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ∂ÏÏËÓÈ΋˜ π·ÙÚÈ΋ 1938; (ÙfiÌ.?): 1-26.
570. º∞§Δ™∏™ ™. ∏ Â›‰Ú·ÛȘ ÙˆÓ ·fi ÙÔ˘ ÛÙfiÌ·ÙÔ˜ ‰ÈÔ˘ÚËÙÈÎÒÓ Â› Ù˘ ·ÓÙ·ÏÏ·Á‹˜ ÙˆÓ ˘‰·Ù·ÓıڿΈÓ.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1965. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
571. °OÀ§∏™ °, ∫O™ªπ¢∏™ Ã. AÈ ‰È·Ù·Ú·¯·› ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙÔ˘ ۷ί¿ÚÔ˘ Â› ·ÛıÂÓÒÓ Ì Ë·ÙÈ΋Ó
·ÓÂ¿ÚÎÂÈ·Ó. ™ÙÔ: ΔfiÌÔ˜ ÚÔ˜ ÙÈÌ‹Ó ÙÔ˘ ηıËÁËÙÔ‡
∂˘ı. ™. ¶·Ó·ÁȈÙfiÔ˘ÏÔ˘. £ÂÛÛ·ÏÔÓ›ÎË, 1970: 12643.
572. ¶∞¶∞ ∞, °π∞¡¡OÀ§∏ Ã, Δ∑øΔ∑∞™ £, ∂À£ÀªπOÀ ∏, ∫∞ª¶OÀƒ∞∫∏™ °. ™˘Û¯¤ÙÈÛË ÙˆÓ ÙÈÌÒÓ ÁÏ˘Îfi˙˘-ÊÚÔ˘ÎÙÔ˙·Ì›Ó˘-ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ¢ÂÏÙ›ÔÓ ∂ÏÏËÓ. ªÈÎÚÔ‚. ∂Ù·ÈÚ›·˜ 1993; 38:
171-9.
573. °π∞¡¡OÀ§∏ Ã, ¶∞¶∞ ∞, ∂À£ÀªπOÀ ∏, Δ∑øΔ∑∞™ £, ∫∞ª¶OÀƒ∞∫∏™ °. ∏ ¯ÚËÛÈÌfiÙËÙ· Ù˘
ÊÚÔ˘ÎÙÔ˙·Ì›Ó˘ ÛÙËÓ Ú‡ıÌÈÛË Ù˘ ÁÏ˘Îfi˙˘ Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ ππ Ì ÚfiÛÊ·ÙË ¤Ó·ÚÍË ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ™ÙÔ: ¶Ú·ÎÙÈο 7Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1992: 178-85.
574. ∞§∂μπ∑O™ ª, ∞ƒÃ∞¡πøΔ∞∫∏ ª, ∫∞ª∞ƒπ∞ º,
∑∞ÃO™ §, μ∞™π§∂π∞¢OÀ ∂, ∑π∞∫∞™ °. ¡Â˘ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ ηډȷÁÁÂÈ·ÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜
Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜-Û˘Û¯ÂÙ›ÛÂȘ. ™ÙÔ ¶Ú·ÎÙÈο
99
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
7Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1992: 190-2.
575. ∞§∂μπ∑O™ ª, ∞ƒÃ∞¡πøΔ∞∫∏ ª, ∫∞ª∞ƒπ∞
º, ∑∞ÃO™ §, ∑π∞∫∞™ °. ∏ ÛËÌ·Û›· Ù˘ Ú‡ıÌÈÛ˘
ÙÔ˘ ‰È·‚‹ÙË ÛÙËÓ ÂÌÊ¿ÓÈÛË Ó¢ÚÔ¿ıÂÈ·˜ Î·È ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ™ÙÔ: ¶Ú·ÎÙÈο 7Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1992:
193-6.
576. °∂øƒ°π§∞™ ¡, §∞ª¶ƒO¶OÀ§O™ ¢, ™πª∂§π¢∏™ ¢, ∫∞ƒOÀΔ™OÀ ª, ∞¡Δø¡π∞¢OÀ ∫,
μ∞ƒ∏-Ã∞Δ∑∏∫ø¡™Δ∞¡Δπ¡OÀ ª, §∂μ∞¡Δ∞∫∏™ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ˘¤ÚÙ·ÛË ÛÙËÓ
ÙÚ›ÙË ËÏÈΛ·. ™ÙÔ ¶Ú·ÎÙÈο 7Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1992: 463-6.
577. μ∞∫∞§∏™ ¢. ªÂÙ·‚ÔÏ·› ÙÔ˘ ˘ÚÔÛÙ·Ê˘ÏÈÎÔ‡ ηÈ
ÙÔ˘ Á·Ï·ÎÙÈÎÔ‡ ÔͤԘ ÂȘ ÙÔ Ï¿ÛÌ· Î·È Ù· ÂÚ˘ıÚ¿
·ÈÌÔÛÊ·›ÚÈ· Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ
ÁÏ˘Îfi˙˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1975. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
578. ∞§∂μπ∑O™ ª. ∂›‰Ú·ÛË Ù˘ Ï¢ΛÓ˘ Â› ‰È·‚ËÙÈÎÒÓ Î·È ˘ÁÈÒÓ ·ÙfïÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1976.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
579. §πO§πO¶OÀ§O™ £. ªÂϤÙË ÙˆÓ ÂÈ¤‰ˆÓ ÁÏ˘Îfi˙˘ ÙÔ˘ ·›Ì·ÙÔ˜ Â› ÓÂÔÁÓÒÓ ·Û¯fiÓÙˆÓ ÂÍ ÈÎÙ¤ÚÔ˘
‰È·ÊfiÚÔ˘ ·ÈÙÈÔÏÔÁ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1976.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
580. £∂O¢øƒO¶OÀ§OÀ °. ªÂϤÙ˜ ÛÙÔ˘˜ Ê˘ÛÈÔÏÔÁÈÎÔ‡˜ Ì˯·ÓÈÛÌÔ‡˜ ·‰Ú·ÓÔÔÈ‹Ûˆ˜ Ù˘ ‰Â¸‰ÚÔÁÔÓ¿Û˘ Ù˘ G-ʈÛÊÔÚÈ΋˜ ÁÏ˘Îfi˙˘ ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1976. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
581. Δƒπ∞¡ΔO™ ∞. ª¤ıÔ‰Ô˜ ·ÔÌÔÓÒÛˆ˜ Ù˘ ÚÔ˚ÓÛÔ˘Ï›Ó˘ ·fi ÙÔ ‚fiÂÈÔ ¿ÁÎÚ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1977. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
582. Ã∞Δ∑∏¢∏ª∏ΔƒπOÀ ∞. ªÂϤÙË Â› Ù˘ ÌÔÚÊÔÏÔÁ›·˜ Î·È Ù˘ ÔÛÔÙÈ΋˜ ηٷÓÔÌ‹˜ ÙˆÓ ·ÚÁ˘ÚÔʛψÓ
΢ÙÙ¿ÚˆÓ ÙÔ˘ Á·ÛÙÚÂÓÙÂÚÈÎÔ‡ ۈϋÓÔ˜ Î·È ÙˆÓ ÓËÛȉ›ˆÓ ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ ÂȘ ÙÔÓ Â›Ì˘Ó. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1977. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
583. ™πø¡ ª. ™¯¤ÛȘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ Î·È 2, 3-‰ÈʈÛÊÔÚÔÁÏ˘ÎÂÚÈÓÈÎÔ‡ ÔͤԘ ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ
Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfïÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1977. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
584. ∫∞™ΔƒOÀ¡∏-∞ƒ¡∞OÀΔO°§OÀ ∂. ªÂϤÙË ÛÙËÓ
Â·ÁˆÁ‹ Ù˘ ‰Â¸‰ÚÔÁÔÓ¿Û˘ Ù˘ 6-ʈÛÊÔÚÈ΋˜ ÁÏ˘Îfi˙˘ Î·È ‰Â¸‰ÚÔÁÔÓ¿Û˘ ÙÔ˘ 6-ʈÛÊÔÁÏ˘ÎÔÓÈÎÔ‡
ÔͤԘ ÙÔ˘ Â›Ì˘Ô˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
585. ¶∂°πOÀ-ΔO¶OÀ∑∏ £. ªÂϤÙË ÛÙËÓ ‰Â¸‰ÚÔÁÔÓ¿ÛË ÙˆÓ ÊˆÛÊÔÚÈÎÒÓ ÂÍÔ˙ÒÓ. π. ªÔÚʤ˜ ÙÔ˘ ÂÓ˙‡ÌÔ˘,
Âȉ›Î¢ÛË Î·È ÙÔÔÁÚ·Ê›· ÙÔ˘˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
586. πø∞¡¡π¢∏™ π. ªÂϤÙË ÛÙËÓ ‰Â¸‰ÚÔÁÔÓ¿ÛË ÙˆÓ 6ʈÛÊÔÚÈÎÒÓ ÂÍÔ˙ÒÓ. ππ. Ãڈ̷ÙÔÁÚ·ÊÈÎfi˜ ‰È·¯ˆÚÈÛÌfi˜ ÙˆÓ ÌÈÎÚÔۈ̷ÙÈ·ÎÒÓÌÔÚÊÒÓ ÙÔ˘ ÂÓ˙‡ÌÔ˘ ÙÔ˘
100
‹·ÙÔ˜ ÂÈ̇ˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
587. ¶∞¶∞°∂øƒ°πOÀ °. ∞ÔÌfiÓˆÛË Î·È ÁÂÓÈο ¯·Ú·ÎÙËÚÈÛÙÈο Ù˘ ·ÚÈ·˜ ÌÔÚÊ‹˜ Ù˘ ‰Â¸‰ÚÔÁÔÓ¿Û˘
ÙˆÓ 6-ʈÛÊÔÚÈÎÒÓ ÂÍÔ˙ÒÓ ÙÔ˘ ‹·ÙÔ˜ Â›Ì˘Ô˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
588. Ãπ™ΔO¢OÀ§OÀ ¢. ¢È·Î›ÓËÛË Î·È ‚ÈÔÛ‡ÓıÂÛË
ÙˆÓ ÌÈÎÚÔۈ̷ÙÈ·ÎÒÓ ÂÓ˙‡ÌˆÓ G6PD Î·È H6PD ˘fi
ÙËÓ Â›‰Ú·ÛË ÁÏ˘Îfi˙˘ Î·È ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
589. °∫∞Δ∑O§∞-∫∞ƒ∞μ∂§∏ ª. ¢È¿ÊÔÚ˜ ÌÔÚʤ˜
‚·Ú›·˜ ·Ê˘‰¿ÙˆÛ˘ ÛÙËÓ ‚ÚÂÊÈ΋ Î·È ·È‰È΋ ËÏÈΛ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1980. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
590. °πøμO™ π. ¡Â˘ÚÈΤ˜ ÂȉڿÛÂȘ ÛÙȘ ·Ú·Ì¤ÙÚÔ˘˜
Ù˘ ÁÏ˘ÎÔÚ˘ı̛ۈ˜ ÌÂÙ¿ ÂÓ‰ÂÁÎÂÊ·ÏÔÎÔÈÏȷ΋ ¯ÔÚ‹ÁËÛË ÈÓÛÔ˘Ï›Ó˘, ÌÔÌÂÛ›Ó˘ Î·È Ó¢ÚÔÙÂÓÛ›Ó˘
(¶ÂÈÚ·Ì·ÙÈ΋ ÌÂϤÙË). π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1983.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
591. μ§∞Δ™∞™ °. ªÂϤÙË ÙˆÓ ÂȉڿÛÂˆÓ Ù˘ ÁÏ˘Îfi˙˘
Î·È Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙȘ ÚˆÙ½Ó˜ ÙÔ˘ ÂÓ‰ÔÏ·ÛÌ·ÙÈÎÔ‡ ‰ÈÎÙ‡Ô˘ ÙˆÓ Ë·ÙÔ΢ÙÙ¿ÚˆÓ Â›Ì˘Ô˜. π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
592. ∫O§π∞∫O™ °. ∂›‰Ú·ÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘ Î·È Ù˘
ÁÏ˘Îfi˙˘ ÛÙË ÊˆÛÊÔÚ˘Ï›ˆÛË-·ÔʈÛÊÔÚ˘Ï›ˆÛË
ÙˆÓ ÚˆÙÂ˚ÓÒÓ ÙÔ˘ ÂÓ‰ÔÏ·ÛÌ·ÙÈÎÔ‡ ‰ÈÎÙ‡Ô˘ Ë·ÙÔ΢ÙÙ¿ÚˆÓ Â›Ì˘Ô˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
593. μ∞μ∞Δ™∏-Ã∞Δ∑∏§∂ø¡π¢∞ ª. ªÂϤÙË Ù˘ Û˘ÌÂÚÈÊÔÚ¿˜ ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì ‰È·Ù·Ú·¯¤˜
ÙÔ˘ ·˘ÙÔÓfiÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ηٿ ÙËÓ ÁÂÓÈ΋
·Ó·ÈÛıËÛ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1984. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
594. Ã∞§∫π¢∏™ Ã. §ÂÈÙÔ˘ÚÁÈÎfiÙËÙ· Ù˘ ·ÚÈÛÙÂÚ¿˜ ÎÔÈÏ›·˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ªÂϤÙË Û ‡ÙÈ· ηÈ
fiÚıÈ· ı¤ÛË Ì ÙËÓ Ì¤ıÔ‰Ô ÙˆÓ ¯ÚfiÓˆÓ Î·Ú‰È·Î‹˜ Û˘ÛÙÔÏ‹˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
595. ∫Oºπ¡∏™ ∞. ¢È·‚‹Ù˘ Ù˘ ·ËÛ˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 1997; 10: 9-16.
596. ∂À£ÀªπOÀ ∏, ¶O¡Δπ∫π¢∏™ ¡, ¶∞¶∞¢O¶OÀ§OÀ º, ¶∞∑∞´ΔOÀ ∫, ∫∞§Δ™∞™ £. ∞˘ÍËÙÈÎÔ› ·Ú¿ÁÔÓÙ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1997; 10: 17-46.
597. ¶∞°∫∞§O™ ∂, Δ∑∂Δ∑∏™ μ, ™∫∞ƒ∞°∫∞™ °,
™Àƒ∂°°∂§∞™ ¢, ™∞´§∂ƒ ¡, ª∏§∞ƒ∞∫∏™ ¢. ∏
ÛËÌ·Û›· Ù˘ ηϋ˜ Ú‡ıÌÈÛ˘ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÚÚÒÛÙÔ˘. ™ÙÚÔÁÁ˘Ï‹ ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1997; 10: 47-84.
598. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ¶∞¶∞¢∂§∏ ∂,
∫∞ƒ∞°π∞¡¡∏ ¢, °∫OÀΔ∫π¢OÀ ™, ™Δ∞°∫π¢∏™
°, ™∞∫∞§§∂ƒOÀ ∞π∫, ∫OÀ°πOÀªΔ∑O°§OÀ
¢. ∞Ô‚ÔÏ‹ ÏÂ˘ÎˆÌ·Ù›Ó˘ ÛÙ· Ô‡Ú· ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ù‡Ô˘ π Ì ‰È¿ÚÎÂÈ· ÓfiÛÔ˘ ÌÈÎÚfiÙÂÚË (‹ ›ÛË)
ÙˆÓ 5 ÂÙÒÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1997; 10: 85-8.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
599. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏, Δ∑øΔ∑∞™ £,
¶∞¶∞ ∞, ∫∞ª¶OÀƒ∞∫∏™ °, ∫ƒ∞™™∞™ °. ΔÔ
Ì·ÁÓ‹ÛÈÔ Û ·ÛıÂÓ›˜ Ì ™¢ Ù‡Ô˘ ππ: MÂÙ·‚ÔϤ˜ ÌÂ
ÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί¿ÚÔ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1997; 10: 89-92.
600. Δ∑øΔ∑∞™ £, ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª,
¶∞¶∞Ãπ™ΔO¢OÀ§OÀ º, ¢OÀ∫π¢∏™ ¢. ∏ Â›‰Ú·ÛË Ù˘ Ê·ÈÓÔÊÈÌÚ¿Ù˘ 250 ÛÙ· Â›‰· ÏÈȉ›ˆÓ, ÁÏ˘Îfi˙˘ Î·È ÈÓˆ‰ÔÁfiÓÔ˘ ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1997;
10: 93-6.
601. ƒ∂¶∞¡Δ∞-™∫∞ƒ∞°∫∞ ∂, ™∫∞ƒ∞°∫∞™ °, ∑∞º∂πƒπOÀ ∫, ∫∞§O°∂ƒOÀ¢∏™ °, Ã∞Δ∑πOÀ μ,
¶∞¶∞∑O°§OÀ ¡, °∂øƒ°∞∫O¶OÀ§OÀ ∂. ∏
‰Ú·ÛÙÈÎfiÙËÙ· Ù˘ ÚˆÙ½Ó˘ C (PrC) Û NIDDM ÌÂ
‹ ¯ˆÚ›˜ ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
1997; 10: 97-9.
602. ¶∞¶∞∑O°§OÀ ¡, ™OÀ§∏™ ∫, ª∞¡∂™ Ã, ™∫∞ƒ∞°∫∞™ °, ™¶∏§πO¶OÀ§O™ ∞, ∫O¡ΔO°π∞¡¡∏™ π, §πOÀΔ∞™ ∞. ∫ÔÈÓˆÓÈÎÔ-ÔÈÎÔÓÔÌÈ΋ ηٿÛÙ·ÛË Î·È ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ
Û هÔ˘ π ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 1997; 10: 100-5.
603. Δ∑øΔ∑∞™ £, ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª,
¶∞¶¶∞ ∞, ∫∞§Δ™∞™ £. ™˘Û¯¤ÙÈÛË ˘ÂÚÏÈȉ·ÈÌ›·˜ Î·È ‰È·‚ËÙÈ΋˜ Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ™ÙÔ: ¶Ú·ÎÙÈο
9Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1994: 814-7.
604. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏, Δ∑øΔ∑∞™ £,
¶∞¶¶∞ ∞, ¶∞¶∞¢O¶OÀ§OÀ º, ∫∞§Δ™∞™ £.
ªÂϤÙË ÙÔ˘ ËÎÙÈÎÔ‡ Ì˯·ÓÈÛÌÔ‡ Û ·ÛıÂÓ›˜ Ì ™¢
Ù‡Ô˘ ππ Î·È Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. ™ÙÔ: ¶Ú·ÎÙÈο 9Ô˘
μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1994: 809-13.
605. ∫∞Δ™π§∞ª¶ƒO™ ¡, ¶πΔ∞ƒO∫Oπ§∏™ π, μ∂ƒÀ∫O∫π¢OÀ ∂, ºƒ∞°∫∞∫∏ ¢, ª∞ƒ∞°°O™ ª,
Ã∞¡πøΔ∏™ ¢. ¶ÂÓÙ·ÂÙ‹˜ ·Ú·ÎÔÏÔ‡ıËÛË (follow
up) ·ÙfiÌˆÓ Ì ÌË ‰È·‚ËÙÈ΋ ÁÏ˘ÎÔ˙Ô˘Ú›·. πÔÎÚ¿Ù˘ 1981; 9: 129-32.
606. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∂ƒπøΔ∏™ π, Ã∞Δ∑∏∫Àƒπ∞∫OÀ ª, ¢∞´∫O™ °. ™¯¤ÛȘ Â·ÁÁ¤ÏÌ·ÙÔ˜ ηÈ
Û˘¯ÓfiÙËÙÔ˜ ‰È·‚‹ÙÔ˘ ÂȘ 3. 520 ¿ÚÚÂÓ·˜ ËÏÈΛ·˜ 40
¤ˆ˜ 79 ÂÙÒÓ. ™ÙÔ: ¶Ú·ÎÙÈο 2Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. 1976; 673-6.
607. ∫∞Δ™π§∞ª¶ƒO™ ¡, E•∞ƒÃ∂∞™ ¢, ∫∞¡∞∫∏™
£, ªOπƒ∞™ ¡, ª∞ƒ∞°∫O™ ª, ¢∞´∫O™ °, ª¶∂∑O™ ∏. ™¿Î¯·ÚÔÓ ·›Ì·ÙÔ˜ Î·È ÏÈ›‰È· ÂÓ ÓËÛÙ›·
Â› 499 ∂ÏÏ‹ÓˆÓ ·Ó‰ÚÒÓ ËÏÈΛ·˜ 20 ¤ˆ˜ 26 ÂÙÒÓ.
Mater Med Greca 1977; 5: 648-54.
608. Ã∞Δ∑∏∫Àƒπ∞∫OÀ ª, Δ∞°∞ƒ∏™ ¡, ªOπƒ∞™ ¡,
ª∞ƒ∞°∫O™ ª, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞´∫O™ °.
§È›‰È· ÙÔ˘ ÔÚÔ‡ ÂÓ ÓËÛÙ›· Â› Ù˘¯·›ˆ˜ ÂÈÏÂÁ¤ÓÙˆÓ
∂ÏÏ‹ÓˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ªateria Medica Greca 1977; 5: 643-7.
609. MICHAILIDOU G, PEREA D, KATSILAMBROS
N. Monounsaturated fat and postprandial triglyceride
levelsin non-insulin-dependent diabetic persons.
Diabet Med 1997; 14: 406-7.
610. ¶∞¶∞§O∏™ ∞, ¡π∫O§∞OÀ ∞, Δ∑∞ƒ¢∏™ ¶,
ª¶O¡∞Δ™O™ °, ∫∞Δ™øƒÃ∏™ £, ¶∞Δ∞ƒ°π∞™
£, °O§∂ª∞Δ∏™ μ. ªÂÙ·ÌfiÛ¯Â˘ÛË ÓËÛȉ›ˆÓ ÙÔ˘
Langerhans Û Â›Ì˘Â˜. ∞ÔÙÂϤÛÌ·Ù· ·ÏÏÔÌÂÙ·ÌÔۯ‡ÛÂˆÓ Ì ¯Ú‹ÛË ÔÏÏ·ÏÒÓ ‰ÔÙÒÓ Î·È ·Ï‹ ·ÓÔÛÔηٷÛÙ·ÏÙÈ΋ ıÂÚ·›·. ¡ÔÛÔÎÔÌ. °Ú·ÌÌ‹ 1994;
22: 1,17,18,22.
611. ¶∞¶∞§O∏™ ∞, ¡π∫O§∞OÀ ∞, ¡π∫O§∞OÀ ∫,
Δ∑∞ƒ¢∏™ ¶, ª¶O¡∞Δ™O™ °, ∫∞Δ™øƒÃ∏™ £,
¶∞Δ∞ƒ°π∞™ £, °O§∂ª∞Δ∏™ μ. ∞ÔÌfiÓˆÛË ÓËÛȉ›ˆÓ ÙÔ˘ Langerhans ·fi ¿ÁÎÚ·˜ ¯Ô›ÚˆÓ Ì ‰‡Ô
ÌÂıfi‰Ô˘˜ ‰È·¯ˆÚÈÛÌÔ‡ Ù˘ ÂÓ‰ÔÎÚÈÓÔ‡˜ ·fi ÙËÓ Â͈ÎÚÈÓ‹ ÌÔ›Ú·. ¡ÔÛÔÎÔÌÂȷ΋ °Ú·ÌÌ‹ 1994; 26: 1-23.
612. ¶∞¶∞§O∏™ μ, ¡π∫O§∞OÀ ∫, ¢∞μ∞ƒ∏™ ¶,
∞¡¢ƒπøΔ∏™ ∞, Δ∑∞ƒ¢∏™ ¶, ¶∞¶∞§O∏™ ∞,
¡π∫O§∞OÀ ∞, °O§∂ª∞Δ∏™ μ. ¶ÂÈÚ·Ì·ÙÈ΋ ·ÏÏÔÌÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·ÙÔ˜: H Â›‰Ú·ÛË Ù˘
ÔÎÙÚÂÔÙ›‰Ë˜ ÛÙËÓ ÚfiÏË„Ë Ù˘ ÌÂÙÂÁ¯ÂÈÚËÙÈ΋˜ ·ÁÎÚ·ٛÙȉ·˜ Î·È ÛÙË ÏÂÈÙÔ˘ÚÁÈ΋ ·fi‰ÔÛË ÙÔ˘ ÌÔۯ‡̷ÙÔ˜. ™ÙÔ: ¶Ú·ÎÙÈο XIX ¶·ÓÂÏÏ‹ÓÈÔ˘ ™˘Ó‰ڛԢ ÃÂÈÚÔ˘ÚÁÈ΋˜. £ÂÛÛ·ÏÔÓ›ÎË, 1994: 490-1.
613. ¶∞¶∞§O∏™ ∞, ¶∞¶∞§O∏™ μ, ¡π∫O§∞OÀ ∫,
¶∂μ∂ƒ∂ΔO™ ¶, SUTHERLAND D, °O§∂ª∞Δ∏™ μ. ™Ù·ÙÈÛÙÈ΋ ·ÚÔ˘Û›·ÛË ÙˆÓ ·ÔÙÂÏÂÛÌ¿ÙˆÓ
ÌÂÙ·ÌfiÛ¯Â˘Û˘ ·ÁÎÚ·ÙÈÎÒÓ ÓËÛȉ›ˆÓ ·fi ÙÔ 1974
¤ˆ˜ ÙÔÓ πÔ‡ÓÈÔ ÙÔ˘ 1995. ¡ÔÛÔÎÔÌÂȷ΋ °Ú·ÌÌ‹
1995: 5,6,31.
614. PAPALOIS A, ARKADOPOULOS N, PATARYAS
TH, PAPADIMITRIOU J, GOLEMATIS B. Combined hepatocyteislet transplantation: ∞n allograft
model. Transpl Int 1994; 7 (Suppl 1): S432-S5.
615. CHAIB E, BRONS I, PAPALOIS A, CALNE R.
Does intrathymic injection of alloantigen-presenting
cells before islet allotransplantation prolong graft survival? Transpl Inter 1994; 7 (Suppl 1): S423-S5.
616. PAPALOIS A, PAPALOIS B, TZARDIS P, BONATSOS G, NIKOLAOU A, KATSORCHIS T,
PATARYAS TH, GOLEMATIS B. Allotransplantation of pancreatic islets in rats using multiple donors.
Transplant Proc 1994; 26: 3474-6.
617. PAPALOIS A, ARCADOPOULOS N, PAPALOIS
B, PATARYAS TH, PAPADIMITRIOU J, GOLEMATIS B. Comparison of two experimental models
for combined hepatocyte-Islet transplantation. Transplant Proc 1994; 26: 3473.
618. NIKOLAOU A, PAPALOIS A, NIKOLAOU C,
PAPALOIS B, GALLATSATOS G, GOLEMATIS
B. Experimental intraportal allotransplantation of
pancre atic islets in pigs: Influence on liver function.
Transplant Proc 1995; 27: 3223.
619. PAPALOIS A, NIKOLAOU C, PAPALOIS B, NIKOLAOU A, TZARDIS P, BONATSOS G, DAVARIS P, GOLEMATIS B. Experimental heterotopic
101
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
autotransplantation of tail of the pancreas: πmmunohistochemical findings. Transplant Proc 1995; 27:
2987-8.
620. PAPALOIS A, PAPALOIS B, NIKOLAOU C, NIKOLAOU A, TZARDIS P, PEVERETOS P, DAVARIS P, GOLEMATIS B. Experimental heterotopic allotransplantation of the tail of the pancreas:
Immunohistochemical results. Transplant Proc 1995;
27: 2989-90.
621. ¶∞¶∞§O∏™ ∞, ∞ƒ∫∞¢O¶OÀ§O™ ¡, ∫∞ƒμOÀ¡∏ ∂, ∂•∞ƒÃ∞∫O™ °, ¶∞Δ∞ƒ°π∞™ £, ¶∞¶∞¢∏ª∏ΔƒπOÀ π, °O§∂ª∞Δ∏™ μ. H·ÙÈ΋ ·Ó·Á¤ÓÓËÛË ÌÂÙ¿ Ë·ÙÈ΋ ·ÓÂ¿ÚÎÂÈ· Î·È ·ÏÏÔÌÂÙ·ÌfiÛ¯Â˘ÛË Ë·ÙÔ΢ÙÙ¿ÚˆÓ Î·È ÓËÛÈ ‰›ˆÓ ÙÔ˘ Langerhans Û Â›Ì˘Â˜. ™ÙÔ: ¶Ú·ÎÙÈο Ãπà ¶·ÓÂÏÏ‹ÓÈÔ˘
™˘Ó‰ڛԢ ÃÂÈÚÔ˘ÚÁÈ΋˜. £ÂÛÛ·ÏÔÓ›ÎË, 1994: 49-51.
622. ¶∞¶∞§O∏™ ∞, ∞ƒ∫∞¢O¶OÀ§O™ ¡, °O§∂ª∞Δ∏™ μ, ¶∞¶∞¢∏ª∏ΔƒπOÀ π, ∫∞Δ™øƒÃ∏™
£, ¶∞Δ∞ƒ°π∞™ £. ™˘Ó‰˘·Ṳ̂ÓË ÌÂÙ·ÌfiÛ¯Â˘ÛË ÓËÛȉ›ˆÓ ÙÔ˘ Langerhans Î·È Ë·ÙÔ΢ÙÙ¿ÚˆÓ. ™‡ÁÎÚÈÛË ‰‡Ô ÂÈÚ·Ì·ÙÈÎÒÓ ÌÔÓ٤ψÓ. ™ÙÔ: ¶Ú·ÎÙÈο 16Ô˘
¶·ÓÂÏÏ‹ÓÈÔ˘ ™˘Ó‰ڛԢ ∂.∂.μ.∂, μfiÏÔ˜, 1994: 5.35.5.
623. ¡π∫O§∞OÀ ∫, ¶∞¶∞§O∏™ μ, ¡π∫O§∞OÀ ∞,
¶∞¶∞§O∏™ ∞, Δ∑∞ƒ¢∏™ ¶, °∞§π∞Δ™∞ΔO™ ¡,
∞¡¢ƒπøΔ∏™ ∞, ¶∞¶∞¢O¶OÀ§O™ ™, ¶∞¡OÀ™O¶OÀ§O™ ¢, SUTHERLAND D, °O§∂ª∞Δ∏™ μ. ∏ Â͈ÎÚÈÓ‹˜ ÌÔ›Ú· ÙÔ˘ ·ÁÎÚ·ÙÈÎÔ‡ ·˘ÙÔÌÔۯ‡̷ÙÔ˜. ∂ÏÏËÓÈ΋ ÃÂÈÚÔ˘ÚÁÈ΋ 1995; 67: 43740.
624. ¶∞¶∞§O∏™ ∞, ∞ƒ∫∞¢O¶OÀ§O™ ¡, ¶∞Δ∞ƒ°π∞™ ¶, ¶∞¶∞¢∏ª∏ΔƒπOÀ π, °O§∂ª∞Δ∏™ μ.
¶ÂÈÚ·Ì·ÙÈ΋, Û˘Ó‰˘·Ṳ̂ÓË ·ÏÏÔÌÂÙ·ÌfiÛ¯Â˘ÛË Ë·ÙÈÎÒÓ Î˘ÙÙ¿ÚˆÓ Î·È ÓËÛȉ›ˆÓ ÙÔ˘ Langerhans Û Â›Ì˘Â˜. ¶Ú·ÎÙÈο ÃVIII ¶·ÓÂÏÏ‹ÓÈÔ˘ ™˘Ó‰ڛԢ ÃÂÈÚÔ˘ÚÁÈ΋˜. ∞ı‹Ó·, 1992: 906-8.
625. ¶∞¶∞§O∏™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ¶ÚÔÔÙÈΤ˜ ÎÏÈÓÈ΋˜ ıÂÚ·›·˜ Ì ÌÂÙ·ÌfiÛ¯Â˘ÛË ÓËÛȉ›ˆÓ
ÙÔ˘ Langerhans. ¶ÂÚÈÛÎfiÈÔ Ù˘ ∂ÈÛÙ‹Ì˘ 1992;
151: 51-5.
626. TOELLER M, BUYKEN A, HEITKAMP G, MILNE R, KLISCHAN A, GRIES F, AND THE EURODIAB IDDM COMPLICATIONS STUDY GROUP.
Repeatability of three-day dietary records in the
EURODIABIDDM Complications Study. Eur J Clin
Nutr 1997; 51: 74-80. EURODIAB InvestigatorsGreece: Karamanos B, Tountas Ch, Kofinis A, Petrou
K, Katsilambros N, Papazoglou N, Goutzourela M,
Manes Ch.
627. SJOLIE AK, STEPHENSON J, ALDINGTON S,
KOHNER E, JANKA H, STEVENS L, FULLER J,
the EURODIAB IDDM COMPLICATIONS STUDY GROUP. Retinopathy and vision loss in insulindependent diabetes in Europe. The EURODIAB
IDDM Complications Study. Ophthalmology 1997;
104: 252-60. EURODIAB Investigators-Greece: Ka-
102
ramanos B, Tountas Ch, Kofinis A, Petrou K, Katsilambros N, Papazoglou N, Goutzourela M, Manes Ch,
Triantaphyllou G.
628. STEPHENSON J, FULLER J, ON BEHALF OF
THE EURODIAB IDDM COMPLICATIONS STUDY GROUP. Microvascular and acute complications
in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-85.
EURODIAB Investigators-Greece: Karamanos B,
Tountas Ch, Kofinis A, Petrou K, Katsilambros N, Papazoglou N, Goutzourela M, Manes Ch, Triantaphyllou G.
629. DIAMOND PROJECT GROUP ON SOCIAL ISSUES. Global regulations on diabetics treated with
insulin and their operation of commercial motor vehicles. Brit Med J 1993; 307: 250-3. Members of DiaMond Project Group on Social Issues-Greece: Bartsocas Ch, Papazoglou N, Skaragkas G, Kontogiannis
I, Manes Ch.
630. STEPHENSON J, FULLER J, VIBERTI GC, SJOLIE AK, NAVALESI R, The EURODIAB IDDM
COMPLICATIONS STUDY. Blood pressure, retinopathy and urinary albumin excretion in IDDM: The
EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 599-603. EURODIAB Investigators-Greece: Karamanos B, Tountas Ch, Kofinis A,
Petrou K, Katsilambros N, Papazoglou N, Manes Ch,
Triantaphyllou G, Skaragkas G, Kontogiannis I.
631. GREEN A, GALE E, PATTERSON C, FOR THE
EURODIAB ACE STUDY GROUP. Incidence of
childhood-onset insulin-dependent diabetes mellitus:
the EURODIAB ACE Study. Lancet 1992; 339: 9059. EURODIAB ACE Study Investigators-Greece:
Athens region: Bartsocas Ch. (study leader), DakouVoutetaki C, Pantelakis S. North Greece region: Papazoglou N. (study leader).
632. ∫O¡∫OÀƒ∏™ §, ÃO§∂μ∞™ ª, 𪶃π∞§O™ ¶,
¶∞¶∞∑O°§OÀ ¡, ¶∞¡∞°πøΔO¶OÀ§O™ ∂. ∏
Á·Ï·ÎÙÈ΋ ÔͤˆÛȘ ÙÔ˘ ÂÁÎÂÊ·ÏÔÓˆÙÈ·›Ô˘ ˘ÁÚÔ‡ Â›
ÔͤˆÓ ÂÁÎÂÊ·ÏÈÎÒÓ ÂÂÈÛÔ‰›ˆÓ. π·ÙÚÈ΋ 1971; 20:
151-6.
633. LEVY-MARCHAL C, PATTERSON C, GREEN A,
ON BEHALF OF THE EURODIAB ACE STUDY
GROUP. Variation by age group and seasonality at
diagnosis of childhood IDDM in Europe. Diabetologia 1995; 38: 823-30. EURODIAB ACE STUDY
CENTRES: Greece-A. (Athens region): Bartsocas
CS. (study leader), Dakou-Voutetaki C, Pantelakis S,
Theodoridis H, Kassiou K. Greece-B. (North regionThessaloniki): Papazoglou N. (study leader), Manes
Ch, Papadeli E, Skaragkas G, Gotsis N.
634. ALDINGTON S, KOHNER E, MEUER S, KLEIN
R, SJOLIE A, FOR THE EURODIAB IDDM
COMPLICATIONS STUDY GROUP. Methodology
for retinal photography and assessment of diabetic
retinopathy: the EURODIAB IDDM Complications
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Study. Diabetologia 1995; 38: 437-44. EURODIAB
Investigators: Greece: Karamanos B, Tountas Ch,
Kofinis A, Petrou K, Katsilambros N, Papazoglou N,
Manes Ch, Triantaphyllou G, Skaragkas G, Kontogiannis I.
635. CHATURVEDI N, STEPHENSON J, FULLER J,
THE EURODIAB IDDM COMPLICATIONS STUDY GROUP. The relationship between smoking and
microvascular complications in the EURODIAB
IDDM Complications Study. Diabetes Care 1995; 18:
785-792. EURODIAB Investigators Greece: Karamanos B, Tountas Ch, Kofinis A, Petrou K, Katsilambros N, Papazoglou N, Manes Ch, Triantaphyllou G,
Skaragkas G, Kontogiannis I.
636. TOELLER M, KLISCHAN A, HEITKAMP G,
SCHUMACHER W, MILNE R, BUYKEN A, KARAMANOS B, GRIES F, AND THE EURODIAB
IDDM COMPLICA-TIONS STUDY GROUP.
Nutritional intake of 2868 IDDM patients from 30
centres in Europe. Diabetologia 1996; 39: 929-39.
EURODIAB Investigators-Greece: Papazoglou N,
Goutzourela M, Manes Ch, Tountas Ch, Kofinis A,
Petrou K, Katsilambros N, Roussi-Penessi D.
637. CHATURVEDI N, STEPHENSON J, FULLER J,
THE EURODIAB IDDM CO MPLICATIONS
STUDY GROUP. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications
Study. Diabetes Care 1996; 19: 423-30. EURODIAB
Investigators-Greece: Karamanos B, Tountas Ch,
Kofinis A, Petrou K, Katsilambros N, Papazoglou N,
Manes Ch, Skaragkas G, Kontogiannis I.
638. TESFAYE S, STEVENS L, STEPHENSON J,
FULLER J, PLATER M, IONESCU TIRGOVISTE
C, NUBER A, POZZA G, WARD J, AND THE EURODIAB IDDM COMPLICATIONS STUDY
GROUP. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential
risk factors: the EURODIAB IDDM Complications
Study. Diabetologia 1996; 39: 1377-84. EURODIAB
Investigators-Greece: Karamanos B, Tountas Ch,
Kofinis A, Petrou K, Katsilambros N, Papazoglou N,
Manes Ch, Skaragkas G, Kontogiannis I.
639. STEPHENSON J, KEMPLER P, CAVALLO PERIN P, FULLER J, AND THE EURODIAB IDDM
COMPLICATIONS STUDY GROUP. Is autonomic
neuropathy a risk factor for severe hypoglycaemia?
The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1372-6. EURODIAB Investigators-Greece: Karamanos B, Tountas Ch, Kofinis A,
Petrou K, Katsilambros N, Papazoglou N, Manes Ch,
Skaragkas G, Kontogiannis I.
640. KOIVISTO V, STEVENS L, MATTOCK M, EBELING P, MUGGEO M, STE PHENSON J, IDZIORWALUS B, THE EURODIAB IDDM COMPLICATIONS STUDY GROUP. Cardiovascular disease
and its risk factors in IDDM in Europe. Diabetes
Care 1996; 19: 689-97. EURODIAB InvestigatorsGreece: Karamanos B, Tountas Ch, Kofinis A, Petrou
K, Katsilambros N, Papazoglou N, Manes Ch, Ioannides A.
641. LLOYD C, STEPHENSON J, FULLER J, ORCHARD T. A comparison of renal disease across two
continents. The Epidemiology of Diabetes Complications Study and the EURODIAB IDDM Complications Study. Diabetes Care 1996; 19: 219-25.
EURODIAB Investigators-Greece: Karamanos B,
Tountas Ch, Kofinis A, Petrou K, Katsilambros N, Papazoglou N, Manes Ch, Skaragkas G, Kontogiannis I.
642. CHATURVEDI N, STEPHENSON J, FULLER J,
AND THE EURODIAB IDDM COMPLICATIONS
STUDY GROUP. The relationship between pregnancy and longterm maternal complications in the
EURODIAB IDDM Complications Study. Diabet
Med 1995; 12: 494-9. EURODIAB InvestigatorsGreece: Karamanos B, Tountas Ch, Kofinis A, Petrou
K, Katsilambros N, Papazoglou N, Manes Ch,
Skaragkas G, Kontogiannis I.
643. HINZ M, KATSILAMBROS N, SCHWEITZER B,
RAPTIS S, PFEIFFER E. The role of the exocrine
pancreas in the stimulation of insulin secretion by intestinal hormones. The effect of pancreozymin, secretin, gastrin pentapeptide andof glucagon upon insulin secretion of isolated islets of rat pancreas. Diabetologia 1971; 7: 1-5.
644. KATSILAMBROS N, ABDEL RAHMAN V, HINZ
M, FUSSGANGER R, SCHRODER K, PFEIFFER
E. Action of streptozotocin on insulin and clucagon
responses of rat islets. Horm Medab Res 1971; 2: 26870.
645. HINZ M, KATSILAMBROS N, PFEIFFER E.
Determination of insulin and proinsulin after separation by continuous flow elution from polyacrylamide
electrophoresis. Horm Metab Res 1970; 2: 123-4.
646. HINZ M, KATSILAMBROS N, MAIER V,
SCHATZ H, PFEIFFER E. Significance of streptozotocin induced nicotinamide-adenine dinucleotide
(nad) degradation in mouse pancreatic islets. Febs
Letters 1973; 30: 225-8.
647. SCHATZ H, KATSILAMBROS N, HINZ M, VOIGT
K, NIERLE C, PFEIFFER E. The effect of growth
hormone (GH) and adrenocorticotrophic hormone
(ACTH) on secretion and biosynthesis of insulin in isolated islets of the rat. Diabetologia 1973; 9: 140-4.
648. SCHATZ H, KATSILAMBROS N, NIERLE C,
PFEIFFER E. The effect of biguanides on secretion
and biosynthesis of insulin in isolated pancreatic islets
of rats. Diabetologia 1972; 8: 402-7.
649. KATSILAMBROS N, ZIEGLER R, SCHATZ H,
HINZ M, MAIER V, PFEIFFER E. Intravenous glucose tolerance and insulin secretion in the rat after
thyroidectomy. Horm Metab Res 1972; 4: 377-9.
103
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
650. PAPADOPOULOS G, VARONOS D, KATSILAMBROS N. Hyperglycemic action of phenazine in rats.
IRCS Medical Science 1974; 2: 1138.
651. KONTOYANNIS P, KATSILAMBROS N, THEOPHANIDES C, DRAGINES E. Insulin levels in cerebrospinal fluid following glucose load in humans.
Europ Neurol 1974; 11: 128-32.
652. CHRISTLIEB A, ASSAN J, KATSILAMBROS N,
WILLIAMS H, KOZAK G, SUZUKI T. Plasma
renin activity and blood volume in uncontrolled diabetes Ketoacidosis, a state of secondary aldosteronism. Diabetes 1975; 24: 120-3.
653. KANIARIS P, KATSILAMBROS N, CASTANAS E,
THEOPHANIDES C. Relation between glucose tolerance and serum insulin levels in man before and after thiopental intravenous administration. Anesth
Analg 1975; 54: 718-21.
654. ∫∞¡π∞ƒ∏™ ¶, ∫∞Δ™π§∞ª¶ƒO™ ¡, ª∂¡¢ƒ∏™
π, £∂Oº∞¡π¢∏™ ∫, ∫∞™Δ∞¡∞™ ∏. ™¯¤ÛÂȘ ηÌ‡Ï˘ ۷ί¿ÚÔ˘ Î·È ÂÈ¤‰ˆÓ ÈÓÛÔ˘Ï›Ó˘ Â› ·ÓıÚÒˆÓ ÚÔ Î·È ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÂÊ’ ¿·Í ‰fiÛˆÓ
Ó·ÙÚÈÔ‡¯Ô˘ ıÂÈÔÌÂÓÙ¿Ï˘. ∂ÏÏËÓÈ΋ ∞Ó·ÈÛıËÛÈÔÏÔÁ›· 1973; 7: 163-77.
655. KATSILAMBROS N, VERYKOKIDOU H, ALEXOPOULOS J, PHILIPPIDES P, MIRAS N, DAIKOS G. Comparison of intravenous and subcutaneous insulin infusions. Horm. Metab Res 1980; 12
(Suppl): 258-60.
656. KATSILAMBROS N, PHILIPPIDES P, BOLETIS J,
MAVROUDIS K, FRANGAKI D, MARANGOS M,
DAIKOS G. Postprandial hyperglycemia after ingestion of peeled and nonpeeled fruits in type -2 diabetics. J Endocrinol Invest 1985; 8: 189-91.
657. KATSILAMBROS N, PHILIPPIDES PH, TOSKAS
A, PROTOPAPAS J, FRANGAKI D, MARANGOS
M, SISKOUDIS P, ANASTASOPOULOU K, XEFTERI H, HILLEBRAND I. A doubleblind study on
the efficasy and tolerance of a new a-glucosidase inhibitor in type-2 diabetics. Drug Res 1986; 36: 1136-8.
658. ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º, ΔOÀ§π∞ΔOÀ ∞, °∂øƒ°∞∫O¶OÀ§O™ ∫, ∫øºOΔ∑OÀ§∏ §, ºƒ∞°∫∞∫∏ ¢, ™π™∫OÀ¢∏™ ¶, ª∞ƒ∞°°O™ ª, ™º∏∫∞∫∏™ ¶. ∂›‰Ú·ÛË Ù˘ ÚÔÛı‹Î˘
ÏÈ·ÚÒÓ ÙÚÔÊ›ÌˆÓ ÛÙËÓ ˘ÂÚÁÏ˘Î·ÈÌ›·, ÙÚÈÁÏ˘ÎÂÚȉ·ÈÌ›· Î·È ÈÓÛÔ˘ÏÈÓ·ÈÌ›· ‰È·‚ËÙÈÎÒÓ ·ÙfiÌˆÓ ÌÂÙ¿
·fi Ï‹„Ë ÌÂÏÈÔ‡. ™ÙÔ: ΔÈÌËÙÈÎfi˜ ΔfiÌÔ˜ ∫·ıËÁËÙÔ‡
°. ∫. ¢¿˚ÎÔ˘. ∞ı‹Ó·, 1988; 237-40.
659. STEPHENSON J, FULLER J, THE EURODIAB
IDDM COMPLICATIONS STUDY GROUP AND
THE WHO MULTINATIONAL STUDY OF VASCULAR DISEASE IN DIABETES STUDY
GROUP. Microalbuminuriais not rare before 5 years
of IDDM. J Diab Complications 1994; 8: 166-73.
EURODIAB Investigators-Greece: Karamanos B,
Tountas Ch, Kofinis A, Petrou K, Katsilambros N,
Papazoglou N, Manes Ch.
104
660. NTAºO°π∞¡¡∏ Ã. ∏ ÁÂÓÂÙÈ΋ ÙÔ˘ ‰È·‚‹ÙË. ™ÙÔ:
∑ËÚÔÁÈ¿ÓÓ˘ ¶ª, ¶È·‰›Ù˘ °, ΔÛÔ˘Ê¿Î˘ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ - ∂ÈÏÔΤ˜. ∞ı‹Ó·: ∂Ù·ÈÚ›· ¡ÔÛËÏ¢ÙÈÎÒÓ ™Ô˘‰ÒÓ, 1997: 133-40.
661. ∑∏ƒO°π∞¡¡∏™ ¶, ¶π∞¢πΔ∏™ °, Δ™OÀº∞∫∏™
°. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ - ∂ÈÏÔΤ˜. ∞ı‹Ó·: ŒÎ‰ÔÛË ∂Ù·ÈÚ›·˜ ¡ÔÛËÏ¢ÙÈÎÒÓ ™Ô˘‰ÒÓ, 1997.
662. GEORGAKOPOULOS K, KATSILAMBROS N,
FRAGAKI M, POULOPOULOU Z, KIMBOURIS
J, SFIKAKIS P, RAPTIS S. Recovery from insulin-induced hypoglycemia after saccharose or glucose administration. Clin Physiol Biochem 1990; 315: 267-72.
663. KATSILAMBROS N, PHILIPPIDES PH, DAVOULOS G, GIALOUROS K, KOFOTZOULI L, MAGLARA E, IOANNIDIS P, SISKOUDIS P, SFIKAKIS P. Sesame-derived candies and glycemic response in type II diabetic subjects. Diabetes Nutr
Metab 1991; 4: 325-7.
664. KATSILAMBROS N, ANTONOPOULOS A, STAMATIADIS D, ALEVIZOU V, SISKOUDIS P.
Lipoprotein-a Lp(a), Apolipoproteine B und A-I bei
Diabetikern Typ II. Diabetes und Stoffwechsel 1992;
1: 261-3.
665. VOYATZOGLOU D, LOUPA Ch, PHILIPPIDES
PH, SISKOUDIS P, KITSOU E, ALEVIZOU V,
MANGLARA E, KATSILAMBROS N. Insulin response to legumes in type 2 diabetic persons. Eur J Intern Med 1995 ; 6: 201-3.
666. KATSILAMBROS N, TSAPOGAS P, ARVANITIS
M, TRITOS N, ALEXIOU Z, RIGAS K. Risk factors
for lower extremity arterial disease in noninsulin dependent diabetic persons. Diabet Med 1996; 13: 2436.
667. MANTZOROS CH, EVANGELOPOULOU K,
GEORGIADIS E, KATSILAMBROS N. Conicity index as a predictor of blood pressure levels, insulin and
TG concentrations of healthy premenopausal women.
Horm Metab Res 1996; 28: 32-4.
668. ANTONOPOULOS A, GIANNAKA M, PANTELAKI P, KATSILAMBROS N. Body fat distribution
in non-insulin dependent diabetic subjects. Diabetes
Management 1996; 2: 7-11.
669. KATSILAMBROS N, KOSTALAS G, MICHALAKIS E, KAPANTAIS E, MANGLARA E, KOURELI CH, MARAGOS M, ALEVIZOU V, SAKELLARIOU CH, RICHARDSON S. Metabolic effects of
long-term diets enriched in olive oil or sunflower oil in
noninsulin dependent diabetes. Nutr Metabol Cardiovasc Dis 1996; 6: 164-7.
670. MANTZOROS CH, GEORGIADIS E, EVANGELOPOULOU K, KATSILAMBROS N. Dehydroepiandrosterone sulfate and testosterone are independently associated with body fat distribution in premenopausal women. Epidemiology 1996; 7: 1-5.
671. KATSILAMBROS N. Régime méditerranéen et dia-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
bète sucré = Mediterranean diet and diabetes mellitus. Cah Nutr Diet 1996; 31: 209-11.
672. KATSILAMBROS N, BRAATEN J, FERGUSON
B, BRADLEY R. Muscular syndrome after clofibrate. Letter to the editor. N Engl J Med 1972; 286:
1110-1.
673. KATSILAMBROS N. Diabetic retinopathy and
blood sugar. Letter to the editor. Lancet 1976; ii:
1253.
674. KATSILAMBROS N, VERIKOKIDOU H, PHILIPPIDES PH, MIRAS G, DAIKOS G. Comparison
of intravenous and subcutaneous insulin infusions in
man. Letter to the editor. Lancet 1979; i: 609-10.
675. KATSILAMBROS N, PHILIPPIDES PH, BOLETIS
J, MAVROUDIS K, FRANGAKI D, CHANIOTIS
D. Blood sugar changes in diabetics after a test meal
containing vegetables and olive oil. Letter to the editor. Acta Diabetol Lat 1981; XIX: 185-6.
676. PHILIPPIDES PH, KATSILAMBROS N, GALANOPOULOS A, PAPPAS T, KOFOTZOULI L,
FRANGAKI D, SISKOUDIS P, SFIKAKIS P. Glycaemic response to carrot in type II diabetic patients.
Letter to the editor. Diabetes Nutr Metab 1988; 1:
363-4.
677. ANTONOPOULOS A, KOSTELETOS G, STAMATIADIS D, KATSILAMBROS N. Eye colour and
type I diabetes. Letter to the editor. Diabetes Care
1993; 16: 1216.
678. KATSILAMBROS N, GEORGIADIS E, ALIFERIS
C, PAPANDREOU L, TRIANTAPHYLLOU O,
KOUROUTIS S, GRIGORIADIS N, TZAVARAS
A. Serum lipids and arterial blood pressure in relation
to waist-to-hip ratio in young males. Am J Clin Nutr
1993; 57: 695-6.
679. HEINEMANN G, THUM K, HINZ M, KATSILAMBROS N, FEDERLIN K. Die Behandlung eines
Falles von metastasierendem Inselzellcarcinom mit
Streptozotocin. Verh Dtsch Ges Inn Med 1970; 76:
409-12.
680. ABDEL RAHMAN V, SCHATZ H, KATSILAMBROS N, HINZ M, BAETZNER P, SCHLEYER M,
PFEIFFER E, NIERLE C. Der Einfluss von Adrenocorticotropem Hormon (ACTH) und Wachstumshormon (STH) auf die Insulinsekre Tion isolierter Langerhansscher Inseln hypophysektomierter Ratten. In:
Magyar I, Beringer A. 2 Internationales Donau-Symposium über Diabetes Mellitus Proceedings. Budapest, 1971: 173-7.
681. SCHATZ H, KATSILAMBROS N, HINZ M,
PFEIFFER E, NIERLE C. Wirkung auf die Insulinsekreation isolierter Langerhansscher Inselin von
Ratten. In: Magyar I, Beringer A. 2 Internationales
Donau-Symposium über Diabetes Mellitus Proceedings. Budapest, 1971: 353-7.
682. WINKLER G, FEHM H, KATSILAMBROS N,
BAETZNER P, FAULHABER J, GOBERNA R,
HINZ M, MAIER V, SCHRODER K, VOIGT K,
ROTHENBUCHNER R. Paradoxe Wirkung niedrig
dosierter 6-dehydro-16-Methyllencortisol- Behandlung auf den Kohlenhydratstoffwechsel. In: Magyar I,
Beringer A. 2 Internationales Donau-Symposium
über Diabetes Mellitus Proceedings. Budapest, 1971:
153-6.
683. KATSILAMBROS N, KONTOYANNIS P, DRAGINES E, TRIANTAPHYLLOU G, DAIKOS G. Glukosetoleranz und Insulinsekretion bei der Virushepatitis. In: 3. Internationales Donau-Symposium über
Diabetes Mellitus: Salzburg, 10-12 Sept. 1973. Wien:
Maudrich, 1973: 289-91.
684. ∫∞Δ™π§∞ª¶ƒO™ ¡, ∫O¡ΔO°π∞¡¡∏™ ¶, ¢ƒ∞°π¡∏™ ∂, ∏¶πøΔOÀ ª, ∫∞ƒ∞∫ø™Δ∞ ∂, Δƒπ∞¡Δ∞ºÀ§§OÀ °. ∏ ۷ί·Ú·ÈÌÈ΋ ηÌ‡ÏË Â› Ù˘
ÔÍ›·˜ ÈÔÁÂÓÔ‡˜ Ë·Ù›ÙȉԘ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ
1975; 1: 328-34.
685. KATSILAMBROS N, POLYZOS A, MAKRIGIANNIS H, STAVROU P, PHILIPPIDES PH, MIRAS N,
DAIKOS G. Influece de la leucine sur l’ insulinemie
et sur la tolerance au glucose par voie intraveineuse
[Effect of leucine on blood insulin levels and intravenous glucose tolerance]. Journ Annu Diabetol Hotel Dieu 1980: 59-64.
686. PHILIPPIDES PH, GIAMARELLOU H, DRANIDIS B, KATSILAMBROS N, PETRIKKOS G,
DAIKOS G. Screening for bacteriuria in diabetics.
Chemioterapia 1985; 4 (Suppl 2): 921-2.
687. SFIKAKIS P, BOUKOUVALAS B, KATSILAMBROS N. Effects of salmon calcitonin’s pharmacological doses, in the hypoglycemic and insulin-releasing
action of tolbutamide in normal man. In: 2nd International Congress on Osteoporosis, Athens. 1985: 340-5.
688. KATSILAMBROS N. Diabetes and exercise. In: Proceedings of 3rd Course on Biochemistry and Exercise.
Athens: Eptalofos, 1987: 267-73.
689. KATSILAMBROS N. Diabetes and atherosclerosis.
In: 7th European congress of the International Union
of Angiology Proceedings of the congress, Rhodes,
1991.
690. ∫∞Δ™π§∞ª¶ƒO™ ¡, °∞∑∂Δ∞™ °, ¶ƒ∞°∫∞™Δ∏™ ¢, ¢∞π∫O™ °. ÀÔÁÏ˘Î·ÈÌÈ΋ Â›‰Ú·ÛȘ ‰‡Ô
ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ Â› Ô˘Ú·ÈÌÈÎÒÓ ÂÈ̇ˆÓ Î·È ÈÓÛÔ˘ÏÈÓ·ÈÌ›· ÌÂÙ¿ ÁÏÈ‚ÂÓÎÏ·Ì›‰ËÓ. ∞گ›· π·ÙÚ.
∂Ù·ÈÚÂÈÒÓ 1978; 3: 415-8.
691. ºπ§π¶¶π¢∏™ º, ∞¡Δø¡πOÀ Ã, ∫∞Δ™π§∞ª¶ƒO™ ¡, ∫∞Δ™∞ª¶∞™ ∞, ∫∞¡Δ∏™ ¶, ™º∏∫∞∫∏™ ¶, ™Δƒ∞Δ∏°O™ π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘
Î·È ·ıÔÏÔÁÈ΋ ·ÓÔ¯‹ ÛÙË ÁÏ˘Îfi˙Ë Û „ˆÚÈ·ÛÈÎÔ‡˜
·ÛıÂÓ›˜. πÔÎÚ¿Ù˘ 1988; 1: 47-51.
692. ¡π∫OÀ °, ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∞ª∞Δπ∞¢∏™
¢, ∫πΔ™OÀ ∂, ºπ§π¶¶π¢∏™ º, ∞¡Δø¡O¶OÀ§O™ ∞, ∞§∂μπ∑OÀ μ, ™º∏∫∞∫∏™ ¶. ŒÎÎÚÈÛË
Á·ÛÙÚ›Ó˘ Û ‰È·‚ËÙÈο ¿ÙÔÌ·. ™ÙÔ: ΔÈÌËÙÈÎfi˜ ÙfiÌÔ˜:
105
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∫·ıËÁËÙÔ‡ ¶·Ó·ÁÈÒÙË ∏Ï. ª·Ï¿. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ §›ÙÛ·˜, 1993: 217-20.
693. ¡π∫OÀ °, ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º,
¶∞¶∞ƒ°ÀƒπOÀ π, ™º∏∫∞ ∫∏™ ¶. ∏ ÁÏ˘Îfi˙Ë ·›Ì·ÙÔ˜ ÌÂÙ¿ Ì·ÎÚÔ¯ÚfiÓÈ· ¯ÔÚ‹ÁËÛË ÛˆÌ·ÙÔÛÙ·Ù›Ó˘
SMS 201-995. ∂ÏÏËÓÈ΋ °·ÛÙÚÂÓÙÂÚÔÏÔÁ›· 1991; 4:
162-6.
694. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¶ÚÔ˚ÓÛÔ˘Ï›ÓË. π·ÙÚÈ΋ 1970;
17: 226-30.
695. ∫∞Δ™π§∞ª¶ƒO™ ¡. ªÂÙ·‚ÔÏÈη› Î·È ÔÚÌÔÓÈη›
ÂÈÙÒÛÂȘ Ù˘ ÓËÛÙ›·˜. ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο
1975; 37: 359-62.
696. Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. K›ÚÚˆÛË ‹·ÙÔ˜ Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi˙˘. πÔÎÚ¿Ù˘
1995; 23: 9-16.
697. Δ™π°°OÀ¡∏™ μ, ∫∞Δ™π§∞ª¶ƒO™ ¡, §ø§∏™
¢, ∫∞™∫∞ƒ∂§∏™ ¢, μ∞ƒø¡O™ ¢. πÓÛÔ˘Ï›ÓË ·›Ì·ÙÔ˜ ÂÌ‚Ú‡Ô˘-ÌËÙÚfi˜ Î·È ·ÌÓÈ·ÎÔ‡ ˘ÁÚÔ‡ ηٿ ÙËÓ
‰È¿ÚÎÂÈ·Ó ÙˆÓ ÙÂÏÂ˘Ù·›ˆÓ ‚‰ÔÌ¿‰ˆÓ Ù˘ ΢‹Ûˆ˜.
Mater Med Greca 1977; 5: 143-6.
698. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∞ÀƒOÀ ¶, ª∞¡Δ∑∞ƒ∏™ μ, ªOπƒ∞™ ¡, ª∞ƒ∞°°O™ ª, ™º∏∫∞∫∏™
¶, ¢∞π∫O™ °. §È›‰È· ÙÔ˘ ÔÚÔ‡ ÌÂÙ¿ ÙËÓ Ï‹„ÈÓ ÂÓfi˜
‰ÔÎÈÌ·ÛÙÈÎÔ‡ ÚÔÁ‡̷ÙÔ˜ (Â›‰Ú·ÛȘ ·¯˘Û·ÚΛ·˜
Î·È ÂÙ¤ÚˆÓ ·Ú·ÁfiÓÙˆÓ). πÔÎÚ¿Ù˘ 1977; 5: 275-81.
699. Ã∞Δ∑∏∫Àƒπ∞∫OÀ ª, TA°∞ƒ∏™ ¡, ªOπƒ∞™ ¡,
ª∞ƒ∞°∫O™ ª, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞´∫O™ °.
§È›‰È· ÙÔ˘ ÔÚÔ‡ ÂÓ ÓËÛÙ›· Â› Ù˘¯·›ˆ˜ ÂÈÏÂÁ¤ÓÙˆÓ
ÂÏÏ‹ÓˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. Mater Med Greca
1977; 5: 643-7.
700. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∞ÀƒOÀ ¶, ¶∞¶∞∑∞ÃO™ °, °∞§∞¡∞∫∏™ ¡, ªOπƒ∞™ ¡, ™º∏∫∞∫∏™ ¶, ¢∞´∫O™ °. IÓÛÔ˘ÏÈÓ·ÈÌ›· ÌÂÙ¿ ·fi Ù·˘Ùfi¯ÚÔÓË ¯ÔÚ‹ÁËÛË ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜ Î·È ·ÙÚÔ›Ó˘ ÛÂ
‰È·‚ËÙÈÎÔ‡˜. πÔÎÚ¿Ù˘ 1978; 6: 389-94.
701. ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º, °∞ƒ∑ø¡∏™ ¶, ¶∞¶∞∑∞ÃO™ °, ªOπƒ∞™ ¡, ºƒ∞°∫∞∫∏ ¢, ª∞ƒ∞°°O™ ª, ¢∞π∫O™ °. HDL-ÃÔÏËÛÙÂÚfiÏË Û ‰È·‚ËÙÈο Î·È Ì‹ ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋
1981; 39: 49-53.
702. ∫∞Δ™π§∞ª¶ƒO™ ¡, ¶πΔ∞ƒO∫Oπ§∏™ π, μ∂ƒÀ∫O∫π¢OÀ ∂, ºƒ∞°∫∞∫∏ ¢, ª∞ƒ∞°°O™ ª,
Ã∞¡πøΔ∏™ ¢. ¶ÂÓÙ·ÂÙ‹˜ ·Ú·ÎÔÏÔ‡ıËÛË (followup) ·ÙfiÌˆÓ Ì ÌË ‰È·‚ËÙÈ΋ ÁÏ˘ÎÔ˙Ô˘Ú›·. πÔÎÚ¿Ù˘ 1981; 9: 129-32.
703. ª∞∫ƒÀ°π∞¡¡∏™ ∏, KOYT™∂§π¡∏™ ∞, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞π∫O™ °. MÂÙ·‚ÔϤ˜ ÙÔ˘ ¯ÚˆÌ›Ô˘
ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ ηٿ ÙËÓ ÂÓ‰ÔÊϤ‚È· ¯ÔÚ‹ÁËÛË ÁÏ˘Îfi˙˘ Û ˘ÁÈ‹ Î·È ‰È·‚ËÙÈο ¿ÙÔÌ·. Mater Med
Greca 1981; 9: 625-8.
704. Ã∞ƒ∞§∞ª¶O¶OÀ§O™ ¢, ∞°∞§πøΔ∏™ ¢, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞π∫O™ °. ¢È·‚ËÙÈ΋ ¯ÂÈÚÔ·ÚıÚÔ¿ıÂÈ·. πÔÎÚ¿Ù˘ 1984; 12: 235-7.
705. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∑¿¯·ÚË: Ó·È ‹ fi¯È ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜; ¢È·ÙÚÔÊ‹ - ¢È·ÈÙÔÏÔÁ›· 1986; 12: 14-6.
106
706. ∫∞Δ™π§∞ª¶ƒO™ ¡, ºπ§π¶¶π¢∏™ º, °∞§∞¡O¶OÀ§O™ ∞, ¶∂¶¶∞™ £, ∫øºOΔ∑OÀ§∏ §,
ª∞°∫§∞ƒ∞ ∂, ºƒ∞°∫∞∫∏ ª, ™π™∫OÀ¢∏™ ¶,
ª∞ƒ∞°∫O™ ª, ™º∏∫∞∫∏™ ¶. MÂÙ·‚ÔÏÈΤ˜ ÂȉڿÛÂȘ ‰È·ÊfiÚˆÓ Ù‡ˆÓ ̷ηÚÔÓÈÒÓ Û ‰È·‚ËÙÈο
¿ÙÔÌ· Ù‡Ô˘ ππ. Mater Med Greca 1988; 16: 88-92.
707. ºπ§π¶¶π¢∏™ º, ¶∂¶¶∞™ £, ª∞¡Δ∞ ª, ¢∞μOÀ§O™ °, ∞μ¢∂§π¢∏™ ¢, ∫∞Δ™π§∞ª¶ƒO™
¡, ™º∏∫∞∫∏™ ¶. ¶·ÚÔ‰È΋ ËÌÈÏËÁ›· ˆ˜ ÂΉ‹ÏˆÛË ˘ÔÁÏ˘Î·ÈÌ›·˜. πÔÎÚ¿Ù˘ 1989; 2: 385-9.
708. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ ηٷÓÔÌ‹ ÙÔ˘ ۈ̷ÙÈÎÔ‡
Ï›Ô˘˜ ˆ˜ ÚÔÁÓˆÛÙÈÎfi˜ ‰Â›ÎÙ˘ ÔÚÈÛÌ¤ÓˆÓ ·ı‹ÛˆÓ. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1991; 8: 91-3.
709. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∞ÓÂÈı‡ÌËÙ˜ ÂÓ¤ÚÁÂȘ, ÂӉ›ÍÂȘ Î·È ·ÓÙÂӉ›ÍÂȘ ÙˆÓ ‰ÈÁÔ˘·‰ÈÓÒÓ. ΔÔ º¿ÚÌ·ÎÔ 1991; 8: (ÛÂÏ.?).
710. K∞Δ™π§∞ª¶ƒO™ ¡. O ¤ÏÂÁ¯Ô˜ Ù˘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ ÚÔÊ˘Ï¿ÛÛÂÈ ·fi ÙË Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1993;
10: 6: 343-5.
711. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ ÎÏÈÓÈ΋ ÛËÌ·Û›· Ù˘ ÌÂÙ¿
Ê·ÁËÙfi ÙÚÈÁÏ˘ÎÂÚȉ·ÈÌ›·˜. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜
1996; 13: 274-7.
712. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ ÏÈÔÚˆÙ½ÓË (·) Î·È Ë ÎÏÈÓÈ΋ Ù˘ ÛËÌ·Û›·. π·ÙÚÈ΋ 1996; 69: 254-5.
713. PFEIFFER E, FUSSGANGER M, HINZ M, KATSILAMBROS N, LAUBE N. Dynamics of insulin
and glucagon secretion of the isolated perfused rat
pancreas and islets following and in the presence of
newer sulfonylureas. In: Dubach UC, Buckert A. Recent hypoglycemic sulfonylureas: Mechanisms of action and clinical indications. Bern: Huber, 1971:
(pages ?).
714. ∫∞Δ™π§∞ª¶ƒO™ ¡. ªÂÙ·‚ÔÏÈÛÌfi˜ ˘‰·Ù·ÓıÚ¿ÎˆÓ Î·È ÏÈÒÓ Î·Ù¿ ÙËÓ ÔÍ›·Ó ÂÈÚ·Ì·ÙÈÎ‹Ó Ô˘Ú·ÈÌ›·Ó. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1974. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
715. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ Ú·ÎÙÈ΋ ·ÓÙÈÌÂÙÒÈÛȘ
ÙÔ˘ ‰È·‚‹ÙÔ˘ Î·È ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ÎÒÌ·ÙÔ˜. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1977: 161 ÛÂÏ.
716. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ ıÂÚ·›· Ù˘ ·¯˘Û·ÚΛ·˜. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
1982: 115 ÛÂÏ.
717. KATSILAMBROS N. Epidemiology of acute manifestations and complicati ons (I) hypoglycaemia,
ketoacidosis, hyperosmolar nonketotic coma and
lactic acidosis. In: Williams R, Papoz L, Fuller J,
Libbey J. Diabetes in Europe. London: John Libbey,
1994: 39-45.
718. ∫∞Δ™π§∞ª¶ƒO™ ¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÁ¯ÂÈÚ‹ÛÂȘ. ™ÙÔ: ™¤¯·˜ ª. ÃÂÈÚÔ˘ÚÁÈ΋. ∞ı‹Ó·, π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ¶.Ã. ¶·Û¯·Ï›‰Ë˜, 1996: (ÛÂÏ.?).
719. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚‹Ù˘. ™ÙÔ: ΔÔ‡ÙÔ˘˙· ¶∫.
∏ ηډȿ ÛÔ˘: ¶ˆ˜ ı· ÙËÓ ÚÔÛٷ٤„ÂȘ. ∞ı‹Ó·:
∂ÏÏËÓÈÎÔ ÿ‰Ú˘Ì· ∫·Ú‰ÈÔÏÔÁ›·˜, 1994: 51-4.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
720. KATSILAMBROS N, RABAVILA V. Exercise in diabetes mellitus. Clinical aspects. In: Cowett RM. Diabetes. New York: Raven Pr, 1995: 215-26.
721. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚ËÙÈ΋ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›· - Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 434-44.
722. ∫∞Δ™π§∞ª¶ƒO™ ¡, ƒOÀ™™O™ Ã. HÏÂÎÙÚÔηډÈÔÁÚ·ÊÈη› ·Ú·ÙËÚ‹ÛÂȘ Â› ÙÔ˘ Â›Ì˘Ô˜ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: ¶Ú·ÎÙÈο ∂ÏÏËÓÈ΋˜ π·ÙÚÔ¯ÂÈÚÔ˘ÚÁÈ΋˜ ∂Ù·ÈÚ›·˜, 1969: 532-8.
723. ∫∞Δ™π§∞ª¶ƒO™ ¡, ¶∞¶∞∑∞ÃO™ °, ¢∞π∫O™
°. ∫ÏÈÓÈÎÔÂÚÁ·ÛÙËÚȷ΋ ÂÌÂÈÚ›· Ì ̛·Ó Óˆ٤ڷÓ
ÈÓÛÔ˘Ï›ÓËÓ (monocomponent). ∞گ›· π·ÙÚ. ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ 1975; 1: 9-11.
724. ∫∞Δ™π§∞ª¶ƒO™ ¡, ∫∞¡∂§§∞∫O¶OÀ§OÀ ∫,
¢∞π∫O™ °. πÓÛÔ˘ÏÈÓÔ¤ÎÎÚÈÛË Â› ˘ÔÎÏÈÓÈÎÔ‡ ηÈ
‹ÈÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÁÏ˘Îfi˙˘ ƒ.O. ∞گ›· ∂ÏÏËÓ. π·ÙÚ. ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ
1975; 173-6.
725. ºπ§π¶¶π¢∏™ º, ™º∏∫∞∫∏™ ¶, ™π™∫OÀ¢∏™ ¶,
∫∞Δ™π§∞ª¶ƒO™ ¡, ª¶∂∑O™ ∏, ¢∞π∫O™ °.
∂›‰Ú·ÛȘ ÂÊ’ ¿·Í ÌÂÁ¿ÏˆÓ ‰fiÛÂˆÓ ÔÈÛÙÚÔÁfiÓÔ˘
Â› Ù˘ ÂÓ‰ÔÊÏ‚›Ô˘ ۷ί·Ú·ÈÌÈ΋˜ ηÌ‡Ï˘.
∞گ›· ∂ÏÏËÓ. π·ÙÚ. ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ 1976: 676-80.
726. •∂ºΔ∂ƒ∏ ∏, ∫∞Δ™π§∞ª¶ƒO™ ¡, ª¶OÀƒ∞¡Δ∞™ ∫, ™Δ∞ÀƒOÀ ¶, §π∞¡OÀ ¶, ¶∞¶∞¢O¶OÀ§O™ °, ¢∞π∫O™ °, ¶∞¶∞Ã∞ƒ∞§∞ª¶OÀ™
¡. ¢È·Ù·Ú·¯·› Ù˘ ‹Íˆ˜ ÙÔ˘ ·›Ì·ÙÔ˜ Â› ‚·Ú¤Ô˜
ÂÈÚ·Ì·ÙÈÎÔ‡ ‰È·‚‹ÙÔ˘ ÙˆÓ ÂÈ̇ˆÓ ÚÔÎÏËı¤ÓÙÔ˜
‰È· ÛÙÚÂÙÔ˙ÔÙÔÛ›Ó˘. ∞گ›· ∂ÏÏËÓ. π·ÙÚ. ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ 1977: 308-11.
727. ∫∞Δ™π§∞ª¶ƒO™ ¡, HEDING L, ºπ§π¶¶π¢∏™
º, ¢∞π∫O™ °. πÓÛÔ˘Ï›ÓË ÔÚÔ‡ Î·È ÁÏ˘Î·ÁfiÓË Ï¿ÛÌ·ÙÔ˜ Â› Ô˘Ú·ÈÌÈÎÒÓ ÂÈ̇ˆÓ Î·È Â›‰Ú·ÛȘ Ù˘
ۈ̷ÙÔÛÙ·Ù›Ó˘. ∞گ›· ∂ÏÏËÓ. π·ÙÚ. ∂Ù·ÈÚ›·˜
∞ıËÓÒÓ 1977: 311-4.
728. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∂ƒ°πøΔ∏™ π, ºπ§π¶¶π¢∏™ º, ™º∏∫∞∫∏™ ¶, ¢∞´∫O™ °. °Ï˘ÎÔ˙Ô˘Ú›·
Î·È ·ÓÔ¯‹ ÂȘ ÙËÓ ÁÏ˘Îfi˙ËÓ ÂÁ·ˆÓ Á˘Ó·ÈÎÒÓ ÂÎ ‰Â›ÁÌ·ÙÔ˜ ÁÂÓÈÎÔ‡ ÏËı˘ÛÌÔ‡. ™˘Û¯¤ÙÈÛȘ ÚÔ˜ Ù· Â˘Ú‹Ì·Ù· Â› ÌË ÂÁ·ˆÓ. ™ÙÔ: ¶Ú·ÎÙÈο μ′ ¶·ÓÂÏÏ‹ÓÈÔ˘
™˘Ó‰ڛԢ ª·È¢ÙÈ΋˜ Î·È °˘Ó·ÈÎÔÏÔÁ›·˜. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ §›ÙÛ·˜, 1977: 297-302.
729. ∫∞Δ™π§∞ª¶ƒO™ ¡, ™Δ∞ÀƒOÀ ¶, ª∞¡Δ∑∞ƒ∏™ μ, ªOπƒ∞™ ¡, ª∞ƒ∞°°O™ ª, Ãπ™ΔO¢OÀ§O¶OÀ§O™ Ã, ™º∏∫∞∫∏™ ¶, ¢∞´∫O™ °. §È›‰È· ÙÔ˘ ÔÚÔ‡ Â› ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ ·ÙfiÌˆÓ ÌÂÙ¿ ÙËÓ Ï‹„ÈÓ ÂÓfi˜ ‰ÔÎÈÌ·ÛÙÈÎÔ‡ ÚÔÁ‡̷ÙÔ˜.
™ÙÔ: ¶Ú·ÎÙÈο 4Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ.
1978: 609-702.
730. ∫∞Δ™π§∞ª¶ƒO™ ¡, ª∞∫ƒÀ°π∞¡¡∏™ ∏, ºƒ∞°∫∞∫∏ ¢, ™Δƒ∞μO§∞πªO™ ™, ºπ§π¶¶π¢∏™ º.
∞ÓÔ¯‹ ÛÙË ÁÏ˘Îfi˙Ë Î·È ÈÓÛÔ˘ÏÈÓÔ¤ÎÎÚÈÛË Û ‰È·‚ËÙÈο ¿ÙÔÌ· ÌÂÙ¿ ÙËÓ ¯ÔÚ‹ÁËÛË Ï¢ΛÓ˘. ∞گ›· π·ÙÚ.
∂Ù·ÈÚÂÈÒÓ 1982; 8: 4-6.
731. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·ÈÙÔÏÔÁÈ΋ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ê¿ÙÔ˜ °, §·Ì·‰¿ÚÈÔ˜ ¢¡. ΔÂÏÂ˘Ù·›Â˜ ÂÍÂÏ›ÍÂȘ ÛÙËÓ ÎÏÈÓÈ΋ ‰È·ÙÚÔÊ‹
Î·È ÂȉËÌÈÔÏÔÁ›· ÙˆÓ ÓÔÛËÌ¿ÙˆÓ ‰È·ÙÚÔÊ‹˜. ™˘Ó¤‰ÚÈÔ ÁÈ· ÙȘ ÙÂÏÂ˘Ù·›Â˜ ÂÍÂÏ›ÍÂȘ ÛÙËÓ ÎÏÈÓÈ΋ ‰È·ÙÚÔÊ‹ Î·È ÙËÓ ÂȉËÌÈÔÏÔÁ›· ÙˆÓ ÓÔÛËÌ¿ÙˆÓ ‰È·ÙÚÔÊ‹˜ (1989: ∏Ú¿ÎÏÂÈÔ ∫Ú‹Ù˘). ∏Ú¿ÎÏÂÈÔ ∫Ú‹Ù˘:
¶·ÓÂÈÛÙ‹ÌÈÔ ∫Ú‹Ù˘, 1990: 118-35.
732. ∫∞Δ™π§∞ª¶ƒO™ ¡. ΔÚ›ÙË ËÏÈΛ· Î·È ÂÓ‰ÔÎÚÈÓÈÎfi
Û‡ÛÙËÌ·. ™ÙÔ: ¶Ú·ÎÙÈο ‰ÈÂıÓÔ‡˜ Û˘ÌÔÛ›Ô˘ ∂ÏÏËÓÔ-°ÂÚÌ·ÓÈÎÔ‡ ™˘Ó‰¤ÛÌÔ˘ «ΔÚ›ÙË ËÏÈΛ·». ∞ı‹Ó·,
1981: 173-81.
733. §π∞¶∏™ Ã, ™∂Ã∞™ ª, ¢Oμ∞™ ¡, ∏§πO¶OÀ§O™ ¢, μ∂ƒÀ∫O∫O™ Ã, çøƒO-°π∞¡-¡∏™ π,
ºπ§π¶¶π¢∏™ º, ∫∞Δ™π§∞ª¶ƒO™ ¡, ™∫∞§∫∂∞™ °. ∏ Â›‰Ú·ÛË Ù˘ ÌÈÎÚԂȷ΋˜ ¯ÏˆÚ›‰Ô˜ ÛÙËÓ
ÂͤÏÈÍË ÙÔ˘ ÂÍËÏΈ̤ÓÔ˘ ‰È·‚ËÙÈÎÔ‡ ¿ÎÚÔ˘. ™ÙÔ:
ΔfiÌÔ˜ ¶Ú·ÎÙÈÎÒÓ XVII ¶·ÓÂÏÏ‹ÓÈÔ˘ ™˘Ó‰ڛԢ
ÃÂÈÚÔ˘ÚÁÈ΋˜. ∞ı‹Ó·, 1990: (ÛÂÏ.?).
734. ∫∞Δ™π§∞ª¶ƒO™ ¡. ÀÔÁÏ˘Î·ÈÌ›· Î·È ıÂÚ·›·
ÙÔ˘ ‰È·‚‹ÙË Ù‡Ô˘ π. ™ÙÔ: ª·ÚÙÛfiη˜ Ù, ™È·Ê¿˜
∫, ¢ÂÏ‹˜ Ã. OÈ ÂÈÏÔΤ˜ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË
ÛÙ· ·È‰È¿ Î·È ÙÔ˘˜ ÂÊ‹‚Ô˘˜. ∞ı‹Ó·: ∂Ή. ∫. Î·È °.
∑ÂÚÌ›Ó˘, 1992: 15-8.
735. ∫∞Δ™π§∞ª¶ƒO™ ¡. H Ú·ÎÙÈ΋ ·ÓÙÈÌÂÙÒÈÛȘ
ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Î·Ù¿ Ù·˜ ¯ÂÈÚÔ˘ÚÁÈο˜
ÂÂÌ‚¿ÛÂȘ. ∞ı‹Ó·, 1974.
736. ∫∞Δ™π§∞ª¶ƒO™ ¡, ¶∞¶∞¢O¶OÀ§O™ °, Ã∞ƒ∞§∞ª¶O¶OÀ§O™ ∞, ™Δ∂ƒ°πøΔ∏™ π, ¢∞´∫O™ °. ÀÔÁÏ˘Î·ÈÌÈ΋ Â›‰Ú·ÛȘ Ù˘ ÙÚ˘ÙÔÊ¿Ó˘
Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ Î·È Ô˘Ú·ÈÌÈÎÒÓ ÂÈÚ·Ì·ÙÔ˙ÒˆÓ.
™ÙÔ: ∂ÂÙËÚ›˜ π·ÙÚÈ΋˜ ™¯ÔÏ‹˜ ∂ıÓÈÎÔ‡ ¶·ÓÂÈÛÙËÌ›Ô˘: ∂Ș ÌÓ‹ÌËÓ Î·ıËÁËÙÔ‡ μ·ÛÈÏ›Ԣ ª·Ï¿ÌÔ˘.
∞ı‹Ó·, 1976; ÙfiÌ. ∞′, 1976.
737. π∫∫O™ π, £∂O¢O™π∞¢∏™ °, ∫∞Δ™π§∞ª¶ƒO™
¡, ª∞´§§∏™ ∞, Δ∞™O¶OÀ§O™ Ã. EÈÏÔη›
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ (·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·, ÓÂÊÚÔ¿ıÂÈ·). ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο 1977;
39: 305-28.
738. ª∞∫ƒÀ°π∞¡¡∏™ ∏, μ∂ƒÀ∫O∫π¢OÀ ∂, ºƒ∞°∫∞∫∏ ¢, ª∞ƒ∞°°O™ ª, ∫OÀ§OÃ∂ƒ∏ ™, ∑∂ƒ∂ºO™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢∞´∫O™ °. ªÂÙ·‚ÔÏÈΤ˜ ÂȉڿÛÂȘ ÂÓfi˜ ·Ó·ÛÙÔϤˆ˜ Ù˘ ·-ÁÏ˘ÎÔÛȉ¿Û˘ ÛÂ Û˘Ó‰˘·ÛÌfi Ì ¤Ó· ‰ÔÎÈÌ·ÛÙÈÎfi ÚfiÁÂ˘Ì·
Û ‰È·‚ËÙÈÎÔ‡˜ ÙÔ˘ Ù‡o˘ ÙÔ˘ ÂÓËÏ›ÎÔ˘. ™ÙÔ: ΔÈÌËÙÈÎfi˜ ΔfiÌÔ˜ ηıËÁËÙÔ‡ ¡. ÃÚËÛÙ¤·. 1986: 255-60.
739. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∞ıËÚˆÁfiÓÔ˜ Â›‰Ú·ÛȘ Ù˘
‰È·ÙÚÔÊ‹˜. ¡ÂfiÙÂÚ· ÛÙÔȯ›·. ™ÙÔ: ΔfiÌÔ˜ ™ÂÌÈÓ·Ú›Ô˘ «¢È·ÁÓˆÛÙÈο Î·È ıÂÚ·¢ÙÈο ÚÔ‚Ï‹Ì·Ù· ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ» °ÂÓÈÎÔ‡ ¡ÔÛÔÎÔÌ›Ԣ ∞ıËÓÒÓ
§·˚Îfi. 1991: 77-9.
740. ∫∞Δ™π§∞ª¶ƒO™ ¡. º˘ÙÈΤ˜ ›Ó˜ Î·È ÁÏ˘Î·ÈÌÈÎfi˜
‰Â›ÎÙ˘ ÛÙË ‰›·ÈÙ· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. π·ÙÚÈÎfi μ‹Ì·
1992; (ÙfiÌ.?) 51-7.
741. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∂ÓÙ·ÙÈÎÔÔÈË̤ÓË ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·. ™ÙÔ: ΔfiÌÔ˜ ™ÂÌÈÓ·Ú›Ô˘ «¢È·ÁÓˆÛÙÈο ηÈ
107
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ıÂÚ·¢ÙÈο ÚÔ‚Ï‹Ì·Ù·-™‡Á¯ÚÔÓ˜ ·fi„ÂȘ» °ÂÓÈÎÔ‡ ¡ÔÛÔÎÔÌ›Ԣ ∞ıËÓÒÓ §·˚Îfi. 1991: 113-8.
742. KATSILAMBROS N. Acute illness at home and sick
day rules. Bulletin of the Mediterranean Group for
Study of Diabetes. 1993; iss.1: 14-5.
743. ∫∞Δ™π§∞ª¶ƒO™ ¡. OÍ›· ÓfiÛËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙÔ Û›ÙÈ. Focus 1992;
(ÙfiÌ.?): (ÛÂÏ.?).
744. ∫∞Δ™π§∞ª¶ƒO™ ¡. ∂ÚÁ·ÛÙËÚȷ΋ ‰È¿ÁÓˆÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Û·Î¯·Ú·ÈÌÈ΋ ηÌ‡ÏË. π·ÙÚÈÎfi μ‹Ì· 1993; 30: 42-3.
745. KATSILAMBROS N. Diabetes in elderly people.
Diabetes Reviews 1994; 4: 1-5.
746. KATSILAMBROS N. Prevention and early detection
of macroagiopathy in diabetics: Costs and benefits.
Bulletin of the Mediterranean Group for Study of
Diabetes. 1993; iss.V: 9-11.
747. KATSILAMBROS N. The public health importance
of non-insulin dependent diabetes mellitus. Diabetographia 1994; 19: 6-8.
748. T∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. ∫›ÚÚˆÛË ‹·ÙÔ˜ Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi˙˘. πÔÎÚ¿Ù˘
1995; 23: 9-16.
749. KATSILAMBROS N, SAVIOLAKIS A, PHILIPPIDES Ph, TSAKIRIS J, SISKOUDIS P, MANGLARA E, KARDARI A. Metabolic effects of chestnuts
in noninsulin-dependent diabetic persons. Role of the
way of cooking. Nutr Metab Cardiovasc Dis 1994; 4:
101-2.
750. VEVES A, UCCIOLI L, MANES Ch, VAN ACKER
K, KOMNINOU H, PHILIPPIDES PH, KATSILAMBROS N, DE LEEUW I, MENZIGER G,
BOULTON A. Comparison of risk factors for foot
problems in diabetic patients attenting teaching
Hospital Outpatient Department Clinics in four defferent European States. Diabet Med 1994; 11: 709-11.
751. ∫∞Δ™π§∞ª¶ƒO™ ¡, πø∞¡¡π¢∏™ π. §ÂÙ›ÓË - ÙÔ
̤ÏÏÔÓ ÛÙËÓ ·¯˘Û·ÚΛ·; π·ÙÚÈÎfi μ‹Ì· 1997; 51: 346.
752. ™∂∫∂ƒ∏ ∑, ª∞¡∂™ Ã, ¶∞¶∞∑O°§OÀ ¡. ¢È·‚‹Ù˘ Î·È Î‡ËÛË. ª·È¢ÙÈο Î·È °˘Ó·ÈÎÔÏÔÁÈο ÃÚÔÓÈο 1995; 2: 100-12.
753. KATSILAMBROS N, PHILIPPIDES PH, MANDA
M, MANGLARA-KATSILAMBROU E, SISKOUDIS P, SFIKAKIS P. Metabolic effects of tomato and
tomato juice in non-insulin dependent diabetics. Aktuel Ernährungsmed 1990; 15: 85-6.
754. CANDILOROS H, MULLER S, ZIEGLER O,
DONNER M, DROUIN P. Role of albumin glycation
on the erythrocyte aggregation: An in vivo study. Diabet Med 1996; 13: 646-50.
755. VEVES A, MANES CH, MURRAY H, YOUNG M,
BOULTON A. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993; 16:
1187-9.
108
756. VEVES A, MANES Ch, BOULTON A. Differences
in peripheral and autonomic nerve function measurements in painful and painless neuropathy: A clinical
study. Diabetes Care 1994; 17: 10: 1200-2.
757. ª∞ÀƒOª∞Δπ¢∏™ ∫, ™¶∞´∞ ™, Ãπ™Δπ¢OÀ º,
∑OÀª¶∞ƒπ¢∏™ ¡, μπ™μ∞ƒ¢∏™ °, Ã∞μ∞§∂ π,
μ∞°πø¡∞™ °. ŒÏÂÁ¯Ô˜ ÙˆÓ ÙÈÌÒÓ Ù˘ ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ ηٿ ÙËÓ ‰È¿ÚÎÂÈ· Ù˘ ·ÈÌÔοı·ÚÛ˘. °·ÏËÓfi˜ 1989; 31: 409-14.
758. Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OÀ ∞, ∞§∂•π∞¢∏™ ¢.
¢È·‚ËÙÔÏÔÁÈΤ˜ ªÔÓ¿‰Â˜-∫¤ÓÙÚ·. °·ÏËÓfi˜ 1994; 36:
647-52.
759. ∂À£ÀªπOÀ ∏. £ÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
°·ÏËÓfi˜ 1991; 33: 542-8.
760. ™∞ª∞ƒ∞-∫O∫∫∂μ∏ μ, Δ™OÀ°∫ƒ∞¡∏™ ∞,
Δ™πΔ∞ªπ¢OÀ ∑, ºÀΔπ§∏ Ã, ¶∞¶∞∑O°§OÀ ∞.
H ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌÔÛÊ·ÈÚ›ÓË (∞bA1c) Û ·ı‹ÛÂȘ ÙˆÓ Ó¢ÌfiÓˆÓ. °·ÏËÓfi˜ 1991; 33: 549-53.
761. ∫OÀΔ∞§∞™ ¶, °π∞¡¡O¶OÀ§O™ ∞. ™¯¤ÛË Ì·ÁÓËÛ›Ô˘ Ì ÈÓÛÔ˘Ï›ÓË Î·È Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1995; 68: 366-9.
762. GREAVES M, MALIA R, GOODFELLOW K,
MATTOCK M, STEVENS L, STEPHENSON J,
FULLER J, AND THE EURODIAB IDDM COMPLICATIONS STUDY GROUP. Fibrinogen and von
Willebrand factor in IDDM: Relationships to lipid vas
cular risk factors, bllod pressure, glycaemic control
and urinary albumin excretion rate: the EURODIAB
IDDM complications study. Diabetologia 1997; 40:
698-705. EURODIAB Investigators-Greece: Karamanos B, Tountas Ch, Kofinis A, Petrou K, Katsilambros N, Papazoglou N, Manes Ch, Scaragas G, Kontogiannis J.
763. ¡Oªπ∫O™ π. ∏ ÌÂÙ·ÌfiÛ¯Â˘ÛË ÓËÛȉ›ˆÓ ·ÁÎÚ¤·ÙÔ˜ ÛÙË ıÂÚ·›· ÙÔ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ‰È·‚‹ÙË. π·ÙÚÈ΋ 1989; 55: 560-5.
764. §∞ª¶ƒO¶OÀ§O™ §, ¶∂ΔƒO°π∞¡¡O¶OÀ§O™ ∫. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. μÂÏÙ›ˆÛ‹ Ù˘ ÌÂ
ÙÔ Ó¤Ô ·ÓÙȉȷ‚ËÙÈÎfi Ê¿ÚÌ·ÎÔ ÙÚÔÁÏÈÙ·˙fiÓË. π·ÙÚÈ΋
1996; 69: 568-73.
765. Δ∞™™O¶OÀ§O™ §. πÓÛÔ˘Ï›ÓˆÌ· ·ÁÎÚ¤·ÙÔ˜. π·ÙÚÈ΋ 1996; 69: 604-6.
766. ¢ƒO°∫∞ƒ∏ ∂, ª∞¡ø§∞∫∏™ ¡, ¡∞∫O¶OÀ§OÀ §, ª∞Δ™∞¡πøΔ∏™ ¡. °Ï˘ÎÔÁÔÓ›·ÛË Ù‡Ô˘
1·. π·ÙÚÈ΋ 1992; 62: 481-5.
767. ∞¡Δ∞ƒ∞∫∏ ∞, çOÀμ∂ƒ∞∫∏™ ∫. πÓÛÔ˘ÏÈÓÔıÂÚ·›·: ∏ ˘ÔηٿÛÙ·ÛË ÌÈ¿˜ Ê˘ÛÈ΋˜ ÔÚÌfiÓ˘ ηÈ
Ù· ÚÔ‚Ï‹Ì·Ù¿ Ù˘. π·ÙÚÈ΋ 1992; 61: 184-9.
768. ™Δƒ∞Δ∏°O™ π. ¢ÂÚÌ·ÙÔ¿ıÂȘ Â› ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ 1989; 56: 219-29.
769. ™Δƒ∞Δ∏°O™ π. ¢ÂÚÌ·ÙÈΤ˜ ·ÏÏÔÈÒÛÂȘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. Mat Med Greca 1987; 15: 3-13.
770. ∫OÀΔ∞§∞™ ¶. πÓÛÔ˘Ï›ÓË Î·È ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜.
π·ÙÚÈ΋ 1990; 58: 279-81.
771. ª∞Àƒπ∫∞∫∏™ ª, ∫O¡ΔO°π∞¡¡∏™ ™, ∞¡Δø-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
¡π∞¢OÀ §, ªπ∫∂¢∏™ ™, ∫O ¡ΔO°π∞¡¡∏™ ¢,
ª∂§∂Δ∏ Ã, ªOÀ§O¶OÀ§OÀ ¢. ∫ÏÈÓÈο ηÈ
‚ÈÔ¯ËÌÈο Â˘Ú‹Ì·Ù· ÛÙËÓ ·Û‚ÂÛÙÔÔÈfi ÂÚÈ·ÚıÚ›Ùȉ· ÙÔ˘ ÒÌÔ˘ ‰È·‚ËÙÈÎÒÓ Ù‡Ô˘ 2. π·ÙÚÈ΋ 1990; 57:
257-62.
772. ∞§∞ª∞¡O™ °, Δ™∞ª∞¡¢OÀƒ∞∫∏ ∫, ∫OÀΔ∏™ ∞, §πO¡∏™ Ã, ºπOƒ∂ΔO™ ª. ªÂϤÙË ÙˆÓ
ÂÈ¤‰ˆÓ ÙˆÓ ÏÈȉ›ˆÓ Î·È ÙÔ˘ ۷ί¿ÚÔ˘ ·›Ì·ÙÔ˜,
Ù˘ ·ÚÙËÚȷ΋˜ ›ÂÛ˘ Î·È ÙÔ˘ ‰Â›ÎÙË Ì¿˙·˜ ÛÒÌ·ÙÔ˜, Û Á˘Ó·ÈÎÂ›Ô ÏËı˘ÛÌfi ÂÓfi˜ ÔÚÂÈÓÔ‡ ‰‹ÌÔ˘ Ù˘
∫Ú‹Ù˘. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1993; 10: 167-70.
773. ¶∞¶∞´ø∞¡¡π¢∏™ ¢, μOÀ¢OÀƒ∏™ ∫, °πøΔ∏™
Ã, ∂À∞°°∂§OÀ ∞, μ∞§∫OÀª∞ ¢, ∫∞ƒ∞°π∞¡¡∏™ ¡, ∫O¡ΔO°π∞¡¡∏™ π. H ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌÔÛÊ·ÈÚ›ÓË (∏bA1) Û ÔÍ›˜ ÌÂı·ÈÌÔÚÚ·ÁÈΤ˜ ηٷÛÙ¿ÛÂȘ. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1986; 3: 133-6.
774. ª∏Δ§π∞°∫∞ ¶, °∂ƒª∞¡π¢∏™ °, ªOÀΔ™O¶OÀ§O™ Ã, ¶∞¶∞¢O¶OÀ§O™ °. ∏ Â›‰Ú·ÛË
Ù˘ ΢ÙÙ·ÚÔΛÓ˘ ÈÓÙÂÚÏ¢ΛÓ˘ 1‚ Â› Ù˘ ‚-ÓËÛȉÈÔ΢ÙÙ·ÚÈ΋˜ ÛÂÈÚ¿˜ RIN-5AH. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1991; 8: 178-85.
775. ª∞ƒπ¡∞∫∏™ £, ∑OÀ¶∞™ Ã, ¶∞¶∞¢∞∫∏ ª,
§OÀ∫O¶OÀ§O™ ¢. ªÂϤÙË Ù˘ ÌÂÙ·ÛÙÚÔÊ‹˜ ÙˆÓ
·Ï‡ÛÂˆÓ Ù˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ Û ÓÂÔÁÓ¿ ‰È·‚ËÙÈÎÒÓ
ÌËÙ¤ÚˆÓ. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1989; 6: 282-9.
776. ¶∞¡π¢∏™ ¢, ∫∞ƒ∞°π∞¡¡∏™ μ, ƒOÀ™™O™ ¢,
¶∞¶¶∞™ Ã, μ§∞™™∏™ °, ∫∞§O°∂ƒO¶OÀ§O™
∞. ÀÂÚ·Ó‰ÚÔÁÔÓ·ÈÌ›·, ÌÂÏ·Ó›˙Ô˘Û· ·Î¿ÓıˆÛË ÌÂ
·¯˘Û·ÚΛ·: Ó¤· ‰È¿ÛÙ·ÛË ÛÙË ‰Ú¿ÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. π·ÙÚÈ΋ 1989; 55: 203-7.
777. ∞£ÀƒO™ μ, ∫O¡ΔO¶OÀ§O™ ∞. ¢˘ÛÏÈȉ·ÈÌ›·
ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË: ™˘Û¯¤ÙÈÛË Ì ÙËÓ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ. ∂ÏÏËÓ. π·ÙÚÈ΋ 1995; 6: 413-25.
778. ∫∞ƒ∞ª∞¡O™ μ. º˘ÙÈΤ˜ ›Ó˜ Î·È ‰È·‚‹Ù˘.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1986; 3: 227-30.
779. ªÀ°¢∞§∏™ ∏, ºøΔO¶OÀ§OÀ ∞, ∑∞Ã∞ƒπ∞¢∏™ ¢, ∫∞§§πª∞¡∏™ °, ∫OÀƒΔ∏ ∞, ∫O¡ΔOÀ§π¢∏™ ∫. H ÌÂϤÙË Ù˘ Á·ÛÙÚÈ΋˜ ΤӈÛ˘
Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì ·˘ÙfiÓÔÌË Ó¢ÚÔ¿ıÂÈ·. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1994; 11:
93-8.
780. ¶∞À§∞ΔO™ º. ∫˘ÓËÁÒÓÙ·˜ ÙË ‰fiÍ·: ¶ÔÈfi˜ ÂÈÙ¤ÏÔ˘˜ ·Ó·Î¿Ï˘„ ÙËÓ ÈÓÛÔ˘Ï›ÓË; ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1994; 11: 139-44.
781. ∫O§πO¶OÀ§O™ π. ∏ ÚÔ‚ÏËÌ·ÙÈ΋ Ù˘ ‰È·‚ËÙÈ΋˜
·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜
1988; 5: 468-70.
782. ª¶∂¡ƒOÀª¶∏ ª. ¡¤· ÂÈÎÔÈÓˆÓȷο ÌÔÓ٤Ϸ
·fi ÙÔÓ ¯ÒÚÔ ÙÔ˘ ‰È·‚‹ÙË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜
1991; 8: 399-401.
783. ∫OÀ¡ΔOÀƒ∞™ π, Δ™∞¶∞™ °. ™˘Ó‰˘·ÛÌfi˜ ÓËÛÙ›·˜ Î·È ¯ÔÚËÁ‹Ûˆ˜ ÁÏԢηÁfiÓÔ˘ Ì ‹ ¯ˆÚ›˜ ıÂÔÊ˘ÏÏ›ÓË ÛÙË ¯ÚÔÓ›· Ë·ÙÈ΋ ÓfiÛÔ. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1989; 6: 43-5.
784. ™∏ºπ∞¡OÀ ¶. πÓÛÔ˘Ï›ÓË Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ÁÏ˘Îfi-
˙˘ ÙÔ˘ ·ÓıÚÒÈÓÔ˘ Ï·ÎÔ‡ÓÙ· in vitro. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 1991; 8: 343-7.
785. ª∞§OÀΔ∞™ ™. H ÂÊ·ÚÌÔÁ‹ ÙˆÓ ·ÎÙ›ÓˆÓ Laser
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ∂ÏÏËÓ. π·ÙÚÈ΋ 1994; 60: 118-23.
786. ¶∞¡π¢∏™ ¢, ™∫π∞¢O¶OÀ§O™ ™, ƒOÀ™™O™ ¢,
ºøΔπ∞¢∏™ ¡, ∫∞§O°∂ƒO¶OÀ§O™ ∞. H Â›‰Ú·ÛË Ù˘ ÊfiÚÙÈÛ˘ Ì ‰ÂÍÙÚfi˙Ë ÛÙ· ‚·ÛÈο Â›‰·
·Ó‰ÚÔÁfiÓˆÓ ·›Ì·ÙÔ˜ Ú›Ó Î·È Î·Ù¿ ÙËÓ ‰È¿ÚÎÂÈ· ¯ÔÚ‹ÁËÛ˘ ·ÓÙÈÛ˘ÏÏËÙÈÎÔ‡ Ê·ÚÌ¿ÎÔ˘. ∂ÏÏËÓ. π·ÙÚÈ΋
1994; 60: 320-30.
787. ∫∞ƒOÀ§∞™ Δ, §OÀƒπ¢∞™ °, ¶∞ƒ∞™∫∂À∞´¢∏™ ™, ¢OÀƒμ∞™ °, ∫∞ƒ∞°πøƒ°O™ ¢, ¶∞ƒÃ∞ƒπ¢∏™ °, ™ΔÀ§π∞¢∏™ π, ∂À£Àªπ∞¢∏™ °,
Δ™πºO¢∏ªO™ ¢. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ˆ˜ ÂÈ‚·Ú˘ÓÙÈÎfi˜ ·Ú¿ÁÔÓÙ·˜ ÛÙË ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ.
∂ÏÏËÓ. π·ÙÚÈ΋ 1996; 62: 138-43.
788. °ƒ∞ªª∞Δπ∫O™ º, ΔƒO¡Δ∑O™ ∫, ™∂ª∞ƒΔ∑π¢∏™ ∏, ¶∞¶¶∞™ ∫, μ§∞ªπ¢∏™ ∫, ∞ƒμ∞¡πΔ∞∫∏™ ∫. ∏ Û˘Ì‚ÔÏ‹ ÙÔ˘ ÓÂÊÚÔÁÚ¿ÌÌ·ÙÔ˜ Ì ‰È·Èı˘ÏÂÓÔ-ÙÚÈ¿ÌÈÓÔ-ÂÓÙ·ÔÍÈÎfi Ô͇-99m-Tc-DTPA ÛÙËÓ
ÂÎÙ›ÌËÛË Ù˘ ÓÂÊÚÔ¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. π·ÙÚÈ΋ 1992; 58: 3640.
789. ∫∞¶OÀ§∞™ ™, ∫∞ƒ∞ªOÀ∑∏™ ª, ™πOÀ§∏™ ∞,
°∫OÀΔ™∞ƒπ¢∏™ ¡, ∫Oƒ¢∞ΔO™ ¶, ¡π∫O§∞´¢∏™ ¶, ¢∏ª∏Δƒπ∞¢OÀ ∞, ΔOÀƒ∫∞¡Δø¡∏™
∞. πÓÛÔ˘Ï›ÓË Î·È ÎÔÏÈÎfi Ó·ÙÚÈÔ˘ÚËÙÈÎfi ÂÙ›‰ÈÔ (·ANP) ÛÙË ¯ÚÔÓ›· ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ·. ∂ÏÏËÓ. π·ÙÚÈ΋ 1992; 58: 242-7.
790. ∞£ÀƒO™ μ, ¶∞¶∞°∂øƒ°πOÀ ∞, ∞μƒ∞ªπ¢∏™
ª, ∫∞ƒ∞°π∞¡¡∏™ ∞, ∫O¡ΔO¶OÀ§O™ ∞, ∑∞ª¶OÀ§∏™ Ã. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Ù˘ Â›‰Ú·Û˘ Ù˘
·ÙÂÓÔÏfiÏ˘ Î·È ÌÔÈÓÙÔÏfiÏ˘ ÛÙ· Â›‰· Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÓËÛÙ›·˜ ÔÚÔ‡ Î·È ¿ÏϘ ‚ÈÔÏÔÁÈΤ˜ ·Ú·Ì¤ÙÚÔ˘˜ ·ÛıÂÓÒÓ Ì ȉÈÔ·ı‹ ˘¤ÚÙ·ÛË. ∂ÏÏËÓ. π·ÙÚÈ΋ 1992; 58: 395-406.
791. ƒOÀ™™O π, °∫∞Δ∑O§∞ ª, ª∞ÀƒOªπÃ∞§∏™ π,
∞°∞£O∫§∂OÀ™ ∫, μO°π∞Δ∑∏™ ¡. ™‡Ó‰ÚÔÌÔ
·˘ÙÔ¿ÓÔÛ˘ ÔÏ˘ÂÓ‰ÔÎÚÈÓÔ¿ıÂÈ·˜. ∂ÏÏËÓ. π·ÙÚÈ΋
1992; 58: 443-6.
792. πø∞¡¡π¢OÀ-¶∞¶∞°π∞¡¡∞∫∏ ∂, Ã∞ƒ∞§∞ª¶π¢OÀ-μƒ∞¡πΔ™∞ ™, ∫§ø¡π∑∞∫∏™ π, ∫O¡∫OÀƒ∏™ §. ∂›‰Ú·ÛË Ù˘ ÌÂÙ·‚ÔÏÈ΋˜ Ú‡ıÌÈÛ˘
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ÏÂÈÙÔ˘ÚÁÈÎfiÙËÙ· ÙˆÓ
·ÈÌÔÂÙ·Ï›ˆÓ. ∂ÏÏËÓ. π·ÙÚÈ΋ 1988; 54: 104-14.
793. ª¶∞™ΔOÀ¡∏™ ∏, ∫∞ƒ∞μ∞™π§∏™ π, Δƒπ∞¡Δ∞ºÀ§§OÀ ∞, §πOƒ¢OÀ ∞, ∫§∏ªO¶OÀ§O™ ™,
ª¶ƒ∞ª∏™ π, ¶∞¡∞°πøΔO¶OÀ§O™ π. ∏ ·ÁÎÚ·ÙÈ΋ ·-Ó·Á¤ÓÓËÛË: ÃÔÚ‹ÁËÛË Ú·‰ÈÂÓÂÚÁÔ‡ 5125-π-iodo-2-deoxy-uridine Û Â›Ì˘Â˜ Î·È ÚÔÛ‰ÈÔÚÈÛÌfi˜ ‚ÈÔ¯ËÌÈÎÒÓ ·Ú·Ì¤ÙÚˆÓ ·›Ì·ÙÔ˜ Î·È ÎÔÚ¿ÓˆÓ. ∂ÏÏËÓ. π·ÙÚÈ΋ 1988; 54: 121-6.
794. °∂ƒ∞™πªπ¢∏™ £, °∫ƒπª¶π∑∏™ °, Ã∞ƒ™OÀ§∏™ º, ¶∞Δ™π∞OÀƒ∞ ∫, ™ª¶∞ƒOÀ¡∏™ Ã. μ·Ú›· ˘ÔÁÏ˘Î·ÈÌ›· Î·È ˘ÂÚ¯ÔÏËÛÙÂÚÈÓ·ÈÌ›· Û ηÚ-
109
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
Λӈ̷ ÙÔ˘ ‹·ÙÔ˜ ·fi ‰È·˘Á‹ ·ÙÙ·Ú·. ∂ÏÏËÓ. π·ÙÚÈ΋ 1988; 54: 298-302.
795. ∫∞ƒ∞°∫πO∑O°§OÀ-§∞ª¶OÀ¢∏ £, ¡OÀ™π∞∞ƒμ∞¡πΔ∞∫∏ ™, ∞À°OÀ™Δπ¢OÀ-™∞μμO¶OÀ§OÀ ¶, ™∞§∂ª ¡, ¶O§Àª∂¡π¢∏™ ∑, ∫∞¡∞∫OÀ¢∏-Δ™∞∫∞§π¢OÀ º. ¶Úԉȷ‚ËÙÈÎÔ› ‰Â›ÎÙ˜
Û ·È‰È¿ Ì ÂÓÙÂÚÔ¿ıÂÈ· ·fi ˘ÂÚ¢·ÈÛıËÛ›· ÛÙË
ÁÏÔ˘Ù¤ÓË. ∂ÏÏËÓ. π·ÙÚÈ΋ 1991; 57: 111-7.
796. ¶∞¡π¢∏™ ¢, ƒOÀ™™O™ ¢, ™∫π∞¢O¶OÀ§O™ ™,
∫∞§O°∂ƒO¶OÀ§O™ ∞. ÀÂÚ·Ó‰ÚÔÁÔÓ·ÈÌ›· ˆ˜
·ÔÙ¤ÏÂÛÌ· Ù˘ ˘ÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›·˜: ª‡ıÔ˜ ‹ Ú·ÁÌ·ÙÈÎfiÙËÙ·; EÏÏËÓ. π·ÙÚÈ΋ 1995; 61: 457-67.
797. °∫OÀ¡∏ π, ∫∞ƒ∞°π∞¡¡O¶OÀ§OÀ °, ∫O¡Δπ∑∞™ °, Ã∞ƒ™OÀ§∏™ º, ¶∞¶∞¢∏ª∏ΔƒπOÀ ∫,
™ª¶∞ƒOÀ¡∏™ Ã. N¢ÚÔÂÓ‰ÔÎÚÈÓÈÎfi˜ fiÁÎÔ˜ ÙÔ˘
·ÁÎÚ¤·ÙÔ˜ Â› Û˘Ó‰ÚfiÌÔ˘ ÔÏÏ·Ï‹˜ ÂÓ‰ÔÎÚÈÓÈ΋˜
ÓÂÔÏ·Û›·˜ Ù‡Ô˘ 1. ∞Û˘Ìʈӛ· ·ÓÔÛÔÈÛÙÔ¯ËÌÈÎÒÓ
Î·È ÔÚÌÔÓÈÎÒÓ Â˘ÚËÌ¿ÙˆÓ. ∂ÏÏËÓ. π·ÙÚÈ΋ 1995; 61:
475-9.
798. ™∞¶π∫∞™ π, °∞ªμƒO™ O, ∞§∂Δƒ∞™ O. AÚÙËÚÈÔ¿ıÂÈ· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. °·ÏËÓfi˜ 1979; 21:
561-8.
799. ∫∞§O°∂ƒO¶OÀ§O™ ∞, °∫OΔ™∏™ ¡, ™ª∞ƒ∞°¢∏™ ™, ª¶∞∫∞Δ™∂§O™ ™. ∏ÏÂÎÙÚÔηډÈÔÁÚ·ÊÈη› ·ÏÏÔÈÒÛÂȘ ÂȘ ¿ÙÔÌ· ÌÂÙ¿ ÌË Ê˘ÛÈÔÏÔÁÈÎÔ‡ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ ˘‰·Ù·ÓıڿΈÓ. °·ÏËÓfi˜
1968; 10: 538-42.
800. ™Δ∞ÀƒO¶OÀ§O™ ∫, μ∞ªμ∞§∏™ Ã, Àæ∏§∞¡Δ∏™ ∫. H ·ÏÏËÏÂ›‰Ú·ÛȘ Ó¢ÌÔÓÈ΋˜ Ê˘Ì·ÙÈÒÛˆ˜ Î·È Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ˘fi ÙÔ Ú›ÛÌ· Ù˘
Û˘Á¯ÚfiÓÔ˘ ıÂÚ·¢ÙÈ΋˜. °·ÏËÓfi˜ 1968; 10: 338-46.
801. ∫O¡π¢∞ƒ∏™ ™. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË.
°·ÏËÓfi˜ 1984; 26: 1171-7.
802. ƒ∞§§∏™ ∞, μOÀ¢OÀƒ∏™ ∫, ª¶∞¡∞μ∞™ ∫,
∞¡ΔO™π¢∏™ ∫, ¶∞¶∞™Δ∂ƒ°πOÀ ™Δ, £øª∞´¢∏™ μ. ¢È·‚ËÙÈ΋ ·ÚıÚÔ¿ıÂÈ· Ù‡Ô˘ Charcot. °·ÏËÓfi˜ 1983; 25: 823-8.
803. Oπ∫O¡Oªπ¢∏™ ¶, ∞§∂•∞¡¢ƒπ¢∏™ ∞, °∂øƒ°π∞¢∏™ ¡, ™Δ∂ƒ°πOÀ °, ∫ø¡™Δ∞™ ¶. ∞ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Ì ʈÙÔËÍ›· Argon-Laser. ∂ÏÏËÓ. π·ÙÚÈ΋ 1985; 51: 202-7.
804. °π∞μƒO°§OÀ ∫. ¢È·‰ÂÚÌ·ÙÈÎfi˜ ‰ÈË·ÙÈÎfi˜ ηıÂÙËÚÈ·ÛÌfi˜ ÙˆÓ ·ÁÎÚ·ÙÈÎÒÓ ÊÏ‚ÒÓ. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘ Î·È ÚÔÂÁ¯ÂÈÚËÙÈ΋ ‰È¿ÁÓˆÛË
ÙˆÓ ÈÓÛÔ˘ÏÈӈ̿وÓ. ∂ÏÏËÓ. π·ÙÚÈ΋ 1985; 51: 229-34.
805. Ã∞ƒ™OÀ§∏™ º, °∂ƒ∞™πªπ¢∏™ £, μ§OΔπ¢∏™
π, ∂À£ÀªπOÀ ∏, μÀ∑∞¡Δπ∞¢∏™ ∞, ∫∂§∂∫∏™
§, ™ª¶∞ƒOÀ¡∏™ Ã. ÀÔÁÏ˘Î·ÈÌ›· ·fi ÈÓÛÔ˘Ï›ÓˆÌ·. ¢È¿ÁÓˆÛË Î·È ÂÁ¯ÂÈÚËÙÈ΋ ıÂÚ·›· (¶·Ú·ÙËÚ‹ÛÂȘ Û ÔÎÙÒ ·ÛıÂÓ›˜). ∂ÏÏËÓ. π·ÙÚÈ΋ 1984; 50:
123-32.
806. ™∫O¡¢ƒ∞ ª, REESE J, ∫OÀ¡ΔOÀƒ∏™ ¢,
™∫O¡¢ƒ∞™ ™. ¡ÔÛ‹Ì·Ù· ÙÔ˘ ÔÙÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜
Û ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. °·ÏËÓfi˜ 1986; 28: 21-5.
807. ª∞¡∞º∏ £, μ∏∫∞™ π. ∂ÌÊ¿ÓÈÛË ˘ÔÁÏ˘Î·ÈÌ›·˜
110
ÚÔÂÁ¯ÂÈÚËÙÈο Û ÓËÛÙÈο ·È‰È¿ Î·È Î›Ó‰˘ÓÔÈ ·fi
·˘Ù‹ ηٿ ÙËÓ ·Ó·ÈÛıËÛ›· Û øƒ§ Â¤Ì‚·ÛË. °·ÏËÓfi˜ 1983; 25: 419-22.
808. ∑∞μπΔ™∞¡∞∫∏™ ∞, ƒ∂´∑O°§OÀ ª, ¶∂ΔƒO¶OÀ§O™ ∞, ∫OÀ™π∞¡O™ ∫, ª∞ƒ∫∞¡Δø¡∞ΔO™ ∞. MÂÙ·‚ÔÏ·› Ù˘ ÙÈÌ‹˜ ÙÔ˘ ۷ί¿ÚÔ˘ ·›Ì·ÙÔ˜
Â› ·›‰ˆÓ ˘fi ÙËÓ Â›‰Ú·ÛÈÓ Ù˘ ÚÔÓ·ÚÎÒÛˆ˜,
ÁÂÓÈ΋˜ ·Ó·ÈÛıËÛ›·˜ Î·È ÂÁ¯ÂÈÚ‹Ûˆ˜. °·ÏËÓfi˜
1975; 17: 12-8.
809. ¢∏ª∏Δƒπ∞¢∏™ °, ƒ∞¶Δ∏™ ™. Δ¯ÓËÙfi ¿ÁÎÚ·˜: §ÂÈÙÔ˘ÚÁ›· Î·È ÎÏÈÓÈ΋ ÂÊ·ÚÌÔÁ‹. π·ÙÚÈ΋ 1986;
50: 449-56.
810. ∫O¡Δ∂™∏™ ¶. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ¶ÚÒÈ̘
ÂΉËÏÒÛÂȘ Î·È ıÂÚ·¢ÙÈ΋ ÚÔÛ¤ÁÁÈÛË. π·ÙÚÈ΋
1988; 54: 523-9.
811. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚ËÙÈ΋ ‰›·ÈÙ· Î·È ÚˆÙ›Ó˜. π·ÙÚÈ΋ 1988; 54: 325-6.
812. ª∞Àƒπ∫∞∫∏™ ª. ∂ΉËÏÒÛÂȘ ·fi ÙÔ ÂÚÂÈÛÙÈÎfi
Û‡ÛÙËÌ· ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1988; 54:
137-48.
813. ª∞Àƒπ∫∞∫∏™ ª, ∫∞ƒ§∏ π, ∫πΔΔ∞™ Ã, ∫O¡ΔO°π∞¡¡∏™ ¢, °π∞°π∞∫OÀ ∂, ªOÀ§O¶OÀ§OÀ ∂, ™∞ƒπ¢∞∫∏™ ¡. °Ï˘ÎÔ˙·ÌÈÓÔÁÏ˘Î¿Ó˜ Ô‡ÚˆÓ, ·ÚıÚÈÎÒÓ Î·È ÂÚÈ·ÚıÚÈÎÒÓ ÈÛÙÒÓ Û ÂÈÚ·Ì·ÙÈÎfi ‰È·‚‹ÙË ·fi ÛÙÚÂÙÔ˙ˆÙÔÛ›ÓË. π·ÙÚÈ΋ 1988; 54:
189-94.
814. ªOÀ¡ΔO∫∞§∞∫∏ £, μ∞ƒ¢∞∫∏ ª. ÀÂÚˆÛ̈ÙÈÎfiÓ ˘ÂÚÁÏ˘Î·ÈÌÈÎfiÓ ÌË ÔÍÔÓÈÎfiÓ ‰È·‚ËÙÈÎfiÓ ÎÒÌ·. ∂ÏÏËÓ. π·ÙÚÈ΋ 1971; 40: 838-43.
815. ¶π∂ƒƒ∞∫∞∫∏™ ™, °∫πOªπ™∏™ £, ¶∞§§∏∫∞ƒπ¢∏™ ¢, •∂¶∞¶∞¢∞∫∏™ °, ∫OÀμ∂§OÀ ª,
°∞ΔO™ ª, ºπ§π¶¶∞∫∏™ ª. ∏ ·Ó·ÏÁËÙÈ΋ ‰Ú¿ÛË
Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙËÓ ÔÍ›· ·ÁÎÚ·ٛÙȉ·. °·ÏËÓfi˜
1985; 27: 629-33.
816. Ã∞Δ™∂ƒ∞™ ¢, μ§∞ÃO°π∞¡¡∏™ ∂, μO™¡∞∫π¢∏™ £, μ§∞ÃO¢∏ª∏ΔƒO™ π, °∫OΔ™∏™ ¡. ∏
ÌÂϤÙË ÙÔ˘ ‰ÈÔÚıˆÌ¤ÓÔ˘ ‰È·ÛÙ‹Ì·ÙÔ˜ Q-T (Q-Tc) ÛÂ
·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ. °·ÏËÓfi˜ 1988; 30: 75-82.
817. ƒ∏°∞™ ∞. À‰·Ù¿ÓıڷΘ Î·È Ê˘ÙÈΤ˜ ›Ó˜ ÛÙË ‰›·ÈÙ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1987; 52: 307-18.
818. ¶∞¶∞¢O¶OÀ§O™ ∫, ™∞∫∞¡Δ∞ª∏™ °. ¶·ıÔÁÂÓÂÙÈΤ˜ ·fi„ÂȘ ÁÈ· ÙȘ ηډȷÁÁÂȷΤ˜ ÂÈÏÔΤ˜
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1987; 21: 1-6.
819. §∞¢∞™ ™, ƒO∫∫∞™ £, §∞ΔOÀº∏™ Ã, Ã∞Δ∑∏πø∞¡¡OÀ π, ƒ∞¶Δ∏™ ™, ÃOÀ™∂´¡ ª, ∫∞æ∞§∏™ ∞, ªπÃ∞∏§ ª, ∫∞™∫∞ƒ∂§∏™ °, ™¶∞¡O™
∏. À‰ÚÔ͢Ô˘Ï›ÓË Ô‡ÚˆÓ 24ÒÚÔ˘ Û ÂÈÚ·Ì·ÙÈÎfi
‰È·‚‹ÙË ·fi ÛÙÚÂÙÔ˙ˆÙÔÛ›ÓË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1987; 4: 43-5.
820. ÃO§∂μ∞™ ª, 𪶃π∞§O™ ¶, ƒ∞¶ΔO¶OÀ§OÀ-°π°∏ ª, ∫∞À∫π∞™ μ, °OÀ§∏™ °. ÀÂÚˆÛ̈ÙÈÎfiÓ ÎÒÌ· Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. °·ÏËÓfi˜
1973; 15: 764-72.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
821. ¶∞¶∞¢O¶OÀ§O™ ∫, §∂À∫O™ ¡, ∞°Oƒ∞™ΔO™
π, ∫Àƒπ∞∫O¶OÀ§O™ °, ∫O¡∫OÀƒ∏™ §. ¶Úfi‰ÚÔÌÔ˜ ·Ó·ÎÔ›ÓˆÛȘ Â› ÙˆÓ ıÂÚ·¢ÙÈÎÒÓ ÂÊ·ÚÌÔÁÒÓ ÙÔ˘ ÁÏ˘Î·ÁfiÓÔ˘ Â› ÙˆÓ Î·Ú‰È·ÎÒÓ ·ı‹ÛˆÓ.
°·ÏËÓfi˜ 1972; 14: 798-805.
822. ªOƒ∞§∏ ∞, °OÀ§∏™ °, ∫O¡∫OÀƒ∏™ §. ªÔÚÊÔÏÔÁ›· ÙÔ˘ ‚ÏÂÓÓÔÁfiÓÔ˘ ÙÔ˘ ÏÂÙÔ‡ ÂÓÙ¤ÚÔ˘ ·ÛıÂÓÒÓ ·Û¯fiÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. °·ÏËÓfi˜
1972; 14: 176-90.
823. °OÀ§∏™ °, ªOƒ∞§∏ ∞, ¶∞¡∞°πøΔO¶OÀ§O™
∂. K·ÚΛÓÔ˜ ·ÁÎÚ¤·ÙÔ˜. °·ÏËÓfi˜ 1969; 11: 65-9.
824. ™∂¡ΔOÀ∫∞™ ∞, °∞Δ™OÀ ª. ¡ÂÊÚÈÎfi˜ ‰È·‚‹Ù˘.
°·ÏËÓfi˜ 1969; 11: 99-111.
825. ¶∞¶∞¢∏ª∏ΔƒπOÀ °, ¡π∫O§∞´¢∏™ ∞, º∞§Δ™∏™ ™. OÛÙÈη› ·ÏÏÔÈÒÛÂȘ Ù˘ ÛÔÓ‰˘ÏÈ΋˜ ÛÙ‹Ï˘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. °·ÏËÓfi˜ 1977; 19:
637-43.
826. ∫∞¡π∞ƒ∏™ ¶, §∂∫∞∫∏™ ¢, ∫∞™Δ∞¡∞™ Δ. ¢È·Ù·Ú·¯·› ÙˆÓ ÂÈ¤‰ˆÓ ÙÔ˘ ۷ί¿ÚÔ˘ ÙÔ˘ ·›Ì·ÙÔ˜ ηٿ ÙËÓ ·Ó·ÈÛıËÛ›· ‰È· ıÂÈÔ‡¯Ô˘ ÂÓÙÔ‚·Ú‚ÈÙfiÏ˘.
°·ÏËÓfi˜ 1974; 16: 677-82.
827. ¶∞¶∞¡π∫O§∞OÀ ¡, μ∞§∞μ∞¡∏™ ∫, ∫∂™π¢∏™
¢. K‡ËÛȘ Î·È ‰È·‚‹Ù˘. °·ÏËÓfi˜ 1971; 13: 132-42.
828. ª¶OÀƒ∞ ¶, ƒ∞¶ΔO¶OÀ§OÀ-°π°∏ ª, Oƒº∞¡OÀ-∫OÀª∂ƒ∫∂ƒπ¢OÀ ∂. §ÂÈÙÔ˘ÚÁÈ΋ ÈηÓfiÙËÙ· ÙˆÓ ÂÚÈÊÂÚÈÎÒÓ ÔÏ˘ÌÔÚÊÔ˘Ú‹ÓˆÓ Î·È ÌÔÓÔ˘Ú‹ÓˆÓ ÛÙÔÓ ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. °·ÏËÓfi˜ 1986; 28: 810-6.
829. STUNVOLL M, MEYER C, MITRAKOU A, NADKARNI V, GERICH J. Renal glucose production and
utilization: new aspects in humans. Diabetologia
1997; 40: 749-57.
830. LAZARIDIS E, CHUNFU Q, KRAFT S, MARRENO D. Same eyes, different doctors: Differences diabetic retinopathy screening. Diabetes Care 1997; 20:
1073-7.
831. PETROGIANNOPOULOS E, ZACHAROF A.
Glibenglamide and liver disease. Letter to the editor.
Diabetes Care 1997; 20: 1215.
832. ∫O¡∫OÀƒ∏™ §, ÃO§∂μ∞™ ª, ¶∞¶∞¢O¶OÀ§O™ ∫, ∂À£Àªπ∞¢∏™ ¶, 𪶃π∞§O™ ¶. ¶·Ú·ÙËÚ‹ÛÂȘ Â› 435 ÂÚÈÙÒÛÂˆÓ ÎÏÈÓÈ΋˜ ÌÔÚÊ‹˜
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ™ÙÔ: ΔfiÌÔ˜ ÚÔ˜ ÙÈÌ‹Ó ÙÔ˘
ηıËÁËÙÔ‡ ∂˘ı. ™. ¶·Ó·ÁȈÙfiÔ˘ÏÔ˘. £ÂÛÛ·ÏÔÓ›ÎË,
1970: 5-15.
833. ¶∂Δƒπ¢∏™ ¶§, WEISS L, LOFFLER G, WIELAND O. π∫∫O™ ¢, ¶∞À§∞ΔO™ º. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘. 2Ë ¤Î‰ÔÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1974: 216 ÛÂÏ.
834. PHILOTHEOU A. Psychosocial issues associated
with diabetes in adolescents from underprivileged
populations in developing countries. IDF Bulletin
1996; 41: 10-6.
835. ∫∞ƒ∞ª∞¡O™ μ, ΔOÀ¡Δ∞™ Ã, °π∞ª∞§∏™ ¢,
∫∞ƒ∞°π∞¡¡∏ ¶, ∫§∂π™π∞ƒ∏™ μ, ∫OÀƒO-
°§OÀ ª, ∫OÀΔ™OÀª∞¡∏ π, ªÀ°¢∞§∏™ ∏,
¶∞¶¶∞™ ™, ÃÀ™∞¡£∏™ ∞. H ÙÚÔÔÔ›ËÛË Ù˘
·¤ÎÎÚÈÛ˘ ÏÂ˘ÎˆÌ·Ù›Ó˘ ÛÙ· Ô‡Ú· Ì ÙËÓ ¯ÔÚ‹ÁËÛË
·ÓÙ·ÁˆÓÈÛÙÒÓ ·Û‚ÂÛÙ›Ô˘ Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ 2 ÌÂ
˘¤ÚÙ·ÛË. ∞ÚÂÙ·›Ô˜ 1997; 1: 33-43.
836. ΔOÀ¡Δ∞™ Ã. ∞ÈÌÔÚÚÂÔÏÔÁÈΤ˜ ‰È·Ù·Ú·¯¤˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∞ÚÂÙ·›Ô˜ 1997; 1: 45-8.
837. Ã∏™ΔOª∞¡O™ ∞. ¶ÂÚ› Ù˘ ÂȉڿÛˆ˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘Â› Ù˘ ηٷÓÔÌ‹˜ ÙˆÓ ÂÓ Ùˆ ÔÚÒ ÙÔ˘ ·›Ì·ÙÔ˜ ÏÈ·ÚÒÓ ÂÓÒÛˆÓ. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 1929; 11:
1120.
838. Xƒ∏™ΔOª∞¡O™ ∞. ∞È Û¯¤ÛÂȘ ÌÂٷ͇ Ù˘ ÈÓÛÔ˘Ï›Ó˘ Î·È ·‰ÚÂÓ·Ï›Ó˘ ÂÓ Ùˆ ÔÚÁ·ÓÈÛÌÒ. Klin Woch
1931; 9: 839.
839. ¶∞¡∞°πøΔO¶OÀ§O™ ∂, Δ™OÀƒOÀ∫Δ™O°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™Ù, ∫∞™Δƒπ¡O™ ¶,
Ã∞Δ∑∏ ∞. AÈ ÌÂÙ·‚ÔÏ·› ÙÔ˘ ·ÓÔÚÁ¿ÓÔ˘ ʈÛÊfiÚÔ˘
ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ Î·ÙfiÈÓ ÂÓ‰ÔÊÏ‚›Ô˘ ¯ÔÚËÁ‹Ûˆ˜ ÁÏ˘Îfi˙˘.
™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢.
1960: 391.
840. ¶∞¡∞°πøΔO¶OÀ§O™ ∂, Δ™OÀƒOÀ∫Δ™O°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™Ù, ∫∞™Δƒπ¡O™ ¶,
Ã∞Δ∑∏ ∞. ∞È ÌÂÙ·‚ÔÏ·› ÙÔ˘ ·ÓÔÚÁ¿ÓÔ˘ ʈÛÊfiÚÔ˘
ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Î·È ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Â›
Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ Î·ÙfiÈÓ ÂÓ‰ÔÊÏ‚›Ô˘ ¯ÔÚËÁ‹Ûˆ˜ ÁÏ˘Îfi˙˘ Î·È ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢. 1961: 96.
841. ¶∞¡∞°πøΔO¶OÀ§O™ ∂, Δ™OÀƒOÀ∫Δ™O°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™Ù, ÃO§∂μ∞™ ª,
∫∞™Δƒπ¡O™ ¶, ªOÀ§OÀ¢∏™ ∫. AÈ ÌÂÙ·‚ÔÏ·›
ÙÔ˘ ·ÓÔÚÁ¿ÓÔ˘ ʈÛÊfiÚÔ˘ ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Î·È ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Â› ·Û¯fiÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ηÙfiÈÓ ÂÓ‰ÔÊÏ‚›Ô˘ ¯ÔÚËÁ‹Ûˆ˜ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢. 1963: 74.
842. ¶∞¡∞°πøΔO¶OÀ§O™ ∂, Δ™OÀƒOÀ∫Δ™O°§OÀ °, ª¶∞∫∞Δ™∂§O™ ™Ù, ∫∞™Δƒπ¡O™ ¶,
Ã∞Δ∑∏ ∞. ∞È ÌÂÙ·‚ÔÏ·› ÙÔ˘ ·ÓÔÚÁ¿ÓÔ˘ ʈÛÊfiÚÔ˘
ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ Î·È ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Â›
·Û¯fiÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ηÙfiÈÓ ÂÓ‰ÔÊÏ‚›Ô˘ ¯ÔÚËÁ‹Ûˆ˜ÁÏ˘Îfi˙˘. ™ÙÔ: ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢. 1963: 91.
843. ¶∞¶∞∏§πOÀ ∞. ¢È·‚‹Ù˘: ∂Ó·˜ ÙÚfiÔ˜ ˙ˆ‹˜.
∞ı‹Ó·: ∂ΉfiÛÂȘ ºÂϤÎË, 1980.
844. ∫§∂π™πOÀ¡∏™ ¡. ™˘Ì‚ÔÏ·› ÂȘ ÙÔÓ Ì˯·ÓÈÛÌfiÓ
Ù˘ ÂÓÂÚÁ›·˜ ÙˆÓ ÛÔ˘ÏÊÔÓ·ÌȉÈÎÒÓ ÂÓÒÛˆÓ. ∂›‰Ú·ÛȘ Â› Ù˘ ˙˘ıÔ˙‡Ì˘. ™ÙÔ: ¶Ú·ÎÙÈο ∞η‰ËÌ›·˜
∞ıËÓÒÓ. 1940; 15: 472.
845. ¶∞ƒ∞ƒ∞™ ª. §ÔÈÌÒÍÂȘ Û ·ÚÚÒÛÙÔ˘˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. Focus 1994; 60-61: 21-8, 62: 13-8.
846. ∑∂ƒμ∞™ π, ¢∞∫OÀ ∞, ¶∞¶∞¢∞∫∏™ °, ∫ø¡™Δ∞¡ΔO¶OÀ§O™ ∫, ¶∞À§∞ΔO™ º, º∂™™∞™
º. HLA ·ÓÙÈÁfiÓ· Â› ·Û¯fiÓÙˆÓ ·fi Ó·ÓÈÎfi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. πÔÎÚ¿Ù˘ 1981; 9: 365-9.
111
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
847. ™º∏∫∞∫∏™ ¶, Δ™∞Δ™∞ƒø¡∏™ ∞, ¢∞´∫O™ °.
™˘ÁÎÚÈÙÈ΋ ÂÎÙ›ÌËÛȘ ÙÔ˘ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ‚ËÙ·ÌÂı·˙fiÓ˘, 16-ÌÂı˘ÏÂÓÔ Ú‰ÓÈ˙ÔÏfiÓ˘ Î·È Ú‰ÓÈ˙ÔÏfiÓ˘ ˘ÂÚÁÏ˘¯·ÈÌÈÎÔ‡ ·ÔÙÂϤÛÌ·ÙÔ˜ ÂȘ ˘ÁÈ›˜.
πÔÎÚ¿Ù˘ 1977; 5: 205-10.
848. ∂À™Δƒ∞Δπ∞¢OÀ ª, ∫OÀΔ™∂§π¡∏ ∂, ªπÃ∞§∞™ ™, ¢∂ÀΔ∂ƒ∂μO™ ∂, §ø§∏™ ¢. ™˘¯ÓfiÙ˘
·ÙÚÔÊÈÎÒÓ ÎÔÏÈÎÒÓ ÂȯÚÈÛÌ¿ÙˆÓ Û ÂÌÌËÓÔ·˘ÛȷΤ˜ Á˘Ó·›Î˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. πÔÎÚ¿Ù˘
1978; 6: 33-8.
849. ∫øΔOÀ§∞™ O, PHILLIPS M. ∏ÏÂÎÙÚÔÓÈη›-ÌÈÎÚÔÛÎÔÈη› η› ÙÈÓ˜ ‚ÈÔ¯ËÌÈη› ·fi„ÂȘ Â› Ù˘ ÎÈÓËÙÔÔÈ‹Ûˆ˜ ÙÔ˘ Ë·ÙÈÎÔ‡ ÁÏ˘ÎÔÁoÓÔ˘. πππ. ªÂϤٷÈ
Â› ÙˆÓ ·ÔÙÂÏÂÛÌ¿ÙˆÓ Ù˘ ¯ÔÚËÁ‹Ûˆ˜ ÈÓÛÔ˘Ï›Ó˘.
Min Med Greca 1973; 1: 646-51.
850. ∫OÀΔƒ∞™ ¢, ∞¡∞¶§πøΔOÀ-μ∞™π§O¶OÀ§OÀ
ª, ª∞ƒ∫∂ΔO™ ™. ∏ Â›‰Ú·ÛË Ù˘ ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜
Â› ÙÔ˘ Û˘ÓÙÂÏÂÛÙÔ‡ ·ÊÔÌÔÈÒÛˆ˜ Ù˘ ÁÏ˘Îfi˙˘
(«k») ÙˆÓ ˘ÂÚı˘ÚÂÔÂȉÈÎÒÓ ·ÛıÂÓÒÓ. Min Med
Greca 1973; 1: 268-73.
851. ∫øΔOÀ§∞™ O, PHILLIPS M. ∏ÏÂÎÙÚÔÓÈη›-ÌÈÎÚÔÛÎÔÈη› η› ÙÈÓ˜ ‚ÈÔ¯ËÌÈη› ·Ú·ÙËÚ‹ÛÂȘ Â› Ù˘
ÎÈÓËÙÔÔÈ‹Ûˆ˜ ÙÔ˘ Ë·ÙÈÎÔ‡ ÁÏ˘ÎÔÁfiÓÔ˘. π. ªÂÏ¤Ù·È Â› ÙÔ˘ ÂÓ‰ÔÏ·ÛÌ·ÙÈÎÔ‡ ‰ÈÎÙ‡Ô˘, Ù˘ Û˘Û΢‹˜
ÙÔ˘ Colgi, ÙˆÓ ÂÓ‰ÔÌÈÙÔ¯ÔÓ‰ÚÈ·ÎÒÓ ÎÔÎΛˆÓ Î·È ÙˆÓ
Ï˘ÛÔۈ̿وÓ. Min Med Greca 1973; 1: 136-44.
852. KøΔOÀ§∞™ O, PHILLIPS M. ∏ÏÂÎÙÚÔÓÈη›-ÌÈÎÚÔÛÎÔÈη› η› ÙÈÓ¤˜ ‚ÈÔ¯ËÌÈÎ·È ·Ú·ÙËÚ‹ÛÂȘ Â› Ù˘
ÎÈÓËÙÔÈ‹Ûˆ˜ ÙÔ˘ Ë·ÙÈÎÔ‡ ÁÏ˘ÎÔÁfiÓÔ˘. ππ. ªÂϤٷÈ
Â› Ù˘ Û˘¯ÓfiÙËÙÔ˜ ÙˆÓ ÚÈ‚ÔÛˆÌ¿ÙˆÓ ÙˆÓ Û˘Ó‰Â‰ÂÌ¤ÓˆÓ ÚÔ˜ Ù·˜ ‰ÂÍ·ÌÂÓ¿˜ ÙÔ˘ ÎÔÎÎÈÒ‰Ô˘˜ ÂÓ‰ÔÏ·ÛÌ·ÙÈÎÔ‡ ‰ÈÎÙ‡Ô˘. Min Med Greca 1973; 1: 145-50.
853. ∫∞ƒ¶∞£πO™ ™, ª¶OΔ™∏™ ¢, °ƒ∏°OƒπOÀ O,
∫OÀΔ∏º∞ƒ∏™ μ. ¢È·‚‹Ù˘ Î·È Î‡ËÛȘ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1981; 7: 837-9.
854. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, ∑OÀ¶∞™ Ã, ∑∏ƒO°π∞¡¡∏™ ¶, ∫∞ƒ∞´™∫O™ ∫, ƒ∞¶Δ∏™ ™, ªOÀ§O¶OÀ§O™ ™. ∏ ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌÔÛÊ·ÈÚ›ÓË
∞1 Â› ÓÂÊÚÔ·ıÒÓ ˘fi ¯ÚÔÓ›·Ó ·ÈÌ·ÙÔοı·ÚÛÈÓ.
∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1981; 7: 689-93.
855. ∞¢∞ªO¶OÀ§O™ ¶, ∞¡£O¶OÀ§O™ §, Ã∞¡πøΔ∏™ ¢, ¶∞¶∞°∂øƒ°πOÀ °, ™∞∫∂§§∞ƒπOÀ
Δ, ªOÀ§O¶OÀ§O™ ™. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
Ô Â’ ·˘ÙÔ‡ ÂÈÔÏ·ÛÌfi˜ Ù˘ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘ ηÈ
ÙˆÓ ÚԉȷıÂÛÈÎÒÓ Ù˘ ·Ú·ÁfiÓÙˆÓ Â› ÙˆÓ ∞ıËÓ·›ˆÓ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1981; 7: 319-24.
856. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, ∞•∞ƒ§∏ ∫, ∫∞ƒ∞´™∫O™ ∫, ∑OÀ¶∞™ Ã, ƒ∞¶Δ∏™ ™, ªOÀ§O¶OÀ§O™ ™. ¶·Ú·ÌÔÚʈÙÈÎfiÙ˘ ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ› ˆÓ Â› ‰È·‚ËÙÈÎÒÓ ÌÂÙ¿ ‹ ¿Ó¢ ·ÔÊÚ·ÎÙÈ΋˜ ·ÚÙËÚÈÔ·ı›·˜ Î·È Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfïÓ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1981; 7: 396-402.
857. ¢OÀμ∞ƒ∞-¶∞¶∞ƒ∏ °, ¶πΔ™π°∞À¢∞∫∏ ∂, ¶∞¶∞¢∞∫∏-ª¶∂£ÀªOÀΔ∏ ∞. ∞ÔÌfiÓˆÛȘ ·ÂÚÔ‚›Ô˘ ·ÎÙÈÓÔÌ˘ÎËÙÈ·ÎÔ‡ ÂȘ ·ÛıÂÓ‹ Ì ‰È·‚‹ÙËÓ.
∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1982; 8: 189-93.
112
858. ΔOÀƒ∫∞¡Δø¡∏™ ∞, º∞ƒª∞∫πøΔ∏™ ∞, §∞∑∞ƒπ¢∏™ ∞, Ã∞ªOÀƒ∞Δπ¢∏™ ¡, ¶OÀƒ¡∞ƒ∞™
π. £ÂÚ·›· ÙÔ˘ ʈÛÊ·ÙÔ˘ÚÈÎÔ‡ ‰È·‚‹ÙË ÙˆÓ ÂÓËÏ›ÎˆÓ Ì ÙËÓ 1·-˘‰ÚÔ͢¯ÔÏËηÏÛÈÊÂÚfiÏË. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1978; 4: 472-3.
859. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, ∫∞ƒ∞´™∫O™ ∫, MANDEL R, ƒ∞¶Δ∏™ ™, ªOÀ§O¶OÀ§O™ ™. ∏ ‚ıÚÔÌ‚ÔÛÊ·ÈÚ›ÓË Â› ‰È·‚ËÙÈ΋˜ ·ÔÊÚ·ÎÙÈ΋˜ ·ÚÙËÚÈÔ¿ıÂÈ·˜ ÙˆÓ Î¿Ùˆ ¿ÎÚˆÓ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈˆÓ 1983; 9: 9-15.
860. SUTHERLAND D, ™¶∞¡O™ ¶, SIMMONS R,
KJELLSTRAND C, NAZARI AN J. ∞È ÌÂÙ·ÌÔۯ‡ÛÂȘ ÓÂÊÚÒÓ Â› ·ÛıÂÓÒÓ ÌÂÙ¿ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ·ı›·˜. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1978; 4: 195-203.
861. Δ™π∞¡O™ ∂, ™Δ∞£∞∫∏™ ¡, °∞ƒ¢π∫∞™ ∫. ∂Ó‰Ô·ÁÁÂȷ΋ ‹ÍȘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ∞گ›·
π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1979; 5: 619-24.
862. ¢∞ƒ™π¡O™ π, ∫ø™ΔO¶OÀ§O™ Ã, ¶∞¶∞¡∞°πøΔOÀ ™, ¶π™Δ∂ÀO™ ∞, ªOÀ§O¶OÀ§O™ ™.
™˘¯ÓfiÙËÙ· ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ Û 1.000 ÛÙÂÊ·ÓÈ·›Ô˘˜ ·ÚÚÒÛÙÔ˘˜ Î·È Â›‰Ú·ÛË ÙÔ‡ÙÔ˘ ÛÙËÓ ÎÏÈÓÈ΋
ÂΉ‹ÏˆÛË. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1982; 8: 405-9.
863. Δƒπ¶O§πΔ∏™ ∞, BEACH K, STRANDNESS D. ∏
‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· Î·È Ë ·ÔÊÚ·ÎÙÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ· Â› ‰È·‚‹ÙÔ˘. À¿Ú¯ÂÈ ·ÏÏËÏÂÍ¿ÚÙËÛȘ ‹ ·ÏÏËÏÂ›‰Ú·ÛȘ; ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1981; 7: 42-5.
864. ∑OÀ¶∞™ Ã, ∑∏ƒO°π∞¡¡∏™ ¶, ∫∞ƒ∞´™∫O™ ∫,
ƒ∞¶Δ∏™ ™. ΔÔ ÂÚÈÙfiÓ·ÈÔÓ ˆ˜ ÛËÌ›ÔÓ ·ÔÚÚÔÊ‹Ûˆ˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘ ·Ô‰ÂÈÎÓ˘Ô̤ÓÔ˘ ‰È· ÙÔ˘ Ù¯ÓËÙÔ‡ ·ÁÎÚ¤·ÙÔ˜. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1980; 6: 1922.
865. ªπÃ∞§O¶OÀ§O™ ¡, ΔOÀ¡Δ∞™ ¡, ™∫§∂π¢∏™
¢, ¶∂ΔƒOÃ∂π§O™ ª, £∞§∞™™π¡O™ ¡. OÊı·ÏÌÔÏÔÁÈο Â˘Ú‹Ì·Ù· Â› ÂÏÏ‹ÓˆÓ ‰È·‚ËÙÈÎÒÓ Î·È ÌÂÙ·‚ÔÏ·› ·˘ÙÒÓ ÂÓ Û¯¤ÛÂÈ Ì ÙËÓ Ú‡ıÌÈÛÈÓ ÙÔ˘ ‰È·‚‹ÙÔ˘ ÙˆÓ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1979; 5: 570-2.
866. ∫OTOULAS O, HO J, ADACHI F, WEIGENSBERG B, PHILLIPS M. Fine structural aspects of the
mobilization of hepatic glycozen. II. Inhibition of
glycogen breakdown. Am J Pathol 1971; 63: 23-6.
867. KOTOULAS O, PHILLIPS M. Fine structural aspects of the mobilization of hepatic glycogen. I. Acceleration of glycogen breakdown. Am J Pathol 1971;
63: 1-22.
868. KOTOULAS O, PHILLIPS M. Observations on glycogen-containing cytolysomes in postnatal rat hepatocytes. Am J Pathol 1970; 59: 84a-5a.
869. ∫øΔOÀ§∞™ O, PHILLIPS M. ÀÂÚ‰ÔÌÈη› ÌÂÙ·‚ÔÏ·› ÙÔ˘ Ë·ÙÈÎÔ‡ ΢ÙÙ¿ÚÔ˘ ηÙfiÈÓ ¯ÔÚËÁ‹Ûˆ˜
ÁÏ˘Îfi˙˘, ÂÚÁÔÙ·Ì›Ó˘ ‹ ÁÏ˘Îfi˙˘ ÌÂÙ¿ Ô˘ÚÔÌ˘Î›Ó˘ ÂȘ Â›Ì˘˜. Min Med Greca 1973; 1: 17.
870. ƒ∞¶Δ∏™ ™. EıÓÈÎfi ∫¤ÓÙÚÔ ŒÚ¢ӷ˜, ¶ÚfiÏ˄˘
Î·È £ÂÚ·›·˜ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÙˆÓ ÂÈÏÔÎÒÓ ÙÔ˘ (∂.∫∂.¢π.). π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 1997;
2: 12-3.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
871. ∞¡¢ƒ∂∞¢∏™ ¶, ∞ƒ∂∞§∏™ ∂, °∏Δ∞™ Ã. ∂ÎÙÂٷ̤ÓÔÓ ˘ÔÙÚÔÈ¿˙ÔÓ ˘Ô‰fiÚÈÔÓ ÂÌʇÛËÌ· ·ÁÓÒÛÙÔ˘ ·ÈÙÈÔÏÔÁ›·˜. °·ÏËÓfi˜ 1980; 22: 100-4.
872. μπΔøƒ∞ΔO™ ¡, ∫∞§O°∏ƒOÀ ¢, ÃÀ™π∫O¶OÀ§O™ ∞, ™∞§∞ª∞§∂∫∏™ ∂, ∫OÀΔ∏º∞ƒ∏™ μ. ∞‰Âӈ̷Ù҉˘-·‰ÂÓÔ΢ÛÙÈ΋ ˘ÂÚÏ·Û›·
ÙÔ˘ ÂÓ‰ÔÌËÙÚ›Ô˘ Â› ÂÌÌËÓÔ·˘ÛÈÎÒÓ ‹ ÌÂÙÂÌÌËÓÔ·˘ÛÈÎÒÓ Á˘Ó·ÈÎÒÓ Î·È Ï·Óı¿ÓˆÓ ‰È·‚‹Ù˘. °·ÏËÓfi˜ 1983; 25: 116-24.
873. X§OÀμ∂ƒ∞∫∏™ ∫. ¶·ıÔÊ˘ÛÈÔÏÔÁ›· Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. OÊı·ÏÌÔÏÔÁ›· 1992;
4: 150-5.
874. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, Ã∞ƒπΔO™ ¢, ƒ∞¶Δ∏™
™. ∂ÍÂÏÎÒÛÂȘ Î·È ÏÔÈÌÒÍÂȘ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡:
Û‡Á¯ÚÔÓË ‰È·ÁÓˆÛÙÈ΋ ÚÔÛ¤Ï·ÛË Î·È ıÂÚ·¢ÙÈ΋
·ÓÙÈÌÂÙÒÈÛË. π·ÙÚÈÎfi μ‹Ì· 1994; 6: 26-32.
875. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫. ¢È¿ÁÓˆÛË Î·È
·ÓÙÈÌÂÙÒÈÛË ÙˆÓ ‰È·Ù·Ú·¯ÒÓ ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÏÈȉ›ˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ∫·Ú‰ÈÔÏ.
∂ÈıÂÒÚËÛË 1994; 35: 132-8.
876. £∞§∞™™π¡O™ ¡. ŒÏÂÁ¯Ô˜ Î·È ·˘ÙÔ¤ÏÂÁ¯Ô˜ ÙÔ˘
‰È·‚ËÙÈÎÔ‡. π·ÙÚÈ΋ 1984; 45: 185-6.
877. ∫Oª∂™π¢OÀ-ª∞°∫§∞ƒ∞ μ. ¢›·ÈÙ· Î·È ‰È·‚‹Ù˘. π·ÙÚÈÎfi μ‹Ì· 1991; 10: 55-9.
878. ∫ƒ∞™™∞™ °, ∑π∞¡¡∞™ π, ∫O´O™ °, Δ∑∂Δ∑∏™ μ,
º∞§Δ™∏™ ™. ∏ ·¿ÓÙËÛȘ Ù˘ ·˘ÍËÙÈ΋˜ ÔÚÌfiÓ˘
Î·È Ù˘ ÚÔÏ·ÎÙ›Ó˘ ÂȘ ÙËÓ ‰ÔÎÈÌ·Û›·Ó TRH Â› ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ, ÚÔ Î·È ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ‚ÚˆÌÔÂÓÂÚÁÔÎÚ˘Ù›Ó˘. Mater Med Greca 1985; 13: 400-4.
879. ª∞Àƒπ∫∞∫∏™ ª, ∫∞ƒ§∏ π, ∫πΔΔ∞™ Ã, ∫O¡ΔO°π∞¡¡∏™ ¢, °π∞°π∞∫OÀ ¢, ªOÀ§O¶OÀ§OÀ ∂, ™∞ƒπ¢∞∫∏™ ¡. °Ï˘ÎÔ˙·ÌÈÓÔÁÏ˘Î¿Ó˜ Ô‡ÚˆÓ, ·ÚıÚÈÎÒÓ Î·È ÂÚÈ·ÚıÚÈÎÒÓ ÈÛÙÒÓ Û ÂÈÚ· Ì·ÙÈÎfi ‰È·‚‹ÙË ·fi ÛÙÚÂÙÔ˙ˆÙÔÛ›ÓË. π·ÙÚÈ΋ 1988; 54:
189-93.
880. ªπÃ∞§O¶OÀ§O™ ∂, °∞ƒΔ∞°∞¡∏™ ™, ª∂§∞ π,
∫∞™™∞ƒ∞™ ∞, ¶∞À§OÀ ∫. ¶·Ú·ÙËÚ‹ÛÂȘ ÛÙËÓ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· ÚÔˆÚfiÙËÙ·˜. OÊı·ÏÌÔÏÔÁ›· 1992; 4: 156-9.
881. ¶∞¶∞¢∏ª∏ΔƒπOÀ-¶∞¶∞∫ø™Δ∞ §. ∞Ó·ÈÛıËÛ›· ÛÙÔÓ ‰È·‚ËÙÈÎfi ¿ÚÚˆÛÙÔ. π·ÙÚÈÎfi μ‹Ì· 1990; 12:
61-4.
882. ¶∞¶∞∂ªª∞¡OÀ∏§ μ, ∫∞ƒ∞°π∞¡¡O¶OÀ§O™ ™, ∞§∂•πOÀ £, §O´∑O™ ∂, ™ΔÀ§π∞¡∂∞ºOÀ¡ΔOÀ§∞∫∏ ∞. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ ÙˆÓ ÂÈ¤‰ˆÓ
Ù˘ ÊÈÌÚÔÓÂÎÙ›Ó˘ ÛÙÔ Ï¿ÛÌ· ·ÛıÂÓÒÓ Ì ‰È·‚ËÙÈ΋ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. ¢ÂÏÙ›Ô ∂ÏÏËÓ. ªÈÎÚÔ‚. ∂Ù·ÈÚ›·˜ 1990; 35: 349-56.
883. ¶∞¶¶∞-Oπ∫O¡Oªπ¢OÀ ¶, ¶∞ƒ§∞¶∞¡∏™ ∞,
¶∞ƒ§∞¶∞¡∏ ∞, μ§∞´∫π¢∏™ ¡, ∫∞ƒ§Oμ∞™πΔOÀ-∫O¡π∞ƒ∏ ∞. ∏ ÂÎÙ›ÌËÛË Ù˘ Ù·¯‡ÙËÙÔ˜ ·ÁˆÁ‹˜ ÛÙ· ÎÂÓÙÚÈο ÙÌ‹Ì·Ù· ÙˆÓ ÂÚÈÊÂÚÈÎÒÓ Ó‡ڈÓ
Û ‰È·‚ËÙÈÎÔ‡˜ Î·È ·ÏÎÔÔÏÈÎÔ‡˜ ·ÛıÂÓ›˜. °·ÏËÓfi˜
1996; 38: 176-82.
884. ¶∞¶¶∞™ ™. ™˘Ó¯È˙Ô̤ÓË ÚˆÙÔ‚¿ıÌÈ· ÊÚÔÓÙ›‰·
ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜ ÛÙÔ Â͈ÙÂÚÈÎfi ‰È·‚ËÙÔÏÔÁÈÎfi È·ÙÚ›Ô. OÈÎÔÁÂÓÂȷ΋ °ÂÓÈ΋ π·ÙÚÈ΋ 1992; 1:
19-24.
885. ¶∞™Ã∞§π¢∏™ £, ∫∞¡∂§§∞™ ¢, ª∏¡∞∫∞∫∏™ ¶, ¶∞ƒOÀ™∏™ ¶, º∂μƒ∞¡O°§OÀ ∂, Δ™πª¶π¢∞™ ¶. ∞ÓÙÈÌÂÙÒÈÛË ÂÛÙÈ·ÎÔ‡ ‹ ‰È¿¯˘ÙÔ˘ Ôȉ‹Ì·ÙÔ˜ Ù˘ ˆ¯Ú¿˜ Ì Argon Laser ʈÙÔËÍ›· ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. OÊı·ÏÌÔÏÔÁ›· 1993; 5: 51-5.
886. TOELLER M, BUYKEN A, HEITKAMP G,
BRAMSWIG S, MANN J, MILNE R, GRIES F,
KEEN H, the EURODIAB IDDM COMPLICATIONS STUDY GROUP. Protein intake and urinary
albumin excretion rates in the EURODIAB IDDM
Complications Study. Diabetologia 1997; 40: 1219-26.
EURODIAB Investigators-Greece: B. Karamanos,
Ch. Tountas, A. Kofinis, K. Petrou, N. Katsilambros,
D. Roussi-Penessi, N. Papazoglou, M. Goutzourela,
Ch. Manes.
887. ™πø¡ ª, ∑πOÀΔ∞™ °, ¶Àƒ¶∞™O¶OÀ§O™ ª,
Δ™OÀƒOÀ∫Δ™O°§OÀ °. ∂›‰Ú·ÛË Ù˘ ηÙÔÚ›Ï˘ ÛÙË ÏÂ˘ÎˆÌ·ÙÔ˘Ú›·, ÛÙËÓ ·ÚÙËÚȷ΋ ›ÂÛË, ÛÙ·
Â›‰· ÁÏ˘Îfi˙˘ Î·È ÛÙË ÓÂÊÚÈ΋ ÏÂÈÙÔ˘ÚÁ›· ‰È·‚ËÙÈÎÒÓ ·ÚÚÒÛÙˆÓ Ì ˘¤ÚÙ·ÛË Î·È ÓÂÊÚÔ¿ıÂÈ·.
∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 1989; 1: 75-81.
888. ™TAM∞Δ∏™ ¢, μÀ™™OÀ§∏™ °, ª¶O¡øƒ∏™ ¶,
ΔOÀΔOÀ∑∞™ ¶, ƒπ∑∞-™Δ∞ª∞Δ∏ ¡, ∫∞ƒOÀΔ™O™ ∫. μ˘ıÔÛÎÔÈΤ˜ ·ÏÏÔÈÒÛÂȘ Û ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜ Ì ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË. Mater Med Greca
1983; 11: 253-6.
889. ™Δ∂º∞¡πøΔOÀ ª, ¶∞™Ãπ¢∏™ ∫, Ãπ™ΔO¢OÀ§OÀ ∞, æÀ§§∞™ ∫. ∫Ú˘ÔËÍ›· Û ÂÓ‰Ô¸·ÏÔÂȉÈ΋ ·ÈÌÔÚÚ·Á›· Â› ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. OÊı·ÏÌÔÏÔÁ›· 1994; 6: 75-9.
890. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ™Δ∂ƒ°πOÀ ¶, ∫∞ƒ∞°π∞¡¡π¢∏™ Ã, Ã∏™Δ∞∫∏ ∂, ¶∞¶∞¶O™ΔO§OÀ ∞. Ÿ„ÈÌ· ·ÔÙÂϤÛÌ·Ù· Ù˘ Laser ʈÙÔËÍ›·˜ ÛÙÔ ‰È¿¯˘ÙÔ ‰È·‚ËÙÈÎfi Ô›‰ËÌ· Ù˘ ˆ¯Ú¿˜.
OÊı·ÏÌÔÏÔÁ›· 1993; 5: 47-50.
891. Δ™πƒOÀ ª, ∫À¶ƒπ∞¡OÀ Ã, ¶O§À¢øƒπ¢∏™ °,
ΔOÀƒªOÀ∑∏™ ∞, ™°OÀƒO™ °. Δ· ·ÔÙÂϤÛÌ·Ù·
Ù˘ ÙÚÔÔÔÈË̤Ó˘ Û ۯ‹Ì· «‰ÈÎÙ‡Ô˘» ʈÙÔËÍ›·˜
Ì Green Argon Laser ÛÙÔ ‰È¿¯˘ÙÔ ‰È·‚ËÙÈÎfi Ô›‰ËÌ·
Ù˘ ˆ¯Ú¿˜. OÊı·ÏÌÔÏÔÁ›· 1993; 5: 41-6.
892. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ∏ ¿ÛÎËÛË Â› ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Û ۯ¤ÛË Ì ÙËÓ ÔÛÙÂÔfiÚˆÛË. OÛÙÔ‡Ó
1994; 5: 235-6.
893. Ãøƒ∂ª∏ ∂, £∞§∞™™π¡O™ ¡, Δ∂ƒ∑O°§OÀ ∫,
ΔOÀ¡Δ∞™ ¡, Oπ∫O¡Oªπ¢OÀ π. ∞˘ÙÔ·ÓÙÈÛÒÌ·Ù· ¤Ó·ÓÙÈ ÙˆÓ Î˘ÙÙ¿ÚˆÓ ÙˆÓ ÓËÛȉ›ˆÓ ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ 1981; 39: 515-8.
894. æÀ§§∞™ ∫. ΔÔ Ô›‰ËÌ· Ù˘ ˆ¯Ú¿˜ ÛÙÔÓ ‰È·‚‹ÙË.
OÊı·ÏÌÔÏÔÁ›· 1989; 1: 78-87.
895. ™Δ∂º∞¡πøΔOÀ ª, ∞™¶πøΔ∏™ ª, °Oƒ°O§∏™
™, æÀ§§∞™ ∫. ¶ÚˆÙfiÎÔÏÏÔ Î·Ù·ÁÚ·Ê‹˜ Î·È ıÂÚ·›·˜ Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Û‡Ì-
113
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ʈӷ Ì ÙËÓ E.A.S.D.E.C. OÊı·ÏÌÔÏÔÁ›· 1994; 6:
368-72.
896. μÀ™™OÀ§∏™ °, ™OÀΔO™ ¢, ™Δ∞ª∞Δ∏™ ¢,
Oƒº∞¡π¢∏™ ∑, ª¶∞™πOÀ∫∞™ ¶, ∫∞ƒOÀΔ™O™
∫. ¶·Ú¿ÌÂÙÚÔÈ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ Î·È ÌË ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. °·ÏËÓfi˜
1983; 25: 504-10.
897. ª¶§∞Δ™πO™ μ, ª¶OÀƒO™ ¢. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË Î·È ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ÌË ÂÍ·ÚÙÒÌÂÓÔ˘ ·fi ÙËÓ
ÈÓÛÔ˘Ï›ÓË Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1984; 18: 91-5.
898. ª¶OÀ§OÀ∫O™ ∞, §π∞¶∏-∞¢∞ªπ¢OÀ °, Ã∞Δ∑∏™ ¢, ¢∞¡∞§∞ΔO™ ∞, ª¶∞ƒΔ™O∫∞™ Ã.
∂›‰Ú·ÛË Ù˘ ‚ÈÙ·Ì›Ó˘ ∂ ÛÙÔ˘˜ ˘ԉԯ›˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÙˆÓ ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ ÈÓ‰ÈÎÒÓ ¯ÔÈÚȉ›ˆÓ in vivo. Mater Med Greca 1987; 15: 487-93.
899. DIMITRIADIS G, HATZIAGELAKI E, LADAS S,
LINOS A, HILLEBRAND I, RAPTIS S. Effects of
prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients
with insulin-dependent diabetes mellitus. Europ J
Clin Invest 1988; 18: 33-8.
900. ªÀ°¢∞§∏™ ∏, WATKINS P. ∏ ÂÎÙ›ÌËÛË ÙÔ˘ ‚·ıÌÔ‡ ¢·ÈÛıËÛ›·˜ ÛÙËÓ ·ÓÙ›ÏË„Ë ‰È·ÊÔÚ¿˜ ıÂÚÌÔÎÚ·ÛÈÒÓ Î·È ÛÙÔ ·›ÛıËÌ· ÎÚ·‰·ÛÌÒÓ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì ·˘ÍËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. Mater Med Greca 1987; 15: 367-70.
901. ¶∞¡∞°πøΔO¶OÀ§OÀ °. ∏ Â›‰Ú·ÛË Ù˘ ¿ÛÎËÛ˘ ÛÙÔÓ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
(Ù‡Ô˘ π). ¶·È‰È·ÙÚÈ΋ μfiÚ. ∂ÏÏ¿‰·˜ 1993; 5: 215-23.
902. ¶∞ÃOÀ§∞-¶∞¶∞™Δ∂ƒπ∞¢∏ Ã, ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, £∞§∞™™π¡O™ ¡, ª∞¡π∞Δ∏ ª, Oπ∫O¡Oªπ¢OÀ π. ∞ÓÙÈÁfiÓ· ÈÛÙÔÛ˘Ì‚·ÙfiÙËÙ·˜ HLAA, B Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË. Mater Med
Greca 1981; 9: 415-8.
903. ¶§∂™™∞™ ™, ¶§∂™™∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
¢›·ÈÙ·, ‰ÈÛΛ· ‹ ÈÓÛÔ˘Ï›ÓË; ∂ÈıÂÒÚ. ∫ÏÈÓÈ΋˜ º·ÚÌ·ÎÔÏ. Î·È º·ÚÌ·ÎÔÎÈÓËÙÈ΋˜ 1985; 2: 108-21.
904. ƒOÀ™™O π. ¶ÚfiÏË„Ë Î·È ıÂÚ·›· ÙÔ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ª‡ıÔ˜ Î·È Ú·ÁÌ·ÙÈÎfiÙËÙ·. ¶·È‰È·ÙÚÈ΋ μfiÚ. ∂ÏÏ¿‰Ô˜ 1992; 4: 161-7.
905. Δ™πΔ∞ªπ¢OÀ ∑, ºÀΔπ§∏ Ã, ¶∞¶∞´ø∞¡¡OÀΔ™∂§∂¶O°§OÀ ∞, ¶∞°∫∞§O™ ∂, ™∞ª∞ƒ∞∫O∫∫∂μ∏ μ. ªÂϤÙË ÙˆÓ ÌÂÙ·‚ÔÏÒÓ ÙˆÓ ÏÈȉ›ˆÓ
Î·È ·ÔÏÈÔÚˆÙÂ˚ÓÒÓ ApoA1 Î·È ∞poB Û Á˘Ó·›Î˜ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË (Ù‡Ô˘ ππ).
¢ÂÏÙ›Ô ∂ÏÏËÓ. ªÈÎÚÔ‚. ∂Ù·ÈÚ›·˜ 1993; 38: 188-94.
906. Δ™πΔ∞ªπ¢OÀ ∑, ¶∞°∫∞§O™ ∂, ºÀΔπ§∏ Ã,
Δ™OÀ§º∞ ™, °∫π¡∏ ™, ∫O¡ΔO¢∏ªOÀ ∞. §ÈÔÚˆÙÂ˚ÓË ·[Lp(a)] Û ·ÛıÂÓ›˜ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË (ªπ™¢) Ì ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›·. ¢ÂÏÙ›Ô ∂ÏÏËÓ. ªÈÎÚÔ‚. ∂Ù·ÈÚ›·˜
1994; 39: 628-35.
907. ∞™∏ª∞∫O¶OÀ§OÀ °, ¢π∞ª∞¡Δ∏-∫À¶πøΔ∏
114
∞. O ÚfiÏÔ˜ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ÛÙËÓ ÂÚÈÔ‰ÔÓÙÈ΋ ÓfiÛÔ. π·ÙÚÈ΋ 1993; 63: 459-62.
908. μ§∞ÃOÀ-πø∞¡¡π¢OÀ Ã. OÛÙÂÔfiÚˆÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ ππ. OÛÙÔ‡Ó 1994; 5: 231-2.
909. ¶∞À§∞ΔO™ º. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. OÚÈÛÌfi˜Ù·ÍÈÓfiÌËÛË-‰È¿ÁÓˆÛË. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜,
1995: 133-57.
910. £∂O¢øƒ∞∫O¶OÀ§O™ ¶, ª¶OÀƒ∞™ ∞, ∞¡∞°∂∞™ ™. ∏ Â›‰Ú·ÛË Ù˘ ÂÓÂÚÁÔ‡ Ó¢ÌÔÓÈ΋˜ Ê˘Ì·ÙÈÒÛˆ˜ ÛÙËÓ ÂÌÊ¿ÓÈÛË ‹ ·ÔÚÚ‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË π∫∞ 1991; 2:
123-7.
911. £∂OÃ∞ƒ∏™ ∞, ∫OÀƒ∏™ Ã, ¶∞¶¶∞™ ™, Ã∞§∞Δ™∏™ ∫, ∫ø¡™Δ∞¡Δπ¡OÀ §, ∞¡Δø¡∞∫O™ ¶.
¶ÚÔοډÈÔ ¿ÏÁÔ˜ Î·È ıÂÙÈ΋ ‰ÔÎÈÌ·Û›· ÎÔÒÛˆ˜
Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ∫·Ú‰ÈÔÏ.
∂ÈıÂÒÚËÛË 1989; 30: 167-71.
912. ∫Oª∂™π¢OÀ-ª∞°∫§∞ƒ∞ μ. ¢È·ÙÚÔÊ‹ Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜ ·Û‚ÂÛÙ›Ô˘ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
OÛÙÔ‡Ó 1994, 5: 233-4.
913. ∫OÀ∫OÀ§∏™ °, ¡π∫OÀ ∞, ™À°∫∂§§∞∫∏™ ¶,
π∫∫O™ ¢. ™˘Ó‡·ÚÍË ¿ÔÈÔ˘ Î·È Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¡ÔÛÔÎÔÌÂȷο ÃÚÔÓÈο 1980; 42: 366-9.
914. §OÀ∫∞ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÔÊı·ÏÌfi˜. π·ÙÚÈÎfi μ‹Ì· 1991; 16: 45-8.
915. §À¢∞∫∏™ Ã, ∂À™Δƒ∞ΔO¶OÀ§O™ ∞. ªÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋
1994; 66: 23-33.
916. ∫Oª∂™π¢OÀ-ª∞°∫§∞ƒ∞ μ, °π∞¡¡∞∫O¶OÀ§O™ º, ƒ∞¶Δ∏™ ™. ¢È·ÙÚÔÊ‹ Î·È ÌÂÙ·‚ÔÏÈÛÌfi˜
·Û‚ÂÛÙ›Ô˘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¢È·ÙÚÔÊ‹ - ¢È·ÈÙÔÏÔÁ›· 1992; 4: 73-8.
917. ª∞¡Δ∑øƒO™ Ã. À¤ÚÙ·ÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋ 1994; 65: 563-71.
918. ª∞Àƒπ∫∞∫∏™ ª. ∂ΉËÏÒÛÂȘ ·fi ÙÔ ÂÚÂÈÛÙÈÎfi
Û‡ÛÙËÌ· ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1988; 54:
137-48.
919. ªÀ§O¶OÀ§O™ ¡. OÚȷ΋ ˘ÂÚÙÔÓ›· Û ·ÛıÂÓ›˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. OÊı·ÏÌÔÏÔÁ›· 1995; 7: 40-3.
920. ¡π∫O§∞´¢OÀ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÎÔÈÏÈÔοÎË. ¢ÂÏÙ›Ô ∞′ ¶·È‰. ∫ÏÈÓ. ¶·ÓÂ. ∞ıËÓÒÓ 1986;
33: 70-7.
921. ƒ∏°∞™ ∞. À‰·Ù¿ÓıڷΘ Î·È Ê˘ÙÈΤ˜ ›Ó˜ ÛÙË ‰›·ÈÙ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1987; 52: 307-18.
922. ™∫O¡¢ƒ∞ ª, REESE J, ∫OÀ¡ΔOÀƒ∏™ ¢,
™∫O¡¢ƒ∞ ™. ¡ÔÛ‹Ì·Ù· ÙÔ˘ ÔÙÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÛÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. °·ÏËÓfi˜ 1986; 28: 21-5.
923. Ã∞§∂μ∂§∞∫∏™ °. §ÔÈÌÒÍÂȘ Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. π·ÙÚÈÎfi μ‹Ì· 1993; 32: 44-8.
924. Ã∞ƒ™OÀ§∏™ º, ∫∞¡∞∫OÀ¢∏-Δ™∞∫∞§π¢OÀ
º, μÀ∑∞¡Δπ∞¢∏™ ∞, ∫∞Δ∑O™ °, ∫∞™πªO™ Ã.
¡Â·ÓÈÎfi˜ ‰È·‚‹Ù˘: ∏ Û¯¤ÛË Ù˘ ÂÎÎÚÈÙÈ΋˜ Âʉڛ·˜ ÙˆÓ ‚-΢ÙÙ¿ÚˆÓ Ì ÙËÓ ·ÚÔ˘Û›· ·ÓÙÈÓËÛȉȷÎÒÓ
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
·ÓÙÈÛˆÌ¿ÙˆÓ Î·È ÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί¿ÚÔ˘ ·›Ì·ÙÔ˜.
Mater Med Greca 1984; 12: 167-74.
925. Ã∞Δ∑∏∞°Oƒ∞∫∏™ ∞. ∞Ó·ÈÛıËÛÈÔÏÔÁÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ÂÈÙfiÎÔ˘ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £¤Ì·Ù·
∞Ó·ÈÛıËÛÈÔÏÔÁ›·˜ Î·È ∂ÓÙ·ÙÈ΋˜ π·ÙÚÈ΋˜ 1991; 1:
32-6.
926. Ã∞Δ∑∏¢∞∫∏™ ¢. OÛÙÂÔfiÚˆÛË Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘ Ù‡Ô˘ π. OÛÙÔ‡Ó 1994; 5: 229-30.
927. DIMITRIADIS G, VLACHONIKOLIS I, HATZIAGELAKI E, KORDONOURI O, ALEXOPOULOS E, RAPTIS S. The “Dawn phenomenon” in
patients with type I diabetes mellitus. Diabetes Nutr
Metab 1988; 1: 37-41.
928. æÀ§§∞™ ∫, ™Δ∂º∞¡πøΔOÀ ª, ∞™¶πøΔ∏™ ª.
梉ԷÔÊÔÏ›‰ˆÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
OÊı·ÏÌÔÏÔÁ›· 1991; 3: 25-7.
929. ¶§∞Δ™∞∫∏™ ∫, ¢π°∂¡∏™ °. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·: ¡ÂÒÙÂÚ˜ ·fi„ÂȘ. Mater Med Greca 1987; 15:
85-94.
930. Ã∞Δ∑∏∞°°∂§∞∫∏ ∂, ¢∏ª∏Δƒπ∞¢∏ °, ƒ∞¶Δ∏™ ™. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ÀÂÚˆÛ̈ÙÈÎfi ÎÒÌ·. π·ÙÚÈÎfi μ‹Ì· 1993; 33: 53-9.
931. ∫∞Δ∑O™ °, ¶∞¶∞¢O¶OÀ§OÀ-∫∂Ã∞°πO¶OÀ§OÀ ª, ∞À°OÀ™Δπ¢OÀ- ™∞μμO¶OÀ§OÀ ¶,
∫∞ƒ∞°∫πO∑O°§OÀ-§∞ª¶OÀ¢∏ £, Ã∞ƒ™OÀ§∏™ º. To Ì·ÁÓ‹ÛÈÔ ÙÔ˘ ÔÚÔ‡ Û ‰È·‚ËÙÈο ·È‰È¿.
™ÙÔ: ¶Ú·ÎÙÈο 1Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË. 1986; ÙfiÌ. μ′: 161-5.
932. ∫∞Δ∑O™ °. ∏ ıÂÚ·›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·È‰ÈÔ‡.
¶·È‰È·ÙÚÈο ÃÚÔÓÈο 1983; 12: 73-8.
933. §π∞∫O¶OÀ§OÀ ª. æ˘¯ÔÏÔÁÈΤ˜ ÂÈÙÒÛÂȘ ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙÔ ·È‰› Î·È ÛÙËÓ ÔÈÎÔÁ¤ÓÂÈ¿
ÙÔ˘. ¢ÂÏÙ. ∞′ ¶·È‰. ∫ÏÈÓ. ¶·ÓÂ. ∞ıËÓÒÓ 1991; 38:
200-5.
934. ª¶OÀ§OÀ∫O™ ∞, ¡OÀ¡O¶OÀ§O™ Ã, ¶∞¶∞Ã∏™ΔOÀ ∂, ª¶∞ƒΔ™O∫∞™ Ã. ∏ HDL ¯ÔÏËÛÙÂÚfiÏË Û ‰È·‚ËÙÈο ·È‰È¿. Mater Med Greca 1981; 9:
456-9.
935. ∞£ÀƒO™ μ, ∫O¡ΔO¶OÀ§O™ ∞. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·. ∂ÏÏËÓ. π·ÙÚÈ΋ 1994; 60: 369-78.
936. ∞¡Oπ¡O™ ¢, ABOUR-NOUR T. ∞ÈÌÔÂÙ·ÏÈ·ÎÔ›
·Ú¿ÁÔÓÙ˜, ‰È·‚‹Ù˘ Î·È ·ÁÁÂȷΤ˜ ·ı‹ÛÂȘ. ∂ÈıÂÒÚËÛË ÀÁ›·˜ 1994; 5: 49-52.
937. Δƒπ∞¡Δ∞ºÀ§§OÀ °. OÊı·ÏÌÔÏÔÁÈΤ˜ ÂÈÏÔΤ˜
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (ÂÎÙfi˜ Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜). ™ÙÔ: ¶Ú·ÎÙÈο 2Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1987;
ÙfiÌ. ∞′: 345-9.
938. Δ™πƒOÀ ª, §∞™∫∞ƒ∞ΔO™ π. £ÂÚ·›· Ì ΢ÎÏÔÎÚ˘ÔËÍ›· Û ‰È·‚ËÙÈÎfi ÓÂÔ·ÁÁÂÈ·Îfi ÁÏ·‡ÎˆÌ·. °·ÏËÓfi˜ 1985; 27: 1073-8.
939. º∂ƒ∂Δ∏™ ∏, ª¶OÀ∑∞ ∂. ∂ÓÂÛË ÂÏ·›Ô˘ ÛÈÏÈÎfiÓ˘
ÛÙËÓ ¯ÂÈÚÔ˘ÚÁÈ΋ ÙÔ˘ ˘·ÏÔÂȉԇ˜ Û ÂÚÈÙÒÛÂȘ ·Ú·ÁˆÁÈ΋˜ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜.
OÊı·ÏÌÔÏÔÁ›· 1989; 1: 97-100.
940. ª∂°∞™ π. ¢È·‚ËÙÈΤ˜ Ó¢ÚÔ¿ıÂȘ. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1992; 26: 9-15.
941. ªÀ°¢∞§∏™ ∏. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·: ∂ΉËÏÒÛÂȘ Î·È ‰È·ÁÓˆÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1992; 9: 15-7.
942. ∞™¶πøΔ∏™ ª. £ÂÚ·›· Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Ì Argon Laser. OÊı·ÏÌÔÏÔÁ›·
1989; 1: 400-7.
943. μ∞ªμOÀ∫O™ ¢. OÈ ·ÎÙ›Ó˜ L·ser ÛÙË ıÂÚ·›·
Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ™ÙÔ: ¶Ú·ÎÙÈο 2Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ.
£ÂÛÛ·ÏÔÓ›ÎË, 1987; ÙfiÌ. ∞′: 342-4.
944. μOÀ¢OÀƒ∏ ∞, °∂øƒ°O¶OÀ§O™ °, £∂O¢O™π∞¢∏™ ¶. MÂϤÙË Ù˘ ÌÂÙ·‚ÔÏ‹˜ Ù˘ ¢·ÈÛıËÛ›·˜
ÙÔ˘ ·ÌÊÈ‚ÏËÛÙÚÔÂȉ‹ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ ÌÂÙ¿
·fi ʈÙÔËÍ›·. OÊı·ÏÌÔÏÔÁ›· 1993; 5: 34-40.
945. ¢∏ª∏Δƒ∞ΔO™ ™. ™˘Ì‚ÔÏ‹ Ù˘ ÊÏÔ˘ÔÚÔ·ÁÁÂÈÔÁÚ·Ê›·˜ ÛÙËÓ ÚÒÈÌË ‰È¿ÁÓˆÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. ™ÙÔ ¶Ú·ÎÙÈο 2Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. £ÂÛÛ·ÏÔÓ›ÎË, 1987; ÙfiÌ.
∞′: 338-41.
946. ∫O§πO¶OÀ§O™ I, °∞ƒΔ∞°∞¡∏™ ™, ¢∂ƒ∂∫§∏™ ¢, ¢∏ªO¶OÀ§O™ ™, ¶O§§∞§∏™ ™, º∂ƒ∂Δ∏™ ∏, æÀ§§∞™ ∫. ∂ÚˆÙ‹Ì·Ù· ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. OÊı·ÏÌÔÏÔÁ›· 1990; 2: 185-99.
947. ∫ÀƒπΔ™∏™ ∞, Δ™ø∫OÀ ª, CHADER G. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. Mater Med Greca 1983;
11: 284-90.
948. ∫ø¡™Δ∞™ ¶, MY§ø¡∞™ π, ∫∞ƒOÀΔ∞™ ™,
Δƒπ∞¡Δ∞ºÀ§§OÀ ∞, §O°O£∂Δ∏™ π. ª¤ÙÚËÛË
·ÈÌ·ÙÈ΋˜ ÂÁÎÂÊ·ÏÈ΋˜ ÚÔ‹˜ Ì XE133 Î·È videomicroscope Û ÂÈÚ·Ì·ÙÈÎfi status epilepticus. ∂ÁΤʷÏÔ˜ 1983; 20: 96-8.
949. §∞¢∞™ π, ¶∞§∏ª∂ƒ∏™ °. ÀÔÛÙÚÔÊ‹ ÓÂÔ·ÁÁÂÈÒÛˆ˜ ÔÙÈ΋˜ ıËÏ‹˜ ·fi ·Ú·ÁˆÁÈ΋ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· ÌÂÙ¿ ·Ó·ÌÊÈ‚ÏËÛÙÚÔÂȉÈ΋
ʈÙÔËÍ›·. Mater Med Greca 1986; 14: 160-4.
950. Oπ∫O¡Oªπ¢∏™ ¶, ∞§∂•∞¡¢ƒπ¢∏™ ∞, °∂øƒ°π∞¢∏™ ¡, ™Δ∂ƒ°πOÀ ¶, ∫ø¡™Δ∞™ ¶. ∞ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ ÌÂ
ʈÙÔËÍ›· Argon-Laser. ∂ÏÏËÓ. π·ÙÚÈ΋ 1985; 51:
202-7.
951. μ∞™π§O¶OÀ§O™ ¢, LUMB M. ¢È·‚ËÙÈ΋ Ì˘·ÙÚÔÊ›·: πÛÙÔÏÔÁÈΤ˜ Î·È ÈÛÙÔ¯ËÌÈΤ˜ ÂӉ›ÍÂȘ ÚˆÙÔ·ıÔ‡˜ ÚÔÛ‚ÔÏ‹˜ ÙÔ˘ Ì˘ÈÎÔ‡ ÈÛÙÔ‡. ∂ÁΤʷÏÔ˜
1981; 18: 47-9.
952. Δ™πΔ∞ªπ¢OÀ ∑, ºƒ∞°∫π∞ ¢, ¶∞°∫∞§O™ ∂,
¢∏ª∏Δƒπ∞¢∏™ Ã, Ã∞´Δπ¢OÀ ∫. ™¯¤ÛË ÌÈÎÚÔ·Ï‚Ô˘ÌÈÓÔ˘Ú›·˜, ÏÈȉ›ˆÓ Î·È ·ÈÌÔÛÙ·ÙÈÎÒÓ ·Ú·ÁfiÓÙˆÓ Û ·ÛıÂÓ›˜ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¢ÂÏÙ›Ô ∂ÏÏËÓ. ªÈÎÚÔ‚. ∂Ù·ÈÚ›·˜
1994; 39: 419-26.
953. ¶∞°∫∞§O™ ∂, £∂O¢øƒπ¢∏™ ™, ∫O§μ∞Δ∑∏™
£, ¶∞¶∞¢O¶OÀ§O™ ™, ∫∞Δ™∞ƒ∏™ °, ª∏§πø-
115
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¡∏™ ∞. ∏ ÚÔÁÓˆÛÙÈ΋ ÛËÌ·Û›· Ù˘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜
ÂÈÛfi‰Ô˘ Û ·ÛıÂÓ›˜ Ì Ô͇ ¤ÌÊÚ·ÁÌ· ÙÔ˘ Ì˘Ôηډ›Ô˘. ∂ÏÏËÓ. ∫·Ú‰ÈÔÏ. ∂ÈıÂÒÚËÛË 1995; 36: 437-40.
954. ∂§π™∞º ª. À¤ÚÙ·ÛË Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈο ÃÚÔÓÈο 1993; 6: 447-58.
955. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫. ¢È¿ÁÓˆÛË Î·È
·ÓÙÈÌÂÙÒÈÛË ÙˆÓ ‰È·Ù·Ú·¯ÒÓ ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙˆÓ
ÏÈȉ›ˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ∫·Ú‰ÈÔÏ.
∂ÈıÂÒÚËÛË 1994; 35: 132-8.
956. ELISAF M, TSATSOULIS A, KATOPODIS K, SIAMOPOULOS K. Acid base and electrolyte disturbances in patients with diabetic ketoacidosis. Diabet
Res Clin Pract 1996; 34: 23-7.
957. ELISAF M, SIAMOPOULOS K. Are the increased
Lp(a) levels in hemodialysis patients related to glucose intolerance and hemodialysiw duration?
Nephron 1996; 74: 623-4.
958. ELISAF M, SIAMOPOULOS K. Survival after severe diabetic ketoacidosis. Europ J Intern Med 1996;
7: 107-8.
959. MICHALIA M, KOMPOTI M, KOUTSIKOU A,
PARIDOU A, GIANNOPOULOU P, TRIKKAGRAPHAKOS E, CLOUVA-MOLYVDAS P. Diabetes mellitus is an independent risk factor for ICUacquired bloodstream infections. Intensive Care Med
2009; 35: 448-54.
960. ¶∞ÃOÀ§∞-¶∞¶∞™Δ∂ƒπ∞¢∏ Ã, ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, £∞§∞™™π¡O™ ¡, ª∞¡π∞Δ∏ ª,
Oπ∫O¡Oªπ¢OÀ π. ∞ÓÙÈÁfiÓ· ÈÛÙÔÛ˘Ì‚·ÙfiÙËÙÔ˜
HLA-A1-B Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË. Materia Medica Greca; 1981; 9: 415-8.
961. £∞§∞™™π¡O™ ¡. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ™ÙÔ:
∞‚Ú·Ì›‰Ë˜ ∞. ∂›ÁÔ˘Û˜ ÂÓ‰ÔÎÚÈÓÔÏÔÁÈΤ˜ ηٷÛÙ¿ÛÂȘ. £ÂÛÛ·ÏÔÓ›ÎË: University Studio Press, 1983:
77-91.
962. £∞§∞™™π¡O™ ¡. ªË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋ 1988; 54: 488-90.
963. ∞¡¢ƒO¡π∫∞∫∏-º∞§¢∞ª∏ ∞, ∞™∏ª∞∫O¶OÀ§OÀ °, ¢π∞ª∞¡Δ∏-∫∏¶πøΔ∏ ∞, ¶∞¶∞¢O¶OÀ§OÀ-ª∞ƒ∫O¶OÀ§OÀ ∫, £∞§∞™™π¡O™ ¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÚÈÔ‰fiÓÙÈÔ. π.
∂ÌÊ¿ÓÈÛË ÂÚÈÔ‰ÔÓÙÈ΋˜ ÓfiÛÔ˘ Û Ó·ÚÔ‡˜ ÈÓÛÔ˘ÏÈÓÔÂÍ·Úو̤ÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ™ÙÔÌ·ÙÔÏÔÁ›· 1990; 47: 73-86.
964. KARAM J, GRODSKY G, PAVLATOS F, FORSHAM P. Critical factors in excessive seruminsulin
response to glucose. Obesity in maturityonset diabetes and growth hormone in acromegaly. Lancet
1965; 1: 286-9.
965. KANE J, LONGCOPE C, PAVLATOS F, GRODSKY G. Studies of carbohydrate metabolism in idiopathic hypertriglyceridemia. Metabolism 1965; 14:
471-86.
966. Ã∞ƒO∫O¶O™ ™, ¶∞À§∞ΔO™ º. O ·È‰ÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈο ÃÚÔÓÈο 1968; 8: 464-84.
116
967. ¶∞À§∞ΔO™ º. ∂Ó‰ÔÎÚÈÓ›˜ ·‰¤Ó˜ - ۷ί·Ú҉˘
‰È·‚‹Ù˘. ™ÙÔ: §Ô˘ÎfiÔ˘ÏÔ˜ ¢. ∞ÍÈÔÏfiÁËÛË ÂÚÁ·ÛÙËÚÈ·ÎÒÓ ÂÍÂÙ¿ÛˆÓ. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
¶.Ã. ¶·Û¯·Ï›‰Ë˜, 1994; 349-75.
968. KATSOYANNIS P. Insulin peptides I. Synthesis of
cysteine-containing peptides related to the A-chain of
sheep insulin. J Am Chem Soc 1961; 83: 4053-7.
969. KATSOYANNIS P, SUZUKI K. Insulin peptides II.
Synthesis of a protected pentapeptide containing the
C-terminal sequence of the A-chain of insulin. J Am
Chem Soc 1961; 83: 4057-9.
970. KATSOYANNIS P, SUZUKI K. Insulin peptides III.
Synthesis of a protected nonapeptide containing the
C-terminal sequence of the B-chain of insulin. J Am
Chem Soc 1962; 84: 1420-3.
971. KATSOYANNIS P. Peptide synthesis and protein
structure. J Polymer Sci 1961; 49: 51-74.
972. KATSOYANNIS P, SUZUKI K, TOMETSKO A. Insulin peptides IV. The synthesis of a protected decapeptide containing the C-terminal sequence of the
A-chain of insulin. J Am Chem Soc 1963; 85: 1139-41.
973. KATSOYANNIS P, SUZUKI K. Insulin peptides V.
The synthesis of a protected nonapeptide amide corresponding to positions 11 to 9 in the B-chain of the
insulin sequence. J Am Chem Soc 1963; 85: 1679-81.
974. KATSOYANNIS P, SUZUKI K, TOMETSKO A. Insulin peptides VI. The synthesis of a partially protected nonapeptide corresponding to the first nine amino
acid residues of the A-chain of insulin. J Am Chem
Soc 1963; 85: 1681-4.
975. KATSOYANNIS P, SUZUKI K. Insulin peptides
VII. The synthesis of two decapeptide derivatives containing the C-terminal sequence of the B-chain of insulin. J Am Chem Soc 1963; 85: 2659-62.
976. KATSOYANNIS P, TILAK M. Insulin peptides VIII.
The synthesis of a protected heptadecapeptide with
amino acid sequences corresponding to the C-terminal portion of the B-chain of insulin. J Am Chem Soc
1963; 85: 4028-31.
977. KATSOYANNIS P, TOMETSKO A, FUKUDA K.
Insulin peptides IX. The synthesis of the A-chain of
insulin and its combination with natural B-chain to
generate insulin activity. J Am Chem Soc 1963; 85:
2863-5.
978. KATSOYANNIS P. On the problem of the chemical
synthesis of proteins with special reference to insulin.
Metabolism 1964; 13: 1059-74.
979. KATSOYANNIS P. Synthetic studies on the A and B
chains of insulin. First Edwin J. Cohn Memorial Lecture of the 15th Annual Scientific Conference of protein foundation, November 25 Cambridge, Massachusetts. Vox Sang 1963; 9: 238-41.
980. KATSOYANNIS P, FUKUDA K, TOMETSKO A,
SUZUKI K, TILAK M. Insulinpeptides X. The synthesis of the B-chain of insulin and its combination
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
with natural or synthetic A-chain to generate insulin
activity. J Am Chem Soc 1964; 86: 930-2.
981. KATSOYANNIS P. The synthesis of the insulin
chains and their combinati on to biologically active
marerial. Diabetes 1964; 13: 339-48.
982. KATSOYANNIS P. The synthesis of the A- and Bchains of insulin and their combination to generate insulin activity. In: Proceedings of the 2nd International Congress of Endocrinology. 1965: 1216-30.
983. KATSOYANNIS P. Insulin generation by recombination of synthetic and natural A- and B-chains.
Science 1965; 150: 376.
984. KATSOYANNIS P, TOMETSKO A, GINOS J, TILAK M. Insulin peptides. XI. The synthesis of the Bchain of human insulin and its combination with the
natural A-chain of bovine insulin to generate insulin
activity. J Am Chem Soc 1966; 88: 164-6.
985. KATSOYANNIS P, TOMETSKO A, ZALUT C. Insulin peptides. XII. Human insulin generationby combination of synthetic A and B chains. J Am Chem Soc
1966; 88: 166-7.
986. KATSOYANNIS P. The chemical synthesis of human
and sheep insulin. Am J Med 1966; 40: 652-61.
987. KATSOYANNIS P, TOMETSKO A. Insulin synthesis by recombination of A and B chains. A highly efficient method. Proc Natl Acad Sci 1966; 55: 1554-61.
988. KATSOYANNIS P, TOMETSKO A, ZALUT C. Insulin peptides XIII. The synthesis of a dodecapeptide
derivative containing the C-terminal sequence of the
A-chain of sheep insulin. J Am Chem Soc 1966; 88:
5618-21.
989. KATSOYANNIS P, TOMETSKO A, ZALUT C. Insulin peptides XIV. Synthetic peptide derivatives related to the N-terminal of the A-chain of sheep insulin (Positions 1-9). J Am Chem Soc 1966; 88: 56225.
990. KATSOYANNIS P, TOMETSKO A, ZALUT C,
FUKUDA K. Insulin peptides XV. The synthesis of
the A-chain of sheep insulin and its combination with
synthetic or natural B-chain to produce insulin. J Am
Chem Soc 1966; 88: 5625-35.
991. KATSOYANNIS P. The synthesis of insulin. Science
1966; 154: 1509-14.
992. KATSOYANNIS P, ZALUT C, TOMETSKO A. Insulin peptides XVI. The synthesis of a nonapeptide
and a dodecapeptide derivative related to the A chain
of human insulin. (Positions 1-9 and 10-21). J Am
Chem Soc 1967; 89: 4502-4.
993. KATSOYANNIS P, TOMETSKO A, ZALUT C. Insulin peptides XVII. The synthesis of the A-chain of
human (porcine) insulin and its isolation as the S-sulfonated derivative. J Am Chem Soc 1967; 89: 4505-13.
994. KATSOYANNIS P. Synthesis of insulin. Sartryk ur
Nordisk Medicin 1967; 78: 936-9.
995. KATSOYANNIS P, TOMETSKO A, ZALUT C,
JOHNSON S, TRAKATELLIS A. Studies on the synthesis of insulin from natural and synthetic A- and Bchains. I. Splitting of insulin and isolation of the S-sulfonated derivatives of the A- and B-chains. Biochemistry 1967; 6: 2635-42.
996. KATSOYANNIS P, TRAKATELLIS A, JOHNSON
S, ZALUT C, SCHWARTZ G. Studies on the synthesis of insulin from natural and synthetic A- and Bchains. II. Isolation of insulin from recombination
mixtures of natural A- and B-chains. Biochemistry
1967; 6: 2642-55.
997. KATSOYANNIS P, TOMETSKO A, DELIHAS N.
The application of high-voltage thin-layer electrophoresis to the separation of peptides, nucleitides,
and proteins. Anal Biochem 1967; 18: 72-80.
998. KATSOYANNIS P. Synthetic insulins. Excerpta
Medica International Congress 1967; 172: 379-94.
999. KATSOYANNIS P. The synthesis of insulin. In: Back
N, Martini L, Paoletti R. International Symposium on
the Pharmacology of Hormonal Polypeptides Milan
1967. New York: Plenum Press, 1968: 278-96.
1000. KATSOYANNIS P, TILAK M, FUKUDA K. Insulin peptides XVIII. The synthesis of a partially protected heneicosapeptide containing the C-terminal sequence of the B-chain of insulin. J Am Chem Soc
1971; 93: 5857-61.
1001. KATSOYANNIS P, TILAK M, GINOS J, SUZUKI
K. Insulin peptides XIX. The synthesis of two nonapeptide derivatives related to the N-terminus of the
B-chain of insulin from various species (positions 19). J Am Chem Soc 1971; 93: 5862-6.
1002. KATSOYANNIS P, GINOS J, TILAK M. Insulin
peptides XX. The synthesis of a heneicosapeptide derivative corresponding to the C-terminal sequence of
the human insulin B-chain. J Am Chem Soc 1971; 93:
5866-70.
1003. KATSOYANNIS P, ZALUT C, TOMETSKO A,
TILAK M, JOHNSON S, TRAKATELLIS A. Insulin
peptides XXI. A synthesis of the B-chain of sheep
(bovine, porcine) insulin and its isolation as the S-sulfonated derivative. J Am Chem Soc 1971; 93: 5871-7.
1004. KATSOYANNIS P, GINOS J, ZALUT C, TILAK
M, JOHNSON S, TRAKA TELLIS A. Insulin peptides XXII. A synthesis of the human insulin B-chain
S-sulfonate. J Am Chem Soc 1971; 93: 5877-82.
1005. KATSOYANNIS P, ZALUT C, HARRIS A, MEYER R. Analogs of insulin I. Synthesis of destripeptide B28-30 bovine insulin and destripeptide B28-30
human insulin. Biochemistry 1971; 10: 3884-9.
1006. KATSOYANNIS P, ZALUT C. Synthesis of deamino A1 sheep insulin. Biochemistry 1972; 11: 1128-32.
1007. KATSOYANNIS P, ZALUT C. Synthesis of destetrapeptide A1-4 sheep insulin and destetrapeptide
A1-4 porcine insulin. Biochemistry 1972; 11: 3065-9.
1008. KATSOYANNIS P, OKADA Y, ZALUT C. Syn-
117
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
thesis of a biologically active insulin analog lacking
the intrachain cyclic system. Biochemistry 1973; 12:
2516-25.
1009. KATSOYANNIS P, GINOS J, COSMATOS A,
SCHWARTZ G. The synthesis of destetrapeptide
B27-30 human (porcine) insulin A biologically active
insulin analog. J Am Chem Soc 1973; 95: 6427-34.
1010. COSMATOS A, KATSOYANNIS P. A biologically
active insulin analog with an enlarged intrachain
cyclic system. J Biol Chem 1973; 248: 7304-9.
1011. SCHWARTZ G, KATSOYANNIS P. Insulin peptides. Part XXIII. The synthesis of a hexadecapeptide
derivative related to the B chain of human insulin. J
Chem Soc Perkin 1 1973: 2890-4.
1012. SCHWARTZ G, KATSOYANNIS P. Insulin peptides. Part XXIV. A novel synthesis of the human insulin B chain S-sulfonate. J Chem Soc Perkin 1 1973:
2894- 901.
1013. KATSOYANNIS P, GINOS J, SCHWARTZ G,
COSMATOS A. A synthesis of a biologically active
truncated insulin. Des(pentapeptide B26-30) human
(porcine) insulin. J Chem Soc Perkin 1 1974: 1311-7.
1014. KATSOYANNIS P, GINOS J, COSMATOS A,
SCHWARTZ G. A synthetic human insulin analogue
modified at position B22. [Lys22-B] human in sulin. J
Chem Soc Perkin 1 1974; 464-9.
1015. HORVAT A, LI E, KATSOYANNIS P. Cellular
binding sites for insulin in rat liver. Biochim Biophys
Acta 1975; 382: 609-20.
1016. COSMATOS A, KATSOYANNIS P. Elongation of
the interchain disulfide bridges of insulin. A synthetic
analog. J Biol Chem 1975; 250: 5315-21.
1017. OKADA Y, KATSOYANNIS P. [Sar1-A1] insulin.
A biologically active analog. J Am Chem Soc 1975; 97:
4366-72.
1018. CHENG K, KATSOYANNIS P. The inhibition of
sugar transport and oxidation in fat cell ghosts by
colchicine. Biochem Biophys Res Comm 1975; 64:
1069-75.
1019. COSMATOS A, JOHNSON S, BREIER B, KATSOYANNIS P. [D-Asn21 A] sheep insulin. A diastereomer of the natural hormone. J Chem Soc
Perkin 1 1975: 2157-63.
1020. SCHWARTZ G, KATSOYANNIS P. Synthesis of
[Leu9-B] human insulin. Biochemistry 1976; 15: 40716.
1021. COSMATOS A, OKADA Y, KATSOYANNIS P.
Synthesis of two biologically active insulin analogs
with modifications at the N-terminal and N- and Cterminal amino acid residues. Biochemistry 1976; 15:
4076-82.
1022. FERDERIGOS N, KATSOYANNIS P. The synthesis of [A≤-·, Á-Diamino- butyric acid, A19-glutamic
acid] sheep insulin. J Chem Soc Perkin 1 1977: 1299305.
118
1023. SCHWARTZ G, KATSOYANNIS P. [10-LeucineB] human insulin, a biologically active analoque. J
Chem Res 1977; (Suppl): 220-1.
1024. COSMATOS A, CHENG K, OKADA Y, KATSOYANNIS P. The chemical synthesis and biological
evaluation of [1-L-Alanine-A] and [1-D-Alanine-A]
insulins. J Biol Chem 1978; 253: 6586-90.
1025. SCHWARTZ G, KATSOYANNIS P. Synthesis of
Des[tetrapeptide B] and Des [pentapeptide Bπ] human insulins. Two biologically active analogs. Biochemistry 1978; 17: 4550-6.
1026. FERDERIGOS N, COSMATOS A, FERDERIGOS A, KATSOYANNIS P. [21-Arginine-A] insulin.
A biologically active analog. Intl J Pept Prot Res 1979;
13: 43-53.
1027. COSMATOS A, FERDERIGOS N, KATSOYANNIS P. Chemical synthe-sis of [Des (Tetrapeptide B≤
≥∞), Tyr(NH2)≤ -B] and [Des) pentapeptide B ≤
≥∞), Phe(NH2)≤ -B] bovine insulins. Intl J Pept Prot
Res 1979; 14: 457-71.
1028. BURKE G, CHANLEY J, OKADA Y, COSMATOS A, FERDERIGOS N, KATSOYANNIS P.
Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue.
[21-Asparaginamide-A] insulin. Biochemistry 1980;
19: 4547-56.
1029. SCHWARTZ G, BURKE G, KATSOYANNIS P.
[12-Asparagine-B] human insulin. An analogue with
modification in the hydrophobic core of insulin. Intl J
Pept Prot Res 1981; 17: 243-55.
1030. OKADA Y, CHANLEY J, BURKE G, KATSOYANNIS P. [2-Norleucine-A] insulin. An analog with
unanticipated biological properties. Hoppe Seylers Z
Physiol Chem 1981; 362: 629-38.
1031. SCHWARTZ G, BURKE G, KATSOYANNIS P.
The importance of the Bπ∞ Amino acid residue to the
biological activity of insulin [Lysπ∞-B] human insulin.
J Protein Chem 1982; 1: 177-89.
1032. FERDERIGOS N, BURKE G, KITAGAWA K,
KATSOYANNIS P. The effect of modifications of
the A5 and A19 amino acid residues on the biological
activity of insulin. [Leu5-A] and [Phe19-A] sheep insulin. J Protein Chem 1983; 2: 147-70.
1033. SCHWARTZ G, BURKE G, CHANLEY J, KATSOYANNIS P. An insulin analogue possessing
higher in vitro biological activity than receptor binding affinity. [21-proline-B] insulin. Biochemistry 1983;
22: 4561-7.
1034. BURKE G, SCHWARTZ G, KATSOYANNIS P.
The nature of the Bπ∞ amino acid residue: Requirements for high biological activity of insulin. Intl J Pept
Prot Res 1984; 23: 394-401.
1035. KITAGAWA K, OGAWA H, BURKE G, CHANLEY J, KATSOYANNIS P. Critical role of the A≤
amino acid residue in the biological activity of insulin.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
[2-Glycine-A] and [2-Alanine-A] INSULINS. Biochemistry 1984; 23: 1405-13.
1036. KITAGAWA K, OGAWA H, BURKE G, CHANLEY J, KATSOYANNIS P. Interaction between the
A≤ and A19 amino acid residues is of critical importance for high biological activity in insulin. [19Leucine-A] insulin. Biochemistry 1984; 23: 4444-8.
1037. OGAWA H, BURKE G, KATSOYANNIS P. Synthesis and Biological E-valuation of a modified insulin
incorporating the C-terminal hexapeptide (“D-region”) of insulin-like growth factor II. J Protein Chem
1984; 3: 327-48.
1038. DE VROEDE M, RECHLER M, NISSLEY S,
JOSHI S, BURKE G, KATSOYANNIS P. Hybrid
molecules containing the B-domain of insulin-like
growth factor I (IGF-I) are recognized by IGF carrier
proteins. Proc Natl Acad Sci USA 1985; 82: 3010-4.
1039. JOSHI S, BURKE G, KATSOYANNIS P. Synthesis
of an insulin-like com pound consisting of the A chain
of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I. Biochemistry 1985; 24: 4208-14.
1040. SCHWARTZ G, WONG D, BURKE G, DE
VROEDE M, RECHLER M, KATSOYANNIS P.
Glutamine B16 insulin: Reduced insulin-like metabolic activity with mitogenic activity. J Protein Chem
1986; 4: 185-97.
1041. JOSHI S, OGAWA H, BURKE G, TSENG L,
RECHLER M, KATSOYANNIS P. Structural features involved in the biological activity of insulin and
the insulinlike growth factors: a27 insulin/B IGF-I.
Biochem Biophys Res Comm 1985; 133: 423-9.
1042. DE VROEDE M, RECHLER M, NISSLEY S,
OGAWA H, JOSHI S, BURKE G, KATSOYANNIS
P. Mitogenic activity and receptor of hybrid molecules
containing portions of the insulin-like growth factor I
(IGF-I), IGF-II, and insulin molecules. Diabetes
1986; 35: 355-61.
1043. DE VROEDE M, TSENG L, KATSOYANNIS P,
NISSLEY S, RECHLER M. Modulation of insulinlike growth factor I binding to human fibroblast
monolayer cultures by insulin-like growth factor I carrier proteins released to the incubation media. J Clin
Inves 1986; 77: 602-13.
1044. SCHWARTZ G, BURKE G, KATSOYANNIS P. A
superactive insulin; [B10-Aspartic Acid] insulin (human). Proc Natl Acad Sci USA 1987; 84: 6408-11.
1045. CHU Y, WANG R, BURKE G, CHANLEY J, KATSOYANNIS P. Possible involvement of the A20A21 peptide bond in the expression of the biological
activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin. Biochemistry 1987;
26: 6966-71.
1046. CHU Y, BURKE G, CHANLEY J, KATSOYAN-
NIS P. Possible involvement of the A20-A21 peptide
bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin Biochemistry 1987; 26: 6972-75.
1047. CHU Y, WANG R, BURKE G, CHANLEY J, KATSOYANNIS P. Possible involvement of the A20A21 peptide bond in the expression of the biological
activity of insulin 3. [21-Desasparagine, 20-cysteine
ethylamide-A] insulin and [21 - Desasparagine, 20 cysteine, 2, 2, 2 - trifluoroethylamide - A] insulin. Biochemistry 1987; 26: 6975-9.
1048. OGAWA H, BURKE G, CHANLEY J, KATSOYANNIS P. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. Int J
Pept Protein Res 1987; 30: 460-73.
1049. TSENG L, SCHWARTZ G, SHLIEKH M, CHEN
Z, JOSHI S, WANG J, NISSLEY S, BURKE G,
KATSOYANNIS P, RECHLER M. Hybrid molecules containing the A-domain of insulin-like growth
factor I and the B-chain of the insulin have increased
mitogenic activity relative to insulin. Biochem Biophys Res Commun 1987; 149: 672-79.
1050. OHTA N, BURKE G, KATSOYANNIS P. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A] insulin. J Protein
Chem 1987; 7: 55-65.
1051. CHEN Z, SCHWARTZ G, ZONG L, BURKE G,
CHANLEY J, KATSOYAN NIS P. Determinants of
growth-promoting activity reside in the A-domain of
insulin-like growth factor I. Biochemistry 1988; 27:
6105-11.
1052. SCHWARTZ G, BURKE G, SHEIKH M, ZONG
L, KATSOYANNIS P. Synthesis of an insulin-like
compound consisting of the B chain of insulin and an
A chain corresponding to the A and D domains of human insulin-like growth factor I. Collect Czech Chem
Commun 1988; 53: 2920-35.
1053. SCHWARTZ G, BURKE G, KATSOYANNIS P. A
highly potent insulin: Des (B26-B30)-[Asp B25 Tyr
B25 NH2 ] insulin (human). Proc Natl Acad Sci U S
A 1989; 86: 458-61.
1054. OHTA N, BURKE G, KATSOYANNIS P. A biologically active insulin ana logue with modification in
the A≤ position. [2-Valine-A] sheep insulin. Chem
Pharm Bull 1989; 37: 670-4.
1055. JOSHI S, BURKE G, KATSOYANNIS P. An insulin-like compound consisting of the B-chain of the
bovine insulin and A-chain corresponding to a modified A- and the D- domains of human insulin-like
growth factor I. J Protein Chem 1990; 9: 235-46.
1056. ZONG L, BURKE G, KATSOYANNIS P. An insulin-like hybrid consisting of a modified A-domain of
human insulin-like growth factor I and the B-chain of
insulin. J Protein Chem 1990; 9: 389-95.
1057. BURKE G, HU S, OHTA N, SCHWARTZ G,
119
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ZONG L, KATSOYANNIS P. Superactive insulins,
Biochem Biophys Res Commun 1990; 173: 982-7.
1058. WANG S, HU S, BURKE G, KATSOYANNIS P.
Insulin analogues with modification in the ‚-turn of
the B-Chain. J Protein Chem 1991; 10: 313-24.
1059. CHU Y, ZONG L, BURKE G, KATSOYANNIS P.
The A14 position of insulin tolerates considerable
structural alterations with modest effects on the biological behavior of the hormone. J Protein Chem
1992; 11: 571-7.
1060. HU S, BURKE G, SCHWARTZ G, FERDERIGOS N, ROSS J, KATSOYANNIS P. Steric requirements at position B12 for high biological activity in insulin. Biochemistry 1993; 32: 2631-5.
1061. CHU Y, BURKE G, ROSS J, KATSOYANNIS P.
The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of
insulin. J Protein Chem 1993; 12: 499-505.
1062. HU S, ZONG L, BURKE G, KATSOYANNIS P.
Contribution of the B16 and B26 tyrosine residues to
the biological activity of insulin. J Protein Chem 1993;
12: 741-7.
1063. CHU Y, HU S, ZONG L, BURKE G, GAMMELTOFT S, CHAN S, STEINER D, KATSOYANNIS P.
Insulin-like compounds related to the amphioxus insulin-like peptide. Biochemistry 1994; 33: 11278-85.
1064. CHU Y, BURKE G, GAMMELTOFT S, CHAN S,
STEINER D, KATSOYANNIS P. High potency hybrid compounds related to insulin and ampioxus insulin-like peptide. Biochemistry 1994; 33: 13087-92.
1065. KUROSE T, PASHMFOROUSH M, YOSHIMASA Y, CARROLL R, SCH-WARTZ G, BURKE G,
KATSOYANNIS P, STEINER D. Cross-linking of a
B25 azidophenylalanine insulin derivative to the carboxy-terminal region of the a-subunit of the insulin
receptor. Identification of a new insulin-binding in the
insulin receptor. J Biol Chem 1994; 269: 29190-7.
1066. LAWS W, SCHWARTZ G, RUSINOVA E, BURKE G, CHU Y, KATSOYANNIS P, ROSS J. 5-Hydroxytryptophan: An absorption and fluorescence
probe which is a conservative replacement for [A14
TYROSINE] in insulin. J Protein Chem 1995; 14:
225-32.
1067. HUA Q, HU S, FRANK B, TIA W, CHU Y,
WANG S, BURKE G, KATSOYANNIS P, WEISS
M. Mapping the functional surface of insulin by design. J Biol Chem 1996; 264: 390-403.
1068. HOFMANN K, KATSOYANNIS P. Synthesis and
function of peptides of biological interest, In: Neurath
H. The Proteins. 2nd ed. New York: Academic Press,
1963: 53-188.
1069. KATSOYANNIS P. Synthetic Insulins. Recent Prog
Horm Res 1967; 23: 505-63.
1070. KATSOYANNIS P, GINOS J. Chemical synthesis
of peptides. Annu Rev Biochem 1969; 38: 881-912.
120
1071. KATSOYANNIS P, COSMATOS A. General aspects of the synthesis of peptide hormones In: Berson
SA, Yalow RS. Methods in Investigative and Diagnostic Endocrinology. Amsterdam; London: NorthHolland Publishing Co, 1973; vol. A: 51-60.
1072. KATSOYANNIS PG. The Chemistry of Polypeptides: Essays in honor of Dr. Leonidas Zervas. New
York: Plenum Press, 1973: 417 p.
1073. KATSOYANNIS P, SCHWARTZ G. The synthesis
of peptides by homogenous solution proceduRes In:
Hirs CHW, Timasheff SN. Enzyme structure. New
York: Acad.Pr., 1977: 501-78.
1074. KATSOYANNIS P. New Synthetic Insulins. In:
Camerini-Davalos RA, Hanover B. Treatment of Early Diabetes. New York; London: Plenum Press, 1979:
319-28.
1075. KATSOYANNIS P. Structure and Function Relationships in Insulin: A Synthetic Approach. In: Liu
TY, Mamiya G. Frontiers in Protein Chemistry. New
York: Elsevier, 1980: 171-92.
1076. KATSOYANNIS P. The Chemical Synthesis of Insulin and the Pursuit of Structure-activity Relationships. In: Dodson G, Glusker JP, Sayre D. Structural
Studies on Molecules of Biological Interest: A volume
in honour of Professor Dorothy Hodgkin. Oxford: Clarendon Press, 1981: 454-86.
1077. KATSOYANNIS P, SCHWARTZ G, BURKE G,
JOSHI S, RECHLER M, TSENG L. Insulin-like
growth factors. In: Theodoropoulos D. Peptides 1986:
Proceedings of the 19th European Peptide Symposium, Porto Carras, Chalkidiki, Greece, August 31September 5, 1986. Berlin; New York: W. de Gruyter,
1987: 43-60.
1078. LAWS W, ROSS J, KATSOYANNIS P, WYSSBROD H. Time resolved fluorometry of the aromatic
amino acids. In: Free-electron laser applications in
the ultraviolet: Summaries of papers in the Ultraviolet Topical Meeting, Cloudcroft, New Mexico. Washington, DC: Optical Society of America, 1988: 129-31.
1079. TSILIBARY E, CHARONIS A, REGER L, WOHLHUETER R, FURCHT L. The effec of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol
Chem 1988; 263: 4302-8.
1080. HADZIDAKIS D, HALVATSIOTIS P, IOANNOU Y, MAVROKEFALOS P, RAPTIS S. The effects of the somatostatin analogue SMS 201-995 on
carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas.
Diab Res Clin Pract 1988; 5: 91-8.
1081. BROWN D, CHARONIS A, FURCHT L, KLEIN
D, MAUER S, STEFFES M, TSILIBARY E. The
role of matrix components. An overview. Diabetes
Care 1991; 14: 157-9.
1082. HAITOGLOU C, TSILIBARY E, BROWNLEE
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
M, CHARONIS A. Altered cellular interactions between endothelial cells and nonenzymaticically glycosylated laminin/type IV collagen. J Biol Chem 1992;
267: 12404-7.
1083. CHARONIS A, TSILIBARY A. Structural and
functional changes of laminin and type IV collagen
following nonenzymatic glycation. Diabetes 1992; 41:
49-51.
1084. CHARONIS A, TSILIBARY E, FURCHT L. Effect
of nonenzymatic glycosylation on the assembly of
basement membrane macromolecules. In: Rudeman
N, Williamson JR, Brownlee M. Hyperglycemia, diabetes and the vascular wall. New York: Oxford
University Press, 1992; 243-62.
1085. ANDERSON S, TSILIBARY E, CHARONIS A.
Nonenzymatic glycosylation induced modifications of
intact tubular basement membrane. J Clinical Invest
1993; 92: 3045-52.
1086. HASEGAWA G, HUNTER A, CHARONIS A.
Matrix nonenzymatic glycosylation leads to altered
cellular phenotype and intracellular tyrosine phosphorilation. J Biol Chem 1995; 270: 3278-83.
1087. TSOPANOGLOU N, TSILIBARY E, CHARONIS
A. Putrescine, a novel inhibitor of glycosylation-induced crosslinks. Microcirculation 1995; 2: 283-7.
1088. ANDERSON S, KIM Y, TSILIBARY E. Effect of
matrix glycation mesangial cell adhesion, spreading
and proliferation on glucose-modified matrix. Kidney
Int 1994; 46: 1359-67.
1089. SETTY S, WAYNER E, KIM Y, TSILIBARY E.
Glucose-induced integrin modifications in cultured
human mesangial cells. Cell Adhes Commun 1995; 3:
187-200.
1090. KALFA T, BINSTICK A, CARLSON E, TSILIBARY E. Effect of retinal basement membrane glycation on the growth rate of retinal microvascular
cells. Invest Ophthalmol Vis Sci 1995; 436: 2358-67.
1091. ANDERSON S, WU K, NAGASI H, STETLERSTEVENSON W, KIM Y, TSILIBARY E. Effect of
matrix glycation on type IV collagen, MMPs and
TIMP expression by human mesangial cells. Cell Adhes Commun 1996; 4: 89-101.
1092. JIN D, FISH A, WAYNER E, MAUER S, SETTY
S, TSILIBARY E, KIM Y. Distribution of integrin
subunits in human diabetic kidneys. J Am Soc
Nephrol 1996; 7: 2636-45.
1093. GRENFELL A, MIGDALIS I, LESLIE R. Short
stature and diabetic complications. Transplant Proc
1986; 18: 1500-1.
1094. ªÀ°¢∞§∏™ ∏, WATKINS P. ∏ Ê˘ÛÈ΋ ÂͤÏÈÍË
Ù˘ Ó¢ÚÔ·ıËÙÈ΋˜ ÔÛÙÂÔ¿ıÂÈ·˜ (¿ÚıÚˆÛË
Charcot) ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1987; 4: 208-10.
1095. ªÀ°¢∞§∏™ ∏, WATKINS P. ∏ ÂÎÙ›ÌËÛË ÙÔ˘
‚·ıÌÔ‡ ¢·ÈÛıËÛ›·˜ ÛÙËÓ ·ÓÙ›ÏË„Ë ‰È·ÊÔÚ¿˜ ıÂÚÌÔ-
ÎÚ·ÛÈÒÓ Î·È ÛÙÔ ·›ÛıËÌ· ÎÚ·‰·ÛÌÒÓ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ¯ˆÚ›˜ ÂÈÏÔΤ˜. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 1987; 5: 374-6.
1096. ªÀ°¢∞§∏™ ∏, WATKINS P. ∏ ·ÎÙÈÓÔÏÔÁÈ΋ ÂÈÎfiÓ· Ù˘ Ó¢ÚÔ·ıËÙÈ΋˜ ·ÚıÚÔ¿ıÂÈ·˜ (¿ÚıÚˆÛË
Charcot) ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓÈ΋ ∞ÎÙÈÓÔÏÔÁ›· 1987; 18: 25-31.
1097. ªÀ°¢∞§∏™ ∏, ΔO§∏™ ∞, ƒ∞¢OÀ-™ºÀƒ∏ ª,
∫OÀ°π∞§∏™ ™, ™∞ª∞ƒΔ∑∏™ ª. ∏ ÌÂϤÙË ÙˆÓ
Úˆ˚ÓÒÓ ÂÈ¤‰ˆÓ ÁÏ˘Îfi˙˘ ·›Ì·ÙÔ˜ ÓËÛÙ›·˜ ÌÂÙ¿
·fi ‰È·ÊÔÚÂÙÈ΋ ıÂÚÌȉÈ΋ Î¿Ï˘„Ë ÙÔ ‚Ú¿‰˘ Û ÌË
ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. Mater Med
Greca 1988; 16: 5: 421-4.
1098. MIGDALIS I, KOURTI A, VOUDOURIS G,
ILIOPOULOU V, YAZDANI N, SAMARTZIS M.
High density lipoprotein cholesterol and peripheral
vascular disease in sulfonylurea-treated diabetic
patients. Progress in Angiology 1988; 127-9.
1099. MIGDALIS I, ILIOPOULOU V, KALOGEROPOULOU K, KOUTOULIDIS K, SAMARTZIS M.
Correlation between high density lipoprotein
cholesterol and C-peptide in sulfonylurea-treated
diabetic patients. J Med 1989; 20: 349-55.
1100. MIGDALIS I, PARARA M, TSORVA A, KATSIKOYANNIS S, LIKOUDI A, SAMARTZIS M.
Prevalence of hepatitis B surface antigen and
antibodies in non-insulin-dependent diabetic patients.
Medicographia 1989, 11: 75-6.
1101. ªÀ°¢∞§∏™ ∏, ΔO§∏™ ∞, £∂O¢øƒO¶OÀ§O™ μ, μOÀ¢OÀƒ∏™ °, ™∞ª∞ƒΔ∑∏™ ª. ∏ ÌÂϤÙË Ù˘ ÛÎÂÏÂÙÈ΋˜ Ì¿˙·˜ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì Ó¢ÚÔ¿ıÂÈ·. ∂ÏÏËÓÈ΋ ƒÂ˘Ì·ÙÔÏÔÁ›· 1989; 1: 163-7.
1102. ªÀ°¢∞§∏™ ∏, ∫∞§O°∂ƒO¶OÀ§OÀ ∫,
∏§πO¶OÀ§OÀ μ, μOÀ¢OÀƒ∏™ °, ∫OÀΔOÀ§π¢∏™ ∫, ™∞ª∞ƒΔ∑∏™ ª. ∏ ÂÎÙ›ÌËÛË ÙˆÓ ÂÈ¤‰ˆÓ ÙÔ˘ ÌÂÙ·ÙÚÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘ Ù˘ ·ÁÁÂÈÔÙÂÓÛ›Ó˘
Î·È Ù˘ ·˘ÍËÙÈ΋˜ ÔÚÌfiÓ˘ ÛÙË ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. Mater Med Greca 1989; 17: 423-6.
1103. ªÀ°¢∞§∏™ ∏, ∫OÀƒΔ∏ ∞, ∏§πO¶OÀ§OÀ μ,
™∞ª∞ƒΔ∑∏™ ª. ∏ ·ÍÈÔÏfiÁËÛË ÙˆÓ ‰È·Ù·Ú·¯ÒÓ
ηډȷ΋˜ ·ÁˆÁÈÌfiÙËÙ·˜ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. Mater Med Greca 1989; 17: 55-8.
1104. ∫OÀƒΔ∏ ∞, ªÀ°¢∞§∏™ ∏. ¢È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·, ¶ÚfiÔ‰Ô˜ π·ÙÚ. ∂ÈÛÙ. 1989; 2: 221-6.
1105. MIGDALIS I, ILIOPOULOU V, KALOGEROPOULOU K, KOUTOULIDIS K, SAMARTZIS M.
Elevation of serum angiotensin-converting enzyme in
diabetic retinopathy. South Med J 1990; 83: 425-7.
1106. MIGDALIS I, KOURTI A, VOUDOURIS G,
LIKOUDI A, SAMARTZIS M. The prevalence of
peripheral vascular disease in sulfonylurea treated diabetic patients with proteinurea. Int Angiol 1990; 9:
271-3.
1107. ªÀ°¢∞§∏™ ∏, ¢∏ª∞∫O¶OÀ§O™ ¡, ΔO§∏™
121
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∞, §À∫OÀ¢∏ ∞, ∫∞§O°∂ƒO¶OÀ§OÀ ∫, ∫OÀΔOÀ§π¢∏™ ∫, ™∞ª∞ƒΔ∑∏™ ª. ™˘Û¯¤ÙÈÛË Ù˘ ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›·˜ Î·È Ù˘ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘ ÛÂ
ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. Mater Med
Greca 1990; 18: 361-4.
1108. ªÀ°¢∞§∏™ ∏, ∏§πO¶OÀ§OÀ μ, μOÀ¢OÀƒ∏™ °, ΔO§∏™ ∞, ™∞ª∞ƒΔ∑∏™ ª. ∂›‰·
·ÛÎÔÚ‚ÈÎÔ‡ ÔͤԘ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜
‰È·‚ËÙÈÎÔ‡˜ Ì ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. Mater Med
Greca 1990;18: 183-6.
1109. MIGDALIS I, KALOGEROPOULOU K, TOLIS
A, KOUTOULIDIS K, SAMARTZIS M. Impaired
pituitary thyrotroph function in type II diabetes
mellitus. Medicographia 1991; 13 (Suppl 1): 20-1.
1110. MIGDALIS I, KOURTI A, ZACHARIADIS D,
VOUDOURIS G, SAMARTZIS M. Antihypertensive treatment and peripheral vascular disease in sulfonylureatreated diabetic patiets. In: Progress in Angiology 1991: 429-31.
1111. MIGDALIS I, KOURTI A, ZACHARIADIS D,
VOUDOURIS G, SAMARTZIS M. Peripheral vascular disease in newly diagnosed non-insulin-dependent diabetics. Int Angiol 1992; 11: 230-2.
1112. ªÀ°¢∞§∏™ ∏, ºøΔO¶OÀ§OÀ ∞, ∑∞Ã∞ƒπ∞¢∏™ ¢, μOÀ¢OÀƒ∏™ °, ∫OÀΔOÀ§π¢∏™ ∫, ™∞ª∞ƒΔ∑∏™ ª. ∞˘ÍË̤ÓË ¤ÎÎÚÈÛË Á·ÛÙÚ›Ó˘ Û ‰È·‚ËÙÈο ¿ÙÔÌ· Ù‡Ô˘ ππ Ì ·˘ÙfiÓÔÌË Ó¢ÚÔ¿ıÂÈ·.
Mater Med Greca 1992; 20: 357-60.
1113. ªÀ°¢∞§∏™ ∏, ∏§πO¶OÀ§OÀ μ, ∑∞Ã∞ƒπ∞¢∏™ ¢, ∫OÀƒΔ∏ ∞, ™∞ª∞ƒΔ∑∏™ ª. ∏ ÂÎÙ›ÌËÛË
ÙˆÓ ÂÈ¤‰ˆÓ ÙÔ˘ ¡-∞cetyl-‚-D-glucosaminidase ÛÂ
ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ì ÌÈÎÚÔ·ÁÁÂÈÔ·ıÂÈ·. Mater Med Greca 1992; 20: 270-3.
1114. ªÀ°¢∞§∏™ ∏. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. π·ÙÚÈΤ˜
∂ÍÂÏ›ÍÂȘ 1993; 54: 16-7.
1115. MIGDALIS I, DIMAKOPOULOS N, KOURTI A,
TOLIS A, KOUTOULIDIS K, SAMARTZIS M. The
prevalence of peipheral vascular disease in type II diabetic patients with and without proteinuria. Int Angiol 1994; 13: 229-32.
1116. MIGDALIS I, KALOGEROPOULOU K, ZACHARIADIS D, KOUTOULIDIS K, SAMARTZIS
M. Serum levels of type III procollagen peptide and
peripheral vascular disease in diabetic patients. Diabetes Res Clin Pract 1994; 23: 179-82.
1117. MIGDALIS I, KALANTZIS L, BAKIDIS S, VOUDOURIS G, SAMARTZIS M. Dissociation of serum
lipids and retinopathy in diabetes mellitus.
Medicographia 1994; 16: 91-2.
1118. ªÀ°¢∞§∏™ ∏, ¡π∞∫∞™ ¢, ¢ƒπ∑∏ §, ∫ÀƒπO¶OÀ§O™ π. ¶ÔÈÔÙÈΤ˜ ‰È·ÊÔÚÔÔÈ‹ÛÂȘ ÈηÓÔÔ›ËÛ˘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ·fi ÙË ¯ÚËÛÈÌÔÔ›ËÛË Ù˘
ÌÂıfi‰Ô˘ NOVOLET. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1994;
11: 36-41.
1119. MIGDALIS I, KALOGEROPOULOU K, KALA-
122
NTZIS L, NOUNOPOULOS CH, BOULOUKOS A,
SAMARTZIS M. Insulin-like growth factor I and
IGF-I receptors in type 2 diabetic patients with neuropathy. Diabet Med 1995; 12: 823-7.
1120. MIGDALIS I, HATZIGAKIS S, DIMAKOPOULOS N, TOLIS A, LIKOUDI A, KOUTOULIDIS K.
Diabetic retinopathy and urinary albumin excetion
rate in type II (non-insulin-dependent) diabetic partients. J Med 1996; 27: 341-50.
1121. MIGDALIS I, ZACHARIADIS D, KALOGEROPOULOU K, NOUNOPOULOS CH, BOULOUKOS A, SAMARTZIS M. Metabolic abnormalities in
offspring of NIDDM patients with a family history of
diabetes mellitus. Diabet Med 1996; 13: 434-40.
1122. MIGDALIS I, ZACHARIADIS D, HATZIGAKIS
S, KOURTI A, KALANTZIS L. Ambulatory blood
pressure measurement in type 2 diabetic patients with
autonomic neuropathy. J Med 1996; 27: 333-40.
1123. ªÀ°¢∞§∏™ ∏. ¶·¯˘Û·ÚΛ· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 1997; 2: 36.
1124. PANAGOULIAS G, TENTOLOURIS N, LADAS
SS. Abdominal pain in an adult with Type 2 diabetes:
A case report. Cases J 2008; 1: 154.
1125. μ∞°πø¡∞™ °, μ∂ƒ°OÀ§∞™ °, ª¶∂∑∞∑∏¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂, §∞∑∞ƒπ¢OÀ ¶,
º∞§Δ™∏™ ™. ªÂÙ·‚ÔϤ˜ Ù˘ ηÌ‡Ï˘ ۷ί¿ÚÔ˘
Î·È ÈÓÛÔ˘Ï›Ó˘ ÌÂÙ¿ ÂÓ‰ÔÊϤ‚È· Î·È per os ¯ÔÚ‹ÁËÛË
ÁÏ˘Îfi˙˘ Û ԢڷÈÌÈÎÔ‡˜ ·ÚÚÒÛÙÔ˘˜. ¶Ú·ÎÙÈο π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ 1982; 1: 354-61.
1126. ∞¡Δ∑OÀ-∞°°OÀƒπ¢∞∫∏ Ã, Δ∑∂Δ∑∏™ μ,
º∞§Δ™∏™ ™. ªÂϤÙË ÙˆÓ ÏÈȉ›ˆÓ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. ™ÙÔ: ¶Ú·ÎÙÈο 6Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ £ÂÛÛ·ÏÔÓ›ÎË, 1989:
(ÛÂÏ.?).
1127. μ∞°πø¡∞™ °, ª∞ÀƒOª∞Δπ¢∏™ ∫, ª¶∂∑∞∑∏-¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂, μ∞§∫OÀª∞ ¢,
º∞§Δ™∏™ ™. ªÂÙ·‚ÔϤ˜ ÁÏ˘Îfi˙˘, ÈÓÛÔ˘Ï›Ó˘ ηÈ
C-ÂÙȉ›Ô˘ ηٿ ÙËÓ ‰È¿ÚÎÂÈ· Ù˘ ·ÈÌÔηı¿ÚÛˆ˜.
Mater Med Greca 1986; 14: 257.
1128. KATOULIS E. C, DROSINOS E, DIMITRIADIS
G, HADJIDAKIS D, MAVROKEFALOS P, RAPTIS S. Efficasy of a new needles insulin delivery system monitoring of blood glucose fluctuations and free
insulin levels. Int J Artif Organs 1989; 12: 333-8.
1129. RAPTIS A, TOUNTAS N, YALOURIS A, HADJIDAKIS D, ZAHARIS A, MIRAS K, RAPTIS S.
Comparative study of the therapeutic effects of
glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide. Acta Diabetol Lat 1990; 27: 11-22.
1130. X∞§∂μ∂§∞∫∏™ °. O ‰È·‚‹Ù˘ ˆ˜ ÚԉȷıÂÛÈÎfi˜
·Ú¿ÁÔÓÙ·˜ ÏÔÈÌÒ͈Ó. ™ÙÔ: ∫ˆÓÛÙ·ÓÙÈÓÔÔ‡ÏÂÈÔ
°¡ ¡. πˆÓ›·˜ «∞Á›· ŸÏÁ·» - μ′ ¶·ıÔÏÔÁÈ΋ ∫ÏÈÓÈ΋. £¤Ì·Ù· ∂ÛˆÙÂÚÈ΋˜ ¶·ıÔÏÔÁ›·˜. ΔfiÌÔ˜ ÚÔ˜ ÙÈÌ‹Ó ÙÔ˘ π. ¶ÚÈfi‚ÔÏÔ˘. 1996: 147-53.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1131. ™∫∞ƒ∞°∫∞™ °, ™∫∞ƒ∞°∫∞-ƒ∂¶∞¡Δ∞ ∂. §ÔÈÌÒÍÂȘ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÔ Ì¤ÁÂıÔ˜ ÙÔ˘
̇ıÔ˘. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 115-30.
1132. ™∞ƒ∞¡ΔO¶OÀ§OÀ μ. O ÚfiÏÔ˜ Ù˘ ·˘ÍËÙÈ΋˜
ÔÚÌfiÓ˘ (GH) Î·È ÙˆÓ ÈÓÛÔ˘ÏÈÓÔÌfiÚÊˆÓ ·˘ÍËÙÈÎÒÓ
·Ú·ÁfiÓÙˆÓ I (IGF-I) Î·È II (IGF-II) ÛÙËÓ ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 131-7.
1133. ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ‰È·ÙÚÔÊ‹ ÙˆÓ ˘ÂÚËϛΈÓ.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 138-43.
1134. ª∞¡∂™ Ã, ¢∏ª∏Δ™π∫O°§OÀ ¡, ™OÀ§∏™ ∫,
™∞Δ™O°§OÀ ∞, ™πª∂§π¢∏™ ¢. E›‰Ú·ÛË ÙˆÓ
ÌÂÙ·‚ÔÏÒÓ ÙÔ˘ ۈ̷ÙÈÎÔ‡ ‚¿ÚÔ˘˜ Î·È Ù˘ Ê˘ÛÈ΋˜
ηٿÛÙ·Û˘ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜.
™ÙÚÔÁÁ‡ÏË ΔÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997;
10: 144-66.
1135. ¶∞¡π¢∏™ ¢, ∫∞§∞Ã∞¡∏™ π, ƒOÀ™™O™ ¢,
™∫π∞¢O¶OÀ§O™ ™, ™Δ∂ƒ°πO¶OÀ§O™ ∫,
ª∞ÀƒOª∞Δπ¢∏™ °, ¶∂çπμ∞¡π¢∏™ ∫, ª∂§∂OÀ¡∏ ∞, ∫∞ƒ∞°π∞¡¡∏™ μ, ª∞ªO¶OÀ§O™ ª. ÀÔÁÔÓÈÌfiÙËÙ· ÏfiÁˆ ·Ó·ÛÙÚÈÊ‹˜ ÂÎÛÂÚÌ¿ÙÈÛ˘ ÔÊÂÈÏÔ̤Ó˘ Û ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 167-70.
1136. ™πª∂§π¢∏™ ¢, ∞¶O™ΔO§π¢OÀ ∫, μ∞¢∞ƒ§∏™ ∂. ÃÚ‹ÛË ‚ÔÙ¿ÓˆÓ ·fi ‰È·‚ËÙÈÎÔ‡˜. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 171-4.
1137. ª∞¡∂™ Ã, ¶∞¶∞∑O°§OÀ ¡, ™ø™™π¢OÀ ∂,
¶∞¶∞¢∂§∏ ∂, ∫∞ƒ∞°π∞¡¡∏ ¢, ∏§π∞¢∏™ μ,
™∞∫∞§§∂ƒOÀ ∞. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· Û هÔ˘ π ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο
1997; 10: 175-8.
1138. ª∂§π¢ø¡∏™ ∞, ∏ƒ∞∫§∂π∞¡OÀ ™, μƒ∞¡OÀ
O, ª¶∂§Δ∂∫O™ ¢, ºOÀ™∞™ ™Δ. §ÂÈÙÔ˘ÚÁÈÎfiÙËÙ· ·ÚÈÛÙÂÚ¿˜ ÎÔÈÏ›·˜ Â› ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›·˜ ÛÙÔÓ
NIDDM. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 1997; 10: 179-83.
1139. ∫∞ƒ∞ª∏Δ™O™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Î·È ‰˘ÛÏÈȉ·È̛˜. ÀÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›· ‹ ·ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË; ∂ÏÏËÓ. π·ÙÚÈ΋
1997; 63: 101-6.
1140. KRAFT S, MARRERO D, LAZARIDIS E, FINEBERG N, QIU C, CLARK C. Primary care physicians
practice patterns and diabetic retinopathy: Current
levels of care. Fam Med 1997; 6: 29-37.
1141. RIGAS A, BITTLES A, HADDEN D, MONTGOMERY D. Circardian variation of glucose, insulin and
free fatty acids during the long term use of oral
hypoglycaemic agents in diabetes mellitus. Brit Med J
1968; 4: 25.
1142. ªO™ÃO™ ∞, ¢∞¡∂§∞ΔOÀ-∞£∞¡∞™π∞¢OÀ ∫,
∫∞ƒ¶OÀ∑∞™ π, ∫∞Δ™∏™ ∫, ƒ∏°∞™ ∞. ¡ÂÔÁÓÈÎfi˜
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ¢ÂÏÙ›ÔÓ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ 1971; 18: 318.
1143. ƒ∏°∞™ ∞. £ÂÚ·›· ÂÈÏÔÎÒÓ Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ¢ÂÏÙ›ÔÓ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ 1971; 2: 190.
1144. ƒ∏°∞™ ∞. °ÏÈ‚ÂÓÎÏ·Ì›‰Ë, ¤Ó Ó¤ÔÓ ÈÛ¯˘ÚfiÓ ·ÓÙȉȷ‚ËÙÈÎfiÓ Ê¿ÚÌ·ÎÔÓ. ¡ÔÛÔÎ. ÃÚÔÓÈο 1971; 33:
769.
1145. ∫∞Δ™πÃΔ∏™ ¶, ¶∞¶∞¢∏ª∞™ π, π∫∫O™ ¢, ªπÃ∞™ ¶, ƒ∏°∞™ ∞. K·ÎfiËı˜ ÔÚÌÔÓÔ·Ú·ÁˆÁfiÓ ÈÓÛÔ˘Ï›ÓˆÌ·. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1974; 8: 102.
1146. ƒ∏°∞™ ∞, °π∞¡¡∞ΔO™ π, ƒ∏°∞∫OÀ-∫∞ƒ¢∞∫OÀ ¢, ∑OÀ§π∞Δ∏™ Ã, π∫-∫O™ ¢. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ˘ÔÁÏ˘Î·ÈÌ›·˜ Î·È ÈÓÛÔ˘ÏÈÓÔÙÚfiÔ˘ ‰Ú¿Ûˆ˜
ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜ Î·È ÁÏÈÈ˙›‰Ë˜ (∫-4024) Â› ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1975; 1: 556.
1147. ƒ∏°∞™ ∞. ¶·¯˘Û·ÚΛ· Î·È ‰È·‚‹Ù˘. ¢È·‚ËÙÔÏÔÁÈο ¡¤· 1976; (ÙfiÌ.?): (ÛÂÏ.?).
1148. ∞º∂¡ΔOÀ§π¢∏™ ¢, °π∞¡¡∞ΔO™ π, ƒ∏°∞™ ∞.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÌÌËÓfi·˘ÛË. (™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Â› 790 ÂÚÈÙÒÛÂˆÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË). ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1978; 3: 696.
1149. ƒ∏°∞™ ∞. ™˘Ó‰ÂÙÈÎfi ÂÙ›‰ÈÔ (C-peptide). ¢Â›ÎÙ˘
Ù˘ ÂÎÎÚÈÙÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ÙÔ˘ ‚-΢ÙÙ¿ÚÔ˘. π·ÙÚÈ΋
1978; 34: 270.
1150. ƒ∏°∞™ ∞. ™·Î¯·Ú›ÓË Î·È Î·ÚÎÈÓÔÁ¤ÓÂÛË. π·ÙÚÈ΋
1980; 38: 78.
1151. ƒ∏°∞™ ∞. MÂÙÂÎ·È‰Â˘ÙÈο Ì·ı‹Ì·Ù· ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ∞ı‹Ó·: ∂ΉfiÛÂȘ ∑·¯·ÚÔÔ‡ÏÔ˘, 1980.
1152. THUM CH, LAUBE H, SCHRODER K, RAPTIS
S, PFEIFFER E. Das kontinuierliche Blutzuckertagesprofil in Korrelation zum Seruminsulin bei idealge-wichtigen und normalgewichtigen stoffwechselgesunden. Dtsch Med Wochenschr 1975; 100: 1595-9.
1153. BEISCHER W, HEINZE E, KELLER L, RAPTIS
S, PFEIFFER E. Human C-peptide , part II Clinical
data. Klin Wochenschr 1976; 54: 717-25.
1154. HERBE H, JONTOFSOHN R, TOURKANTONIS
A, HEINZE V, SCHRODER K, RAPTIS S. Wachstumshormon (HGH) und Glukosestoffwechsel bei
Patienten unter Langzeittdialysebehandlung. Nierenund Hochdruck-krankheiten 1976; 1: 37-42.
1155. DIMITRIADIS G, HATZIANGELAKI E, ALEXOPOULOS E, KORDONOURI O, KOMESIDOU
V, GANOTAKIS E, RAPTIS S. Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I
diabetes mellitus. Diabetes Care 1991;14: 393-8.
1156. KERNER W, BEISCHER W, TAMAS jr Gy, RAPTIS S, PFEIFFER E. Die Insulinbehandlung des
entgleisten Diabetes Mellitus mit einen künstlichen
endokrinen Pankreas. Dtsch Med Wochenschr 1977;
102: 1500-5.
1157. RAPTIS S, ESCOBAR-JIMENEZ F, ROSENTHAL J, DITSCHUNEIT H, PFEIFFER E. Somatostatin modulation of pancreatic glucagon, insulin glucose and free fatty acids following beta adrenergic
stimulation. J Clin Endocrinol Metab 1977; 44: 108893.
123
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1158. ROVENSTRUNK U, BEISCHER W, LOEPRECHT H, RAPTIS S, PFEIFFER E. Hepatic
clearance of C-peptide and insulin. Konstanz: Schnetztor Verlag, 1977: 41-53.
1159. BEISCHER W, KERNER W, RAPTIS S, KELLER
L, BEISCHER B, PFEIFFER E. Insulin therapy in
relation to C-peptide levels. Diabetes 1978; 27 (Suppl
1): 235-40.
1160. BEISCHER W, RAPTIS S, KELLER L, MAAS M,
BEISCHER B, FEILEN K, PFEIFFER E. Sekretionsdynamik der Betazelle bei erwachsenen Diabetikern nach Stimulation mit Glibenclamid-glucose i.v.
Klin Wochenschr 1978; 56: 111-20.
1161. GRUBE D, RAPTIS S, SCHLEGEL W, MAIER V.
Immunoreactivity of the endocrine pancreas. Evidence for the presence of cholecystikinin. Histochem
Cell Biol 1978; 56: 13-35.
1162. HATZIDAKIS D, RAPTIS S. Proinsulin as a possible therapeutic agent. Horm Metab Res Suppl 1992;
26: 131-7.
1163. RAPTIS S, ZOURAS CH, DIMITRIADIS G,
MOULOPOULOS S. The use of the artificial beta
cell in diagnosis and treatment of insulinoma. Horm
Metab Res 1979; 8: 169-72.
1164. DIMITRIADIS G, RAPTIS S, ZOUPAS CH,
SCHIZAS N. The validity of C-peptide measurement
in the diagnosis of factitious hypoglycemia. Acta Diabetol Lat 1980; 17: 67-71.
1165. PFEIFFER E, RAPTIS S. Intestinale hormone und
insulinsekretion. Klin Wochenschr 1968; 46: 337-42.
1166. RAPTIS S, SCHRODER K, FAULHABER J,
PFEIFFER E. Stimulierung der insulinsekretion
durch sekretin beim diabetiker. Dtsch Med Wochenschr 1968; 93: 2420-4.
1167. DOLLINGER H, RAPTIS S, ROMMEL K, PFEIFFER E. Effects of secretin and cholecystokinin-pancreozymin on water, electrolyte and glucose absorption in human jejunum. A comparison between defferent hormone preparation. Res Exp Med (Berl)
1982; 180: 215-21.
1168. TELIB M, RAPTIS S, SCHRODER K, PFEIFFER
E. Serotonin and insulin release in vitro. Diabetologia
1968; 4: 253-6.
1169. FUSSGANGER R, HINZ M, GOBERNA R, JAROS P, KARSTEN O, PFEIFFER E, RAPTIS S.
Comparatie studies on the dynamics of insulinsecretion
following HB 419 and tolbutamide on the perfused isolated rat pancreas and the perfused isolated islets of
Langerhans. Horm Metab Res Suppl 1969; 1: 34-40.
1170. FUSSGANGER R, STRAUB K, GOBERNA R,
JAROS P, SCHRODER K, RAPTIS S, PFEIFFER
E. Primary secretion of insulin and secondary release
of glycagon from isolated perfused rat pancreas following stimulation with pancreozymin. Horm Metab
Res 1969; 1: 224-7.
124
1171. GOBERNA R, FUSSGANGER R, RAPTIS S,
DITSCHUNEIT H, PFEIFFER E. Glybenclamid
(HB 419) and the prediabetes of subtotally pancreatomized rats. Horm Metab Res 1969; 1: 175-7.
1172. RAPTIS S, DIAMANTOPOULOS E. Die derzeitige Stellung der oralen Diabetesbehandlung. Dtsch
Arztebl 1982; 38: 29-39.
1173. RAPTIS S, SCHRODER K, FAULHABER J,
PFEIFFER E. Antagonistische Wirkung von instestinalen Hormonen und Diazoxid auf die Insulinsekretion beim Menschen. Horm Metab Res 1969; 1: 116121.
1174. RAPTIS S, SCHRODER K, PFEIFFER E. Insulin
stimulating action of secretin in maturity onset diabetes. Horm Metab Res 1969; 1: 91-2.
1175. ROMMEL K, RAPTIS S, BURKHARDT H, ENDRES O. Seruminsulin bei galactose- und galactoseglucose resorption. Z. Gastroenterologie 1969; 7: 18891.
1176. RAPTIS S, HATZIDAKIS D, ENZMANN F,
RAPTIS A, DIAMANTOPOULOS E, ROSENTHAL J. Inhibition of pancreatic glucagon responses
to arginine by human insulin (recombinant DNA) and
purified porcine insulin in normal and diabetic
subjects. Diabetes Care 1982; 5 (Suppl 2): 93-101.
1177. BEYER J, SCHOFFLING K, DITSCHUNEIT H,
RAPTIS S, PFEIFFER E. Hypoglykamien bei inselzelltumoren. Diagnostik 1970; 3: 163-6.
1178. RAPTIS S, RAU R, SCHRODER K, ROTHENBUCHNER G, PFEIFFER E. Die Dynamik der
Insulinsekretion bei der Hypothyreose vor und
während der Substitutionstherapie. Klin Wochenschr
1970; 48: 362-6.
1179. RAPTIS S, ROTHENBUCHNER G, SCHRODER
K, FAULHABER J, PFEIFFER E. Klinische und
experimentelle Untersuchungen über die Wirkung
eines Benzothiazins (Diazoxid) auf den Kohlenhydratstonfwechel. Wien Z Inn Med 1970; 51: 557-71.
1180. BOHMER R, ROMMEL K, GOBERNA R, RAPTIS S. Disaccharidasenaktivität des Jejunums
subtotal pankreatektomierter Ratten. Clin Chim Acta
1971; 33: 63-7.
1181. GOBERNA R, FUSSGANGER R, RAPTIS S, TELIK M, PFEIFFER E. The role of exocrine pancreas
in the stimulation of insulin secretion by intestinal
hormones. II. Insulin responses to secretin and
pancreozymin in experimentally-induced pancreatic
exocrine insufficiency. Diabetologia 1971; 7: 68-72.
1182. RAPTIS S, DIMITRIADIS G. Human insulin. Clin
Physiol Biochem 1985; 3: 29-42.
1183. DIMITRIADIS G, KARAISKOS C, RAPTIS S.
Effects of prolonged alpha-glucosidase inhibition on
blood glucose control and insulin requirements in
patients with insulin-dependent diabetes mellitus.
Horm Metab Res 1986; 18: 253-5.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1184. RAPTIS S, RAU R, SCHRODER K, HARTMANN W, FAULHABER J, CLODI P, PFEIFFER
E. The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. III.
Insulin responses to secretin and pancreozymin and to
oral and intravenous glucose, in patients suffering
from chronic insufficiency of exocrine pancreas.
Diabetologia 1971; 7: 160-7.
1185. DIMITRIADIS G, RAPTIS S, RAPTIS A, HATZIAGELAKI E, MITRAKOU A, HALVATSIOTIS P,
LADAS S, HILLEBRAND I. Effects of two new
alpha-glucosidase inhibitors (BAY-1248 and BAY1099) on glycemic control in patients with insulin
dependent diabetes mellitus. Klin Wochenschr 1986;
64: 405-10.
1186. CHALEVELAKIS G, KARATAPANIS S, YALOURIS A, THALASSINOS N, PALLIKARIS G,
ANASTASSIOU C, RAPTIS S. Estimation of glycosylated fetal haemoglobin in normal cord blood by
isoelectric focusing and birth. Acta Diabetol Lat 1987;
24: 249-56.
1187. DOLLINGER H, RAPTIS S, GREBE B, MULLER
R, HINZE H, PFEIFFER E. The influence of 1-(5oxohexyl)-3, 7-dimethyl-xanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretion and cholecystokinin pancreozymin stimulation. Res Exp Med (Berl) 1973;
191: 327-34.
1188. JONTOFSOHN R, TOURKANTONIS A, HERB
H, RAPTIS S, HEINZE V. Glucose-und insulinstoffwechsel bei dialysepatienten. Klin Wochenschr 1973;
51: 1010-5.
1189. DOLLINGER H, RAPTIS S, PFEIFFER E. Effects
of somatostatin on exocrine and endocrine pancreatic
function stimulated by intestinal hormones in man.
Horm Metab Res 1976; 8: 74-8.
1190. DIAMANTOPOULOS E, RAPTIS S, MOULOPOULOS S. Red blood cell deformability index in diabetic retinopathy. Horm Metab Res 1987; 19: 56973.
1191. RAPTIS S, DOLLINGER H, CHRISSIKU M, ROTHEBUCHNER G, PFEIFFER E. The influence of
beta sympathic blockade (propranolol) on the endocrine and exocrine function of the pancreas after
administration of intestinal hormones (SK/ CCK-PZ)
in man. Eur J Clin Invest 1973; 3: 163-8.
1192. RAPTIS S, DOLLINGER H, LAUBE H, RAU R,
FAULHABER J, PFEIFFER E. Der Einfluß von
Atropin auf die durch intestinale Hormone induzierte Insulinsekretion des Menschen. Res Exp Med
(Berl) 1973; 160: 234-7.
1193. RAPTIS S, DOLLINGER H, SCHRODER K,
SCHLEYER M, ROTHENBUCHNER G, PFEIFFER E. Insulin growth hormone and pancreatic secretion induced by amino acids in man. N Engl J Med
1973; 288: 1199-202.
1194. HATZIDAKIS D, RAPTIS S, RAPTIS A, KARAISKOS C, SOUVATZOGLOU A, DIAMANTOPOULOS E. The antidiabetic action of somatostatin28 as assessed by the artificial endocrine pancreas:
Greater potency than somato statin-14. Horm Metab
Res 1987; 19: 571-8.
1195. LAUBE H, Der Einfluß von Ernährungsfaktoren
auf die Entstehung von Fettsucht und Hyperinsulinismus. Dtsch Med Wochenschr 1973; 98: 1256-59.
1196. RAPTIS S, DOLLINGER H, ROTHENBUCHNER G, FUSSGANGER R, KLOR U, PFEIFFER
E. Effect of acetazolamide on the insulin response to
intravenous administration of secretin. Ann Nutr
Metab 1974; 16: 79-86.
1197. RAPTIS S. Orale Antidiabetika einschieblich Glucosidasehemmern. Internist 1987; 28: 243-53.
1198. RAPTIS S, MITRAKOU A, HATZIDAKIS D,
DIAMANTOPOULOS E, ANASTASSIOU C,
FOUNTAS A, FULLER R. 24-h blood glucose pattern in type I and type II diabetics after oral treatment
with pentoxifylline as assessed by the artificial endocrine pancreas. Acta Diabetol Lat 1987; 24: 181-92.
1199. RAPTIS S, BERGER VON L, DOLLINGER H,
GOSTOMZYK J, PFEIFFER E. Influence of
ethanol, caffeine and intragastric cooling on gastrin
and insulin secretion in man. Ann Nutr Metab 1974;
17: 352-9.
1200. YALOURIS A, RAPTIS S. Effect of diabetes on
porphyrine attacts. Br Med J 1987; 295: 1237-8.
1201. KARAVANAKI K, TSOKA E, KARAYIANNI C,
PETROU V, PIPPIDOU E, BRISIMITZI M, MAVRIKIOU M, KAKLEAS K, KONSTANTOPOULOS I, MANOUSSAKIS M, DACOU-VOUTETAKIS C. Prevalence of allergic symptoms among children with diabetes mellitus type 1 of different socioeconomic status. Pediatr Diabetes 2008; 9 (4 Pt 2): 40716.
1202. RAPTIS S, DOLLINGER H, BERGER von L,
KISSING J, SCHRODER K, KLOR U, PFEIFFER
E. Effect of lipids on insulin growth hormone and exocrine pancreatic function in humans. Eur J Clin Invest 1975; 5: 521-6.
1203. DIMITRIADIS G, VLACHONIKOLIS I, HATZIAGELAKI E, KORDONOURI O, ALEXOPOULOS E, RAPTIS S. The dawn phenomenon in
patients with type II diabetes mellitus. Diabetes Nutr
Metab 1988; 1: 37-41.
1204. PAPADAKI A, LINARDAKIS M, CODRINGTON C, KAFATOS A. Nutritional intake of children
and adolescents with insulin-dependent diabetes mellitus in Crete, Greece. A case-control study. Ann Nutr
Metab 2008; 52: 308-14.
1205. DIAMANTOPOULOS E, RAPTIS S, CHRISTODOULOU M, MOULOPOULOS S. Impaired red
blood cell deformability in diabetic angiopathy. The
125
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
Royal Society of Medicine, London, International
Congress and Symposium Series 1984; 77: 93-104.
1206. RAPTIS S, HATZIDAKIS D, RAPTIS A, MITRAKOU A, DIAMANTOPOULOS E. Comparison between purified porcine insulin and biosynthetic human insulin in clinical and experimental studies. The
Royal Society of Medicine, London International
Congress and Symposium Series. 1984; 77: 35-48.
1207. ADAM E, RAPTIS S, SCHRODER K, PFEIFFER
E. Untersuchungen zur Kinetik von Insulin , Glukose
und fettsauren bei normalgewichtigen, adiposen und
diabetischen Patienten. Radioaktive Isotope in Klinik
und Forschung. In: 8. International Symposium Bad
Gastein 1968, München: Urban und Schwarzenberg,
1968: 278-90.
1208. DITSCHUNEIT H, PETRUZZI E, FAULHABER
J, SCHRODER K, RAPTIS S. Der ∂influss körperlicher Blastung auf die Lpolyse bei fettsüchtigen und
potentiellen Dabetikern. Verh Dtsch Ges Inn Med
1968; 74: 941-4.
1209. SCHRODER K, RAPTIS S, FAULHABER J,
PFEIFFER E. Die Wirkung von Pankreozymin auf
Blutzucker, immunologisch mebbares insulin, freie
Fettsäuren und Glycerin beim Menschen. In: Kracht
J. Nebenschilddrüse und endokrine Regulationen des
Calciumstoffwechsels: 14 Symposion der Deutschen
Gesellschaft für Endokrinologie Heidelberg 07 -09
März 1968. Berlin: Springer Verlag, 1968: 170-3.
1210. CLODI H, HARTMANN W, ROTT W, RAPTIS S,
PFEIFFER E. Das Verhalten des Serum-Insulins
(IMI) bei Sekretin-und Pankreozymin-Test. Verh
Dtsch Ges Inn Med 1969; 75: 642-5.
1211. HARTMANN W, BRETSCHNEIDER H, RAPTIS
S, WOLFERT W, CLODI P. Die exokrine Pankreasfunktion beim Diabetes Mellitus und seiner Behandlung. In: Proceedings of the 1st Internationales Donau-Symposium über Diabetes Mellitus Proceedings
Wien 27-28 Juni 1969. 1969: 303-6.
1212. FEDERLIN K, RAPTIS S, BEYER J, PFEIFFER
E. Immunhistologische Untersuchungen unter Nachweis von Serum und Tumor-Insulin bei insulom. In:
15 Symposion der Deutschen Gesellschaft für Endokrinologie 06 - 08. März 1969 Köln. Berlin: Springer
Verlag, 1969: 415-7.
1213. PFEIFFER E, FUSSGANGER R, HINZ M, RAPTIS S. Dynamics of insulin secretion: Comparisons
of various in vitro preparations. In: Falkmer S, Hellman B, Taljedal IB. The Structure and metabolism of
the pancreatic islets: A centennial of Paul Langerhans’ discovery. Proceedings of an international symposium held in Umea, Sweden, Feb. 17-19. Oxford,
New York, Pergamon Press, 1970: 423-34.
1214. RAPTIS S, GOBERNA R, SCHRODER K,
DITSCHUNEIT H, PFEIFFER E. Die Wirkung der
intestinalen Hormone Sekretin und Pankreozymin bei
der total pankreatektomierten Ratte. In: 75 Kongress
126
der Deutschen Gesselschaft für Innere Medizin Wiesbaden 1969. München: Bergmann Verlag, 1969: 650-3.
1215. RAPTIS S, SCHRODER K, ROTHENBUCHNER
G, PFEIFFER E. Die Hemmung der Inssulinsekretion durch Diazoxid und seine Anwendung bei Inselzelltumoren. In: Proceedings of the 1st Internationales Donau-Symposium über Diabetes Mellitus Proceedings Wien 27-28 Juni 1969. 1969: 283-7.
1216. SCHRODER K, RAPTIS S, PFEIFFER E. Glukoseassimilation und Seruminsulin bei der Akromegalie.
I. In: Proceedings of the 1st Internationales DonauSymposium über Diabetes Mellitus Proceedings Wien
27-28 Juni 1969: 1969: 225-8.
1217. SCHRODER K, RAPTIS S, TELIB M, PFEIFFER
E. Intestinal hormones affecting insulin secretion in
vitro: Secretin, pancreozymin, gastrin, 6th Congress
Intern. Diab. Fed. Stockholm 30.07.-04.08.1967. In:
Pfeiffer EF. Intestinal factors controlling insulin
secretion, 6th Congress IDF, Stockholm 1967, Exc.
Med. Foundation, ICS, 1969; 172: 419-24.
1218. STRAUB K, GOBERNA R, FUSSGANGER R,
RAPTIS S. Die Wirkung des oralen Antidiabetikums
Glybenclamid (HB 419) an Ratten. 1: In Vivo-Untersuchungen zu verschiedenen Parametern des Glukosestoffwechsels an normalen und subtotalpankreatektomierten Ratten. In: Proceedings of the 1st Internationales Donau-Symposium über Diabetes Mellitus
Proceedings Wien 27-28 Juni 1969. 1969: 89-92.
1219. TELIB M, RAPTIS S, PFEIFFER E. Vergleiche der
Untersuchugen über die Wirkung von HB 419 und
Tolbutamid auf die Insulinsekretion am isolierten
Pankreasgewebe. In: Proceedings of the 1st Internationales Donau-Symposium über Diabetes Mellitus
Proceedings Wien 27-28 Juni 1969. 1969: 387-90.
1220. PFEIFFER E, FUSSGANGER R, HINZ M,
RAPTIS S, SCHLEYER M, STRAUB K. Extrapancreatic hormones and insulin secretion. Proceedings
of the 7th International Congress Diab. Federation
Buenos Aires 23 - 28 August 1970. Int Congr Ser
1970: 460-71.
1221. PFEIFFER E, RAPTIS S. Direkte und indirekte
Einflusse intestinaler Hormone auf die Insulinsekretion. In: Dtsch. Ges. fur Ernhärung, 3. Symp. über klinische Ernährungslehre, München, 19. April 1968.
1970: 34-8.
1222. PFEIFFER E, RAPTIS S, SCHRODER K. Alimentary polypeptides and insulin secretion. 3rd Symposium European Pancreatic Club, Prag. 02 -04 Juli
1968. In: Progress in Pancreatology. Praha: Czechoslovak Medical Press, 1970: 54-64.
1223. STRAUB K, FUSSGANGER R, GOBERNA R,
RAPTIS S, PFEIFFER E. Zur Regulation der L-Serin Dehydratase in der Leber subtotal pankreatomierter Ratten durch Glibenclamid. Arbeitsgesprach Mediz. Univ. Klinik Freiburg, Enzyme und Pharmaka,
Editions Roche. 1970: 249-54.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1224. RAPTIS S, THUM Ch, SCHRODER K, ROTHENBUCHNER G, KLOR U, RAU R, PFEIFFER E. Die Insulinsekretion nach der einfachen und
wiederholten Injektion von RO6-4563/8, Glibenclamid (HB 419), Tolbutamid oder Chlorpropamide ohne und mit gleichzeitiger Gabe von Glukose bei Stoffwechselgesunden und Altersdiabetikern. In: 2 Internationales Donau-Symposium über Diabetes Mellitus
Proceedings. Budapest, 1971: 347-51.
1225. STRAUB K, FUSSGANGER R, SCHLEYER M,
GOBERNA R, RAPTIS S, PFEIFFER E. Insulinotropic effect of adipokinetic porcine hypophyseal
extract. IV Congressus Endocrinologicus HUNGARICUS, Budapest 29. Sept. -1. October 1969. In: Polypeptide Hormones. Budapest: Akademiai Kiado,
1971: 197-204.
1226. THUM Ch, RAPTIS S, KLOR U, ROTHENBUCHNER G, SCHLEYER M, RAU R, PFEIFFER
E. Radioimmunologisch messbares Insulin (IMI),
Blutzucker (BZ), freie Fettsäuren (FFS) und freies
Glyzerin (FG) nach der Gabe von RO6-4563/8, Tolbutamid, Glibenclamid und Chloropropamid bei
Stoffwechselgesunden und Diabetikern. In: 2 Internationales Donau-Symposium über Diabetes Mellitus
Proceedings. Budapest, 1971: 219-23.
1227. PFEIFFER E, FUSSGANGER R, GOOBERNA
R, HINZ M, RAPTIS S. Gastrin and related hormones, and islet function. Proceedings of the 2nd International Symposium on protein and polypeptide
hormones, 27.09 – 01.10 1971 Liege. Int Congr Ser
1972: 486-8.
1228. PFEIFFER E, FUSSGANGER R, RAPTIS S. Gastrointestinal hormones and islet function. 4th International Congress of Endocrinology, Washington 1972.
Int Congr Ser 1972: 512-9.
1229. PFEIFFER E, FUSSGANGER R, RAPTIS S. Gastrointestinal hormones and islet function. Acta Diabetol Lat 1972; 9 (Suppl 1): 233-73.
1230. RAPTIS S, ROTHENBUCHNER G, PFEIFFER
E. An experimental clinical investigation of the effect
of diazoxide on carbohydrate metabolism and its
therapeutic application. Estratto da Acta Isotopica.
Hypoglycaemia and Diazoxide. Padova, Cedam, 1973:
XI: 347–64.
1231. HIRTH-SCHMIDT H, RAPTIS S, SCHRODER K,
PFEIFFER E. Die Wirkung der Betarezeptorenblocker Pindolol (LB 46) und beta-adrenol (KL 255)
auf die durch Arginin und Muskelarbeit induzierte
Wachstumshormonsekretion beim Menschen. In: 3
Internationales Donau-Symposium über Diabetes
Mellitus: Salzburg, 10. - 12. Sept. 1973. Wien:
Maudrich, 1973: 781-6.
1232. LAUBE H, RAPTIS S, PFEIFFER E. Übergewichtt
und Hyperinsulinismus als Folge qualitativer
Ernährungsfaktoren. In: 79 Tagung der Deutschen
Gesellschaft für innere Medizin. 1973: 1197-9.
1233. PFEIFFER E, FRANK M, FUSSGANGER R,
GOBERNA R, HINZ M, RAPTIS S. Gastrointestinal hormones and islet function. In: Andersson S.
Frontiers in gastrointestinal hormone research: Proceedings. Nobel Symposium, 16th, Stockholm 1970.
Stockholm: Almquist & Wiksell, 1973: 245-59.
1234. RAPTIS S, SCHRODER K. Wie Euglycon auf die
Betazelle wirkt. Diabetes Journal 1973; 3: 86-7.
1235. RAPTIS S, SCHRODER K, PFEIFFER E. Die
kombinierte Intravenose Glukose-Glibenclamid-Belastung als Test zur Vorhersage des erfolges der oralen Dauerbehandlung des Diabetes der erwachsenen
mit Glibenclamid. In: 79. Tagung der Deutschen Gesellschaft für Innere Medizin, Wiesbaden 29. April bis
3. Mai 1973. München: Bergmann Verlag, 1973: 12103.
1236. ROTHENBUCHNER G, RAPTIS S, PFEIFFER
E. Die πnsulinsekretion unter dem ∂influss von SHDrivaten. 2 Osterr. Internistentagung Salzburg, 10-11
Okt. 1971. Wien Z Inn Med 1973; 54: 69-77.
1237. STUBER G, RAPTIS S, BERGER L, PFEIFFER
E. Die Bedeutung der intestinalen Hormone auf die
durch Glukose induzierte Insulinsekretion bei normalgewichtigen und adiposen manifesten Diabetikern. In: 3. Internationales Donau-Symposium über
Diabetes Mellitus: Salzburg, 10. - 12. Sept. 1973. Wien: Maudrich, 1973: 109-15.
1238. BERGER L, RAPTIS S, KISSING J, ROTHENBUHNER G, PFEIFFER E. Potenzierung der durch
Arginin induzierten Insulinsekretion durch eine
gleichzeitige Fettinfusion. In: 3 Internationales Donau-Symposium über Diabetes Mellitus: Salzburg, 10.
- 12. Sept. 1973. Wien: Maudrich,1973: 139-42.
1239. PFEIFFER E, HEINZE E, MAIER V, RAPTIS S.
The case of the glucose receptor of the beta cell: Its
significance and impact upon the pathogenesis and
the treatment of diabetes mellitus. In: Proceedings of
the 5th Asia and Oceania Congress of Endocrinology.
Chandigarh India 28.01 – 01.02.1974. Chandigarh
India: Harmonic Half-Tone Printers, 1974: 443-72.
1240. PFEIFFER E, RAPTIS S. Les hormones parieto digestives et la fonction des ilots de Langerhans. Journees de diabetologie. 1974: (vol.?): 249-63.
1241. BEISCHER W, KELLER L, SCHRURMEYER E,
RAPTIS S, THUM CH, PFEIFFER E. Insulin, Proinsulin und C-Peptid im Serum bei Hypoglycaemia
Factitia. In: 81 Tagung der Deutschen Gesellschaft
für innere Medizin Wiesbaden. 1975: 1493-6.
1242. THUM CH, LAUBE H, SCHRODER K, RAPTIS
S, PFEIFFER E. Das kontinuierliche BZ-Tagesprofil
in Abhängigkeit von Seruminsulin bei idealgewichtigen und normalgewichtigen Stoffwechselgesunden.
In: 81 Tagung der Deutschen Gesellschaft für innere
Medizin Wiesbaden. 1975: 1476-8.
1243. BEISCHER W, KELLER L, RAPTIS S, THUM
CH, PFEIFFER E. Nachweis von körpereigenen In-
127
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
sulinreserven beim Insulinbehandelten Diabetiker
mittels C-Peptid-Bestimmung. XII Kongress der Südwestdeutschen Gesellschaft für Innere Medizin, Stuttgart, 6-7 Juni 1975. Therapiewoche 1976; 26: 1936-47.
1244. BEISCHER W, RAPTIS S, KELLER L, KERNER
W, PFEIFFER E. C-Peptid Bestimmung als Parameter für die orale Diabetestherapie. In: 82 Tagung der
Deutschen Gesellschaft für innere Medizin Wiesbaden 25-29 April 1976. 1976: 791-4.
1245. DOLLINGER H, RAPTIS S, GOEBELL H,
PFEIFFER E. Effect of somatostatin on gastrin, insulin, gastric and exocrine pancreatic secretion in
man. In: Conference on Stimulus-Secretion Coupling
in the Gastrointestinal Tract, May 27-29, 1975. Lancaster England: MTP Press Ltd, 1976: 403-5.
1246. THUM CH, BEISCHER W, RAPTIS S, TAMAS
GY, PFEIFFER E. Die klinische Anwendung des
künstlichen Pancreas bei der Behandlung des Zuckerkranken. XII Kongress der Sudwestdeutschen Gesellschaft für Innere Medizin, Stuttgart, 6-7 Juni 1975.
Therapiewoche 1976; 26: 1948-57.
1247. BEISCHER W, KERNER W, RAPTIS S, KELLER
L, PFEIFFER E. Autonomie der Hormonsekretion
beim Insulom. In: 83 Tagung der Deutschen Gesellschaft für innere Medizin. München: Bergmann Verlag, 1977: 294-6.
1248. PFEIFFER E, MEISSNER C, BEISCHER W,
KERNER W, RAPTIS S. The antidiabetic action of
somatostatin assessed by artificial betacell. 1st International Somatostatin Symposium. Metabolism 1978;
22 (Suppl 1): 1415-26.
1249. ZOUPAS Ch, RAPTIS S, ZIROGIANNIS P,
KARAISKOS K, PAPADAKIS J, PAPADOGIANNAKIS K. Insulin absorption from peritoneum controlled by the artificial pancreas in man. In: Proceedings 6th Annual Meeting Europ. Society from Artificial Organs, 29-30 September 1979, Geneva. 1979; VI:
273-7.
1250. RAPTIS S, ZOUPAS Ch, MOULOPOULOS S. Somatostatin analogues in insulin dependent diabetics.
In: IDF-Congress Wien. 1980: 452-7.
1251. RAPTIS S, SCHRODER K, MELANI F, BEYER J,
PFEIFFER E. Die Stimulierung der Insulinsekretion
durch Sekretin beim Menschen. 6th Congress Intern.
Diab. Fed. Stockholm 30.07.-04.08.1967. In: Pfeiffer
EF. Intestinal factors control-ling insulin secretion,
6th Congress IDF, Stockholm 1967, Exc. Med.
Foundation, ICS, 1969; 172: (pages ?).
1252. ZOUPAS CH, ZIROGIANNIS P, KARAISKOS K,
PAPADAKIS I, HATZI-DAKIS D, PAPADOYANNAKIS N, RAPTIS S. The artificial pancreas as regulator of diabetic renal failure patients on peritoneal
dialysis. 2nd Vienna-Lainz Diabetes Symposium,
April 23-26, 1980. In: Kunzk OD, Regal H. New approaches to insulin therapy. Lancaster England: MTP
Press Ltd, 1981: 65-72.
128
1253. RAPTIS S, KARAISKOS K, ENZMANN F, HATZIDAKIS D, ZOUPAS CH. , MOULOPOULOS S.
Die biologische Aktivitat des Biosyntheschen (rekombinierten) Humanen Insulins beim Menschen. In: 87
Tagung der Deutschen Gesellschaft für innere Medizin 26-30 April, 1981: 215-6.
1254. RAPTIS S, KARAISKOS K, HATZIDAKIS D,
ZOUPAS CH, DIAMANTOPOULOS E, MOULOPOULOS S. Comparison of glycemic and metabolic
control in diabetics, achieved by an arificial endocrine
pancreas versus an open loop intravenous delivery
system. Workshop, Islet-Pancreas-Transplal. And
Artificial Organs Vouliameni Beach. Horm Metab
Res Suppl 1982: 11: 277-87.
1255. DIAMANTOPOULOS E, RAPTIS S, KARAISKOS K, MOULOPOULOS S. Thrombozytenaktivität und Erythrozytenrigidität bei Altersdiabetiken
mit arteriellen Verschlubkrankheit der unteren Extremitaten. In: F. Nobe und G. Rudovsky. München:
Pflaum Verlag, 1983: 164-74.
1256. RAPTIS S, ENZMANN F, HATZIDAKIS D,
RAPTIS A, HATZIIOANNOU I, DIAMANTOPOULOS E, THALASSINOS N. Difference endogenous insulin and glucagon secretion. Inhibition by human insulin recombinant DNA in man. Diabetologia
1983; 25: 188-9.
1257. RAPTIS S, DIAMANTOPOULOS E, ENZMANN
F, RAPTIS A, HATZIDAKIS D. Direkte Hemmung
der endogenen Insulin und Glukagonsekretion durch
Biosynthetisches Humaninsulin beim Menschen. In:
89 Tangung der Deutschen Gesellschaft für Innere
Medizin. 1983: 713-6.
1258. RAPTIS S, HATZIDAKIS D, ENZMANN F,
RAPTIS A. Hemmung der ∞rginin stimulierten
pankreatischen Glucagonsekretion durch biosynthetisches ∏uman Insulin und Schweineinsulin bei Stoffwechselgesunden und Diabetiker. In: Deutsch. Symposium BHI. Fortschrette in der Insulin Therapie,
Ulm 10-12. 10. 1982. Munch Med Wochenschr 1983;
125: 38-43.
1259. RAPTIS S, HATZIDAKIS D. Somatostatin in
clinical medicine. Proc. Exc. Med. 1983, ICN Nr 600,
Diabetes, 1982: 267-73.
1260. RAPTIS S, RAPTIS A, HATZIDAKIS D, DIAMANTOPOULOS E. New hormonal aspects of sulfonylurea therapy. Excerpta Med 1983: (vol.?): 18-29.
1261. RAPTIS S, ROSENTHAL J, DIAMANTOPOULOS E, RAPTIS A, MOULOPOULOS S. Der Einfluss der Langzeitbehandlung mit Betarezeptorenblocker auf den täglichen Insulinbedarf gemessen mit
Hilfe des künstlichen endokrinen Pankreas bei Insulinpflichtigen Diabetikern mit Hypertonie. In: 89 Tagung der Deutschen Gesellschaft für Innere Medizin.
München: Bergmann Verlag, 1983: 736-78.
1262. KOSTAKIS A, KARAYANNAKOS P, ETZORDT
H, KOTRARELIS D, SARIKAS L, KARATZAS G,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
KATSILAMBROS N, RAPTIS S, SKALKEAS GR.
Hormonal activity of the transplanted pancreas in
dogs. In: Proceedings XII Congress Europ. Society
Artificial Organs, W. B. Saunders Company Ltd, London, 1985: 691-5.
1263. RAPTIS S. Enterohormone und endokrines Pankreas. In: Bartelheimer H, Kuhn HA, Berker VF,
Stelzner G. Gastroenterlogie und Stoffwechsel.
Georg Thieme Verlag, 1974: vol.5: (pages ?).
1264. RAPTIS S, DIMITRIADIS G, HATZIDAKIS D.
Acarbose treatment in insulin dependent (type I) diabetes mellitus. 2nd Intern. Symposium on acarbose,
Berlin, November 12-14, 1987. In: Creutzfeldt W.
Acarbose for the treatment of diabetes mellitus.
Springer Verlag, 1988: 141-55.
1265. DIAMANTOPOULOS E, GRAMMOUSTIANOS
C, STAYREAS N, RAPTIS S, MOULOPOULOS S.
Controlled trial of buflomedil in diabetic peripheral
occlusive arterial disease. Intern. Symp. Frankfurt
1989. In: Messmer K. Ischemic Diseases and the Microcirculation. W. Zuckschwerdt Verlag, 1989: 80-4.
1266. FEDERLIN K, PFEIFFER E, RAPTIS S. Islet-Pancreas-Transplantation and artificial pancreas. Workshop Vouliagmeni Beach/Athens. Horm Metab Res
Suppl 1982; 11: 315.
1267. RAPTIS S, HATZIDAKIS D. Hypertonie und diabetes mellitus. In: Rosenthal J. Arterielle Hypertonie.
Ätiopathogenese Diagnostik Therapie. Berlin: Springer Verlag, 1984: 138-49.
1268. RAPTIS S. Radioimmunoassay of insulin: comparison of different separation techniques. Horm Metab
Res Suppl 1971; 3: 26-8.
1269. RAPTIS S, ROTHENBUCHNER G, PFEIFFER
E. Fortschritte in der Diabetestherapie. Wien Med
Wochenschr 1971; 14: 261-9.
1270. ROTHENBUCHNER G, RAPTIS S, PFEIFFER
E. Insulin oder orale Anti-diabetika aus der Sicht von
Forschung und Klinik. Heilkunst 1971; 84: 215-20.
1271. RAPTIS S. Orale diabetes Therapie. Dtsch Med J
1972; 23: 617-24.
1272. RAPTIS S, PFEIFFER E. Progress in oral therapy
of diabetes mellitus with sulfonylureas of the second
generation. Acta Diabetol Lat 1972; 9: 865-99.
1273. RAPTIS S. Insulinsekretion unter normalen und
pathologischen Bedingungen. Neue Möglichkeiten
der oralen Diabetestherapie mit Sulfonylharnstoffen
der 2. Generation. Tagungsband 1973: 25-47.
1274. RAPTIS S. Possibilities and limits of modern oral
therapy. Publicazione Via S. Uguzzone, 5-Milano,
1973: 287-303.
1275. RAPTIS S. Factores que controlan el eje enteroinsular. Publicaciones de la Universidad de Sevilla.
1974: 31-6.
1276. RAPTIS S. Biochemicka regulace a terapie diabeta.
Verhandlungen 1975: 95-129.
1277. DOLLINGER H, RAPTIS S. Inhibition of exocrine
and endocrine pancreatic function by somatostatin in
man. Verhandlungsband 1976; 10: 56-9.
1278. RAPTIS S. Aussichten für einen Organersatz beim
Diabetes Mellitus. Verhandlungen 1976: 33-47.
1279. RAPTIS S, FUSSGANGER R, BEISCHER W,
MAIER V, PFEIFFER E. Gegenwürtige Vorstellung
zur Biochemie und Klinik der Insulinsekretion. Mag
Diab Tarsasag 1976: 157-98.
1280. SCHRODER K, RAPTIS S, BEISCHER W. Radioimmunologische bestimmung von STH, insulin
und C-peptide. Med Welt 1976; 27: 1720-5.
1281. RAPTIS S. Orale diabetec therapy in 1979. Med Dig
1979; 5: 28-37.
1282. RAPTIS S. Treatment of diabetes mellitus: Oral hypoglycaemic agents. In: Federlin K, Scholtholt J. The
importance of islets of Langerhans for modern endocrinology. 12th Workshop Conference Hoechst,
Schloss Reisenburg, April 16-18, 1982. New York:
Raven Press, 1982: 129-65.
1283. KORDONOURI O, JAMES RW, BENNETTS B,
CHAN A, KAO YL, DANNE T, SILINK M, DONAGHUE K. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. Metabolism 2001;
50: 657-60.
1284. RAPTIS S. Acarbose in der Behandlung des Typ I
Diabetes Mellitus Vorsymposium. Aktuel Endokrinol
Stoffwechsel 1987; 8: 224-5.
1285. RAPTIS S. Alpha-glucosidasehemmer. Verh Dtsch
Ges Inn Med 1987; 93: 186-7.
1286. RAPTIS S. Therapie mit Insulinpumpen und Pensystem. In: Bretzel RG. Diabetes mellitus. Immunologische und dynamische Aspekte der Insulinsubstitution. Bretzel von Springer-Verlag , 1992: (pages ?).
1287. RAPTIS S. Hypertension and diabetes mellitus. In:
Rosenthal J. Arterielle Hypertonie. Ätiopathogenese
Diagnostik Therapie. Berlin: Springer Verlag, 1982:
93-100.
1288. GOBERNA R, FUSSGANGER R, LAUBE H,
RAPTIS S, PFEIFFER E. Verhalten von Seruminsulin und Blutglukose bei der Entwicklung eines Diabetes Mellitus bei Ratten nach subtotaler Pankreatektomie. In: 5 Tagung der Deutschen Gesellschaft 1970.
1970: 133-6.
1289. RAPTIS S. Verbesserung der Insulinsekretion und
Glukoseassimilation unter Langzeittherapie mit
Glibenclamid bei Patienten mit Subklinischen und Altersdiabetes. In 6 Kongress Dtsch. Diabetes Ges. Dusseldorf 1971. 1971: 65-67.
1290. LAUBE H, RAPTIS S, CHRISSIKU M, PFEIFFER E. Der Einfluss verschiedener Diäten auf den
Hyperinsulinismus bei Adipositas. Therapiewoche
1972; 22: 4535-6.
1291. RAPTIS S, SCHRODER K, ROTHENBUCHNER
129
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
G, THUM CH, KLOR U, PFEIFFER E. Immunologisch messbares Insulin, Glukagon und Wachstumshormon nach intravenoser Gabe von Arginin mit
und ohne gleichzeiteger Gabe von Sulfonylharnstoffen beim Menschen. In: 7 Kongress Dtsch. Diabetes
Ges, Bad Nauheim 4. -6. Mai 1972. 1972: 263-7.
1292. ROTHENBUCHNER G, RAPTIS S, SCHRODER
K, PFEIFFER E. Das Verhalten von immunologisch
messbarem Insulin (IMI), Glucagon (IMG) und
Wachstumshormon (STH) während der Glibenclamid-Hypoglykamie. In: 7 Kongress Dtsch. Diabetes Ges, Bad Nauheim 4. -6. Mai 1972. 1972: 270-3.
1293. PFEIFFER E, RAPTIS S, FUSSGANGER R. Gastrointestinal hormones and islet function. Handbuch
der experimentelle Pharmakologie. 1973; 84: 259-309.
1294. RAPTIS S. Hypertonie und Diabetes Mellitus. In:
Rosenthal J. Arterielle Hypertonie. Ätiopathogenese
Diagnostik Therapie. Berlin: Springer Verlag, 1980:
55-63.
1295. DIAMANTOPOULOS E, RAPTIS S, MOULOPOULOS S. Increased platelet activity in diabetic
macroangiopathy. Horm Metab Res Suppl 1992; 26:
95-102.
1296. VENEMAN T, MITRAKOU A, MOKAN M,
CRYER P, GERICH J. Induction of hypoglycemia
unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993; 42: 9: 1233-7.
1297. MITRAKOU A, MOKAN M, RYAN C, VENEMAN T, CRYER P, GERICH J. Influence of plasma
glucose rate of decrease on hierarchy of responses to
hypoglycemia. J Clin Endocrinol Metab 1993; 76: 4625.
1298. SKYLER J, RAPTIS S. Proceedings of the Symposium on Biosynthetic human insulin. St. Francisco,
USA. Diabetes Care 1981; 4: 139-264.
1299. DIAMANTI-KANDARAKIS E, MITRAKOU A,
HENNES M, PLATANISIOTIS D, KAKLAS N, SPINA I, GEORGIADOU E, HOFFMANN R, KISSEBAH A, RAPTIS S. Insulin ssensitivity and antiadrogenic therapy in women with polycystic ovary syndrome. Metabolism 1995; 44: 526-31.
1300. DURRANT J, GERICH J, MITRAKOU A, JENSSEN T, HYRE R. Changesin BAEP under hypoglycemia: Temperature-related? Electroencephalogr
Clin Neurophysiol 1991; 80: 547-50.
1301. MITRAKOU A, JONES R, OKYDA Y, PENA J,
NURIJHAN N, FIELD J, GERICH J. Pathway and
carbon sources for hepatic glycogen repletion in dogs.
Am J Physiol 1991; 260: (2 Pt 1): E194-∂202.
1302. MITRAKOU A, KELLEY D, VENEMANN T,
JENSSEN T, PANGBURN T, REILLY J, GERICH
J. Contribution of abnormal muscle and liver glucose
metabolism to postprandial hyperglycemia in
NIDDM. Diabetes 1990; 39: 1381-90.
1303. STANKO R, MITRAKOU A, GRENAWALT K,
130
GERICH J. Effect of dihydroxyacetone and pyruvate
on plasma glucose concetration and turnover in noninsulin-dependent diabetes mellitus. Clin Physiol
Biochem 1990; 8: 283-8.
1304. MITRAKOU A, KELLEY D, VENEMAN T,
PANGBURN T, REILLY J, GE RICH J. Role of reduced supression of glucose production and diminished earlyinsulin release in impaired glucose tolerance. N Engl J Med 1992; 326: 22-9.
1305. MITRAKOU A, MOKAN M, BOLLI G, VENEMANN T, JENSSEN T, CRYER P, GERICH J. Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man.
Metabolism 1992; 41: 198-200.
1306. MITRAKOU A, VUORINEN-MARKKOLA H,
RAPTIS G, TOFT I, MOKAN M, STRUMPH P,
PIMENTA W, VENEMAN T, JENSSEN T, BOLLI
G, KORYTKOWSKI M. YKI-JARVINEN H.
GERICH J. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperoglycemia
clamp. J Clin Endocrinol Metab 1992; 75: 379-82.
1307. DIMITRIADIS G, TEGOS K, GOLFINOPOULOS L, ROBOTI C, RAPTIS S. Furosemide-induced
hyperglycaemia: The implication of glycolutic kanases. Horm Metab Res 1993; (vol.?): (pages ?).
1308. LADAS S, GIORGIOTIS K, RAPTIS S. Complex
carbohydrate malabsorption in exocrine pancreatic
insufficiency. Gut 1993; 34: 984-7.
1309. MAVRIKAKIS M, KARLI J, ANTONIADES L,
SFIKAKIS P, KONTOYANNAKIS S, MOULOPOULOS S, KOUTRAS D, RAPTIS S. Twenty-four
hours urinary hydroxyproline excretion in long term
experimental diabetes mellitus. Horm Metab Res
1993; 25: 498-9.
1310. HATZIDAKIS D, LEMBERT U, MINNE H, ZIEGLER R. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. Horm Metab Res 1993; 25: 77-81.
1311. DIMITRIADIS G, RAPTIS S. Alpha-glucosidase
inhibition in the treatment of diabetes mellitus. Horm
Metab Res Suppl 1992; 26: 42-9.
1312. DIMITRIADIS G, PARRY-PILLINGS M, BEAVANT S, TANGER E, BEAVANT T, KRAUSE U,
VEGENER G, NEWSHOLME E. Effects of insulinlike growth factor I on the rates of glucose transport
and utilization in skeletal muscle in vitro. Biochem J
1992; 285: 269-74.
1313. DIMITRIADIS G, PARRY-PILLINGS M, TANGER D, BEAVANT S, SOLGQUHOM A, TAYLOR A, CALTER P, KRAUSE U, VAGENER G,
NEWSHOLME E. Effects of in vivo administration
of insulin like growth factor I on the rate of glucose
utilization in the soleus muscle of the rat. J Endocrinol 1992; 133: 37-43.
1314. LADAS S, FRYDAS A, PAPADOPOULOS A, RA-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
PTIS S. Effect of aglucosidase inhibitors on mouth to
caecum transit time in humans. Gut 1992; 33: 1246-8.
1315. ƒ∞™π¢∞∫∏™ ¡. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙË Ù˘ ˘ÔΈ̷ÙÒ‰Ô˘˜ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ Â› ÙˆÓ „˘¯ˆÛÈÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1959. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1316. ¡π∫O§∞´¢∏™ º. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ·ÓÙ·ÏÏ·Á‹Ó ÙÔ˘
۷ί¿ÚÔ˘ Â› ‰˘ÛÙÚÔÊÈÎÒÓ ‚ÚÂÊÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1953. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1317. μOÀ¡Δ∞ Ãπ™Δπ¡∞. ∏ ·ÓÙ·ÏÏ·Á‹ ÙÔ˘ ۷ί¿ÚÔ˘
Â› ‰˘ÛÙÚÔÊÈÎÒÓ ‚ÚÂÊÒÓ Î·È Ë Â›‰Ú·ÛȘ Ù˘ ‰È¸‰ÚÔÂÚÁÔÙ·Ì›Ó˘ Â’ ·˘Ù‹˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1955. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1318. ¶∂ΔƒπΔ∏™ π. ™˘¯ÓfiÙ˘ ÙˆÓ ·ÁÁÂÈ·ÎÒÓ ÂÈÏÔÎÒÓ
Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1959. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1319. ª∞¡π∞Δ∏-Ãπ™Δπ¢∏ ª. HLA ·ÓÙÈÁfiÓ· Î·È ·ÓÙÈ·ÁÎÚ·ÙÈο Î·È ÏÔÈ¿ ·˘ÙÔ·ÓÙÈÛÒÌ·Ù· Û ·È‰È¿
Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1987. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1320. ∫ø¡™Δ∞¡ΔO¶OÀ§O™ Ã. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ ‰È·‚ËÙÈ΋˜ ÔÛÙÂÔ¿ıÂÈ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1965. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1321. ∫OΔ∑π∞ª¶∞™∏™ ∞. ∫‡ËÛË Î·È ‰È·‚‹Ù˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1966. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1322. ª∞ƒ∫∞∫∏™ ¡. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ ‰È·‚ËÙÔÁfiÓÔ˘ ‰Ú¿Ûˆ˜ ÙˆÓ ıÂÈÔ˙ȉÒÓ (‰È· Ù˘ ‰ÔÎÈÌ·Û›·˜ Ù˘ ÂÓ‰ÔÊÏ‚›Ô˘ ·ÓÔ¯‹˜ ÂȘ ÙËÓ ÙÔÏ‚Ô˘Ù·Ì›‰ËÓ).
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞ - ¡ÔÛÔÎÔÌÂ›Ô ∂ÏÏËÓÈÎÔ‡ ∂Ú˘ıÚÔ‡ ™Ù·˘ÚÔ‡ ∞ı‹Ó·, 1969. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1323. ªO™ÃO™ ª. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ¤Ú¢ӷ Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1970. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1324. KORDONOURI O, DIETERICH W, SCHUPPAN
D, WEBERT G, MÜLLER C, SARIOGLU N, BECKER M, DANNE T. Autoantibodies to tissue
transglutaminase are sensitive serological parameters
for detecting silent coeliac disease in patients with
Type 1 diabetes mellitus. Diabet Med 2000; 17: 441-4.
1325. ¡π∫OÀ ¢. ∞Ï·Ó›ÓË ÔÚÔ‡ ·›Ì·ÙÔ˜ ÂȘ ۷ί·Úԉȷ‚ËÙÈο ·È‰È¿. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1973. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1326. ºπ§π¶¶π¢∏™ º. ∏ Â›‰Ú·ÛȘ ÙˆÓ ÔÈÛÙÚÔÁfiÓˆÓ ÂȘ
ÙËÓ Û·Î¯·Ú·ÈÌÈÎ‹Ó Î·Ì‡ÏËÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1975. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1327. ™∂ƒπøΔ∏™ π. ªË ‰È·‚ËÙÈ΋ ÁÏ˘ÎÔ˙Ô˘Ú›· Â› ‰Â›ÁÌ·ÙÔ˜ ÂÏÏËÓÈÎÔ‡ ÏËı˘ÛÌÔ‡ (Â› 17.758 ·ÙfiÌˆÓ ËÏÈΛ·˜ ÌÂÁ·Ï˘Ù¤Ú·˜ ÙˆÓ 10 ÂÙÒÓ). π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1975. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1328. ¢π∞∫Oª∞¡ø§∏™ ∂ªª. ∏ Û˘Ì‚ÔÏ‹ ÓÂÒÙÂÚˆÓ
ÌÂıfi‰ˆÓ ÂȘ ÙËÓ ÂÏ¿ÙÙˆÛÈÓ Ù˘ ÂÚÈÁÂÓÓËÙÈ΋˜ ıÓËÛÈÌfiÙËÙÔ˜ Â› ‰È·‚ËÙÈ΋˜ ÂÁ·Ԣ. University of London, 1975. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1329. Δ∑π°°OÀ¡∏™ μ. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÙˆÓ ÂÈ¤‰ˆÓ
ÈÓÛÔ˘Ï›Ó˘ ÂȘ ÙÔ ·›Ì· ÂÌ‚Ú‡Ô˘-ÌËÙÚfi˜ Î·È ·ÌÓÈ·ÎÔ‡
˘ÁÚÔ‡. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1976. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1330. ™À∫πøΔ∏™ ∫. ªÂÙ·‚ÔÏ‹ ÂÈ¤‰Ô˘ ۷ί¿ÚÔ˘ ÙÔ˘
·›Ì·ÙÔ˜ ηٿ ÙËÓ ‰È¿ÚÎÂÈ· ¯ÂÈÚÔ˘ÚÁÈÎÒÓ Á˘Ó·ÈÎÔÏÔÁÈÎÒÓ ÂÂÌ‚¿ÛÂˆÓ ˘fi ÙËÓ Â›‰Ú·ÛÈÓ Ù˘ Ó¢ÚÔÏËÙ·Ó·ÏÁËÛ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1977. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1331. ºƒ∞°∫∞∫∏ ª∞ƒπO°∫∞ ∫. ¢ÔÎÈÌ·Û›· ‹Íˆ˜
ÙÔ˘ ·›Ì·ÙÔ˜ Â› ·ÛıÂÓÒÓ ÌÂÙ¿ Ë›Ô˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1979. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1332. °π∞¡¡O¶OÀ§O™ ∞. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ‰È¿ÁÓˆÛÈÓ
Î·È ıÂÚ·›·Ó ÙˆÓ ÈÓÛÔ˘ÏÈӈ̿وÓ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1333. Δ™π∞¡O™ ∂¶∞ª. ∂Ó‰·ÁÁÂȷ΋ ‹ÍȘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ªÂϤÙË ‰È· ¯ÚˆÌ·ÙÔÁÚ·Ê›·˜ ÌÔÚÈ·ÎÔ‡ ·ÔÎÏÂÈÛÌÔ‡ ÙÔ˘ ÈÓˆ‰ÔÁfiÓÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1334. ΔOÀ¡Δ∞™ Ã∞ƒ. ΔÔ ·ÈÌÔÛÊ·ÈÚÈÓÈÎfiÓ ÎÏ¿ÛÌ· ∞1c
Â› ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1335. §∂∫∞∫∏™ π. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Zn, Cu, Mg
Î·È 2, 3 DPG ÂȘ ÙÔÓ Û·Î¯·ÚÒ‰ËÓ ‰È·‚‹ÙËÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1336. ª∂§∞ ∞. ªÂϤÙË Ù˘ ¯ÚÔÓ›·˜ ÂÚÈÊÂÚÈ΋˜ ·ÚÙËÚÈÔÛÎÏËÚ˘ÓÙÈ΋˜ ·ÔÊÚ·ÎÙÈ΋˜ ·ÚÙËÚÈÔ¿ıÂÈ·˜ ÂȘ
ÌË ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜: ∫ÏÈÓÈ΋ ÌÂϤÙË Î·È ÛÙ·ÙÈÛÙÈο ÛÙÔȯ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1337. ªOÀ™OÀ§∏™ °. O˘ÚÈÎfiÓ Ô͇ ·›Ì·ÙÔ˜ Î·È ÓÂÊÚÈ΋ οı·ÚÛȘ ·˘ÙÔ‡ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1338. ª∏Δƒ∞∫OÀ-º∞¡OÀƒπøΔOÀ ∞. ™¯¤ÛȘ ÙÈÌÒÓ
HDL-¯ÔÏËÛÙÂÚfiÏ˘ Î·È ÂÈ¤‰ˆÓ ·ÈÌÔÛÊ·ÈÚ›Ó˘ ∞1
Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ Ô„›ÌÔ˘ ÂÓ¿Ú͈˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1339. °∫∞¡π∞ ¶. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Ì·ÎÚÔ¯ÚfiÓÈ·˜ ¯ÔÚËÁ‹Ûˆ˜ ÈÓÛÔ˘Ï›Ó˘ ·ÓıÚÒÂÈÔ˘ Ù‡Ô˘ (ËÌÈÛ˘ÓıÂÙÈ΋) Î·È ÎÂηı·Ṳ́Ó˘ ¯ÔÈÚ›Ԣ Û ·ÛıÂÓ›˜ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1989. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1340. ∫∞§§πμƒ∂Δ∞∫∏™ ¡. ¶ÚÔÛ‚ÔÏ‹ ÙÔ˘ ΢ÎÏÔÊÔÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ·fi ·˘ÙfiÓÔÌË Ó¢ÚÔ¿ıÂÈ· Û ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1986. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1341. ∫OÀ§OÃ∂ƒ∏ ™. ∂›‰Ú·ÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙË
ʈÛÊÔÚ˘Ï›ˆÛË ÙˆÓ ÚˆÙÂ˚ÓÒÓ Ù˘ ÌÂÌ‚Ú¿Ó˘ ÙˆÓ
Ë·ÙÔ΢ÙÙ¿ÚˆÓ in vitro. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1982.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1342. ∫O§§πO¶OÀ§O™ μ. ¢È·ÁÓˆÛÙÈ΋ Î·È ÚÔÁÓˆÛÙÈ΋ ÛËÌ·Û›· Ù˘ ηÌ‡Ï˘ «ÁÏ˘Î·ÈÌ›·˜» Î·È «ÈÓÛÔ˘ÏÈÓ·ÈÌ›·˜» ηٿ ÙË ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ Ù˘ ÁÏ˘Îfi˙˘, Û ÛÙÂÊ·ÓÈ·›Ô˘˜ ·ÚÚÒÛÙÔ˘˜ ÌË ‰È·‚ËÙÈÎÔ‡˜.
ªÂϤÙË Â› 88 ÛÙÂÊ·ÓÈÔÁÚ·ÊËı¤ÓÙˆÓ ·ÙfïÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
131
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1343. ¶ƒO∫Oμ∞™ π. ¢ÈÂÚ‡ÓËÛË Ù˘ Û¯¤Û˘ ÌÂٷ͇ Û˘ÁÎÂÓÙÚÒÛÂˆÓ ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ ∞ ηÈ
·Ó¿Ù˘Í˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË fi„ÈÌ˘ ¤Ó·Ú͢ (Ù‡Ô˜ ππ). π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1344. μƒ∂ΔΔO™ ∞. ªÂϤÙË ÙˆÓ ·ÚÙËÚÈÒÓ ÙˆÓ Î¿Ùˆ
¿ÎÚˆÓ ÂÓËÏ›ÎˆÓ ‰È·‚ËÙÈÎÒÓ Ì ÙË Ì¤ıÔ‰Ô Doppler.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1345. ¢∏ª∏Δƒπ∞¢∏™ °. ∏ ¯Ú‹ÛË ÂÓfi˜ ·Ó·ÛÙÔϤ· ÙˆÓ
·-ÁÏ˘ÎÔÛȉ·ÛÒÓ (·Î·Ú‚fi˙Ë) ÛÙËÓ ıÂÚ·›· ÙˆÓ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1346. ™πª∂§π¢∏™ ¢. Δ·¯Â›Â˜ ÌÂÙ·‚ÔϤ˜ Ù˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ ∞1 (∏μ∞1) Â› ÚÔÎÏËÙ‹˜ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ ÛÂ
Ê˘ÛÈÔÏÔÁÈο ¿ÙÔÌ· Î·È ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1347. ƒ∞¶Δ∏™ ∞. ∫ÏÈÓÈΤ˜ Î·È ‚ÈÔ¯ËÌÈΤ˜ ·Ú¿ÌÂÙÚÔÈ
ÌÂÙ¿ ·fi Ì·ÎÚÔ¯ÚfiÓÈ· ¯ÔÚ‹ÁËÛË ËÌÈÛ˘ÓıÂÙÈ΋˜ ·ÓıÚˆ›Ó˘ ÈÓÛÔ˘Ï›Ó˘ Û ÈÓÛÔ˘ÏÈÓÔÂÍ·Úو̤ÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1988. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1348. ª∞¡Δ∑∞ƒ∏™ §. ∂›‰Ú·ÛË ÂÊ¿·Í ‰fiÛÂˆÓ Î·ÏÛÈÙÔÓ›Ó˘ ÛÔψÌÔ‡ ÛÙËÓ ˘ÔÁÏ˘Î·ÈÌÈ΋ Î·È ÈÓÛÔ˘ÏÈÓÔÂÎÎÚÈÙÈ΋ ÂÓ¤ÚÁÂÈ· Ù˘ ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜ Û ˘ÁÈ‹
¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1988. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1349. ∫∞ƒ∞ª∞¡O™ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ªÂڛη˜ °E. ∂ÛˆÙÂÚÈ΋ ¶·ıÔÏÔÁ›·. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ¶.Ã. ¶·Û¯·Ï›‰Ë˜, 1973; ÙfiÌ.1: 142-61.
1350. Ãπ™Δ∞∫O¶OÀ§O™ ¶, ∫∞ƒ∞ª∞¡O™ μ, ¢∂§∏°π∞¡¡∏™ ∞, ∫∞ƒ¢∞ΔO™ Ã. O ۷ί·Ú҉˘
‰È·‚‹Ù˘ Î·È ÙÈÓ˜ ÎÏÈÓÈη› ÙÔ‡ÙÔ˘ ·Ú¿ÌÂÙÚÔÈ ˆ˜
·Ú¿ÁÔÓÙ˜ ÚÔÎÏ‹Ûˆ˜ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘. Min
Med Greca 1974; 2: 635.
1351. ∫∞§O™ ∞, ∫∞ƒ∞ª∞¡O™ μ, §∞ª¶ƒ∞∫∏™ ∫,
Ãπ™Δ∞∫O¶OÀ§O™ ¶. ∏ Û˘¯ÓfiÙ˘ ÙÔ˘ ÚÂ˘Ì·ÙÔÂȉԇ˜ ·Ú¿ÁÔÓÙÔ˜ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘.
∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1976; 2: 116-8.
1352. ∫∞ƒ∞ª∞¡O™ μ, Ãπ™Δ∞∫O¶OÀ§O™ ¶, ΔOÀ¡Δ∞™ Ã, ª∂ƒπ∫∞™ °. ∏ ·ÍÈÔÈÛÙ›· ÙÔ˘ Ù·¯¤ˆ˜
ÚÔÛ‰ÈÔÚÈÛÌÔ‡ Ù˘ ÁÏ˘Îfi˙˘ ‰È· Ù·ÈÓÈÒÓ ÚÔÂÌÔÙÈÛÌ¤ÓˆÓ ˘fi ÙˆÓ ·ÓÙȉڷÛÙËÚ›ˆÓ Î·È ·Ó·ÎÏ·ÛÈ̤ÙÚÔ˘. ∞گ›· π·ÙÚ. ∂Ù·ÈÚÂÈÒÓ 1977; 3: 817-21.
1353. ∫∞ƒ∞ª∞¡O™ μ. ªÂϤÙË Ù˘ ÏÂÈÙÔ˘ÚÁ›·˜ ÙÔ˘
ÂÓÙÂÚÔ·ÁÎÚ·ÙÈÎÔ‡ ¿ÍÔÓÔ˜ Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ Î·È
‰È·‚ËÙÈÎÒÓ ·ÙfïÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1978. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1354. ∫∞ƒ∞ª∞¡O™ μ, ƒ∞¶Δ∏™ ™. ∏ ıÂÚ·›· Ì ÈÓÛÔ˘Ï›ÓË. ∂Ê·ÚÌÔṲ̂ÓÔ ÎÏÈÓÈÎfi ÊÚÔÓÙÈÛÙ‹ÚÈÔ. ™ÙÔ:
ΔfiÌÔ˜ ¶Ú·ÎÙÈÎÒÓ 5Ô˘ ∂Ù‹ÛÈÔ˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛԢ. 1979: 33-43.
1355. ∫∞ƒ∞ª∞¡O™ μ. EÙ‹ÛÈ· ÌÂÙÂÎ·È‰Â˘ÙÈο Ì·ı‹Ì·Ù· Â› ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. ΔfiÌÔ˜ ™ËÌÂÈÒÛˆÓ. ∞ı‹Ó·, 1979.
1356. KARAMANOS B, CHRISTACOPOULOS P.
132
Dextrostix-Eytone system for blood glucose mesurement. Br Med J 1977; 2: 673.
1357. KARAMANOS B, CHRISTACOPOULOS P, ANDRIOTIS A, TOUNTAS C, KOMNINOS Z. Metabolic and cardiac effects of mild exercise in non-insulin dependent diabetics. In: Berger M, Christacopoulos P, Wahren J. Diabetes and exercise. μern:
Hans Huber Publishers, 1982; 147-55.
1358. FALHOLT K, HOSKAN J, KARAMANOS B,
SUSSTRUNK H, VISWANATHAN M, HEDING L.
Insulin-specific IgE in serum of 67 diabetic patients
against human insulin (Novo), porcine insulin and
bovine insulin. Four case reports. Diabetes Care 1983;
6 (Suppl): 61-5.
1359. KATIRTZOGLOU A, DIGENIS G, KONTESIS P,
KARAMANOS B, SYMVOULIDIS A. Is peritoneal
ultrafiltration influenced by acetate or laktate
buffers? In: Maher J, Winchester J. Frontiers in peritoneal dialysis. Berlin: Springer Verlag, 1985: 270-3.
1360. PASCHALI A, KARAMANOS B, GRIFFINS I. Effect of relaxation therapy on the control of diabetes
mellitus. In: Christodoulou GN. Phychosomatic
Medicine, Past and Future. New York: Plenum Press,
1987: 307-13.
1361. ∫∞ƒ∞ª∞¡O™ μ. ¢È·‚‹Ù˘ Î·È Î·Ú‰ÈÔ¿ıÂÈ·.
™ÙÔ: ΔÔ‡ÙÔ˘˙·˜ ¶. ∫·Ú‰ÈÔÏÔÁÈο ı¤Ì·Ù· 1988. ¢È·Ï¤ÍÂȘ πÔÎÚ·Ù›Ԣ. ∞ı‹Ó·: ¡. ∫fiÏÏÈ·˜, 1988; 549.
1362. KAƒ∞ª∞¡O™ μ. ∏ ıÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™˘ÓÙ·ÁÔÁÚ·Ê›· 1988; 5: 33.
1363. KAƒ∞ª∞¡O™ μ. ¶ÚfiÔ‰ÔÈ ÛÙË ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚‹ÙË. πÔÎÚ¿Ù˘ 1988; 1: 301.
1364. TOÀ¡Δ∞™ Ã, ∫∞ƒ¢O°π∞¡¡∏™ £, ∫OÀΔ™OÀª∞¡∏ π, ∫∞ƒ∞ª∞¡O™ μ. ∏ ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ·
Ù˘ ÁÏÈÈ˙›‰Ë˜ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË
Ù‡Ô˘ ππ. π·ÙÚÈο ÃÚÔÓÈο 1988; 11: 1081.
1365. KARAMANOS B. Obesity and diabetes. Medicographia 1989; 11 (Suppl 1): 24.
1366. ∫∞ƒ∞ª∞¡O™ μ. O ¯ÂÈÚÔ˘ÚÁÔ‡ÌÂÓÔ˜ ‰È·‚ËÙÈÎfi˜.
™ÙÔ: ¶Ú·ÎÙÈο 3Ô˘ ¶·ÓÂÏÏ‹ÓÈÔ˘ ™ÂÌÈÓ·Ú›Ô˘ ∞Ó·ÈÛıËÛÈÔÏÔÁ›·˜. 1990: 31-4.
1367. ∫∞ƒ∞ª∞¡O™ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ ™Â˚Ù·Ó›‰Ë˜ μ, ∫·Ïfi˜ ∞. ∂ÍÂÏ›ÍÂȘ ÛÙË ¶·ıÔÏÔÁ›·: ¡ÂÒÙÂÚ˜ ·fi„ÂȘ ÛÙË ‰È¿ÁÓˆÛË Î·È ıÂÚ·›·. ∞ı‹Ó·:
∑∏Δ∞ π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 1991: 133-52.
1368. KARAMANOS B. Diet and diabetes. In: Williams
R, Papoz L, Fuller J, Libbey J. Diabetes in Europe.
London: John Libbey, 1994: 78-93.
1369. ∫∞ƒ∞ª∞¡O™ μ. YÔÁÏ˘Î·ÈÌÈÎfi ÎÒÌ·. ∫ÏÈÓÈο
ºÚÔÓÙÈÛÙ‹ÚÈ· 1994; 6: 59-68.
1370. ∫∞ƒ∞ª∞¡O™ μ. ¢È·‚ËÙÈÎfi ÎÒÌ·. ∫ÏÈÓÈο ºÚÔÓÙÈÛÙ‹ÚÈ· 1994; 6: 69-86.
1371. ∫∞ƒ∞ª∞¡O™ μ. ÀÂÚˆÛ̈ÙÈÎfi ÌË-ÎÂÙˆÙÈÎfi
‰È·‚ËÙÈÎfi ÎÒÌ·. ∫ÏÈÓÈο ºÚÔÓÙÈÛÙ‹ÚÈ· 1994; 6: 8790.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1372. ∫∞ƒ∞ª∞¡O™ μ. °·Ï·ÎÙÈ΋ ÔͤˆÛË. ∫ÏÈÓÈο
ºÚÔÓÙÈÛÙ‹ÚÈ· 1994; 6: 103-5.
1373. KARAMANOS B. Diabete et regime alimentaire.
In: Papoz L, Williams R, Fuller J. Le diabete en
Europe. Les Editions INSERM, 1994: 117-42.
1374. ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Ô‰ÔÓÙÈ·ÙÚÈο ÚÔ‚Ï‹Ì·Ù·. ™ÙÔÌ·ÙÔÏÔÁ›· 1994: 5: 73-8.
1375. °∂øƒ°∞∫O¶OÀ§O™ ∫. ∂›‰Ú·ÛË Ù˘ ÁÏ˘Îfi˙˘
Î·È Ù˘ ۷ί·Úfi˙˘ ÛÙËÓ ˘ÔÁÏ˘Î·ÈÌ›· ÌÂÙ¿ ·fi ¯ÔÚ‹ÁËÛË ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1986. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1376. ¢ƒO™π¡O™ ∂. O ¤ÏÂÁ¯Ô˜ Ù˘ ‰Ú¿Ûˆ˜ ÌÈ·˜ Ó¤·˜
ÛÔ˘ÏÊÔÓ˘ÏÔ˘Ú›·˜, Ù˘ ÁÏ˘ÌÂÈÚ›‰Ë˜ ÛÙËÓ ÔÌÔÈÔÛÙ·Û›· ÙˆÓ ˘‰·Ù·ÓıÚ¿ÎˆÓ ‰È·‚ËÙÈÎÒÓ Ù‡Ô˘ ππ Ì ÙË
‚Ô‹ıÂÈ· ÙÔ˘ Ù¯ÓËÙÔ‡ ·ÁÎÚ¤·ÙÔ˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1987. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1377. ªπ¡Δ∑πO™ ¢. OÈ Úfi‰ÚÔ̘ Ô˘Û›Â˜ Ù˘ ·›Ì˘ Â›
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1994.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1378. ª∞ƒπ¡∞∫∏™ £. MÂϤÙË Ù˘ ÌÂÙ·ÛÙÚÔÊ‹˜ Ù˘ Û¯¤Û˘ ÙˆÓ ·Ï‡ÛÂˆÓ Gg/AÁ Ù˘ ÂÌ‚Ú˘È΋˜ ·ÈÌÔÛÊ·ÈÚ›Ó˘ Û ÓÂÔÁÓ¿ ‰È·‚ËÙÈÎÒÓ ÌËÙ¤ÚˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1989. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1379. ¶∂¡Δ∂∞ ™. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÚÔÛÎÔÏÏËÙÈÎfiÙËÙ·˜ Ù˘ escherichia coli Û ÂÈıËÏȷο ΢ÙÙ·Ú·Ô˘ÚÔÔÈËÙÈÎÔ‡ ‰È·‚ËÙÈÎÒÓ - Ê˘ÛÈÔÏÔÁÈÎÒÓ Á˘Ó·ÈÎÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1996. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1380. ¶∞¶∞¢O¶OÀ§O™ ∞°. ∂ÎÙ›ÌËÛË Ù˘ ‰Ú·ÛÙËÚÈfiÙËÙÔ˜ ÙÔ˘ Ë·ÙÈÎÔ‡ ΢ÙÙÔ¯ÚÒÌ·ÙÔ˜ ƒ-450 Ì ÙËÓ ·Ó·Ó¢ÛÙÈ΋ ‰ÔÎÈÌ·Û›· C14-·ÌÈÓÔ˘Ú›Ó˘ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1991. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1381. ª∞ƒ∫OÀ ∫. ™‡ÁÎÚÈÛË ÙÔ˘ ÚÔÛ‰ÈÔÚÈÛÌÔ‡ Ù˘
ÔÛÙÈ΋˜ Ì¿˙·˜ Ì ÌÔÚÊÔÌÂÙÚÈÎÔ‡˜ ‰Â›ÎÙ˜ Î·È Ì ̤ıÔ‰Ô ·ÔÚÚfiÊËÛ˘ ·Ï‹˜ ‰¤ÛÌ˘ ʈÙÔÓ›ˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1991. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1382. ∫∞§π¢ø¡∏ ∂. ∏ Û˘Ì‚ÔÏ‹ Ù˘ ÙÚȯÔÂȉÔÛÎÔ‹Ûˆ˜ ÛÙË ÌÂϤÙË Ù˘ ‰È·‚ËÙÈ΋˜ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜
ÙˆÓ ¿ÎÚˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1383. ª¶OÀΔ∞Δ∏ ∂. ¶·Ú·ÎÔÏÔ‡ıËÛË ÙˆÓ ‰È·Î˘Ì¿ÓÛÂˆÓ Ù˘ ·Ó·Ó¢ÛÙÈ΋˜ ‰ÔÎÈÌ·Û›·˜ 14c-·ÌÈÓÔ˘Ú›Ó˘ Û˘Ó·ÚÙ‹ÛÂÈ ÙÔ˘ ÙÚfiÔ˘ Î·È ÙÔ˘ ‚·ıÌÔ‡ Ú˘ı̛ۈ˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ‹˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1993. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1384. ¢∂§∏™ ¢. OÈÎÔÁÂÓÂȷ΋ ÌÂϤÙË Ù˘ ÁÂÓÂÙÈ΋˜ ÚԉȿıÂÛ˘ ÁÈ· ÙËÓ ÂΉ‹ÏˆÛË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 2006. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1385. ∫ƒ∞¡π¢πøΔ∏™ ∞. ∞ÓÔÛÔÁÂÓÂÙÈ΋ ÌÂϤÙË ÙÔ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (ÚÒËÓ
Ù‡Ô˘ π). π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1989. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1386. ∞¡Àº∞¡Δ∞∫∏ ¢. ∏ Û¯¤ÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ-
‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Î·È Ù˘ ÓÂÊÚÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜
ÛÙÔÓ Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ ππ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1996. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1387. ª∞ƒπ¡O™ Ã. ™Ù·ÙÈÛÙÈ΋ ·Ó¿Ï˘ÛË ÙÔ˘ ‰È·‚‹ÙÔ˘ ÂÓ
∂ÏÏ¿‰È. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1954. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1388. ¶∞ƒπ∞Δ∂§∏™ ∫. ∏ ·ÓÙ·ÏÏ·Á‹ ÙÔ˘ Î·Ï›Ô˘ Î·È ÙÔ˘
۷ί¿ÚÔ˘ Â› Ù˘ ÔÏÈÔÌ˘ÂÏ›ÙȉԘ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1955. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1389. ªÀ§ø¡∞™ ¡. Δ· Ô͢ÛÙÂÚÈÓÔÂȉ‹ Î·È ·È ‰È·Î˘Ì¿ÓÛÂȘ ·˘ÙÒÓ Â› ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1955. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1390. ºƒ∞°∫∞∫∏™ Ã. ¶ÂÈÚ·Ì·ÙÈ΋ ¤Ú¢ӷ Â› Ù˘ ‰È·‚·ÙfiÙËÙÔ˜ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ï·ÎÔ‡ÓÙÔ˜. ™¯¤ÛÂȘ Ù·˘Ù˘ ÚÔ˜ Ù·˜ ‰È·‚ËÙÈο˜ ÂÌ‚Ú˘Ô·ı›·˜. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1957. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1391. çOÀμ∂ƒ∞∫∏™ ∫. ¶·¯˘Û·ÚΛ·, ˘ÂÚÁÏ˘Î·ÈÌ›·
Î·È ÈÓÛÔ˘ÏÈÓÔ·ÓÙÔ¯‹. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1971.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1392. ∫∞¡∞°∫π¡∏™ £. ªÂϤÙË Ù˘ ÂÎÎÚ›Ûˆ˜ ÙÔ˘ ÂÓ‰ÔÁÂÓÔ‡˜ ·Ú¿ÁÔÓÙÔ˜ ÙÔ˘ Castle Î·È ÙˆÓ Î·Ù’ ·˘ÙÔ‡
·ÓÙÈÛˆÌ¿ÙˆÓ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1972. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1393. μ∞ƒ∂§Δ∑π¢∏™ ∂. ¢Ú·ÛÙÈÎfiÙ˘ Ù˘ ·Ì˘Ï¿Û˘ ÙÔ˘
۷ί¿ÚÔ˘ ηٿ ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1973. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1394. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ∏ ·ÈÌÔ‰˘Ó·ÌÈ΋ Ù˘ ÌÈÎÚÔ΢ÎÏÔÊÔÚ›·˜ Â› ÚˆÙÔ·ıÔ‡˜ Î·È ‰Â˘ÙÂÚÔ·ıÔ‡˜ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1980. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1395. ª∞Àƒπ∫∞∫∏™ ª. ™˘Ì‚ÔÏ‹ ÙˆÓ ÌÂÏÂÙÒÓ Ù˘
·Û‚ÂÛÙÔÔÈÔ‡ ÂÚÈ·ÚıÚ›ÙȉԘ ÙÔ˘ ÒÌÔ˘ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1987. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1396. ∞ƒÃ∞¡πøΔ∞∫∏ ª. ™¯¤ÛË ÂÈ¤‰ˆÓ Ì·ÁÓËÛ›Ô˘
ÔÚÔ‡ Î·È ÂÚ˘ıÚÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ ·ÛıÂÓÒÓ ÛÙË ‰È·‚ËÙÈ΋ ıÚÔÌ‚Ô¿ıÂÈ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1397. KORDONOURI O, WLADIMIROWA A, DANNE T. High total serum renin concentrations are associated with the development of background
retinopathy in adolescents with type 1 diabetes. Diabetes Care 2000; 23: 1025-6.
1398. ¢π¢∞°°∂§O™ Δ. ∂›‰Ú·ÛË Ù˘ ÙÔÏÚÂÛÙ¿Ù˘ ÛÙËÓ
‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ Ê˘ÙÈÎÔ‡ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÙÔ˘ ΢ÎÏÔÊÔÚÈÎÔ‡. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1998.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1399. £∞¡O¶OÀ§OÀ ∞. ∂›‰Ú·ÛË ÙˆÓ ‰ÈÁÔ˘·Ó›‰ÈˆÓ
Û ÏÈÔ·ÙÙ·Ú·: ™‡ÛÙËÌ· ÌÂϤÙ˘ Ù˘ Á·Ï·ÎÙÈ΋˜
ÔͤˆÛ˘ Ô˘ Û¯ÂÙ›˙ÂÙ·È Ì ÙËÓ ·ÓÙȉȷ‚ËÙÈ΋ ıÂÚ·›· Ì ‰ÈÁÔ˘·Ó›‰È·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1998. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1400. ¶∞°∫∞§O™ ∂. ∏ Û˘ÌÌÂÙÔ¯‹ Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙËÓ
·ıÔÁ¤ÓÂÈ· Ù˘ ·ÚÙËÚȷ΋˜ ˘¤ÚÙ·Û˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ¢¶£, 1997. ¢È‰·ÎÙÔÚÈ΋ ‰È·ÙÚÈ‚‹.
133
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1401. ∫∞∑∞∫O™ ∫. OÈ ÂÈÙÒÛÂȘ Ù˘ ·˘ÙfiÓÔÌ˘ Ó¢ÚÔ¿ıÂÈ·˜ ÛÙÔ Ê·ÈÓfiÌÂÓÔ ÈÓÎÚÂÙ›Ó˘ Û ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1402. ª∞ÀƒOª∞Δπ¢∏™ °. ¢ÈÂÚ‡ÓËÛË ÙÔ˘ ÚfiÏÔ˘ Ù˘
ÈÓÛÔ˘Ï›Ó˘ ÛÙË ‰Ú·ÛÙÈÎfiÙËÙ· Ù˘ ·ÚˆÌ·Ù¿Û˘ in
vivo. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1998. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1403. °∫O°∫O™ °. ∂Ê·ÚÌÔÁ‹ Ù˘ Ù¯ÓËÙ‹˜ ÓÔËÌÔÛ‡Ó˘
ÛÙËÓ ÛÙ‹ÚÈÍË ·ÔÊ¿ÛÂˆÓ ·ÓÙÈÌÂÙÒÈÛ˘ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2001. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1404. ∞£∞¡∞™π∞¢∏™ §. ªÂϤÙË Ù˘ ÛÂÍÔ˘·ÏÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ‰È·‚ËÙÈÎÒÓ Á˘Ó·ÈÎÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
2002. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1405. Δ™∞¶∞™ ∞. ∏ Â›‰Ú·ÛË Ù˘ ˘ÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›·˜
ÛÙË ÓÂÊÚÔÛˆÏËÓ·Úȷ΋ ÌÂÙ·ÊÔÚ¿ ÙÔ˘ Ó·ÙÚ›Ô˘ ÛÂ
ÌÔÓ‹ÚË ÓÂÊÚfi. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2002. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1406. ¶∞¶∞¢O¶OÀ§OÀ º. ªÂϤÙË Ù˘ ÂÓ‰ÔÎÚÈÓÔÏÔÁ›·˜ ÙÔ˘ Ï·ÎÔ‡ÓÙ· ÛÂ Ê˘ÛÈÔÏÔÁÈΤ˜ ΢‹ÛÂȘ Î·È ÛÂ
΢‹ÛÂȘ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 2000. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1407. ™∞º§π∞¡∏™ π. Test ÊÔÚÙ›Ûˆ˜ Ì ¯ÔÏËÛÙÂÚfiÏË
Î·È Ï›Ô˜ ÛÂ Ê˘ÛÈÔÏÔÁÈο Î·È ‰È·‚ËÙÈο ¿ÙÔÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1408. ∑O§øΔ∞™ ¡. E›‰Ú·ÛË Ù˘ ηÏÙÛÈÙÔÓ›Ó˘ ÛÙËÓ
˘ÔÁÏ˘Î·ÈÌÈ΋ ÂÓ¤ÚÁÂÈ· Ù˘ ÁÏÈ‚ÂÓÎÏ·Ì›Ó˘ Û ¿Û¯ÔÓÙ˜ ·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1409. °§∏¡∂§∏ ∂. ŒÏÂÁ¯Ô˜ Ù˘ ÓÂÊÚÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜
ÛÙ· ·È‰È¿ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1410. ∑∞Ã∞ƒπ∞¢∏™ ¢. ¶ÚÒÈ̘ ÌÂÙ·‚ÔÏÈΤ˜ ‰È·Ù·Ú·¯¤˜ ·fi ÁÔÓ›˜ Ì ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1411. ªÀΔ∏™ °. E›‰· ÂÚ˘ıÚÔÔÈËÙ›Ó˘ (∂ƒO) ÛÙÔ
ÂÚÈÊÂÚÂÈ·Îfi ·›Ì·, ÔÌÊ¿ÏÈÔ ÏÒÚÔ Î·È ·ÌÓÈ·Îfi ˘ÁÚfi
ÛÂ Ê˘ÛÈÔÏÔÁÈ΋ ·ËÛË, ÚÔÂÎÏ·Ì„›· Î·È ÚÔÂÎÏ·Ì„›· ‰È·‚ËÙÈÎÒÓ Á˘Ó·ÈÎÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ
ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1412. ∫π∞°π∞™ °. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÌÂÙ·‚ÔÏÒÓ Û Â›‰· Ï¿ÛÌ·ÙÔ˜ Ù˘ Lp(·) Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜
ÚÈÓ Î·È ÌÂÙ¿ ·fi ÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί¿ÚÔ˘ ·›Ì·ÙÔ˜.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1413. μO°π∞Δ∑∏™ ¢. H Â›‰Ú·ÛË ÙˆÓ ı˘ÚÂÔÂȉÈÎÒÓ ÔÚÌÔÓÒÓ ÛÙË ÏÂÈÙÔ˘ÚÁ›· ÙˆÓ ˘Ô‰Ô¯¤ˆÓ ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1415. ∑∞°∫∞ ∞. ¢È¿¯˘ÙÔ˜ ȉÈÔ·ı‹˜ ÛÎÂÏÂÙÈ΋ ˘ÂÚfiÛÙˆÛË ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™˘Û¯¤ÙÈÛË Ì ÎÏÈÓÈΤ˜, ‚ÈÔ¯ËÌÈΤ˜ Î·È ÔÚÌÔÓÈΤ˜ ·Ú·Ì¤ÙÚÔ˘˜. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
134
1416. ∫OÀ∫∞ƒ∞™ ¢. MÂϤÙË ÎÏÈÓÈÎÔÂÚÁ·ÛÙËÚÈ·ÎÒÓ Â˘ÚËÌ¿ÙˆÓ Û ÈÛ¯·ÈÌÈο ‹ ÌË ÈÛ¯·ÈÌÈο (Ó¢ÚÔÙÚÔÊÈο
¤ÏÎË) ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ
ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1417. ª¶∂∏™ Ã. ™Ù¿ı̘ ÁÏ˘Î·ÁfiÓ˘ Ï¿ÛÌ·ÙÔ˜ ˘fi
‚·ÛÈΤ˜ Û˘Óı‹Î˜ Î·È ÌÂÙ¿ ‰˘Ó·ÌÈ΋ ‰ÔÎÈÌ·Û›· ÛÙË
Ê˘ÛÈÔÏÔÁÈ΋ ÂÁ΢ÌÔÛ‡ÓË Î·È ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î˘‹Ûˆ˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1418. ªπÃ∞∏§π¢OÀ °. MÂÙ·‚ÔÏÈΤ˜ ÂȉڿÛÂȘ (ÁÏ˘Î·ÈÌ›·-ÈÓÛÔ˘ÏÈÓ·ÈÌ›·-ÙÚÈÁÏ˘ÎÂÚȉ·ÈÌ›·) Û ‰È·‚ËÙÈο ¿ÙÔÌ· Ù‡Ô˘ ππ ÌÂÙ¿ ·fi ηٷӿψÛË ‰È·ÊfiÚˆÓ
ÏÈÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1419. ¶ƒO∂™ΔOÀ-μOÀ¢OÀƒ∏ £. H ÂÎÙ›ÌËÛË Ù˘ ·˘ÙfiÓÔÌ˘ Ó¢ÚÔ¿ıÂÈ·˜ Û ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1420. ∂À∞°°∂§O¶OÀ§O™ ∞. O ÚfiÏÔ˜ ÙˆÓ Î˘ÙÙ·ÚÔÎÈÓÒÓ ÛÙËÓ ·ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË ÛÙËÓ ·¯˘Û·ÚΛ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1421. Ã∞§∞ ∂. ¶·Ú¿ÁÔÓÙ˜ ÁÈ· ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ ÛÂ
·‰¤ÏÊÈ· ‰È·‚ËÙÈÎÒÓ Ù‡Ô˘ ππ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1422. ∑∞ª∞¡∏™ ¡. ™ÙÂÊ·ÓÈ·›· Âʉڛ· Ì ÙË ¯Ú‹ÛË
ÔÈÛÔÊ·Á›Ԣ ˘ÂÚ˯ÔηډÈÔÁÚ·Ê‹Ì·ÙÔ˜ Û ‰È·‚ËÙÈÎÔ‡˜ ÌÂÙ¿ ·fi ÂÓ‰ÔÊϤ‚È· ¯ÔÚ‹ÁËÛË ‰È˘ÚÈÏ·ÌfiÏ˘.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1423. ™∞§∞¶¶∞ ¶. ¶ÔÈÔÙÈÎfi˜ Î·È ÔÛÔÙÈÎfi˜ ÚÔÛ‰ÈÔÚÈÛÌfi˜ ÙˆÓ ÁÏ˘ÎÔ˙·ÌÈÓÔÁÏ˘Î·ÓÒÓ ÛÙÔ ∂¡À Î·È ·›Ì·
‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1425. ª∞∫ƒ∏™ °. E›‰Ú·ÛË ÔÏÏ·ÏÒÓ ÂÓ¤ÛÂˆÓ ÈÓÛÔ˘Ï›Ó˘ ÛÙ· Â›‰· ·ÓÙÈÈÓÛÔ˘ÏÈÓÈÎÒÓ ·ÓÙÈÛˆÌ¿ÙˆÓ ÛÂ
ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘˜ Ù‡Ô˘ π. ¢ÈÂÙ‹˜ Û˘ÁÎÚÈÙÈ΋
ÌÂϤÙË Ì ÙÔ ÎÏ·ÛÛÈÎfi Û¯‹Ì· ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1426. ¶∂ΔƒOÀ ∫. MÂϤÙË Ù˘ ·¤ÎÎÚÈÛ˘ Ù˘ ÊÏÔ˘ÔÚÂÛËÙ›Ó˘ ·fi ÙËÓ ·ÚˆÙ›‰· ÛÂ Ê˘ÛÈÔÏÔÁÈο Î·È ‰È·‚ËÙÈο ¿ÙÔÌ·. ™˘Û¯¤ÙÈÛË Ì ÙËÓ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1427. ™¶ÀƒO¶OÀ§OÀ-μ§∞ÃOÀ ª. °ÂÓÂÙÈ΋ Û‡Ó‰ÂÛË ÙˆÓ ÔÏ˘ÌÔÚÊÈÛÌÒÓ Ù˘ D· ÂÚÈÔ¯‹˜ ÙÔ˘ Û˘ÛÙ‹Ì·ÙÔ˜ HLA Ì ÙÔÓ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 2004. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
1429. º§øƒ∞∫∏ ∫. MÂϤÙË Û ËÏÂÎÙÚÔÓÈÎfi ΢ڛˆ˜ ÌÈÎÚÔÛÎfiÈÔ ÈÓÔ·ÁÁÂÈ·ÎÒÓ Â·ÌÊÈ‚ÏËÛÙÚÔÂȉÈÎÒÓ
ÌÂÌ‚Ú·ÓÒÓ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ Ù‡Ô˘ π ηÈ
Ù‡Ô˘ ππ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, ÂÓ ÂÍÂÏ›ÍÂÈ. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1430. ¢π∞∫OÀªO¶OÀ§OÀ ∂. ™˘¯ÓfiÙËÙ· Î·È ·›ÙÈ· ÌÈÎÚÔ‚ÈÔ˘Ú¿˜ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ ππ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1431. ∫∞ƒ∞°π∞¡¡∏ ¢. ∞ÎÚˆÙËÚÈ·ÛÌÔ› ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¶ÏËı˘ÛÌȷ΋ ÌÂϤÙË. π·ÙÚÈ΋ ™¯ÔÏ‹
¢¶£, 2002. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1432. ™OÀ§∏™ ∫. ∫·Ú‰È·ÁÁÂȷΤ˜ ÂÈÏÔΤ˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË (¡ÔÌfi˜ ∫ÈÏΛ˜ - ÏËı˘ÛÌȷ΋ ÌÂϤÙË). π·ÙÚÈ΋ ™¯ÔÏ‹ ¢¶£, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1433. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ¶∞¶∞¢∂§∏ ∂. ªËÙÚÒo ∂ÚÁ·ÛÈÒÓ ∂ÏÏ‹ÓˆÓ ∂Ú¢ÓËÙÒÓ Î·È
™˘ÁÁڷʤˆÓ Ì ÁÓˆÛÙÈÎfi ·ÓÙÈΛÌÂÓo ÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞′ ¤Î‰. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1997; 10
(™˘ÌÏ).
1434. THALASSINOS N, SIOULA L, KOUVETOPOULOU K, MITRAKOU A, ARAPAKIS G. Glycosylated haemoglobin in correlation to plasma lipids in diabetes mellitus. Acta Endocrinol (Copenh) 1983; (Suppl): 58-9.
1435. GERIC J, MOKAN M, KORYTKOWSKI M,
VENEMAN T, MITRAKOU A. Hypoglycemia unawareness. Endocr Rev 1991;12: 356-71.
1436. MITRAKOU A, MELDE J, MICHENFELDER J,
GERICH J. Rates of lactate appearance and disappearance and brain lactate balance after oral glucose
in the dog. Horm Metab Res 1989; 21: 238-9.
1437. BENN J, BOZZARD S, KELLEY D, MITRAKOU
A, AOKI T, SORENSEN J, GERICH J, SONSKEN
P. Persistent abnormalities of the matabolism of an
oral glucose load in insulin treated type I diabetics.
Metabolism 1989; 38: 1047-56.
1438. GERICH J, MITRAKOU A, KELLEY D, MANDARINO L, NURJHAN N, REILLY J, JENSSEN T,
VENEMAN T, CONSOLI A. Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM. Diabetes 1990; 39: 211-6.
1439. KELLEY D, MITRAKOU A, MARSH H,
SCHWENK F, BENN J, SONNE-BERG G, AOKI T,
SORENSEN J, BERGER M, SONSKEN P, GERICH J. Skeletal muscle glycolysis, oxidation and
storage of an oral glucose load. J Clin Invest 1988; 81:
1563-71.
1440. FOLEY J, CHAN C, LILLIOJA S, NURJHAN N,
CONSOLI A, KELLEY D, MITRAKOU A, CAMBELL P, MANDARINO L, GERICH J, FRELDENBERG G, HENRY R, GARVEY W, BRILLON D,
OLEFSKY J. Pathofgenesis and impact of insulin resistance in noninsulin dependent diabetes mellitus.
Diabetes Nutr Metab 1988; 1: 329-62.
1441. MITRAKOU A, RYAN C, VENEMAN T, CRYER
P, GERICH J. Influence of plasma glucose rate of decrease on hierarchy of responses to hypoglycemia. J
Clin Endocrinol Metab 1993; 76: 462-5.
1442. VENEMAN T, MITRAKOU A, MOKAN M,
CRYER P, GERICH J. Effect of hyperketonemia
and hyperlacticacidemia on symptons, cognitive function and counterregulatory hormones responses during hypoglycemia in normal humans. Diabetes 1994;
43: 1311-7.
1443. MOKAN M, MITRAKOU A, VENEMAN T,
RYAN C, CRYER P, GERICH J. Hypglycemia unwareness in IDDM. Diabetes Care 1994; 17: 1397-403.
1444. MITRAKOU A, GERICH J. Commentary on counterregulation in the elderly. Diabetes Spectrum 1994;
7: 366-8.
1445. FERRANNINI E, VICHI S, BECK-NIELSEN H,
LAAKSO M, PAOLISSO G, SMITH U, European
Group for the study of Insulin resistance (EGIR). Insulin action and age. Diabetes 1996; 45: 947-53. EGIR
- greek investigator: Mitrakou A. University of
Athens, Greece.
1446. PIMENTA W, KORYTKOWSKI M, MITRAKOU
A, JENSSEN T, YKI-JARVINEN H, EVRON W,
DAILEY G, GERICH J. Pancreatic betacell dysfunction as the primary genetic lesion in NIDDM. JAMA
1995; 273: 1855-61.
1447. PERIELLO G, MITRAKOU A, GUNBINER B,
GERICH J. Non-esterified fatty acids in non-insulin
dependent diabetes: A critical update. In: Diabetes
Annual. New York: Elsevier, 1995: 91-6.
1448. PIMENTA W, MITRAKOU A, JENSSEN T, YKIJARVINEN H, DAILEY G. GERICH J. Insulin secretion and insulin sensitivity in people with impaired
glucose tolerance. Diabet Med 1996; 13: (Suppl 6):
S33-S6.
1449. FERRANNINI E, CAMASTRA S, COPPACK S,
FILSER D, GOLAY A, MITRAKOU A. Insulin action and non-esterified fatty acids. The European
Group for the study of insulin resistance (EGIR).
Proc Nutr Soc 1997; 58: 753-61.
1450. KRANIDIS A, ZAMANIS N, MITRAKOU A, PATSILINAKOS S, BOUKI T, TOUNTAS N,
ANTHOPOULOS P, RAPTIS S, ANTHOPOULOU
L. Coronary microcirculation evaluation with transesophageal echocardiography doppler in type II diabetics. Int J Cardiol 1997; 59: 119-24.
1451. HADDEN D, BHATIA S, RIGAS A, WEAVER J,
MONTGOMERY D. Circadian variation of glucose
insulin and fatty acids during the long term use of oral
hypoglycaemic agents in diabetes mellitus with special
reference to Hb419. Horm Metab Res 1969; 1: 77.
1452. KOTSANOS J, VIGNATI L, HUSTER W,
ANDREJASICH C, BOGGS MB, JACOBSON A,
MARRERO D, MATHIAS S, PATRICK D, ZALANI S, ANDERSON J. Health-related quality-of-life
results from multinational clinical trials of insulin Lispro. Assessing benefits of a new diabetes therapy. Diabetes Care 1997; 20: 948-58.
135
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1453. DANNE T, KORDONOURI O, HOVENER G,
WEBER B. Diabetic angiopathy in children. Diabetic
Med 1997; 14: 1012-25.
1454. LUZI L, PETRIDES A, DE FRONZO R. Different
sensitivity of glucose and amino acid metabolism to
insulin in NIDDM. Diabetes, 1993; 42: 1868-77.
1455. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏. ∏ oÌoÈfiÛÙ·ÛË Ùo˘ Ì·ÁÓËÛ›o˘ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ.
¢È·‚. ÃÚoÓÈο 1998; 11: 9-14.
1456. °πøμO™ π, ªOÀ™§∂à Δ, ™Àª∂ø¡π¢∏™ °, ∫∞∑∞∫O™ ∫. ¢È·Ù·Ú·¯‹ ·Óo¯‹˜ ÛÙËÓ ÁÏ˘Îfi˙Ë (¢∞°).
™ÙÚoÁÁ‡ÏË ÙÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 1998; 11:
15-31.
1457. ª¶∞∫∞Δ™∂§O™ ™, ¢π¢∞°°∂§O™ Δ, ∞ƒÃ∞¡πøΔ∞∫∏ ª, ∫∞ƒ∞°π∞¡¡∏ ¢. À¤ÚÙ·ÛË ÛÙo
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 1998; 11:
1: 32-57.
1458. ¶∞¶∞∑O°§OÀ ¡, ª∞¡∂™ Ã, ∫∞ƒ∞ª∏Δ™O™
¢, ª∏§∞ƒ∞∫∏™ ¢, ™∞Δ™O°§OÀ ∞, ∞¡∞°¡ø™ΔOÀ ∂, Ã∞Δ∑∏¶∂ΔƒOÀ ∞, ª∞ƒ∞™ ¶, ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫Àƒ∫OÀ¢∏™ ∞, ª∞ƒπ¡O™ ∂,
°∫πƒΔ∑∏™ π, Ãπ™Δ∞∫π¢∏™ ¢. EȉËÌÈoÏoÁ›· Ùo˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·.VII. E›ÙˆÛË
(incidence) π∂™¢ Û ¤ÓÙ ¡oÌo‡˜ Ù˘ μfiÚÂÈ·˜
∂ÏÏ¿‰·˜ ÙËÓ ÂÚ›o‰o 1989-1995. ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 1998; 11: 58-66.
1459. ™OÀ§πOÀ ∂, ™Àª∂ø¡π¢∏™ °, ªOÀ™§∂à Δ,
∞ƒÃ∞¡πøΔ∞∫∏ ª, ¢π∑∞ ∂, ∫Àƒπ∞∑O¶OÀ§OÀ μ. ™‡ÁÎÚÈÛË ÌÂıfi‰ˆÓ ÚoÛ‰ÈoÚÈÛÌo‡ Ù˘
ÁÏ˘Îo˙˘ÏȈ̤Ó˘ ·ÈÌoÛÊ·ÈÚ›Ó˘ (HbA1). ∂ÏÏËÓ.
¢È·‚. ÃÚoÓÈο 1998; 11: 67-73.
1460. ¢∞ªπ∞¡∞∫∏ ¢, Δ™OÀΔ™π¡O™ ∞, ∑π∫∞ π, ª∂§π¢ø¡∏™ ∞. πÓÛo˘ÏÈÓo·ÓÙ›ÛÙ·ÛË Î·È ÏÈȉ·ÈÌÈÎfi
profile Û ·È‰È¿ Ì ·¯˘Û·ÚΛ·. ∂ÏÏËÓ. ¢È·‚.
ÃÚoÓÈο 1998; 11: 74-82.
1461. ƒ∂¶∞¡Δ∞ ∂, ™∫∞ƒ∞°∫∞™ °, ª¶OÀ™πOÀ £,
°∫OÀΔ∫π¢OÀ ™, ∫∂™π¢∏™ Ã, ¶∞¶∞∑O°§OÀ
¡. B·ÎÙËÚÈo˘Ú›· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ.
¢È·‚. ÃÚoÓÈο 1998; 11: 83-5.
1462. §π¡O™ ¢, ¡∂™ΔOƒπ¢∏ ∂. ™‡Á¯ÚoÓË ‰È·ÁÓˆÛÙÈ΋
Î·È ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ÈÓÛo˘ÏÈÓÒÌ·Ùo˜.
π·ÙÚÈ΋ 1997; 72: 154-65.
1463. §EYKO™ N, EY£YMIA¢H™ A, M¶OYNTøNA™ °, ™TY§IA¢H™ I, §IAT™H™ I, T™A¶A™ °. ∏
Â›‰Ú·ÛË ÙˆÓ ·Ó·ÛÙoϤˆÓ Ù˘ ΢ÎÏoo͢ÁÂÓ¿Û˘ ÛÙo
‰Â›ÎÙË ÈÓÛo˘ÏÈÓoÁ¤ÓÂÛ˘. °·ÏËÓfi˜ 1997; 39: 284-91.
1464. CHATURVEDI N, SJOLIE A-K, STEPHENSON
J, ABRAHAMIAN H, KEIPES M, CASTELLARIN
A, ROGULJIA-PEPEONIK Z, FULLER J, AND
THE EUCLID STUDY GROUP. Effect of lisinopril
on progression of retinopathy in normotensive people
with type I diabetes. Lancet 1998; 351: 28-31.
1465. BARTSOKAS CH, DACOU-VOUTETAKIS C,
DAMIANAKI D, KARAYANNI CH, KASSIOU C,
QADREH A, THEODORIDIS CH, TSOKA H,
136
GREEN A, FOR THE EURODIAB ACE G1
GROUP. Epidemiology of childhood IDDM in
Athens: Trends in incidence for the years 1989-1995.
Letter to the editor. Diabetologia 1998; 41: 245-6.
1466. μOÀ¢OÀƒ∏™ ∫. ∂ȉÈΤ˜ Î·È Ì‹ ÂȉÈΤ˜ ·ÚıÚo¿ıÂȘ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. OÛÙo‡Ó 1990; 1: 43-5.
1467. ™Àª∂ø¡π¢∏™ π, Δ™OÃ∞™ ∫, μOÀ¢OÀƒ∏™ ∫.
™¯¤ÛȘ ÂȉÈÎo‡ ‚¿Úo˘˜ Î·È Û·Î¯¿Úo˘ o‡ÚˆÓ ‰È· ÂÈÚ·Ì·ÙÈÎÒÓ Î·Ì˘ÏÒÓ in vitro. °·ÏËÓfi˜ 1966; 9: 594600.
1468. ¶∞¶∞´ø∞¡¡π¢∏™ ¢, μOÀ¢OÀƒ∏™ ∫, ª¶∞¡∞μ∞™ ∫Ï, μ∞§∫OÀª∞ ¢, °π∞°∞ ∞, ¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂. °Ï˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌoÛÊ·ÈÚ›ÓË Î·È ·Ó·ÈÌ›· ÚÂ˘Ì·ÙoÂȉo‡˜ ·ÚıÚ›Ùȉo˜. ™ÙÔ ¶Ú·ÎÙÈο πà ¶·ÓÂÏÏËÓ›o˘ ™˘Ó‰ڛo˘ ƒÂ˘Ì·ÙoÏoÁ›·˜.
∞ı‹Ó·, 1986: 155-62.
1469. ¶∞¶∞´ø∞¡¡π¢∏™ ¢, μOÀ¢OÀƒ∏™ ∫, °πøΔ∏™ Ã, ∂À∞°°∂§OÀ ∞, ∫∞ƒ∞°π∞¡¡∏™ ¡,
μ∞§∫OÀª∞ ¢. °Ï˘Îo˙˘ÏȈ̤ÓË ·ÈÌoÛÊ·ÈÚ›ÓË
(HbA1) Î·È Î·Ù·‚oÏ‹. ™ÙÔ: ¶Ú·ÎÙÈο 1o˘ ¢ÈÂıÓo‡˜
™˘Ó‰ڛo˘ ÁÈ· ÙËÓ Î·Ù·‚oÏ‹. ∞ı‹Ó· 1985: 249-59.
1470. ∫∞ƒ∞°π∞¡¡∏™ ¡, ¶∞¶∞´ø∞¡¡π¢∏™ ¢, ¶∞¶∞´ø∞¡¡OÀ ¶, μOÀ¢OÀƒ∏™ ∫, °πøΔ∏™ Ã,
∂À∞°°∂§OÀ ∞, ¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂. °Ï˘ÎÔ˙˘ÏȈ̤ÓË ·ÈÌoÛÊ·ÈÚ›ÓË (HbA1) Î·È ·ÛÈÚ›ÓË.
™ÙÔ: ¶Ú·ÎÙÈο 1o˘ μoÚÂÈoÂÏÏ·‰ÈÎo‡ π·ÙÚÈÎo‡ ™˘Ó‰ڛo˘. 1986; ÙfiÌ. μ′: 658-61.
1471. ¶∞¶∞´ø∞¡¡π¢∏™ ¢, °πøΔ∏™ Ã, ∫∞ƒ∞°π∞¡¡∏™ ¡, μOÀ¢OÀƒ∏™ ∫, ∂À∞°°∂§OÀ ∞. ÀÂÚÁÏ˘Î·ÈÌ›· ÌÂÙ¿ ·fi ¯oÚ‹ÁËÛË ÓÈʉÈ›Ó˘. π·ÙÚÈο
ÃÚoÓÈο 1985; 8: 629-32.
1472. ¶∞¶∞´ø∞¡¡π¢∏™ ¢, °πøΔ∏™ Ã, ∫∞ƒ∞°π∞¡¡∏™ ¡, ∂À∞°°∂§OÀ ∞, ª∞°¡∏™∞§∏™ ∞,
μOÀ¢OÀƒ∏™ ∫. ÀÂÚÁÏ˘Î·ÈÌ›· ηٿ ÙËÓ ‰È¿ÚÎÂÈ·
ıÂÚ·›·˜ Ì ·ÌÈo‰·ÚfiÓË. π·ÙÚÈο ÃÚoÓÈο 1986; 9:
137-42.
1473. μOÀ¢OÀƒ∏™ ∫. ƒÂ˘Ì·ÙÈΤ˜ ÂΉËÏÒÛÂȘ ÂÓ‰oÎÚÈÓo·ıÂÈÒÓ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ (¢È·‚ËÙÈο
ÚÂ˘Ì·ÙÈο Û‡Ó‰ÚoÌ·). ™Ùo: μÔ˘‰Ô‡Ú˘ ∫. ¢È·ÁÓˆÛÙÈ΋ ƒÂ˘Ì·ÙoÏoÁ›·. University Studio Press. £ÂÛÛ·ÏoÓ›ÎË 1987: 614-7.
1474. MARKOPOULOS A, BELAZI M. Histopathological and immunohistological features of the labial salivary glands in children with type I diabetes. J Diab
Complications 1998; 12: 39-42.
1475. MANTZOROS Ch, FREDERICH R, QU D,
LOWELL B, MARATOS-FLIER E, FLIER J. Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin. A
mice despite suppression of hypotha-lamic neuropeptide Y and circulating corticosterone concetrations.
Diabetes 1998; 47: 230-8.
1476. Δ™∞¶O°∞™ ¶, ∫∞Δ™π§∞ª¶ƒO™ ¡. ¡¤· ÎÚÈÙ‹ÚÈ· ÁÈ· ÙËÓ ‰È¿ÁÓˆÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1997; 72: 243-5.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1477. ª∞¡Δ∑øƒO™ Ã, ™¶∂¡Δ∑O™ ¢. πÓÛo˘ÏÈÓo·ÓÙo¯‹. Δo Ê¿ÛÌ· ÙˆÓ ÎÏÈÓÈÎÒÓ ÂΉËÏÒÛˆÓ. π·ÙÚÈ΋
1997; 72: 246-52.
1478. O’DEA K,TRAIANEDES K, IRELAND P, NIALL
M, SADLER J, DELUISE M. The effect of diet differing in fat, carbohydrate and fiber on carbohydrate
and lipid metabolism in type II diabetes. J Am Diet
Assoc 1989; 89: 1076-86.
1479. πø∞¡¡π¢∏™ π, ª∞¡Δ∞™ ¶, ∞μƒ∞∞ª °, ∫∞Δ™π§∞ª¶ƒO™ ¡. ¶·¯˘Û·ÚΛ· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘ Ù‡o˘ 2. ∏ ÛËÌ·Û›· Ù˘ ηٷÓoÌ‹˜ Ùo˘
Ï›o˘˜. ∫·Ú‰›· & ∞ÁÁ›· 1998; 1: 27-42.
1480. πø∞¡¡π¢∏™ °, £∞§∞™™π¡O™ ¡. ªÈÎÚoÏÂ˘ÎˆÌ·ÙÈÓo˘Ú›· Î·È Î·Ú‰È·ÁÁÂȷ΋ ÓfiÛo˜ ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 1997; 72: 344-5.
1481. BARTSOCAS CH, KASSIOU C, DAFOGIANNI
C. Myocardial infarction on a 17-year old diabetic
adolescent. Letter to Editor. Diabet Med 1998; 15:
349.
1482. ROGLIC G, COLHOUN H, STEVENS L, LEMKES H, MANES CH, FUL- LER J, AND THE
EURODIAB IDDM COMPLICATIONS STUDY
GROUP. Parental history of hypertension and
parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: The
EURODIAB IDDM Complications Study. Diabet
Med 1998; 15: 418-26.
1483. ∞™∞¡∏™ π. ¶ÂÚ›ÙÈÓo˜ ıÂÚ·›·˜ ‰È·‚‹Ùo˘. O
¡∂O™ ∞™∫§∏¶πO™ 1842; º˘ÏÏ¿‰ÈÔ 7-10: 192-6.
1484. ªÀ°¢∞§∏™ ∏¡. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·:
∑∏Δ∞ π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 1998: 297 ÛÂÏ.
1485. ƒ∞¶Δ∏™ ™. £ÂÚ·¢ÙÈÎo› ÛÙfi¯oÈ Î·È ‰˘Ó·ÙfiÙËÙ˜
ÛÙËÓ ·ÓÙÈÌÂÒÈÛË Ùo˘ ‰È·‚ËÙÈÎo‡ Û˘Ó‰ÚfiÌo˘. ™Ùo:
ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞
π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 1-8.
1486. μ§∞™™∞ƒ∞ ∂. ∏ ÛËÌ·Û›· ÙˆÓ AGEs ÛÙȘ ‰È·‚ËÙÈΤ˜ ÂÈÏoΤ˜. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜
Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 19-30.
1487. ∫O§πO¶OÀ§O™ π. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘
۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË.
∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 31-40.
1488. ∫ø™Δ∞∫∏™ ∞. ªÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·Ùo˜. ™Ùo:
ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞
π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 281-97.
1489. ∫∂º∞§O°π∞¡¡∏™ ¡. ∞˘ÙfiÓoÌË Ó¢Úo¿ıÂÈ·:
ÎÏÈÓÈΤ˜ ÂΉËÏÒÛÂȘ Î·È ·ÓÙÈÌÂÙÒÈÛË. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË
– ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜
ÂΉfiÛÂȘ, 1998: 57-68.
1490. ª∂§π¢ø¡∏™ ∞. ∂ÚÁ·ÛÙËÚȷ΋ ‰È¿ÁÓˆÛË Ó¢Úo-
¿ıÂÈ·˜. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘
۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË.
∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 69-78.
1491. ª¶∂¡ƒOÀª¶∏ ª. Δo ‰È·‚ËÙÈÎfi fi‰È. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 79-86.
1492. §∞∑∞¡∞™ ª. μ·ÎÙËÚȷΤ˜ ÏoÈÌÒÍÂȘ Ùo˘ o˘ÚooÈËÙÈÎo‡ ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘
Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË –
¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 87-100.
1493. ∫∞ƒ∞ª∞¡O™ μ. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛo˘Ï›ÓË Î·È
˘ÂÚÈÓÛo˘ÏÈÓ·ÈÌ›·: O Û˘Ó‰ÂÙÈÎfi˜ ÎÚ›Îo˜ ÌÂٷ͇
۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË Ù‡o˘ 2, ÌÈÎÚo·ÁÁÂÈo¿ıÂÈ·˜,
˘¤ÚÙ·Û˘ Î·È ‰˘ÛÏÈȉ·ÈÌ›·˜. ™Ùo: ª˘Á‰¿Ï˘ Ã.
ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 119-28.
1494. ªÀ°¢∞§∏™ ∏¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ‰˘ÛÏÈȉ·ÈÌ›·. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜
Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 129-40.
1495. ∫∞Δ™π§∞ª¶ƒO™ ¡. O ÚfiÏo˜ Ù˘ ÌÂÙ·ÁÂ˘Ì·ÙÈ΋˜
ÙÚÈÁÏ˘ÎÂÚȉ·ÈÌ›·˜ ÛÙËÓ ·ıËÚoÛÎÏ‹ÚˆÛË. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 141-8.
1496. ¶∞¶¶∞™ ™. £ÂÚ·›· ‰˘ÛÏÈȉ·ÈÌ›·˜. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 149-60.
1497. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, Àº∞¡Δ∏ °, ª∞ƒ∞∫OªπÃ∂§∞∫∏™ °™. ∞Ó·›Ì·ÎÙ˜ ‰È·ÁÓˆÛÙÈΤ˜ Ù¯ÓÈΤ˜ ÛÙË ‰È¿ÁÓˆÛË Ù˘ ÂÚÈÊÂÚÈ΋˜ Î·È Â͈ÎÚ·Óȷ΋˜ ·ÁÁÂȷ΋˜ ÓfiÛo˘ ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·:
∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 161-74.
1498. ΔOÀ¡Δ∞™ Ã. ¶ÂÚÈÊÂÚÈ΋ ·ÁÁÂȷ΋ ÓfiÛo˜. ™Ùo:
ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞
π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 175-84.
1499. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ™ÙÂÊ·ÓÈ·›· ÓfiÛo˜ ÛÙo
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998:
185-94.
1500. ∑∏ƒO°π∞¡¡∏™ ¶, ∑OÀƒπ¢∞∫∏™ ∞. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ ÓÂÊÚo¿ıÂÈ· ·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 1. ™Ùo:
ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞
π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 195-210.
1501. μ∞ƒ™∞ª∏™ ∂. ∞ÓÙÈ˘ÂÚÙ·ÛÈ΋ ıÂÚ·›· ÛÙo
137
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ,
1998: 211-26.
1502. ∑OÀ¶∞™ Ã,∫∂¶∞¶Δ™O°§OÀ O. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ÂÁ΢ÌoÛ‡ÓË: ÃÚfiÓȘ ÂÈÏoΤ˜. ™Ùo:
ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞
π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 227-30.
1503. ª¶∞ƒΔ™O∫∞™ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË ÛÙo ·È‰› Î·È ÛÙoÓ ¤ÊË‚o. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 231-8.
1504. ¶∞¶∞¢∞ª ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÓ‰oÎÚÈÓÈΤ˜ ÂÈÏoΤ˜. ™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·: ∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998:
239-48.
1505. °πøμO™ π. ∏ ·¯˘Û·ÚΛ· ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·:
∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 249-70.
1506. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂. ™‡Á¯ÚoÓË ÛÙÚ·ÙËÁÈ΋ ÚfiÏ˄˘ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË Ù‡o˘ 2.
™Ùo: ª˘Á‰¿Ï˘ Ã. ÃÚfiÓȘ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË – ¶ÚfiÏË„Ë, ·ÓÙÈÌÂÙÒÈÛË. ∞ı‹Ó·:
∑∏Δ∞ π·ÙÚÈΤ˜ ÂΉfiÛÂȘ, 1998: 271-80.
1507. PA¶TH™ ™∞. ¢È·‚ËÙÈÎfi Û‡Ó‰ÚoÌo. ™ÙÔ: ƒ¿Ù˘
™∞. ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1998: 2148-63.
1508. PA¶TH™ ™∞. °ÂÓÈÎo› ηÓfiÓ˜ ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ‰È·‚ËÙÈÎo‡ Û˘Ó‰ÚfiÌo˘. ™ÙÔ: ƒ¿Ù˘ ™∞. ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 1998: 2163-5.
1509. PA¶TH™ ™∞. º·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ùo˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ƒ¿Ù˘ ™∞. ∂ÛˆÙÂÚÈ΋
¶·ıoÏoÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1998: 2166-75.
1510. PA¶TH™ ™∞. «π‰Â·Ùo›» ÙÚfioÈ ¯oÚ‹ÁËÛ˘ ÈÓÛo˘Ï›Ó˘. ™ÙÔ: ƒ¿Ù˘ ™∞. ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1998:
2178-9.
1511. ∫O§πO¶OÀ§O™ π. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·. ™ÙÔ: ∫oÏÈfio˘Ïo˜ π. OÊı·ÏÌoÏoÁ›·: μ·ÛÈΤ˜ ÁÓÒÛÂȘ. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1995: 304-12.
1512. ∞§πμπ∑∞ΔO™ π. ÀoÁÏ˘Î·ÈÌ›· ÛÙo ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË (È·ÙÚoÁÂÓ‹˜ ˘oÁÏ˘Î·ÈÌ›·). ™ÙÔ: ΔÔ‡ÓÙ·˜
â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-Ú¿ÍË. ∞ı‹Ó·:
∂Ù¿ÏÔÊÔ˜, 1995: 326-52.
1513. ™Δ∞ª¶OÀ§∏™ ∂. ∞˘ÙfiÓoÌË Ó¢Úo¿ıÂÈ·. ™ÙÔ:
™Ù·Ìo˘Ï‹˜ ∂. ¢È·‚ËÙÈΤ˜ Ó¢Úo¿ıÂȘ. ∞ı‹Ó·:
∂ÚÁ·ÛÙ‹ÚÈo ∏ÏÂÎÙÚoÌ˘oÁÚ·Ê›·˜ ∂¶∂, 1989: 129209.
138
1514. ªÀ°¢∞§∏™ ∏. ¢È·‚ËÙÈ΋ Ó¢Úo¿ıÂÈ·. ™ÙÔ:
ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-Ú¿ÍË.
∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜, 1995: 420-8.
1515. ™Δ∞ª¶OÀ§∏™ ∂. ∏ÏÂÎÙÚoÊ˘ÛÈoÏoÁÈο Â˘Ú‹Ì·Ù·. ™ÙÔ: ™Ù·Ìo˘Ï‹ ∂. ¢È·‚ËÙÈΤ˜ Ó¢Úo¿ıÂȘ.
∞ı‹Ó·: ∂ÚÁ·ÛÙ‹ÚÈo ∏ÏÂÎÙÚoÌ˘oÁÚ·Ê›·˜ ∂¶∂,
1989: 59-72.
1516. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂. ∞ÈÌoÚÚÂoÏoÁÈΤ˜ ηÈ
‚Èo¯ËÌÈΤ˜ ·Ú¿ÌÂÙÚoÈ ÛÙË ‰È·‚ËÙÈ΋ ·ÁÁÂÈo¿ıÂÈ·.
∫ÏÈÓÈ΋ Î·È ÂÈÚ·Ì·ÙÈ΋ ÌÂϤÙË. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1517. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛo˜ Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1996. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1518. BAKRIS G, BAMHILL B, SADLER R. Treatment
of arterial hypertension in diabetic humans: Importance of therapeutic selection. Kidney Int 1992; 41:
912-9.
1519. ∫∞™™πOÀ ∫. ¢È·‚ËÙÈ΋ ÓÂÊÚo¿ıÂÈ· ·fi ÙËÓ
ÏÂ˘Ú¿ Ùo˘ ·È‰È¿ÙÚo˘. ™ÙÔ: ª·ÚÙÛfiη˜ Ù, ™È·Ê¿˜ ∫, ¢ÂÏ‹˜ ¢. OÈ ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙ· ·È‰È¿ Î·È Ùo˘˜ ÂÊ‹‚o˘˜. ∞ı‹Ó·: ∂Ή. ∫.
Î·È °. ∑ÂÚÌ›Ó˘, 1992: 81-8.
1520. ª¶∞ƒΔ™O∫∞™ Ù ™π∞º∞™ ∫, ¢∂§∏™ ¢. OÈ
ÂÈÏoΤ˜ Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙ· ·È‰È¿ ηÈ
Ùo˘˜ ÂÊ‹‚o˘˜. ∞ı‹Ó·: ∂Ή. ∫. Î·È °. ∑ÂÚÌ›Ó˘,
1992.
1521. Δ™∞°∫∞ƒ∞∫∏™ ™, £∞§∞™™π¡O™ ¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È oÚÌfiÓ˜. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-Ú¿ÍË. ∞ı‹Ó·: ∂Ù¿ÏÔÊÔ˜,
1995: 95-106.
1522. ∫ø™Δ∞∫∏™ ∞. ™˘Ì‚oÏ‹ ÛÙË ÌÂϤÙË Ù˘ ·ÏÁoÚÈıÌÈ΋˜ ÂÎÎÚ›Ûˆ˜ ·ÁÎÚ·ÙÈÎÒÓ oÚÌoÓÒÓ Â› Ê˘ÛÈoÏoÁÈÎo‡ Î·È ÌÂÙ·ÌoÛ¯Â˘ı¤ÓÙo˜ ·ÁÎÚ¤·Ùo˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
1523. °ƒ∏°Oƒπ∞¢OÀ ∂. £ÂÚ·›· Ù˘ ˘¤ÚÙ·Û˘. ∫·Ú‰›· & ∞ÁÁ›· 1998; 3: 222-4.
1524. μUYKEN A, TOELLER M, HEITKAMP G, VITELLI F, STEHLE P, SCHER BAUM W, FULLER
J, EURODIAB IDDM COMPLICATIONS STUDY
GROUP. Relation of fibre intake to HbA1c and the
prevalence of severe ketoacidosis and severe hypoglycaemia. Diabetologia 1998; 41: 882-90.
1525. MITRAKOU A, TOUNTAS N, RAPTIS A, BAUER R, SCHULZ H, RAPTIS S. Long term effectiveness of a new ·-glucosidase inhibitor (BAY
m1099-miglitol) in insulin-treated type 2 diabetes
mellitus. Diabet Med 1998; 15: 657-60.
1526. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ¢∏ª∏Δ™π∫O°§OÀ §, ƒO∑∏-¶∞¡OÀ ¶, ¡∞§ª¶∞¡Δ∏™ π, ¶∞¶∞¡π∫O§∞OÀ-∫ƒÀø¡∞ ∫,
¶∞¶∞¢∏ª∏ΔƒπOÀ-ªπ™∫∞ ∑. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ·ÁÚoÙÈÎfi Â¿ÁÁÂÏÌ·. ¶ÚˆÙo‚¿ıÌÈ·
ºÚoÓÙ›‰· ÀÁ›·˜ 1988; 3: 35-40.
1527. ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
¢∏ª∏Δ™π∫O°§OÀ ¡, ªøƒ∞§´Δ∏™ °, ∂À™Δ∞£π∞¢OÀ-™Δ∞ª∞ΔO¶OÀ§OÀ ª, ¶∞¶∞ªO™ÃOÀ ª, ¶∞ª¶OÀ∫π¢∏™ π, ™∫∂ª¶∂ƒ∏™ μ.
ªÂȈ̤ÓË ·ÓÙ›ÏË„Ë ËÏÂÎÙÚÈÎÒÓ ÒÛÂˆÓ Û Ó·Úo˘˜
‰È·‚ËÙÈÎo‡˜. ∞Û˘Ìو̷ÙÈ΋ Ó¢Úo¿ıÂÈ·; ¶·È‰È·ÙÚÈο ÃÚoÓÈο 1990; 17: 19-26.
1528. ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §,
¢∏ª∏Δ™π∫O°§OÀ ¡, ƒO∑∏-¶∞¡OÀ ¶, ™∫∂ª¶∂ƒ∏™ μ, ªøƒ∞πΔ∏™ °. ∂ÌÂÈÚ›· Î·È ‚·ıÌfi˜
·ÍÈoÈÛÙ›·˜ ÙˆÓ ÌÂÙÚ‹ÛÂˆÓ Ù˘ ÁÏ˘Îfi˙˘ Ùo˘ ·›Ì·Ùo˜
Ì ·Ó·ÎÏ·Û›ÌÂÙÚo. ¶·È‰È·ÙÚÈο ÃÚoÓÈο 1990; 17: 2734.
1529. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ¢∏ª∏Δ™π∫O°§OÀ §, ƒO∑∏-¶∞¡OÀ ¶, ∂À™Δ∞£π∞¢OÀ-™Δ∞ª∞ΔO¶OÀ§OÀ ª, ¶∞¶∞ªO™ÃOÀ ª, ¶∞ª¶OÀ∫π¢∏™ π, ªøƒ∞´Δ∏™ °.
§È›‰È· Î·È ÏÈoÚˆÙ›Ó˜ Ùo˘ Ï¿ÛÌ·Ùo˜ Û Ó·Úo‡˜ ‰È·‚ËÙÈÎo‡˜ Ù‡o˘ π: ™˘Û¯¤ÙÈÛË Ì Ùo ‚·ıÌfi
ÁÏ˘Î·ÈÌÈÎo‡ ÂϤÁ¯o˘. ¶·È‰È·ÙÚÈο ÃÚoÓÈο 1990;
17: 67-76.
1530. ∫ø¡™Δ∞¡Δπ¡π¢OÀ-¢∏ª∏Δ™π∫O°§OÀ §,
¢∏ª∏Δ™π∫O°§OÀ ¡, ƒO∑∏-¶∞¡OÀ ¶, ªøƒ∞πΔ∏™ °, ™∫∂ª¶∂ƒ∏™ μ. ™˘Ì‚·ÙÈ΋ ÈÓÛo˘ÏÈÓoıÂÚ·›·: ¶ÂÚÈoÚÈṲ̂ÓË ·Í›· ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ó·ÚÒÓ (Ù‡o˘ π) ‰È·‚ËÙÈÎÒÓ. ¶·È‰È·ÙÚÈ΋ 1988;
51: 285-94.
1531. MALAMITSI-PUCHNER A, SARADAKOU A,
DAFOYANNI CH, TZIOTIS J, BARTSOCAS C.
Serum angiogenin levels in children and adolescents
with insulin-dependent diabetes mellitus. Pediatr Res
1998; 43: 798-800.
1532. ¡Δ∞ºO°π∞¡¡∏ Ã. ™ˆÌ·ÙÈ΋ ¿ÛÎËÛË ÛÙ· ·È‰È¿
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™Ùo: ªÂÏȉÒÓË ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛˆÌ·ÙÈ΋ ¿ÛÎËÛË. ¶ÂÈÚ·È¿˜:
Medical Graphic Center ∂ΉoÙÈ΋, 1998; 17-23.
1533. ª∂§π¢ø¡∏™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛˆÌ·ÙÈ΋ ¿ÛÎËÛË. ¶ÂÈÚ·È¿˜: Medical Graphic Center,
1998.
1534. KONTESSIS P, BOSSINAKOU I, SARIKA L,
ILIOPOULOU E, PAPANTONIOU A, TREVISAN
R, ROUSSI D, STIPHANELLI K, GRIGORAKIS S,
SOUVATZOGLOU A. Renal, metabolic and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabeticpatients. Diabetes Care 1995; 18: 1233-40.
1535. OIKONOMO¶OÀ§OÀ ¶. ¡Â˘ÚoÂÓ‰oÎÚÈÓÈÎo›
fiÁÎoÈ Ùo˘ ÂÙÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜ - ∫ÏÈÓÈο Û‡Ó‰ÚoÌ·.
™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο
1998; 7: 7-10.
1536. ¶OÀ§OÀ ∞. K‡ÙÙ·Ú· APUD-¶ÂÙȉÈΤ˜ oÚÌfiÓ˜. ™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο 1998; 7: 12-16.
1537. ª∞ƒ∞∫∏ £. ∫·ÚÎÈÓoÂȉ¤˜-πÓÛo˘Ï›ÓˆÌ·-μ›ˆÌ·
(™‡Ó‰ÚoÌo Verner-Morrison, ™‡Ó‰ÚoÌo WDHA).
™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο
1998; 7: 18-26.
1538. ∫∞ƒOÀª¶∞§∏ π. °·ÛÙڛӈ̷ (™‡Ó‰ÚoÌo Zollinger-Ellison) – °Ï˘Î·Áfiӈ̷ – ™ˆÌ·ÙoÛٷٛӈ̷ §oÈo› Ó¢ÚoÂÓ‰oÎÚÈÓÈÎo› fiÁÎoÈ. ™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο 1998; 7: 30-42.
1539. AM¶∂ƒπ∞¢∏ ¶. ™‡Ó‰ÚoÌ· oÏÏ·Ï‹˜ ÂÓ‰oÎÚÈÓo¿ıÂÈ·˜ (™‡Ó‰ÚoÌ· ª∂¡). ™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο 1998; 7: 44-6.
1540. ∞ª¶∂ƒπ∞¢∏ ¶. ¢È·ÁÓˆÛÙÈ΋ ·ÂÈÎoÓÈÛÙÈ΋
ÚoÛ¤ÁÁÈÛË ÙˆÓ Ó¢ÚoÂÓ‰oÎÚÈÓÈÎÒÓ fiÁΈÓ. ™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο 1998; 7:
48-50.
1541. ¶OÀ§OÀ ∞. MË ¯ÂÈÚo˘ÚÁÈ΋ ıÂÚ·›· ÙˆÓ Ó¢ÚoÂÓ‰oÎÚÈÓÈÎÒÓ fiÁΈÓ. ™ÙÚoÁÁ˘Ï‹ ÙÚ¿Â˙·. °·ÛÙÚÂÓÙÂÚoÏoÁÈο ÃÚoÓÈο 1998; 7: 52-8.
1542. ANASTASIOU E, ALEVIZAKI M, GRIGORAKIS S, PHILIPPOU G, KYPRIANOU M, SOUVATZOGLOU A. Decreased stature in gestational
diabetes mellitus. Diabetologia 1998; 41: 997-1001.
1543. ¶∞¶∞¢O°∂øƒ°∞∫∏™ ¡. ÃÂÈÚo˘ÚÁÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÏoÈÌÒÍÂˆÓ Ù˘ ÙÚ·¯ËÏoÚoÛˆÈ΋˜ ¯ÒÚ·˜
Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. π·ÙÚÈÎfi μ‹Ì· 1998; 59:
24-6.
1544. THE EURODIAB ACE STUDY GROUP AND
THE EURODIAB ACE SUBSTUDY 2 STUDY
GROUP. Familial risk of type I diabetes in european
children. Diabetologia 1998; 41: 1151-6.
1545. XƒÀ™OÃOÀ Ã,ΔOÀΔOÀ∑∞™ ¶. ∏ ¯Ú‹ÛË Ûo˘ÏÊoÓ˘Ïo˘ÚÈÒÓ Û ·ÛıÂÓ›˜ Ì ÛÙÂÊ·ÓÈ·›· ÓfiÛo. ∫·Ú‰›· & ∞ÁÁ›· 1998; 3: 467-71.
1546. Δ∂ƒΔπ¶∏ ∞, ∑∞Ã∞ƒπOÀ ª, ∫∞§¢ƒÀªπ¢∏™
º. OÈ ÏÈoÚˆÙ½Ó˜ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚ.
∂ÈηÈÚfiÙËÙ· 1997; 1: 13-15.
1547. ª∞°OÀ§∞ π. À¤ÚÙ·ÛË Î·È ÌÂÙ·‚oÏÈÎfi Û‡Ó‰ÚoÌo
Ã: O ÚfiÏo˜ Ù˘ ·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ÈÓÛo˘Ï›ÓË Î·È Ùo˘
Û˘Ì·ıËÙÈÎo‡ Ó¢ÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜ (SNS). °·ÏËÓfi˜
1998; 40: 135-42.
1548. ¶∞¶∞°∂øƒ°πOÀ ¢, ¶∞¶∞¢∏ª∏ΔƒπOÀ ¢,
Δ™O§∫∞™ ¶, ∫ø¡™Δ∞¡Δπ¡π¢OÀ ∞, ¡Δπ¡O¶OÀ§OÀ ∂, ∫∞§∞´Δ∑∏™ ∂. ∏ ηٿ ʇÏo ηٷÓoÌ‹ ÙˆÓ ÏÈȉ›ˆÓ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ ππ Î·È ÂÚÈÊÂÚÈ΋ ·ÚÙËÚÈo¿ıÂÈ·. °·ÏËÓfi˜ 1998; 40: 152-9.
1549. ANASTASIOU E, LEKAKIS J, ALEVIZAKI M,
PAPAMICHAEL C, MEGAS J, SOUVATZOGLOU A, STAMATELOPOULOS S. Impaired
endothelium deprntdent vasodilatation in women
with previous gestational diabetes. Diabetes Care
1998; 21: 2111-5.
1550. PEPPA-PATRIKIOU M, SCORDILI M, ANTONIOU A, GIANNAKI M, DRACOPOULOU M,
DACOU-VOUTETAKIS C. Carotid atherosclerosis
in adolescents and young adults with IDDM. Diabetes
Care 1998; 21: 1004-7.
1551. AHMED AB, MALLIAS J, HOME P. Optimization
of evening insulin dose in patients using the short-
139
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
acting insulin analog Lispro. Diabetes Care 1998; 21:
1162-6.
1552. ELKELES R, DIAMOND J, POULTER C,
DHANJIL S, NICOLAIDES A, Mahmood S, Richmond W, Mather H, Sharp P, Feher MD. Cardiovascular outcomes in type 2 diabetes. (the SENDCAP
Study). Diabetes Care 1998; 21: 641-8.
1553. DEMIRTZIAN S, BARDIN C, SAVIN S, ZIRINIS
P, CHAST F, SLAMA G, SÉLAM JL. Lispro insulin
is suitable for external pumps but not for implantable
pumps. Diabetes Care 1998; 21: 867-8.
1554. ∫∞ƒ∞ª∏Δ™O™ ¢. ªÂÙ·‚oÏÈο ÓoÛ‹Ì·Ù·. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™Ùo: ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£ - Δo̤·˜ ¶·ıoÏoÁ›·˜. £ÂÛÛ·ÏoÓ›ÎË:
University Studio Press, 1998; ÙfiÌ. 2: 1038-64.
1555. ¶∞¶∞∑O°§OÀ ¡. OÍ›˜ ÌÂÙ·‚oÏÈΤ˜ ηٷÛÙ¿ÛÂȘ ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™Ùo: ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£ - Δo̤·˜ ¶·ıoÏoÁ›·˜.
£ÂÛÛ·ÏoÓ›ÎË: University Studio Press, 1998; ÙfiÌ. 2:
1065-73.
1556. ™¶∏§πO¶OÀ§O™ ∞. ∏ ‰È‹ıËÛË Ùo˘ ‰È·‚ËÙÈÎo‡
·ÛıÂÓo‡˜. ™Ùo: ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£ - Δo̤·˜ ¶·ıoÏoÁ›·˜. £ÂÛÛ·ÏoÓ›ÎË: University Studio Press, 1998; ÙfiÌ. 2: 1073-5.
1557. ∫∞ƒ∞ª∏Δ™O™ ¢, Ã∞ƒ™OÀ§∏™ º. ∞˘ÙfiÌ·ÙË
˘oÁÏ˘Î·ÈÌ›·. ™Ùo: ∂ÛˆÙÂÚÈ΋ ¶·ıoÏoÁ›·. π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£ - Δo̤·˜ ¶·ıoÏoÁ›·˜. £ÂÛÛ·ÏoÓ›ÎË:
University Studio Press, 1998; ÙfiÌ. 2: 1075-7.
1558. TENTO§OYPH™ N, KAT™I§AM¶PO™ N. ¡Â˘Úo¿ıÂÈ· Ùo˘ ·˘ÙfiÓoÌo˘ Ó¢ÚÈÎo‡ ηډȷÁÁÂÈ·Îo‡
Û˘ÛÙ‹Ì·Ùo˜ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 95-108.
1559. °πøμO™ π, ªOÀ™§∂à Δ, ∫∞∑∞∫O™ ∫, §πª∂¡O¶OÀ§O™ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÎÂÓÙÚÈÎfi
Ó¢ÚÈÎfi Û‡ÛÙËÌ·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11:
109-25.
1560. ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª, Δ∑øΔ∑∞™
£, ¶∞¶¶∞ ∞, Δƒπ∞¡ΔO™ ∞. ∂›‰· Ì·ÁÓËÛ›o˘
ÛÙ· ÂÚ˘ıÚ¿ ·ÈÌoÛÊ·›ÚÈ· Î·È ÛÙoÓ oÚfi Û ·ÛıÂÓ›˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 1998; 11: 126-9.
1561. ∂À£Àªπ∞¢∏™ ∞, §∂À∫O™ ¡, ¶∞¶∞¢O¶OÀ§O™ π, ∫∞ƒOÀ§π∞™ ™Δ, ∂À£Àªπ∞¢∏™ π,
Δ™∞¶∞™ °. £ÂÚ·›· Ì ÌoÍoÓȉ›ÓË ·ÛıÂÓÒÓ ÌÂ
ȉÈo·ı‹ ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Î·È ÌË ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (¡πDDM). ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 130-6.
1562. ∫∞ƒ∞°π∞¡¡∏ ¢, ™∫∞ƒ∞°∫∞™ °, ¶∞¶∞¢∂§∏
∂, °∫OÀΔ∫π¢OÀ ™, ™Δ∞°∫π¢∏™ °, ∑∞Ã∞ƒπOÀ¢∞∫∏ ∫, ¶∞¶∞∑O°§OÀ ¡. ¶ÂÚ›ÙˆÛË ÓÂÎÚˆÙÈ΋˜ ·oÓÂ˘ÚˆÛ›Ùȉ·˜ ‹ ÂÚÈÙoÓ·˝Ùȉ·˜ (necrotizing
fascitis) Û ‰È·‚ËÙ‹ ·ÛıÂÓ‹. ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο
1998; 11: 137-9.
1563. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞ ∂, ∑∞º∂πƒπOÀ ∫,
∫OÀ°πOÀªΔ∑O°§OÀ ¢, Δ∑∞Δ∑∞°OÀ °, ¶∞-
140
¶∞∑O°§OÀ ¡. ∏ Û˘ÛÛÒÚ¢ÛË ÙˆÓ ·ÈÌoÂÙ·Ï›ˆÓ,
Ù· Â›‰· Ùo˘ ÈÓˆ‰oÁfiÓo˘ Î·È Ùo˘ ·Ú¿ÁoÓÙ· von
Willebrand ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ ππ.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 140-3.
1564. ª¶OÀ°OÀ§π∞ ª, Δ∑øΔ∑∞™ £, ∂À£ÀªπOÀ
∏, ∫O§π∞∫O™ °, Δƒπ∞¡ΔO™ ∞, ∫ƒ∞™™∞™ °.
E›‰· ÏÂÙ›Ó˘ Û ·¯‡Û·ÚΘ Á˘Ó·›Î˜ Ì ‹ ¯ˆÚ›˜ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ ππ. ∂ÏÏËÓ. ¢È·‚ËÙ.
ÃÚoÓÈο 1998; 11: 144-7.
1565. ª∂§π¢ø¡∏™ ∞, ΔOÀƒ¡∏™ ™, ∏ƒ∞∫§∂πøΔ∏
™, ∏ƒ∞∫§∂π∞¡OÀ ™. ™¯¤ÛË ÛÈ·ÏÈÎo‡ oͤo˜ ηÈ
‰È·‚ËÙÈ΋˜ ÓÂÊÚo¿ıÂÈ·˜ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
Ù‡o˘ ππ. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 148-55.
1566. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ §,
∫OÀΔª∂ƒπ¢∏™ ª, °∂øƒ°∏∂º∂¡¢∏™ ∫, ∫∞ƒ∞∫O§πO™ ∞, ª∏§π¢∏™ £. H ‰oÎÈÌ·Û›· ‚·ı¤o˜
ηı›ÛÌ·Ùo˜ (Squatting test) ÛÙË ÌÂϤÙË Ù˘ ‰È·Ù·Ú·¯‹˜ Ùo˘ ·˘ÙfiÓoÌo˘ Ó¢ÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜ ÛÙo˘˜ ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11:
156-64.
1567. Δ™πΔ∞ªπ¢OÀ ƒ, ºÀΔπ§∏ Ã, ¶∞°∫∞§O™ ∂,
Δ™∞ƒ¢∞∫∏ ª, ¶ƒO°π∞ ∂. ™˘Û¯¤ÙÈÛË ÙˆÓ ·ÓÙÈoÍÂȉˆÙÈÎÒÓ ÂÓ˙‡ÌˆÓ ÙˆÓ ÂÚ˘ıÚo΢ÙÙ¿ÚˆÓ {˘ÂÚoÍÂȉ¿Û˘ Ù˘ ÁÏo˘Ù·ıÂÈfiÓ˘ (GPX) Î·È ‰˘ÛÌo˘Ù¿Û˘ Ùo˘ ˘ÂÚoÍÂȉ›o˘ (SOD)] Î·È Ùo˘ ÌÂÙ·‚oÏÈÎo‡
ÂϤÁ¯o˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘
ππ. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 165-9.
1568. ª∞¡∂™ Ã, ™OÀ§∏™ ∫, μOÀ∫π∞™ ª, Δƒπ∞¡Δ∞ºÀ§§OÀ °, ™∫∞ƒ∞°∫∞™ °, ∏§π∞¢∏™ μ,
¶∞¶∞∑O°§OÀ ¡. H ‰Ú¿ÛË Ùo˘ ·Ó·ÛÙoϤˆ˜ Ùo˘
ÌÂÙ·ÙÚÂÙÈÎo‡ ÂÓ˙‡Ìo˘ Ù˘ ·ÁÁÂÈoÙÂÓÛ›Ó˘ (ACE)
Lisinopril ÛÙËÓ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·
·ÛıÂÓÒÓ Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ ¢È·‚ËÙ. ÃÚoÓÈο 1998; 11: 170-4.
1569. COLLADO-MESA F, COLHOUN H, STEVENS
L, BOAVIDA J, FERRISS J, KARAMANOS B,
KEMPLER P, MICHEL G, ROGLIC G, FULLER J.
and the EURODIAB IDDM COMPLICATIONS
STUDY GROUP. Prevalence and management of
hypertension in type I diabetes mellitus in Europe:
The EURODIAB IDDM Complications Study.
Diabet Med 1999; 16: 41-8.
1570. VEGLIO M, BORRA M, STEVENS L, FULLER J,
PERIN P. and the EU-RODIAB IDDM COMPLICATIONS STUDY GROUP. The relation between
QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complications Study.
Diabetologia 1999; 42: 68-75.
1571. KEFALIDES N. Biochemical properties of human
gromerular basement membrane in normal and diabetic kidneys. Adv Metab Disord 1973; 2 (Suppl 2):
167-77.
1572. KEFALIDES N. Basement membrane research in
diabetes mellitus. Coll Relat Res 1981; 1: 295-9.
1573. TOELLER M, BUYKEN A, HEITKKAMP G,
PERCOLA G, GIORGINO F, FULLER J, The EU-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
RODIAB IDDM COMPLICATIONS STUDY
GROUP. Fiber intake, serum cholesterol levels, and
cardiovascular disease in European individuals with
type I diabetes. Diabetes Care 1999; 22 (Suppl 2):
B21-B8.
1574. Ã∞ƒ™OÀ§∏™ º. OÚÌoÓÈ΋ Î·È Ó¢ÚÈ΋ Ú‡ıÌÈÛË
Ù˘ ÂÓ‰oÎÚÈÓÈ΋˜ ÏÂÈÙo˘ÚÁ›·˜ Ùo˘ ·ÁÎÚ¤·Ùo˜.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 9-16.
1575. ∞ƒμ∞¡πΔ∞∫∏™ ∂. Δ‡Ïo˜ (οÏo˜): ™ËÌ·Û›· ηÈ
·ÓÙÈÌÂÙÒÈÛË ÛÙo ‰È·‚ËÙÈÎfi fi‰È. ∂ÏÏËÓ. ¢È·‚ËÙ.
ÃÚoÓÈο 1999; 12: 17-22.
1576. ¶∞¶∞∑O°§OÀ ¡. ¢È·‚ËÙÈ΋ ÎÂÙoͤˆÛË. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 23-30.
1577. ¶∞¶∞∑O°§OÀ ¡. ÀÂÚˆÛ̈ÙÈÎfi ÌË ÎÂÙoÙÈÎfi
˘ÂÚÁÏ˘Î·ÈÌÈÎfi ÎÒÌ·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
1999; 12: 31-5.
1578. μO§πøΔ∏™ ∫, ∞ƒ∞°π∞¡¡∏ ¢, ™πª∂§π¢∏™ ¢,
ª∞ƒ∞™ ¶, ª∞ƒπ¡O™ ∂, °∫πƒΔ∑∏™ π. OÍ›˜ ÌÂÙ·‚oÏÈΤ˜ ÂÈÏoΤ˜ Ùo˘ Û·¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 36-68.
1579. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ §,
°∂øƒ°∏∂º∂¡¢∏™ ∫, ¶∂Δƒ∞ μ, ¶∞¶∞Oπ∫O¡OªOÀ ¶, ªO™ÃOÀ ∫. O ÂÈoÏ·ÛÌfi˜ Ù˘ (¯ÚfiÓÈ·˜ ·ÈÛıËÙÈÎoÎÈÓËÙÈ΋˜) ÂÚÈÊÂÚÈ΋˜ oÏ˘Ó¢Úo¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ùo˘ Â͈ÙÂÚÈÎo‡ ‰È·‚ËÙoÏoÁÈÎo‡
È·ÙÚ›o˘. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 69-76.
1580. ¶∞°∫∞§O™ ∂, ¶∞ƒÃ∞ƒπ¢OÀ μ, Δ∑OÀ¡∞™ ∫,
∞μƒ∞∞ª Ã, ª∞¡ø§∞∫∏ Ã, ¶∂Δƒπ¢∏™ ™,
£∂O¢øƒπ¢∏™ ™, °∂øƒ°π∞¢∏™ ∏, ª∏§πø¡∏™
∞. ªÂ›ˆÛË Ù˘ ÁÏ˘Îo˙˘ÏȈ̤Ó˘ ·ÈÌoÛÊ·ÈÚ›Ó˘ ηÈ
Ù˘ ÌÂÙ·ÁÂ˘Ì·ÙÈ΋˜ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ Ì ·Î·Ú‚fi˙Ë ÛÂ
·ÛıÂÓ›˜ Ì هo˘ ππ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™˘ÁÎÚÈÙÈ΋, Ù˘¯·ÈooÈË̤ÓË ÌÂϤÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
1999; 12: 77-82.
1581. ¶∞¶∞∑O°§OÀ ¡, °∫OÀΔ∑OÀƒ∂§∞ ª, ™OÀ§∏™ ∫, ª∞¡∂™ Ã, ¶∞¶∞¢∂§∏ ∂, ™∫OÀΔ∞™ ¢.
¢È·ÙÚoÊÈΤ˜ Û˘Ó‹ıÂȘ ÙˆÓ IDDM ·ÛıÂÓÒÓ Ùo˘ ∫¤ÓÙÚo˘ Ì·˜. ™‡ÁÎÚÈÛË Ì ·Ó¿ÏoÁ· Â˘Ú‹Ì·Ù· Ù˘
EURODIAB IDDM Complications Study. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 83-9.
1582. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ª∞¡∂™ Ã,
∫∞ƒ∞°π∞¡¡∏ ¢, °∫OÀΔ∫π¢OÀ ™, ∑∞Ã∞ƒπOÀ¢∞∫∏ ∫. O ·Ú¿ÁˆÓ von Willebrand (Vwf) Û ‰È·‚ËÙÈÎo‡˜ Ù‡o˘ π, ÛÙ· Ï·›ÛÈ· Ù˘ EURODIAB
IDDM Complications Study. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
1999; 12: 90-4.
1583. Δƒπ∞¡Δ∞ºÀ§§OÀ °, °ƒ∞ªª∂¡O™ ∞, ™∫OÀº∞ƒ∞™ ∞, ∫∞ƒ∞°π∞¡¡∏ Δ, Δƒ∞´∞¡π¢∏™ ¶. ∏
ÂͤÏÈÍË Ù˘ ÌË ÂÍȉڈ̷ÙÈ΋˜ ÁÂÚoÓÙÈ΋˜ ÂÎʇÏÈÛ˘
Ù˘ ˆ¯Ú¿˜ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ· ˘oÛÙÚÒÌ·Ùo˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 95-9.
1584. ∫∞ƒ∞ª∏Δ™O™ ¢, ¢π¢∞°°∂§O™ Δ, μ∞°¢∞Δ§∏ ∂, ∫OÀƒΔO°§OÀ °. ÃÚËÛÈÌoo›ËÛË ÛÈÚoÊÈÌÚ¿Ù˘ Û ‰˘ÛÏÈȉ·È̛˜ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ.
™ÙÔ: ¶Ú·ÎÙÈο 12o˘ μoÚÂoÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛo˘. £ÂÛÛ·ÏoÓ›ÎË, 1997: 338-40.
1585. μ∞ƒ∂§∞ ª, ∑πOÀΔ∞™ ¢, Δ™π∞ª∏™ ¡, ™πª∂§π¢∏™ ¢, ¶O§Àª∂¡π¢∏™ ∑, ∫∞∫OÀ§π¢∏™ π.
ªÂϤÙË HLA ·ÓÙÈÁfiÓˆÓ Û oÈÎoÁ¤ÓÂÈ· ·Û¯fiÓÙˆÓ
·fi π∂™¢. ™ÙÔ: ¶Ú·ÎÙÈο 12o˘ μoÚÂoÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛo˘. £ÂÛÛ·ÏoÓ›ÎË, 1997: 288-92.
1586. ¶∞ƒÃ∞ƒπ¢∏™ °, °∫∂ªπΔ∑∏™ ∫, ∫∞ƒμOÀ¡∏™ Ã, ∫∂Δπ∫O°§OÀ ¢, ™∞μμO¶OÀ§O™ °,
ªOÀ™§∂à Δ, §πª∂¡O¶OÀ§O™ μ, ™ΔÀ§π∞¢∏™ π, §OÀƒπ¢∞™ °. O Ù‡o˜ Ï‹ÚˆÛ˘ Ù˘ ‰ÂÍÈ¿˜
ÎoÈÏ›·˜ Û ·ÛıÂÓ›˜ Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ¶Ú·ÎÙÈο 12o˘ μoÚÂoÂÏÏ·‰ÈÎÔ‡
π·ÙÚÈÎÔ‡ ™˘Ó‰ڛo˘. £ÂÛÛ·ÏoÓ›ÎË, 1997: 685-8.
1587. ™Δ∂º∞¡πøΔOÀ ª, ¶∞™Ãπ¢∏™ ∫, æÀ§§∞™ ∫.
£ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ûo‚·ÚÒÓ ÌoÚÊÒÓ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·˜. ™ÙÔ: ¶Ú·ÎÙÈο 12o˘
μoÚÂoÂÏÏ·‰ÈÎÔ‡ π·ÙÚÈÎÔ‡ ™˘Ó‰ڛo˘. £ÂÛÛ·ÏoÓ›ÎË,
1997: 730-4.
1588. Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡, §π¡OÀ ∞, ™Δ∞ª¶OÀ§∏™ ∂, ¶∞¶∞°∂øƒ°πOÀ ∫.
™˘Ìو̷ÙÈ΋ ÂÚÈÊÂÚÈ΋ Î·È ·˘ÙfiÓoÌË Ó¢Úo¿ıÂÈ· ÛÙ· ‰È·‚ËÙÈο ¿ÙoÌ·. π·ÙÚÈ΋ 1999; 75: 218-24.
1589. ∑π∞∫∞™ °, ™∞μμO¶OÀ§O™ ∑, ∫OÀ¡∞¡∏™ ∞,
ª¶∂¡∏™ ∞, ∞ƒÃ∞¡πøΔ∞∫∏ ª, ¢∂§∏μOƒπ∞
Ã, ∑π∞∫∞™ ∞. N¢Úo·ÚıÚo¿ıÂÈ· Charcot Û Á˘Ó·›Î· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. π·ÙÚÈ΋ 1999; 64:
228-30.
1590. ™∫∞ƒ∞°∫∞™ °. O ÌÂÙ·‚oÏÈÛÌfi˜ ÙˆÓ ÚˆÙÂ˚ÓÒÓ
ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
1999; 12: 109-26.
1591. μO°π∞Δ∑O°§OÀ ¢, §OÀ¶∞ Ã. Lucilia sericata:
ªÈ· ÂÓ·ÏÏ·ÎÙÈ΋ ıÂÚ·¢ÙÈ΋ ÚoÛ¤ÁÁÈÛË Û ÂÎÙÂٷ̤ӷ ‰È·‚ËÙÈο ¤ÏÎË Î¿Ùˆ ¿ÎÚˆÓ ÈÛ¯·ÈÌÈ΋˜ ·ÈÙÈoÏoÁ›·˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 127-35.
1592. ª∞¡∂™ Ã, ™∞´§∂ƒ ¡, ¶O¡Δπ∫π¢∏™ ¡, ¶∞∑∞´ΔOÀ ∫, ™OÀ§∏™ ∫, ¢∏ª∏Δ™π∫O°§OÀ ¡,
∂À£ÀªπOÀ ∏. ¶·¯˘Û·ÚΛ·: ªÂÙ·‚oÏÈΤ˜ ‰È·Ù·Ú·¯¤˜. º·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË. ™ÙÚoÁÁ‡ÏË ÙÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 136-68.
1593. £∂OÃ∞ƒ∏ ª, πø∞¡¡π¢OÀ ¢, ¡OÀ¡O¶OÀ§O™ Ã, ª¶OÀ§OÀ∫O™ ∞, ¶∞¶∞¢O°π∞¡¡∏™
ª, ∫∞Δ™π∫∞ƒ∏ ª, ∫∞ƒ¶∞£πO™ £, ª¶∞ƒΔ™O∫∞™ Ã. O ˘ÂÚ˯oÁÚ·ÊÈÎfi˜ ¤ÏÂÁ¯o˜ Ùo˘ ·ÁÎÚ¤·Ùo˜, ˆ˜ ‰Â›ÎÙ˘ ÏÂÈÙo˘ÚÁÈÎfiÙËÙ¿˜ Ùo˘, ÛÙ· ·È‰È¿ ÌÂ
‚-ÌÂÛoÁÂȷ΋ ·Ó·ÈÌ›·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
1999; 12: 169-73.
1594. ª∂§π¢ø¡∏™ ∞, ΔOÀƒ¡∏™ ™, ∏ƒ∞∫§∂π∞¡OÀ
™, §∂ª¶π¢∞∫∏™ ∂, Ã∞Δ∑∏™∞μμ∞™ π, Δ™∞Δ™OÀ§∏™ ∞, ºOÀ™™∞™ ™. ¢È·ÊoÚ¤˜ ˆ˜ Úo˜ Ùo
ʇÏo ÌÂٷ͇ Ù‡o˘ ππ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì ·ÁÁÂÈoÁÚ·ÊÈο ÙÂÎÌËÚȈ̤ÓË ÛÙÂÊ·ÓÈ·›· ÓfiÛo. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 1999; 12: 174-81.
1595. ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫ø¡™Δ∞¡Δπ¡π¢OÀ §,
°∂øƒ°∏∂º∂¡¢∏™ ∫, °OÀ¡∞ƒπ¢∏™ ∂§, ¶∞-
141
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
¶∞¢O¶OÀ§O™ ™, °∞∫O™ ∂. HKG-ÊÈÎfi ‰È¿ÛÙËÌ· QT Î·È ‰È·‚ËÙÈ΋ Ó¢Úo¿ıÂÈ· Ùo˘ ·˘ÙfiÓoÌo˘
Ó¢ÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999;
12: 182-90.
1596. ¶∞¶∞∑O°§OÀ ¡, πø∞¡¡π¢∏™ ∞, ª∞¡∂™ Ã,
™∫∞ƒ∞°∫∞™ °, ∫∞ƒ∞°π∞¡¡∏ ¢, ∫O¡ΔO¶OÀ§O™ ª. ¢È¿ÛÙËÌ· QT Û هo˘ π ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. ™¯¤ÛË Ì ÙȘ ÌÈÎÚo·ÁÁÂȷΤ˜ ÂÈÏoΤ˜.
∞Ó·ÊoÚ¿ ÛÙ· Â˘Ú‹Ì·Ù· Ù˘ EURODIAB IDDM
Complications Study. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 1999;
12: 191-6.
1597. MALAMITSI-PUCHNER A, SARANDAKOU A,
TZIOTZIS J, DAFOGIANNI C, BARTSOCAS CS.
Serum levels of basic fibroblast growth factor and
vascular endothelial growth factor in children and
adolescents with type 1 diabetes mellitus. Pediatr Res
1998; 44: 873-5.
1598. GIANNOUKAKIS N, RUDERT W.A, ROBBINS
P.D, TRUCCO M. Targeting autoimmune diabetes
with gene therapy. Diabetes 1999; 48: 2107-21.
1599. ™øΔ∏ƒO¶OÀ§O™ ∞. ªÈÎÚoÏÂ˘ÎˆÌ·Ùo˘Ú›· ηÈ
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ∞ÚÂÙ·›o˜ 1999; ª¤Úo˜ ∞′: 337, ª¤Úo˜ μ′: 9-16.
1600. DIMITRIADIS G, GERICH J. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes
Care 1983; 6: 374-7.
1601. BOLLI G, DIMITRIADIS G, PEHLING G, BAKER B, HAYMOND M, CRYER P, GERICH J. Abnormal glucose counterregulation after subcutaneous
insulin in insulin-dependent diabetes mellitus. N Engl
J Med 1984; 310: 1706-11.
1602. KOBBERLING J, TILLIL H, SIMOPOULOS A,
CHILDS B. Genetic and nutritional factors in the aetiology and pathogenesis of diabetes. World Rev Nutr
Diet. 1990; 63: 102-15.
1603. DECHENES C, VERCHERE C, ANDRIKOPOULOS S, KAHN S. Humanaging is associated with parallel reductions in insulin and amylin release. Am J
Physiol 1998; 275: E785-E91.
1604. VAN HAEFTEN T, PIMENTA W, MITRAKOU
A, KORYTKOWSKI M, JENSSEN T, YKI-JARVINEN H, GERICH J. Different factors regulate glucose tolerance and insulinemia in NGT and IGT subjects. Diabetes 1999; (Suppl): A436-A7.
1605. KATOYLIS E,EBDON-PARRY M, LANSHAMMAR H, VILEIKYTE L, KULKARNI J, BOULTON A. Gait abnormalities in diabetic neuropathy.
Diabetes Care 1997; 20: 1904-7.
1606. ∑∞ª¶∂§∏™ £, ∞¡¢ƒ∂∞¢OÀ ∂, ∫∞§∞ª∞À∫π∞¡∞∫∏ ∫, ∫∞Δ™∞ƒO™ ¡, ∑∏™ μ, ¶∞¶∞°∂øƒ°πOÀ ∫. ™Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡o˘ 1,
oÙÈ΋ ·ÙÚoÊ›· Î·È ÎÒʈÛË (Û‡Ó‰ÚoÌo Wolfram).
¶ÂÚÈÁÚ·Ê‹ ‰‡o ÂÚÈÙÒÛˆÓ. π·ÙÚÈ΋ 1998; 74: 3437.
142
1607. KENYON NS, FERNANDEZ LA, LEHMANN R,
MASETTI M, RANUNCOLI A, CHATZIPETROU
M, IARIA G, HAN D, WAGNER JL, RUIZ P,
BERHO M, INVERARDI L, ALEJANDRO R,
MINTZ DH, KIRK AD, HARLAN DM, BURKLY
LC, RICORDI C. Long-term survival and function of
intrahepatic islet allografts in baboons treated with
humanized anti-CD154. Diabetes 1999; 48: 1473-81.
1608. GIANNOUKAKIS N, RUDERT W, GHIVIZZANI S, GAMBOTTO A, RICORDI C, TRUCCO M,
ROBBINS P. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets
prevents IL-1‚-induced ‚-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999; 48:
1730-6.
1609. HE C, SABOL J, MITSUHASHI T, VLASSARA
H. Inhibition of reactive products by aminoguanidine
facilitates renal clearance and reduces tissue sequestration. Diabetes 1999; 48: 1308-15.
1610. DAPERGOLAS G, GREGORIADIS G. Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet 1976; 2: 824-6.
1611. GREGORIADIS G. The carrier potential of liposomes in biology and medicine (second of two parts).
N Engl J Med 1976; 295: 765-70.
1612. DAPERGOLAS G, GREGORIADIS G. The effect
of liposomal lipid composition on the fate and effect
of liposome-entrapped insulin and tubocurarine.
Biochem Trans 1977; 5: 1383- 6.
1613. GREGORIADIS G. Medical applications of liposome-entrapped enzymes. Methods Enzymol 1976;
44: 698-709.
1614. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG
Z, SKOLNIK E, DELANEY V, FRIEDMAN EA,
CERAMI A, VLASSARA H. Advanced glycosylation
end products in patients with diabetic nephropathy.
N. Engl J Med 1991; 325: 836-42.
1615. YANG CW, VLASSARA H, PETEN EP, HE CJ,
STRIKER GE, STRIKER LJ. Advanced glycation
end products upregulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA
1994; 91: 9436-40.
1616. BUCALA R,VLASSARA H. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995; 26: 875-88.
1617. YANG C, VLASSARA H, STRIKER G, STRIKER
L. Administation of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis. Kidney Int
Suppl 1995; 49: S55-S8.
1618. NAKAMURA Y, HORII Y, NISHINO T, SHIIKI
H, SAKAGUCHI Y, KAGOSHIMA T, DOHI K,
MAKITA Z, VLASSARA H, BUCALA R. Immunohistological localization of advanced glycosylation
end-products in coronary atheroma and cardiac tissue
in diabetes mellitus. Am J Pathol 1993; 143: 1649-56.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1619. MAKITA Z, YANAGISAWA K, KUWAJIMA S,
BUCALA R, VLASSARA H, KOIKE T. The role of
advanced glycosylation end-products in the pathogenesis of atherosclerosis. Nephrol Dial Transplant 1996;
11 (Suppl 5): 31-3.
1620. ZIMMERMAN GA, MEISTRELL M, BLOOM O,
COCKROFT KM, BIANCHI M, RISUCCI D,
BROOME J, FARMER P, CERAMI A, VLASSARA H. Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of
aminoguanidine. Proc Natl Acad Sci USA 1995; 92:
3744-8.
1621. STITT AW, MOORE JE, SHARKEY JA, MURPHY G, SIMPSON DA, BUCALA R, VLASSARA
H, ARCHER DB. Advanced glycation end products
in vitreous:structural and functional implications for
diabetic vitreopathy. Invest Ophthalmol Vis Sci 1998;
39: 2517-23.
1622. VLASSARA H, BUCALA R. Recent progress in
advanced glycation and diabetic vascular disease: role
of advanced glycation end product receptors. Diabetes 1996; 45 (Suppl 3): 65-6.
1623. LI YM, STEFFES M, DONNELLY T, LIU C, FUH
H, BASGEN J, BUCALA R, VLASSARA H. Prevention of cardiovascular and renal pathology of aging
by the advanced glycation inhibitor aminoguanidine.
Proc Natl Acad Sci USA 1996; 93: 3902-7.
1624. VLASSARA H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997; 46 (Suppl 2): 19-25.
1625. KOSCHINSKY T, HE CJ, MITSUHASHI T, BUCALA R, LIU C, BUENTING C, HEITMANN K,
VLASSARA H. Orally absorbed reactive glycation
products (glycotoxins): An enviromental risk factor in
diabetic nephropathy. Proc Natl Acad Sci USA 1997;
94: 6474-9.
1626. WU K, SETTY S, MAUER SM, KILLEN P, NAGASE H, MICHAEL AF, TSILIBARY EC. Altered
kidney matrix expression in experimental diabetes.
Acta Anat (Basel) 1997; 158: 155-65.
1627. KRISHNAMURTI U, MICHAEL A, RONDEAU
E, TSILIBARY EE. Altered signal transduction pathways in human glomerular epithelial cells, in response
to matrix glycation. J Biol Chem 1997; 272: 27966-70.
1628. VAFIADIS P, BENNETT S, TODD J, GRABS R,
POLYCHRONAKOS C,: Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1
diabetes. J Clin Endocrinol Metab 1998; 83: 2933-9.
1629. PAQUETTE J, GIANNOUKAKIS N, POLYCHRONAKOS C, VAFIADIS P, DEAL C. The INS
5’ variable number of tandem repeats is associated
with IGF2 expression in humans. J Biol Chem 1998;
273: 14158-64.
1630. VAFIADIS P, GRABS R, GOODYER CG, COL-
LE E, POLYCHRONAKOS C. A functional analysis
of the role of IGF2 in IDDM2-encoded susceptibility
to type 1 diabetes. Diabetes 1998; 47: 831-6.
1631. VAFIADIS P, BENNETT ST, COLLE E, GRABS
R, GOODYER CG, POLYCHRONAKOS C. Imprinted and genotype-specific expression of genes at
the IDDM2 locus in pancreas and leukocytes. J Autoimmun 1996; 9: 397-403.
1632. POLYCHRONAKOS C, GIANNOUKAKIS N,
DEAL C. Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: ∞ hypothesis.
Dev Genet 1995; 17: 253-62.
1633. POLYCHRONAKOS C, KUKUVITIS A, GIANOUKAKIS N, COLLE E. Parental imprinting effect
at the INS-IGF2 diabetes susceptibility locus. Diabetologia 1995; 38: 715-19.
1634. PAPADOPOULOS G. Genetics of insulin-dependent diabetes mellitus. In: Bartsocas CS, Beighton P.
Genetic Counseling in the Dawn of the 21st Century.
Athens: ZHTA Medical Publications, 1998; Chapter
15.
1635. ROUTSIAS J, PAPADOPOULOS G. Polymorphic
structural features of modellet HLA-DQ molecules
segregate according to susceptibility of resistance to
IDDM. Diabetologia 1995; 38: 1251-61.
1636. PALIAKASIS K, ROUTSIAS J, PETRATOS K,
OUZOUNIS C, KOKKINIDIS M, PAPADOPOULOS GK. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by
modelling based on the published structure of the related molecule HLA-DR1. J Struct Biol 1996; 117:
145-63.
1637. HATZIAGELAKI E, JAEGER C, PETZOLDT R,
SEISSLER J, SCHERBAUM WA, FEDERLIN K,
BRETZEL RG. The combination of antibodies to
GAD-65 and IA-2ic can replace the islet-cell antibody
assay to identify subjects at risk of type 1 diabetes mellitus. Horm Met Res 1999; 31: 564-9.
1638. TSIGOS C, PAPANICOLAOU D, KYROU I, DEFENSOR R, MITSIADIS CS, CHROUSOS GP.
Dose dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol
Metab 1997; 82: 4167-70.
1639. TSIGOS C, KYROU I, CHALA E, TSAPOGAS P,
STAVRIDIS JC, RAPTIS SA, KATSILAMBROS N.
Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999; 48: 1332-5.
1640. NEWSHOLME E, BEVAN S, DIMITRIADIS G,
KELLY R. Physiological aspects of insulin action. In:
Ashcroft FM. Insulin: Molecular Biology to Pathology. Oxford: IRL Press, 1992; 155-90.
1641. DIMITRIADIS G, TEGOS C, AZAS E, et al. Rates
of glucose metabolism in human erythrocytes. Diabetologia 1995; 38 (Suppl 1): 548.
143
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1642. NEWSHOLME E, DIMITRIADIS G. Some
thoughts on the importance of insulin in the regulation of the blood glucose level. Experientia 1996; 52:
421-6.
1643. DIMITRIADIS G, NEWSHOLME E. Integration
of some biochemical and physiological effects of insulin that may play a role in control of blood glucose
leve. In: LeRoith D, Olefsky J, Taylor S. Diabetes
Mellitus: A Fundamental and Clinical Text. 2nd ed.
Lippincott-Raven Press, 1999; (pages ?).
1644. DIMITRIADIS G, LEIGHTON B, PARRYBILLINGS M, NEWSHOLME E. Effects of the diuretic furosemide on the sensitive of glucolysis. Diabetologia 1988; 31: 58-61.
1645. BARTSOCAS C. The Greek contribution to diabetes research. Diabetes Metab Res Rev 1999; 15:
362-72.
1646. VLASSARA H. Advanced nonenzymatic tissue glycosylation: cell-mediated interactions associated with
diabetes and aging. Blood Purif 1990; 8: 223-32.
1647. VLASSARA H. Chronic diabetic complications and
tissue glycosylation. Relevant concern for diabetes
prone black population. Diabetes Care 1990; 13:
1180-5.
1648. REDOLFF S, MAKITA Z, VLASSARA H. Radioreceptor assay for advanced glycosylation end
products. Diabetes 1991; 40: 1721-38.
1649. TOELLER M, BUYKEN A, HEITKAMP G,
BERG G, SCHERBAUM W, AND THE EURODIAB COMPLICATIONS STUDY GROUP. Prevalence of chronic complications, metabolic control and
nutritional intake in type 1 diabetes: Comparison between different European regions. Horm Metab Res
1999; 31: 680-5.
1650. DIMITRIADIS G, LEIGHTON B, PARRYBILLINGS M, TOUNTAS C, RAPTIS S, NEWSHOLME EA. Furosemide decreases the sensitivity of
glucose transport to insulin in skeletal muscle in vitro.
Eur J Endocrinol 1998; 139: 118-22.
1651. COOPER GJ, LEIGHTON B, DIMITRIADIS GD,
PARRY-BILLINGS M, KOWALCHUK JM, HOWLAND K, ROTHBARD JB, WILLIS AC, REID KB.
Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates
glycogen metabolism in skeletal muscle. Proc Natl
Acad Sci USA 1998; 85: 7763-6.
1652. DIMITRIADIS G, CROWNE E, CLARK A, DUNGER D. Isletamyloid polypeptide decreases the effects of insulinlike growth factor I on glucose transport and glycogen synthesis in skeletal muscle. Int J
Biochem Cell Biol 1988; 30: 1039-46.
1653. LEIGHTON B, BLOMSTRAND E, CHALLISS
RA, LOZEMAN FJ, PARRY-BILLINGS M, DIMITRIADIS GD, NEWSHOLME EA. Acute and
chronic effects of strenuous exercise on glucose me-
144
tabolism in isolated, incubated soleus muscle of exercise-trained rats. Acta Physiol Scand 1989; 36: 177-84.
1654. LEIGHTON B, DIMITRIADIS GD, PARRYBILLINGS M, LOZEMAN FJ, NEWSHOLME EA.
Effects of aging on the responsiveness and sensitivity
of glucose metabolism to insulin in the incubated
soleus muscle isolated from Sprague-Dawley and Wistar rats. Biochem J 1989; 261: 383-7.
1655. LEIGHTON B, PARRY-BILLINGS M, DIMITRIADIS GD, BOND J, NEWSHOLME EA. Effect
of the Walker 256 carcinoma in rats on insulin-stimulated glucose metabolism in soleus muscle in vitro.
Biochem Soc Trans 1989; 17: 1043-4.
1656. PARRY-BILLINGS M, LEIGHTON B, DIMITRIADIS GD, CURI R, BOND J, BEVAN S, COLQUHOUN A, NEWSHOLME EA. The effect of tumor bearing on skeletal muscle glutamine metabolism. Int J Biochem 1991; 23: 933-7.
1657. LEIGHTON B, PARRY-BILLINGS M, DIMITRIADIS G, BOND J, NEWSHOLME EA, DACOSTA C, FOOT EA. Physiological glucocorticoid levels
regulate glutamine and insulin-mediated glucose metabolism in skeletal muscle of the rat. Studies with RU
486 (mifepristone). Biochem J 1991; 274: 187-92.
1658. DIMITRIADIS G, LEIGHTON B, PARRYBILLINGS M, SASSON S, YOUNG A, BEVAN S,
KRAUSE U, PIVA T, WEGENER G, NEWSHOLME E. The effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin
in rat skeletal muscle. Biochem J 1997; 321: 707-12.
1659. PARRY-BILLINGS M, DIMITRIADIS G,
LEIGHTON B, DUNGER DB, NEWSHOLME EA.
The effects of growth hormone administration in vivo
on skeletal muscle glutamine meyabolism of the rat.
Horm Metab Res 1993; 25: 292-3.
1660. DIMITRIADIS G, PARRY-BILLINGS M,
LEIGHTON B, PIVA T, DUNGER D, CALDER P,
BOND J, NEWSHOLME E. Studies on the effects of
growth hormone administration in vivo on the rates of
glucose transport and utilization in rat skeletal muscle. Eur J Clin Invest 1994; 24: 161-5.
1661. DIMITRIADIS G, BAKER B, MARSH H, MANDARINO L., BERGMAN R., RIZZA R., HAYMOND M., GERICH J. Effect of thyroid hormone
excess on the action, secretion and metabolism of insulin in man. Am J Physiol 1985; 248: E593-E601.
1662. DIMITRIADIS G,TEGOS C,THALASSINOS N.
Studies of monocyte insulin receptor binding in patients with hyper- and hypothyroidism. The Biochemist 1988; 629: 109.
1663. DIMITRIADIS GD, LEIGHTON B, VLACHONIKOLIS IG, PARRY-BILLINGS M, CHALLISS RA,
WEST D, NEWSHOLME EA. Effect of hyperthyroidism on the sensitivity of glycolysis and glycogen
synthesis to insulin in the soleus muscle of the rat.
Biochem J 1988; 253: 87-92.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1664. DIMITRIADIS G, LEIGHTON B, PARRYBILLINGS M, ET AL. Effects of hypothyroidism on
the sensitivity of glycolysis and hypothyroidism on glutamine metabolism by skeletal muscle of the rat.
Biochem J 1990; 40: 1161-4.
1665. PARRY-BILLINGS M, DIMITRIADIS G,
LEIGHTON B, BOND J, BEVAN SJ, OPARA E,
NEWSHOLME EA. Effects of hyperthyroidism and
hypothyroidism on glutamine metabolism by skeletal
muscle of the rat. Biochem J 1990; 272: 319-22.
1666. LEIGHTON B, DIMITRIADIS G, PARRYBILLINGS M. Thyroid hormone analogue SKF L94901: Effects on amino acid and carbohydrate metabolism in rat skeletal muscle in vitro. Biochem Pharmacol 1990; 40: 1161-4.
1667. DIMITRIADIS G, RICHARDS S, PARRYBILLINGS M, LEIGHTON B, NEWSHOLME EA,
CHALLISS RA. Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal
muscle in different thyroid states.. Biochem J 1991;
278: 587-93.
1668. DIMITRIADIS G, PARRY-BILLINGS M,
LEIGHTON B, KRAUSE U, PIVA T, TEGOS K,
CHALLISS RA, WEGENER G, NEWSHOLME
EA. The effects of insulin on the transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997; 27:
475-83.
1669. MEYER C, STUMVOLL M, NADKARNI V, DOSTOU J, MITRAKOU A, GERICH J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes
mellitus. J Clin Invest 1998; 102: 619-24.
1670. MEYER C, CROSSMAN R, MITRAKOU A. Effects of autonomic neuropathy on counterregulation
and awarenes of hypoglycemiain type 1 diabetic patients. Diabetes Care 1998; 21: 1960-9.
1671. KORYTKOWSKI M, MOKAN M, VENEMAN T,
MITRAKOU A, CRYER PE, GERICH JE. Reduced beta adrenergic sensitivity in patients with type
1 diabetes and hypoglycemia anawareness. Diabetes
Care 1998; 21: 1939-43.
1672. DAKOU-VOUTETAKIS C, PEPPA-PATRIKIOU
M, DRACOPOULOU M. Urinary free cortisol and
its nyctohemeral variation in adolescents and young
adults with IDDM: Relation to endothelin 1 and indices of diabetic angiopathy. J Pediatr Endocrinol
Metab 1998; 11: 437-45.
1673. THEOCHARI M, VYSSOULIS G, GIANNAKOPOULOU A, PALEOLOGOS AA, BARTSOCAS
CS, TOUTOUZAS PK. Myocardial trophic effects of
blood pressure in children with insulin-dependent diabetes mellitus. J Hum Hypertens 1995; 9: 633-6.
1674. TSIGOS C, WHITE A, YOUNG R. Discrimination
between painful and painless diabetic neuropathy
based on testing of large somatic nerve and sympathetic nerve function. Diab Med 1992; 9: 359-65.
1675. BRADLEY JL, THOMAS PK, KING RH, MUDDLE JR, WARD JD, TESFAYE S, BOULTON AJ,
TSIGOS C, YOUNG RJ. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: Correlation with type of diabetes. Acta Neuropathol (Berl)
1995; 90: 403-10.
1676. TSIGOS C, REED P, WEINKOVE C, WHITE A,
YOUNG RJ. Plasma norepinephrine in sensory diabetic polyneuropathy. Diabetes Care 1993; 16: 722-7.
1677. TSIGOS C, DIEMEL L, WHITE A, TOMLINSON
DR, YOUNG RJ. Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: Correlation with sural nerve levels and neuropathic signs in
sensory diabetic polyneuropathy. Clin Sci 1993; 84:
305-11.
1678. THOMAS P, BEAMISH N, SMALL J, KING
RHM, TESFAYE S, WARD JD, TSIGOS C,
YOUNG RJ, BOULTON AJM. Paranodal structure
in diabetic sensory polyneuropathy. Acta Neuropathol 1996; 92: 614-20.
1679. TSIGOS C, GIBSON S, CROSBY SR, WHITE A,
YOUNG RY. Cerebrospinal fluid levels of beta endorphin in painful and painless diabetic polyneuropathy. J Diabetes Complications 1995; 9: 92-6.
1680. KARAMITSOS D, DIDANGELOS T, ATHYROS
V, KONTOPOULOS A. The natural history of recently diagnosed autonomic neuropathy over a period
of 2 years. Diabetes Res Clin Pract 1998; 42: 55-63.
1681. DIDANGELOS T, KARAMITSOS D, ATHYROS
V, KOURTOGLOU GI. Effects of aldose reductase
inhibition on cardiovascular reflex tests in patients
with definite diabetic autonomic neuropathy over a
period of 2 years. J Diabetes Complications 1998; 12:
201-7.
1682. DIDANGELOS T, ATHYROS V, KARAMITSOS
D, PAPAGEORGIOU AA, KOURTOGLOU
GI, KONTOPOULOS AG. Effect of aldose reductase inhibition on heart rate variability in patients with
severe or moderate diabetic autonomic neuropathy.
Clin Pharmacodyn 1998; 15: 111-21.
1683. ATHYROS V, DIDANGELOS T, KARAMITSOS
D, PAPAGEORGIOU AA, BOUDOULAS H, KONTOPOULOS AG. Long-term effect of converting
enzyme inhibition on circadian sympathetic and
parasympathetic modulation in patients with diabetic
autonomic neuropathy. Acta Cardiol 1998; 53: 201-9.
1684. RAPTIS A, TOUNTAS N, YALOURIS A, HALVATSIOTIS PG, RAPTIS SA. Therapeutic effect of
glibe nclamide in a fixed combination with metformin
or phenformin in NIDDM patients. Horm Metab Res
1996; 28: 89-94.
1685. AEBISHER A, LACY P, GERASIMIDI-VAZEOU A, HAUPTFELD V. Production of marked
prolongation of islet xenograft survival (rat to mouse)
by local release of mouse and rat antilymphocyte sera
at transplant site. Diabetes 1991; 40: 457-61.
145
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1686. MARCHETTI P, FINKE EH, GERASIMIDI-VAZEOU A, FALQUI L, SCHARP DW, LACY PE.
Automated large scale isolation ,in vivo function and
xenotransplantation of porcine islets of Langerhans.
Transplantation 1991; 52: 209-13.
1687. LACY PE, HEGRE OD, GERASIMIDI-VAZEOU A, GENTILE FT, DIONNE KE. Maintenance of nor moglycemia in diabetic mice by subcutaneuous xenografts of encapsulated islets. Science
1991; 254: 1782-4.
1688. MARCHETTI P, SCHARP DW, PFIFFNER K,
SWANSON CJ, FINKE EH, OLACK BJ, GERASIMIDI-VAZEOU A, MCLEAR M, LACY PE. Cryogenic storage of isolated purified porcine pancreatic
islets. Transplantation 1994; 57: 340-6.
1689. MARCHETTI P, SCHARP DW, FINKE E,
SWANSON CJ, GERASIMIDI-VAZEOU A,
OLACK BJ, NAVALESI R, LACY PE. Effect of different temporary immunosuppressive therapies and
low temperature culture on pancreatic islet xenograft
survival (pig to mouse). Transplant Proc 1994; 26:
760-1.
1690. MARCHETTI P, SCHARP DW, FINKE E,
SWANSON CJ, GERASIMIDI-VAZEOU A,
OLACK BJ, NAVALESI R, LACY PE. Anti-CD4
antibody treatment in xenografts of differently immunomodulated porcine islets. Transplant Proc 1994;
26: 1132.
1691. MCLEAR M, MARCHETTI P, FINKE E, GERASIMIDI-VAZEOU A, SCHARP DW, LACY PE.
Porcine islets function:effects of arginine,leucine and
butyrate. Transplant Proc 1992; 24: 980-2.
1692. MARCHETTI P, PFIFFNER K, SCHARP DW,
LACY PE, GERASIMIDI-VAZEOU A, FINKE E.
Successful cryopreservation of porcine pancreatic
islets. Transplant Proc 1992; 24: 1005-6.
1693. MARCHETTI P, SWANSON C, MCLEAR M,
FINKE E, GERASIMIDI-VAZEOU A, SCHARP
DW, LACY PE. In vitro function and xenotransplantation of long-term (3 weeks) cultured porcine islets
of Langerhans. Transplant Proc 1992; 24: 637.
1694. GERASIMIDI-VAZEOU A, DIONNE K, GENTILE F, HAZLETT T, LYSAGHT M, HEGRE O,
LACY PE. Reversal of streptozotocin-induced diabetes in non-immunosuppressed mice with immunoisolated xenogenic rat islets. Transplant Proc 1992; 24:
667-8.
1695. MARCHETTI P, FINKE EH, SWANSON C,
GERASIMIDI-VAZEOU A, SCHARP DW, NAVALESI R, LACY PE. The potential of porcine islet
xenotransplantation in the therapy of diabetes. Diabetes Nutr Metab 1992; 5 (Suppl 1): 151-4.
1696. GERASIMIDI-VAZEOU A, SHEEHAN K,
SCHREIBER R, LACY P. Tumor necrosis factor ·
prevents rejection of islet xenografts (rat to mouse).
Diabetes 1993; 42: 651-7.
146
1697. GERASIMIDI-VAZEOU A, LAFFERTY K,
DAFOYIANNI C, ET AL. Effects of BCG in newly
diagnosed patients with IDDM. J Pediatr Endocrinol
Metab 1995; 8 (Suppl): 219.
1698. DIAKOPOULOU M, KORVESSI M, DAKOUVOUTETAKIS C. Personality characteristics, enviromental factors and glycemic control in adolescents
with diabetes. Eur Child Adolesc Psychiatry 1992; 1:
82-8.
1699. PANDELIDOU A, ZERVA L, MOUTSOPOULOS H, PAPADOPOULOS GK. Human monoclonal antibodies from the peripheral blood lymphocytes
of a 64 kd positive individual. Hellenic Biophys
Biochem Soc Newsletter 1990; 30: 15.
1700. KONIDARIS C, PAPADOPOULOS GK. Monoclonal antibodies against the surface of INS-1 insulinoma cells. Diabetologia 1997; 40: 72A.
1701. MITLIANGA P, GERMANIDIS G, MOUTSOPOULOS H, PAPADOPOULOS GK. The effect of
transforming growth factor ‚ and tumor necrosis factor · on the cytotoxic-cytostatic action of interleukin1 (· and ‚ isoforms) on the pancreatic ‚-cell line
RIN-5AH. Int J Immunopathol Pharmacol 1995; 8:
66-7.
1702. VASSILIADIS S, PAPADOPOULOS GK. IL-6 mediated MHG class II induction on RIN-5AH insulinoma cells by IFN-Á occurs via the G-protein path-way.
Med Inf (Lond) 1995; 4: 374-9.
1703. VASSILIADIS S, SOTERIADOU K, PAPADOPOULOS GK. IL-1· transduced different signals that
IL-1‚ leading to class II antigen expression on ‚-insulinoma RIN-5AH cells through specific receptors. J
Recept Signal Transplant Res 1997; 17: 211-5.
1704. MITLIANGA P, VARELI K, PAPADOPOULOS
GK. IL-1 and TFG‚1 effect the expression of type II
IL-1 receptors in the rat insulinoma cell line RIN5AH. Diabetologia 1997; 40: A88.
1705. VASSILIADIS S, DRAGIOTIS V, PROTOPAPADAKIS E, ATHANASSAKIS I, MITLIANGA P,
KONIDARIS K. PAPADOPOULOS GK. The destructive action of IL-1alpha and IL-1beta in IDDM is
a multistage process: Evidence and confirmation by
apoptotic studies, induction of intermediates and
electron microscopy. Med Inf (Lond) 1999; 8: 85-91.
1706. MITLIANGA P, KNEETMAN A, RAZOTTE R,
PAPADOPOULOS GK. Glutamic acid decarboxylase in the sera of pancreatectomised and islet transplanted dogs. Hellenic Biochem Biophys Soc Newsletter 1996; 41: 18-9.
1707. PAPADOPOULOS GK. MHC Class II molecules
and the immune response to the ABBOS peptide of
bovine serum albumine: Prelude to type 1 (insulin-dependent) diabetes? Diabetologia 1993; 36: 1214-5.
1708. ROUTSIAS J, PAPADOPOULOS GK. Polymorphic structural features of modelled HLA-DQ mole-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
cules segregate according to susceptibility of resistance to IDDM. Diabetologia 1995; 38: 1251-61.
1709. PALIAKASIS K, ROUTSIAS J, PETRATOS K,
OUZOUNIS C, KOKKINIDIS M, PAPADOPOULOS GK. Novel sytructural features of the human histocompatibility molecules HLA-DQ as revealed by
modelling based on the published structure of the related molecule HLA-DR1. J Struct Biol 1996; 117:
145-63.
1710. PAPADOPOULOS GK. The genetics of type 1 diabetes. Immunol Today 1998; 15: 292-3.
1711. PAPADOPOULOS GK, OUZOUNIS C, ELIOPOULOS E. RGD sequences in several receptor proteins: novel cell adhesion function for receptors? Int J
Biol Macromol 1998; 22: 51-7.
1712. VAN DE WAL Y, KOOY M, DRIJFHOUT W,
AMONS R, PAPADOPOULOS GK, KONING F.
Peptide-binding features of the coeliac-disease-associated DQ (·1*0501,‚1 *0201) molecule versus the
non-disease-associated DQ (·1*0201,‚1*0202) allele.
Immunogenetics 1997; 46: 464-92.
1713. VAN DE WAL Y, KOOY Y, VAN VEELEN P,
PEÑA S, MEARIN L, PAPADOPOULOS G,
KONING F. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-8.
1714. GREOGORI S, TREMBLEAU S, PENNA G, PAPADOPOULOS GK, ADORINI L. A binding motif
for I-Eg7, the MHC class II molecule which protects
NOD-E· transgenic mice from autoimmune diabetes.
J Immunol 1999; 162: 6630-40.
1715. LEKAKIS J, PAPAMICHAEL C, ANASTASIOU
H, ALEVIZAKI M, DESSES N, SOUVATZOGLOU A, STAMATELOPOULOS S, KOUTRAS
DA. Endothelial dysfunction of conduit arteries in insulin-deprendent diabetes mellitus without microalbuminuria. Cardiovasc Res 1997; 34: 164-8.
1716. ∞™™∞¡∏™ π. ¶ÂÚ›ÙˆÛȘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹Ùo˘
ÂȘ ·›‰· 14 ÂÙÒÓ ·ÈÊÓȉ›o˘ ÌÂÙ¿ ¢ÏfiÁo˘ ·ÈÙ›·˜ o˘‰ÂÌÈ¿˜ Ë ‰Â Ùo˘ o‡Úo˘˜ ·Ó¿Ï˘ÛȘ ·¤‰ÂÈÍ ÙËÓ Û¿Î¯·ÚÈÓ ¿ÊıoÓoÓ. ∂ÚÌ‹˜ o §fiÁÈo˜ 1814: 117-23.
1717. ∫∞ƒ∞ª¶∂ƒO¶OÀ§O™ ¢. ¶ÂÚ›ÙˆÛË Ó·ÓÈÎo‡
۷ί·ÚÒ‰o˘˜ ‰È·‚‹Ùo˘ ÛÙoÓ ∂ÚÌ‹ ÙoÓ §fiÁÈo Ùo˘
1814 (ÂÚ›Ï). ™ÙÔ: 25o ¶·ÓÂÏÏ‹ÓÈÔ π·ÙÚÈÎfi ™˘Ó¤‰ÚÈÔ
¶·ıoÏoÁ›·˜. ∞ı‹Ó·, 1999: 21.
1718. EURODIAB ACE STUDY GROUP. Variation
and trends in incidence of childhood diabetes in
Europe. Lancet 2000; 355: 873-6.
1719. ANTONIADES H. Circulating hormones. In: Putnam FW. The Plasma Proteins. Academic Press, 1960;
Vol.2: 105-36.
1720. ANTONIADES H, BEIGELMAN P, RENOLD A.
The state of insulun in human plasma. In: Antoniades
HN. Hormones in Human Plasma. Boston, Massachusetts: Little, Brown & Co, 1960: 101-10.
1721. JOACHIMOGLU G, ANTONIADES H. Effect of
proteins on the blood glucose levels. Diabetes, 1956;
5: 383-7.
1722. BEIGELMAN P, GOETZ F, ANTONIADES H,
THORN G. Insulin-like activity of human plasma
constituents. I. Discription and Evaluation of biologic
assay for insulin-like activity. Metabolism 1956; 5: 3543.
1723. BIEGELMAN P, ANTONIADES H, GOETZ F,
RENOLD A, ONCLEY J, THORN G. Insulin-like
activity of human plasma constituents. II. Biologic assay of human plasma fractions for insulin-like activity.
Metabolism 1956; 5: 44-50.
1724. ANTONIADES H, BEIGELMAN P, PENNEL R,
THORN G, ONCLEY J. Insulin-like activity of human plasma constituents. III. Elution of insulin-like
activity from cationic exchange resins. Metabolism
1958; 7: 266-68.
1725. BEIGELMAN P, ANTONIADES H. Insulin-like
activity of human plasma constituents. IV. Insulin levels of normal human serum and plasma. Metabolism
1958; 7: 269-73.
1726. ANTONIADES H. Separation of human plasma
protein consetrate with insulin activity. Science 1958;
127: 593-4.
1727. ANTONIADES H. Hormone transport in human
blood. Vox Sang 1959; 4: 72-3.
1728. ANTONIADES H. Studies on the state of insulin in
blood and pancreas. Vox Sang 1960; 5: 63-4.
1729. ANTONIADES H, RENOLD A, DAGENAIS Y,
STEINKE J. Preliminary observations on the state of
insulin in human and bovine pancreas. Proc Soc Exp
Biol Med 1960; 103: 677-9.
1730. GUNDERSEN K, ANTONIADES H. Biological
activity of blood insulin comlexes examined by the rat
diaphragm tissue assay. Proc Soc Exp Biol Med 1960;
104: 411-3.
1731. ANTONIADES H. Basic protein-insulin complexes
in blood and pancreas: A theory on the secretion and
transport of insulin (abstract). In: Proc. VIII Cong. Int.
Soc. of Hem. Tokyo: Pan Pasific Press, 1962: 1908-11.
1732. RENOLD A, STEINKE J, ANTONIADES H. Insulin-like activity in human serum and pancreatic extracts as measured with rat adipose issue. First Int.
Cong. Of Endocrinology, Copenhagen. Acta Endocrinol Suppl (Copenh). 1960; 35 (Suppl 1): 1235.
1733. ANTONIADES H. Studies on the state of insulin in
blood: The state and transport of insulin in blood. Endocrinology 1961; 68: 7-16.
1734. ANTONIADES H, GUNDERSEN K. Studies on
the state of insulin in blood: Dissociation of purified
human blood complex(es) by incubation with adipose
tissue extracts in vitro. Endocrinology 1961; 68: 36-42.
1735. ANTONIADES H, BEIGELMAN P, TRANGUADA R, GUNDERSEN K. Studies on the state of in-
147
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
sulin in blood: “Free” insulin and insulin complexes
inhuman sera and their in vitro biological properties.
Endocrinology 1961; 69: 46-54.
1736. ANTONIADES H, GUNDERSEN K, BEIGELMAN P, TRANGUADA R, PYLE H. Insulin complexes in blood and their in vitro dissociation by adipose tissue extracts. Vox Sang 1961; 6: 210-1.
1737. ANTONIADES H,GUNDERSEN K,PYLE H.
Studies on the state of insulin in blood: The role of
glucose in the in vivo dissociation of insulin complexes in blood. Endocrinology 1961; 69:163-9.
1738. STEINKE J, RENOLD A, KNAACK J, ANTONIADES H. Insulin content of pancreas from nondiabetic subjects and from pancreatic islet cell tumors as
extracted on cationic exchange resin and with acid
ethanol. J Clin Invest 1961; 40: 1083.
1739. ANTONIADES H, GUDERSEN K, PYLY H. The
effect of blood glucose on circulating “bound” and
“free” insulin. J Clin Invest 1961; 40: 1022.
1740. ANTONIADES H, GUDERSEN K, PYLE H.
Transport and regulation of insulin activity in blood.
In: Proc. 4 Congress de la Federation Internationale
du Diabete, Geneva, 1961: 638-40.
1741. ANTONIADES H, GUDERSEN K. Studies on the
state of insulin in blood: Materials and methods for
the estimation of “free” and “bound” insulin-like activity in serum. Endocrinology 1962; 70: 95-8.
1742. ANTONIADES H, BOUGAS J, PYLE H. Studies
on the state of insulin in blood: Examination in
splenic, portal and peripheral vein blood serum of diabetic and nondiabetic subjects for “free” insulin and
insulin complexes. N Engl J Med 1962; 267: 218-22.
1743. ANTONIADES H, BOUGAS J, PYLE H, CAMERINI-DAVALOS R, GUDERSEN K. Studies on the
state of insulin in blood: the regulation of “free” insulin and insulin complexes in the blood of diabetic
and nondiabetic subjects. N Engl J Med 1962; 267:
953-7.
1744. ANTONIADES H, PYLE H, BOUGAS J. Tolbutamide and regulation of endogenous insulin. Diabetes 1962; 11: 34-5.
1745. ANTONIADES H, PYLE H, BOUGAS J. A biochemical mechanism regulating insulin activity in human blood. Vox Sang 1963; 8: 116-7.
1746. ANTONIADES H. State ,transport and regulation
of hormones in blood. In: Eckstein P. Techniques in
endocrine research. Academic Press, 1963: 105-32.
1747. RENOLD A, STEINKE J, SOELDER S, SMITH R,
ANTONIADES H. Response of calves and heifers to
the prolonged administration of porcine and bovine
insulin.Vox Sang 1963; 8: 121-2.
1748. ANTONIADES H, BOUGAS J, CAMERINI-DAVALOS R, PYLE H. Insulin regulatory mechanisms
and diabetes mellitus. Diabetes 1964; 13: 230-40.
1749. HUBER A, GERSHOFF S, ANTONIADES H. The
148
effect of fasting and refeeding on isolated rat adipose
tissue activity in the presence of crystalline and
“bound” insulin. Metabolism 1965; 14: 619-24.
1750. ANTONIADES H, HUBER A, BOSHELL B,
SARAVIS C, GERSHOFF S. Studies on the state of
insulin in blood: Properties of circulating “free” and
“bound” insulin. Endocrinology 1965; 76: 709-21.
1751. ANTONIADES H. “Bound” insulin and tissue resistance to insulin. Lancet 1965; 2: 159-60.
1752. ANTONIADES H. Mechanisms of insulin transport
and regulation. In: Int. Cong. of Endocr, London,
1964. Amsterdam: Excerpta Medica, 1965: 342-9.
1753. ANTONIADES H. Studies on the mechanisms regulating insulin activity. Rev Invest 1965; 5: 79-88.
1754. ANTONIADES H, CAMERINI-DAVALOS R.
Circulating free and bound insulin in prediabetics. VI.
Pan-American Cong. of Endocrinology, Mexico City,
1965. In: ICS International Congress Series Excerpta
Medica 1965; 127: 302-7.
1755. ANTONIADES H. La etiologia de la diabetes. In:
III Simposio PanAmericano de Farmocologia y Terapeutica, Mexico City, 1965. Exerpta Medica, 1965:
187-95.
1756. ANTONIADES H. Extrapancreatic regulation of insulin activity in human beings. In: Wrenshall GA,
Leibel BS. On the nature and treatment of diabetes.
Amsterdam: Excerpta Medica, 1965: 194-207.
1757. BALODIMOS M, IRWIN I, MERRIL W, ANTONIADES H, BARKOUKIS G. Free and bound insulin and lipid studies in a case of hypogonadism associated with XYZ genotype. Clin. Res 1965; 13: 317.
1758. GERSHOFF S, HUBER A, ANTONIADES H. Responses of obese-hyperglycemic mice and normal
mice to “bound” and crystalline insulin. Metabolism
1966; 15: 325-9.
1759. ANTONIADES H,GERSHOFF S. “Bound” insulin:
Biologic effects in intact, hypophysectomized or
adrenalectomized rats followin intravenous administration. Endocrinology 1966; 78: 1079-081.
1760. SWEENEY E, GERSHOFF S, ANTONIADES H.
Observations on the in vitro and in vivo agglutination
of platelets by “bound” insulin concentrates. Proc Soc
Exp Biol Med 1966; 121: 880-5.
1761. RENOLD A, STEINKE J, ANTONIADES H,
SMITH R. Immunological response to the prolonged
administration of heterologous and homologous insulin in cattle. J Clin Invest 1966; 45: 702-13.
1762. ANTONIADES H, HUBER A, GERSHOFF S.
“Bound” insulin: In vivo and in vitro biologic activity.
Diabetologia 1966; 1: 195-200.
1763. ANTONIADES H, GERSHOFF S. Inhibitory effects of “bound” insulin or insulin uptake by isolated
tissues. Diabetes 1966; 15: 655-62.
1764. ANTONIADES H. Rat serum “bound” insulin in vivo biologic effects in rats. Diabetes 1966; 15: 889-93.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1765. ANTONIADES H. Studies on circulating free and
bound insulin. Acta Physiol Lat Am 1966; 16: 18-24.
1766. ANTONIADES H. Hypoglycemic effects of adipose-tissue extracts in adrenalectomized rats. Lancet
1967; (vol.?): 602-4.
1767. SWEENEY E, ANTONIADES H. The presence of
immunologically reactive insulin in parotid saliva and
its relation to changes in serum insulin concetration.
Vox Sang 1967; 13: 54-6.
1768. POSNER B, SOTMAN S, ANTONIADES H. The
effect of bound insulin on the dispotition of crystalline
insulin in perfused rat heart. Vox Sang 1967; 13: 3740.
1769. POSNER B, SOTMAN S, ANTONIADES H. Insulin dispotition in the isolated perfused rat heart: Effect of “bound” insulin. Diabetes 1968; 17: 427-36.
1770. ANTONIADES H. Insulin and insulin antagonism.
In: Gold JJ. Gynecologic Endocrinology. Harper &
Row, 1968; 607-20.
1771. ANTONIADES H. Study on circulating free and
bound insulin. Folia Endocrinologica Japonica 1968;
44: 440.
1772. ANTONIADES H. Extrapancreatic factors in the
etiology of diabetes mellitus. In: Proc. of XXXXI Annual Meeting of Japan Endocrinological Society. Kyoto, 1968: (pages ?).
1773. ANTONIADES H. Bound insulin: Properties and
physiological significance.Excerpta Medica, In: Ostman J, Milner RDG. Diabetes. Proceedings of the
Sixth Congress of the International Diabetes Federation 1967. Amsterdam: Excerpta Medica, 1969: 17192.
1774. ANTONIADES H. In vivo effects of adipose tissue
extracts (ATE) on the blood glucose concetrations of
infant, spontaneously diabetic mice of the KK strain
and adrenalectomized rats. Endocrinology 1969; 84:
1268-73.
1775. ANTONIADES H, PYLE H. Further studies on the
effects of adipose tissue extracts (ATE) on the blood
glucose concetrations of diabetic KK mice, adrenalectomized rats and patients with diabetes mellitus.
Progress Report. Vox Sang 1969; 17: 68-73.
1776. STERN J, ANTONIADES H, BAILE C, MAYER
J. Insulin-like activity in goat serum. Endocrinology
1969; 85: 976-81.
1777. GERSHOFF S, WEICH N, ANTONIADES H. Production of nonimmunoassayable insulin-like material
by the perfused rat liver. Diabetes 1970; 19: 296-301.
1778. GERSHOFF S, WEICH N, ANTONIADES H. Production of “bound”: Insulin-like material from insulin
by perfused rat liver. Panminerva Med 1970; 12: 230-2.
1779. ANTONIADES H. In vivo effects of human and
bovine adipose tissue extracts (ATE) in diabetic KK
mice and adrenalectomized rats. Panminerva Med
1970; 12: 269-72.
1780. CHIERI R, BASABE J, CRESTO J, ANTONIADES H, FOGLIA V. Serum insulin and blood glucose
concetrations in recently pancreatectomized dogs.
Panminerva Med 1970; 12: 280-5.
1781. ANTONIADES H, SIMON J, BAILE C, ETTLINGER M. Prolonged hypoglycemic effect of adipose
tissue extracts (ATE) in nondiabetic and diabetic
mice. Endocrinology 1971; 88: 1222-9.
1782. ANTONIADES H, SIMON J. Hypoglycemic effects
of adipose tissue extracts (ATE) in nondiabetic and
diabetic animals.Vox Sang 1971; 20: 466.
1783. ANTONIADES H, SIMON J. Current advances on
the state of insulin-like activity in blood. ICS International Congress Series Excerpta Medica 1971; 231: 6387.
1784. ZUCKER L, ANTONIADES H. Insulin and obesity in the zucker genetically obese rat “fatty”. Endocrinology 1972; 90: 1320.
1785. ANTONIADES H, IATRIDIS P, WESTMORELAND N, SIMON J, HAYES K, SURGENOR D. Effects of nutritional,endocrine and metabolic state on
the development of intravascular coagulation induced
by human serum preparations with procoaguland activity. Thromb Diath Haemorrh1975; 29: 33.
1786. ANTONIADES H, STATHAKOS D, SIMON J.
Conversion of 125 insulin and 125 I-Proinsulin in to
high molecular weight forms in vivo. Endocrinology
1974; 95: 1543-53.
1787. SIMON J, ANTONIADES H. Transport of peptide
hormones across isolated rat mesentery: Effect of human serum bound insulin. Diabetes 1975; 24: 9971004.
1788. ANTONIADES H. Metabolism of single component and high molecular weight radioactive insulin in
rats. Endocrinology 1976; 99: 481-9.
1789. ANTONIADES H. Effect of serum insulin complexes on the uptake and normal utilization of insulin by
isolated tissues and organs. Panminerva Med 1977;
19: 133-4.
1790. ANTONIADES H, LARSEN J, ANTONIADES N,
ANTONIADES A. A gastrointestinal clearance of intravenously injected radioactive insulin and glucagon
in rats. Diabetes 1977; 26 (Suppl 1): 133.
1791. KARAMANOS B, PORTA M, SONGINI M, METELKO Z, KERENYI Z, TAMAS G, ROTTIERS R,
STEVENS L, FULLER J, AND THE EURODIAB
IDDM COMPLICATIONS STUDY GROUP. Different risk factors of microangiopathy in pati- ents
with type 1 diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications
Study. Diabetologia 2000; 43: 348-55.
1792. ∫∞ƒ∞ª∏Δ™O™ ¢. ™ÙÚ·ÙËÁÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋
1999; 65: 53-8.
1793. ∫∞μ∞¡O∑∏ ∞, ∞§∂μπ∑O™ ª. ∏ ¿ÛÎËÛË Û ‰È·-
149
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. ∞ıÏËÙÈ΋ ∞fi‰oÛË Î·È ÀÁ›·
1999; 1: 283-92.
1794. Δ™∞°∫∞ƒ∞∫∏ μ, ª∞ƒ∫∞¡Δø¡∏-∫ÀƒOÀ¢∏
™. ∂›‰Ú·ÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙË Ê·ÚÌ·ÎoÎÈÓËÙÈ΋. π·ÙÚÈ΋ 2000; 77: 30-9.
1795. μ∞∑∞πOÀ-°∂ƒ∞™πªπ¢OÀ ∞. ªÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·Ùo˜. ¡ÂÒÙÂÚ· ‰Â‰o̤ӷ. ∞ÚÂÙ·›o˜ 2000; 3:
153-61.
1796. BUYKEN A, TOELLER M, HEITKAMP G, IRSIGLERT K, HOLLERT C, SANTEUSANIO F,
STEHLE P, FULLER J. AND THE EURODIAB
IDDM COMPLICATIONS STUDY GROUP. Carbohydrate sources and glycaemic control in type 1 diabetes mellitus. Diabetic Med 2000; 17: 351-9.
1797. TENTOLOURIS N, JUDE E, SMIRNOF I,
KNOWLES E, BOULTON A. Methicilin-resistant
staphylococcus aureus:an increasing problem in a diabetic foot clinic. Diabetic Med 1999; 16: 767-71.
1798. COLLADO-MESA F, COLBOUN H, STEVENS L,
BOAVIDA J, FERRISS J, KARAMANOS B,
KEMPLER P, MICHEL G, ROGLIC G, FULLER J,
THE EURODIAB IDDM COMPLICATIONS
STUDY GROUP. Prevalence and management of
hypertension in type 1 diabetes mellitus in Europe:the
EURODIAB IDDM Complications Study. Diabetic
Med 1999; 161: 41-8.
1799. SOTIROPOULOS A, PEPPAS T, SKLHROS E,
APOSTOLOU O, KOTSINI V, PAPPAS S. Low
prevalence of hepatitis C virus infection in Greek diabetic patients. Diabetic Med 1999; 16: 250-2.
1800. ALEVIZAKI M, THALASSINOU L, GRIGORAKIS S, PHILIPPOU G, LILI K, SOUVATZOGLOU
A, ANASTASIOU E. Study of the Trp64 Arg polymorphism of the ‚3-adrenergic receptor in Greek
women with gestational diabetes. Diabedic Med 2000;
23: 1079-83.
1801. TOUTOUZAS K, STEFANADIS C, TSIAMIS E,
VLACHOPOULOS Ch, TOUSOULIS D, TSIOUFIS C, TOUTOUZAS P. Aortic pressurediameterrelation in patients with non-insulin dependent diabetes mellitus: New insights. Diabetologia 2000; 43:
1070-8.
1802. ª¶∞ƒΔ™O∫∞™ Ã. O ÚfiÏo˜ Ù˘ ÁÂÓÂÙÈ΋˜ ÛÙËÓ ·ÈÙÈo·ıoÁ¤ÓÂÈ· Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË Ù‡o˘ 1.
™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 19-30.
1803. ∫∞ƒ∞ª∞¡O™ μ. ∂ȉËÌÈoÏoÁ›· ÙˆÓ ¯ÚfiÓÈˆÓ ÂÈÏoÎÒÓ Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2000: 69-81
1804. ∫O§πO¶OÀ§O™ π. ¢È·ÁÓˆÛÙÈ΋ ÚoÛ¤ÁÁÈÛË ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·˜. ™Ùo: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË
150
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2000: 83-91
1805. ª¶∂¡ƒOÀª¶∏ ª. ¢È·‚ËÙÈΤ˜ ÂÈÏoΤ˜ Ùo˘ Á·ÛÙÚÂÓÙÂÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2000: 109-18.
1806. ª∞¡∂™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛÙ˘ÙÈ΋ ‰˘ÛÏÂÈÙo˘ÚÁ›·. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË
‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 119-24.
1807. °π∞ª∞ƒ∂§§OÀ ∂. OÈ Û˘¯ÓfiÙÂÚ˜ ÏoÈÌÒÍÂȘ ÛÙo
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ë ÛÙÚ·ÙËÁÈ΋ ·ÓÙÈÌÂÙÒÈÛ‹˜
Ùo˘˜. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 125-34.
1808. ªOÀ¡ΔO∫∞§∞∫∏™ £. ∂ÎÙ›ÌËÛË Ù˘ ÓÂÊÚÈ΋˜
ÏÂÈÙo˘ÚÁ›·˜ ÛÙo ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2000: 135-42.
1809. ∫O∫∫π¡O™ ¢. ∫·Ú‰È·Î¤˜ ·ı‹ÛÂȘ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË
‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 143-9.
1810. ∫∞Δ™π§∞ª¶ƒO™ ¡, Δ∂¡ΔO§OÀƒ∏™ ¡, Δ™∞¶O°∞™ ¶. ∫ÏÈÓÈ΋ Î·È ÂÚÁ·ÛÙËÚȷ΋ ÚoÛ¤ÁÁÈÛË
Ù˘ ÂÚÈÊÂÚÈ΋˜ ·ÚÙËÚÈo¿ıÂÈ·˜ ÙˆÓ Î¿Ùˆ ¿ÎÚˆÓ
ÛÙo ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË
‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 151-61.
1811. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, °ƒ∏°Oƒπ∞¢OÀ ª.
£ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ÂÚÈÊÂÚÈ΋˜ ·ÚÙËÚÈo¿ıÂÈ·˜ ÛÙo ‰È·‚‹ÙË. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2000: 163-72.
1812. ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ˘¤ÚÙ·ÛË. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË
Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 173-81.
1813. μ∞°∂¡∞∫∏™ ∞, °∂øƒ°O¶OÀ§O™ ¡. OÚÌoÓÈ΋ ˘oηٿÛÙ·ÛË Û ‰È·‚ËÙÈΤ˜ Á˘Ó·›Î˜ ÌÂÙ¿ ÙËÓ
ÂÌÌËÓfi·˘ÛË. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË
‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 183-8.
1814. ªÀ°¢∞§∏™ ∏. ªÂıo‰oÏoÁÈ΋ ÚoÛ¤ÁÁÈÛË ÛÙË
‰˘ÛÏÈȉ·ÈÌ›· Ùo˘ ۷ί· ÚÒ‰o˘˜ ‰È·‚‹ÙË Ù‡o˘ 2.
™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 189-202.
1815. ¶∞¶¶∞™ ™. £ÂÚ·›· ‰˘ÛÏÈȉ·ÈÌ›·˜. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 203-23.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
1816. ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ¿ÛÎËÛË ÛÙo ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË
Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 225-31.
1817. £∞§∞™™π¡O™ ¡, πø∞¡¡π¢∏™ °. ¶Úo‚ÏËÌ·ÙÈÛÌo› ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ۷ί·ÚÒ‰o˘˜ ‰È·‚‹ÙË
ÛÙËÓ ÙÚ›ÙË ËÏÈΛ·. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜
ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 23343.
1818. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ∏ ÈÓÛo˘ÏÈÓoıÂÚ·›·
ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. ™Ùo: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2000: 245-53.
1819. ª∏Δƒ∞∫OÀ ∞. ªÂıo‰oÏoÁ›· ‰ÈÂÚ‡ÓËÛ˘ Ù˘
˘oÁÏ˘Î·ÈÌ›·˜. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË
‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 255-64.
1820. °πøμO™ π. ∏ ÂÚÁ·ÛÙËÚȷ΋ ‰ÈÂÚ‡ÓËÛË Ù˘ ·¯˘Û·ÚΛ·˜. ™Ùo: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 165-279.
1821. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂. ∫ÚÈÙÈ΋ ·ÍÈoÏfiÁËÛË Ù˘ ıÂÚ·›·˜ Ù˘ ·¯˘Û·ÚΛ·˜. ™Ùo: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2000: 281-303.
1822. Ãπ™Δ∞∫O¶OÀ§O™ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
¶Úo‚Ï‹Ì·Ù· Î·È Ï¿ıË ÛÙËÓ ıÚ·›· Ùo˘. ¡oÛoÎoÌÂȷο ÃÚoÓÈο 1974; 36: 426.
1823. ™øΔ∏ƒO¶OÀ§O™ ∞, ∫OΔ™π¡∏ μ. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ÏoÈÌÒÍÂȘ. π·ÙÚÈ΋ 2000; 77: 256-67.
1824. STUMVOLL M, MITRAKOU A, PIMENTA W,
JENSSEN T, YKI-JÄRVINEN H, VAN HAEFTEN
T, RENN W, GERICH J. Use of the oral glucose
tolerance test to asses insulin release and
insulinsensitivity. Diabetes Care 2000; 23: 295-301.
1825. ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £ÂÛÛ·ÏoÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2000:
445 ÛÂÏ.
1826. ∫∞ƒ∞ª∏Δ™O™ ¢, ª∞ªO¶OÀ§O™ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË. ™Ùo: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £ÂÛÛ·ÏoÓ›ÎË: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2000; 333-45.
1827. ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ¢. ¢È·‚ËÙÈ΋
Ó¢Úo¿ıÂÈ·. ™Ùo: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £ÂÛÛ·ÏoÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2000: 255-307.
1828. ∞¡Δø¡π∞¢∏™ ∞. ªÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·Ùo˜.
™Ùo: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
£ÂÛÛ·ÏoÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2000: 250-5.
1829. ¶∞¶∞∑O°§OÀ ¡. ∂ȉËÌÈoÏoÁ›· Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™Ùo: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £ÂÛÛ·ÏoÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2000: 67-74.
1830. Ã∞ƒ™OÀ§∏™ º. Ào‰o¯Â›˜ Ûo˘ÏÊoÓ˘Ïo˘ÚÈÒÓ,
‰›·˘ÏoÈ Î·Ï›o˘ Î·È Ú‡ıÌÈÛË ¤ÎÎÚÈÛ˘ ÈÓÛo˘Ï›Ó˘.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000: 13: 7-14.
1831. ∞¶O™ΔO§π¢∏™ ∞, Ã∞Δ∑∏Ã∏™ΔOÀ ¢. ∞Ó‰ÚÈ΋ ÛÂÍo˘·ÏÈ΋ ‰˘ÛÏÂÈÙo˘ÚÁ›· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∂ȉËÌÈoÏoÁ›· Î·È ·ıoÏoÁoÊ˘ÛÈoÏoÁ›·.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 15-26.
1832. ∞¶O™ΔO§π¢∏™ ∞, Ã∞Δ∑∏Ã∏™ΔOÀ ¢. ∞Ó‰ÚÈ΋ ÛÂÍo˘·ÏÈ΋ ‰˘ÛÏÂÈÙo˘ÚÁ›· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ¢È¿ÁÓˆÛË Î·È ıÂÚ·›·. ∂ÏÏËÓ. ¢È·‚ËÙ.
ÃÚoÓÈο 2000; 13: 27-35.
1833.∫ø¡™Δ∞¡Δπ¡π¢OÀ §, ™Δ∞ª∞ΔO¶OÀ§OÀ ª,
¢∏ª∏Δ™π∫O°§OÀ ¡, ¢∂ªπƒΔ∑O°§OÀ £, ¡∞μƒO∑π¢OÀ ∂, ¢∏ª∏Δ™π∫O°§OÀ π. ∏ ‰È·‚ËÙÈ΋
Ó ÊÚo¿ıÂÈ· ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 1.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 36-44.
1834. ¢∏ª∏Δ™π∫O°§OÀ ¡, ™∞ª∞ƒΔ∑π¢∏™ ∫,
ªπ∫∏∫∏™ μ, ƒO∑∏-¶∞¡OÀ ¶, ª¶∞ƒª¶OÀΔ∏™ ∫, ¢∂ªπƒΔ∑O°§OÀ £. ∏ ‰È·‚ËÙÈ΋ ÓÂÊÚo¿ıÂÈ· ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 45-54.
1835. ƒ∂¶∞¡Δ∞ ∂, ™∫∞ƒ∞°∫∞™ °, °∫OÀΔ∫π¢OÀ ™,
πø∞¡¡π¢∏™ ∏, °∫∞¡ Δ∑∞ƒOÀ ∞, ¶∞¶∞∑O°§OÀ ¡, °∂øƒ°∞∫O¶OÀ§OÀ ∂. ∂›‰·
ÚoıÚoÌ‚ÈÓÈÎo‡ ÎÏ¿ÛÌ·Ùo˜ 1+2 (F1+2) Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜ Ù‡o˘ 1 Ì ÌÈÎÚoÏÂ˘ÎˆÌ·Ùo˘Ú›·.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 55-8.
1836. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞ ∂, Δ∑∞Δ∑∞°OÀ °,
°∫∞¡Δ∑∞ƒOÀ ∞, ª∞¡∂™ Ã, Ã∞ƒπΔπ¢∏™ ∂,
ª∞ƒΔ∞™π¢OÀ ∫, ¶∞¶∞∑O°§OÀ ¡. ™˘¯ÓfiÙËÙ·
Helico bacter pylori (Hp) Ïo›ÌˆÍ˘ Û ·ÛıÂÓ›˜ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000;
13: 59-62.
1837. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ª∞¡∂™ Ã,
°∫OÀΔ∫π¢OÀ ™, Δ∑∞ Δ∑∞°OÀ °, ∫∞ƒ∞°π∞¡¡∏ ¢, ∫OÀ°πOÀªΔ∑O°§OÀ ¢. πÓˆ‰oÁfiÓo ÛÂ
‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜ Ù‡o˘ 1. ∞Ó·ÊoÚ¿ Î·È ÛÙ· Â˘Ú‹Ì·Ù· Ù˘ EURODIAB Complications Study.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 63-8.
1838. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∫∞ƒ∞μ∞™π§∏ ∫, æ∞ƒƒ∞ ¶, ƒ∏°∞ ª, πOÀ§π∞¡OÀ ™, Δƒ∞´∞¡π¢∏™ ¶.
¶ÚfiÛıÈ· ÈÛ¯·ÈÌÈ΋ oÙÈ΋ Ó¢Úo¿ıÂÈ· Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13:
69-73.
1839. ™∞´§∂ƒ ¡, ™Δ∞Àƒπ¢∏™ ∏, ÃÀΔ∏ƒπ¢OÀ ¢, μO§πøΔ∏™ ∫, ™¶∏§πO¶OÀ§O™ ∞. ™˘Ó¤ÂÈ· ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ˆ˜ Úo˜ ÙËÓ ·Ú·ÎoÏo‡ıËÛË ÙˆÓ
∂͈ÙÂÚÈÎÒÓ π·ÙÚ›ˆÓ. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000;
13: 74-6.
151
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1840. ™∞´§∂ƒ ¡, ÃÀΔ∏ƒπ¢OÀ ¢, ™Δ∞Àƒπ¢∏™ ∏,
μO§πøΔ∏™ ∫, ™¶∏§πO¶OÀ§O™ ∞. ¶fiÛo ÛˆÛÙ‹
Â›Ó·È Ë ·Ú·ÎoÏo‡ıËÛË ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·fi ÌË ÂȉÈÎo‡˜ ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 77-80.
1841. ∫∞Δ™π§∞ª¶ƒO™ ¡, Δ∂¡ΔO§OÀƒ∏™ ¡. ∂ÍÂÏ›ÍÂȘ Î·È ÚooÙÈΤ˜ ÛÙo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋
2000; 77: 370-3.
1842. °OÀ§∏™ ¢, ∞μƒ∞ªπ¢∏™ ∞. £ÂÚ·›· oÚÌoÓÈ΋˜ ˘oηٿÛÙ·Û˘ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. °·ÏËÓfi˜ 2000; 42: 88-99.
1843. ∂§π™∞º ª, °OÀ¢∂μ∂¡O™ π. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ‰˘ÛÏÈȉ·ÈÌ›·˜. ∫·Ú‰›· &
∞ÁÁ›· 2000; 6: 497-503.
1844. •∂¡∞∫∏™ ∫, Δ∂¡ΔO§OÀƒ∏™ ∫, ¶πΔ™∞μO™
Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛÙÂÊ·ÓÈ·›· ÓfiÛo˜: ΔÈ
Ú¤ÂÈ Ó· ÁÓˆÚ›˙ÂÈ o ηډÈoÏfiÁo˜; ∫·Ú‰›· &
∞ÁÁ›· 2000; 6: 533-52 (∞′ ̤Úo˜), 2001; VI: 51-68
(μ′ ̤Úo˜ ).
1845. ANDRIKOPOULOS S, VERCHERE C, TERAUCHI Y, KADOWAKI T, KAHN S. ‚-cell glucokinase
deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of
type 2 diabetes. Diabetes 2000; 49: 2056-63.
1846. ∞§∂μπ∑O™ ª. £ÂÚ·›· ۷ί·ÚÒ‰o˘˜ ‰È·‚‹Ùo˘.
¢Èo›ÎËÛË Î·È ÀÁ›· 1999; 1: 118-30.
1847. ∫∞ƒ∞°π∞¡¡∏ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ÛÙȘ Á˘Ó·›Î˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 99-106.
1848. XATZHAXMET A, ¶∞¶∞∑O°§OÀ N. ∏ Ú‡ıÌÈÛË Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·Ù¿ ÙËÓ ‰È¿ÚÎÂÈ· ÙˆÓ ÓËÛÙÂÈÒÓ Ùo˘ ÈÂÚo‡ Ì‹Ó· Ùo˘ ƒ·Ì·˙·ÓÈo‡ ÙˆÓ ªo˘Ûo˘ÏÌ¿ÓˆÓ. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 107-12.
1849. ª¶∞∫∞Δ™∂§O™ ™. ◊·Ú Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ¢È·Ù·Ú·¯‹ Ùo˘ ÌÂÙ·‚oÏÈÛÌo‡ ÙˆÓ ˘‰·Ù·ÓıڿΈÓ, Û˘ÌÌÂÙo¯‹ Ùo˘ ‹·Ùo˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο
2000; 13: 113-23.
1850. ª¶∞∫∞Δ™∂§O™ ™. ¢È·‚ËÙÈÎfi ÏÈ҉˜ ‹·Ú.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 124-8.
1851. ª¶∞∫∞Δ™∂§O™ ™. ªË¯·ÓÈÛÌo› Ù˘ ÌÂÙ·ÁÂ˘Ì·ÙÈ΋˜ ‰˘Û·ÓÂÍ›·˜ ÛÙË ÁÏ˘Îfi˙Ë. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 129-33.
1852. ¢∏ª∏Δ™π∫O°§OÀ ¡, ¶OÀ§OÀ ∞, æøª∞Δ™πΔƒOÀ ∂, ™∞ª∞ƒΔ∑π¢∏™ ∫. To C-ÂÙ›‰Èo
ÛÙËÓ Ù·˘Ùoo›ËÛË Ùo˘ ‰È·‚‹ÙË Ù‡o˘ LADA. ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 134-45.
1853. ¶∞¶∞∑O°§OÀ ¡, °∫OÀΔ∑OÀƒ∂§∞ ª,
™OÀ§∏™ ∫, ∫∞ƒ∞°π∞¡¡∏ ¢, ¶∞¶∞¢∂§∏ ∂,
§∂ΔΔ∞ μ, ºƒ∞°∫OÀ§π¢OÀ ∂. ¢›·ÈÙ· IDDM
·ÛıÂÓÒÓ Ùo˘ ∫¤ÓÙÚo˘ Ì·˜. ¶ÚfiÛÏË„Ë ÏÂ˘ÎˆÌ¿ÙˆÓ
Î·È Ú˘ıÌfi˜ ·¤ÎÎÚÈÛ˘ ÏÂ˘ÎˆÌ·Ù›Ó˘ (∂˘Ú‹Ì·Ù· ÂÎ
Ù˘ EURODIAB IDDM Compications Study).
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 146-53.
1854. ¶∞¶∞∑O°§OÀ ¡, °∫OÀΔ∑OÀƒ∂§∞ ª, ™OÀ§∏™ ∫, ª∞¡∂™ Ã, ¶∞¶∞¢∂§∏ ∂, ™∫OÀΔ∞™ ¢.
¶ÚfiÛÏË„Ë ÈÓÒÓ, Â›‰· ¯oÏËÛÙÂÚ›Ó˘ Î·È ‚·ıÌfi˜
ηډȷÁÁÂÈ·Îo‡ ÎÈÓ‰‡Óo˘ Û IDDM ·ÛıÂÓ›˜. (∂˘-
152
Ú‹Ì·Ù· ÂÎ Ù˘ EURODIAB IDDM Complications
Study). ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 154-60.
1855. ¶∞¶∞∑O°§OÀ ¡, ™OÀ§∏™ ∫, ¶∞¶∞¢∂§∏ ∂,
∫Àƒ∫OÀ¢∏™ ∞, ∫∞∑∞ƒ∞™ π, Ã∞ƒπΔπ¢∏™ ∂,
Δ™π∞¡∞∫∞ ∞. §È›‰È· Ï¿ÛÌ·Ùo˜ Î·È ÏÂ˘ÎˆÌ·Ùo˘Ú›· Û هo˘ 1 ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË: (∂Î Ù˘
EURODIAB IDDM Complications Study). ∂ÏÏËÓ.
¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 161-7.
1856. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ª∞¡∂™ Ã,
°∫OÀΔ∫π¢OÀ ™, ¡π∫O§∞∫O¶OÀ§O™ ∞,
πø∞¡¡π¢∏™ ∏. ÃÚfiÓȘ ÂÈÏoΤ˜, ÌÂÙ·‚oÏÈÎfi˜
¤ÏÂÁ¯o˜ Î·È ‰È·ÙÚoÊÈΤ˜ Û˘Ó‹ıÂȘ Û ‰È·‚ËÙÈÎo‡˜
·ÛıÂÓ›˜ Ù‡o˘ 1 (∂Î Ù˘ EURODIAB IDDM
Complications Study). ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000;
13: 168-72.
1857. ∫∞ƒ∞ª∏Δ™O™ ¢, ¶∞™Ã∞§π¢OÀ ∂, ¶OÀƒOÀ
∂, ™OÀ°πOÀ§Δ∑O°§OÀ º, ¢π¢∞°°∂§O™ Δ,
∫OÀƒΔO°§OÀ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ì ‰È¿ÁÓˆÛË ÚÈÓ ·fi Ùo 36o ¤Ùo˜ Ù˘ ËÏÈΛ·˜ ¯ˆÚ›˜ ·Ú¯È΋
·Ó¿ÁÎË ÈÓÛo˘ÏÈÓoıÂÚ·›·˜. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2000; 13: 173-6.
1858. KARAMANOS B, THANOPOULOU A, ROUSSIPENESI D. Maximal postprandial triglyceride increase reflects post-prandial hypertriglyceridaemia
and is associated with the insulin resistance syndrom.
Diabet Med 2001; 18: 32-9.
1859. MATTOCK M, CRONIN N, CAVALLO-PERIN P,
IDZIOR-WALUS B, PENNO G, BANDINELLI S,
STANDL E, KOFINIS A, FULLER J, THE
EURODI AB IDDM COMPLICATIOS STUDY
GROUP. Plasma lipids and urinary albumin excre
tion rate in type 1 diabetes mellitus: the EURODIAB
IDDM Complications Study. Diabet Med 2001; 18:
59-67.
1860. PORTA M, SJOLIE AK, CHATURVEDI N, STEVENS L, ROTTIERS R, VEGLIO M, FULLER JH
AND THE EURODIAB PROSPECTIVE COMPLICATIONS STUDY GROUP. Risk factors for progression to proliferative diabetic retinopathy in the
EURODIAB Prospective Complications Study. Diabetolologia 2001; 44: 2203-9.
1861. CHATURVEDI N, SJOELIE A-K, PORTA M,
ALDINGTON S, FULLER J, SONGINI M, KOHNER E, THE EURODIAB PROSPECTIVE COMPLICATIONS STUDY GROUP. Markers of insulin
resistance are strong risk factors for retinopathy incidence in type 1 diabetes: The EURODIAB Prospective
Complications Study. Diabetes Care 2001; 24: 284-9.
1862. CROOK M, PICKUP J, LUMB P, GEORGINO F,
WEBB D, FULLER J, THE EURODIAB IDDM
COMPLICATIONS STUDY GROUP. Relationship
between plasma sialic acid concetration and microvascular and macrovascular complications in type 1 diabetes. The EURODIAB Complications Study. Diabetes Care 2001; 24: 316-22.
1863. £Àª∂§§∏ π. ∂›Ó·È o ۷ί·Ú҉˘ ‰È·‚‹Ù˘ o
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
«ÂÊÈ¿ÏÙ˘ ÙˆÓ ÁÂÓÂÙÈÛÙÒÓ»; ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∂∫¶∞, 2001. ªÂÙ·Ù˘¯È·Î‹ ¢È·ÙÚÈ‚‹.
1864. ¶∞™ÃOÀ ¶. °ÂÓÂÙÈ΋ Û˘Ì‚o˘Ï¢ÙÈ΋ ÛÙoÓ ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∂∫¶∞, 1999. ªÂÙ·Ù˘¯È·Î‹ ¢È·ÙÚÈ‚‹.
1865. ªπ¡∂ΔOÀ ∂. ∏ ÂÎ·›‰Â˘ÛË ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ
ˆ˜ ·Ú¿ÁˆÓ Ú‡ıÌÈÛ˘ Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋˜ ™¯ÔÏ‹ ∂∫¶∞, 1997. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1866. ∞¡∞¶§πøΔOÀ-μ∞™π§O¶OÀ§OÀ ª. ∂›‰Ú·ÛË Ù˘ ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜ Â› Ùo˘ ÌÂÙ·‚oÏÈÛÌo‡ ÙˆÓ
˘‰·Ù·ÓıÚ¿ÎˆÓ Â› ۷ί·ÚÒ‰o˘˜ ‰È·‚‹Ùo˘ Î·È ˘ÂÚı˘ÚÂoÂȉÈÛÌo‡. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1970. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1867. ∫OÀƒ∏-∫∞§∂ƒ°∏ O. ∞ÍÈoÏfiÁËÛË Ù˘ ÂÌ‚Ú˘oÏ·Îo˘ÓÙÈ΋˜ ÌoÓ¿‰o˜ ÛÙËÓ Î‡ËÛË Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË, Ù˘ Úo‹˜ Ùo˘ ·›Ì·Ùo˜ ÙˆÓ oÌÊ·ÏÈÎÒÓ Î·È ÌËÙÚÈ·›ˆÓ ·ÚÙËÚÈÒÓ Ì doppler. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1997. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1868. ª∏Δ™ø¡∏™ π. ∂Ú¢ÓËÙÈ΋ ÌÂϤÙË Ù˘ ·ÓÙÈÛÙ¿Ûˆ˜ ÙˆÓ ÙÚȯoÂȉÒÓ Ùo˘ ‚oÏ‚ÈÎo‡ ÂÈÂÊ˘ÎfiÙo˜ Â›
‰È·‚‹Ùo˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1979. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1869. ¶∂¡Δ∂∞ ™. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ÚoÛÎoÏÏËÙÈÎfiÙËÙ·˜ Ù˘ escherichia coli Û ÂÈıËÏȷο ·ÙÙ·Ú· o˘ÚooÈËÙÈÎo‡ ‰È·‚ËÙÈÎÒÓ Î·È ˘ÁÈÒÓ Á˘Ó·ÈÎÒÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1996. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1870. ∫OÀƒ∏ ∂. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Ì·ÛÙo΢ÙÙ¿ÚˆÓ ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì ÂÚÈo‰oÓÙ›Ùȉ·. O‰ÔÓÙÈ·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1984. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1871. ª∞¡Δ∑øƒO™ Ã. ™˘Û¯¤ÙÈÛË ·Ó‰ÚoÁfiÓˆÓ Î·È ÈÓÛo˘Ï›Ó˘ Ì ÙËÓ Î·Ù·Óo Ì‹ Ùo˘ ۈ̷ÙÈÎo‡ Ï›o˘˜ ÛÂ
Ó·ڤ˜ ÂÏÏËÓ›‰Â˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1996. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1872. ∏§πO¶OÀ§OÀ μ. ∏ ÂÎÙ›ÌËÛË Ù˘ Â͈ÁÂÓo‡˜ ·ÁÎÚ·ÙÈ΋˜ ÏÂÈÙo˘ÚÁ›·˜ ÛÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË ÌÂ
ÙËÓ ¤ÎÎÚÈÛË Ùo˘ C-ÂÙȉ›o˘ Ù˘ ÂÓ‰oÎÚÈÓo‡˜ Ìo›Ú·˜.
ΔÌ‹Ì· º·Ú̷΢ÙÈ΋˜ ¶·ÓÂÈÛÙ‹ÌÈÔ˘ ¶·ÙÚÒÓ,
1994. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1873. ª∏Δ§π∞°∫∞ ¶. ∏ ·ÏÏËÏÂ›‰Ú·ÛË Î˘ÙÙ·ÚoÎÈÓÒÓ
Ì ÙËÓ μ-ÓËÛȉÈo΢ÙÙ·ÚÈ΋ ÛÂÈÚ¿ RIN-5AH. π·ÙÚÈ΋
™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ πˆ·ÓÓ›ÓˆÓ, 1997. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1874. ™∞∫∂§§∞ƒπOÀ-¶∞ƒ∞ƒ∞ ∑. ª˘ÎËÙoÏoÁÈ΋ ¯ÏˆÚ›˜ ·Û¯fiÓÙˆÓ ÂÎ Ó¢ÌoÓo·ıÂÈÒÓ, ۷ί·ÚÒ‰o˘˜
‰È·‚‹Ùo˘ Î·È ÓÂoÏ·ÛÈÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1976. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1875. °∫OÀª∞™ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Ó¢ÌoÓÈ΋ Ê˘Ì·Ù›ˆÛȘ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1975. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1876. ¶∂ΔƒOÀ-∞ª∂ƒπ∫∞¡OÀ Ã. O ¤ÏÂÁ¯o˜ Ù˘ ÊÏÂÁÌoÓÒ‰o˘˜ ·ÓÙ›‰Ú·Û˘ Ùo˘ ‚ÏÂÓÓoÁfiÓo˘ ÙˆÓ o‡ÏˆÓ
ÂÈ̇ˆÓ Û ÂÈÚ·Ì·ÙÈÎfi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È o
Ú˘ıÌÈÛÙÈÎfi˜ ÚfiÏo˜ Ù˘ ‚ÈÙ·Ì›Ó˘ C. O‰ÔÓÙÈ·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1877. ∫π∞°O™ π. Δ· Â›‰· Ù˘ ÏÈoÚˆÙ›Ó˘ (·) ÛÂ
‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜ ÚÈÓ Î·È ÌÂÙ¿ ·fi ‚ÂÏÙ›ˆÛË
Ù˘ ÁÏ˘¯·ÈÌ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1878. ¶O§ÀÃO¡O¶OÀ§O™ ¶. ¶·Ú¿ÁoÓÙ˜ ÎÈÓ‰‡Óo˘ ·ÁÁÂÈ·Îo‡ ÂÁÎÂÊ·ÏÈÎo‡ ÂÂÈÛo‰›o˘. π·ÙÚÈ΋
™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ¶·ÙÚÒÓ, 1994. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1879. ∫∞§∞μƒOÀ∑πøΔ∏™ °. ΔÚ·‡Ì· ·ÁÎÚ¤·Ùo˜ ÛÂ
ÎÏÂÈÛÙ‹ ÎoÈÏȷ΋ οΈÛË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1993. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1880. ∞§∂•O¶OÀ§OÀ ∞. ªÂϤÙË Ù˘ ‰Â˘ÙÂÚo·ıo‡˜
·ÛÙo¯›·˜ ÛÙ· ·ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ· Û ·ÛıÂÓ›˜ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. ™˘Û¯¤ÙÈÛË Ì ÎÏÈÓÈΤ˜
Î·È ‚Èo¯ËÌÈΤ˜ ·Ú·Ì¤ÙÚo˘˜ Î·È Ù· ·ÓÙÈÓËÛȉȷο
·ÓÙÈÛÒÌ·Ù·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1993. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1881. ™Δ∞ª∞Δ∞∫∏ ∞. ∏ Â›‰Ú·ÛË Ùo˘ ۷ί·ÚÒ‰o˘˜
‰È·‚‹Ùo˘ Ù‡o˘ 2 Â› Ù˘ ˆoıËÎÈ΋˜ ÏÂÈÙo˘ÚÁ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1990. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1882. μ§∞ÃOÀ-πø∞¡¡π¢OÀ Ã. ªÂÙ·‚oϤ˜ Ù˘ oÛÙÈ΋˜ Ì¿˙·˜ Û ÌÂÙÂÌÌËÓo·˘ÛȷΤ˜ Á˘Ó·›Î˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2 (ÌË ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo).
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1990. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1883. ¶∞¶∞¢ƒO™O™ ∏. O ¤ÏÂÁ¯o˜ Ù˘ ‰Ú·ÛÙËÚÈfiÙËÙ·˜
Ùo˘ Û˘Ì·ıËÙÈÎo‡ Ó¢ÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜ ÛÙ· ¿ÎÚ·
ÙˆÓ ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ ·ÚÙËÚÈo·ıÒÓ
·ÛıÂÓÒÓ Ì ÙË ¯ÚËÛÈÌoo›ËÛË ÙˆÓ ¯ÚˆÌ·ÙoÁÚ·ÊÈÎÒÓ ÌÂıfi‰ˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1985. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1884. ∫§∂∞¡£OÀ™ π. ™˘Û¯ÂÙ›ÛÂȘ ÙÈÌÒÓ ·ÈÌoÛÊ·ÈÚ›Ó˘
∞1 (∏μ∞1) Î·È oÏÏ·ÏÒÓ ÚoÛ‰ÈoÚÈÛÌÒÓ ÁÏ˘Îfi˙˘
·›Ì·Ùo˜ ÓËÛÙ›·˜ Â› ۷ί·ÚÒ‰o˘˜ ‰È·‚‹Ùo˘ o„›Ìo˘
ÂÓ¿Ú͈˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1986. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1885. º∂ƒ∂Δ∏™ ∏. ∏ Û˘Ì‚oÏ‹ Ù˘ ˘·ÏoÂȉÂÎÙoÌ‹˜ ÛÙËÓ
ηٷÓfiËÛË Î·È ıÂÚ· ›· Ù˘ oÍ›·˜ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ¶·ÙÚÒÓ, 1986. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1886. ∞™∏ª∞∫O¶OÀ§OÀ °. ∞Ó›¯Ó¢ÛË Ù˘ Û‡ÓıÂÛ˘
Ù˘ ˘oo˘ÏÈ΋˜ ¯ÏˆÚ›‰o˜ Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜
Ù‡o˘ 2. O‰ÔÓÙÈ·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1989. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1887. Δƒπ∞¡Δ∞ºÀ§§OÀ ¶∏ Â›‰Ú·ÛË Ù˘ ¯ÂÈÚo˘ÚÁÈ΋˜ ÂÍ·Ï›„ˆ˜ ÙˆÓ ÛÙoÌ·ÙÈÎÒÓ ÏoÈÌÒÍÂˆÓ ÛÙË Ú‡ıÌÈÛË Ùo˘ ۷ί¿Úo˘ ·›Ì·Ùo˜ Û ÈÓÛo˘ÏÈÓoÂÍ·Úو̤Óo˘˜ Î·È ÌË ÈÓÛo˘ÏÈÓoÂÍ·Úو̤Óo˘˜ ‰È·‚ËÙÈÎo‡˜.
O‰ÔÓÙÈ·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1992. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1888. æÀƒO°π∞¡¡∏™ ∞. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Ù˘ ·ÓıÚÒÈÓ˘ Î·È ¯oÈÚ›·˜ ÈÓÛo˘Ï›Ó˘ Û ·ÛıÂÓ›˜ Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo (Ù‡o˘ 1) ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ¶·ÙÚÒÓ, 1993. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1889. Ãπ™Δ∞∫π¢∏™ ¢. OÈ ‰È·Î˘Ì¿ÓÛÂȘ Ù˘ ÁÏ˘Îo˙˘-
153
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ÏȈ̤Ó˘ ·ÈÌoÛÊ·ÈÚ›Ó˘ ∞1 ÛÙo˘˜ ¿Û¯oÓÙ˜ ·fi
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ۯ¤ÛË Ì ٷ Â›‰· Ùo˘
ÈÍÒ‰o˘˜ Ùo˘ Ï¿ÛÌ·Ùo˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ¢¶¢, 1992.
¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1890. ªÀ°¢∞§∏™ ∏, μ∞ƒμ∞ƒπ°O™ ¡, ƒ∞¢OÀ-™ºÀƒ∏ ª, Ã∞ƒ∞§∞ª¶π¢∏™ π, §∂O¡Δπ∞¢∏™ ∂,
ª∞¡Δ∑∞ƒ∞ º. ∏ Â›‰Ú·ÛË Ù˘ Û˘¯ÓfiÙËÙ·˜ ÙˆÓ
ÁÂ˘Ì¿ ÙˆÓ ÛÙo ÌÂÙ·‚oÏÈÎfi ¤ÏÂÁ¯o ·ÙfiÌˆÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2. π·ÙÚÈ΋ 2000; 78: 257-60.
1891. ¢π¢∞°°∂§O™ Δ, ∞£ÀƒO™ °, ¶∞¶∞°∂øƒ°πOÀ
∞, ∫OÀƒΔO°§OÀ °, ∫∞ƒ∞ª∏Δ™O™ ¢. ª·ÎÚo¯ÚfiÓÈ· Â›‰Ú·ÛË Ù˘ ÎÈÓ·Ú›Ï˘ ÛÙȘ Û˘Ì‚·ÙÈΤ˜
ηډȷÁÁÂȷΤ˜ ‰ÈÎÈ̷ۛ˜ ·ÛıÂÓÒÓ Ì ‰È·‚ËÙÈ΋
Ó¢Úo¿ıÂÈ· Ùo˘ Ê˘ÙÈÎo‡ Ó¢ÚÈÎo‡ Û˘ÛÙ‹Ì·Ùo˜.
∂ÏÏËÓ. π·ÙÚÈ΋ 2000; 66: 159-66.
1892. ¶∞™ÃOÀ ¶. ∞ÈÙÈoÏoÁ›· Î·È ·ıoÁ¤ÓÂÈ· Ùo˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 1. π·ÙÚÈ΋ 2000; 78: 315-27.
1893. §∂À∫O™ ¡. ªÂÙ·‚oÏÈÎfi Û‡Ó‰ÚoÌo. ∞ÚÙËÚȷ΋
À¤ÚÙ·ÛË 1999; 8: 13-34.
1894. ∑∂ª¶∂∫∞∫∏™ ¶. H Â›‰Ú·ÛË Ù˘ ÂÓ‰oÁÂÓo‡˜ ÈÓÛo˘Ï›Ó˘ ÛÙËÓ oÌoÈoÛÙ·Û›· ÙˆÓ ËÏÂÎÙÚoÏ˘ÙÒÓ ÛÙËÓ
ȉÈo·ı‹ ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1998. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1895. ∑∂ª¶∂∫∞∫∏™ ¶. ¢Ú¿ÛÂȘ Ù˘ ÈÓÛo˘Ï›Ó˘ ÛÙo ÓÂÊÚÈÎfi ÈÛo˙‡ÁÈo ÙˆÓ ËÏÂÎÙÚoÏ˘ÙÒÓ Î·È ÛÙË ‰È·Ù·Ú·¯‹
ÙˆÓ ‰È·ÌÂÌ‚Ú·ÓÈÎÒÓ ÌÂÙ·ÎÈÓ‹ÛÂÒÓ Ùo˘˜ ÛÙo ÌÂÙ·‚oÏÈÎfi Û‡Ó‰ÚoÌo. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 1999; 8:
35-47.
1896. BARTSOCAS CH, LAB M, SPYROU N. KRIKELIS N, SERIÉ C, PAPADATOS CJ. Are viral studies
indicated in juvenile-onset diabetes? Padiatr Padol
1982; 17: 603-6.
1897. ™OÀ°πOÀ§Δ∑O°§OÀ º. AÓ·˙‹ÙËÛË ·ÙfiÌˆÓ ÌÂ
Úo‰È¿ıÂÛË ÁÈ· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 1 ÌÂ
ÚoÛ‰ÈoÚÈÛÌfi ÂȉÈÎÒÓ ·˘Ùo·ÓÙÈۈ̿وÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£, 1998. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1898. μ∞º∂π∞¢OÀ ∂. ∏ Â›‰Ú·ÛË Ù˘ oÚÌoÓÈ΋˜ ˘oηٿÛÙ·Û˘ ÛÙËÓ ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Î·È ÙËÓ ÈÓÛo˘ÏÈÓo·ÓÙo¯‹ Û ÂÌÌËÓo·˘ÛȷΤ˜ Á˘Ó·›Î˜. π·ÙÚÈ΋
™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1899. °∞μƒ∞-ƒ∞μ∞¡∏ ª. ¡·ÙÚÈo¢·ÈÛıËÛ›· Î·È ÌÂÙ·‚oÏÈÎfi Û‡Ó‰ÚoÌo ÛÙËÓ È‰Èo·ı‹ ˘¤ÚÙ·ÛË. O
ÚfiÏo˜ ÙˆÓ ÂÓ‰o΢ÙÙ·Ú›ˆÓ ηÙÈfiÓÙˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1900. ™∞μμπ¢∏™ ¡. ∂›‰Ú·ÛË Ù˘ ¯oÚ‹ÁËÛ˘ ·Û‚ÂÛÙ›o˘
ÛÙË Û¯¤ÛË ÈÓÛo˘ÏÈÓo¢·ÈÛıËÛ›·˜ Î·È ÂÓ‰o΢ÙÙ·Ú›ˆÓ
ËÏÂÎÙÚoÏ˘ÙÒÓ ÛÙËÓ È‰Èo·ı‹ ˘ÂÚÙ·ÛË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1901. ™º∂Δ™πOÀ ¶. In vivo Î·È in vitro ÌÂϤÙË Ù˘ ‰Ú¿Û˘ ÙˆÓ ·ÓoÛoηٷÛÙ·ÏÙÈÎÒÓ Ê·ÚÌ¿ÎˆÓ ÛÙ· Â›‰· Ù˘ ÏÂÙ›Ó˘ Û ·È‰È¿ Ì ηÎo‹ıË ÓÂoÏ¿ÛÌ·Ù·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1902. ∞§∂•π∞¢∏™ ™. ªÂϤÙË Ù˘ Û¯¤Û˘ ·ÓÙ›ÛÙ·Û˘
ÛÙËÓ ÈÓÛo˘Ï›ÓË Î·È ÌÈÎÚoÏÂ˘ÎˆÌ·ÙÈÓo˘Ú›· Û ÌoÓo-
154
Ó¤ÊÚo˘˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋
¢È·ÙÚÈ‚‹.
1903. ∑ø™∏ ¶. ∂›‰Ú·ÛË ‚ÈoÛ˘ÓıÂÙÈ΋˜ ·˘ÍËÙÈ΋˜ oÚÌfiÓ˘ (rhGH) ÛÙo ÏÈÒ‰Ë ÈÛÙfi Î·È ÛÙ· Â›‰· ÏÂÙ›Ó˘ Ùo˘ oÚo‡ Û ·È‰È¿ Ì ·ÓÂ¿ÚÎÂÈ· Ù˘ ·˘ÍËÙÈ΋˜ oÚÌfiÓ˘ (GH). π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1904. Δ™πOÀ¶ƒOÀ O. ∂›‰· ÂÓ‰oÁÂÓÒÓ ·Ú·ÁfiÓÙˆÓ
‹Í˘-ÈÓˆ‰fiÏ˘Û˘ Î·È Î˘ÎÏoÊoÚo‡ÓÙˆÓ ÌoÚ›ˆÓ
ÚoÛÎfiÏÏËÛ˘ Û ·È‰È¿ Ì ÈÓÛo˘ÏÈÓo ÂÍ·ÚÙÒÌÂÓo
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1905. ¶∞™Ã∞§π¢OÀ ∂. O ÈÓˆ‰oÏ˘ÙÈÎfi˜ Ì˯·ÓÈÛÌfi˜
‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Û ۯ¤ÛË Ì ÈÓÛo˘Ï›ÓË Î·È
Úo˚ÓÛo˘Ï›ÓË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1999. ¢È‰·ÎÙoÚÈ΋ ¢È·ÙÚÈ‚‹.
1906. ∂À£ÀªπOÀ ∏. ∂Ó‰oÎÚÈÓoÏoÁÈΤ˜ ‰È·Ù·Ú·¯¤˜ Ù˘
ÂÊ˂›·˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘
1. °·ÏËÓfi˜ 1999; 41: 207-13.
1907. CHATURVEDI N, FULLER J, POKRAS F, ROTIERS R, PAPAZOGLOU N, AIELLO L. AND
THE EUCLID STUDY GROUP. Circulation plasma
vascular endothelial growth factor and microvascular
complications of type 1 diabetes mellitus: The influence of ACE inhibition. Diab Med 2001; 18: 288-94.
1908. DEISS D, KORDONOURI O, MEYER K, DANNE T. Long hypoglycae mic periods detected by subcutaneous continoous glucose monitoring in toddlers
and pre-school children with diabetes mellitus. Letter
to the Editor. Diab Med 2001; 18: 337-8
1909. ABIRU N, MANIATIS A, YU L, MIAO D, MORIYAMA H, WEGMANN D, EISENBARTH G. Peptide and major histocompatibility complex – specific
breaking of humoral tolerance to native insulin with
the B9-23 peptide in diabetes-prone and normal mice.
Diabetes 2001; 50: 1274-81.
1910. μ∞ƒμ∞ƒπ°O™ ¡, ∫∞ª∞ƒ∞¢OÀ ∂, ∂À£Àªπ∞¢∏™ ¡, ∫OÀƒΔ∏ ∞, ∫Àƒπ∞∫O¶OÀ§O™ ª,
ªÀ°¢∞§∏™ ∏. ∞Û˘Ìو̷ÙÈ΋ ‚·ÎÙËÚÈo˘Ú›· ÛÂ
·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡o˘ 2 Î·È Û‡ÁÎÚÈÛË ÙˆÓ Â˘ÚËÌ¿ÙˆÓ Ì ·˘Ù¿ ÌË ‰È·‚ËÙÈÎo‡ ÏËı˘ÛÌo‡. °·ÏËÓfi˜ 2000; 42: 633-40.
1911. IRAKLIANOU S, MELIDONIS A, TOURNIS S,
KONSTANDELOU E, TSATSOULIS A, ELISSAF
M, SIDERIS D. Postprandial leptin responses after
an oral fat tolerance test. Letter to the editor. Diabetes Care 2001; 24: 1299-301.
1912. SKRAPARI I, PERREA D, IOANNIDIS I, KARABINA S, ELISAF M, TSE-LEPIS A, KARAGIANNACOS P, KATSILAMBROS N. Glibenclamide improves postprandial hypertriglyceridaemia in type 2
diabetic patients by reducing chylomicrons but not the
very low-density lipoprotein subfraction levels. Diab
Med 2001; 18: 781-5.
1913. IDZIOR-WALUS B, MATTOCK M, SOLNICA B,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
STEVENS L, FULLER J. Factors associated with
plasma lipids and lipoprotein in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Diab Med 2001; 18: 786-96.
1914. LIONIS D, SASAROLIS S, KOUTIS A, ANTONAKIS N, BENOS A, PA- PAVASILIOU S. Measuring the prevalence of diabetes mellitus in a Greek primary health care district. Fam Pract 1996; 13: 18-21.
1915. LIONIS C, BATHIANAKI M, ANTONAKIS N,
PAPAVASILIOU S, PHILA LITHIS A. A high prevalence of diabetes mellitus in a municipality of rural
Crete, Greece. Letter to the editor. Diab Med 2001;
18: 768-9.
1916. KA´ª∞ƒ∞-¶∞¶∞£∞¡∞™πOÀ ∞, Ã∞Δ∑∏∞£∞¡∞™πOÀ Ã, £∂O¢øƒπ¢∏™ Ã. ¢È·Ù·Ú·¯¤˜ ı˘ÚÂoÂȉÈ΋˜ ÏÂÈÙo˘ÚÁ›·˜ Û ·È‰È¿ Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ¶·È‰È·ÙÚÈ΋ 2001; 64: 18893.
1917. ∫ø¡™Δ∞¡Δπ¡π¢OÀ §, ∂À™Δ∞£π∞¢OÀ ª, ¢∏ª∏Δ™π∫O°§OÀ ¡, ¶OÀ§OÀ ∞, æøª∞ ∂, ¢∏ª∏Δ™π∫O°§OÀ π. ∏ ‚·ÛÈ΋ ÂÎÎÚÈÙÈ΋ Âʉڛ·
Ùo˘ ·ÁÎÚ¤·Ùo˜ ÛÙËÓ Ù·˘Ùoo›ËÛË Ùo˘ ‰È·‚‹ÙË Ù‡o˘
1. ¶·È‰È·ÙÚÈ΋ 2000; 63: 129-36.
1918. ∫ø¡™Δ∞¡Δπ¡π¢OÀ §, ™Δ∞ª∞ΔO¶OÀ§OÀ
ª, ™∫∂ª¶∂ƒ∏™ μ, ¢π¶§∞ μ, ∑∂ƒμ∞∫∏™ π,
ªÀΔ∞ºΔ™∏™ ∞, ¢∏ª∏Δ™π∫O°§OÀ ¡. ∏ ‰oÎÈÌ·Û›· ‚·ı¤o˜ ηı›ÛÌ·Ùo˜ ÛÙËÓ ·Ó›¯Ó¢ÛË Ù˘ ·˘ÙfiÓoÌ˘ Ó¢Úo¿ıÂÈ·˜ Û ‰È·‚ËÙÈο ·È‰È¿ ηÈ
Ó¤o˘˜. ¶·È‰È·ÙÚÈ΋ 1999; 62: 141-50.
1919. ™π¢∂ƒ∏ °, ¶∞¶∞∑O°§OÀ ∫, ¶∞¶∞¢∞ΔO™ π.
μ·ÚÂÈ¿ Ó¢ÚoÏoÁÈ΋ Û˘Ó ‰ÚoÌ‹ Û ·È‰› Ì ‰È·‚ËÙÈ΋ ÎÂÙoͤˆÛË oÊÂÈÏfiÌÂÓË Û ¤ÌÊÚ·ÎÙ· ÂÁÎÂÊ¿Ïo˘.
¶·È‰È·ÙÚÈ΋ 1999; 62: 369-99.
1920. ∫∞æ∞§∏ ∞, ∫OÀª∂§∞™ ¢, ∞À§ø¡πΔ∏™ ™,
Δ™πμπΔ∞¡π¢OÀ Δ, ¢∂§∏ °∂øƒ°∏™ ¢. ™‡Ó‰ÚoÌo
ÂÚÈoÚÈÛÌo‡ Ù˘ ÎÈÓËÙÈÎfiÙËÙ·˜ ÙˆÓ ·ÚıÚÒÛÂˆÓ ÛÂ
·È‰› Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
¶·È‰È·ÙÚÈ΋ 1997; 60: 520-4.
1921. ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, ∫∞ƒ∞μ∞¡∞∫∏-∫∞ƒ∞£∞¡∞™πOÀ ∫, Δ™O∫∞-°∂¡¡∞Δ∞ ∂. ªÂϤÙË
Ù˘ ÂȉËÌÈoÏoÁ›·˜ Ùo˘ Ó·ÓÈÎo‡ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË (IDDM) ÛÙËÓ ∂ÏÏ¿‰·. ¶·È‰È·ÙÚÈ΋ 1996; 59: 29714.
1922. ∫∞ƒ∞°∫πO∑O°§OÀ-∞ª¶OÀ¢∏ £, §∂∫π¢OÀ-¶∞ª¶OÀ∫∞ O, ™¶ÀƒO°§OÀ ∫, ¶∞¶∞¢O¶OÀ§OÀ ª, ¶∞¶∞™Δ∞ÀƒOÀ-ª∞ÀƒOÀ¢∏
£, Ã∞ª∞§π¢OÀ Ã, ∞¢∞ª ∫, ƒO∏§π¢∏™ π,
∫∞ƒ¶OÀ∑∞™ π. ∫oÈÏÈoοÎË Û ·È‰È¿ Î·È ÂÊ‹‚o˘˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË: ·ÓÙÈÁÏoÈ·ÓȉÈο ·ÓÙÈÛÒÌ·Ù·
ˆ˜ ̤ıo‰o˜ ‰È·ÏoÁ‹˜. ¶·È‰È·ÙÚÈ΋ 1996; 59: 402-7.
1923. °π∞¡¡∞∫O¶OÀ§OÀ-μƒ∂¡Δ∑OÀ Ã, ª∞Δ∞§πøΔ∞∫∏™ π. ¢È·‚‹Ù˘ Î·È Î‡ËÛË - ¡ÂoÁÓ¿ ‰È·‚ËÙÈÎÒÓ ÌËÙ¤ÚˆÓ. ¶·È‰È·ÙÚÈ΋ 1994; 57: 305-11.
1924. ∫ø™Δ∞§O™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù˘ ÂÁ·o˘
Î·È Û˘ÁÁÂÓ›˜ ·ÓˆÌ·Ï›Â˜ ÛÙo ¤Ì‚Ú˘o-ÓÂoÁÓfi. ¢ÂÏ-
Ù›oÓ ∞′ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›o˘ ∞ıËÓÒÓ 1998; 45: 208-12.
1925. ºøΔπ∞¢∏™ ∫, ¶∞¶∞§O∏™ ∞. O ÛÏ‹Ó·˜ ˆ˜ ı¤ÛË ÌÂÙ·ÌfiÛ¯Â˘Û˘ Î·È ÂÌʇÙ¢Û˘ ·ÁÎÚ·ÙÈÎÒÓ
ÓËÛȉ›ˆÓ Ùo˘ Langerhans Î·È Ë·Ùo΢ÙÙ¿ÚˆÓ.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2000; 17: 528-30.
1926. ∞¡Δ™∞∫§∏™ ∞, ¶∞¶∞¡Δø¡πOÀ ¡, ª∂™O°πΔ∏ ™, ∫OÀΔƒ∞ ¶, ¶∞¶∞°∂øƒ°πOÀ π, ¶∞¶∞πø∞¡¡OÀ ™, ∫OÀƒ∏-∫∞§§∂ƒ°∏ O, ∞¡∞™Δ∞™πOÀ ∂, ™OÀμ∞Δ∑O°§OÀ ∞, ∞ƒ∞μ∞¡Δπ¡OÀ
¢. ∏ Û˘Ì‚oÏ‹ Ùo˘ ‚ÈoÊ˘ÛÈÎo‡ ÚoÊ›Ï ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ùo˘ ‰È·‚‹ÙË Ù˘ ·ËÛ˘. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜
1992; 9: 131-5.
1927. Δ∞ƒ∞™∏ ∞, ª¶π∫∞™ ¡, μ∞™π§∂π∞¢∏™ ∫,
πø∞¡¡π¢∏™ °, ∞¡∞°¡ø™ΔOÀ-∫∞∫∞ƒ∞ ∂, £∞§∞™™π¡O™ ¡, ¶∞¶∞™Δ∂ƒπ∞¢∏ Ã. Δ· HLA ·ÓÙÈÁfiÓ· ˆ˜ ÚoÁÓˆÛÙÈÎfi˜ ‰Â›ÎÙ˘ ·Ú¯fiÌÂÓ˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚo¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ì ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒÌÂÓo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ¡oÛoÎoÌÂȷο ÃÚoÓÈο
1995; 57: 33-7.
1928. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂, °ƒ∏°Oƒπ∞¢OÀ ª.
∞ıËڈ̿وÛË Î·È ‰˘ÛÏÈȉ·ÈÌ›· ÛÙo ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ¡oÛoÎoÌÂȷο ÃÚoÓÈο 1999; 61: 205-19.
1929. ª¶π∫∞™ ¡, μ∞™π§∂π∞¢∏™ ∫. ªÈÎÚo·Ï‚ÈÌÈÓo˘Ú›· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ¡oÛoÎoÌÂȷο ÃÚoÓÈο 1990; 50: 34-41
1930. Δ∞ƒ∞™∏ ∞, ª¶π∫∞™ ¡, πø∞¡¡π¢∏™ °, ¶∞¶¶∞ ∂, £∞§∞™™π¡O™ ¡, ¶∞¶∞™Δ∂ƒπ∞¢∏ Ã. Δ·
HLA-A B, DR, DQ ·ÓÙÈÁfiÓ· Î·È ÈÓÛo˘ÏÈÓoÂÍ·ÚÙÒ
ÌÂÓo˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ (IDDM) Û ÂÏÏËÓÈÎfi
ÏËı˘ÛÌfi. ¡oÛoÎoÌÂȷο ÃÚoÓÈο 1993; 55: 18-23.
1931. ΔOÀΔOÀ∑∞™ ¶. ™¿Î¯·Úo Î·È ÁÏ˘Îo˙˘ÏȈ̤ÓË
∫·Ú‰›· & ∞ÁÁ›· 2001; 6: 373-4.
1932. KORDONOURI O, KAHL A, JÖRRES A, HOPFENMÜLLER W, MÜLLER C, DANNE T. The
prevalence of incipient tubular dysfunction, but not of
glomerular dysfunction, is increased in patients with
diabetes onset in childhood. J Diabetes Complications 1999; 13: 320-4
1933. KORDONOURI O, BÜHRER C. Circulating L-selectin concentrations in children with recent-onset
IDDM. J Pediatr Endocrinol Metab 2000; 13: 85-9.
1934. CHIARELLI F, CASANI A, TUMINI S, KORDONOURI O, DANNE T. Diabetic nephropathy in
childhood and adolescents. Diabetes Nutr Metab
1999; 12: 144-53.
1935. DANNE T, KORDONOURI O, CASANI A, TUMINI S, CHIARELLI F. Recent advances on the pathogenesis and management of both diabetic retinopathy and nephropathy with particular reference to
children and adolescents with Type 1 diabetes. Diabetes Nutr Metab 1999; 12: 136-44.
1936. KORDONOURI O, DANNE T. Present and future
perspectives on children with type 1 diabetes. Acta
Paediatr Suppl 1999; 88: 43-6.
155
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
1937. Ã∞ƒ™OÀ§∏™ º. ∂ÓÂÚÁooÈË̤ÓoÈ ˘o‰o¯Â›˜ ÙˆÓ
oÏÏ·Ï·ÛÈ·ÛÙÒÓ ÙˆÓ ˘ÂÚoÍ˘ÛˆÌ¿ÙˆÓ: O ÚfiÏo˜
Ùo˘˜ ÛÙËÓ ·ıoÁ¤ÓÂÛË ÌÂÙ·‚oÏÈÎÒÓ ·ı‹ÛÂˆÓ Î·È
ÛÙË ‰Ú¿ÛË ÙˆÓ ıÂÈ·˙oÏÈÓ‰ÈoÓÒÓ. ∂ÏÏËÓ. ¢È·‚ËÙ.
ÃÚoÓÈο 2001; 14: 36-46.
1938. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞ ∂. πÓˆ‰oÁfiÓo, ‰È·‚‹Ù˘, ·ÁÁÂÈo¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14:
47-60.
1939. μO§πøΔ∏™ ∫, ∞¡£πªπ¢∏™ °, ¢∏ª∏Δ™π∫O°§OÀ ¡, ∫OÀƒΔO°§OÀ °, ™Àª∂§π¢∏™ ¢.
¢È¿ÁÓˆÛË Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÈ ·ÏÏ¿˙ÂÈ; ™ÙÚoÁÁ‡ÏË ÙÚ¿Â˙·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 61-80.
1940. ∫∞ƒ∞ª∏Δ™O™ ¢, ™OÀ°πOÀ§Δ∑O°§OÀ º,
¶∞™Ã∞§π¢OÀ ∂, ¶∂çπμ∞¡π¢∏™ ∞, ¶∞¡∞°O™ Ã, ¶OÀƒOÀ ∂. ¶·Ú·ÙËÚ‹ÛÂȘ ÁÈ· Ùo ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ¿ÙoÌ· ËÏÈΛ·˜ ¿Óˆ ÙˆÓ 65 ÂÙÒÓ.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 81-4.
1941. ™OÀ§∏™ ∫, ºÀΔπ§∏ Ã, ª∞¡∂™ Ã, ∞§πÃ∞¡π¢OÀ O, ¶∞¶∞∑O°§OÀ ¡, ¶ƒO°π∞ ∂, ∫OÀ∫OÀƒπ∫O™ ™, ÃO§∂μ∞™ ª. ™¯¤ÛË Ùo˘ ‰Â›ÎÙË ÎˆÓÈÎfiÙËÙ·˜ Ì ÙoÓ ‰Â›ÎÙË Ì¿˙·˜ ÛÒÌ·Ùo˜, ÙoÓ ÏfiÁo ̤Û˘/ÈÛ¯›ˆÓ Î·È Ù· ÏÈ›‰È· ÛÙoÓ Ù‡o 2 ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 85-92.
1942. Δ™πOΔ™π∞ °, Δ∑øΔ∑∞™ £, ∂À£ÀªπOÀ ∏,
∞¶O™ΔO§O¶OÀ§OÀ ¢, ª¶OÀ°OÀ§π∞ ª,
∫ƒ∞™™∞™ °. ¢˘Ó·ÌÈ΋ ÌÂϤÙË ÙˆÓ ÂÈ¤‰ˆÓ Ù˘ ·˘ÍËÙÈ΋˜ oÚÌfiÓ˘ Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜ Ù‡o˘ 2 ÌÂ
·Ï‹ Î·È ·Ú·ÁˆÁÈÎo‡ Ù‡o˘ ·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 93-8.
1943. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∫ø¡™Δ∞¡Δπ¡OÀ π, ¶∞¶OÀ§π∞™ ¢, ªOπƒ∞™°∂¡Δ∏ ∞, Δƒ∞´∞¡π¢∏™
¶. ∞oÙÂϤÛÌ·Ù· Ù˘ ·Ó·ÌÊÈ‚ÏËÛÙÚoÂȉÈ΋˜ Laser
ʈÙoËÍ›·˜ ÛÙË ‰È·‚ËÙÈ΋ ÂÚ‡ıÚˆÛË Ù˘ ›Úȉ·˜.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 99-102.
1944. ™∫∞ƒ∞°∫∞™ °, ∫OÀΔ™πOÀ ∫, ƒ∂¶∞¡Δ∞ ∂,
ºƒ∞°∫OÀ§π¢OÀ ∂, πø™∏ºπ¢∏™ ¡, ¶∞¶∞∑O°§OÀ ¡. ∂ÌÊ˘ÛËÌ·ÙÈ΋ ˘ÂÏoÓÂÊÚ›ÙȘ. ¶·Úo˘Û›·ÛË ‰‡o ÂÚÈÙÒÛÂˆÓ Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜.
∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚoÓÈο 2001; 14: 103-6.
1945. MANES CH, PAPAZOGLOU N, SOSSIDOU E,
SOULIS K, MILARAKIS D, SATSOGLOU A,
SAKALLEROU A. Prevalence of diabetic neuropathy and foot ulceration. Population based study.
Identification of risk factors. Hellenic Diabet.
Chronicle 2001; 14: 114-5.
1946. SOULIS K, MANES CH, KOUKOURIKOS S,
PAPAZOGLOU N. Prevalence of cardiovascular
complications in diabetic patients. Hellenic Diabet.
Chronicle 2001; 14: 115.
1947. DIDAGGELOS T, ATHYROS B, PAPAGEORGIOU A, KOURTOGLOU G, KARAMITSOS D.
Long-term effect of converting enzyme inhibition on
diabetic autonomic neuropathy as estimated by
cardiovascular reflex tests. Hellenic Diabet. Chronicle
2001; 14: 119.
156
1948. TRIANTAFYLLOU G. Progression of diabetic
retinopathy in laser treated patients. Hellenic Diabet.
Chronicle 2001; 14: 120-1.
1949. ª∞¡∂™ Ã, Δƒπ∞¡Δ∞ºÀ§§OÀ °, ™∫OÀΔ∞™ ¢,
∫Oƒ∞´¢∏™ ∫, °∂øƒ°π∞¢OÀ ™, ¶∞¶∞∑O°§OÀ
¡. K›Ó‰˘Óo˜ ÂͤÏÈ͢ Úo˜ ·Ú·ÁˆÁÈ΋ ‰È·‚ËÙÈ΋
·ÌÊÈ‚ÏËÛÙÚoÂȉo¿ıÂÈ· (¢∞) Û ‰È·‚ËÙÈÎo‡˜ Ù‡o˘
1. (∂˘Ú‹Ì·Ù· ·fi ÙËÓ EURODIAB Prospective
Complications Study). ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 2001;
14: 183-7.
1950. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ª∞¡∂™ Ã,
°∫OÀΔ∫π¢OÀ ™, Δ∑∞Δ∑∞°OÀ °, ∫OÀΔ™πOÀ ∫.
∂›‰· ÛÈ·ÏÈÎo‡ oͤo˜ Ï¿ÛÌ·Ùo˜ (™O), ÌÈÎÚo- ηÈ
Ì·ÎÚo·ÁÁÂÈo¿ıÂÈ· Û ‰È·‚ËÙÈÎo‡˜ ·ÛıÂÓ›˜ Ù‡o˘
1. (∂˘Ú‹Ì·Ù· ·fi ÙËÓ EURODIAB Prospective
Complications Study). ∂ÏÏËÓ. ¢È·‚. ÃÚoÓÈο 2002;
15: 55-8.
1951. ABRAHAM K, PÄPKE O, GROSS A, KORDONOURI O, WIEGAND S, WAHN U, HELGE H.
Time course of PCDD/PCDF/PCB concentrations in
breastfeeding mothers and their infants. Chemosphere 1998; 37: 1731-41.
1952. DANNE T, KORDONOURI O, ENDERS I, HÖVENER G. Monitoring for retinopathy in children
and adolescents with type 1 diabetes. Acta Paediatr
Suppl 1998; 425: 35-41.
1953. DANNE T, KORDONOURI O, ENDERS I, HÖVENER G, WEBER B. Factors modifying the effect
of hyperglycemia on the development of retinopathy
in adolescents with diabetes. Results of the Berlin
Retinopathy Study. Horm Res 1998; 50 (Suppl 1): 2832.
1954. ¶∞¶∞∑O°§OÀ ¡, ™∫∞ƒ∞°∫∞™ °, ª¶∞ƒΔ™O∫∞™ Ã, ª∞¡∂™ Ã. ªËÙÚÒo ∂ÚÁ·ÛÈÒÓ ∂ÏÏ‹ÓˆÓ
∂Ú¢ÓËÙÒÓ & ™˘ÁÁڷʤˆÓ Ì ÁÓˆÛÙÈÎfi ·ÓÙÈΛÌÂÓo
ÙoÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. μ′ ¤Î‰. ∂ÏÏËÓ. ¢È·‚ËÙ.
ÃÚoÓÈο 2002; 15 (™˘ÌÏ 1): 128 ÛÂÏ.
1955. KORDONOURI O, HARTMANN R, MÜLLER
C, DANNE T, WEBER B. Predictive value of tubular
markers for the development of microalbuminuria in
adolescents with diabetes. Horm Res 1998; 50 (Suppl
1): 23-7.
1956. BY™™OY§H™ °, MAPINAKH™ A, KAP¶ANOY
E, M¶APM¶AT™EA™ I, PIZO™ I, TOYTOYZA™
¶. O ÏfiÁÔ˜ ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›·˜ ÚÔ˜ ÎÚ·ÙÈÓ›ÓË
Ô‡ÚˆÓ ˆ˜ ÚÔ‚ÏÂÙÈÎfi˜ ‰Â›ÎÙ˘ ˘ÂÚÙÚÔÊ›·˜ Ù˘
·ÚÈÛÙÂÚ‹˜ ÎÔÈÏ›·˜, Û ˘ÂÚÙ·ÛÈÎÔ‡˜ ÌË ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜. AÚÙËÚȷ΋ Y¤ÚÙ·ÛË 1999; 8: 150-5.
1957. GREEN A, PATTERSON C, Ôn behalf of the EURODIAB TIGER Study Group. Trends in the incidence of childhood-onset diabetes in Europe 19891998. Diabetologia 2001; 44 (Suppl 3): B3-B8. Greek
Investigators: Papazoglou N. (Thessaloniki), Bartsocas Ch, Kassiou K, Dacou-Voutetaki C, Kafourou A,
AI-Qadreh A, Karagianni C. (Athens).
1958. PATTERSON C, DAHLQUIST G, SOLTEZ G,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
GREN A. ON BEHAIF OF THE EURODIAB ACE
STUDY GROUP. Is childhood-onset type 1 diabetes
a we althrelated disease? An ecological analysis of
European incidence rates. Diabetologia 2001; 1: 44:
Supplement 3: B9-B16.
1959. RONNINGEN K, KEIDING N, GREEK A, ON
BEHALF OF GENOMIC MARKER CONTRIBUTORS AND THE EURODIAB ACE STUDY
GROUP. Correlations between the indicence of
childhood-onset type 1 diabetes in Europe and HLA
genotypes. Diabetologia 2001; 44 (Suppl 3): B51-B9.
1960. GIANNOPOULOS A, GIAMARELLOS-BOURBOULIS E, ADAMAKIS I, GEORGOPOULOU I,
PETRIKKOS G, KATSILAMBROS N. Epididymitis
caused by candida glarata. A novel infection in diabetic patients? Letter to the editor. Diabetes Care
2001; 24: 2003.
1961. ªÀ°¢∞§∏™ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 270 ÛÂÏ.
1962. ªÀ°¢∞§∏™ ∏¡. ∏ ÈÛÙÔÚ›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 19-22.
1963. ªÀ°¢∞§∏™ ∏¡. ∂ȉËÌÈÔÏÔÁ›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡
Ô‰ÈÔ‡. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 23-36.
1964. ªÀ°¢∞§∏™ ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 45-62.
1965. ªÀ°¢∞§∏™ ∏¡. ¶ÂÚÈÊÂÚÈ΋ ·ÁÁÂȷ΋ ÓfiÛÔ˜ ηÈ
‰È·‚‹Ù˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 63-84.
1966. ªÀ°¢∞§∏™ ∏¡. O ÚfiÏÔ˜ Ù˘ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ ÛÙËÓ ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 85-98.
1967. ªÀ°¢∞§∏™ ∏¡. §ÔÈÌÒÍÂȘ Î·È ÙÔ ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 99-120.
1968. ªÀ°¢∞§∏™ ∏¡. ¶·ıÔÁ¤ÓÂÈ· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ¤ÏÎÔ˘˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 121-38.
1969. ªÀ°¢∞§∏™ ∏¡. ¡Â˘ÚÔ·ıËÙÈ΋ ·ÚıÚÔ¿ıÂÈ· ‹
¿ÚıÚˆÛË Charcot. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 16382.
1970. ªÀ°¢∞§∏™ ∏¡. O ÚfiÏÔ˜ ÙˆÓ ·ÂÈÎÔÓÈÛÙÈÎÒÓ ÌÂıfi‰ˆÓ ÛÙË ‰È¿ÁÓˆÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 183-96.
1971. ªÀ°¢∞§∏™ ∏¡. N¤ÔÈ ·Ú¿ÁÔÓÙ˜ ÁÈ· ÙËÓ ÂԇψÛË ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÂÏÎÒÓ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ
¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2001: 231-8.
1972. ªÀ°¢∞§∏™ ∏¡. O ÚfiÏÔ˜ Ù˘ ‰È·‚ËÙÔÏÔÁÈ΋˜
ÔÌ¿‰·˜ ÛÙË ÊÚÔÓÙ›‰· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 253-65.
1973. ¶A¶A¶O§YXPONIOY £. H ÔÚıÔ·È‰È΋ ÂÎÙ›ÌËÛË Î·È ·Ú¤Ì‚·ÛË ÛÙÔ ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 239-52.
1974. YºANTO¶OY§O™ I. OÈÎÔÓÔÌÈΤ˜ ‰È·ÛÙ¿ÛÂȘ ÛÙÔ
‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi
¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 37-44.
1975. CHATURVEDI N, FULLER J, TASKINEN M-R.
ON BEHALF OF THE EURO DIAB PCS GROUP:
Differing associations of lipid and lipoprotein disturbances with the macro vascular and microvascular
complications of type 1 diabetes. Diabetes Care 2001;
14: 2071-7.
1976. PORTA M, SJOELIE A-K, CHATURVEDI N,
STEVENS L, VEGLIO M, FULLER J, AND THE
EURODIAB PROSPECTIVE COMPLICATIONS
STUDY GROUP. Risk factors for progression to
proliferative diabetic retinopathyin the EURODIAB
Prospective Complications Study. Diabetologia 2001;
44: 2203-9.
1977. MIGDALIS I, VARVARIGOS N, CHARALABEDES J, LEONTIADES E, GEROLIMOU B, MANTZARA F, KARMANIOLAS K. Effects of bulfomedil on early carotid atherosclerosis in type 2 diabetic patients. Intern Angiology 2001; 20: 126-30.
1978. DANNE T, KORDONOURI O. Controversies on
the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? J Pediatr Endocrinol
Metab 1998; 11 (Suppl 2): 347-63.
1979. MANES CH, PAPAZOGLOU N, SOSSIDOU E,
SOULIS K, MILARAKIS D, SATSOGLOU A, SAKALLEROU A. Prevalence of Diabetic Neuropathy
and Foot Ulceration: Identification of Potential Risk
Factors - A Population-Based Study. WOUNDS
2002; 14: 1-5.
1980. ∞¶O™ΔO§π¢∏™ ∞, Ã∞Δ∑∏Ã∏™ΔOÀ ¢. °˘Ó·ÈΛ· ÛÂÍÔ˘·ÏÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 21-8
1981. ¶O¡Δπ∫π¢∏™ ¡. GLP-1 ·Ó¿ÏÔÁ·: ∂›‰Ú·ÛË ÛÙÔ
‚- ·ÙÙ·ÚÔ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 29-35
1982. ª¶∞∫∞Δ™∂§O™ ™¶, Δ™∞¶∞™ μ. ∞Ó·ÛÙÔÏ›˜
ÙÔ˘ ÌÂÙ·ÙÚÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘ Ù˘ ·ÁÁÂÈÔÙÂÓÛ›Ó˘ ηÈ
Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ· Û ·ÛıÂÓ›˜ Ì ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 36-44.
1983. ¢π¢∞°°∂§O™ Δ, ™OÀ°πOÀ§Δ∑O°§OÀ º,
°∫∞§π∞°∫OÀ™∏ ∂, ∑ø°ƒ∞ºOÀ π, μ∞™π§∂π∞¢∏™ ¶, ∫∞ƒ∞ª∏Δ™O™ ¢, ¶∞¶∞¢∏ª∏ΔƒπOÀ
ª. ∞ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ· ·ÓÙÈ˘ÂÚÙ·ÛÈ΋˜ ·ÁˆÁ‹˜ ÛÂ
·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2002; 15: 45-9.
1984. ∫∞§Δ™∞™ £, Δ™πΔ™π∞ ∂, ∂À£ÀªπOÀ ∏, ¶∞¶∞¢O¶OÀ§OÀ º, ∫O§π∞∫O™ °. ∂›‰· ·‰ÚÂ-
157
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ÓÔÌÂ‰Ô˘Ï›Ó˘ Î·È ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›·˜ ÌÂÙ¿ ¯ÔÚ‹ÁËÛË ÏÔÛ·ÚÙ¿Ó˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2 (™¢ Ù‡Ô˘ 2) Î·È ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 50-4.
1985. KORDONOURI O, VELIN P, HASALA M, LENNERT T, DANNE T. Beta-cell dysfunction complicating haemolytic uraemic syndrome. Nephrol Dial
Transplant 1998; 13: 1271-2.
1986. Δ™∞¶∞™ ∞, ª∞°OÀ§∞ π, ª¶∂∫π∞ƒ∏ ∂,
Δ™∞¶∞™ μ, §∂À∫O™ ¡. ∏ Â›‰Ú·ÛË Ù˘ ˘ÂÚÈÓÛÔ˘ÏÈÓ·ÈÌ›·˜ ÛÙË ÓÂÊÚÔÛˆÏËÓ·Úȷ΋ ÌÂÙ·ÊÔÚ¿ ÙÔ˘
Ó·ÙÚ›Ô˘. ∂ÏÏËÓ. ¢È·‚ËÙ. ÃÚÔÓÈο 2002; 15: 59-66.
1987. ª¶Oª¶OΔ∏™ °Ã, Ã∞Δ∑∏¡π∫O§∞OÀ ∂π,
™Δƒ∞μ∂§∞™ μ°, ª¶∂§∂μ∂™§∏™ £∂, Δ™∞ª∏™ ¡∂, μ∞™π§∂π∞¢∏™ ∫∂, ™πO§∞μO™ ∞∂,
∫OÀƒO°§OÀ ™∞. ∏ Â›‰Ú·ÛË ÙÔ˘ ™·Î¯·ÚÒ‰Ë
¢È·‚‹ÙË Ù‡Ô˘ 2 ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ‰È·‚ËÙÈÎÒÓ ÌÂ
ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ, Ì ‰È·‰ÂÚÌÈ΋ ÛÙÂÊ·ÓÈ·›· Â·Ó·ÈÌ¿ÙˆÛË (PCI). MÂϤÙË Û ÛÂÈÚ¿ ·ÛıÂÓÒÓ Ì·˜.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 67-72.
1988. °π∞¡¡O°§OÀ °, °π∞¡¡∞∫OÀ§∞™ °. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·: ¡ÂfiÙÂÚ˜ ·fi„ÂȘ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2002; 15: 94-101.
1989. ¶∞¶∞¢O¶OÀ§OÀ º°, ∫ƒ∞™™∞™ °∂. ¢È·‚‹Ù˘
Ù‡Ô˘ 1 ó: ª‡ıÔ˜ ‹ Ú·ÁÌ·ÙÈÎfiÙËÙ·; ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2002; 15: 102-10.
1990. ™∫∞ƒ∞°∫∞™ °. OÌÔ΢ÛÙÂ˚ÓË (O∫) Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ (™¢). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15:
111-25.
1991. ¶∞¶∞¡∞™ ¡, ™Àª∂ø¡π¢∏™ °, °π∞¡¡∞∫∏™ π,
ª∞Àƒπ¢∏™ °, §∞∫∞™∞™ °, ∞ƒΔO¶OÀ§O™ π.
∂ÎÙ›ÌËÛË Ù˘ Â·Û‚¤ÛÙˆÛ˘ ÙÔ˘ ·ÔÚÙÈÎÔ‡ ÙfiÍÔ˘ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2002; 15: 126-31.
1992. ¢∏ª∏Δ™π∫O°§OÀ ∞¡, æøª∞-Δ™πΔƒOÀ ∂,
∫ø¡™Δ∞¡Δπ¡π¢OÀ §, ™∞ª∞ƒΔ∑π¢∏™ ∫,
°∂øƒ°∏∂º∂¡¢∏™ ∫, ¢∏ª∏Δ™π∫O°§OÀ ¡π. ∏
‚·ÛÈ΋ ÂÎÎÚÈÙÈ΋ Âʉڛ· ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ ÛÙËÓ
Ù·˘ÙÔÔ›ËÛË ÙÔ˘ ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 132-40.
1993. Δƒπ∞¡Δ∞ºÀ§§OÀ °, Δƒπ°∫OÀ¢∏™ ¢, °∞Δ∞∫∏™ °, ∫OÀ¡ΔOÀƒ∞ ª, ∞ª¶∂¡Δπ¡π ƒ, Δƒ∞´∞¡π¢∏™ ¶. ∏ Â›‰Ú·ÛË ÙˆÓ ·Ó·ÛÙÔϤˆÓ Ù˘ ηڂÔÓÈ΋˜ ·Ó˘‰Ú¿Û˘ ÛÙÔ Ô›‰ËÌ· Ù˘ ˆ¯Ú¿˜ ·ÛıÂÓÒÓ ÌÂ
ÌË ·Ú·ÁˆÁÈ΋ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2002; 15: 141-7.
1994. ™OÀ°πOÀ§Δ∑O°§OÀ º, FALORNI A, ∫∞™™∏
°, §∂∫π¢OÀ O, ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™
¢, ¶∞¶∞¢∏ª∏ΔƒπOÀ ª. ∞Ó·˙‹ÙËÛË ·ÙfiÌˆÓ ÌÂ
ÚԉȿıÂÛË ÁÈ· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1 ÌÂ
ÚÔÛ‰ÈÔÚÈÛÌfi ÂȉÈÎÒÓ ·˘ÙÔ·ÓÙÈۈ̿وÓ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2002; 15: 148-52.
1995. ª∂§π¢ø¡∏™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î·Ú‰È·Î‹ ·ÓÂ¿ÚÎÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16:
21-7.
158
1996. ∫∞ƒ∞°π∞¡¡∏ ¢, ª∞¡∂™ Ã. ∞ÎÚˆÙËÚÈ·ÛÌÔ›: ΔÔ
̤ÁÂıÔ˜ ÙÔ˘ ÚÔ‚Ï‹Ì·ÙÔ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2003; 16: 28-33.
1997. ∫∞ƒ∞ª∏Δ™O™ ¢, ¢π¢∞°°∂§O™ Δ, ¶∞™Ã∞§π¢OÀ ∂, ™OÀ°πOÀ§Δ∑O°§OÀ º, °∫∞§π∞°∫OÀ™∏ ∂, ∑ø°ƒ∞ºOÀ π, ¶OÀƒOÀ ∂, ¶∞¶∞¢∏ª∏ΔƒπOÀ ª. ∞ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Û ·ÛıÂÓ›˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16: 34-8.
1998. °∂øƒ°∞ ™, ∞ƒ™O™ °, ¢π¢∞°°∂§O™ Δ, ª∞§§π∞™ π, ¶∞°∫∞§O™ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢, ∫∞ƒ∞∫∞Δ™∞¡∏™ ∫°. ¢È·ÊÔÚÈ΋ ‰È¿ÁÓˆÛË ÔÛÙÂÔÌ˘ÂÏ›Ùȉ·˜ ÛÙÔ ‰È·‚ËÙÈÎfi fi‰È ÛÂ Û˘Ó‰˘·ÛÌfi Ú·‰ÈÔ˚ÛÔÙÔÈÎÒÓ ÌÂıfi‰ˆÓ. ¶Úfi‰ÚÔÌË ·Ó·ÎÔ›ÓˆÛË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2003; 16: 39-48.
1999. ¶∞¶∞¡∞™ ¡, ª∞Àƒπ¢∏™ °, ∫∞ƒ∞μ∞°°∂§∏
∂, §∞∫∞™∞™ °, μO™¡∞∫π¢∏™ £, ™Àª∂ø¡π¢∏™ °. ªÂϤÙË ÙÔ˘ ̤ÛÔ˘ fiÁÎÔ˘ ·ÈÌÔÂÙ·Ï›ˆÓ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16:
49-53.
2000. Δ™πΔOÀƒπ¢∏™ π, ∫∞ƒ∞Δ∑π¢OÀ ∫, ª∂§π¢∏™
¢, ∂ªª∞¡OÀ∏§π¢OÀ ª, ÃO¡¢ƒOª∞Δπ¢OÀ
™, °∫OÀΔ∑∞ƒπ¢OÀ º, ™Δƒ∞Δ∏§∞Δ∏ ™, TARAZI L, ªOƒπÃOμπΔOÀ ∞, ∫∞∫∞ƒπ¡OÀ ∂, ª¶∂∑πƒ°π∞¡¡π¢∏™ Ã. §È҉˘ ‰È‹ıËÛË ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜: ªÂϤÙË Ì ÙËÓ ·ÍÔÓÈ΋ ÙÔÌÔÁÚ·Ê›·. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2003; 16: 54-8.
2001. ƒ∂¶∞¡Δ∞ ∂, ™∫∞ƒ∞°∫∞™ °, °∫OÀΔ∫π¢OÀ ™,
¶∞¶∞∑O°§OÀ ¡, °∂øƒ°∞∫O¶OÀ§OÀ ∂. ∏
Â›‰Ú·ÛË Ù˘ ÔÌÔ΢ÛÙÂ˚Ó˘ (O∫) ÛÙËÓ ÏÂÈÙÔ˘ÚÁÈÎfiÙËÙ· ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ Û ‰È·‚ËÙÈÎÒÓ Ù‡Ô˘ 1 ÌÂ
‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· (¢¡º). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16: 59-62.
2002. KALO I. μÂÏÙ›ˆÛË Ù˘ ÊÚÔÓÙ›‰·˜ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡
ÏËı˘ÛÌÔ‡ Ì ÙËÓ ÔÈÔÙÈ΋ ·Ó·‚¿ıÌÈÛË ÙˆÓ Û˘ÛÙËÌ¿ÙˆÓ ˘Á›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16: 89-97.
2003. §∞∑∞ƒπ¢∏™ ∞¡, ™∞ƒ∞ºπ¢∏™ ¶∞. ∏ ·ÓÙÈ˘ÂÚÙ·ÛÈ΋ ·ÁˆÁ‹ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16: 98-110.
2004. Ãπ™ΔO¢OÀ§O™ ∞. ÕÛÎËÛË Û ·ÛıÂÓ›˜ Ì هÔ˘ 2 ·fi ÙËÓ ¿Ô„Ë Ù˘ ÂÈÛÙ‹Ì˘ Ù˘ º˘ÛÈ΋˜
∞ÁˆÁ‹˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16: 111-24.
2005. ª¶∞∫∞Δ™∂§O™ ™, Δ™∞¶∞™ μ, ¢∏ª∏ΔƒOÀ§∞ Ã, Ã∞Δ∑∏∫Àƒ∫OÀ Ã, ¶∞¶∞¢O¶OÀ§O™
°, ΔOÀƒΔOÀƒ∏™ ™, πOƒ¢∞¡π¢OÀ ª, ™∞∫∞§§∂ƒOÀ ∞, ª¶π™¢ƒ∂ª∏™ ∂, ™∂§∞§ª∞Δ∑π¢OÀ ¢. ∏ ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË HbA1c ‚ÂÏÙÈÒÓÂÈ ÙËÓ
·Ó›¯Ó¢ÛË ÙÔ˘ ™·Î¯. ¢È·‚‹ÙË Ù‡Ô˘ 2 Û ¿ÙÔÌ· ˘„ËÏÔ‡ ÎÈÓ‰‡ÓÔ˘ Ì ÌË ‰È·ÁÓˆÛÙÈο Â›‰· ÁÏ˘Îfi˙˘
Ï¿ÛÌ·ÙÔ˜ ÓËÛÙ›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16:
125-30.
2006. ƒ∂¶∞¡Δ∞ ∂, ™∫∞ƒ∞°∫∞™ °, ∞¢∞ª ∂, ¶∞¶∞∑O°§OÀ ¡. ∂›‰· ÔÌÔ΢ÛÙÂ˚Ó˘ (O∫) Î·È ıÚÔÌ‚ÔÌÔ‰Ô˘Ï›Ó˘ (Δª) Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ 1 Ì ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· (¢¡º). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2003; 16: 131-5.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2007. ª∞¡∂™ Ã, ªπ∫OÀ¢∏ ∫, ¶π°°∞™ °, ∫∞ƒ∞°π∞¡¡∏ ¢, ™∫OÀΔ∞™ ¢, ∞ƒ™∂¡πOÀ Ã, ™∫∞ƒ∞°∫∞™ °. ™˘Ó‰˘·ÛÌfi˜ ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ Î·È ÈÓÛÔ˘Ï›Ó˘. ™‡ÁÎÚÈÛË ÌÂ Û˘Ì‚·ÙÈ΋ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›· Û ‰Â˘ÙÂÚÔ·ı‹ ·ÛÙÔ¯›· ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2003; 16:136-40.
2008. ¢π¢∞°°∂§O™ Δ, ∞ƒ™O™ °, μ∞™π§∂π∞¢∏™ ¶,
∫∞ƒ∞∫∞Δ™∞¡∏™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢. ª·ÎÚÔ¯ÚfiÓÈ· ¯ÔÚ‹ÁËÛË ÛÈ˙·Ú›‰Ë˜ Û ·ÛıÂÓ‹ Ì ‚·ÚÈ¿
‰È·‚ËÙÈ΋ Á·ÛÙÚÔ¿ÚÂÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2003; 16: 141-8.
2009. ™∞ª¶∞¡∏™ Ã, ¢π¢∞°°∂§O™ Δ, Δ™πΔ™πOÀ ¡,
ƒπ∑O¶OÀ§OÀ ¢, ™∂ª∂ƒΔ∑π¢∏™ ¶, ∫∞ƒ∞ª∏Δ™O™ ¢. πÓÛÔ˘Ï›ÓË Lispro Î·È Î‡ËÛË. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2003; 16: 149-52.
2010. MY°¢∞§∏™ ∏¡, ª∞ÀƒO°π∞¡¡∞∫∏ ∞¡,
¶∞¶∞¡∞™ ¡¶, ™øΔ∏ƒO¶OÀ§O™ ∞∂. ∞ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2008; 94:
490 ÛÂÏ.
2011. ∞¡Δø¡O¶OÀ§O™ ∞. πÓÛÔ˘ÏÈÓÈ΋ ·ÓÙ›ÛÙ·ÛË,
ıÚfiÌ‚ˆÛË Î·È ·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜ Û ‰È·‚ËÙÈο ¿ÙÔÌ· Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 25-32.
2012. ª¶∞∫∞Δ™∂§O™ ™, Δ™∞¶∞™ μ. ªÂÙ·ÁÂ˘Ì·ÙÈ΋
˘ÂÚÁÏ˘Î·ÈÌ›· Î·È Î·Ú‰È·ÁÁÂȷ΋ ÓfiÛÔ˜. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2004; 17: 33-42.
2013.∞§∂μπ∑O™ ª, ∞¢∞ªπ¢OÀ ∞, ∫O™ªπ¢OÀ ª,
∏§π∞¢∏™ º, Ã∞Δ∑∏ΔO§πO™ ∞, ™∞μμO¶OÀ§O™ Ã. ªÂϤÙË ÙˆÓ ÙÈÌÒÓ Ù˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ (Hb),
ÙÔ˘ ·ÈÌ·ÙÔÎÚ›ÙË (∏t) Î·È Ù˘ Ù·¯‡ÙËÙ·˜ ηı›˙ËÛ˘
ÂÚ˘ıÚÒÓ (Δ∫∂) Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2004; 17: 43-7.
2014. ΔÀÃ∞§∞™ ∞, ™∞Δ™O°§OÀ ∞, ™OÀ§∏™ ∫,
Δ™OÃ∞Δ∑∏™ π, ∫OÀμ∞Δ™∏ ∞, Δƒπ∞¡Δ∞ºÀ§§π¢∏™ ∫. ™˘Û¯¤ÙÈÛË ÙÔ˘ ÔÏ˘ÌÔÚÊÈÛÌÔ‡ Pro12Ala
ÙÔ˘ ÁÔÓȉ›Ô˘ PPARÁ Ì ÙËÓ ÂÌÊ¿ÓÈÛË Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ 2 ÛÙËÓ ∫ÂÓÙÚÈ΋ ª·Î‰ÔÓ›·. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2004; 17: 48-59.
2015. ¢π¢∞°°∂§O™ Δ, ∞£ÀƒO™ μ, ∫O¡ΔO¶OÀ§O™
∞, ¶∞¶∞°∂øƒ°πOÀ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢. ∂›‰Ú·ÛË Ù˘ ÙÔÏÚÂÛÙ¿Ù˘ ÛÙËÓ ËÌÂÚÔÓ‡ÎÙÈ· ‰È·Î‡Ì·ÓÛË Ù˘
ÌÂÙ·‚ÏËÙfiÙËÙ·˜ Ù˘ ηډȷ΋˜ Û˘¯ÓfiÙËÙ·˜ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 60-9.
2016. ª¶∞∫∞Δ™∂§O™ ™, Δ™∞¶∞™ μ, μOÀ¢OÀƒ∏
¶, Ã∞Δ∑∏∫Àƒπ∞∫OÀ Ã, ¶∞¶∞¢O¶OÀ§O™ °,
™∞∫∞§§∂ƒOÀ ∞, ¢∏ª∏ΔƒOÀ§∞ Ã, ¶πΔ™∞μ∞
∂, ™∂§∞§ª∞Δ∑π¢OÀ ¢, •∞¡£∏™ ∞. ∏ ÛËÌ·Û›·
ÙˆÓ ÂÈ¤‰ˆÓ ÁÏ˘Îfi˙˘ Ï¿ÛÌ·ÙÔ˜ ÛÙÔ ¿¯Ô˜ ÙÔ˘
¤Ûˆ-̤ÛÔ˘ ¯ÈÙÒÓ· ÙˆÓ Î·ÚˆÙ›‰ˆÓ (πªΔ) Û ¿ÙÔÌ·
˘„ËÏÔ‡ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2
(Δ2™¢). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 70-8.
2017. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∑πø°∞™ ∫, ∫OÀ¡ΔOÀƒ∞ ª, ∞¡∞™Δ∞™π§∞∫∏™ ∫, ª∞§∞ªO™ ∫,
Δƒ∞´∞¡π¢∏™ ¶. ∏ ÔÊı·ÏÌÔÏËÁ›· Û ·ÛıÂÓ›˜ ÌÂ
‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2004; 17: 79-82.
2018. ™∫∞ƒ∞°∫∞™ °, ∫∞ƒ∞°π∞¡¡∏ ¢, ¶∞¶∞¢O¶OÀ§O™ ƒ, Δ∑∞Δ∑∞°OÀ °, ∫∞ƒ∞∫OÀ§∞∫∏™
™, ƒ∂¶∞¡Δ∞ ∂. ∂ÌÊ˘ÛËÌ·ÙÈ΋ ¯ÔÏÔ΢ÛÙ›Ùȉ· (∂Ã)
Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ (™¢). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 83-6.
2019. ™∞ª¶∞¡∏™ Ã, ∫∞ƒ∞ª∏Δ™O™ ¢. ∏ ıÂÚ·›·
Ù˘ ‰˘ÛÏÈȉ·ÈÌ›·˜ ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÙfïÓ. ∂˘Ú‹Ì·Ù· ÙˆÓ Î˘ÚÈÔÙ¤ÚˆÓ ÔÏ˘ÎÂÓÙÚÈÎÒÓ ÌÂÏÂÙÒÓ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2004; 17: 107-17.
2020. ∫OÀ∑∏-∫O§π∞∫OÀ ∫, ∫∞Δ™π∫∏ ¡, ª∞¡∂™
Ã. ΔÂÏÈο ÚÔ˚fiÓÙ· ÚÔ¯ˆÚË̤Ó˘ ÌË ÂÓ˙˘Ì·ÙÈ΋˜
ÁÏ˘ÎÔ˙˘Ï›ˆÛ˘ (AGE˜) Î·È ‚ÈÔÏÔÁÈ΋ ÙÔ˘˜ ‰Ú¿ÛË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 118-38.
2021. μO§∞∫§∏™ ∫, ∑ø∏™ Ã, ΔO∫ª∞∫π¢∏™ ™.
ÕÛÎËÛË Ì ‚¿ÚË Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 139-45.
2022. ¢∞ªπ∞¡π¢∏™ °, ¢π¢∞°°∂§O™ Δ, ™∞ª¶∞¡∏™
Ã, ∫OÀ∫OÀƒπ∫OÀ ª, Δ™πΔ™πOÀ ¡, ∫∞ƒ∞ª∏Δ™O™ ¢. ΔÔÍÈÎfiÙËÙ· ˘ÔÏÈȉ·ÈÌÈ΋˜ ·ÁˆÁ‹˜ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004;
17: 146-9.
2023. °∂øƒ°∞ ™, ¢π¢∞°°∂§O™ Δ, ∞ƒ™O™ °, ∫∞ƒ∞ª∏Δ™O™ ¢, ∫∞ƒ∞∫∞Δ™∞¡∏™ ∫°. ™ÈÓıËÚÔÁÚ·ÊÈ΋ ‰È¿ÁÓˆÛË Î·È ·Ú·ÎÔÏÔ‡ıËÛË ÔÛÙÂÔÌ˘ÂÏ›Ùȉ·˜
Û ‰È·‚ËÙÈ΋ ·ÛıÂÓ‹ Ì ÙË Ì¤ıÔ‰Ô ÙˆÓ ÂÈÛËÌ·ÛÌ¤ÓˆÓ Ì 99m Tc-HMPAO ·˘ÙfiÏÔÁˆÓ Ï¢ÎÒÓ ·ÈÌÔÛÊ·ÈÚ›ˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17: 150-7.
2024. ª∞°OÀ§∞ π, Δ™∞¶∞™ ∞, ¶∞§∂Δ∞™ ∫, ª¶∂∫π∞ƒ∏ ∂, ∫∞æ∞§π∞ƒ∏™ ∞, ¢∏ª∏Δƒ∞∫O¶OÀ§O™ ∫, §∂À∫O™ ¡. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ‰ÂÈÎÙÒÓ Â˘·ÈÛıËÛ›·˜ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË Î·È Â˘ÁÏ˘Î·ÈÌÈÎÔ‡ ˘ÂÚÈÓÛÔ˘ÏÈÓ·ÈÌÈÎÔ‡ ÈÓÛÔ˘ÏÈÓÈÎÔ‡ ·ÔÎÏÂÈÛÌÔ‡. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2004; 17: 158-64.
2025. ∫∞¡πOÀƒ∞™ ¢, ∞¡∞™Δ∞™π§∞∫∏™ ∫, Δ™∂∫OÀƒ∞ ∞, μ∞∫∞§∏™ ∞. ∏ ÚÒÈÌË ·Ó·ÌÊÈ‚ÏËÛÙÚÔÂȉÈ΋ ʈÙÔËÍ›· Ì Blue-Green Argon laser
‚ÂÏÙÈÒÓÂÈ ÙËÓ ÚfiÁÓˆÛË Ù˘ ÔÙÈ΋˜ Ô͇ÙËÙ·˜ ÛÂ
·ÛıÂÓ›˜ Ì ÛÔ‚·Ú‹ ÌË ·Ú·ÁˆÁÈ΋ Î·È ·Ú·ÁˆÁÈ΋
‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2004; 17: 165-9.
2026. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∂, §OÀ™Δ∏™
∫, ∫ƒ∞™™∞™ °∂. ªÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›· Û ·ÛıÂÓ›˜ Ì ™¢ Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2004; 17:
170-3.
2027. ∫Àƒπ∞∫π¢∏™ °, μ∂ƒƒOÀ ∂, ∫∞ƒ∞ºø§∞™ π.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù˘ ·ËÛ˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2005; 18: 17-21.
2028. ∫∞ƒ∞ª∏Δ™O™ ¢£, ¢π¢∞°°∂§O™ Δ¶. ¶ÚfiÏË„Ë ÙÔ˘ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2005; 18: 22-7.
2029. §OÀ¶∞ Ãμ, μO°π∞Δ∑O°§OÀ ¢∂. §ÔÈÌÒÍÂȘ ÛÂ
·ÛıÂÓ›˜ Ì ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2005; 18: 28-35.
2030. ¶∞¶∞°∂øƒ°πOÀ ∫, ª¶∞∫∞Δ™∂§O™ ™, Ã∞Δ∑∏πø∞¡¡π¢∏™ ∞, πOƒ¢∞¡π¢OÀ ª, μƒ∞¢∂-
159
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
§∏™ ∫. ™ËÙÈΤ˜ ·ÚıÚÔ¿ıÂȘ ÛÙÔÓ ™·Î¯·ÚÒ‰Ë
¢È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2005; 18: 36-41.
2031. Δƒπ∞¡Δ∞ºÀ§§OÀ °, Δ™∂∫OÀƒ∞ ∞, °OÀ§π∞
O, ª∞§∞ªO™ ∫, ∫Oƒ∞´¢∏™ ∫, Δƒ∞´∞¡π¢∏™
¶. ∏ ÂͤÏÈÍË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ô˘ ˘Ô‚Ï‹ıËÎ·Ó Û ʈÙÔ‰˘Ó·ÌÈ΋
ıÂÚ·›· ÁÈ· ¯ÔÚÈÔÂȉÈ΋ ÓÂÔ·ÁÁ›ˆÛË Û˘Ó¤ÂÈ·
ËÏÈÎȷ΋˜ ÂÎʇÏÈÛ˘ ˆ¯Ú¿˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2005; 18: 42-9.
2032. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏, ∞¶O™ΔO§O¶OÀ§OÀ ¢, §OÀ™Δ∏™ ∫, ∫ƒ∞™™∞™ °∂. ™˘¯ÓfiÙËÙ· Î·È ÂͤÏÈÍË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ì ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2005; 18: 50-4.
2033. ∫πΔ™O™ ∫, Δ™∞¡π∫π¢∏™ ∏, ¶OÀ§∞∫O™ ¶,
ª¶∞¡ΔπO™ ™, μO§πøΔ∏™ ∫, ™∞´§∂ƒ ¡. ÀÔÁÏ˘Î·ÈÌÈÎfi ÎÒÌ· Û ·ÛıÂÓ‹ Ì Ë·ÙÈΤ˜ ÌÂÙ·ÛÙ¿ÛÂȘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2005; 18: 55-9.
2034. ¶∞À§∞ΔO™ º. ¶ÔÈfi˜ ÛÎfiÙˆÛ ÙÔÓ πÔÎÚ¿ÙË;
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2005; 18: 77-84.
2035. ∞ƒμ∞¡πΔ∏™ ¢¶, ¢∂ƒμπ™∏™ ∫π, °∂øƒ°O¶OÀ§O™ ™∏, ÃO¡O¶OÀ§O™ ∞μ. ¢È·‚ËÙÈÎfi fi‰È.
∂ÏÏËÓÈ΋ ∞ÁÁÂÈÔ¯ÂÈÚÔ˘ÚÁÈ΋ 1999; (ÙfiÌ.?): 3.
2036. Δ™∞°∫∞ƒ∞∫∏™ ∂π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
ÏÔÈÌÒÍÂȘ. π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 2001; (ÙfiÌ.?): 13004.
2037. ∫ø¡™Δ∞¡Δπ¡π¢OÀ §, ∂À™Δ∞£π∞¢OÀ ª, ¢∏ª∏Δ™π∫O°§OÀ ∞¡, ¶OÀ§OÀ ∞, æøª∞ ∂,
¢∏ª∏Δ™π∫O°§OÀ ¡π. ∏ ‚·ÛÈ΋ ÂÎÎÚÈÙÈ΋ Âʉڛ· ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ ÛÙËÓ Ù·˘ÙÔÔ›ËÛË ÙÔ˘ ‰È·‚‹ÙË
Ù‡Ô˘ 1. ¶·È‰È·ÙÚÈ΋ 2000; 63: 21-42.
2038. KORDONOURI O, DANNE T, ENDERS I, WEBER B. Does the long-term clinical course of type I
diabetes mellitus differ in patients with prepubertal
and pubertal onset? Results of the Berlin Retinopathy
Study. Eur J Pediatr 1998; 157: 202-7.
2039. ZERVOU MI, MAMOULAKIS D, PANIERAKIS
C, BOUMPAS DT, GOULIELMOS GN. STAT4: A
risk factor for type 1 diabetes? Hum Immunol 2008;
69: 647-50.
2040. KARVOUNIS HI, PAPADOPOULOS CE, ZAGLAVARA TA, NOUSKAS IG, GEMITZIS KD,
PARHARIDIS GE, LOURIDAS GE. Evidence of
left ventricular dysfunction in asymptomatic elderly
patients with non-insulin-dependent diabetes mellitus. Angiology 2004; 55: 549-55.
2041. ATHYROS VG, BOULOUKOS VI, PEHLIBANIDIS AN, PAPAGEORGIOU AA, DIONYSOPOULOU SG, SYMEONIDIS AN, PETRIDIS DI,
KAPOUSOUZI MI, SATSOGLOU EA, MIKHAILIDIS DP; METS-GREECE COLLABORATIVE
GROUP. The prevalence of the Metabolic Syndrome
in GREECE: The METS-GREECE Multicenter
Study. Diabetes Obes Metab 2005; 7: 397-405.
2042. ATHYROS BG, MIKHAILIDIS DP, PAPA-
160
GEORGIOU AA, DIDANGELOS Δƒ, GANOTAKIS ES, SYMEONIDIS ∞¡, DASKALOPOULOU
SS, KAKAFIKA ∞π, ELISAF ª; FOR THE METSGREECE COLLABORATIVE GROUP. Prevalence of atherosclerotic cardiovascular disease among
subjects with the metabolic syndrome with or without
diabetes mellitus. Curr Med Res Opin 2004; 20: 1691701.
2043. ATHYROS VG, MIKHAILIDIS DP, PAPAGEORGIOU AA, DIDANGELOS TR, PELETIDOU A, KLETA D, KARAGIANNIS A, KAKAFIKA AI, TZIOMALOS K, ELISAF M. Targeting vascular risk in patients with metabolic syndrome but
without diabetes. Metabolism 2005; 54: 1065-74.
2044. ATHYROS VG, GANOTAKIS ES, ELISAF M,
MIKHAILIDIS DP. The prevalence of the metabolic
syndrome using the National Cholesterol Education
Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157-9.
2045. PANAGIOTAKOS DB, PITSAVOS C, CHRYSOHOOU C, SKOUMAS J, TOUSOULIS D, TOUTOUZA M, TOUTOUZAS P, STEFANADIS C. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the
ATTICA study. Am Heart J 2004; 147: 106-12.
2046. ΔOÀ¡Δ∞™ â. πÛÙÔÚ›· ÙÔ˘ ‰È·‚‹ÙË ÛÙËÓ ∂ÏÏ¿‰·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 17-26.
2047. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¶·ıÔÁ¤ÓÂÈ· Ù˘ ‰È·‚ËÙÈ΋˜
ÓÂÊÚÔ¿ıÂÈ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 2737.
2048. ¶∞°∫∞§O™ ª, ∫OÀ´¢∏ ∂. ∞ÓÙÈıÚÔÌ‚ˆÙÈÎfi˜ ÚfiÏÔ˜ Ù˘ ¿ÛÎËÛ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 3842.
2049. ª¶OÀ°OÀ§π∞ ª. OÍÂȉˆÙÈÎfi ÛÙÚ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 4354.
2050. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ¢ƒ∞°∫πøΔ∏™ ∂, ΔƒOÃO¶OÀ§O™ ª, £ø´¢OÀ ∂, ª∞§∞ªO™ ∫,
∫Oƒ∞´¢∏™ ∫. ∏ ¤Á¯˘ÛË ÙÚ·ÌÈÓÔÏfiÓ˘ Û˘Óԉ¢fiÌÂÓË ·fi Laser ʈÙÔËÍ›· ‚ÂÏÙÈÒÓÂÈ ¿ÌÂÛ· Î·È Ì·ÎÚÔÚfiıÂÛÌ· ÙËÓ fiÚ·ÛË ·ÛıÂÓÒÓ Ì ‰È·‚ËÙÈÎfi ΢ÛÙÈÎfi Ô›‰ËÌ· Ù˘ ˆ¯Ú¿˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006;
19: 55-8.
2051. ¶∞¶∞¡∞™ ¡, ™Àª∂ø¡π¢∏™ °, ª∞Àƒπ¢∏™ °,
¶∞¶∞∑O°§OÀ ¢, ª∞§Δ∂∑O™ ∂, °π∞¡¡∞∫∏™
π, ¶∞¶∞£∂O¢øƒOÀ ∫, ¶∞™ΔOƒ∂ º, §∞∫∞™∞™ °. μ·Ú‡ÙËÙ· ÏÈÒ‰Ô˘˜ ‰È‹ıËÛ˘ ÙÔ˘ ‹·ÙÔ˜:
ŒÌÌÂÛÔ˜ ‰Â›ÎÙ˘ Ù˘ ·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË ÛÂ
‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19:
59-64.
2052. ¢∏ª∏Δ™π∫O°§OÀ ¡∞, ∫ø¡™Δ∞¡Δπ¡π¢OÀ
§, ƒO•∏-¶∞¡OÀ ¶, ª∞ƒ∫OÀ º, ¢∏ª∏Δ™π∫O°§OÀ π¡. ∏ ‰È¿ÚÎÂÈ· ÙÔ˘ ‰È·‚‹ÙË, ÙÔ˘ C-ÂÙȉ›Ô˘
Î·È Ë ·ÛÙÔ¯›· ÙˆÓ ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2006; 19: 65-75.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2053. μO°π∞Δ∑∏™ π∞, ∫∞ƒ∞ª∏Δ™O™ £, ∫∞Ãπª∞¡π¢OÀ ª, ∫∞ª¶πΔ™∏ ∂, ¶ƒO¢ƒOªπ¢∏™ ¶,
™∞ª∞¡π¢∏™ ¢, μO°π∞Δ∑∏™ πª. ªÂÙ·‚ÔÏÈ΋
ÚÔÛÙ·Û›· ÙÔ˘ ‰È·Ï‡Ì·ÙÔ˜ ÁÏ˘Îfi˙˘-ÈÓÛÔ˘Ï›Ó˘-Î·Ï›Ô˘ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ì ıÚÔÌ‚ÔÏ˘ı¤Ó Ô͇
¤ÌÊÚ·ÁÌ· ÙÔ˘ Ì˘Ôηډ›Ô˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2006; 19: 76-84.
2054. ∫∞ƒ∞ª∏Δ™O™ £¢. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 105-17.
2055. ¢π¢∞°°∂§O™ Δ, ª¶∞∫∞Δ™∂§O™ ™, ¢OÀ§°∂ƒ∏™ Ã, ¢∏ª∏ΔƒπOÀ ¢, ∫OÀƒΔO°§OÀ °,
ƒøª∞¡π¢OÀ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢. ™˘¯ÓfiÙËÙ·
Ù˘ ÂÚÈÊÂÚÈ΋˜ ·ÁÁÂÈÔ¿ıÂÈ·˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2006; 19: 118-22.
2056. ∞£ÀƒO™ μ°, °∞¡øΔ∞∫∏™ ∂™, ª¶∞£π∞¡∞∫∏ ª, ªO¡∂¢∞™ π, °OÀ¢∂μ∂¡O™, π∞, ¶∞¶∞°∂øƒ°πOÀ ∞∞, ¶∞¶∞£∞¡∞™πOÀ ∞, ∫∞∫∞º∏∫∞ ∞π, ªπÃ∞∏§π¢∏™ ¢¶, ∂§π™∞º ª. μ·ıÌfi˜
Â›ÁÓˆÛ˘ Î·È ·ÔÙÂÏÂÛÌ·ÙÈ΋˜ ·ÓÙÈÌÂÙÒÈÛ˘ ÙÔ˘
ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘ Î·È ÙˆÓ Û˘ÛÙ·ÙÈÎÒÓ ÙÔ˘ ÛÂ
ÂÏÏËÓÈÎfi ÁÂÓÈÎfi ÏËı˘ÛÌfi. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2006; 19: 123-9.
2057. ∫∞∑∞∫O™ ∫. ªÂÙ·‚ÔϤ˜ ÙˆÓ ÂÈ¤‰ˆÓ ÈÓÛÔ˘Ï›Ó˘ Î·È C-ÂÙȉ›Ô˘ Û ¿ÙÔÌ· Ì ™¢2 Î·È Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ∞¡™. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 130-4.
2058. §OÀ¶∞ Ã, ¶∂ΔƒOÀ °, °∂øƒ°πOÀ ™, °π∞°OÀƒΔ∞ ∂, ∞¡∞°¡ø™ΔOÀ ∞, ƒ∂¡π∂ƒ∏™ π, ª∞ƒ∞£ø¡πΔ∏™ °, §∂§∂∫∏™ ª, μO°π∞Δ∑O°§OÀ
¢. ∞Ú¯È΋ Î·È Ì·ÎÚÔÚfiıÂÛÌË Ú‡ıÌÈÛË ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ù‡Ô˘ 2 ÌÂÙ¿ ÙËÓ ¤Ó·ÚÍË ÙÔ˘˜ Û ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19:
135-9.
2059. ∫∞∑∞∫O™ ∫. ¶ÂÙ›‰ÈÔ 1 ÚÔÛÔÌÔÈ¿˙Ô˘Ó Ì ÙÔ
ÁÏÔ˘ÎoÁfiÓÔ (GLP-1) Û ·ÛıÂÓ›˜ Ì ™¢2 Î·È Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ∞¡™. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19:
140-4.
2060. Ã∞Δ∑∏™ ¢∫, §∞ƒªOÀ Ã, πø∞¡¡OÀ π, ª¶∞ƒΔ∑O∫∞™ Ã. ∞¢·ÈÛıËÙÔÔ›ËÛË ·ÏÏÂÚÁ›·˜ ÛÙËÓ
ÈÓÛÔ˘Ï›ÓË Û ÎÔÚ›ÙÛÈ 7 ÂÙÒÓ Ì هÔ˘ 1 ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 145-9.
2061. ªÀ°¢∞§∏™ ∏, FERRANINI EA. ¢È·ÎÚÈÙÈ΋ Â›‰Ú·ÛË Ù˘ ·¯˘Û·ÚΛ·˜ Î·È Ù˘ ·ÓÔ¯‹˜ ÛÙË ÁÏ˘Îfi˙Ë
ÛÙÔ Ê·ÈÓfiÌÂÓÔ Ù˘ ÈÓÎÚÂÙ›Ó˘, ÛÂ Ê˘ÛÈÔÏÔÁÈο ¿ÙÔÌ·
Î·È Û ·ÛıÂÓ›˜ Ì ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 63-82.
2062. ª∏ΔƒOÀ ¶, ¢∏ª∏Δƒπ∞¢∏™ °¢. ÀÂÚı˘ÚÂÔÂȉÈÛÌfi˜ Î·È ·ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 83-96.
2063. μ∞°∂¡∞∫∏™ ∞°. ™Ï·Á¯ÓÈ΋ ·¯˘Û·ÚΛ· ηÈ
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 97-101.
2064. Δ™∞Δ™OÀ§∏™ ∞∞. ªË¯·ÓÈÛÌÔ› ÂÈ‚›ˆÛ˘ ÙÔ˘
·ÓıÚÒÔ˘ Î·È ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 103-9.
2065. ∫∞ƒ∞ª∏Δ™O™ ¢£. ªË ·ÏÎÔÔÏÈ΋ ÏÈ҉˘ ÓfiÛÔ˜ ÙÔ˘ ‹·ÙÔ˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2008: 111-23.
2066. ΔOÀ¡Δ∞™ â. ∫¿ÓÈÛÌ· Î·È ‰È·‚‹Ù˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 125-37.
2067. ƒ∞¶Δ∏™ ™∞, ª¶OÀΔ∞Δ∏ ∂. £ÂÚ·¢ÙÈÎÔ› ÛÙfi¯ÔÈ Î·È ‰˘Ó·ÙfiÙËÙ˜ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘: ÂÚÈÔÚÈÛÌÔ› Î·È ·Á›‰Â˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 139-52.
2068. ∞¡∞™Δ∞™πOÀ ∂∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
·ËÛË. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2008: 153-64.
2069. ºπ§π¶¶π¢∏™ º¶. ∏ ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜
ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2008: 165-74.
2070. ª∞ÀƒO°π∞¡¡∞∫∏ ∞¡. ∏ ·ÓÙÈÌÂÙÒÈÛË Ù˘
˘ÂÚÁÏ˘Î·ÈÌ›·˜ ÛÙÔ ÓÔÛÔÎÔÌ›Ô. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 175-90.
2071. °πøμO™ π°. ªÈÌËÙÈο ÈÓÎÚÂÙ›Ó˘ Î·È ÂÓÈÛ¯˘ÙÈο
Ù˘ ‰Ú¿Û˘ ÙˆÓ ÈÓÎÚÂÙÈÓÒÓ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 191-210.
2072. Ãπ™Δ∞∫O¶OÀ§O™ ¶¢. ∫ÚÈÙÈ΋ ıÂÒÚËÛË Ù˘
ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘
2. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008:
211-23.
2073. ª∂§π¢ø¡∏™ ∞π. ∞ÓÙϛ˜ Î·È Û¯‹Ì·Ù· ÂÓÙ·ÙÈÎÔÔÈË̤Ó˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 225-35.
2074. ª¶∞ƒΔ™O∫∞™ Ù. ∞ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙ· ·È‰È¿ Î·È ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 237-57.
2075. ¢π¢∞°°∂§O™ Δ¶. ∞ÈÛıËÙ‹Ú˜ ÁÏ˘Îfi˙˘: ·ÚfiÓ
Î·È Ì¤ÏÏÔÓ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 259-67.
2076. ∫∞Δ™π§∞ª¶ƒO™ ¡§, §π∞Δ∏™ ™£. °Ï˘Î·ÈÌÈÎfi˜
‰Â›ÎÙ˘ Î·È ·¯˘Û·ÚΛ·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù·
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 269-76.
2077. •Àƒ∞º∏™ •∞, ∂À∞¡¢£π∞ ¢, ¢π∞ª∞¡Δ∏∫∞¡¢∞ƒ∞∫∏ ¢. £ÂÚ·›· Ù˘ ·¯˘Û·ÚΛ·˜ ÛÙÔ
161
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 277-92.
2078. ªÀ°¢∞§∏™ ∏¡. ∂ȉËÌÈÔÏÔÁ›· Î·È ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ÂÚÈÊÂÚÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 293-308.
2079. æÀƒO°π∞¡¡∏™ ∞π. ∂Ò‰˘Ó· Û‡Ó‰ÚÔÌ· ÛÙÔ ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹: ¡Â˘ÚÔ¿ıÂÈ·-ÛÙ˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2008: 309-13.
2080. °π∞ª∞ƒ∂§§O™-ª¶OÀƒª¶OÀ§∏™ ∂π, °π∞ª∞ƒ∂§§OÀ ∂§. §ÔÈÌÒÍÂȘ Î·È ‰È·‚ËÙÈÎfi fi‰È.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008:
315-20.
2081. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂π, Àº∞¡Δ∏ °∫. ¶ÂÚÈÊÂÚÈ΋ ‰È·‚ËÙÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 321-34.
2082. °∞ƒΔ∞°∞¡∏™ ™¶. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2008: 335-56.
2083. μ∂ªªO™ ∫¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÈÛ¯·ÈÌÈÎfi ÂÁÎÂÊ·ÏÈÎfi ÂÂÈÛfi‰ÈÔ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù·
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 357-71.
2084. ∫∞ƒ∞ª∞¡O™ μ°. ∂ȉËÌÈÔÏÔÁ›· Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ Î·È ˘¤ÚÙ·Û˘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008:
373-85.
2085. ∞§∞μ∂ƒ∞™ ∞°. À¤ÚÙ·ÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 387-407.
2086. ¶∞¶¶∞™ ™π, ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∫.
¶ÏÂÈÔÙÚÔÈΤ˜ ‰Ú¿ÛÂȘ ÙˆÓ ÛÙ·ÙÈÓÒÓ Î·È ÙˆÓ ÁÏÈÙ·˙ÔÓÒÓ: ∞fi ÙË ıˆڛ· ÛÙËÓ Ú¿ÍË. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 409-37.
2087. °∞∑∏ ∂º, ∂§π™∞º ª™. Δ· ȉȷ›ÙÂÚ· ¯·Ú·ÎÙËÚÈÛÙÈο Ù˘ ‰È·‚ËÙÈ΋˜ ‰˘ÛÏÈȉ·ÈÌ›·˜ Î·È Ë ıÂÚ·¢ÙÈ΋ Ù˘ ÚÔÛ¤ÁÁÈÛË. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 439-49.
2088. ªÀ°¢∞§∏™ ∏¡. ¢È·‚ËÙÈ΋ ¡Â˘ÚÔ¿ıÂÈ·. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 258 ÛÂÏ.
2089. LYONS TE, RICH J, VEVES A. Foot pressure abnormalities in the diabetic foot. In: Veves A, Giurini
JM, LoGerfo FW. The Diabetic Foot: Medical and
Surgical Management. Totowa, N.J.: Humana Press,
2002: 127-46.
162
2090. PHAM HT, VEVES A. Living skin equivalents for
the diabetic foot ulcer. In: Veves A, Giurini JM,
LoGerfo FW. The Diabetic Foot: Medical and Surgical Management. Totowa, N.J.: Humana Press, 2002:
397-10.
2091. VEVES A, CASELLI A, ECONOMIDES PA. New
therapies for the treatment of diabetic neuropathy. In:
Barnett AH. Diabetes Annual 2002. London: Martin
Dunitz, 2002: 185-207.
2092. COTTER MA, VEVES A, TESFAYE S, CAMERON NE. Nerve Blood Flow. In: Gries A, Ziegler D,
Low P, Cameron NE. Diabetic Neuropathy. Stuttgart:
Thieme, 2002: 115-23.
2093. DINH T, VEVES A. The Diabetic Foot. In:
DeFronzo RA, Ferrannini E, Keen H, Zimmet P. International Textbook of Diabetes Mellitus. 3rd edition, Chichester: John Wiley & Sons, 2004: 1315-32.
2094. KHAODHIAR L, VEVES A. Therapeutic Interventions to Improve Endothelial Function in Diabetes. In: Johnstone MT, Veves A. Diabetes and Cardiovascular Disease. 2nd ed. Totowa, N.J.: Humana
Press, 2005: 465-85.
2095. HILE C, VEVES A. Microcirculation of the Diabetic Foot. In: Johnstone MT, Veves A. Diabetes and
Cardiovascular Disease. 2nd ed. Totowa, N.J.: Humana Press, 2005: 403-18.
2096. MALIK RA, VEVES A. Diabetic Neuropathy. In:
Johnstone MT, Veves A, Diabetes and Cardiovascular Disease. 2nd ed. Totowa, N.J.: Humana Press,
2005: 381-401.
2097. DINH T, VEVES A. The Diabetic Foot. In: Mantzoros CS. Obesity and Diabetes. Totowa, N.J.: Humana Press, 2006: 351-62.
2098. KHAODHIAR L, VEVES A. Cutaneous Blood
Flow, Laser Doppler Measurement. In: Webster J.
Encyclopedia of Medical Devices And Instrumentation. Inc, NJ: John Wiley & Sons, 2007: (pages ?).
2099. VEVES A, LYONS TE. Foot Care in Older Adults
with Diabetes Mellitus. In: Munshi M, Lipsitz LA.
Geriatric Diabetes. Taylor & Francis, 2007: 241-60.
2100. DINH T, VEVES A. Microvascular changes in the
diabetic foot. In: Veves A, Giourini JM, LoGerfo FW,
eds. The Diabetic Foot: Medical and Surgical Management. 2nd ed, Totowa, N.J.: Humana Press, 2006:
131-45.
2101. LYONS TE, ROSENBLUM BI, VEVES A. Foot
pressure abnormalities in the diabetic foot. In: Veves
A, Giourini JM, LoGerfo FW. The Diabetic Foot:
Medical and Surgical Management. 2nd ed. Totowa,
N.J.: Humana Press, 2006: 163-84.
2102. DINH T, VEVES A. Living skin equivalents for the
diabetic foot ulcer. In: Veves A, Giourini JM, LoGerfo FW. The Diabetic Foot: Medical and Surgical
Management. 2nd ed. Totowa, N.J.: Humana Press,
2006: 459-72.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2103. MALIK RA, VEVES A. Pathogenesis of Human
Diabetic Neuropathy. In: Veves A, Malik RA. The
Clinical Management of Diabetic Neuropathy. 2nd ed.
Totowa, N.J.: Humana Press, 2007: 231-42.
2104. VEVES A. Aldose reductase inhibitors. In: Veves A,
Malik RA. The Clinical Management of Diabetic
Neuropathy. 2nd ed. Totowa, N.J.: Humana Press,
2007: 309-20.
2105. VEVES A, CASELLI A. Micro- and Macrovascular
Disease in Diabetic Neuropathy. In: Veves A, Malik
RA. The Clinical Management of Diabetic Neuropathy. 2nd ed. Totowa, N.J: Humana Press, 2007: 259-74.
2106. HATZICHRISTOU DG, SEFTEL AD, SAENZ
DE TEJADA I. Sexual dysfunction in diabetes and
other autonomic neuropathies. In Siuger G, Weiner
WJ. Sexual Dysfunction: A Neuromedical Approach.
Armonk, NY: Futura Publishing Company, 1994: 16798.
2107. SYMEONIDIS G, PAPANAS N, GIANNAKIS I,
MAVRIDIS G, LAKASAS G, KYRIAKIDIS G.
Gravity of aortic arc calcification as evaluated in adult
greek patients. Int Angol 2002; 21: 233-6.
2108. TOURNIS S, MELIDONIS A, STEFANIDIS A,
HANDANIS S, IRAKLIANOU S, TSATSOULIS A,
GOUDEVENOS J, FOUSSAS S, SIDERIS D. Insulin resistance is a prominent feature of chronic
heart failure, independent of the underlying etiology.
Diabetologia 2001; A187: 716.
2109. MELIDONIS A, STEFANIDIS A, TOURNIS S,
MANOUSSAKIS S, HANDANIS S, ZAIRIS M,
DADIOTIS L, FOUSSAS S. The role of strict metabolic control by insulin infusion on fibrinolytic profile
during a coronary event in diabetic patients. Clin Cardiol 2000; 23: 160-4.
2110. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ ™¢.
¶ÚˆÙÔÁÂÓ›˜ Î·È ‰Â˘ÙÂÚÔÁÂÓ›˜ ÚÔÏËÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∏ ÚfiÏË„Ë ÛÙÔÓ ™¢ ηÈ
ÛÙȘ ÂÈÏÔΤ˜. ¶ÂÈÚ·È¿˜: Medical Graphic Center,
2001: 215-21.
2111. DANNE T, KORDONOURI O, ENDERS I, WEBER B. Factors influencing height and weight
development in children with diabetes. Results of the
Berlin Retinopathy Study. Diabetes Care 1997; 20:
281-5.
2112. ΔOÀƒ¡∏™ ™, ª∂§π¢ø¡∏™ ∞. O ÚfiÏÔ˜ Ù˘ ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ™¢ Ù‡Ô˘
ππ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∏ ÚfiÏË„Ë ÛÙÔÓ ™¢ Î·È ÛÙȘ
ÂÈÏÔΤ˜. ¶ÂÈÚ·È¿˜: Medical Graphic Center, 2001:
75-95.
2113. ¶πΔ™∞μO™ Ã, •∂¡∞∫∏™ ∫, μ∞μOÀƒ∞¡∞∫∏™ ∂ª, Δ∂¡ΔO§OÀƒ∏™ ∫, ΔOÀΔOÀ∑∞™ ¶.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜. ∂ÏÏ.
∫·Ú‰. ∂Èı. 2001; 42: 302-26.
2114. MELIDONIS A, DIMOPOULOS V, LEMPIDAKIS C, HAJISAVVAS I, FOUSSAS S. Angiographic
study of CAD in diabetic patients in comparison with
non diabetics. Angiology 1999; 50: 997-1006.
2115. ª∂§π¢ø¡∏™ ∞. ¢È·‚‹Ù˘ Î·È Î·Ú‰È¿: ∫Ï·ÛÈο
‰Â‰Ô̤ӷ - Û‡Á¯ÚÔÓÔÈ ÚÔ‚ÏËÌ·ÙÈÛÌÔ›. ¶ÂÈÚ·È¿˜,
Medical Graphic Center, 1999: 156 ÛÂÏ.
2116. MANES CH, PAPAZOGLOU N, SOSSIDOU E,
SOULIS K, MILARAKIS D, SATSOGLOU A,
SAKALLEROU A. Prevalence of Diabetic Neuropathy and Foot Ulceration: Identification of Potential
Risk Factors – A Population-Based Study. Wounds
2002; 14: 11-5.
2117. TOKMAKIDIS S, VOLAKLIS K, ZOIS C, KARAMOUZIS M, DOUDA H, PILIANIDIS T, KOTSA
K. Four weeks of training induces positive adaptations
in patients with type 2 diabetes. In: Mester J, King G,
Struder H, Tsolakidis E, Osterburg A. 6th Annual
Congress of the European College of Sport Science
24-28 July 2001 Cologne, Germany. 2001: (page ?).
2118. ¢∞§∞ª∞°∫∞™ °. £ÂÚ·›· Ù˘ ÈÛ¯·ÈÌ›·˜ ÛÙÔÓ
‰È·‚ËÙÈÎfi ·ÛıÂÓ‹: ¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ Î·È ÛÙÚ·ÙËÁÈ΋ Â·Ó·ÈÌ¿ÙˆÛ˘. ™ÙÔ: ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ∫·Ú‰ÈÔÏÔÁ›·˜ 1998-99. £ÂÛÛ·ÏÔÓ›ÎË: University Studio Press, 1999: 21-39
2119. ΔO∫ª∞∫π¢∏™ ™, ∞°°∂§O¶OÀ§O™ £, ª∏Δƒ∞∫OÀ ∞, º∞ΔOÀƒO™ π, Ã∞™πøΔ∏™ ¢. ∏ ۈ̷ÙÈ΋ ¿ÛÎËÛË ˆ˜ ̤ÛÔ ÚfiÏ˄˘ Î·È ıÂÚ·›·˜ ÙÔ˘
™·Î¯·ÚÒ‰Ô˘˜ ¢È·‚‹ÙË. ÕıÏËÛË Î·È ∫ÔÈÓˆÓ›· 2000;
24: 9-29.
2120. ΔO∫ª∞∫π¢∏™ ™. ÕÛÎËÛË Î·È ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘. ™ÙÔ: ΔÔÎ̷Λ‰Ë˜ ™. ÕÛÎËÛË Î·È ÃÚfiÓȘ ¶·ı‹ÛÂȘ. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ¶.Ã. ¶·Û¯·Ï›‰Ë˜,
2003: 69-87.
2121. KORDONOURI O, DANNE T, WEBER B. Do
GAD antibodies at IDDM onset predict the clinical
course of diabetes in children? Diabetes Care 1996;
19: 901-2.
2122. KORDONOURI O, DANNE T, HOPFENMÜLLER W, ENDERS I, HÖVENER G, WEBER B.
Lipid profiles and blood pressure: Are they risk factors for the development of early background
retinopathy and incipient nephropathy in children
with insulin-dependent diabetes mellitus? Acta Paediatr 1996; 85: 43-8.
2123. KORDONOURI O, DRACOU C, PAPADELLIS
F, TOUROUTSIKA P, MÜLLER C, JÖRRES A.
Glomerular microproteinuria in children treated with
non-steroidal anti-inflammatory drugs for juvenile
chronic arthritis. Clin Exp Rheumatol 1994; 12: 56771.
2124. JÖRRES A, KORDONOURI O, SCHIESSLER A,
HESS S, FARKE S, GAHL GM, MÜLLER C,
DJURUP R. Urinary excretion of thromboxane and
markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 1994; 18: 565-9.
2125. ¶∞¶∞°π∞¡¡∏™ ∞∫. ªÈÏÒÓÙ·˜ Ì ÙÔÓ ¿ÚÚˆÛÙÔ.
163
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
∂ÈÛ·ÁˆÁ‹ ÛÙËÓ ÎÏÈÓÈ΋ ÂÈÎÔÈÓˆÓ›·. £ÂÛÛ·ÏÔÓ›ÎË:
University Studio Press, 2003: 156 ÛÂÏ.
2126. ∞¡Δø¡O¶OÀ§O™ ∞¶. ∏ ıÂÚ·¢ÙÈ΋ Û˘Ì‚ÔÏ‹
Ù˘ ·Î·Ú‚fi˙˘ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË Î·È ÛÙËÓ ÚfiÏË„Ë Ù˘ ηډȷÁÁÂȷ΋˜ ÓfiÛÔ˘. ™ÙÔ: ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‹ıˆÓ ·ı‹ÛÂˆÓ ·fi ÙÔ
ÁÈ·ÙÚfi ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜. ∞ı‹Ó·,
2004: (ÛÂÏ.?).
2127. KORDONOURI O, JÖRRES A, MÜLLER C, ENDERS I, GAHL GM, WEBER B. Quantitative assessment of urinary protein and enzyme excretion—a
diagnostic programme for the detection of renal involvement in type I diabetes mellitus. Scand J Clin
Lab Invest 1992; 52: 781-90.
2128. JÖRRES A, CHIABRANDO C, KORDONOURI
O, SCHIESSLER A, HESS S, FARKE S, GAHL
GM, MÜLLER C, RIVOLTELLA L, DJURUP R.
Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass. Eicosanoids 1992;
5: 147-51.
2129. DANNE T, DE VALK HW, KRACHT T, WALTE
K, GELDMACHER R, SÖLTER L, VON DEM
BERGE W, WELSH ZK, BUGLER JR, LANGE K,
KORDONOURI O. Reducing glycaemic variability
in type 1 diabetes self-management with a continuous
glucose monitoring system based on wired enzyme
technology. Diabetologia. 2009 [Epub ahead of print]
2130. ELIOPOULOS G, et al. Emphysematous Cholecystitis (infections in the diabetic patient). Infectious
Diseases 1997; 3: 4.
2131. CHARONIS A, REGER L, DEGE J, KOYZI-KOLIAKOU K, FURCHT L, WOHLHUETER R,
TSILLIBARY E. Laminin alterations after in vitro
nonenzymatic glycosylation. Diabetes 1989; 39: 80714.
2132. ATHYROS V, PAPAGEORGIOU A, ATHYROU
V, DEMITRIADIS DS, KONTOPOULOS AG.
Atorvastatin and micronized fenofibrate alone in
combination in type-2 Diabetes with combined hyperlipidemia. Diabetes Care 2002; 25: 1198-202.
2133. VRENTZOS GE, PAPADAKIS JA, MALLIARAKI N, ZACHARIS EA, MAZOKOPAKIS E, MARGIORIS A, GANOTAKIS ES, KAFATOS A. Diet
serum homocysteine levels and ischaemic heart disease in a Mediterranean population. Br J Nutr 2004;
91: 1013-9.
2134. PITSAVOS C, PANAGIOTAKOS DB, CHRYSOHOU C, PAPAIOANNOU I, PAPADIMITRIOU L,
TOUSOULIS D, STEFANADIS C, TOUTOUZAS
P. The adoption of Mediterranean Diet attenuates the
development of acute coronary syndromes in people
with the metabolic syndrome. Nutr J 2003; 2: 1 (7
pages).
2135. DIDANGELOS TP, ARSOS GA, KARAMITSOS
DT, ATHYROS VG, KARATZAS ND. Left ventricular systolic and diastolic function in normotensive
164
type 1 diabetic patients with or without autonomic
neuropathy: a radionuclide ventriculography study.
Diabetes Care 2003; 26: 1955-60.
2136. KARAMITSOS D. The metabolic syndrome is a
really artificial concept. Hellen Diab Chronicle 2006;
19: 171-75.
2137. ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª. ¢˘ÛÏÂÈÙÔ˘ÚÁ›· ÙÔ˘ ÂÓ‰ÔıËÏ›Ô˘ Û ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1
Î·È 2 . ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 247-60.
2138. ª∂§π¢ø¡∏™ ∞. πÓÎÚÂÙÈÓÔÌÈÌËÙÈο Î·È DPPIV
·Ó·ÛÙÔÏ›˜: OÈ Ó¤Â˜ ıÂÚ·¢ÙÈΤ˜ ÚÔÙ¿ÛÂȘ ÛÙËÓ
·ÁˆÁ‹ ÙÔ˘ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2006; 19: 261-71.
2139. ∫Àƒπ∞∫π¢∏™ °¶. ∏ ·ÓÙÈÌÂÙÒÈÛË ÙˆÓ ¯·ÌËÏÒÓ
ÂÈ¤‰ˆÓ Ù˘ HDL- ¯ÔÏËÛÙÂÚfiÏ˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2006; 19: 272-81.
2140. ¶∏Δ∞ ƒ, °ƒ∏°Oƒπ∞¢OÀ ∂, ª∞ƒπ¡∞ ∂, ∫OÀμ∞Δ™OÀ ∑, ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ∫.
¶ÔÈfiÙËÙ· ˙ˆ‹˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 1.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 282-94.
2141. ∏§π∞¢∏™ º, ∞§∂μπ∑O™ ª, ª¶∞§Δ∞Δ∑∏ ª,
™∞μμO¶OÀ§O™ Ã, Ã∞Δ∑∏ΔO§πO™ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢. ªÂÙ·‚ÔÏÈΤ˜ ÂȉڿÛÂȘ ÁÏÈÌÂÈÚ›‰Ë˜
Î·È ÚÂ·ÁÏÈÓ›‰Ë˜ Û ·ÛıÂÓ›˜ Ì ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË Ù‡Ô˘ 2 ÚfiÛÊ·Ù˘ ‰È¿ÁÓˆÛ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 295-99.
2142. ¶ƒøΔOæ∞§Δ∏™ π, ∫O∫∫Oƒ∏™ ™, Ã∞ƒ∞ª∏™
∞, ∫∞∫∞Δ™O™ π, §∂μπ™π∞¡OÀ ¢, ∫∞ª∞ƒ∞ΔO™
∞, ¢∞¢πøΔ∏™ §, ¶OÀ§O¶OÀ§OÀ Ã, ª∂§π¢ø¡∏™ ∞. ™˘Û¯¤ÙÈÛË ÌÔÚ›ˆÓ Ì ·ÔÙˆÙÈ΋ ‰Ú¿ÛË
Ì ٷ Â›‰· ÌÈÎÚÔÏÂ˘ÎˆÌ·ÙÔ˘Ú›·˜ Û ·ÛıÂÓ›˜ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2006; 19: 300-5.
2143. ¶∞¶∞¢O¶OÀ§OÀ ª, ∫πΔ™πO™ ∫, ∫∞¢O°§OÀ ¡, ™∞´§∂ƒ ¡. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 1 Û ·È‰È¿ Î·È ÂÊ‹‚Ô˘˜. ¶·Ú¿ÁÔÓÙ˜ Ô˘ Û˘Û¯ÂÙ›˙ÔÓÙ·È Ì ÙÔÓ ÁÏ˘Î·ÈÌÈÎfi ¤ÏÂÁ¯Ô. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2006; 19: 306-12.
2144. ¢π¢∞°°∂§O™ Δ, °∂øƒ°∞ ™, ∞ƒ™O™ °, ƒπ∑O¶OÀ§OÀ ¢, ∫∞ƒ∞∫∞Δ™∞¡∏™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢. ∂ԇψÛË ¯ÚfiÓÈÔ˘ ‰È·‚ËÙÈÎÔ‡ Ó¢ÚÔ·ıËÙÈÎÔ‡ ¤ÏÎÔ˘˜ ¤ÏÌ·ÙÔ˜ Ì ÙÔÈ΋ ÂÊ·ÚÌÔÁ‹ ·˘ÍËÙÈÎÔ‡ ·Ú¿ÁÔÓÙ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2006; 19: 31319.
2145. ¶∞À§∞ΔO™ º. ∫Ú›ÛË ÛÙË ‚ÈÔ˚·ÙÚÈ΋ ¤Ú¢ӷ.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 19-45.
2146. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢›·ÈÙ˜ ·‰˘Ó·Ù›ÛÌ·ÙÔ˜ ÛÙÔÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2007; 20: 46-53.
2147. ¢π¢∞°°∂§O™ Δ, Ã∞Δ∑∏ΔO§πO™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ·ÁÁÂȷο ÂÁÎÂÊ·ÏÈο ÂÂÈÛfi‰È·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 54-65.
2148. ∏§π∞¢∏™ º, ∞§∂μπ∑O™ ª, ª¶∞§Δ∞Δ∑∏ ª,
ª∞ƒ°∞ƒπΔπ¢∏™ Ã, ∞¢∞ªπ¢OÀ ∞, ∑πOÀΔ∞™ °,
∫∞ƒ∞ª∏Δ™O™ ¢. ∏ Â›‰Ú·ÛË Ù˘ ÌÔÓÔıÂÚ·›·˜
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Ì ‰È¿ÊÔÚ˜ ηÙËÁÔڛ˜ ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ ÛÙË
Ú‡ıÌÈÛË ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2
ÚfiÛÊ·Ù˘ ‰È¿ÁÓˆÛ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007;
20: 66-70.
2149. ¶O§ÀÃO¡∞∫O™ ∫. ¶ÚfiÛÊ·Ù˜ ÂÍÂÏ›ÍÂȘ ÛÙË
ÁÂÓÂÙÈ΋ ÙÔ˘ ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007;
20: 93-5.
2150. KELLY DJ, AALTONEN P, COX AJ, RUMBLE
JR, LANGHAM R, PANAGIOTOPOULOS S, JERUMS G, HOLTHOFER H, GILBERT RE. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: Differing effects of anti-proteinuric therapies. Nephrol Dial Transplant
2002; 17: 1327-32.
2151. OSICKA TM, YU YX, PANAGIOTOPOULOS S,
CLAVANT SP, KIRIAZIS Z, PIKE RN, PRATT
LM, RUSSO LM, KEMP BE, COMPER WD,
JERUMS G. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of
glomerular protein kinase C. Diabetes 2000; 49: 8793.
2152. LEE FT, CAO Z, LONG DM, PANAGIOTOPOULOS S, JERUMS G, COOPER ME, FORBES JM.
Interactions between angiontensin II and NF- kappaB-dependent pathways in modulating macrophage
infiltration in experimental diabetic nephropathy. J
Am Soc Nephrol 2004; 15: 2139-51.
2153. VINEREANU D, NICOLAIDES E, TWEDDEL
AC, MÄDLER CF, HOLST B, BODEN LE, CINTEZA M, REES AE, FRASER AG. Subclinical left ventricular dysfunction in asymptomatic patients with
Type II diabetes mellitus, related to serum lipids and
glycated haemoglobin. Clin Sci 2003; 105: 537-40.
2154. ∞¡£πªπ¢∏™ °, μ∞™π§∂π∞¢∏™ ¶, μO§πøΔ∏™
∫, μO™¡∞∫π¢∏™ £, °∂ø°∏∂º∂¡Δ∏™ ∫, °∫πƒΔ∑∏™ π, ¢π¢∞°°∂§O™ Δƒ, ¢O§°Àƒ∞™ ™, ∫∞∑∞∫O™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢, ∫∞™™∏ °, ∫§∂π™π∞ƒ∏™ μ, ∫OÀ∫OÀƒπ∫OÀ ª, ∫OÀƒΔO°§OÀ
°, ∫ø¡™Δ∞¡Δ∞™ ∂, ª∞§∂∑∞ ∞, ª∞¡∂™ Ã,
ª∞¡ø§∞∫∏ Ã, ª∞ƒ∞™ ¶, ª∞Àƒπ¢∏™ °, ª∏§πΔ™∏™ ª, ª¶πΔ™πO™ ∞, OÀμ∂¡∏™ π, ¶∞°∫∞§O™ ∂, ¶∞∑∞ƒ§O°§OÀ ª, ¶∞§∂Δ∞™ ∫, ¶∞¶∞§∂•πOÀ °, ¶∞¶∞Oπ∫O¡OªOÀ ¶, ¶∞™Ã∞§π¢OÀ ∂, ™∞´§∂ƒ ¡, ™∞ª∞ƒΔ∑π¢∏™ ∫, ™∞ªæOÀ¡∏ ™, ™∞Δ™O°§OÀ ∞π, ™OÀ§∏™ ∫, ΔπªO™π¢∏™ ª, Δƒπ∞¡Δ∞ºÀ§§OÀ °, Δ™∞¶∞™ ∞¶,
Δ™πμπΔ∞¡π¢∏™ ∞, Ã∞´¢O™ ∫, Ãπ™Δ∞∫π¢∏™ ¢.
O‰ËÁfi˜ ÙÔ˘ ¢È·‚ËÙÈÎÔ‡. £ÂÛÛ·ÏÔÓÈÎË: ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›· μÔÚ›Ԣ ∂ÏÏ¿‰Ô˜, 2004: 68 ÛÂÏ.
2155. ¶∞¶¶∞™ π™, ™øΔ∏ƒO¶OÀ§O™ ∞, ∞¶O™ΔO§OÀ O. ¡ÂÒÙÂÚ· ·ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ· π. ™ÙÔ: ΔÔ‡ÓÙ·˜ ¢Ã. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: £ÂˆÚ›· – Ú¿ÍË. 2Ë
ÂΉ. ∞ı‹Ó·, 2003: 423-50.
2156. ¶∞¶∞∑O°§OÀ ¡. ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ ∂ÏÏ‹ÓˆÓ
∂Ú¢ÓËÙÒÓ Î·È ™˘ÁÁڷʤˆÓ Ì ÁÓˆÛÙÈÎfi ·ÓÙÈΛÌÂ-
ÓÔ ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. °′ ¤Î‰. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2009; 22 (™˘ÌÏ 1): 232 ÛÂÏ.
2157. ¶∞¶¶∞™ ™, ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007;
20: 169-79.
2158. ™Δ∂ƒ°πOÀ πº, ∞¢∞ªπ¢OÀ ∞. ∂Ó‰Ô΢ÙÙ¿ÚÈÔ
·Û‚¤ÛÙÈÔ, ÚˆÙÂ˚Ó˜ ÔÍ›·˜ Ê¿Û˘ Î·È Î˘ÙÙ·ÚÔΛÓ˜
Û ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2007; 20: 180-5.
2159. §∞ª¶ƒO¶OÀ§O™ §°, ™∞§¶π°∫Δ∏™ π™. ƒÂ˙ÈÛÙ›ÓË: ¡¤· ÔÚÌfiÓË ÙÔ˘ ÏÈÒ‰Ô˘˜ ÈÛÙÔ‡. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2007; 20: 186-9.
2160. ¶∞ª¶OÀ∫∞™ π, Δ™∞μ¢∞ƒπ¢∏™ π. ΔÈ ÙÔ ÓÂfiÙÂÚÔ ÛÙË ıÂÚ·›· ÙÔ˘ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË; ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2007; 20: 190-206.
2161. ¶ƒøΔOæ∞§Δ∏™ π, ¡π∫O§O¶OÀ§O™ °,
§πOÀƒ∏ ∂, §∂μπ™π∞¡OÀ ¢, ∫OÀΔ™Oμ∞™π§∏™
∞, ¢∏ªOÀ ∂, ª∂§π¢ø¡∏™ ∞. ∂ȉÈÎÔ› Û˘Ó‰˘·ÛÌÔ› ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘ Û¯ÂÙ›˙ÔÓÙ·È Ì ·˘ÍË̤ÓÔ Î›Ó‰˘ÓÔ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ù‡Ô˘ ππ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007;
20: 207-14.
2162. Ãπ™ΔO¢OÀ§O™ ∞¢, °∫π∫∞ ∂, ¢OÀ¢∞ ∂, μ∂§π™™∞ƒπ¢OÀ ∞, ΔO∫ª∞∫π¢∏™ ™¶. ™¯¤ÛË ÛÙÔȯ›ˆÓ ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘, Ù˘ Ê˘ÛÈ΋˜ ‰Ú·ÛÙËÚÈfiÙËÙ·˜ Î·È Ù˘ ηډÈÔ·Ó·Ó¢ÛÙÈ΋˜ ·ÓÙÔ¯‹˜
ÛÙËÓ ·È‰È΋ ËÏÈΛ·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20:
215-23.
2163. ¶∞¶∞¢O¶OÀ§OÀ ª, ∫πΔ™πO™ ∫, ∫∞¢O°§OÀ ¡, ™∞´§∂ƒ ¡. ΔÂÏÈÎfi ·Ó¿ÛÙËÌ· Û ·È‰È¿
Î·È ÂÊ‹‚Ô˘˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2007; 20: 224-30.
2164. μ∞¢π∞∫∞ ª, ¶∞Δ™π§π¡∞∫O™ ∞, ƒO¢∏™ π,
μπΔ∞§∏ °, ∑∞º∂πƒ∏™ ∞, ™Àª¶∞ƒ¢∏ ™,
Ã∞™ª¶∞¡Δ Δ, ∞¡Δø¡O¶OÀ§O™ ∞. º˘Ì·ÙÈ҉˘ ÂÚÈηډ›Ùȉ· Û ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹ Ì ˘ÂÚı˘ÚÂÔÂȉÈÛÌfi. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 231-4.
2165. LEE JH, CHAN JL, YIANNAKOURIS N, KONTOGIANNI M, ESTRADA E, SEIP R, ORLOVA
C, MANTZOROS CS. Circulating resistin levels are
not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administation: Cross sectional and interventional studies
in normal, insulin-resistant and diabetic subjects. J
Clin Endocrinol Metab 2003; 88: 4848-56.
2166. ªÀ°¢∞§∏™ ∏¡, ∞¡∞™Δ∞™πOÀ ∂∞, ª¶∂¡ƒOÀª¶∏ ª¢. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 194 ÛÂÏ.
2167. μ∞§™∞ª∞∫∏™ °, ª∞ÀƒO°π∞¡¡∞∫∏ ∞,
∫Àƒ§∞∫∏ ∂, ∫OÀΔ™Oμ∞™π§∏™ ∞, §∂μπ™π∞¡OÀ ¢, ¡OÀΔ™OÀ ª, ª¶π§π∞¡OÀ ∂, ∞¡Δø¡O¶OÀ§O™ ∞, ¶∞¡∞°πøΔOÀ £, ª∂§π¢ø¡∏™
∞. ∏ ÁÏ˘Î·ÈÌÈ΋ Ú‡ıÌÈÛË ÛÙËÓ Î·Ú‰ÈÔÏÔÁÈ΋ ÌÔÓ¿‰·
ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜ Ì ÈÛ¯·ÈÌÈ΋ ηډȷ΋ ÓfiÛÔ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 261-73.
165
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2168. ª¶∞∫∞Δ™∂§O™ ™, ∫∞§Àμπ¡O™ ∞. π·ÙÚÔÁÂÓ‹˜
˘ÔÁÏ˘Î·ÈÌ›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 27488.
2169. ∞°∞¶∞∫∏™ ¢π. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2007; 20: 289-306.
2170. ∫∞Δ™π∫∏ ¡. ÀÂÚˆÛ̈ÙÈ΋ ˘ÂÚÁÏ˘Î·ÈÌÈ΋ ηٿÛÙ·ÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 307-18.
2171. ∏§π∞¢∏™ º, ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™
¢. ∞ÓÙÂӉ›ÍÂȘ, ·ÓÂÈı‡ÌËÙ˜ ÂÓ¤ÚÁÂȘ Î·È ·ÏÏËÏÂȉڿÛÂȘ ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2007; 20: 319-32.
2172. μ∞™π§∂πOÀ ∞ª. OÈÓfiÓÂ˘Ì· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2007; 20: 333-42.
2173. ¢π¢∞°°∂§O™ Δ, •∞¡£∏™ ∞. ∂›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙËÓ ÎÈÓËÙÈÎfiÙËÙ· ÙˆÓ ·ÚıÚÒÛÂˆÓ Î·È ÛÙÔÓ ÙÚfiÔ ‚·‰›ÛÌ·ÙÔ˜- ‚ËÌ·ÙÈÛÌÔ‡. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2008; 21: 15-22.
2174. ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞, Δ∂¡ΔO§OÀƒ∏™
¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. ¡ÂfiÙÂÚÔÈ ·Ú¿ÁÔÓÙ˜ ηډȷÁÁÂÈ·ÎÔ‡ ÎÈÓ‰‡ÓÔ˘ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 23-33.
2175. ª¶OÀ°OÀ§π∞ ª, ∂À£ÀªπOÀ ∏. º·Ú̷΢ÙÈ΋ ıÂÚ·›· Ù˘ ·¯˘Û·ÚΛ·˜ ÙˆÓ ·È‰ÈÒÓ Î·È ÙˆÓ
ÂÊ‹‚ˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 34-40.
2176. ª∏§OÀ™∏™ ∞, ∫∞Δ∂ƒ°∞ƒ∏ ™∞, ∞™∏ª∞∫O¶OÀ§O™ μ, °∞∫∏ μ, ¶∞¶∞Ã∏™ΔOÀ ¢¡. μÈÛÊ·Ù›ÓË: ÌÈ· Ó¤· ÏÈÔ-ÔÚÌfiÓË; ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2008; 21: 41-4.
2177. Δƒπ∞¡Δ∞ºÀ§§OÀ °, Δƒπ∞¡Δ∞ºÀ§§OÀ ∞,
º∂§∂∫π¢∏™ ∞, ∫ÀƒO¶OÀ§O™ ∞, Δƒπ∞¡Δ∞ºÀ§§π¢∏™ ∞, ∫Oƒ∞´¢∏™ ∫. ™‡ÁÎÚÈÛË ÎÏÈÓÈÎÒÓ
Î·È ˘ÂÚ˯ÔÁÚ·ÊÈÎÒÓ Â˘ÚËÌ¿ÙˆÓ Û ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜ Ù‡Ô˘ 2 Ì ·ÈÌÔÚÚ·Á›· ÂÓÙfi˜ ÙÔ˘ ˘·ÏÔÂȉԇ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 45-54.
2178. ªπ∫OÀ¢∏ ∫. ∞˘ÙÔ¤ÏÂÁ¯Ô˜ ۷ί¿ÚÔ˘ ·›Ì·ÙÔ˜
ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2008; 21: 55-64.
2179. Ã∞Δ∑∏ΔO§πO™ ∞π, ª¶∞§Δ∞Δ∑∏ ª™, ™∞μμO¶OÀ§O™ ð. ∞ÓÙÈÌÂÙÒÈÛË Ù˘ ·ÚÙËÚȷ΋˜
˘¤ÚÙ·Û˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 65-82.
2180. ∫∞ƒ∞ª∏Δ™O™ ¢£, ∫O§πOÀ™∫∞™ ¢. ªË ·ÏÎÔÔÏÈ΋ ÏÈ҉˘ ÓfiÛÔ˜ ÙÔ˘ ‹·ÙÔ˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 101-10.
2181. ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞∫, ¶∞¶¶∞™ ™π.
ªË ·ÏÎÔÔÏÈ΋ ÏÈ҉˘ ‰È‹ıËÛË ‹·ÙÔ˜: ¢È¿ÁÓˆÛË,
·ıÔÁ¤ÓÂÈ·, ıÂÚ·›·, Û˘Û¯¤ÙÈÛË Ì ·Ú¿ÁÔÓÙ˜
ηډȷÁÁÂÈ·ÎÔ‡ ÎÈÓ‰‡ÓÔ˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2008; 21: 111-22.
2182. ¢π¢∞°°∂§O™ Δ, ∏§π∞¢∏™ º. ™˘Ó¯‹˜ ηٷÁÚ·Ê‹ ÙˆÓ ÂÈ¤‰ˆÓ ÁÏ˘Îfi˙˘ Ì ÙË ¯Ú‹ÛË ÂȉÈÎÒÓ ·ÈÛıËÙ‹ÚˆÓ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 123-29.
2183. ∫∞∑∞∫O™ ∫. ¶ÔÏ˘·Ú·ÁÔÓÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË
ηډȷÁÁÂÈ·ÎÔ‡ ÎÈÓ‰‡ÓÔ˘ Û ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 130-7.
166
2184. ªOÀ™§∂à Δ. º·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘
·¯˘Û·ÚΛ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 13851.
2185. °π∞°§∏™ °¢, ∫ø¡™Δ∞¡Δπ¡π¢OÀ ∂, ∞¶O™ΔO§π¢∏™ ∞. ¢È·Ù·Ú·¯¤˜ Ô‡ÚËÛ˘ Û ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜: ÓÂfiÙÂÚ· ‰Â‰Ô̤ӷ ÛÙË ‰È·ÁÓˆÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË Î·È ıÂÚ·›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008;
21: 152-65.
2186. ∫πΔ™πO™ ∫, ¢∏ªOÀ¢∏™ ™, ∫OÀ°π∞™ ¶, μO§πøΔ∏™ ∫, ™∞´§∂ƒ ¡. ∂ÌÊ˘ÛËÌ·ÙÈ΋ ˘ÂÏÔÓÂÊÚ›Ùȉ· Û Ó·ڋ Á˘Ó·›Î· Ì ‰È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË Î·È
ÚˆÙԉȷÁÓˆÛı¤ÓÙ· ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2008; 21: 166-70.
2187. μ∂μ∂™ ∞. ∏ ·ÏÏËÏÂ›‰Ú·ÛË ÌÂٷ͇ Ù˘ ÂÓ‰ÔıËÏȷ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ Î·È Ù˘ Ó¢ÚÔ¿ıÂÈ·˜ ÛÙËÓ ·Ó¿Ù˘ÍË ·ÁÁÂȷ΋˜ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·˜ ÛÙÔÓ ‰È·‚‹ÙË.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 186-9.
2188. ¢π¢∞°°∂§O™ Δƒ. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÙÔ˘ ΢ÎÏÔÊÔÚÈÎÔ‡.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2001; 14: 157-70.
2189. ∞¡Δø¡O¶OÀ§O™ ∞, ∞§∂•πOÀ ∑. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÔÈÓfiÓÂ˘Ì·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2001; 14: 171-7.
2190. ™∫∞ƒ∞°∫∞™ °, ƒ∂¶∞¡Δ∞ ∂, ∫OÀΔ™πOÀ ∫,
Δ∑∞Δ∑∞°OÀ °, £∂O¢O™πOÀ ∂, ¶∞¶∞∑O°§OÀ ¡. OÌÔ΢ÛÙÂ˚ÓË (O∫) Ï¿ÛÌ·ÙÔ˜ Î·È ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ· (¢¡º). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2001; 14: 178-82.
2191. ™OÀ§∏™ ∫, ∫Oƒ∫∞∫∞ ∂, ™∞ç∞ ∑, °π∞∫OOÀª¶∫Oμ∞ ª, ¶∞À§π¢∏™ °. ¢È·ÙÚÔÊÈΤ˜
Û˘Ó‹ıÂȘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Î·È Û˘ÌÌfiÚʈۋ
ÙÔ˘˜ Ì ÙȘ Ô‰ËÁ›Â˜ ‰È·ÙÚÔÊ‹˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2001; 14: 188-92.
2192. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∫OÀ§∞§∏ ∂, ™∫Oƒ¢∞™
∞, ª∂Δ∞§§π¢∏™ ™, ∞ª¶∂¡Δπ¡π ƒ, ¶∂ΔƒOÀ ∑,
¢π∞ª∞¡ΔO¶OÀ§OÀ ∞π, Δ∞Δ∞ƒπ¢∏™ °,
Δƒ∞´∞¡π¢∏™ ¶. ∏ ÂͤÏÈÍË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ ÌÂÙ¿ ÙËÓ ÂÁ¯Â›ÚËÛË Î·Ù·ÚÚ¿ÎÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2001; 14: 197-200.
2193. ª∞¡∂™ Ã, ∫∞Δ™∞ƒO™ £, ¶∞°∫∞§O™ ∂,(Û˘ÓÙÔÓÈÛÙ¤˜), ∞ƒμ∞¡πΔ∞∫∏™ ∂, μ∂μ∂™ ∞, ∫∞ƒ∞∫∞Δ™∞¡∏™ ∫.°, ∫∞ƒ∞ªO™ÃO™ ∫, ªÀ°¢∞§∏™ ∏¡, ¶∞¶∞∑O°§OÀ ∫O, Δ™πΔOÀƒπ¢∏™
π,(ÂÈÛËÁËÙ¤˜). ¢È·‚ËÙÈο ¤ÏÎË ÛÙ· οو ¿ÎÚ·
–∞ÎÚˆÙËÚÈ·ÛÌÔ›. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2001; 14:
201-22.
2194. Δƒπ∞¡Δ∞ºÀ§§OÀ °, Ã∞ƒ∞§∞ª¶π¢∏™ Ã,
¢OÀ™OÀ μ, ªÀ§ø¡∞™ °, ªO§∂ ∂, ∫O∫∫ø¡π¢∏™ ¶, Δƒ∞´∞¡π¢∏™ ¶. ∂ÈÏÔΤ˜ ÛÙËÓ ÂÁ¯Â›ÚËÛË Î·Ù·ÚÚ¿ÎÙË Ì ÙÔÔı¤ÙËÛË ÂÓ‰ÔÊ·ÎÔ‡ ·ÚÔ˘Û›· ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. OÊı·ÏÌÔÏÔÁ›· 1996; 8: 195-99.
2195. ∫∞ƒ∞ª∏Δ™O™ ¢. OÈ ÂȉڿÛÂȘ ÙÔ˘ ÔÈÓÔÓ‡̷ÙÔ˜ ÛÙÔÓ ÌÂÙ·‚ÔÏÈÛÌfi Ê˘ÛÈÔÏÔÁÈÎÒÓ Î·È ‰È·‚ËÙÈÎÒÓ
·ÙfïÓ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›·
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2000:
104-11.
2196. ATHYROS VG, MIKHAILIDIS DP, DIDANGELOS TP, GIOULEME OI, LIBEROPOULOS
EN, KARAGIANNIS A, KAKAFIKA AI, TZIOMALOS K, BURROUGHS AK, ELISAF MS. Effect of
multifactorial treatment on non- alcoholic fatty liver
disease in metabolic syndrome: A randomized study.
Curr Med Res Opin 2006; 22: 873-83.
2197. ATHYROS VG, PAPAGEORGIOU AA, SYMEONIDIS AN, DIDANGELOS TP, PEHLIVANIDIS AN, BOULOUKOS VI, MIKHAILIDIS DP,
GREACE STUDY COLLABORATIVE GROUP.
Early benefit from structured care with atorvastatin in
patients with coronary heart disease and diabetes mellitus: A subgroup analysis of die GREEK Atorvastatin
and Coronary-heart-disease Evaluation (GREACE)
Study. Angiology 2003; 54: 679-90.
2198. PAPAZAFIROPOULOU A, TENTOLOURIS N,
MOYSSAKIS I, PERREA D, KATSILAMBROS N.
The potential Effect of Some Newer Risk Factors for
Atherosclerosis on Aortic Dispensability in Subjects
with and without Type 2 Diabetes Mellitus. Diabetes
Care 2006; 29: 1926-8.
2199. DIAKOYMOPOULOU E, TENTOLOURIS N,
KIRLAKI E, PERREA D, KITSOU E, PSALLAS M,
DOULGERAKIS D, KATSILAMBROS N. Plasma
lomocysteine levels in patients with type 2 diabetes in
a Mediterranean population: Relation with nutritional and other factors. Nutr Metab Cardiovasc Dis 2005;
15: 109-17.
2200. BADENHOOP K, KAHLES H, SEIDL C, KORDONOURI O, LOPEZ ER, WALTER M, ROSINGER S, ZIEGLER A, BÖHM BO, DIABETES GENETICS CONSORTIUM. MHC-environment interactions leading to type 1 diabetes: Feasibility of an
analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth. Diabetes Obes
Metab 2009; 11 (Suppl 1): 88-91.
2201. SAMPANIS C, ZAMBOULIS C. Arterial hypertension in diabetes mellitus: From theory to clinical practice. Hippokratia 2008; 12: 74-80.
2202. KAHLES H, KORDONOURI O, RAMOS LOPEZ
E, WALTER M, ROSINGER S, BOEHM BO, BADENHOOP K, SEIDL C, ZIEGLER A, DIABETES
GENETICS CONSORTIUM. Mating in parents of
type 1 diabetes families as a function of the HLA DRDQ haplotype. Diabetes Obes Metab 2009; 11 (Suppl
1): 84-7.
2203. DANNE T, LANGE K, KORDONOURI O. Realtime glucose sensors in children and adolescents with
type-1 diabetes. Horm Res 2008; 70: 193-202.
2204. BAKRIS GL, FONSECA V, KATHOLI RE,
MCGILL JB, MESSERLI FH, PHILLIPS RA,
RASKIN P, WRIGHT JT , OAKES R, LUKAS MA,
ANDERSON KM, BELL DS; GEMINI INVESTIGATORS. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial. JAMA
2004; 292: 2227-36.
2205. BAKRIS GL, COPLEY JB, VICKNAIR N, SADLER R, LEURGANS S. Calcium channel blockers
versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int
1996; 50: 1641-50.
2206. BAKRIS GL, WEIR MR, DE QUATTRO V,
MCMAHON FG: Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic
nephropathy. Kidney Int 1998; 54: 1283-9.
2207. BAKRIS G. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.
Ann Intern Med 1990; 112: 707-8.
2208. Δ™∞∫πƒπ¢OÀ ∂, Ã∞Δ∑∏ΔO§πO™ ∞, ∞ƒ°ÀƒπOÀ ∫, ™∞μμO¶OÀ§O™ Ã. ¶ÚfiÏË„Ë Î·È ·ÓÙÈÌÂÙÒÈÛË ÙˆÓ ·Ú·ÁfiÓÙˆÓ ÎÈÓ‰‡ÓÔ˘ Ù˘ ‰È·‚ËÙÈ΋˜
ÓÂÊÚÔ¿ıÂÈ·˜: ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2007; 19: 12134.
2209. DIDANGELOS TR, ARSOS GA, KARAMITSOS
DT, ATHYROS VG, GEORGA SD, KARATZAS
ND. Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. J Diabetes Complications 2006;
20: 1-7.
2210. BAKRIS GL, GAXIOLA E, MESSERLI FH,
MANCIA G, ERDINE S, COOPER-DEHOFF R,
PEPINE CJ. FOR THE INVEST INVESTIGATORS. Clinical outcomes in the diabetes cohort of
the International Verapamil SR-Trandolapril study.
Hypertension 2004; 44: 637-42
2211. BAKRIS GL, WILLIAMS M, DWORKIN L, ELLIOTT WJ, EPSTEIN M, TOTO R, TUTTLE K,
DOUGLAS J, HSUEH W, SOWERS J. Preserving
renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000; 36:
646-61.
2212. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™‡ÁÎÚÈÛË ·ÓÙÏÈÒÓ Î·È ÔÏÏ·ÏÒÓ ÂÓ¤ÛÂˆÓ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË 2002. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002; 141-8.
2213. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™˘ÓÙËÚËÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË
·¯˘Û·ÚΛ·˜. ™ÙÔ: ¡ÔÛÔÁfiÓÔ˜ ·¯˘Û·ÚΛ·. ªÂÙÂÎ·È‰Â˘ÙÈ΋ ∏ÌÂÚ›‰· °ÂÓÈÎÔ‡ ¡ÔÛÔÎÔÌ›Ԣ £ÂÛÛ·ÏÔӛ΢ «°. °ÂÓÓËÌ·Ù¿˜». £ÂÛÛ·ÏÔÓ›ÎË, 2006: 12735.
2214. ∞§∂•π∞¢OÀ ∂, °ƒ∂∫∞™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2 Î·È ·Ó·ÈÌ›·: ¶ÚÔÁÓˆÛÙÈÎÔ› ·Ú¿ÁÔÓÙ˜
Î·È ÔÈfiÙËÙ· ˙ˆ‹˜. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 2008; 74: 160-6.
167
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2215. BARTSOCAS CS. From adolescence to adulthood:
The transition from child to adult care. Diabetes
Voice 2007; 52: 15-7.
2216. BARTSOCAS CS, GERASIMIDOU-VASEOU A.
Genetics of Type 1 Diabetes Mellitus. Pediatr Endocrinol Rev 2006; 3 (Suppl): 508-13.
2217. BARTSOCAS CS, LESLIE RDG. The Genetics of
Diabetes Mellitus. Am J Med Genet 2002; 115: 1-3.
2218. BARTSOCAS CS, PASCHOU P, BOZAS E, DOKOPOULOU M, GIANNAKOPOULOU C, MAMOULAKIS D, GERASIMIDOU-VAZEOU A.
HLA DQB1 genotype variation between Cretans and
Athenians with type 1 diabetes mellitus. In: Mayo O,
Leach C. Fifty Years of Human Genetics: A Festschrift and Liber Amicorum to Celebrate the Life and
Work of George Robert Fraser. Kent Town, S.Austr.:
Wakefield Press, 2007: 359-63.
2219. ILONEN J, SJOROOS M, KNIP M, VEJOLA R,
SIMELL O, AKERBLOM H, PASCHOU P, BOZAS
E, HARAVANI B, MALAMITSI-PUCHNER A,
THYMELLI J, VAZEOU A, BARTSOCAS CS. Estimation of Genetic Risk for Type 1 Diabetes. Am J
Med Genet 2002; 115: 30-6.
2220. GUTHRIE DW, BARTSOCAS CS, JAROSZCHOBOT P, KONSTANTINOVA M. Psychosocial
issues for children and adolescents with diabetes:
Overview and recommendations. Diabetes Spectrum
2003; 16: 7-12.
2221. HERMANN R, BARTSOCAS CS, SOLTESZ G,
VAZEOU A, PASCHOU P, BOZAS E, MALAMITSI-PUCHNER A, SIMELL O, KNIP M, ILONEN J. Genetic screening for individuals at high risk
for type 1 diabetes in the general population using
HLA class II alerts as disease markers: A comparison
between three European populations with variable
rates of disease incidence. Diabetes Metab Res Rev
2004; 20: 322-29.
2222. SYMEONIDIS G, PAPANAS N, GIANNAKIS I,
MAVRIDIS G, LAKASAS G, KYRIAKIDIS G,
ARTOPOULOS I. Gravity of aortic arch calcification
as evaluated in adult Greek patients. Int Angiol 2002;
3: 233-6.
2223. SYMEONIDIS G, PAPANAS N, MAVRIDIS G,
MALTEZOS E. Evidence that patients at diagnosis
of type 2 Diabetes Mellitus in Nothern Greece are increasingly younger and more obese during the last
years. Acta Diabetol 2003; 40: 1-2.
2224. PAPANAS N, SYMEONIDIS G, MALTEZOS E,
MAVRIDIS G, KARAVAGELI E, VOSNAKIDIS
TH, LAKASAS G. Mean platelet volume in patients
with type 2 diabetes mellitus. Platelets 2004; 15: 4758.
2225. PAPANAS N, SYMEONIDIS G, MALTEZOS E,
GIANNAKIS I, MAVRIDIS G, LAKASAS G,
ARTOPOULOS I. Evaluation of aortic arch calcification in type 2 diabetic patients. Vasa 2005; 34: 133-17.
168
2226. PAPANAS N, MAVRIDIS G, KARAVAGELI E,
SYMEONIDIS G, MALTEZOS E. Peripheral neuropathy is associated with increased mean platelet
volume in type 2 diabetic patients. Platelets 2005; 16:
498-9.
2227. PAPANAS N, SYMEONIDIS G, MAVRIDIS G,
PAPAZOGLOU D, GIANNAKIS I, PAPATHEODOROU K, PASTORE F, LAKASAS G, MALTEZOS E. Severity of liver echogenicity is correlated to
serum C-peptide levels in type 2 diabetic patients. Acta Clin Belg 2006; 61: 5-9.
2228. MAVRIDIS G, SOULIOU E, DIZA E, SYMEONIDIS G, PASTORE G, VASSILIOU AM, KARAMITSOS D. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2008; 18: 471-6.
2229. ª¶∞§∞¶∞¡π¢OÀ ∂, Ã∞Δ∑∏ΔO§πO™ ∞, ª¶π™Ãπ¡πøΔ∏™ π, ∞™™∞¡Δ∏™ μ, ∫∞ƒ∞ª∏Δ™O™ ¢.
∏ OÚıÔ·È‰È΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. OÚıÔ·È‰È΋ 2006; 19: 47-54.
2230. •∞¡£∏™ ∞, Ã∞Δ∑∏ΔO§πO™ ∞, ∫O§π∞∫O™ °.
∏ ‚Ï·ÙÈ΋ Â›‰Ú·ÛË ÙˆÓ ÙÂÏÈÎÒÓ ÚÔ˚fiÓÙˆÓ ÚÔ¯ˆÚË̤Ó˘ ÁÏ˘ÎÔ˙˘Ï›ˆÛ˘ ÙˆÓ ÙÚÔÊÒÓ ÛÙË ‰È·‚ËÙÈ΋
·ÁÁÂÈÔ¿ıÂÈ· Î·È Ë ÚfiÏË„‹ Ù˘. ∫·Ú‰È¿ & ∞ÁÁ›·
2007; 12: 34-42.
2231. Δ™∞∫πƒπ¢OÀ ∂, Ã∞Δ∑∏ΔO§πO™ ∞, ∞ƒ°ÀƒπOÀ ∫, ™∞μμO¶OÀ§O™ Ã. ¶ÚfiÏË„Ë Î·È ·ÓÙÈÌÂÙÒÈÛË ÙˆÓ ·Ú·ÁfiÓÙˆÓ ÎÈÓ‰‡ÓÔ˘ Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ¿ıÂÈ·˜. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2007; 19: 121-34.
2232. MOUSLECH J, IACOVIDES A, YOVOS J,
FOUNTOULAKIS N, KAZAKOS K, KARAGIANNI M, VLACHOGIANNIS A, KAPRINIS G, IERODIAKONOU CH. Phychiatric Morbidity and Metabolic Control in Diabetic Patients. German Journal of
Psychiatry. 2000; 3: 1-13.
2233. HATZITOLIOS A, DIDANGELOS T, ZANDIDIS
A, TZIOMALOS K, KARAMITSOS D. Diabetes
mellitus and cerebrovascular disease: Which are the
actual data? J Diabetes Complications 2008 [ahead of
print].
2234. ILIADIS F, ALEVIZOS M, KADOGLOU N, HATZITOLIOS A, KARAMOUZIS M, KARAMITSOS D. Metabolic effects of rosiglitazone and metformin in patients with recently diagnosed type 2 diabetes. In Vivo 2007; 21: 1107-14.
2235. SAVOPOULOS C, HATZITOLIOS A, PANAGOPOULOU P, KOSMIDOU M, TSIROGOGIANNI
E, KONSTANTINOU V. Hypothyroidism in PraderWilli syndrome: A case report and review of the literarure. J Endocrinol Invest 2007; 30: 804-5.
2236. KRASSAS G, TZOTZAS TH, PAPAZISIS K, PAZAITOU-PANAYIOTOU K, BOBORIDIS K. The
efficacy of somatostatin analogues in the treatment of
diabetic retinopathy and thyroid eye disease. Clin
Ophthalmol 2007; 1: 209-15.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2237. SARAFIDIS PA, LASARIDIS AN, NILSSON PM,
MOUSLECH TF, HITOGLOU-MAKEDOU AD,
STAFYLAS PC, KAZAKOS KA, YOVOS JG,
TOURKANTONIS AA. The effect of rosiglitazone
on novel atherosclerotic risk factors in patients with
type 2 diabetes mellitus and hypertension. An open-label observational study. Metabolism 2005; 54:1236-42.
2238. VEVES A, FREEMAN R. Diagnosing Endothelial
Cell Dysfunction. In: Aird WC. Endothelial Biomedicine. Cambridge: Cambridge University Press, 2007:
1659-67.
2239. STEED DL, ATTINGER C, COLAIZZI T,
CROSSLAND M, FRANZ M, HARKLESS L,
JOHNSON A, MOOSA H, ROBSON M, SERENA
T, SHEEHAN P, VEVES A, WIERSMA-BRYANT
L. Guidelines for the treatment of diabetic ulcers.
Wound Repair Regen 2006; 14: 680-92.
2240. STEED DL, ATTINGER C, BREM H, COLAIZZI
T, CROSSLAND M, FRANZ M, HARKLESS L,
JOHNSON A, MOOSA H, ROBSON M, SERENA
T, SHEEHAN P, VEVES A, WIERSMA-BRYANT
L. Guidelines for the treatment of diabetic ulcers.
Wound Repair Regen 2008; 16: 169-74.
2241. JOHNSTONE MT, VEVES A. Diabetes and Cardiovascular Disease. 2nd ed. Totowa, N.J.: Humana
Press, 2005.
2242. VEVES A, GIURINI JM, LOGERFO FW. The Diabetic Foot: Medical and Surgical Management. 2nd
ed. Totowa, N.J.: Humana Press, 2006.
2243. VEVES A, MALIK RA. The Clinical Management
of Diabetic Neuropathy. 2nd ed. Totowa, N.J.: Humana Press, 2007.
2244. REGENSTEINER JC, REUSCH JEB, STEWART
K, VEVES A. Diabetes and Exercise. Totowa, N.J.:
Humana Press, 2009.
2245. VEVES A, FALANGA B. Diabetic Foot Ulcers:
Prevention and Treatment. Wounds 2000; 12 (Suppl
B): 102 pages.
2246. VEVES A, BOULTON AJM. Treatment of diabetic neuropathy. In: Sharma AK, Galadari I, Abdulrazzaq Y, Behara M, Mehra NK, Manchanda SK. Diabetes Mellitus and its complications: An update. New
Delhi: Vedams Books International, 1993: (pages ?).
2247. VEVES A, BOULTON AJM. Tolrestat. In: Dollery
CT. Therapeutic drugs. Supplement 1. Edinburgh:
Churchill Livingstone, 1992: 206-10.
2248. BOULTON AJM, VEVES A. Young MJ. Etiopathogenesis and management of abnormal foot pressures. In: Levin ME, O’Neal LW, Bowker JH. The Diabetic Foot. 5th ed. St. Louis; London: Mosby Year
Book, 1993: 233-46.
2249. VEVES A, BOULTON AJM. Diabetic neuropathy:
The diabetologist’s view. In: Horrobin D. Treatment
of Diabetic Neuropathy: A New Approach. Edinburgh: Churchill Livingstone, 1992; 1-10.
2250. MALIK RA, TESFAYE S, VEVES A, SHARMA
AK, WARD JK, BOULTON AJM. The progression
of microangiopathy with neuropathic severity. In:
Hotta N, Greene DA, Sima AAF, Boulton AJM. Diabetic Neuropathy: New Concepts and Insights. Amsterdam: Excepta Medica, Elsevier, 1996; 131-5.
2251. VEVES A. Diagnosis of diabetic neuropathy. In:
Veves A. The Clinical Management of Diabetic
Neuropathy. Totowa, N.J.: Humana Press, 1998; 6175.
2252. VEVES A. Aldose reductase inhibitors. In: Veves A.
The Clinical Management of Diabetic Neuropathy.
Totowa, N.J.: Humana Press, 1998; 121-32.
2253. CABALLERO AE, LIM SC, HORTON ES, VEVES A. Vascular abnormalities in the prediabetic
stage. In: Johnstone MT, Veves A. Diabetes and Cardiovascular Disease. Totowa, N.J.: Humana Press,
2001; 65-80.
2254. HAMDY O, ABOU-ELENIN K, VEVES A. Microcirculation of the diabetic foot. In: Johnstone MT,
Veves A. Diabetes and Cardiovascular Disease. Totowa, N.J.: Humana Press, 2001; 431-46.
2255. VEVES A. The Clinical Management of Diabetic
Neuropathy. Totowa, N.J.: Humana Press, 1998.
2256. JOHNSTONE MT, VEVES A Diabetes and Cardiovascular Disease. Totowa, N.J.: Humana Press,
2001.
2257. VEVES A, GIURINI JM, LOGERFO FW. The Diabetic Foot: Medical and Surgical Management. Totowa, N.J.: Humana Press, 2002.
2258. MASSON EA, VEVES A, FERNANDO DJS,
BOULTON AJM. Current perception thresholds: A
new quick and reproducible method of assessing peripheral nerve function in diabetes mellitus. Diabetologia 1989; 32: 724-8.
2259. MASSON EA, HAY EM, STOCKLEY I, VEVES
A, BETTS R, BOULTON AJM. Abnormal foot pressures alone may not cause ulceration. Diabet Med
1989; 6: 426-8.
2260. VEVES A, MASSON EA, FERNANDO DJS,
BOULTON AJM. Studies of experimental hosiery in
diabetic patients with high foot pressures. Diabet Med
1990; 7: 324-6.
2261. FERNANDO DJS, MASSON EA, VEVES A,
BOULTON AJM. Limited Joint Mobility: Relationship to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991; 14: 8-11.
2262. VEVES A, FERNANDO DJS, WALEWSKI P,
BOULTON AJM. A study of plantar pressures in a
diabetic clinic population. The Foot 1991; 1: 89-92.
2263. FERNANDO DJS, HUTCHISON A, VEVES A,
GOKAL R, BOULTON AJM. Risk factors for nonischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991; 8: 223-5.
2264. THOMSON FJ, VEVES A, ASHE H, KNOWLES
169
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
EA, GEM J, WALKER MG, HIRST P, BOULTON
AJM. A team approach to diabetic foot care - the
Manchester experience. The Foot 1991; 1: 75-82.
2265. KUMAR S, FERNANDO DJS, VEVES A, KNOWLES EA, YOUNG MJ, BOULTON AJM. SemmesWeinstein monofilaments: A simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin
Pract 1991; 13: 63-7.
2266. DENT MT, VEVES A, TEBBS SE, GONZALEZ
AM, MALIK RA, BOULTON AJM, WARD JD,
WILSON RM. Neutrophil aldose reductase activity as
a potential marker for neuropathy and cataract in diabetes. Diabet Med 1991; 8: 911-6.
2267. VEVES A, HAY EM, BOULTON AJM. The use of
specially padded hosiery in the painful rheumatoid
foot. The Foot 1992; 1: 175-7.
2268. VEVES A, VAN ROSS ERE, BOULTON AJM.
Foot pressure measurements in diabetic and non-diabetic amputees. Diabetes Care 1992; 15: 905-7.
2269. VEVES A, BOULTON AJM. Measuring subjective
symptoms. Letter to the editor. Diabetes Care 1992;
15: 1434.
2270. YOUNG MJ, VEVES A, WALKER MG, BOULTON AJM. Correlations between nerve function and
tissue oxygenation in diabetic patients: Further clues
to the aetiology of diabetic neuropathy. Diabetologia
1990; 35: 1146-50.
2271. YOUNG MJ, MURRAY HJ, VEVES A, BOULTON AJM. A comparison of the Musgrave Footprint
and Optical Pedobarograph systems for measuring
dynamic foot pressures in diabetic patients. The Foot
1993; 3: 62-4.
2272. MALIK RA, TESFAYE S, THOMPSON SD,
VEVES A, SHARMA AK, BOULTON AJM,
WARD JD. Endoneurial localization of microvascular damage in human diabetic neuropathy. Diabetologia 1993; 36: 454-9.
2273. MURRAY HJ, VEVES A, YOUNG MJ, RICHIE
DM, BOULTON AJM. The role of experimental
socks in the care of the high risk diabetic foot: a multicentre patient evaluation study. Diabetes Care 1993;
16: 1190-2.
2274. YOUNG MJ, BREDDY JL, VEVES A, BOULTON AJM. The prediction on diabetic foot ulceration
using vibration thresholds: A prospective study. Diabetes Care 1994; 17: 557-60.
2275. VEVES A, WEBSTER L, CHEN TF, PAYNE S,
BOULTON AJM. Aetiopathogenesis and management of impotence in diabetic males: Four years experience from a combined clinic. Diabet Med 1995;
12: 77-82.
2276. SARNOW MR, VEVES A, GIURINI JM, ROSENBLUM BI, CHRZAN JS, HABERSHAW GM. Inshoe foot pressure measurements in diabetic patients
170
with at risk feet and healthy subjects. Diabetes Care
1994; 17: 1002-6.
2277. MALIK RA, TESFAYE S, THOMSON SD, VEVES A, HUNTER A, SHARMA AK, WARD JD,
BOULTON AJM. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic
neuropathy. Microvasc Res 1994; 48: 236-45.
2278. VEVES A, SARNOW MR, GIURINI JM, ROSENBLUM BI, LYONS TE, CHRZAN JS, HABERSHAW GM. Differences in joint mobility and foot
pressures between black and white diabetic patients.
Diabetic Medicine 1995; 12: 585-9.
2279. DONAGHUE VM, GIURINI JM, ROSENBLUM
BI, WEISSMAN PN, VEVES A. Variability in function measurements of three sensory foot nerves in
neuropathic diabetic patients. Diabetes Res Clin
Pract 1995; 29: 37-42.
2280. YOUNG MJ, VEVES A, SMITH JV, WALKER
MG, BOULTON AJM. Restoring lower limb blood
flow improves conduction velocity in diabetic patients.
Diabetologia 1995; 38: 1051-4.
2281. VEVES A, DONAGHUE VM, SARNOW MR,
GIURINI JM, CAMPBELL DR, LOGERFO FW.
The Impact of Reversal of Hypoxia by Revascularization In the Peripheral Nerve Function of Diabetic Patients. Diabetologia 1996; 39: 344-8.
2282. DONAGHUE VM, SARNOW MR, GIURINI JM,
CHRZAN JS, HABERSHAW GM, VEVES A.
Longitudinal In-Shoe Foot Pressure Relief Achieved
by Specially Designed Footwear in High Risk Diabetic Patients. Diabetes Res Clin Pract 1996; 31:
109-14.
2283. AKBARI CM, GIBBONS GW, HABERSHAW
GM, LOGERFO FW, VEVES A. The effect of Arterial Reconstruction on the Natural History of Diabetic Neuropathy. Arch Surg 1997; 132: 148-52.
2284. YOUNG MJ, BENNETT JL, LIDERTH SA, VEVES A, BOULTON AJM, DOUGLAS JT. Rheological and microvascular parameters in diabetic peripheral neuropathy. Clin Sci 1996; 90: 183-7.
2285. FRYKBERG RG, PIAGGESI A, DONAGHUE
VM, SCHIPANI E, HABERSHAW GM, NAVALESI R, VEVES A. Outcome Variation of Foot Ulcer
Treatment in Two Different Centers. Diabetes Res
Clin Pract 1997; 35: 21-6.
2286. VEVES A, SAOUAF R, DONAGHUE VM, MULLOOLY CA, KISTLER JA, GIURINI JM, HORTON ES, FIELDING RA. Aerobic exercise capacity remains normal despite impaired endothelial function
in the micro- and macrocirculation of physically active
IDDM patients. Diabetes 1997; 46: 1846-52.
2287. DONAGHUE VM, CHRZAN JS, ROSENBLUM
BI, GIURINI JM, HABERSHAW GM, VEVES A.
A clinical evaluation of a collagen-alginate topical
wound dressing (FIBRACOL*Dressing) in the man-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
agement of diabetic foot ulcers. Adv Wound Care
1998; 11: 114-7.
2288. VEVES A, AKBARI CM, PRIMAVERA J, DONAGHUE VM, ZACHAROUDIS D, CHRZAN JS,
DEGIROLAMI U, LOGERFO FW, FREEMAN R.
Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes
1998; 47: 457-63.
2289. ARORA S, VEVES A, CABALLERO AE, SMAKOWSKI P, LOGERFO FW. Estrogen improves endothelial function. J Vasc Surg 1998; 27: 1141-7.
2290. SAOUAF R, ARORA S, SMAKOWSKI P, AE CABALLERO, VEVES A. Reactive hyperemic response
of the brachial artery to proximal and distal occlusion.
Acad Radiol 1998; 5: 556-60.
2291. ARORA S, SMAKOWSKI P, FRYKBERG RG,
FREEMAN R, LOGERFO FW, VEVES A. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes
Care 1998; 21: 1339-44.
2292. FRYKBERG RG, LAVERY LA, PHAM H, HARVEY C, HARKLESS L, VEVES A. The risk of ulceration in diabetic patients with high foot pressures and
neuropathy. Diabetes Care 1998; 21: 1714-19.
2293. AKBARI CM, SAOUAF R, BARNHILL DF,
NEWMAN PA, LOGERFO FW, VEVES A. Endothelium-Dependent Vasodilatation is Impaired in
Both Micro- and Macrocirculation During Acute
Hyperglycemia. J Vasc Surg 1998; 28: 687-94.
2294. CABALLERO AE, ARORA S, SAOUAF R, LIM
SC, SMAKOWSKI P, PARK JY, KING GL, LOGERFO FW, HORTON ES, VEVES A. Micro- and
macro-vascular reactivity is impaired in subjects at
risk for type 2 diabetes. Diabetes 1999; 48: 1863-7.
2295. PHAM HT, ROSENBLUM BI, LYONS TE,
GIURINI JM, CHRZAN JS, HABERSHAW GM,
VEVES A. Evaluation of Graftskin (Apligraf®), a
Human Skin Equivalent, for the Treatment of Diabetic Foot Ulcers in a Prospective, Randomized, Clinical Trial. Wounds 1999; 11: 79-86.
2296. LIM SC, CABALLERO AE, ARORA S, SMAKOWSKI P, BASHOFT E, BROWN G, LOGERFO
FW, HORTON ES, VEVES A. The effect of gender
and hormonal replacement therapy on the vascular
reactivity of healty individuals and individuals with
type 2 diabetes. J Clin Endocrinol Metab 1999; 84:
4159-64.
2297. LIM SC, CABALLERO AE, SMAKOWSKI P,
LOGERFO FW, HORTON ES, VEVES A. Soluble
Intercellular Adhesion Molecule (ICAM), Vascular
Cell Adhesion Molecule (VCAM) and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999; 22: 1865-70.
2298. PHAM HT, ARMSTRONG DG, HARVEY C,
HARKLESS LB, GIURINI JM, VEVES A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicentre trial. Diabetes Care 2000; 23: 606-11.
2299. MALIK RA, VEVES A, WALKER D, LYE RH,
SCHADY W, BOULTON AJM. Sural nerve fibre
pathology in diabetic patients with mild neuropathy:
Relationship to pain, quantitative sensory testing and
peripheral nerve electrophysiology. Acta Neuropathol
2001; 101: 367-74.
2300. RICH J, VEVES A. Forefoot and Rearfoot Plantar
Pressures in Diabetic Patients: Correlation to Foot
Ulceration. Wounds 2000; 12: 82-7.
2301. HAMDY O, ABOU-ELENIN A, LOGERFO FW,
HORTON FW, VEVES A. The contribution of nerve
axon reflex-related vasodilation to the total endothelium-dependent vasodilation in the skin of diabetic
patients with and without neuropathy. Diabetes Care
2001; 24: 344-9.
2302. VEVES A, FALANGA V, ARMSTRONG DG, SABOLINSKI ML, FOR THE APLIGRAF DIABETIC
FOOT ULCER STUDY. Graftskin, a human skin
equivalent is effective in treating diabetic foot ulcers
in a prospective, randomized, multicenter clinical trial. Diabetes Care 2001; 24: 290-5.
2303. ARORA S, POMPOSELLI F, LOGERFO FW,
VEVES A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not
completely after successful lower extremity revascularization. J Vasc Surg 2002; 35: 501-5.
2304. ABOU-ELENIN A, XYDAKIS A, HAMDY O,
ECONOMIDES PA, HORTON ES, VEVES A. The
effect of aspirin and various iontophoresis solution vehicles in skin microvascular reactivity. Microvasc Res
2002; 63: 91-5.
2305. EPSTEIN FH, VEVES A, PRASAD P. Effect of
diabetes mellitus on renal medullary oxygenation
during water diuresis. Diabetes Care 2002; 25: 575-8.
2306. VEVES A, SHEEHAN P, PHAM TH. A comparison of a new topical treatment, Promogran® versus
standart treatment in the management of diabetic
foot ulcers. Arch Surg 2002; 137: 822-7.
2307. CASELLI A, PHAM HT, GIURINI JM, ARMSTRONG DG, VEVES A. The forefoot / rearfoot
plantar pressure ratio is increased in severe diabetic
neuropathy and can predict foot ulceration. Diabetes
Care 2002; 25: 1066-71.
2308. PHAM HT, EXELBERT L, SEGAL-OWENS AC,
VEVES A. A Prospective Randomized Controlled
Double-Blind Study of a Moisturizer Containing 10%
Urea and 4% Lactic Acid Versus the Vehicle for
Xerosis of the Feet in Subjects with Diabetes. Ostomy
Wound Manage 2002; 48: 30-6.
2309. CASELLI A, SINGH BEDI D, O’ CONNOR C,
171
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
SHAH C, VEVES A. Assessment of Laser Perfusion
Imager’s in vivo Reliability: Can it be used for a
prospective analysis? J Laser Appl 2002; 14: 198-202.
2310. SZABO C, ZANCHI A, KOMJATI K, PACHER P,
KROLEWSKI AS, QUIST WC, LOGERFO FW,
HORTON ES, VEVES A. Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing
type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002; 106: 2680-6.
2311. CABALLERO AE, SAOUAF R, LIM SC, HAMDY O, ABOU-ELENIN K, O’CONNOR K, LOGERFO FW, HORTON ES, VEVES A The effects
of troglitazone, an insulin sensitizing agent, on the endothelial function in early and late type 2 diabetes. A
placebo-controlled, randomized, clinical trial. Metabolism 2003; 52: 173-80.
2312. CASELLI A, RICH J, HANANE T, UCCIOLI L,
VEVES A. Role of c-nociceptive fibers in the impairment of nerve axon reflex-related vasodilation in diabetes. Neurology 2003; 60: 297-300.
2313. CASELLI A, HANANE T, BRADY J, CARTER S,
KHAODHIAR L, VEVES A. Methyl Nicotinate- Induced Skin Vasodilation In Diabetic Neuropathy. J
Diabetes Complications 2003; 17: 205-10.
2314. SHEEHAN P, JONES P, CASELLI A, GIURINI
JM, VEVES A. Percent in wound area of diabetic
foot ulcers over a 4-week period is a robust predictor
of complete healing in a 12-week prospective trial. Diabetes Care 2003; 26: 1879-82.
2315. HAMDY O, LEDBURY S, MULLLOOLY C, JAREMA C, PORTER D, OVALLE K, MOUSSA A,
CESELLI A, CABALLERO AE, ECONOMIDES
PA, VEVES A, HORTON ES. Lifestyle modification
improves endothelial function in obese subjects with
the insulin resistance syndrome. Diabetes Care 2003;
26: 2119-25.
2316. VARO N, VICENT D, LIBBY P, NUZZO R, CALLE-PASCUAL AL, BERNAL MR, FERNADEZCRUZ A, VEVES A, JAROLIM P, VARO JJ,
GOLDFINE A, HORTON ES, SCHONBECK U. Elevated plasma levels of the atherogenic mediator
sCD40L in diabetic patients: A novel target of thizolidinediones? Circulation 2003; 107: 2664-9.
2317. CASELLI A, UCCIOLI L, KHAODHIAR L, VEVES A. Local anesthesia reduces the maximal skin vasodilation during iontophoresis of sodium nitroprusside and heating. Microcirculation Research 2003; 66:
134-9.
2318. ECONOMIDES PA, CASELLI A, ZUO CS,
KHAODHIAR L, SPARKS C, KATSILAMBROS
N, HORTON ES, VEVES A. Kidney oxygenation
during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 2004; 53: 222-7.
2319. KHAODHIAR L, NIEMI JB, HARRY LD,
EARNEST R, LIMA C, VEVES A. Enhancing sen-
172
sation in diabetic neuropathic foot with mechanical
noise. Diabetes Care 2003; 26: 3280-3.
2320. ECONOMIDES PA, CASELLI A, TIANI E,
KHAODHIAR L, HORTON ES, VEVES A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. Diabetes. J Clin Endocrinol Metab 2004; 89: 740-7.
2321. SHETTY GK, ECONOMIDES PA, HORTON ES,
MANTZOROS CS, VEVES A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in
diabetic patients and subjects at risk for diabetes. Diabetes Care 2004; 27: 2450-7.
2322. ECONOMIDES PA, KHAODHIAR L, CASELLI
A, CABALLERO AE, KEENAN H, BURSELL S,
KING GL, JOHNSTONE MT, HORTON ES, VEVES A. The effect of vitamin E on the endothelial
function of the micro- and macro-circulation and the
left ventricular function of type 1 and 2 diabetic patients. Diabetes 2005; 54: 204-11.
2323. O’ NEILL MS, VEVES A, ZANOBETTI A, SARNAT JA, GOLD DR, ECONOMIDES PA, HORTON ES, SCHWARTZ J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function.
Circulation 2005; 111: 2913-20.
2324. GREENMAN RL, KHAODHIAR L, LIMA C,
DINH T, GIURINI JM, VEVES A. Foot Small Muscle Atrophy is Present Before the Detection of Clinical Neuropathy. Diabetes Care 2005; 28: 1425-30.
2325. BURAS J, REENSTRA WR, ORLOW D, HORTON ES, VEVES A. Changes in adiponectin levels
related to treatment with troglitazone do not affect
endothelial function in type 2 diabetes. Obes Res
2005; 13: 1167-74.
2326. PRIPLATA AA, PATRITTI BL, NIEMI JB, HUGHES R, GRAVELLE DC, LIPSTITZ LA, VEVES
A, STEIN J, BONATO P, COLLINS JJ. Vibrating insoles and enhanced balance control in patients with
diabetic neuropathy and patients with stroke. Annals
of Neurology, 2006; 59: 4-12.
2327. GREENMAN RL, PANASYUK S, WANG X,
LYONS TE, DINH T, LONGORIA L, GIURINI JM,
FREEMAN J, KHAODHIAR L, VEVES A. Early
changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 2005; 366: 1711-7.
2328. SHRIKHANDE G, SCALI S, LIMA C, HUBBARD M, DUDLEY K, GANDA O, FERRAN C,
VEVES A. Valsartan Improves Resting Skin Blood
Flow In Type 2 Diabetic Patients And Reduces PARP
Activation. J Vasc Surg 2006; 43: 760-70.
2329. CASELLI A, SPALLONE V, MARFIA GA, BATTISTA C, PACHATZ C, VEVES A, UCCIOLI L.
Validation Of The Nerve Axon Reflex For The
Assessment Of Small Nerve Fibers’ Dysfunction. J
Neurol Neurosurg Psychiatry 2006; 77: 927-32.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2330. LYONS TE, MILLER MS, SERENA T, SHEEHAN P, LAVERY L, KIRSNER RS, ARMSTRONG DG, REESE A, YANKEE EW, VEVES
A. Talactoferrin, a recombinant human lactoferrin
promotes healing of diabetic neuropathic ulcers: A
phase I/II clinical study. Am J Surg 2007; 193: 49-54.
2331. O’NEILL MS, VEVES A, SARNAT JA, ZANOBETTI A, GOLD DR, ECONOMIDES PA, HORTON ES, SCHWARTZ J. Air pollution and inflammation in Type 2 diabetes: A mechanism for susceptibility. Occup Environ Med 2007; 64: 373-9.
2232. KHAODHIAR L, DINH T, SCHOMACKER KT,
PANASYUK S, FREEMAN JE, LEW R, VO T,
PANASYUK AA, LIMA C, GIURINI JM, LYONS
TE, VEVES A. The Use of Medical Hyperspectral
Technology to Evaluate Microcirculatory Changes in
Diabetic Foot Ulcers and Predict Clinical Outcomes.
Diabetes Care 2007; 30: 903-10.
2333. DINH T, VEVES A. The Influence of Gender as a
Risk Factor in Diabetic Foot Ulcerations. Wounds
2008; 20: 127-31.
2334. YIM YEH S, DOUPIS J, RAHANGDALE S,
HORR S, MALHORTA A, VEVES A. Total serum
bilirubin does not affect vascular reactivity in patients
with diabetes. Vasc Med 2009; 14: 129-36.
2335. CLOUTIER R, HORR S, NIEMI JB, SCOFFONE
H, D’ANDREA S, LIMA C, HARRY JD, VEVES A.
Prolonged Mechanical Noise Restores Tactile Sense
in Diabetic Neuropathic Patients. Int J Low Extrem
Wounds. 2009; 8: 6-10.
2336. VITORATOS N, VALSAMAKIS G, MASTORAKOS G, BOUTSIADIS A, SALAKOS N, KOUSKOUNI E, CREATSAS G. Pre- and early post-partum adiponectin and interleukin-1beta levels in
women with and without gestational diabetes. Hormones (Athens) 2008; 7: 230-6.
2337. MELIDONIS A, TOURNIS S, KOURAVAS G,
BALTARETSOU E, HADANIS S, HAJISAVAS J,
TSATSOULIS A, FOUSSAS S. Comparison of coronary collated circulation in diabetic and non- diabetic
patients suffering from coronary artery disease. Clin
Cardiol 1999; 22: 465-71.
2338. MELIDONIS A, IRAKLIANOU S, TOURNIS S,
KONSATNTELLOU J, TSATSOULIS A, FOUSSAS S. Leptin levels are not related to risk factors for
coronary heart disease in patients with type 2 diabetes mellitus or normal controls: Trials in special
populations. Current Therapeutic Research 1999; 60:
502-10.
2339. MELIDONIS A, STEFANIDIS A, TOURNIS S,
MANOUSAKIS S, HANTANIS S, ZAIRIS M,
DADIOTIS L, FOUSSAS S. The role of strict metabolic control by insulin infusion on fibrinolytic profile
during an acute coronary event in diabetic patients.
Clin Cardiol 2000; 23: 160-5.
2340. KOMPOTI M, MARIOLIS A, ALEVIZOS A, KY-
RIAZIS I, PROTOPSALTIS I, DIMOU E, LENTZAS I, LEVISIANOU D, GOVA A, MELIDONIS
A. Elevated serum triglycerides in the strongest single
indicator for the presence of metabolic syndrome in
patients with type 2 diabetes. Cardiovasc Diabetol
2006; 4: 21-5.
2341. MELIDONIS A, KYRIAZIS I, GEORGOPALI A,
ZAIRIS M, LYRAS A, LAMPROPOULOS T, MATSAIDONIS D, FOUSSAS S. Prognostic value of the
carotid artery intima-media thickness for the presence
and severity of coronary artery disease in type 2 diabetic patients. Diabetes Care 2003; 26: 3189-90.
2342. VEVES A, BOULTON AJM. Commentary. Diabetes Spectrum 1992; 6: 336-7.
2343. VEVES A , BOULTON AJM. Editorial: An optimistic message for foot problems in diabetes. West J
Med 1993; 158: 78-9.
2344. VEVES A, BOULTON AJM. The optical pedobarograph. Clin Podiatr Med Surg 1993; 10: 463-70.
2345. VEVES A, BOULTON AJM. Diabetic foot: Diagnostic considerations. IDF Bulletin 1993; 38: 10-3.
2346. VEVES A, BOULTON AJM. The importance of
documenting diabetic neuropathy. Treating Diabetes
(Australian edition). 1992; 10: 3-8.
2347. YOUNG MJ, VEVES A, BOULTON AJM. The diabetic Foot. Diabetes Metab Rev 1993; 9: 109-27.
2348. VEVES A, BOULTON AJM. Comment. Clinical
Diabetes 1993; 11: 38-9.
2349. VEVES A, SARNOW MR. Diagnosis, classification
and treatment of diabetic peripheral neuropathy. Clin
Podiatr Med Surg 1995; 12: 19-30.
2350. VEVES A, DONAGHUE VM. Review of Neurometer CPT Quantitative Sensory Nerve Tester. J Clin
Neurophysiol 1995; 12: 197.
2351. DONAGHUE VM, VEVES A. Foot Pressure Measurements. Orthop Phys Ther Clin N Am 1997; 6: 116.
2352. FRYKBERG RG, VEVES A. Diabetic Foot Infections. Diabetes Metab Rev 1996; 12: 255-70.
2353. SIMEONE LR, VEVES A. Screening techniques to
identify the diabetic patient at risk of ulceration. J Am
Podiatr Med Assoc 1997; 87: 1-5.
2354. PHAM H, ECONOMIDES PA, VEVES A. The
role of endothelial function on the foot microcirculation and wound healing in diabetic patients. Clin Podiatr Med Surg 1998; 15: 85-94.
2355. PHAM H, RICH J, VEVES A. Wound Healing in
Diabetic Foot Ulceration. Wounds 2000; 12: 79-82.
2356. ECONOMIDES PA, VEVES A. Etiopathogenesis
of Foot Ulceration in Diabetes. Wounds 2000; 12
(Suppl B): 1B-6B.
2357. VEVES A, KING GL. Can VEGF reverse diabetic
neuropathy in human subjects? J Clin Invest 2001;
107: 1215-8.
173
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2358. RICH J, PHAM HT, VEVES A. Living Skin Equivalents- Changing Trend for Diabetic Foot Ulceration.
Lower Limb Wounds 2002; 1: 27-31.
2359. DINH D, PHAM HT, VEVES A. Emerging Treatments in Diabetic Wound Care. Wounds 2002; 14: 210.
2360. HILE C, VEVES A. Diabetic Neuropathy and Microcirculation. Curr Diab Rep 2003; 3: 446-51.
2361. DINH D, VEVES A. Microcirculation in the diabetic foot: An Update. Int J Low Extrem Wounds 2004;
3: 60-1.
2362. DINH T, VEVES A. Microcirculation of the Diabetic Foot. Curr Pharm Des 2005; 11: 2301-9.
2363. SKLJAREVSKI V, VEVES A. Impact of Diabetes
on vasculature-Focus on Nervous System. Curr Diabetes Rev 2005; 1: 245-53.
2364. DINH D, VEVES A. The efficacy of Apligraf in the
treatment of diabetic foot ulcers. Ann Plast Surg
2006; 117 (Suppl): 152S-7S.
2365. MALIK RA, VEVES A, TESFAYE S. Ameliorating
human diabetic neuropathy: Lessons from implanting
hematopoietic mononuclear cells. Exp Neurol 2006;
20: 1: 7-14.
2366. SCHRAMM J, DINH T, VEVES A. Microvascular
Changes in the Diabetic Foot. Int J Low Extrem
Wounds 2006; 5: 149-59.
2367. PRADHAN L, ANDERSEN ND, LOGERFO FW,
VEVES A. Molecular Targets for Promoting Wound
Healing in Diabetes. Recent Patents on Endocrine,
Metabolic and Immune Drug Discovery, 2007; 1: 1-13.
2368. YIM S, MALHOTRA A, VEVES A. Antioxidants
and CVD in diabetes: Where do we stand now? Curr
Diab Rep 2007; 7: 8-13.
2369. DINH TL, VEVES A. Treatment of Diabetic Ulcers. Dermatol Ther 2006; 19: 348-55.
2370. PRADHAN L, ANDERSEN ND, NABZDYK C,
LOGERFO FW, VEVES A. Wound Healing Abnormalities in Diabetes and New Therapeutic Interventions. U.S. Endocrine Disease, 2007: 69-72.
2371. VEVES A, MALIK RA, BACKONJA M. Painful
Diabetic Neuropathy: Epidemiology Natural History,
Early Diagnosis and Treatment Options. Pain Med
2008; 9: 660-74.
2372. SKLJAREVSKI V, VEVES A. Impact of diabetes
on vasculature: Focus on nervous system. Curr Diabetes Rev 2005; 1: 245-53.
2373. DOUPIS J, VEVES A. Treatment of Diabetic Ulcers. Wounds 2008; 20: 117-26.
2374. DINH T, VEVES A. Evidence-based Medicine and
the Management of the Chronic Wound: Is it
enough? Int J Low Extrem Wounds 2008; 7: 118-9.
2375. RAHANGDALE J, YIM YEH S, MALHOTRA A,
VEVES A. Therapeutic interventions and oxidative
stress in diabetes. Front Biosci 2009; 14: 192-209.
174
2376. DOUPIS J, VEVES A. DPP4 Inhibitors: a new approach in diabetes treatment. Adv Ther 2008; 1: 62743.
2377. ¶∞¶∞¢O¶OÀ§O™ ∞∞, Oπ∫O¡Oª∞∫∏™ ∂,
∫O¡ΔO¢∏ªO¶OÀ§O™ ¡, ºƒÀ¢∞™ ∞, ¡π∞∫∞™ ¢. ∂ÎÙ›ÌËÛË Ù˘ Û¯ÂÙÈ˙Ô̤Ó˘ Ì ÙËÓ ˘Á›· ÔÈfiÙËÙ·˜ ˙ˆ‹˜ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ù‡Ô˘ 2. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 2008; 25 (™˘ÌÏ 1): 1-9.
2378. IORDANIDOU M, TAVRIDOU A, VASILIADIS
MV, ARVANITIDIS KI, PETRIDIS J, CHRISTAKIDIS D, VARGEMEZIS V, BOUGIOUKAS G,
MANOLOPOULOS V. The -759C/T polymorphism
of the 5-HT2c receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenet
Genomics 2008; 18: 153-9.
2379. ∫Àƒπ∞∫∞∫∏ ¢, ª∞§Δ∂∑O™ ∂, μ∞º∂π∞¢OÀ
∂, ∫∞ƒ∞∫ÀƒπOÀ ª, ª∏§OÀ™∏™ ∞, Oπ∫O¡Oªπ¢∏™ §, Ãπ™Δ∞∫π¢∏™ ¢, °∫OΔ™∏™ ¡. πÍ҉˜
ÔÏÈÎÔ‡ ·›Ì·ÙÔ˜, ÏÈ›‰È· Î·È ÈÓˆ‰ÔÁfiÓÔ Ï¿ÛÌ·ÙÔ˜ ÛÂ
¿Û¯ÔÓÙ˜ ·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ·È‰Â›·
1996; 4: 39-50.
2380. ¶∞¶∞´ø∞∫∂πª ª, Ãπ™Δ∞∫π¢∏™ ¢, ª∞§Δ∂∑O™ ∂, °∫OΔ™∏™ ¡. πÓˆ‰ÔÁfiÓÔ Î·È πÍ҉˜ ÙÔ˘
Ï¿ÛÌ·ÙÔ˜ ÛÙÔ˘˜ ÌË Ú˘ıÌÈ˙fiÌÂÓÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜. π·ÙÚÈ΋ ·È‰Â›· 1994; 2: 24-9.
2381. MALTEZOS E, PAPAZOGLOU D, EXIARA T,
PAPAZOGLOU L, KATATHANASIS E, CHRISTAKIDIS D, KTENIDOU-KARTALI S. Tumour
necrosis factor-a levels in non-diabetic offspring of
patients with type 2 diabetes mellitus. J Int Med Res
2002; 30: 576-83.
2382. ∏ƒ∞∫§∂π∞¡OÀ ™Δ. ¶fiÙ Ú¤ÂÈ Ó· Ì·›ÓÂÈ Ô
‰È·‚ËÙÈÎfi˜ ÛÙÔ ÓÔÛÔÎÔÌ›Ô; ¢È·‚ËÙÔÏÔÁÈο ¡¤·
2003; 22: 21-4.
2383. ¶ƒøΔOæ∞§Δ∏™ °, ∫Oª∞¡Δ∑π∞ ∞, ∫∞ª∞ƒ∞ΔO™ ∞, ∫∞∫∞Δ™O™ π, ª∂§π¢ø¡∏™ ∞. ∂ÈÔÏ·ÛÌfi˜ ηÓÔÓÈ΋˜ ¯Ú‹Û˘ ·ÛÈÚ›Ó˘ Û ‰È·‚ËÙÈÎÔ‡˜
Ù‡Ô˘ 2 ÛÙËÓ ÚˆÙÔÁÂÓ‹ Î·È ‰Â˘ÙÂÚÔÁÂÓ‹ ÚfiÏË„Ë
ηډȷÁÁÂȷ΋˜ ÓfiÛÔ˘. π·ÙÚÈο ÃÚÔÓÈο 2004; 27:
218-21.
2384. ∏ƒ∞∫§∂π∞¡OÀ ™. ∏ ÀÂÚÔ˘Úȯ·ÈÌ›· Û·Ó ‰Â˘ÙÂÚÔ·ı‹˜ ‰˘ÛÏÈȉ·ÈÌ›·. ™ÙÔ: ∫ÔÏÔ‚fi˜ °, ∫fiÎÎÈÓÔ˜ ¢.
Δ· ÏÈ›‰È· ÛÙËÓ ÎÏÈÓÈ΋ Ú¿ÍË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2005; 179-86.
2385. ª∂§π¢ø¡∏™ ∞. ™ÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ∫˘ÚȷΛ‰Ë˜ ª. ∫·Ú‰ÈÔÏÔÁ›·.
2006: 31-7.
2386. ª∂§π¢ø¡∏™ ∞. ªÂÙ·ÁÂ˘Ì·ÙÈ΋ ˘ÂÚÁÏ˘Î·ÈÌ›·
Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ∞ıËÚÔÛÎÏ‹ÚˆÛË
2006; 9: 2-6.
2387. ª∂§π¢ø¡∏™ ∞. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË: ∂›Ó·È
ÌÈ· Ó¤· ·ÛÊ·Ï‹˜ ıÂÚ·¢ÙÈ΋ ÚfiÙ·ÛË ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË; OÈ ·ÏÌÔ› ÙÔ˘ È·ÙÚÈÎÔ‡ Û˘ÏÏfiÁÔ˘ ¶ÂÈÚ·È¿ 2007; 8: 14-8.
2388. ª∂§π¢ø¡∏™ ∞. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË: Δ· ‰Â-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
‰Ô̤ӷ Î·È ÔÈ ÚÔ‚ÏËÌ·ÙÈÛÌÔ›. ∞ıËÚÔÛÎÏ‹ÚˆÛË
2007; 17: 21-5.
2389. ∫∞ª∞ƒ∞ΔO™ ∞, ∫OÀΔ™Oμ∞™π§∏™ ∞, º∞∫∞Δ™∂§∏ ∫, §∂¡Δ∑∞™ π, ¶∞¶OÀ§∏™ Ã, ∏ƒ∞∫§∂π∞¡OÀ ™, ª∂§π¢ø¡∏™ ∞. °Ï˘Î·ÈÌÈ΋ Ú‡ıÌÈÛË ‰È·‚ËÙÈÎÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1 ÌÂ
ÙË ¯Ú‹ÛË ·ÓÙÏ›·˜ ÈÓÛÔ˘Ï›Ó˘. ∞ÔÙÂϤÛÌ·Ù· ÌÂϤÙ˘
‰ÈÂÙÔ‡˜ ·Ú·ÎÔÏÔ‡ıËÛ˘. ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο
2007; 2: 35-40.
2390. DANNE T, DATZ N, ENDAHL L, HAAHR H,
NESTORIS C, WESTERGAARD L, FJORDING
MS, KORDONOURI O. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents
with type 1 diabetes: Results from a randomized, double-blind, controlled trial. Pediatr Diabetes. 2008; 9:
554-60.
2391. ª∂§π¢ø¡∏™ ∞. O ÚfiÏÔ˜ ÙˆÓ ÈÓÎÚÂÙÈÓÈÎÒÓ ÔÚÌÔÓÒÓ Î·È Ë Ó¤· ıÂÚ·¢ÙÈ΋ ÚfiÙ·ÛË Ù˘ exenatide
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ™.¢. ππ. OÈ ·ÏÌÔ› ÙÔ˘ π·ÙÚÈÎÔ‡ ™˘ÏÏfiÁÔ˘ ¶ÂÈÚ·È¿ 2007; 12: 38-40.
2392. ª∂§π¢ø¡∏™ ∞. ΔÔ ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ: ¢È¿ÁÓˆÛË Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ™‡Á¯ÚÔÓ˜ ıˆڋÛÂȘ. ∞ıËÚÔÛÎÏ‹ÚˆÛË 2008; 17: 2-5.
2393. KARAMITSOS TD, TSAPAS A, ARNOLD JR. Diabetic cardiomyopathy: A controversial entity. Letter
to the editor. Eur Heart J 2008; 29: 564.
2394. ª∂§π¢ø¡∏™ ∞, ΔOÀƒ¡∏™ ™, μπΔ∞§∏™ ª,
¢∞ªπ∞¡∞∫∏ ¢, ∏ƒ∞∫§∂π∞¡OÀ ™, ∫ø¡™Δ∞¡Δ∂§OÀ ∂. ªÂÙ·‚ÔÏÈΤ˜ ‰È·Ù·Ú·¯¤˜ Û ∞′
‚·ıÌÔ‡ Û˘ÁÁÂÓ›˜ ·ÛıÂÓÒÓ Ì ÌË ÈÓÛÔ˘Ï/ÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο 1998; 4: 34-8.
2395. FRÖHLICH-REITERER EE, HOFER S, KASPERS S, HERBST A, KORDONOURI O,
SCHWARZ HP, SCHOBER E, GRABERT M,
HOLL RW, DPV-WISS STUDY GROUP. Screening
frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus-data from a German/Austrian multicentre survey. Pediatr Diabetes. 2008; 9: 546-53.
2396. ª∂§π¢ø¡∏™ ∞. ¢È·‚ËÙÈ΋ ‰˘ÛÏÈȉ·ÈÌ›·. π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 1998; 9: 31-3.
2397. ª∂§π¢ø¡∏™ ∞, ΔOÀƒ¡∏™ ™, ∏ƒ∞∫§∂πøΔ∏
™, ∏ƒ∞∫§∂π∞¡OÀ ™. ™¯¤ÛË ÛÈ·ÏÈÎÔ‡ ÔͤԘ ηÈ
‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ¿ıÂÈ·˜ ÛÙÔÓ ™.¢. Ù‡Ô˘ ππ. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 1998; 11: 148-55.
2398. KORDONOURI O, VON SCHÜTZ W, MEYER
N, ASCHEMEIER B, KRACHT T, DANNE T. Type
1 diabetes in children and adolescents-new strategies
in management and treatment. Med Monatsschr
Pharm 2008; 31: 200-6.
2399. ª∂§π¢ø¡∏™ ∞. ™ÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 1999; 2: 431-4.
2400. MACKAY DJ, CALLAWAY JL, MARKS SM,
WHITE HE, ACERINI CL, BOONEN SE, DA-
YANIKLI P, FIRTH HV, GOODSHIP JA, HAEMERS AP, HAHNEMANN JM, KORDONOURI
O, MASOUD AF, OESTERGAARD E, STORR J,
ELLARD S, HATTERSLEY AT, ROBINSON DO,
TEMPLE IK. Hypomethylation of multiple imprinted
loci in individuals with transient neonatal diabetes is
associated with mutations in ZFP57. Nat Genet 2008;
40: 949-51.
2401. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ ™.¢..
π·ÙÚÈ΋ ∂ÈηÈÚfiÙËÙ· 2000; 4: 1045-9.
2402. ∫∞ª∞ƒ∞ΔO™ ∞, Ã∞§π∫π∞ ¡, ª∂§π¢ø¡∏™ ∞.
™ˆÌ·ÙÈ΋ Ì˘˚΋ ¿ÛÎËÛË Î·È ™.¢. ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο 2000; 1: 25-31.
2403. ª∂§π¢ø¡∏™ ∞. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË: ¢Â‰Ô̤ӷ, ÂÏ›‰Â˜ Î·È ÚÔ‚ÏËÌ·ÙÈÛÌÔ›. ¢È·‚ËÙÔÏÔÁÈο ¡¤·
2001; 15: 8-11.
2404. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙ· ¿ÙÔÌ·
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∑ˆ‹ Î·È ¢È·‚‹Ù˘ 2001; 4:
14-8.
2405. ∏ƒ∞∫§∂π∞¡OÀ ™. ∞ÏÏÂÚÁ›· Û ¿ÙÔÌ· Ì ™.¢..
¢È·‚ËÙÔÏÔÁÈο ¡¤· 2001; 14: 24-6.
2406. ª∂§π¢ø¡∏™ ∞, ™Δ∂º∞¡π¢∏™ ∞, ΔOÀƒ¡∏™
™, ¡∞•∞∫∏ ∞, ª¶π§π∞¡OÀ ∂, ∏ƒ∞∫§∂π∞¡OÀ
™, ºOÀ™™∞™ ™. πÓˆ‰ÔÁfiÓÔ Î·È LP(∞) Û¯ÂÙ›˙ÔÓÙ·È
Ì ÙËÓ ·ÁÁÂÈÔÁÚ·ÊÈ΋ ‚·Ú‡ÙËÙ· Ù˘ ™¡ ÛÙÔÓ ™.¢. Ù‡Ô˘ 2. π·ÙÚÈο ÃÚÔÓÈο 2001; 24: 481-5.
2407. ª∂§π¢ø¡∏™ ∞, ΔOÀƒ¡∏™ ™, ∏ƒ∞∫§∂π∞¡OÀ
™, ™Δ∂º∞¡π¢∏™ ∞, §Àƒ∞™ ∞, ºOÀ™™∞™ ™. ¢È·ÊÔÚ¤˜ ˆ˜ ÚÔ˜ ÙÔ Ê‡ÏÔ ÌÂٷ͇ Ù‡Ô˘ 2 ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ì ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ. ∞ÁÁÂÈÔÁÚ·ÊÈ΋ ÌÂϤÙË. π·ÙÚÈο ÃÚÔÓÈο 2002; 25: 113-8.
2408. ª∂§π¢ø¡∏™ ∞, ¡π∫∏Δπ∞¢∏™ ∂, Ã∞ƒª∞¡∏™
°, §Àƒ∞™ ∞, ∏ƒ∞∫§∂π∞¡OÀ ™, ∫OÀΔ™OÀº§∞∫∏™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ (™.¢.) Î·È ˘ÔÓ·ÙÚ·ÈÌ›·: ŒÓ· Û˘¯Ófi «‰›‰˘ÌÔ» ÛÙËÓ ÎÏÈÓÈ΋ Ú¿ÍË.
π·ÙÚÈο ÃÚÔÓÈο 2002; 25: 309-13.
2409. ª∂§π¢ø¡∏™ ∞. ∫·Ú‰È·ÁÁÂȷΤ˜ ÂÈÏÔΤ˜ ÛÙÔÓ
™.¢. °Ï˘ÎÈ¿ ∑ˆ‹ 2002; 35: 4-8.
2410. ¶∞°∫∞§O™ ∂ª. ∞ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ‰˘ÛÏÈȉ·ÈÌ›·˜. π·ÙÚÈ΋ 2008; 94: 438-440.
2411. ƒ∞¶Δ∏™ ∞∂. ∏ ·ÓÙÈ˘ÂÚÙ·ÛÈ΋ ıÂÚ·›· ÛÙÔ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2008; 94: 441-6.
2412. ¶∞¡∞°πøΔOÀ £. ¶ÚfiÏË„Ë Î·È ıÂÚ·›· Ù˘ ÓÂÊÚÔ¿ıÂÈ·˜ ÛÙÔ ‰È·‚‹ÙË Ù‡Ô˘ 1. π·ÙÚÈ΋ 2008; 94:
447-53.
2413. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂¢, Ã∏™ΔOÀ ª,
∑∂ƒμ∞ ∞, ∫∞ƒ∞Ã∞§πO™ ∞. ™‡Ó‰ÚÔÌÔ ÔÏ˘Î˘ÛÙÈÎÒÓ ˆÔıËÎÒÓ: ÛÙfi¯Ô˜ Ù˘ Ê·Ú̷΢ÙÈ΋˜ ·Ú¤Ì‚·Û˘ ÔÈ Î·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘. π·ÙÚÈ΋ 2008; 94: 454-80.
2414. ∞§∞μ∂ƒ∞™ ∞. ªÂÏÏÔÓÙÈΤ˜ ÂÍÂÏ›ÍÂȘ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2008;
94: 481-90.
2415. PROTOPSALTIS ID, NIKOLOPOULOS G, MELIDONIS A. Comparative study of prognostic value
175
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
for coronary disease risk between the U.K. prospective diabetes study and Framingham models: response
to Stevens and Holman. Diabetes Care 2004; 27:
1844-5.
2416. PROTOPSALTIS J, KOKKORIS S, NIKOLOPOULOS G, SPYROPOULOU P, KATSAROS T,
SALVANOS L, BRESTAS P, KORANTZOPOULOS P, MELIDONIS A. Correlation between increased serum SFAS levels and microalbuminuria in
type 1 diabetic patients. Med Princ Pract 2007; 16:
222-5.
2417. DANNE T, BATTELINO T, JAROSZ-CHOBOT
P, KORDONOURI O, PÁNKOWSKA E, LUDVIGSSON J, SCHOBER E, KAPRIO E, SAUKKONEN T, NICOLINO M, TUBIANA-RUFI N, KLINKERT C, HABERLAND H, VAZEOU A, MADACSY L, ZANGEN D, CHERUBINI V, RABBONE I,
TONI S, DE BEAUFORT C, BAKKER-VAN
WAARDE W, VAN DEN BERG N, VOLKOV I,
BARRIO R, HANAS R, ZUMSTEG U, KUHLMANN B, AEBI C, SCHUMACHER U,
GSCHWEND S, HINDMARSH P, TORRES M,
SHEHADEH N, PHILLIP M; PEDPUMP STUDY
GROUP. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and
adolescents with type 1 diabetes: experience of the
PedPump Study in 17 countries. Diabetologia 2008;
51: 1594-601.
2418. ª∂§π¢ø¡∏™ ∞. ¶ÚˆÙÔ‚¿ıÌÈ· ÊÚÔÓÙ›‰· ˘Á›·˜
ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË, ¶ÂÈÚ·È¿˜: Medical
Graphic Center, 2000: 145 ÛÂÏ.
2419. ª∂§π¢ø¡∏™ ∞. ∏ ÚfiÏË„Ë ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÛÙȘ ÂÈÏÔΤ˜. ¶ÂÈÚ·È¿˜: Medical Graphic
Center, 2001: 330 ÛÂÏ.
2420. ª∂§π¢ø¡∏™ ∞. O ¯ÂÈÚÔ˘ÚÁÔ‡ÌÂÓÔ˜ ‰È·‚ËÙÈÎfi˜.
¶ÂÈÚ·È¿˜: Medical Graphic Center, 1998: 72 ÛÂÏ.
2421. ª∂§π¢ø¡∏™ ∞. ΔÔ ‰È·‚ËÙÈÎfi fi‰È. ¶ÂÈÚ·È¿˜:
Medical Graphic Center, 1999.
2422. EDGHILL EL, FLANAGAN SE, PATCH AM,
BOUSTRED C, PARRISH A, SHIELDS B, SHEPHERD MH, HUSSAIN K, KAPOOR RR, MALECKI M, MACDONALD MJ, STØY J, STEINER DF,
PHILIPSON LH, BELL GI. Neonatal Diabetes International Collaborative Group, Hattersley AT, Ellard S. Insulin mutation screening in 1,044 patients
with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes
2008; 57: 1034-42.
2423. STEFANIDIS A, MELIDONIS A, TOURNIS S,
ZAIRIS M, HANDANIS S, BELDEKOS D, ARGYRAKIS S, ASIMACOPOULOS P, FOUSSAS S. Effect of intravenous insulin administration on left ventricular performance during non-st-elevation acute
coronary events in patients with diabetes mellitus. Am
J Cardiol 2003; 91: 1237-40.
176
2424. FOUSSAS S, STEFANIDIS A, MELIDONIS A,
TOURNIS S, MICHALI P, DOSIOS T, ASIMACOPOULOS P. Intensive insulin treatment and QT-interval. Diabetes Care 2003; 26: 954-5.
2425. KOLOVOU GD, DASCALOVA CH, IRAKLIANOU A, ADAMOPOULOU EN, PILATIS ND,
HATZIGEORGIOU GC, COKKINOS DV. Postprandial lipemia in hypertension. J Am Coll Nutr
2003; 22: 1-8.
2426. PROTOPSALTIS ID, KONSTANTINOPOULOS
PA, KAMERATOS AV, MELIDONIS AI. Comparative study of prognostic value for coronary disease
risk between the U.K. prospective diabetes study and
Framingham models. Diabetes Care 2004; 27: 277-8.
2427. KAMARATOS A, KOKKORIS S, PROTOPSALTIS J, AGORGIANITIS D, KOUMPOULIS H,
LENTZAS J, MELIDONIS A, GIANNOULIS G. Simultaneous bilateral facial palsy in a diabetic patient.
Diabetes Care 2004; 27: 623-4.
2428. PROTOPSALTIS I, NIKOLOPOULOS G, DIMOU E, BRESTAS P, KOKKORIS S, KORANTZOPOULOS P, MELIDONIS A. Metabolic syndrome and its components as predictors of all-cause
mortality and coronary heart disease in type 2 diabetic patients. Atherosclerosis 2007; 195: 189-94.
2429. KORANTZOPOULOS P, KOKKORIS S, KOUNTOURIS E, PROTOPSALTIS I, SIOGAS K, MELIDONIS A. Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy. Int J
Cardiol 2008; 125: 51-4.
2430. FOUSSAS SG, ZAIRIS MN, MAKRYGIANNIS
SS, MANOUSAKIS SJ, PATSOURAKOS NG,
ADAMOPOULOU EN, BELDEKOS DJ, MELIDONIS AJ, HANDANIS SM, MANOLIS AJ, HATZISAVVAS JJ, ARGYRAKIS SK. The impact of
circulating total homocysteine levels on long-term
cardiovascular mortality in patients with acute coronary syndromes. Int J Cardiol 2008; 124: 312-8.
2431. PROTOPSALTIS J, KORANTZOPOULOS P,
MILLIONIS JH, KOUTSOVASILIS A, NIKOLOPOULOS KG, DIMOU E, KOKKORIS S, BRESTAS P, ELISAF SM, MELIDONIS A. Metabolic
syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients. Stroke 2008;
39: 1036-8.
2432. ¶ƒøΔOæ∞§Δ∏™ π, ∫O∫∫Oƒ∏™ ™, ∫∞ƒ∑∏ ∂,
∞¡∞™Δ∞™O¶OÀ§OÀ ∞, ºπ§πøΔ∏ ∫, ∞¡Δø¡O¶OÀ§O™ ™, ∫∞ƒ∞§∏ ª, ™¶ÀƒO¶OÀ§OÀ
¡, ∫∞Δ™OÀ§∞∫OÀ ™, ª∂§π¢ø¡∏™ ∞, °π∞¡¡OÀ§∏™ °. ¶ÚfiÁÓˆÛË Ì·ÎÚÔÚfiıÂÛÌ˘ ÏÂÈÙÔ˘ÚÁÈ΋˜ ¤Î‚·Û˘ ÙˆÓ ·ÛıÂÓÒÓ Ì Ô͇ ÈÛ¯·ÈÌÈÎfi ÌË ÂÌ‚ÔÏÈÎfi ÂÁÎÂÊ·ÏÈÎfi ÂÂÈÛfi‰ÈÔ. ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο
2008; 3: 116-23.
2433. IRAKLIANOU S, MELIDONIS A, TOURNIS S,
KONSTADELOU E, TSATSOULIS A, ELISSAF
M, SIDERIS D. Postprandial leptin responses after
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
an oral fat tolerance test: differences in type 2 diabetes. Diabetes Care 2001; 24: 1299-301.
2434. LIONIS C, PAPATHANASIOU A. Primary care diabetes in Greece. Prim Care Diabetes 2008; 2: 97-9.
2435. FOUSSAS SG, ZAIRIS MN, MAKRYGIANNIS
SS, MANOUSAKIS SJ, PATSOURAKOS NG,
ADAMOPOULOU EN, BELDEKOS DJ, MELIDONIS AI, HANDANIS SM, MANOLIS AJ, HATZISAVVAS JJ, ARGYRAKIS SK. The impact of
circulating total homocysteine levels on long-term
cardiovascular mortality in patients with acute coronary syndromes. Int J Cardiol 2008; 124: 312-8.
2436. PROTOPSALTIS I, KORANTZOPOULOS P, MILIONIS HJ, KOUTSOVASILIS A, NIKOLOPOULOS GK, DIMOU E, KOKKORIS S, BRESTAS P,
ELISAF MS, MELIDONIS A. Metabolic syndrome
and its componets as predictors of ischemic stroke in
type 2 diabetic patients. Stroke 2008; 39: 1036-8.
2437. PEPONIS V, PAPATHANASIOU M, KAPRANOU, MAGKOU C, TYLIGADA A, MELIDONIS
A, DROSOS T, SITARAS NM. Protective role of
oral antioxidant supplementation in ocular surface of
diabetic patients. Br J Ophthalmol 2002; 86: 1369-73.
2438. KAMARATOS A, LENTZAS J, PAPATHANASIOU M, GERAKARI S, MARIOLIS A, ALEVIZOS A, SALVANOS L, KOKKORIS S, MELIDONIS A. The role of general practitioners in the follow
up of type 1 diabetic patients with insulin pump therapy. Letter to the editor. Rural Remote Health 2007;
7: 657.
2439. ª∂§π¢ø¡∏™ ∞. OÈ ÛÙÚ·ÙËÁÈΤ˜ ÂÓ›Û¯˘Û˘ Ù˘ ÈÓÎÚÂÙÈÓÈ΋˜ ‰Ú¿Û˘: ∏ Ó¤· ıÂÚ·¢ÙÈ΋ ÚfiÙ·ÛË ÛÙÔÓ
™¢ ππ. ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο 2008; 1: 14-20.
2440. ª∂§π¢ø¡∏™ ∞, §∂μπ™π∞¡OÀ ¢, ∫OÀΔ™Oμ∞™π§∏™ ∞, ∫OÀ∫OÀ§∏ ª¶, ∞¢∞ªO¶OÀ§OÀ
∂, ∏ƒ∞∫§∂π∞¡OÀ ™, ºOÀ™™∞™ ™. ¶ÔÈ· Ë Û¯¤ÛË
ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘ Î·È ÙˆÓ Û˘Ó‰˘·ÛÌÒÓ
ÙˆÓ ·Ú·Ì¤ÙÚˆÓ Ô˘ ÙÔ Û˘ÓÈÛÙÔ‡Ó Ì ÙËÓ ·ÚÙËÚȷ΋
ÛÎÏ‹Ú˘ÓÛË Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2; ∂ÈÛÙËÌÔÓÈο ÃÚÔÓÈο 2008; 2: 66-70.
2441. ª∂§π¢ø¡∏™ ∞. ΔÔ Ï·›ÛÈÔ ·ÛÊ¿ÏÂÈ·˜ ÁÈ· ÁÏ˘Î¤˜, ÍÂÎÔ‡Ú·ÛÙ˜ ηÏÔηÈÚÈÓ¤˜ ‰È·ÎÔ¤˜. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ – ºÚÔÓÙ›‰· ÁÈ· fiÏÔ˘˜ 2008; 3: 58-9.
2442. ª∂§π¢ø¡∏™ ∞. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ: ™‡Á¯ÚÔÓ˜ ıˆڋÛÂȘ Î·È ·Ó·ıˆڋÛÂȘ. ∂ÈÛÙËÌÔÓÈο
ÃÚÔÓÈο 2008; 3: 112-5.
2443. PAPANAS N, SYMEONIDIS G, MAVRIDIS G,
GEORGIADIS GS, PAPAS TT, LAZARIDES MK,
MALTEZOS E. Ankle-brachial index: a surrogate
marker of microvascular complications in type 2 diabetes mellitus? Intern Angiology 2007; 26: 253-7.
2444. PAPANAS N, MALTEZOS E. Advances in Treating the Ischaemic Diabetic Foot. Curr Vasc Pharmacol 2008; 6: 23-28.
2445. ∂À™Δƒ∞Δπ∞¢∏™ °, ∫πƒªπ∑∏™ ¢, ª∂ªªO™ ¢,
Oπ∫O¡Oªπ¢OÀ ¢, ¶∞¡Δ∑∞∫∏ ∞, ¶∞¶∞¡∞™
¡, °∂øƒ°OÀ§π¢OÀ ∞, ª¶∂§∂Ã∏ ∞ª,
¶∞¶∞¢∏ª∏ΔƒπOÀ ª. ªË ·Ó·ÛÙÚ¤„ÈÌË O¡∞
·fi ¯ÔÚ‹ÁËÛË Ó¤·˜ ÁÂÓÈ¿˜ ÛÎÈ·ÛÙÈÎÔ‡ Û ·ÛıÂÓ‹ ÌÂ
‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2003;
15: 83-6.
2446. TRYFON S, PAPANAS N. Corticosteroid-induced
diabetes in patients with chronic obstructive pulmonary disease. Brief Review. Clinical Pulmonary
Medicine 2008; 15: 127-31.
2447. PAPANAS N, ANTONOGLOU CH, MALTEZOS
E. An Unusual Case of Hypoglycemia or Who’s
Afraid of the Big Bad Wolf? Diabetes Educ 2006; 32:
355-6.
2448. PAPANAS N, PAPATHEODOROU K, PAPAZOGLOU D, MONASTIRIOTIS C, MALTEZOS E.
Foot temperature in type 2 Diabetic Patients with or
without Peripheral Neuropathy. Exp Clin Endocrinol
Diabetes 2009; 117: 44-7.
2449. DIAMANTOPOULOS E, ANDREADIS E,
TSOUROUS G, YFANTI G, KATSANOU P,
GEORGIOPOULOS D, VASSILOPOULOS C, DIMITRIADIS G, RAPTIS S. Metabolic syndrome and
prediabetes exhibit an overlapping pattern in an obese
Caucasian population. Exp Clin Endocrinol Diabetes
2006; 114: 377-84.
2450. DIAMANTOPOULOS E, ANDREADIS E,
TSOUROUS G, KATSANOU P, GEORGIOPOULOS D, DIMITRIADIS G, RAPTIS S. Intermediate
postchallenge hyperglycemia in overweight and obese
subjects. A new marker of impaired glucose regulation? Angiology 2006; 57: 709-16.
2451. DIMITRIADIS G, MITROU P, LAMBADIARI V,
BOUTATI E, MARATOU E, PANAGIOTAKOS D,
KOUKKOU E, TZANELA M, THALASSINOS N,
RAPTIS S. Insulin action in adipose tissue and Muscle in hypothyroidism. J Clin Endocrinol Metab 2006;
91: 4930-7.
2452. MARATOU E, DIMITRIADIS G, KOLLIAS A,
BOUTATI E, LAMBADIARI B, MITROU P,
RAPTIS S. Glucose transporter expression on the
plasma membrane of resting and activated white
blood cells. Eur J Clin Invest 2007; 37: 282-90.
2453. DIMITRIADIS G, LAMBADIARI B, MITROU P,
MARATOU E, BOUTATI E, PANAGIOTAKOS D,
ECONOMOPOULOS T, RAPTIS S. Impaired postprandial blood flow in adipose tissue may be an early
marker of insulin resistance in type 2 diabetes. Diabetes Care 2007; 30: 3128-30.
2454. DIMITRIADIS G, MARATOU E, BOUTATI E,
KOLLIAS A, TSEGKA K, ALEVIZAKI M, PEPPA
M, RAPTIS SA, HADJIDAKIS DJ. IGF-I increases
the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Eur J Endocrinol 2008; 158: 361-6.
2455. DIMITRIADIS G, MITROU P, LAMBADIARI V,
177
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
BOUTATI E, MARATOU E, KOUKKOU E,
PANAGIOTAKOS D, TOUNTAS N, ECONOMOPOULOS T, RAPTIS SA. Insulin-stimulated rates of
glucose uptake in muscle in hyperthyroidism: The importance of blood flow. J Clin Endocrinol Metab
2008; 93: 2413-5.
2456. MARATOU E, HADJIDAKIS D, KOLLIAS A,
TSEGKA K, PEPPA M, ALEVIZAKI M, MITROU
P, LAMBADIARI V, BOUTATI E, NIKZAS D,
TOUNTAS N, ECONOMOPOULOS T, RAPTIS
SA, DIMITRIADIS G. Studies of insulin resistance in
patients with clinical and subclinical hypothyroidism.
Eur J Endocrinol 2009; 160: 785-90.
2457. DIMITRIADIS G, BOUTATI E, RAPTIS S. The
lipotoxicity and glucotoxicity hypothesis in the metabolic syndrome and type 2 diabetes. In: Rios MS,
Caro J, Carraro R, Gutierrez Fuentes J. The Metabolic syndrome at the beginning of The XXIst century: A genetic and molecular approach. Madrid: Elsevier, 2005: 271-82.
2458. CALDER PH, DIMITRIADIS G, NEWSHOLME
PH. Glucose metabolism in lymphoid and inflammatory cells. Curr Opin Clin Nutr Metab Care 2007; 10:
531-40.
2459. PAPANAS N, MALTEZOS E. The diabetic Foot:
Established and emerging treatments. Acta Clin Belg
2007; 62: 230-8.
2460. PAPANAS N, SYMEONIDIS G, MAVRIDIS G,
PAPAZOGLOU D, GIANNAKIS I, PAPATHEODOROU K, PASTORE F, LAKASAS G, MALTEZOS E. Severity of liver echogenicity is correlated to
serum C-peptide levels in type 2 diabetic patients. Acta Clin Belg 2006; 61: 5-9.
2461. PAPANAS N, TZIAKAS D, MALTEZOS E, STAKOS D, HATZINIKOLAOU E, PARCHARIDIS G,
LOURIDAS G, HATSERAS D. Risk factors for concomitant peripheral arterial occlusive disease in patients with coronary artery disease: Is there a difference between diabetic and non-diabetic patients? Acta Clin Belg 2005; 60: 122-8.
2462. PAPANAS N, TZIAKAS D, MALTEZOS E,
KEKES A, HATZINIKOLAOU E, PARCHARIDIS
G, LOURIDAS G, HATSERAS D. Impact of diabetes mellitus on severity of concomitant peripheral
arterial occlusive disease in patients with coronary
artery disease. Acta Clin Belg 2005; 60: 129-34.
2463. PAPANAS N, EDMONDS M. Facing real necessities in the diabetic foot. The Diabetic Foot 2005; 8:
118-9.
2464. PAPANAS N, SYMEONIDIS G, MALTEZOS E,
GIANNAKIS I, MAVRIDIS G, LAKASAS G,
ARTOPOULOS I. Evaluation of aortic arch calcification in type 2 diabetic patients. VASA 2005; 34: 1137.
2465. PAPANAS N, TZIAKAS D, MALTEZOS E, STAKOS D, HATZINIKOLAOU E, PARCHARIDIS G,
178
LOURIDAS G, HATSERAS D. Risk factors for concomitant peripheral arterial occlusive disease in patients with coronary artery disease: Is there a difference between diabetic and non-diabetic patients? Acta Clin Belg 2005; 60: 122-8
2466. PAPANAS N, GIATROMANOLAKI A, GALAZIOS G, MALTEZOS E, SIVRIDIS E. Endometrial
carcinoma and diabetes revisited. Eur J Gynaec Oncol
2006; 27: 505-8.
2467. PAPAZOGLOU D, PAPANAS N, PAPATHEODOROU K, KOTSIOU S, CHRISTAKIDIS D,
MALTEZOS E. An Insertion/ Deletion Polymorphism in the alpha2B Adrenoceptor Gene is Associated with Age at Onset of Type 2 Diabetes Mellitus.
Exp Clin Endocrinol Diabetes 2006; 114: 424-7.
2468. PAPANAS N, PAPATHEODOROU K, PAPAZOGOU D, KOTSIOU S, CHRISTAKIDIS D,
MALTEZOS E. An Insertion/ Deletion Polymorphism in the Alpha2B Adrenoceptor Gene is Associated with Peripheral Neuropathy in Patients with
Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2007; 115: 327-30.
2469. PAPANAS N, TZIAKAS D, MAVRIDIS G, GIANNAKIS I, SYMEONIDIS G, STAKOS D, MILOUSIS A, MALTEZOS E, LOURIDAS G, HATSERAS
D. Aortic arch calcification predicts the extent of
coronary atherosclerosis in patients with or without
type 2 diabetes: Short communication. Acta Clin Belg
2007; 62: 52-5.
2470. PAPANAS N, MALTEZOS E, EDMONDS M. St.
Vincent declaration after 15 years or who cleft the
devil’s foot? VASA 2006; 35: 3-4.
2471. PAPANAS N, MALTEZOS E, EDMONDS A, EDMONDS M. The 10 commandments of the diabetic
foot. Brit Med J 2005; 331: 1497.
2472. PAPANAS N, PAPATHEODOROU K, PAPAZOGLOU D, CHRISTAKIDIS D, MONASTIRIOTIS
C, MALTEZOS E. Reproducibility of the New Indicator Test for Sudomotor Function (Neuropad®) in
Patients with 2 Diabetes Mellitus: Short Communication. Exp Clin Endocrinol Diabetes 2005; 113: 577-81.
2473. PAPANAS N, EDMONDS M, MALTEZOS E.
Pseudoclaudication as a manifestation of diabetic
neuropathy. Diabet Med 2005; 22: 1608-10.
2474. PAPANAS N, GIASSAKIS G, PAPATHEODOROU K, PAPAZOGLOU D, MONASTIRIOTIS C,
CHRISTAKIDIS D, PIPERIDOU H, MALTEZOS
E. Use of the New Indicator Test (Neuropad®) for
the Assessment of the Staged Severity of Neuropathy
in Type 2 Diabetic Patients. Exp Clin Endocrinol Diabetes 2007; 115: 58-61.
2475. PAPANAS N, GRIES A, MALTEZOS E, ZICK R.
The steel ball-bearing test: a new test for evaluating
protective sensation in the diabetic foot. Diabetologia
2006; 49: 4: 739-743.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2476. PAPANAS N, HELIOPOULOS I, PIPERIDOU H,
MALTEZOS E. Simultaneous, painless, homolateral
oculomotor and trochlear nerve palsies in a patient
with type 2 diabetes mellitus. Neuropathy or brainstem infarction? Acta Diabetol 2006; 43: 1: 19-21.
2477. PAPANAS N, LIAKOPOULOS V, MALTEZOS E,
STEFANIDIS I. The Diabetic Foot in End Stage Renal Disease. Renal Failure 2007; 29: 519-28.
2478. DIAMANTOPOULOS EJ, KITTAS C, CHARITOS D, GRIGORIADOU M, IFANTI G, RAPTIS
SA. Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus.
Horm Metab Res 2004; 36: 142-7.
2479. ™øΔ∏ƒO¶OÀ§O™ ∞, ∞¶O™ΔO§OÀ O, ƒ∞¶Δ∏™ ∞, Î.·. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2: ıÂÚ·›· Ì ‰ÈÛΛ·. ™ÙÔ: ™ˆÙËÚfiÔ˘ÏÔ˜ ∞, ™ÎÏËÚfi˜ ∂,
ΔÔ‡ÓÙ·˜ â. ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‹ıˆÓ ·ı‹ÛÂˆÓ ÛÙËÓ
¶ÚˆÙÔ‚¿ıÌÈ· ºÚÔÓÙ›‰· ÀÁ›·˜. ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ
Î·È Û˘ÛÙ¿ÛÂȘ. 2Ë ¤Î‰. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 757-80.
2480. ™¶ÀƒO¶OY§OÀ π. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ Â›‰Ú·Û˘
ÙˆÓ ÂÈ¤‰ˆÓ Ù˘ ‰È·ÙÚÔÊÈ΋˜ ÚˆÙÂ˚Ó˘ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2. ΔÌ‹Ì· ∂ÈÛÙ‹Ì˘ ¢È·ÈÙÔÏÔÁ›·˜ - ¢È·ÙÚÔÊ‹˜ ÷ÚÔÎfiÂÈÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘, 2004. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2481. THANOPOULOU A, KARAMANOS B, ANGELICO G, ASSAAD-KHALIL S, BARBATO A, DEL
BEN M, DJORDJEVIC P, DIMITRIJEVICSRECKOVIC V, GALLOTTI C, KATSILAMBROS
N, MIGDALIS I, MRABET M, PETKOVA M,
ROUSSI D, TENCONI MT. MULTI-CENTRE
STUDY OF THE MEDITERRANEAN GROUP
FOR THE STUDY OF DIABETES (MGSD). MultiCentre Study of the Mediterranean Group for the
Study of Diabetes (MGSD). Nutritional habits of subjects with Type 2 diabetes mellitus in the Mediterranean Basin: Comparison with the non-diabetic population and the dietary recommendations. Multi-Centre Study of the Mediterranean Group for the Study
of Diabetes (MGSD). Diabetologia 2004; 47: 367-76.
2482. PAPANAS N, MALTEZOS E. Growth Factors in
the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises? Int J Low Extrem Wounds
2007; 6: 37-53.
2483. PAPANAS N, GIASSAKIS G, PAPATHEODOROU K, PAPAZOGLOU D, MONASTIRIOTIS
CH, CHRISTAKIDIS D, PIPERIDOU H, MALTEZOS E. Sensitivity and specificity of a new indicator
test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: A comparison
with clinical examination and nerve conduction study.
J Diabetes Complications 2007; 21: 353-8.
2484. PAPANAS N, PAPATHEODOROU K, CHRISTAKIDIS D, PAPAZOGLOU D, GIASSAKIS G,
PIPERIDOU H, MONASTIRIOTIS C, MALTEZOS E. Evaluation of a New Indicator Test for Sudo-
motor Function (Neuropad®) in the Diagnosis of Peripheral Neuropathy in Type 2 Diabetic Patients. Exp
Clin Endocrinol Diabetes 2005; 113: 195-8.
2485. PAPANAS N, SYMEONIDIS G, MALTEZOS E,
MAVRIDIS G, KARAVAGELI E, VOSNAKIDIS
TH, LAKASAS G. Mean platelet volume in patients
with type 2 diabetes mellitus. Platelets 2004; 15: 4758.
2486. PAPANAS N, MAVRIDIS G, KARAVAGELI E,
SYMEONIDIS G, MALTEZOS E. Peripheral neuropathy is associated with increased mean platelet
volume in type 2 diabetic patients. Platelets 2005; 16:
498-9.
2487. PAPANAS N, TZIAKAS D, CHALIKIAS G, FLOROS D, TRYPSIANIS G, PAPADOPOULOU E,
KORTSARIS A, SYMEONIDIS G, SOULIOU E,
MALTEZOS E, HATSERAS D. Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients. Diabetic Metab 2006;
32: 344-9.
2488. LAZARAKI G, KOUNTOURAS J, METALLIDIS
S, VRETTOU E, ALEVIZOS M, TZIOUFA V,
DOKAS S, GERMANIDIS G, ZAVOS C, NIKOLAIDIS P. Endothelial nitric oxide synthase (eNOS)
is not upregulated in gastric mucosa of Helicobacter
pylori (H. pylori)-positive patients with type 2 diabetes mellitus. Dig Liver Dis 2009; 41: 253-62.
2489. PAPANAS N, MALTEZOS E. Education for Dietary Freedom in Type 1 Diabetes? Yes, it’s Possible.
Diabetes Educ 2008; 34: 54-8.
2490. PAPANAS N, PAPATHEODOROU K, PAPAZOGLOU D, CHRISTAKIDIS D, MONASTIRIOTIS
CH, MALTEZOS E. The New Indicator Test (Neuropad®): A Valuable Diagnostic Tool for Small-Fiber
Impairment in Patients With Type 2 Diabetes. Diabetes Educ 2007; 33: 257-66.
2491. PAPANAS N, MALTEZOS E. Becaplermin gel in
the treatment of diabetic neuropathic foot ulcers. Clin
Interv Aging 2008; 3: 233-40.
2492. PAPANAS N, MALTEZOS E, EDMONDS M. The
diabetic foot: A plea for the elementary? Acta Diabetol 2006; 43: 152-3.
2493. DIMITRIADIS G, BOUTATI E, RAPTIS SA. The
importance of adipose tissue in diabetes pathophysiology and treatment. Horm Metab Res 2007; 39: 7056.
2494. DIMITRIADIS G, BOUTATI E, LAMBADIARI
V, MITROU P, BRUNEL P, RAPTIS S: Restoration
of early insulin secretion after a meal in type 2 diabetes: Effects on lipid and glucose metabolism. Eur J
Clin Invest 2004; 34: 490-7.
2495. DIMITRIADIS G, MARATOU E, ALEVIZAKI
M, BOUTATI E, PSARA K, PAPASTERIADES
CHR, RAPTIS S. Thyroid hormone excess increases
basal and insulin-stimulated recruitment of GLUT3
179
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
glucose transporters on cell surface. Horm Metab Res
2005; 37: 15-20.
2496. DIMITRIADIS G, MARATOU E, ALEVIZAKI
M, BOUTATI E, PSARA K, PAPASTERIADES
CHR, RAPTIS S. Evaluation of glucose transport and
its regulation by insulin in human monocytes using
flow cytometry. Cytometry A 2005; 64: 27-33.
2497. ª∞ÀƒOª∞Δπ¢∏™ ∫, ™¶∞´∞ ™, ¢∏ª∏Δƒ∞∫O¶OÀ§O™ ∫, OÀ∑OÀ¡∏ ∞π∫. ª¶∂∑∞∑∏-¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∂, μ∞°πø¡∞™ °. ™˘Û¯¤ÙÈÛË
ÁÏ˘ÎÔ˙˘ÏȈ̤Ó˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ & Ô˘Ú·ÈÌ›·˜. Mater
Med Greca 1988; 16: 150-60
2498. SPAIA S, CHRISTIDOU G, PAGIDIS P, TSOULKAS TH, PAZARLOGLOU M, PAPPA A, VAYONAS G. Variability of protein losses in diabetics and
non diabetics on CAPD. Perit Dial Int 1993; 13 (Suppl 2): 242-4.
2499. SPAIA S, PANGALOS M, ASKEPIDIS N, PAZARLOGLOU M, MAVROPOULOU E, THEODORIDIS S, DIMITRAKOPOULOS K, MILIONIS
A, VAYONAS G. The effect of short-term rhu-EPO
treatment on insulin resistance in haemodialysis patients. Nephron 2000; 84: 320-5.
2500. DIMITRIADIS G, NEWSHOLME EA. Integration
of some biochemical and physiologic effects of insulin
that may play a role in the control of blood glucose
concentration. In: LeRoith D, Taylor Sπ, Olefsky JO.
Diabetes Mellitus: A fundamental and clinical text.
3rd ed. London: Lippincott Williams & Wilkins, 2004:
183-197.
2501. PAPANAS N, TZIAKAS D, HATZINIKOLAOU
E, CHALIKIAS G, MALTEZOS E, LOURIDAS G,
HATSERAS D. Revisiting the frequency of peripheral arterial disease in patients with coronary artery disease: Is there a difference between diabetic and nondiabetic patients? VASA 2006; 35: 227-31.
2502. PAPANAS N, TZIAKAS D, MALTEZOS E, KEKES A, HATZINIKOLAOU E, PARCHARIDIS G,
LOURIDAS G, HATSERAS D. Peripheral arterial
occlusive disease as a predictor of the extent of coronary atherosclerosis in patients with coronary artery
disease with and without diabetes mellitus. J Int Med
Res 2004; 32: 422-8.
2503. ƒ∞¶Δ∏™ ™∞, ª¶OÀΔ∞Δ∏ ∂π. ™Ùfi¯ÔÈ Î·È ‰˘Ó·ÙfiÙËÙ˜ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ Ù‡Ô˘ 2 ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË. π·ÙÚÈ΋ 2008; 94: 196-217.
2504. ∫∞Δ™π§∞ª¶ƒO™ ¡§, §π∞Δ∏™ ™£. ∏ ‰È·ÙÚÔÊÈ΋ ·Ú¤Ì‚·ÛË ÛÙÔ ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹. π·ÙÚÈ΋ 2008;
94: 218-29.
2505. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÏÈÁÔıÂÚÌÈΤ˜ ÚˆÙÂ˚ÓÈΤ˜
‰›·ÈÙ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋
2008; 94: 230-5.
2506. ªÀ°¢∞§∏™ ∏¡, ™Δ∂§πOÀ π∫. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ¿ÛÎËÛË. π·ÙÚÈ΋ 2008; 94: 236-42.
2507. ∏ƒ∞∫§∂π∞¡OÀ ™∞. O ÚfiÏÔ˜ Ù˘ ÂÎ·›‰Â˘Û˘
180
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2008; 94:
243-9.
2508. ºπ§π¶¶π¢∏™ º¶. ∏ ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋ 2008; 94: 250-4.
2509. Δ™∞Δ™OÀ§∏™ ∞. O ÚfiÏÔ˜ ÙˆÓ ÁÏÈÙ·˙ÔÓÒÓ ÛÙËÓ
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2008; 94: 255-60.
2510. ¶∞¶¶∞™ ™.π, ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞..∫.
ΔÔ Û‡ÛÙËÌ· ÙˆÓ ÈÓÎÚÂÙÈÓÒÓ: ·Ó·ÛÙÔÏ›˜ Ù˘ ‰ÈÂÙȉ˘ÏÂÙȉ¿Û˘ 4. π·ÙÚÈ΋ 2008; 94: 261-73.
2511. ∫∞ƒ∞ª∞¡O™ μ, £∞¡O¶OÀ§OÀ ∞, ∞ƒÃπª∞¡¢ƒπΔ∏™ ∞. ΔÔ Û‡ÛÙËÌ· ÙˆÓ ÈÓÎÚÂÙÈÓÒÓ: ∞ÁˆÓÈÛÙ¤˜ ÙÔ˘ ˘Ô‰Ô¯¤· ÙÔ˘ GLP-1. π·ÙÚÈ΋ 2008; 94:
274-90.
2512. §∞ª¶∞¢π∞ƒ∏ μ∞, ¢∏ª∏Δƒπ∞¢∏™ °¢. ∂ÓÙ·ÙÈÎÔÔÈË̤ӷ Û¯‹Ì·Ù· ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. π·ÙÚÈ΋ 2008; 94: 291-8.
2513. ª∞ÀƒO°π∞¡¡∞∫∏ ∞¡. ∏ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2 Ì ÈÓÛÔ˘Ï›ÓË. π·ÙÚÈ΋
2008; 94: 299-319.
2514. ΔOÀ¡Δ∞™ â. ¶ÚÔ‚ÏËÌ·ÙÈÛÌÔ› ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙËÓ ÙÚ›ÙË ËÏÈΛ·. π·ÙÚÈ΋ 2008; 94: 320-31.
2515. ∞¡∞™Δ∞™πOÀ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË: £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË. π·ÙÚÈ΋ 2008; 94:
332-40.
2516. ™øΔ∏ƒO¶OÀ§O™ ∞∂, ∞¶O™ΔO§OÀ O¡. ¢È·‚ËÙÈ΋ ÎÂÙÔÔͤˆÛË Î·È ˘ÂÚÁÏ˘Î·ÈÌÈÎfi ˘ÂÚˆÛ̈ÙÈÎfi ÌË ÎÂÙˆÙÈÎfi ÎÒÌ·. π·ÙÚÈ΋ 2008; 94: 350-67.
2517. Δ∂¡ΔO§OÀƒ∏™ ¡, ∂§∂À£∂ƒπ∞¢OÀ π. ¡ÂfiÙÂÚ· ‰Â‰Ô̤ӷ ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ÂÚÈÊÂÚÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜. π·ÙÚÈ΋ 2008; 94: 368-76.
2518. ¢π¢∞°°∂§O™ Δ¶. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· ÙÔ˘
·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ Î·È Î·Ú‰È·ÁÁÂÈ·Îfi
Û‡ÛÙËÌ·. π·ÙÚÈ΋ 2008; 94: 377-97.
2519. ¶∞¶∞¡∞™ ¡¶. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. π·ÙÚÈ΋ 2008; 94: 398-408.
2520. ª∂§π¢ø¡∏™ ∞π. ∏ Û˘ÓÔÏÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘
Ì·ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜ ÛÙ· ¿ÙÔÌ· Ì ‰È·‚‹ÙË. π·ÙÚÈ΋
2008; 94: 409-16.
2521. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂π, Àº∞¡Δ∏ °∫. ∞ÓÙÈÌÂÙÒÈÛË Ù˘ ÎÚ›ÛÈÌ˘ ÈÛ¯·ÈÌ›·˜ ÛÙÔ ‰È·‚‹ÙË. π·ÙÚÈ΋
2008; 94: 417-33.
2522. ∫Àƒπ∞∑O¶OÀ§OÀ μ, ªπÃ∞§∞∫∏ ª. ∏ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ·¯˘Û·ÚΛ·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
π·ÙÚÈ΋ 2008; 94: 434-7.
2523. KALOFOUTIS C, PIPERI C, KALOFOUTIS A,
HARRIS F, PHOENIX D, SINGH J. Type II diabetes mellitus and cardiovascular risk factors: Current
therapeutic approaches. Exp Clin Cardiol 2007; 12:
17-28.
2524. ™¶∞´∞ ™, ¶∞°∫∞§O™ ∂, ∞™∫∂¶π¢∏™ ¡, ¶∞∑∞ƒ§O°§OÀ ª, ª∞ÀƒO¶OÀ§OÀ ∂, £∂O¢øƒπ¢∏™ ™, ¢∏ª∏Δƒ∞∫O¶OÀ§O™ ∫, ª∏§πø¡∏™ ∞, μ∞°πø¡∞™ °. ªÂÙ·‚ÔϤ˜ Ù˘ ·ÓÙ›ÛÙ·Û˘
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ÙˆÓ ÈÛÙÒÓ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË ÌÂÙ¿ ·fi ¯ÔÚ‹ÁËÛË ·ÓıÚÒÈÓ˘ ·Ó·Û˘Ó‰˘·Ṳ̂Ó˘ ÂÚ˘ıÚÔÔÈËÙ›Ó˘ Û ·ÈÌÔηı·ÈÚfiÌÂÓÔ˘˜ ·ÛıÂÓ›˜. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›·
1996; 8: 567-93.
2525. VERETTAS DA, CHATZIPAPAS CN, DROSOS
GI, XARCHAS KC, STAIKOS C, CHLOROPOULOU P, KAZAKOS KI, VERVERIDIS A. Maggot
infestation (myiasis) of external fixation pin sites in diabetic patients. Trans R Soc Trop Med Hyg 2008; 102:
950-2.
2526. MELIDONIS A, STEFANIDIS A, TOURNIS S,
MANOUSSAKIS S, HANDANIS S, ZAIRIS M, DADIOTIS L, FOUSSAS S. The role of strict metabolic
control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients. Clin.
Cardiol 2000; 23: 160-4.
2527. STEFANIDIS A, MELIDONIS A, TOURNIS S,
ZAIRIS M, HANDANIS S, OLYMPIOS C, ASIMACOPOULOS P, FOUSSAS S. Intensive insulin treatment reduces transient ischaemic episodes during
acute coronary events in diabetic patients. Acta Cardiol 2002; 57: 357-64.
2528. SAKELLARIDIS N, ANDROULIS A. Influence of
diabetes mellitus on cervical intervertebral disc herniation. Clin Neurol Neurosurg 2008; 110: 810-2.
2529. TROUGAKOS IP, POULAKOU M, STATHATOS
M, CHALIKIA A, MELIDONIS A, GONOS ES.
Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes
type II and during development of coronary heart disease or at myocardial infarction. Exp.Gerontol 2002;
37: 1175-87.
2530. FLORENTIN M, LIBEROPOULOS EN, MIKHAILIDIS DP, ELISAF MS. Sitagliptin in clinical
practice: a new approach in the treatment of type 2 diabetes. Expert Opin Pharmacother 2008; 9: 1705-20.
2531. KARAVANAKI K, TSOKA E, LIACOPOULOU
M, KARAYIANNI C, PETROU V, PIPPIDOU E,
BRISIMITZI M, MAVRIKIOU M, KAKLEAS K,
DACOU-VOUTETAKIS C. Psychological stress as a
factor potentially contributing to the pathogenesis of
Type 1 diabetes mellitus. J Endocrinol Invest 2008;
31: 406-15.
2532.YANNAKOULIA M, POULIA KA, MYLONA E,
KONTOGIANNI MD. Effectiveness of an intensive
nutritional intervention in patients with type 2 diabetes mellitus: Results from a pilot study. Rev Diabet
Stud 2007; 4: 226-30.
2533. LEWY H, HAMPE CS, KORDONOURI O, HABERLAND H, LANDIN-OLSSON M, TORN C,
LARON Z. Seasonality of month of birth differs between type 1 diabetes patients with pronounced betacell autoimmunity and individuals with lesser or no
beta-cell autoimmunity. Pediatr Diabetes 2008; 9: 4652.
2534. ª∂§π¢ø¡∏™ ∞. ¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ Î·È Î·Ú-
‰È·ÁÁÂȷΤ˜ ÂÈÏÔΤ˜ ÛÙÔÓ ™.¢. ΔÔ ‚‹Ì· Ù˘
¶∂¡¢π 2003; 21: 9-13.
2535. ª∂§π¢ø¡∏™ ∞. ™ÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ ™.¢.
¡ÂfiÙÂÚÔÈ ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘. ¢È·‚ËÙÔÏÔÁÈο ¡¤·
2003; 21: 26-30.
2536. KARAMITSOS TD, KARVOUNIS HI, DIDANGELOS TP, PAPADOPOULOS CE, KACHRIMANIDOU MK, SELVANAYAGAM JB, PARHARIDIS GE. Aortic elastic properties are related to left
ventricular diastolic function in patients with type 1
diabetes mellitus. Cardiology 2008; 109: 99-104.
2537. BELAZI M, VELEGRAKI A, FLEVA A, GIDARAKOU I, PAPANAUM L, BAKA D, DANIILIDOU N, KARAMITSOS D. Candidal overgrowth in
diabetic patients: Potential predisposing factors. Mycoses 2005; 48: 192-6.
2538. SOUGIOULTZOGLOU F, FALORNI A, KASSI
G, BROZZETTI A, KARAMITSOS D, KOLIAKOS
GG. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients
with type 1 diabetes. Exp Clin Endocrinol Diabetes
2005; 113: 85-9.
2539. KARAMITSOS TD, KARVOUNIS HI, DIDANGELOS T, PARCHARIDIS GE, KARAMITSOS
DT. Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients:
a tissue Doppler echocardiographic study. Diabetes
Care 2008; 31: 325-7.
2540. KARAMITSOS TD, KARVOUNIS HI, DIDANGELOS TP, PAPADOPOULOS CE, DALAMANGA EG, KARAMITSOS DT, PARHARIDIS GE,
LOURIDAS GE. Usefulness of colour tissue Doppler
imaging in assessing aortic elastic properties in Type 1
diabetic patients. Diabet Med 2006; 23: 1201-6.
2541. KARAMITSOS TD, KARVOUNIS HI, DALAMANGA EG, PAPADOPOULOS CE, DIDANGELLOS TP,KARAMITSOS DT, PARHARIDIS
GE, LOURIDAS GE. Early diastolic impairment of
diabetic heart: The significance of right ventricle. Int
J Cardiol 2007; 114: 218-23.
2542. LANGE K, SASSMANN H, VON SCHÜTZ W,
KORDONOURI O, DANNE T. Prerequisites for
age-appropriate education in type 1 diabetes: A model programme for paediatric diabetes education in
Germany. Pediatr Diabetes 2007; 8 (Suppl 6): 63-71.
2543. DIAMANTOPOULOS EJ, ATHYROS VG, YFANTI GK, MIGDALIS EN, ELISAF M, VARDAS
PE, MANOLIS AS, KARAMITSOS DT, GANOTAKIS ES, HATSERAS D; OLYMPIC STUDY
GROUP. The control of dyslipidemia in outpatient
clinics in Greece (OLYMPIC) Study. Angiology 2005;
56: 731-41.
2544. DIDANGELOS TP, THANOPOULOU AK, BOUBOULAS SH, SAMBANIS CL, ATHYROS VG,
SPANOU EA, DIMITRIOU KC, PAPPAS SI, KARAMANOS BG, KARAMITSOS DT. The ORLIstat
181
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
and CARdiovascular risk profile in patients with
metabolic syndrome and type 2 DIAbetes
(ORLICARDIA) Study. Curr Med Res Opin 2004;
20: 1393-401.
2545. ∞À°OY™Δ∏™ π¡. ¶·¯˘Û·ÚΛ· Î·È ‰È·ÙÚÔÊ‹: ¢È·‚‹Ù˘: ªÂÙ·‚ÔÏÈΤ˜ Î·È ÂÓ‰ÔÎÚÈÓÈΤ˜ ‰È·Ù·Ú·¯¤˜.
∞ı‹Ó·, 1988: 175 ÛÂÏ.
2546. ∫∞Δ™π§∞ª¶ƒO™ ¡, πø∞¡¡π¢∏™ π, Δ∂¡ΔO§OÀƒ∏™ ¡, Δ™∞¶O°∞™ ¶. M·ı·›Óˆ Ó· ˙ˆ Ì ÙÔÓ
‰È·‚‹ÙË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ §›ÙÛ·˜, 2000:
254 ÛÂÏ.
2547. KAPARIANOS A, ARGYROPOULOU E, SAMPSONAS F, KARKOULIAS K, TSIAMITA M,
SPIROPOULOS K. Pulmonary complications in diabetes mellitus. Chron Respir Dis 2008; 5: 101-8.
2548. SARAFIDIS PA, STAFYLAS PC, KANAKI AI,
LASARIDIS AN. Effects of renin-angiotensin system
blockers on renal outcomes and all-cause mortality in
patients with diabetic nephropathy: an updated metaanalysis. Am J Hypertens 2008; 21: 922-9.
2549. HADJIDAKIS DI, ANDROULAKIS II, MYLONAKIS AM, SFAKIANAKIS ME, RAPTIS AE,
PAPAEFSTATHIOU AG, ECONOMOPOULOS
TC, RAPTIS SA. Diabetes in Postmenopause: Different influence on Bone Mass According to Age and
Disease Duration. Exp Clin Endocrinol Diabetes
2009; 117: 199-204.
2550. HADJIDAKIS DJ, RAPTIS AE, SFAKIANAKIS
M, MYLONAKIS A, RAPTIS SA. Bone mineral density of both genders in Type 1 diabetes according to
bone composition. J Diabetes Complications 2006;
20: 302-7.
2551. HADJIDAKIS DJ, MYLONAKIS AM, SFAKIANAKIS ME, RAPTIS AE, RAPTIS SA. Diabetes and
premature menopause: Is their coexistence detrimental to the skeleton? Eur J Endocrinol 2005; 152: 43742.
2552. ™¶∞´∞ ™, ¶∞∑∞ƒ§O°§OÀ ª, ∂§∂À£∂ƒπ∞¢∏™ £, ∞™∫∂¶π¢∏™ ¡, Δ∞ª¶OÀ∫∞ ∞, μ∞°πø¡∞™ °. ∂ӉȷʤÚÔ˘Û· ÂÚ›ÙˆÛ˘ ıÂÚ·›·˜ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡ Ì ÙÔÈ΋ ¤Á¯˘ÛË Ê·ÈÓ˘ÙÔ˚Ó˘. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2001; 11: 194-8.
2553. SPAIA S, ELEFTHERIADIS TH, PAZARLOGLOU M, ASKEPIDIS N, IOANNIDIS I, TAMBUKA A, VAYONAS G. Phenytoin efficacy in treatment of diabetic foot ulcer in a hemodialysis patient.
Nephrol Dial Translant 2004; 19: 753.
2554. PAZARLOGLOU M, SPAIA S, PAGKALOS E,
IOANNIDIS H, ASKEPIDIS N, VARYEMEZIS V.
Evaluation of insulin resistance and sodium sensitivity in normotensive offspring of hypertensive individuals. Am J Kidney Dis 2007; 49: 540-6.
2555. CANDILOROS H, ZEGHARI N, ZIEGLER O,
DONNER M, DROUIN P. Hyperinsulinemia is related to erythrocyte Phospholipid Composition and
182
membrane fluidity changes in obese nondiabetic
women. J Clin Endocrinol 1996; 81: 2912-8.
2556. CANDILOROS H, MULLER S, ZEGHARI N,
DONNER M, DROUIN P, ZIEGLER O. Decreased
erythrocyte membrane fluidity in poorly controlled
IDDM. Diabetes Care 1995; 18: 549-51.
2557. KIAYIAS J, VLACHOU E, BAKIDES S, PETRIDOU E, MIGDALIS I. Prostatic cancer, hypogonatism and insulin resistance. Diabetes Care 2006; 29:
1178-9.
2558. KIAYIAS J, VLACHOU E, LAKKA-PAPADODIMA E. Metformin and lipoprotein (a) levels. Diabetes Care 1999; 22: 859.
2559. KIAYIAS J, VLACHOU E, THEODOSOPOULOU E, LAKKA-PAPADODIMA E. Rosiglitazone
in combination with glimepiride plus metformin in
type 2 diabetic patients. Diabetes Care 2002; 25: 12512.
2560. KIAYIAS J, VLACHOU E, LAKKA-PAPADODIMA E. Venlafaxine HCl in the treatment of painful
peripheral diabetic neuropathy. Diabetes Care 2000;
23: 699.
2561. THANOPOULOU A, KARAMANOS B, ANGELICO F, ASSAAD-KHALIL S, BARBATO A, DEL
BEN M, DJORDJEVIC P, DIMITRIJEVIC-SRECKOVIC V, GALLOTTI C, KATSILAMBROS N,
MIGDALIS I, MRABET M, PETKOVA M, ROUSSI D, TENCONI M, ARCHIMANDRITIS A. Epidemiological evidence for the non-random clustering
of the components of the Metabolic Syndrome. Multi-Centre Study of the Mediterranean Group for the
Study of Diabetes (MGSD). Eur J Clin Nutr 2006; 60:
1376-83.
2562. LOIZOU T, POULOUKAS S, TOUNTAS C, THANOPOULOU A, KARAMANOS B. An epidemiologic study on the prevalence of diabetes, glucose intolerance and metabolic syndrome in the adult population of the Republic of Cyprus. Diabetes Care 2006;
29: 1714-5.
2563 ∫∞Δ™π∫∏ ¡, ∑∞¡Δπ¢∏™ ∞, ¢π¢∞°°∂§O™ Δ,
NATHAN D.M, BUSE J.B, DAVIDSON M.B, FERRANINI E, HOLMAN R.R, ZINMAN B. ∞ÏÁfiÚÈıÌÔ˜ ıÂÚ·¢ÙÈ΋˜ ·ÓÙÈÌÂÙÒÈÛ˘ Ù˘ ˘ÂÚÁÏ˘Î·ÈÌ›·˜
Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2: ŒÓ·ÚÍË Î·È ÚÔÛ·ÚÌÔÁ‹ Ù˘ ıÂÚ·›·˜. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2008; 21: 239-66.
2564. THANOPOULOU A, KARAMANOS B, ROUSSIPENESI D. A standardized triglyceride and carbohydrate challenge: Response to Mohanlal and Holman.
Diabetes Care 2004; 27: 2092-93.
2565. £∞¡O¶OÀ§OÀ ∞, ƒOÀ™™∏-¶∞π¡∂™∏ ¢, ª∞ƒ∞∫∏ ¶, ∫∞ƒ∞ª∞¡O™ μ. ∏ ªÂÛÔÁÂȷ΋ ‰›·ÈÙ·
Û‹ÌÂÚ·. ™‡ÁÎÚÈÛË 4 ¯ˆÚÒÓ. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ∂Ù·ÈÚ›· ∂ÈÛÙËÌfiÓˆÓ Δ¯ÓÔÏfiÁˆÓ ΔÚÔÊ›ÌˆÓ Î·È °ÂˆÔÓÈÎÔ‡ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ, 2001: 21-7.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2566. £∞¡O¶OÀ§OÀ ∞. ÀÂÚˆÛ̈ÙÈ΋ ÌË ÎÂÙÔÙÈ΋
ηٿÛÙ·ÛË. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2002: 117-9.
2567. £∞¡O¶OÀ§OÀ ∞, ΔOÀ¡Δ∞™ Ã. °·Ï·ÎÙÈ΋
OͤˆÛË. ™ÙÔ ΔÔ‡ÓÙ·˜ Ã. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘: £ÂˆÚ›·-¶Ú¿ÍË. ∞ı‹Ó·, 2003; ÙfiÌ. μ′: 675-91.
2568. £∞¡O¶OÀ§OÀ ∞. ∏ ¿ÛÎËÛË ÛÙÔÓ ™·Î¯·ÚÒ‰Ë
¢È·‚‹ÙË ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2003: 92-6.
2569. £∞¡O¶OÀ§OÀ ∞. ªË ·ÓÙȉȷ‚ËÙÈο Ê¿Ú̷η
Î·È ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ
™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2003: 220-2.
2570. £∞¡O¶OÀ§OÀ ∞, ∫∞ƒ∞ª∞¡O™ μ. ∏ ÂȉËÌÈÔÏÔÁ›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È ÙˆÓ ÂÈÏÔÎÒÓ
ÙÔ˘. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2007: 49-62.
2571. £∞¡O¶OÀ§OÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÙÚ›ÙË ËÏÈΛ·. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 257-60.
2572. £∞¡O¶OÀ§OÀ ∞. ¡ÂfiÙÂÚ˜ ·ÓÙȉȷ‚ËÙÈΤ˜ Ô˘Û›Â˜. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2005: 170-4.
2573. ∞ƒÃπª∞¡¢ƒπΔ∏™ ∞, £∞¡O¶OÀ§OÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÙÈÎfi Û‡ÛÙËÌ·. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 261-2.
2574. £∞¡O¶OÀ§OÀ ∞. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË
Ù˘ ·¯˘Û·ÚΛ·˜. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞.
ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë
¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2007:
118-21.
2575. ∫∞ƒ∞ª∞¡O™ μ, £∞¡O¶OÀ§OÀ ∞. ∏ ıÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù·
ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2007: 122-39.
2576. £∞¡O¶OÀ§OÀ ∞. ¶ÚfiÏË„Ë ÙÔ˘ ™·Î¯·ÚÒ‰Ë
¢È·‚‹ÙË. ¡¤ÔÈ ÔÚ›˙ÔÓÙ˜. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·,
2008: 340-53.
2577. ∫∞ƒ∞ª∞¡O™ μ, £∞¡O¶OÀ§OÀ ∞. ªÂÏÏÔÓÙÈÎÔ› ÛÙfi¯ÔÈ ÛÙË ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚‹ÙË. ™ÙÔ ∫·Ú·Ì¿ÓÔ˜ μ, £·ÓÔÔ‡ÏÔ˘ ∞. ªÂÙÂÎ·È‰Â˘ÙÈο ª·ı‹Ì·Ù· ÁÈ· ÙÔÓ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ¢È·‚ËÙÔÏÔÁÈÎfi ∫¤ÓÙÚÔ πÔÎÚ¿ÙÂÈÔ˘ ¡ÔÛÔÎÔÌ›Ԣ ∞ıËÓÒÓ, 2007: 193-6.
2578. ªOÀ™§∂à ∑. ∂›ÙˆÛË Ù˘ ·¯˘Û·ÚΛ·˜ Î·È ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ·Ó··Ú·ÁˆÁÈ΋ ÏÂÈÙÔ˘ÚÁ›· ÙÔ˘ ¿Ó‰Ú·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 26782.
2579. ∫∞Δ™π∫∏ ¡, °∫OΔ∑∞ª∞¡∏-æ∞ƒƒ∞∫OÀ ∞,
∏§π∞¢∏™ º, ¢π¢∞°°∂§O™ Δ, °πøμO™ π, ∫∞ƒ∞ª∏Δ™O™ ¢. O ÏfiÁÔ˜ ÏÂÙ›Ó˘/·‰ÈÔÓÂÎÙ›Ó˘ ˆ˜
·ÓÂÍ¿ÚÙËÙÔ˜ ÚÔÁÓˆÛÙÈÎfi˜ ·Ú¿ÁÔÓÙ·˜ 10ÂÙÔ‡˜
ηډȷÁÁÂÈ·ÎÔ‡ ÎÈÓ‰‡ÓÔ˘ Û ÈÓÛÔ˘ÏÈÓÔıÂÚ·¢fiÌÂÓÔ˘˜ ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 283-91.
2580. ∫∞ƒ∞ª∏Δ™O™ ¢, ∏§π∞¢∏™ º, ∑∞¡Δπ¢∏™ ∞,
¢π¢∞°°∂§O™ Δ. Δ¤ÛÛÂÚȘ ÂÚÈÙÒÛÂȘ ÈÓÒ‰Ô˘˜
‰È·‚ËÙÈ΋˜ Ì·ÛÙÔ¿ıÂÈ·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2008; 21: 301-4.
2581. ™∫OÀΔ∞™ ¢. ∫¿ÓÈÛÌ· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2008; 21: 307-17.
2582. LEIGHTON B, DIMITRIADIS G, PARRY-BILLINGS M, BOND J, VASCONCELOS P, NEWSHOLME E.A. Effects of insulin on glucose metabolism in skeletal muscle from septic and endotoxaemic
rats. Clin Science (Lond), 1989; 77: 61-7.
2583. KARAMANOS B, THANOPOULOU A, ANGELICO F, ASSAAD-KHALIL S, DJORDJEVIC P,
KATSILAMBROS N, MIGDALIS I, MRABET M,
PETKOVA M, TENCONI M. Nutritional Habits in
the Mediterranean Basin. The macronutrient composition of the diet and its relation with the traditional
Mediterranean diet. Multi-Centre Study of the
Mediterranean group for the Study of Diabetes
(MGSD). Eur J Clin Nutr 2002; 56: 983-91.
2584. THANOPOULOU A, KARAMANOS B, ANGELICO F, ASSAAD-KHALIL S, DJORDJEVIC P,
KATSILAMBROS N, MIGDALIS I, MRABET M,
PETKOVA M, TENCONI M. Dietary fat intake as
risk factor for the development of diabetes mellitus.
Multinational, Multi-Centre Study of the Mediterranean Group for the Study of Diabetes (MGSD). Diabetes Care 2003; 26: 302-7.
2585. PITSAVOS C, MAKRILAKIS K, PANAGIOTAKOS DB, CHRYSOHOOU C, IOANNIDIS I, DIMOSTHENOPOULOS C, STEFANADIS C, KATSILAMBROS N. The J-shape effect of alcohol intake
on the risk of developing Acute Coronary Syndromes
in diabetic subjects: The CARDIO 2000 1-1 Study.
Diabet Med 2005; 22: 243-8.
2586. THANOPOULOU AC, KARAMANOS BG, ANGELICO FV, ASSAAD-KHALIL SH, BARBATO
AF, DEL BEN MP, DJORDJEVIC PB, DIMITRIJEVIC-SRECKOVIC VS, GALLOTTI CA, KATSILAMBROS N, MIGDALIS IN, MRABET MM,
PETKOVA MK, ROUSSI DP,TENCONI MT. Dietary fat intake as risk factor for the development of
diabetes: Multinational, multicenter study of the
Mediterranean Group for the Study of Diabetes
(MGSD). Diabetes Care 2003; 26: 302-7.
183
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2587. ¶∞¶¶∞™ ™, ∞¶O™ΔO§OÀ O, ª¶OÀ™ª¶OÀ§∞™ ™. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2 Î·È Î·Ú‰ÈÔ·ÁÁÂȷ΋ ÓfiÛÔ˜: OʤÏË ÙˆÓ Â˘·ÈÛıËÙÔÔÈËÙÒÓ Ù˘
ÈÓÛÔ˘Ï›Ó˘ ¤Ú· ·fi ÙÔ ÁÏ˘Î·ÈÌÈÎfi ¤ÏÂÁ¯Ô. ™ÙÔ:
¶·¿˜ ™π. ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‹ıˆÓ ·ı‹ÛÂˆÓ ·fi
ÙÔ ÁÈ·ÙÚfi Ù˘ ¶ÚˆÙÔ‚¿ıÌÈ·˜ ºÚÔÓÙ›‰·˜ ÀÁ›·˜.
∞ı‹Ó·: ∂Ή. ΔÛ›Ë, 2005: 81-93.
2588. ∫∞ƒ∞ª∞¡O™ μ°. £ÂÈ·˙ÔÏȉÈÓ‰ÈfiÓ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¶ÂÚ›Ô‰Ô˜ ÂÊ˂›·˜ ‹ ˆÚ›Ì·ÓÛ˘;
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2006. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006:
136-46.
2589. ∞§∞μ∂ƒ∞™ ∞°. ∞ÓÙÈ˘ÂÚÙ·ÛÈ΋ ·ÁˆÁ‹ ÛÙÔ ‰È·‚ËÙÈÎfi ¿ÙÔÌÔ Ì ˘¤ÚÙ·ÛË Î·È ÏÂ˘ÎˆÌ·ÙÔ˘Ú›·. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 281-95.
2590. ∞§∞μ∂ƒ∞™ ∞°. O ÚfiÏÔ˜ ÙˆÓ ·Ó·ÛÙÔϤˆÓ ÙÔ˘ ÌÂÙ·ÙÚÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘ Ù˘ ·ÁÁÂÈÔÙ·Û›Ó˘ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2006.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006: 307-25.
2591. ªÀ°¢∞§∏™ ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2006. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006: 249-61.
2592. POLYZOGOPOULOU EV, KALFARENTZOS F,
VAGENAKIS AG, ALEXANDRIDES TK. Restoration of euglycemia and normal acute insulin response
to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 1098-103.
2593. ª∞∫ƒÀ§∞∫∏™ ∫, πø∞¡¡π¢∏™ π. ¢È·ÙÚÔÊ‹ ηÈ
‰È·‚‹Ù˘. ™ÙÔ: ∫·ÙÛÈÏ¿ÌÚÔ˜ ¡, ¢È·ÎÔ˘ÌÔÔ‡ÏÔ˘ ∂,
πˆ·ÓÓ›‰Ë˜ π, §È¿Ù˘ ™. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ÛÙËÓ
ÎÏÈÓÈ΋ Ú¿ÍË: O ‰È·‚‹Ù˘ ·fi ÙÔ ∞ ˆ˜ ÙÔ ø Ì ÂÚˆÙ‹ÛÂȘ Î·È ··ÓÙ‹ÛÂȘ. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
§›ÙÛ·˜, 2005: 345-58.
2594. KATSILAMBROS NL. Nutrition in diabetes mellitus. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl
2): 250-8.
2595. RAPTIS S, DIMITRIADIS G. Oral hypoglycaemic
agents: πnsulin secretagogues, ·-glucosidase inhibitors and insulin sensitizers. Exp Clin Endocrinol
Diabetes 2001; 109 (Suppl 2): 265-87.
2596. ºπ§π¶¶π¢∏™ º. ∞ÓÙȉȷ‚ËÙÈ΋ ·ÁˆÁ‹. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 689-717.
2597. ª∞ÀƒO°π∞¡¡∞∫∏ ∞. O ‰È·‚ËÙÈÎfi˜ ÛÙÔ ÓÔÛÔÎÔÌ›Ô. π·ÙÚÈ΋ 2006; 89: 399-411.
2598. ª∞ÀƒO°π∞¡¡∞∫∏ ∞. O ÓÔÛËÏ¢fiÌÂÓÔ˜ ‰È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡ (ÂÈÌ. ¤Î‰.). μ·ÛÈΤ˜ ·Ú¯¤˜ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ∞ı‹Ó·: π·ÙÚÈ΋ ∂Ù·ÈÚ›· ∞ıËÓÒÓ, 2006: 64-80.
2599. ƒ∞¶Δ∏™ ™∞, ª¶OÀΔ∞Δ∏ ∂π. ¡¤Â˜ ÂÏ›‰Â˜ ÛÙÔ
·‰È¤ÍÔ‰Ô ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. ™ÙÔ ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2006.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006: 417-37.
184
2600. HATZITOLIOS A, SAVOPOULOS C, LAZARAKI G, SIDIROPOULOS I, HARITANTI P, LEFKOPOULOS A. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease
with dyslipidemia. Indian J Gastroenterol 2004; 23:
131-4.
2601. DIMITRIADIS G, TESSARI P, GERICH J. Effects
of a long acting somatostatin analog on postprandial
hyperglycaemia in insulin-depended diabetes mellitus. Metabolism 1983; 32: 987-92.
2602. KAKAFIKA AI, MIKHAILIDIS DP, KARAGIANNIS A, ATHYROS VG. The role of endocannabinoid system blockade in the treatment of the
metabolic syndrome. J Clin Pharmacol 2007; 47: 64252.
2603. DIMITRIADIS G, TESSARI P, GO VL, GERICH
H. ·-Glucosidase inhibition improves postprandial
hyperglycemia and decreases insulin requirements in
insulin dependent diabetes mellitus. Metabolism
1985; 34: 261-5.
2604. MIGDALIS IN, XENOS K, CHAIROPOULOS K,
VARVARIGOS N, LEONTIADES E, KARMANIOLAS K. Ca2+ Mg2+ -ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy. Diabetes Res Clin Pract 2000; 49: 113-8.
2605. VLASSARA HV, PEPPA MM. Glycoxidation: ∞
normal pathway with major impact on diabetic
complications. ™ÙÔ ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 2002. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2002: 59-68.
2606. DIMITRIADIS G, GERICH J. Effect of twice daily
subcutaneous administration of a long-acting somatostatin analog on 24 hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus. Horm
Metab Res 1985; 17: 510-1.
2607. ºπ§π¶¶π¢∏™ º¶. ¶·ıÔÁÂÓÂÙÈÎÔ› Ì˯·ÓÈÛÌÔ› Ó¢ÚÔ¿ıÂÈ·˜: O‰fi˜ ÔÏ˘fiÏ˘ ÔÍÂȉˆÙÈ΋ ηٷfiÓËÛË.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004:
73-84.
2608. PEPPA MP, VLASSARA HV. Oxidant stress, diabetes mellitus and its complications. ™ÙÔ ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2006.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006: 31-41.
2609. DIMITRIADIS G, PEHLING G, GERICH J. Abnormal glucose modulation of ·- and ‚-cell responses
to arginine in non-insulin dependent diabetes mellitus. Diabetes 1985; 34: 541-7.
2610. VLASSARA H. The AGE-receptor in the pathogenesis of diabetes complications. Diabetes Metab
Res Rev 2001; 17: 436-43.
2611. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂¢, ∞§∂•∞¡¢ƒ∞∫∏ ∫¡. ¶ÚˆÙÂ˚ÓÈ΋ ÎÈÓ¿ÛË C: ŒÓ·˜ Ó¤Ô˜ ıÂÚ·¢ÙÈÎfi˜ ÛÙfi¯Ô˜ Ù˘ ‰È·‚ËÙÈ΋˜ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004:
41-71.
2612. ¡π∫O§O¶OÀ§O™ ∞, Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. OÈ Ì˯·ÓÈÛÌÔ› ÙˆÓ ÂÈÏÔÎÒÓ
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ¡ÂfiÙÂÚ˜ ·fi„ÂȘ.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2006; 23: 131-9.
2613. ªÀ°¢∞§∏™ ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002: 45-62.
2614. LIATIS S, MARINOU K, TENTOLOURIS N, PAGONI S, KATSILAMBROS N. Usefulness of a new
indicator test for the diagnosis of peripheral and
autonomic neuropathy in patients with diabetes
mellitus. Diabet Med 2007; 24: 1375-80.
2615. MIGDALIS IN. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
Res Com Mol Path Pharm 2006; 119: 105-14.
2616. ™Δ∞ª¶OÀ§∏™ ∂. ∞ÈÙÈÔÏÔÁÈ΋ ıÂÚ·›·. ™ÙÔ:
™Ù·ÌÔ˘Ï‹˜ ∂. £ÂÚ·›· ‰È·‚ËÙÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜.
∞ı‹Ó·, 1995: 23-77.
2617. PAPANAS N, PAPATHEODOROU K, PAPAZOGLOU D, KOTSIOU S, CHRISTAKIDIS D, MALTEZOS E. An insertion/deletion polymorphism in the
alpha 2 B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes
mellitus: Short communication. Exp Clin Endocrinol
Diabetes 2007; 115: 327-30.
2618. KARAVANAKI K, KAZIANIS G, KAKLEAS K,
KONSTANTOPOULOS I, KARAYIANNI C. QT
interval prolongation in association with impaired circadian variation of blood pressure and heart rate in
adolescents with Type 1 diabetes. Diabet Med 2007;
24: 1247-53.
2619. ∫∞ƒ∞ª∏Δ™O™ ¢£, ∫∞ƒ∞ª∏Δ™O™ £¢. À¿Ú¯ÂÈ ‰È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·; ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2006. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006: 205-17.
2620. ∫∂º∞§O°π∞¡¡∏™ ¡∫. O ‰È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜
ÛÙÔ ¯ÂÈÚÔ˘ÚÁ›Ô. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜
ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2004: 165-81.
2621. VAN HAEFTEN T, BOLLI G, DIMITRIADIS G,
GOTTESMAN I, HORWITZ D, GERICH J. Effect
of insulin antibodies and their kinetic characteristics
on plasma free-insulin dynamics in patients with diabetes mellitus. Metabolism 1986; 35: 649-56.
2622. Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡, §π¡OÀ ∞, ™Δ∞ª¶OÀ§∏™ ∂, ¶∞¶∞°∂øƒ°πOÀ ∫.
ªÂÙ·‚ÔϤ˜ Ù˘ ·ÚÙËÚȷ΋˜ ›ÂÛ˘ Î·È ÙÔ˘ ηډȷÎÔ‡ Ú˘ıÌÔ‡ ηٿ ÙËÓ Â›Î˘„Ë Û ‰È·‚ËÙÈο Î·È Ê˘ÛÈÔÏÔÁÈο ¿ÙÔÌ·. ∞Ú¯ ∂ÏÏ π·ÙÚ 1997; 14: 402-11.
2623. TENTOLOURIS N, LIATIS S, KATSILAMBROS
N. Sympathetic nervous system activity in obesity and
metabolic syndrome. Ann N Y Acad Sci 2006; 1083:
129-52.
2624. KARAVANAKI K, BAUM JD. Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J Pediatr Endocrinol Metab
1999; 12: 411-22.
2625. MIGDALIS IN, THOMAIDES T, CHAIROPOULOS C, KALOGEROPOULOU C, CHARALABIDES J, MANTZARA F. Changes of gastric emptying
rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients. Clin
Auton Res 2001; 11: 259-63.
2626. SARAFIDIS PA, LASARIDIS AN, NILSSON PM,
PAGKALOS EM, HITOGLOU-MAKEDOU AD,
PLIAKOS CI, KAZAKOS KA, YOVOS JG,
ZEBEKAKIS PE, TZIOLAS IM, TOURKANTONIS AN. Ambulatory blood pressure reduction after
rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens 2004; 22: 1769-77.
2627. ∫Àƒπ∞∫O¶OÀ§O™ ª. ¢È·ÁÓˆÛÙÈ΋ ÚÔÛ¤Ï·ÛË. ™ÙÔ: ∫˘ÚÈ·ÎfiÔ˘ÏÔ˜ ª. ™Ù˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·.
∞ı‹Ó·, 2003: 43-4.
2628. ªÀ°¢∞§∏™ ∏¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ·Ó‰ÚÈ΋ ÛÙ˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›· - Ú¿ÍË. ∞ı‹Ó·: 2003:
869-82.
2629. ªÀ°¢∞§∏™ ∏¡, °∂øƒ°OÀ§π∞™ ¶, ¢∏ª∞∫O¶OÀ§O™ ¡, ¶∞¶∞¡∞°πøΔOÀ ¡, Ã∞πƒO¶OÀ§O™ ∫, μ∞ƒμ∞ƒπ°O™ ¡∏. ∞ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ·
Ù˘ ÛÈ˙·Ú›‰Ë˜ ÛÙË ‰È·‚ËÙÈ΋ Á·ÛÙÚÔ¿ÚÂÛË. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 2000; 17: 390-4.
2630. ™Δ∞ª¶OÀ§∏™ ∂. ™˘Ìو̷ÙÈ΋ ıÂÚ·›·. ™ÙÔ:
™Ù·ÌÔ˘Ï‹˜ ∂. £ÂÚ·›· ‰È·‚ËÙÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜.
∞ı‹Ó·, 1995: 93-126.
2631. Àº∞¡ΔO¶OÀ§O™ π¡. OÈÎÔÓÔÌÈΤ˜ ‰È·ÛÙ¿ÛÂȘ
ÛÙÔ ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi
¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2001: 37-44.
2632. PAPADOPOULOU-ALATAKI E, PAPADOPOULOU-LEGBELOU K, DOUKAS L, KARATZIDOU K, PAVLITOU-TSIONTSI A, PAGKALOS E.
Clinical and biochemical manifestations of syndrome
X in obese children. Eur J Pediatr 2004; 163: 573-9.
2633. DANNE T, KORDONOURI O. Current challenges
in children with type 1 diabetes. Pediatr Diabetes
2007; 8 (Suppl 6): 3-5.
2634. DANNE T, LANGE K, KORDONOURI O. New
developments in the treatment of type 1 diabetes in
children. Arch Dis Child 2007; 92: 1015-9.
2635. ROBBINS DC, BEISSWENGER PJ, CERIELLO
A, GOLDBERG RB, MOSES RG, PAGKALOS
EM, MILICEVIC Z, JONES CA, SARWAT S, TAN
MH. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus
metformin, in the achievement of target HbA1c and
pre- and postprandial blood glucose levels in patients
with type 2 diabetes: A multinational, 24- week, ran-
185
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
domized, open-label, parallel-group comparison. Clin
Ther 2007; 29: 2349-64.
2636. ªÀ°¢∞§∏™ ∏¡, μ∞ƒμ∞ƒπ°O™ ¡, ∫∂ƒ∫OÀ§∞™ ∂, Δ∞ƒ∞μ∏ƒ∞ ∞. ¡Â˘ÚÔ·ıËÙÈ΋ ·ÚıÚÔ¿ıÂÈ· (¿ÚıÚˆÛË Charcot) ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏ. ƒÂ˘Ì·ÙÔÏÔÁ›· 1997; 8: 279-82.
2637. ªÀ°¢∞§∏™ ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ:
∑ËÚÔÁÈ¿ÓÓ˘ ¶, ¶È·‰›Ù˘ °, ΔÛÈÔ˘Ê¿Î˘ °. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘-∂ÈÏÔΤ˜. ∞ı‹Ó·: ∂Ù·ÈÚ›· ¡ÔÛËÏ¢ÙÈÎÒÓ ™Ô˘‰ÒÓ, 1997: 69-71.
2638. ªÀ°¢∞§∏™ ∏¡. ΔÔ ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 176-90.
2639. PAGKALOS M, KOUTLIANOS N, KOUIDI E,
PAGKALOS E, MANDROUKAS K, DELIGIANNIS A. Heart rate variability modifications following
exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy. Br J Sports Med
2008; 42: 47-54.
2640. ™øΔ∏ƒO¶OÀ§OÀ ∞, ∞¶O™ΔO§OÀ O, ¶∂¶¶∞™ £, ∫OΔ™π¡∏ μ, ™∫§∏ƒO™ ∂, ¶∞¶∞¢∏ª∏ΔƒπOÀ ¶, ¶∞¶∞¢∞∫∏™ °, ¶∞¶¶∞™ ™. ∂ÎÙ›ÌËÛË Û˘ÌÌfiÚʈÛ˘ ÙˆÓ È·ÙÚÒÓ ÛÙËÓ Ù‹ÚËÛË ÙˆÓ Î·Ù¢ı˘ÓÙ‹ÚÈˆÓ Ô‰ËÁÈÒÓ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË Î·È ¤Î‚·ÛË ·˘ÙÒÓ Û ·ıÔÏÔÁÈ΋ ÎÏÈÓÈ΋.
¶ÚˆÙÔ‚¿ıÌÈ· ºÚÔÓÙ›‰· ÀÁ›·˜ 1999; 11: 133-8.
2641. ™Δ∞ª¶OÀ§∏™ ∂, ∞∫OÀ∞μπμ∞ Δ, μ§∞ÃOÀ
¡, °π∞ª∞§∏™ ¢, ∫ø¢OÀ¡∏™ ∞, ¢∞μ∞∫∏ ¶,
∫∞ƒ∞ƒπ∑OÀ ∂. ™¯¤ÛË ÎÏÈÓÈ΋˜ Î·È Ó¢ÚÔÊ˘ÛÈÔÏÔÁÈ΋˜ ÂͤٷÛ˘ ÛÙËÓ ‰È¿ÁÓˆÛË Ù˘ Û˘ÌÌÂÙÚÈ΋˜ ‰È·‚ËÙÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜. ¡Â˘ÚÔÏÔÁ›· 1999; 8: 121-33.
2642. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ ™¢ Ù‡Ô˘ ππ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
2007: 535-7.
2643. MÀ°¢∞§∏™ ∏¡. §ÔÈÌÒÍÂȘ Î·È ‰È·‚ËÙÈÎfi fi‰È.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ΔÔ ‰È·‚ËÙÈÎfi fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002: 99-119.
2644. ªÀ°¢∞§∏™ ∏¡. ∫·Ú‰ÈÔ·ÁÁÂÈ·Îfi Û‡ÛÙËÌ· ηÈ
Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜.
™ÙÔ: ª˘Á‰¿ÏË ∏¡. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 117-29.
2645. BOUTATI EI, RAPTIS SA. Postprandial hyperglycaemia in type 2 diabetes: Pathophysiological
aspects, teleological notions and flags for clinical
practice. Diabet Metab Res Rev 2004; 20 (Suppl 2):
S13-S23.
2646. ªÀ°¢∞§∏™ ∏. ¡Â˘ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏. ¢È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008: 95116.
2647. ∞¶O™ΔO§π¢∏™ ¡, ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ¯ÂÈÚÔ˘ÚÁÈÎfi˜ ·ÛıÂÓ‹˜. ™ÙÔ: ΔÔ‡ÓÙ·˜ Ã.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-¶Ú¿ÍË. ∞ı‹Ó·: ∂Ή.
∂Ù¿ÏÔÊÔ˜, 1995: 593-99.
186
2648. ∫∞ƒ∞ª∏Δ™O™ ¢£, ∞¡∞™Δ∞™π∞¢∏™ ∫∏. ∏
Ú‡ıÌÈÛË Ù˘ ÁÏ˘Îfi˙˘ ÙÔ˘ ·›Ì·ÙÔ˜ ÛÙËÓ ÂÚÈÂÁ¯ÂÈÚËÙÈ΋ ÂÚ›Ô‰Ô ÂÁ¯ÂÈÚ‹ÛÂˆÓ Ì Â͈ۈ̷ÙÈ΋ ΢ÎÏÔÊÔÚ›·. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 177-81.
2649. Δ™πOÀº∏™ ∫, ™Δ∂º∞¡∞¢∏™ Ã, ∞¡Δø¡π∞¢∏™ ¢π, ∑∞ª¶∞ƒ∞™ ¶, ΔOÀΔOÀ∑∞ ª, °∫OÀª∞™ °™, ΔOÀΔOÀ∑∞™ ¶∫. ™˘Û¯¤ÙÈÛË Ù˘ ÌÈÎÚÔ·Ï‚Ô˘ÌÈÓÔ˘Ú›·˜ Ì ÙËÓ ˘ÂÚÙÚÔÊ›· Ù˘ ·ÚÈÛÙÂÚ¿˜
ÎÔÈÏ›·˜ Û ÌË ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ì ȉÈÔ·ı‹
˘¤ÚÙ·ÛË. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 1998; 7: 31-7.
2650. ªÀ°¢∞§∏™ ∏¡. ∏ ¿ÛÎËÛË ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡, ¶·¿˜ ™π. £ÂÚ·¢ÙÈ΋ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2. ∞ı‹Ó·: π·ÙÚÈ΋ ∂Ù·ÈÚ›· ∞ıËÓÒÓ, 2002: 46-58.
2651. K∞ƒ∞ª∏Δ™O™ ¢£. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
¯ÂÈÚÔ˘ÚÁÈΤ˜ ÂÂÌ‚¿ÛÂȘ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2000: 377-83.
2652. ΔOÀ¡Δ∞™ â, §∞£OÀƒ∏™ ¶. O ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ ÛÙËÓ ÙÚ›ÙË ËÏÈΛ·. ™ÙÔ: ΔÔ‡ÓÙ·˜ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·-Ú¿ÍË. ∞ı‹Ó·, 2003;
ÙÔÌ. ∞′: 227-48.
2653. DIAMANTOPOULOS EJ, GRIGORIADOU M,
IFANTI G, RAPTIS SA. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent Claudication. Int Angiol 2001; 20: 337-44.
2654. DIAMANTOPOULOS EJ, HARITOS D, IFANTI
G, GRIGORIADOU M, MARGARITI G, PANIARA Q, RAPTIS SA. Management and outcome of severe diabetic foot infections. Exp Clin Endocrinol Diabetes 1998; 106: 346-52.
2655. ªÀ°¢∞§∏™ ∏¡. ÕÛÎËÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002:
107-21.
2656. PETRAKIS E, SCIACCA V. Prospective study of
transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation
in diabetic patients with lower limb ischemia. Int Angiol 2000; 19: 18-25.
2657. ∫∞ƒ∞ª∏Δ™O™ ¢. πÓÛÔ˘ÏÈÓÔıÂÚ·›·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢. ¢È·‚ËÙÔÏÔÁ›·. £ÂÛÛ·ÏÔÓ›ÎË: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2000: 129-67.
2658. ¶∞¶∞∑∞º∂πƒO¶OÀ§OÀ ∞, Δ∂¡ΔO§OÀƒ∏™
¡, §π∞Δ∏™ ™, ªøÀ™∞∫∏™ π, ∫∞Δ™π§∞ª¶ƒO™
¡, ¶∂ƒƒ∂∞ ¢, ™O§¢∞ΔO™ ƒº. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ÂÏ·ÛÙÈΤ˜ ȉÈfiÙËÙ˜ Ù˘ ·ÔÚÙ‹˜ Û ÌË ‰È·‚ËÙÈο ¿ÙÔÌ· Î·È Û ·ÛıÂÓ›˜ Ì ‰È·‚‹ÙË Ù‡Ô˘ 2.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2007; 24: 178-85.
2659. ª∞ƒμ∞∫∏ Ã, ∫ÀƒπΔ™∏ ∂, ¶O§À∫∞¡¢ƒπøΔ∏
ª, ∞ƒ°ÀƒπOÀ °, °OÀ§∞ ª, Ã∞ƒπ∑∞¡∏ º, °∫∞Δ∑ø¡∏ ª. ™˘Ì‚ÔÏ‹ Ù˘ ÂÓË̤ڈÛ˘ ÛÙË ‰È·Ù‹ÚËÛË
ÙÔ˘ ۷ί¿ÚÔ˘ ÙÔ˘ ·›Ì·ÙÔ˜ Û ÈηÓÔÔÈËÙÈο Â›‰·
Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ΔÔ ‚‹Ì· ÙÔ˘ ∞ÛÎÏËÈÔ‡ 2004; 3: 200-3.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2660. BOLLI G, DIMITRIADIS G, DEFEO P, PERIELLO G, VENTURA M, BRUNETTI P, GERISH J.
Effects of insulin antibodies on insulin pharmacokinetics, hypoglycemic glucose counter-regulation and
post-hypoglycemic hyperglycemia. In: Andreani D,
Lefebvre P, Marks V. Hypoglycemia. New York:
Raven Press, 1987; 38: 133-47.
2661. ∞§∂•∞¡¢ƒπ¢∏™ £, ∞¡∞™Δ∞™πOÀ ∂, μ∞™π§O¶OÀ§O™ Ã, πø∞¡¡π¢∏™ °, ∫OÀ∫OÀ ∂,
ª¶∞ƒΔ™O∫∞™ Ã, ¶∞¡Δ™πøΔOÀ ∫. ∫·Ù¢ı˘ÓÙ‹ÚȘ Ô‰ËÁ›Â˜ ÁÈ· ÙË ‰È¿ÁÓˆÛË Î·È ·Ú·ÎÔÏÔ‡ıËÛË
·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. Focus
2003; 7: 32-44.
2662. ∞§∂•O¶OÀ§OÀ ∞, ™∂μ∞™Δπ∞¡O™ μ, ∫∞§OΔ∞πƒ∞∫∏™ ∞, ¶∂Δƒπ∫∫O™ °, ¶∂Δƒ∞∫∏ ∫, Ã∞Δ∑∏°π∞¡¡∏™ ™π. ƒÈÓÔ-ÔÊı·ÏÌÈ΋ ÌÔ˘ÚÎÔÚ̇ΈÛË
Û ·ÛıÂÓ‹ Ì ÔÍ›· ÏÂÌÊÔÁÂÓ‹ Ï¢¯·ÈÌ›· Î·È È·ÙÚÔÁÂÓ‹ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2000; 77: 563-8.
2663. ∞¡¢ƒOÀ§∞∫∏™ ¶, Ã∞Δ∑∏¢∞∫∏™ ¢, ªÀ§ø¡∞∫∏™ ∞, ƒ∞¶Δ∏™ ∞∂, ƒ∞¶Δ∏™ ™∞. O ÚfiÏÔ˜
ÙÔ˘ ۈ̷ÙÈÎÔ‡ ‚¿ÚÔ˘˜ ÛÙËÓ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ ÛÙËÓ ÔÛÙÈ΋ ˘ÎÓfiÙËÙ· ÙˆÓ ·Ó‰ÚÒÓ. OÛÙÔ‡Ó 2005; 16: 216-21.
2664. ∞§∞ƒ°∫øº ∂. O ÚfiÏÔ˜ Ù˘ ÙÂÛÙÔÛÙÂÚfiÓ˘ Ù˘
ÚÔÏ·ÎÙ›Ó˘ Î·È ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙË ÛÙ˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·, Î·È Ë ÂÎÙ›ÌËÛ‹ ÙÔ˘˜ ÛÙËÓ ÎÏÈÓÈ΋
Ú¿ÍË. ∞Ó‹Ú 2002; 4: 85-90.
2665. ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚‹Ù˘. ∏ ÁÓÒÛË ‰›ÓÂÈ
˙ˆ‹. ∞ı‹Ó·: ª. ¶ÈÙÛÈÏ›‰Ë˜, 2004: 80 ÛÂÏ.
2666. μ∂§πøΔ∏™ Ã, ª∞¡π∞Δ∏ ª, §∞°∫ø¡∞ ∂,
ÃOÀ™O™ °. ¢È·‚ËÙÈ΋ ÎÂÙÔÔͤˆÛË. ¢ÂÏÙ›Ô ∞′
¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ
2002; 49: 179-82.
2667. °∫πOªπ™∏ ∞, ∞¡∞™Δ∞™π§∞∫∏™ ∞, ∞μƒ∞ªπ¢∏™ ∞, Δ∑∞º∂ΔΔ∞™ π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ·ËÛ˘. £¤Ì·Ù· ª·È¢ÙÈ΋˜-°˘Ó·ÈÎÔÏÔÁ›·˜ 2007; 21:
225-31.
2668. μ∏Δ∞™ ∞. ¢ÈÂÚ‡ÓËÛË ÙˆÓ ÔͤˆÓ ÛÙÂÊ·ÓÈ·›ˆÓ
ÈÛ¯·ÈÌÈÎÒÓ ÂÂÈÛÔ‰›ˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜.
∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 2003; 69: 154-9.
2669. °∞§§∏-Δ™π¡O¶OÀ§OÀ ∞, ¡OÀ™π∞-∞ƒμ∞¡πΔ∞∫∏ ™, ∑∞ƒμ∞§∏ ∞, ¶∞πO¡π¢∏™ ∞. Δ·˘Ùfi¯ÚÔÓË ÂΉ‹ÏˆÛË Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π Î·È ·ÈÌÔÏ˘ÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘ Û ˙‡ÁÔ˜ ÌÔÓÔˆÔÁÂÓÒÓ ‰È‰‡ÌˆÓ. ¶·È‰È·ÙÚÈ΋ μÔÚ›Ԣ ∂ÏÏ¿‰Ô˜ 1999; 11: 224-6.
2670. ¢π∞∫O°§OÀ ∂, ¢π∞∫O°§OÀ ∞, ∑∞ƒ¶∞Δ∏ ¶,
∑ø°πOÀ ¶. O ‰È·‚‹Ù˘ ΢‹Ûˆ˜. Focus 2003; 7: 404.
2671. °ŸÀ¢∂μ∂¡O™ π∞. ¶fiÙÂ, Ò˜ Î·È ÔÈfiÓ ·Û˘Ìو̷ÙÈÎfi ‰È·‚ËÙÈÎfi ı· ÂϤÁÍÂÈ Ô Î·Ú‰ÈÔÏfiÁÔ˜ ÁÈ·
ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ. ∫·Ú‰È¿ Î·È ∞ÁÁ›· 2006; 11: 50510.
2672. ¢∞¡π∏§π¢∏™ ∞, Δ∞¡Δ∞¡∞™∏™ £. ΔÔÎÂÙfi˜ ηÈ
‰È·‚‹Ù˘ – Ò˜ Î·È ÁÈ·Ù›. ∂ÏÏËÓÈ΋ ª·È¢ÙÈ΋ ηÈ
°˘Ó·ÈÎÔÏÔÁ›· 2008; 20: 163-6.
2673. ¢∂ƒ∂∫§∏™ ¢, §∞∫∂ ™, ∫Oæ∞Ã∂π§∏™ ∂, ª∞§OÀΔ∞™ ™, ª¶∞§∞¡π∫∞™ °, ¢π∞º∞™ ™. ∂ÈÏÔΤ˜ ‚ÈÙÚÂÎÙÔÌ‹˜ ÛÙËÓ ·Ú·ÁˆÁÈ΋ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. OÊı·ÏÌÔÏÔÁ›· 1996; 8: 22531.
2674. ¢∂ƒ∂∫§∏™ ¢§. ∏ ‚ÈÙÚÂÎÙÔÌ‹ ÛÙÔÓ ‰È·‚ËÙÈÎfi
·ÛıÂÓ‹. OÊı·ÏÌÔÏÔÁ›· 1997; 9: 89-93.
2675. ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª. ™ÂÍÔ˘·ÏÈ΋
‰˘ÛÏÂÈÙÔ˘ÚÁ›· Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. °·ÏËÓfi˜
2005; 47: 151-63.
2676. ¢∞ªπ∞¡∞∫∏ ¢, Δ™OÀΔ™π¡O™ ∞. ªÂÙ·‚ÔÏÈ΋
Ú‡ıÌÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·È‰ÈÔ‡ ηٿ ÙËÓ ÂÁ¯Â›ÚËÛË.
¶·È‰È·ÙÚÈο ÃÚÔÓÈο 1998; 23: 63-70.
2677. πø∞¡¡π¢∏™ πª. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È Úԉȷ‚‹Ù˘: ¶ÚfiÎÂÈÙ·È ÁÈ· Ù· ›‰È· ¿ÙÔÌ·; ∞˘Í¿ÓÔ˘Ó ÙÔ
›‰ÈÔ ÙÔÓ Î›Ó‰˘ÓÔ ÂÌÊ¿ÓÈÛ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË
Î·È Î·Ú‰È·ÁÁÂÈ·ÎÒÓ ÓÔÛËÌ¿ÙˆÓ. ∫·Ú‰È¿ Î·È ∞ÁÁ›·
2006; 11: 405-13.
2678. ∫∞§∞¶O¢∏ ª, ∑∞Ã∞ƒπ∞¢∏™ O. ƒ‡ıÌÈÛË Ù˘
·ÚÙËÚȷ΋˜ ›ÂÛ˘ Û ·ÛıÂÓ›˜ ¿Û¯ÔÓÙ˜ ·fi ™¢
Ù‡Ô˘ 2. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 2007; 16: 224-8.
2679. ∂∫ª∂Δ∑O°§OÀ ∫, ∑ø°ƒ∞ºO™ °, ¶∂ƒƒ∂∞ ¢.
∏ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙËÓ ÂԇψÛË ¯ÂÈÚÔ˘ÚÁÈÎÒÓ ÙÚ·˘Ì¿ÙˆÓ ÙÔ˘ Á·ÛÙÚÂÓÙÂÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜: ∂ÓÙÂÚÈΤ˜ ·Ó·ÛÙÔÌÒÛÂȘ. ∂ÏÏËÓÈ΋ ÃÂÈÚÔ˘ÚÁÈ΋ 2008; 80: 84-93.
2680. ∂À£ÀªπOÀ ∏, ª¶OÀ°OÀ§π∞ ª. OÈ ÏÂÈÙÔ˘ÚÁÈΤ˜ ‰È·Ù·Ú·¯¤˜ ÙˆÓ ÓÂÊÚÒÓ Î·È ÌÂÙ·‚ÔϤ˜ ÙÔ˘ ÌÂÁ¤ıÔ˘˜ ÙˆÓ Û ·ÛıÂÓ›˜ Ì ™¢ Ù‡Ô˘ 1 Î·È 2. ∏ ¯ÚËÛÈÌfiÙËÙ· ÙÔ˘ ÚÔÛ‰ÈÔÚÈÛÌÔ‡ Ù˘ ÌÈÎÚÔÏÂ˘ÎˆÌ·Ù›Ó˘
ÙˆÓ Ô‡ÚˆÓ. °·ÏËÓfi˜ 2004; 46: 357-65.
2681. ∂À£ÀªπOÀ ∏. ¡ÂfiÙÂÚ· ‰Â‰Ô̤ӷ ÛÙËÓ ·ıÔÊ˘ÛÈÔÏÔÁ›· Ù˘ ‰È·‚ËÙÈ΋˜ ÎÂÙÔÔͤˆÛ˘ (¢.∫.O.): ƒfiÏÔ˜ ÙˆÓ ·ÓÙÈÚÚÔÈÛÙÈÎÒÓ ÔÚÌÔÓÒÓ. °·ÏËÓfi˜ 2002; 44:
243-53.
2682. ∫∂º∞§O°π∞¡¡∏™ ¡∫. O ‰È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜
ÛÙÔ ¯ÂÈÚÔ˘ÚÁ›Ô. π·ÙÚÈ΋ 2008; 94: 341-9.
2683. ∫ø™Δ∞§O™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù˘ ÂÁ·Ԣ
Î·È Û˘ÁÁÂÓ›˜ ·ÓˆÌ·Ï›Â˜ ÛÙÔ ¤Ì‚Ú˘Ô- ÓÂÔÁÓfi. ¢ÂÏÙ›Ô
∞′ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ
1998; 45: 208-12.
2684. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¡ÂfiÙÂÚ˜ ÈÓÛÔ˘Ï›Ó˜ ÛÙË ıÂÚ·¢ÙÈ΋ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 2002; 68: 35-7.
2685. ∫∞¡∞∫∞-GANTENBEIN Ã. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË ÛÙÔ ¢È·‚‹ÙË. ¢ÂÏÙ›Ô ∞′ ¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜
¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ 2006; 53: 193-6.
2686. ∫O¡ΔO°π∞¡¡∏ ªª. ™˘ÛÙ¿ÛÂȘ ÁÈ· ÙË ‰È·ÈÙÔÏÔÁÈ΋ ·ÓÙÈÌÂÙÒÈÛË ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
¢È·ÙÚÔÊ‹-¢È·ÈÙÔÏÔÁ›· 2001; μ5: 33-8.
2687. ∫∞Δ∑O™ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2 ÛÙ·
·È‰È¿ Î·È ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜. ¶·È‰È·ÙÚÈ΋ μÔÚ›Ԣ
∂ÏÏ¿‰Ô˜ 2001; 13: 17-22.
2688. ∫ø™ΔO°§OÀ-∞£∞¡∞™πOÀ π, ∞£∞¡∞™πOÀ ¶,
°∂øƒ°π∞¢∏™ π, Δ∑πOÀ¶∏™ Ã. ™·Î¯·Ú҉˘ ‰È·-
187
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
‚‹Ù˘. ª˘ÔÛÎÂÏÂÙÈΤ˜ ÂΉËÏÒÛÂȘ. ∞ÛÎÏËÈÂȷο
ÃÚÔÓÈο 2003; 3: 172-7.
2689. ∫∞¡∞∫∏™ ∫, ¶∂ΔƒO°π∞¡¡O¶OÀ§O™ ∫,
º§∂μ∞ƒ∏™ Ã, ¢∂§πOÀ™∏™ ∞, ∫∞ƒ∞Ã∞§πO™
°, ∑∞Ã∞ƒøº ∞. ¡ÂÎÚˆÙÈ΋ Ïԛ̈ÍË Ì·Ï·ÎÒÓ ÌÔÚ›ˆÓ ·fi Ï·ÎÙfiÎÔÎÎÔ Û ·¯‡Û·ÚÎË ·ÛıÂÓ‹ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. π·ÙÚÈ΋ 2006; 90: 253-6.
2690. ∫∞¢O°§OÀ ¡, ΔƒO¡Δ∑O™ Ã. ∏ ÛËÌ·Û›· Ù˘
ÌÂıfi‰Ô˘ SPET123 I-MIBG ÛÙË ‰È¿ÁÓˆÛË Î·È ÚfiÁÓˆÛË Ù˘ ‰È·‚ËÙÈ΋˜ ηډȷ΋˜ ·˘ÙfiÓÔÌ˘ Ó¢ÚÔ¿ıÂÈ·˜. ∂ÏÏËÓÈ΋ ¶˘ÚËÓÈ΋ π·ÙÚÈ΋ 2004; 7: 71-7.
2691. ∫OÀƒ∫OÀª¶∞™ μ¢, ∫OÀ∫OÀ§∏™ °¡. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·: ª›· ·Ú·ÁÓˆÚÈṲ̂ÓË ‰È·‚ËÙÈ΋ ÂÈÏÔ΋. ∫·Ú‰È·Î‹ ∞ÓÂ¿ÚÎÂÈ· 2005; 2:
181-94.
2692. ∫ø¡™Δ∞¡Δπ§∞∫∏ O. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘:
·Ó·˙ËÙÒÓÙ·˜ ÙËÓ Â˘ÁÏ˘Î·ÈÌ›·. ¡ÔÛËÏ¢ÙÈÎfi μ‹Ì·
2003; 1: 126-7.
2693. §OÀ∫∞ °, ª∞ƒ∫∂Δ∞∫∏™ ∞, ∫∞ª¶∞™ ¡, ª∞§∞ªO™ ¶, ¶∞ƒ£∂¡πOÀ Ã, ™ΔO∫π¢∏™ ¢. ™¯¤ÛË
Ô˘ÏÒ‰Ô˘˜ ʛ̈Û˘ Ì ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
∂ÏÏËÓÈ΋ O˘ÚÔÏÔÁ›· 2006; 18: 70-5.
2694. ∫∞ƒ∞∫π¢OÀ ∞, Ãπ™ΔOº∂§∏ ∞, ªπÃ∞§πOÀ
¢, ¶∞¶∞ª∂§∂Δ∏ ª, ™∞∫∂§§∞ƒπOÀ Δ. ™˘Û¯¤ÙÈÛË ·ÚÔ˘Û›·˜ ·ÚÙËÚȷ΋˜ ˘¤ÚÙ·Û˘ ‹/ Î·È Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ì ÙÔÓ ‰Â›ÎÙË Ì¿˙·˜ ÛÒÌ·ÙÔ˜ (μªπ).
¶ÚˆÙÔ‚¿ıÌÈ· ºÚÔÓÙ›‰· ÀÁ›·˜ 2001; 13: 29-33.
2695. §∞∑∞ƒπ¢∏™ ∞¡, ∑∂ª¶∂∫∞∫∏™ ¶∂. ∏ ı¤ÛË
ÙˆÓ ·Ó·ÛÙÔϤˆÓ ÙÔ˘ Û˘ÛÙ‹Ì·ÙÔ˜ ÚÂÓ›Ó˘-·ÁÁÂÈÔÙÂÓÛ›Ó˘ Î·È ÙˆÓ ·ÓÙ·ÁˆÓÈÛÙÒÓ ·Û‚ÂÛÙ›Ô˘ ÛÙË ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 2001; 10: 6571.
2696. ∫Àƒπ∞∫π¢∏™ °, ∫∞ƒ∞°∫πO∑∞∫∏ μ, ¶§∞™∫∞™ ¢. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· ηÈ
·ËÛË. OÊı·ÏÌÔÏÔÁ›· 2004; 16: 180-5.
2697. §∞ª¶ƒO¶OÀ§O™ §. À¤ÚÙ·ÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË 2007;
19: 103-8.
2698. ∫OÀƒΔ∏™ ∞, ª∞∫∂¢OÀ ∫, ƒOÀ™™O™ ¢. ¢È·ÁÓˆÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË Î·È ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË ∫‡ËÛ˘. ∂ÏÏËÓÈ΋ ª·È¢ÙÈ΋ Î·È °˘Ó·ÈÎÔÏÔÁ›· 2008; 20: 24-31.
2699. ∫∞ƒ∞ª¶∂ƒO¶OÀ§O™ ¢. ¶·ÚÔ˘Û›·ÛË ÂÚ›ÙˆÛ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË ÛÙÔ ÂÚÈÔ‰ÈÎfi ∂ÚÌ‹˜
Ô §fiÁÈÔ˜ ÙÔ˘ 1814. ¶·È‰È·ÙÚÈ΋ 2003; 66: 232-5.
2700. ª∂§π¢ø¡∏™ ∞. ™ÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞ÛÎÏËÈÂȷο ÃÚÔÓÈο 2002; 2: 52-4.
2701. ª¶∞ƒΔ™O∫∞™ Ù. ∏ ÂÊ˂›· ÛÙÔ ‰È·‚ËÙÈÎfi
·ÁfiÚÈ. ∞Ó‹Ú 2002; 4: 154-8.
2702. KATSILAMBROS N, TENTOLOURIS N, TSAPOGAS P, DOUNIS E. Atlas of the Diabetic Foot.
Chichester; Hoboken, NJ: Wiley, 2003: 232 p.
2703. ª¶∞ƒª¶∞§π∞™ °∞. ¶ÚÔÛÙ·ÙÈ΋ ÓfiÛÔ˜ ÛÙÔÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∞Ó‹Ú 2002; 4: 169-72.
188
2704. ª¶π™Ãπ¡πøΔ∏™ π, ∞∏¢O¡O¶OÀ§O™ ∞. ΔÔ
‰È·‚ËÙÈÎfi fi‰È: ∞Ó·ÙÔÌÔÎÏÈÓÈΤ˜ ÌÔÚʤ˜ Î·È ‰˘Ó·ÙfiÙËÙ˜ ¯ÂÈÚÔ˘ÚÁÈ΋˜ ·ÓÙÈÌÂÙÒÈÛ˘. ÃÂÈÚÔ˘ÚÁÈο
ÃÚÔÓÈο 2002; 7: 184-91.
2705. ª¶OÀ¡Δø¡∞™ °∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘
2 Î·È ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜. πÔÎÚ¿ÙÂÈ· 2005; 9: 73-9.
2706. ª¶∂ƒ∑OμπΔ∏™ ∞. Δ¯ÓËÙfi ¿ÁÎÚ·˜ Î·È ÌÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ·ÙÈÎÒÓ ÓËÛȉ›ˆÓ ·fi ÂÌ‚Ú˘ÔÓÈο
‚Ï·ÛÙÔ·ÙÙ·Ú· ηٿ Ó·ÓÈÎÔ‡ ™¢. π·ÙÚÈÎfi μ‹Ì·
2008; 114: 50.
2707. ¡π∫O§O¶OÀ§O™ ∞, Δ∂¡ΔO§OÀƒ∏™ ¡, ∫ø™Δ∞∫∏ ª, ∫∞Δ™π§∞ª¶ƒO™ ¡. §ÔÈÌÒÍÂȘ ÛÙÔ
‰È·‚ËÙÈÎfi fi‰È. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2006; 23:
222-32.
2708. ªÀ§ø¡∞∫∏™ ∞, Ã∞Δ∑∏¢∞∫∏™ ¢, ƒ∞¶Δ∏™
∞∂, ™º∞∫π∞¡∞∫∏™ ª, ƒ∞¶Δ∏™ ™∞. O ÚfiÏÔ˜
ÙÔ˘ Ù‡Ô˘ ÙÔ˘ ‰È·‚‹ÙË ÛÙË Û˘ÌÂÚÈÊÔÚ¿ Ù˘ ÔÛÙÈ΋˜
Ì¿˙·˜. OÛÙÔ‡Ó 2001; 12: 162-8.
2709. ª∞ƒ°∂§§O™ μ, ∞¶O™ΔO§OÀ £, ¡π∫O§O¶OÀ§OÀ ¡, Ãπ™ΔO¢OÀ§π¢OÀ Ã, ª∂Δ∞•∞ΔO™ °, ª¶π§§∏™ ∞. ™˘Ó¯‹˜ ÊÔÚËÙ‹ ÂÚÈÙÔÓ·˚΋
οı·ÚÛË Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·.
∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2001; 13 (™˘ÌÏ): 181-6.
2710. ªπÃ∞™ °¢. ∏ ÛËÌ·Û›· ÙÔ˘ ·Û‚ÂÛÙ›Ô˘ Î·È Ù˘ ‚ÈÙ·Ì›Ó˘ D ÛÙÔÓ ‰È·‚‹ÙË Ù‡Ô˘ ππ. ™ÎÂÏÂÙÈ΋ ÀÁ›·
2008; 7: 47-8.
2711. ª∞ƒ°∞ƒ∏ ∫ª, Ãπ™ΔOºOƒ∞∫∏™ ∑. ¢È·‚‹Ù˘
Î·È Î‡ËÛË. ¡ÂÔÁÓfi ‰È·‚ËÙÈ΋˜ ÌËÙ¤Ú·˜. °·ÏËÓfi˜
2008; 50: 327-36.
2712. ª¶OÀ∑∞ ∂. ∂Ó‰Ô¸·ÏÔÂȉÈ΋ ¤Á¯˘ÛË ÙÚÈ·ÌÛÈÓÔÏfiÓ˘ ÁÈ· ÙË ıÂÚ·›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ôȉ‹Ì·ÙÔ˜ Ù˘
ˆ¯Ú¿˜ ÎËÏ›‰·˜. OÊı·ÏÌÔÏÔÁ›· 2004; 16: 71-4.
2713. ¶∞™Δƒøª∞™ ™. £ÂÈ·˙ÔÏȉÈÓ‰ÈfiÓ˜: ∞ÓÙȉȷ‚ËÙÈο Ê¿Ú̷η Ì ηډȷÁÁÂȷ΋ ‰Ú¿ÛË. ∂ÏÏËÓÈ΋
∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 2007; 48: 49-59.
2714. ¡π∫O§∞OÀ ∞, Oπ∫O¡OªOÀ ™, ∑∏Δ∏™ ∏,
∫∞ƒ∫OÀ§∏™ ¢, SOUSSAN W. ΔÔ ÂÓ‰Ôı‹ÏÈÔ ÙÔ˘
ÎÂÚ·ÙÔÂȉԇ˜ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜: ∫ÏÈÓÈ΋
ÌÂϤÙË Î·È ÂÚÁ·ÛÙËÚȷ΋ ‰ÈÂÚ‡ÓËÛË Ì ηÙÔÙÚÈÎfi
ÌÈÎÚÔÛÎfiÈÔ. OÊı·ÏÌÔÏÔÁ›· 1998; 10: 185-7.
2715. ¡π∫O§O¶OÀ§O™ ∞, Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. OÈ Ì˯·ÓÈÛÌÔ› ÙˆÓ ÂÈÏÔÎÒÓ
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ¡ÂfiÙÂÚ˜ ·fi„ÂȘ.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2006; 23: 131-9.
2716. O§Àª¶πO™ â. ∂ÂÌ‚¿ÛÂȘ Â·Ó·ÁÁÂÈÒÛˆ˜ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ∂ÏÏËÓÈ΋ ∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 2002; 43: 233-5.
2717. ¶∞™∞¢∞∫∏™ ¶, £ø¢∏™ ∏, øƒ∞πO¶OÀ§O™
¢. ∏ ‚ÂÏÙ›ˆÛË Ù˘ ÂÈ‚›ˆÛ˘ ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ Ì á∞ ÙÂÏÈÎÔ‡ ÛÙ·‰›Ô˘ Ô˘ ˘Ô‚¿ÏÏÔÓÙ·È ÛÂ
™º¶∫. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 1998; 10: 501-19.
2718. ¶∞™∞¢∞∫∏™ ¶, μ∞ƒ°∂ª∂∑∏™ μ. ∂ÎÙ›ÌËÛË Ù˘
ηٿÛÙ·Û˘ ıÚ¤„˘ ÛÙÔ˘˜ ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ô˘
˘Ô‚¿ÏÏÔÓÙ·È ÛÂ Û˘Ó¯‹ ÊÔÚËÙ‹ ÂÚÈÙÔÓ·˚΋ οı·ÚÛË. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 1999; 11 (™˘ÌÏ): 109-26.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2719. ¶∞™∞¢∞∫∏™ ¶, μ∞ƒ°∂ª∂∑∏™ μ. ∏ ÎÏÈÓÈ΋
¤Î‚·ÛË ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ÛÙË Û˘Ó¯‹ ÊÔÚËÙ‹
ÂÚÈÙÔÓ·˚΋ οı·ÚÛË. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2001;
13 (™˘ÌÏ): 104-13.
2720. ¶O¡Δπ∫π¢∏™ ¡∂, ∫ƒ∞™™∞™ °∂. ∞Ó‰ÚÔÁÔÓÔÂÓ›· ÛÙÔÓ ÌÂÁ¿Ï˘ ËÏÈΛ·˜ ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹. ∞Ó‹Ú
2002; 4: 173-80.
2721. ¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∞, ∫∞μOÀƒ∞™ ™∞.
º˘ÛÈ΋ ‰Ú·ÛÙËÚÈfiÙËÙ· Î·È ÚfiÏË„Ë ÙÔ˘ ‰È·‚‹ÙË Ù‡Ô˘ 2. ¢È·ÙÚÔÊ‹-¢È·ÈÙÔÏÔÁ›· 2005; 9: 30-8.
2722. ¶∂ΔƒOÀ ∞, μ∂§O¡∞∫∏™ ∂. O ۷ί·Ú҉˘
‰È·‚‹Ù˘ Δ‡Ô˘ 2 ˆ˜ Úfi‚ÏËÌ· ‰ËÌfiÛÈ·˜ ˘Á›·˜:
∂ÎÙ›ÌËÛË ÙˆÓ Ú·ÁÌ·ÙÈÎÒÓ ÙÔ˘ ‰È·ÛÙ¿ÛÂˆÓ ÛÙËÓ
∂ÏÏ¿‰·. ¶ÚˆÙÔ‚¿ıÌÈ· ºÚÔÓÙ›‰· ÀÁ›·˜ 2005; 17:
69-79.
2723. ¶ƒø´ªO™ ∂, ¶∂ƒO°∞ªμƒ∞∫∏™ °, ∫∞§O°∂ƒ∞∫∏ §, •∏ƒ∞∫∏ μ, ¶∞¶∞¢∞∫∏™ Ã. ¢È·Ù·Ú·¯¤˜ ·ÎÔ‹˜ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. °·ÏËÓfi˜ 2005; 47: 519-24.
2724. ¶∂ƒπª∂¡∏™ ¶. ™Ù˘ÙÈ΋ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· Î·È ‰È·‚‹Ù˘. ∞Ó‹Ú 2002; 4: 163-8.
2725. ¶∞¶∞¢O¶OÀ§OÀ ∂, ª∞ªOÀ§∞∫∏™ ¢, ™∏º∞∫∏™ ™. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 1: °ÂÓÂÙÈ΋
Î·È ·ÓÔÛÔÏÔÁÈ΋ ‚¿ÛË Ù˘ ÓfiÛÔ˘. ¶·È‰È·ÙÚÈ΋ 2003;
66: 334-43.
2726. ™∞ª¶∞¡∏™ Ã. ∏ ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 2005; 71: 85-96.
2727. ™∞ƒ∞ºπ¢∏™ ¶∞, §∞∑∞ƒπ¢∏™ ∞¡, ΔOÀƒ∫∞¡Δø¡∏™ ∞∞. ΔÔ ·ıÔÊ˘ÛÈÔÏÔÁÈÎfi ˘fi‚·ıÚÔ ÙÔ˘
ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘: ∏ ÏÂÈÙÔ˘ÚÁÈ΋ Û‡Ó‰ÂÛË Ù˘
·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË Ì ÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
Ù‡Ô˘ 2, ÙË ‰˘ÛÏÈȉ·ÈÌ›· Î·È ÙËÓ ÎÂÓÙÚÈ΋ ·¯˘Û·ÚΛ·. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 2000; 9: 101-23.
2728. ™∂μ∞™Δπ∞¡O™ μ∞, ¡ΔOÀƒ∞∫∏™ ™¶, ºOÀƒ§∞™ Ã, ΔOÀ¡Δ∞™ Ã, Ã∞Δ∑∏°π∞¡¡∏™ ™π. ¢È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË ˆ˜ ·ÓÂÈı‡ÌËÙË ÂÓ¤ÚÁÂÈ· ıÂÚ·›·˜ Ì ÔÏ·Ó˙·›ÓË. π·ÙÚÈ΋ 2001; 79: 547-50.
2729. Δ™π°∫O™ ∫∏, ∫ÀƒOÀ π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘
Î·È ·Ó‰ÚÈ΋ ˘ÔÁÔÓÈÌfiÙËÙ·. ∞Ó‹Ú 2002; 4: 159-63.
2730. ™πøÃOÀ ∞, ¶∂ƒ¶∂ƒπ¢OÀ ¶, πø∞¡¡π¢OÀ ª.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù˘ ·ËÛ˘: ™˘¯ÓfiÙËÙ· ÂÌÊ¿ÓÈÛ˘ Û ÂÁ·Ԣ˜ ÌÂÙ¿ ·fi ‰ÔÎÈÌ·Û›· ·ÓÔ¯‹˜ ÛÙË
ÁÏ˘Îfi˙Ë. £¤Ì·Ù· ª·È¢ÙÈ΋˜ - °˘Ó·ÈÎÔÏÔÁ›·˜ 2008;
22: 44-7.
2731. ™πªO¶OÀ§O™ ∞¶. ø̤Á·-6/ ø̤Á·-3 ÏÈ·Ú¿
Ôͤ· Î·È trans ÏÈ·Ú¿ Ôͤ· ÛÙÔ ÌË ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ¢È·ÙÚÔÊ‹-¢È·ÈÙÔÏÔÁ›·
1999; μ3: 67-77.
2732. ƒ∞§§π¢∏™ §™, ¶∞§∏O™ πª, ∫ƒ∂ª∞™Δπ¡O™
¢£. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. π·ÙÚÈ΋ 2008; 94: 19-24.
2733. Δ∞º§∞¡π¢OÀ-¶∞¡ΔøΔ∏ ∞, °OÀ§∏™ ¢°, ¡π∫O§∞´¢∏™ ¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÁ΢ÌÔÛ‡ÓË. ∂ÏÏËÓÈ΋ ª·È¢ÙÈ΋ Î·È °˘Ó·ÈÎÔÏÔÁ›· 2006;
18: 206-13.
2734. Δƒπª∏™ °, ªO™ÃOμ∏ ª, ∫∞ƒ∞¡π∫∞™ ∏,
∫∞¡∞ƒπOÀ ª, ƒ∞ºΔO¶OÀ§OÀ ∞, Δ∑øƒΔ∑∞ΔOÀ-™Δ∞£O¶OÀ§OÀ º. ÀÔÍ›· ÔÛÙÂÔÌ˘ÂÏ›ÙȘ
Ù˘ ÛÔÓ‰˘ÏÈ΋˜ ÛÙ‹Ï˘ Û ·È‰› Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ π. ¶·È‰È·ÙÚÈ΋ 2003; 66: 47-51.
2735. Δƒπ∞¡Δ∞ºÀ§§OÀ °, ∞μƒ∞ªπ¢∏™ ™, ∫∞ƒ∞°π∞¡¡∏ Δ, ªπƒ∞ÃΔ™∏™ £, °OÀ§∞ ∂, Δƒ∞´∞¡π¢∏™ ¶. ∏ ÚÔÛı›· Ú·ÁÔÂȉ›Ùȉ· Û ‰È·‚ËÙÈÎÔ‡˜
·ÛıÂÓ›˜ Ô˘ ˘Ô‚¿ÏÏÔÓÙ·È Û Laser ʈÙÔËÍ›·.
OÊı·ÏÌÔÏÔÁ›· 1998; 10: 206-8.
2736. ΔOÀμƒ∞ ∞, μO§∞∫§∏™ ∫∞, ΔO∫ª∞∫π¢∏™
™¶. ∏ ıÂÚ·¢ÙÈ΋ ‰Ú¿ÛË Ù˘ ¿ÛÎËÛ˘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∫·Ú‰È¿ Î·È ∞ÁÁ›· 2008; 13:
141-5.
2737. Δ∞ª¶∞∫∏™ £, ¢ƒπ∞°∫∞ ∫, ™π°∞§∞™ π. ¶·ÚÔ‰ÈÎfi˜ ÓÂÔÁÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘. ¶·È‰È·ÙÚÈο
ÃÚÔÓÈο 1990; 117: 93-6.
2738. Δ™∞ª¶∞ƒ§∏-∫πΔ™∞ƒ∞ ∞, ∫OÀ¡∂¡OÀ ∫. OÈ
ÔÈÎÔÁÂÓÂȷΤ˜ Û¯¤ÛÂȘ ˆ˜ ·Ú¿ÁÔÓÙ·˜ Ú‡ıÌÈÛ˘ ÙÔ˘
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 1. ¶·È‰È·ÙÚÈ΋ 2003;
66: 357-63.
2739. Δ™∞ª¶∞ƒ§∏-∫πΔ™∞ƒ∞ ∞, ∫OÀ¡∂¡OÀ ∫. O
ÚfiÏÔ˜ Ù˘ Û¯¤Û˘ ÌËÙ¤Ú·˜-·È‰ÈÔ‡ ÛÙË ‰˘ÛÎÔÏ›·
Ú‡ıÌÈÛ˘ Ù˘ ÁÏ˘Îfi˙˘ ÛÙ· ·È‰È¿ Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ 1. ¶·È‰› Î·È ŒÊË‚Ô˜: æ˘¯È΋ ÀÁ›·
Î·È æ˘¯Ô·ıÔÏÔÁ›· 2003; 5: 37-52.
2740. Δ™πΔ™πO™ Δ, ∞ƒª∂¡Δ∑πO´OÀ-Δ∞™πO¶OÀ§OÀ ∫, ™øΔ∏ƒ∞∫O¶OÀ§O™ ¡, ∫∞§O°π∞¡¡π¢OÀ ∂, ™πμƒπ¢∏™ ¢, ª∞ÀƒOª∞Δπ¢∏™ ∫. °·Ï·ÎÙÈ΋ ÔͤˆÛË ·fi ÌÂÙÊÔÚÌ›ÓË. ¶ÂÚÈÁÚ·Ê‹ 3 ÂÚÈÙÒÛÂˆÓ Î·È ·Ó·ÛÎfiËÛË Ù˘ ‚È‚ÏÈÔÁÚ·Ê›·˜. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›· 2008; 20: 210-4.
2741. KORDONOURI O, HARTMANN R, RIEBEL T,
LIESENKOETTER KP. Early treatment with Lthyroxine in children and adolescents with type 1
diabetes, positive thyroid antibodies, and thyroid
gland enlargement. Pediatr Diabetes 2007; 8: 180-4.
2742. MAKRILAKIS K. Pharmaceutical treatment of diabetes in the metabolic syndrome. ∞Ó‹Ú 2008; 10: 201-3.
2743. EMMANOUILIDOY E, GALLI-TSINOPOULOU
A, KARAVATOS A, NOUSIA-ARVANITAKIS S.
Quality of life of children and adolescents with diabetes of Northern Greek origin. Hippokratia 2008; 12:
168-75.
2744. SAMPANIS C, ZAMBOULIS C. Arterial hypertension in diabetes mellitus: From theory to clinical practice. Hippokratia 2008; 12: 74-80.
2745. DOULOUMPAKAS I, PYRPASOPOULOU A,
TRIANTAFYLLOU A, SAMBANIS CH, ASLANIDIS S. Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: A Pilot study.
Hippokratia 2007; 11: 216-8.
2746. SAMPANIS CH. Management of hyperglycemia in
patients with diabetes mellitus and chronic renal failure. Hippokratia 2008; 12: 22-7.
189
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2747. æ∞ƒƒ∞ ¶, μ∞°°∂§O¶OÀ§O™ π, ƒOÀ¡ΔOÀ μ,
π™∞∞∫π¢∏™ ¶, §À∫O™ ¢, Δ∞§¶π¢∏™ ∞. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· Î·È ÁÏ˘ÎÔ˙˘ÏȈ̤ÓË
·ÈÌÔÛÊ·ÈÚ›ÓË. OÊı·ÏÌÔÏÔÁ›· 2006; 18: 139-43.
2748. EFSTRATIADIS G, TSIAOUSIS G, MANES C,
KARAGIANNI D, GIANNAKOU-DARDA A. Insulin-like Growth Factor-1 and the cardiovascular system. Hippokratia 2006; 10: 68-74.
2749. æ∞§§∞™ ª, Δ∂¡ΔO§OÀƒ∏™ ¡, ∫O∫∫π¡O™
∞, ¶∞¶∞¢O°π∞¡¡∏™ ¢, ∫O∫∫π¡O™ ¢μ, ∫∞Δ™π§∞ª¶ƒO™ ¡. ∏ ‰È·ÛÔÚ¿ ÙÔ˘ QT ¢È·ÛÙ‹Ì·ÙÔ˜: ™‡ÁÎÚÈÛË ÌÂٷ͇ ‰È·‚ËÙÈÎÒÓ Î·È ÌË ‰È·‚ËÙÈÎÒÓ
·ÙfiÌˆÓ Î·È Û˘Û¯¤ÙÈÛË Ì ÙË ¡Â˘ÚÔ¿ıÂÈ· ÙÔ˘ ∫·Ú‰È·ÎÔ‡ ∞˘ÙfiÓÔÌÔ˘ ¡Â˘ÚÈÎÔ‡ ™˘ÛÙ‹Ì·ÙÔ˜. ∂ÏÏËÓÈ΋
∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 2006; 47: 246-55.
2750. GERASSIMIDIS T, KARKOS CD, KARAMANOS D, KAMPAROUDIS A. Current endovascular
management of the ischaemic diabetic foot. Hippokratia 2008; 12: 67-73.
2751. Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OÀ ∞. ∏ ıÂÚ·›· ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË-¶ÚfiÔ‰ÔÈ. πÔÎÚ¿ÙÂÈ· 2005; 9:
180-3.
2752. Ã∞ƒπ∑O¶OÀ§OÀ μÃ, °OÀ§∏™ ¢°, ™∞ƒ∞¡Δ∏
∂™, μ∞μπ§∏™ ¢, ¶∞¶∞¢∏ª∞™ π. ¶ÚfiÏË„Ë ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2 Û Á˘Ó·›Î˜ Ì ÈÛÙÔÚÈÎfi
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù˘ ·ËÛ˘. ∂ÏÏËÓÈ΋ ª·È¢ÙÈ΋ Î·È °˘Ó·ÈÎÔÏÔÁ›· 2008; 20: 233-43.
2753. Ã∞ƒπ∑O¶OÀ§OÀ μÃ, ™∞ƒ∞¡Δ∏ ∂™, °OÀ§∏™ ¢°. ∏ ¿ÛÎËÛË ˆ˜ ̤ÛÔ ÚfiÏ˄˘ Î·È ıÂÚ·›·˜ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù˘ ·ËÛ˘. ∂ÏÏËÓÈ΋
ª·È¢ÙÈ΋ Î·È °˘Ó·ÈÎÔÏÔÁ›· 2008; 20: 211-8.
2754. ºπ§πO¶OÀ§O™ μ, Δ∞∫OÀ§∏ §, μO°π∞Δ∑O°§OÀ ¢, μ§∞™™O¶OÀ§O™ ¢. ¶ÂÚÈÊÂÚÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ· οو ¿ÎÚˆÓ Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘
Î·È ¯ÚfiÓÈ·˜ ÓÂÊÚÈ΋˜ ÓfiÛÔ˘. ∂ÏÏËÓÈ΋ ¡ÂÊÚÔÏÔÁ›·
2008; 20: 259-77.
2755. ºπΔ™πøƒ∏™ º, £∂Oº∞¡π¢∏™ ¢. ¡Â˘ÚÔÊ˘ÛÈÔÏÔÁÈο Â˘Ú‹Ì·Ù· ÛÙË ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. ∂ÁΤʷÏÔ˜ 2003; 40: 74-83.
2756. ∂À£Àªπ∞¢∏™ ∞, ¶∞™Ã∞§π¢OÀ ∂, ¶∞¶∞¢O¶OÀ§O™ π, ∂À£Àªπ∞¢∏™ π, §∂À∫O™ ¡,
æÀƒƒO¶OÀ§O™ ¢, ƒ∞¶ΔO¶OÀ§OÀ-°π°∏ ª.
∞ÓÙÈÌÂÙÒÈÛË ·ÛıÂÓÔ‡˜ Ì IDDM, ÌÈÎÙ‹-‚·ÚÈ¿
˘ÂÚÏÈȉ·ÈÌ›· Î·È Â·ÓÂÈÏËÌ̤ӷ ÂÂÈÛfi‰È· ·ÁÎÚ·ٛÙȉ·˜. °·ÏËÓfi˜ 2005; 47: 604-13.
2757. §πO™∏™ °. ΔÔ ¿ÚÚÂÓ ÓÂÔÁÓfi ‰È·‚ËÙÈ΋˜ ÌËÙ¤Ú·˜.
∞Ó‹Ú 2002; 4: 148-53.
2758. ª∞°OÀ§∞-¶∞¶∞¢O¶OÀ§OÀ π. O ÚfiÏÔ˜ Ù˘
·ÁÁÂÈÔÙÂÓÛ›Ó˘ ππ ÛÙË ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. °·ÏËÓfi˜ 2001; 43: 503-16.
2759. §OÀ∫π¢∏™ ™. ∏ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ÔÚ›· ÙˆÓ ÏÔÈÌÒÍÂˆÓ Û ·ÛıÂÓ›˜ Ì ¯ÚfiÓÈ·
·ÔÊÚ·ÎÙÈ΋ Ó¢ÌÔÓÔ¿ıÂÈ·. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË
∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1999; 33: 47-51.
2760. ª¶π™Ãπ¡πøΔ∏™ π, ª¶∞§∞ª¶∞¡π¢OÀ ∂,
190
∫OÀ§OÀƒ∏™ ¡, °∞ªμƒO™ O, ∞∏¢O¡O¶OÀ§O™ ∞. ∞ÓÔÈÎÙfi «ÁψÛÛÔÂȉ¤˜» οٷÁÌ· Ù¤ÚÓ˘
Â› ·ÛıÂÓÔ‡˜ Ì ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ· ÙˆÓ Î¿Ùˆ
¿ÎÚˆÓ. ∞ÓÙÈÌÂÙÒÈÛË Ì ÌÂÚÈ΋ ÙÂÚÓÂÎÙÔÌ‹ ηÈ
ÂÈÌ‹Î˘ÓÛË ÙÔ˘ ∞¯›ÏÏÂÈÔ˘ Ù¤ÓÔÓÙ· (¶·ÚÔ˘Û›·ÛË
·ÛıÂÓÔ‡˜). ÃÂÈÚÔ˘ÚÁÈο ÃÚÔÓÈο 2000; 5: 123-6.
2761. ¶∞°∫∞§O™ ∂. ∞ÓÂÈı‡ÌËÙ˜ ‰Ú¿ÛÂȘ ÙˆÓ ˘ÔÁÏ˘Î·ÈÌÈÎÒÓ ‰ÈÛΛˆÓ. ™˘ÓÙ·ÁÔÁÚ·Ê›· 1995; 1: 2-7.
2762. Ã∞Δ∑∏°π∞¡¡∞∫∏™ ∂π, §∞∫OÀª∂¡Δ∞ ™,
¢ƒ∞∫O¶OÀ§O™ ™, ¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ∞,
μOÀ°∞™ μ, ª∞£πOÀ§∞∫∏™ ™, ¶OÀ§Δ™π¢∏ ∞,
°∂øƒ°O¶OÀ§O™ ¡, ƒ∞¶Δ∏™ ∞, ƒ∞¶Δ∏™ ™.∞.
∏ ÚÒÙË ÛÙËÓ ∂ÏÏ¿‰· Ù·˘Ùfi¯ÚÔÓË ÌÂÙ·ÌfiÛ¯Â˘ÛË
‹·ÙÔ˜ Î·È ·ÁÎÚ¤·ÙÔ˜. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1998; 32: 157-63.
2763. ¶∞¶∞¢O¶OÀ§O™ °, ª¶ƒπª∏™ ¢, ª¶πª¶∞∫∏ ∂, §∞¢øª∂¡OÀ º, ∫∞∫OÀ§∞∫∏ ™, ∫O∫O§∞∫∏ ∂, ¡Δ∞°π∞¡Δ∞ ª, ¢ƒ∞∫ø¡∞∫∏™ ¡.
∞Ó›¯Ó¢ÛË Î·È ‰È·¯Â›ÚÈÛË ÙˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ
ÛÙËÓ ÚˆÙÔ‚¿ıÌÈ· ÊÚÔÓÙ›‰· ˘Á›·˜: H ÂÌÂÈÚ›· ÙÔ˘
¶ÂÚÈÊÂÚÂÈ·ÎÔ‡ π·ÙÚ›Ԣ ∞ÛËÌ›Ô˘. ¶ÚˆÙÔ‚¿ıÌÈ·
ºÚÔÓÙ›‰· ÀÁ›·˜ 2008; 20: 7-11.
2764. ™∞ƒ∞ºπ¢∏™ ¶∞, §∞∑∞ƒπ¢∏™ ∞¡, ¶∞°∫∞§O™ ∂ª, ÃπΔO°§OÀ-ª∞∫∂¢OÀ ∞¢, ¶§π∞∫O™ Ãπ, ∫∞∑∞∫O™ ∫∞, °πøμO™ π°, ∑∂ª¶∂∫∞∫∏™ ¶∂, Δ∑πO§∞™ πª, ΔOÀƒ∫∞¡Δø¡∏™ ∞∞.
∏ ÚÔÛÈÁÏÈÙ·˙fiÓË ‚ÂÏÙÈÒÓÂÈ Ù· Â›‰· Ù˘ 24ˆÚ˘
·ÚÙËÚȷ΋˜ ›ÂÛ˘ ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË
Ù‡Ô˘ 2 Î·È ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË 2004; 13: 116-28.
2765. ™∞ƒ∞ºπ¢∏™ ¶∞, §∞∑∞ƒπ¢∏™ ∞¡, ¶Oπ∫π§π¢OÀ ªπ, ∫∞¡∞∫∏ ∞π, ∑∂ª¶∂∫∞∫∏™ ¶, Δ∑πO§∞™ π, ™Δ∞ºÀ§∞™ ¶, °πøμO™ π, ΔOÀƒ∫∞¡Δø¡∏™ ∞∞. ∞ÍÈÔÈÛÙ›· Î·È ·Ó··Ú·ÁˆÁÈÌfiÙËÙ·
ÙˆÓ ‰ÂÈÎÙÒÓ HOMA-IR, 1/HOMA-IR, QUICKI ηÈ
McAuley Û ·ÛıÂÓ›˜ Ì ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Î·È
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ∞ÚÙËÚȷ΋ À¤ÚÙ·ÛË
2007; 16: 109-20.
2766. ªÀΔ∞™ ¢∑, ∑∞´ƒ∏™ ª¡, ™ΔOÀ°π∞¡¡O™ ¶¡,
ª¶∂§¡Δ∂∫O™ ¢π, ∞¢∞ªO¶OÀ§OÀ ∂.¡,
ºOÀ™™∞™ ™. °, ¶Àƒ°∞∫∏™ μ.¡. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·: ∞fi ÙËÓ ˘fiıÂÛË ÚÔ˜ ÙËÓ ÙÂÎÌËÚ›ˆÛË. ∂ÏÏËÓÈ΋ ∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 2006; 47:
370-9.
2767. KORDONOURI O, MAGUIRE AM, KNIP M,
SCHOBER E, LORINI R, HOLL RW, DONAGHUE KC. ISPAD Clinical Practice Consensus
Guidelines 2006-2007. Other complications and associated conditions. Pediatr Diabetes 2007; 8: 171-6.
2768. DEISS D, KORDONOURI O, HARTMANN R,
HOPFENMÜLLER W, LÜPKE K, DANNE T.
Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents
with type 1 diabetes. Pediatr Diabetes 2007; 8: 157-62.
2769. ™∞ª¢∞¡∏™ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î·Ù·Á-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Ì·ÙÈ΋ ÓfiÛÔ˜. À¿Ú¯ÂÈ ¿ÌÂÛË ·ÈÙÈÔÏÔÁÈ΋ Û˘Û¯¤ÙÈÛË.
™ÎÂÏÂÙÈ΋ ÀÁ›· 2008; 7: 49-51.
2770. PHILIS-TSIMIKAS A, CHARPENTIER G,
CLAUSON P, RAVN GM, ROBERTS VL, THORSTEINSSON B. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.
Clin Ther 2006; 28: 1569-81.
2771. μO°π∞Δ∑O°§OÀ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008
2772. HERBST A, KORDONOURI O, SCHWAB KO,
SCHMIDT F, HOLL RW; DPV INITIATIVE OF
THE GERMAN WORKING GROUP FOR PEDIATRIC DIABETOLOGY GERMANY. Impact of
physical activity on cardiovascular risk factors in children with type 1 diabetes: A multicenter study of
23,251 patients. Diabetes Care 2007; 30: 2098-100.
2773. PANIDIS D, FARMACIOTIS D, ROUSSO D,
KOURTIS A, KATSIKIS I, KRASSAS G. Obesity,
weight loss and the polycystic ovary syndrome: Effect
of treatment with diet and orlistat for 24 weeks on insuline resistance and androgen levels. Fertil Steril
2008; 89: 899-906.
2774. μO°π∞Δ∑O°§OÀ ¢∂. ∏ ÈÛÙÔÚ›· ÙÔ˘ ¢È·‚ËÙÈÎÔ‡
¶Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢.∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
23-46
2775. μO°π∞Δ∑O°§OÀ ¢∂. ∂ȉËÌÈÔÏÔÁ›· – ∫fiÛÙÔ˜
¢È·‚ËÙÈÎÔ‡ ¶Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 47-76.
2776. μO°π∞Δ∑O°§OÀ ¢∂. ¶·ıÔÊ˘ÛÈÔÏÔÁ›· ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ ¶Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 77-144.
2777. §OÀ¶∞ Ã, μO°π∞Δ∑O°§OÀ ¢∂. O ÚfiÏÔ˜ Ù˘
ÍËÚÔ‰ÂÚÌ›·˜ ÛÙÔ Û‡Ó‰ÚÔÌÔ ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ ¶Ô‰ÈÔ‡:
¶ÂÚÈÁÚ·Ê‹ Î·È ‰È·¯Â›ÚÈÛË ÙÔ˘ ÚÔ‚Ï‹Ì·ÙÔ˜. ™ÙÔ:
μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 145-67.
2778. ª∞¡∂™ Ã. ¢È·‚ËÙÈ΋ ¡Â˘ÚÔ¿ıÂÈ· Î·È Ë ·ıÔÁ¤ÓÂÈ¿ Ù˘. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
168-75.
2779. Δ∂¡ΔO§OÀƒ∏™ ¡. ∂Ò‰˘ÓË ¢È·‚ËÙÈ΋ ¡Â˘ÚÔ¿ıÂÈ·. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
176-84.
2780. Δ™∞¶O°∞™ ¶∏ ‰È¿ÁÓˆÛË ÙÔ˘ Ó¢ÚÔ·ıËÙÈÎÔ‡
‰È·‚ËÙÈÎÔ‡ ¿ÎÚÔ˘ Ô‰fi˜. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ
¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2008: 185-200.
2781. ª∂§π¢ø¡∏™ ∞. ∏ ·ıÔÁ¤ÓÂÈ· Ù˘ Ì·ÎÚÔ·ÁÁÂÈÔ·ıËÙÈ΋˜ ÓfiÛÔ˘, Ù˘ ÂÚÈÊÂÚÈ΋˜ ·ÁÁÂÈÔ¿ıÂÈ·˜
ÛÙ· ¿ÙÔÌ· Ì ‰È·‚‹ÙË. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ
¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2008: 201-14.
2782. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂π, Àº∞¡Δ∏ °∫. ¶ÂÚÈÊÂÚÈ΋ ‰È·‚ËÙÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ·. ∫ÏÈÓÈ΋ Î·È ÂÚÁ·ÛÙËÚȷ΋ ‰È·ÁÓˆÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘
¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 215-40.
2783. ¢π¢∞°°∂§O™ Δ. ∂›‰Ú·ÛË ÙÔ˘ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË ÛÙËÓ ÎÈÓËÙÈÎfiÙËÙ· ÙˆÓ ·ÚıÚÒÛÂˆÓ Î·È ÛÙÔÓ
ÙÚfiÔ ‚·‰›ÛÌ·ÙÔ˜ - ‚ËÌ·ÙÈÛÌÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘
¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 241-48.
2784. ª¶OÀΔ∞Δ∏ ∂π. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ Î·È §ÔÈÌÒÍÂȘ. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
249-63.
2785. §OÀ¶∞ Ã. §ÔÈÌÒÍÂȘ ÛÙÔ ¢È·‚ËÙÈÎfi fi‰È (ÏËÓ
ÔÛÙÂÔÌ˘ÂÏ›Ùȉ·˜). O ÚfiÏÔ˜ ÙˆÓ Î·ÏÏÈÂÚÁÂÈÒÓ ÛÙËÓ
Ù·˘ÙÔÔ›ËÛË ÙˆÓ ·ıÔÁfiÓˆÓ ÌÈÎÚÔÔÚÁ·ÓÈÛÌÒÓ. ∫·Ù¢ı‡ÓÛÂȘ ·ÓÙÈ‚ÈÔÙÈ΋˜ ·ÁˆÁ‹˜. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘
¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 264-78.
2786. IOANNIDIS I. The road from obesity to type 2 diabetes. Angiology 2008; 59 (Suppl 2): 39S-43S.
2787. ALAVERAS A, THOMAS SM, SARGIOTIS A,
VIBERTI GC. Promoters of progression of diabetic
nephropathy: the relative roles of blood glucose and
blood pressure control. Nephrol Dialysis Transplant
1997; 12 (Suppl 2): 71-4.
2788. §∞∑∞¡∞™ ª, Ãπ¡∏ ª, ∫∞OÀΔ™OÀ ™. OÛÙÂÔÌ˘ÂÏ›Ùȉ· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 279-94
2789. SIGALA F, GEORGOPOULOS S, LANGER S,
BAUNACH C, PAPALAMBROS E, SIGALAS K,
BRAMIS J, BAKOYIANNIS C, BASTOUNIS E,
HEPP W. Outcome of infrainguinal revascularization
for critical limb ischemia in diabetics with end stage
renal disease. VASA 2006; 35: 15-20.
2790. RAPTIS SA, HATZIAGELAKI E, DIMITRIADIS
G, DRAEGER KE, PFEIFFER C, RAPTIS AE.
Comparative effects of glimepiride and glibenclamide
on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal
man. Exp Clin Endocrinol Diabetes 1999; 107: 350-5.
2791. TENTOLOURIS N, BOUTATI E, KARAMBAKALIS N, PEREA D, TSELEPIS A.D, TSOUKALA C, KYRIAKI D, LOURIDA E, ANASTASOPOULOU I, KARAFOULLIDOU A, RAPTIS SA,
KATSILAMBROS N. Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial Metabolism coagulation, and fibrinolysis.
Nutr Metab Cardiovasc Dis 2005; 15: 6-12.
2792. ºOÀ¡ΔOÀ§∞∫∏ ¢. ∂›‰Ú·ÛË ‚ÈÔÛ˘ÌÂÚÈÊÔÚÈÎÒÓ ·Ú·ÁfiÓÙˆÓ ÛÙË ÛˆÌ·ÙÈ΋ Î·È „˘¯È΋ ¢ÂÍ›·
191
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ÙˆÓ ‰È·‚ËÙÈÎÒÓ. ΔÌ‹Ì· æ˘¯ÔÏÔÁ›·˜ ¶·ÓÂÈÛÙËÌ›Ô˘
∫Ú‹Ù˘, 2007. ¢Èψ̷ÙÈ΋ ∂ÚÁ·Û›·.
2793. μ§∞™O¶OÀ§O™ ¢, ºπ§πO¶OÀ§O™ μ, Δ∞∫OÀ§∏ §. ΔÔ ‰È·‚ËÙÈÎfi fi‰È Â› ¯ÚÔÓ›·˜ ÓÂÊÚÈ΋˜
ÓfiÛÔ˘. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
295-326.
2794. ∫∞Δ™∞ƒO™ £. ∫ÏÈÓÈ΋ Ù·ÍÈÓfiÌËÛË ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi
¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
2008: 335-34.
2795. ¶∞¶¶∞™ ∞. Δ·ÍÈÓfiÌËÛË Ù˘ ·ıÔÏÔÁ›·˜ ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ ¶Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 345-54.
2796. ¢OÀ¡∞μ∏™ ∞. ∏ Û˘Ì‚ÔÏ‹ ÙÔ˘ ¯ÂÈÚÔ˘ÚÁÔ‡ ÛÙËÓ
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 367-73.
2797. ∫∞™Δ∞¡∞ OÀƒ. ¶Ï·ÛÙÈ΋ ¯ÂÈÚÔ˘ÚÁÈ΋ ·ÔηٿÛÙ·ÛË ¢È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ
¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2008: 374-406.
2798. ª¶∞¢∂∫∞™ ∞Ã. ΔÔ ¢È·‚ËÙÈÎfi fi‰È, Ó¢ÚÔ·ıËÙÈ΋ ·ÚıÚÔ¿ıÂÈ· ÛÙÔÓ ¿ÎÚÔ fi‰· Î·È ÛÙËÓ Ô‰ÔÎÓËÌÈ΋. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
407-44.
2799. ∫∞§§π°π∞¡¡∏ ∫. ¶ÂÚÈÊÂÚÈ΋ ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·. ∏ ı¤ÛË Î·È Ë ÂÎÙ›ÌËÛ‹ Ù˘ ·fi ÙË ÛÎÔÈ¿ ÙÔ˘
∞ÁÁÂÈÔ¯ÂÈÚÔ˘ÚÁÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 445-56.
2800. °∫∞Δ∑πOÀ μ. ∏ ·Ó·ÈÛıËÛÈÔÏÔÁÈ΋ ÚÔÛ¤ÁÁÈÛË
ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ
¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2008: 457-62.
2801. μO°π∞Δ∑O°§OÀ ∂. O ÚfiÏÔ˜ Ù˘ ¶Ô‰ÔÏÔÁ›·˜
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 463-79.
2802. ª¶∂¡ƒOÀª¶∏ ª. ∏ ÂÎ·›‰Â˘ÛË ÙÔ˘ ·ÛıÂÓÔ‡˜
Ì ¢È·‚ËÙÈÎfi fi‰È. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 480-84.
2803. ∫∞ƒ∞¡Δ∞¡∞™ ∞, ºøΔπ∞¢OÀ ∞, Δ™∂Δ∏™ ¢.
∞ÂÈÎÔÓÈÛÙÈ΋ ‰ÈÂÚ‡ÓËÛË ÛÙÔ ¢È·‚ËÙÈÎfi fi‰È. ™ÙÔ:
μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 485-506.
2804. ∫∞æπª∞¡∏ ∞π∫. ∂Ì‚ÈÔÌ˯·ÓÈ΋, ·ÙÚ·˘Ì·ÙÈο
˘Ô‰‹Ì·Ù·, ·ÔÊfiÚÙÈÛË Î·È ÔÚıˆÙÈο ̤۷ ÛÙÔ ¢È·‚ËÙÈÎfi fi‰È. ∏ ÂÏÏËÓÈ΋ ÂÌÂÈÚ›·. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 507-22.
2805. ªπ§∏ ∂À°.¶, μO°π∞Δ∑O°§OÀ ¢∂. ∏ Ê˘ÛÈ΋
192
‰È·‰Èηۛ· Ù˘ ÂԇψÛ˘. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂.
ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2008: 523-28.
2806. ΔO§O™ ∞, μO°π∞Δ∑O°§OÀ ¢∂. ∂ԇψÛË
ÙÚ·‡Ì·ÙÔ˜: ªÔÚȷ΋ Î·È Î˘ÙÙ·ÚÈ΋ ÚÔÛ¤ÁÁÈÛË ÛÙÔ
‰È·‚ËÙÈÎfi ¿ÙÔÌÔ. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 529-34.
2807. ∫∞§∂ªπ∫∂ƒ∞∫∏™ π. Δ· Û‡Á¯ÚÔÓ· ÂÈı¤Ì·Ù·
ÛÙË ÊÚÔÓÙ›‰· ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÂÏÎÒÓ. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 535-62.
2808. ∂ÀªOƒºπ∞¢∏™ ∏, μO°π∞Δ∑O°§OÀ ¢∂. £ÂÚ·›· Ì ¯Ú‹Û˘ ΔÔÈ΋˜ ∞ÚÓËÙÈ΋˜ ¶›ÂÛ˘ (VAC)
ÛÙÔ ¢È·‚ËÙÈÎfi fi‰È. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 563-74.
2809. ª∞Àƒπ¢∏™ ∞, μO°π∞Δ∑O°§OÀ ¢∂. ¶ÚÔÓ‡Ìʘ ÂÓÙfiÌˆÓ (maggots) ÛÙËÓ ÂԇψÛË ‰È·‚ËÙÈÎÒÓ
ÂÏÎÒÓ. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
575-89.
2810. ¶∞¶∞¡∞™ ¡. O ÚfiÏÔ˜ ÙˆÓ ·˘ÍËÙÈÎÒÓ ·Ú·ÁfiÓÙˆÓ ÛÙË ıÂÚ·›· ÙÔ˘ ¤ÏÎÔ˘˜ ÙÔ˘ ¢È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 590614.
2811. ¶∂ΔƒOÀ °, μO°π∞Δ∑O°§OÀ ¢∂. ΔÔ Ì¤ÏÈ ÛÙË
ıÂÚ·›· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ¤ÏÎÔ˘˜. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘
¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 615-22.
2812. ª∂™∏ª∂ƒ∏™ £. ¢È·‚ËÙÈÎfi fi‰È. O ÚfiÏÔ˜ ÙÔ˘
ÀÂÚ‚·ÚÈÎÔ‡ O͢ÁfiÓÔ˘ Û ¤Ó· ÔÏ˘‰È¿ÛÙ·ÙÔ Úfi‚ÏËÌ·. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È.
∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008:
623-36.
2813. ¢∂§∏∫ø¡™Δ∞¡Δπ¡OÀ ∏, μO°π∞Δ∑O°§OÀ
¢∂. ∞ÓÙÈÌÂÙÒÈÛË ‰È·‚ËÙÈÎÒÓ ÂÏÎÒÓ. ªË¯·ÓÈ΋ ÙˆÓ
ÈÛÙÒÓ ‹ tissue-tech autograft system. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 637-43.
2814. £∂π∞™¶ƒ∞™ §. ∏ÏÂÎÙÚÈ΋ ‰È¤ÁÂÚÛË Û·Ó ıÂÚ·¢ÙÈ΋ ̤ıÔ‰Ô˜ ›·Û˘ ‰È·‚ËÙÈÎÒÓ ÂÏÎÒÓ. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 644-52.
2815. ¶∞¶∞¡∞™ ¡, EDMONDS ME. ¢È·‚ËÙÈÎfi fi‰È:
ª›· ÚfiÎÏËÛË ÁÈ· ÙË Ó¤· ¯ÈÏÈÂÙ›·. ™ÙÔ: μÔÁÈ·Ù˙fiÁÏÔ˘ ¢∂. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2008: 659-62.
2816. ª∂§π¢ø¡∏™ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004.
2817. Ãπ™Δ∞∫O¶OÀ§O™ ¶¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ, ∞ıËÚÔÛÎÏ‹Ú˘ÓÛË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÂÏ›‰·, 2004: 17-21.
2818. ¡OÀΔ™OÀ ª. ∏ ·ıËÚÔÛÎÏËÚ˘ÓÙÈ΋ ‰È·‰Èηۛ·.
™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 25-39.
2819. Ã∞Δ∑∏∞°°∂§∞∫∏ ∂. ∞ÓÔÛÔÏÔÁÈÎÔ› Ì˯·ÓÈÛÌÔ›
ÛÙËÓ ·ıËÚÔÛÎÏ‹Ú˘ÓÛË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 417.
2820. ª∂§π¢ø¡∏™ ∞. ¶·¯˘Û·ÚΛ· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∏ Û˘Û¯¤ÙÈÛË Î·È ÔÈ ıÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘,
ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 151-61.
2821. ¶∞¡∞°πøΔOÀ £. À¤ÚÙ·ÛË Î·È ‰È·‚‹Ù˘. ™ÙÔ:
ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi
™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 205-16.
2822. ∏ƒ∞∫§∂π∞¡OÀ ™. ¢È·‚ËÙÈ΋ ‰˘ÛÏÈȉ·ÈÌ›·. ™ÙÔ:
ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi
™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 255-71.
2823. ™∞º§π∞¡∏™ πÃ. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ ÛÙË
‰˘ÛÏÈȉ·ÈÌ›· ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹Ù˘. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÂÏ›‰·, 2004: 273-9.
2824. ª∂§π¢ø¡∏™ ∞. ∏ ·ıËڈ̿وÛË ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘,
ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 283-308.
2825. ¢π¢∞°°∂§O™ Δ. ∏ Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘
Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÙÔ˘ ηډȷÁÁÂÈ·ÎÔ‡ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ë Û˘Ì‚ÔÏ‹ Ù˘ ÛÙÔÓ ·˘ÍË̤ÓÔ
ηډȷÁÁÂÈ·Îfi ΛӉ˘ÓÔ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004:
309-20.
2826. ∏ƒ∞∫§∂π∞¡OÀ ™. ¢˘ÛÁÏ˘Î·ÈÌ›·- ¢È·Ù·Ú·¯‹
ÛÙËÓ ·ÓÔ¯‹ ÁÏ˘Îfi˙˘- ∫·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜.
IGT ·ÛıÂÓ›˜- ¶ÚfiÏË„Ë ‹ ηı˘ÛÙ¤ÚËÛË ÙÔ˘ ‰È·‚‹ÙË
Ù‡Ô˘ 2. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘,
ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 321-34.
2827. ∞§∞μ∂ƒ∞™ ∞. ªÂÙ·ÁÂ˘Ì·ÙÈΤ˜ ·È¯Ì¤˜ ۷ί¿ÚÔ˘
Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ™ÙÔ: ªÂÏȉÒÓ˘ ∞.
™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È
∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·,
2004: 335-47.
2828. ª∂§π¢ø¡∏™ ∞. ∞˘ÍË̤ÓË Ë Â›ÙˆÛË Ù˘ ÛÙÂÊ·ÓÈ·›·˜ ·ıËڈ̿وÛ˘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2: ªË¯·ÓÈÛÌÔ› Î·È ıÂÚ·¢ÙÈΤ˜ ÂÂÌ‚¿ÛÂȘ.
™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚Ô-
ÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 349-61.
2829. ª∂§π¢ø¡∏™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, Ì˘ÔηډÈÔ¿ıÂÈ· Î·È Î·Ú‰È·Î‹ ·ÓÂ¿ÚÎÂÈ·. ∏ Û˘Ì‚ÔÏ‹ Ù˘
ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·Û˘. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 363-76.
2830. ∫Àƒπ∞∑∏™ π∞. £ÂÚ·›· ÔÚÌÔÓÈ΋˜ ˘ÔηٿÛÙ·Û˘ ÛÙË ‰È·‚ËÙÈ΋ ÌÂÙÂÌÌËÓÔ·˘Ûȷ΋ Á˘Ó·›Î· ηÈ
ηډȷÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004:
377-407.
2831. ¶∞°∫∞§O™ ∂ª. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ
ÛÙËÓ ·ıËÚÔÛÎÏ‹ÚˆÛË ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ:
ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi
™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 409-18.
2832. ™Δ∂º∞¡π¢∏™ ∞, ºOÀ™∞™ ™. ∂ÓÙ·ÙÈÎÔÔÈË̤ÓË
ÈÓÛÔ˘ÏÈÓÔıÂÚ·›· Î·È Â·Ó·ÁÁÂȈÙÈΤ˜ ÂÂÌ‚¿ÛÂȘ: ∏ ÚfiÙ·ÛË ÛÙ· Ôͤ· ÈÛ¯·ÈÌÈο ÂÂÈÛfi‰È· ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘
¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 419-31.
2833. ∫∞∑∞∫O™ ∫. ∞ÓÙÈ·ÈÌÔÂÙ·Ïȷ΋ ·ÁˆÁ‹ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘
¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 433-44.
2834. ΔO§∏™ ∞μ. ∏ ·Ó·ÁηÈfiÙËÙ· ÙÔ˘ ηÏÔ‡ ÁÏ˘Î·ÈÌÈÎÔ‡ ÂϤÁ¯Ô˘ Î·È Ë ÔÚıÔÏÔÁÈ΋ ¯Ú‹ÛË ÙˆÓ ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 445-63.
2835. ª∏Δƒ∞∫OÀ ∞. ¡ÂfiÙÂÚ˜ ıÂÚ·¢ÙÈΤ˜ ÂÍÂÏ›ÍÂȘ
ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2 Î·È ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 465-73.
2836. ∞§∂•∞¡¢ƒπ¢∏™ £. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË:
ªÔÚÈ·ÎÔ› Ì˯·ÓÈÛÌÔ›, ۷ί·Ú҉˘ ‰È·‚‹Ù˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ, ·ıËÚÔÛÎÏ‹Ú˘ÓÛË. ™ÙÔ: ªÂÏȉÒÓ˘
∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘, ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ
Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 477-503.
2837. ∂§π™∞º ª. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ ÈÓÛÔ˘ÏÈÓÔ·ÓÙÔ¯‹˜: ¢È·ÁÓˆÛÙÈο ÎÚÈÙ‹ÚÈ· – £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘,
ªÂÙ·‚ÔÏÈÎfi ™‡Ó‰ÚÔÌÔ Î·È ∞ıËڈ̿وÛË. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÂÏ›‰·, 2004: 505-21.
2838. ∫∞Δ™π§∞ª¶ƒO™ ¡, §π∞Δ∏™ ™, ª∞∫ƒÀ§∞∫∏™ ∫. ¢È·ÙÚÔÊ‹ Î·È Î·Ú‰ÈÔ·ÁÁÂȷο ÓÔÛ‹Ì·Ù·
ÛÙ· ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ∫ÚÈÙÈ΋ ıÂÒÚËÛË
ÙˆÓ ‰ÈÂıÓÒÓ Î·Ù¢ı˘ÓÙ‹ÚÈˆÓ Ô‰ËÁÈÒÓ. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋
¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25
193
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋
∂Ù·ÈÚ›·, 2006: 9-21.
2839. æÀƒO°π∞¡¡∏™ ∞. ∏ ÂȉËÌÈÔÏÔÁ›· ÙˆÓ ·Ú·ÁfiÓÙˆÓ ÎÈÓ‰‡ÓÔ˘ Î·È ÙˆÓ Ì·ÎÚÔ·ÁÁÂÈÔ·ıËÙÈÎÒÓ ÂÈÏÔÎÒÓ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ™·Î¯·Ú҉˘
¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜.
¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 23-8.
2840. ª∂§π¢ø¡∏™ ∞. ∏ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË ÛÙËÓ ·ıÔÁ¤ÓÂÛË Ù˘ ·ıËڈ̿وÛ˘. ™ÙÔ:
™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜
24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 37-48.
2841. ∞§∞μ∂ƒ∞™ ∞. ªÈÎÚÔÏÂ˘ÎˆÌ·ÙÈÓÔ˘Ú›·, ¶ÚÒÈÌË
∞ıËڈ̿وÛË Î·È ™ÙÂÊ·ÓÈ·›· ¡fiÛÔ˜. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋
¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25
ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋
∂Ù·ÈÚ›·, 2006: 49-59.
2842. Δ∂¡ΔO§OÀƒ∏™ ¡, ∫∞Δ™π§∞ª¶ƒO™ ¡. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘
2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·,
2006: 69-80.
2843. ª∏Δƒ∞∫OÀ ∞. ∏ Û˘Ì‚ÔÏ‹ Ù˘ ÁÏ˘Î·ÈÌ›·˜ (Úԉȷ‚‹Ù˘-‰È·‚‹Ù˘) ÛÙËÓ Î·Ú‰ÈÔ·ÁÁÂȷ΋ ÓfiÛÔ: KÏÈÓÈο Î·È ÂȉËÌÈÔÏÔÁÈο ‰Â‰Ô̤ӷ. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋
∂Ù·ÈÚ›·, 2006: 91-7.
2844. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∂›Ó·È Ë ÈÓÛÔ˘Ï›ÓË ·ıËڈ̷ÙÔÁfiÓÔ˜ ÔÚÌfiÓË; ∏ ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·ÛË ‰Â›ÎÙ˘ ‹ ·Ú¿ÁˆÓ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ηډÈÔ·ÁÁÂȷ΋ ÓfiÛÔ; ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋
¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25
ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋
∂Ù·ÈÚ›·, 2006: 113-9.
2845. ºπ§π¶¶π¢∏™ º¶. ∏ ™ÙÂÊ·ÓÈ·›· ¡fiÛÔ˜ ÛÙÔ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË: ¶ÚˆÙÔÁÂÓ›˜ ÚÔÏËÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ∏ ·ÓÙÈ·ÈÌÔÂÙ·Ïȷ΋ ·ÁˆÁ‹. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋
∂Ù·ÈÚ›·, 2006: 121-9.
2846. ºOÀ™∞™ ™°. Δ· Ôͤ· ÛÙÂÊ·ÓÈ·›· Û‡Ó‰ÚÔÌ· ÛÙÔ
‰È·‚ËÙÈÎfi ·ÛıÂÓ‹: ∞Èٛ˜ ÂÈ‚·ÚË̤Ó˘ ÚfiÁÓˆÛ˘,
Ê·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË, Ë ·Í›· Ù˘ ÂÓÙ·ÙÈÎÔÔÈË̤Ó˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜.
¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 131-5.
194
2847. ¢π¢∞°°∂§O™ Δ¶. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ
ÛÙËÓ Î·Ú‰È·Î‹ ·ÓÂ¿ÚÎÂÈ· ÛÙÔ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË.
™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋
¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 143-8.
2848. ª¶OÀ™ª¶OÀ§∞™ ™. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ ÛÙËÓ ¶ÂÚÈÊÂÚÈ΋ ∞ÁÁÂȷ΋ ¡fiÛÔ ÛÙÔ ™·Î¯·ÚÒ‰Ë ¢È·‚‹ÙË. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·:
∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 149-62.
2849. ¶∞¡∞°πøΔOÀ £. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
ÈÛ¯·ÈÌÈÎÔ‡ ·ÁÁÂÈ·ÎÔ‡ ÂÁÎÂÊ·ÏÈÎÔ‡ ÂÂÈÛÔ‰›Ô˘ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο
∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006.
∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006:
163-68.
2850. ª∏ΔƒOÀ ¶, ¢∏ª∏Δƒπ∞¢∏™ °. O ÚfiÏÔ˜ Ù˘
·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË Î·È Ù˘ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·˜
ÙˆÓ ‚-΢ÙÙ¿ÚˆÓ ÛÙËÓ ·ÈÙÈÔ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ™·Î¯·ÚÒ‰Ô˘˜ ¢È·‚‹ÙË Ù‡Ô˘ 2. ¢˘Ó·ÙfiÙËÙ˜ ÚfiÏ˄˘ Ù˘ ÓfiÛÔ˘. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜
¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 171-7.
2851. πø∞¡¡π¢∏™ πª. O ÚfiÏÔ˜ ÙˆÓ Â˘·ÈÛıËÙÔÔÈÒÓ Ù˘
ÈÓÛÔ˘Ï›Ó˘ ÛÙËÓ Â›Ù¢ÍË Î·È ‰È·Ù‹ÚËÛË ÙÔ˘ ÁÏ˘Î·ÈÌÈÎÔ‡ ÂϤÁ¯Ô˘. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË - ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜ ¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 179-88.
2852. ¶∞¶¶∞™ ™π. ∂˘ÂÚÁÂÙ‹Ì·Ù· ·fi ÙÔ˘˜ ¢·ÈÛıËÙÔÔÈËÙ¤˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘ Î·È ¤Ú· ·fi ÙÔ ÁÏ˘Î·ÈÌÈÎfi
¤ÏÂÁ¯Ô. ™ÙÔ: ™·Î¯·Ú҉˘ ¢È·‚‹Ù˘ - ∞ıËڈ̿وÛË
- ∫·Ú‰È·ÁÁÂȷ΋ ¡fiÛÔ˜. ¶Ú·ÎÙÈο ∂ÈÛÙËÌÔÓÈ΋˜
¢ÈËÌÂÚ›‰·˜ 24-25 ºÂ‚ÚÔ˘·Ú›Ô˘ 2006. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2006: 189-207.
2853. ∫∞ƒ∞°∂øƒ°∏™ μ¶. ∏ ÈÓÛÔ˘Ï›ÓË ÂÓ ÙË ¯ÂÈÚÔ˘ÚÁÈ΋. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1930. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2854. ∫Oª¡∏¡O™ ¢, ª¶∞∫∞§O™ ¢.ª. £ÂÚ·›·
‚·ÚÂÈÒÓ ÌÔÚÊÒÓ Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ‰È¿ ÙˆÓ
ÌÂÈÎÙÒÓ ‰È·Ï˘Ì¿ÙˆÓ Î·È Ù˘ ÈÓÛÔ˘Ï›Ó˘ NPH. ™ÙÔ:
¶Ú·ÎÙÈο Ù˘ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ. ™˘Ó‰ڛ·
16 ª·˝Ô˘ 1953. ∞ı‹Ó·: Ã. §ÂÔÓÙÈ¿‰Ë˜, 1953.
2855. ºƒ∂ƒ∏™ ¡ª, ¶∞¶∞μ∞™π§O¶OÀ§O™ °¶.
∂ÎÙ›ÌËÛË ÙˆÓ ·Ú·Ì¤ÙÚˆÓ ÂÓfi˜ Ó¤Ô˘ ÌÔÓÙ¤ÏÔ˘ ÈÓÛÔ˘Ï›Ó˘-ÁÏ˘Îfi˙˘. ™¯ÔÏ‹ ∏ªªÀ ∂ª¶, 2005. ¢Èψ̷ÙÈ΋ ∂ÚÁ·Û›·.
2856. ∫O§O∫OÀ™∏™ ð. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ıÂÚ·›·Ó
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ‰È· ÙˆÓ ÓÂÒÙÂÚˆÓ ÈÓÛÔ˘ÏÈÓÒÓ Î·È ÙˆÓ ÛÔ˘ÏÊÔÓ˘ÏÔ˘ÚÈÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, £ÂÚ·Â˘Ù‹ÚÈÔ «O ∂˘·ÁÁÂÏÈÛÌfi˜», 1960. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
2857. ∫∞ƒ∞ºøΔπ∞™ ∞, ™OÀ§πøΔ∏™ ∞, ºOÀ™Δ∞§π∂ƒ∞∫∏ ™. ¡Â·ÓÈÎfi˜ ‰È·‚‹Ù˘ Î·È „˘¯ÔÎÔÈÓˆÓÈΤ˜-Û˘Ó·ÈÛıËÌ·ÙÈΤ˜ ÂȉڿÛÂȘ Û ӤԢ˜ ¿Û¯ÔÓÙ˜
·Ô ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2007. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
2858. ∫OÀΔƒOÀª¶∞¡OÀ ∞, ºπº∏ ¶. ™˘Ó·ÈÛıËÌ·ÙÈ΋ ηٿÛÙ·ÛË ÂÊ‹‚ˆÓ Î·È Ó¤ˆÓ ÌÂÙÂÊË‚È΋˜ ËÏÈΛ·˜
Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË (Ù‡Ô˘
π): O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2001. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·. 2001
2859. ¢ƒ∞°∫πøΔ∏ μ. ∏ ‰Ú¿ÛË Ù˘ ÈÓÙÂÚÏ¢ΛÓ˘ 1 ÛÙÔ˘˜
Ì˯·ÓÈÛÌÔ‡˜ ı·Ó¿ÙˆÛ˘ ÙˆÓ ‚ ·ÁÎÚ·ÙÈÎÒÓ Î˘Ù¿ÚÚˆÓ ÛÙÔÓ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ ‰È·‚‹ÙË. ΔÌ‹Ì· μÈÔÏÔÁ›·˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘, 1998. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2860. ¡Δ∞§∏ °. ªÂϤÙË Ù˘ Û˘Û¯¤ÙÈÛ˘ Ù˘ Û‡ÛÙ·Û˘
ÙÔ˘ ‰È·ÈÙËÙÈÎÔ‡ Ï›Ô˘˜ Ì ÙËÓ ÈÓÛÔ˘ÏÈÓÈ΋ ¢·ÈÛıËÛ›· Û Á˘Ó·›Î˜ ÌÂ Ê˘ÛÈÔÏÔÁÈ΋ ·ÓÔ¯‹ ÛÙË ÁÏ˘Îfi˙Ë
Ô˘ Â›Ó·È ·fiÁÔÓÔÈ ÚÒÙÔ˘ ‚·ıÌÔ‡ ·ÛıÂÓÒÓ Ô˘
¿Û¯Ô˘Ó ·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ΔÌ‹Ì·
∂ÈÛÙ‹Ì˘ ¢È·ÈÙÔÏÔÁ›·˜ - ¢È·ÙÚÔÊ‹˜ ÷ÚÔÎfiÂÈÔ˘
¶·ÓÂÈÛÙËÌ›Ô˘, 2004. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2861. ™π¢∂ƒ∏ °∫. ∏ Â·ÁÁÂÏÌ·ÙÈ΋ ·Ó¿Ù˘ÍË ÙˆÓ ·ÙfiÌˆÓ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
ΔÌ‹Ì· º.¶.æ. ∂∫¶∞, 2004 ¢Èψ̷ÙÈ‹ ∂ÚÁ·Û›·.
2862. ∏§π∞¢∏™ º. ∂›‰Ú·ÛË Ù˘ Ê·Ú̷΢ÙÈ΋˜ ·ÁˆÁ‹˜ ÛÙË ÏÂÈÙÔ˘ÚÁ›· ÙˆÓ ‚-΢ÙÙ¿ÚˆÓ Î·È ÛÙËÓ ·ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2006. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2863. CLARKE SL, CRAIG ME, GARNETT SP, CHAN
AK, COWELL CT, CUSUMANO JM, KORDONOURI O, SAMBASIVAN A, DONAGHUE KC.
Increased adiposity at diagnosis in younger children
with type 1 diabetes does not persist. Diabetes Care
2006; 29: 1651-3.
2864. DANNE T, VON SCHÜTZ W, LANGE K, NESTORIS C, DATZ N, KORDONOURI O. Current
practice of insulin pump therapy in children and
adolescents - the Hannover recipe. Pediatr Diabetes
2006; 7 (Suppl 4): 25-31.
2865. ∞¡¢ƒπøΔ∞∫∏™ ∫¡. £ÂÚ·›· ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘ ‰È· ÙˆÓ ÌÂÙ·ÏÏÈÎÒÓ ˘‰¿ÙˆÓ. ∞η‰ËÌ·˚΋
π·ÙÚÈ΋ 1956; 20: 506-15
2866. ªO™Ãø¡∞™ π∞. ∂Á¯ÂÈÚ›‰ÈÔ ÚÔÛ¤ÁÁÈÛ˘ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2000.
2867. Ã∞ƒ∞Δ™∏-°πøΔ∞∫∏ ∂. ™˘ÓÙ·Á¤˜ Î·È ‰È·ÈÙÔÏfiÁÈ· ÁÈ· ˘ÁÈÂÈÓ‹ ‰È·ÙÚÔÊ‹: ŒÓ·˜ Ï‹Ú˘ Ô‰ËÁfi˜ ‰È·ÙÚÔÊ‹˜ ÁÈ· ‰È·‚ËÙÈÎÔ‡˜ ‚·ÛÈṲ̂ÓÔ ÛÙËÓ ÂÏÏËÓÈ΋ ·Ú·‰ÔÛȷ΋ ÌÂÛÔÁÂȷ΋ ÎÔ˘˙›Ó·. ∞ı‹Ó·: ∂ΉfiÛÂȘ
ªÂÙ·›¯ÌÈÔ, 2007.
2868. ¶∞¡O™ °, ºπ§∞¡¢ƒ∞ º.: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘
& ‰È·‚ËÙÈο ÎÒÌ·Ù·: ∫ÏÈÓÈÎfi ÂÁ¯ÂÈÚ›‰ÈÔ Â›ÁÔ˘Û·˜
‰È·ÊÔÚԉȿÁÓˆÛ˘ Î·È ıÂÚ·¢ÙÈ΋˜ ·ÓÙÈÌÂÙÒÈÛ˘.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ¶.Ã. ¶·Û¯·Ï›‰Ë˜, 2003.
2869. ∫O¡π¢∞ƒ∏™ ∫. ªÂϤÙ˜ ¿Óˆ Û Èı·Ó¿ ·˘ÙÔ·ÓÙÈÁfiÓ· ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 1. π·ÙÚÈ΋
™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ πˆ·ÓÓ›ÓˆÓ, 2004. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2870. °∫π∫∞ ∂. æ˘¯·Ó·Ï˘ÙÈ΋ Î·È „˘¯Ôۈ̷ÙÈ΋ ÚÔÛ¤ÁÁÈÛË ÙÔ˘ ÂÊ‹‚Ô˘ Ì Ó·ÓÈÎfi ‰È·‚‹ÙË. ΔÌ‹Ì· æ˘¯ÔÏÔÁ›·˜ ¶¿ÓÙÂÈÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫ÔÈÓˆÓÈÎÒÓ Î·È
¶ÔÏÈÙÎÒÓ ∂ÈÛÙËÌÒÓ, 2007. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2871. ∫∞§º∞ £∞. ªÂϤÙ˜ ÛÙË ‰ÔÌ‹ Ù˘ ‚·ÛÈ΋˜ ÌÂÌ‚Ú¿Ó˘ Î·È ÛÙ· ·ÔÙÂϤÛÌ·Ù· ÙˆÓ ÌÂÙ·‚ÔÏÒÓ Ù˘
ηٿ ÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£,
1997. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2872. ∫ø™Δπ¢OÀ ∂∞, ∫O§π∞∫O™ °. ∞ÏÏËÏÂȉڿÛÂȘ
ÌÔÓÔ΢ÙÙ¿ÚˆÓ-Ï·ÌÈÓ›Ó˘: ™‡Ó‰ÂÛË ÌÂÙ¿ ·fi ʈÛÊÔÚ˘Ï›ˆÛË ‹ ÔÍ›‰ˆÛË, ‰È·ÊÔÚ¤˜ ÌÂٷ͇ Ê˘ÛÈÔÏÔÁÈÎÒÓ
·ÙfiÌˆÓ Î·È ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘
ππ. ΔÌ‹Ì· μÈÔ¯ËÌ›·˜ Î·È μÈÔÙ¯ÓÔÏÔÁ›·˜ ¶·ÓÂÈÛÙËÌ›Ô˘ £ÂÛÛ·Ï›·˜, 2004. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2873. ∫∞Δ™π§∞ª¶ƒO™ ¡, ¢π∞∫OÀªO¶OÀ§OÀ ∂,
πø∞¡¡π¢∏™ π, §π∞Δ∏™ ™. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ÛÙËÓ ÎÏÈÓÈ΋ Ú¿ÍË: O ‰È·‚‹Ù˘ ·fi ÙÔ ∞ ˆ˜ ÙÔ
ø Ì ÂÚˆÙ‹ÛÂȘ Î·È ··ÓÙ‹ÛÂȘ. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ §›ÙÛ·˜, 2005.
2874. ∫∞§O°∏ƒOÀ ¶°. ™‡Á¯ÚÔÓÔ˜ ‰È·ÈÙËÙÈ΋ Î·È ‰È·‚‹Ù˘. 2Ë ¤Î‰. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 1964.
2875. £∂O¢øƒOÀ π. ªÂϤÙË Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ¿ıÂÈ·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ πˆ·ÓÓ›ÓˆÓ,
2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2876. °π∞§∏ ™¡. ∏ Â›‰Ú·ÛË Ù˘ ‰È·‚ËÙÈ΋˜ ÎÂÙÔͤˆÛ˘ ÛÙÔ ·ÓÔÛÔÏÔÁÈÎfi Û‡ÛÙËÌ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ¶·ÙÚÒÓ, 2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2877. æÀƒO°π∞¡¡∏™ ∞π. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Ù˘ ·ÓıÚÒÈÓ˘ Î·È ¯Ô›ÚÂÈ·˜ ÈÓÛÔ˘Ï›Ó˘ Û ·ÛıÂÓ›˜ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ (Ù‡Ô˘ π) ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ¶·ÙÚÒÓ, 1993. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2878. ™Δ∞ƒ∞∫∏™ π∫. ¢ÈÂÚ‡ÓËÛË ·ıÔÁ¤ÓÂÈ·˜ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ¿ÙÔÌ· ¿Û¯ÔÓÙ· ·fi ÔÌÔ˙˘Á‹ ‚ÌÂÛÔÁÂȷ΋ ·Ó·ÈÌ›·. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘
¶·ÙÚÒÓ, 1994. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2879. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂π. ∞ÈÌÔÚÚÂÔÏÔÁÈΤ˜ ηÈ
‚ÈÔ¯ËÌÈΤ˜ ·Ú¿ÌÂÙÚÔÈ ÛÙË ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·:
∫ÏÈÓÈ΋ Î·È ÂÈÚ·Ì·ÙÈ΋. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶, 1984.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2880. ª∂°∞§OÀ¢∏ ∞. ∏ Û˘ÌÌÂÙÔ¯‹ ·ÙfiÌˆÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ÚÔÁÚ¿ÌÌ·Ù· ¿ÛÎËÛ˘: ∂Ê·ÚÌÔÁ‹
Ù˘ ıˆڛ·˜ ۯ‰ȷṲ̂Ó˘ Û˘ÌÂÚÈÊÔÚ¿˜. ΔÌ‹Ì·
∂ÈÛÙ‹Ì˘ º˘ÛÈ΋˜ ∞ÁˆÁ‹˜ Î·È ∞ıÏËÙÈÛÌÔ‡ ∂∫¶∞,
2004. ªÂÙ·Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2881. ∂¶∞¡øª∂ƒπΔ∞∫∏™ ∂∏. ∫ÈÓËÙÈΤ˜ ‰È·Ù·Ú·¯¤˜
ÙÔ˘ ÔÈÛÔÊ¿ÁÔ˘ Î·È Ù˘ ÔÚıÔÚˆÙÈ΋˜ ÂÚÈÔ¯‹˜
ÛÙÔ˘˜ ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ·Ú¿ÏÏËÏ·
195
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
Ì ÙË ‰È¿ÚÎÂÈ· Ù˘ ÓfiÛÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘, 1999. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2882. Δ™πƒOÀ ª¡. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ ıÂÚ·¢ÙÈ΋˜ ·ÓÙÈÌÂÙˆ›Ûˆ˜ Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÔ·ÁÁÂÈÒÛˆ˜ Ù˘ ›ÚȉԘ Î·È ÙÔ˘ ÓÂÔ·ÁÁÂÈ·ÎÔ‡ ÁÏ·˘ÎÒÌ·ÙÔ˜
‰È· ΢ÎÏÔÎÚ˘ÔËÍ›·˜ Î·È ·Ó·ÌÊÈ‚ÏËÛÙÚÔÂȉÈ΋˜
ʈÙÔËÍ›·˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2883. °π∞¡¡∞∫∞∫∏™ £¢. ¶·Ú·ÙËÚ‹ÛÂȘ ÂÈ Ù˘ ÔÛÙÈ΋˜ ˘ÎÓfiÙËÙÔ˜ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ‰È· Ù˘ ÌÂıfi‰Ô˘ Ù˘ ·ÔÚÚÔÊ‹Ûˆ˜ ÙˆÓ Á ʈÙÔÓ›ˆÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1980. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2884. SCHAEFER-GRAF UM, HARTMANN R, PAWLICZAK J, PASSOW D, ABOU-DAKN M, VETTER K, KORDONOURI O. Association of breastfeeding and early childhood overweight in children
from mothers with gestational diabetes mellitus. Diabetes Care 2006; 29: 1105-7.
2885. Δ∂™™∂ƒOªª∞Δ∏ Ã. πÛÙÔÏÔÁÈη› Î·È ÎÏÈÓÈη›
·ÏÏÔÈÒÛÂȘ ÙˆÓ Ô‡ÏˆÓ Â› ‰È·‚ËÙÈÎÒÓ ÂÈÚ·Ì·Ùfi˙ˆˆÓ Î·È ·ÓıÚÒˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1979. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2886. §∞∑∞ƒ∞∫∏ °π. ∏ ÛËÌ·Û›· Ù˘ ¤ÎÊÚ·Û˘ Ù˘ ÂÓ‰ÔıËÏȷ΋˜ Û˘ÓıÂÙ¿Û˘ ÙÔ˘ ÌÔÓÔÍÂȉ›Ô˘ ÙÔ˘ ·˙ÒÙÔ˘(eNOS) ÛÙÔ Á·ÛÙÚÈÎfi ‚ÏÂÓÓÔÁfiÓÔ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2007. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2887. ºøΔπ∞¢∏™ ™¢. ¡·ÙÚÈÔ˘ÚËÙÈο ÂÙ›‰È· Î·È Î·Ú‰È·Î‹ ÏÂÈÙÔ˘ÚÁ›· Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2007. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2888. ¶∞°∫∞§O™ ª∂. ∏ Â›‰Ú·ÛË Ù˘ Û˘ÛÙËÌ·ÙÈ΋˜
·ÂÚfi‚È·˜ ¿ÛÎËÛ˘ ÛÙËÓ Î·Ú‰È·Î‹ ÏÂÈÙÔ˘ÚÁ›· ·ÛıÂÓÒÓ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2 Î·È Ó¢ÚÔ¿ıÂÈ·
ÙÔ˘ ·˘ÙfiÓÔÌÔ˘ Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜. ΔÌ‹Ì· ∂ÈÛÙ‹Ì˘ º˘ÛÈ΋˜ ∞ÁˆÁ‹˜ Î·È ∞ıÏËÙÈÛÌÔ‡ ∞¶£, 2007.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2889. °π∞°§∏™ °¢. ∂ÎÙ›ÌËÛË ÂȉËÌÈÔÏÔÁÈÎÒÓ, ÎÏÈÓÈÎÒÓ Î·È Ó¢ÚÔÊ˘ÛÈÔÏÔÁÈÎÒÓ ·Ú·Ì¤ÙÚˆÓ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· Î·È ‰˘ÛÏÂÈÙÔ˘ÚÁ›·
ÙÔ˘ Ô˘ÚÔÔÈÔÁÂÓÓËÙÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∞¶£, 2006. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2890. ∫O§πO¶OÀ§O™ °•. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· 2000. ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, ∞ı‹Ó·, 1999.
2891. ∫∞ƒ∞ª∏Δ™O™ £¢. ∫·Ú‰È·Î‹ ‰˘ÛÏÂÈÙÔ˘ÚÁ›· ηÈ
‰È·Ù·ÛÈÌfiÙËÙ· Ù˘ ·ÔÚÙ‹˜ Û ¿ÙÔÌ· Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ 1. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2006. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2892. Δƒ∞¡O™ ¶°. ∏ ıÂÚ·›· Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ· Ì ʈÙÔËÍ›· Î·È Ë Â›‰Ú·Û‹ Ù˘
ÛÙËÓ Û¯ÂÙÈ˙fiÌÂÓË Ì ÙËÓ ˘Á›· ÔÈfiÙËÙ· ˙ˆ‹˜. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2893. ∑∏∫∞ Ã∞. ™‡ÓıÂÛË Ó¤ˆÓ ÂÙÂÚÔ΢ÎÏÈÎÒÓ ¯ËÌÂÈÔÙ‡ˆÓ Ì Èı·Ó‹ Ê·ÚÌ·ÎÔıÂÚ·¢ÙÈ΋ ¯ÚËÛÈÌfiÙËÙ·
196
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ηٿıÏȄ˘ Î·È ÙˆÓ ¯ÚfiÓȈÓ
ÂÈÏÔÎÒÓ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË: μÈÔ¯ËÌÈ΋ ηÈ
˘ÔÏÔÁÈÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË. ΔÌ‹Ì· º·Ú̷΢ÙÈ΋˜
∞¶ı, 2004. ¢È‰·ÎÙÔÚÈ΋ ∂ÚÁ·Û›·.
2894. °∫O°∫OÀ °. ∂Ê·ÚÌÔÁ‹ Ù˘ Ù¯ÓËÙ‹˜ ÓÔËÌÔÛ‡Ó˘
ÛÙË ÛÙ‹ÚÈÍË ·ÔÊ¿ÛÂˆÓ ·ÓÙÈÌÂÙÒÈÛ˘ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2001. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
2895. ¢π∞ƒ∂ª∂ ª. ªÂÙ·‚ÔÏÈ΋ ·¿ÓÙËÛË ‰È·‚ËÙÈÎÒÓ
·ÙfiÌˆÓ ˘¤Ú‚·ÚˆÓ Î·È ÌË Î·Ù¿ ÙË ‰È¿ÚÎÂÈ· ۈ̷ÙÈ΋˜ ¿ÛÎËÛ˘ (‰ÔÎÈÌ·Û›· ÎÔÒÛˆ˜ ηٿ BRUCE).
ΔÌ‹Ì· ÃËÌ›·˜ ∂∫¶∞, 2004. ªÂÙ·Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2896. ∫ƒ∞μμ∞ƒπΔ∏ ª. ∞ÍÈÔÏfiÁËÛË Ù˘ ΢ÛÙ·Ù›Ó˘ C
ˆ˜ ‰Â›ÎÙË ÁÈ· ÙËÓ ÚÒÈÌË ‰È¿ÁÓˆÛË Ù˘ ‰È·‚ËÙÈ΋˜
ÓÂÊÚÔ¿ıÂÈ·˜. ΔÌ‹Ì· ÃËÌ›·˜ ∞¶£, 2004. ªÂÙ·Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2897. ∂À∞°°∂§∞ΔOÀ ∂. ∏ ‰È·ÙÚÔÊ‹ Ù˘ ÂÁ·Ԣ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î‡ËÛ˘. ΔÌ‹Ì· ∂ÈÛÙ‹Ì˘ ¢È·ÈÙÔÏÔÁ›·˜ Î·È ¢È·ÙÚÔÊ‹˜ ÷ÚÔÎfiÂÈÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2898. ¶OΔ™∏ º. §ÂÙ›ÓË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ (Ù‡Ô˘ ππ). ΔÌ‹Ì· ∂ÈÛÙ‹Ì˘ ¢È·ÈÙÔÏÔÁ›·˜ Î·È ¢È·ÙÚÔÊ‹˜ ÷ÚÔÎfiÂÈÔ˘ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ, 1999.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2899. ∫∞ƒ∞ª∂™π¡∏™ ¶.ª. ∞ÏÏÔÈÒÛÂȘ Ì˯·ÓÈÛÌÒÓ
΢ÙÙ·ÚÈ΋˜ ÂÈÎÔÈÓˆÓ›·˜ Ì ÂÍˆÎ˘ÙÙ¿ÚÈ· Ô˘Û›· ÛÂ
¢È·‚ËÙÈ΋ ¡ÂÊÚÔ¿ıÂÈ·. ΔÌ‹Ì· μÈÔÏÔÁ›·˜ ∂∫¶∞,
2004. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2900. ºø∫∞™ ∂∞, Î.·. ¢È·‚ËÙÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ·. π·ÙÚÈο ÃÚÔÓÈο 1962; 1: 161-6.
2901. ºø∫∞™ ∂∞, Î.·. ∂›‰Ú·ÛȘ Ù˘ ·Ó‰ÚÂÓ·Ï›Ó˘ Â›
ÙˆÓ ‰È·ÊfiÚˆÓ ÏÈȉ›ˆÓ Î·È ÚˆÙÂ˚ÓÒÓ Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfiÌˆÓ Î·È Â› ¿Û¯ÔÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘. π·ÙÚÈο ÃÚÔÓÈο 1962; 1: 531-7.
2902. ºø∫∞™ ∂∞, Î.·. ŒÚÂ˘Ó·È Â› ÙˆÓ ÏÈȉ›ˆÓ, ÏÈÔÚˆÙÂ˚ÓÒÓ, ÁÏ˘ÎÔÚˆÙÂ˚ÓÒÓ Î·È ˘‰·Ù·ÓıÚ·ÎÈÎÒÓ
·Ú¿ÁˆÁˆÓ ÙÔ˘ ·›Ì·ÙÔ˜ Â› Ê˘ÛÈÔÏÔÁÈÎÒÓ ·ÙfïÓ
Î·È Â› ·Û¯fiÓÙˆÓ ÂΠ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘.
∞Ú¯Â›Ô π·ÙÚÈÎÒÓ ∂ÈÛÙËÌÒÓ. ∞ı‹Ó·: Δ‡ÔȘ ¡.
∞ÚÁ˘ÚÔ‡, 1960: 16: (ÛÂÏ.?).
2903. ∞¡Δø¡O¶OÀ§O™ ªπ. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ
Ù˘ ıÂÚ·›·˜ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ‰È¿ ÙˆÓ
per os ˘ÔÁÏ˘Î·ÈÌÈÎÒ˜ ‰ÚÒÓÙˆÓ Û΢·ÛÌ¿ÙˆÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1967. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2904. ™ª¶∞ƒOÀ¡∏ ∂μ. ΔÔ ‰È·‚ËÙÈÎfi fi‰È: ∫ÏÈÓÈÎÔÂÚÁ·ÛÙËÚȷ΋ ÌÂϤÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 1990. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2905. TENTOLOURIS N, MARINOU K, KOKOTIS P,
KARANTI A, DIAKOUMOPOULOU E, KATSILAMBROS N. Sudomotor dysfunction is associated
with foot ulceration in diabetes. Diabet Med 2009; 26:
302-5.
2906. PIKILIDOU MI, LASARIDIS AN, SARAFIDIS
PA, BEFANI CD, KOLIAKOS GG, TZIOLAS IM,
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
KAZAKOS KA, YOVOS JG, NILSSON PM. Insulin
sensitivity increase after calcium supplementation and
change in intraplatelet calcium and sodium-hydrogen
exchange in hypertensive patients with Type 2 diabetes. Diabet Med 2009; 26: 211-9.
2907. PAPANAS N, MONASTIRIOTIS C, CHRISTAKIDIS D, MALTEZOS E. Metformin and lactic acidosis in patients with type 2 diabetes—from pride and
prejudice to sense and sensibility. Acta Clin Belg
2009; 64: 42-8.
2908. VOUDRIS V, KARIOFILLIS P, THOMOPOULOU S, PATSILINAKOS S, MANGINAS A, SPARGIAS C, PAVLIDES G, COKKINOS DV. Predictors
for very late stent thrombosis after drug-eluting stent
implantation in diabetic patients. EuroIntervention
2009; 4: 485-91.
2909. VAIRAKTARIS E, GOUTZANIS L, YAPIJAKIS
C, VASSILIOU S, SPYRIDONIDOU S, VYLLIOTIS A, NKENKE E, LAZARIS A.C, STRANTZIAS
P, PATSOURIS E. Diabetes enhances the expression
of H-ras and suppresses the expression of EGFR
leading to increased cell proliferation. Histol Histopathol 2009 24: 531-9.
2910. PANAGIOTAKOS DB, LIONIS C, ZEIMBEKIS
A, GELASTOPOULOU K, PAPAIRAKLEOUS N,
DAS UN, POLYCHRONOPOULOS E. Long-term
tea intake is associated with reduced prevalence of
(type 2) diabetes mellitus among elderly people from
Mediterranean islands: MEDIS epidemiological
study. Yonsei Med J 2009; 50: 31-8.
2911. KARAVANAKI K, KAKLEAS K, PASCHALI E,
KEFALAS N, KONSTANTOPOULOS I, PETROU
V, KANARIOU M, KARAYIANNI C. Screening for
Associated Autoimmunity in Children and Adolescents with Type 1 Diabetes Mellitus (T1DM). Horm
Res 2009; 71: 201-6.
2912. ¢∞¡O¶OÀ§O™ ∂¢, ∞°°∂§O¶OÀ§O™ μ. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË Â› ÙˆÓ ÌÂÙ·ÏÏ·ÁÒÓ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ ηٿ Ù· ÚÔ ÙÔ˘ ÔϤÌÔ˘, Ù· ÔÏÂÌÈο Î·È ÌÂÙ·ÔÏÂÌÈο ¤ÙË ÂÓ ∂ÏÏ¿‰È. ™ÙÔ: ¶Ú·ÎÙÈο
Ù˘ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ ∞ıËÓÒÓ. ∞ı‹Ó·: Ã. §ÂÔÓÙÈ¿‰Ë˜, (19??): (ÛÂÏ.?).
2913. ∞¡¢ƒπøΔ∞∫∏™ ∫¡, ™∫§∏ƒO™ º∫. ™¯¤ÛÂȘ
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘ Î·È ¯ÔÏÔÏÈıÈ¿Ûˆ˜: ∂’ ¢ηÈÚ›· ÙÚÈÒÓ ¯ÂÈÚÔ˘ÚÁËÛıÂÈÛÒÓ ÂÚÈÙÒÛˆÓ. π·ÙÚÈο ÃÚÔÓÈο 1963; 2: (Û.?).
2914. ªOÀΔ∑π£ƒO¶OÀ§O™ ∫Ã. ™¿Î¯·ÚÔ ‰È·‚‹Ù˘:
¶Ú·ÎÙÈÎfi˜ Ô‰ËÁfi˜ ‰È¿ ÙÔÓ È·ÙÚfiÓ Î·È ÙÔÓ ¿Û¯ÔÓÙ·.
∞ı‹Ó·: 95 ÛÂÏ.
2915. ∫∞ƒ∞°∫OÀ¡∏ ∞, ∫∞ƒ∞∫ø™Δ∞ ª. ∏ ÎÔÈÓÔÙÈ΋
ÓÔÛËÏ¢ÙÈ΋ ÛÙËÓ ÂÎ·›‰Â˘ÛË ÙÔ˘ ÂÓ‹ÏÈη ‰È·‚ËÙÈÎÔ‡. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2916. §OÀΔ™π¢∏™ ∂. ™˘Ì‚Ô˘Ï·› ÂȘ ÙÔÓ ¿ÚÚˆÛÙÔÓ ‰È·‚ËÙÈÎfiÓ: ∞ÁÒÓ Î·Ù¿ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘.
∞ı‹Ó·, 1967: 164 ÛÂÏ.
2917. ª¶OÀ™π∞ Ã, ¶∞¡∞°O¶OÀ§OÀ ∂. æ˘¯ÔÏÔÁÈ΋ ˘ÔÛÙ‹ÚÈÍË Û ·È‰È¿ Î·È ÁÔÓ›˜ Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2918. ∫§OÀμ∞ΔOÀ ∂, ¶∞¡∞°πøΔOÀ ∞. ¡ÔÛËÏ¢ÙÈ΋ ÚÔÛ¤ÁÁÈÛË Û ·È‰› Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
2919. μ∞§§π∞¡∞ΔOÀ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2920. §∞∫OÀª∂¡Δ∞ O. ∏ ÂÎ·›‰Â˘ÛË ÙÔ˘ ·È‰ÈÔ‡ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ô ÚfiÏÔ˜ Ù˘ ÔÈÎÔÁ¤ÓÂÈ·˜.
ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
2921. °ƒ∏°OƒO¶OÀ§OÀ ∫, ™∫OÀƒ∞∫∏ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÈÏÔΤ˜: O ÚfiÏÔ˜ ÙˆÓ ÓÔÛËÏ¢ÙÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2922. ¡Δ∂§∞∫∏ ª, ¶∞¡Δ∞∑∞ΔOÀ ¡. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ‰È·ÙÚÔÊ‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2923. ∫Oƒ∂§∏ ∞. ¡ÔÛËÏ¢ÙÈ΋ ÚÔÛ¤ÁÁÈÛË Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ ππ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2924. §π∞∫O¶OÀ§OÀ ª. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘, Ô
¤ÊË‚Ô˜ Î·È Ë ÔÈÎÔÁ¤ÓÂÈ¿ ÙÔ˘. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2003.
2925. ∫∞ª¶OÀƒ∏ ∞. ∏ Û˘Ì‚ÔÏ‹ Ù˘ ÓÔÛËÏ¢ÙÈ΋˜ ÛÙËÓ
ÚfiÏË„Ë Î·È ·ÓÙÈÌÂÙÒÈÛË-ÊÚÔÓÙ›‰· ÙÔ˘ ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ˘ ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2926. ∞°°∂§O¶OÀ§OÀ ∂, ∞§∂μπ∑O¶OÀ§OÀ O.
¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·. 2008.
2927. ª∂Δ∂μ∂§∏™ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ & ÂÈÏÔΤ˜. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2928. μ§∞ÃO¶OÀ§O™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: O
ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2008 ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2929. Δ∑Oμ∞ƒ∞ ¶, ™¶∏§πøΔO¶OÀ§OÀ ¶. ∑·¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÙÚfiÔ˜ ˙ˆ‹˜. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2930. ¶πΔ™πOÀ ¶. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘.
ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
2931. ™Δ∞ª∞ΔπOÀ ¡. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ ‚′
Î·È ÓÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·. 2008.
2932. ∫ƒO∫π¢∞ ∞, §À∫OÀƒπ¡OÀ ∑. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008 ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
197
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
2933. ªπÃ∞§O¶OÀ§O™ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 1: O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2934. ¶∞¡OÀΔ™OÀ ∞, ¶∞ƒπ™∏ ƒ, Δƒπ∫∫∏ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ÂÓËϛΈÓ: ¡ÔÛËÏ¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2007. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
2935. ºƒ∞°∫π™∫O™ º, ∞§∂•∞¡¢ƒπ¢∏™ ∫, μ∞°∂¡∞™ ¡, ∫O§O∫OÀ¢π∞™ ª, ¡π∫O§∞ΔOÀ O,
ª∞™OÀ§∞™ °. ªÂÙÂÍ·ÎÙÈ΋ ÂԇψÛË Û ‰È·‚ËÙÈο ÂÈÚ·Ì·Ùfi˙ˆ·. O‰ÔÓÙÔÛÙÔÌ·ÙÔÏÔÁÈ΋ ¶ÚfiÔ‰Ô˜
1992; 46: 83-92.
2936. ∞¢∞ªπ¢∏™ °, Δ∑∂°∞™ °, ¢∏ª∏ΔƒO¶OÀ§O™
™, πø∞¡¡π¢∏™ ∫, μƒ∞∫∞™ •. ΔÔ ÛËÙÈÎfi fi‰È ÛÙÔ
‰È·‚‹ÙË. °·ÏËÓfi˜ 1992; 34: 627-31.
2937. ASSIMAKOPOULOS D, TZIOURIS D, ASSIMAKOPOULOS AD. Bilateral auricular perichondritis
and diabetes mellitus. Otolaryngol Head Neck Surg
2009; 140: 431-2.
2938. PRAIDOU A, KLANGAS I, PAPAKONSTANTINOU E, ANDROUDI S, GEORGIADIS N, KARAKIULAKIS G, DIMITRAKOS S. Vitreous and
serum levels of platelet-derived growth factor and
their correlation in patients with proliferative diabetic retinopathy. Curr Eye Res 2009; 34: 152-61.
2939. ºπ§O¶OÀ§O™ ∂, μ∞™π§Oª∞¡ø§∞∫∏™ ª,
∂ºƒ∞πªπ¢OÀ ∞, μ∞™π§O¶OÀ§O™ ¶¶. ÀÔÁÏ˘Î·ÈÌÈÎfi ÎÒÌ· Û ÌË ‰È·‚ËÙÈ΋ ·ÛıÂÓ‹ ¢ÚÈÛÎfiÌÂÓË Û ÔÍ›· ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ·. π·ÙÚÈ΋ 1991; 59:
502-4.
2940. Δ™∂ƒ°∏™ ∞, ª∞Àƒπ∫∞∫∏™ ª, ¢ƒπª∏™ ™,
∏ƒ∞∫§∂π∞¡OÀ ™, ∫∞∫OÀ§Àƒ∏™ ™, ∫OÀμ∂§∏ ™, ™∂ƒπº∞ª¶OÀ Ã, ¶∞¶∞°°∂§O¶OÀ§O™
™. ∫ÏÈÓÈΤ˜ Î·È ‚ÈÔ¯ËÌÈΤ˜ ·Ú¿ÌÂÙÚÔÈ Û ·Û‚ÂÛÙÔÔÈfi ÂÚÈ·ÚıÚ›Ùȉ· ÙÔ˘ ÒÌÔ˘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ.
∫ÏÈÓÈο ÃÚÔÓÈο 1991; 14: 111-4.
2941. ª∂°∞™ π. ¢È·‚ËÙÈΤ˜ ¡Â˘ÚÔ¿ıÂȘ. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1992; 26: 9-15.
2942. ¶π∂ƒƒ∞∫OÀ ∂, ¢O¡Δ∞ ∞. ∞ÎÙÈÓÔÁÚ·ÊÈΤ˜ ÌÂÙ·‚ÔϤ˜ Ù˘ ÚfiÛıÈ·˜ ÂÚÈÔ¯‹˜ Ù˘ οو ÁÓ¿ıÔ˘ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. O‰ÔÓÙÔÛÙÔÌ·ÙÔÏÔÁÈ΋ ¶ÚfiÔ‰Ô˜ 1990; 44: 331-7.
2943. ∂À£ÀªπOÀ ∏. ΔÔ Û˘ÓıÂÙÈÎfi ·Ó¿ÏÔÁÔ Ù˘ ۈ̷ÙÔÛÙ·Ù›Ó˘ SMS 201-995 ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË π∫∞ 1991; 2:
41-4.
2944. °π∞ª∞§∏™ ¢. ΔÔ Â͈ÙÂÚÈÎfi ‰È·‚ËÙÔÏÔÁÈÎfi È·ÙÚÂ›Ô ÙÔ˘ ÚÒÙÔ˘ ÓÔÛÔÎÔÌ›Ԣ. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË
π∫∞ 1990; 1: 35.
2945. ∫OÀΔ∞§∞™ ¶, ¶Oªø¡∏™ ∂. ™˘Ó‡·ÚÍË ·ÚÙËÚȷ΋˜ ˘¤ÚÙ·Û˘ Î·È Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ 1991; 59: 459-67.
2946. MOUTZOURI AG, ATHANASSIOU GA, DIMITROPOULOU D, SKOUTELIS AT, GOGOS CA.
Severe sepsis and diabetes mellitus have additive ef-
198
fects on red blood cell deformability. J Infect 2008: 57:
147-51.
2947. GALANAKIS E, KOFTERIDIS D, STRATIGI K,
PETRAKI E, VAZGIOURAKIS V, FRAGOULI E,
MAMOULAKIS D, BOUMPAS DT, GOULIELMOS GN. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both
type 1 and type 2 diabetes in a genetically homogeneous population. Hum Immunol 2008; 69: 279-83.
2948. ∫OÀΔ∏™ ∞, §πO¡∏™ Ã, ∞¡Δø¡∞∫∏™ ¡,
™∞™∞ƒø§∏™ ™, ºƒ∞¡Δ∑∂™∫∞∫∏™ °, ºπOƒ∂ΔO™ ª. ∂ÎÙ›ÌËÛË ÂÈÔÏ·ÛÌÔ‡ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË
Î·È ·ÚÙËÚȷ΋˜ ˘¤ÚÙ·Û˘ Û’ ¤Ó· ÁˆÁÚ·ÊÈο ηıÔÚÈṲ̂ÓÔ ÏËı˘ÛÌfi. π·ÙÚÈ΋ 1995; 68: 53-8.
2949. ª∞Àƒπ∫∞∫∏™ ª∂. ƒÂ˘Ì·ÙÔÏÔÁÈΤ˜ ‰È·Ù·Ú·¯¤˜
ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓÈ΋ ƒÂ˘Ì·ÙÔÏÔÁ›·
1992; 4: 145-51.
2950. ∫ø¡™Δ∞¡ΔO¶OÀ§OÀ ™, ™º∏¡π∞¢∞∫∏™ π.∫,
∞¢∞ª ∞, ∫∞§§π¶O§πΔ∏™ °, ªπÃ∞§∞™ ™,
∞ƒ∞μ∞¡Δπ¡O™ ¢. ∂›‰· ·ÏηÏÈ΋˜ ʈÛÊ·Ù¿Û˘ Î·È Ï·ÎÔ˘ÓÙÈ·ÎÔ‡ Á·Ï·ÎÙÔÁfiÓÔ˘ Û ·ıÔÏÔÁÈΤ˜ ÂÁ΢ÌÔÛ‡Ó˜. ¶ÚÔÂÎÏ·Ì„›·-۷ί·Ú҉˘ ‰È·‚‹Ù˘-‰›‰˘ÌÔ˜ ·ËÛË. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiψÓ
¢˘Ó¿ÌÂˆÓ 1995; 29: 23-31.
2951. ª∞¢π∞™ ¡∏. ∏ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ¿ıÂÈ·˜. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1994; 11: 35787.
2952. ∞¡∞™Δ∞™π∞¢∏™ §∫, ∞¡Δø¡O¶OÀ§O™ ∞°,
¶∂Δ™∞™ ∞∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘-∫·Ú‰È·ÁÁÂȷΤ˜ ÂÈÏÔΤ˜. π·ÙÚÈ΋ ∫‡ÚÔ˜ 1991; 9: 24-7.
2953. ∂§π™∞º ª, ™π∞ªO¶OÀ§O™ ∫Ã. £ÂÚ·›· Ù˘
ÌÂÙ·‚ÔÏÈ΋˜ ÔͤˆÛ˘. π·ÙÚÈ΋ 1992; 61: 378-81.
2954. ∞¡¢ƒπ∫OÀ§∞ ª, Δ™∞Δ™OÀ§∏™ ∞. O ÚfiÏÔ˜
Ù˘ ·fiÙˆÛ˘ Î·È Ô‰Ô‡ Fas-Fas Ligand ÛÙËÓ ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 1. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 2001; 18: 349-53.
2955. ¶∞™ÃOÀ ¶. ∏ ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 1. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2001; 18: 566-74.
2956. ∞§∂•O¶OÀ§OÀ ∞, ™∂μ∞™Δπ∞¡O™ μ, ∫∞§OΔ∞πƒ∞∫∏™ ∞, ¶∂Δƒπ∫∫O™ °, ¶∂Δƒ∞∫∏ ∫,
Ã∞Δ∑∏°π∞¡¡∏™ ™π. ƒÈÓÔ-ÔÊı·ÏÌÈ΋ ÌÔ˘ÎÔÚ̇ΈÛË Û ·ÛıÂÓ‹ Ì ÔÍ›· ÏÂÌÊÔÁÂÓ‹ Ï¢¯·ÈÌ›· ηÈ
È·ÙÚÔÁÂÓ‹ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2000; 77:
563-8.
2957. ™øΔ∏ƒO¶OÀ§O™ ∞, ∫OΔ™π¡∏ μ. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ÏÔÈÌÒÍÂȘ. π·ÙÚÈ΋ 2000; 77: 250-67.
2958. ∫O§πO¶OÀ§O™ π. ¶·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘ ÁÈ· ÙË
‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ∞گ›· ∂ÏÏËÓ.
π·ÙÚÈ΋˜ 1999; 16: 12-3.
2959. ¶∞¶¶∞™ ™π. ƒƒARÁ (Peroxisome ProliferatorActivated Receptors Á). ∞fi ÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
Î·È ÙËÓ ∞ıËÚÔÛÎÏ‹Ú˘ÓÛË, ÛÙË ÊÏÂÁÌÔÓ‹ Î·È ÙËÓ Î·ÚÎÈÓÔÁ¤ÓÂÛË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2001; 18: 331-4.
2960. ™∞ƒ∞ºπ¢∏™ ¶∞. ∏ Â›‰Ú·ÛË Ù˘ ÚÔÛÈÁÏÈÙ·˙fiÓ˘
Û ·ÛıÂÓ›˜ Ì ·ÚÙËÚȷ΋ ˘¤ÚÙ·ÛË Î·È Û·Î¯·ÚÒ‰Ë
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
2961. ºøΔπ∞¢OÀ-¶∞¶¶∞ ∂. °ÔÓȉȷ΋ ıÂÚ·›· ÛÙÔ
™¢ Ù‡Ô˘ 1. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 182-7.
2962. ∞§∞μ∂ƒ∞™ ∞. ªÂÏÏÔÓÙÈΤ˜ ÚÔÛÂÁÁ›ÛÂȘ ÛÙËÓ
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002;
82 (™˘ÌÏ): 188-94.
2963. ¶π∂ƒƒ∞∫O™ °. ∫fiÛÙÔ˜ ıÂÚ·›·˜ ¤ÏÎÔ˘˜ ÛÙÔ fi‰È ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜. ¡ÔÛËÏ¢ÙÈ΋ 2002; 41: 20616.
2964. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂, ¶∞Δ∂ƒ∞∫∏™ £.
£ÂÚ·›· ÔÚÌÔÓÈ΋˜ ˘ÔηٿÛÙ·Û˘ ÛÙË ‰È·‚ËÙÈ΋
Á˘Ó·›Î·. π·ÙÚÈ΋ 2002; 82: 38-43.
2965. ¶∞¶∞¢O°∂øƒ°∞∫∏™ ¡, §O°O£∂Δ∏™ π,
ª∞ƒΔ∏-∑ø°ƒ∞ºOÀ ∫, ƒO¡ΔO°π∞¡¡∏ ¢,
ºOÀ¡Δ∞™ ∞, Ã∞§∂μ∂§∞∫∏™ °, ƒ∞¶Δ∏™ ™∞.
Ÿ„ÈÌË ¯ÂÈÚÔ˘ÚÁÈ΋ ·Ú¤Ì‚·ÛË Û ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹
Ì ÙÚ·¯ËÏÔÚÔÛˆÈ΋ ÌÔ˘ÎÔÚ̇ΈÛË, ‡ÛÙÂÚ· ·fi
Ì·ÎÚ¿ ıÂÚ·›· Ì ÏÈÔÛˆÌȷ΋ ·ÌÊÔÙÂÚÈΛÓË-‚.
∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1999; 16: 496-500.
2966. ∫∞Δ™π§∞ª¶ƒO™ ¡, πø∞¡¡π¢∏™ π. ¡ÂfiÙÂÚ·
·ÓÙȉȷ‚ËÙÈο Ê¿Ú̷η. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜
1999; 16: 552-6.
2967. ªÀ°¢∞§∏™ ∏¡. ¶·¯˘Û·ÚΛ· Î·È Û·Î¯·Ú҉˘
‰È·‚‹Ù˘. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1997; 14: 369-71.
2968. ¡ΔOÀƒ∞∫∏™ ™¶. OÍ›· Ë·Ù›Ùȉ· ·fi Ï‹„Ë ÁÏÈÎÏ·˙›‰Ë˜. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1998; 15: 87-9.
2969. ¶∞¡∞°πøΔOÀ £¡. ∏ ‰˘ÛÏÈȉ·ÈÌ›· ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1998; 15: 5216.
2970. Δ™O§∞∫∏ ª, ™Àª∂ø¡π¢∏™ °, ∫∞∑∏™ ∞. ¢È·‚ËÙÈ΋ ÎÂÙÔͤÔÛË ˆ˜ ·ÓÂÈı‡ÌËÙË ÂÓ¤ÚÁÂÈ· ıÂÚ·›·˜ Ì ÔÏ·Ó˙·›ÓË. æ˘¯È·ÙÚÈ΋ 2002; 13: 222-7.
2971. Ã∞Δ∑∏πø∞¡¡π¢∏™ ∏, ∂À¢øƒπ¢OÀ π, ¶∞¶∞πø∞¡¡OÀ °, ∑∞º∂πƒπOÀ ¢, μOÀ°πOÀ∫§∏™ ¡,
Δ™πΔOÀƒπ¢∏™ π, ∫ƒ∂ª∂¡O¶OÀ§O™ °. ¶ÚˆÙÔ·ı¤˜ ·ÓÙÈʈÛÊÔÏÈȉÈÎfi Û‡Ó‰ÚÔÌÔ Û ÙÂÏÂÈfiÌËÓÔ
ÓÂÔÁÓfi ‰È·‚ËÙÈ΋˜ ÌËÙ¤Ú·˜. ¶·È‰È·ÙÚÈ΋ μÔÚ›Ԣ
∂ÏÏ¿‰Ô˜ 2003; 15: 397-401.
2972. ™OÀª¶∞™∏ §¶, Ã∞¡πøΔ∏™ ¢π. O ÚfiÏÔ˜ ÙˆÓ
·˘ÍËÙÈÎÒÓ ·Ú·ÁfiÓÙˆÓ ÛÙËÓ ·ıÔÁ¤ÓÂÈ· Ù˘ ‰È·‚ËÙÈ΋˜ ÓÂÊÚÔ¿ıÂÈ·˜. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiψÓ
¢˘Ó¿ÌÂˆÓ 2003; 37: 135-43.
2973. ∫∞§OÃ∞πƒ∂Δ∏™ ¶, ∑∂ƒª¶∞§∞ ™, ∑Oƒª¶∞™ ™, ™¶∞¡OÀ ∂, ¢ƒOÀ∑∞™ ∞, ∫ø¡™Δ∞¡Δπ¡π¢∏™ ™, ™øºƒO¡π∞¢OÀ ™, π∞ΔƒOÀ Ã. ∏
·Ó·‹‰ËÛË ÙÔ˘ Î·Ï›Ô˘ ÌÂÙ¿ ÙËÓ ·ÈÌÔοı·ÚÛË. ¶ÚÔÛ¤ÁÁÈÛË ÙˆÓ ·ÈÙ›ˆÓ Î·È ÂÎÙ›ÌËÛË ÙÔ˘ ÌÂÁ¤ıÔ˘˜ ÙÔ˘
Ê·ÈÓÔ̤ÓÔ˘ Û ÌË ‰È·‚ËÙÈÎÔ‡˜ Î·È ÌË ˘ÂÚÙ·ÛÈÎÔ‡˜
¯ÚfiÓÈ· ·ÈÌÔηı·ÈÚfiÌÂÓÔ˘˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ 2004;
85: 215-21.
2974. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂, ¶∞Δ∂ƒ∞∫∏™ £.
ª¤ıÔ‰ÔÈ ·ÓÙÈÛ‡ÏÏ˄˘ ÛÙË ‰È·‚ËÙÈ΋ Á˘Ó·›Î·. π·ÙÚÈ΋ 2004; 86: 19-23.
2975. Δ™πƒ§∏™ ∞, §π§§∏™ £. OÈ È‰È·ÈÙÂÚfiÙËÙ˜ ÙÔ˘
‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜ Î·È Ë ·ÓÙÈÌÂÙÒÈÛ‹ ÙÔ˘ ÛÙÔ
Ô‰ÔÓÙÈ·ÙÚ›Ô. ™ÙÔÌ·ÙÔÏÔÁ›· 2006; 63: 59-71.
2976. Ã∞ƒ∞§∞ª¶OÀ™ ∞. O ÚfiÏÔ˜ ÙÔ˘ ÂȉÈÎÔ‡ ÎÏÈÓÈÎÔ‡ ÓÔÛËÏÂ˘Ù‹ ÛÙËÓ ÂÎ·›‰Â˘ÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·È‰ÈÔ‡. ¡ÔÛËÏ¢ÙÈ΋ 2006; 45: 483-90.
2977. °∂ƒO°π∞¡¡∏ ™∫, °∂ƒO°π∞¡¡∏ °∫. ¢È·‚ËÙÈÎfi
fi‰È. O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹ ÛÙËÓ ÚfiÏË„Ë Î·È ·ÔÙÂÏÂÛÌ·ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛ‹ ÙÔ˘. ¡ÔÛËÏ¢ÙÈ΋ 2007;
46: 493-500.
2978. º∂ƒ∞∫∏™ ¡, ª¶OÀƒO¶OÀ§O™ ∫, Ã∞ƒ∞§∞ª¶O°π∞¡¡∏™ ¡, ¶OÀ§π∞™ ∏. ™˘Ó‡·ÚÍË ÍËÚ¿˜ Á¿ÁÁÚ·ÈÓ·˜ ÙÔ˘ ¤Ô˘˜ Ì Á¿ÁÁÚ·ÈÓ· ÙÔ˘
Fournier Û ‰È·‚ËÙÈÎfi ·ÛıÂÓ‹. ∂ÏÏËÓÈ΋ O˘ÚÔÏÔÁ›·
2008; 20: 306-9.
2979. FERRANNINI EA, MÀ°¢∞§∏™ ∏¡. O ΢ڛ·Ú¯Ô˜ ÚfiÏÔ˜ Ù˘ ÌÂȈ̤Ó˘ ¢·ÈÛıËÛ›·˜ ÙˆÓ ‚‹Ù·-΢ÙÙ¿ÚˆÓ ÛÙË ÁÏ˘Îfi˙Ë ¤Ó·ÓÙÈ Ù˘ ·ÓÙ›ÛÙ·Û˘ ÛÙËÓ ÈÓÛÔ˘Ï›ÓË ÛÙËÓ ·ıÔÏÔÁÈ΋ ·ÓÔ¯‹ ÛÙË ÁÏ˘Îfi˙Ë. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 29-40.
2980. ¢π∞ª∞¡Δ∏- ∫∞¡¢∞ƒ∞∫∏ ∂, ∞§∂•∞¡¢ƒ∞∫∏
∫¡. ¶ÚˆÙÂ˚ÓÈ΋ ÎÈÓ¿ÛË C: ŒÓ·˜ Ó¤Ô˜ ıÂÚ·¢ÙÈÎfi˜
ÛÙfi¯Ô˜ Ù˘ ‰È·‚ËÙÈ΋˜ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 41-71.
2981. ºπ§π¶¶π¢∏™ º¶. ¶·ıÔÁÂÓÂÙÈÎÔ› Ì˯·ÓÈÛÌÔ› Ó¢ÚÔ¿ıÂÈ·˜: O‰fi˜ ÔÏ˘fiÏ˘, ÔÍÂȉˆÙÈ΋ ηٷfiÓËÛË.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004:
73-84.
2982. Δ™∞Δ™OÀ§∏™ ∞∞, ºOÀ¡ΔOÀ§∞∫∏™ ™°. ΔÔ
ÂÓ‰ÔÎÚÈÓÈÎfi ÏÈÔ·ÙÙ·ÚÔ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù·
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 85-95.
2983. ƒ∞¶Δ∏™ ™∞. ∞fi ÙËÓ ·ıÔÊ˘ÛÈÔÏÔÁ›· ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2 ÛÙË ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2004: 97-106.
2984. ¢∏ª∏Δƒπ∞¢∏™ °¢. ∏ ·Ó·ÁηÈfiÙËÙ· Ù˘ ·ÓÙÈÌÂÙÒÈÛ˘ Ù˘ ÌÂÙ·ÁÂ˘Ì·ÙÈ΋˜ ˘ÂÚÁÏ˘Î·ÈÌ›·˜ ÛÙË
Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 107-12.
2985. ª∞∫ƒÀ§∞∫∏™ ∫Ã, ∫∞Δ™π§∞ª¶ƒO™ ¡§.
°Ï˘Î·ÈÌÈÎfi˜ ‰Â›ÎÙ˘: ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 113-20.
2986. ∫∞ƒ∞ª∞¡O™ μ°. O ÚfiÏÔ˜ ÙˆÓ ıÂÈ·˙ÔÏȉÈÓ‰ÈÔÓÒÓ ÛÙË ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 121-34.
2987. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¶ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË Ù‡Ô˘ 2: ¶·ÚÂÌ‚¿ÛÂȘ ÛÙÔÓ ÙÚfiÔ ˙ˆ‹˜ ‹
199
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
Ê·Ú̷΢ÙÈ΋ ·ÁˆÁ‹; ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 135-42.
2988. °πøμO™ π°. ∞fi ÙËÓ ·¯˘Û·ÚΛ· ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ 2: ™ÙÚ·ÙËÁÈΤ˜ ÚfiÏ˄˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 143-53.
2989. KALAITZIDIS RG, SARAFIDIS PA, BAKRIS
GL. Effects of thiazolidinediones beyond glycaemic
control.Curr Pharm Des 2009; 15: 529-36.
2990. ∫∂º∞§O°π∞¡¡∏™ ¡∫. O ‰È·‚ËÙÈÎfi˜ ·ÛıÂÓ‹˜
ÛÙÔ ¯ÂÈÚÔ˘ÚÁ›Ô. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜
ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2004: 165-81.
2991. ∞¡∞™Δ∞™πOÀ ∂∞. ∏ ‰È·‚ËÙÈ΋ ¤ÁÎ˘Ô˜ Î·È Ô ÙÔÎÂÙfi˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2004: 183-90.
2992. Ãπ™Δ∞∫O¶OÀ§O™ ¶¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘
Î·È ·ÁÁÂÈ·Îfi ÂÁÎÂÊ·ÏÈÎfi ÂÂÈÛfi‰ÈÔ. ™ÙÔ: ª˘Á‰¿Ï˘
∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004.
∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 191-9.
2993. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂π, °ƒ∏°Oƒπ∞¢OÀ ª∂.
∞ÓÙÈ·ÈÌÔÂÙ·ÏÈ·ÎÔ› ·Ú¿ÁÔÓÙ˜ Î·È Ê¿Ú̷η Ì ÚÂÔÏÔÁÈΤ˜ ȉÈfiÙËÙ˜ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ·ÁÁÂÈÔ¿ıÂÈ·˜ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡.
™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·:
∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 201-7.
2994. æÀƒO°π∞¡¡∏™ ∞π. £ÂÚ·›· ‰È·‚ËÙÈ΋˜ ÂÚÈÊÂÚÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 209-16.
2995. ªÀ°¢∞§∏™ ∏¡. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÛÙ˘ÙÈ΋˜ ‰˘ÛÏÂÈÙÔ˘ÚÁ›·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 241-51.
2996. °π∞ª∞ƒ∂§§O™-ª¶OÀƒª¶OÀ§∏™ ∂π, °π∞ª∞ƒ∂§§OÀ ∂∫. OÈ Î˘ÚÈfiÙÂÚ˜ ÏÔÈÌÒÍÂȘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ë ÛÙÚ·ÙËÁÈ΋ ·ÓÙÈÌÂÙÒÈÛ‹˜
ÙÔ˘˜. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2004: 253-60.
2997. ΔOÀ¡Δ∞™ â. º·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘
·¯˘Û·ÚΛ·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ:
ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 261-72.
2998. ªOÀ¡ΔO∫∞§∞∫∏™ £¢. ∞ÓÙÈ˘ÂÚÙ·ÛÈ΋ ıÂÚ·›· Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ Ì ·Ú¯fiÌÂÓË ÓÂÊÚÔ¿ıÂÈ·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ,
2004: 273-9.
2999. ∞§∞μ∂ƒ∞™ ∞°. ∞ÓÙÈ˘ÂÚÙ·ÛÈ΋ ·ÁˆÁ‹ ÛÙÔ ‰È·‚ËÙÈÎfi Ì ˘¤ÚÙ·ÛË Î·È ÏÂ˘ÎˆÌ·ÙÔ˘Ú›·. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË
2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 281-95.
200
3000. ¶∞¶¶∞™ ™π. O ÚfiÏÔ˜ ÙˆÓ ÛÙ·ÙÈÓÒÓ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰˘ÛÏÈȉ·ÈÌ›·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004:
297-323.
3001. ∂§π™∞º ª™. ¢˘ÛÏÈȉ·ÈÌ›· Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ºÈÌÚ¿Ù˜- Û˘Ó‰˘·ÛÌÔ› ˘ÔÏÈȉ·ÈÌÈÎÒÓ
Ê·Ú̿ΈÓ. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜
∂ΉfiÛÂȘ, 2004: 325-33.
3002. μ∞°∂¡∞∫∏™ ∞°. ™˘ÓÔÏÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ÌÂÙ·‚ÔÏÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. ™ÙÔ: ª˘Á‰¿Ï˘ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004: 335-42.
3003. ƒ∞¶Δ∏™ ™∞. ™Ùfi¯ÔÈ Î·È ‰˘Ó·ÙfiÙËÙ˜ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Û˘Ó‰ÚfiÌÔ˘. π·ÙÚÈ΋ 2002; 82
(™˘ÌÏ): 20-6.
3004. ª¶∂¡ƒOÀª¶∏ ª¢. ∏ ıÂÚ·¢ÙÈ΋ ·Í›· Ù˘ ÂÎ·›‰Â˘Û˘ ÙˆÓ ·ÙfiÌˆÓ Ì ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002; 82
(™˘ÌÏ): 33-7.
3005. ª∞¡∂™ Ã. ¡ÂfiÙÂÚ· ·ÓÙȉȷ‚ËÙÈο ‰ÈÛΛ·. π·ÙÚÈ΋
2002; 82 (™˘ÌÏ): 38-43.
3006. ¢∏ª∏Δƒπ∞¢∏™ °. πÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. ∂ÓÙ·ÙÈÎÔÔÈË̤ӷ Û¯‹Ì·Ù·. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 44-9.
3007. ΔOÀ¡Δ∞™ â. ™˘Ó‰˘·ÛÌfi˜ ‰ÈÛΛˆÓ Î·È ÈÓÛÔ˘Ï›Ó˘. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 50-4.
3008. ª¶∞ƒΔ™O∫∞™ Ù. O Ù‡Ô˜ 2 ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙ· ·È‰È¿ Î·È ÙÔ˘˜ ÂÊ‹‚Ô˘˜. £ÂÚ·¢ÙÈ΋ ÚÔÛ¤ÁÁÈÛË. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 55-60.
3009. ∞§∂μπ∑∞∫∏ ª. ¶ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË Ù‡Ô˘ 2. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 61-3.
3010. ¢π∞ª∞¡Δ∏-∫∞¡¢∞ƒ∞∫∏ ∂, ª¶OÀΔ™π∫OÀ
£. ∫ÔÚÙÈÎÔÂȉ‹ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. π·ÙÚÈ΋
2002; 82 (™˘ÌÏ): 75-81.
3011. ∞¡∞™Δ∞™πOÀ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ·ËÛ˘
(™¢∫). π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 82-7.
3012. ∫∞Δ™π§∞ª¶ƒO™ ¡, Δ∂¡ΔO§OÀƒ∏™ ¡. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ Ó¢ÚÔ¿ıÂÈ·˜.
π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 88-94.
3013. ªÀ°¢∞§∏™ ∏¡. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 95-101.
3014. æÀƒO°π∞¡¡∏™ ∞π. §ÔÈÌÒÍÂȘ Î·È ‰È·‚ËÙÈÎfi fi‰È. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 102-4.
3015. ∫Oºπ¡∏™ ∞π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÛÙ˘ÙÈ΋
‰˘ÛÏÂÈÙÔ˘ÚÁ›·. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 105-10.
3016. ¶∂ΔƒOÀ ∫. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜. π·ÙÚÈ΋ 2002; 82
(™˘ÌÏ): 111-18.
3017. ¶∞¡∞°πøΔOÀ £, ªOÀ¡ΔO∫∞§∞∫∏™ £. ∏
ı¤ÛË ÙˆÓ ·ÓÙ·ÁˆÓÈÛÙÒÓ ÙÔ˘ ÌÂÙ·ÙÚÂÙÈÎÔ‡ ÂÓ˙‡ÌÔ˘
(·-ª∂∞) Î·È ÙˆÓ ·ÔÎÏÂÈÛÙÒÓ ÙˆÓ ˘Ô‰Ô¯¤ˆÓ Ù˘
·ÁÁÂÈÔÙ·Û›Ó˘ ππ (∞À∞), ÛÙË ıÂÚ·¢ÙÈ΋ ÙÔ˘ ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 119-25.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3018. ¢π∞ª∞¡ΔO¶OÀ§O™ ∂.π, °ƒ∏°Oƒπ∞¢OÀ ª∂.
∞ÓÙÈÌÂÙÒÈÛË Ù˘ ÎÚ›ÛÈÌ˘ ÈÛ¯·ÈÌ›·˜ ÙˆÓ Î¿Ùˆ
¿ÎÚˆÓ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002; 82
(™˘ÌÏ): 126-34.
3019. ª∂§π¢ø¡∏™ ∞. ∏ Û˘ÓÙËÚËÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘
·¯˘Û·ÚΛ·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002;
82 (™˘ÌÏ): 135-40.
3020. ¶∞¶¶∞™ ™π. O ÚfiÏÔ˜ ÙˆÓ ÛÙ·ÙÈÓÒÓ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰˘ÛÏÈȉ·ÈÌ›·˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË.
π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 141-53.
3021. ª¶OÀΔ∞Δ∏ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÏÔÈÌÒÍÂȘ. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 154-9.
3022. £∞§∞™™π¡O™ ¡Ã. OÚÌÔÓÈ΋ ˘ÔηٿÛÙ·ÛË ÛÂ
‰È·‚ËÙÈΤ˜ Á˘Ó·›Î˜ ÌÂÙ¿ ÙËÓ ÂÌÌËÓfi·˘ÛË. π·ÙÚÈ΋
2002; 82 (™˘ÌÏ): 160-4.
3023. ∫∞ƒ∞ª∞¡O™ μ. ¢È·‚ËÙÈ΋ ÎÂÙÔÔͤˆÛȘ Î·È ˘ÂÚˆÛ̈ÙÈÎfi ÌË-ÎÂÙˆÙÈÎfi ‰È·‚ËÙÈÎfi ÎÒÌ·. π·ÙÚÈ΋
2002; 82 (™˘ÌÏ): 165-76.
3024. º∂ƒ∂Δ∏™ ∏, ª∞ƒΔπ¡∏™ ∞, º§øƒ∞∫∏ ∫. Δ¯ÓÈ΋ EN BLOCK ÂÎÙÔÌ‹˜ ÈÓÔ-·ÁÁÂÈ·ÎÒÓ ÌÂÌ‚Ú¿ÓˆÓ ÛÙËÓ ˘ÂÚÏ·ÛÙÈ΋ ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. OÊı·ÏÌÔÏÔÁÈο ÃÚÔÓÈο 1988; 25: 287-93.
3025. °∂øƒ°O¶OÀ§OÀ ª, ∫OÀƒ∫OÀª¶∂Δ∏ ∫.
∂Ó‰Ô‰ÔÓÙÈ΋ ıÂÚ·›· Û ÂȉÈÎÔ‡˜ ·ÛıÂÓ›˜. ™ÙÔÌ·ÙÔÏÔÁ›· 1988; 45: 405-14.
3026. ªOÀ¡ΔO∫∞§∞∫∏™ £¢. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·: ¡ÂÒÙÂÚ·. π·ÙÚÈ΋ ∫‡ÚÔ˜ 1988; 7: 5-7.
3027. μ∞∑∞πOÀ-°∂ƒ∞™πªπ¢∏ ∞. ªÂÙ·ÌÔۯ‡ÛÂȘ ·ÁÎÚ¤·ÙÔ˜-ÓËÛȉ›ˆÓ. π·ÙÚÈ΋ 2002; 82 (™˘ÌÏ): 64-74.
3028. º∂ƒ∂Δ∏™ ∏, ∫∞¶O¶OÀ§OÀ μ, ¶∞¶¶∞ Δ,
™Δ∂º∞¡πøΔOÀ ª, ª∞ƒΔπ¡∏™ ∞. πÓÔ΢ÙÙ·ÚÈΤ˜
Î·È ÈÓÔ·ÁÁÂȷΤ˜ ÌÂÌ‚Ú¿Ó˜ ÛÙË ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. OÊı·ÏÌÔÏÔÁÈο ÃÚÔÓÈο 1987; 24:
23-31.
3029. ¡ΔOμ∞™ ∞, ªÀ§ø¡∞™ ¢, °∫∞§∂∞™ £, §∞¶¶∞™ Ã, ¶∞¶∞£∞¡∞™πOÀ ∂. ¶ÂÚ›ÙˆÛȘ ÁÈÁ·ÓÙÈÛÌÔ‡-ÌÂÁ·Ï·ÎÚ›·˜ Ì ÎÏÈÓÈÎ‹Ó ÂΉ‹ÏˆÛÈÓ Û·Î¯·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈο ÃÚÔÓÈο 1987; 10: 717-24.
3030. ƒO¡ΔO°π∞¡¡∏™ °, BUSKIRK ER. ∞ÔÌ¿ÎÚ˘ÓÛË ÙÔ˘ Á·Ï·ÎÙÈÎÔ‡ ÔͤԘ ·fi ÙÔ ·›Ì· ηٿ ÙË ‰È¿ÚÎÂÈ· Ì˘˚ÎÔ‡ ¤ÚÁÔ˘ Â› ‰È·‚ËÙÈÎÒÓ. ∞گ›· π·ÙÚ.
∂Ù·ÈÚÂÈÒÓ 1982; 8: 143-50.
3031. ¡π∫O§∞´¢∏™ ¶, ∞°°∂§OÀ¢∏ ª, ∫O§§∞ƒ∞™
¶, ∞£∞¡∞™πOÀ ∂, ∫ø™ΔO¶OÀ§O™ π, Δ™ø¡∞
∞, ª∂Δ∞§§π¢∏™ ™, ΔOÀƒ∫∞¡Δø¡∏™ ∞. ¢ÂÚÌ·ÙÈ΋ ÌÔ˘ÎÔÚ̇ΈÛË Û ·ÛıÂÓ‹ Ì ÔÍ›· ÏÂÌÊÔ‚Ï·ÛÙÈ΋ Ï¢¯·ÈÌ›· Î·È Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 2001; 67: 190-4.
3032. ¢ƒπμ∞™ °, ∫OÀºO™ Ã, ª¶∞ª¶π¡πOΔ∞∫∏™
∞, ∞ƒ¡∏™ ™, ∫∞§O™ ∞. ªÂϤÙË 4 ÔÏ˘ÌÔÚÊÈÎÒÓ
Û˘ÛÙËÌ¿ÙˆÓ (∞1 ∞ÓÙÈıÚ˘„›Ó˘, GC ™Ê·ÈÚ›ÓˆÓ,
∞ÙÔÛÊ·ÈÚ›ÓˆÓ Î·È ∞ÏÏÔÙ‡ˆÓ GM INV) Û ¿Û¯ÔÓÙ˜ ·fi ‰È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. π·ÙÚÈο ÃÚÔÓÈο
1987; 10: 797-803.
3033. ∫OÀΔ™π∫O™ ¢, ∞°ƒO°π∞¡¡∏™ μ, ™∞ƒƒ∏™ ∂,
∫∞°π∞ ™. ∏ ‚ÈÔÙ›ÓË ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ‰È·‚ËÙÈ΋˜
Ó¢ÚÔ¿ıÂÈ·˜. Mater Med Greca 1987; 15: 56-8.
3034. SCORDIS N, MACLAREN NK, RILEY WJ. Genetic loading: Gender, HLA-DR Alleles, and familiar
occurrence affects the age of onset of insulin dependent diabetes. π·ÙÚÈ΋ ∫‡ÚÔ˜ 1987; 6: 31-4.
3035. ∫ø™ΔO°§OÀ-∞£∞¡∞™πOÀ π. ∏ ÁÂÓÂÙÈ΋ ‚¿ÛË
ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË
∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1990; 24: 263-6.
3036. ¢ƒO™O™ £, ∞¡OÀ™∏™ ™, ∫∞ƒ¢∞ƒ∏ ∞, Δ∑øƒΔ∑∏™ ∂, ∫O¡Δø¡∏™ ¢, °∂øƒ°O¶OÀ§O™ ¡,
∫∞¶∂§§∞™ °. ∏ Â›‰Ú·ÛË Ù˘ ÌÂ˙·ÊÈ‚Ú¿Ù˘
ÛÙÔ˘˜ ˘ÂÚÏÈȉ·ÈÌÈÎÔ‡˜ ‰È·‚ËÙÈÎÔ‡˜ Û ٷ˘Ùfi¯ÚÔÓË
¯ÔÚ‹ÁËÛË ÁÏÈ‚ÂÓÎÏ·Ì›‰Ë˜. π·ÙÚÈο ÃÚÔÓÈο 1989;
12: 851-3.
3037. §πO™∏™ ∫, μ∞ƒ™∞ª∏-£øªO¶OÀ§OÀ ∏,
∫OªπΔO¶OÀ§O™ ¡, º§øƒO™ π, μ∞ƒ™∞ª∏™
∂. ∞ÍÈÔÏfiÁËÛË Ù˘ °∞ª∞-GT Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ ÌÂ Î·È ¯ˆÚ›˜ ÂÌÊ·Ó›˜ ·ÁÁÂȷΤ˜ ÂÈÏÔΤ˜. π·ÙÚÈο ÃÚÔÓÈο 1986; 9: 520-4.
3038. ¶∞¶∞¢∏ª∏ΔƒπOÀ ∞, ª∞™ΔƒOª∏¡∞™ ª,
™π¢∂ƒ∏™ π. O ‰È·‚‹Ù˘ Î·È Ë Î‡ËÛË Û‹ÌÂÚ·. Ÿ¯È
ϤÔÓ Î·Î‹ ÚfiÁÓˆÛË ÁÈ· ÙË ÌËÙ¤Ú· Î·È ÙÔ ¤Ì‚Ú˘Ô ‹
ÙÔ ÓÂÔÁÓfi. π·ÙÚÈο ÃÚÔÓÈο 1989; 12: 923-30.
3039. ∫OªπΔO¶OÀ§O™ ¡, ªπÃ∞∏§π¢∏™ ¡, ™øΔ∏ƒO¶OÀ§OÀ °, μ∞ƒ™∞ª∏™ ∂. ∏ ‰È·‚ËÙÔÁfiÓÔ˜
‰Ú¿ÛË ÙˆÓ ıÂÈ·˙ȉÒÓ. π·ÙÚÈο ÃÚÔÓÈο 1989; 12:
992-5.
3040. Δ∞ª¶∞∫OÀ¢∏™ ¶, ¶∞¶∞°∂øƒ°πOÀ °, ª∞¡Δ∞§∂¡∞∫∏™ ™. ∏ Û˘¯ÓfiÙËÙ· ÙˆÓ ÚԉȷıÂÛÈÎÒÓ ·Ú·ÁfiÓÙˆÓ Ù˘ ËÏÈΛ·˜, Ù˘ ·¯˘Û·ÚΛ·˜, Ù˘
˘¤ÚÙ·Û˘ Î·È ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ·ÛıÂÓ›˜
Ì ˘ÂÚÏ·Û›· Î·È Î·ÚΛÓÔ ÙÔ˘ ÂÓ‰ÔÌ‹ÙÚÈÔ˘. π·ÙÚÈ΋
∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1989; 23: 303-6.
3041. §∞™∫∞ƒ∞ΔO™ π, ∞§∏™πª∏ ™, ™Δ∞ª∞Δπ¡∏™
Ã. ∏ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜ Ì ·ÎÙ›Ó˜ LASER. π·ÙÚÈο ÃÚÔÓÈο 1989;
12: 516-8.
3042. ª∞Àƒπ∫∞∫∏™ ¡, ∞¡Δø¡πOÀ ∞, ¶∞¶∞™π¢∂ƒ∏ π, ∫πΔΔ∞™ Ã, ªOÀ§O¶OÀ§OÀ ∂, ∫O¡ΔO°π∞¡¡∏™ ¢, ∫O¡ΔO°π∞¡¡∏™ ™, ¶∞¶∞°∂øƒ°πOÀ ∫. ™˘ÁÎÚÈÙÈ΋ ÌÂϤÙË ·ÏÏÔÈÒÛÂˆÓ ·ÚÙËÚÈÒÓ
ÂÁÎÂÊ¿ÏÔ˘ Î·È Ì˘Ôηډ›Ô˘ Û ÂÈÚ·Ì·ÙÈÎfi ‰È·‚‹ÙË
·fi ÛÙÚÂÙÔ˙ˆÙÔÛ›ÓË. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1989;
6: 371-5.
3043. º∂ƒ∂Δ∏™ ∏, ª∞ƒΔπ¡∏™ ∞, ™¶∞™OÀ ∂, Ã∞Δ∑∂§∏ º, ¶OÀ§∞∫∏ £, º§øƒ∞∫∏ ∫, ™Δ∂º∞¡πøΔOÀ ª. À·ÏÔÂȉÂÎÙÔÌ‹-Ó¤ÔÈ ÔÚ›˙ÔÓÙ˜ ÛÙË ¯ÂÈÚÔ˘ÚÁÈ΋ ‚·ÚÈÒÓ ÌÔÚÊÒÓ ‰È·‚ËÙÈ΋˜ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·˜, ÙÚ·˘Ì¿ÙˆÓ Î·È ·ÔÎÔÏÏ‹ÛÂˆÓ ·ÌÊÈ‚ÏËÛÙÚÔÂȉԇ˜. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 1989; 6: 389-92.
3044. ∑OÀª¶OÀ§∏™ Ã, Δ™OÀƒ¢∏™ ∞. ¶ÂÚ›ÙˆÛË
ÔÍ›·˜ ÓÂÎÚˆÙÈ΋˜ ·ÁÎÚ·ٛÙȉ·˜ Ì ÂÈÎfiÓ· ‰È·‚ËÙÈÎÔ‡ ÎÒÌ·ÙÔ˜. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1988; 22: 49-52.
201
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3045. πø∞¡¡π¢OÀ-¶∞¶∞°π∞¡¡∞∫∏ ∂, Ã∞ƒ∞§∞ª¶π¢OÀ-μƒ∞¡πΔ™∞ ™, ∫§ø¡π∑∞∫∏™ π, ∫O¡∫OÀƒ∏™ §. ∂›‰Ú·ÛË Ù˘ ÌÂÙ·‚ÔÏÈ΋˜ Ú‡ıÌÈÛ˘
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙË ÏÂÈÙÔ˘ÚÁÈÎfiÙËÙ· ÙˆÓ ·ÈÌÔÂÙ·Ï›ˆÓ. ∂ÏÏËÓÈ΋ π·ÙÚÈ΋ 1988; 54: 109-14.
3046. SARAFIDIS PA, LASARIDIS AN, NILSSON PM,
HITOGLOU-MAKEDOU AD, PAGKALOS EM,
YOVOS JG, PLIAKOS CI, TOURKANTONIS AA.
The effect of rosiglitazone on urine albumin excretion
in patients with type 2 diabetes mellitus and hypertension. Am J Hypertens 2005; 18 (2 Pt 1): 227-34.
3047. ¶∞°∫∞§O™ ª∂, ¶∞°∫∞§O™ ∂ª. ¶ÚfiÙ˘·
‰È·ÙÚÔÊ‹˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ 2002; 82
(™˘ÌÏ): 27-32.
3048. MIGDALIS IN, TRIANTAFILOU P, PETRIDOU
E, VARVARIGOS N, TOTOLOS N, RIGOPOULOS A. Lipid peroxides in type 2 diabetic patients
with neuropathy. Res Com Mol Pathol Pharmacol
2005; 117-8: 5-12.
3049. ∂ƒøΔO∫ƒπΔOÀ °. º·Ú̷΢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ∫ÏÈÓÈο ÃÚÔÓÈο 1991;
14: 101-10.
3050. ∫∞™™∞¡O™ ¢, ª¶OΔ™∏™ ¢, ∫∞Δ∞™O™ £,
∑OÀƒ§∞™ ¶∞. ÀÂÚ˯ÔÁÚ·ÊÈ΋ ·Ú·ÎÔÏÔ‡ıËÛË
ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÂÁ·ˆÓ ÁÈ· ÙË ‰È¿ÁÓˆÛË Ì·ÎÚÔÛˆÌÈ·ÛÙÔ‡ ÂÌ‚Ú‡Ô˘. π·ÙÚÈ΋ 1990; 58: 57-60.
3051. ¶∞¶∞¡∞™Δ∞™πOÀ ™, §∂μ∂¡Δ∏ ∂. ∏ ÓÔÛËÏ¢ÙÈ΋ ÛÙËÓ ÂÎ·›‰Â˘ÛË ·È‰ÈÔ‡ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3052. ª∞§∂Àƒ∏ μ, ™Δƒ∞Δ∏ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘:
O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3053. ∫O∫§πøΔ∏ ∞, ΔOª∞ƒ∞ ™. ∞ÓÙÈÌÂÙÒÈÛË ÂÈÏÔÎÒÓ ÛÙÔÓ ˙·¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3054. Ã∞Δ∑∏ °, Δ∞°∫∞Δπ¢OÀ ª. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3055. ª∞§∞∫OÀ £. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË:
O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3056. ∞§∂•O¶OÀ§OÀ £. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3057. ¢∞¡¢OÀ§∞∫∏ ∂. OÈ „˘¯ÔÎÔÈÓˆÓÈΤ˜ ÂÈÙÒÛÂȘ
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Û ·È‰È¿ ËÏÈΛ·˜ ¤ˆ˜ 12
ÂÙÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2008 ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3058. ∫∞Δø¶O¢∏ Ã, ∫O™™Àμ∞ μ, ∫Àƒπ∞∫∂∞ ∞.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ π: ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË: æ˘¯Ôۈ̷ÙÈΤ˜ ÂÈÙÒÛÂȘ ÛÙËÓ ˘Á›· ÙˆÓ
ÂÊ‹‚ˆÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2003.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3059. ¢ƒO™OÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋
202
·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3060. ∫OΔ™πƒ∏ ∞, ™Δ∞ÀƒO¶OÀ§OÀ ∞. ¡ÔÛËÏ¢ÙÈ΋
ÊÚÔÓÙ›‰· ·ÛıÂÓÔ‡˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2.
ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2006. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3061. ∫O™ªO¶OÀ§OÀ ª, ∞£∞¡∞™O¶OÀ§OÀ
ª∫. O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2007. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3062. TSIPOURAS MG, EXARCHOS TP, FOTIADIS
DI. Automated creation of transparent fuzzy models
based on decision trees -application to diabetes diagnosis. Conf Proc IEEE Eng Med Biol Soc 2008; 2008:
3799-802.
3063. DEISS D, HARTMANN R, SCHMIDT J, KORDONOURI O. Results of a randomised controlled
cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes.
Exp Clin Endocrinol Diabetes 2006; 114: 63-7.
3064. PITA R, FOTAKOPOULOU O, KIOSSEOGLOU
G, ZAFIRI M, ROIKOU K, SIMOS G, DIDAGGELOS T, KARAMITSOS D. Depression, quality of life
and diabetes mellitus. Hippokratia 2002; 6 (™˘ÌÏ 1):
44-7.
3065. TENTOLOURIS N, PERTIKKOS G, VALLIANOU N, ZACHOS C, DAIKOS GL, TSAPOGAS P,
MARKOU G, KATSILAMBROS N. Prevalence of
methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbial
Infect 2006; 12: 186-9.
3066. HATZICHRISTOU D, GAMBLA M, RUBIOAURIOLES E, BUVAT J, BROCK GB, SPERA G,
ROSE L, LORDING D, LIANG S. Efficasy of
tadalafil once daily in men with diabetes mellitus and
erectile dysfunction. Diabet Med 2008; 25: 138-46.
3067. Δ∂ƒ∑∏ ∞ª. ∏ Û˘Ì‚ÔÏ‹ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹ ÛÙËÓ ÚfiÏË„Ë ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ Ô‰ÈÔ‡. ¡ÔÛËÏ¢ÙÈ΋ 2008; 47:
73-7.
3068. ªÀΔ∞™ ¢∑, ∫Àƒπ∞∑∏™ π∞. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·. ∞گ›· ∂ÏÏËÓ. π·ÙÚÈ΋˜ 2008; 25: 432-41.
3069. §∂μ∂π¢πøΔOÀ- ™Δ∂º∞¡OÀ ™. §ÔÈÌÒÍÂȘ ·fi
̇ÎËÙ˜ Û ‰È·‚ËÙÈÎÔ‡˜ Î·È ÓÂÊÚÔ·ı›˜ ·ÛıÂÓ›˜.
¢ÂÏÙ›ÔÓ ∂ÏÏËÓÈ΋˜ ªÈÎÚÔ‚ÈÔÏÔÁÈ΋˜ ∂Ù·ÈÚ›·˜
2008; 53: 83-8.
3070. ª∏ΔƒO¶OÀ§OÀ ∂, Ã∞ƒμ∞§∞∫OÀ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1990. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3071. ∫∏¶OÀƒOÀ μ, ¶π¶∂ƒ∂§∏ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1990. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3072. Δ™πø™∏ ∫. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋
‰ÈÂÚÁ·Û›·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
1990. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3073. ∑∞ƒƒ∞ ∞. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1990. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3074. ∫∞§∞´Δ∑π¢OÀ-∫O§§π∞ Ã, ª¶∞ƒΔ™πO∫∞™
Ã, ∫πΔ™πOÀ-Δ∑∂§∏ ™, ƒ∞¶Δ∏™ ™. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·-·Ó·›Ì·ÎÙË ‰È·ÁÓˆÛÙÈ΋ ÌÂϤÙË Ì ʈÙÔÁÚ¿ÊÈÛË ÙÔ˘ ‚˘ıÔ‡. ¶·È‰È·ÙÚÈ΋ 1984; 47:
112-5.
3075. ∫∞ƒ¶∞£πO™ £, æÀÃOÀ º, ¡π∫O§∞´¢OÀ ¶,
∫∞ƒ∞ª¶OÀ§∞ ∞, ª∂™™∞ƒπΔ∞∫∏™ π. æˆÚ›·ÛË
Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ¶ÂÚÈÁÚ·Ê‹ ‰‡Ô ÂÚÈÙÒÛÂˆÓ Û ·È‰È¿. ¶·È‰È·ÙÚÈ΋ 1984; 47: 305-7.
3076. Δ™πƒOÀ ª, §∞™∫∞ƒ∞ΔO™ π. ¶·Ú·ÙËÚ‹ÛÂȘ ÛÙȘ
ÌÂÙ·‚ÔϤ˜ Ù˘ ÂÓ‰ÔÊı¿ÏÌÈ·˜ ȤÛˆ˜ Û ‰È·‚ËÙÈÎfi
ÓÂÔ·ÁÁÂÈ·Îfi ÁÏ·‡ÎˆÌ· ÌÂÙ¿ ·fi ·Ó·ÌÊÈ‚ÏËÛÙÚÔÂȉÈ΋ ʈÙÔËÍ›· Î·È Î˘ÎÏÔÎÚ˘ÔËÍ›·. π·ÙÚÈο
ÃÚÔÓÈο 1985; 8: 753-9.
3077. Δ∑π°°OÀ¡∏™ μ∞, §OÀΔƒ∞¢∏™ ¢Ã, ∞°ƒ∞¶π¢∏™ â, ªOÀ§O¶OÀ§O™ °°, ∞ƒ°ÀƒO™ π. ∂›‰· Ï·ÎÔ˘ÓÙÈ·ÎÔ‡ Á·Ï·ÎÙfiÓÔ˘ (HPL), ÈÓÛÔ˘Ï›Ó˘
Î·È ÎÔÚÙÈ˙fiÏ˘ ÛÙÔ ·›Ì· ÂÌ‚Ú‡Ô˘- ÌËÙ¤Ú·˜ ηÈ
·ÌÓÈ·ÎÔ‡ ˘ÁÚÔ‡ ÛÙË ‰È·‚ËÙÈ΋ ÂÁ΢ÌÔÛ‡ÓË. π·ÙÚÈο
ÃÚÔÓÈο 1985; 8: 533-7.
3078. ™ΔÀ§π∞¡∂∞-ºOÀ¡ΔOÀ§∞∫∏ ∞, ∫∞ƒ∞°π∞¡¡O¶OÀ§O™ ™, ¶∞¶∞∂ªª∞¡OÀ∏§ μ. ¶ÚÔÛ‰ÈÔÚÈÛÌfi˜ ÂÈ¤‰ˆÓ Û˘ÌÏËÚÒÌ·ÙÔ˜ C3 Î·È C4 ÛÂ
ÔÌ¿‰· ‰È·‚ËÙÈÎÒÓ. ¢ÂÏÙ›ÔÓ ∂ÏÏËÓÈ΋˜ ªÈÎÚÔ‚ÈÔÏÔÁÈ΋˜ ∂Ù·ÈÚ›·˜ 1983; 28: 304-9.
3079. ∫∞ƒ∞ª∞¡O™ μ, ∂À™Δƒ∞ΔO¶OÀ§O™ ∞,
ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™˘˙‹ÙËÛË
ÛÙÚÔÁÁ˘Ï‹˜ ΔÚ¿Â˙·˜. πÔÎÚ¿Ù˘ 1988; 1∞: 301-8.
3080. ΔOÀ¡Δ∞™ Ã. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ∏ ÛËÌ·Û›·
Ù˘ Ú‡ıÌÈÛ˘ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ÂÌÊ¿ÓÈÛË
ÙˆÓ ¯ÚfiÓÈˆÓ ÂÈÏÔÎÒÓ. ™˘˙‹ÙËÛË ÛÙÚÔÁÁ˘Ï‹˜ ÙÚ¿Â˙·˜. πÔÎÚ¿Ù˘ 1988; 1∞: 308-11.
3081. ∂À™Δƒ∞ΔO¶OÀ§O™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘.
À¤ÚÙ·ÛË Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™˘˙‹ÙËÛË
ÛÙÚÔÁÁ˘Ï‹˜ ÙÚ¿Â˙·˜. πÔÎÚ¿Ù˘ 1988; 1∞: 311-18.
3082. TSIOTRA PC, TSIGOS C, ANASTASIOU E,
YFANTI E, BOUTATI E, SOUVATZOGLOU E,
KYROU I, RAPTIS SA. Peripheral mononuclear cell
resistin mRNA expression is increased in type 2 diabetic women. Mediators Inflamm 2008; 2008: 892864
(8 pages).
3083. STAMBOULIS E, VOUMVOURAKIS K, ANDRIKOPOULOU A, KOUTSIS G, TENTOLOURIS N, KODOUNIS A, TSIVGOULIS G. Association between asymptomatic median mononeuropathy
and diabetic polyneuropathy severity in patients with
diabetes mellitus. J Neurol Sci 2009; 278: 41-3.
3084. ¶O°°∞™ ¡, ¶πΔ™π°∞À¢∞∫∏ ∂, °ƒ∞ªª∂¡OÀ™∞μO°§OÀ ™, ¢OÀμ∞ƒ∞-¶∞¶∞ƒ∏ °. ™˘¯ÓfiÙ˘
˘ÂÚÏÈÔÚˆÙÂ˚Ó·ÈÌ›·˜ Û ·ÛıÂÓ›˜ Ì ‰È·‚ËÙÈ΋
·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. π·ÙÚÈο ÃÚÔÓÈο 1983; 6:
737-40.
3085. °π∞¡¡O¶OÀ§O™ ∞, ¶∞¡∞°πøΔπ¢∏™ ¡, £∞¡O™ ∞, ™∞μμO¶OÀ§O™ Ã, ¢∞μπ§§∞™ ¡. ¡ÂfiÏ·ÛÌ· ·Ó‰ÚÈ΋˜ Ô˘Ú‹ıÚ·˜ Ô˘ ÂΉËÏÒıËΠˆ˜ ÂÚÈÔ˘ÚËıÚÈÎfi˜ ÊϤÁÌÔÓ·˜ Û ۷ί·Úԉȷ‚ËÙÈÎfi ·ÛıÂÓ‹. ∂ÏÏËÓÈ΋ O˘ÚÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 1982; 19: 17-9.
3086. μÀ™™OÀ§∏™ °, ™OÀΔO™ ¢, Oƒº∞¡π¢∏™ ∑,
¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ª, ™Δ∞ª∞Δ∏™ ¢,
ΔOÀ¡Δ∞™ Ã, ΔOÀΔOÀ∑∞™ ¶, ¶OÀ°°OÀƒ∞™
¶. ªÂÙ·‚ÔϤ˜ ÙˆÓ ÏÂ˘ÎˆÌ¿ÙˆÓ ÙÔ˘ ÔÚÔ‡ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ì ‹ ¯ˆÚ›˜ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ. ∞گ›· π·ÙÚ.
∂Ù·ÈÚÂÈÒÓ 1982; 8: 137-40.
3087. ™πOÀ¡∞-μ∞™π§O¶OÀ§OÀ Ã, ∫ø™Δ∞§O™ Ã,
§∞ª¶∞¢∞ƒπ¢∏™ π. ÀÂÚÙÚÔÊÈ΋ ηډÈÔÌ˘Ô¿ıÂÈ· Û ÓÂÔÁ¤ÓÓËÙÔ ÌËÙ¤Ú·˜ Ì ‰È·‚‹ÙË Î‡ËÛ˘. ¶·È‰È·ÙÚÈ΋ 1987; 50: 39-43.
3088. THEOPHANIDES CG, EKOE JM, BEATON M.
Diabetes Mellitus Syndrome-Family in Cyprus.
π·ÙÚÈ΋ ∫‡ÚÔ˜ 1986; 5: 18-20.
3089. Δ™πƒOÀ ª, §∞™∫∞ƒ∞ΔO™ π. ∏ ¯Ú‹ÛȘ ÙˆÓ
Lasers ÛÙËÓ ÔÊı·ÏÌÔÏÔÁ›· Û‹ÌÂÚ·. ¶·Ú·ÙËÚ‹ÛÂȘ
Î·È Û˘ÌÂÚ¿ÛÌ·Ù· ÌÂÙ¿ ÂÍ·ÂÙ‹ ÂÌÂÈÚ›· ÛÙË ‰È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. π·ÙÚÈο ÃÚÔÓÈο 1985;
8: 46-54.
3090. ª¶∞§Δ∞ ¢. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
ÓÔÛËÏ¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3091. ∫∞ƒ∞ª¶∂§∞ º. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÔÈ
ÂÈÏÔΤ˜ ÙÔ˘: O ÚfiÏÔ˜ ÙˆÓ ÓÔÛËÏ¢ÙÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3092. ∑∂μ§∞ ª, ∫Oƒø¡∏ ª, ∫À¢ø¡π∞Δ∏ ∞. ¢È·Ù·Ú·¯¤˜ ÓÂÊÚÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ÔÊÂÈÏfiÌÂÓ˜ Û ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3093. ƒ∏°∞ μ, ™∞ƒ∞¡ΔO¶OÀ§OÀ ¡. OÈ Î·Ú‰ÈÔ¿ıÂȘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2005. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3094. ™∞∫∂ΔOÀ μ, ¢π∞∫O¶OÀ§O™ °. ÀÔÛÙ‹ÚÈÍË
·ÛıÂÓÒÓ Ì ‰È·‚‹ÙË Ì¤Ûˆ ‰È·‰ÈÎÙ‡Ô˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2007. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3095. ¶∞¶∞¢∏ª∏ΔƒO¶OÀ§O™ º. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Î·È Ô ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2007. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3096. ª¶∞Ω§OÀ μ, §π∞∫O¶OÀ§OÀ, º. ∞ÁˆÁ‹ ˘Á›·˜ Û ·È‰È¿ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3097. ª∞ƒ°∞ƒπΔ∏ ™, ªπÃ∞§∏™ ∞, ¶∞¡Δ∑πO™ ∞.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 1988. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3098. ∫∂∫∫∂ ∂, ∫∂™OÀ¢π¢OÀ π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1988. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3099. ∫∞§Àμ∞ Δ, ª∏ΔƒOμ°∂¡∏ ™. O ۷ί·Ú҉˘
‰È·‚‹Ù˘ Î·È Ë ÚfiÏË„‹ ÙÔ˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1989. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
203
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3100. ¶∞¶∞¢O¶OÀ§OÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
‰›·ÈÙ·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1991.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3101. ™∫O¡¢ƒ∞ ∂. ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰· Û ÂÓ‹ÏÈΘ
·ÛıÂÓ›˜ Ô˘ ¿Û¯Ô˘Ó ·fi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË.
ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1991. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3102. ª¶∞ƒ∞ª¶∞Δ∏™ ¡, ™Δ∂º∞¡∞ΔO™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Û ·ÁÚÔÙÈ΋ ÂÚÈÔ¯‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1991. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3103. ¶∞¶¶∞ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ÂÓËÏ›ÎˆÓ Î·È
ÓÔÛËÏ¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1991. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3104. ∫ø™Δ∏™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ÛÙËÓ ·È‰È΋
ËÏÈΛ·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1993.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3105. £∂O¢øƒOÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1994. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3106. ™Δ∂§§∞ΔO™ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1993. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3107. ¡π∫O§O¶OÀ§OÀ μ. ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰·
·ÛıÂÓÔ‡˜ Ì fi„ÈÌÔ ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1993. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3108. •À¢∏ ∫. ¢È·‚ËÙÈ΋ ·ÌÊÈÛ‚ÏËÙÚÔÂȉÔ¿ıÂÈ·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1989. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3109. ª¶O§∏ ¶. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1994. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3110. ¶∞¡∞°πøΔO¶OÀ§OÀ ∫. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1994. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3111. ƒ∂¡Δ∑∂¶∏ μ. ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰· ·ÛıÂÓÔ‡˜
Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1995. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3112. ∫OÀΔ™OÀ∫OÀ £. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3113. ∞¡Δø¡O¶OÀ§OÀ ∞. ¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
1995. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3114. ∫OÀμƒOÀ∫∏ ™. ∏ Û˘Ì‚ÔÏ‹ Ù˘ ÓÔÛËÏ¢ÙÈ΋˜
ÛÙËÓ ÚfiÏË„Ë ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÂÓËÏ›ÎˆÓ Î·ıÒ˜ Î·È ÙˆÓ ÂÈÏÔÎÒÓ ÙÔ˘. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1995. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3115. ¶∞°ø¡∏™ ¢. ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË Û ·ÛıÂÓ‹
Ì Ó·ÓÈÎfi ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1995. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3116. ºO¡ΔOƒ∂∞¡ ª. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1997. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3117. ∑ø°ƒ∞ºOÀ μ, ∫O§§π∞ Ã. ƒ‡ıÌÈÛË Û·Î¯¿ÚÔ˘
‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓ‹ (¤Ú¢ӷ), ÓÔÛËÏ¢ÙÈΤ˜ ·ÚÂÌ‚¿-
204
ÛÂȘ ÛÙÔÓ ˘ÂÚ‹ÏÈη ‰È·‚ËÙÈÎfi. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1998. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3118. Ã∞ƒO∫O¶OÀ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ π
Î·È „˘¯Ôۈ̷ÙÈ΋ ˘ÔÛÙ‹ÚÈÍË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 1999. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3119. ª¶ƒOÀª∞ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
1999. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3120. ∂À£ÀªπOÀ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ∂ÈÏÔΤ˜
Î·È Ô ÚfiÏÔ˜ ÙÔ˘ ÓÔËÏÂ˘Ù‹/ÙÚÈ·˜. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 1999. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3121. ¢OÀ™∏ μ. ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰· ·ÛıÂÓÔ‡˜ ÌÂ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜
∞Δ∂π ¶·ÙÚÒÓ, 2000. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3122. ∫∞¡∂§§O¶OÀ§OÀ O, Δ∂ƒ∂∑∞∫∏ ¡, §O°∞ƒ∞ ¶. ∏ ‰›·ÈÙ· Î·È Ë Ê·Ú̷΢ÙÈ΋ ·ÁˆÁ‹ ÛÙË Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ô ÚfiÏÔ˜ ÙˆÓ ÓÔÛËÏ¢ÙÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2001.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3123. ™∞ƒ∞´Δπ∫∞ ∂, ™¶∏§πO¶OÀ§OÀ μ. ∏ ¡ÔÛËÏ¢ÙÈ΋ ÛÙËÓ ·Ó›¯Ó¢ÛË Î·È ÊÚÔÓÙ›‰· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡
Ô‰ÈÔ‡. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2000.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3124. ª¶∂∏ ™. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈ΋.
ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2000. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3125. ∫O∫∫πOÀ ∂. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
ÓÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2001. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3126. ª∞ƒOÀΔ∞ π. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡ÔÛËÏ¢ÙÈ΋
·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
2001. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3127. SUMNIK Z, CINEK O, BRATANIC N, KORDONOURI O, KULICH M, ROSZAI B, ARATO A,
LEBL J, SOLTESZ G, DANNE T, BATTELINO T,
SCHOBER E. Risk of celiac disease in children with
type 1 diabetes is modified by positivity for HLADQB1*02-DQA1*05 and TNF -308A. Diabetes Care
2006; 29: 858-63.
3128. ª∞§∞∫OÀ £. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË.
O ÚfiÏÔ˜ ÙÔ˘ ÓÔÛËÏÂ˘Ù‹. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3129. ΔO¶∏ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ÓÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË Î·È ÚfiÏË„Ë ÂÈÏÔÎÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2004. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3130. ∫ø¡™Δ∞¡Δπ¡OÀ ∞, ¶∞¶∞Ã∞ƒ∞§∞ª¶OÀ™
ª, Δ∑∂ªOÀ ∞. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 1: æ˘¯ÔÎÔÈÓˆÓÈΤ˜ ÂÈÙÒÛÂȘ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2002. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3131. ∞¶O™ΔO§π¢∏ ∂. ∏ ÓÔÛËÏ¢ÙÈ΋ ÛÙËÓ ÚfiÏË„Ë
ÂÈÏÔÎÒÓ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3132. °OÀ§∞ ∞. ¡ÔÛËÏ¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ ÛÙÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3133. §πOÀƒΔ∞™ ∫. ¡¤· ‰Â‰Ô̤ӷ ÛÙË ‰È·¯Â›ÚÈÛË ÙÔ˘
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π
¶·ÙÚÒÓ, 2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3134. ™∞§∂¶Δ™∏ ¶. ¡ÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰· ·ÛıÂÓÒÓ
·ıÔÏÔÁÈ΋˜ & ¯ÂÈÚÔ˘ÚÁÈ΋˜ ÎÏÈÓÈ΋˜ ÌÂ Û˘Ó˘¿Ú¯Ô˘Û· ÓfiÛÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3135. ƒ∞ÃπøΔ∏™ π, ¶∞™ΔO™ ∫. ¢È·‚ËÙÈÎfi fi‰È: ÃÂÈÚÔ˘ÚÁÈ΋ Î·È Û˘ÓÙËÚËÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË: ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3136. VITORATOS N, DELIVELIOTOU A, VLAHOS
NF, MASTORAKOS G, PAPADIAS K, BOTSIS D,
CREATSAS GK. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes
and normal controls. Gynecol Endocrinol 2008; 24:
614-9.
3137. ∫∞ƒ∞ª¶∂ƒ∏ ∞, ∫∞∫OÀ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Î‡ËÛË: ∏ ·Ú¤Ì‚·ÛË ÙÔ˘ ÓÔÛËÏÂ˘Ù‹ ÛÙËÓ
·Ûı¤ÓÂÈ·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2006.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3138. ∞§∂•∂§§∏ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÔÈ ÂÈÙÒÛÂȘ ÙÔ˘ Û ¯ÂÈÚÔ˘ÚÁË̤ÓÔ˘˜ ·ÚÚÒÛÙÔ˘˜. ΔÌ‹Ì·
¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2006. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3139. ¡Δ∞¡OÀ ¶.∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ II:
OÏÈÛÙÈ΋ ÓÔÛËÏ¢ÙÈ΋ ÊÚÔÓÙ›‰·. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2006. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3140. °OÀƒ¡∞ƒ∏ ¡, ¢∂§∏™Δ∞£∏ ¢. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2006. ¶Ù˘¯È·Î‹
∂ÚÁ·Û›·.
3141. Δ∑O§∞ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÓÔÛËÏ¢ÙÈ΋
·ÓÙÈÌÂÙÒÈÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ,
2006. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3142. ∫∞ƒ∞ª¶∞§∏™ £. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
·ËÛË: ¡ÔÛËÏ¢ÙÈ΋ ·Ú¤Ì‚·ÛË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3143. ™Δ∞Àƒπ∞¡O¶OÀ§O™ £, Δ™∞ª∏ ¢. O ÚfiÏÔ˜
ÙÔ˘ ÓÔÛËÏÂ˘Ù‹ ÛÙÔ ™·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2004. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3144. Ã∞™∞∫∏™ μ, æÀÃO°ÀπOÀ ¶. ∏ ηıËÌÂÚÈÓ‹
˙ˆ‹ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜ Î·È Ë ÓÔÛËÏ¢ÙÈ΋ ˘ÔÛÙ‹ÚÈÍË. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2001.
¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3145. Δ™∞¶∞ƒ∞ ∂. ¡Â·ÓÈÎfi˜ ۷ί·Ú҉˘ ‰È·‚‹Ù˘:
™˘Ì‚Ô‡ÏË Ù˘ ÓÔÛËχÙÚÈ·˜ ÁÈ· ÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙˆÓ ÚÔ‚ÏËÌ¿ÙˆÓ Î·È ÂÈÏÔÎÒÓ. ΔÌ‹Ì· ¡ÔÛËÏ¢ÙÈ΋˜ ∞Δ∂π ¶·ÙÚÒÓ, 2003. ¶Ù˘¯È·Î‹ ∂ÚÁ·Û›·.
3146. §∂ªO¡π¢OÀ Ã. £ÂÚ·¢ÙÈ΋ ·ÁˆÁ‹ ˘ÁÂÈ¿˜ ‰È·‚ËÙÈÎÒÓ. ∞ÍÈÔÏfiÁËÛË ÂÎ·È‰Â˘ÙÈÎÔ‡ ÚÔÁÚ¿ÌÌ·ÙÔ˜.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1988. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3147. Ã∞Δ∑∏¡π∫O§∞OÀ §. ™˘ÌÂÚ¿ÛÌ·Ù· ·fi ÙË
¯Ú‹ÛË ·ÏÈÓ‰ÚfiÌËÛ˘ ηډÈÔÏËÁ›·˜ Û ·ÛıÂÓ›˜ ÌÂ
·˘ÙfiÓÔÌË ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ· Î·È ‰È·‚ËÙÈ΋ ηÚ-
‰ÈÔÌ˘Ô¿ıÂÈ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1993. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3148. Ã∞ƒ∞§∞ª¶∞∫∏™ ∞. ∏Ï·Ùو̤ÓË Â˘·ÈÛıËÛ›·
ÙˆÓ Ù·ÛÂÔ¸Ô‰Ô¯¤ˆÓ ÂȘ ‰È·‚ËÙÈÎÔ‡˜ Î·È ·‡ÍËÛȘ
Ù·‡Ù˘ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ‰·ÎÙ˘Ï›ÙȉԘ. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1976. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3149. ∫OÀƒ∏™ Ã. ∞ÓÙÈÛÒÌ·Ù· ηٿ ÙˆÓ ÙÔȯˆÌ·ÙÈÎÒÓ
΢ÙÙ¿ÚˆÓ Â› ∂ÏÏ‹ÓˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1972. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3150. ELEFTHERIADOU I, GRIGOROPOULOU P,
KATSILAMBROS N, TENTOLOURIS N. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.
Curr Diabetes Rev 2008; 4: 340-56.
3151. SOTIROPOULOS A, PAPAZAFIROPOULOU A,
APOSTOLOU O, KOKOLAKI A, GIKAS A, PAPPAS S. Prevalence of depressive symptoms among
non insulin treated Greek type 2 diabetic subjects.
BMC Res Notes 2008; 1: 101 (4 pages).
3152. DOVAS S, LIAKOPOULOS V, SIMOPOULOU T,
GIANNOPOULOU M, KANAKI A, ANIFANDIS
G, STEFANIDIS I. A case report of osteomyelitis pubis in a hemodialysis patient with diabetes mellitus.
Ther Apher Dial 2008; 12: 409-12.
3153. ¢∞ƒ™π¡O™ π, ¶π™Δ∂ÀO™ ∞, ªOÀ§O¶OÀ§O™
™, ∫∞ƒ§∏ π. ∫ÏÈÓÈ΋ ÂΉ‹ÏˆÛË Î·È ÚԉȷıÂÛÈÎÔ›
·Ú¿ÁÔÓÙ˜ ÛÙÂÊ·ÓÈ·›·˜ ÓfiÛÔ˘. ∂ÏÏËÓÈ΋ ∫·Ú‰ÈÔÏÔÁÈ΋ ∂ÈıÂÒÚËÛË 1985; 26: 216-24.
3154. ∫∞Δ∑O™ °. Àԉԯ›˜ Ù˘ ÈÓÛÔ˘Ï›Ó˘. ¶·È‰È·ÙÚÈο ÃÚÔÓÈο 1985; 14: 11-20.
3155. ATHYROS VG, PAPAGEORGIOU A.A, HATZIKONSTANDINOU H.A, DIDANGELOS T.P,
CARINA M.V, KRANITSAS D.F, KONTOPOULOS A.G. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial
combined hyperlipidemia. Am J Cardiol 1997; 80:
608-13.
3156. TENTOLOURIS N, ARAPOSTATHI C, PERREA
D, KYRIAKI D, REVENAS C, KATSILAMBROS
N. Differential effects of two isoenergetic meals rich
in saturated or monounsaturated fat on endothelial
function in subjects with type 2 diabetes. Diabetes
Care 2008; 31: 2276-8.
3157. PANAGIOTAKOS D.B, PITSAVOS C, SKOUMAS Y, LENTZAS Y, STEFANADIS C. Five-year
incidence of type 2 diabetes mellitus among cardiovascular disease-free Greek adults: Findings from the
ATTICA study.Vasc Health Risk Manag 2008; 4: 6918.
3158. TERMENTZI A, ALEXIOU P, DEMOPOULOS
VJ, KOKKALOU E. The aldose reductase inhibitory
capacity of Sorbus domestica fruit extracts depends
on their phenolic content and may be useful for the
control of diabetic complications. Pharmazie 2008; 63:
693-6.
205
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3159. ª¶∂¡ƒOÀª¶∏ ª. ∂ÓÙ·ÙÈÎÔÔÈË̤ÓË ıÂÚ·›·
Ì ÈÓÛÔ˘Ï›ÓË: EÚˆÙ‹Ì·Ù· ÚÔ˜ Û˘˙‹ÙËÛË. ∞گ›·
∂ÏÏËÓ. π·ÙÚÈ΋˜ 1994; 11: 11-2.
3160. ºƒ∞°∫π™∫O™ º, ª∞™OÀ§∞™ °, μ∞°∂¡∞™ ¡.
OÈ ÂÍ·ÁˆÁ¤˜ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. O‰ÔÓÙÔÛÙÔÌ·ÙÔÏÔÁÈ΋ ¶ÚfiÔ‰Ô˜ 1990; 44: 45-56.
3161. ™Δ∞ª∞Δ∏™ ¢, μÀ™™OÀ§∏™ °, ¶∞¶∞∫ø¡™Δ∞¡Δπ¡OÀ ª, ΔOÀΔOÀ∑∞™ ¶, ™OÀ™∞¡∏™
∏, ¶OÀ°°OÀƒ∞™ ¶. ∏ÏÂÎÙÚÔηډÈÔÁÚ·ÊÈο Â˘Ú‹Ì·Ù· Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. π·ÙÚÈ΋ ∂ÈıÂÒÚËÛË ∂ÓfiÏˆÓ ¢˘Ó¿ÌÂˆÓ 1983; 17: 147-51.
3162. μ∞ƒΔ∑∂§∏ - ∫O¡¢À§∞∫∏ ™. ¡˘¯ıËÌÂÚfi˜ ‰È·Î‡Ì·ÓÛ˘ Ù˘ ·˘ÍËÙÈ΋˜ ÔÚÌfiÓ˘ ÙÔ˘ Ï¿ÛÌ·ÙÔ˜ Â›
‰È·‚ËÙÈÎÒÓ ·È‰ÈÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1976. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3163. ∫OÀ∫OÀƒπ∫OÀ ª. O ÚfiÏÔ˜ Ó¤ˆÓ ‚ÈÔÌ˯·ÓÈÎÒÓ
·Ú·Ì¤ÙÚˆÓ (IL-S, TNF, NO, C-GMP, TXB_2) ÛÙËÓ
·ıÔÁ¤ÓÂÛË ÙˆÓ ·ÁÁÂÈ·ÎÒÓ ÂÈÏÔÎÒÓ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∞¶£, 2005. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3164. ¡ΔOÀ¶∏™ π. ∏ ÔÍ›· Â›‰Ú·ÛË Ù˘ ˘ÂÚÔÌÔ΢ÛÙÂ˚Ó·ÈÌ›·˜ Ô˘ ÚÔηÏÂ›Ù·È ÌÂÙ¿ ÙË Ï‹„Ë ÌÂıÂÈÔÓ›Ó˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 2007. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3165. ∫OÀ¡∂¡OÀ ∫. ∏ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙË Ù‡Ô˘ π ÛÙË ÏÂÈÙÔ˘ÚÁ›· Ù˘ ÔÈÎÔÁ¤ÓÂÈ·˜. ¶·È‰·ÁˆÁÈÎfi ΔÌ‹Ì· ¢ËÌÔÙÈ΋˜ ∂Î·›‰Â˘Û˘ ¶·ÓÂÈÛÙ‹ÌÈÔ ∞ÈÁ·›Ô˘, 2003. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3166. ª∏ΔΔ∞™ ∂. OÈ ÂÈÙÒÛÂȘ ÛÙÔ˘˜ Ô‰ÔÓÙÈÎÔ‡˜ ηÈ
Ô˘ÏÈÎÔ‡˜ ÈÛÙÔ‡˜ ÙˆÓ Á˘Ó·ÈÎÒÓ Ô˘ ÂΉËÏÒÓÔ˘Ó Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Î‡ËÛ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘, 2007. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3167. §À°¡O™ ª. ªÂÙ·‚ÔϤ˜ ÛÙ· Â›‰· ÙˆÓ VEGF,
bFGF, TGF-‚1, ET-1 Î·È Skl, ÛÙÔ Ï¿ÛÌ· Ù˘ ÂÁ·Ԣ
ηٿ ÙË ‰È¿ÚÎÂÈ· Ù˘ Ê˘ÛÈÔÏÔÁÈ΋˜ ·ËÛ˘, Ù˘ ˘ÂÚÙ·ÛÈ΋˜ ·ËÛ˘ Î·È Ù˘ ‰È·‚ËÙÈ΋˜ ·ËÛ˘. π·ÙÚÈ΋
™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘, 2007. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
3168. ¶∞¶¶∞ ∫. ªÂÙ·‚ÔÏÈÛÌfi˜ Ù˘ ∫·ÚÓÈÙ›Ó˘ Î·È ÌÂÙ·‚ÔϤ˜ ÛÙÔÓ ÂӉȿÌÂÛÔ ÌÂÙ·‚ÔÏÈÛÌfi ÙˆÓ ‰È·‚ËÙÈÎÒÓ ÂÁ·ˆÓ Á˘Ó·ÈÎÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ ∫Ú‹Ù˘, 2004. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3169. ∫∂º∞§O°π∞¡¡∏™ π. ™˘¯ÓfiÙ˘ ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜
‰È·‚‹ÙÔ˘ Â› ÙˆÓ ∂ÏÏ‹ÓˆÓ: ŒÚ¢ӷ Â› 90.605 Ù˘¯·›ˆÓ ·ÛıÂÓÒÓ. °ÂÓÈÎfi ¡ÔÛÔÎÔÌÂ›Ô ∞™∫§∏¶π∂πO
μԇϷ˜, 1970. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3170. Δ™∞∫∞§∞∫O™ ¡. ∞ÏÏËÏÂ›‰Ú·ÛË ÌËÙ¤Ú·˜-·È‰ÈÔ‡ ÛÙË ‰È·‚ËÙÈ΋ ÂÁ΢ÌÔÛ‡ÓË: H Â›‰Ú·ÛË ÙˆÓ Û˘ÛÙ·ÙÈÎÒÓ Ù˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘, ÙˆÓ ·Ú·ÁfiÓÙˆÓ Ô͢ÁÔÓÒÛˆ˜ Î·È Ù˘ ÏÂÈÙÔ˘ÚÁ›·˜ ÙˆÓ ‚-΢ÙÙ¿ÚˆÓ ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜ ÛÙÔ ‚¿ÚÔ˜ ÁÂÓÓ‹Ûˆ˜ ÙˆÓ ‚ÚÂÊÒÓ. ∞ı‹Ó·:
University of Stellenbosch & π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞,
1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3171. °ƒ∞°OÀ¢∞™ ∂. ∂Ή‹ÏˆÛȘ ÌÈÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·˜
Â› ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘: ¶ÂÈÚ·Ì·ÙÈ΋ ÌÂϤÙË ÙˆÓ
206
·ÁÁ›ˆÓ Ù˘ ›ÚȉԘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ ‰È· ÊÏÔ˘ÔÚÂÛÎÂÈÓÈ΋˜ ·ÁÁÂÈÔÁÚ·Ê›·˜. Departhment of Medicine - Harvard University, 1971. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3172. Δƒ∞¶∞§∏ ª. ªÂϤÙË Ù˘ Û¯¤Û˘ ÙÔ˘ ·Ú¿ÁÔÓÙ·
ÂÓÂÚÁÔÔ›ËÛ˘ ·ÈÌÔÂÙ·Ï›ˆÓ (PAF) Ì ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ΔÌ‹Ì· ÃËÌ›·˜ ∂∫¶∞, 1996. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3173. ∫∞ƒ∞°π∞¡¡∏™ ™. ∞ÓÙÈÛÒÌ·Ù· ηٿ ÙˆÓ ı˘ÚÂÔÂȉÈÎÒÓ Î˘ÙÙ¿ÚˆÓ Â› ∂ÏÏ‹ÓˆÓ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ.
π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1973. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3174. °ø°OÀ μ. ªÂϤÙË, ۯ‰ȷÛÌfi˜ Î·È ·Ó¿Ù˘ÍË ¤Í˘Ó˘ οÚÙ·˜ ÔÏÏ·ÏÒÓ ÂÊ·ÚÌÔÁÒÓ ÁÈ· ¯Ú‹ÛË ‰È·‚ËÙÈÎÔ‡ ΤÓÙÚÔ˘. ΔÌ‹Ì· ∏ÏÂÎÙÚÔÏfiÁˆÓ ªË¯·ÓÈÎÒÓ
Î·È ªË¯·ÓÈÎÒÓ ÀÔÏÔÁÈÛÙÒÓ ∂ª¶ 2002. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3175. ªO™ÃOÀ ª.∂. ¶ÔÛÔÙÈÎfi˜ ÚÔÛ‰ÈÔÚÈÛÌfi˜ ÙˆÓ
ÁÏ˘ÎÔ˙·ÌÈÓÔÁÏ˘Î·ÓÒÓ ÛÙ· ‰¿ÎÚ˘· Î·È ÙÔÓ ÔÚfi ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 2001. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3176. ∞Ãπ§§∂ø™ ∫. ∏ οı·ÚÛË (clearance) Ù˘ ÎÚ·ÙÈÓ›Ó˘ Û ˘ÂÚÙ·ÛÈÎÔ‡˜ Î·È ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜
ÚÔÂÁ¯ÂÈÚËÙÈο Î·È ÌÂÙÂÁ¯ÂÈÚËÙÈο. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1995. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3177. °∂øƒ°O¶OÀ§O™ ¡. ∏ ÔÚÌÔÓÈ΋ ·ÓÙ·fiÎÚÈÛË
ÛÙÔ Stress Î·È Ù· ¯·Ú·ÎÙËÚÈÛÙÈο Ù˘ ÚÔÛˆÈÎfiÙËÙ·˜ Û ÂÊ‹‚Ô˘˜ Ì ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·. π·ÙÚÈ΋
™¯ÔÏ‹ ∂∫¶∞, 1995. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3178. μ∂μ∂™ ∞. ∂Ò‰˘ÓË ‰È·‚ËÙÈ΋ Ó¢ÚÔ¿ıÂÈ·. Department of Medicine – University of Manchester,
1992. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3179. ∫∞ƒ∞ª∞¡∞∫OÀ-Oƒº∞¡∞∫OÀ °. §ÈÔÚˆÙ½Ó˜ ÙÔ˘ ÔÚÔ˘ Û ‰È·‚ËÙÈο Î·È ÌË ‰È·‚ËÙÈο ¿ÙÔÌ·
Ì ÂÚÈÊÂÚÈ΋ ·ÚÙËÚÈÔÛÎÏËÚ˘ÓÙÈ΋ ·ÔÊÚ·ÎÙÈ΋
·ÚÙËÚÈÔ¿ıÂÈ·. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1980. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3180. ∫OÀ°∂μ∂ΔO¶OÀ§OÀ ∫. ™¯¤ÛȘ ÙÈÌÒÓ Hdl - ¯ÔÏËÛÙÂÚfiÏ˘ Î·È ÂÈ¤‰ˆÓ Hba_1 Â› Ó·ÓÈÎÔ‡ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3181. Δ™OÀ∫∞¡∞™ μ. ∏ ÚÔÛÎÔÏÏËÙÈÎfiÙ˘ ÙˆÓ ÔÏ˘ÌÔÚÊÔ‡ÚËÓˆÓ Ô˘‰ÂÙÂÚfiÊÈÏˆÓ Ï¢ÎÔ΢ÙÙ¿ÚˆÓ Â›
۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙÔ˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1975.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3182. ª∞ƒ∫π¢OÀ-Ãπ™ΔO¢OÀ§OÀ, º. ªÂÙ·‚ÔϤ˜
ÙˆÓ ÂÈ¤‰ˆÓ Ù˘ ·ÈÌÔÛÊ·ÈÚ›Ó˘ ∞1(Hb A1) ηٿ
ÙËÓ Ú‡ıÌÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 1981. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3183. ∞¡Δø¡πOÀ ∞. ∞ÏÏÔÈÒÛÂȘ ·ÚÙËÚÈÒÓ ÂÁÎÂÊ¿ÏÔ˘
Î·È Ì˘Ôηډ›Ô˘ Â› ‚Ú·¯˘¯ÚfiÓÈÔ˘ Î·È Ì·ÎÚÔ¯ÚfiÓÈÔ˘
ÂÈÚ·Ì·ÙÈÎÔ‡ ‰È·‚ËÙÔ‡ ÚÔηÏÔ‡ÌÂÓÔ˘ ‰È· ÛÙÚÂÙÔ˙ˆÙÔÛ›Ó˘ ÂȘ ÂÈÌ˘˜. ªÂϤÙË ‰È· ·ÏÔ‡ & ËÏÂÎÙÚÔÓÈÎÔ‡ ÌÈÎÚÔÛÎÔ›Ô˘. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1983. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3184. ∞ƒμ∞¡πΔ∏™ Ã. ™˘Ì‚ÔÏ‹ ÂȘ ÙËÓ ÌÂϤÙËÓ Ù˘ Û˘-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
Ì·ıËÙÈ΋˜ Ó¢ÚÒÛˆ˜ ÙˆÓ ¿ÎÚˆÓ ÙË ¯Ú‹ÛÂÈ Ù˘ ‰ÔÎÈÌ·Û›·˜ NINHYDRIN Â› ·ÁÁÂÈÔ·ıÒÓ Î·È ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. π·ÙÚÈ΋ ™¯ÔÏ‹ ∂∫¶∞, 1984. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3185. ∫∞§O°∂ƒO¶OÀ§OÀ ∫.∂. ∏ ÂÎÙ›ÌËÛË ÙˆÓ Û˘ÁÎÂÓÙÚÒÛÂˆÓ Ù˘ ÂÓ‰ÔıËÏ›Ó˘-1-21 Î·È ÙˆÓ ÂÏ¢ı¤ÚˆÓ ÚÈ˙ÒÓ Û ‰È·‚ËÙÈο ¿ÙÔÌ· Ù‡Ô˘ 2 Ì ̷ÎÚÔ·ÁÁÂÈÔ¿ıÂÈ·. ΔÌ‹Ì· º·Ú̷΢ÙÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘
¶·ÙÚÒÓ, 2001. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3186. ∂À∞°°∂§OÀ ¡. Proteinanalyse der Tränenflussigkeit bei Diabetikern und bei Patienten mit trockenen
Augen. Rheinische Friedrich-Wilhelms Universität
Bonn, 1998. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹,
3187. ¶∂¶¶∞ - ¶∞Δƒπ∫πOÀ ª. ∂Ó‰ÔıËÏ›ÓË Î·È ‰È·‚ËÙÈ΋ ·ÁÁÂÈÔ¿ıÂÈ·. ΔÈ̤˜ ÂÓ‰ÔıËÏ›Ó˘ Û ·È‰È¿,
ÂÊ‹‚Ô˘˜ Î·È Ó·ÚÔ‡˜ ÂÓ‹ÏÈΘ Ì ÈÓÛÔ˘ÏÈÓÔÂÍ·ÚÙÒÌÂÓÔ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË (™¢1). ™˘Û¯¤ÙÈÛË ÂÓ‰ÔıËÏ›Ó˘ Ì ÙËÓ ‰È¿ÚÎÂÈ· ‰È·‚‹ÙË, ÙÔ Â›Â‰Ô ÁÏ˘Î·ÈÌ›·˜, ÙËÓ ·ÚÙËÚȷ΋ ›ÂÛË, Ù· Â›‰· ÏÈȉ›ˆÓ, ÙËÓ
ÌÈÎÚÔÏÂ˘ÎˆÌ·Ù›ÓË Ô‡ÚˆÓ, ÙËÓ ÂχıÂÚË ÎÔÚÙÈ˙fiÏË
Ô‡ÚˆÓ, Î·È ¿ÏÏÔ˘˜ ·Ú¿ÁÔÓÙ˜. π·ÙÚÈ΋ ™¯ÔÏ‹
∂∫¶∞, 2001. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3188. ∏ƒ∞∫§∂π∞¡OÀ ™. §Èȉ·ÈÌÈ΋ Ê˘ÛÈÔÁӈ̛· ηÈ
Ì˯·ÓÈÛÌfi˜ ÈÓˆ‰fiÏ˘Û˘ Û ‰È·‚ËÙÈÎÔ‡˜ Ù‡Ô˘˜ ππ,
ÛÙÂÊ·ÓÈ·›Ô˘˜ Î·È ÌË ·ÛıÂÓ›˜ ÌÂÙ¿ ·fi ÏÈ·Úfi Á‡̷. π·ÙÚÈ΋ ™¯ÔÏ‹ ¶·ÓÂÈÛÙËÌ›Ô˘ πˆ·ÓÓ›ÓˆÓ, 2005.
¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3189. SALTIKI K, CIMPONERIU A, LILI K, PEPPA M,
ANASTASIOU E, ALEVIZAKI M. Severity of coronary artery disease in postmenopausal diabetic
women. Hormones (Athens) 2008; 7: 148-55.
3190. KARAVANAKI K, KAZIANIS G, KONSTANTOPOULOS I, TSOUVALAS E, KARAYIANNI C.
Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of
impaired circadian modulation of blood pressure and
heart rate. J Endocrinol Invest 2008; 31: 289-96.
3191. PEPPA M, RAPTIS SA. Advanced glycation end
products and cardiovascular disease. Curr Diabetes
Rev 2008; 4: 92-100.
3192. TOUTOUZAS K, PATSA C, VAINA S, TSIAMIS
E, VAVURANAKIS M, STEFANADI E, SPANOS
A, ILIOPOULOS D, PANAGIOTOU M, CHLOROGIANNIS I, PATTAKOS E, STEFANADIS C. A
preliminary experience report: Drug-eluting stents
versus coronary artery bypass surgery in patients with
a single lesion in the proximal left anterior descending
artery suffering from diabetes mellitus and chronic
stable angina. Hellenic J Cardiol 2008; 49: 65-71.
3193. KOSTIDOU E, KOLIAKOS G, PALETAS K, KALOYIANNI M. Monocyte attachment and migration
through collagen IV in diabetes mellitus. Mol Cells
2008; 25: 452-6.
3194. SARAFIDIS PA. Thiazolidinedione derivatives in
diabetes and cardiovascular disease: ∞n update. Fundam Clin Pharmacol 2008; 22: 247-64.
3195. KOFTERIDIS DP, MANTADAKIS E, KARATZANIS AD, BOUROLIAS CA, PAPAZOGLOU
G, VELEGRAKIS GA, SAMONIS G. Non-Candida
albicans Candida mediastinitis of odontogenic origin
in a diabetic patient. Med Mycol 2008; 46: 345-8.
3196. PAPAZAFIROPOULOU A, TENTOLOURIS N,
SOLDATOS RP, LIAPIS CD, DOUNIS E,
KOSTAKIS AG, BASTOUNIS E, KATSILAMBROS N. Mortality in diabetic and nondiabetic patients after amputations performed from 1996 to 2005
in a tertiary hospital population: ∞ 3-year follow-up
study. J Diabetes Complications 2009; 23: 7-11.
3197. GINIERI-COCCOSSIS M, VASLAMATZIS G.
Dysregulation and containment in the psychoanalytic
psychotherapy of a poorly controlled diabetic patient.
J Am Acad Psychoanal Dyn Psychiatry 2008; 36: 3347.
3198. CHOLONGITAS E, PIPILI C, DASENAKI M.
Prevalence of upper and lower gastrointestinal
symptoms in Greek patients with type 2 diabetes
mellitus. J Gastrointestin Liver Dis 2008; 17: 115-6.
3199. TSAPAS A, MATTHEWS DR. N of 1 trials in diabetes: Making individual therapeutic decisions. Diabetologia 2008; 51: 921-5.
3200. DASKALAKIS G, MARINOPOULOS S, KRIELESI V, PAPAPANAGIOTOU A, PAPANTONIOU N, MESOGITIS S, ANTSAKLIS A. Placental
pathology in women with gestational diabetes. Acta
Obstet Gynecol Scand 2008; 87: 403-7.
3201. KAZAKOS KA, SARAFIDIS PA, YOVOS JG. The
impact of diabetic autonomic neuropathy on the incretin effect. Med Sci Monit 2008; 14: CR213-20.
3202. CHRISTOPOULOU-ALETRA H, PAPAVRAMIDOU N. “Diabetes” as described by Byzantine writers
from the fourth to the ninth century AD: The GraecoRoman influence. Diabetologia 2008; 51: 892-6.
3203. MOUTZOURIS DA, KASSIMATIS TI, MARGELLOS V, HADJICONSTANTINOU V. Fatal arteriovenous graft infection in a diabetic haemodialysis
patient. Emerg Med J 2008; 25: 240.
3204. PANAGIOTAKOS DB, POLYSTIPIOTI A, POLYCHRONOPOULOS E. Prevalence of type 2 diabetes and physical activity status in elderly men and
women from Cyprus (the MEDIS Study). Asia Pac J
Public Health 2007; 19: 22-8.
3205. KADOGLOU NP, ILIADIS F, ANGELOPOULOU N, PERREA D, LIAPIS CD, ALEVIZOS M.
Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus. Diabet Med 2008; 25: 333-40.
3206. VARDAKAS KZ, HORIANOPOULOU M, FALAGAS ME. Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials. Diabetes Res Clin Pract 2008; 80: 344-51.
207
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3207. MAKRIS K, SPANOU L, RAMBAOUNI-ANTONELI A, KONIARI K, DRAKOPOULOS I, RIZOS
D, HALIASSOS A. Relationship between mean
blood glucose and glycated haemoglobin in Type 2 diabetic patients. Diabet Med 2008; 25: 174-8.
3208. VAIRAKTARIS E, SPYRIDONIDOU S, GOUTZANIS L, VYLLIOTIS A, LAZARIS A, DONTA
I, PERREA D, YAPIJAKIS C, PATSOURIS E. Diabetes and oral oncogenesis. Anticancer Res 2007; 27:
4185-93.
3209. TENTOLOURIS N, ARGYRAKOPOULOU G,
KATSILAMBROS N. Perturbed autonomic nervous
system function in metabolic syndrome. Neuromolecular Med 2008; 10: 169-78.
3210. ALEXANDRAKI K.I, PIPERI C, ZIAKAS P.D,
APOSTOLOPOULOS N.V, MAKRILAKIS K, SYRIOU V, DIAMANTI-KANDARAKIS E, KALTSAS G, KALOFOUTIS A. Cytokine secretion in
long-standing diabetes mellitus type 1 and 2: ∞ssociations with low-grade systemic inflammation. J Clin
Immunol 2008; 28: 314-21.
3211. SKRAPARI I, TENTOLOURIS N, KATSILAMBROS N. Baroreflex function: Determinants in
healthy subjects and disturbances in diabetes, obesity
and metabolic syndrome. Curr Diabetes Rev 2006; 2:
329-38.
3212. ATHYROS VG, LIBEROPOULOS EN, MIKHAILIDIS DP, PAPAGEORGIOU AA, GANOTAKIS
ES, TZIOMALOS K, KAKAFIKA AI, KARAGIANNIS A, LAMBROPOULOS S, ELISAF M. Association of drinking pattern and alcohol beverage
type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, Stroke and peripheral
arterial disease in a Mediterranean cohort. Angiology
2007; 58: 689-97.
3213. TENTOLOURIS N, VOULGARI C, KATSILAMBROS N. A review of nateglinide in the management
of patients with type 2 diabetes. Vasc Health Risk
Manag 2007; 3: 797-807.
3214. TENTOLOURIS N, PAPAZAFIROPOULOU A,
MOYSSAKIS I, LIATIS S, PERREA D, KOSTAKIS
M, KATSILAMBROS N. Metabolic syndrome is not
associated with reduction in aortic distensibility in
subjects with type 2 diabetes mellitus. Cardiovasc Diabetol 2008; 7: 1 (8 pages).
3215. SARAFIDIS PA. Thiazolidinediones and diabetic
nephropathy: need for a closer examination? J Cardiometab Syndr 2007; 2: 297-301.
3216. STAFYLAS PC, SARAFIDIS PA, LASARIDIS
AN, TSAKNI E, NIAKAS DA, DOMBROS NV,
GREKAS DM, BAKRIS GL. Cost-effectiveness of
losartan in diabetic nephropathy: A Greek perspective. J Nephrol 2007; 20: 703-15.
3217. MARKETOU ME, ZACHARIS EA, KOUKOURAKI S, STATHAKI MI, ARFANAKIS DA, KOCHIADAKIS GE, CHLOUVERAKIS G, KAR-
208
KAVITSAS NS, VARDAS PE. Effect of angiotensinconverting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus. J
Hum Hypertens 2008; 22: 191-6.
3218. KADOGLOU NP, ILIADIS F, ANGELOPOULOU N, PERREA D, AMPATZIDIS G, LIAPIS
CD, ALEVIZOS M. The anti-inflammatory effects of
exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837-43.
3219. MANIOS Y, MOSCHONIS G, KOURLABA G,
BOULOUBASI Z, GRAMMATIKAKI E, SPYRIDAKI A, HATZIS C, KAFATOS A, FRAGIADAKIS GA. Prevalence and independent predictors of
insulin resistance in children from Crete, Greece: The
Children Study. Diabet Med 2008; 25: 65-72.
3220. TENTOLOURIS N, ACHTSIDIS V, MARINOU
K, KATSILAMBROS N. Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 2008; 31:
236-7.
3221. VAIRAKTARIS E, GOUTZANIS L, NKENKE E,
SPYRIDONIDOU S, VASSILIOU S, DERKA S,
VYLLIOTIS A, YAPIJAKIS C, LAZARIS A, PATSOURIS E. Expression of cell cycle regulator p16 is
not affected by diabetes during oral oncogenesis. In
Vivo 2007; 21: 745-50.
3222. ZARKOGIANNI K, MOUGIAKAKOU SG,
PROUNTZOU A, VAZEOU A, BARTSOCAS CS,
NIKITA KS. An insulin infusion advisory system for
type 1 diabetes patients based on non-linear model
predictive control methods. Conf Proc IEEE Eng
Med Biol Soc 2007; 2007: 5972-5.
3223. SKEVOFILAKAS M, MOUGIAKAKOU S.G,
ZARKOGIANNI K, ASLANOGLOU E, PAVLOPOULOS SA, VAZEOU A, BARTSOCAS CS,
NIKITA KS. A communication and information technology infrastructure for real time monitoring and
management of type 1 diabetes patients. Conf Proc
IEEE Eng Med Biol Soc 2007; 2007: 3685-8.
3224. XANTHIS A, HATZITOLIOS A, KOLIAKOS G,
TATOLA V. Advanced glycosylation end products
and nutrition—a possible relation with diabetic atherosclerosis and how to prevent it. J Food Sci 2007; 72:
R125- R9.
3225. KAKAGIA DD, KAZAKOS KJ, XARCHAS KC,
KARANIKAS M, GEORGIADIS GS, TRIPSIANNIS G, MANOLAS C. Synergistic action of proteasemodulating matrix and autologous growth factors in
healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 2007; 21: 387-91.
3226. VAZEOU A, PAPADOPOULOU A, MIHA M,
DRAKATOS A, GEORGACOPOULOS D. Cardiovascular impairment in children, adolescents, and
young adults with type 1 diabetes mellitus (T1DM).
Eur J Pediatr 2008; 167: 877-84.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3227. ZYGALAKI E, KAKLAMANIS L, NIKOLAOU
N.I, KYRZOPOULOS S, HOURI M, KYRIAKIDES Z, LIANIDOU ES, KREMASTINOS DT. Expression profile of total VEGF, VEGF splice variants
and VEGF receptors in the myocardium and arterial
vasculature of diabetic and non-diabetic patients with
coronary artery disease. Clin Biochem 2008; 41: 82-7.
3228. TSIOTRA PC, TSIGOS C, YFANTI E, ANASTASIOU E, VIKENTIOU M, PSARRA K, PAPASTERIADES C, RAPTIS SA. Visfatin, TNF-alpha and
IL-6 mRNA expression is increased in mononuclear
cells from type 2 diabetic women. Horm Metab Res
2007; 39: 758-63.
3229. KYMIONIS GD, PANAGIOTOGLOU T, TSILIMBARIS MK. The effect of intense, short-term
topical dexamethasone disodium phosphate eyedrops
on blood glucose level in diabetic patients. Ophthalmologica 2007; 221: 426-9.
3230. MOUGIAKAKOU SG, PROUNTZOU A, ILIOPOULOU D, NIKITA KS, VAZEOU A, BARTSOCAS CS. Neural network based glucose - insulin metabolism models for children with Type 1 diabetes.
Conf Proc IEEE Eng Med Biol Soc 2006; 1: 3545-8.
3231. OULIS P, KARAPOULIOS E, KOUZOUPIS AV,
MASDRAKIS VG, KONTOANGELOS KA, MAKRILAKIS K, KARAKATSANIS NA, PAPAGEORGIOU C, KATSILAMBROS N, SOLDATOS
CR. Oxcarbazepine as monotherapy of acute mania in
insufficiently controlled type-1 diabetes mellitus: a
case-report. Ann Gen Psychiatry 2007; 6: 25 (4 pages).
3232. STAFYLAS PC, SARAFIDIS PA, GREKAS DM,
LASARIDIS AN. A cost-effectiveness analysis of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy. J
Clin Hypertens (Greenwich) 2007; 9: 751-9.
3233. MAKRILAKIS K, LAVRANOS G, NIKOLAOU
A, KOLIAKI C, DOUFEXIS D, KATSILAMBROS
N. Correlation of family history of obesity and diabetes mellitus with the BMI of Greek medical students. Nutr Metab Cardiovasc Dis 2008; 18: e7-8.
3234. VARDAKAS KZ, SIEMPOS II, FALAGAS ME.
Diabetes mellitus as a risk factor for nosocomial
pneumonia and associated mortality. Diabet Med
2007; 24: 1168-71.
3235. PAVLATOU MG, MASTORAKOS G, LEKAKIS
I, LIATIS S, VAMVAKOU G, ZOUMAKIS E,
PAPASSOTIRIOU I, RABAVILAS AD, KATSILAMBROS N, CHROUSOS GP. Chronic administration of an angiotensin II receptor antagonist resets
the hypothalamic-pituitary-adrenal (HPA) axis and
improves the affect of patients with diabetes mellitus
type 2: Preliminary results. Stress 2008; 11: 62-72.
3236. VAIRAKTARIS E, KALOKERINOS G, GOUTZANIS L, YAPIJAKIS C, DERKA S, VASSILIOU
S, SPYRIDONIDOU S, VYLLIOTIS A, NKENKE
E, LAZARIS A, PATSOURIS E. Diabetes enhances
cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis. Int J Oral Maxillofac Surg
2008; 37: 60-5.
3237. PANAGIOTAKOS DB, LIONIS C, ZEIMBEKIS A,
MAKRI K, BOUNTZIOUKA V, ECONOMOU M,
VLACHOU I, MICHELI M, TSAKOUNTAKIS N,
METALLINOS G, POLYCHRONOPOULOS E.
Long-term, moderate coffee consumption is associated
with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the Mediterranean Islands
(MEDIS Study). Rev Diabet Stud 2007; 4; 105-11.
3238. PITSAVOS C, TAMPOURLOU M, PANAGIOTAKOS D.B, SKOUMAS Y, CHRYSOHOOU C,
NOMIKOS T, STEFANADIS C. Association Between Low-Grade Systemic Inflammation and Type 2
Diabetes Mellitus Among Men and Women from the
ATTICA Study. Rev Diabet Stud 2007; 4: 98-104.
3239. ZINTZARAS E, UHLIG K, KOUKOULIS GN,
PAPATHANASIOU AA, STEFANIDIS I. Methylenetetrahydrofolate reductase gene polymorphism as
a risk factor for diabetic nephropathy: A metaanalysis. J Hum Genet 2007; 52: 881-90.
3240. SAMBANIS C, TZIOMALOS K, KOUNTANA E,
KAKAVAS N, ZOGRAFOU I, BALASKA A, KOULAS G, KARAGIANNIS A, ZAMBOULIS C. Effect
of pioglitazone on heart function and N-terminal probrain natriuretic peptide levels of patients with type 2
diabetes. Acta Diabetol 2008; 45: 23-30.
3241. SFYRIDIS PG, KAPETANAKIS EI, BALTAYIANNIS NE, BOLANOS NV, ANAGNOSTOPOULOS DS, MARKOGIANNAKIS A, CHATZIMICHALIS A. Bronchial stump buttressing with an
intercostal muscle flap in diabetic patients. Ann Thorac Surg 2007; 84: 967-71.
3242. VAIRAKTARIS E, GOUTZANIS L, NKENKE E,
SPYRIDONIDOU S, VASSILIOU S, DERKA S,
VYLLIOTIS A, YAPIJAKIS C, LAZARIS A,
STRANTZIAS P, KALIMERAS E, PATSOURIS E.
Diabetes does not influence oral oncogenesis through
fibroblast growth factor receptors. In Vivo 2007; 21:
623-8.
3243. VAIRAKTARIS E, GOUTZANIS L, KALOKERINOS G, YANNOPOULOS A, YAPIJAKIS C,
VASSILIOU S, SPYRIDONIDOU S, VYLLIOTIS
A, NKENKE E, LAZARIS A.C, TESSEROMATIS
C, PATSOURIS E. Diabetes increases both N-ras
and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic
potential. In Vivo 2007; 21: 615-21.
3244. PAPAVRAMIDOU N, CHRISTOPOULOU-ALETRA H. Diabetes and the “Natural Faculties” in the
Galenic treatises. Hormones (Athens) 2007; 6: 157-9.
3245. PASTROMAS S, TERZI AB, TOUSOULIS D,
KOULOURIS S. Postprandial lipemia: An underrecognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol 2008; 126: 3-12.
209
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3246. TENTOLOURIS N, NZIETCHUENG R, CATTAN V, POITEVIN G, LACOLLEY P, PAPAZAFIROPOULOU A, PERREA D, KATSILAMBROS N,
BENETOS A. White blood cells telomere length is
shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 2007; 30: 2909-15.
3247. PAPADOPOULOS AA, KONTODIMOPOULOS
N, FRYDAS A, IKONOMAKIS E, NIAKAS D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 2007; 7:
186 (9 pages).
3248. SKLIROS E, SOTIROPOULOS A, VASIBOSSIS
A, XIPNITOS C, CHRONOPOULOS I, RAZIS N,
MERKOURIS P. Poor hypertension control in Greek
patients with diabetes in rural areas. TheVANK study
in primary care. Rural Remote Health 2007; 7: 583 (6
pages).
3249. VAIRAKTARIS E, KALOKERINOS G, GOUTZANIS L, SPYRIDONIDOU S, VASSILIOU S,
DERKA S, NKENKE E, YAPIJAKIS C, VYLLIOTIS A, LAZARIS A, PATSOURIS E. Diabetes alters
expression of p53 and c-myc in different stages of oral
oncogenesis. Anticancer Res 2007; 27: 1465-73.
3250. KADOGLOU NP, ILIADIS F, LIAPIS CD, PERREA D, ANGELOPOULOU N, ALEVIZOS M.
Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in
patients with type 2 diabetes. Diabetes Care 2007; 30:
2242-4.
3251. DEDOUSSIS GV, KALIORA AC, PANAGIOTAKOS DB. Genes, diet and type 2 diabetes mellitus: A
review. Rev Diabet Stud 2007; 4: 13-24.
3252. TSILIMBARIS MK, PANAGIOTOGLOU TD,
CHARISIS SK, ANASTASAKIS A, KRIKONIS TS,
CHRISTODOULAKIS E. The use of intravitreal
etanercept in diabetic macular oedema. Semin Ophthalmol 2007; 22: 75-9.
3253. ANTONIADES C, TOUSOULIS D, MARINOU
K, PAPAGEORGIOU N, BOSINAKOU E, TSIOUFIS C, STEFANADI E, LATSIOS G, TENTOLOURIS C, SIASOS G, STEFANADIS C. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin Cardiol 2007; 30: 295-300.
3254. SARAFIDIS PA, MCFARLANE SI, BAKRIS GL.
Antihypertensive agents, insulin sensitivity, and newonset diabetes. Curr Diab Rep 2007; 7: 191-9.
3255. KARAKITSOS D, PATRIANAKOS AP, PARTHENAKIS FI, MALLIARAKI N, NIKITOVIC D,
KYRIAZIS J, KARABINIS A, GROOTHOFF JW,
DE GROOT E, FOURTOUNAS C, DAPHNIS
E,VARDAS PE. Altered proximal aortic stiffness and
endothelin plasma levels in diabetic patients with endstage renal disease. ASAIO J 2007; 53: 343-50.
3256. PETROPOULOS IK, KOLIOPOULOS JX. Images
210
in clinical medicine. Severe proliferative diabetic
retinopathy. N Engl J Med 2007; 356: 1979.
3257. PITSAVOS C, KOURLABA G, PANAGIOTAKOS DB, STEFANADIS C. Characteristics and inhospital mortality of diabetics and nondiabetics with
an acute coronary syndrome; the GREECS study.
Clin Cardiol 2007; 30: 239-44.
3258. YANNAKOULIA M. Eating behavior among type 2
diabetic patients: A poorly recognized aspect in a
poorly controlled disease. Rev Diabet Stud 2006; 3:
11-6.
3259. PANAGIOTAKOS DB, TZIMA N, PITSAVOS C,
CHRYSOHOOU C, PAPAKONSTANTINOU E,
ZAMPELAS A, STEFANADIS C. The relationship
between dietary habits, blood glucose and insulin levels among people without cardiovascular disease and
type 2 diabetes; the ATTICA study. Rev Diabet Stud
2005; 2: 208-15.
3260. ALEXANDRIDES TK, SKROUBIS G, KALFARENTZOS F. Resolution of diabetes mellitus and
metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 2007; 17: 176-84.
3261. KOSTIDOU E, KOLIAKOS G, ALAMDARI DH,
PALETAS K, TSAPAS A, KALOYIANNI M. Enhanced laminin carbonylation by monocytes in diabetes mellitus. Clin Biochem 2007; 40: 671-9.
3262. SARAFIDIS PA, LASARIDIS AN, NILSSON PM,
PIKILIDOU MI, STAFILAS PC, KANAKI A, KAZAKOS K, YOVOS J, BAKRIS GL. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI
and McAuley’s indices in patients with hypertension
and type II diabetes. J Hum Hypertens 2007; 21: 70916.
3263. TRIANTAFYLLOU K, KALANTZIS C, PAPADOPOULOS AA, APOSTOLOPOULOS P, ROKKAS T, KALANTZIS N, LADAS SD. Video-capsule
endoscopy gastric and small bowel transit time and
completeness of the examination in patients with diabetes mellitus. Dig Liver Dis 2007; 39: 575-80.
3264. PANAGIOTAKOS DB, PITSAVOS C, ARVANITI F, STEFANADIS C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity,
among healthy adults; the accuracy of the MedDietScore. Prev Med 2007; 44: 335-40.
3265. KADOGLOU NP, PERREA D, ILIADIS F, ANGELOPOULOU N, LIAPIS C, ALEVIZOS M. Exercise reduces resistin and inflammatory cytokines in
patients with type 2 diabetes. Diabetes Care 2007; 30:
719-21.
3266. MOUGIAKAKOU S, STOITSIS J, ILIOPOULOU
D, PRENTZA A, NIKITA K, KOUTSOURIS DA.
Communication Platform for Tele-monitoring and
Tele-management of Type 1 Diabetes. Conf Proc
IEEE Eng Med Biol Soc 2005; 3: 2207-10.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3267. MOUGIAKAKOU S, PROUNTZOU K, NIKITA
K. A real time simulation model of glucose-insulin
metabolism for type 1 diabetes patients. Conf Proc
IEEE Eng Med Biol Soc 2005; 1: 298-301.
3268. GEORGOULIAS P, DEMAKOPOULOS N, ORFANAKIS A, XYDIS K, XAPLANTERIS P, VARDAS P, FEZOULIDIS I. Evaluation of abnormal
heart-rate recovery after exercise testing in patients
with diabetes mellitus: Correlation with myocardial
SPECT and chronotropic parameters. Nucl Med
Commun 2007; 28: 165-71.
3269. MITTAS E, EREVNIDOU K, KOUMANTAKIS
E, PAPAVASILEIOU S, HELIDONIS E. Gingival
condition of women with gestational diabetes on a
Greek island. Spec Care Dentist 2006; 26: 214-9.
3270. PAPPA KI, VLACHOS G, THEODORA M, ROUBELAKI M, ANGELIDOU K, ANTSAKLIS A. Intermediate metabolism in association with the amino
acid profile during the third trimester of normal pregnancy and diet-controlled gestational diabetes. Am J
Obstet Gynecol 2007; 196: 65.e1-5.
3271. ALAMDARI DH, PALETAS K, PEGIOU T, SARIGIANNI M, BEFANI C, KOLIAKOS G. A novel
assay for the evaluation of the prooxidant-antioxidant
balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem
2007; 40: 248-54.
3272. ANASTASIADIS K, MOSCHOS G. Diabetes mellitus and coronary revascularization procedures. Int J
Cardiol 2007; 119: 10-4.
3273. KALOFOUTIS C, PIPERI C, ZISAKI A, SINGH J,
HARRIS F, PHOENIX D, ALAVERAS A, KALOFOUTIS A. Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients
of different age. Ann N Y Acad Sci 2006; 1084: 16677.
3274. ALEXANDRAKI K, PIPERI C, KALOFOUTIS C,
SINGH J, ALAVERAS A, KALOFOUTIS A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci 2006; 1084: 89-117.
3275. PSALLAS M, TENTOLOURIS N, COKKINOS A,
PAPADOGIANNIS D, COKKINOS DV, KATSILAMBROS N. QT dispersion: Comparison between
diabetic and non-diabetic individuals and correlation
with cardiac autonomic neuropathy. Hellenic J Cardiol 2006; 47: 255-62.
3276. GIKAS A, SOTIROPOULOS A, POLITAKIS P,
SPANOU E, APOSTOLOU O, PAPPAS S. Level of
glycaemic and lipid control among diabetic patients in
Greek primary care. Eur J Gen Pract 2006; 12: 181-2.
3277. SYMEONIDES P, KOULOURIS S, VRATSISTA
E, TRIANTAFYLLOU K, IOANNIDIS G, THALASSINOS N, KATRITSIS D. Both ramipril and
telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study. Eur J Echocardiogr
2007; 8: 480-6.
3278. THEODOROPOULOU E, CHELIOTI E, REVENAS K, KATSILAMBROS N, KOSTAKIS A,
BOLETIS JN. Diabetic muscle infarction after kidney
and pancreas transplantation: case report and literature review. Transplant Proc 2006; 38: 3147-50.
3279. TENTOLOURIS N, STYLIANOU A, LOURIDA
E, PERREA D, KYRIAKI D, PAPAVASILIOU EC,
TSELEPIS AD, KATSILAMBROS N. High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria. J Lipid Res 2007; 48:
218-25.
3280. DOUNIS V, SIEGMUND T, HANSEN A, JENSEN J, SCHUMM-DRAEGER PM, VON BIBRA
H. Global myocardial perfusion and diastolic function
are impaired to a similar extent in patients with type 2
diabetes mellitus and in patients with coronary artery
disease-evaluation by contrast echocardiography and
pulsed tissue Doppler. Diabetologia 2006; 49: 272940.
3281. LITOU H, ANASTASIOU E, THALASSINOU L,
SARIKA HL, PHILIPPOU G, ALEVIZAKI M. Increased prevalence of VNTR III of the insulin gene in
women with gestational diabetes mellitus (GDM). Diabetes Res Clin Pract 2007; 76: 223-8.
3282. ANTONOPOULOU S, FRAGOPOULOU E, KARANTONIS H.C, MITSOU E, SITARA M, REMENTZIS J, MOURELATOS A, GINIS A, PHENEKOS C. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. J
Med Food 2006; 9: 356-62.
3283. PSYROGIANNIS A, KYRIAZOPOULOU V, SYMEONIDIS A, LEOTSINIDIS M, VAGENAKIS
AG. Relative iron “overload” in offspring of patients
with type 2 diabetes mellitus: a new component in the
conundrum of insulin resistance syndrome? Hormones (Athens) 2003; 2: 161-8.
3284. HABEOS IG, PSYROGIANNIS A, KYRIAZOPOULOU V, PSILOPANAGIOTOU A, PAPAVASSILIOU AG, VAGENAKIS AG. The role of Hemochromatosis C282Y and H63D mutations in the development of type 2 diabetes mellitus in Greece. Hormones (Athens) 2003; 2: 55-60.
3285. MAKRILAKIS K, KATSILAMBROS N. Prediction
and prevention of type 2 diabetes. Hormones
(Athens) 2003; 2: 22-34.
3286. IOANNIDIS G, PEPPA M, RONTOGIANNI P,
CALLIFRONAS M, PAPADIMITRIOU C, CHRYSANTHOPOULOU G, ANTHOPOULOS L, KESSE M, THALASSINOS N. The concurrence of microalbuminuria and retinopathy with cardiovascular
risk factors. Reliable predictors of asymptomatic
coronary artery disease in type 2 diabetes. Hormones
(Athens) 2004; 3: 198-203.
3287. KOTSOVILIS S, KAROUSSIS IK, FOURMOUSIS
I. A comprehensive and critical review of dental im-
211
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
plant placement in diabetic animals and patients. Clin
Oral Implants Res 2006; 17: 587-99.
3288. MOUTZOURIS DA, MICHALAKIS K, MANETAS S. Severe emphysematous pyelonephritis in diabetic patient. Lancet Infect Dis 2006; 6: 614.
3289. VOULGARI CH, TENTOLOURIS N, MOYSSAKIS I, DILAVERIS P, GIALAFOS E, PAPADOGIANNIS D, VOTTEAS V, COKKINOS DV, STEFANADIS CH, KATSILAMBROS N. Spatial QRST angle: association with diabetes and left ventricular
performance. Eur J Clin Invest 2006; 36: 608-13.
3290. SAKELLARIDIS N. The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surg
Neurol 2006; 66: 152-4.
3291. GOUTZANIS L, VAIRAKTARIS E, YAPIJAKIS
C, KAVANTZAS N, NKENKE E, DERKA S,
VASSILIOU S, ACIL Y, KESSLER P, STAVRIANEAS N, PERREA D, DONTA I, SKANDALAKIS
P, PATSOURIS E. Diabetes may increase risk for
oral cancer through the insulin receptor substrate-1
and focal adhesion kinase pathway. Oral Oncol 2007;
43: 165-73.
3292. KARAKITSOS D, DE GROOT E, PATRIANAKOS AP, PARTHENAKIS F, BOLETIS J, KARABINIS A, KYRIAZIS J, VARDAS P, DAPHNIS E.
Adiponectin and cardiovascular remodeling in endstage renal disease and comorbid diabetes mellitus.
Am J Nephrol 2006; 26: 340-7.
3293. DOURAKIS SP, ALEXOPOULOU A, METALLINOS G, THANOS L, ARCHIMANDRITIS AJ. Pubic osteomyelitis due to Klebsiella pneumoniae in a
patient with diabetes mellitus. Am J Med Sci 2006;
331: 322-4.
3294. KALANTZIS G, ANGELOU M, POULAKOUREBEAKOU E. Diabetic retinopathy: An historical
assessment. Hormones (Athens) 2006; 5: 72-5.
3295. EKMEKTZOGLOU KA, ZOGRAFOS GC. A concomitant review of the effects of diabetes mellitus and
hypothyroidism in wound healing. World J Gastroenterol 2006; 12: 2721-9.
3296. TRICHOPOULOU A, PSALTOPOULOU T, ORFANOS P, TRICHOPOULOS D. Diet and physical
activity in relation to overall mortality amongst adult
diabetics in a general population cohort. J Intern Med
2006; 259: 583-91.
3297. EFSTRATIADIS G, TSIAOUSIS G, ATHYROS
VG, KARAGIANNI D, PAVLITOU-TSIONTSI A,
GIANNAKOU-DARDA A, MANES C. Total serum
insulin-like growth factor-1 and C-reactive protein in
metabolic syndrome with or without diabetes. Angiology 2006; 57: 303-11.
3298. PAPATHEODORIDIS GV, CHRYSANTHOS N,
SAVVAS S, SEVASTIANOS V, KAFIRI G, PETRAKI K, MANESIS E.K. Diabetes mellitus in
chronic hepatitis B and C: Prevalence and potential
212
association with the extent of liver fibrosis. J Viral
Hepat 2006; 13: 303-10.
3299. SOTIROPOULOS A, SKLIROS EA, TOUNTAS
C, APOSTOLOU U, PEPPAS TA, PAPPAS SI. Risk
factors for severe hypoglycaemia in type 2 diabetic patients admitted to hospital in Piraeus, Greece. East
Mediterr Health J 2005; 11: 485-9.
3300. MELIDONIS AM, TOURNIS SM, KOMPOTI
MK, LENTZAS IL, ROUSSOU VR, IRAKLIANOU
SL, MICHAIL IM, MARIOLIS AM. Increased
prevalence of diabetes mellitus in a rural Greek population. Rural Remote Health 2006: 6: 534 (8 pages).
3301. PAPAIOANNOU A, PAPANTONAKI S, NYKTARI V, PSOMOPOULOS H, KARATSIS P, FRAIDAKIS O, ASKITOPOULOU H. Hypomagnesaemia
associated with diabetes mellitus may cause laryngospasm. Acta Anaesthesiol Scand 2006; 50: 512-3.
3302. PSALLAS M, TENTOLOURIS N, PAPADOGIANNIS D, DOULGERAKIS D, KOKKINOS A,
COKKINOS DV, KATSILAMBROS N. QT dispersion: Comparison between participants with Type 1
and 2 diabetes and association with microalbuminuria
in diabetes. J Diabetes Complications 2006; 20: 88-97.
3303. PERIMENIS P, KONSTANTINOPOULOS A,
PERIMENI PP, GYFTOPOULOS K, KARTSANIS
G, LIATSIKOS E, ATHANASOPOULOS A. Longterm treatment with intracavernosal injections in diabetic men with erectile dysfunction. Asian J Androl
2006; 8: 219-24.
3304. MYLONA-KARAYANNI C, GOURGIOTIS D,
BOSSIOS A, KAMPER EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: A possible link. Pediatr Diabetes 2006; 7: 51-9.
3305. KATTAMIS C, LADIS V, TSOUSSIS D, KALOUMENOU I, THEODORIDIS C. Evolution of glucose
intolerance and diabetes in transfused patients with
thalassemia. Pediatr Endocrinol Rev 2004; 2 (Suppl
2): 267-71.
3306. LYGNOS MC, PAPPA KI, PAPADAKI HA, RELAKIS C, KOUMANTAKIS E, ANAGNOU NP,
ELIOPOULOS GD. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 2006; 20: 157-63.
3307. TZIAKAS DN, CHALIKIAS GK, KASKI JC. Epidemiology of the diabetic heart. Coron Artery Dis
2005; 16 (Suppl 1): S3-S10.
3308. KYRIAKIDES ZS, KREMASTINOS DT, RAPTIS
AE, JOHNSTON N, RAPTIS SA, WEBB DJ,
KYRZOPOULOS S, SBAROUNI E. Impaired effect
of endothelin-1 on coronary artery stiffness in type 2
diabetes. Int J Cardiol 2006; 112: 207-12.
3309. RAPIDI CA, KARANDREAS N, KATSIFOTIS C,
BENROUBI M, PETROPOULOU K, THEODOROU C. A combined urodynamic and electrophysio-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
logical study of diabetic cystopathy. Neurourol Urodyn 2006; 25: 32-8.
3310. PANAGIOTAKOS DB, PITSAVOS C, CHRYSOHOOU C, STEFANADIS C. The epidemiology of
Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005; 22: 1581-8.
3311. KARANTONIS HC, FRAGOPOULOU E, ANTONOPOULOU S, REMENTZIS J, PHENEKOS C,
DEMOPOULOS CA. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects platelet aggregation. Diabetes Res Clin
Pract 2006; 72: 33-41.
3312. TRYFONOPOULOS D, ANASTASIOU E, PROTOGEROU A, PAPAIOANNOU T, LILY K,
DAGRE A, SOUVATZOGLOU E, PAPAMICHAEL C, ALEVIZAKI M, LEKAKIS J. Arterial
stiffness in type 1 diabetes mellitus is aggravated by
autoimmune thyroid disease. J Endocrinol Invest
2005; 28: 616-22.
3313. PAPAKONSTANTINOU E, PANAGIOTAKOS
DB, PITSAVOS C, CHRYSOHOOU C, ZAMPELAS A, SKOUMAS Y, STEFANADIS C. Food
group consumption and glycemic control in people
with and without type 2 diabetes: The ATTICA study.
Diabetes Care 2005; 28: 2539-40.
3314. KOTOULA MG, KOUKOULIS GN, ZINTZARAS E, KARABATSAS CH, CHATZOULIS DZ.
Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal
photocoagulation. Diabetes Care 2005; 28: 2454-7.
3315. TOUTOUZAS K, MARKOU V, DRAKOPOULOU M, MITROPOULOS I, TSIAMIS E,
STEFANADIS C. Patients with type two diabetes
mellitus: Increased local inflammatory activation in
culprit atheromatous plaques. Hellenic J Cardiol
2005; 46: 283-8.
3316. LIAKOPOULOS V, WURTH P, MERTENS PR,
ELEFTHERIADIS T, KOURTI P, VOLIOTIS G,
HEINTZ B, KOUKOULIS GN, STEFANIDIS I. Endothelin-1 plasma levels in hemodialysis treatment—
the influence of type 2 diabetes. Ren Fail 2005; 27:
515-22.
3317. SYMEONIDIS A, KOURAKLIS-SYMEONIDIS
A, PSIROYIANNIS A, LEOTSINIDIS M, KYRIAZOPOULOU V, VASSILAKOS P, VAGENAKIS A,
ZOUMBOS N. Inappropriately low erythropoietin
response for the degree of anemia in patients with
noninsulin-dependent diabetes mellitus. Ann Hematol 2006; 85: 79-85.
3318. TOUTOUZAS K, MARKOU V, DRAKOPOULOU M, MITROPOULOS I, TSIAMIS E, VAVURANAKIS M, VAINA S, STEFANADIS C. Increased heat generation from atherosclerotic plaques
in patients with type 2 diabetes: An increased local inflammatory activation. Diabetes Care 2005; 28: 165661.
3319. HYPHANTIS T, KALTSOUDA A, TRIANTAFILLIDIS J, PLATIS O, KARADAGI S, CHRISTOU K,
MANTAS C, ARGYROPOULOS A, MAVREAS V.
Personality correlates of adherence to type 2 diabetes
regimens. Int J Psychiatry Med 2005; 35: 103-7.
3320. KAVVOURA FK, IOANNIDIS JP. CTLA-4 gene
polymorphisms and susceptibility to type 1 diabetes
mellitus: A HuGE Review and meta-analysis. Am J
Epidemiol 2005; 162: 3-16.
3321. IOACHIM E, STEFANIOTOU M, GOREZIS S,
TSANOU E, PSILAS K, AGNANTIS NJ. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative
retinopathy and proliferative diabetic retinopathy.
Eur J Ophthalmol 2005;15: 384-91.
3322. ANTONOPOULOS A, VIJAY ANAND D, LAHIRI A. Diabetes mellitus: Evaluation of patients with
known or suspected coronary artery disease and the
role played by myocardial perfusion imaging. Nucl
Med Commun 2005; 26: 587-91.
3323. TSIAVOU A, HATZIAGELAKI E, CHAIDAROGLOU A, KONIAVITOU K, DEGIANNIS D,
RAPTIS SA. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+
and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus
and latent autoimmune diabetes of adults (LADA).
Cytokine 2005; 31: 135-41.
3324. TENTOLOURIS N, MATSAGURA M, PSALLAS
M, CHATZIZACHARIAS A, FOTIA M, ARVANITIS M, KATSILAMBROS N. Relationship between
antidiabetic treatment with QT dispersion during
acute coronary syndromes in type 2 diabetes: Comparison between patients receiving sulfonylureas and
insulin. Exp Clin Endocrinol Diabetes 2005; 113: 298301.
3325. LEGAKIS IN. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Drug News
Perspect 2005; 18: 173-7.
3326. KOULOURIS S, SYMEONIDES P, TRIANTAFYLLOU K, IOANNIDIS G, KARABINOS I,
KATOSTARAS T, EL-ALI M, THEODORIDIS T,
VRATSISTA E, THALASSINOS N, KOKKINOU
V, NANAS I, STAMATELOPOULOS S, TOUTOUZAS P. Comparison of the effects of ramipril versus
telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density
lipoprotein cholesterol in patients with type 2 diabetes
mellitus. Am J Cardiol 2005; 95: 1386-8.
3327. ZINTZARAS E, CHATZOULIS D.Z, KARABATSAS C.H, STEFANIDIS I. The relationship between C677T methylenetetrahydrofolate reductase
gene polymorphism and retinopathy in type 2 diabetes: A meta-analysis. J Hum Genet 2005; 50: 26775.
3328. STAKOS DA, SCHUSTER DP, SPARKS EA,
213
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
WOOLEY CF, OSEI K, BOUDOULAS H. Cardiovascular effects of type 1 diabetes mellitus in children.
Angiology 2005; 56: 311-7.
3329. BEIS C, GRIGORAKIS SI, PHILIPPOU G, ALEVIZAKI M, ANASTASIOU E. Lack of suppression
of plasma glucagon levels in late pregnancy persists
postpartum only in women with previous gestational
diabetes mellitus. Acta Diabetol 2005; 42: 31-5.
3330. LIOUPIS C. The role of distal arterial reconstruction in patients with diabetic foot ischemia. Int J Low
Extrem Wounds 2005; 4: 45-9.
3331. TSAMPARLI A, KOUNENOU K. The Greek family system when a child has diabetes mellitus type 1.
Acta Paediatr 2004; 93: 1646-53.
3332. PAPPA KI, ANAGNOU NP, SALAMALEKIS E,
BIKOUVARAKIS S, MAROPOULOS G, ANOGIANAKI N, EVANGELIOU A, KOUMANTAKIS
E. Gestational diabetes exhibits lack of carnitine deficiency despite relatively low carnitine levels and alterations in ketogenesis. J Matern Fetal Neonatal Med
2005; 17: 63-8.
3333. KADOGLOU NP, DASKALOPOULOU SS, PERREA D, LIAPIS CD. Matrix metalloproteinases and
diabetic vascular complications. Angiology 2005; 56:
173-89.
3334. VAN DIJK PC, JAGER KJ, STENGEL B, GRÖNHAGEN-RISKA C, FEEST TG, BRIGGS JD. Renal replacement therapy for diabetic end-stage renal
disease: Data from 10 registries in Europe (19912000). Kidney Int 2005; 67: 1489-99.
3335. LIOUPIS C. Effects of diabetes mellitus on wound
healing: an update. J Wound Care 2005; 14: 84-6.
3336. STAMBOULIS E, VASSILOPOULOS D, KALFAKIS N. Symptomatic focal mononeuropathies in diabetic patients: Increased or not? J Neurol 2005; 252:
448-52.
3337. PANARITIS V, KYRIAKIDIS A.V, PYRGIOTI
M, RAFFO L, NAGNOSTOPOULOU E, GOURNIEZAKI G, KOUKOU E. Pulsatility index of temporal and renal arteries as an early finding of arteriopathy in diabetic patients. Ann Vasc Surg 2005; 19:
80-3.
3338. ZINTZARAS E, STEFANIDIS I. Association between the GLUT1 gene polymorphism and the risk of
diabetic nephropathy: A meta-analysis. J Hum Genet
2005; 50: 84-91.
3339. SFIKAKIS PP, MARKOMICHELAKIS N, THEODOSSIADIS GP, GRIGOROPOULOS V, KATSILAMBROS N, THEODOSSIADIS PG. Regression
of sight-threatening macular edema in type 2 diabetes
following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care
2005; 28: 445-7.
3340. BOULBOU MS, KOUKOULIS GN, MAKRI ED,
PETINAKI EA, GOURGOULIANIS KI, GERME-
214
NIS AE. Circulating adhesion molecules levels in type
2 diabetes mellitus and hypertension. Int J Cardiol
2005; 98: 39-44.
3341. BOULBOU MS, KOUKOULIS GN, PETINAKI
EA, GERMENIS A, GOURGOULIANIS KI. Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients. Acta Diabetol 2004; 41: 118-22.
3342. MOSCHOVI M, TRIMIS G, ANASTASOPOULOS J, KANARIOU M, RAFTOPOULOU A,
TZORTZATOU-STATHOPOULOU F. Subacute
vertebral osteomyelitis in a child with diabetes mellitus associated with Fusarium. Pediatr Int 2004; 46:
740-2.
3343. GEORGOPOULOS S, FILIS K, VOURLIOTAKIS
G, BAKOYANNIS C, PAPAPETROU A, KLONARIS C, PAPALAMBROS E, BASTOUNIS E. Lower
extremity Boltshauser bypass procedures in diabetic
patients with end-stage renal disease: Is it worthwhile? Nephron Clin Pract 2005; 99: c37- c41.
3344. TSIAVOU A, HATZIAGELAKI E, CHAIDAROGLOU A, MANGINAS A, KONIAVITOU K, DEGIANNIS D, RAPTIS SA. TNF-alpha, TGF-beta1,
IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes
mellitus. J Clin Immunol 2004; 24: 591-9.
3345. SOTIROPOULOS A, MERKOURIS P, GIKAS A,
SKOURTIS S, SKLIROS E, LANARAS L, NIKOLAOU T, PAPPAS S. Influenza and pneumococcal
vaccination rates among Greek diabetic patients in
primary care. Diabet Med 2005; 22: 110-1.
3346. TSAKIRIS D, IOANNOU K. An underdiagnosed
type of diabetes: the MODY syndromes. Pathophysiology, clinical presentation and renal disease progression. J Nephrol 2004; 17: 637-41.
3347. KAVVOURA FK, IOANNIDIS JP. Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: A meta-analysis. Hum Genet 2005; 116:
192-9.
3348. GIKAS A, SOTIROPOULOS A. Underuse of aspirin therapy among patients with type 2 diabetes mellitus attending primary care in Greece. Eur J Gen
Pract 2004; 10: 108.
3349. VOUDRIS VA, SKOULARIGIS JS, DIMITRIOU
YK, GRAPSA GN, MALAKOS JS, PAVLIDES GS,
MANGINAS AN, COKKINOS DV. Diabetes mellitus and unstable coronary artery disease: Improved
clinical outcome of coronary artery stenting in an era
of glycoprotein IIb/IIIa inhibitors and lipid-lowering
therapy. Coron Artery Dis 2004; 15: 353-9.
3350. MAMOULAKIS D, GALANAKIS E, DIONYSSOPOULOU E, EVANGELIOU A, SBYRAKIS S. Carnitine deficiency in children and adolescents with type
1 diabetes. J Diabetes Complications 2004; 18: 271-4.
3351. TSIAVOU A, DEGIANNIS D, HATZIAGELAKI
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
E, KONIAVITOU K, RAPTIS SA. Intracellular IFNgamma production and IL-12 serum levels in latent
autoimmune diabetes of adults (LADA) and in type 2
diabetes. J Interferon Cytokine Res 2004; 24; 381-7.
3352. ASSIMAKOPOULOS E, ATHANASIADIS A,
ZAFRAKAS M, DRAGOUMIS K, BONTIS J. Caudal regression syndrome and sirenomelia in only one
twin in two diabetic pregnancies. Clin Exp Obstet
Gynecol 2004; 31: 151-3.
3353. TOKMAKIDIS SP, ZOIS CE, VOLAKLIS KA,
KOTSA K, TOUVRA AM. The effects of a combined
strength and aerobic exercise program on glucose
control and insulin action in women with type 2 diabetes. Eur J Appl Physiol 2004; 92: 437-42.
3354. BONOVAS S, FILIOUSSI K, TSANTES A. Diabetes mellitus and risk of prostate cancer: A metaanalysis. Diabetologia 2004; 47: 1071-8.
3355. MALTEZOS E, PAPAZOGLOU D, EXIARA T,
KAMBOUROMITI G, ANTONOGLOU C. Serum
magnesium levels in non-diabetic offspring of patients
with Type 2 diabetes mellitus. Diabetes Nutr Metab
2004; 17: 12-6.
3356. BOULBOU MS, KOUKOULIS GN, VASIOU KG,
PETINAKI EA, GOURGOULIANIS KI, FEZOULIDIS IB. Increased soluble E-selectin levels in type 2
diabetic patients with peripheral arterial disease. Int
Angiol 2004; 23: 18-24.
3357. BONOVAS S, PEPONIS V, FILIOUSSI K. Diabetes mellitus as a risk factor for primary open-angle
glaucoma: A meta-analysis. Diabet Med 2004; 21:
609-14.
3358. ANTONIADES C, TOUSOULIS D, TOUNTAS C,
TENTOLOURIS C, TOUTOUZA M, VASILIADOU C, TSIOUFIS C, TOUTOUZAS P, STEFANADIS C. Vascular endothelium and inflammatory
process, in patients with combined Type 2 diabetes
mellitus and coronary atherosclerosis: The effects of
vitamin C. Diabet Med 2004; 21: 552-8.
3359. STEFANIOTOU M, ASPIOTIS M, KALOGEROPOULOS C, CHRISTODOULOU A, PSYLLA M,
IOACHIM E, ALAMANOS I, PSILAS K. Vitrectomy results for diffuse diabetic macular edema with
and without inner limiting membrane removal. Eur J
Ophthalmol 2004; 14: 137-43.
3360. PEPONIS V, BONOVAS S, KAPRANOU A, PEPONI E, FILIOUSSI K, MAGKOU C, SITARAS
NM. Conjunctival and tear film changes after vitamin
C and E administration in non-insulin dependent diabetes mellitus. Med Sci Monit 2004; 10: CR213- CR7.
3361. ANDROULAKIS AE, ANDRIKOPOULOS GK,
KARTALIS AN, STOUGIANNOS PN, KATSAROS
AA, SYROGIANNIDIS DN, TAPANLIS EN, STEFANADIS C, KALLIKAZAROS IE. Relation of
coronary artery ectasia to diabetes mellitus. Am J
Cardiol 2004; 93: 1165-7.
3362. PASCHOU P, BOZAS E, DOKOPOULOU M,
HAVARANI B, MALAMITSI-PUCHNER A, YLLI
A, YLLI Z, THYMELLI I, GERASIMIDI-VAZEOU A, BARTSOCAS CS. HLA alleles and type 1
diabetes mellitus in low disease incidence populations
of Southern Europe: A comparison of Greeks and Albanians. J Pediatr Endocrinol Metab 2004; 17: 173-82.
3363. KARAGIANNI C, STABOULI S, ROUMELIOTOU K, TRAEGER-SYNODINOS J, KAVAZARAKIS E, GOURGIOTIS D, LAMBROU J, KANAVAKIS E. Severe hypertriglyceridaemia in diabetic
ketoacidosis: Clinical and genetic study. Diabet Med
2004; 21: 380-2.
3364. ZAIRIS MN, LYRAS AG, MAKRYGIANNIS SS,
PSAROGIANNI PK, ADAMOPOULOU EN, HANDANIS SM, PAPANTONAKOS A, ARGYRAKIS
SK, PREKATES AA, FOUSSAS SG. Type 2 diabetes
and intravenous thrombolysis outcome in the setting
of ST elevation myocardial infarction. Diabetes Care
2004; 27: 967-71.
3365. GIKAS A, SOTIROPOULOS A, PANAGIOTAKOS D, PEPPAS T, SKLIROS E, PAPPAS S. Prevalence, and associated risk factors, of self-reported diabetes mellitus in a sample of adult urban population
in Greece: MEDICAL Exit Poll Research in Salamis
(MEDICAL EXPRESS 2002). BMC Public Health
2004; 4: 2 (9 pages).
3366. ILIAS I, TSELEBIS A, THEOTOKA I, HATZIMICHELAKIS E. Association of perceived family support through glycemic control in native Greek patients managing diabetes with diet alone. Ethn Dis
2004; 14: 2.
3367. DAMILAKIS J, GALANAKIS E, MAMOULAKIS
D, SBYRAKIS S, GOURTSOYIANNIS N. Quantitative ultrasound measurements in children and adolescents with: Type 1 diabetes. Calcif Tissue Int 2004;
74: 424-8.
3368. VAZEOU A, PAPADOPOULOU A, PAPADIMITRIOU A, KITSOU E, STATHATOS M, BARTSOCAS CS. Autonomic neuropathy and gastrointestinal
motility disorders in children and adolescents with
type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr
2004; 38: 61-5.
3369. TENTOLOURIS N, LIATIS S, MOYSSAKIS I,
TSAPOGAS P, PSALLAS M, DIAKOUMOPOULOU E, VOTEAS V, KATSILAMBROS N. Aortic
distensibility is reduced in subjects with type 2 diabetes and cardiac autonomic neuropathy. Eur J Clin
Invest 2003; 33: 1075-83.
3370. MIGDALIS IN. Cytokines and diabetes mellitus: A
review. Res Commun Mol Pathol Pharmacol 2002;
111: 115-38.
3371. PSYROGIANNIS A, HABEOS I, KYRIAZOPOULOU V. Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic
parents. Lipids Health Dis 2003; 2: 8 (6 pages).
215
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3372. KALATZIS I, PAPPAS D, PILIOURAS N, CAVOURAS D. Support vector machines based analysis
of brain SPECT images for determining cerebral abnormalities in symptomatic diabetic patients. Med Inform Internet Med 2003; 28: 221-30.
3373. ATHYROS VG, PAPAGEORGIOU AA, ELISAF
M, MIKHAILIDIS DP, GREACE STUDY COLLABORATIVE GROUP. Statins and renal function in
patients with diabetes mellitus. Curr Med Res Opin
2003; 19: 615-7.
3374. PANUTSOPULOS D, ZAFIROPOULOS A,
KRAMBOVITIS E, KOCHIADAKIS GE, IGOUMENIDIS NE, SPANDIDOS DA. Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression. J Transl Med 2003; 1: 6 (11 pages).
3375. TENTOLOURIS N, KOLIA M, TSELEPIS AD,
PEREA D, KITSOU E, KYRIAKI D, TAMBAKI
AP, KARABINA SP, SALA C, FRAGOULOPOULOS E, KATSILAMBROS N. Lack of effect of acute
repaglinide administration on postprandial lipaemia
in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2003; 111: 370-3.
3376. BOULBOU MS, GOURGOULIANIS KI, PETINAKI EA, KLISIARIS VK, MANIATIS AN, MOLYVDAS PA. Pulmonary function and circulating
adhesion molecules in patients with diabetes mellitus.
Can Respir J 2003; 10; 259-64.
3377. LASARIDIS AN, SARAFIDIS PA. Diabetic
nephropathy and antihypertensive treatment: What
are the lessons from clinical trials? Am J Hypertens
2003; 16: 689-97.
3378. KOFTERIDIS DP, KARABEKIOS S, PANAGIOTIDES JG, BIZAKIS J, KYRMIZAKIS D, SARIDAKI Z, GIKAS A. Successful treatment of
rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction. J Chemother 2003; 15: 282-6.
3379. MAMOULAKIS D, GALANAKIS E, BICOUVARAKIS S, PARASKAKIS E, SBYRAKIS S. Epidemiology of childhood type I diabetes in Crete, 19902001. Acta Paediatr 2003; 92: 737-9.
3380. KONIDARIS C, MITLIANGA PG, PAPADOPOULOS GK. No specific reactivity to E. coli glutamic acid decarboxylase from sera of newly-diagnosed insulin dependent diabetic patients. Int J Immunopathol Pharmacol 2003; 16: 129-38.
3381. FILIOUSSI K, BONOVAS S, KATSAROS T.
Should we screen diabetic patients using biguanides
for megaloblastic anaemia? Aust Fam Physician 2003;
32: 383-4.
3382. LADAS ID. Use of digitized fluorescein angiogram
system to guide laser treatment of diabetic macular
edema: A new technique. Ophthalmologica 2003; 217:
194-8.
216
3383. BOULBOU MS, GOURGOULIANIS KI, KLISIARIS VK, TSIKRIKAS TS, STATHAKIS NE, MOLYVDAS PA. Diabetes mellitus and lung function.
Med Princ Pract 2003; 12: 87-91.
3384. KARAVANAKI K, BAUM JD. Coexistence of impaired indices of autonomic neuropathy and diabetic
nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003; 16:
79-90.
3385. GOGOU G, MAVROMATIS A, MAGLAVERAS
N, ENGELBRECHT R, PAPPAS C. DIABCARD
CCMIS - a portable and scalable CPR for Diabetes
Care. IEEE Trans Biomed Eng 2002; 49: 1412-9.
3386. PAPAIOANNIDES D, AKRITIDIS N. Photo quiz.
Skin rash in a patient with diabetes. Am Fam Physician 2003; 67: 139-40.
3387. VITORATOS N, CHRYSTODOULACOS G, SALAMALEKIS E, KASSANOS D, KOUSKOUNI E,
CREATSAS G. Fetoplacental leptin levels and their
relation to birth weight and insulin in gestational diabetic pregnant women. J Obstet Gynaecol 2002; 22:
29-33.
3388. DIAMANTOPOULOS EJ, ANDREADIS EA, KAKOU MG, VASSILOPOULOS CV, VLACHONIKOLIS IG, GIANNA-KOPOULOS NA, TARASSI
KE, PAPASTERIADES CA, NICOLAIDES AN.
Association of the HLA antigens with early atheromatosis in subjects with type 2 diabetes mellitus. Int
Angiol 2002; 21: 379-83.
3389. PHARMAKAKIS NM, PETROPOULOS IK,
PERISTEROPOULOS PA, VANTZOU CV, KOLIOPOULOS JX. Evaluating the management of diabetic retinopathy in a teaching center. Eur J Ophthalmol 2002; 12: 488-94.
3390. BOULBOU MS, GOURGOULIANIS KI, KROMMYDAS GC, KLISIARIS VK, ARSENIOU AA,
DAFOPOULOS KC, MOLYVDAS PA. Diabetes
mellitus vs. Raynaud disease: Different lung vascular
bed disorders. Arch Med Res 2002; 33: 531-5.
3391. MILIONIS HJ, DIMOS G, ELISAF MS. Severe hyperkalaemia in association with diabetic ketoacidosis
in a patient presenting with severe generalized muscle
weakness. Nephrol Dial Transplant 2003; 18: 198-200.
3392. OIKONOMAKOS NG. Glycogen phosphorylase as
a molecular target for type 2 diabetes therapy. Curr
Protein Pept Sci 2002; 3: 561-86.
3393. EFSTATHIOU SP, TSIAKOU AG, TSIOULOS
DI, ZACHAROS ID, MITROMARAS AG, MASTORANTONAKIS SE, PANAGIOTOU TN,
MOUNTOKALAKIS TD. A mortality prediction
model in diabetic ketoacidosis. Clin Endocrinol (Oxf)
2002; 57: 595-601.
3394. DIONYSSIOU-ASTERIOU A, PAPASTAMATIOU M, VATALAS IA, BASTOUNIS E. Serum
apolipoprotein AI levels in atherosclerotic and dia-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
betic patients. Eur J Vasc Endovasc Surg 2002; 24:
161-5.
3395. ANASTASIOS R, GORITSAS C, PAPAMIHAIL
C, TRIGIDOU R, GARZONIS P, FERTI A. Helicobacter pylori infection in diabetic patients: Prevalence and endoscopic findings. Eur J Intern Med
2002; 13: 376.
3396. MOUSTAKAS AK, PAPADOPOULOS GK. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: Keys to the fate of islet beta-cells. Am
J Med Genet 2002; 115: 37-47.
3397. MITRAKOU A. Pathogenesis of hyperglycaemia in
type 2 diabetes. Diabetes Obes Metab 2002; 4: 249-54.
3398. PERIMENIS P, MARKOU S, GYFTOPOULOS K,
ATHANASOPOULOS A, GIANNITSAS K, BARBALIAS G. Switching from long-term treatment with
self-injections to oral sildenafil in diabetic patients
with severe erectile dysfunction. Eur Urol 2002; 41:
387-91.
3399. KALOGEROPOULOU K, MORTZOS G, MIGDALIS I, VELENTZAS C, MIKHAILIDIS DP,
GEORGIADIS E, CORDOPATIS P. Carotid atherosclerosis in type 2 diabetes mellitus: Potential role of
endothelin-1, lipoperoxides, and prostacyclin. Angiology 2002; 53: 279-85.
3400. TSAMASIROS J, BARTSOCAS CS. Transition of
the adolescent from the children’s to the adults’ diabetes clinic. J Pediatr Endocrinol Metab 2002; 15:
363-7.
3401. TAVANI A, GALLUS S, BOSETTI C, TZONOU
A, LAGIOU P, NEGRI E, TRICHOPOULOS D, LA
VECCHIA C. Diabetes and the risk of prostate cancer. Eur J Cancer Prev 2002; 11: 125-8.
3402. KARAVANAKI-KARANASSIOU K. Autonomic
neuropathy in children and adolescents with diabetes
mellitus. J Pediatr Endocrinol Metab 2001; 14 (Suppl
5): 1379-86.
3403. KOULOURIDIS E. Diabetic nephropathy in children and adolescents and its consequences in adults. J
Pediatr Endocrinol Metab 2001; 14 (Suppl 5): 136777.
3404. DIAMANTOPOULOS EJ, ANDREADIS E, KAKOU M, VLACHONIKOLIS I, VASSILOPOULOS
C, GIANNAKOPOULOS N, TARASSI K, PAPASTERIADES C, NICOLAIDES A, RAPTIS S.
Atherosclerosis of carotid arteries and the ace insertion/deletion polymorphism in subjects with diabetes
mellitus type 2. Int Angiol 2002; 21; 63-9.
3405. GIANNAKOPOULOU C, KORAKAKI E, HATZIDAKI E, MANOURA A, ALIGIZAKIS A,
VELIVASAKIS E. Peroneal nerve palsy: A complication of umbilical artery catheterization in the fullterm newborn of a mother with diabetes. Pediatrics
2002; 109: e66.
3406. TSIGOS C, KYROU I, RAPTIS SA. Monogenic
forms of obesity and diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15: 241-53.
3407. LEKAKIS JP, PAPAMICHAEL CM, BARBAKI P,
PAPAIOANNOU TG, STAMATELOPOULOS KS,
DAGRE AG, STAMATELOPOULOS SF. Comparison of low-density lipoprotein cholesterol lowering
by pravastatin to <100 mg/dl versus >100 mg/dl on
brachial artery vasoreactivity in patients with severe
hypercholesterolemia and previous atherosclerotic
events or diabetes mellitus. Am J Cardiol 2002; 89:
857-60.
3408. MANOLOPOULOS K, KIESS W, BRAEMS GA,
DELIGEOROGLOU E, CREATSAS G, MICHALAS S, LANG U. Which contraceptive methods are
recommended for young women with type 1 diabetes
mellitus? A survey among gynaecologists in Greece.
Eur J Obstet Gynecol Reprod Biol 2001; 99: 232-7.
3409. MIGDALIS IN, KALOGEROPOULOU K, IIOPOULOU V, VARVARIGOS N, KARMANIOLAS
KD, MORTZOS G, CORDOPATIS P. Progression
of carotid atherosclerosis and the role of endothelin
in diabetic patients. Res Commun Mol Pathol Pharmacol 2000; 108: 27-37.
3410. MIGDALIS IN, KALOGEROPOULOU K, KARMANIOLAS KD, VARVARIGOS N, MORTZOS
G, CORDOPATIS P. Plasma levels of endothelin and
early carotid atherosclerosis in diabetic patients. Res
Commun Mol Pathol Pharmacol 2000; 108: 15-25.
3411. KYRIAKIDES ZS, PSYCHARI S, CHRYSOMALLIS N, GEORGIADIS M, SBAROUNI E,
KREMASTINOS DT. Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated
balloon inflations during angioplasty. Heart 2002; 87:
61-6.
3412. PERIMENIS P, GYFTOPOULOS K, ATHANASOPOULOS A, BARBALIAS G. Diabetic impotence treated by intracavernosal injections: High
treatment compliance and increasing dosage of vasoactive drugs. Eur Urol 2001; 40: 398-403.
3413. MIGDALIS IN, KALOGEROPOULOU K, ILIOPOULOU V, TRIANTAFILOU P, CHARALABIDES J, MORTZOS G, CORDOPATIS C. Plasma
levels of endothelin, lipid peroxides and prostacyclin
in diabetic patients with macroangiopathy. Diabetes
Res Clin Pract 2001; 54: 129-36.
3414. BAKOGIANNI MC, KALOFOUTIS CA, SKENDERI KI, KALOFOUTIS AT. Clinical evaluation of
plasma high-density lipoprotein subfractions (HDL2,
HDL3) in non-insulin-dependent diabetics with coronary artery disease. J Diabetes Complications 2001;
15: 265-9.
3415. ILIAS I, HATZIMICHELAKIS E, SOUVATZOGLOU A, ANAGNOSTOPOULOU T, TSELEBIS
A. Perception of family support is correlated with
217
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
glycemic control in Greeks with diabetes mellitus.
Psychol Rep 2001; 88: 929-30.
3416. SYMEONIDIS A, ATHANASSIOU G, PSIROYANNIS A, KYRIAZOPOULOU V, KAPATAISZOUMBOS K, MISSIRLIS Y, ZOUMBOS N. Impairment of erythrocyte viscoelasticity is correlated
with levels of glycosylated haemoglobin in diabetic patients. Clin Lab Haematol 2001; 23: 103-9.
3417. GOGOS CA, GIALI S, PALIOGIANNI F, DIMITRACOPOULOS G, BASSARIS HP, VAGENAKIS
AG. Interleukin-6 and C-reactive protein as early
markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia 2001; 44: 1011-4.
3418. MOUGIAKAKOU SG, NIKITA KS. A neural network approach for insulin regime and dose adjustment in type 1 diabetes. Diabetes Technol Ther 2000;
2: 381-9.
3419. RAPTIS AE, VIBERTI G. Pathogenesis of diabetic
nephropathy. Exp Clin Endocrinol Diabetes 2001; 109
(Suppl 2): S424- S37.
3420. KOLIAKOS G, PAPACHRISTOU F, PAPADOPOULOU M, TRACHANA V, GAITATZI M,
SOTIRIOU I. Electrophoretic analysis of urinary proteins in diabetic adolescents. J Clin Lab Anal 2001; 15:
178-83.
3421. NOUSIA-ARVANITAKIS S, GALLI-TSINOPOULOU A, KARAMOUZIS M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-9.
3422. MILIONIS HJ, LIBEROPOULOS EN, ELISAF
MS. Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus. Diabetes Metab 2001;
27: 160-3.
3423. MILIONIS HJ, LIAMIS GL, ELISAF MS. Hyperosmolar syndrome in a patient with uncontrolled diabetes mellitus. Am J Kidney Dis 2001; 37: E41.
3424. HABEOS I, PAPAVASSILIOU AG. Type 2 diabetes mellitus and worm longevity: A transcriptional
link to cure? Trends Endocrinol Metab 2001; 12: 13940.
3425. LIAKOPOULOU M, ALIFIERAKI T, KATIDENIOU A, PEPPA M, MANIATI M, TZIKAS D,
HIBBS E.D, DACOU-VOUTETAKIS C. Maternal
expressed emotion and metabolic control of children
and adolescents with diabetes mellitus. Psychother
Psychosom 2001; 70: 78-85.
3426. VITORATOS N, SALAMALEKIS E, LOGHIS S,
KASSANOS D, GIANNARIS D, CREATSAS G.
Changes of glucose tolerance after delivery in women
with gestational diabetes. Clin Exp Obstet Gynecol
2000; 27: 212-4.
3427. TENTOLOURIS N, PAGONI S, TZONOU A, KATSILAMBROS N. Peripheral neuropathy does not
invariably coexist with autonomic neuropathy in diabetes mellitus. Eur J Intern Med 2001; 12: 20-7.
218
3428. PASSADAKIS P, OREOPOULOS D. Peritoneal
dialysis in diabetic patients. Adv Ren Replace Ther,
2001; 8: 1: 22-41.
3429. VITORATOS N, SALAMALEKIS E, KASSANOS
D, LOGHIS C, PANAYOTOPOULOS N, KOUSKOUNI E, CREATSAS G. Maternal plasma leptin
levels and their relationship to insulin and glucose in
gestational-onset diabetes. Gynecol Obstet Invest
2001; 51: 17-21.
3430. PASSADAKIS P, THODIS E, VARGEMEZIS V,
OREOPOULOS D. Long-term survival on peritoneal
dialysis in end-stage renal disease owing to diabetes.
Adv Perit Dial 2000; 16: 59-66.
3431. GALLI-TSINOPOULOU A, NOUSIA-ARVANITAKIS S. Glucose-6-phosphate dehydrogenase deficiency-induced hemolysis in newly diagnosed diabetic
monozygotic twins. J Pediatr Endocrinol Metab 2000;
13: 669-72.
3432. LAGIOU P, KUPER H, STUVER SO, TZONOU
A, TRICHOPOULOS D, ADAMI HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000; 92: 1096-9.
3433. TSAOUSIS G, KOUTSOURI A, GATSIOU C, PANIARA O, PEPPAS C, CHALEVELAKIS G. Liver
and brain mucormycosis in a diabetic patient type II
successfully treated with liposomial amphotericin B.
Scand J Infect Dis 2000; 32: 335-7.
3434. THANASA G, AFTHENTOPOULOS IE. The patient with diabetic nephropathy in the hospital.
EDTNA ERCA J 1999; 25: 28-31.
3435. GALLI-TSINOPOULOU A, NOUSIA-ARVANITAKIS S, DRACOULACOS D, XEFTERI M, KARAMOUZIS M. Autoantibodies predicting diabetes
mellitus type I in celiac disease. Horm Res 1999; 52:
119-24.
3436. GOGOU G, MAVROMATIS A, MAGLAVERAS
N, PAPPAS C, ENGELBRECHT R. DIABCARD
core system-a chip card medical information system
for Diabetes Care. Stud Health Technol Inform 1999;
68: 805-8.
3437. NOUSIA-ARVANITAKIS S, GALLI-TSINOPOULOU A, DRACOULACOS D, KARAMOUZIS M,
DEMITRIADOU A. Islet autoantibodies and insulin
dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000; 13: 319-24.
3438. ATHANASSIOU G, MATSOUKA P, KALERIDIS
V, MISSIRLIS Y. Deformability and filterability of
white blood cell subpopulations. Evaluation of these
parameters in the cell line HL-60 and in type II diabetes mellitus. Clin Hemorheol Microcirc 2000; 22:
35-43.
3439. GRIGORAKIS SI, ALEVIZAKI M, BEIS C,
ANASTASIOU E, ALEVIZAKI CC, SOUVATZOGLOU A. Hormonal parameters in GE subpopulations stational diabetes mellitus during the third
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
trimester: High glucagon levels. Gynecol Obstet Invest 2000; 49: 106-9.
3440. PETRAKIS I, GONIANAKIS C, VRACHASSOTAKIS N, TSATSAKIS A, VALLILAKIS IS, CHALKIADAKIS G. Prospective study of preincisional intraparietal single-dose ceftriaxone in reducing postoperative wound infection in type I and II diabetic patients. Acta Diabetol 1999; 36: 159-62.
3441. TENTOLOURIS N, GRAPSAS E, STAMBULIS
E, PAPAGEORGIOU K, KATSILAMBROS N. Impact of body mass on autonomic function in persons
with type 2 diabetes. Diabetes Res Clin Pract 1999;
46: 29-33.
3442. EPANOMERITAKIS E, KOUTSOUMBI P,
TSIAOUSSIS I, GANOTAKIS E, VLATA M, VASSILAKIS JS, XYNOS E. Impairment of anorectal
function in diabetes mellitus parallels duration of disease. Dis Colon Rectum 1999; 42: 1394-400.
3443. LABROPOULOU-KARATZA C, GORITSAS C,
FRAGOPANAGOU H, REPANDI M, MATSOUKA P, ALEXANDRIDES T. High prevalence of diabetes mellitus among adult beta-thalassaemic patients
with chronic hepatitis C. Eur J Gastroenterol Hepatol
1999; 11: 1033-6.
3444. PASSADAKIS P, THODIS E, VARGEMEZIS V,
OREOPOULOS DG. Nutrition in diabetic patients
undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 1999; 19 (Suppl 2): S248- S54.
3445. TAMBOURIS E, MAKROPOULOS C. Application of telemedicine technologies for the diabetes
care of patients in greek rural areas. Adv Clin Path
1998; 2: 163-5.
3446. KASSIOU K, TSAMASIROS J. Family management of insulin-dependent diabetes mellitus: A practical problem-solving approach. Acta Paediatr Suppl
1999; 88: 47-51.
3447. DACOU-VOUTETAKIS C, SERTEDAKI A,
MANIATIS-CHRISTIDIS M, SARRI C, KARADIMA G, PETERSEN M.B, XAIDARA A, KANARIOU M, NICOLAIDOU P. Insulin dependent diabetes mellitus (IDDM) and autoimmune thyroiditis in
a boy with a ring chromosome 18: Additional evidence of autoimmunity or IDDM gene(s) on chromosome 18. J Med Genet 1999; 36: 156-8.
3448. PEPPA-PATRIKIOU M, DRACOPOULOU M,
DACOU-VOUTETAKIS C. Urinary endothelin in
adolescents and young adults with insulin-dependent
diabetes mellitus: Relation to urinary albumin, blood
pressure, and other factors. Metabolism 1998; 47:
1408-12.
3449. DIAMANTOPOULOS EJ, HARITOS D, YFANDI
G, GRIGORIADOU M, MARGARITI G, PANIARA O, RAPTIS SA. Management and outcome of severe diabetic foot infections. Exp Clin Endocrinol Diabetes 1998; 106: 346-52.
3450. PETROU-AMERIKANOU C, MARKOPOULOS
A.K, BELAZI M, KARAMITSOS D, PAPANAYOTOU P. Prevalence of oral lichen planus in diabetes
mellitus according to the type of diabetes. Oral Dis
1998; 4: 37-40.
3451. MIGDALIS IN, GEROLIMOU B, KOZANIDOU
G, VOUDOURIS G, HATZIGAKIS SM, PETROPOULOS A. Effect of gemfibrozil on early carotid
atherosclerosis in diabetic patients with hyperlipidaemia. Int Angiol 1997; 16: 258-61.
3452. BELAZI MA, GALLI-TSINOPOULOU A,
DRAKOULAKOS D, FLEVA A, PAPANAYIOTOU PH. Salivary alterations in insulin-dependent diabetes mellitus. Int J Paediatr Dent 1998; 8: 29-33.
3453. MARKOPOULOS AK, BELAZI MA, DRAKOULAKOS D. Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes. Diabetes
Res Clin Pract 1997; 38: 169-72.
3454. TENTOLOURIS N, KATSILAMBROS N, PAPAZACHOS G, PAPADOGIANNIS D, LINOS A,
STAMBOULIS E, PAPAGEORGIOU K. Corrected
QT interval in relation to the severity of diabetic autonomic neuropathy. Eur J Clin Invest 1997; 27: 104954.
3455. MANTIDES A, STEFANIDES G, KIOULANIS J,
TZOVARAS G, EPANOMERITAKIS E, XYNOS
E. Cutaneous electrogastrography for the assessment
of gastric myoelectrical activity in type I diabetes mellitus. Am J Gastroenterol 1997; 92: 1190-3.
3456. SKORDIS N, HADJILOIZOU S. Incidence of insulin dependent diabetes mellitus in Greek Cypriot
children and adolescents, 1990-1994. J Pediatr Endocrinol Metab 1997; 10: 203-7.
3457. MIGDALIS IN, GEROLIMOU B, KOZANIDOU
G, HATZIGAKIS SM, KARMANIOLAS KD. Effect
of fosinopril sodium on early carotid atherosclerosis
in diabetic patients with hypertension. J Med 1997;
28: 371-80.
3458. GRIGORAKIS SI, ALEVIZAKI M, RAPTI E,
ANASTASIOU E, ALEVIZAKI CC, SOUVATZOGLOU A. Islet amyloid polypeptide (amylin) does
not seem to be directly involved in the development of
gestational diabetes mellitus. Gynecol Obstet Invest
1997; 44: 6-10.
3459. STAMATAKI KE, SPINA J, RANGOU DB,
CHLOUVERAKIS CS, PIADITIS GP. Ovarian
function in women with non-insulin dependent diabetes mellitus. Clin Endocrinol (Oxf) 1996; 45: 61521.
3460. STEFANIDIS CJ, PAPATHANASSIOU A, MICHELIS K, THEODORIDIS X, PAPACHRISTOU
F, SOTIRIOU J. Diabetes mellitus after therapy with
recombinant human growth hormone (rhGH). Br J
Clin Pract Suppl 1996; 85: 66-7.
3461. SYRIGOS KN, KONSTANTOULAKIS MM, FYS-
219
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
SAS I, KATSILAMBROS N, GOLEMATIS BC. Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus. Int J Cancer 1996; 66: 624-6.
3462. LOUKIDES S, POLYZOGOPOULOS D. The effect of diabetes mellitus on the outcome of patients
with chronic obstructive pulmonary disease exacerbated due to respiratory infections. Respiration 1996;
63: 170-3.
3463. AMBROSIADOU BV, GOULIS DG, PAPPAS C.
Clinical evaluation of the DIABETES expert system
for decision support by multiple regimen insulin dose
adjustment. Comput Methods Programs Biomed
1996; 49: 105-15.
3464. TSOPELAS N, KOKOLAKIS N, DROUTSAS D,
THEODOSSIADIS G. Extracapsular cataract extraction in diabetic eyes. The role of YAG laser capsulotomy. Doc Ophthalmol 1995; 91: 17-24.
3465. STEFANIOTOU M, KALOGEROPOULOS C,
PSILAS K. Long-term visual results after laser photocoagulation for diabetic maculopathy. Ophthalmologica 1995; 209: 64-7.
3466. HARALAMBOUS S, BLACKWELL C, MAPPOURAS DG, WEIR DM, KEMMETT D, LYMBERI P. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus. Autoimmunity 1995; 20: 267-75.
3467. KAKOUROU T, DACOU-VOUTETAKIS C, KAVADIAS G, BAKOULA C, ARONI K. Limited joint
mobility and lipodystrophy in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dermatol 1994; 11: 310-4.
3468. MAMOPOULOS M, BILI H, TSANTALI C, ASSIMAKOPOULOS E, MANTALENAKIS S, FARMAKIDES G. Erythropoietin umbilical serum levels during labor in women with preeclampsia, diabetes, and
preterm labor. Am J Perinatol 1994; 11: 427-9.
3469. KALAPOTHAKI V, TZONOU A, HSIEH CC,
TOUPADAKI N, KARAKATSANI A, TRICHOPOULOS D. Tobacco, ethanol, coffee, pancreatitis,
diabetes mellitus, and cholelithiasis as risk factors for
pancreatic carcinoma. Cancer Causes Control 1993; 4:
375-82.
3470. LADAS ID, THEODOSSIADIS GP. Long-term effectiveness of modified grid laser photocoagulation
for diffuse diabetic macular edema. Acta Ophthalmol
(Copenh) 1993; 71: 393-7.
3471. THALASSINOS NC, HADJIYANNI P, TZANELA M, ALEVIZAKI C, PHILOKIPROU D. Calcium
metabolism in diabetes mellitus: Effect of improved
blood glucose control. Diabet Med 1993; 10: 341-4.
3472. PHENEKOS C, SIAFAKA-KAPADAI A, TRAPALI M, BOTITSI E, MAVRIS M. Effect of gliclazide
on platelet-activating factor-induced platelet aggrega-
220
tion in patients with non-insulin-dependent diabetes
mellitus. Metabolism 1992; 41 (Suppl 5): 30-2.
3473. BALAS P. Diabetic capillary angiopathy of the dermis of the hand and foot in patients with diabetes mellitus. Semin Thromb Hemost 1991; 17: 448-9.
3474. PSILAS KG, STEFANIOTOU MJ, ASPIOTIS MB.
Pseudoexfoliation syndrome and diabetes mellitus.
Acta Ophthalmol (Copenh) 1991; 69: 664-6.
3475. MAVRIKAKIS ME, SFIKAKIS PP, KONTOYANNIS SA, ANTONIADES LG, KONTOYANNIS DA,
MOULOPOULOU DS. Clinical and laboratory parameters in adult diabetics with and without calcific
shoulder periarthritis. Calcif Tissue Int 1991; 49: 28891.
3476. MAGOULA I, TSAPAS G, PALETAS K, MAVROMATIDIS K. Insulin-dependent diabetes and renal hypouricemia. Nephron 1991; 59: 21-6.
3477. MIGDALIS IN, VOUDOURIS G, KALOGEROPOULOU K, ILIOPOULOU V, KOUTOULIDIS K,
SAMARTZIS M. Size of the pancreas in non-insulindependent diabetic patients. J Med 1991; 22: 179-86.
3478. STEFANIOTIS TD, DONTA CN. Valuable information from the medical history and intraoral examination of diabetic patients. Hell Period Stomat
Gnathopathoprosopike Cheir 1990; 5: 25-30.
3479. THEODOSSIADIS GP, BOUDOURI A, GEORGOPOULOS G, KOUTSANDREA C. Central visual
field changes after panretinal photocoagulation in
proliferative diabetic retinopathy. Ophthalmologica
1990; 201: 71-8.
3480. KOUTSIKOS D, AGROYANNIS B, TZANATOSEXARCHOU H. Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 1990; 44: 511-4.
3481. KOUVARAS G, COKKINOS D, SPYROPOULOU M. Increased mortality of diabetics after acute
myocardial infarction attributed to diffusely impaired
left ventricular performance as assessed by echocardiography. Jpn Heart J 1988; 29: 1-9.
3482. MOSCHOS M, PANAGAKIS E, ANGELOPOULOS A. Changes of oscillatory potentials of the ERG
in diabetic retinopathy. Ophthalmic Physiol Opt 1987;
7: 477-9.
3483. KANAGHINIS T, FOSTIROPOULOS G, GATSOU P, IKKOS D, KARAYANNIS S, KOURIS C,
GARDIKAS C. The incidence of gastric and thyroid
autoimmunity in insulin-dependent Greek diabetic
patients. Am J Dig Dis 1973; 18: 92-8.
3484. DANOPOULOS E, ANGELOPOULOS B. Comparative study on the change of diabetes in Greece before, during and after the war. Klin Wochenschr 1953;
31: 1076-7.
3485. PAPANAS N, PAPATHEODOROU K, PAPAZOGLOU D, MONASTIRIOTIS C, CHRISTAKIDIS
D, MALTEZOS E. A comparison of the new indicator test for sudomotor function (Neuropad) with the
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in
subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 2008; 116: 135-8.
3486. TOUSOULIS D, ANTONIADES C, TOUNTAS C,
BOSINAKOU E, KOTSOPOULOU M, TOUTOUZAS P, STEFANADIS C. Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in
patients with type 2 diabetes and coronary artery disease. Diabetes Care 2003; 26: 2749-53.
3487. TRYFON S, STANOPOULOS I, KAKAVELAS E,
NIKOLAIDOU A, KIOUMIS I. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus:
A case report. J Oral Maxillofac Surg 2002; 60: 32830.
3488. PARVING HH, PERSSON F, LEWIS JB, LEWIS
EJ, HOLLENBERG NK, AVOID STUDY INVESTIGATORS (INVESTIGATORS – GREECE:
SIAMOPOULOS K, THEODOROU I, PAGKALOS E, GAVRA M, KLITSAS A, SOULIS K).
Aliskiren combined with losartin in type 2 diabetes
and neuropathy. N Engl J Med 2008; 358: 2433-46.
3489. Δ™OÀƒOÀ∫Δ™O°§OÀ °, Î.·. ¶·Ú·ÙËÚ‹ÛÂȘ Â›
Ù˘ ·ÓÙ·Ï·Á‹˜ ÙˆÓ ˘‰·Ù·ÓıÚ¿ÎˆÓ ÂÓÙfi˜ ÙˆÓ ÂÚ˘ıÚÔ΢ÙÙ¿ÚˆÓ ‰È·‚ËÙÈÎÒÓ ·ÙfiÌˆÓ ÌÂÙ¿ ¯ÔÚ‹ÁËÛÈÓ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ ¶Ú·ÎÙÈο Ù˘ π·ÙÚÈ΋˜ ∂Ù·ÈÚ›·˜ £ÂÛÛ·ÏÔӛ΢. ™˘Ó‰ڛ· 29.5.1965: 115-25.
3490. ¢∞∫OÀ-μOÀΔ∂Δ∞∫∏ ∞, Î.·. ªÂÙ··ÚˆÙȉÈÎfi˜
۷ί·Ú҉˘ ‰È·‚‹Ù˘: ∂ÎÎÚÈÛȘ ÈÓÛÔ˘Ï›Ó˘. ¢ÂÏÙ›Ô
¶·È‰È·ÙÚÈ΋˜ ∫ÏÈÓÈ΋˜ ¶·ÓÂÈÛÙËÌ›Ô˘ ∞ıËÓÒÓ,
1973; 20: 29-36.
3491. Ã∞ª∞§π¢OÀ - ∞§∂•π∞¢OÀ ∞. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È ¯ÔÏÔÏÈı›·ÛË: ∏ Û˘¯ÓfiÙËÙ· Î·È Ë ·ıÔÁ¤ÓÂÛË Ù˘ ¯ÔÏÔÏÈı›·Û˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. π·ÙÚÈ΋ ™¯ÔÏ‹ ¢¶£, 1999. ¢È‰·ÎÙÔÚÈ΋
¢È·ÙÚÈ‚‹.
3492. STAIGER H, MACHICAO F, STEFAN N,
TSCHRITTER O, THAMER C, KANTARTZIS K,
SCHÄFER SA, KIRCHHOFF K, FRITSCHE A,
HÄRING HU. Polymorphisms within novel risk loci
for type 2 diabetes determine b-cell function. PLoS
ONE 2007; 2: e832.
3493. BACHMANN W, PETZINNA D, RAPTIS SA,
WASCHER T, WESTERMEIER T AND THE
EUROPEAN ACARBOSE STUDY GROUP. Longterm improvement of metabolic control by acarbose
in type 2 diabetes patients poorly controlled with maximum sulfonylurea therapy. Clin Drug Investig 2003;
23: 679-86.
3494. DIAMANTOPOULOS EJ, ANDREADIS EA,
TSOUROUS GI, KATSANOU PM, GEORGIOPOULOS DX, NESTORA KC, RAPTIS SA. Early
vascular lesions in subjects with metabolic syndrome
and prediabetes. Int Angiol 2006; 25: 179-83.
3495. STANDL E, MAXEINER S, RAPTIS S, HOE
901/4009 STUDY GROUP. Once-daily insulin
glargine administration in the morning compared to
bedtime in combination with morning glimepiride in
patients with type 2 diabetes: An assessment of treatment flexibility. Horm Metab Res 2006; 38: 172-7.
3496. STANDL E, MAXEINER S, RAPTIS S, KARIMIANDERESI Z, SCHWEITZER MA, HOE901/4009
STUDY GROUP. Good glycemic control with flexibility in timing of basal insulin supply: A 24-week
comparison of insulin glargine given once daily in the
morning or at bedtime in combination with morning
glimepiride. Diabetes Care 2005; 28: 419-20.
3497. LAMEIRE N, STEVENS P, RAPTIS S, THOMAS
S, SCHERNTHANER G. Individualized risk management in diabetics: How to implement best practice
guidelines-design and concept of the IRIDIEM studies. Kidney Blood Press Res 2004; 27: 127-33.
3498. STANDL E, SCHERNTHANER G, RYBKA J,
HANEFELD M, RAPTIS SA, NADITCH L. Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics. Diabetes Res Clin Pract
2001; 51: 205-13.
3499. GOMIS R, RAPTIS SA, RAVELLA R. Appropriate timing of glimepiride administration in patients
with type 2 diabetes millitus: A study in Mediterranean countries. Endocrine 2000; 13: 117-21.
3500. TSIGOS C, IOANNIDIS I, RAPTIS SA, KATSILAMBROS N. Screening for diabetes in obese
women: comparison between the New American Diabetes Association and WHO criteria. Clin Endocrinol
(Oxf) 2000; 52: 248-50.
3501. KATOULIS EC, BOULTON AJ, RAPTIS SA. The
role of diabetic neuropathy and high plantar pressures
in the pathogenesis of foot ulceration. Horm Metab
Res 1996; 28: 159-64.
3502. KATOULIS EC, RAPTIS SA. Insulin injectors: A
practical approach to insulin therapy. Int J Artif Organs 1995; 18: 177-80.
3503. STAIGER H, MACHICAO F, KANTARTZIS K,
SCHÄFER SA, KIRCHHOFF K, GUTHOFF M,
SILBERNAGEL G, STEFAN N, FRITSCHE A,
HÄRING HU. Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes. PLoS ONE 2008; 3: e3019.
3504. STAIGER H, MACHICAO F, SCHÄFER SA,
KIRCHHOFF K, KANTARTZIS K, GUTHOFF M,
SILBERNAGEL G, STEFAN N, HÄRING HU,
FRITSCHE A. Polymorphisms within the Novel Type
2 Diabetes Risk Locus MTNR1B Determine betaCell Function. PLoS ONE. 2008;3: e3962. [Epub
ahead of print].
3505. MÜSSIG K, STAIGER H, MACHICAO F,
KIRCHHOFF K, GUTHOFF M, SCHÄFER SA,
KANTARTZIS K, SILBERNAGEL G, STEFAN N,
HOLST JJ, GALLWITZ B, HÄRING HU, FRITSCHE A. Association of type 2 diabetes candidate
polymorphisms in KCNQ1 with incretin and insulin
221
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
secretion. Diabetes 2009 Apr 14. [Epub ahead of
print].
3506. ¶∞°∫∞§O™ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: OÈÎÔÁÂÓÂÈ·Îfi˜ È·ÙÚÈÎfi˜ Ô‰ËÁfi˜. £ÂÛÛ·ÏÔÓ›ÎË, 2002: 56-9.
3507. ¶∞°∫∞§O™ ∂. ∏ ¯ÔÚ‹ÁËÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙÔ˘˜
·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ¶·¿˜ ™. ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‹ıˆÓ ·ı‹ÛÂˆÓ ·fi ÙÔ ÁÈ·ÙÚfi ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜. ∞ı‹Ó·, 2004:
553-6.
3508. ¶∞°∫∞§O™ ∂. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2:
™Ùfi¯ÔÈ ıÂÚ·›·˜- Û ÔÈÔ‡˜, fiÙÂ Î·È Ò˜ ·Ú¯›˙Ô˘Ì ÙËÓ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·. ™ÙÔ: ¶·¿˜ ™. ∞ÓÙÈÌÂÙÒÈÛË Û˘Ó‹ıˆÓ ·ı‹ÛÂˆÓ ·fi ÙÔ ÁÈ·ÙÚfi ÚˆÙÔ‚¿ıÌÈ·˜ ÊÚÔÓÙ›‰·˜ ˘Á›·˜. ∞ı‹Ó·, 2005: 119-22.
3509. ¶∞°∫∞§O™ ∂. ∏ Û˘Ì‚ÔÏ‹ ÙÔ˘ Û˘ÛÙ‹Ì·ÙÔ˜ ÚÂÓ›Ó˘- ·ÁÁÂÈÔÙÂÓÛ›Ó˘ ÛÙËÓ ·ıËÚÔÛÎÏ‹ÚˆÛË. ∏ ı¤ÛË
ÙˆÓ ·ÔÎÏÂÈÛÙÒÓ ÙˆÓ ˘Ô‰Ô¯¤ˆÓ Ù˘ ·ÁÁÂÈÔÙÂÓÛ›Ó˘
ππ. ™ÙÔ: ¶Ú·ÎÙÈο ÂÎ·È‰Â˘ÙÈÎÔ‡ ÛÂÌÈÓ·Ú›Ô˘- ÂÊ·ÚÌÔṲ̂ÓÔ˘ ÊÚÔÓÙÈÛÙËÚ›Ô˘: ¢È·‚‹Ù˘ Î·È ‰˘ÛÏÈȉ·ÈÌ›·, Ô ‰›‰˘ÌÔ˜ ÌÂÙ·‚ÔÏÈÎfi˜ ηډȷÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. 2006: 132-6.
3510. Δ™πΔ∞ªπ¢OÀ ∑, ºƒ∞°∫π∞ ¢, ¶∞°∫∞§O™ ∂,
¢∏ª∏Δƒπ∞¢∏™ Ã, ºø∫∞ ∑, £∂ø¢Oƒπ¢OÀ ∞.
πÓˆ‰ÔÏ˘ÙÈ΋ Î·È ËÎÙÈ΋ ‰Ú·ÛÙËÚÈfiÙ˘ Û ‰È·‚ËÙÈÎÔ‡˜ Ì ‰È·‚‹ÙË Ù‡Ô˘ ππ: ™¯¤ÛË Ì ÌÂÙ·‚ÔÏÈÎfi ¤ÏÂÁ¯Ô. ™ÙÔ: ¶Ú·ÎÙÈο 10Ô˘ μÔÚÂÈÔÂÏÏ·‰ÈÎÔ‡ Û˘Ó‰ڛԢ.
1995: 520-3.
3511. KARALLIEDDE J, BUCKINGHAM R, STARKIE
M, LORAND D, STEWART M, VIBERTI G; FOR
THE ROSIGLITAZONE FLUID RETENTION
STUDY GROUP (INVESTIGATORS – GREECE:
PAGKALOS E, TSALHI L., PAPPAS S, BOUSBOULAS S, DIMITRIOU K, RAPTIS S, RAPTIS
A). Effect of Various Diuretic Treatments on Rosiglitazone-Indused Fluid Retention. J Am Soc Nephrol
2006; 17: 3482-90.
3512. DAVIES M, LAVALLE-GONZALEZ F,
STORMS F, GOMIS R.; AT.LANTUS STUDY
GROUP (INVESTIGATORS – GREECE: ANASTASIOU E, BARTSOCAS C, BENROUBI M,
GIANNOULAKI E, IOANNIDIS I, KARAMITSOS
D, KATSILAMBROS N, MELIDONIS A, MIGDALIS I, PAGKALOS E, PAPPAS S, PHENEKOS C,
RAPTIS S, SKARAGAS G, THALASSINOS N,
TSAKATARAS D, TSATSOULIS A, ZOUPAS C).
Initiation of insulin glargine therapy in type 2 diabetes
subjects suboptimally controlled on oral antidiabetic
agents: Results from the AT.LANTUS trial. Diabetes
Obes Metab 2008; 10: 5: 387-99.
3513. SJOLIE AK, KLEIN R, PORTA M, ORCHARD T,
FULLER J, PARVING HH, BILOUS R, CHATURVEDI N, DIRECT PROGRAMME STUDY
GROUP (INVESTIGATORS – GREECE: GOMIS
R, KATSILAMBROS N, KATSILAMBROS N, KARAMANOS B, MELIDONIS A, MYGDALIS I,
NOUTSOU M, PAGALOS E, PAPADAM A, PAP-
222
PAS A, PAPPAS S, PHENEKOS K, PIADITIS G).
Effect of candesartan on progression and regression
of retinopathy in type 2 diabetes (Direct-Protect 2): A
randomised placebo-controlled trial. Lancet 2008;
372: 1385-93.
3514. CHATURVEDI N, PORTA M, KLEIN R, ORCHARD T, FULLER J, PARVING HH, BILOUS R,
SJOLIE AK; DIRECT PROGRAMME STUDY
GROUP (INVESTIGATORS – GREECE: GOMIS
R, KATSILAMBROS N, ZOUNGAS S, KATSILAMBROS N, KARAMANOS B, MELIDONIS A,
MYGDALIS I, NOUTSOU M, PAGALOS E, PAPADAM A, PAPPAS A, PAPPAS S, PHENEKOS K,
PIADITIS G, CREPALDI G). Effect of candesartan
on prevention (DIRECT-Prevent 1) and progression
(DIRECT-Protect 1) of retinopathy in type 1 diabetes: Randomised placebo-controlled trials. Lancet
2008; 372: 1394-402.
3515. SCHWAB KO, DOERFER J, HECKER W,
GRULICH-HENN J, WIEMANN D, KORDONOURI O, BEYER P, HOLL RW; DPV INITIATIVE OF THE GERMAN WORKING GROUP
FOR PEDIATRIC DIABETOLOGY. Spectrum and
prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: Cross-sectional data from the German diabetes
documentation and quality management system
(DPV). Diabetes Care 2006; 29: 218-25.
3516. HADJIDAKIS DI, ANDROULAKIS II, MYLONAKIS AM, SFAKIANAKIS ME, RAPTIS AE,
PAPAEFSTATHIOU AG, ECONOMOPOULOS
TC, RAPTIS SA. Diabetes in Postmenopause: Different Influence on Bone Mass According to Age and
Disease Duration. Exp Clin Endocrinol Diabetes
2008 [Epub ahead of print]
3517. ZARROS A, LIAPI C, GALANOPOULOU P,
MARINOU K, MELLIOS Z, SKANDALI N, ALHUMADI H, ANIFANTAKI F, GKROUZMAN E,
TSAKIRIS S. Effects of adult-onset streptozotocininduced diabetes on the rat brain antioxidant status
and the activities of acetylcholinesterase, (Na(+),K
(+))- and Mg (2+)-ATPase: Modulation by L-cysteine. Metab Brain Dis 2009 Mar 19. [Epub ahead of
print].
3518. KOSTIDOU E, TRACHANA V, TOPOURIDOU
K, PALETAS K, TSAPAS A, KALOYIANNI M,
KOLIAKOS G. Monocyte attachment to laminin in
diabetes mellitus: The role of ATP. Cell Adh Migr
2009; 3. [Epub ahead of print].
3519. DOUPIS J, LYONS TE, WU S, GNARDELLIS C,
DINH T, VEVES A. Microvascular Reactivity and
Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy. J Clin Endocrinol
Metab 2009 [Epub ahead of print].
3520. CHOUSSEIN S, MAKRI AA, FRANGOS CC, PETRIDOU ET, DASKALOPOULOU SS. Effect of
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
antiobesity medications in patients with type 2 diabetes mellitus. Diabetes Obes Metab 2009 [Epub
ahead of print].
3521. STEIROPOULOS P, PAPANAS N, NENA E,
TSARA V, FITILI C, TZOUVELEKIS A, CHRISTAKI P, MALTEZOS E, BOUROS D. Markers of
glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea
Syndrome: Does adherence to CPAP treatment improve glycemic control? Sleep Med 2009 [Epub ahead
of print].
3522. LIATIS S, TSAPOGAS P, CHALA E, DIMOSTHENOPOULOS C, KYRIAKOPOULOS K,
KAPANTAIS E, KATSILAMBROS N. The consumption of bread enriched with betaglucan reduces
LDLCholesterol and improves insulin resistance in
patients with type2 diabetes. Diabetes Metab 2009
[Epub ahead of print].
3523. TSIROGIANNI A, PIPI E, SOUFLEROS K. Specificity of islet cell autoantibodies and coexistence with
other organ specific autoantibodies in type 1 diabetes
mellitus. Autoimmun Rev 2009 [Epub ahead of print].
3524. PAPANAS N, MALTEZOS E. The diabetic hand: A
forgotten complication? J Diabetes Complications
2009 [Epub ahead of print].
3525. MAVROGIANNAKI A, KARAMANOS B, MANESIS EK, PAPATHEODORIDIS GV, KOSKINAS
J, ARCHIMANDRITIS AJ. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a
prospective case-control study. J Viral Hepat 2009
[Epub ahead of print].
3526. JONES S, BENROUBI M, CASTELL C, GODAY
A, LIEBL A, TIMLIN L, NICOLAY C, SIMPSON
A, TYNAN A. Characteristics of patients with type 2
diabetes mellitus initiating insulin therapy: Baseline
data from the INSTIGATE study. Curr Med Res
Opin 2009 [Epub ahead of print].
3527. PEPPA M, BROUNTZOS E, ECONOMOPOULOS N, BOUTATI E, PIKOUNIS V, PATAPIS P,
ECONOMOPOULOS T, RAPTIS S.A, HADJIDAKIS D. Embolization as an Alternative Treatment of
Insulinoma in a Patient with Multiple Endocrine Neoplasia Type 1 Syndrome. Cardiovasc Intervent Radiol
2009 [Epub ahead of print].
3528. MARATOU E, HADJIDAKIS D, KOLLIAS A,
TSEGKA K, PEPPA M, ALEVIZAKI M DR, MITROU P, LAMBADIARI V, BOUTATI E, NIKZAS
D, TOUNTAS N, ECONOMOPOULOS T, RAPTIS
S, DIMITRIADIS G. Studies of insulin resistance in
patients with clinical and subclinical hypothyroidism.
Eur J Endocrinol 2009 [Epub ahead of print].
3529. KOSTIDOU E, KOLIAKOS G, KALOYIANNI M.
Increased monocyte alphaL, alphaM and beta2 integrin subunits in diabetes mellitus.Clin Biochem 2008
[Epub ahead of print].
3530. PAPATHANASSIOU K, NAKA KK, KAZAKOS
N, KANIOGLOU C, MAKRIYIANNIS D, PAPPAS
K, KATSOURAS CS, LIVERIS K, KOLETTIS T,
TSATSOULIS A, MICHALIS LK. Pioglitazone vs
glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes.
Atherosclerosis 2008 [Epub ahead of print].
3531. HADJIDAKIS DI, ANDROULAKIS II, MYLONAKIS AM, SFAKIANAKIS ME, RAPTIS AE,
PAPAEFSTATHIOU AG, ECONOMOPOULOS
TC, RAPTIS SA. Diabetes in Postmenopause: Different Influence on Bone Mass According to Age and
Disease Duration. Exp Clin Endocrinol Diabetes
2008 [Epub ahead of print].
3532. PAPAZAFIROPOULOU A, PERREA D, MOYSSAKIS I, KOKKINOS A, KATSILAMBROS N, TENTOLOURIS N. Plasma levels of MMP-2, MMP-9
and TIMP-1 are not associated with arterial stiffness
in subjects with type 2 diabetes mellitus. J Diabetes
Complications 2008 [Epub ahead of print].
3533. ANDREADIS EA, KATSANOU PM, GEORGIOPOULOS DX, TSOUROUS GI, YFANTI GK,
GOUVERI ET, DIAMANTOPOULOS EJ. The Effect of Metformin on the Incidence of Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Factors in Overweight and Obese Subjects - The Carmos
Study. Exp Clin Endocrinol Diabetes 2008 [Epub
ahead of print].
3534. CHRISTOPOULOS AI, DIAMANTOPOULOS
AA, DIMOPOULOS PA, GOUMENOS DS, BARBALIAS GA. Male-female differences in the risk of
tuberculosis in dialysis patients. Int Urol Nephrol
2008 [Epub ahead of print].
3535. TOULIS KA, GOULIS DG, KOLIBIANAKIS EM,
VENETIS CA, TARLATZIS BC, PAPADIMAS I.
Risk of gestational diabetes mellitus in women with
polycystic ovary syndrome: A systematic review and a
meta-analysis. Fertil Steril 2008 [Epub ahead of
print].
3536. TZELLOS TG, TAHMATZIDIS DK, LALLAS A,
APOSTOLIDOU K, GOULIS DG. Pernicious anemia in a patient with Type 1 diabetes mellitus and
alopecia areata universalis. J Diabetes Complications
2008 [Epub ahead of print].
3537. GEORGOULIAS P, DEMAKOPOULOS N, VALOTASSIOU V, ORFANAKIS A, ZAGANIDES A,
TSOUGOS I, FEZOULIDIS I. Long-term prognostic
value of heart-rate recovery after treadmill testing in
patients with diabetes mellitus. Int J Cardiol 2008
[Epub ahead of print].
3538. MYTAS DZ, STOUGIANNOS PN, ZAIRIS MN,
FOUSSAS SG, PYRGAKIS VN, KYRIAZIS IA. Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options. J Diabetes Complications 2008 [Epub ahead of print].
3539. KADOGLOU NP, ILIADIS F, ANGELOPOULOU N, SAILER N, FOTIADIS G, VOLIOTIS K,
223
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
VITTA I, LIAPIS CD, ALEVIZOS M. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
J Diabetes Complications. 2008 [Epub ahead of
print].
3540. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009:
943 ÛÂÏ.
3541. ∞§∂μπ∑O™ ª, ∫∞ƒ∞ª∏Δ™O™ ¢£. ™ÙÔȯ›· ÌÂÙ·‚ÔÏÈÛÌÔ‡. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 4-16.
3542. ∫∞∑∞∫O™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢£. Δ· ÓËÛ›‰È·
ÙÔ˘ ·ÁÎÚ¤·ÙÔ˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 17-23.
3543. ∫∞∑∞∫O™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ¤ÎÎÚÈÛË Ù˘
ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 24-9.
3544. ∫∞∑∞∫O™ ∫. ΔÔ Ê·ÈÓfiÌÂÓÔ Ù˘ ÈÓÎÚÂÙ›Ó˘. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 29-39.
3545. ∫∞ƒ∞ª∏Δ™O™ ¢£. Δ·ÍÈÓfiÌËÛË – ‰È¿ÁÓˆÛË –
ÌÔÚʤ˜ ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 42-51.
3546. ∫OÀƒΔO°§OÀ °, ∫∞ƒ∞ª∏Δ™O™ ¢£. ∂ÚÁ·ÛÙËÚȷΤ˜ ̤ıÔ‰ÔÈ ‰È¿ÁÓˆÛ˘, ·Ú·ÎÔÏÔ‡ıËÛ˘ ηÈ
¤Ú¢ӷ˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 52-66.
3547. ™OÀ°πOÀ§Δ∑O°§OÀ º, ∫∞ƒ∞ª∏Δ™O™ ¢£.
∞ÈÙÈÔÏÔÁ›· – ·ıÔÁ¤ÓÂÈ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›·
Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 70-89.
3548. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞ÈÙÈÔÏÔÁ›· – ·ıÔÁ¤ÓÂÈ· ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 89-107.
3549. ¶∞°∫∞§O™ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢£. °ÂÓÂÙÈÎÔ›
·Ú¿ÁÔÓÙ˜ Î·È Û·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ 2. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 107-12.
224
3550. ¶∞°∫∞§O™ ∂, ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚‹Ù˘ Ù‡Ô˘ ÒÚÈÌ˘ ËÏÈΛ·˜ ÙˆÓ Ó¤ˆÓ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 112-16.
3551. Δ™∞¶∞™ ∞. ¢ÔÎÈ̷ۛ˜ ̤ÙÚËÛ˘ Ù˘ ·ÓÙ›ÛÙ·Û˘
ÛÙËÓ ÈÓÛÔ˘Ï›ÓË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 116-25.
3552. ¶∞¶∞∑O°§OÀ ¡. ∂ȉËÌÈÔÏÔÁ›· ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ 1 Î·È Ù‡Ô˘ 2. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 128-35.
3553. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞˘ÍËÙÈΤ˜ Ù¿ÛÂȘ ÂÈÔÏ·ÛÌÔ‡ ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ·ÁÎÔÛÌ›ˆ˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 135-44.
3554. ∫∞ƒ∞ª∏Δ™O™ ¢£, ¢π¢∞°°∂§O™ Δ. ¶ÚfiÏË„Ë
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 2. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 144-8.
3555. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∫ÏÈÓÈ΋ ÂÈÎfiÓ· ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 152-8.
3556. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ‰›·ÈÙ· ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 162-71.
3557. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÈ ˘‰·Ù¿ÓıڷΘ ÛÙË ‰È·ÙÚÔÊ‹ ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 171-80.
3558. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢›·ÈÙ˜ ·‰˘Ó·Ù›ÛÌ·ÙÔ˜ ÛÂ
‰È·‚ËÙÈο ¿ÙÔÌ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 180-7.
3559. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ‰È·ÙÚÔÊ‹ ÙˆÓ ˘ÂÚËϛΈÓ.
™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009:
187-91.
3560. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÈ ÂȉڿÛÂȘ ÙÔ˘ ÔÈÓÔÓ‡̷ÙÔ˜ ÛÙÔÓ ÌÂÙ·‚ÔÏÈÛÌfi Ê˘ÛÈÔÏÔÁÈÎÒÓ Î·È ‰È·‚ËÙÈÎÒÓ ·ÙfïÓ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 191-201.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3561. •∞¡£∏™ ∞, Ã∞Δ∑∏ΔO§πO™ ∞. ΔÂÏÈο ÚÔ˚fiÓÙ· ÚÔ¯ˆÚË̤Ó˘ ÁÏ˘ÎÔ˙˘Ï›ˆÛ˘ (AGEs) Î·È Ë
Û˘ÌÌÂÙÔ¯‹ ÙÔ˘˜ ÛÙË ‰È·‚ËÙÈ΋ ·ıËڈ̿وÛË. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 201-8.
3562. ∫∞Δ™π∫∏ ¡. ƒ‡ıÌÈÛË ÚfiÛÏ˄˘ ÙÚÔÊ‹˜ ηÈ
ÂÓÂÚÁÂȷ΋˜ ÔÌÔÈÔÛÙ·Û›·˜, ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 208-24.
3563. ∫∞Δ™π∫∏ ¡, ∫∞ƒ∞ª∏Δ™O™ ¢£. ƒ‡ıÌÈÛË ÚfiÛÏ˄˘ ÙÚÔÊ‹˜ Î·È ÂÓÂÚÁÂȷ΋˜ ÔÌÔÈÔÛÙ·Û›·˜ ÛÂ
‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 225-8.
3564. ∏§π∞¢∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢£. º·Ú̷΢ÙÈ΋
ıÂÚ·›· Ì ‰ÈÛΛ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 228-84.
3565. ∫∞ƒ∞ª∏Δ™O™ ¢£. πÛÙÔÚ›· Ù˘ ÈÓÛÔ˘Ï›Ó˘. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 284-96.
3566. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞Ú¯¤˜ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜.
™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009:
296-313.
3567. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™‡Á¯ÚÔÓ· Û¯‹Ì·Ù· Î·È Ì¤ıÔ‰ÔÈ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 313-29.
3568. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™¯ÔÏÈ·ÛÌfi˜ ÂÓÙ·ÙÈÎÔÔÈË̤Ó˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 329-34.
3569. ∫∞ƒ∞ª∏Δ™O™ ¢£. πÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙÔÓ ™¢
Ù‡Ô˘ 2. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 334-43.
3570. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞ÓıÚÒÈÓË ÈÓÛÔ˘Ï›ÓË Î·È
˘ÔÁÏ˘Î·ÈÌ›·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 343-7.
3571. ∫∞ƒ∞ª∏Δ™O™ ¢£. O ·ÛÙ·ı‹˜ ‹ ‰˘ÛÚ‡ıÌÈÛÙÔ˜
‰È·‚‹Ù˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 347-58.
3572. ∏§π∞¢∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢£. º¿Ú̷η ηÈ
‰È·‚‹Ù˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 358-78.
3573. ¶∏Δ∞ °, ª∞§§πOÀ ¡, Δ∑∏ªOÀ °. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, „˘¯ÔÏÔÁ›· Î·È ÔÈfiÙËÙ· ˙ˆ‹˜. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 378-87.
3574. ∫∞ƒ∞ª∏Δ™O™ ¢£. ÀÂÚÁÏ˘Î·ÈÌÈΤ˜ ηٷÛÙ¿ÛÂȘ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›·
Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 390-408.
3575. ª¶∞∫∞Δ™∂§O™ ™, ∫∞ƒ∞ª∏™ΔO™ ¢£. π·ÙÚÔÁÂÓ‹˜ ˘ÔÁÏ˘Î·ÈÌ›·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 408-20.
3576. ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ¢£. ÃÚfiÓȘ
‰È·‚ËÙÈΤ˜ ÂÈÏÔΤ˜ Î·È Ú‡ıÌÈÛË ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 424-30.
3577. °∂øƒ°π∞¢∏™ ¡, §∞∫∂ ™, ∫∞ƒ∞ª∏Δ™O™ ¢£.
¢È·‚ËÙÈ΋ ·ÌÊÈ‚ÏËÛÙÚÔÂȉÔ¿ıÂÈ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 430-53.
3578. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∂›‰Ú·ÛË ÙÔ˘ ‰È·‚‹ÙË ÛÙÔÓ
Ê·Îfi ÙÔ˘ ÔÊı·ÏÌÔ‡. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 453-4.
3579. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚ËÙÈ΋ ÓÂÊÚÔ¿ıÂÈ·. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 454-80.
3580. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞ÓÙÈÌÂÙÒÈÛË ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ì á∞ ÙÂÏÈÎÔ‡ ÛÙ·‰›Ô˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 480-2.
3581. μ∞™π§∂πOÀ ™, °ƒ∂∫∞™ ¢. ∏ ·ÈÌÔοı·ÚÛË ÛÙËÓ
·ÔηٿÛÙ·ÛË Ù˘ ÓÂÊÚÈ΋˜ ÏÂÈÙÔ˘ÚÁ›·˜ ‰È·‚ËÙÈÎÒÓ
·ÛıÂÓÒÓ Ì ÓÂÊÚÈ΋ ·ÓÂ¿ÚÎÂÈ· ÙÂÏÈÎÔ‡ ÛÙ·‰›Ô˘.
™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009:
482-6.
3582. £∂O¢øƒπ¢∏™ ª, μ∞ƒ°∂ª∂∑∏™ μ. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È ÂÚÈÙÔÓ·˚΋ οı·ÚÛË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 486-9.
225
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3583. ∞¡Δø¡π∞¢∏™ ∞, ∫∞ƒ∞ª∏Δ™O™ ¢£. ªÂÙ·ÌfiÛ¯Â˘ÛË ·ÁÎÚ¤·ÙÔ˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 489-97.
3584. ¢π¢∞°°∂§O™ Δ, ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚ËÙÈ΋
Ó¢ÚÔ¿ıÂÈ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 498-566.
3585. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢ÂÚÌ·ÙÈΤ˜ ÂÈÏÔΤ˜ ηÈ
·ı‹ÛÂȘ ÛÙÔÓ ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 567-71.
3586. ∏§π∞¢∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢£. O ÚfiÏÔ˜ ÙÔ˘
‰È·‚‹ÙË ÛÙËÓ ·ıËڈ̿وÛË Î·È ıÚfiÌ‚ˆÛË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 571-87.
3587. ∫∞ƒ∞ª∏Δ™O™ £¢, ∫∞ƒ∞ª∏Δ™O™ ¢£. ™ÙËı¿Á¯Ë Î·È ¤ÌÊÚ·ÁÌ· Ì˘Ôηډ›Ô˘ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 587-93.
3588. ∞¡∞™Δ∞™π∞¢∏™ ∫. ∂ÈÏÔÁ¤˜ Â·Ó·ÈÌ¿ÙˆÛ˘ ÙÔ˘
Ì˘Ôηډ›Ô˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 594-600.
3589. ∫∞ƒ∞ª∏Δ™O™ £¢. ¢È·‚ËÙÈ΋ Ì˘ÔηډÈÔ¿ıÂÈ·.
™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· ηÈ
Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009:
600-12.
3590. ∫π™∫π¡∏™ ¢, ª∂§∞™ ¡, ™∞ƒ∞Δ∑∏™ ¡. ¶ÂÚÈÊÂÚÈ΋ ·ÚÙËÚÈÔ¿ıÂÈ· οو ¿ÎÚˆÓ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 613-24.
3591. ∫∞ƒ∞ª∞¡O™ ¢, °∂ƒ∞™πªπ¢∏™ £. ΔÔ ÈÛ¯·ÈÌÈÎfi ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 624-31.
3592. Ã∞Δ∑∏ΔO§πO™ ∞, ™∞μμO¶OÀ§O™ Ã, ∫∞ƒ∞ª∏Δ™O™ ¢£. ∞ÁÁÂȷο ÂÁÎÂÊ·ÏÈο ÂÂÈÛfi‰È· ηÈ
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 631-8.
3593. ∫∞ƒ∞ª∏Δ™O™ ¢£. ŒÌÊÚ·ÁÌ· Ì˘fi˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 638-9.
226
3594. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏·ÙÈ΋ ÁÏ˘ÎÔÁÔÓ›·ÛË ÛÙÔÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 639-41.
3595. ∫O§πOÀ™∫∞™ ¢, ∫∞ƒ∞ª∏Δ™O™ ¢£. ªË ·ÏÎÔÔÏÈ΋ ÏÈ҉˘ ÓfiÛÔ˜ ÙÔ˘ ‹·ÙÔ˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 641-50.
3596. ∫∞ƒ∞ª∏Δ™O™ ¢£. §ÔÈ¤˜ ·ı‹ÛÂȘ ‹·ÙÔ˜ ηÈ
۷ί·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 650-3.
3597. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÛÙ¿, Ù¤ÓÔÓÙ˜, ·ÚıÚÒÛÂȘ
Î·È Û‡Ó‰ÂÛÌÔÈ ÛÙÔÓ ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 653-6.
3598. ¢π¢∞°°∂§O™ Δ. ∂›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ÎÈÓËÙÈÎfiÙËÙ· ÙˆÓ ·ÚıÚÒÛÂˆÓ Î·È ÛÙÔÓ
ÙÚfiÔ ‚·‰›ÛÌ·ÙÔ˜ – ‚ËÌ·ÙÈÛÌÔ‡. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 657-63.
3599. ¶∞¶∞¢O¶OÀ§OÀ º. ¢È·‚‹Ù˘, ÔÛÙÂÔfiÚˆÛË
Î·È Î·Ù¿ÁÌ·Ù·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 663-77.
3600. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚ËÙÈ΋ Ì·ÛÙÔ¿ıÂÈ·. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 677-79.
3601. ª∞ªO¶OÀ§O™ ∞, ª∞ªO¶OÀ§O™ ª, ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ‰È·‚ËÙÈ΋ ¤ÁÎ˘Ô˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 682-703.
3602. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È·‚‹Ù˘ Ù˘ ÂÁ΢ÌÔÛ‡Ó˘.
™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 704-10.
3603. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙËÓ
ÂÁ΢ÌÔÛ‡ÓË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 710-6.
3604. ∫∞ƒ∞ª∏Δ™O™ ¢£. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ÛÙ·
·È‰È¿ Î·È ÙÔ˘ ÂÊ‹‚Ô˘˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 720-49.
3605. ∞¡£πªπ¢∏™ °. O ۷ί·Ú҉˘ ‰È·‚‹Ù˘ ÛÙËÓ ÙÚ›-
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
ÙË ËÏÈΛ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 752-69.
3606. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ¿ıÏËÛË ÛÙÔÓ ‰È·‚ËÙÈÎfi
·ÛıÂÓ‹. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 772-6.
3607. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
¯ÂÈÚÔ˘ÚÁÈΤ˜ ÂÂÌ‚¿ÛÂȘ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£.
¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 780-7.
3608. ∞¡∞™Δ∞™π∞¢∏™ ∫, ∫∞ƒ∞ª∏Δ™O™ ¢£. ÃÂÈÚÔ˘ÚÁÈΤ˜ ÂÂÌ‚¿ÛÂȘ ˘fi Â͈ۈ̷ÙÈ΋ ΢ÎÏÔÊÔÚ›· Û ‰È·‚ËÙÈο ¿ÙÔÌ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 787-91.
3609. ∫∞ƒ∞ª∏Δ™O™ ¢£. ¢È¿ÊÔÚ˜ ÏÔÈÌÒÍÂȘ Û ‰È·‚ËÙÈο ¿ÙÔÌ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 794-802.
3610. °∂øƒ°∞ ™, Õƒ™O™ °. ∞ÂÈÎÔÓÈÛÙÈΤ˜ ̤ıÔ‰ÔÈ
‰È¿ÁÓˆÛ˘ Ù˘ ÔÛÙÂÔÌ˘ÂÏ›Ùȉ·˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 802-15.
3611. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÛÙÂÔÌ˘ÂÏ›Ùȉ· ÛÙÔ ‰È·‚ËÙÈÎfi fi‰È. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë
‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 816-9.
3612. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
˘¤ÚÙ·ÛË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 822-30.
3613. Ã∞Δ∑∏ΔO§πO™ ∞, ™∞μμO¶OÀ§O™ Ã, ∫∞ƒ∞ª∏Δ™O™ ¢£. £ÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘ ˘¤ÚÙ·Û˘ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜
¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·:
π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 831-48.
3614. ∫∞ƒ∞ª∏Δ™O™ ¢£. ªÂÙ·‚ÔÏÈÛÌfi˜ ÏÈȉ›ˆÓ- Ê˘ÛÈÔÏÔÁ›· Î·È Î·Ù¿Ù·ÍË ‰˘ÛÏÈȉ·ÈÌÈÒÓ. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 848-54.
3615. ∫∞ƒ∞ª∏Δ™O™ ¢£. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ ηÈ
‰˘ÛÏÈÔÚˆÙÂ˚Ó·È̛˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 855-61.
3616. Õ£ÀƒO™ μ, ∫∞ƒ∞ª∏Δ™O™ ¢£. £ÂÚ·›· Ù˘
‰˘ÛÏÈȉ·ÈÌ›·˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋
ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰.
∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 861-5.
3617. ∫∞ƒ∞ª∏Δ™O™ ¢£. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ. ™ÙÔ:
∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë
¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 865-72.
3618. ¢∞™∫∞§O¶OÀ§OÀ ∂, μ§∞ÃO°π∞¡¡∏™ ∂.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Î·È Û‡Ó‰ÚÔÌÔ ¿ÓÔÈ·˜ – ˘fiÓÔÈ·˜ ‡ÓÔ˘. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·:
£ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ
™ÈÒ΢, 2009: 873-8.
3619. ∏§π∞¢∏™ º, ∫∞ƒ∞ª∏Δ™O™ ¢£. ™·Î¯·Ú҉˘
‰È·‚‹Ù˘ Î·È Î¿ÓÈÛÌ·. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 878-84.
3620. ª∞Δπ∞∫∏™ ∞. ™ÙÔÌ·ÙÔÏÔÁÈΤ˜ ÂΉËÏÒÛÂȘ ÛÙÔÓ
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 888-93.
3621. ª∞Δπ∞∫∏™ ∞. ∏ Ô‰ÔÓÙÈ·ÙÚÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘
‰È·‚ËÙÈÎÔ‡ ·ÛıÂÓÔ‡˜. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›· Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË
ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜
∂ΉfiÛÂȘ ™ÈÒ΢, 2009: 893-6.
3622. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ÂÎ·›‰Â˘ÛË ÙÔ˘ ‰È·‚ËÙÈÎÔ‡. ™ÙÔ: ∫·Ú·Ì‹ÙÛÔ˜ ¢£. ¢È·‚ËÙÔÏÔÁ›·: £ÂˆÚ›·
Î·È Ú·ÎÙÈ΋ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË. 2Ë ¤Î‰. ∞ı‹Ó·: π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ ™ÈÒ΢,
2009: 900-10.
3623. ∫πΔ™πO™ ∞, Δƒ∞ª¶∞™ ∞. ™‡ÁÎÚÈÛË ‚Ú·¯˘ÚfiıÂÛÌˆÓ ·Û΋ÛÂˆÓ ‰È·ÊÔÚÂÙÈ΋˜ ¤ÓÙ·Û˘ Û ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ 1. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2009; 22: 15-24.
3624. ªOÀ™§∂à ∑. O ÚfiÏÔ˜ ÙˆÓ ÈÓÎÚÂÙÈÓÒÓ, ÙˆÓ ·Ó¿ÏÔÁˆÓ ÈÓÎÚÂÙÈÓÒÓ Î·È ÙˆÓ ·Ó·ÛÙÔϤˆÓ Ù˘ ‰ÈÂÙ˘ÏÂÙ›‰·Û˘ 4 ÛÙËÓ ·ıÔÊ˘ÛÈÔÏÔÁ›· Î·È ÙË ıÂÚ·¢ÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË 2. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2009; 22: 25-38.
3625. ∫Àƒπ∞∑∏™ π∞, ª∂¡¢ƒπ¡O™ ¢, ∫∞ª¶∞™ ¡π.
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘ ππ, ÂÌÌËÓfi·˘ÛË Î·È
ÔÚÌÔÓÈ΋ ˘ÔηٿÛÙ·ÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2009; 22: 39-48.
3626. °π∞μƒO¶OÀ§OÀ ª¶, μ∞º∂π∞¢OÀ ∂, ∫øΔ™∞
∫, ∞¡∞™Δ∞™πOÀ O, ∫∞∑∞∫O™ ∫, ∫O∫∫∞ƒ∞∫∏ °, ∫OÀ∫OÀμπΔ∏™ ∞, ∞°°OÀƒπ¢∞∫∏ Ã,
°πøμO™ π°. OÈ ÌÂÙ·‚ÔϤ˜ ÛÙÔ˘˜ ‰Â›ÎÙ˜ ÔÛÙÈÎÔ‡ ÌÂÙ·‚ÔÏÈÛÌÔ‡ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ ÌÂÙ¿ ¯ÔÚ‹ÁËÛË
ÈÔÁÏÈÙ·˙fiÓ˘ ÁÈ· 16 ‚‰ÔÌ¿‰Â˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 49-54.
227
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
3627. ∫∞ƒ∞Δ∑π¢OÀ ∫., ¶∞™O°§OÀ μ., ¶∞™Ã∞§π¢OÀ ∂., ∫∞ƒ∞°π∞¡¡∏™ π. Δ™∞∫πƒ∏ ∫., Ãπ™™∞¡
™., ¢ƒ∞¶∞ μ., ¶∞°∫∞§O™ ∂. ¶ÂÚ›ÙˆÛË Ó¢ÌÔÌÂÛÔÓ¢ÌÔÓ›Ô˘ Û ‰È·‚ËÙÈ΋ ÎÂÙÔͤˆÛË. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2009; 22: 55-8.
3628. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ÈÛÙÔÚ›· Ù˘ ·Ó·Î¿Ï˘„˘
Ù˘ ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 8593.
3629. ∫∞¡Δ∞ƒΔ∑∏™ ∫. ªÔÚÈ·ÎÔ› Ì˯·ÓÈÛÌÔ› ¤ÎÎÚÈÛ˘
ÈÓÛÔ˘Ï›Ó˘ ·fi ÙÔ ‚-·ÙÙ·ÚÔ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2009; 22: 94-7.
3630. °πøμO™ π. O ÚfiÏÔ˜ ÙˆÓ ·-, ‰- Î·È pp ΢ÙÙ¿ÚˆÓ ÛÙËÓ
¤ÎÎÚÈÛË Î·È ‰Ú¿ÛË Ù˘ ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2009; 22: 98-9.
3631. ∫∞∑∞∫O™ ∫. º·ÈÓfiÌÂÓÔ ÈÓÎÚÂÙ›Ó˘. ¢Ú¿ÛÂȘ
GLP-1, GIP, DPP4. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22:
102-7.
3632. ª¶∂¡ƒOÀª¶∏ ª. ∂Î·›‰Â˘ÛË ÛÙËÓ πÓÛÔ˘ÏÈÓÔıÂÚ·›·. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 112-4.
3633. ™OÀ§∏™ ∫. ª¤ıÔ‰ÔÈ ÂÎÙ›ÌËÛ˘ ÈÓÛÔ˘ÏÈÓÔ¢·ÈÛıËÛ›·˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 115-21.
3634. ¢∏ª∏Δƒπ∞¢∏™ °, ª∏ΔƒOÀ ¶, ƒ∞¶Δ∏™ ™∞.
¢Ú¿ÛË ÈÓÛÔ˘Ï›Ó˘ ÛÂ Ì˘˚Îfi Î·È ÏÈÒ‰Ë ÈÛÙfi. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2009; 22: 122-4.
3635. ¢π¢∞°°∂§O™ Δ¶. ∞ÓÙϛ˜ πÓÛÔ˘Ï›Ó˘ Û ∂Ó‹ÏÈΘ. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 127-31.
3636. °∂ƒ∞™πªπ¢∏-μ∞∑∞πOÀ ∞. ™˘Ó¯‹˜ ηٷÁÚ·Ê‹
ÁÏ˘Îfi˙˘ ·›Ì·ÙÔ˜ (CGMS). ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2009; 22: 132-3.
3637. °∞§§∏-Δ™π¡O¶OÀ§OÀ ∞. πÓÛÔ˘ÏÈÓÔıÂÚ·›·
ÛÙ· ·È‰È¿ Î·È ÛÙÔ˘˜ ÂÊ‹‚Ô˘˜. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο
2009; 22: 134-7.
3638. ∫Oƒ¢O¡OÀƒ∏ O. ∞ÓÙϛ˜ ÈÓÛÔ˘Ï›Ó˘ Û ·È‰È¿.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 138-9.
3639. ∫OÀƒΔO°§OÀ °π. πÓÛÔ˘ÏÈÓÔıÂÚ·›· Î·È ¿ÛÎËÛË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 140-2.
3640. ∫∞ƒ∞Δ∑π¢OÀ ∫. πÓÛÔ˘ÏÈÓÔıÂÚ·›· ÛÙÔ ÓÔÛÔÎÔÌ›Ô. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 143-9.
3641. ∏§π∞¢∏™ º. πÓÛÔ˘Ï›ÓË Î·È Î·Ú‰È¿. ∂ÏÏËÓ. ¢È·‚.
ÃÚÔÓÈο 2009; 22: 150-2.
3642. ª∏Δƒ∞∫OÀ ∞. πÓÛÔ˘Ï›ÓË Î·È ¡ÂÊÚfi˜. ∂ÏÏËÓ.
¢È·‚. ÃÚÔÓÈο 2009; 22: 153-5.
3643. ª¶∞∫∞Δ™∂§O™ ™. ∞ÓÂ›ÁÓˆÛÙË ˘ÔÁÏ˘Î·ÈÌ›·.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 156-61.
3644. ¶∞°∫∞§O™ ∂ª. ™˘Ó‰˘·ÛÌÔ› ÈÓÛÔ˘Ï›Ó˘ – ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ Û ™¢Δ2. ¶fiÙ – ˆ˜ – ÁÈ·Ù›.
∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 162-3.
3645. ªÀ°¢∞§∏™ ∏¡. ™¯‹Ì·Ù· ·Ó·ÏfiÁˆÓ ¤Ó·ÓÙÈ Û¯ËÌ¿ÙˆÓ ·ÓıÚˆ›ÓÔ˘ Ù‡Ô˘ ÈÓÛÔ˘Ï›Ó˘ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 164-5.
3646. ∫∞ƒ∞ª∏Δ™O™ ¢£. AÓÙÈ·ıËڈ̷ÙÈΤ˜ ȉÈfiÙËÙ˜
Ù˘ ÈÓÛÔ˘Ï›Ó˘. ∂ÏÏËÓ. ¢È·‚. ÃÚÔÓÈο 2009; 22: 1669.
3647. KORDONOURI O, HARTMANN R. Higher body
228
weight is associated with earlier onset of Type 1 diabetes in children: confirming the “Accelerator Hypothesis”. Diabet Med 2005; 22: 1783-4.
3648. DANNE T, BATTELINO T, KORDONOURI O,
HANAS R, KLINKERT C, LUDVIGSSON J, BARRIO R, AEBI C, GSCHWEND S, MULLIS PE,
SCHUMACHER U, ZUMSTEG U, MORANDI A,
RABBONE I, CHERUBINI V, TONI S, DE BEAUFORT C, HINDMARSH P, SUMNER A, VAN
WAARDE WM, VAN DEN BERG N, PHILLIP M.
A cross-sectional international survey of continuous
subcutaneous insulin infusion in 377 children and
adolescents with type 1 diabetes mellitus from 10
countries. Pediatr Diabetes 2005; 6: 193-8.
3649. KORDONOURI O, HARTMANN R, LAUTERBORN R, BARNEKOW C, HOEFFE J, DEISS D.
Age-specific advantages of continuous subcutaneous
insulin infusion as compared with multiple daily injections in pediatric patients: One-year follow-up comparison by matched-pair analysis. Diabetes Care 2006;
29: 133-4.
3650. SCHAEFER-GRAF UM, PAWLICZAK J, PASSOW D, HARTMANN R, ROSSI R, BÜHRER C,
HARDER T, PLAGEMANN A, VETTER K, KORDONOURI O. Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 2005; 28: 1745-50.
3651. KORDONOURI O, HARTMANN R, DEISS D,
WILMS M, GRÜTERS-KIESLICH A. Natural
course of autoimmune thyroiditis in type 1 diabetes:
association with gender, age, diabetes duration, and
puberty. Arch Dis Child 2005; 90: 411-4.
3652. KASPERS S, KORDONOURI O, SCHOBER E,
GRABERT M, HAUFFA BP, HOLL RW; GERMAN WORKING GROUP FOR PEDIATRIC
DIABETOLOGY. Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with
celiac disease: A multicenter survey. J Pediatr 2004;
145: 790-5.
3653. DEISS D, HARTMANN R, HOEFFE J, KORDONOURI O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with
type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 2004; 5: 117-21.
3654. KORDONOURI O, MEYER K, EGERER K,
HARTMANN R, SCHEFFLER S, BURMESTER
GR, KUCKELKORN U, DANNE T, FEIST E.
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis. J Pediatr Endocrinol Metab 2004; 17: 975-81.
3655. LANGE K, DANNE T, KORDONOURI O,
BERNDT V, MÜLLER B, SCHWARZ HP, HESSE
V, BUSSE-WIDMANN P. Diabetes in childhood:
everyday burden and professional consequences for
parents. Dtsch Med Wochenschr 2004; 129: 1130-4.
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
3656. KORDONOURI O, DANNE T. Diabetes-associated autoimmune disease in children and juveniles:
How important is early recognition? Dtsch Med
Wochenschr 2004; 129: 1145-8.
3657. BHATIA E, BALASUBRAMANIUM K, RAJESWARI J, KORDONOURI O, WITT H, LANDT O,
SIMON P, LERCH MM. Absence of association between SPINK1 trypsin inhibitor mutations and Type 1
or 2 diabetes mellitus in India and Germany. Diabetologia; 46: 1710-1.
3658. DONAGHUE KC, KORDONOURI O, CHAN A,
SILINK M. Secular trends in growth in diabetes: Are
we winning? Arch Dis Child 2003; 88: 151-4.
3659. KORDONOURI O, LAUTERBORN R, DEISS D.
Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care 2002; 25: 634.
3660. ª∂§π¢ø¡∏™ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜:
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
2007: 821 ÛÂÏ.
3661 ª∂§π¢ø¡∏™ ∞. ∏ Û˘ÓÙËÚËÙÈ΋ ·ÓÙÈÌÂÙÒÈÛË Ù˘
·¯˘Û·ÚΛ·˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘
‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘,
ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 269-88.
3662. ∏ƒ∞∫§∂π∞¡OÀ ™, ™∞º§π∞¡∏™ π. ¢È·‚ËÙÈ΋
‰˘ÛÏÈȉ·ÈÌ›·. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ
Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2007: 445-68.
3663. ª∂§π¢ø¡∏™ ∞. ∏ Â›‰Ú·ÛË ÙÔ˘ ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË ÛÙËÓ ·ıÔÁ¤ÓÂÛË Ù˘ ·ıËڈ̿وÛ˘. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 47186.
3664. ∏ƒ∞∫§∂π∞¡OÀ ™. ¢È·Ù·Ú·¯‹ ·ÓÔ¯‹˜ ÁÏ˘Îfi˙˘
(IGT). ™˘Ó‰¤ÂÙ·È Ì ·˘ÍË̤ÓÔ Î·Ú‰È·ÁÁÂÈ·Îfi ΛӉ˘ÓÔ; À¿Ú¯Ô˘Ó ‰˘Ó·ÙfiÙËÙ˜ ·Ú¤Ì‚·Û˘ ÁÈ· ÙËÓ ÚfiÏË„Ë ÙÔ˘ ‰È·‚‹ÙË Ù‡Ô˘ ππ; ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘,
ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 487-500.
3665. ª∂§π¢ø¡∏™ ∞. ªÂÙ·ÁÂ˘Ì·ÙÈ΋ ˘ÂÚÁÏ˘Î·ÈÌ›·
Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ™ÙÔ: ªÂÏȉÒÓ˘ ∞.
∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 501-13.
3666. ¢π¢∞°°∂§O™ Δ¶. ∏ Ó¢ÚÔ¿ıÂÈ· ÙÔ˘ ·˘ÙfiÓÔÌÔ˘
Ó¢ÚÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ÙÔ˘ ηډȷÁÁÂÈ·ÎÔ‡ ÛÙÔÓ Û·Î-
¯·ÚÒ‰Ë ‰È·‚‹ÙË Î·È Ë Û˘Ì‚ÔÏ‹ Ù˘ ÛÙÔÓ ·˘ÍË̤ÓÔ
ηډȷÁÁÂÈ·Îfi ΛӉ˘ÓÔ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi
Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜
∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 515-34.
3667. ª∂§π¢ø¡∏™ ∞. ∏ ÛÙÂÊ·ÓÈ·›· ÓfiÛÔ˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ∂ȉËÌÈÔÏÔÁÈο, ÎÏÈÓÈο ‰Â‰Ô̤ӷ. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘
‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘,
ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 535-56.
3668. ª∂§π¢ø¡∏™ ∞. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, Ì˘ÔηډÈÔ¿ıÂÈ· Î·È Î·Ú‰È·Î‹ ·ÓÂ¿ÚÎÂÈ·. ∏ Û˘Ì‚ÔÏ‹˜
Ù˘ ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·Û˘. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘,
ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 557-77.
3669. ¶∞°∫∞§O™ ∂. £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ ÛÙËÓ
·ıËÚÔÛÎÏ‹ÚˆÛË ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 579-89.
3670. ∫Àƒπ∞∑∏™ π, ªÀΔ∞™ ¢. £ÂÚ·›· ÔÚÌÔÓÈ΋˜
˘ÔηٿÛÙ·Û˘ ÛÙË ‰È·‚ËÙÈ΋ ÌÂÙÂÌÌËÓÔ·˘Ûȷ΋
Á˘Ó·›Î· Î·È Î·Ú‰È·ÁÁÂÈ·Îfi˜ ΛӉ˘ÓÔ˜. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘
‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘,
ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·:
∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 591-627.
3671. ™Δ∂º∞¡π¢∏™ ∞, ºOÀ™∞™ ™. O ÚfiÏÔ˜ Ù˘ ÈÓÛÔ˘ÏÈÓÔıÂÚ·›·˜ ηٿ ÙË ‰È¿ÚÎÂÈ· ÔͤˆÓ ÛÙÂÊ·ÓÈ·›ˆÓ
Û˘Ó‰ÚfiÌˆÓ Î·È ÂÂÌ‚¿ÛÂˆÓ Â·Ó·ÁÁ›ˆÛ˘ ‰È·‚ËÙÈÎÒÓ ·ÛıÂÓÒÓ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ
Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2007: 629-59.
3672. ∫∞∑∞∫O™ ∫. ™‡Á¯ÚÔÓ˜ ·fi„ÂȘ ÁÈ· ÙË ¯ÔÚ‹ÁËÛË
·ÓÙÈ·ÈÌÔÂÙ·Ïȷ΋˜ ·ÁˆÁ‹˜ ÛÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜:
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
2007: 661-88.
3673. ΔO§∏™ ∞μ, ºπ§π¶¶π¢∏™ º. ∏ ·Ó·ÁηÈfiÙËÙ·
ÙÔ˘ ηÏÔ‡ ÁÏ˘Î·ÈÌÈÎÔ‡ ÂϤÁ¯Ô˘ Î·È Ë ÔÚıÔÏÔÁÈ΋
¯Ú‹ÛË ÙˆÓ ·ÓÙȉȷ‚ËÙÈÎÒÓ ‰ÈÛΛˆÓ. ™ÙÔ: ªÂÏȉÒÓ˘
∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 689-721.
3674. ª∂§π¢ø¡∏™ ∞. πÓÎÚÂÙÈÓÔÌÈÌËÙÈο Î·È DPPIV
229
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
·Ó·ÛÙÔÏ›˜: OÈ Ó¤Â˜ ıÂÚ·›˜ ÁÈ· ÙÔÓ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË Ù‡Ô˘ ππ. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ
Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ
¶·ÚÈÛÈ¿ÓÔ˘, 2007: 723-40.
3675. ª∂§π¢ø¡∏™ ∞. ∂ÈÛÓÂfiÌÂÓË ÈÓÛÔ˘Ï›ÓË: Δ· ‰Â‰Ô̤ӷ, Ë ·ÔÙÂÏÂÛÌ·ÙÈÎfiÙËÙ· Î·È ÔÈ ÚÔ‚ÏËÌ·ÙÈÛÌÔ›. ™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 741-56.
3676. ∞§∂•∞¡¢ƒπ¢∏™ £. ∞ÓÙ›ÛÙ·ÛË ÛÙËÓ ÈÓÛÔ˘Ï›ÓË:
ªÔÚÈ·ÎÔ› Ì˯·ÓÈÛÌÔ›, ۷ί·Ú҉˘ ‰È·‚‹Ù˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ, ·ıËÚÔÛÎÏ‹Ú˘ÓÛË. ™ÙÔ: ªÂÏȉÒÓ˘
∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘, 2007: 759-93.
3677. §Àª¶∂ƒO¶OÀ§O™ ∂¡, ∂§π™∞º ª™. ªÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ – ™‡Ó‰ÚÔÌÔ ÈÓÛÔ˘ÏÈÓÔ·ÓÙ›ÛÙ·Û˘.
¢È·ÁÓˆÛÙÈο ÎÚÈÙ‹ÚÈ· – £ÂÚ·¢ÙÈΤ˜ ·ÚÂÌ‚¿ÛÂȘ.
™ÙÔ: ªÂÏȉÒÓ˘ ∞. ∫·Ú‰ÈÔÌÂÙ·‚ÔÏÈÎfi˜ ΛӉ˘ÓÔ˜:
™·Î¯·Ú҉˘ ‰È·‚‹Ù˘, ηډÈÔÌÂÙ·‚ÔÏÈÎÔ› ·Ú¿ÁÔÓÙ˜ ÎÈÓ‰‡ÓÔ˘, ÌÂÙ·‚ÔÏÈÎfi Û‡Ó‰ÚÔÌÔ Î·È ·ıËڈ̿وÛË. ∞ı‹Ó·: ∂ÈÛÙËÌÔÓÈΤ˜ ∂ΉfiÛÂȘ ¶·ÚÈÛÈ¿ÓÔ˘,
2007: 795-831.
3678. ª∞¡OÀ™∞∫∏™ °∂. ™˘ÌÏËÚÒÌ·Ù· ‰È·ÙÚÔÊ‹˜
ÁÈ· ·ıÔÏÔÁÈΤ˜ ηٷÛÙ¿ÛÂȘ: ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘. ™ÙÔ: ª·ÓÔ˘Û¿Î˘ °∂. ™˘ÌÏËÚÒÌ·Ù· ‰È·ÙÚÔÊ‹˜: ŸÏ· fiÛ· Ú¤ÂÈ Ó· ͤÚÂÙÂ. £ÂÛÛ·ÏÔÓ›ÎË, 2008:
271-3.
3679. ∫∞ƒ∞ª∏Δ™O™ ¢£. ∏ ‰È·‚ËÙÔÏÔÁ›· ÛÙËÓ £ÂÛÛ·ÏÔÓ›ÎË. ™ÙÔ: ¶Ú·ÎÙÈο 1Ô˘ ÂÈÛÙËÌÔÓÈÎÔ‡ Û˘Ó‰ڛԢ,
£ÂÛÛ·ÏÔÓ›ÎË 10-11 ¢ÂÎÂÌ‚Ú›Ô˘ 2004. ∏ ÈÛÙÔÚ›· Ù˘
È·ÙÚÈ΋˜ ÛÙËÓ fiÏË Ù˘ £ÂÛÛ·ÏÔӛ΢: £ÂÛÌÔ›, Ú·ÎÙÈΤ˜ Î·È ÚfiÛˆ· ·fi ÙÔÓ ¯ÒÚÔ Ù˘ ˘Á›·˜. £ÂÛÛ·ÏÔÓ›ÎË, 2006: 198-205.
3680. ∫∞ƒ∞ª∏Δ™O™ ¢£. OÍ›˜ ‰È·Ù·Ú·¯¤˜ ÙÔ˘ ÌÂÙ·‚ÔÏÈÛÌÔ‡ ÙÔ˘ ۷ί¿ÚÔ˘ ÛÙË ª.∂.£. ™ÙÔ: ª·Ù¿Ì˘ ¢,
°È·ÓÓ¿ÎÔ˘ - ¶ÂÊÙÔ˘Ï›‰Ô˘ ª. 9Ô ÌÂÙÂÎ·È‰Â˘ÙÈÎfi ÛÂÌÈÓ¿ÚÈÔ ·Ó·ÈÛıËÛÈÔÏÔÁ›·˜ Î·È ÂÓÙ·ÙÈ΋˜ ıÂÚ·›·˜,
£ÂÛÛ·ÏÔÓ›ÎË 24-25 ¡ÔÂÌ‚Ú›Ô˘ 2001: 95-9.
3681. STERGIOU GS, ALAMARA C, DRAKATOS A,
STEFANIDIS CJ, VAZEOU A. Prediction of albuminuria by different blood pressure measurement
methods in type 1 diabetes: A pilot study. Hypertens
Res 2009. [Epub ahead of print].
3682. HERMANN R, BARTSOCAS CS, SOLTÉSZ G,
VAZEOU A, PASCHOU P, BOZAS E, MALAMITSI-PUCHNER A, SIMELL O, KNIP M, ILONEN
J. Genetic screening for individuals at high risk for
type 1 diabetes in the general population using HLA
Class II alleles as disease markers. A comparison between three European populations with variable rates
230
of disease incidence. Diabetes Metab Res Rev 2004;
20: 322-9.
3683. VAZEOU A, PAPADOPOULOU A, BOOTH IW,
BARTSOCAS CS. Prevalence of gastrointestinal
symptoms in children and adolescents with type 1 diabetes. Diabetes Care 2001; 24: 962-4.
3684. DE ROOIJ S, DEKKER J, KOZAKOVA M, MITRAKOU A, MELANDER O, GABRIEL R, GUIDONE C, HOJLUND K, MURPHY M, NIJPELS G.
Fasting insulin has a stronger association with an adverse cardio-metabolic risk profile than insulin resistance: The RISC study. Eur J Endocrinol 2009 [Epub
ahead of print].
3685. EMERSON P, VAN HAEFTEN TW, PIMENTA
W, PLUMMER E, WOERLE HJ, MITRAKOU A,
SZOKE E, GERICH J, MEYER C. Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus. Metabolism 2009; 58: 602-7.
3686. GASTALDELLI A, KOZAKOVA M, HOJLUND
K, FLYVBJERG A, FAVUZZI A, MITRAKOU A,
BALKAU B; RISC INVESTIGATORS. Fatty liver is
associated with insulin resistance, risk of coronary
heart disease, and early atherosclerosis in a large
European population. Hepatology 2009; 49: 1537-44.
3687. MUSCELLI E, KOZÀKOVÀ M, FLYVBJERG A,
KYRIAKOPOULOU K, ASTIARRAGA BD,
GLINTBORG D, KONRAD T, FAVUZZI A,
PETRIE J; RISC INVESTIGATORS (INVESTIGATORS – GREECE: MITRAKOU A, TOURNIS S,
KYRIAKOPOULOU K, THOMAKOS P). The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy
women. Am J Hypertens. 2009; 22: 364-70.
3688. KOZAKOVA M, PALOMBO C, PATERNI M,
ANDERWALD CH, KONRAD T, COLGAN MP,
FLYVBJERG A, DEKKER J; RELATIONSHIP
BETWEEN INSULIN SENSITIVITY CARDIOVASCULAR RISK INVESTIGATORS (INVESTIGATORS – GREECE: MITRAKOU A, TOURNIS S,
KYRIAKOPOULOU K, THOMAKOS P). Body
composition and common carotid artery remodeling
in a healthy population. J Clin Endocrinol Metab.
2008; 93: 3325-32.
3689. CHATZINIKOLAOU A, FATOUROS I, PETRIDOU A, JAMURTAS A, AVLONITI A, DOUROUDOS I, MASTORAKOS G, LAZAROPOULOU C,
PAPASSOTIRIOU I, TOURNIS S, MITRAKOU A,
MOUGIOS V. Adipose tissue lipolysis is upregulated
in lean and obese men during acute resistance exercise. Diabetes Care 2008; 31: 1397-9.
3690. HAINER V, TOPLAK H, MITRAKOU A. Treatment modalities of obesity: What fits whom? Diabetes
Care. 2008; 31 (Suppl 2): S269- S77.
3691. BONNET F, PATEL S, LAVILLE M, BALKAU B,
FAVUZZI A, MONTI LD, LALIC N, WALKER M;
EÏÏËÓÈο ¢È·‚ËÙÔÏÔÁÈο XÚÔÓÈο
EUROPEAN GROUP FOR THE STUDY OF
INSULIN RESISTANCE RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND CARDIOVASCULAR DISEASE RISK STUDY GROUP
(INVESTIGATORS – GREECE: MITRAKOU A,
TOURNIS S, KYRIAKOPOULOU K, THOMAKOS P). Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired
glucose tolerance in healthy subjects. Diabetes Care
2008; 31: 789-94.
3692. SZOKE E, SHRAYYEF MZ, MESSING S,
WOERLE HJ, VAN HAEFTEN TW, MEYER C,
MITRAKOU A, PIMENTA W, GERICH JE. Effect
of aging on glucose homeostasis: Accelerated deterioration of beta-cell function in individuals with impaired
glucose tolerance. Diabetes Care 2008; 31: 539-43.
3693. FERRANNINI E, MUSCELLI E, NATALI A,
GABRIEL R, MITRAKOU A, FLYVBJERG A,
GOLAY A, HOJLUND K; RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND CARDIOVASCULAR DISEASE RISK (RISC) PROJECT
INVESTIGATORS. Association of fasting glucagon
and proinsulin concentrations with insulin resistance.
Diabetologia 2007; 50: 2342-7.
3694. MARGONIS K, FATOUROS IG, JAMURTAS
AZ, NIKOLAIDIS MG, DOUROUDOS I, CHATZINIKOLAOU A, MITRAKOU A, MASTORAKOS G, PAPASSOTIRIOU I, TAXILDARIS K,
KOURETAS D. Oxidative stress biomarkers responses to physical overtraining: Implications for diagnosis.
Free Radic Biol Med 2007; 43: 901-10.
3695. TOURNIS S, MITRAKOU A. The effects of calcium and vitamin D supplementation on blood glucose
and markers of inflammation in nondiabetic adults:
Response to Pittas et al. Diabetes Care 2007; 30: e81.
3696. MITRAKOU A. Women’s health and the metabolic
syndrome. Ann N Y Acad Sci 2006; 1092: 33-48.
3697. PETRIDOU A, CHATZINIKOLAOU A, FATOUROS I, MASTORAKOS G, MITRAKOU A, CHANDRINOU H, PAPASSOTIRIOU I, MOUGIOS V.
Resistance exercise does not affect the serum concentrations of cell adhesion molecules. Br J Sports Med
2007; 41: 76-9.
3698. MEYER C, PIMENTA W, WOERLE HJ, VAN
HAEFTEN T, SZOKE E, MITRAKOU A, GERICH
J. Different mechanisms for impaired fasting glucose
and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29: 1909-14.
3699. FATOUROS IG, DESTOUNI A, MARGONIS K,
JAMURTAS AZ, VRETTOU C, KOURETAS D,
MASTORAKOS G, MITRAKOU A, TAXILDARIS
K, KANAVAKIS E, PAPASSOTIRIOU I. Cell-free
plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining. Clin
Chem 2006; 52: 1820-4.
3700. FATOUROS IG, TOURNIS S, LEONTSINI D,
JAMURTAS AZ, SXINA M, THOMAKOS P, MANOUSAKI M, DOUROUDOS I, TAXILDARIS K,
MITRAKOU A. Leptin and adiponectin responses in
overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 2005; 90: 5970-7.
3701. MEYER C, TOLIAS A, PLATANISIOTIS D,
STUMVOLL M, VLACHOS L, MITRAKOU A. Increased renal glucose metabolism in Type 1 diabetes
mellitus. Diabet Med. 2005; 22: 453-9.
3702. WOERLE HJ, PIMENTA WP, MEYER C, GOSMANOV NR, SZOKE E, SZOMBATHY T, MITRAKOU A, GERICH JE. Diagnostic and therapeutic implications of relationships between fasting, 2hour postchallenge plasma glucose and hemoglobin
a1c values. Arch Intern Med 2004; 164: 1627-32.
3703. VAN HAEFTEN TW, PIMENTA W, MITRAKOU
A, KORYTKOWSKI M, JENSSEN T, YKI-JARVINEN H, GERICH JE. Disturbances in beta-cell
function in impaired fasting glycemia. Diabetes; 51
(Suppl 1): S265- S70.
3704. HOME PD, POCOCK SJ, BECK-NIELSEN H,
CURTIS PS, GOMIS R, HANEFELD M, JONES
NP, KOMAJDA M, MCMURRAY JJ; RECORD
STUDY TEAM (INVESTIGATORS – GREECE:
RAPTIS S, PAGKALOS E, PAPPAS S, FRAGKOULIA A, KATSILAMBROS N, MELIDONIS A, PIADITIS G, ZOUPAS C, SOULIS K, VAGENAKIS A,
MAKRIYANNIS D, KALDRIMIDIS P, MIGDALIS
I). Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2
diabetes (RECORD): A multicentre, randomised,
open-label trial. Lancet 2009; 373: 2125-35.
3705. ∫∞§¢ƒÀªπ¢∏™ º. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘ Ù‡Ô˘
ππ: ¶ÚÔ‚ÏËÌ·ÙÈÛÌÔ› ÛÙËÓ Ú¿ÍË. ∞ı‹Ó·, 1992: 176
ÛÂÏ.
3706. ΔOY¡Δ∞™ â. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: £ÂˆÚ›·Ú¿ÍË. 2Ë ¤Î‰. ∞ı‹Ó·, 2003; 2 ÙfiÌÔÈ.
3707. ™∫OÀΔ∞™ ¢. ™·Î¯·Ú҉˘ ‰È·‚‹Ù˘: ¡Â˘ÚÔ·ıËÙÈο Î·È ÈÛ¯·ÈÌÈο ¤ÏÎË Î¿Ùˆ ¿ÎÚˆÓ. ¶·ıÔÁ¤ÓÂÈ· Û˘Ì‚ÔÏ‹ ÛÙËÓ ·ÓÙÈÌÂÙÒÈÛË Î·È ÂͤÏÈÍË. π·ÙÚÈ΋
™¯ÔÏ‹ ¢¶£, 2009. ¢È‰·ÎÙÔÚÈ΋ ¢È·ÙÚÈ‚‹.
3708. ªÀ°¢∞§∏™ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙË ‰ÈÂÚ‡ÓËÛË Î·È
·ÓÙÈÌÂÙÒÈÛË ÙÔ˘ ۷ί·ÚÒ‰Ô˘˜ ‰È·‚‹ÙË. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2000: 303 ÛÂÏ.
3709. ªÀ°¢∞§∏™ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2002. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002:
340 ÛÂÏ.
3710. ªÀ°¢∞§∏™ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2004. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2004:
342 ÛÂÏ.
3711. ªÀ°¢∞§∏™ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
‰È·‚‹ÙË 2006. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2006:
350 ÛÂÏ.
3712. ªÀ°¢∞§∏™ ∏¡. ™ÙÚ·ÙËÁÈΤ˜ ÛÙÔ Û·Î¯·ÚÒ‰Ë
231
ªËÙÚÒÔ ∂ÚÁ·ÛÈÒÓ
‰È·‚‹ÙË 2008. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2008:
450 ÛÂÏ.
3713. ªÀ°¢∞§∏™ ∏¡. ΔÔ ¢È·‚ËÙÈÎfi ¶fi‰È. ∞ı‹Ó·: ∑‹Ù· π·ÙÚÈΤ˜ ∂ΉfiÛÂȘ, 2002: 270 ÛÂÏ.
3714. KARAGIANNI P, SAMPANIS CH, KATSOULIS
CH, MISERLIS G, POLYZOS S, ZOGRAFOU I,
STERGIOPOULOS S, DOULOUMBAKAS I,
ZAMBOULIS CH. Continuous subcutaneous insulin
infusion versus multiple daily injections. Hippokratia
2009; 13: 93-6.
3715. DOUMA S, PETIDIS K, KARTALI N, MAHERA
K, SABANIS C, ZAMBOULIS C. Pheochromocytoma presenting as diabetic ketoacidosis. J Diabetes
Complications 2008; 22: 295-6.
3716. ªOÀ™§∂à Δ, ∂À™Δƒ∞ΔπOY ∂. πÓÛÔ˘ÏÈÓÔıÂÚ·›· & ÌÂÛÔÁÂȷ΋ ‰È·ÙÚÔÊ‹ ÛÙËÓ Î·ıËÌÂÚÈÓ‹ Ú¿ÍË.
£ÂÛÛ·ÏÔÓ›ÎË: μ·ÚıÔÏÔÌ·›Ô˜-°Ú¿ÌÌ·, 2008: 303 ÛÂÏ.
3717. ANASTASIADIS KH, KARAMITSOS DT. Diabetes mellitus and coronary artery bypass. Hellenic J
Cardiol 2003; 44: 408-17
3718. ∞§∂•π∞¢∏™ ∞¢, Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OY
∞¡, ¶∞¶∞∑O°§OÀ ¡. ∂͈ÙÂÚÈο ¢È·‚ËÙÔÏÔÁÈο
232
π·ÙÚ›·. π·ÙÚÈÎfi μ‹Ì· 1991; 21: 50-3.
3719. ∞§∂•π∞¢∏™ ∞¢, Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OY
∞¡. ∂ıÓÈÎfi ¢›ÎÙ˘Ô ÀÁ›·˜ ÁÈ· ÙÔÓ Û·Î¯·ÚÒ‰Ë ‰È·‚‹ÙË. π·ÙÚÈÎfi μ‹Ì· 1999; 63: 28-32.
3720. Δ™π¶Δ™πO™ π, ºøΔπOÀ ¢, Δ™π¶Δ™πO™ ¢, ™πΔ™O°§OÀ ∫, ¶∞¶∞¡π∫O§∞OY ∞, μ§∞ÃO°π∞¡¡∏™ ∂, Ã∞ª∞§π¢OÀ-∞§∂•π∞¢OÀ ∞¡,
™∞ªOYH§π¢∏™ π, °π∞¡Δ™∂§π¢∏™ Ã, ºøΔπOÀ
º. ∂ÎÙ›ÌËÛË ÙÔ˘ ÎÂÓÙÚÈÎÔ‡ Î·È ÂÚÈÊÂÚÈÎÔ‡ ¯ÚfiÓÔ˘
·ÁˆÁ‹˜ ÛÙÔ˘˜ ·ÛıÂÓ›˜ Ì ۷ί·ÚÒ‰Ë ‰È·‚‹ÙË Ù‡Ô˘ ππ. ¡Â˘ÚÔÏÔÁ›· 2004; 13: (ÛÂÏ. ?).
3721. CHAMALIDOY - ALEXIADOY AN. Social and financial problems of the diapetic patients. Actual
Nephrology 2005; 5: 14-5.
3722. μ∞∑∞πOÀ ∞. O‰ËÁfi˜ ¢È·ÙÚÔ‚‹˜ ÁÈ· ÙË Ú‡ıÌÈÛË
ÙÔ˘ ‰È·‚‹ÙË. ∞ı‹Ó·: ∂ÏÏËÓÈ΋ ¢È·‚ËÙÔÏÔÁÈ΋ ∂Ù·ÈÚ›·, 2008: 208 ÛÂÏ.
3723. SKOUTAS D, PAPANAS N, GEORGIADIS GS,
ZERVAS V, MANES C, MALTEZOS E, LAZARIDES MK. Risk factors for ipsilateral reamputation in
patients with diabetic foot lesions. Int J Low Extrem
Wounds 2009; 8: 69-74.